Citrus Sinensis ID: 008374

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------57
Protein Sequence
MWRDPRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEKDWKWLVISAGVGVPLVAVLLVLCAIAYVKKRRSRVAEPHHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPAFTWPSTSPPISMFDSILSSITLSSPGSG
Secondary Structure (PSIPRED)
ccccccccccccccEEEEEEccccccccccccccccccccccccccccccEEEEEEEcccccccccccccEEEEcccEEcccccccccccccccccccEEEEEEEEccccEEEEEEEEccccccccccEEEEEcccccccccEEEEEEEEcccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEcHHHHHHHHcccccccccccccccEEEEEEEcccccccccccEEEEEEcccccccHHHHHHHHHHHHHcccccccccccEEEccccEEEEEEEccccccHHHHcccccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEccccccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccEEEHHHcccccccccccccccccHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHccccccccccccHHHHHHHHcccccccccccccccEEcccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccEEEEEEEccccccccccHHHHEEEEEcccccccccEcEEEEEEcccccccccccEEEEEEccccccEEEEccccccEEEcccccEEEEEEEccccEEEEEEEcccccccccccEEEEEEccHHHccccEEEEEEcccccEcccEEEEEEEEEccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHcccccccccccccccEEEEcEccccccccccccEEEEEEEccccHccHHHHHHHHHHHHHHHHHHHHHHHHHHcccccEEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEcccccccHcccccccccccccEEEEEcHHHccHHHHHccccccccHHHHHHHHHHHHHcccccccccccccccEEEHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccccccccHccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mwrdprpawdisghglafviapndsfppessygqwlgltnaftdgnkanhfvaiefdtvkqgfdpddnhlglninsvvsrknvplkdnynitlsdgtsYTVWVQYDGKSKLIQVFMdregetmpqkpllketinlkdylkpesyfgfsastgyphiqlncvrswtlDIDVIQTKKEKDWKWLVISAGVGVPLVAVLLVLCAIAYVKKRrsrvaephhnlgklrlpgmprefKYKELKKATNNFhesmrlgeggfgIVYKGIihhndqyhvdntQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVydfmpngslekylygtseqvtlnwnHRYKILTGVASAVYYLQNeydqkvvhrdLKASNILLDADFNARLGDFGLARAIENERNsyaehglvgvpgtmgyvapecfhtgkatpesdvfgFGAVVLEVVCgrspgnmiphqqhaYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLAcshpiaserpkteDILQIIsgtstvpyvpqfkpaftwpstsppismfDSILSSITLSSPGSG
Flexible Loop (DISEMBL)
mwrdprpawdisgHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNInsvvsrknvplkdnynitlsdgtsytVWVQYDGKSKLIQVFMDregetmpqkpllkETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEKDWKWLVISAGVGVPLVAVLLVLCAIAYVKkrrsrvaephhnlgklrlpgmprEFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACShpiaserpktEDILQIISGTSTVPYVPQFKPAFTWPSTSPPISMFDSILSSITLSSPGSG
Low Complexity Region (SEG)
MWRDPRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEKDWKWLVISagvgvplvavllvlcaiayvKKRRSRVAEPHHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIhrlrhkhlvhlvGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPAFTWPSTSPPISMFDSILSSITLSSPGSG
Disordered region (IsUnstruct)
********WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDRE*******PLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEKDWKWLVISAGVGVPLVAVLLVLCAIAYVKKRRSRV******************FKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPAFTWPS***********************
Disordered Region (DISOPRED)
MWRDPRPAWDISGHGLAFVIAPNDSF****SYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWT*************WKWLVISAGVGVPLVAVLLVLCAIAYVKKRRSRV*****NL*KLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR*****KGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPG******QHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPA****************************
Disordered Region (DISEMBL)
MWRDPRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEKDWKWLVISAGVGVPLVAVLLVLCAIAYVKKRRSRVAEPHHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPAFTWPSTSPPISMFDSILSSI********
Disordered Region (DISPRO)
MWRDPRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEKDWKWLVISAGVGVPLVAVLLVLCAIAYVKKRRSRVAEPHHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPAFTWP*T**********************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MWRDPRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEKDWKWLVISAGVGVPLVAVLLVLCAIAYVKKRRSRVAEPHHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPAFTWPSTSPPISMFDSILSSITLSSPGSG
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	568	2.2.26 [Sep-21-2011]
Q9FG33	652	Probable L-type lectin-do	yes	no	0.934	0.814	0.393	1e-107
Q9FHG4	681	Probable L-type lectin-do	no	no	0.910	0.759	0.406	1e-104
O80939	675	L-type lectin-domain cont	no	no	0.878	0.739	0.393	6e-98
O81292	674	L-type lectin-domain cont	no	no	0.880	0.741	0.379	2e-94
Q9M345	677	L-type lectin-domain cont	no	no	0.883	0.741	0.378	1e-93
O81291	669	L-type lectin-domain cont	no	no	0.875	0.742	0.384	1e-91
Q9FIF1	674	Probable L-type lectin-do	no	no	0.904	0.762	0.384	6e-90
Q9LXA5	651	L-type lectin-domain cont	no	no	0.904	0.789	0.372	3e-89
Q9SZD5	669	L-type lectin-domain cont	no	no	0.876	0.744	0.373	4e-88
Q9M2S4	684	L-type lectin-domain cont	no	no	0.904	0.751	0.370	2e-87

>sp|Q9FG33|LRKS5_ARATH Probable L-type lectin-domain containing receptor kinase S.5 OS=Arabidopsis thaliana GN=LECRKS5 PE=2 SV=1

 Score =  389 bits (1000), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 223/567 (39%), Positives = 333/567 (58%), Gaps = 36/567 (6%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQ-GFDPDDN 68
           D  G GLAFV+ P ++ P  SS G WLG+ N  T+ N  +  V++EFDT K    D D N
Sbjct: 103 DPGGEGLAFVLTPEETAPQNSS-GMWLGMVNERTNRNNESRIVSVEFDTRKSHSDDLDGN 161

Query: 69  HLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPL 128
           H+ LN+N++ S     L     I +  G   T  V+YDGK+  + V++ R  +   Q+ L
Sbjct: 162 HVALNVNNINSVVQESLSGR-GIKIDSGLDLTAHVRYDGKN--LSVYVSRNLDVFEQRNL 218

Query: 129 L-KETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEKDWKWLVIS-- 185
           +    I+L  YL    Y GF+AST     +LNCVRSW+ +   I       W W+ I   
Sbjct: 219 VFSRAIDLSAYLPETVYVGFTASTS-NFTELNCVRSWSFEGLKIDGDGNMLWLWITIPIV 277

Query: 186 --AGVGVPLVAVLLVLCAIAYVKKRRSRVAEPHHNL-GKL-RLPGMPREFKYKELKKATN 241
              G+G  L A+ L         + RS+  E + ++  +L      P++FK +ELK+AT 
Sbjct: 278 FIVGIGAFLGALYL---------RSRSKAGETNPDIEAELDNCAANPQKFKLRELKRATG 328

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL 301
           NF    +LG+GGFG+V+KG     D        IAVK+ S  S + K +F+AE+  I  L
Sbjct: 329 NFGAENKLGQGGFGMVFKGKWQGRD--------IAVKRVSEKSHQGKQEFIAEITTIGNL 380

Query: 302 RHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLY-GTSEQVTLNWNHRYKILTGVASAV 360
            H++LV L+GWC+E+ + LLVY++MPNGSL+KYL+     +  L W  R  I+TG++ A+
Sbjct: 381 NHRNLVKLLGWCYERKEYLLVYEYMPNGSLDKYLFLEDKSRSNLTWETRKNIITGLSQAL 440

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            YL N  +++++HRD+KASN++LD+DFNA+LGDFGLAR I+  ++    H    + GT G
Sbjct: 441 EYLHNGCEKRILHRDIKASNVMLDSDFNAKLGDFGLARMIQ--QSEMTHHSTKEIAGTPG 498

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGN-MIPHQQHAY--TLVDWVWMLHRE 477
           Y+APE F  G+AT E+DV+ FG ++LEVV G+ P   ++   Q+ Y  ++V+W+W L+R 
Sbjct: 499 YMAPETFLNGRATVETDVYAFGVLMLEVVSGKKPSYVLVKDNQNNYNNSIVNWLWELYRN 558

Query: 478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQF 537
           G I DA D  +      +E K +LLLGLAC HP  ++RP  + +L++++G ++ P VP  
Sbjct: 559 GTITDAADPGMGNLFDKEEMKSVLLLGLACCHPNPNQRPSMKTVLKVLTGETSPPDVPTE 618

Query: 538 KPAFTWPSTSPPISMFDSILSSITLSS 564
           +PAF WP+  P  S  D  L+   ++S
Sbjct: 619 RPAFVWPAMPPSFSDIDYSLTGSQINS 645

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FHG4|LRKS7_ARATH Probable L-type lectin-domain containing receptor kinase S.7 OS=Arabidopsis thaliana GN=LECRKS7 PE=2 SV=1

 Score =  379 bits (973), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 234/576 (40%), Positives = 318/576 (55%), Gaps = 59/576 (10%)

Query: 4   DPRPAWDISGHGLAFVIA-PNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDT-VKQ 61
           DP  A    G GLAF ++  ND+     S G +LGL N+       N FVAIEFDT +  
Sbjct: 105 DPTSA----GDGLAFFLSHDNDTL---GSPGGYLGLVNS--SQPMKNRFVAIEFDTKLDP 155

Query: 62  GF-DPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREG 120
            F DP+ NH+GL+++S+ S        +  I L  G S T W+ Y    +L+ VF+    
Sbjct: 156 HFNDPNGNHIGLDVDSLNSISTSDPLLSSQIDLKSGKSITSWIDYKNDLRLLNVFLSYTD 215

Query: 121 ETM----PQKPLLKETINLKDYLKPESYFGFSAST-GYPHIQLNCVRSWTL--------- 166
                  P+KPLL   I+L  +L  E Y GFS ST G   I L  + +W+          
Sbjct: 216 PVTTTKKPEKPLLSVNIDLSPFLNGEMYVGFSGSTEGSTEIHL--IENWSFKTSGFLPVR 273

Query: 167 -----------------DIDVIQTKKEKDWKWLVISAGVGVPLVAVLLVLCAIAYVKKRR 209
                            D  VI +KK +    L I  G+  P V + L L    Y   ++
Sbjct: 274 SKSNHLHNVSDSSVVNDDPVVIPSKKRRHRHNLAIGLGISCP-VLICLALFVFGYFTLKK 332

Query: 210 SRVAEPHHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYH 269
            +  +    L    + G+ REF YKEL  AT  FH S  +G G FG VY+ +      + 
Sbjct: 333 WKSVKAEKELKTELITGL-REFSYKELYTATKGFHSSRVIGRGAFGNVYRAM------FV 385

Query: 270 VDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNG 329
              T  AVK+   +S + K +FLAEL+II  LRHK+LV L GWC+EKG+LLLVY+FMPNG
Sbjct: 386 SSGTISAVKRSRHNSTEGKTEFLAELSIIACLRHKNLVQLQGWCNEKGELLLVYEFMPNG 445

Query: 330 SLEKYLYGTSEQ--VTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF 387
           SL+K LY  S+   V L+W+HR  I  G+ASA+ YL +E +Q+VVHRD+K SNI+LD +F
Sbjct: 446 SLDKILYQESQTGAVALDWSHRLNIAIGLASALSYLHHECEQQVVHRDIKTSNIMLDINF 505

Query: 388 NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLE 447
           NARLGDFGLAR  E++++  +        GTMGY+APE    G AT ++D F +G V+LE
Sbjct: 506 NARLGDFGLARLTEHDKSPVS----TLTAGTMGYLAPEYLQYGTATEKTDAFSYGVVILE 561

Query: 448 VVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLAC 507
           V CGR P +  P  Q    LVDWVW LH EG + +AVD+RL      +  K+LLL+GL C
Sbjct: 562 VACGRRPIDKEPESQKTVNLVDWVWRLHSEGRVLEAVDERLKGEFDEEMMKKLLLVGLKC 621

Query: 508 SHPIASERPKTEDILQIISGTSTVPYVPQFKPAFTW 543
           +HP ++ERP    +LQI++       VP+ KP  ++
Sbjct: 622 AHPDSNERPSMRRVLQILNNEIEPSPVPKMKPTLSF 657

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1

 Score =  358 bits (919), Expect = 6e-98,   Method: Compositional matrix adjust.
 Identities = 216/549 (39%), Positives = 311/549 (56%), Gaps = 50/549 (9%)

Query: 11  ISGHGLAFVIAPNDSFPPESSYG---QWLGLTNAFTDGNKANHFVAIEFDTV--KQGFDP 65
           +SGHG+AFV+APN S P    YG   Q++GL N   +GN+ NH  A+E DT+   +  D 
Sbjct: 100 LSGHGIAFVVAPNASLP----YGNPSQYIGLFNLANNGNETNHVFAVELDTILSTEFNDT 155

Query: 66  DDNHLGLNINSVVSRKNVPL-----KDNY-NITLSDGTSYTVWVQYDGKSKLIQVFMDRE 119
           +DNH+G++INS+ S ++ P      K  + N+TL       VWV YDG++  I V M   
Sbjct: 156 NDNHVGIDINSLKSVQSSPAGYWDEKGQFKNLTLISRKPMQVWVDYDGRTNKIDVTMAPF 215

Query: 120 GETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDID-------VIQ 172
            E  P +PL+    +L   L  + Y GFS++TG   +  + +  W+  ++       + +
Sbjct: 216 NEDKPTRPLVTAVRDLSSVLLQDMYVGFSSATG-SVLSEHYILGWSFGLNEKAPPLALSR 274

Query: 173 TKKEKDWKWLVISA--GVGVPLVAVLLVLCAI---AYVKKRRSRVAEPHHN----LGKLR 223
             K   ++   IS    +G+PL+++ L+   I    Y+ +RR + AE         GK R
Sbjct: 275 LPKLPRFEPKRISEFYKIGMPLISLFLIFSFIFLVCYIVRRRRKFAEELEEWEKEFGKNR 334

Query: 224 LPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD 283
                  F++K+L  AT  F E   LG GGFG VYKG++           +IAVK+ S +
Sbjct: 335 -------FRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGT------KLEIAVKRVSHE 381

Query: 284 SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVT 343
           S +   +F+AE+  I R+ H++LV L+G+C  +G+LLLVYD+MPNGSL+KYLY T E VT
Sbjct: 382 SRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNTPE-VT 440

Query: 344 LNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE 403
           LNW  R K++ GVAS ++YL  E++Q V+HRD+KASN+LLD + N RLGDFGLAR  ++ 
Sbjct: 441 LNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 500

Query: 404 RNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH 463
            +    H    V GT+GY+APE   TG+AT  +DVF FGA +LEV CGR P         
Sbjct: 501 SDPQTTH----VVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQQETDE 556

Query: 464 AYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
            + LVDWV+ L  +G I  A D  +       E + +L LGL CSH     RP    +L 
Sbjct: 557 TFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPSMRQVLH 616

Query: 524 IISGTSTVP 532
            + G + +P
Sbjct: 617 YLRGDAKLP 625

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1

 Score =  347 bits (889), Expect = 2e-94,   Method: Compositional matrix adjust.
 Identities = 210/554 (37%), Positives = 314/554 (56%), Gaps = 54/554 (9%)

Query: 11  ISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVK--QGFDPDDN 68
           ISGHG+AF IAPN       +  Q+LGL ++  +GN  NH +A+EFDT+   +  D +DN
Sbjct: 102 ISGHGMAFFIAPNPVLSSAMA-SQYLGLFSSTNNGNDTNHILAVEFDTIMNPEFDDTNDN 160

Query: 69  HLGLNINSVVSRKNV------PLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGET 122
           H+G+NINS+ S K+        +    N+TL       VWV YD ++  I V M   GE 
Sbjct: 161 HVGININSLTSVKSSLVGYWDEINQFNNLTLISRKRMQVWVDYDDRTNQIDVTMAPFGEV 220

Query: 123 MPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDID------------- 169
            P+K L+    +L      + Y GFSA+TGY  +  + V  W+  +              
Sbjct: 221 KPRKALVSVVRDLSSVFLQDMYLGFSAATGYV-LSEHFVFGWSFMVKGKTAPPLTLSKVP 279

Query: 170 ----VIQTKKEKDWK-WLVISAGVGVPLVAVLLVLCAIAYVKKRRSRVAEPHHN----LG 220
               V  T  ++ +K  + + + + +P++ V+ ++  + ++ +RR + AE   +     G
Sbjct: 280 KFPRVGPTSLQRFYKNRMPLFSLLLIPVLFVVSLIFLVRFIVRRRRKFAEEFEDWETEFG 339

Query: 221 KLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF 280
           K RL       ++K+L  AT  F +   LG GGFG VY+G++    +      +IAVK+ 
Sbjct: 340 KNRL-------RFKDLYYATKGFKDKDLLGSGGFGRVYRGVMPTTKK------EIAVKRV 386

Query: 281 SRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE 340
           S +S +   +F+AE+  I R+ H++LV L+G+C  + +LLLVYD+MPNGSL+KYLY   E
Sbjct: 387 SNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLDKYLYDCPE 446

Query: 341 QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI 400
            VTL+W  R+ ++ GVAS ++YL  E++Q V+HRD+KASN+LLDA++N RLGDFGLAR  
Sbjct: 447 -VTLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNGRLGDFGLARLC 505

Query: 401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPH 460
           ++  +         V GT GY+AP+   TG+AT  +DVF FG ++LEV CGR P  +   
Sbjct: 506 DHGSDPQTTR----VVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACGRRPIEIEIE 561

Query: 461 QQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVD--EAKRLLLLGLACSHPIASERPKT 518
              +  LVD V+    EG+I DA D   N+ SV D  E + +L LGL CSH     RP  
Sbjct: 562 SDESVLLVDSVFGFWIEGNILDATDP--NLGSVYDQREVETVLKLGLLCSHSDPQVRPTM 619

Query: 519 EDILQIISGTSTVP 532
             +LQ + G +T+P
Sbjct: 620 RQVLQYLRGDATLP 633

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1

 Score =  344 bits (882), Expect = 1e-93,   Method: Compositional matrix adjust.
 Identities = 207/547 (37%), Positives = 309/547 (56%), Gaps = 45/547 (8%)

Query: 11  ISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG--FDPDDN 68
           +SGHG+AFV+AP    P  +   Q++GL N   +GN  NH  A+EFDT++     DP+DN
Sbjct: 100 LSGHGIAFVVAPTLGLP-FALPSQYIGLFNISNNGNDTNHIFAVEFDTIQSSEFGDPNDN 158

Query: 69  HLGLNINSVVSR--KNVPLKDNY----NITLSDGTSYTVWVQYDGKSKLIQVFMDREGET 122
           H+G+++N + S        +D++    N++L       VW+ YD +S  I V +      
Sbjct: 159 HVGIDLNGLRSANYSTAGYRDDHDKFQNLSLISRKRIQVWIDYDNRSHRIDVTVAPFDSD 218

Query: 123 MPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDID-------VIQTKK 175
            P+KPL+    +L   L  + Y GFS++TG   +  + +  W+  ++       + +  K
Sbjct: 219 KPRKPLVSYVRDLSSILLEDMYVGFSSATG-SVLSEHFLVGWSFRLNGEAPMLSLSKLPK 277

Query: 176 EKDWKWLVISA--GVGVPLVAVLLVLCAIA---YVKKRRSRVAEP----HHNLGKLRLPG 226
              ++   IS    +G+PL+++ L+   I    Y+ +R+ +  E         GK R   
Sbjct: 278 LPRFEPRRISEFYKIGMPLISLSLIFSIIFLAFYIVRRKKKYEEELDDWETEFGKNR--- 334

Query: 227 MPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK 286
               F++KEL  AT  F E   LG GGFG VY+GI+           ++AVK+ S DS +
Sbjct: 335 ----FRFKELYHATKGFKEKDLLGSGGFGRVYRGILP------TTKLEVAVKRVSHDSKQ 384

Query: 287 SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNW 346
              +F+AE+  I R+ H++LV L+G+C  +G+LLLVYD+MPNGSL+KYLY   E  TL+W
Sbjct: 385 GMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNNPE-TTLDW 443

Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
             R  I+ GVAS ++YL  E++Q V+HRD+KASN+LLDADFN RLGDFGLAR  ++  + 
Sbjct: 444 KQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGDFGLARLYDHGSDP 503

Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYT 466
              H    V GT+GY+APE   TG+AT  +DV+ FGA +LEVV GR P          + 
Sbjct: 504 QTTH----VVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIEFHSASDDTFL 559

Query: 467 LVDWVWMLHREGHIQDAVDQRLNINSV-VDEAKRLLLLGLACSHPIASERPKTEDILQII 525
           LV+WV+ L   G+I +A D +L  +   ++E + +L LGL CSH     RP    +LQ +
Sbjct: 560 LVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRARPSMRQVLQYL 619

Query: 526 SGTSTVP 532
            G   +P
Sbjct: 620 RGDMALP 626

Required during pollen development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81291|LRK44_ARATH L-type lectin-domain containing receptor kinase IV.4 OS=Arabidopsis thaliana GN=LECRK44 PE=3 SV=1

 Score =  337 bits (864), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 212/551 (38%), Positives = 310/551 (56%), Gaps = 54/551 (9%)

Query: 13  GHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVK--QGFDPDDNHL 70
            HG+AFVIAPN   P  S   Q+LGL N   +GN  NH  A+E DT+   +  D ++NH+
Sbjct: 101 AHGMAFVIAPNPRLPFGSPL-QYLGLFNVTNNGNVRNHVFAVELDTIMNIEFNDTNNNHV 159

Query: 71  GLNINSVVSRKNVPL-----KDNY-NITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMP 124
           G++INS+ S K+ P       D + N+TL       VWV +DG + LI V M   GE  P
Sbjct: 160 GIDINSLNSVKSSPAGYWDENDQFHNLTLISSKRMQVWVDFDGPTHLIDVTMAPFGEVKP 219

Query: 125 QKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDI---------------- 168
           +KPL+    +L   L  + + GFS++TG    ++  V  W+  +                
Sbjct: 220 RKPLVSIVRDLSSVLLQDMFVGFSSATGNIVSEI-FVLGWSFGVNGEAQPLALSKLPRLP 278

Query: 169 --DVIQTKKEKDWK-WLVISAGVGVPLVAVLLVLCAIAYVKKRRSRVAEPHHN----LGK 221
             D+  T+  + +K W+ + + +   L+  LL++  + ++ KRR + AE   +     GK
Sbjct: 279 VWDLKPTRVYRFYKNWVPLISLL---LIPFLLIIFLVRFIMKRRRKFAEEVEDWETEFGK 335

Query: 222 LRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS 281
            RL       ++K+L  AT  F +   LG GGFG VYKGI+    +      +IAVK+ S
Sbjct: 336 NRL-------RFKDLYYATKGFKDKNILGSGGFGSVYKGIMPKTKK------EIAVKRVS 382

Query: 282 RDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQ 341
            +S +   +F+AE+  I ++ H++LV LVG+C  + +LLLVYD+MPNGSL+KYLY + E 
Sbjct: 383 NESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPNGSLDKYLYNSPE- 441

Query: 342 VTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE 401
           VTL+W  R+K++ GVASA++YL  E++Q V+HRD+KASN+LLDA+ N RLGDFGLA+  +
Sbjct: 442 VTLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGDFGLAQLCD 501

Query: 402 NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQ 461
           +  +         V GT GY+AP+   TG+AT  +DVF FG ++LEV CGR P  +    
Sbjct: 502 HGSDPQTTR----VVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGRRPIEINNQS 557

Query: 462 QHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDI 521
                LVDWV+    E +I DA D  L       E + +L LGL CSH     RP    +
Sbjct: 558 GERVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHSDPLARPTMRQV 617

Query: 522 LQIISGTSTVP 532
           LQ + G + +P
Sbjct: 618 LQYLRGDAMLP 628

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIF1|LRK21_ARATH Probable L-type lectin-domain containing receptor kinase II.1 OS=Arabidopsis thaliana GN=LECRK21 PE=2 SV=1

 Score =  332 bits (850), Expect = 6e-90,   Method: Compositional matrix adjust.
 Identities = 218/567 (38%), Positives = 301/567 (53%), Gaps = 53/567 (9%)

Query: 13  GHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVK--QGFDPDDNHL 70
           GHG+AFV++P        S    LG+ N   D   A H  A+E DT +  + FD   N +
Sbjct: 101 GHGMAFVVSPTKDLRSNGSANSNLGIFNRANDNKTATHIFAVELDTNQNSESFDKGGNDV 160

Query: 71  GLNINSVVSRK-------NVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDR----- 118
           G++INS+VS +       N     N ++ L+ G S  VW+ YDG  K++ V +       
Sbjct: 161 GIDINSIVSVESADASYFNARKGKNISLPLASGKSILVWIDYDGIEKVLNVTLAPVQTPK 220

Query: 119 ------EGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLN-CVRSWT------ 165
                      P+ PLL  +INL +      Y GFS STG   I+ N  +  W+      
Sbjct: 221 PDSPYFSSFIKPKVPLLSRSINLSEIFTETMYVGFSGSTG--SIKSNQYILGWSFKQGGK 278

Query: 166 ---LDIDVIQTKKEKDWKW-LVISAGVGVPLVAVLLVLCAIAYVKKRRSRVAEPHHNLGK 221
              LDI  +        ++ L    G  +  +A  L L  I Y+ K++ + AE    L +
Sbjct: 279 AESLDISRLSNPPPSPKRFPLKEVLGATISTIA-FLTLGGIVYLYKKK-KYAEV---LEQ 333

Query: 222 LRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS 281
                 P+ + ++ L KAT  F E+  LG GGFG VYKGI+          TQIAVK+  
Sbjct: 334 WEKEYSPQRYSFRILYKATKGFRENQLLGAGGFGKVYKGILP-------SGTQIAVKRVY 386

Query: 282 RDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQ 341
            D+ +    ++AE+A + RLRHK+LVHL+G+C  KG+LLLVYD+MPNGSL+ YL+  ++ 
Sbjct: 387 HDAEQGMKQYVAEIASMGRLRHKNLVHLLGYCRRKGELLLVYDYMPNGSLDDYLFHKNKL 446

Query: 342 VTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE 401
             L W+ R  I+ GVASA+ YL  E++Q V+HRD+KASNILLDAD N +LGDFGLAR  +
Sbjct: 447 KDLTWSQRVNIIKGVASALLYLHEEWEQVVLHRDIKASNILLDADLNGKLGDFGLARFHD 506

Query: 402 NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNM-IPH 460
              N  A      V GT+GY+APE    G  T  +DV+ FGA +LEVVCGR P +   P 
Sbjct: 507 RGVNLEATR----VVGTIGYMAPELTAMGVTTTCTDVYAFGAFILEVVCGRRPVDPDAPR 562

Query: 461 QQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTED 520
           +Q    LV WV    +   + D VD +L I+  V+EAK LL LG+ CS      RP    
Sbjct: 563 EQ--VILVKWVASCGKRDALTDTVDSKL-IDFKVEEAKLLLKLGMLCSQINPENRPSMRQ 619

Query: 521 ILQIISGTSTVPYVPQFKPAFTWPSTS 547
           ILQ + G  +VP +     A   P+ S
Sbjct: 620 ILQYLEGNVSVPAISFGTVALGIPNIS 646

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LXA5|LRK91_ARATH L-type lectin-domain containing receptor kinase IX.1 OS=Arabidopsis thaliana GN=LECRK91 PE=2 SV=1

 Score =  329 bits (844), Expect = 3e-89,   Method: Compositional matrix adjust.
 Identities = 203/545 (37%), Positives = 313/545 (57%), Gaps = 31/545 (5%)

Query: 13  GHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQ-GFDPDD--NH 69
           GHG AF +AP     P +S G +LGL N   + + A   V +EFDT     +DP D  +H
Sbjct: 98  GHGFAFFLAPARIQLPPNSAGGFLGLFNGTNNQSSAFPLVYVEFDTFTNPEWDPLDVKSH 157

Query: 70  LGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMP-QKPL 128
           +G+N NS+VS        ++N T  +     V + YD   + + V    +  + P +   
Sbjct: 158 VGINNNSLVSSNYT----SWNATSHNQDIGRVLIFYDSARRNLSVSWTYDLTSDPLENSS 213

Query: 129 LKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLD--IDVIQTKK-EKDWKWLVIS 185
           L   I+L   L  E   GFSA++G    + N + SW     +++I  KK + D K ++I 
Sbjct: 214 LSYIIDLSKVLPSEVTIGFSATSG-GVTEGNRLLSWEFSSSLELIDIKKSQNDKKGMIIG 272

Query: 186 AGVGVPLVAVLLVLCAIAYVK-KRRSRVAEPHHNLGK----LRLPGMPREFKYKELKKAT 240
             V   ++    +   I ++K K++ + AE   NL      L     PR+F YK+L  A 
Sbjct: 273 ISVSGFVLLTFFITSLIVFLKRKQQKKKAEETENLTSINEDLERGAGPRKFTYKDLASAA 332

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHR 300
           NNF +  +LGEGGFG VY+G ++  D        +A+KKF+  S + K +F+ E+ II  
Sbjct: 333 NNFADDRKLGEGGFGAVYRGYLNSLDM------MVAIKKFAGGSKQGKREFVTEVKIISS 386

Query: 301 LRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
           LRH++LV L+GWCHEK + L++Y+FMPNGSL+ +L+G      L W+ R KI  G+ASA+
Sbjct: 387 LRHRNLVQLIGWCHEKDEFLMIYEFMPNGSLDAHLFGKKPH--LAWHVRCKITLGLASAL 444

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            YL  E++Q VVHRD+KASN++LD++FNA+LGDFGLAR +++E          G+ GT G
Sbjct: 445 LYLHEEWEQCVVHRDIKASNVMLDSNFNAKLGDFGLARLMDHELGPQT----TGLAGTFG 500

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYT-LVDWVWMLHREGH 479
           Y+APE   TG+A+ ESDV+ FG V LE+V GR   +    +    T LV+ +W L+ +G 
Sbjct: 501 YMAPEYISTGRASKESDVYSFGVVTLEIVTGRKSVDRRQGRVEPVTNLVEKMWDLYGKGE 560

Query: 480 IQDAVDQRLNINSVVD-EAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFK 538
           +  A+D++L I    + +A+ L+++GL C+HP  + RP  +  +Q+++  + VP++P   
Sbjct: 561 VITAIDEKLRIGGFDEKQAECLMIVGLWCAHPDVNTRPSIKQAIQVLNLEAPVPHLPTKM 620

Query: 539 PAFTW 543
           P  T+
Sbjct: 621 PVATY 625

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SZD5|LRK59_ARATH L-type lectin-domain containing receptor kinase V.9 OS=Arabidopsis thaliana GN=LECRK59 PE=2 SV=1

 Score =  326 bits (835), Expect = 4e-88,   Method: Compositional matrix adjust.
 Identities = 206/552 (37%), Positives = 302/552 (54%), Gaps = 54/552 (9%)

Query: 11  ISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVK-QGFDP-DDN 68
           + GHGLAFVI+P    P  SS  Q+LGL N   +G+ +NH VA+EFDT + Q FD  D+N
Sbjct: 96  LDGHGLAFVISPTKGLPYSSS-SQYLGLFNLTNNGDPSNHIVAVEFDTFQNQEFDDMDNN 154

Query: 69  HLGLNINSVVSRKNVP---LKDN----YNITLSDGTSYTVWVQYDGKSKLIQVFMDREGE 121
           H+G++INS+ S K       +D+     NI L +      W++YD   + + V +     
Sbjct: 155 HVGIDINSLSSEKASTAGYYEDDDGTFKNIRLINQKPIQAWIEYDSSRRQLNVTIHPIHL 214

Query: 122 TMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTL-------DIDVIQ-- 172
             P+ PLL  T +L  YL    Y GF+++TG      + +  WT        +ID+ +  
Sbjct: 215 PKPKIPLLSLTKDLSPYLFDSMYVGFTSATGRLRSS-HYILGWTFKLNGTASNIDISRLP 273

Query: 173 -----TKKEKDWKWLVISAGVGVPLVAVLLVLCAIAYVKKRRSRVAEPHHNLGKLRLPGM 227
                ++     K L IS  +    + V L +  + ++K+++         L    +   
Sbjct: 274 KLPRDSRSTSVKKILAISLSLTSLAILVFLTISYMLFLKRKKLMEV-----LEDWEVQFG 328

Query: 228 PREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS 287
           P  F YK+L  AT  F  S  LG+GGFG VYKG +         N  IAVKK S DS + 
Sbjct: 329 PHRFAYKDLYIATKGFRNSELLGKGGFGKVYKGTLS------TSNMDIAVKKVSHDSRQG 382

Query: 288 KGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWN 347
             +F+AE+A I RLRH +LV L+G+C  KG+L LVYD MP GSL+K+LY   EQ +L+W+
Sbjct: 383 MREFVAEIATIGRLRHPNLVRLLGYCRRKGELYLVYDCMPKGSLDKFLYHQPEQ-SLDWS 441

Query: 348 HRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY 407
            R+KI+  VAS + YL +++ Q ++HRD+K +N+LLD   N +LGDFGLA+         
Sbjct: 442 QRFKIIKDVASGLCYLHHQWVQVIIHRDIKPANVLLDDSMNGKLGDFGLAK--------L 493

Query: 408 AEHGL----VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH 463
            EHG       V GT GY++PE   TGKA+  SDVF FG ++LE+ CGR P  ++P    
Sbjct: 494 CEHGFDPQTSNVAGTFGYISPELSRTGKASTSSDVFAFGILMLEITCGRRP--VLPRASS 551

Query: 464 AYTLVDWVWMLHR-EGHIQDAVDQRLNINS--VVDEAKRLLLLGLACSHPIASERPKTED 520
              +V   W+L   E  I   VD+R+  +   + ++   +L LGL CSHP+A+ RP    
Sbjct: 552 PSEMVLTDWVLDCWEDDILQVVDERVKQDDKYLEEQVALVLKLGLFCSHPVAAVRPSMSS 611

Query: 521 ILQIISGTSTVP 532
           ++Q + G + +P
Sbjct: 612 VIQFLDGVAQLP 623

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1

 Score =  323 bits (829), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 205/553 (37%), Positives = 297/553 (53%), Gaps = 39/553 (7%)

Query: 11  ISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVK--QGFDPDDN 68
           + GHGLAF I P       S   Q+LGL N+ +  N ++HF A+EFDTV+  +  D +DN
Sbjct: 99  LGGHGLAFAITPTPDLRG-SLPSQYLGLLNS-SRVNFSSHFFAVEFDTVRDLEFEDINDN 156

Query: 69  HLGLNINSVVSRKNVPL------KDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGET 122
           H+G++INS+ S  + P            + L  G     W+ YD   K + V +    E 
Sbjct: 157 HVGIDINSMESSISTPAGYFLANSTKKELFLDGGRVIQAWIDYDSNKKRLDVKLSPFSEK 216

Query: 123 MPQKPLLKETINLKDYLKPESYFGFSASTGY---PHIQLN-----CVRSWTLDIDVIQTK 174
            P+  LL   ++L   L  E Y GFSASTG     H  L         +++L +  +   
Sbjct: 217 -PKLSLLSYDVDLSSVLGDEMYVGFSASTGLLASSHYILGWNFNMSGEAFSLSLPSLPRI 275

Query: 175 KEK--DWKWLVISAGVGVPLVAVLLVLCAIAYVKKRRSRVAEPHHNLGKLRLPGMPREFK 232
                  K    S  +GV L+  LL+   +        R  +    + +  L   P  F 
Sbjct: 276 PSSIKKRKKKRQSLILGVSLLCSLLIFAVLVAASLFVVRKVKDEDRVEEWELDFGPHRFS 335

Query: 233 YKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFL 292
           Y+ELKKATN F +   LG GGFG VYKG +  +D++      +AVK+ S +S +   +F+
Sbjct: 336 YRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEF------VAVKRISHESRQGVREFM 389

Query: 293 AELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKI 352
           +E++ I  LRH++LV L+GWC  +  LLLVYDFMPNGSL+ YL+  + +V L W  R+KI
Sbjct: 390 SEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENPEVILTWKQRFKI 449

Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           + GVAS + YL   ++Q V+HRD+KA+N+LLD++ N R+GDFGLA+  E+     ++ G 
Sbjct: 450 IKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYEHG----SDPGA 505

Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP--GNMIPHQQHAYTLVDW 470
             V GT GY+APE   +GK T  +DV+ FGAV+LEV CGR P   + +P +     +VDW
Sbjct: 506 TRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPEE---LVMVDW 562

Query: 471 VWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST 530
           VW   + G I+D VD+RLN     +E   ++ LGL CS+     RP    ++  +     
Sbjct: 563 VWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYLEKQFP 622

Query: 531 VPYV---PQFKPA 540
            P V   P F  A
Sbjct: 623 SPEVVPAPDFLDA 635

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	568
224131956	608	predicted protein [Populus trichocarpa]	0.934	0.873	0.676	0.0
255546668	703	serine-threonine protein kinase, plant-t	0.941	0.761	0.640	0.0
225428360	667	PREDICTED: probable L-type lectin-domain	0.966	0.823	0.618	0.0
449453642	691	PREDICTED: probable L-type lectin-domain	0.940	0.772	0.629	0.0
449500132	691	PREDICTED: LOW QUALITY PROTEIN: probable	0.940	0.772	0.629	0.0
225431640	666	PREDICTED: probable L-type lectin-domain	0.948	0.809	0.567	1e-178
224061553	682	predicted protein [Populus trichocarpa]	0.954	0.794	0.570	1e-176
5545339	676	lectin-like protein kinase [Populus nigr	0.948	0.797	0.580	1e-174
255575267	690	serine-threonine protein kinase, plant-t	0.943	0.776	0.574	1e-170
297744450	636	unnamed protein product [Vitis vinifera]	0.899	0.803	0.565	1e-169

>gi|224131956|ref|XP_002328149.1| predicted protein [Populus trichocarpa] gi|222837664|gb|EEE76029.1| predicted protein [Populus trichocarpa]

 Score =  702 bits (1811), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 372/550 (67%), Positives = 424/550 (77%), Gaps = 19/550 (3%)

Query: 12  SGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGF--DPDDNH 69
           +G GLAF+IAPN S P E+SYGQ+LGLTNA TDGN ANHFVAIEFDT KQ +  DPD NH
Sbjct: 62  AGSGLAFLIAPNASIP-EASYGQYLGLTNASTDGNTANHFVAIEFDTEKQDYIEDPDHNH 120

Query: 70  LGLNINSVVSRKNVPLKDNYNITLSD---GTSYTVWVQYDGKSKLIQVFMDREGETMPQK 126
           +G NINS+ S+  +PL D YNITLS    G +YTVWV Y+G SKL+QV+M +EG   P +
Sbjct: 121 IGFNINSIRSKNAIPL-DKYNITLSPDPPGVNYTVWVDYNGTSKLMQVYMVKEGNQKPGE 179

Query: 127 PLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEKDWKWLVISA 186
           PLL ETI+LK+YLK ESYFGF+ASTG P I+LNCV  W+L I+  Q  +E D KW  I A
Sbjct: 180 PLLNETIDLKEYLKQESYFGFAASTGDPRIELNCVLKWSLQINN-QPDEENDEKWWKIGA 238

Query: 187 GVGVPLVAVLLVLCAIAYV---KKRRSRVAEPHHNLGKLRL---PGMPREFKYKELKKAT 240
           GV V +V ++ +      V   KKR     E     G   L   PGMPREFKYKELKKAT
Sbjct: 239 GVCVSVVMIIFIFVVCRVVFVRKKRSKASLEEATEFGTYILKWLPGMPREFKYKELKKAT 298

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQ-----YHVDNTQIAVKKFSRDSIKSKGDFLAEL 295
           +NFHESM+LGEGGFGIVYKG++  ND+          T+IAVKKFSRDSIK K DFLAEL
Sbjct: 299 SNFHESMKLGEGGFGIVYKGVLLLNDKADDGTTTTTTTEIAVKKFSRDSIKGKDDFLAEL 358

Query: 296 AIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG 355
            IIH LRHK+LV LVGWC+EKGKLLLVYDFMPNGSLEK+L    EQ TLNWN RY+IL G
Sbjct: 359 TIIHHLRHKNLVRLVGWCYEKGKLLLVYDFMPNGSLEKHLQKGPEQDTLNWNRRYRILVG 418

Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           VASA++YL NEYD+KVVHRDLK SNILLDADFN+RLGDFGLARA+ENE+NSY E GL GV
Sbjct: 419 VASALHYLHNEYDKKVVHRDLKTSNILLDADFNSRLGDFGLARALENEKNSYNELGLGGV 478

Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH 475
           PGTMGYVAPECFHTG+ATPESDVFGFG VVLEVVCG+ PG  I H QH Y++VDWVW LH
Sbjct: 479 PGTMGYVAPECFHTGRATPESDVFGFGVVVLEVVCGKGPGTKIRHNQHLYSMVDWVWTLH 538

Query: 476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVP 535
           REG I +AVD+ L  + V DEA RLLLLGLACSHPI SERPKTE I+QI+SGT   P+VP
Sbjct: 539 REGRILEAVDENLGNDFVHDEANRLLLLGLACSHPIDSERPKTETIIQIVSGTLPPPHVP 598

Query: 536 QFKPAFTWPS 545
            FKP FTWPS
Sbjct: 599 PFKPVFTWPS 608

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255546668|ref|XP_002514393.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223546490|gb|EEF47989.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  692 bits (1786), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 355/554 (64%), Positives = 428/554 (77%), Gaps = 19/554 (3%)

Query: 6   RPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQ-GFD 64
            P WD +GHGLAF+IAPN S  P++S+GQWLGLTN+ TDG+  NH +AIEFDT KQ G D
Sbjct: 117 EPEWD-AGHGLAFIIAPNYS-TPDASFGQWLGLTNSSTDGSPDNHILAIEFDTQKQDGID 174

Query: 65  P-DDNHLGLNINSVVSRKNVPLKDNYNITLSD---GTSYTVWVQYDGKSKLIQVFMDREG 120
             D +H+G N NSV S+++V L D +NITLS    G +Y+VW+ Y+G +K+++V++  EG
Sbjct: 175 EIDGDHVGFNTNSVRSKQSVSL-DKHNITLSPPPPGANYSVWIDYNGAAKILEVYIVNEG 233

Query: 121 ETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEKDWK 180
              PQ+P+L+E+INLKDYLK ESYFGF+ASTG P I+LNCV  W L+ID I  ++  D  
Sbjct: 234 NAKPQEPILRESINLKDYLKQESYFGFAASTGDPEIELNCVLKWRLEIDDIPKEESDDKL 293

Query: 181 WLVISAGVGVP---LVAVLLVLCAIAYVKKRRSRVAEPHHNLGKL----RLPGMPREFKY 233
            + I  G+GV    ++A+L V   + + +KRRS  +E     G +    RLPGMPREFKY
Sbjct: 294 GMKIGVGLGVSGGTILAILAVCACVYHARKRRSSESESGSGAGVVEDLKRLPGMPREFKY 353

Query: 234 KELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA 293
           KELK ATN F ESM+LGEGGFGIVYKG+++  D+ H   T+IAVKKFSRD+IK K DFLA
Sbjct: 354 KELKNATNKFDESMKLGEGGFGIVYKGVLY--DKNHTSATEIAVKKFSRDNIKGKDDFLA 411

Query: 294 ELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKIL 353
           EL IIHRLRHK+LV LVGWC+EKGKLLLVYDFMPNGSLEK+LY   +Q  LNW+ R K+L
Sbjct: 412 ELTIIHRLRHKNLVRLVGWCYEKGKLLLVYDFMPNGSLEKHLYEAPQQDKLNWSRRCKVL 471

Query: 354 TGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLV 413
           TGVASA++YL  EYDQ V+HRDLKASNILLD DFNARLGDFGLARA+ENE+NSYAE GL 
Sbjct: 472 TGVASALHYLHAEYDQTVIHRDLKASNILLDKDFNARLGDFGLARALENEKNSYAELGLG 531

Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM 473
           GVPGT+GYVAPECFHT  AT ESDVFGFGAVVLEVVCG+ PG  I H QH Y+LVDWVWM
Sbjct: 532 GVPGTIGYVAPECFHT--ATRESDVFGFGAVVLEVVCGKGPGMKIHHNQHLYSLVDWVWM 589

Query: 474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPY 533
           LHREG I +AVD+RL  + V DEA RLL+LGLACSHPI SERPK + I+QI+SG    P+
Sbjct: 590 LHREGRILEAVDERLENDYVKDEANRLLILGLACSHPIDSERPKAQAIVQILSGALAAPH 649

Query: 534 VPQFKPAFTWPSTS 547
           VP FKP F WPS +
Sbjct: 650 VPPFKPVFMWPSLA 663

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225428360|ref|XP_002280067.1| PREDICTED: probable L-type lectin-domain containing receptor kinase S.5-like [Vitis vinifera]

 Score =  684 bits (1764), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 352/569 (61%), Positives = 431/569 (75%), Gaps = 20/569 (3%)

Query: 6   RPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDP 65
           +P+W+ +G G AFVIAPN + P E+S+GQWLGLTNA TDG++ N  VA+EFDT KQ FDP
Sbjct: 110 QPSWN-AGEGFAFVIAPNLTIP-EASHGQWLGLTNATTDGDRTNQIVAVEFDTEKQDFDP 167

Query: 66  DDNHLGLNINSVVSRKNVPLK-DNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMP 124
           DDNH+GLNINSV S   V L      I+  +GT+Y+VWVQYDG++K+++V+M +EG+  P
Sbjct: 168 DDNHIGLNINSVRSYTTVSLTPSGIEISPEEGTNYSVWVQYDGQAKVMEVYMGKEGDPKP 227

Query: 125 QKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEKDWKWLVI 184
             PLL++TI+LK Y+K ESYFGF+ASTGYP IQLNCV  W LD++++   K   W  L I
Sbjct: 228 SSPLLRDTIDLKHYVKQESYFGFAASTGYPAIQLNCVLKWKLDMEILPGDKGFMWWLLSI 287

Query: 185 SAGVGVPLVAVLLVLCAIAYV---KKRRSRVAEPHHNLGKLR-LPGMPREFKYKELKKAT 240
            A     ++ +L+V+  I Y+   K+R     E  + LG LR L GMPREF+YK+LKKAT
Sbjct: 288 PA-----VILILVVVGGIVYLNYKKRREGGNREEGNVLGDLRRLTGMPREFRYKDLKKAT 342

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHR 300
            NF ES +LG+GGFG+VYKG++  +       T++AVK+FSRD IK KGDF+AEL IIHR
Sbjct: 343 KNFDESTKLGQGGFGVVYKGVLQEDGDDST--TEVAVKQFSRDDIKGKGDFMAELTIIHR 400

Query: 301 LRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
           LRHKHLV LVGWC+EKGKLLLVYDFMPNGSL+K+L+G     TLNW  RY I+TGV SA+
Sbjct: 401 LRHKHLVRLVGWCYEKGKLLLVYDFMPNGSLDKHLFGDHYDNTLNWERRYNIVTGVGSAL 460

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            YL NE+DQKVVHRDLK SNI+LD+ FNARLGDFGLARA++N+R+SYAE  L G PGTMG
Sbjct: 461 LYLHNEFDQKVVHRDLKGSNIMLDSTFNARLGDFGLARALDNDRSSYAELELGGFPGTMG 520

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI 480
           YVAPECFHT KAT ESDV+ FGAVVLEVVCGRSPG+ I + Q  Y+LVDWVWMLHREG I
Sbjct: 521 YVAPECFHTQKATVESDVYAFGAVVLEVVCGRSPGSEISYNQRLYSLVDWVWMLHREGRI 580

Query: 481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPA 540
            +AVD+RL  N V DEA+RLLLLGLACSHP ASERP T  I+QI+SG+ + P+VP FKPA
Sbjct: 581 VEAVDERLGNNYVDDEARRLLLLGLACSHPSASERPATLAIVQILSGSVSAPHVPPFKPA 640

Query: 541 FTWPS----TSPPISMFDSILSSITLSSP 565
           FTW S    T+P  +    IL SI   SP
Sbjct: 641 FTWASMASLTTPTTTSI--ILPSIASLSP 667

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449453642|ref|XP_004144565.1| PREDICTED: probable L-type lectin-domain containing receptor kinase S.5-like [Cucumis sativus]

 Score =  672 bits (1733), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 347/551 (62%), Positives = 426/551 (77%), Gaps = 17/551 (3%)

Query: 6   RPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDP 65
           R  W  +G GL F+IAP  S  PE S+GQW+GLTN   DG++ N  VAIEFDT KQ FDP
Sbjct: 124 REEW-TAGEGLTFLIAPT-SVVPEQSWGQWMGLTNETIDGDEKNQIVAIEFDTQKQDFDP 181

Query: 66  DDNHLGLNINSVVSRKNVPLKDNYNITLSD--GTSYTVWVQYDGKSKLIQVFMDREGETM 123
           D+NH+GLNINSV SRK VPLK+   I LS   GT++++WV+YDGK+KL+QV+M    +  
Sbjct: 182 DNNHIGLNINSVKSRKTVPLKE-AGIVLSPEVGTNHSIWVEYDGKAKLLQVYMSINKDPK 240

Query: 124 PQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEKDWKWLV 183
           P KPLL ET+NLK+++K ES+ GFSASTG P IQLNCV  WTL+++ +  KK  +  WL 
Sbjct: 241 PNKPLLNETLNLKEFVKQESFIGFSASTGSPEIQLNCVLEWTLEMERLPEKK--NLTWLK 298

Query: 184 ISAGVGVPLVAVLLVLCA---IAYVKKRRSRVAEPHHNLGKL-RLPGMPREFKYKELKKA 239
           I AGVG+P++ + +++     + Y KKRR  V E  +  G L RLPGMPREFKYKELK+A
Sbjct: 299 ILAGVGIPVLTIAILVGVWLFVGYRKKRREHVDEESNVQGTLKRLPGMPREFKYKELKRA 358

Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNT------QIAVKKFSRDSIKSKGDFLA 293
           T+NFHESM LG GGFGIVYKG++   D+    ++      +IAVK+FSRDSIKSK DFL 
Sbjct: 359 THNFHESMVLGNGGFGIVYKGVLQDKDRDITASSNSGSRLEIAVKQFSRDSIKSKSDFLD 418

Query: 294 ELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKIL 353
           EL IIHRLRH++LV L GWC+EKGKLLLVYDFMPNGSLE +LY   EQ  LNW HRYKIL
Sbjct: 419 ELTIIHRLRHRNLVRLEGWCYEKGKLLLVYDFMPNGSLENHLYDVDEQNVLNWGHRYKIL 478

Query: 354 TGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLV 413
            GVASA++YL NEYDQKV+HRD+K+SNILLD++FNARLGDFGLARA++ ERNSYA+    
Sbjct: 479 CGVASALHYLHNEYDQKVLHRDIKSSNILLDSEFNARLGDFGLARALDPERNSYADLHCG 538

Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM 473
           GV GTMGYVAPECFH G+ATPESDV+G+GAVVLE+VCGR PG ++  +Q  Y+L+DWVW 
Sbjct: 539 GVAGTMGYVAPECFHEGRATPESDVYGYGAVVLEIVCGRRPGAVVEDEQDHYSLIDWVWK 598

Query: 474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPY 533
           LHREGHI+ AVD +L  + VVDEA+RLLLLGLACSHP+ASERP+T+ ILQI++G    P+
Sbjct: 599 LHREGHIEKAVDNQLGNDIVVDEARRLLLLGLACSHPVASERPQTQAILQILNGAVPPPH 658

Query: 534 VPQFKPAFTWP 544
           VP FKP F WP
Sbjct: 659 VPPFKPVFMWP 669

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449500132|ref|XP_004161013.1| PREDICTED: LOW QUALITY PROTEIN: probable L-type lectin-domain containing receptor kinase S.5-like [Cucumis sativus]

 Score =  671 bits (1732), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 347/551 (62%), Positives = 425/551 (77%), Gaps = 17/551 (3%)

Query: 6   RPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDP 65
           R  W  +G GL F+IAP  S  PE S+GQW+GLTN   DG+  N  VAIEFDT KQ FDP
Sbjct: 124 REEW-TAGEGLTFLIAPT-SVVPEQSWGQWMGLTNETIDGDXKNQIVAIEFDTQKQDFDP 181

Query: 66  DDNHLGLNINSVVSRKNVPLKDNYNITLSD--GTSYTVWVQYDGKSKLIQVFMDREGETM 123
           D+NH+GLNINSV SRK VPLK+   I LS   GT++++WV+YDGK+KL+QV+M    +  
Sbjct: 182 DNNHIGLNINSVKSRKTVPLKE-AGIVLSPEVGTNHSIWVEYDGKAKLLQVYMSINKDPK 240

Query: 124 PQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEKDWKWLV 183
           P KPLL ET+NLK+++K ES+ GFSASTG P IQLNCV  WTL+++ +  KK  +  WL 
Sbjct: 241 PNKPLLNETLNLKEFVKQESFIGFSASTGSPEIQLNCVLEWTLEMERLPEKK--NLTWLK 298

Query: 184 ISAGVGVPLVAVLLVLCA---IAYVKKRRSRVAEPHHNLGKL-RLPGMPREFKYKELKKA 239
           I AGVG+P++ + +++     + Y KKRR  V E  +  G L RLPGMPREFKYKELK+A
Sbjct: 299 ILAGVGIPVLTIAILVGVWLFVGYRKKRREHVDEESNVQGTLKRLPGMPREFKYKELKRA 358

Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNT------QIAVKKFSRDSIKSKGDFLA 293
           T+NFHESM LG GGFGIVYKG++   D+    ++      +IAVK+FSRDSIKSK DFL 
Sbjct: 359 THNFHESMVLGNGGFGIVYKGVLQDKDRDITASSNSGSRLEIAVKQFSRDSIKSKSDFLD 418

Query: 294 ELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKIL 353
           EL IIHRLRH++LV L GWC+EKGKLLLVYDFMPNGSLE +LY   EQ  LNW HRYKIL
Sbjct: 419 ELTIIHRLRHRNLVRLEGWCYEKGKLLLVYDFMPNGSLENHLYDVDEQNVLNWGHRYKIL 478

Query: 354 TGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLV 413
            GVASA++YL NEYDQKV+HRD+K+SNILLD++FNARLGDFGLARA++ ERNSYA+    
Sbjct: 479 CGVASALHYLHNEYDQKVLHRDIKSSNILLDSEFNARLGDFGLARALDPERNSYADLHCG 538

Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM 473
           GV GTMGYVAPECFH G+ATPESDV+G+GAVVLE+VCGR PG ++  +Q  Y+L+DWVW 
Sbjct: 539 GVAGTMGYVAPECFHEGRATPESDVYGYGAVVLEIVCGRRPGAVVEDEQDHYSLIDWVWK 598

Query: 474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPY 533
           LHREGHI+ AVD +L  + VVDEA+RLLLLGLACSHP+ASERP+T+ ILQI++G    P+
Sbjct: 599 LHREGHIEKAVDNQLGNDIVVDEARRLLLLGLACSHPVASERPQTQAILQILNGAVPPPH 658

Query: 534 VPQFKPAFTWP 544
           VP FKP F WP
Sbjct: 659 VPPFKPVFMWP 669

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225431640|ref|XP_002263211.1| PREDICTED: probable L-type lectin-domain containing receptor kinase S.5 [Vitis vinifera]

 Score =  630 bits (1624), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 318/560 (56%), Positives = 415/560 (74%), Gaps = 21/560 (3%)

Query: 13  GHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGL 72
           G G AF+IAP+ + PP S  G++LGLTN+ TDGN  NH +A+E DT KQ FD +DNH+GL
Sbjct: 112 GEGFAFIIAPDLNLPPGSD-GEYLGLTNSTTDGNPNNHLIAVELDTFKQDFDSNDNHIGL 170

Query: 73  NINSVVSRKNVPLKD-NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKE 131
           +INS+ S + V L D    I   D  +Y+VWV+YDG++K++ V+M  EG   P +P++  
Sbjct: 171 DINSIRSNRTVSLSDLGIQIAPLDPKNYSVWVEYDGENKVMDVYMVEEGNPRPAEPVMSA 230

Query: 132 TINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEKDWKWLVISAGVGVP 191
            + L++ +K  SY GF+ASTG    QLNCV  W L +++++  ++ D +W+ +  G GVP
Sbjct: 231 KVELREIVKQYSYMGFAASTGNA-TQLNCVLQWNLTVELLE--EDGDAEWVKVVLGAGVP 287

Query: 192 LVAVLLVLCAIA--YVKKRRSRVAEPHHNLGKLR-LPGMPREFKYKELKKATNNFHESMR 248
            + V+L+ C     YV+K+R   ++P+  LG LR LPG PREF++K+LKKATNNF E ++
Sbjct: 288 AIVVVLIACVFLWYYVQKKRRAKSDPNI-LGTLRSLPGTPREFEFKDLKKATNNFDEKLK 346

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH 308
           LGEGGFG+VYKG++        ++  +AVKKFSRD +K K DFLAEL II+RLRHKHLV 
Sbjct: 347 LGEGGFGVVYKGLLPK------EHVHVAVKKFSRD-VKGKDDFLAELTIINRLRHKHLVP 399

Query: 309 LVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
           L+GWCH+ G LLLVYD+MPNGSL+K L+   E  TL W+ RYKI+ GVASA++YL NEYD
Sbjct: 400 LLGWCHKNGMLLLVYDYMPNGSLDKQLFCGREMRTLEWSVRYKIIAGVASALHYLHNEYD 459

Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           Q+VVHRDLKASNI+LD+++NARLGDFGLARA+ENE+NSYAE  L GVPGTMGY+APECFH
Sbjct: 460 QRVVHRDLKASNIMLDSNYNARLGDFGLARALENEKNSYAE--LEGVPGTMGYIAPECFH 517

Query: 429 TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRL 488
           TGKATPESDV+GFGAV+LEVVC + P          + LVDWVW LHREG I +AVD+RL
Sbjct: 518 TGKATPESDVYGFGAVLLEVVCAQRP---WASDATFHFLVDWVWCLHREGRIVEAVDERL 574

Query: 489 NINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPAFTWPSTSP 548
             + VV+EA+RLLLLGLACSHPIA+ERPKT+ I+Q++SG+ +VPYVP FKPAF WPS + 
Sbjct: 575 GNDYVVEEAQRLLLLGLACSHPIATERPKTQAIVQVLSGSVSVPYVPPFKPAFVWPSMAS 634

Query: 549 PISMFDSILSSITLSSPGSG 568
             +  D  ++  T S   SG
Sbjct: 635 VPTATDIDITDDTSSRFDSG 654

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224061553|ref|XP_002300537.1| predicted protein [Populus trichocarpa] gi|222847795|gb|EEE85342.1| predicted protein [Populus trichocarpa]

 Score =  625 bits (1613), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 322/564 (57%), Positives = 408/564 (72%), Gaps = 22/564 (3%)

Query: 11  ISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHL 70
           I G G AF+IAP+   P E+S GQ+LGLTN+ TD N +N  VAIE DTVKQ FDPDDNH+
Sbjct: 112 IPGEGFAFLIAPDLELP-ENSNGQYLGLTNSTTDNNPSNGIVAIELDTVKQEFDPDDNHM 170

Query: 71  GLNINSVVSRKNVPLKD-NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLL 129
           GLNI+SV+SRK VPL +    I    G ++ VWV Y G SK ++V+M  EG+  P  P L
Sbjct: 171 GLNIHSVISRKTVPLVNLGIEIAPVGGRNHMVWVHYYGNSKRMEVYMVEEGKGKPATPTL 230

Query: 130 KETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDID-----VIQTKKEKDWKWLVI 184
              +NLK++++P+SYFGF+ASTG  + QLNCV  W L ++     V+      + K + I
Sbjct: 231 AAELNLKEHVRPKSYFGFAASTG-SNFQLNCVLKWNLTVEMLSDPVVNGSGRDNKKLIKI 289

Query: 185 SAGVGVPLVAVLLV-LCAIAYVKKRRSRVAEPHHNLGKLRLPGMPREFKYKELKKATNNF 243
             G+GV L + LL+ + ++ Y   ++   ++P        LPGMPREF +K+LKKATNNF
Sbjct: 290 CVGIGVALFSFLLIGVGSLVYYLHKKRAASDPKLLRALQSLPGMPREFPFKDLKKATNNF 349

Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRH 303
            E  +LG+GGFG+VYKG++        +N Q+AVKKFSRD+IK + DFL+EL +I+RLRH
Sbjct: 350 DEKHKLGQGGFGVVYKGVLPK------ENIQVAVKKFSRDNIKGQDDFLSELTVINRLRH 403

Query: 304 KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVT-LNWNHRYKILTGVASAVYY 362
           KHLV L+GWCH+ G LLLVYD+MPNGSL+ +L+   E+ T L WN RYKI++GVASA++Y
Sbjct: 404 KHLVRLLGWCHKNGMLLLVYDYMPNGSLDNHLFHEDEENTILGWNLRYKIISGVASALHY 463

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
           L  EYDQ VVHRDLKASNI+LD++FNARLGDFGLARA+ENE+ SYAE  L GVPGT+GY+
Sbjct: 464 LHKEYDQTVVHRDLKASNIMLDSEFNARLGDFGLARALENEKTSYAE--LEGVPGTLGYI 521

Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD 482
           APECFHTGKATPESDV+GFGAVVLEVVCG+ P   I   Q    LVDWVW LHREG I +
Sbjct: 522 APECFHTGKATPESDVYGFGAVVLEVVCGQRPWTKIGGFQF---LVDWVWSLHREGRILE 578

Query: 483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPAFT 542
           AVD+RLN + V +EA+RLLLLGLACSHPIA+ERPKT+ I QI+SG+   P VP FKPAF 
Sbjct: 579 AVDERLNNDYVAEEAQRLLLLGLACSHPIANERPKTQAIFQIVSGSVPAPRVPPFKPAFV 638

Query: 543 WPSTSPPISMFDSILSSITLSSPG 566
           WP+    I  FD+  +  T  + G
Sbjct: 639 WPAYDGSID-FDASSAGTTPITSG 661

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|5545339|dbj|BAA82556.1| lectin-like protein kinase [Populus nigra]

 Score =  618 bits (1594), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 325/560 (58%), Positives = 400/560 (71%), Gaps = 21/560 (3%)

Query: 13  GHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGL 72
           G GLAF+IAP+ + P E+S GQ+LGLTN+ TD N  N  VAIE DTVKQ FDPDDNH+GL
Sbjct: 114 GEGLAFLIAPDLALP-ENSDGQYLGLTNSTTDRNPENGIVAIELDTVKQEFDPDDNHMGL 172

Query: 73  NINSVVSRKNVPLKD-NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKE 131
           NI+SV+S K V L D    I      ++ VWV YDG SK ++V+M  EG   P  P L  
Sbjct: 173 NIHSVISLKTVSLDDLGIEIAPVGARNHMVWVHYDGNSKKMEVYMAEEGRAKPATPALAA 232

Query: 132 TINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDI-----DVIQTKKEKDWKWLVISA 186
            +NLKD ++ +SYFGF+ASTG  + QLNCV  W L +     D ++     + K + I  
Sbjct: 233 ELNLKDLVREKSYFGFAASTGR-NFQLNCVLKWNLTVEMLSDDSVENGGNDNKKLIKICV 291

Query: 187 GVGVPLVAVLLVLCAIAYVKKRRSRVAEPHHNLGKLR-LPGMPREFKYKELKKATNNFHE 245
           G+GV L ++LL+          + + A   + LG L+ LPG PREF +K+LKKATNNF E
Sbjct: 292 GIGVGLFSLLLIGVGTWLYYLHKKKAASDPNLLGALKSLPGTPREFPFKDLKKATNNFDE 351

Query: 246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKH 305
             +LG+GGFG+VYKG++        +N QIAVKKFSR++IK + DFL+EL II+RLRHKH
Sbjct: 352 RHKLGQGGFGVVYKGLLTK------ENIQIAVKKFSRENIKGQDDFLSELTIINRLRHKH 405

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE-QVTLNWNHRYKILTGVASAVYYLQ 364
           LV L+GWCH  G LLLVYD+MPNGSL+ +L+   E  V L WN RYKI++GVASA++YL 
Sbjct: 406 LVRLLGWCHRNGMLLLVYDYMPNGSLDNHLFHELEGNVILEWNLRYKIISGVASALHYLH 465

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
           NEYDQ VVHRDLKASNI+LD++FNARLGDFGLARA+ENE+ SYAE  L GVPGTMGY+AP
Sbjct: 466 NEYDQTVVHRDLKASNIMLDSEFNARLGDFGLARALENEKTSYAE--LEGVPGTMGYIAP 523

Query: 425 ECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV 484
           ECFHTGKAT ESDV+GFGAVVLEVVCG+ P   I   Q    LVDWVW LHRE  I +AV
Sbjct: 524 ECFHTGKATRESDVYGFGAVVLEVVCGQRPWTKIGGFQF---LVDWVWSLHREERILEAV 580

Query: 485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPAFTWP 544
           D+RLN + V +EAKRLLLLGLACSHPIASERPKT+ I QIISG+   P+VP FKPAF WP
Sbjct: 581 DERLNSDYVAEEAKRLLLLGLACSHPIASERPKTQAIFQIISGSVPPPHVPLFKPAFVWP 640

Query: 545 STSPPISMFDSILSSITLSS 564
           +    I +  S   +I ++S
Sbjct: 641 AAVGNIDVDASSADTIPITS 660

Source: Populus nigra

Species: Populus nigra

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255575267|ref|XP_002528537.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223532039|gb|EEF33849.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  604 bits (1558), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 323/562 (57%), Positives = 403/562 (71%), Gaps = 26/562 (4%)

Query: 11  ISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHL 70
           + G GLAF+IAP+ + P  +S+GQ+LGLTN+ TDG+ +N  VAIE DT KQ FDPD NH+
Sbjct: 114 VPGEGLAFLIAPDLNLP-RNSHGQYLGLTNSTTDGDPSNSIVAIELDTFKQDFDPDGNHI 172

Query: 71  GLNINSVVSRKNVPLKD-NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLL 129
           GL+I+SV S K V L D    I  ++   Y VWVQY G +K +QV+M   G   P  P+L
Sbjct: 173 GLDIHSVRSNKTVSLSDFGIEIAPAETKLYMVWVQYSGVNKELQVYMAERGRAKPTIPVL 232

Query: 130 KETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEK-----DWKWLVI 184
              ++LK  +   SYFGF+ASTG   IQLNCV  W L ++++ +  E      D K L I
Sbjct: 233 TADLDLKGLVNQNSYFGFAASTGTA-IQLNCVLGWNLTVELLPSAIENGENNNDHKLLKI 291

Query: 185 SAGVGVPLVAVLLVLCAIA---YVKKRRSRVAEPHHNLGKLR-LPGMPREFKYKELKKAT 240
             GVGV     LLV+   +   Y++K+R+   EP   +G L+ LPG PREFKY++LKKAT
Sbjct: 292 GIGVGVSGGLALLVIAVASFSCYIRKKRA-ACEPSL-MGALKSLPGTPREFKYRDLKKAT 349

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHR 300
           +NF E  +LG+GGFG+VYKG++        +N  +AVKKFSRD++KS+ DFLAEL II+R
Sbjct: 350 SNFDEKNKLGQGGFGVVYKGVLPK------ENIAVAVKKFSRDNLKSQDDFLAELTIINR 403

Query: 301 LRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLY-GTSEQVTLNWNHRYKILTGVASA 359
           LRHKHLV LVGWCH+   LLLVY++MPNGSL+ +++ G  E+ TL W  RY I+ GVASA
Sbjct: 404 LRHKHLVRLVGWCHKNEVLLLVYEYMPNGSLDSHIFHGPEEKTTLEWRLRYNIIAGVASA 463

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
           ++YL NEYDQKVVHRDLKASNI+LD++FNARLGDFGLARA++NE+ SYAE  L GVPGTM
Sbjct: 464 LHYLHNEYDQKVVHRDLKASNIMLDSNFNARLGDFGLARALDNEKTSYAE--LEGVPGTM 521

Query: 420 GYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH 479
           GY+APECFHTGKAT ESDV+GFGAVVLEVVCG  P   +   Q    LVDWVW LHREG 
Sbjct: 522 GYIAPECFHTGKATCESDVYGFGAVVLEVVCGLRPWTKVGGFQF---LVDWVWWLHREGR 578

Query: 480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKP 539
           I +AVD+RL  + +V+EA+RLLLLGLACSHPIASERPK + I QIISG   VP +P FKP
Sbjct: 579 ILEAVDERLGNDYIVEEAQRLLLLGLACSHPIASERPKAQAIFQIISGLVAVPRIPPFKP 638

Query: 540 AFTWPSTSPPISMFDSILSSIT 561
           AF WPST+ P +   SI   IT
Sbjct: 639 AFVWPSTAGPDTSVSSINMDIT 660

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297744450|emb|CBI37712.3| unnamed protein product [Vitis vinifera]

 Score =  603 bits (1554), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 322/569 (56%), Positives = 396/569 (69%), Gaps = 58/569 (10%)

Query: 6   RPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDP 65
           +P+W+ +G G AFVIAPN + P E+S+GQWLGLTNA TDG++ N  VA+EFDT KQ FDP
Sbjct: 117 QPSWN-AGEGFAFVIAPNLTIP-EASHGQWLGLTNATTDGDRTNQIVAVEFDTEKQDFDP 174

Query: 66  DDNHLGLNINSVVSRKNVPLK-DNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMP 124
           DDNH+GLNINSV S   V L      I+  +GT+Y+VWVQYDG++K+++V+M +EG+  P
Sbjct: 175 DDNHIGLNINSVRSYTTVSLTPSGIEISPEEGTNYSVWVQYDGQAKVMEVYMGKEGDPKP 234

Query: 125 QKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEKDWKWLVI 184
             PLL++TI+LK Y+K ESYFGF+ASTGYP IQLNCV  W LD++++   K   W  L I
Sbjct: 235 SSPLLRDTIDLKHYVKQESYFGFAASTGYPAIQLNCVLKWKLDMEILPGDKGFMWWLLSI 294

Query: 185 SAGVGVPLVAVLLVLCAIAYV---KKRRSRVAEPHHNLGKLR-LPGMPREFKYKELKKAT 240
            A     ++ +L+V+  I Y+   K+R     E  + LG LR L GMPREF+YK+LKKAT
Sbjct: 295 PA-----VILILVVVGGIVYLNYKKRREGGNREEGNVLGDLRRLTGMPREFRYKDLKKAT 349

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHR 300
            NF ES +LG+GGFG+VYKG++  +       T++AVK+FSRD IK KGDF+AEL IIHR
Sbjct: 350 KNFDESTKLGQGGFGVVYKGVLQEDGDD--STTEVAVKQFSRDDIKGKGDFMAELTIIHR 407

Query: 301 LRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
           LRHKHLV LVGWC+EKGKLLLVYDFMPNGSL+K+L+G     TLNW  RY I+TGV SA+
Sbjct: 408 LRHKHLVRLVGWCYEKGKLLLVYDFMPNGSLDKHLFGDHYDNTLNWERRYNIVTGVGSAL 467

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            YL NE+DQKV+                                       L G PGTMG
Sbjct: 468 LYLHNEFDQKVLE--------------------------------------LGGFPGTMG 489

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI 480
           YVAPECFHT KAT ESDV+ FGAVVLEVVCGRSPG+ I + Q  Y+LVDWVWMLHREG I
Sbjct: 490 YVAPECFHTQKATVESDVYAFGAVVLEVVCGRSPGSEISYNQRLYSLVDWVWMLHREGRI 549

Query: 481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPA 540
            +AVD+RL  N V DEA+RLLLLGLACSHP ASERP T  I+QI+SG+ + P+VP FKPA
Sbjct: 550 VEAVDERLGNNYVDDEARRLLLLGLACSHPSASERPATLAIVQILSGSVSAPHVPPFKPA 609

Query: 541 FTWPS----TSPPISMFDSILSSITLSSP 565
           FTW S    T+P  +    IL SI   SP
Sbjct: 610 FTWASMASLTTPTTTSI--ILPSIASLSP 636

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	568
TAIR|locus:2170224	652	AT5G06740 [Arabidopsis thalian	0.941	0.820	0.378	8.4e-97
TAIR|locus:2162212	681	AT5G55830 [Arabidopsis thalian	0.713	0.594	0.406	5.4e-94
TAIR|locus:2083986	715	AT3G53380 [Arabidopsis thalian	0.577	0.458	0.452	2.1e-90
TAIR|locus:2040681	675	RLK "receptor lectin kinase" [	0.512	0.431	0.440	7.2e-88
TAIR|locus:2143528	711	AT5G03140 [Arabidopsis thalian	0.551	0.440	0.455	3.1e-87
TAIR|locus:2084375	677	AT3G53810 [Arabidopsis thalian	0.512	0.429	0.442	7.2e-86
TAIR|locus:2133229	674	LPK1 "lectin-like protein kina	0.507	0.427	0.429	1e-84
TAIR|locus:2133239	669	AT4G02420 [Arabidopsis thalian	0.510	0.433	0.428	1.3e-84
TAIR|locus:2142499	651	AT5G10530 [Arabidopsis thalian	0.945	0.824	0.354	5.2e-81
TAIR|locus:2020608	666	AT1G70110 [Arabidopsis thalian	0.515	0.439	0.410	4.6e-80

TAIR|locus:2170224 AT5G06740 [Arabidopsis thaliana (taxid:3702)]

 Score = 962 (343.7 bits), Expect = 8.4e-97, P = 8.4e-97
 Identities = 213/563 (37%), Positives = 318/563 (56%)

Query:    10 DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDP-DDN 68
             D  G GLAFV+ P ++ P  SS G WLG+ N  T+ N  +  V++EFDT K   D  D N
Sbjct:   103 DPGGEGLAFVLTPEETAPQNSS-GMWLGMVNERTNRNNESRIVSVEFDTRKSHSDDLDGN 161

Query:    69 HLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPL 128
             H+ LN+N++ S     L     I +  G   T  V+YDGK+  + V++ R  +   Q+ L
Sbjct:   162 HVALNVNNINSVVQESLSGR-GIKIDSGLDLTAHVRYDGKN--LSVYVSRNLDVFEQRNL 218

Query:   129 L-KETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEKDWKWLVISXX 187
             +    I+L  YL    Y GF+AST     +LNCVRSW+ +   I       W W+ I   
Sbjct:   219 VFSRAIDLSAYLPETVYVGFTASTSN-FTELNCVRSWSFEGLKIDGDGNMLWLWITIPIV 277

Query:   188 XXXXXXXXXXXXXXXXXXKKRRSRVAEPHHNL-GKL-RLPGMPREFKYKELKKATNNFHE 245
                                + RS+  E + ++  +L      P++FK +ELK+AT NF  
Sbjct:   278 FIVGIGAFLGALYL-----RSRSKAGETNPDIEAELDNCAANPQKFKLRELKRATGNFGA 332

Query:   246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXX 305
               +LG+GGFG+V+KG     D        IAVK+ S  S + K +F+AE+  I       
Sbjct:   333 ENKLGQGGFGMVFKGKWQGRD--------IAVKRVSEKSHQGKQEFIAEITTIGNLNHRN 384

Query:   306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY-GTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                  GWC+E+ + LLVY++MPNGSL+KYL+     +  L W  R  I+TG++ A+ YL 
Sbjct:   385 LVKLLGWCYERKEYLLVYEYMPNGSLDKYLFLEDKSRSNLTWETRKNIITGLSQALEYLH 444

Query:   365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
             N  +++++HRD+KASN++LD+DFNA+LGDFGLAR I+    ++  H    + GT GY+AP
Sbjct:   445 NGCEKRILHRDIKASNVMLDSDFNAKLGDFGLARMIQQSEMTH--HSTKEIAGTPGYMAP 502

Query:   425 ECFHTGKATPESDVFGFGAVVLEVVCGRSPGN-MIPHQQHAY--TLVDWVWMLHREGHIQ 481
             E F  G+AT E+DV+ FG ++LEVV G+ P   ++   Q+ Y  ++V+W+W L+R G I 
Sbjct:   503 ETFLNGRATVETDVYAFGVLMLEVVSGKKPSYVLVKDNQNNYNNSIVNWLWELYRNGTIT 562

Query:   482 DAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPAF 541
             DA D  +      +E K +LLLGLAC HP  ++RP  + +L++++G ++ P VP  +PAF
Sbjct:   563 DAADPGMGNLFDKEEMKSVLLLGLACCHPNPNQRPSMKTVLKVLTGETSPPDVPTERPAF 622

Query:   542 TWPSTSPPISMFDSILSSITLSS 564
              WP+  P  S  D  L+   ++S
Sbjct:   623 VWPAMPPSFSDIDYSLTGSQINS 645

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

GO:0000041 "transition metal ion transport" evidence=RCA

TAIR|locus:2162212 AT5G55830 [Arabidopsis thaliana (taxid:3702)]

 Score = 738 (264.8 bits), Expect = 5.4e-94, Sum P(2) = 5.4e-94
 Identities = 183/450 (40%), Positives = 244/450 (54%)

Query:   124 PQKPLLKETINLKDYLKPESYFGFSAST-GYPHIQLNCVRSWTL---------------- 166
             P+KPLL   I+L  +L  E Y GFS ST G   I L  + +W+                 
Sbjct:   223 PEKPLLSVNIDLSPFLNGEMYVGFSGSTEGSTEIHL--IENWSFKTSGFLPVRSKSNHLH 280

Query:   167 ----------DIDVIQTKKEKDWKWLVISXXXXXXXXX-XXXXXXXXXXXKKRRSRVAEP 215
                       D  VI +KK +    L I                      KK +S  AE 
Sbjct:   281 NVSDSSVVNDDPVVIPSKKRRHRHNLAIGLGISCPVLICLALFVFGYFTLKKWKSVKAEK 340

Query:   216 HHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQI 275
                L    + G+ REF YKEL  AT  FH S  +G G FG VY+ +      +    T  
Sbjct:   341 E--LKTELITGL-REFSYKELYTATKGFHSSRVIGRGAFGNVYRAM------FVSSGTIS 391

Query:   276 AVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYL 335
             AVK+   +S + K +FLAEL+II            GWC+EKG+LLLVY+FMPNGSL+K L
Sbjct:   392 AVKRSRHNSTEGKTEFLAELSIIACLRHKNLVQLQGWCNEKGELLLVYEFMPNGSLDKIL 451

Query:   336 YGTSEQ--VTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD 393
             Y  S+   V L+W+HR  I  G+ASA+ YL +E +Q+VVHRD+K SNI+LD +FNARLGD
Sbjct:   452 YQESQTGAVALDWSHRLNIAIGLASALSYLHHECEQQVVHRDIKTSNIMLDINFNARLGD 511

Query:   394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRS 453
             FGLAR  E++++  +   L    GTMGY+APE    G AT ++D F +G V+LEV CGR 
Sbjct:   512 FGLARLTEHDKSPVST--LTA--GTMGYLAPEYLQYGTATEKTDAFSYGVVILEVACGRR 567

Query:   454 PGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIAS 513
             P +  P  Q    LVDWVW LH EG + +AVD+RL      +  K+LLL+GL C+HP ++
Sbjct:   568 PIDKEPESQKTVNLVDWVWRLHSEGRVLEAVDERLKGEFDEEMMKKLLLVGLKCAHPDSN 627

Query:   514 ERPKTEDILQIISGTSTVPYVPQFKPAFTW 543
             ERP    +LQI++       VP+ KP  ++
Sbjct:   628 ERPSMRRVLQILNNEIEPSPVPKMKPTLSF 657

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

TAIR|locus:2083986 AT3G53380 [Arabidopsis thaliana (taxid:3702)]

 Score = 732 (262.7 bits), Expect = 2.1e-90, Sum P(2) = 2.1e-90
 Identities = 157/347 (45%), Positives = 221/347 (63%)

Query:   228 PREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS 287
             P+EF YKELK  T NF+ES  +G G FG+VY+GI+            +AVK+ S  S   
Sbjct:   361 PKEFSYKELKAGTKNFNESRIIGHGAFGVVYRGILPETGDI------VAVKRCSHSSQDK 414

Query:   288 KGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWN 347
             K +FL+EL+II            GWCHEKG++LLVYD MPNGSL+K L+    + TL W+
Sbjct:   415 KNEFLSELSIIGSLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALF--ESRFTLPWD 472

Query:   348 HRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY 407
             HR KIL GVASA+ YL  E + +V+HRD+K+SNI+LD  FNA+LGDFGLAR IE++++  
Sbjct:   473 HRKKILLGVASALAYLHRECENQVIHRDVKSSNIMLDESFNAKLGDFGLARQIEHDKSPE 532

Query:   408 AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNM-IPHQQHAY- 465
             A    V   GTMGY+APE   TG+A+ ++DVF +GAVVLEVV GR P    +  Q+H   
Sbjct:   533 AT---VAA-GTMGYLAPEYLLTGRASEKTDVFSYGAVVLEVVSGRRPIEKDLNVQRHNVG 588

Query:   466 ---TLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDIL 522
                 LV+WVW L++EG +  A D RL       E  R+L++GLACSHP  + RP    ++
Sbjct:   589 VNPNLVEWVWGLYKEGKVSAAADSRLEGKFDEGEMWRVLVVGLACSHPDPAFRPTMRSVV 648

Query:   523 QIISGTSTVPYVPQFKPAFTWPSTSPPISMFDSI--LSSITLSSPGS 567
             Q++ G + VP VP+ +P  ++ ++   +S+ D++   +++ L+S  S
Sbjct:   649 QMLIGEADVPVVPKSRPTMSFSTSHLLLSLQDTLSDCNTVALNSSRS 695

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 634 (228.2 bits), Expect = 7.2e-88, Sum P(2) = 7.2e-88
 Identities = 133/302 (44%), Positives = 178/302 (58%)

Query:   231 FKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD 290
             F++K+L  AT  F E   LG GGFG VYKG++           +IAVK+ S +S +   +
Sbjct:   335 FRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGT------KLEIAVKRVSHESRQGMKE 388

Query:   291 FLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRY 350
             F+AE+  I            G+C  +G+LLLVYD+MPNGSL+KYLY T E VTLNW  R 
Sbjct:   389 FVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNTPE-VTLNWKQRI 447

Query:   351 KILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEH 410
             K++ GVAS ++YL  E++Q V+HRD+KASN+LLD + N RLGDFGLAR  ++  +    H
Sbjct:   448 KVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGSDPQTTH 507

Query:   411 GLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
                 V GT+GY+APE   TG+AT  +DVF FGA +LEV CGR P          + LVDW
Sbjct:   508 ----VVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQQETDETFLLVDW 563

Query:   471 VWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST 530
             V+ L  +G I  A D  +       E + +L LGL CSH     RP    +L  + G + 
Sbjct:   564 VFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPSMRQVLHYLRGDAK 623

Query:   531 VP 532
             +P
Sbjct:   624 LP 625

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2143528 AT5G03140 [Arabidopsis thaliana (taxid:3702)]

 Score = 676 (243.0 bits), Expect = 3.1e-87, Sum P(2) = 3.1e-87
 Identities = 154/338 (45%), Positives = 210/338 (62%)

Query:   228 PREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS 287
             PREF YKELK AT+ F  S  +G G FG VYKGI+  + +       IA+K+ S  S + 
Sbjct:   359 PREFTYKELKLATDCFSSSRVIGNGAFGTVYKGILQDSGEI------IAIKRCSHIS-QG 411

Query:   288 KGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWN 347
               +FL+EL++I            G+C EKG++LL+YD MPNGSL+K LY      TL W 
Sbjct:   412 NTEFLSELSLIGTLRHRNLLRLQGYCREKGEILLIYDLMPNGSLDKALY--ESPTTLPWP 469

Query:   348 HRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY 407
             HR KIL GVASA+ YL  E + +++HRD+K SNI+LDA+FN +LGDFGLAR  E++++  
Sbjct:   470 HRRKILLGVASALAYLHQECENQIIHRDVKTSNIMLDANFNPKLGDFGLARQTEHDKSPD 529

Query:   408 AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY-- 465
             A        GTMGY+APE   TG+AT ++DVF +GAVVLEV  GR P    P  +     
Sbjct:   530 A----TAAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVCTGRRPITR-PEPEPGLRP 584

Query:   466 ----TLVDWVWMLHREGHIQDAVDQRLN-INSVVDEAKRLLLLGLACSHPIASERPKTED 520
                 +LVDWVW L+REG +  AVD+RL+  N   +E  R++++GLACS P    RP    
Sbjct:   585 GLRSSLVDWVWGLYREGKLLTAVDERLSEFNP--EEMSRVMMVGLACSQPDPVTRPTMRS 642

Query:   521 ILQIISGTSTVPYVPQFKPAFTWP-STSPPI-SMFDSI 556
             ++QI+ G + VP VP  KP+ +   STS  + ++ DS+
Sbjct:   643 VVQILVGEADVPEVPIAKPSSSMSFSTSELLLTLQDSV 680

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)]

 Score = 637 (229.3 bits), Expect = 7.2e-86, Sum P(2) = 7.2e-86
 Identities = 134/303 (44%), Positives = 182/303 (60%)

Query:   231 FKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD 290
             F++KEL  AT  F E   LG GGFG VY+GI+           ++AVK+ S DS +   +
Sbjct:   335 FRFKELYHATKGFKEKDLLGSGGFGRVYRGILP------TTKLEVAVKRVSHDSKQGMKE 388

Query:   291 FLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRY 350
             F+AE+  I            G+C  +G+LLLVYD+MPNGSL+KYLY   E  TL+W  R 
Sbjct:   389 FVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNNPE-TTLDWKQRS 447

Query:   351 KILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEH 410
              I+ GVAS ++YL  E++Q V+HRD+KASN+LLDADFN RLGDFGLAR  ++  +    H
Sbjct:   448 TIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGDFGLARLYDHGSDPQTTH 507

Query:   411 GLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
                 V GT+GY+APE   TG+AT  +DV+ FGA +LEVV GR P          + LV+W
Sbjct:   508 ----VVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIEFHSASDDTFLLVEW 563

Query:   471 VWMLHREGHIQDAVDQRLNINSV-VDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS 529
             V+ L   G+I +A D +L  +   ++E + +L LGL CSH     RP    +LQ + G  
Sbjct:   564 VFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRARPSMRQVLQYLRGDM 623

Query:   530 TVP 532
              +P
Sbjct:   624 ALP 626

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009555 "pollen development" evidence=IMP

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2133229 LPK1 "lectin-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 604 (217.7 bits), Expect = 1.0e-84, Sum P(2) = 1.0e-84
 Identities = 130/303 (42%), Positives = 183/303 (60%)

Query:   232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF 291
             ++K+L  AT  F +   LG GGFG VY+G++    +      +IAVK+ S +S +   +F
Sbjct:   344 RFKDLYYATKGFKDKDLLGSGGFGRVYRGVMPTTKK------EIAVKRVSNESRQGLKEF 397

Query:   292 LAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYK 351
             +AE+  I            G+C  + +LLLVYD+MPNGSL+KYLY   E VTL+W  R+ 
Sbjct:   398 VAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLDKYLYDCPE-VTLDWKQRFN 456

Query:   352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
             ++ GVAS ++YL  E++Q V+HRD+KASN+LLDA++N RLGDFGLAR  ++  +      
Sbjct:   457 VIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNGRLGDFGLARLCDHGSDPQTTR- 515

Query:   412 LVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV 471
                V GT GY+AP+   TG+AT  +DVF FG ++LEV CGR P  +      +  LVD V
Sbjct:   516 ---VVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACGRRPIEIEIESDESVLLVDSV 572

Query:   472 WMLHREGHIQDAVDQRLNINSVVD--EAKRLLLLGLACSHPIASERPKTEDILQIISGTS 529
             +    EG+I DA D   N+ SV D  E + +L LGL CSH     RP    +LQ + G +
Sbjct:   573 FGFWIEGNILDATDP--NLGSVYDQREVETVLKLGLLCSHSDPQVRPTMRQVLQYLRGDA 630

Query:   530 TVP 532
             T+P
Sbjct:   631 TLP 633

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009625 "response to insect" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

TAIR|locus:2133239 AT4G02420 [Arabidopsis thaliana (taxid:3702)]

 Score = 612 (220.5 bits), Expect = 1.3e-84, Sum P(2) = 1.3e-84
 Identities = 129/301 (42%), Positives = 179/301 (59%)

Query:   232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF 291
             ++K+L  AT  F +   LG GGFG VYKGI+    +      +IAVK+ S +S +   +F
Sbjct:   339 RFKDLYYATKGFKDKNILGSGGFGSVYKGIMPKTKK------EIAVKRVSNESRQGLKEF 392

Query:   292 LAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYK 351
             +AE+  I            G+C  + +LLLVYD+MPNGSL+KYLY + E VTL+W  R+K
Sbjct:   393 VAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPNGSLDKYLYNSPE-VTLDWKQRFK 451

Query:   352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
             ++ GVASA++YL  E++Q V+HRD+KASN+LLDA+ N RLGDFGLA+  ++  +      
Sbjct:   452 VINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGDFGLAQLCDHGSDPQTTR- 510

Query:   412 LVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV 471
                V GT GY+AP+   TG+AT  +DVF FG ++LEV CGR P  +         LVDWV
Sbjct:   511 ---VVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGRRPIEINNQSGERVVLVDWV 567

Query:   472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTV 531
             +    E +I DA D  L       E + +L LGL CSH     RP    +LQ + G + +
Sbjct:   568 FRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHSDPLARPTMRQVLQYLRGDAML 627

Query:   532 P 532
             P
Sbjct:   628 P 628

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2142499 AT5G10530 [Arabidopsis thaliana (taxid:3702)]

 Score = 813 (291.2 bits), Expect = 5.2e-81, P = 5.2e-81
 Identities = 203/572 (35%), Positives = 311/572 (54%)

Query:    13 GHGLAFVIAP-NDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDT-VKQGFDPDD--N 68
             GHG AF +AP     PP S+ G +LGL N   + + A   V +EFDT     +DP D  +
Sbjct:    98 GHGFAFFLAPARIQLPPNSA-GGFLGLFNGTNNQSSAFPLVYVEFDTFTNPEWDPLDVKS 156

Query:    69 HLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMP-QKP 127
             H+G+N NS+VS        ++N T  +     V + YD   + + V    +  + P +  
Sbjct:   157 HVGINNNSLVSSNYT----SWNATSHNQDIGRVLIFYDSARRNLSVSWTYDLTSDPLENS 212

Query:   128 LLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLD--IDVIQTKK-EKDWKWLVI 184
              L   I+L   L  E   GFSA++G    + N + SW     +++I  KK + D K ++I
Sbjct:   213 SLSYIIDLSKVLPSEVTIGFSATSGGV-TEGNRLLSWEFSSSLELIDIKKSQNDKKGMII 271

Query:   185 SXXXXXXXXXXXXXXXXXXXXK-KRRSRVAEPHHNLGKL-----RLPGMPREFKYKELKK 238
                                  K K++ + AE   NL  +     R  G PR+F YK+L  
Sbjct:   272 GISVSGFVLLTFFITSLIVFLKRKQQKKKAEETENLTSINEDLERGAG-PRKFTYKDLAS 330

Query:   239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAII 298
             A NNF +  +LGEGGFG VY+G ++  D        +A+KKF+  S + K +F+ E+ II
Sbjct:   331 AANNFADDRKLGEGGFGAVYRGYLNSLDM------MVAIKKFAGGSKQGKREFVTEVKII 384

Query:   299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVAS 358
                         GWCHEK + L++Y+FMPNGSL+ +L+G      L W+ R KI  G+AS
Sbjct:   385 SSLRHRNLVQLIGWCHEKDEFLMIYEFMPNGSLDAHLFGKKPH--LAWHVRCKITLGLAS 442

Query:   359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
             A+ YL  E++Q VVHRD+KASN++LD++FNA+LGDFGLAR +++E          G+ GT
Sbjct:   443 ALLYLHEEWEQCVVHRDIKASNVMLDSNFNAKLGDFGLARLMDHELGPQT----TGLAGT 498

Query:   419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYT-LVDWVWMLHRE 477
              GY+APE   TG+A+ ESDV+ FG V LE+V GR   +    +    T LV+ +W L+ +
Sbjct:   499 FGYMAPEYISTGRASKESDVYSFGVVTLEIVTGRKSVDRRQGRVEPVTNLVEKMWDLYGK 558

Query:   478 GHIQDAVDQRLNINSVVD-EAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQ 536
             G +  A+D++L I    + +A+ L+++GL C+HP  + RP  +  +Q+++  + VP++P 
Sbjct:   559 GEVITAIDEKLRIGGFDEKQAECLMIVGLWCAHPDVNTRPSIKQAIQVLNLEAPVPHLPT 618

Query:   537 FKPAFTWPSTSPPISMFDSILSSITLSSPGSG 568
               P  T+  +S   +   S  +++T SS   G
Sbjct:   619 KMPVATYHVSSSNTTSVSSGGATVTFSSAQHG 650

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2020608 AT1G70110 [Arabidopsis thaliana (taxid:3702)]

 Score = 611 (220.1 bits), Expect = 4.6e-80, Sum P(2) = 4.6e-80
 Identities = 126/307 (41%), Positives = 182/307 (59%)

Query:   228 PREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS 287
             P  F +K+L  AT  F ++  LG+GGFG VYKG +       V N +IAVK  S DS + 
Sbjct:   329 PHRFAFKDLHIATKGFKDTEVLGKGGFGKVYKGTLP------VSNVEIAVKMVSHDSRQG 382

Query:   288 KGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWN 347
               +F+AE+A I            G+C  KG+L LVYD M  GSL+K+LY   +   L+W+
Sbjct:   383 MREFIAEIATIGRLRHPNLVRLQGYCRHKGELYLVYDCMAKGSLDKFLYH-QQTGNLDWS 441

Query:   348 HRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY 407
              R+KI+  VAS +YYL  ++ Q ++HRD+K +NILLDA+ NA+LGDFGLA+  ++  +  
Sbjct:   442 QRFKIIKDVASGLYYLHQQWVQVIIHRDIKPANILLDANMNAKLGDFGLAKLCDHGTDPQ 501

Query:   408 AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPH-QQHAYT 466
               H    V GT+GY++PE   TGKA+  SDVF FG V+LE+ CGR P  ++P   Q    
Sbjct:   502 TSH----VAGTLGYISPELSRTGKASTRSDVFAFGIVMLEIACGRKP--ILPRASQREMV 555

Query:   467 LVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS 526
             L DWV        I   +D ++    V ++A  +L LGL CSHP+A+ RP    ++Q++ 
Sbjct:   556 LTDWVLECWENEDIMQVLDHKIGQEYVEEQAALVLKLGLFCSHPVAAIRPNMSSVIQLLD 615

Query:   527 GTSTVPY 533
               + +P+
Sbjct:   616 SVAQLPH 622

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9FG33	LRKS5_ARATH	2, ., 7, ., 1, 1, ., 1	0.3932	0.9348	0.8144	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.66.708.1 hypothetical protein (608 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	568
cd06899	236	cd06899, lectin_legume_LecRK_Arcelin_ConA, legume	7e-58
pfam00139	231	pfam00139, Lectin_legB, Legume lectin domain	5e-50
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-47
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-45
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-44
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-44
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-43
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-42
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-42
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-34
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-32
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-29
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-28
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-27
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-26
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-26
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-26
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-25
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-24
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-24
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-23
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-23
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-22
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-22
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-22
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-22
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-22
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	9e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-21
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-21
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-21
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-21
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-20
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-20
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-20
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-20
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-20
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-19
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-19
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-19
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-19
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-19
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-19
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-19
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-18
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-17
cd01951	223	cd01951, lectin_L-type, legume lectins	2e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-17
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-17
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-17
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-16
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	9e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-15
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-15
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-15
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-14
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-14
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-14
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	9e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-13
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-13
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-11
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-11
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-10
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	8e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-09
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-09
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	6e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	9e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-08
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-08
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-07
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-07
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-06
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-06
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-05
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-05
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-05
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-04
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-04
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-04
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-04
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.001
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.002
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	0.002
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.002

>gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

 Score =  192 bits (491), Expect = 7e-58
 Identities = 68/159 (42%), Positives = 93/159 (58%), Gaps = 5/159 (3%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGF--DPDD 67
            + G GLAF +AP DS PP +S G +LGL N+  +GN +NH VA+EFDT +     DPDD
Sbjct: 77  SLGGDGLAFFLAPTDSLPP-ASSGGYLGLFNSSNNGNSSNHIVAVEFDTFQNPEFGDPDD 135

Query: 68  NHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKP 127
           NH+G+++NS+VS K     D+    L  G     W+ YD  SK + V +   G   P+KP
Sbjct: 136 NHVGIDVNSLVSVKAGYWDDD-GGKLKSGKPMQAWIDYDSSSKRLSVTLAYSGVAKPKKP 194

Query: 128 LLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTL 166
           LL   ++L   L  E Y GFSASTG    +L+ + SW+ 
Sbjct: 195 LLSYPVDLSKVLPEEVYVGFSASTGLL-TELHYILSWSF 232

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236

>gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain

 Score =  172 bits (437), Expect = 5e-50
 Identities = 61/164 (37%), Positives = 90/164 (54%), Gaps = 7/164 (4%)

Query: 4   DPRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGF 63
              P     G GLAF +AP+ +  P +S G +LGL N+  +GN +NH VA+EFDT     
Sbjct: 71  KNIPKSTNGGDGLAFFLAPSGT-QPGASSGGYLGLFNSSNNGNSSNHIVAVEFDTFLNPE 129

Query: 64  --DPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGE 121
             D DDNH+G+++NS++S  +        + L+ G    VW+ YDG SK + V +     
Sbjct: 130 FNDIDDNHVGIDVNSIISVASESASFV-PLDLNSGKPIQVWIDYDGSSKRLSVTLA--YP 186

Query: 122 TMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWT 165
             P++PLL  +++L   L    Y GFSASTG    + + V SW+
Sbjct: 187 NKPKRPLLSASVDLSTVLPEWVYVGFSASTGGA-TESHYVLSWS 229

Length = 231

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  165 bits (419), Expect = 5e-47
 Identities = 69/215 (32%), Positives = 101/215 (46%), Gaps = 20/215 (9%)

Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD--FLAELAIIHR 300
           +    +LG G FG VYK   H      V     AVK   + S KSK D     E+ I+ R
Sbjct: 1   YELLRKLGSGSFGTVYKAK-HKGTGKIV-----AVKILKKRSEKSKKDQTARREIRILRR 54

Query: 301 LRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
           L H ++V L+    +K  L LV ++   G L  YL   S    L+ +   KI   +   +
Sbjct: 55  LSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGL 111

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            YL   +   ++HRDLK  NILLD +   ++ DFGLA+ +    +S      V   GT  
Sbjct: 112 EYL---HSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFV---GTPW 163

Query: 421 YVAPE-CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           Y+APE         P+ DV+  G ++ E++ G+ P
Sbjct: 164 YMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  159 bits (405), Expect = 1e-45
 Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 19/202 (9%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAIIHRLRHKHLV 307
           LGEGGFG VY        +      ++A+K   + DS     + L E+ I+ +L H ++V
Sbjct: 1   LGEGGFGTVYLA------RDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIV 54

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L G   ++  L LV ++   GSL+  L     +  L+ +   +IL  +   + YL +  
Sbjct: 55  KLYGVFEDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHS-- 110

Query: 368 DQKVVHRDLKASNILLDAD-FNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
              ++HRDLK  NILLD+D    +L DFGL++ + ++++      L  + GT  Y+APE 
Sbjct: 111 -NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL-----LKTIVGTPAYMAPEV 164

Query: 427 FH-TGKATPESDVFGFGAVVLE 447
               G  + +SD++  G ++ E
Sbjct: 165 LLGKGYYSEKSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  158 bits (402), Expect = 1e-44
 Identities = 68/221 (30%), Positives = 111/221 (50%), Gaps = 15/221 (6%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLV 307
           LGEG FG VYKG +  + +     T++AVK      S + + +FL E +I+ +L H ++V
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGT--ETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L+G C +   L +V ++MP G L  +L    E++TL      ++   +A  + YL+   
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE--- 119

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA-EHGLVGVPGTMGYVAPEC 426
            +  VHRDL A N L+  +   ++ DFGL+R I  +        G + +     ++APE 
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPES 175

Query: 427 FHTGKATPESDVFGFGAVVLEVVC-GRSP-GNMIPHQQHAY 465
              GK T +SDV+ FG ++ E+   G  P   M   +    
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEL 216

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  157 bits (399), Expect = 3e-44
 Identities = 71/222 (31%), Positives = 114/222 (51%), Gaps = 18/222 (8%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLV 307
           LGEG FG VYKG +   D    +   +AVK    D S + + DFL E  ++ +L H ++V
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTE---VAVKTLKEDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYL------YGTSEQVTLNWNHRYKILTGVASAVY 361
            L+G C E+  L LV ++M  G L  YL      + + E+ TL+          +A  + 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGY 421
           YL +   +K VHRDL A N L+  D   ++ DFGL+R + ++ + Y +     +P  + +
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD-DYYRKKTGGKLP--IRW 173

Query: 422 VAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP-GNMIPHQ 461
           +APE    G  T +SDV+ FG ++ E+   G +P   +   +
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE 215

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  155 bits (395), Expect = 1e-43
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 19/207 (9%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK-GDFLAELAIIHRLRHKHLV 307
           LGEG FG VY                +A+K   +  IK      L E+ I+ +L+H ++V
Sbjct: 7   LGEGSFGKVYLAR------DKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L     ++ KL LV ++   G L   L    ++  L+ +     L  + SA+ YL    
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLH--- 114

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            + +VHRDLK  NILLD D + +L DFGLAR ++           V   GT  Y+APE  
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFV---GTPEYMAPEVL 168

Query: 428 HTGKATPESDVFGFGAVVLEVVCGRSP 454
                    D++  G ++ E++ G+ P
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  151 bits (385), Expect = 3e-42
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 14/216 (6%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLAELAIIHRLRHKHLV 307
           LGEG FG VYKG +           ++AVK    D+ +    +FL E  I+ +L H ++V
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKK--VEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L+G C E+  L +V ++M  G L  YL        L+ +        +A  + YL    
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP--KLSLSDLLSFALQIARGMEYL---E 119

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R + ++       G + +     ++APE  
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPESL 175

Query: 428 HTGKATPESDVFGFGAVVLEVV--CGRSPGNMIPHQ 461
             GK T +SDV+ FG ++ E+     +    M   +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 211

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  151 bits (384), Expect = 4e-42
 Identities = 65/220 (29%), Positives = 106/220 (48%), Gaps = 13/220 (5%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLV 307
           LGEG FG VYKG +           ++AVK    D S +   +FL E  I+ +L H ++V
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKE--VEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L+G C E+  L++V ++MP G L  YL   +    L+ +        +A  + YL    
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYL---E 120

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R + ++     + G + +     ++APE  
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPESL 176

Query: 428 HTGKATPESDVFGFGAVVLEVV--CGRSPGNMIPHQQHAY 465
             GK T +SDV+ FG ++ E+          M   +   Y
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEY 216

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  129 bits (327), Expect = 4e-34
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 25/223 (11%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK--FSRDSIKSKGDFLAELAIIHRLRHKHL 306
           LG G FG VY  +             +AVK    S DS +       E+ I+  L+H ++
Sbjct: 8   LGRGSFGSVYLALDKDT------GELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI 61

Query: 307 VHLVGWCHEKGK--LLLVYDFMPNGSLEKYL--YGT-SEQVTLNWNHRYKILTGVASAVY 361
           V   G   ++ K  L +  +++  GSL   L  +G   E V   +  +  IL G+A    
Sbjct: 62  VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ--ILEGLA---- 115

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGY 421
           YL       +VHRD+K +NIL+D+D   +L DFG A+ + +         + G P  M  
Sbjct: 116 YLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM-- 170

Query: 422 VAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHA 464
            APE     +    +D++  G  V+E+  G+ P + + +   A
Sbjct: 171 -APEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  125 bits (315), Expect = 3e-32
 Identities = 84/293 (28%), Positives = 135/293 (46%), Gaps = 40/293 (13%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNT--QIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKH 305
           LGEG FG V      ++     DNT  Q+AVK  +     + + DF  E+ I+  L H++
Sbjct: 12  LGEGHFGKVELC--RYDPLG--DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 306 LVHLVGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRY--KILTGVASAVY 361
           +V   G C + G   L L+ +++P+GSL  YL    +Q+ L     +  +I  G+     
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMD---- 123

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGY 421
           YL +   Q+ +HRDL A NIL++++   ++ DFGLA+ +  +++ Y        P  + +
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP--IFW 178

Query: 422 VAPECFHTGKATPESDVFGFGAVVLEVVC-GRS----PGN---MIPHQQHAYTLVDWVWM 473
            APEC  T K +  SDV+ FG  + E+   G      P     MI   Q    +   + +
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238

Query: 474 LHREGHIQDAVDQRLNI-NSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
           L           +RL    S  DE   L+ L   C      +RP   D++ I+
Sbjct: 239 LKE--------GERLPRPPSCPDEVYDLMKL---CWEAEPQDRPSFADLILIV 280

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  116 bits (293), Expect = 2e-29
 Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 17/208 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           +LG G FG V+ G            T++AVK     ++ S   FL E  I+ +LRH  LV
Sbjct: 13  KLGAGQFGEVWMG-------TWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLV 64

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L   C E+  + +V ++M  GSL  +L  + E   L       +   +A  + YL++  
Sbjct: 65  QLYAVCSEEEPIYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMAAQIAEGMAYLES-- 121

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A NIL+  +   ++ DFGLAR IE+  + Y        P  + + APE  
Sbjct: 122 -RNYIHRDLAARNILVGENLVCKIADFGLARLIED--DEYTAREGAKFP--IKWTAPEAA 176

Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
           + G+ T +SDV+ FG ++ E+V  GR P
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 9e-29
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 22/212 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH 308
           +G+G FG V  G             ++AVK   +D   +   FLAE +++  LRH +LV 
Sbjct: 14  IGKGEFGDVMLGDYR--------GQKVAVKC-LKDDSTAAQAFLAEASVMTTLRHPNLVQ 64

Query: 309 LVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
           L+G   +   L +V ++M  GSL  YL      V +    +      V   + YL+   +
Sbjct: 65  LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLE---E 120

Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           +  VHRDL A N+L+  D  A++ DFGLA+         A  G       + + APE   
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAKE--------ASQGQDSGKLPVKWTAPEALR 172

Query: 429 TGKATPESDVFGFGAVVLEVVC-GRSPGNMIP 459
             K + +SDV+ FG ++ E+   GR P   IP
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  113 bits (285), Expect = 2e-28
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 16/202 (7%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           +LG G FG V++G+         +  ++A+K    D +  + DF  E+  + RLRHKHL+
Sbjct: 13  KLGSGYFGEVWEGLWK-------NRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L   C     + ++ + M  GSL  +L  + E   L       +   VA  + YL+   
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLE--- 121

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           +Q  +HRDL A NIL+  D   ++ DFGLAR I+ +    ++     +P    + APE  
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK---KIP--YKWTAPEAA 176

Query: 428 HTGKATPESDVFGFGAVVLEVV 449
             G  + +SDV+ FG ++ E+ 
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMF 198

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  113 bits (284), Expect = 3e-28
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 24/207 (11%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF-SRDSIKSKGDFLAELAIIHRLRHKHLV 307
           +G G FG V +G +    +  +D   +A+K   +  S K + DFL E +I+ +  H +++
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEID---VAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L G   +   ++++ ++M NGSL+K+L     + T        +L G+AS + YL    
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT--VGQLVGMLRGIASGMKYLS--- 123

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG------Y 421
           +   VHRDL A NIL++++   ++ DFGL+R +E+   +Y          T G      +
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT---------TKGGKIPIRW 174

Query: 422 VAPECFHTGKATPESDVFGFGAVVLEV 448
            APE     K T  SDV+ FG V+ EV
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEV 201

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 6e-27
 Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 23/208 (11%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLAELAIIHRLRHKHL 306
            LG G FG V KG+        V   ++AVK   ++ I + K +FL E +++ +L H  +
Sbjct: 2   ELGHGNFGSVVKGVYLMKSGKEV---EVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCI 58

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKILTGVASAVYYL 363
           V L+G C  +  L+LV +  P G L KYL               H+      VA  + YL
Sbjct: 59  VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYL 111

Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY--AEHGLVGVPGTMGY 421
           +    +  VHRDL A N+LL     A++ DFG++RA+    + Y     G   +     +
Sbjct: 112 E---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK----W 164

Query: 422 VAPECFHTGKATPESDVFGFGAVVLEVV 449
            APEC + GK + +SDV+ +G  + E  
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 7e-27
 Identities = 64/219 (29%), Positives = 113/219 (51%), Gaps = 27/219 (12%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAIIH 299
           N+     +G G FG+VYKG+      +      +A+K+ S + IK +     + E+ ++ 
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDF------VAIKQISLEKIKEEALKSIMQEIDLLK 54

Query: 300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGT-SEQVTLNWNHRYKILTGV 356
            L+H ++V  +G       L ++ ++  NGSL + +  +G   E  +L   + Y++L G+
Sbjct: 55  NLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE--SLVAVYVYQVLQGL 112

Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA-RAIENERNSYAEHGLVGV 415
           A    YL   ++Q V+HRD+KA+NIL   D   +L DFG+A +  +  ++   +  +VG 
Sbjct: 113 A----YL---HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD---DASVVGT 162

Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           P  M   APE      A+  SD++  G  V+E++ G  P
Sbjct: 163 PYWM---APEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  108 bits (271), Expect = 2e-26
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 17/207 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           ++G+GGFG VYK   H      V     A+K    +S + K   + E+ I+ + +H ++V
Sbjct: 7   KIGKGGFGEVYKAR-HKRTGKEV-----AIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G   +K +L +V +F   GSL+  L  T++  TL  +    +   +   + YL +  
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ--TLTESQIAYVCKELLKGLEYLHS-- 116

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
              ++HRD+KA+NILL +D   +L DFGL+  + + +   A + +V   GT  ++APE  
Sbjct: 117 -NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK---ARNTMV---GTPYWMAPEVI 169

Query: 428 HTGKATPESDVFGFGAVVLEVVCGRSP 454
           +      ++D++  G   +E+  G+ P
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 2e-26
 Identities = 68/209 (32%), Positives = 105/209 (50%), Gaps = 19/209 (9%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           +LG G FG V++G+ +       + T +AVK     ++  K DFLAE  I+ +LRH  L+
Sbjct: 13  KLGAGQFGEVWEGLWN-------NTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLI 64

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L   C  +  + +V + M  GSL +YL G      L       +   VAS + YL+   
Sbjct: 65  QLYAVCTLEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEA-- 121

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAI-ENERNSYAEHGLVGVPGTMGYVAPEC 426
            Q  +HRDL A N+L+  +   ++ DFGLAR I E+   +       G    + + APE 
Sbjct: 122 -QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR-----EGAKFPIKWTAPEA 175

Query: 427 FHTGKATPESDVFGFGAVVLEVVC-GRSP 454
               + + +SDV+ FG ++ E+V  GR P
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  110 bits (274), Expect = 3e-26
 Identities = 66/240 (27%), Positives = 108/240 (45%), Gaps = 21/240 (8%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELAII 298
           ++    +LGEG FG VY            D   +A+K  ++       +   FL E+ I+
Sbjct: 1   SYRILRKLGEGSFGEVYLAR---------DRKLVALKVLAKKLESKSKEVERFLREIQIL 51

Query: 299 HRLRH-KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
             L H  ++V L  +  ++G L LV +++  GSLE  L     +  L+ +    IL  + 
Sbjct: 52  ASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQIL 111

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDAD-FNARLGDFGLARAIENER-NSYAEHGLVGV 415
           SA+ YL   + + ++HRD+K  NILLD D    +L DFGLA+ + +    S         
Sbjct: 112 SALEYL---HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168

Query: 416 PGTMGYVAPECFH---TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW 472
            GT GY+APE         A+  SD++  G  + E++ G  P     +       +  + 
Sbjct: 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228

Length = 384

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  107 bits (268), Expect = 4e-26
 Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 17/205 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLAELAIIHRLRHKHL 306
           +LG+G FG+V +G    +    +    +AVK    D +     DFL E AI+H L H++L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVI---PVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL 58

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQ---VTLNWNHRYKILTGVASAVYYL 363
           + L G       L++V +  P GSL   L   +     ++   ++  +I  G+     YL
Sbjct: 59  IRLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR----YL 113

Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
           ++   ++ +HRDL A NILL +D   ++GDFGL RA+    + Y     + VP    + A
Sbjct: 114 ES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWCA 168

Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE   T   +  SDV+ FG  + E+
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  106 bits (266), Expect = 1e-25
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 20/219 (9%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLAELAIIHRLRHKHLV 307
           LGEG FG V+ G  +H +  + D   +AVK     +    + DF  E  ++   +H+++V
Sbjct: 13  LGEGAFGKVFLGECYHLEPEN-DKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYL-----------YGTSEQVTLNWNHRYKILTGV 356
              G C E    ++V+++M +G L K+L              S    L  +   +I   +
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP 416
           AS + YL +   Q  VHRDL   N L+  D   ++GDFG++R +    + Y   G   +P
Sbjct: 132 ASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT-DYYRVGGHTMLP 187

Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
             + ++ PE     K T ESDV+ FG V+ E+   G+ P
Sbjct: 188 --IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  105 bits (264), Expect = 2e-25
 Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 41/233 (17%)

Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK--FSRDSIKSKG 289
           KY+ +K+          +G+G FG VY  +   +D          +K+   S  S K + 
Sbjct: 1   KYEIIKQ----------IGKGSFGKVYL-VRRKSDGKLY-----VLKEIDLSNMSEKERE 44

Query: 290 DFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--------YGTSEQ 341
           D L E+ I+ +L H +++       EKGKL +V ++   G L + +            EQ
Sbjct: 45  DALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQ 104

Query: 342 VTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE 401
           + L+W         +  A+ YL   + +K++HRD+K  NI L ++   +LGDFG+++ + 
Sbjct: 105 I-LDW------FVQLCLALKYL---HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS 154

Query: 402 NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +         +VG P    Y++PE         +SD++  G V+ E+   + P
Sbjct: 155 S--TVDLAKTVVGTP---YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 1e-24
 Identities = 70/239 (29%), Positives = 115/239 (48%), Gaps = 32/239 (13%)

Query: 229 REFKYKELKKATNNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSRDS-IK 286
           R  K  EL+K          LG G FG VYKG+ I   ++  +    +A+K    ++  K
Sbjct: 2   RILKETELEKIK-------VLGSGAFGTVYKGVWIPEGEKVKIP---VAIKVLREETSPK 51

Query: 287 SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE----QV 342
           +  + L E  ++  + H H+V L+G C    ++ L+   MP G L  Y+    +    Q 
Sbjct: 52  ANKEILDEAYVMASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQY 110

Query: 343 TLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN 402
            LNW         +A  + YL+   ++++VHRDL A N+L+    + ++ DFGLA+ ++ 
Sbjct: 111 LLNWC------VQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161

Query: 403 ERNSY-AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIP 459
           +   Y AE G V +     ++A E       T +SDV+ +G  V E++  G  P   IP
Sbjct: 162 DEKEYHAEGGKVPIK----WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  101 bits (254), Expect = 3e-24
 Identities = 66/208 (31%), Positives = 110/208 (52%), Gaps = 18/208 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           +LG G FG V+ G       Y+  +T++A+K   + S+ S   FLAE  ++ +L+H  LV
Sbjct: 13  KLGAGQFGEVWMG-------YYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLV 64

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L      +  + ++ ++M NGSL  +L  T E + L  N    +   +A  + +++   
Sbjct: 65  RLYAVV-TQEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIER-- 120

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL+A+NIL+      ++ DFGLAR IE+   +  E    G    + + APE  
Sbjct: 121 -KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAI 175

Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
           + G  T +SDV+ FG ++ E+V  GR P
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 1e-23
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 34/215 (15%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF----SRDSIKSKGDFLAELAIIHRLRH 303
           +LGEG +G+VYK       +       +A+KK       + I S    L E++++  L+H
Sbjct: 6   KLGEGTYGVVYKARDKKTGEI------VALKKIRLDNEEEGIPSTA--LREISLLKELKH 57

Query: 304 KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNW--NHRYKILTGVASAVY 361
            ++V L+   H + KL LV+++     L+KYL      ++ N   +  Y++L G+     
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGL----A 112

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGY 421
           Y    +  +++HRDLK  NIL++ D   +L DFGLARA      +Y  H +V    T+ Y
Sbjct: 113 YC---HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT-HEVV----TLWY 164

Query: 422 VAPE----CFHTGKATPESDVFGFGAVVLEVVCGR 452
            APE      H        D++  G +  E++ G+
Sbjct: 165 RAPEILLGSKHYS---TAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =   99 bits (249), Expect = 1e-23
 Identities = 62/208 (29%), Positives = 110/208 (52%), Gaps = 16/208 (7%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++  ++H +LV
Sbjct: 13  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 65

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L+G C  +    ++ +FM  G+L  YL   + Q  +N      + T ++SA+ YL+   
Sbjct: 66  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK-- 122

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +  +  +Y  H     P  + + APE  
Sbjct: 123 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFP--IKWTAPESL 177

Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIATYGMSP 205

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 27/215 (12%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK-FSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           LG+G FG+VY+G+     +   + T++A+K      S++ + +FL E +++      H+V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPE-TRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGT-------------SEQVTLNWNHRYKILT 354
            L+G        L+V + M  G L+ YL                + Q  +      +I  
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM--AAEIAD 130

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           G+A    YL     +K VHRDL A N ++  D   ++GDFG+ R I  E + Y + G   
Sbjct: 131 GMA----YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI-YETDYYRKGGKGL 182

Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
           +P  + ++APE    G  T +SDV+ FG V+ E+ 
Sbjct: 183 LP--VRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 97.1 bits (242), Expect = 1e-22
 Identities = 63/203 (31%), Positives = 107/203 (52%), Gaps = 18/203 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF-SRDSIKSKGDFLAELAIIHRLRHKHL 306
           ++G+G FG VYKG++         NT++AVK   S      K  FL E  I+ +  H ++
Sbjct: 2   KIGKGNFGDVYKGVLK-------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNI 54

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
           V L+G C +K  + +V + +P GSL  +L     ++T+      ++    A+ + YL++ 
Sbjct: 55  VKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLES- 111

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLVGVPGTMGYVAPE 425
             +  +HRDL A N L+  +   ++ DFG++R  E E   Y    GL  +P  + + APE
Sbjct: 112 --KNCIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIP--IKWTAPE 165

Query: 426 CFHTGKATPESDVFGFGAVVLEV 448
             + G+ T ESDV+ +G ++ E 
Sbjct: 166 ALNYGRYTSESDVWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 98.2 bits (244), Expect = 1e-22
 Identities = 71/223 (31%), Positives = 115/223 (51%), Gaps = 27/223 (12%)

Query: 249 LGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHL 306
           LG G FG VYKGI +   +   +    +A+K  +  +  K+  +F+ E  I+  + H HL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKI---PVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILTGVASAVYY 362
           V L+G C     + LV   MP+G L  Y++        Q+ LNW         +A  + Y
Sbjct: 72  VRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMY 124

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM--G 420
           L+   ++++VHRDL A N+L+ +  + ++ DFGLAR +E +   Y   G     G M   
Sbjct: 125 LE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG-----GKMPIK 176

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQ 462
           ++A EC H  K T +SDV+ +G  + E++  G  P + IP ++
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 219

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 96.9 bits (241), Expect = 2e-22
 Identities = 64/252 (25%), Positives = 113/252 (44%), Gaps = 37/252 (14%)

Query: 246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKH 305
              +G G FG+V+ G       Y ++  ++A+K   R+   S+ DF+ E  ++ +L H  
Sbjct: 9   VQEIGSGQFGLVWLG-------YWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPK 60

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           LV L G C E+  + LV++FM +G L  YL   +++   +      +   V   + YL+ 
Sbjct: 61  LVQLYGVCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLE- 117

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
                V+HRDL A N L+  +   ++ DFG+ R + +++ + +     G    + + +PE
Sbjct: 118 --SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPE 171

Query: 426 CFHTGKATPESDVFGFGAVVLEVVC-------GRSPGNMIPH-------------QQHAY 465
            F   K + +SDV+ FG ++ EV          RS   ++                Q  Y
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVY 231

Query: 466 TLVDWVWMLHRE 477
            L+   W    E
Sbjct: 232 ELMQHCWKERPE 243

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 96.5 bits (240), Expect = 2e-22
 Identities = 74/276 (26%), Positives = 131/276 (47%), Gaps = 27/276 (9%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLV 307
           +G G FG V +G +    +       +A+K      + K + DFL+E +I+ +  H +++
Sbjct: 12  IGAGEFGEVCRGRLKLPGK---REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
           HL G   +   ++++ +FM NG+L+ +L     Q T+       +L G+A+ + YL    
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI--QLVGMLRGIAAGMKYLS--- 123

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           +   VHRDL A NIL++++   ++ DFGL+R +E++ +       +G    + + APE  
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQ 486
              K T  SDV+ +G V+ EV+  G  P                 W +  +  I +A++Q
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERP----------------YWDMSNQDVI-NAIEQ 226

Query: 487 RLNINSVVDEAKRLLLLGLACSHPIASERPKTEDIL 522
              +   +D    L  L L C     + RPK   I+
Sbjct: 227 DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIV 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 96.4 bits (240), Expect = 4e-22
 Identities = 76/302 (25%), Positives = 143/302 (47%), Gaps = 41/302 (13%)

Query: 235 ELKKATNNFHESMRLGEGGFGIVYKG-IIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFL 292
           E+  +   F E   LGEG FG VYKG +   N++     T +A+K    +   K + +F 
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSA--TSVAIKTLKENAEPKVQQEFR 56

Query: 293 AELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL-------------YGTS 339
            E  ++  L+H ++V L+G C ++    ++++++ +G L ++L                +
Sbjct: 57  QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116

Query: 340 EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA 399
            + +L+ +    I   +A+ + YL + +    VHRDL A N L+      ++ DFGL+R 
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRD 173

Query: 400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIP 459
           I +  + Y       +P  + ++ PE    GK T ESD++ FG V+ E+    S G + P
Sbjct: 174 IYSA-DYYRVQSKSLLP--VRWMPPEAILYGKFTTESDIWSFGVVLWEIF---SYG-LQP 226

Query: 460 HQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTE 519
           +  + ++  + + M+ R   +         +    D   R+  L + C + I + RP+ +
Sbjct: 227 Y--YGFSNQEVIEMI-RSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFK 274

Query: 520 DI 521
           DI
Sbjct: 275 DI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 95.3 bits (237), Expect = 6e-22
 Identities = 59/213 (27%), Positives = 111/213 (52%), Gaps = 25/213 (11%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           ++G+G FG+V+K +   + + +    QI + K +R   + + + + E  ++ +L   +++
Sbjct: 7   KIGKGSFGVVFKVVRKADKRVYA-MKQIDLSKMNR---REREEAIDEARVLAKLDSSYII 62

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYG------TSEQVTLNWNHRYKILTGVASAVY 361
                  +KGKL +V ++  NG L K L          +QV   W    +IL G+A    
Sbjct: 63  RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV---WRFFIQILLGLA---- 115

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGY 421
           +L   + +K++HRD+K+ N+ LDA  N ++GD G+A+ + ++  ++A   +VG P    Y
Sbjct: 116 HL---HSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFAN-TIVGTP---YY 167

Query: 422 VAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           ++PE         +SDV+  G V+ E   G+ P
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 95.0 bits (236), Expect = 7e-22
 Identities = 72/241 (29%), Positives = 121/241 (50%), Gaps = 25/241 (10%)

Query: 286 KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN 345
           K + DFL+E +I+ +  H +++HL G   +   +++V ++M NGSL+ +L     Q T+ 
Sbjct: 47  KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI 106

Query: 346 WNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN 405
                 +L G+AS + YL    D   VHRDL A NIL++++   ++ DFGL+R +E++  
Sbjct: 107 --QLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161

Query: 406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHA 464
             A +   G    + + APE     K T  SDV+ +G V+ EV+  G  P          
Sbjct: 162 --AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP---------- 209

Query: 465 YTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI 524
                  W +  +  I+ A+++   + + +D    L  L L C     +ERPK E I+ I
Sbjct: 210 ------YWEMSNQDVIK-AIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSI 262

Query: 525 I 525
           +
Sbjct: 263 L 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 95.4 bits (237), Expect = 8e-22
 Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 24/221 (10%)

Query: 249 LGEGGFGIVYKGIIHH--NDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHL 306
           LGEG FG V+    H+   +Q   D   +AVK     S  ++ DF  E  ++  L+H+H+
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQ---DKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQV----------TLNWNHRYKILT 354
           V   G C E   LL+V+++M +G L ++L  +G   ++           L       I +
Sbjct: 70  VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
            +AS + YL + +    VHRDL   N L+      ++GDFG++R I +  + Y   G   
Sbjct: 130 QIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST-DYYRVGGRTM 185

Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           +P  + ++ PE     K T ESD++ FG V+ E+   G+ P
Sbjct: 186 LP--IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 95.3 bits (238), Expect = 9e-22
 Identities = 58/237 (24%), Positives = 102/237 (43%), Gaps = 39/237 (16%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAI 297
           ++F     +GEG F  V              N + A+K   +  +   K       E  +
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKET------NKEYAIKILDKRQLIKEKKVKYVKIEKEV 54

Query: 298 IHRL-RHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGT-SEQVTLNWNHRYKIL 353
           + RL  H  ++ L     ++  L  V ++ PNG L +Y+  YG+  E+ T     R+   
Sbjct: 55  LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT-----RF-YA 108

Query: 354 TGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLV 413
             +  A+ YL   + + ++HRDLK  NILLD D + ++ DFG A+ + +  +S   +   
Sbjct: 109 AEILLALEYL---HSKGIIHRDLKPENILLDKDMHIKITDFGTAK-VLDPNSSPESNKGD 164

Query: 414 GVP----------------GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                              GT  YV+PE  +   A   SD++  G ++ +++ G+ P
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 94.1 bits (235), Expect = 1e-21
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 26/212 (12%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAIIHRLRHKH 305
           LG+G FG V         + +      A+K   +  I  + +    L E  I+ R+ H  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLY------AMKVLKKKKIIKRKEVEHTLTERNILSRINHPF 54

Query: 306 LVHLVGWC--HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG-VASAVYY 362
           +V L        + KL LV ++ P G L  +L   S++   +   R +     +  A+ Y
Sbjct: 55  IVKL--HYAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFS-EERARFYAAEIVLALEY 108

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
           L +     +++RDLK  NILLDAD + +L DFGLA+ + +E +           GT  Y+
Sbjct: 109 LHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR-----TNTFCGTPEYL 160

Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           APE           D +  G ++ E++ G+ P
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 94.9 bits (237), Expect = 1e-21
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 27/213 (12%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA--ELAIIHRLRHKH 305
           ++GEG +G VYK      ++       +A+KK   ++ K      A  E+ ++ +LRH +
Sbjct: 6   QIGEGTYGQVYKAR----NKK--TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPN 59

Query: 306 LVHLVGWCHEKGK--LLLVYDFMP---NGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
           +V L      KGK  + +V+++M     G L+      +E            +  +   +
Sbjct: 60  IVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES------QIKCYMKQLLEGL 113

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            YL +     ++HRD+K SNIL++ D   +L DFGLAR      ++   + ++    T+ 
Sbjct: 114 QYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI----TLW 166

Query: 421 YVAPEC-FHTGKATPESDVFGFGAVVLEVVCGR 452
           Y  PE      +  PE D++  G ++ E+  G+
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 94.2 bits (234), Expect = 2e-21
 Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 23/220 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLAELAIIHRLRHKHLV 307
           LG G FG VY+G             ++AVK   + +    K +FL E  ++    H ++V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVT----LNWNHRYKILTGVASAVYYL 363
            L+G C       ++ + M  G L  YL     +      L       I   VA    YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 364 QNEYDQKVVHRDLKASNILL-----DADFNARLGDFGLARAIENERNSYAE---HGLVGV 415
           +       +HRDL A N L+     DAD   ++GDFGLAR I   ++ Y      GL+ V
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI--YKSDYYRKEGEGLLPV 177

Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
                ++APE    GK T +SDV+ FG ++ E++  G+ P
Sbjct: 178 R----WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 75/280 (26%), Positives = 135/280 (48%), Gaps = 31/280 (11%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLV 307
           +G G FG V++GI+    +  V    +A+K      + K + DFL+E +I+ +  H +++
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEV---AVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L G   +    +++ ++M NG+L+KYL     + +        +L G+A+ + YL    
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY--QLVGMLRGIAAGMKYLS--- 124

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENE-RNSYAEHGLVGVPGTMGYVAPEC 426
           D   VHRDL A NIL++++   ++ DFGL+R +E++   +Y   G   +P  + + APE 
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG-GKIP--IRWTAPEA 181

Query: 427 FHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVD 485
               K T  SDV+ FG V+ EV+  G  P                 W +     +  A++
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERP----------------YWDMSNH-EVMKAIN 224

Query: 486 QRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
               + + +D    +  L L C     + RP+  DI+ ++
Sbjct: 225 DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 93.5 bits (232), Expect = 2e-21
 Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 17/204 (8%)

Query: 247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQI--AVKKFSRDSIKSKGD-FLAELAIIHRLRH 303
           + LG G FG V KG+      Y +   QI  A+K    ++ KS  D  + E  I+H+L +
Sbjct: 1   VELGSGNFGCVKKGV------YKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDN 54

Query: 304 KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYL 363
            ++V ++G C E   L+LV +    G L K+L G  +++T++  +  +++  V+  + YL
Sbjct: 55  PYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVS--NVVELMHQVSMGMKYL 111

Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
           +    +  VHRDL A N+LL     A++ DFGL++A+  + + Y        P  + + A
Sbjct: 112 E---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWP--LKWYA 166

Query: 424 PECFHTGKATPESDVFGFGAVVLE 447
           PEC +  K +  SDV+ +G  + E
Sbjct: 167 PECINFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 93.6 bits (233), Expect = 3e-21
 Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 24/206 (11%)

Query: 249 LGEGGFGIVYKGIIH-HNDQYHVDNTQIAVKKFSRDSIKSKGD-FLAELAIIHRLRHKHL 306
           +GEG FG VY+G+     +    +   +AVK     +  S  + FL E  I+ +  H H+
Sbjct: 14  IGEGQFGDVYQGVYMSPEN----EKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVAS----AVYY 362
           V L+G   E   + +V +  P G L  YL      + L        L   +     A+ Y
Sbjct: 70  VKLIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDL------ASLILYSYQLSTALAY 122

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
           L++   ++ VHRD+ A N+L+ +    +LGDFGL+R +E+E  SY +     +P  + ++
Sbjct: 123 LES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE--SYYKASKGKLP--IKWM 175

Query: 423 APECFHTGKATPESDVFGFGAVVLEV 448
           APE  +  + T  SDV+ FG  + E+
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 92.9 bits (231), Expect = 4e-21
 Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 21/208 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAIIHRLRHKHLV 307
           +G+G FG VY G +  +D         AVK  +R   ++    FL E  I+    H +++
Sbjct: 3   IGKGHFGCVYHGTLIDSDG---QKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVL 59

Query: 308 HLVGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG----VASAVYY 362
            L+G C   +G  L+V  +M +G L  ++   +   T+      K L G    VA  + Y
Sbjct: 60  SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV------KDLIGFGLQVAKGMEY 113

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI-ENERNSYAEHGLVGVPGTMGY 421
           L +   +K VHRDL A N +LD  F  ++ DFGLAR I + E  S   H    +P  + +
Sbjct: 114 LAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP--VKW 168

Query: 422 VAPECFHTGKATPESDVFGFGAVVLEVV 449
           +A E   T K T +SDV+ FG ++ E++
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 92.4 bits (229), Expect = 5e-21
 Identities = 80/280 (28%), Positives = 130/280 (46%), Gaps = 39/280 (13%)

Query: 245 ESMRL----GEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHR 300
           ES+RL    G+G FG V+ G  +         T++A+K     ++  +  FL E  ++ +
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTMSPEA-FLQEAQVMKK 57

Query: 301 LRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
           LRH+ LV L     E+  + +V ++M  GSL  +L G   +  L       +   +AS +
Sbjct: 58  LRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGM 115

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            Y++       VHRDL+A+NIL+  +   ++ DFGLAR IE+  N Y        P  + 
Sbjct: 116 AYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP--IK 168

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGH 479
           + APE    G+ T +SDV+ FG ++ E+   GR P               +  M++RE  
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNRE-- 211

Query: 480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTE 519
           + D V++   +    +  + L  L   C      ERP  E
Sbjct: 212 VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 92.0 bits (228), Expect = 7e-21
 Identities = 65/219 (29%), Positives = 111/219 (50%), Gaps = 20/219 (9%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KGDFLAELAIIHRLRHKH 305
           R+G G FG V+ G      +   DNT +AVK   R+++    K  FL E  I+ +  H +
Sbjct: 2   RIGRGNFGEVFSG------RLRADNTPVAVKS-CRETLPPDLKAKFLQEARILKQYSHPN 54

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           +V L+G C +K  + +V + +  G    +L   +E   L      +++   A+ + YL++
Sbjct: 55  IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLES 112

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEH-GLVGVPGTMGYVAP 424
           ++    +HRDL A N L+      ++ DFG++R  E E   YA   G+  +P  + + AP
Sbjct: 113 KH---CIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIP--VKWTAP 165

Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQ 462
           E  + G+ + ESDV+ FG ++ E    G  P   + +QQ
Sbjct: 166 EALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ 204

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 92.0 bits (229), Expect = 7e-21
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 23/209 (11%)

Query: 250 GEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAIIHRLRHKHL 306
           G+G FG V   I+   D         A+K  ++     KG   + L E  I+  L H  L
Sbjct: 9   GKGAFGKVC--IVQKRD----TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFL 62

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKI-LTGVASAVYYLQN 365
           V+L     ++  + LV D +  G L    Y  S++V  +   + K  +  +  A+ YL +
Sbjct: 63  VNLWYSFQDEENMYLVVDLLLGGDLR---YHLSQKVKFS-EEQVKFWICEIVLALEYLHS 118

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
              + ++HRD+K  NILLD   +  + DF +A  +  +  +          GT GY+APE
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT------TSTSGTPGYMAPE 169

Query: 426 CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                  +   D +  G    E + G+ P
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 91.7 bits (228), Expect = 9e-21
 Identities = 79/284 (27%), Positives = 125/284 (44%), Gaps = 46/284 (16%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG-----DFLAELAIIHRLRH 303
           LG G FG VY+G+  + D    D    AVK+ S       G         E+A++ +L+H
Sbjct: 8   LGSGSFGSVYEGL--NLD----DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61

Query: 304 KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGT-SEQVTLNWNHRYKILTGVASAV 360
            ++V  +G   E+  L +  + +P GSL K L  YG+  E V   +    +IL G+    
Sbjct: 62  PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR--QILLGLE--- 116

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            YL   +D+  VHRD+K +NIL+D +   +L DFG+A+ +                G+  
Sbjct: 117 -YL---HDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS------FAKSFKGSPY 166

Query: 421 YVAPE-CFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH 479
           ++APE     G     +D++  G  VLE+  G+ P             V  V+ + R   
Sbjct: 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP-------WSQLEGVAAVFKIGRSKE 219

Query: 480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
           +    D       + DEAK  +L    C     S RP   ++L+
Sbjct: 220 LPPIPD------HLSDEAKDFILK---CLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 67/210 (31%), Positives = 108/210 (51%), Gaps = 27/210 (12%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHV--DNTQ--IAVKKFSRDSIKSKGDFLAELAIIHRLRHK 304
           LG+G FG V         +Y    DNT   +AVKK    + +   DF  E+ I+  L+H 
Sbjct: 12  LGKGNFGSVELC------RYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHD 65

Query: 305 HLVHLVGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKIL--TGVASAV 360
           ++V   G C+  G+  L LV +++P GSL  YL    E++    +HR  +L  + +   +
Sbjct: 66  NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL----DHRKLLLYASQICKGM 121

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT-- 418
            YL +   ++ VHRDL   NIL++++   ++GDFGL + +  ++  Y     V  PG   
Sbjct: 122 EYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYY----KVREPGESP 174

Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           + + APE     K +  SDV+ FG V+ E+
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 92.0 bits (228), Expect = 1e-20
 Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 21/220 (9%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH 308
           LGEG FG V+    + N     D   +AVK     ++ ++ DF  E  ++  L+H+H+V 
Sbjct: 13  LGEGAFGKVFLAECY-NLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 309 LVGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQV-----------TLNWNHRYKILTG 355
             G C +   L++V+++M +G L K+L  +G    +            L  +    I + 
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           +AS + YL +   Q  VHRDL   N L+ A+   ++GDFG++R + +  + Y   G   +
Sbjct: 132 IASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST-DYYRVGGHTML 187

Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           P  + ++ PE     K T ESDV+ FG ++ E+   G+ P
Sbjct: 188 P--IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 91.9 bits (228), Expect = 1e-20
 Identities = 66/206 (32%), Positives = 110/206 (53%), Gaps = 16/206 (7%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNT--QIAVKKFSRDSIKSK-GDFLAELAIIHRLRHKH 305
           LGEG FG V   +  ++ +   DNT  Q+AVK    +S  +   D   E+ I+  L H++
Sbjct: 12  LGEGHFGKVE--LCRYDPEG--DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 67

Query: 306 LVHLVGWCHEKG--KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYL 363
           +V   G C E G   + L+ +F+P+GSL++YL     ++ L    +Y     +   + YL
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA--VQICKGMDYL 125

Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
            +   ++ VHRDL A N+L++++   ++GDFGL +AIE ++  Y     +  P  + + A
Sbjct: 126 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP--VFWYA 180

Query: 424 PECFHTGKATPESDVFGFGAVVLEVV 449
           PEC    K    SDV+ FG  + E++
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 91.2 bits (226), Expect = 1e-20
 Identities = 56/200 (28%), Positives = 105/200 (52%), Gaps = 17/200 (8%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLAELAIIHRLRHKHLV 307
           LG+G FG V+KG +        D T +AVK    D  +  K  FL+E  I+ +  H ++V
Sbjct: 3   LGKGNFGEVFKGTLK-------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIV 55

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L+G C ++  + +V + +P G    +L    +++      ++ +    A+ + YL++  
Sbjct: 56  KLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL--DAAAGMAYLES-- 111

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFG++R  + +   Y+  GL  +P  + + APE  
Sbjct: 112 -KNCIHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIP--IKWTAPEAL 166

Query: 428 HTGKATPESDVFGFGAVVLE 447
           + G+ + ESDV+ +G ++ E
Sbjct: 167 NYGRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 95.7 bits (238), Expect = 2e-20
 Identities = 85/375 (22%), Positives = 159/375 (42%), Gaps = 64/375 (17%)

Query: 174 KKEKDWKWLVISAGVGVPLVAVLLVLCAIAYVKKRR-SRVAEPHHNLGKLRLPGMPREFK 232
           +K   W W  I+  +G   + + LV     +++ R    +    +  G   L    + F 
Sbjct: 623 RKTPSW-WFYITCTLGA-FLVLALVAFGFVFIRGRNNLELKRVENEDGTWEL----QFFD 676

Query: 233 YKELKKAT-NNFHESMR----LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR-DSIK 286
            K  K  T N+   S++    +  G  G  YKG    N        Q  VK+ +  +SI 
Sbjct: 677 SKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNG------MQFVVKEINDVNSIP 730

Query: 287 SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNW 346
           S    +A++    +L+H ++V L+G C  +    L+++++   +L + L        L+W
Sbjct: 731 SS--EIADMG---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSW 779

Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
             R KI  G+A A+ +L       VV  +L    I++D      L               
Sbjct: 780 ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL--------------- 824

Query: 407 YAEHGLVGVPGTM----------GYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGN 456
                 + +PG +           YVAPE   T   T +SD++GFG +++E++ G+SP +
Sbjct: 825 -----RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879

Query: 457 MIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLA--CSHPIASE 514
                 H  ++V+W    + + H+   +D  +  +  V++ + + ++ LA  C+    + 
Sbjct: 880 -AEFGVHG-SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTA 937

Query: 515 RPKTEDILQIISGTS 529
           RP   D+L+ +   S
Sbjct: 938 RPCANDVLKTLESAS 952

Length = 968

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 66/237 (27%), Positives = 111/237 (46%), Gaps = 29/237 (12%)

Query: 248 RLGEGGFGIVY----KGIIHHNDQYHVDN------TQIAVKKFSRDSIKS-KGDFLAELA 296
           +LGEG FG V+     G+   +++   +N        +AVK    D+  + + DFL E+ 
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 297 IIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKIL--- 353
           I+ RL   ++  L+G C     L ++ ++M NG L ++L       T       K L   
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQ-KHVAETSGLACNSKSLSFS 130

Query: 354 ------TGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY 407
                 T +AS + YL++      VHRDL   N L+  ++  ++ DFG++R +    + Y
Sbjct: 131 TLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY-SSDYY 186

Query: 408 AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV--VCGRSPGNMIPHQQ 462
              G   +P  + ++A E    GK T +SDV+ FG  + E+  +C   P   +  QQ
Sbjct: 187 RVQGRAPLP--IRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 65/238 (27%), Positives = 107/238 (44%), Gaps = 44/238 (18%)

Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK---FSRDSIKSK 288
            Y+ L+           +G+G FG V K +   +D       +I V K   +   + K K
Sbjct: 1   DYEVLET----------IGKGSFGTVRK-VRRKSDG------KILVWKEIDYGNMTEKEK 43

Query: 289 GDFLAELAIIHRLRHKHLVHLVGWCH--EKGKLLLVYDFMPNGSLEKYL--------YGT 338
              ++E+ I+  L+H ++V             L +V ++   G L + +        Y  
Sbjct: 44  QQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIE 103

Query: 339 SEQVTLNWNHRYKILTGVASAVYYLQNEYD--QKVVHRDLKASNILLDADFNARLGDFGL 396
            E +   W    +ILT +  A+Y   N  D    V+HRDLK +NI LDA+ N +LGDFGL
Sbjct: 104 EEFI---W----RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL 156

Query: 397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           A+ +    +S+A    VG P    Y++PE  +      +SD++  G ++ E+     P
Sbjct: 157 AKIL-GHDSSFA-KTYVGTP---YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 90.7 bits (226), Expect = 3e-20
 Identities = 67/246 (27%), Positives = 107/246 (43%), Gaps = 36/246 (14%)

Query: 213 AEPHHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDN 272
            E    L  +   G PRE  YK L+K          +GEG  G VYK             
Sbjct: 2   EELKAALKDIVSEGDPREL-YKNLEK----------IGEGASGEVYKAT------DRATG 44

Query: 273 TQIAVKK--FSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL-LVYDFMPNG 329
            ++A+KK    + + +   +   E+ I+   +H ++V      +  G  L +V ++M  G
Sbjct: 45  KEVAIKKMRLRKQNKELIIN---EILIMKDCKHPNIVDYYD-SYLVGDELWVVMEYMDGG 100

Query: 330 SLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA 389
           SL   +      V +N      +   V   + YL +   Q V+HRD+K+ NILL  D + 
Sbjct: 101 SLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSV 155

Query: 390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEV 448
           +L DFG A  +  E++    + +VG P  M   APE     K   P+ D++  G + +E+
Sbjct: 156 KLADFGFAAQLTKEKSK--RNSVVGTPYWM---APEVI-KRKDYGPKVDIWSLGIMCIEM 209

Query: 449 VCGRSP 454
             G  P
Sbjct: 210 AEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 90.5 bits (225), Expect = 3e-20
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 28/214 (13%)

Query: 247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK--GDFLAELAIIHRLRHK 304
             LG G  G+V K         H    +I   K  R  I        L EL I+H+    
Sbjct: 7   GELGAGNSGVVSK-------VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSP 59

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL---YGTSEQVTLNWNHRYKILTGVASAVY 361
           ++V   G  +  G + +  ++M  GSL+K L    G   +  L      KI   V   + 
Sbjct: 60  YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLT 114

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER-NSYAEHGLVGVPGTMG 420
           YL  ++  K++HRD+K SNIL+++    +L DFG++  + N    ++         GT  
Sbjct: 115 YLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV--------GTSS 164

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           Y+APE       + +SD++  G  ++E+  GR P
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 89.6 bits (223), Expect = 5e-20
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 47/222 (21%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF------LAELAIIHRLR 302
           LG+G  G+VYK        +       A+KK     I   GD       L EL  +    
Sbjct: 9   LGQGSSGVVYKVR------HKPTGKIYALKK-----IHVDGDEEFRKQLLRELKTLRSCE 57

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLE---KYLYGTSEQV----TLNWNHRYKILTG 355
             ++V   G  +++G++ +V ++M  GSL    K +    E V            +IL G
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIA------RQILKG 111

Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN---ERNSYAEHGL 412
           +     YL     + ++HRD+K SN+L+++    ++ DFG+++ +EN   + N++     
Sbjct: 112 LD----YLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV---- 161

Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
               GT+ Y++PE       +  +D++  G  +LE   G+ P
Sbjct: 162 ----GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 89.5 bits (222), Expect = 6e-20
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 27/221 (12%)

Query: 249 LGEGGFGIVYKGIIHHND--QYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHL 306
           LGEG FG V +G +  +D  Q  V    + +   +   I+   +FL+E A +    H ++
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIE---EFLSEAACMKDFDHPNV 63

Query: 307 VHLVGWC---HEKGKL---LLVYDFMPNGSLEKYLY-----GTSEQVTLNWNHRYKILTG 355
           + L+G C       K+   +++  FM +G L  +L      G  E++ L      K +  
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQ--TLLKFMVD 121

Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG- 414
           +A  + YL N   +  +HRDL A N +L  D    + DFGL++ I +    Y   G +  
Sbjct: 122 IALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG--DYYRQGRIAK 176

Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           +P  + ++A E       T +SDV+ FG  + E+   G++P
Sbjct: 177 MP--VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 88.9 bits (220), Expect = 8e-20
 Identities = 68/208 (32%), Positives = 104/208 (50%), Gaps = 24/208 (11%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
            +GEG FG V +G      +Y     ++AVK    D       FL E A++ +L HK+LV
Sbjct: 13  IIGEGEFGAVLQG------EYT--GQKVAVKNIKCDVTAQA--FLEETAVMTKLHHKNLV 62

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L+G     G L +V + M  G+L  +L  T  +  ++     +    VA  + YL++  
Sbjct: 63  RLLGVILHNG-LYIVMELMSKGNLVNFLR-TRGRALVSVIQLLQFSLDVAEGMEYLES-- 118

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +K+VHRDL A NIL+  D  A++ DFGLAR          ++  + V  T    APE  
Sbjct: 119 -KKLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMG--VDNSKLPVKWT----APEAL 169

Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ +G ++ EV   GR+P
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 18/207 (8%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH 308
           LG G FG+V+ G              +A+K   R+   S+ DF+ E  ++ +L H +LV 
Sbjct: 12  LGSGQFGVVHLG-------KWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQ 63

Query: 309 LVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
           L G C ++  + +V ++M NG L  YL     ++   W     + + V  A+ YL+    
Sbjct: 64  LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLE---S 118

Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
              +HRDL A N L+  D   ++ DFGLAR + +++ + ++    G    + +  PE F 
Sbjct: 119 NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFD 174

Query: 429 TGKATPESDVFGFGAVVLEV-VCGRSP 454
             + + +SDV+ FG ++ EV   G+ P
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 18/208 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           +LG G FG V+ G  +        NT++AVK     ++ S   FL E  I+ +LRH  LV
Sbjct: 13  KLGNGQFGEVWMGTWN-------GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLV 64

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L     E+  + +V ++M  GSL  +L    E   L   +   +   VA+ + Y++   
Sbjct: 65  QLYAVVSEE-PIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIER-- 120

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
               +HRDL+++NIL+      ++ DFGLAR IE+  N Y        P  + + APE  
Sbjct: 121 -MNYIHRDLRSANILVGDGLVCKIADFGLARLIED--NEYTARQGAKFP--IKWTAPEAA 175

Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
             G+ T +SDV+ FG ++ E+V  GR P
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 88.4 bits (219), Expect = 1e-19
 Identities = 71/277 (25%), Positives = 126/277 (45%), Gaps = 33/277 (11%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH 308
           LG G FG+V  G      QY V     A+K     S+ S+ +F+ E  ++ +L H+ LV 
Sbjct: 12  LGTGQFGVVKYG--KWRGQYDV-----AIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQ 63

Query: 309 LVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
           L G C ++  + +V ++M NG L  YL    ++     +   ++   V   + YL++   
Sbjct: 64  LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLES--- 118

Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           ++ +HRDL A N L+D     ++ DFGL+R + ++  + +    VG    + +  PE   
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLL 174

Query: 429 TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRL 488
             K + +SDV+ FG ++ EV                Y+L    +         + V Q L
Sbjct: 175 YSKFSSKSDVWAFGVLMWEV----------------YSLGKMPYERFNNSETVEKVSQGL 218

Query: 489 NINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
            +      ++++  +  +C H  A ERP  + +L  I
Sbjct: 219 RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 89.7 bits (222), Expect = 1e-19
 Identities = 87/319 (27%), Positives = 146/319 (45%), Gaps = 50/319 (15%)

Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRL-RHKH 305
           LGEG FG +V    I  +         +AVK    D+  K   D ++E+ ++  + +HK+
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE-------------QVTLNWNHRYKI 352
           +++L+G C + G L ++ ++   G+L +YL                  +  L +      
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
              VA  + YL +   QK +HRDL A N+L+  D   ++ DFGLAR + N  + Y +   
Sbjct: 140 AYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHN-IDYYKKTTN 195

Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWV 471
             +P  + ++APE       T +SDV+ FG ++ E+   G SP   IP        V+ +
Sbjct: 196 GRLP--VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--------VEEL 245

Query: 472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISG 527
           + L +EGH  D            +    L ++   C H + S+RP      ED+ ++++ 
Sbjct: 246 FKLLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296

Query: 528 TSTVPY----VP--QFKPA 540
           TST  Y    VP  Q+ P 
Sbjct: 297 TSTDEYLDLSVPFEQYSPG 315

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 77/289 (26%), Positives = 135/289 (46%), Gaps = 48/289 (16%)

Query: 248 RLGEGGFGIV----YKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRL- 301
            LGEG FG V      G+ + N+      + +AVK    D+  K   D ++E+ ++  + 
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNET-----STVAVKMLKDDATEKDLSDLVSEMEMMKMIG 73

Query: 302 RHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLY-----GTSEQVTLNWNHRYKI---- 352
           +HK++++L+G C ++G L +V ++  +G+L  +L      G              +    
Sbjct: 74  KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133

Query: 353 LTG----VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
           L      VA  + +L +   +K +HRDL A N+L+  D   ++ DFGLAR I +  + Y 
Sbjct: 134 LVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDI-HHIDYYR 189

Query: 409 EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
           +     +P  + ++APE       T +SDV+ FG ++ E+   G SP   IP ++    L
Sbjct: 190 KTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----L 243

Query: 468 VDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP 516
                 L +EG+    +++  N      E   L+     C H + S+RP
Sbjct: 244 FK----LLKEGY---RMEKPQNCT---QELYHLM---RDCWHEVPSQRP 279

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 88.2 bits (218), Expect = 2e-19
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 19/213 (8%)

Query: 246 SMRLGEGGFGIVYKGIIHH--NDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLR 302
           S  LG+G FG+VY+GI      D+     T++A+K  +   S++ + +FL E +++    
Sbjct: 11  SRELGQGSFGMVYEGIAKGVVKDE---PETRVAIKTVNEAASMRERIEFLNEASVMKEFN 67

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLY-------GTSEQVTLNWNHRYKILTG 355
             H+V L+G   +    L++ + M  G L+ YL            Q   +     ++   
Sbjct: 68  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127

Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           +A  + YL      K VHRDL A N ++  DF  ++GDFG+ R I  E + Y + G   +
Sbjct: 128 IADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYYRKGGKGLL 183

Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           P  + +++PE    G  T  SDV+ FG V+ E+
Sbjct: 184 P--VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 74/280 (26%), Positives = 127/280 (45%), Gaps = 37/280 (13%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH 308
           LG G FG+V+ G      Q      ++A+K    +   S+ DF+ E  ++ +L H  LV 
Sbjct: 12  LGSGQFGVVHLG--KWRAQI-----KVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQ 63

Query: 309 LVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYL-QNEY 367
           L G C ++  L +V +FM NG L  YL     Q  L+ +    +   V   + YL +N +
Sbjct: 64  LYGVCTQQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNSF 121

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLAR-AIENERNSYAEHGLVGVPGTMGYVAPEC 426
               +HRDL A N L+ +    ++ DFG+ R  +++E  S +     G    + +  PE 
Sbjct: 122 ----IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS-----GAKFPVKWSPPEV 172

Query: 427 FHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQ 486
           F+  K + +SDV+ FG ++ EV    + G M   ++  Y +V+ +    R    + A   
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVF---TEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMT 229

Query: 487 RLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS 526
              +  V+           +C H     RP   ++L+ I+
Sbjct: 230 ---VYEVM----------YSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 88.0 bits (218), Expect = 3e-19
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 20/207 (9%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQ-IAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHL 306
           LGEG FG   K  ++  D  +    + +AVK   R+   ++   +  E+ I+  L H+++
Sbjct: 12  LGEGHFG---KVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68

Query: 307 VHLVGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
           V   G C E+G   L L+ +++P GSL  YL      +        +I  G+A    YL 
Sbjct: 69  VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMA----YL- 123

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY--AEHGLVGVPGTMGYV 422
             + Q  +HRDL A N+LLD D   ++GDFGLA+A+      Y   E G       + + 
Sbjct: 124 --HSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG----DSPVFWY 177

Query: 423 APECFHTGKATPESDVFGFGAVVLEVV 449
           A EC    K +  SDV+ FG  + E++
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 58/223 (26%), Positives = 109/223 (48%), Gaps = 26/223 (11%)

Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK---FSRDSIKSKGDFLAELA 296
             NF    ++G+G F +VYK I        +D   +A+KK   F     K++ D L E+ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICL------LDGRVVALKKVQIFEMMDAKARQDCLKEID 54

Query: 297 IIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTL-----NWNHRYK 351
           ++ +L H +++  +    E  +L +V +    G L + +    +Q  L      W +  +
Sbjct: 55  LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114

Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
           +     SA+ ++   + ++++HRD+K +N+ + A    +LGD GL R   ++  + A H 
Sbjct: 115 L----CSALEHM---HSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHS 165

Query: 412 LVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           LVG P    Y++PE  H      +SD++  G ++ E+   +SP
Sbjct: 166 LVGTP---YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 20/212 (9%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVK--KFSRDSIKSKGDFLAELAIIHRLRHKHL 306
           +G G FG VY  +  + D        +AVK  +   +  K+  +   E+ ++  L+H +L
Sbjct: 8   IGGGTFGKVYTAV--NLD----TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNL 61

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYL-YGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           V   G    + K+ +  ++   G+LE+ L +G      +   +  ++L G+A    YL  
Sbjct: 62  VKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLA----YL-- 115

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            +   +VHRD+K +NI LD +   +LGDFG A  ++N   +  E     + GT  Y+APE
Sbjct: 116 -HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ-SLAGTPAYMAPE 173

Query: 426 CFHTGKATPE---SDVFGFGAVVLEVVCGRSP 454
               GK       +D++  G VVLE+  G+ P
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 18/216 (8%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLV 307
           LG G FG VY+G+    D   V+  Q+AVK      S + + DFL E  I+ +  H+++V
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVE-LQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILTGVASAVYYL 363
            L+G   E+    ++ + M  G L+ +L           +L           VA    YL
Sbjct: 73  RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132

Query: 364 QNEYDQKVVHRDLKASNILLD---ADFNARLGDFGLARAIENERNS-YAEHGLVGVPGTM 419
           +   +   +HRD+ A N LL        A++ DFG+AR I   R S Y + G   +P  +
Sbjct: 133 E---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI--YRASYYRKGGRAMLP--I 185

Query: 420 GYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
            ++ PE F  G  T ++DV+ FG ++ E+   G  P
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 87.2 bits (216), Expect = 6e-19
 Identities = 64/225 (28%), Positives = 119/225 (52%), Gaps = 31/225 (13%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAII 298
           NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E++++
Sbjct: 1   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLL 53

Query: 299 HRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTS-EQVTLNW--NHRYKILTG 355
             L H ++V L+   H + KL LV++F+ +  L+K++  +    + L    ++ +++L G
Sbjct: 54  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112

Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           +A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +V  
Sbjct: 113 LAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVV-- 162

Query: 416 PGTMGYVAPECFHTGK--ATPESDVFGFGAVVLEVVCGRS--PGN 456
             T+ Y APE     K  +T   D++  G +  E+V  R+  PG+
Sbjct: 163 --TLWYRAPEILLGCKYYSTA-VDIWSLGCIFAEMVTRRALFPGD 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 87.0 bits (215), Expect = 6e-19
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 18/217 (8%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH 308
           LGEG FG V+    + N     D   +AVK     S  ++ DF  E  ++  L+H+H+V 
Sbjct: 13  LGEGAFGKVFLAECY-NLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 309 LVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVT----------LNWNHRYKILTGVAS 358
             G C E   L++V+++M +G L K+L                  L  +    I   +A+
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
            + YL +   Q  VHRDL   N L+  +   ++GDFG++R + +  + Y   G   +P  
Sbjct: 132 GMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST-DYYRVGGHTMLP-- 185

Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           + ++ PE     K T ESDV+  G V+ E+   G+ P
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 86.2 bits (213), Expect = 6e-19
 Identities = 74/213 (34%), Positives = 105/213 (49%), Gaps = 24/213 (11%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH 308
           +G+G FG V  G       Y     ++AVK    D+      FLAE +++ +LRH +LV 
Sbjct: 14  IGKGEFGDVMLG------DYR--GNKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQ 63

Query: 309 LVG-WCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
           L+G    EKG L +V ++M  GSL  YL      V L  +   K    V  A+ YL+   
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEA-- 120

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
               VHRDL A N+L+  D  A++ DFGL +    E +S  + G + V  T    APE  
Sbjct: 121 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT----APEAL 171

Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSPGNMIP 459
              K + +SDV+ FG ++ E+   GR P   IP
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 7e-19
 Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 28/216 (12%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKFSR--DSIKSKGDFLAELAIIHRLRHK 304
           ++GEG +G+VYK              +I A+KK     +S       L E+ ++  L H 
Sbjct: 6   KIGEGTYGVVYKA-------RDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHP 58

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNW--NHRYKILTGVASAVYY 362
           +++ L+     KG L LV++FM +  L K +      +  +   ++ Y++L G+A    +
Sbjct: 59  NIIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA----F 113

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
               +   ++HRDLK  N+L++ +   +L DFGLAR+  +    Y  +       T  Y 
Sbjct: 114 C---HSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY-----VVTRWYR 165

Query: 423 APECFHTGKA-TPESDVFGFGAVVLEVVCGRS--PG 455
           APE     K  +   D++  G +  E++  R   PG
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG 201

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.0 bits (213), Expect = 8e-19
 Identities = 69/223 (30%), Positives = 114/223 (51%), Gaps = 27/223 (12%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDN-TQIAVKK--FSRDSIKSKGDFLA---E 294
            N+     LG+G FG VY         Y VD   ++AVK+  F  DS ++K +  A   E
Sbjct: 2   TNWRRGKLLGQGAFGRVYLC-------YDVDTGRELAVKQVPFDPDSPETKKEVNALECE 54

Query: 295 LAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGT-SEQVTLNWNHRYK 351
           + ++  L+H+ +V   G   +   L +  ++MP GS++  L  YG  +E VT  +    +
Sbjct: 55  IQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYT--RQ 112

Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
           IL GV     YL   +   +VHRD+K +NIL D+  N +LGDFG ++ ++   +S    G
Sbjct: 113 ILEGVE----YL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGT--G 163

Query: 412 LVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +  V GT  +++PE         ++DV+  G  V+E++  + P
Sbjct: 164 MKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 86.6 bits (214), Expect = 8e-19
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 15/208 (7%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLV 307
           LG+G FG+VY+G      +   + T++AVK  +   S++ + +FL E +++      H+V
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAE-TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------WNHRYKILTGVASAV 360
            L+G   +    L+V + M +G L+ YL     +   N            ++   +A  +
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            YL     +K VHRDL A N ++  DF  ++GDFG+ R I  E + Y + G   +P  + 
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY-ETDYYRKGGKGLLP--VR 186

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEV 448
           ++APE    G  T  SD++ FG V+ E+
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 87.0 bits (215), Expect = 8e-19
 Identities = 84/303 (27%), Positives = 143/303 (47%), Gaps = 46/303 (15%)

Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRL-RHKH 305
           LGEG FG +V    I  + +     T++AVK    D+  K   D ++E+ ++  + +HK+
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYL---------YGTSEQVTLNWNHRYKILTG- 355
           +++L+G C + G L ++ ++   G+L +YL         Y  +          +K L   
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 356 ---VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN-ERNSYAEHG 411
              VA  + YL +   +K +HRDL A N+L+  D   ++ DFGLAR I + +      +G
Sbjct: 146 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 412 LVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDW 470
            + V     ++APE       T +SDV+ FG ++ E+   G SP   +P        V+ 
Sbjct: 203 RLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--------VEE 250

Query: 471 VWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIIS 526
           ++ L +EGH  D      N          L ++   C H + S+RP      ED+ +I++
Sbjct: 251 LFKLLKEGHRMDKPSNCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301

Query: 527 GTS 529
            TS
Sbjct: 302 LTS 304

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 86.2 bits (213), Expect = 8e-19
 Identities = 64/230 (27%), Positives = 111/230 (48%), Gaps = 29/230 (12%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           +LG G FG V+ G       Y+ ++T++AVK     ++  +  FL E  ++  L+H  LV
Sbjct: 13  KLGAGQFGEVWMG-------YYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLV 64

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLY---GTSEQVTLNWNHRYKILTGVASAVYYLQ 364
            L     ++  + ++ ++M  GSL  +L    G    +    +   +I  G+A   Y  +
Sbjct: 65  RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA---YIER 121

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
             Y    +HRDL+A+N+L+      ++ DFGLAR IE+   +  E    G    + + AP
Sbjct: 122 KNY----IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE----GAKFPIKWTAP 173

Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-------GRSPGNMIPHQQHAYTL 467
           E  + G  T +SDV+ FG ++ E+V        G S  +++   Q  Y +
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM 223

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 85/308 (27%), Positives = 143/308 (46%), Gaps = 56/308 (18%)

Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRL-RHKH 305
           LGEG FG +V    +  +     +   +AVK    D+  K   D ++E+ ++  + +HK+
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYG---------------TSEQVTLNWNHRY 350
           +++L+G C + G L ++ ++   G+L +YL                   EQ+T      +
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT------F 136

Query: 351 KILTG----VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
           K L      VA  + YL +   QK +HRDL A N+L+  +   ++ DFGLAR + N  + 
Sbjct: 137 KDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDVNN-IDY 192

Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAY 465
           Y +     +P  + ++APE       T +SDV+ FG ++ E+   G SP   IP      
Sbjct: 193 YKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 244

Query: 466 TLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDI 521
             V+ ++ L +EGH  D      N          L ++   C H I S RP      ED+
Sbjct: 245 --VEELFKLLKEGHRMDKPANCTN---------ELYMMMRDCWHAIPSHRPTFKQLVEDL 293

Query: 522 LQIISGTS 529
            +I++ T+
Sbjct: 294 DRILTLTT 301

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 85.4 bits (211), Expect = 3e-18
 Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 37/226 (16%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLV 307
           +GEG FG V K  I   D   +D     +K+++  S     DF  EL ++ +L  H +++
Sbjct: 15  IGEGNFGQVLKARIK-KDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNII 71

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGT-------------SEQVTLNWNHRYKILT 354
           +L+G C  +G L L  ++ P+G+L  +L  +             S   TL+         
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
            VA  + YL     ++ +HRDL A NIL+  ++ A++ DFGL+R  E           V 
Sbjct: 132 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE-----------VY 177

Query: 415 VPGTMG-----YVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           V  TMG     ++A E  +    T  SDV+ +G ++ E+V  G +P
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 84.0 bits (207), Expect = 4e-18
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 18/209 (8%)

Query: 247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHL 306
           ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  I+ +LRH  L
Sbjct: 12  VKLGQGCFGEVWMGTWN-------GTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKL 63

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
           V L     E+  + +V +FM  GSL  +L    +   L       +   +A  + Y++  
Sbjct: 64  VPLYAVVSEE-PIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIER- 120

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
                +HRDL+A+NIL+  +   ++ DFGLAR IE+  N Y        P  + + APE 
Sbjct: 121 --MNYIHRDLRAANILVGDNLVCKIADFGLARLIED--NEYTARQGAKFP--IKWTAPEA 174

Query: 427 FHTGKATPESDVFGFGAVVLEVVC-GRSP 454
              G+ T +SDV+ FG ++ E+V  GR P
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 84.1 bits (208), Expect = 5e-18
 Identities = 60/217 (27%), Positives = 113/217 (52%), Gaps = 25/217 (11%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHR 300
           NF +  +LGEG +  VYKG      +       +A+K+   D+ + +    + E++++  
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEI------VALKEIHLDAEEGTPSTAIREISLMKE 54

Query: 301 LRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWN----HRYKILTGV 356
           L+H+++V L    H + KL+LV+++M +  L+KY+     +  L+ N      Y++L G+
Sbjct: 55  LKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGI 113

Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP 416
           A         ++ +V+HRDLK  N+L++     +L DFGLARA     N+++   +    
Sbjct: 114 AFC-------HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---- 162

Query: 417 GTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGR 452
            T+ Y AP+     +    S D++  G ++ E++ GR
Sbjct: 163 -TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 84.2 bits (208), Expect = 5e-18
 Identities = 70/232 (30%), Positives = 111/232 (47%), Gaps = 39/232 (16%)

Query: 229 REFKYKELKKATNNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVK----KFSRD 283
           R  K  EL+K          LG G FG V+KGI I   D   +    +A+K    +  R 
Sbjct: 2   RILKETELRKLK-------LLGSGVFGTVHKGIWIPEGDSIKI---PVAIKTIQDRSGRQ 51

Query: 284 SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLY----GTS 339
           + +   D +  LA+   L H ++V L+G C     L LV    P GSL  ++        
Sbjct: 52  TFQEITDHM--LAM-GSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLD 107

Query: 340 EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA 399
            Q  LNW         +A  +YYL+   + ++VHR+L A NILL +D   ++ DFG+A  
Sbjct: 108 PQRLLNW------CVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADL 158

Query: 400 I--ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
           +  ++++  Y+EH        + ++A E    G+ T +SDV+ +G  V E++
Sbjct: 159 LYPDDKKYFYSEH-----KTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 84.3 bits (208), Expect = 6e-18
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 32/238 (13%)

Query: 248 RLGEGGFGIVY----KGIIHH-----NDQYHVDNTQIAVKKFSRDSIKS-KGDFLAELAI 297
           +LGEG FG V+    +G+         +        +AVK    D  K+ + DFL E+ I
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVL-VAVKMLRADVTKTARNDFLKEIKI 70

Query: 298 IHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKI----- 352
           + RL++ +++ L+G C     L ++ ++M NG L ++L  +  ++   + H   I     
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL--SQREIESTFTHANNIPSVSI 128

Query: 353 ------LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
                    +AS + YL +      VHRDL   N L+   +  ++ DFG++R + +  + 
Sbjct: 129 ANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG-DY 184

Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV--VCGRSPGNMIPHQQ 462
           Y   G   +P  + ++A E    GK T  SDV+ FG  + E+  +C   P +++  +Q
Sbjct: 185 YRIQGRAVLP--IRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 83.4 bits (206), Expect = 7e-18
 Identities = 54/202 (26%), Positives = 99/202 (49%), Gaps = 22/202 (10%)

Query: 273 TQIAVK--KFSRDSIKSKGD----FLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFM 326
           T +AVK   + R++   + +       E+ ++ RL H H++ ++G   E     L  ++M
Sbjct: 26  TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWM 85

Query: 327 PNGSLEKYL--YGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL 383
             GS+   L  YG   E V +N+    ++L G++    YL   ++ +++HRD+K +N+L+
Sbjct: 86  AGGSVSHLLSKYGAFKEAVIINYTE--QLLRGLS----YL---HENQIIHRDVKGANLLI 136

Query: 384 DAD-FNARLGDFGLARAIENERNSYAEHGLVG-VPGTMGYVAPECFHTGKATPESDVFGF 441
           D+     R+ DFG A  +  +     E    G + GT+ ++APE     +     DV+  
Sbjct: 137 DSTGQRLRIADFGAAARLAAKGTGAGE--FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSV 194

Query: 442 GAVVLEVVCGRSPGNMIPHQQH 463
           G V++E+   + P N   H  H
Sbjct: 195 GCVIIEMATAKPPWNAEKHSNH 216

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 83.9 bits (207), Expect = 9e-18
 Identities = 74/285 (25%), Positives = 137/285 (48%), Gaps = 40/285 (14%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK--GDFLAELAIIHRL-RHKH 305
           LGEG FG V +   +  D+   D T     K  +D+   K   D ++E+ ++  + +HK+
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYG-------------TSEQVTLNWNHRYKI 352
           +++L+G C ++G L ++ ++   G+L ++L                  +  L++      
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
              VA  + YL++   ++ +HRDL A N+L+  D   ++ DFGLAR + ++ + Y +   
Sbjct: 140 AYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGV-HDIDYYKKTSN 195

Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWV 471
             +P  + ++APE       T +SDV+ FG ++ E+   G SP   IP ++        +
Sbjct: 196 GRLP--VKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--------L 245

Query: 472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP 516
           + L REGH    +D+  N          L +L   C H + ++RP
Sbjct: 246 FKLLREGH---RMDKPSNCTH------ELYMLMRECWHAVPTQRP 281

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 63/246 (25%), Positives = 112/246 (45%), Gaps = 36/246 (14%)

Query: 249 LGEGGFGIVYK----GIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRH 303
           +G+G FG V++    G++ +        T +AVK    + S   + DF  E A++    H
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPF-----TMVAVKMLKEEASADMQADFQREAALMAEFDH 67

Query: 304 KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVT-------------------L 344
            ++V L+G C     + L++++M  G L ++L   S +                     L
Sbjct: 68  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127

Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
           +   +  I   VA+ + YL    ++K VHRDL   N L+  +   ++ DFGL+R I +  
Sbjct: 128 SCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA- 183

Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQH 463
           + Y       +P  + ++ PE     + T ESDV+ +G V+ E+   G  P   + H++ 
Sbjct: 184 DYYKASENDAIP--IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241

Query: 464 AYTLVD 469
            Y + D
Sbjct: 242 IYYVRD 247

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 31/218 (14%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKF--SRDSIKSKGDFLAELAIIHRLRHK 304
            +GEG +G+V K         +    +I A+KKF  S D    K   L E+ ++ +LRH+
Sbjct: 8   VVGEGAYGVVLKC-------RNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNG---SLEKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
           ++V+L      KG+L LV++++       LE    G               +  +  A+ 
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAV------RSYIWQLLQAIA 114

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI-ENERNSYAEHGLVGVPGTMG 420
           Y    +   ++HRD+K  NIL+      +L DFG ARA+     +   ++       T  
Sbjct: 115 YC---HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDY-----VATRW 166

Query: 421 YVAPECF-HTGKATPESDVFGFGAVVLEVVCGRS--PG 455
           Y APE            DV+  G ++ E++ G    PG
Sbjct: 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 33/216 (15%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAIIHRLRHKH 305
           LG+GGFG V         Q        A KK  +  +K +      L E  I+ ++  + 
Sbjct: 1   LGKGGFGEVCAC------QVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF 54

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYY--- 362
           +V L      K  L LV   M  G L+ ++Y   E                A A++Y   
Sbjct: 55  IVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGF-----------PEARAIFYAAQ 103

Query: 363 ----LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
               L++ + +++V+RDLK  N+LLD   N R+ D GLA  ++  +      G  G P  
Sbjct: 104 IICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---KGRAGTP-- 158

Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            GY+APE           D F  G  + E++ GRSP
Sbjct: 159 -GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173886 cd01951, lectin_L-type, legume lectins

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 39/160 (24%), Positives = 70/160 (43%), Gaps = 18/160 (11%)

Query: 15  GLAFVIAPNDSFPP-ESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGF--DPDDNHLG 71
           G+AFV+  + +        G  LG            + VA+EFDT K     DP+ NH+ 
Sbjct: 74  GIAFVLQNDPAGALGGGGGGGGLG-------YGGIGNSVAVEFDTYKNDDNNDPNGNHIS 126

Query: 72  LNINSVVS----RKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKP 127
           +++N   +      ++      N T   G  +TV + YD  +  + V++D    +     
Sbjct: 127 IDVNGNGNNTALATSLGSASLPNGT-GLGNEHTVRITYDPTTNTLTVYLD--NGSTLTSL 183

Query: 128 LLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLD 167
            +   ++L      ++YFGF+ASTG     L+ + +W+  
Sbjct: 184 DITIPVDLIQLGPTKAYFGFTASTGGLT-NLHDILNWSFT 222

The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 223

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 85/295 (28%), Positives = 128/295 (43%), Gaps = 54/295 (18%)

Query: 249 LGEGGFGIVYKGIIHHNDQ-----YHVDNTQIAVKKFSRDSIKSKGDFLAELAII-HRLR 302
           LG G FG VYK    +N Q       ++    A  K  R+  KS GD ++E+ II  +LR
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSL--------EKYLYGTSEQVTLNWNHRYKILT 354
           H ++V       E  +L +V D +    L        EK    T E++   WN    I  
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI---WN----IFV 120

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
            +  A+ YL  E  +++VHRDL  +NI+L  D    + DFGLA+  + +  S     L  
Sbjct: 121 QMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESK----LTS 172

Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP---GNMIPHQQHAYTLVDWV 471
           V GT+ Y  PE         ++DV+ FG ++ ++   + P    NM+     A  +V+ V
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SLATKIVEAV 229

Query: 472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS 526
           +    EG   + V     I S              C  P A  RP   DI+Q+ +
Sbjct: 230 YEPLPEGMYSEDV--TDVITS--------------CLTPDAEARP---DIIQVSA 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 69/211 (32%), Positives = 107/211 (50%), Gaps = 24/211 (11%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           +LG G FG V+    +        +T++AVK     S+ S   FLAE  ++  L+H  LV
Sbjct: 13  KLGAGQFGEVWMATYN-------KHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLV 64

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLY---GTSEQVTLNWNHRYKILTGVASAVYYLQ 364
            L      K  + ++ +FM  GSL  +L    G+ + +    +   +I  G+A   +  Q
Sbjct: 65  KLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA---FIEQ 120

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
             Y    +HRDL+A+NIL+ A    ++ DFGLAR IE+  N Y        P  + + AP
Sbjct: 121 RNY----IHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFP--IKWTAP 172

Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           E  + G  T +SDV+ FG +++E+V  GR P
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 61/207 (29%), Positives = 104/207 (50%), Gaps = 27/207 (13%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQ--IAVKKFSRDSIKS--KGDFLAELAIIHRLRHK 304
           LG G FG V KG+      Y +  ++  +AVK    D+     K + L E  ++ +L + 
Sbjct: 3   LGSGNFGTVKKGM------YKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNP 56

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL----YGTSEQVTLNWNHRYKILTGVASAV 360
           ++V ++G C E    +LV +    G L K+L    + T + +T       +++  V+  +
Sbjct: 57  YIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-------ELVHQVSMGM 108

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            YL+   +   VHRDL A N+LL     A++ DFGL++A+  + N Y        P  + 
Sbjct: 109 KYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWP--VK 163

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLE 447
           + APEC +  K + +SDV+ FG ++ E
Sbjct: 164 WYAPECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 15/214 (7%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF-SRDSIKSKGDFLAELAIIHR 300
           N  E   LG G FG V+       ++     T + VK          + +F  EL +  +
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEE-EGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64

Query: 301 LRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVT------LNWNHRYKILT 354
           L HK++V L+G C E     ++ ++   G L+++L  T  +        L+   +  + T
Sbjct: 65  LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
            +A  + +L    + + VHRDL A N L+ +    ++    L++ + N    Y +     
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS--EYYKLRNAL 179

Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           +P  + ++APE       + +SDV+ FG ++ EV
Sbjct: 180 IP--LRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 69/225 (30%), Positives = 109/225 (48%), Gaps = 31/225 (13%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDN-TQIAVKKF-----SRDSIKSKGDFLAEL 295
           N+     LG G FG VY         Y  D   ++AVK+      S+++ K       E+
Sbjct: 3   NWRLGKLLGRGAFGEVYLC-------YDADTGRELAVKQVPFDPDSQETSKEVNALECEI 55

Query: 296 AIIHRLRHKHLVHLVGWC---HEKGKLLLVYDFMPNGSLEKYL--YGT-SEQVTLNWNHR 349
            ++  LRH  +V   G C    E+ KL +  ++MP GS++  L  YG  +E VT  +   
Sbjct: 56  QLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR- 113

Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
            +IL GV     YL   +   +VHRD+K +NIL D+  N +LGDFG ++ I+    S   
Sbjct: 114 -QILQGV----SYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGT- 164

Query: 410 HGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            G+  V GT  +++PE         ++DV+     V+E++  + P
Sbjct: 165 -GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 81.9 bits (202), Expect = 4e-17
 Identities = 63/244 (25%), Positives = 108/244 (44%), Gaps = 51/244 (20%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQ------------------IAVKKFSRDSIK-SK 288
           +LGEG FG V+           V N Q                  +AVK    D+ K ++
Sbjct: 12  KLGEGQFGEVH--------LCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR 63

Query: 289 GDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLY------GTSEQV 342
            DFL E+ I+ RL+  +++ L+G C ++  L ++ ++M NG L ++L             
Sbjct: 64  NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123

Query: 343 ----------TLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG 392
                      ++++    +   +AS + YL +      VHRDL   N L+  +   ++ 
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIA 180

Query: 393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV--VC 450
           DFG++R +    + Y   G   +P  + ++A EC   GK T  SDV+ FG  + E+  +C
Sbjct: 181 DFGMSRNLY-AGDYYRIQGRAVLP--IRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237

Query: 451 GRSP 454
              P
Sbjct: 238 KEQP 241

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 81.9 bits (202), Expect = 4e-17
 Identities = 63/236 (26%), Positives = 117/236 (49%), Gaps = 27/236 (11%)

Query: 248 RLGEGGFGIVY----KGIIHHNDQY------HVDNTQIAVKKFSRDSIK-SKGDFLAELA 296
           +LGEG FG V+    +G+    D+             +AVK    D+ K ++ DFL E+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 297 IIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLY--------GTSEQVTLNWNH 348
           I+ RL+  +++ L+  C     L ++ ++M NG L ++L           ++ VT++++ 
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
              + T +AS + YL +      VHRDL   N L+  ++  ++ DFG++R + +  + Y 
Sbjct: 132 LIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG-DYYR 187

Query: 409 EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV--CGRSPGNMIPHQQ 462
             G   +P  + +++ E    GK T  SDV+ FG  + E++  C   P + +  +Q
Sbjct: 188 IQGRAVLP--IRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 81.6 bits (201), Expect = 5e-17
 Identities = 63/228 (27%), Positives = 113/228 (49%), Gaps = 41/228 (17%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLV 307
           +GEG FG V + +I   D   ++     +K+F+ ++     DF  EL ++ +L  H +++
Sbjct: 10  IGEGNFGQVIRAMIK-KDGLKMNAAIKMLKEFASEN--DHRDFAGELEVLCKLGHHPNII 66

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYL---------------YGTSEQVTLNWNHRYKI 352
           +L+G C  +G L +  ++ P G+L  +L               +GT+   TL      + 
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAS--TLTSQQLLQF 124

Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
            + VA+ + YL    +++ +HRDL A N+L+  +  +++ DFGL+R  E           
Sbjct: 125 ASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSRGEE----------- 170

Query: 413 VGVPGTMG-----YVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           V V  TMG     ++A E  +    T +SDV+ FG ++ E+V  G +P
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 81.5 bits (201), Expect = 5e-17
 Identities = 67/257 (26%), Positives = 117/257 (45%), Gaps = 38/257 (14%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK-GDFLAELAIIHRLRHKHLV 307
           LGEG FG V K       +     T +AVK    ++  S+  D L+E  ++ ++ H H++
Sbjct: 8   LGEGEFGKVVKATAFRL-KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYL------------YGTSEQVTLNWNHRYKILT- 354
            L G C + G LLL+ ++   GSL  +L               +   +   N   + LT 
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 355 --------GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
                    ++  + YL    + K+VHRDL A N+L+      ++ DFGL+R +  E +S
Sbjct: 127 GDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY-EEDS 182

Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAY 465
           Y +     +P  + ++A E       T +SDV+ FG ++ E+V  G +P   I  ++   
Sbjct: 183 YVKRSKGRIP--VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER--- 237

Query: 466 TLVDWVWMLHREGHIQD 482
                ++ L + G+  +
Sbjct: 238 -----LFNLLKTGYRME 249

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 56/217 (25%), Positives = 106/217 (48%), Gaps = 18/217 (8%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK---FSRDSIKSKGDFLAELAII 298
           NF    ++G G F  VY+          +D   +A+KK   F     K++ D + E+ ++
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCL------LDRKPVALKKVQIFEMMDAKARQDCVKEIDLL 56

Query: 299 HRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL-YGTSEQVTLNWNHRYKILTGVA 357
            +L H +++  +    E  +L +V +    G L + + Y   ++  +     +K    + 
Sbjct: 57  KQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC 116

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
           SAV ++   + ++V+HRD+K +N+ + A    +LGD GL R   ++  + A H LVG P 
Sbjct: 117 SAVEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTP- 170

Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
              Y++PE  H      +SD++  G ++ E+   +SP
Sbjct: 171 --YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 69/221 (31%), Positives = 105/221 (47%), Gaps = 31/221 (14%)

Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLA--ELAIIH 299
           F +   LG+GGFG V         Q        A K+  +  IK  KG+ +A  E  I+ 
Sbjct: 2   FRQYRVLGKGGFGEVCAC------QVRATGKMYACKRLEKKRIKKRKGESMALNEKQILE 55

Query: 300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLY-----GTSEQVTLNWNHRYKILT 354
           ++  + +V+L      K  L LV   M  G L+ ++Y     G  E+  L +    +IL 
Sbjct: 56  KVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA--EILC 113

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI-ENERNSYAEHGLV 413
           G       L++ + +  V+RDLK  NILLD   + R+ D GLA  I E E        + 
Sbjct: 114 G-------LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-------IR 159

Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           G  GT+GY+APE  +  + T   D +G G ++ E++ G+SP
Sbjct: 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 79.5 bits (197), Expect = 2e-16
 Identities = 50/182 (27%), Positives = 83/182 (45%), Gaps = 22/182 (12%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA-----ELAIIHRLRH 303
           LGEG + +VYK       +       +A+KK      K   D +      E+ ++  L+H
Sbjct: 8   LGEGTYAVVYKA------RDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 304 KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYL 363
            +++ L+     K  + LV++FM    LEK +   S  + L        +      + YL
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYL 118

Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
            + +   ++HRDLK +N+L+ +D   +L DFGLAR+  +       H +V    T  Y A
Sbjct: 119 HSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT-HQVV----TRWYRA 170

Query: 424 PE 425
           PE
Sbjct: 171 PE 172

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 33/222 (14%)

Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLA--ELAIIH 299
           F +   LG+GGFG V         Q        A KK  +  IK  KG+ +A  E  I+ 
Sbjct: 2   FRQYRVLGKGGFGEVCAC------QVRATGKMYACKKLEKKRIKKRKGESMALNEKQILE 55

Query: 300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASA 359
           ++  + +V L      K  L LV   M  G L+ ++Y           H  +       A
Sbjct: 56  KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-----------HMGEAGFEEGRA 104

Query: 360 VYY-------LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           V+Y       L++ + +++V+RDLK  NILLD   + R+ D GLA  +   +       +
Sbjct: 105 VFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT------I 158

Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            G  GT+GY+APE     + T   D +  G ++ E++ G+SP
Sbjct: 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 69/222 (31%), Positives = 101/222 (45%), Gaps = 45/222 (20%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLA--ELAIIHRLRHKH 305
           LG+GGFG V         Q        A KK  +  IK  KG+ +A  E  I+ ++  + 
Sbjct: 8   LGKGGFGEVCAC------QVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLY-----GTSEQVTLNWNHRYKILTGVASAV 360
           +V L      K  L LV   M  G L+ ++Y     G  EQ                 A+
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQ----------------RAI 105

Query: 361 YY-------LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI-ENERNSYAEHGL 412
           +Y       L++   +++V+RDLK  NILLD   + R+ D GLA  I E E        +
Sbjct: 106 FYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-------V 158

Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            G  GT+GY+APE  +  K T   D +G G ++ E++ G+SP
Sbjct: 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 58/218 (26%), Positives = 109/218 (50%), Gaps = 26/218 (11%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---------FLAELAIIH 299
           +G G FG VY G+             +AVK+    S+ +               E+A++ 
Sbjct: 8   IGSGSFGSVYLGM------NASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVA 357
            L+H+++V  +G   +   L +  +++P GS+   L  YG  E+ TL  N   +IL G+ 
Sbjct: 62  ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE-TLVRNFVRQILKGLN 120

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE-NERNSYAEHGLVGVP 416
               YL N   + ++HRD+K +NIL+D     ++ DFG+++ +E N  ++        + 
Sbjct: 121 ----YLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173

Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           G++ ++APE       T ++D++  G +V+E++ G+ P
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 45/222 (20%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLA--ELAIIHRLRHKH 305
           LG+GGFG V         Q        A KK  +  IK  KG+ +A  E  I+ ++  + 
Sbjct: 8   LGKGGFGEVCAC------QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLY-----GTSEQVTLNWNHRYKILTGVASAV 360
           +V L      K  L LV   M  G L+ ++Y     G  E+                 AV
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEE----------------RAV 105

Query: 361 YY-------LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI-ENERNSYAEHGL 412
           +Y       L++ + +++V+RDLK  NILLD   + R+ D GLA  I E E        +
Sbjct: 106 FYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-------I 158

Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            G  GT+GY+APE     + T   D +G G ++ E++ G+SP
Sbjct: 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 78.2 bits (193), Expect = 6e-16
 Identities = 69/241 (28%), Positives = 109/241 (45%), Gaps = 48/241 (19%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKF--SRDSIKSKGDFLAELAIIHRLRHK 304
           ++GEG +G+V+K         + +  QI A+KKF  S D    K   L E+ ++ +L+H 
Sbjct: 8   KIGEGSYGVVFKC-------RNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPN---GSLEKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
           +LV+L+     K KL LV+++  +     LEK   G  E +        KI+     AV 
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK------KIIWQTLQAVN 114

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGY 421
           +    +    +HRD+K  NIL+      +L DFG AR +    + Y ++       T  Y
Sbjct: 115 FC---HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY-----VATRWY 166

Query: 422 VAPECFHTG--KATPESDVFGFGAVVLEVVCG-----------------RSPGNMIP-HQ 461
            APE    G  +  P  DV+  G V  E++ G                 ++ G++IP HQ
Sbjct: 167 RAPELL-VGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQ 225

Query: 462 Q 462
           Q
Sbjct: 226 Q 226

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 77.8 bits (192), Expect = 7e-16
 Identities = 67/241 (27%), Positives = 106/241 (43%), Gaps = 51/241 (21%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKF--SRDSIKSKGDFLAELAIIHRLRHKH 305
           +GEG +G+V K         H +  QI A+KKF  S D    K   + E+ ++ +LRH++
Sbjct: 9   VGEGSYGMVMKC-------KHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61

Query: 306 LVHLVGWCHEKGKLLLVYDFMPN---GSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYY 362
           LV+L+     K +L LV++F+ +     LEKY  G  E          K L  +   + +
Sbjct: 62  LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRV------RKYLFQILRGIEF 115

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
             +     ++HRD+K  NIL+      +L DFG AR +      Y ++       T  Y 
Sbjct: 116 CHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY-----VATRWYR 167

Query: 423 APECF----HTGKATPESDVFGFGAVVLEVVCG-----------------RSPGNMIPHQ 461
           APE        G+A    D++  G +V E++ G                 +  GN+IP  
Sbjct: 168 APELLVGDTKYGRAV---DIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH 224

Query: 462 Q 462
           Q
Sbjct: 225 Q 225

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 78.2 bits (193), Expect = 8e-16
 Identities = 75/251 (29%), Positives = 120/251 (47%), Gaps = 52/251 (20%)

Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF 291
           KY++L K          +G+G FG V+K   H   +  V     A+KK   ++ K +G F
Sbjct: 13  KYEKLAK----------IGQGTFGEVFKAR-HKKTKQIV-----ALKKVLMENEK-EG-F 54

Query: 292 ----LAELAIIHRLRHKHLVHLVGWCHE--------KGKLLLVYDFMPNGSLEKYLYG-- 337
               L E+ I+  L+H+++V+L+  C          KG   LV++F      E  L G  
Sbjct: 55  PITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF-----CEHDLAGLL 109

Query: 338 TSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA 397
           +++ V    +   K++  + + +YY+   +  K++HRD+KA+NIL+  D   +L DFGLA
Sbjct: 110 SNKNVKFTLSEIKKVMKMLLNGLYYI---HRNKILHRDMKAANILITKDGILKLADFGLA 166

Query: 398 RAIENERNSYAEHGLVGVPGTMGYVAPE----CFHTGKATPESDVFGFGAVVLEVVCGRS 453
           RA    +NS   +       T+ Y  PE        G   P  D++G G ++ E+   RS
Sbjct: 167 RAFSLSKNS-KPNRYTNRVVTLWYRPPELLLGERDYG---PPIDMWGAGCIMAEMWT-RS 221

Query: 454 P---GNMIPHQ 461
           P   GN   HQ
Sbjct: 222 PIMQGNTEQHQ 232

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 77.4 bits (190), Expect = 9e-16
 Identities = 65/224 (29%), Positives = 114/224 (50%), Gaps = 29/224 (12%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDN-TQIAVKK--FSRDSIKSKGDFLA---EL 295
           N+     LG+G FG VY         Y VD   ++A K+  F  +S ++  +  A   E+
Sbjct: 3   NWRRGKLLGQGAFGRVYLC-------YDVDTGRELAAKQVQFDPESPETSKEVSALECEI 55

Query: 296 AIIHRLRHKHLVHLVGWCHEKGK--LLLVYDFMPNGSLEKYL--YGT-SEQVTLNWNHRY 350
            ++  L+H+ +V   G   ++ +  L +  ++MP GS++  L  YG  +E VT  +    
Sbjct: 56  QLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR-- 113

Query: 351 KILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEH 410
           +IL G++    YL   +   +VHRD+K +NIL D+  N +LGDFG ++ ++    S    
Sbjct: 114 QILEGMS----YL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGT-- 164

Query: 411 GLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           G+  V GT  +++PE         ++DV+  G  V+E++  + P
Sbjct: 165 GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 77.4 bits (190), Expect = 9e-16
 Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 41/228 (17%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLV 307
           +GEG FG V K  I   D   +D     +K+++        DF  EL ++ +L  H +++
Sbjct: 3   IGEGNFGQVLKARIK-KDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHHPNII 59

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYL---------------YGTSEQVTLNWNHRYKI 352
           +L+G C  +G L L  ++ P+G+L  +L                 T+   TL+       
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS--TLSSQQLLHF 117

Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
              VA  + YL     ++ +HRDL A NIL+  ++ A++ DFGL+R  E           
Sbjct: 118 AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE----------- 163

Query: 413 VGVPGTMG-----YVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           V V  TMG     ++A E  +    T  SDV+ +G ++ E+V  G +P
Sbjct: 164 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 18/217 (8%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK---FSRDSIKSKGDFLAELAII 298
           NF    ++G G F  VY+          +D   +A+KK   F     K++ D + E+ ++
Sbjct: 3   NFRIEKKIGRGQFSEVYRA------TCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLL 56

Query: 299 HRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR-YKILTGVA 357
            +L H +++       E  +L +V +    G L + +    +Q  L      +K    + 
Sbjct: 57  KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC 116

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
           SA   L++ + ++V+HRD+K +N+ + A    +LGD GL R   ++  + A H LVG P 
Sbjct: 117 SA---LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTP- 170

Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
              Y++PE  H      +SD++  G ++ E+   +SP
Sbjct: 171 --YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 40/236 (16%)

Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF--SRDSIKSKG 289
           KY ++KK          +GEG FG   K I+  + +   D  Q  +K+   S+ S K + 
Sbjct: 1   KYVKVKK----------IGEGSFG---KAILVKSKE---DGKQYVIKEINISKMSPKERE 44

Query: 290 DFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGT-----SEQVTL 344
           +   E+A++  ++H ++V       E G L +V D+   G L K +         E   L
Sbjct: 45  ESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQIL 104

Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
           +W                L++ +D+K++HRD+K+ NI L  D   +LGDFG+AR +    
Sbjct: 105 DW---------FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL---- 151

Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGR---SPGNM 457
           NS  E     + GT  Y++PE         +SD++  G V+ E+   +     GNM
Sbjct: 152 NSTVELARTCI-GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 59/229 (25%), Positives = 109/229 (47%), Gaps = 30/229 (13%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK--FSRDSIKSKGDFLAELAIIH 299
            +    ++GEG FG +Y        +   D+    +K+   ++  +K K     E+ ++ 
Sbjct: 1   RYEIIKKIGEGSFGKIYLA------KAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLA 54

Query: 300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL---YGT--SEQVTLNWNHRYKILT 354
           +++H ++V       E G+L +V ++   G L K +    G   SE   L+W    +I  
Sbjct: 55  KMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISL 112

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDAD-FNARLGDFGLARAIENERNSYAEHGLV 413
           G       L++ +D+K++HRD+K+ NI L  +   A+LGDFG+AR + N+    A   + 
Sbjct: 113 G-------LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCV- 163

Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP--GNMIPH 460
              GT  Y++PE         ++D++  G V+ E+   + P  GN +  
Sbjct: 164 ---GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 30/212 (14%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA---ELAIIHRLRHKH 305
           LGEG +G VYK I      +      +A+K         + D      E++I+ +    +
Sbjct: 11  LGEGSYGSVYKAI------HKETGQVVAIKVVP-----VEEDLQEIIKEISILKQCDSPY 59

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           +V   G   +   L +V ++   GS+   +  T    TL       IL      + YL  
Sbjct: 60  IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYL-- 115

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN---ERNSYAEHGLVGVPGTMGYV 422
            +  K +HRD+KA NILL+ +  A+L DFG++  + +   +RN+          GT  ++
Sbjct: 116 -HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI--------GTPFWM 166

Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           APE         ++D++  G   +E+  G+ P
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 65/224 (29%), Positives = 114/224 (50%), Gaps = 40/224 (17%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS----IKSKGDFLAELAIIHRLRH 303
           ++GEG +G+VYK       +  V N  IA+KK   +     + S    + E++++  ++H
Sbjct: 9   KIGEGTYGVVYKA------RDRVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQH 60

Query: 304 KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR------YKILTGVA 357
            ++V L    H + +L LV++++ +  L+K++  + +      N R      Y+IL G+A
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIA 116

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNA-RLGDFGLARAIENERNSYAEHGLVGVP 416
                    +  +V+HRDLK  N+L+D   NA +L DFGLARA      ++  H +V   
Sbjct: 117 YC-------HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT-HEVV--- 165

Query: 417 GTMGYVAPECFHTGK--ATPESDVFGFGAVVLEVVCGRS--PGN 456
            T+ Y APE     +  +TP  D++  G +  E+V  +   PG+
Sbjct: 166 -TLWYRAPEILLGSRHYSTP-VDIWSVGCIFAEMVNQKPLFPGD 207

Length = 294

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 16/209 (7%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAIIHRLRHKH 305
           LG+GGFG V         Q        A KK ++  +K +  +   + E  I+ ++  + 
Sbjct: 1   LGKGGFGEVSAC------QMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRF 54

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           +V L      K  L LV   M  G L  ++Y   E+       R    T  A  +  L++
Sbjct: 55  IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYT--AQIISGLEH 112

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            + +++++RDLK  N+LLD D N R+ D GLA  +++ ++        G  GT G++APE
Sbjct: 113 LHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK-----GYAGTPGFMAPE 167

Query: 426 CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                +     D F  G  + E++  R P
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 75.7 bits (186), Expect = 3e-15
 Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 20/213 (9%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFL-AELAIIHRLRHKHLV 307
           LG+G +G VY G+ +      V   Q+ +   +  + + + + L  E+ ++  L+H ++V
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAV--KQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRY--KILTGVASAVYYL 363
             +G C +   + +  +F+P GS+   L  +G   +       +Y  +IL GVA    YL
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC---KYTKQILDGVA----YL 118

Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR--AIENERNSYAEHGLVGVPGTMGY 421
              ++  VVHRD+K +N++L  +   +L DFG AR  A      +++   L  + GT  +
Sbjct: 119 ---HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM-LKSMHGTPYW 174

Query: 422 VAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +APE  +      +SD++  G  V E+  G+ P
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 28/217 (12%)

Query: 252 GGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAIIHRLRHKHLV 307
           G +G V+        D Y       A+K   +  +  K      L E  I+ + +  ++V
Sbjct: 4   GAYGRVFLAKKKSTGDIY-------AIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVV 56

Query: 308 HLV-GWCHEKGKLLLVYDFMPNGSLEKYL--YGT-SEQVTLNWNHRYKILTGVASAVYYL 363
            L   +  +K  L LV +++P G L   L   G+  E V          +  +  A+ YL
Sbjct: 57  KLYYSFQGKK-NLYLVMEYLPGGDLASLLENVGSLDEDVARI------YIAEIVLALEYL 109

Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN---SYAEHGLVGVPGTMG 420
            +     ++HRDLK  NIL+D++ + +L DFGL++     R    +  E     + GT  
Sbjct: 110 HS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNM 457
           Y+APE       +   D +  G ++ E + G  P + 
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 76.0 bits (187), Expect = 4e-15
 Identities = 69/248 (27%), Positives = 113/248 (45%), Gaps = 18/248 (7%)

Query: 228 PREFKYKE-LKKATNNFHESMRLGEGGFGIVYKGIIH---HNDQYHVDNTQIAVKKFSRD 283
           P +  Y    +   NN      LG G FG V +   +    +D       ++AVK     
Sbjct: 21  PTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDA----VMKVAVKMLKPT 76

Query: 284 SIKS-KGDFLAELAIIHRL-RHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQ 341
           +  S +   ++EL I+  L  H+++V+L+G C   G +L++ ++   G L  +L    E 
Sbjct: 77  AHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE- 135

Query: 342 VTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE 401
             L           VA  + +L +   +  +HRDL A N+LL      ++ DFGLAR I 
Sbjct: 136 SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192

Query: 402 NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPH 460
           N+ N Y   G   +P  + ++APE       T ESDV+ +G ++ E+   G +P   +P 
Sbjct: 193 NDSN-YVVKGNARLP--VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV 249

Query: 461 QQHAYTLV 468
               Y L+
Sbjct: 250 DSKFYKLI 257

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 76.2 bits (188), Expect = 4e-15
 Identities = 61/240 (25%), Positives = 97/240 (40%), Gaps = 47/240 (19%)

Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF----LAE 294
              ++    +LGEG FG VYK               +A+KK    +   K  F    L E
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKAR--QIK----TGRVVALKKILMHN--EKDGFPITALRE 57

Query: 295 LAIIHRLRHKHLVHLVGWCHEKG-----KLLLVYDFMP------NGSLEKYLYGTSEQVT 343
           + I+ +L+H ++V L+    E+      K   VY   P      +G LE      +  V 
Sbjct: 58  IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE------NPSVK 111

Query: 344 LNWNH----RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA 399
           L  +       ++L G+     YL   ++  ++HRD+KA+NIL+D     ++ DFGLAR 
Sbjct: 112 LTESQIKCYMLQLLEGIN----YL---HENHILHRDIKAANILIDNQGILKIADFGLARP 164

Query: 400 IENERNSY------AEHGLVGVPGTMGYVAPE-CFHTGKATPESDVFGFGAVVLEVVCGR 452
            +    +              +  T  Y  PE      + T   D++G G V  E+   R
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 75.3 bits (185), Expect = 4e-15
 Identities = 74/302 (24%), Positives = 129/302 (42%), Gaps = 47/302 (15%)

Query: 230 EFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG 289
           E++Y+      +   E + LG+G +GIVY               +IA+K+      +   
Sbjct: 2   EYEYE-----YDENGERVVLGKGTYGIVYAARDLST------QVRIAIKEIPERDSRYVQ 50

Query: 290 DFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL---YG--TSEQVTL 344
               E+A+   L+H+++V  +G   E G   +  + +P GSL   L   +G     + T+
Sbjct: 51  PLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTI 110

Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA-RLGDFGLARAIENE 403
            +  + +IL G+     YL   +D ++VHRD+K  N+L++      ++ DFG ++ +   
Sbjct: 111 IFYTK-QILEGLK----YL---HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG- 161

Query: 404 RNSYAEHGLVGVPGTMGYVAPECFHTGKA--TPESDVFGFGAVVLEVVCGRSPGNMIPHQ 461
            N   E       GT+ Y+APE    G       +D++  G  ++E+  G+ P   +   
Sbjct: 162 INPCTE----TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP 217

Query: 462 QHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDI 521
           Q A   V    M      I +         S+  EAK  +   L C  P   +R    D+
Sbjct: 218 QAAMFKVG---MFKIHPEIPE---------SLSAEAKNFI---LRCFEPDPDKRASAHDL 262

Query: 522 LQ 523
           LQ
Sbjct: 263 LQ 264

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 75.2 bits (185), Expect = 5e-15
 Identities = 57/215 (26%), Positives = 108/215 (50%), Gaps = 21/215 (9%)

Query: 249 LGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA---ELAIIHRLRHK 304
           +G+G +G VY  + +   +   V   ++      R   + K    A   E+  +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGT-SEQVTLNWNHRYKILTGVASAVY 361
           ++V  +G+   +  L +  +++P GS+   L  YG   EQ+   +    ++L G+A    
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE--QVLEGLA---- 122

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGY 421
           YL +   + ++HRDLKA N+L+DAD   ++ DFG+++  +   + Y     + + G++ +
Sbjct: 123 YLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSD---DIYDNDQNMSMQGSVFW 176

Query: 422 VAPECFHTGKA--TPESDVFGFGAVVLEVVCGRSP 454
           +APE  H+     + + D++  G VVLE+  GR P
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 60/219 (27%), Positives = 109/219 (49%), Gaps = 24/219 (10%)

Query: 249 LGEGGFGIVYKGIIHHND---QYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKH 305
           LGEG FG V +G ++ +D   +  V   +IA+   +R  ++   DFL+E   +    H +
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI--CTRSEME---DFLSEAVCMKEFDHPN 61

Query: 306 LVHLVGWCHEKGKL------LLVYDFMPNGSLEKYLYGT---SEQVTLNWNHRYKILTGV 356
           ++ L+G C +  +       +++  FM +G L  +L  +        L      K +T +
Sbjct: 62  VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP 416
           AS + YL +   +  +HRDL A N +L+ + N  + DFGL++ I N  + Y +  +  +P
Sbjct: 122 ASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG-DYYRQGRIAKMP 177

Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
             + ++A E       T +SDV+ FG  + E+   G++P
Sbjct: 178 --VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 74.8 bits (184), Expect = 8e-15
 Identities = 64/238 (26%), Positives = 99/238 (41%), Gaps = 45/238 (18%)

Query: 225 PGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS 284
           PG PR                 +++GEG  GIV         +      Q+AVKK     
Sbjct: 14  PGDPRS-----------YLDNFVKIGEGSTGIVCIATDKSTGR------QVAVKKMDLRK 56

Query: 285 IKSKGDFLAELAIIHRLRHKHLV-----HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTS 339
            + +     E+ I+   +H ++V     +LVG      +L +V +F+  G+L   +    
Sbjct: 57  QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-----DELWVVMEFLEGGALTDIV---- 107

Query: 340 EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA 399
               +N      +   V  A+ +L     Q V+HRD+K+ +ILL +D   +L DFG    
Sbjct: 108 THTRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164

Query: 400 IENE---RNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +  E   R S     LVG P  M   APE         E D++  G +V+E+V G  P
Sbjct: 165 VSKEVPRRKS-----LVGTPYWM---APEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 74.7 bits (183), Expect = 9e-15
 Identities = 72/243 (29%), Positives = 118/243 (48%), Gaps = 34/243 (13%)

Query: 229 REFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVK-KFSRD--SI 285
           R  K  ELKK          LG G FG VYKGI   + +    N +I V  K  R+  S 
Sbjct: 2   RILKETELKKV-------KVLGSGAFGTVYKGIWIPDGE----NVKIPVAIKVLRENTSP 50

Query: 286 KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQV--- 342
           K+  + L E  ++  +   ++  L+G C     + LV   MP G L  Y+    +++   
Sbjct: 51  KANKEILDEAYVMAGVGSPYVCRLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQ 109

Query: 343 -TLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE 401
             LNW         +A  + YL+   + ++VHRDL A N+L+ +  + ++ DFGLAR ++
Sbjct: 110 DLLNW------CVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160

Query: 402 -NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIP 459
            +E   +A+ G V +     ++A E     + T +SDV+ +G  V E++  G  P + IP
Sbjct: 161 IDETEYHADGGKVPIK----WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216

Query: 460 HQQ 462
            ++
Sbjct: 217 ARE 219

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 64/225 (28%), Positives = 115/225 (51%), Gaps = 33/225 (14%)

Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS----IKSKGDFLAELAII 298
           + +  ++GEG +G+VYK       +  +    +A+KK   ++    + S    + E++++
Sbjct: 1   YQKVEKIGEGTYGVVYKA------RDKLTGEIVALKKIRLETEDEGVPSTA--IREISLL 52

Query: 299 HRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQV---TLNWNHRYKILTG 355
             L H ++V L+   H + KL LV++F+ +  L+KY+  +        L  ++ Y++L G
Sbjct: 53  KELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111

Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           +A         +  +V+HRDLK  N+L+D +   +L DFGLARA      +Y  H +V  
Sbjct: 112 IAYC-------HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT-HEVV-- 161

Query: 416 PGTMGYVAPECFHTGK--ATPESDVFGFGAVVLEVVCGRS--PGN 456
             T+ Y APE     +  +TP  D++  G +  E+V  R   PG+
Sbjct: 162 --TLWYRAPEILLGSRQYSTP-VDIWSIGCIFAEMVNRRPLFPGD 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 36/226 (15%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLAELAIIH 299
               E  RLGEG  G V K  + +           A+K  + D     +   L EL I  
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMI------FALKTITTDPNPDLQKQILRELEINK 54

Query: 300 RLRHKHLVHLVGWCHEK--GKLLLVYDFMPNGSLEKYLYG--------TSEQVTLNWNHR 349
             +  ++V   G   ++    + +  ++   GSL+  +Y           E+V       
Sbjct: 55  SCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLG----- 108

Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA-RAIENERNSYA 408
            KI   V   + YL   + +K++HRD+K SNILL      +L DFG++   + +   ++ 
Sbjct: 109 -KIAESVLKGLSYL---HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT 164

Query: 409 EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                   GT  Y+APE       +  SDV+  G  +LEV   R P
Sbjct: 165 --------GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 53/224 (23%), Positives = 101/224 (45%), Gaps = 37/224 (16%)

Query: 249 LGEGGFGIVYKGIIHH-NDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           LG+G F  ++KGI     D   +  T++ +K   +        F    +++ +L HKHLV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C    + ++V +++  GSL+ YL      + ++W  + ++   +A A+++L+   
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE--- 117

Query: 368 DQKVVHRDLKASNILLDADFNA--------RLGDFG-----LARAIENERNSYAEHGLVG 414
           D+ + H ++ A N+LL  + +         +L D G     L + I  ER          
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER---------- 167

Query: 415 VPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSPGNM 457
           +P    +V PEC    +  +  +D + FG  + E+  G   G+ 
Sbjct: 168 IP----WVPPECIENPQNLSLAADKWSFGTTLWEIFSG---GDK 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 65/228 (28%), Positives = 108/228 (47%), Gaps = 27/228 (11%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVK-KFSRD--SIKSKGDFLAELAIIHRLRHKH 305
           LG G FG VYKG+     +      +I V  K  R+  S K+  + L E  ++  + + H
Sbjct: 15  LGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 70

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQV----TLNWNHRYKILTGVASAVY 361
           +  L+G C     + L+   MP G L  Y+    + +     LNW         +A  + 
Sbjct: 71  VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMN 123

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLVGVPGTMG 420
           YL+   ++++VHRDL A N+L+    + ++ DFGLA+ +  +   Y AE G V +     
Sbjct: 124 YLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK---- 176

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
           ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 224

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 19/209 (9%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELAIIHRLRHKH 305
           LG+GGFG V    + +  + +      A KK  +  +K K      L E  I+ ++    
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMY------ACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF 54

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           +V+L      K  L LV   M  G L+ ++Y    +  L           +   + +L  
Sbjct: 55  IVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHL-- 111

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            +   +V+RD+K  N+LLD   N RL D GLA  +++ +            GT GY+APE
Sbjct: 112 -HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR------AGTNGYMAPE 164

Query: 426 CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                  +   D F  G  + E+V GR+P
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 23/219 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAIIHRLRHKHL 306
           LG+G FG V +  +   D       ++AVK    D   S    +FL E A +    H ++
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQ---KVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNV 63

Query: 307 VHLVGWC---HEKGKL---LLVYDFMPNGSLEKYLYGT---SEQVTLNWNHRYKILTGVA 357
           + L+G       KG+L   +++  FM +G L  +L  +    E  TL      + +  +A
Sbjct: 64  IKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG-VP 416
           S + YL +   +  +HRDL A N +L+ +    + DFGL++ I +    Y   G    +P
Sbjct: 124 SGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYS--GDYYRQGCASKLP 178

Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
             + ++A E       T  SDV+ FG  + E++  G++P
Sbjct: 179 --VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 73/304 (24%), Positives = 134/304 (44%), Gaps = 45/304 (14%)

Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFL 292
           EL  +   F E   LGE  FG +YKG   H     +D+ Q+   K  +D  + +  G+F 
Sbjct: 1   ELPLSAVRFME--ELGECAFGKIYKG---HLYLPGMDHAQLVAIKTLKDINNPQQWGEFQ 55

Query: 293 AELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE------------ 340
            E +++  L H ++V L+G   ++  + ++++++  G L ++L   S             
Sbjct: 56  QEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115

Query: 341 --QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR 398
             + +L+      I   +A+ + YL + +    VH+DL A NIL+    + ++ D GL+R
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR 172

Query: 399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNM 457
            I +  + Y       +P  + ++ PE    GK + +SD++ FG V+ E+   G  P   
Sbjct: 173 EIYSA-DYYRVQPKSLLP--IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229

Query: 458 IPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK 517
             +Q+                 + + V +R  +    D   R+  L   C     S RP+
Sbjct: 230 FSNQE-----------------VIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPR 272

Query: 518 TEDI 521
            +DI
Sbjct: 273 FKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 29/217 (13%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDN-TQIAVKK--FSRDSIKSKGDFLA---ELAIIHRLR 302
           LG+G FG VY         Y  D   ++AVK+  F  +S ++  +  A   E+ ++  L 
Sbjct: 10  LGQGAFGRVYLC-------YDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 303 HKHLVHLVGWCHE--KGKLLLVYDFMPNGSLEKYL--YGT-SEQVTLNWNHRYKILTGVA 357
           H+ +V   G   +  +  L +  + MP GS++  L  YG  +E VT  +    +IL GV 
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR--QILEGV- 119

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
               YL   +   +VHRD+K +NIL D+  N +LGDFG ++ ++      +  G+  V G
Sbjct: 120 ---SYL---HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI--CLSGTGMKSVTG 171

Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           T  +++PE         ++D++  G  V+E++  + P
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 29/230 (12%)

Query: 225 PGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS 284
           PG PRE+         ++F   +++GEG  GIV      H  +      Q+AVKK     
Sbjct: 17  PGDPREY--------LDSF---IKIGEGSTGIVCIATEKHTGK------QVAVKKMDLRK 59

Query: 285 IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTL 344
            + +     E+ I+    H+++V +        +L +V +F+  G+L   +  T     +
Sbjct: 60  QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----M 115

Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
           N      +   V  A+ YL N   Q V+HRD+K+ +ILL +D   +L DFG    +  E 
Sbjct: 116 NEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172

Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                  LVG P  M   APE         E D++  G +V+E++ G  P
Sbjct: 173 PK--RKSLVGTPYWM---APEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 57/186 (30%), Positives = 96/186 (51%), Gaps = 29/186 (15%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS----IKSKGDFLAELAIIHRLRH 303
           ++GEG +G+VYKG      Q       +A+KK   +S    + S    + E++++  L+H
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQI------VAMKKIRLESEEEGVPSTA--IREISLLKELQH 58

Query: 304 KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL----YGTSEQVTLNWNHRYKILTGVASA 359
            ++V L     ++ +L L+++F+ +  L+KYL     G      L  ++ Y+IL G+   
Sbjct: 59  PNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI--- 114

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
             +    + ++V+HRDLK  N+L+D     +L DFGLARA       Y  H +V    T+
Sbjct: 115 -LFC---HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT-HEVV----TL 165

Query: 420 GYVAPE 425
            Y APE
Sbjct: 166 WYRAPE 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 26/220 (11%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA-ELAIIHRLRHKHLV 307
           +G G   +VY  I   N      N ++A+K+   +  ++  D L  E+  + +  H ++V
Sbjct: 9   IGVGATAVVYAAICLPN------NEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV 62

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVASAVYY 362
                     +L LV  ++  GSL       Y  G  ++  +       +L  V   + Y
Sbjct: 63  KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA-----TVLKEVLKGLEY 117

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN--ERNSYAEHGLVGVPGTMG 420
           L   +    +HRD+KA NILL  D + ++ DFG++ ++ +  +R        VG P  M 
Sbjct: 118 L---HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM- 173

Query: 421 YVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSPGNMIP 459
             APE          ++D++ FG   +E+  G +P +  P
Sbjct: 174 --APEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 60/226 (26%), Positives = 93/226 (41%), Gaps = 51/226 (22%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH 308
           LG+G FG VYK    H +         A K    +S +   DF+ E+ I+   +H ++V 
Sbjct: 13  LGDGAFGKVYK--AQHKET----GLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVG 66

Query: 309 LVGWCHEKGKLLLVYDFMPNGSL------------EKYLYGTSEQVT--LNWNHRYKILT 354
           L      + KL ++ +F   G+L            E  +     Q+   LN+ H      
Sbjct: 67  LYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH------ 120

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
                          KV+HRDLKA NILL  D + +L DFG++   ++          +G
Sbjct: 121 -------------SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIG 165

Query: 415 VPGTMGYVAPE---CFHTGKATP---ESDVFGFGAVVLEVVCGRSP 454
            P  M   APE   C  T K  P   ++D++  G  ++E+     P
Sbjct: 166 TPYWM---APEVVAC-ETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 71.7 bits (176), Expect = 6e-14
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 35/219 (15%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHL 306
           LG+G +G VYK       +   DN   A+K+    S+  K + D + E+ I+  + H ++
Sbjct: 8   LGKGSYGSVYKV------KRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 307 VHLVGWCHEK----GKLLLVYDFMPNGSLEKYLYGTSEQVTL-----NWNHRYKILTGVA 357
           +       E      KL +V ++ P G L K +    ++  L      W    ++L G  
Sbjct: 62  ISY----KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG-- 115

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
                LQ  ++QK++HRDLK++NILL A+   ++GD G+++ ++               G
Sbjct: 116 -----LQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-------AKTQIG 163

Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGN 456
           T  Y+APE +     + +SD++  G ++ E+     P  
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 71.8 bits (177), Expect = 8e-14
 Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 44/225 (19%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR----H 303
           +LG+G FG VY                +A+KK  +    S  + +  L  +  LR    H
Sbjct: 6   QLGDGTFGSVYLARNKET------GELVAIKKMKK-KFYSWEECM-NLREVKSLRKLNEH 57

Query: 304 KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGT---------SEQVTLNWNHRYKILT 354
            ++V L     E  +L  V+++M     E  LY           SE V  +    Y+IL 
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSI--IYQILQ 110

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           G+A   +  ++ +     HRDLK  N+L+      ++ DFGLAR I + R  Y ++  V 
Sbjct: 111 GLA---HIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAREIRS-RPPYTDY--V- 159

Query: 415 VPGTMGYVAPECF-HTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
              T  Y APE    +   +   D++  G ++ E+   R   PG+
Sbjct: 160 --STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 71.6 bits (175), Expect = 9e-14
 Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 29/230 (12%)

Query: 225 PGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS 284
           PG PR +         +NF   +++GEG  GIV    +  + +       +AVKK     
Sbjct: 15  PGDPRTY--------LDNF---IKIGEGSTGIVCIATVKSSGKL------VAVKKMDLRK 57

Query: 285 IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTL 344
            + +     E+ I+   +H+++V +        +L +V +F+  G+L       ++ VT 
Sbjct: 58  QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL-------TDIVTH 110

Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
              +  +I     + +  L   + Q V+HRD+K+ +ILL  D   +L DFG    +  E 
Sbjct: 111 TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 170

Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                  LVG P  M   APE        PE D++  G +V+E+V G  P
Sbjct: 171 PR--RKSLVGTPYWM---APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 31/210 (14%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH 308
           LG+G FG VYK     N +         ++  S + ++   D++ E+ I+    H ++V 
Sbjct: 20  LGDGAFGKVYKA---KNKETGALAAAKVIETKSEEELE---DYMVEIEILATCNHPYIVK 73

Query: 309 LVGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSE-QVTLNWNHRYKILTGVASAVYYL 363
           L+G  +  GKL ++ +F P G+++  +     G +E Q+ +       I   +  A+ YL
Sbjct: 74  LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------ICRQMLEALQYL 126

Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
              +  K++HRDLKA N+LL  D + +L DFG+  + +N +        +G P  M   A
Sbjct: 127 ---HSMKIIHRDLKAGNVLLTLDGDIKLADFGV--SAKNVKTLQRRDSFIGTPYWM---A 178

Query: 424 PECF--HTGKATP---ESDVFGFGAVVLEV 448
           PE     T K TP   ++D++  G  ++E+
Sbjct: 179 PEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 24/212 (11%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF-SRDSIKSKGDFLAELAIIHRLRHKHLV 307
           +G G FG V  G  H      +   ++ VK+  +  +   +  FL E+     L H +++
Sbjct: 3   IGNGWFGKVLLGEAHRG----MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVL 58

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRY--KILTGVASAVYYL-Q 364
             +G C E    LLV +F P G L+ YL      V          ++   VAS + +L Q
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG-LVGVPGTMGYVA 423
            ++    +H DL   N  L AD + ++GD+GL  A+E     Y        VP  + ++A
Sbjct: 119 ADF----IHSDLALRNCQLTADLSVKIGDYGL--ALEQYPEDYYITKDCHAVP--LRWLA 170

Query: 424 PEC---FH----TGKATPESDVFGFGAVVLEV 448
           PE              T +S+++  G  + E+
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 65/246 (26%), Positives = 117/246 (47%), Gaps = 32/246 (13%)

Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KGDFL 292
           E+  +T  F E   LGE  FG VYKG  H       + TQ    K  +D  +   + +F 
Sbjct: 1   EINLSTVRFME--ELGEDRFGKVYKG--HLFGTAPGEQTQAVAIKTLKDKAEGPLREEFK 56

Query: 293 AELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLY--------GTSE---- 340
            E  +  RL+H ++V L+G   ++  L +++ +  +  L ++L         G+++    
Sbjct: 57  HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116

Query: 341 -QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA 399
            + TL       I+T +A+ + +L + +   VVH+DL   N+L+    N ++ D GL R 
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFRE 173

Query: 400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-------CGR 452
           +    + Y   G   +P  + +++PE    GK + +SD++ +G V+ EV        CG 
Sbjct: 174 VYAA-DYYKLMGNSLLP--IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230

Query: 453 SPGNMI 458
           S  ++I
Sbjct: 231 SNQDVI 236

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 31/214 (14%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA-ELAIIHRLRHKHL 306
            +G+G FG VYK I          N  +A+K    +  + + + +  E+  + + R  ++
Sbjct: 8   CIGKGSFGEVYKAIDKRT------NQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYI 61

Query: 307 VHLVGWCHEKG-KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYL 363
               G    KG KL ++ ++   GS    L      E           IL  V   + YL
Sbjct: 62  TKYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIA------FILREVLLGLEYL 114

Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN---ERNSYAEHGLVGVPGTMG 420
                +  +HRD+KA+NILL  + + +L DFG++  + +   +RN++     VG P  M 
Sbjct: 115 HE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF-----VGTPFWM- 165

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             APE         ++D++  G   +E+  G  P
Sbjct: 166 --APEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 23/210 (10%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAIIHRLRHKH 305
           R+GEG  GIV+K       +       +A+KK +   ++       L E+  +   +H +
Sbjct: 7   RIGEGAHGIVFKAKDRETGE------TVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRY--KILTGVASAVYYL 363
           +V L+         +LV ++MP   L + L      +       Y   +L GVA    Y+
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVA----YM 115

Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
                  ++HRDLK +N+L+ AD   ++ DFGLAR    E      H +     T  Y A
Sbjct: 116 HAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV----ATRWYRA 168

Query: 424 PEC-FHTGKATPESDVFGFGAVVLEVVCGR 452
           PE  +   K  P  D++  G +  E++ G 
Sbjct: 169 PELLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 18/208 (8%)

Query: 247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHL 306
           +++GEG  GIV      H+ +      Q+AVK       + +     E+ I+   +H+++
Sbjct: 27  IKIGEGSTGIVCIAREKHSGR------QVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNV 80

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
           V +        +L ++ +F+  G+L   +     Q  LN      +   V  A+ YL   
Sbjct: 81  VEMYKSYLVGEELWVLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYL--- 133

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
           + Q V+HRD+K+ +ILL  D   +L DFG    I   ++      LVG P  M   APE 
Sbjct: 134 HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKSLVGTPYWM---APEV 188

Query: 427 FHTGKATPESDVFGFGAVVLEVVCGRSP 454
                   E D++  G +V+E+V G  P
Sbjct: 189 ISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 70.3 bits (173), Expect = 4e-13
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 57/229 (24%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIHRLRHKH 305
           +G G +G+V   +    D+      ++A+KK S    D I +K   L E+ ++  LRH++
Sbjct: 8   IGSGAYGVVCSAV----DK--RTGRKVAIKKISNVFDDLIDAK-RILREIKLLRHLRHEN 60

Query: 306 LVHLV-----GWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR---YKILTGVA 357
           ++ L+         +   + +V + M    L K +   S Q   + + +   Y+IL G+ 
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIK--SPQPLTDDHIQYFLYQILRGLK 117

Query: 358 ---SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
              SA           V+HRDLK SNIL++++ + ++ DFGLAR ++ + +         
Sbjct: 118 YLHSA----------NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE-------- 159

Query: 415 VPGTM-GYV------APE----CFHTGKATPESDVFGFGAVVLEVVCGR 452
             G +  YV      APE         KA    D++  G +  E++  +
Sbjct: 160 -KGFLTEYVVTRWYRAPELLLSSSRYTKAI---DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 69.6 bits (170), Expect = 4e-13
 Identities = 59/244 (24%), Positives = 101/244 (41%), Gaps = 27/244 (11%)

Query: 284 SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVT 343
           S K +  FLAE   + +  H ++V L G       +++V ++M NG+L+ +L     Q+ 
Sbjct: 46  SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLV 105

Query: 344 LNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE 403
                   +L G+AS + YL    +   VH+ L A  +L+++D   ++  F   +    E
Sbjct: 106 A--GQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ----E 156

Query: 404 RNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQ 462
             S A +  +     + + APE       +  SDV+ FG V+ EV+  G  P   +  Q 
Sbjct: 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD 216

Query: 463 HAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDIL 522
                            +  AV+    + +  +    L  L L C      ERP+   I 
Sbjct: 217 -----------------VIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIH 259

Query: 523 QIIS 526
            I+S
Sbjct: 260 SILS 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 70.4 bits (172), Expect = 4e-13
 Identities = 60/226 (26%), Positives = 108/226 (47%), Gaps = 31/226 (13%)

Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KGDFL 292
           ELK   ++F +   LG G  G+V+K         H  +  I  +K     IK   +   +
Sbjct: 1   ELKD--DDFEKISELGAGNGGVVFKVS-------HKPSGLIMARKLIHLEIKPAIRNQII 51

Query: 293 AELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHR 349
            EL ++H     ++V   G  +  G++ +  + M  GSL++ L       EQ+       
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------ 105

Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA-RAIENERNSYA 408
            K+   V   + YL+ ++  K++HRD+K SNIL+++    +L DFG++ + I++  NS+ 
Sbjct: 106 GKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 163

Query: 409 EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                   GT  Y++PE       + +SD++  G  ++E+  GR P
Sbjct: 164 --------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 69.6 bits (170), Expect = 5e-13
 Identities = 57/221 (25%), Positives = 110/221 (49%), Gaps = 23/221 (10%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHRLRHKHL 306
           +LGEG +  VYKG      +  + +  +A+K+   +  + +    + E++++  L+H ++
Sbjct: 13  KLGEGTYATVYKG------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKI-LTGVASAVYYLQN 365
           V L    H +  L LV++++ +  L++YL      + +   H  K+ L  +   + Y   
Sbjct: 67  VTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINM---HNVKLFLFQLLRGLNYC-- 120

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            + +KV+HRDLK  N+L++     +L DFGLARA      +Y+   +     T+ Y  P+
Sbjct: 121 -HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-----TLWYRPPD 174

Query: 426 C-FHTGKATPESDVFGFGAVVLEVVCGRS--PGNMIPHQQH 463
               +   + + D++G G +  E+  GR   PG+ +  Q H
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH 215

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 69.1 bits (169), Expect = 6e-13
 Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 24/214 (11%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVK--KFSRDSIKSKGDFLAELAIIHRLRHKHL 306
           LG+G +G VYK ++H           +A+K  +   D  K     + EL I+H+    ++
Sbjct: 9   LGKGNYGSVYK-VLHRPT-----GVTMAMKEIRLELDESKFNQ-IIMELDILHKAVSPYI 61

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
           V   G    +G + +  ++M  GSL+K   G      +  +   +I   V   + +L+ E
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
           ++  ++HRD+K +N+L++ +   +L DFG++  +     S A+  +    G   Y+APE 
Sbjct: 122 HN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTNI----GCQSYMAPER 172

Query: 427 FHTGKA------TPESDVFGFGAVVLEVVCGRSP 454
             +G        T +SDV+  G  +LE+  GR P
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 68.6 bits (168), Expect = 7e-13
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 21/206 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK--FSRDSIKSKGDFLAELAIIHRLRHKHL 306
           LG+G FG      ++   +   D++ +  K+   +R S K + D L E+ I+  L+H ++
Sbjct: 8   LGKGAFGE---ATLYRRTE---DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKI--LTGVASAVYYLQ 364
           +       +   LL+  ++   G+L   +     Q    +     +  L  + SAV Y+ 
Sbjct: 62  IAYYNHFMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVSYIH 118

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
                 ++HRD+K  NI L      +LGDFG+++ I     S AE     V GT  Y++P
Sbjct: 119 KA---GILHRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAE----TVVGTPYYMSP 170

Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC 450
           E     K   +SD++  G V+ E++ 
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 23/209 (11%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLAELAIIHRLRHKHLV 307
           LG G  G V K  + H        T +A K     +  S +   L EL I+H  R  ++V
Sbjct: 13  LGAGNGGSVSK--VKHIPT----GTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIV 66

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G    +  + +  +FM  GSL++     G      L      KI   V   + YL N
Sbjct: 67  SFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYN 121

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            +  +++HRD+K SNIL+++    +L DFG++  +    NS A+  +    GT  Y++PE
Sbjct: 122 VH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL---INSIADTFV----GTSTYMSPE 172

Query: 426 CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
               GK T +SDV+  G  ++E+  G+ P
Sbjct: 173 RIQGGKYTVKSDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 62/243 (25%), Positives = 94/243 (38%), Gaps = 56/243 (23%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF----SRDSIKSKGDFLAELAI 297
            F +  R+GEG +GIVY+      D        +A+KK      RD I      L E+ +
Sbjct: 8   EFEKLNRIGEGTYGIVYRA----RDT--TSGEIVALKKVRMDNERDGIPISS--LREITL 59

Query: 298 IHRLRHKHLVHL---------------VGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQ 341
           +  LRH ++V L               + +C  +   LL   D MP    E  +     Q
Sbjct: 60  LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL---DNMPTPFSESQVKCLMLQ 116

Query: 342 VTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE 401
           +          L G+     YL   +   ++HRDLK SN+LL      ++ DFGLAR   
Sbjct: 117 L----------LRGLQ----YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159

Query: 402 NERNSYAEHGLVGVPGTMGYVAPEC-FHTGKATPESDVFGFGAVVLEVVCGRS--PGNMI 458
                     +     T+ Y APE        T   D++  G ++ E++  +   PG   
Sbjct: 160 LPAKPMTPKVV-----TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214

Query: 459 PHQ 461
             Q
Sbjct: 215 IEQ 217

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 26/215 (12%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRH-KHL 306
           +G G FG V K +  H        T +AVK+       K +   L +L ++ R     ++
Sbjct: 12  IGRGAFGTVNKML--HKPS----GTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYI 65

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLE---KYLYGTSEQVTLNWNHRYKILTGVASAVYYL 363
           V   G    +G   +  + M + SL+   KY+Y    +  +      KI      A+ YL
Sbjct: 66  VKFYGALFREGDCWICMELM-DISLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYL 123

Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV-PGTMGYV 422
           + E   K++HRD+K SNILLD + N +L DFG++  +    +S A+    G  P    Y+
Sbjct: 124 KEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRP----YM 174

Query: 423 APECFHTGKATP---ESDVFGFGAVVLEVVCGRSP 454
           APE             SDV+  G  + EV  G+ P
Sbjct: 175 APERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 16/207 (7%)

Query: 244 HESMRL-GEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR 302
           +E +R+ G G FGIV+       DQ  V   QI V++ ++D   +      E  ++  L 
Sbjct: 2   YEKIRVVGRGAFGIVHL-CRRKADQKLVIIKQIPVEQMTKDERLAA---QNECQVLKLLS 57

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYY 362
           H +++       E   L++V ++ P G+L +Y+    ++   +      IL      +  
Sbjct: 58  HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYI----QKRCNSLLDEDTILHFFVQILLA 113

Query: 363 LQNEYDQKVVHRDLKASNILLDADFN-ARLGDFGLARAIENERNSYAEHGLVGVPGTMGY 421
           L + + + ++HRDLK  NILLD      ++GDFG+++ + ++  +Y       V GT  Y
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT------VVGTPCY 167

Query: 422 VAPECFHTGKATPESDVFGFGAVVLEV 448
           ++PE         +SD++  G V+ E+
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 48/185 (25%), Positives = 79/185 (42%), Gaps = 22/185 (11%)

Query: 276 AVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE-KGKLLLVYDFMPNG---SL 331
            +KK    +     +  AE AI+        V  + +  + K  L LV +++  G   SL
Sbjct: 28  VLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASL 87

Query: 332 EKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL 391
            K L G  E     W  +Y     +A  V  +++ + + ++HRD+K  N+L+D   + +L
Sbjct: 88  IKTLGGLPED----WAKQY-----IAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKL 138

Query: 392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCG 451
            DFGL+R     +            GT  Y+APE          SD +  G V+ E + G
Sbjct: 139 TDFGLSRNGLENKK---------FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189

Query: 452 RSPGN 456
             P +
Sbjct: 190 YPPFH 194

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 24/159 (15%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS----IKSKGDFLAELAIIHRLRH 303
           ++GEG +G V+K            +  +A+K+   D     + S    L E+ ++  L+H
Sbjct: 7   KIGEGTYGTVFKAKNRE------THEIVALKRVRLDDDDEGVPSSA--LREICLLKELKH 58

Query: 304 KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKY---LYGTSEQVTLNWNHRYKILTGVASAV 360
           K++V L    H   KL LV+++  +  L+KY     G  +   +  +  +++L G+A   
Sbjct: 59  KNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVK-SFMFQLLKGLAFC- 115

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA 399
                 +   V+HRDLK  N+L++ +   +L DFGLARA
Sbjct: 116 ------HSHNVLHRDLKPQNLLINKNGELKLADFGLARA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 31/217 (14%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA--ELA-IIHRLRHKH 305
           LG+G F  +YKG++       +      V    +       D LA  E A ++ +L HKH
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           LV L G C     ++ V +++  G L+ +L+     V+L+W  +  +   +ASA++YL+ 
Sbjct: 63  LVKLYGVCVRDENIM-VEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE- 118

Query: 366 EYDQKVVHRDLKASNILL-DADFN------ARLGDFGLARAI--ENERNSYAEHGLVGVP 416
             D+K+VH ++   NIL+     N       +L D G+   +    ER            
Sbjct: 119 --DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP------- 169

Query: 417 GTMGYVAPECFHTGKATPES--DVFGFGAVVLEVVCG 451
               ++APEC   G+A+     D + FG  +LE+   
Sbjct: 170 ----WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 25/223 (11%)

Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KGDFL 292
           ELK   ++F     LG G  G+V K         H  +  I  +K     IK   +   +
Sbjct: 1   ELKD--DDFERISELGAGNGGVVTK-------VQHKPSGLIMARKLIHLEIKPAIRNQII 51

Query: 293 AELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKI 352
            EL ++H     ++V   G  +  G++ +  + M  GSL++ L    E   +      K+
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKV 108

Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA-RAIENERNSYAEHG 411
              V   + YL+ ++  +++HRD+K SNIL+++    +L DFG++ + I++  NS+    
Sbjct: 109 SIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--- 163

Query: 412 LVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                GT  Y++PE       + +SD++  G  ++E+  GR P
Sbjct: 164 -----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 18/203 (8%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAE--LAIIHRLRHKHL 306
           +G+G +G V   ++ H      D  Q  +KK +  +   +    AE    ++ +L+H ++
Sbjct: 8   VGKGSYGEV--SLVRHRT----DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61

Query: 307 V-HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           V +   W  E G L +V  F   G L   L     ++    N   +    +A A+ YL  
Sbjct: 62  VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVVEWFVQIAMALQYLHE 120

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
           ++   ++HRDLK  N+ L      ++GD G+AR +EN+ +  +   L+G P    Y++PE
Sbjct: 121 KH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTP---YYMSPE 172

Query: 426 CFHTGKATPESDVFGFGAVVLEV 448
            F       +SDV+  G  V E+
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 32/216 (14%)

Query: 249 LGEGGFGIVY--KGIIHHNDQYHVDNTQIAVKKFS---RDSIKSKGDFLAELAIIHRLRH 303
           LG+G FG V+  + I    D   +   ++ +KK +   RD +++K     E  I+  + H
Sbjct: 4   LGQGSFGKVFLVRKITG-PDAGQLYAMKV-LKKATLKVRDRVRTK----MERDILAEVNH 57

Query: 304 KHLVHLVGWCHEKGKLLLVYDFMPNGS----LEKYLYGTSEQVTLNWNHRYKILTGVASA 359
             +V L      +GKL L+ DF+  G     L K +  T E V          L  +A A
Sbjct: 58  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-------YLAELALA 110

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR-AIENERNSYAEHGLVGVPGT 418
           + +L +     +++RDLK  NILLD + + +L DFGL++ +I++E+ +Y+        GT
Sbjct: 111 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS------FCGT 161

Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           + Y+APE  +    T  +D + FG ++ E++ G  P
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 55/216 (25%), Positives = 103/216 (47%), Gaps = 25/216 (11%)

Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR 302
           F +  R+G+G FG VYKGI +   +  V   +I   + + D I+   D   E+ ++ +  
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKE--VVAIKIIDLEEAEDEIE---DIQQEITVLSQCD 60

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGS-LEKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
             ++    G   +  KL ++ +++  GS L+    G  E+  +       IL  +   + 
Sbjct: 61  SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLD 115

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN---ERNSYAEHGLVGVPGT 418
           YL +E   + +HRD+KA+N+LL    + +L DFG+A  + +   +RN++         GT
Sbjct: 116 YLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--------GT 164

Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             ++APE         ++D++  G   +E+  G  P
Sbjct: 165 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 23/206 (11%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH 308
           LG+G FG VYK     N +  V      +   S + ++   D++ E+ I+    H ++V 
Sbjct: 13  LGDGAFGKVYKA---QNKETGVLAAAKVIDTKSEEELE---DYMVEIDILASCDHPNIVK 66

Query: 309 LVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKIL-TGVASAVYYLQNEY 367
           L+   + +  L ++ +F   G+++  +      +T     + +++      A+ YL   +
Sbjct: 67  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYL---H 120

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           + K++HRDLKA NIL   D + +L DFG+  + +N R        +G P  M   APE  
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGV--SAKNTRTIQRRDSFIGTPYWM---APEVV 175

Query: 428 --HTGKATP---ESDVFGFGAVVLEV 448
              T K  P   ++DV+  G  ++E+
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 30/223 (13%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KGDFLAELAIIH 299
           +F +   LG G  G+V K +       H  +  I  +K     IK   +   + EL ++H
Sbjct: 2   DFEKLGELGAGNGGVVTKVL-------HRPSGLIMARKLIHLEIKPAIRNQIIRELKVLH 54

Query: 300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVA 357
                ++V   G  +  G++ +  + M  GSL++ L   G   +  L      KI   V 
Sbjct: 55  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVL 109

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA-RAIENERNSYAEHGLVGVP 416
             + YL+ ++  K++HRD+K SNIL+++    +L DFG++ + I++  NS+         
Sbjct: 110 RGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-------- 159

Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIP 459
           GT  Y++PE       T +SD++  G  ++E+  GR P   IP
Sbjct: 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP---IP 199

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 66.6 bits (162), Expect = 6e-12
 Identities = 56/223 (25%), Positives = 113/223 (50%), Gaps = 27/223 (12%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHRLRHKHL 306
           +LGEG +  V+KG      +  +    +A+K+   +  + +    + E++++  L+H ++
Sbjct: 13  KLGEGTYATVFKG------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR---YKILTGVASAVYYL 363
           V L    H    L LV++++ +  L++Y+      ++++ N +   Y+IL G+A      
Sbjct: 67  VTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMH-NVKIFLYQILRGLAYC---- 120

Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
              + +KV+HRDLK  N+L++     +L DFGLARA      +Y+   +     T+ Y  
Sbjct: 121 ---HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-----TLWYRP 172

Query: 424 PEC-FHTGKATPESDVFGFGAVVLEVVCGRS--PGNMIPHQQH 463
           P+    + + + + D++G G +  E+  GR   PG+ +  + H
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELH 215

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 68.3 bits (167), Expect = 7e-12
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 22/173 (12%)

Query: 291 FLAELAIIHRLRHKHLVHLV--GWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNH 348
           F  E A+  RL H ++V L+  G     G L  V++++P  +L + L   +    L    
Sbjct: 25  FRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVL---AADGALPAGE 80

Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL---DADFNARLGDFGL------ARA 399
             +++  V  A   L   ++Q +VHRDLK  NI++       +A++ DFG+       R 
Sbjct: 81  TGRLMLQVLDA---LACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRD 137

Query: 400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGR 452
            +    +     ++G P    Y APE       TP SD++ +G + LE + G+
Sbjct: 138 ADVATLT-RTTEVLGTPT---YCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 65.7 bits (160), Expect = 7e-12
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 28/209 (13%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKFSRD-SIKSKGDFLAELAIIHRLRHKHL 306
           LG G  G VYK        YH+   +I AVK    D +++ +   ++EL I+++    ++
Sbjct: 9   LGHGNGGTVYKA-------YHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
           +   G    + ++ +  +FM  GSL+  +Y    +  L      +I   V   + YL   
Sbjct: 62  IGFYGAFFVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYL--- 111

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE-RNSYAEHGLVGVPGTMGYVAPE 425
           +  K++HRD+K SN+L++     +L DFG++  + N    +Y         GT  Y+APE
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV--------GTNAYMAPE 163

Query: 426 CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                +    SDV+  G   +E+  GR P
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 65.6 bits (161), Expect = 8e-12
 Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 41/218 (18%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKH 305
           LG G FG V   ++ H           A+K  S+  I   K     L E  I+  +RH  
Sbjct: 9   LGTGSFGRVM--LVRHKGSGKY----YALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG------VASA 359
           LV+L G   +   L LV +++P G L  +L           + R+           V  A
Sbjct: 63  LVNLYGSFQDDSNLYLVMEYVPGGELFSHL---------RKSGRFPEPVARFYAAQVVLA 113

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
           + YL +     +V+RDLK  N+LLD+D   ++ DFG A+ ++    +Y    L G P   
Sbjct: 114 LEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG--RTYT---LCGTP--- 162

Query: 420 GYVAPECFHT---GKATPESDVFGFGAVVLEVVCGRSP 454
            Y+APE   +   GKA    D +  G ++ E++ G  P
Sbjct: 163 EYLAPEIILSKGYGKA---VDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 62/239 (25%), Positives = 103/239 (43%), Gaps = 79/239 (33%)

Query: 248 RLGEGGFGIVYKGIIHHNDQ----------YHVDNTQIAVKKFSRDSIKSKGDFLAELAI 297
           R+G G  G VYK +IH               H D  +  + +              E+ I
Sbjct: 81  RIGSGAGGTVYK-VIHRPTGRLYALKVIYGNHEDTVRRQICR--------------EIEI 125

Query: 298 IHRLRHKHLVHLVGWCHE----KGKLLLVYDFMPNGSL-------EKYLYGTSEQVTLNW 346
           +  + H ++V     CH+     G++ ++ +FM  GSL       E++L   + Q     
Sbjct: 126 LRDVNHPNVVK----CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ----- 176

Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER-- 404
                IL+G+A    YL   + + +VHRD+K SN+L+++  N ++ DFG++R +      
Sbjct: 177 -----ILSGIA----YL---HRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224

Query: 405 -NSYAEHGLVGVPGTMGYVAPECFHT--------GKATPESDVFGFGAVVLEVVCGRSP 454
            NS          GT+ Y++PE  +T        G A    D++  G  +LE   GR P
Sbjct: 225 CNSSV--------GTIAYMSPERINTDLNHGAYDGYA---GDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 30/170 (17%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA--ELAIIHRLRHKHL 306
           +GEG +G VYK       +       +A+KK   D+ K      A  E+ I+ +L H+++
Sbjct: 15  IGEGTYGQVYKARDKDTGEL------VALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 307 VHL----------VGWCHEKGKLLLVYDFMPN---GSLEKYLYGTSEQVTLNWNHRYKIL 353
           V+L          + +  +KG   LV+++M +   G LE      S  V  + +H    +
Sbjct: 69  VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLE------SGLVHFSEDHIKSFM 122

Query: 354 TGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE 403
             +   + Y    + +  +HRD+K SNILL+     +L DFGLAR   +E
Sbjct: 123 KQLLEGLNYC---HKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 59/245 (24%), Positives = 102/245 (41%), Gaps = 38/245 (15%)

Query: 220 GKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK 279
           G L + G        +L            +G G  G VYK       ++      +AVK+
Sbjct: 1   GYLTIDGQKYPADLNDL-------ENLGEIGSGTCGQVYKM------RFKKTGHVMAVKQ 47

Query: 280 FSRDSIK-SKGDFLAELAIIHRLRH--KHLVHLVGWCHEKGKLLLVYDFMPN--GSLEKY 334
             R   K      L +L ++    H   ++V   G+      + +  + M      L K 
Sbjct: 48  MRRTGNKEENKRILMDLDVV-LKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKR 106

Query: 335 LYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDF 394
           + G   +  L      K+   +  A++YL+ +    V+HRD+K SNILLDA  N +L DF
Sbjct: 107 IQGPIPEDILG-----KMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDF 159

Query: 395 GLA-RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE----SDVFGFGAVVLEVV 449
           G++ R ++++  + +        G   Y+APE        P+    +DV+  G  ++E+ 
Sbjct: 160 GISGRLVDSKAKTRSA-------GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELA 212

Query: 450 CGRSP 454
            G+ P
Sbjct: 213 TGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 57/221 (25%), Positives = 111/221 (50%), Gaps = 23/221 (10%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHRLRHKHL 306
           +LGEG +  V+KG      +  +    +A+K+   +  + +    + E++++  L+H ++
Sbjct: 12  KLGEGTYATVFKG------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
           V L    H +  L LV++++ +  L++YL      +++   H  KI   +   +  L   
Sbjct: 66  VTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSM---HNVKIF--MFQLLRGLSYC 119

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
           + +K++HRDLK  N+L++     +L DFGLARA      +Y+   +     T+ Y  P+ 
Sbjct: 120 HKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-----TLWYRPPDV 174

Query: 427 F--HTGKATPESDVFGFGAVVLEVVCGRS--PGNMIPHQQH 463
               T  +TP  D++G G ++ E+  GR   PG+ +  + H
Sbjct: 175 LLGSTEYSTP-IDMWGVGCILYEMATGRPMFPGSTVKEELH 214

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 20/209 (9%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAIIHRLRHKH 305
           LG+G FG V       + +Y+      A+K   ++ I +K +    L E  ++   RH  
Sbjct: 3   LGKGTFGKVILVREKASGKYY------AMKILKKEVIIAKDEVAHTLTESRVLKNTRHPF 56

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           L  L      K +L  V +++  G L  + + + E+V      R+     + SA+ YL  
Sbjct: 57  LTSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRF-YGAEIVSALDYL-- 111

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            +  K+V+RDLK  N++LD D + ++ DFGL +  E   ++       G P    Y+APE
Sbjct: 112 -HSGKIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTP---EYLAPE 165

Query: 426 CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                      D +G G V+ E++CGR P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 63.8 bits (156), Expect = 3e-11
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 21/209 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAIIHRLRHKH 305
           LG GGFG V    +   ++        A+K   +  I   G      +E  I+    H  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTF------ALKCVKKRHIVETGQQEHIFSEKEILEECNHPF 54

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           +V L     +K  + ++ ++   G L   L    ++   +       +  V  A  YL N
Sbjct: 55  IVKLYRTFKDKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLHN 111

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
              + +++RDLK  N+LLD++   +L DFG A+ +++ + ++      G P    YVAPE
Sbjct: 112 ---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTP---EYVAPE 162

Query: 426 CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                      D +  G ++ E++ GR P
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 66/216 (30%), Positives = 93/216 (43%), Gaps = 30/216 (13%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAIIHRLRHKH 305
           +G+G FG VY+  +   D   +     A+K  S+  I +K +    + E  I+ R     
Sbjct: 1   IGKGTFGQVYQ--VRKKDTRRI----YAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDE 54

Query: 306 LVHLVGW---CHEKGKLLLVYDFMPNGSLEKYLYGT---SEQVTLNWNHRYKILTGVASA 359
              +VG          L LV D+M  G L  +L      SE        R K    +A  
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-------RAKFY--IAEL 105

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
           V  L++ +   +V+RDLK  NILLDA  +  L DFGL++A     N           GT 
Sbjct: 106 VLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKA-----NLTDNKTTNTFCGTT 160

Query: 420 GYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSP 454
            Y+APE     K  T   D +  G +V E+ CG SP
Sbjct: 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 30/215 (13%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK-GDFLA-----ELAIIHRLR 302
           +G GGFG VY        + +      A+K   +  IK K G+ LA      L+++    
Sbjct: 2   IGRGGFGEVYGCRKADTGKMY------AMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 55

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAV 360
              +V +    H   KL  + D M  G L  +L  +G   +  + + +  +I+ G     
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILG----- 109

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
             L++ +++ VV+RDLK +NILLD   + R+ D GLA     ++     H  V   GT G
Sbjct: 110 --LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV---GTHG 160

Query: 421 YVAPECFHTGKATPES-DVFGFGAVVLEVVCGRSP 454
           Y+APE    G A   S D F  G ++ +++ G SP
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 50/214 (23%), Positives = 88/214 (41%), Gaps = 29/214 (13%)

Query: 249 LGEGGFGIV----YKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAIIHRL 301
           LG+G FG V     KG    ++ Y       AVK   +D I    D    + E  ++   
Sbjct: 3   LGKGSFGKVLLAELKGT---DELY-------AVKVLKKDVILQDDDVECTMTEKRVLALA 52

Query: 302 -RHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
            +H  L  L      K +L  V +++  G L   ++        +          +   +
Sbjct: 53  GKHPFLTQLHSCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAEIVLGL 109

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            +L    ++ +++RDLK  N+LLD++ + ++ DFG+ +  E            G P    
Sbjct: 110 QFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTP---D 161

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           Y+APE        P  D +  G ++ E++ G+SP
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF-SRDSIKSKGDFLAELAIIHRLRHKHLV 307
           +G G FG V  G ++          Q+ VK+     S++ +  FL E      L+H +L+
Sbjct: 3   IGNGWFGKVILGEVNSG----YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYG--TSEQVTLNWNHRYKILTGVASAVYYL-Q 364
             +G C E    LLV +F P G L+ YL     +E +T +     ++   +A  + +L +
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
           N +    +H DL   N LL AD   ++GD+GL+     E + Y     + VP  + ++AP
Sbjct: 119 NNF----IHSDLALRNCLLTADLTVKIGDYGLSHNKYKE-DYYVTPDQLWVP--LRWIAP 171

Query: 425 ECF---HTG----KATPESDVFGFGAVVLEV 448
           E     H        T ES+V+  G  + E+
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 48/189 (25%), Positives = 83/189 (43%), Gaps = 28/189 (14%)

Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR 302
           +    R+G G +G VYK       +       +A+K    +          E++++   R
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGEL------VAIKVIKLEPGDDFEIIQQEISMLKECR 58

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLE---KYLYGTSEQVTLNWNHRYKILTGVASA 359
           H ++V   G    + KL +V ++   GSL+   +   G   ++ + +  R   L G+A  
Sbjct: 59  HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE-TLKGLA-- 115

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN---ERNSYAEHGLVGVP 416
             YL        +HRD+K +NILL  D + +L DFG++  +     +R S+     +G P
Sbjct: 116 --YLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF-----IGTP 165

Query: 417 GTMGYVAPE 425
             M   APE
Sbjct: 166 YWM---APE 171

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 63/224 (28%), Positives = 111/224 (49%), Gaps = 31/224 (13%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA--ELAIIHRLRHKH 305
           +LGEG +  VYKG      Q       +A+K+   +  +    F A  E +++  L+H +
Sbjct: 12  KLGEGSYATVYKGRSKLTGQL------VALKEIRLEH-EEGAPFTAIREASLLKDLKHAN 64

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR---YKILTGVASAVYY 362
           +V L    H K  L LV++++ +  L++Y+      ++++ N R   +++L G+A    Y
Sbjct: 65  IVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMH-NVRLFLFQLLRGLA----Y 118

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
               + ++V+HRDLK  N+L+      +L DFGLARA      +Y+ + +V    T+ Y 
Sbjct: 119 C---HQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS-NEVV----TLWYR 170

Query: 423 APECF--HTGKATPESDVFGFGAVVLEVVCGRS--PGNMIPHQQ 462
            P+     T  +T   D++G G +  E+  GR   PG+     Q
Sbjct: 171 PPDVLLGSTEYST-SLDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 31/215 (14%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHR------LR 302
           LG+G FG V+   +   +Q+       A+K   +D +    D   E  ++ +        
Sbjct: 3   LGKGSFGKVFLAELKGTNQF------FAIKALKKDVVLMDDD--VECTMVEKRVLSLAWE 54

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGV---ASA 359
           H  L HL      K  L  V +++  G L  ++            H++ +       A  
Sbjct: 55  HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC---------HKFDLPRATFYAAEI 105

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
           +  LQ  + + +V+RDLK  NILLD D + ++ DFG+ +      N   +       GT 
Sbjct: 106 ICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCK-----ENMLGDAKTCTFCGTP 160

Query: 420 GYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            Y+APE     K     D + FG ++ E++ G+SP
Sbjct: 161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 63.2 bits (153), Expect = 6e-11
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 23/215 (10%)

Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR 302
           F +  ++G+G FG V+KGI   N    V   +I   + + D I+   D   E+ ++ +  
Sbjct: 6   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIE---DIQQEITVLSQCD 60

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYY 362
             ++    G   +  KL ++ +++  GS    L    E   L+      IL  +   + Y
Sbjct: 61  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDY 116

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN---ERNSYAEHGLVGVPGTM 419
           L +E   K +HRD+KA+N+LL      +L DFG+A  + +   +RN++         GT 
Sbjct: 117 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--------GTP 165

Query: 420 GYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            ++APE         ++D++  G   +E+  G  P
Sbjct: 166 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 63.2 bits (153), Expect = 7e-11
 Identities = 48/207 (23%), Positives = 96/207 (46%), Gaps = 18/207 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           ++G+G  G VY  +     Q      ++A+++ +      K   + E+ ++   ++ ++V
Sbjct: 27  KIGQGASGTVYTAMDVATGQ------EVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
           + +       +L +V +++  GSL       ++ VT       +I       +  L+  +
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH 133

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
             +V+HRD+K+ NILL  D + +L DFG    I  E++  +   +VG P  M   APE  
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWM---APEVV 188

Query: 428 HTGKATPESDVFGFGAVVLEVVCGRSP 454
                 P+ D++  G + +E++ G  P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 62.3 bits (151), Expect = 8e-11
 Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 24/211 (11%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH 308
           +GEG FG     + H N        +I + K S     S+     E  ++ +++H ++V 
Sbjct: 8   VGEGSFGRALL-VQHVNSDQKYAMKEIRLPKSSSAVEDSR----KEAVLLAKMKHPNIVA 62

Query: 309 LVGWCHEKGKLLLVYDFMPNGSLEKYLYGT-----SEQVTLNWNHRYKILTGVASAVYYL 363
                   G L +V ++   G L + +         E   L W         +   V ++
Sbjct: 63  FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHI 116

Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
              ++++V+HRD+K+ NI L  +   +LGDFG AR + +   +YA        GT  YV 
Sbjct: 117 ---HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-GAYA----CTYVGTPYYVP 168

Query: 424 PECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           PE +       +SD++  G ++ E+   + P
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 63.0 bits (153), Expect = 8e-11
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 18/207 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           ++G+G  G VY  I     Q      ++A+K+ +      K   + E+ ++   +H ++V
Sbjct: 26  KIGQGASGTVYTAIDVATGQ------EVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
           + +       +L +V +++  GSL       ++ VT       +I       +  L+  +
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH 132

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
             +V+HRD+K+ NILL  D + +L DFG    I  E++  +   +VG P  M   APE  
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWM---APEVV 187

Query: 428 HTGKATPESDVFGFGAVVLEVVCGRSP 454
                 P+ D++  G + +E+V G  P
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 51/219 (23%), Positives = 103/219 (47%), Gaps = 27/219 (12%)

Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK-GDFLAELAIIHRL 301
           F +  R+G+G FG V+KGI +   Q       +A+K    +  + +  D   E+ ++ + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQV------VAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 302 RHKHLVHLVGWCHEKGKLLLVYDFMPNGS-LEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
              ++    G   +  KL ++ +++  GS L+    G  ++        ++I T +   +
Sbjct: 60  DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDE--------FQIATMLKEIL 111

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN---ERNSYAEHGLVGVPG 417
             L   + +K +HRD+KA+N+LL    + +L DFG+A  + +   +RN++         G
Sbjct: 112 KGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--------G 163

Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGN 456
           T  ++APE         ++D++  G   +E+  G  P +
Sbjct: 164 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 60/235 (25%), Positives = 101/235 (42%), Gaps = 52/235 (22%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF--SRDSIKSKGDFLAELAII 298
           N F     +GEG +G+V K    H +   +    +A+KKF  S ++ + K   L EL ++
Sbjct: 1   NKFEVLGVVGEGAYGVVLK--CRHKETKEI----VAIKKFKDSEENEEVKETTLRELKML 54

Query: 299 HRLRHKHLVHLVGWCHEKGKLLLVYDF-----------MPNGSL----EKYLYGTSEQVT 343
             L+ +++V L      +GKL LV+++           MPNG        Y+Y   + + 
Sbjct: 55  RTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAI- 113

Query: 344 LNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI-EN 402
            +W H+                     +VHRD+K  N+L+  +   +L DFG AR + E 
Sbjct: 114 -HWCHK-------------------NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153

Query: 403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRS--PG 455
              +Y E+       T  Y +PE           D++  G ++ E+  G+   PG
Sbjct: 154 SNANYTEY-----VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 23/211 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHR-LRHK 304
           +G+G FG V         +   D +  AVK   + +I   K +   +AE  ++ + L+H 
Sbjct: 3   IGKGSFGKVLLA------KRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHP 56

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
            LV L        KL  V D++  G L  + +   E+  L    R+     VASA+ YL 
Sbjct: 57  FLVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARF-YAAEVASAIGYL- 112

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLAR-AIENERNSYAEHGLVGVPGTMGYVA 423
             +   +++RDLK  NILLD+  +  L DFGL +  +E E  +          GT  Y+A
Sbjct: 113 --HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST------FCGTPEYLA 164

Query: 424 PECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           PE           D +  GAV+ E++ G  P
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 19/209 (9%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAIIHRLRHKH 305
           LG+G FG V         +Y+      A+K   ++ I +K +    L E  ++   RH  
Sbjct: 3   LGKGTFGKVILVKEKATGRYY------AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 56

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           L  L        +L  V ++   G L  + + + E+V      R+     + SA+ YL +
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARF-YGAEIVSALDYLHS 113

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
           E  + VV+RDLK  N++LD D + ++ DFGL +  E  ++        G P    Y+APE
Sbjct: 114 E--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTP---EYLAPE 166

Query: 426 CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                      D +G G V+ E++CGR P
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 49/208 (23%)

Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA---ELAIIH 299
           +     +G G +G VYK    +      D  + A+KKF  D  +  G   +   E+A++ 
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGK----DGKEYAIKKFKGDKEQYTGISQSACREIALLR 57

Query: 300 RLRHKHLVHLVGWC--HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR-------- 349
            L+H+++V LV     H    + L++D+      E  L+       + + HR        
Sbjct: 58  ELKHENVVSLVEVFLEHADKSVYLLFDYA-----EHDLWQI-----IKF-HRQAKRVSIP 106

Query: 350 --------YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR----LGDFGLA 397
                   ++IL GV     YL   +   V+HRDLK +NIL+  +   R    +GD GLA
Sbjct: 107 PSMVKSLLWQILNGVH----YL---HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159

Query: 398 RAIENERNSYAEHGLVGVPGTMGYVAPE 425
           R         A+  L  V  T+ Y APE
Sbjct: 160 RLFNAPLKPLAD--LDPVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 25/212 (11%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHR------LR 302
           LG+G FG V    +    +Y       AVK   +D +    D   E  ++ +        
Sbjct: 3   LGKGSFGKVLLAELKGKGEY------FAVKALKKDVVLIDDD--VECTMVEKRVLALAWE 54

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYY 362
           +  L HL      K  L  V +F+  G L   ++   ++   +    Y+     A  V  
Sbjct: 55  NPFLTHLYCTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDL---YRATFYAAEIVCG 108

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
           LQ  + + +++RDLK  N++LD D + ++ DFG+ +      N + ++      GT  Y+
Sbjct: 109 LQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCK-----ENVFGDNRASTFCGTPDYI 163

Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           APE     K T   D + FG ++ E++ G+SP
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 61.3 bits (148), Expect = 3e-10
 Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 18/207 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           ++G+G  G VY  I     Q      ++A+K+ +      K   + E+ ++   ++ ++V
Sbjct: 26  KIGQGASGTVYTAIDIATGQ------EVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
           + +       +L +V +++  GSL       ++ VT       +I       +  L   +
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALDFLH 132

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
             +V+HRD+K+ NILL  D + +L DFG    I  E++  +   +VG P  M   APE  
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWM---APEVV 187

Query: 428 HTGKATPESDVFGFGAVVLEVVCGRSP 454
                 P+ D++  G + +E+V G  P
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 21/210 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELAI-IHRLRHK 304
           +G+G FG V         ++  D    AVK   + +I  K +    +AE  + +  ++H 
Sbjct: 3   IGKGSFGKVLLA------KHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHP 56

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
            LV L        KL  V D++  G L  +L    E+       R+     +ASA+ YL 
Sbjct: 57  FLVGLHYSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARF-YAAEIASALGYL- 112

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
             +   +++RDLK  NILLD+  +  L DFGL +  E   +S       G P    Y+AP
Sbjct: 113 --HSLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTP---EYLAP 165

Query: 425 ECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           E           D +  GAV+ E++ G  P
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAIIHRLRHKH 305
           LG+G FG V         +Y+      A+K   ++ I +K +    + E  ++   RH  
Sbjct: 3   LGKGTFGKVILVREKATGRYY------AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 56

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           L  L        +L  V ++   G L  + + + E+V      R+     + SA+ YL  
Sbjct: 57  LTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF-YGAEIVSALEYL-- 111

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            + + VV+RD+K  N++LD D + ++ DFGL +  E   +        G P    Y+APE
Sbjct: 112 -HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTP---EYLAPE 165

Query: 426 CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                      D +G G V+ E++CGR P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 60.7 bits (147), Expect = 4e-10
 Identities = 68/224 (30%), Positives = 100/224 (44%), Gaps = 48/224 (21%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKFSRDSIKSK-GDFLAELAIIHRLRHKHL 306
           +G GGFG VY            D  ++ A+K   +  IK K G+ LA       L  + +
Sbjct: 2   IGRGGFGEVYGC-------RKADTGKMYAMKCLDKKRIKMKQGETLA-------LNERIM 47

Query: 307 VHLV--GWC----------HEKGKLLLVYDFMPNGSLEKYL--YGT-SEQVTLNWNHRYK 351
           + LV  G C          H   KL  + D M  G L  +L  +G  SE          +
Sbjct: 48  LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---------E 98

Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
           +    A  +  L++ +++ VV+RDLK +NILLD   + R+ D GLA     ++     H 
Sbjct: 99  MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHA 154

Query: 412 LVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGRSP 454
            V   GT GY+APE    G A   S D F  G ++ +++ G SP
Sbjct: 155 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 29/220 (13%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELAI 297
            +F    ++G+GG+G V+  +    D   +    +A+K+  +  +    +    L E  I
Sbjct: 1   KDFQILTQVGQGGYGQVF--LAKKKDTGEI----VALKRMKKSLLFKLNEVRHVLTERDI 54

Query: 298 IHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNH-RYKILTGV 356
           +   + + LV L+    +   L L  +++P G     L        L+ +H R+ +    
Sbjct: 55  LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG---VLSEDHARFYMAEMF 111

Query: 357 A--SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
               A++ L        +HRDLK  N L+DA  + +L DFGL++ I    NS     +VG
Sbjct: 112 EAVDALHEL------GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVG 160

Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            P    Y+APE           D +  G ++ E +CG  P
Sbjct: 161 SP---DYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 23/211 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK-GDFLAELAIIHRLRHKHLV 307
           +G G +G VY+G   H     V    +A+K  + D+      D   E+A++ +LR     
Sbjct: 9   IGRGAYGAVYRGK--HVPTGRV----VALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 308 HLVGW--CHEKG-KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
           ++  +   + KG +L ++ ++   GS+   +    +   +   +   I+  V  A+ Y+ 
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYI- 117

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
             +   V+HRD+KA+NIL+    N +L DFG+A  +    NS      VG P  M   AP
Sbjct: 118 --HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ--NSSKRSTFVGTPYWM---AP 170

Query: 425 ECFHTGKA-TPESDVFGFGAVVLEVVCGRSP 454
           E    GK    ++D++  G  + E+  G  P
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 60.5 bits (146), Expect = 5e-10
 Identities = 50/207 (24%), Positives = 97/207 (46%), Gaps = 18/207 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           ++G+G  G V+  I     Q      ++A+K+ +      K   + E+ ++  L++ ++V
Sbjct: 26  KIGQGASGTVFTAIDVATGQ------EVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
           + +       +L +V +++  GSL       ++ VT       +I       +  L+  +
Sbjct: 80  NFLDSFLVGDELFVVMEYLAGGSL-------TDVVTETCMDEAQIAAVCRECLQALEFLH 132

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
             +V+HRD+K+ N+LL  D + +L DFG    I  E++  +   +VG P  M   APE  
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWM---APEVV 187

Query: 428 HTGKATPESDVFGFGAVVLEVVCGRSP 454
                 P+ D++  G + +E+V G  P
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 60.3 bits (146), Expect = 6e-10
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 21/210 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAIIHRLR-HK 304
           LG+G FG V    +  + + +      AVK   +D I    D    + E  I+   R H 
Sbjct: 3   LGKGSFGKVMLARLKESGRLY------AVKVLKKDVILQDDDVECTMTEKRILSLARNHP 56

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
            L  L        +L  V +F+  G L   ++   +    +          + SA+ +L 
Sbjct: 57  FLTQLYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFL- 112

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
             +D+ +++RDLK  N+LLD + + +L DFG+ +  E   N        G P    Y+AP
Sbjct: 113 --HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTP---DYIAP 165

Query: 425 ECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           E        P  D +  G ++ E++CG +P
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 61.2 bits (148), Expect = 7e-10
 Identities = 41/145 (28%), Positives = 70/145 (48%), Gaps = 18/145 (12%)

Query: 322 VYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNI 381
           +Y FM + + +       +   L    R  I+  +  AV Y+   +D+K++HRD+K  NI
Sbjct: 249 LYSFMYDEAFD------WKDRPLLKQTR-AIMKQLLCAVEYI---HDKKLIHRDIKLENI 298

Query: 382 LLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGF 441
            L+ D    LGDFG A   E ER ++ ++G V   GT+   +PE          +D++  
Sbjct: 299 FLNCDGKIVLGDFGTAMPFEKEREAF-DYGWV---GTVATNSPEILAGDGYCEITDIWSC 354

Query: 442 GAVVLEVV----CGRSPGNMIPHQQ 462
           G ++L+++    C    G   P +Q
Sbjct: 355 GLILLDMLSHDFCPIGDGGGKPGKQ 379

Length = 501

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 28/227 (12%)

Query: 234 KELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGD 290
           ++ K    +F+    LG G FG V     + N+ +      +A+K+F +  I   K    
Sbjct: 23  RKNKMKYEDFNFIRTLGTGSFGRVILAT-YKNEDF----PPVAIKRFEKSKIIKQKQVDH 77

Query: 291 FLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRY 350
             +E  I++ + H   V+L G   ++  L LV +F+  G    +L           N R+
Sbjct: 78  VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL---------RRNKRF 128

Query: 351 KILTGV-ASAVYYLQNEYDQ--KVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY 407
               G   +A   L  EY Q   +V+RDLK  N+LLD D   ++ DFG A+ ++      
Sbjct: 129 PNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR---- 184

Query: 408 AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             + L G P    Y+APE          +D +  G  + E++ G  P
Sbjct: 185 -TYTLCGTP---EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 59.6 bits (145), Expect = 8e-10
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 34/212 (16%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF--LAELAIIHRLR-HK 304
           ++GEG F  V K       +Y+      A+K   +   KS      L E+  + RL  H 
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYY------AIKCM-KKHFKSLEQVNNLREIQALRRLSPHP 58

Query: 305 HLVHLVGWCHEK--GKLLLVYDFMPNGSLEKYLYGT----SEQVTLNWNHRYKILTGVAS 358
           +++ L+    ++  G+L LV++ M + +L + + G      E+   ++   Y++L     
Sbjct: 59  NILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSY--MYQLLKS--- 112

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
               L + +   + HRD+K  NIL+  D   +L DFG  R I   +  Y E+       T
Sbjct: 113 ----LDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGI-YSKPPYTEY-----IST 161

Query: 419 MGYVAPECFHT-GKATPESDVFGFGAVVLEVV 449
             Y APEC  T G   P+ D++  G V  E++
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 52/230 (22%)

Query: 247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKFSRDSIKSKGD--FLAELAIIHRLRH 303
             LG G +G+V K         HV    I AVK+  R ++ S+     L +L I  R   
Sbjct: 7   EELGRGAYGVVDK-------MRHVPTGTIMAVKRI-RATVNSQEQKRLLMDLDISMRSVD 58

Query: 304 -KHLVHLVGWCHEKGKLLLVYDFMPNGSLEK-YLYGTSEQVTLNWNHRYKILTGVASAVY 361
             + V   G    +G + +  + M + SL+K Y     + +T+  +   KI   +  A+ 
Sbjct: 59  CPYTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFG--------LARAIENERNSYAEHGLV 413
           YL ++    V+HRD+K SN+L++ +   +L DFG        +A+ I+            
Sbjct: 118 YLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID------------ 163

Query: 414 GVPGTMGYVAPECFHTGKATPE---------SDVFGFGAVVLEVVCGRSP 454
              G   Y+APE     +  PE         SDV+  G  ++E+  GR P
Sbjct: 164 --AGCKPYMAPE-----RINPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 57/231 (24%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIHRLRHKH 305
           +G G +G V         +       +A+KK SR    +I +K  +  EL ++  + H++
Sbjct: 23  VGSGAYGQVCSAFDTKTGRK------VAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHEN 75

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKY-------------LYGTSEQVTLNWNH---- 348
           ++           LL V  F P  SLE +             L    +   L+ +H    
Sbjct: 76  VI----------GLLDV--FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFL 123

Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
            Y+IL G       L+  +   ++HRDLK SNI ++ D   ++ DFGLAR  ++E   Y 
Sbjct: 124 VYQILRG-------LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV 176

Query: 409 EHGLVGVPGTMGYVAPEC-FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                    T  Y APE   +        D++  G ++ E++ G++  PG+
Sbjct: 177 --------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 20/209 (9%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAIIHRLRHKH 305
           LG+G FG V         +Y+      A+K   ++ I +K +    L E  ++   RH  
Sbjct: 3   LGKGTFGKVILVREKATGKYY------AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPF 56

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           L  L        +L  V ++   G L  + + + E+V      R+     + SA+ YL  
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARF-YGAEIVSALGYL-- 111

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            +   VV+RDLK  N++LD D + ++ DFGL +    E  S     +    GT  Y+APE
Sbjct: 112 -HSCDVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGAT-MKTFCGTPEYLAPE 165

Query: 426 CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                      D +G G V+ E++CGR P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 41/154 (26%), Positives = 61/154 (39%), Gaps = 26/154 (16%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFL---AELAIIHRLRHKH 305
             +     + K    H       NT +AVKK + DS  SK D      E+    +L+H +
Sbjct: 10  FEDLMIVHLAK----HKP----TNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPN 60

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYL-----YGTSEQVTLNWNHRYKILTGVASAV 360
           ++  V       +L +V   M  GS E  L      G  E           IL  V +A+
Sbjct: 61  ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF------ILKDVLNAL 114

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDF 394
            Y+ ++     +HR +KAS+ILL  D    L   
Sbjct: 115 DYIHSK---GFIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 41/219 (18%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS---RDSIKSKGDFLAELAIIHRLRHKH 305
           +G G FG VY       ++       +A+KK S   + S +   D + E+  + +LRH +
Sbjct: 23  IGHGSFGAVYFARDVRTNEV------VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 306 LVHLVGWCHEKGKLL-LVYDFMPNGSLEKYLYGTSEQVT------LNWNHRYKILTGVAS 358
            +   G C+ +     LV +         Y  G++  +       L       I  G   
Sbjct: 77  TIEYKG-CYLREHTAWLVME---------YCLGSASDILEVHKKPLQEVEIAAICHGALQ 126

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
            + YL +    + +HRD+KA NILL      +L DFG A ++ +  NS+     VG P  
Sbjct: 127 GLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSA-SLVSPANSF-----VGTPYW 177

Query: 419 MGYVAPE---CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           M   APE       G+   + DV+  G   +E+   + P
Sbjct: 178 M---APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 58.7 bits (143), Expect = 3e-09
 Identities = 67/230 (29%), Positives = 108/230 (46%), Gaps = 38/230 (16%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK-FSRDSIKSKGD---------FLAELAI 297
           +LG+G +GIV+K I    D+       +A+KK F  D+ ++  D         FL EL  
Sbjct: 14  KLGKGAYGIVWKAI----DR--RTKEVVALKKIF--DAFRNATDAQRTFREIMFLQELG- 64

Query: 298 IHRLRHKHLVHLVGWCH--EKGK-LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILT 354
                H ++V L+      E  K + LV+++M     E  L+       L   H+  I+ 
Sbjct: 65  ----DHPNIVKLLN-VIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMY 114

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
            +  A+ Y+   +   V+HRDLK SNILL++D   +L DFGLAR++     +     L  
Sbjct: 115 QLLKALKYI---HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171

Query: 415 VPGTMGYVAPEC-FHTGKATPESDVFGFGAVVLEVVCGRS--PGNMIPHQ 461
              T  Y APE    + + T   D++  G ++ E++ G+   PG    +Q
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ 221

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 21/210 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHR-LRHK 304
           +G+G FG V         ++  +    AVK   + +I   K +   ++E  ++ + ++H 
Sbjct: 3   IGKGSFGKVLLA------RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 56

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
            LV L        KL  V D++  G L  +L    E+  L    R+     +ASA+ YL 
Sbjct: 57  FLVGLHFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARF-YAAEIASALGYL- 112

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
             +   +V+RDLK  NILLD+  +  L DFGL +  EN  ++       G P    Y+AP
Sbjct: 113 --HSLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTP---EYLAP 165

Query: 425 ECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           E  H        D +  GAV+ E++ G  P
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 52/192 (27%), Positives = 84/192 (43%), Gaps = 37/192 (19%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHRL-RHKHL 306
           +GEG +G VYK         H    Q+   K   D I+  + +   E  I+ +   H ++
Sbjct: 14  IGEGTYGKVYKAR-------HKKTGQLVAIKI-MDIIEDEEEEIKEEYNILRKYSNHPNI 65

Query: 307 VHLVG-------WCHEKGKLLLVYDFMPNGS---LEKYLYGTSEQVTLNWNHRYKILTGV 356
               G         ++  +L LV +    GS   L K L    +++   W   Y IL   
Sbjct: 66  ATFYGAFIKKNPPGNDD-QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-IAY-ILRET 122

Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE---RNSYAEHGLV 413
              + YL   ++ KV+HRD+K  NILL  +   +L DFG++  +++    RN++     +
Sbjct: 123 LRGLAYL---HENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF-----I 174

Query: 414 GVPGTMGYVAPE 425
           G P  M   APE
Sbjct: 175 GTPYWM---APE 183

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 32/219 (14%)

Query: 249 LGEGGFGIVY--KGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFL----AELAIIHRLR 302
           LG G +G V+  + +  H+          A+K   + +I  K         E  ++  +R
Sbjct: 8   LGTGAYGKVFLVRKVGGHDA-----GKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR 62

Query: 303 HK-HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
               LV L        KL L+ D++  G L  +LY   E  T       ++   +A  V 
Sbjct: 63  RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFTE---SEVRVY--IAEIVL 116

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR---AIENER-NSYAEHGLVGVPG 417
            L + +   +++RD+K  NILLD++ +  L DFGL++   A E ER  S+         G
Sbjct: 117 ALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC--------G 168

Query: 418 TMGYVAPECFHTGKATPES--DVFGFGAVVLEVVCGRSP 454
           T+ Y+APE    G    +   D +  G +  E++ G SP
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 58.0 bits (140), Expect = 5e-09
 Identities = 38/165 (23%), Positives = 69/165 (41%), Gaps = 12/165 (7%)

Query: 285 IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTL 344
           I  KG  L E  ++  + H  ++ +           +V   +P+ S + Y Y T     L
Sbjct: 98  IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPL 154

Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
             +    I   +   + YL   + Q+++HRD+K  NI ++      +GD G A+      
Sbjct: 155 PIDQALIIEKQILEGLRYL---HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211

Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
                    G+ GT+   APE     K   ++D++  G V+ E++
Sbjct: 212 AFL------GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 21/208 (10%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA--ELAIIHRLRHKH 305
           +LGEG +  VYKGI   N Q       +A+K  S  + +    F A  E +++  L+H +
Sbjct: 12  KLGEGSYATVYKGISRINGQL------VALKVISMKT-EEGVPFTAIREASLLKGLKHAN 64

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           +V L    H K  L  V+++M +  L +Y+      +     H Y +   +   +  L  
Sbjct: 65  IVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGL-----HPYNVRLFMFQLLRGLAY 118

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            + Q ++HRDLK  N+L+      +L DFGLARA      +Y+   +     T+ Y  P+
Sbjct: 119 IHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-----TLWYRPPD 173

Query: 426 CF-HTGKATPESDVFGFGAVVLEVVCGR 452
                   +   D++G G + +E++ G+
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 57.5 bits (139), Expect = 6e-09
 Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 25/212 (11%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHR------LR 302
           LG+G FG V    +   +++       A+K   +D +    D   E  ++ R        
Sbjct: 3   LGKGSFGKVMLAELKGTNEFF------AIKALKKDVVLEDDD--VECTMVERRVLALAWE 54

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYY 362
           H  L HL      K  L  V +++  G L  ++     Q +  ++         A  +  
Sbjct: 55  HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHI-----QSSGRFDEARARFYA-AEIICG 108

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
           LQ  + + +++RDLK  N+LLD D + ++ DFG+ +      N   E       GT  Y+
Sbjct: 109 LQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCK-----ENMNGEGKASTFCGTPDYI 163

Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           APE     K     D + FG ++ E++ G+SP
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.9 bits (137), Expect = 6e-09
 Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 34/217 (15%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIA--VKKFSRDSIKSKGD----FLAELAIIHRLR 302
           LG G    +Y GI+++ D    D       +K   +    S  D    F    +++ ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYY 362
           HKH+V L G C    + ++V +F+  G L+ +++  S+ +T  W  ++K+   +ASA+ Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT---- 418
           L+   D+ +VH ++   NILL     AR G       I+ E   + +    G+P T    
Sbjct: 121 LE---DKDLVHGNVCTKNILL-----AREG-------IDGECGPFIKLSDPGIPITVLSR 165

Query: 419 ------MGYVAPECFHTGKA-TPESDVFGFGAVVLEV 448
                 + ++APEC    K  +  +D + FG  + E+
Sbjct: 166 QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 57.4 bits (139), Expect = 7e-09
 Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 34/217 (15%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK---FSRDSIKS----KGDFLAELAIIHRL 301
           LG G FG V         + +      A+KK    +RD ++S    K  F       +  
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIK---ALKKGDIIARDEVESLMCEKRIFET----ANSE 59

Query: 302 RHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
           RH  LV+L      +  +  V ++   G L  +++  ++  +      Y      A  V 
Sbjct: 60  RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH--TDVFSEPRAVFY-----AACVVL 112

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN----ERNSYAEHGLVGVPG 417
            LQ  ++ K+V+RDLK  N+LLD +   ++ DFGL +  E     +R S          G
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTS-------TFCG 163

Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           T  ++APE       T   D +G G ++ E++ G SP
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 56.8 bits (138), Expect = 8e-09
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 46/217 (21%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQ---IAVKKFSRDSIKSKGDF----LAELAIIHR 300
           R+ EG +G+VY+           D      +A+KK   +  K K  F    L E+ I+ +
Sbjct: 12  RIEEGTYGVVYRA---------RDKKTGEIVALKKLKME--KEKEGFPITSLREINILLK 60

Query: 301 LRHKHLVHL----VGWCHEKGKLLLVYDFMPN---GSLE--KYLYGTSEQVTLNWNHRYK 351
           L+H ++V +    VG   +K  + +V +++ +     +E  K  +  SE   L      +
Sbjct: 61  LQHPNIVTVKEVVVGSNLDK--IYMVMEYVEHDLKSLMETMKQPFLQSEVKCL----MLQ 114

Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
           +L+GVA    +L    D  ++HRDLK SN+LL+     ++ DFGLAR   +    Y    
Sbjct: 115 LLSGVA----HLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT-QL 166

Query: 412 LVGVPGTMGYVAPEC-FHTGKATPESDVFGFGAVVLE 447
           +V    T+ Y APE      + +   D++  G +  E
Sbjct: 167 VV----TLWYRAPELLLGAKEYSTAIDMWSVGCIFAE 199

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 57.0 bits (138), Expect = 9e-09
 Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 37/229 (16%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR--DSIKSKGDFLAELAIIHRLRHKHL 306
           +G G +G+V   I   + +      ++A+KK     D        L EL I+   +H ++
Sbjct: 13  IGSGAYGVVCSAIDTRSGK------KVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI 66

Query: 307 VHLVGWCHEKGKLL----LVYDFMPNGSLEKYLYGTSEQVTLNWNH----RYKILTGVAS 358
           + +       G       +V D M +  L   ++  S+Q  L   H     Y++L G+  
Sbjct: 67  IAIRDILRPPGADFKDVYVVMDLMES-DLHHIIH--SDQ-PLTEEHIRYFLYQLLRGLK- 121

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP-- 416
              Y+   +   V+HRDLK SN+L++ D   R+GDFG+AR +    +S  EH        
Sbjct: 122 ---YI---HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS---SSPTEHKYFMTEYV 172

Query: 417 GTMGYVAPEC-FHTGKATPESDVFGFGAVVLEVVCGRS---PGNMIPHQ 461
            T  Y APE      + T   D++  G +  E++ GR    PG    HQ
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQ 220

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 51/222 (22%), Positives = 96/222 (43%), Gaps = 35/222 (15%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS-RDSIKSKGD--FLAELAII 298
           +      +G G FG V+        +  +     A+K  +  + I+ K +     E  ++
Sbjct: 2   DLERIKTVGTGTFGRVHL------VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVL 55

Query: 299 HRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG--- 355
             + H  ++ L    H++  L ++ +++P G L  YL  +          R+   TG   
Sbjct: 56  KEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG---------RFSNSTGLFY 106

Query: 356 ---VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
              +  A+ YL   + +++V+RDLK  NILLD + + +L DFG A+ + +   +      
Sbjct: 107 ASEIVCALEYL---HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC---- 159

Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
               GT  Y+APE   +       D +  G ++ E++ G  P
Sbjct: 160 ----GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 44/147 (29%), Positives = 66/147 (44%), Gaps = 17/147 (11%)

Query: 315 EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHR 374
           +K  L LV ++ P G L   L    +Q   +    Y     +A  V  + + +    VHR
Sbjct: 72  DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----LAELVLAIHSVHQMGYVHR 126

Query: 375 DLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP-GTMGYVAPECFHT---- 429
           D+K  N+L+D   + +L DFG A  +   +          +P GT  Y+APE   T    
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANK-----MVNSKLPVGTPDYIAPEVLTTMNGD 181

Query: 430 GKAT--PESDVFGFGAVVLEVVCGRSP 454
           GK T   E D +  G +  E++ GRSP
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 55.3 bits (134), Expect = 2e-08
 Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 41/200 (20%)

Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF----SRDSIKSKGDFLAELAII 298
           + E   +GEG +G VYK       +       +A+KK     S + I      L E+A++
Sbjct: 1   YEELAEIGEGAYGTVYKA------RDLNTGRFVALKKVRVPLSEEGIPLS--TLREIALL 52

Query: 299 HRLR---HKHLVHLVGWCH-----EKGKLLLVYDFMPNGSLEKYL-----YGTSEQVTLN 345
            +L    H ++V L+  CH      + KL LV++ + +  L  YL      G   +   +
Sbjct: 53  KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKD 111

Query: 346 WNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN 405
                ++L GV     +L   +  ++VHRDLK  NIL+ +D   ++ DFGLAR       
Sbjct: 112 LMR--QLLRGVD----FL---HSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF--- 159

Query: 406 SYAEHGLVGVPGTMGYVAPE 425
              E  L  V  T+ Y APE
Sbjct: 160 ---EMALTSVVVTLWYRAPE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 11/156 (7%)

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYY 362
           H  LV L      + +L  V +++  G L   ++    Q  L   H       ++ A+ Y
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
           L   +++ +++RDLK  N+LLD++ + +L D+G+ +  E  R         G P    Y+
Sbjct: 112 L---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTP---NYI 163

Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMI 458
           APE           D +  G ++ E++ GRSP +++
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 56.7 bits (136), Expect = 2e-08
 Identities = 61/254 (24%), Positives = 106/254 (41%), Gaps = 46/254 (18%)

Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF 291
           KY + +   N +    ++G G FG V+  + H   Q       I+ +       + K   
Sbjct: 4   KYDDGESRLNEYEVIKKIGNGRFGEVFL-VKHKRTQEFFCWKAISYRGLKE---REKSQL 59

Query: 292 LAELAIIHRLRHKHLVHLVGWCHEKG--KLLLVYDFMPNGSLEK------YLYGTSEQVT 343
           + E+ ++  L+HK++V  +     K   KL ++ +F   G L +       ++G  E+  
Sbjct: 60  VIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHA 119

Query: 344 LNWNHRYKILTGVASAVYYLQNEYD----QKVVHRDLKASNILLDADFN----------- 388
           +       I   +  A+ Y  N  D    ++V+HRDLK  NI L                
Sbjct: 120 I-----VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174

Query: 389 ------ARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF--HTGKATPESDVFG 440
                 A++GDFGL++ I  E  +   H  VG P    Y +PE     T     +SD++ 
Sbjct: 175 LNGRPIAKIGDFGLSKNIGIESMA---HSCVGTP---YYWSPELLLHETKSYDDKSDMWA 228

Query: 441 FGAVVLEVVCGRSP 454
            G ++ E+  G++P
Sbjct: 229 LGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 21/210 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAIIHRLR-HK 304
           LG+G FG V    +   D+ +      A+K   +D I    D    + E  I+     H 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVY------AIKVLKKDVILQDDDVDCTMTEKRILALAAKHP 56

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
            L  L      K +L  V +++  G L   ++        +          V  A+ +L 
Sbjct: 57  FLTALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFL- 112

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
             +   V++RDLK  NILLDA+ + +L DFG+ +  E   N        G P    Y+AP
Sbjct: 113 --HRHGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTP---DYIAP 165

Query: 425 ECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           E     +  P  D +  G ++ E++ G+ P
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 41/230 (17%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK---FSRDSIKSKGDFLAELAIIHRLRHKH 305
           +GEG +G+V                ++A+KK   F   +   +   L E+ I+ R +H++
Sbjct: 13  IGEGAYGMVCSATHKPT------GVKVAIKKISPFEHQTFCQRT--LREIKILRRFKHEN 64

Query: 306 LVHL-----VGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNH----RYKILTGV 356
           ++ +              + +V + M     E  LY   +   L+ +H     Y+IL G 
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIKTQHLSNDHIQYFLYQILRG- 118

Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG--LVG 414
                 L+  +   V+HRDLK SN+LL+ + + ++ DFGLAR  + E     +H   L  
Sbjct: 119 ------LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE----HDHTGFLTE 168

Query: 415 VPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRS--PGNMIPHQ 461
              T  Y APE     K  T   D++  G ++ E++  R   PG    HQ
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ 218

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 28/215 (13%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKFSRDSI----KSKGDFLAELAIIHRLRH 303
           LG+GG+G V++           D  +I A+K   + +I    K      AE  I+  ++H
Sbjct: 4   LGKGGYGKVFQVRKVTGA----DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH 59

Query: 304 KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYL 363
             +V L+      GKL L+ +++  G L  +L    E + +     + +    +     L
Sbjct: 60  PFIVDLIYAFQTGGKLYLILEYLSGGELFMHL--EREGIFMEDTACFYL----SEISLAL 113

Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
           ++ + Q +++RDLK  NILLDA  + +L DFGL +  E+       H      GT+ Y+A
Sbjct: 114 EHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFC---GTIEYMA 168

Query: 424 PE----CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           PE      H GKA    D +  GA++ +++ G  P
Sbjct: 169 PEILMRSGH-GKAV---DWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 32/84 (38%), Positives = 49/84 (58%), Gaps = 4/84 (4%)

Query: 372 VHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK 431
           +HRD+ A N+LL     A++ DFGLAR I N+ N Y   G   +P  + ++APE      
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-YVVKGNARLP--VKWMAPESIFDCV 290

Query: 432 ATPESDVFGFGAVVLEVVC-GRSP 454
            T +SDV+ +G ++ E+   G+SP
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 59/246 (23%), Positives = 93/246 (37%), Gaps = 49/246 (19%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK--GDFLAELAII 298
           ++F     +G G FG V+  ++   D   V   ++  K    D IK        AE  I+
Sbjct: 1   DDFEVIKVIGRGAFGEVW--LVRDKDTGQVYAMKVLRKS---DMIKRNQIAHVRAERDIL 55

Query: 299 HRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG--- 355
                  +V L     ++  L LV ++MP G L            +N   R  +      
Sbjct: 56  ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETA 103

Query: 356 ---VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI----ENERNSYA 408
              +A  V  L + +    +HRD+K  NIL+DAD + +L DFGL + +    + E     
Sbjct: 104 RFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLND 163

Query: 409 EHGLVGVP--------------------GTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
            H L+                       GT  Y+APE         E D +  G ++ E+
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223

Query: 449 VCGRSP 454
           + G  P
Sbjct: 224 LYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 63/240 (26%), Positives = 99/240 (41%), Gaps = 58/240 (24%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR--DSIKSKGDFLAELAIIHRLRHKHL 306
           +G+G +G+V   I  H  +      ++A+KK +   + +      L E+ ++  LRH  +
Sbjct: 8   IGKGSYGVVCSAIDTHTGE------KVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 307 VH-----LVGWCHEKGKLLLVYDFM---------PNGSLEKYLYGTSEQVTLNWNHRYKI 352
           V      L     E   + +V++ M          N  L    +    Q  L     Y++
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH----QFFL-----YQL 112

Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS------ 406
           L         L+  +   V HRDLK  NIL +AD   ++ DFGLAR   N+  +      
Sbjct: 113 LRA-------LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165

Query: 407 YAEHGLVGVPGTMGYVAPE---CFHTGKATPESDVFGFGAVVLEVVCGRS--PGNMIPHQ 461
           Y          T  Y APE    F + K TP  D++  G +  EV+ G+   PG  + HQ
Sbjct: 166 YV--------ATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 216

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 56/233 (24%), Positives = 93/233 (39%), Gaps = 30/233 (12%)

Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD- 290
           K  +L+    +F     +G G FG V   ++ H     V     A+K  S+  +  + D 
Sbjct: 34  KITKLRMKAEDFDVIKVIGRGAFGEVQ--LVRHKSSKQV----YAMKLLSKFEMIKRSDS 87

Query: 291 --FLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNH 348
             F  E  I+     + +V L     +   L +V ++MP G L   +  ++  +   W  
Sbjct: 88  AFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWAR 145

Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
            Y      A  V  L   +    +HRD+K  N+LLD   + +L DFG    ++       
Sbjct: 146 FY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN----- 195

Query: 409 EHGLV---GVPGTMGYVAPECF----HTGKATPESDVFGFGAVVLEVVCGRSP 454
             G+V      GT  Y++PE        G    E D +  G  + E++ G +P
Sbjct: 196 --GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 54.9 bits (132), Expect = 4e-08
 Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 4/98 (4%)

Query: 372 VHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK 431
           +HRDL A NILL      ++ DFGLAR I N+ N Y   G   +P  + ++APE      
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSN-YVVKGNARLP--VKWMAPESIFNCV 292

Query: 432 ATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLV 468
            T ESDV+ +G ++ E+   G SP   +P     Y ++
Sbjct: 293 YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI 330

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 54.8 bits (132), Expect = 4e-08
 Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 11/161 (6%)

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYY 362
           H  LV L      + +L  V +F+  G L   ++    Q  L   H       ++ A+ +
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNF 111

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
           L   +++ +++RDLK  N+LLDA+ + +L D+G+ +  E  R         G P    Y+
Sbjct: 112 L---HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTP---NYI 163

Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH 463
           APE           D +  G ++ E++ GRSP +++    +
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN 204

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 54.7 bits (131), Expect = 5e-08
 Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 11/153 (7%)

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           LV L        +L LV +++  G L   ++    Q  L   H       +  A+ +L  
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFL-- 112

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            +++ +++RDLK  N+LLDAD + +L D+G+ +  E            G P    Y+APE
Sbjct: 113 -HERGIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTP---NYIAPE 166

Query: 426 CFHTGKATPESDVFGFGAVVLEVVCGRSPGNMI 458
                +     D +  G ++ E++ GRSP ++I
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 54.4 bits (131), Expect = 6e-08
 Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 33/230 (14%)

Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK----FSRDSIKSKGDFLAEL 295
           TN + +   +G G FG+V        DQ  +    +A+KK    FS   + +K  +  EL
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSA----RDQ--LTGQNVAIKKIMKPFSTPVL-AKRTY-REL 60

Query: 296 AIIHRLRHKHLVHLVG-WCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILT 354
            ++  LRH++++ L   +      +  V + +    L + L     +        Y+IL 
Sbjct: 61  KLLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILR 119

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           G       L+  +   VVHRDLK SNIL++ + + ++ DFGLAR          +  + G
Sbjct: 120 G-------LKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--------QDPQMTG 164

Query: 415 VPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH 463
              T  Y APE   T  K   E D++  G +  E++ G+    + P + H
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP---LFPGKDH 211

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 54.2 bits (130), Expect = 6e-08
 Identities = 33/87 (37%), Positives = 49/87 (56%), Gaps = 4/87 (4%)

Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           +K +HRDL A NILL  +   ++ DFGLAR I  + + Y   G   +P  + ++APE   
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARLP--LKWMAPESIF 249

Query: 429 TGKATPESDVFGFGAVVLEVVC-GRSP 454
               T +SDV+ FG ++ E+   G SP
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFSLGASP 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 54.2 bits (130), Expect = 7e-08
 Identities = 40/141 (28%), Positives = 63/141 (44%), Gaps = 14/141 (9%)

Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           L LV D+   G L   L    +++  +    Y     +A  V  + + +    VHRD+K 
Sbjct: 76  LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEMVLAIHSIHQLHYVHRDIKP 130

Query: 379 SNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-----GKAT 433
            N+LLD + + RL DFG    + N+  +      VG P    Y++PE         GK  
Sbjct: 131 DNVLLDMNGHIRLADFGSCLKM-NQDGTVQSSVAVGTP---DYISPEILQAMEDGMGKYG 186

Query: 434 PESDVFGFGAVVLEVVCGRSP 454
           PE D +  G  + E++ G +P
Sbjct: 187 PECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 53.9 bits (129), Expect = 8e-08
 Identities = 57/218 (26%), Positives = 107/218 (49%), Gaps = 29/218 (13%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA--ELAII 298
           +++ +  +LGEG +  VYKG      +  V+   +A+K   R   +    F A  E +++
Sbjct: 5   DSYEKLEKLGEGSYATVYKG------KSKVNGKLVALKVI-RLQEEEGTPFTAIREASLL 57

Query: 299 HRLRHKHLVHLVGWCHEKGKLLLVYDFMPNG---SLEKYLYGT-SEQVTLNWNHRYKILT 354
             L+H ++V L    H K  L LV++++       ++K+  G   E V L     +++L 
Sbjct: 58  KGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL---FLFQLLR 114

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           G++    Y+   Y   ++HRDLK  N+L+      +L DFGLARA     ++Y+   +  
Sbjct: 115 GLS----YIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-- 165

Query: 415 VPGTMGYVAPEC-FHTGKATPESDVFGFGAVVLEVVCG 451
              T+ Y  P+    + + +   D++G G + +E++ G
Sbjct: 166 ---TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 44/226 (19%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH 308
           LG G  G+V+  +    D+      ++AVKK      +S    L E+ II RL H ++V 
Sbjct: 13  LGCGSNGLVFSAVDSDCDK------RVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 309 L--------------VGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNH----RY 350
           +              VG   E   + +V ++M     E  L    EQ  L+  H     Y
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLFMY 121

Query: 351 KILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA-DFNARLGDFGLARAI--ENERNSY 407
           ++L G+     Y+   +   V+HRDLK +N+ ++  D   ++GDFGLAR +        Y
Sbjct: 122 QLLRGLK----YI---HSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174

Query: 408 AEHGLVGVPGTMGYVAPE-CFHTGKATPESDVFGFGAVVLEVVCGR 452
              GLV    T  Y +P         T   D++  G +  E++ G+
Sbjct: 175 LSEGLV----TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 22/210 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAIIHRLRHKH 305
           +G+G FG V +  +   D   +     A+K   +  I S+ +    LAE  ++ ++    
Sbjct: 1   IGKGSFGKVMQ--VRKRDTQRI----YALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPF 54

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWN-HRYKILTGVASAVYYLQ 364
           +V L        KL LV  F+  G L  +L     Q    ++  R +  T  A  +  L+
Sbjct: 55  IVPLKFSFQSPEKLYLVLAFINGGELFHHL-----QREGRFDLSRARFYT--AELLCALE 107

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
           N +   V++RDLK  NILLD   +  L DFGL +   N ++    +   G P    Y+AP
Sbjct: 108 NLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTP---EYLAP 162

Query: 425 ECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           E       T   D +  G ++ E++ G  P
Sbjct: 163 ELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 33/87 (37%), Positives = 49/87 (56%), Gaps = 4/87 (4%)

Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           +K +HRDL A NILL  +   ++ DFGLAR I  + + Y   G   +P  + ++APE   
Sbjct: 198 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLP--LKWMAPETIF 254

Query: 429 TGKATPESDVFGFGAVVLEVVC-GRSP 454
               T +SDV+ FG ++ E+   G SP
Sbjct: 255 DRVYTIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 27/164 (16%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD--------------FLAE 294
           LGEG +G V K      D   +    +A+KK     I +                  L E
Sbjct: 17  LGEGTYGKVEKAY----DT--LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRE 70

Query: 295 LAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILT 354
           L I++ ++H++++ LV    E   + LV D M    L+K +     ++ L  +    IL 
Sbjct: 71  LKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV---DRKIRLTESQVKCILL 126

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR 398
            + + +  L   Y    +HRDL  +NI +++    ++ DFGLAR
Sbjct: 127 QILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 38/139 (27%), Positives = 68/139 (48%), Gaps = 12/139 (8%)

Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK 377
           KL L+ D++  G L  +L   S++         +I +G    V  L++ +   +++RD+K
Sbjct: 79  KLHLILDYINGGELFTHL---SQRERFK-EQEVQIYSG--EIVLALEHLHKLGIIYRDIK 132

Query: 378 ASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES- 436
             NILLD++ +  L DFGL++    +    A        GT+ Y+AP+    G    +  
Sbjct: 133 LENILLDSNGHVVLTDFGLSKEFHEDEVERA----YSFCGTIEYMAPDIVRGGDGGHDKA 188

Query: 437 -DVFGFGAVVLEVVCGRSP 454
            D +  G ++ E++ G SP
Sbjct: 189 VDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 27/213 (12%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHR-LRHK 304
           +G+G FG V         +  +D    AVK   +  +   K +   +AE  ++ + ++H 
Sbjct: 3   IGKGSFGKVLLA------KRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHP 56

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
            LV L        KL  V DF+  G L  + +   E+       R+     +ASA+ YL 
Sbjct: 57  FLVGLHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYA-AEIASALGYL- 112

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLAR---AIENERNSYAEHGLVGVPGTMGY 421
             +   +V+RDLK  NILLD+  +  L DFGL +   A  +   ++         GT  Y
Sbjct: 113 --HSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC--------GTPEY 162

Query: 422 VAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +APE           D +  GAV+ E++ G  P
Sbjct: 163 LAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 27/218 (12%)

Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK---GDFLAELAIIH 299
           F +   +G G FG VY      N      +  +A+KK S    +S     D + E+  + 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRN------SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASA 359
           +LRH + +   G    +    LV ++   GS    L     +  L       +  G    
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAVTHGALQG 127

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
           + YL +     ++HRD+KA NILL      +LGDFG A +I    N +         GT 
Sbjct: 128 LAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA-SIMAPANXFV--------GTP 175

Query: 420 GYVAPE---CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            ++APE       G+   + DV+  G   +E+   + P
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 51.7 bits (124), Expect = 4e-07
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 46/210 (21%)

Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG-- 289
            Y++L+K          +GEG +G VYK    +  +       +A+KK +R  +  +G  
Sbjct: 2   AYEKLEK----------IGEGTYGKVYKARDKNTGKL------VALKK-TRLEMDEEGIP 44

Query: 290 -DFLAELAIIHRLRHK-HLVHLVGWCHEKGK-----LLLVYDFMPNGSLEKYL------Y 336
              L E++++  L    ++V L+   H + K     L LV++++ +  L+K++       
Sbjct: 45  PTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGP 103

Query: 337 GTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA-RLGDFG 395
           G         +  Y++L GVA         +   V+HRDLK  N+L+D      ++ D G
Sbjct: 104 GRPLPAKTIKSFMYQLLKGVAHC-------HKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156

Query: 396 LARAIENERNSYAEHGLVGVPGTMGYVAPE 425
           L RA      SY  H +V    T+ Y APE
Sbjct: 157 LGRAFSIPVKSYT-HEIV----TLWYRAPE 181

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 48/219 (21%), Positives = 93/219 (42%), Gaps = 25/219 (11%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL 301
           +F+  M LG+G FG V        D+ +      A+K   +D +    D   E  ++ + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELY------AIKILKKDVVIQDDD--VECTMVEKR 52

Query: 302 ------RHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG 355
                 +   L  L        +L  V +++  G L   +Y   +       H       
Sbjct: 53  VLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAE 109

Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           +A  +++L +   + +++RDLK  N++LD++ + ++ DFG+ +  EN  +        G 
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGT 164

Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           P    Y+APE           D + FG ++ E++ G++P
Sbjct: 165 P---DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 24/230 (10%)

Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD- 290
           K ++L+    ++     +G G FG V   ++ H     V     A+K  S+  +  + D 
Sbjct: 34  KIRDLRMKAEDYEVVKVIGRGAFGEVQ--LVRHKSTRKV----YAMKLLSKFEMIKRSDS 87

Query: 291 --FLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNH 348
             F  E  I+       +V L     +   L +V ++MP G L   +  ++  V   W  
Sbjct: 88  AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWAR 145

Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
            Y      A  V  L   +    +HRD+K  N+LLD   + +L DFG    +  E     
Sbjct: 146 FY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 200

Query: 409 EHGLVGVPGTMGYVAPECFHT----GKATPESDVFGFGAVVLEVVCGRSP 454
           +  +    GT  Y++PE   +    G    E D +  G  + E++ G +P
Sbjct: 201 DTAV----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.6 bits (123), Expect = 6e-07
 Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 30/233 (12%)

Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD- 290
           K ++L+    ++     +G G FG V   ++ H     V     A+K  S+  +  + D 
Sbjct: 34  KIRKLQMKAEDYDVVKVIGRGAFGEVQ--LVRHKSSQKV----YAMKLLSKFEMIKRSDS 87

Query: 291 --FLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNH 348
             F  E  I+       +V L     +   L +V ++MP G L   +  ++  V   W  
Sbjct: 88  AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAK 145

Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
            Y      A  V  L   +   ++HRD+K  N+LLD   + +L DFG    ++       
Sbjct: 146 FY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD------- 193

Query: 409 EHGLV---GVPGTMGYVAPECFHT----GKATPESDVFGFGAVVLEVVCGRSP 454
           E G+V      GT  Y++PE   +    G    E D +  G  + E++ G +P
Sbjct: 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 73/310 (23%), Positives = 123/310 (39%), Gaps = 46/310 (14%)

Query: 220 GKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK 279
           G L+ P +   F  ++ +K   +  E   +G G FG VY      + +    N  +A+KK
Sbjct: 7   GSLKDPEIAELFFKEDPEKLFTDLRE---IGHGSFGAVY---FARDVR---TNEVVAIKK 57

Query: 280 FS---RDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLY 336
            S   + S +   D + E+  + R++H + +   G    +    LV ++   GS    L 
Sbjct: 58  MSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLL- 115

Query: 337 GTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL 396
               +  L       I  G    + YL   +   ++HRD+KA NILL      +L DFG 
Sbjct: 116 -EVHKKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNILLTEPGQVKLADFGS 171

Query: 397 ARAIENERNSYAEHGLVGVPGTMGYVAPE---CFHTGKATPESDVFGFGAVVLEVVCGRS 453
           A +I +  NS+         GT  ++APE       G+   + DV+  G   +E+   + 
Sbjct: 172 A-SIASPANSFV--------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 222

Query: 454 PGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIAS 513
           P   +      Y             HI       L  N   D  +  +    +C   I  
Sbjct: 223 PLFNMNAMSALY-------------HIAQNESPTLQSNEWSDYFRNFV---DSCLQKIPQ 266

Query: 514 ERPKTEDILQ 523
           +RP +E++L+
Sbjct: 267 DRPTSEELLK 276

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.0 bits (122), Expect = 8e-07
 Identities = 33/87 (37%), Positives = 49/87 (56%), Gaps = 4/87 (4%)

Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           +K +HRDL A NILL  +   ++ DFGLAR I  + + Y   G   +P  + ++APE   
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLP--LKWMAPESIF 248

Query: 429 TGKATPESDVFGFGAVVLEVVC-GRSP 454
               T +SDV+ FG ++ E+   G SP
Sbjct: 249 DKVYTTQSDVWSFGVLLWEIFSLGASP 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 50.5 bits (121), Expect = 8e-07
 Identities = 34/157 (21%), Positives = 69/157 (43%), Gaps = 16/157 (10%)

Query: 251 EGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVH 308
           EG FG ++ GI+           +    K  +D  S       L E  +++ L H++++ 
Sbjct: 16  EGTFGRIFYGILIDEKP---GKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72

Query: 309 LVGWCHE-KGKLLLVYDFMPNGSLEKYLY------GTSEQVTLNWNHRYKILTGVASAVY 361
           ++  C E      ++Y +M  G+L+ +L         + Q  L+      +   +A  + 
Sbjct: 73  ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ-ALSTQQLVHMAIQIACGMS 131

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR 398
           YL     + V+H+D+ A N ++D +   ++ D  L+R
Sbjct: 132 YLHK---RGVIHKDIAARNCVIDEELQVKITDNALSR 165

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 50.6 bits (121), Expect = 9e-07
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 37/216 (17%)

Query: 249 LGEGGFGIVYKGIIHH--NDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRH 303
           LG G FG V   I  H    +Y+      A+K   +  I   K       E +I+  L H
Sbjct: 26  LGTGSFGRVR--IAKHKGTGEYY------AIKCLKKREILKMKQVQHVAQEKSILMELSH 77

Query: 304 KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLY--GTSEQVTLNWNHRYKILTGVASAVY 361
             +V+++    ++ ++  + +F+  G L  +L   G        + H   +L     A  
Sbjct: 78  PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL-----AFE 132

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGY 421
           YL +   + +++RDLK  N+LLD   + ++ DFG A+ +  +R       L G P    Y
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRT----FTLCGTP---EY 181

Query: 422 VAPECFHT---GKATPESDVFGFGAVVLEVVCGRSP 454
           +APE   +   GKA    D +  G ++ E + G  P
Sbjct: 182 LAPEVIQSKGHGKAV---DWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 21/143 (14%)

Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK 377
           KL L+ D++  G +  +LY    Q         +  +G    +  L++ +   +V+RD+K
Sbjct: 79  KLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSG--EIILALEHLHKLGIVYRDIK 132

Query: 378 ASNILLDADFNARLGDFGLARAI--ENERNSYAEHGLVGVPGTMGYVAPECFHT----GK 431
             NILLD++ +  L DFGL++    E +  +Y+        GT+ Y+APE        GK
Sbjct: 133 LENILLDSEGHVVLTDFGLSKEFLSEEKERTYS------FCGTIEYMAPEIIRGKGGHGK 186

Query: 432 ATPESDVFGFGAVVLEVVCGRSP 454
           A    D +  G ++ E++ G SP
Sbjct: 187 AV---DWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 4/114 (3%)

Query: 372 VHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK 431
           VHRDL A N+L+      ++ DFGLAR I  + N Y   G   +P  + ++APE      
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSN-YISKGSTFLP--LKWMAPESIFNNL 317

Query: 432 ATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV 484
            T  SDV+ FG ++ E+   G +P   +P  +  Y  +   + + +  H  D +
Sbjct: 318 YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEI 371

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 55/207 (26%)

Query: 274 QIAVKKFSR--DSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSL 331
           ++AVKK SR   SI        EL ++  ++H++++ L+              F P  SL
Sbjct: 44  RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPARSL 91

Query: 332 EKY--LYGTSEQVTLNWNHR---------------YKILTGVASAVYYLQNEYDQKVVHR 374
           E++  +Y  +  +  + N+                Y+IL G       L+  +   ++HR
Sbjct: 92  EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG-------LKYIHSADIIHR 144

Query: 375 DLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC----FHTG 430
           DLK SN+ ++ D   ++ DFGLAR  ++E   Y          T  Y APE      H  
Sbjct: 145 DLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV--------ATRWYRAPEIMLNWMHYN 196

Query: 431 KATPESDVFGFGAVVLEVVCGRS--PG 455
           +     D++  G ++ E++ GR+  PG
Sbjct: 197 QTV---DIWSVGCIMAELLTGRTLFPG 220

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 41/201 (20%)

Query: 274 QIAVKKFSR--DSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSL 331
           ++AVKK SR   S+        EL ++  ++H++++ L+              F P  S+
Sbjct: 42  KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV------------FTPATSI 89

Query: 332 EK----YLYGTSEQVTLNWNHRYKILTG--VASAVYYL----QNEYDQKVVHRDLKASNI 381
           E     YL        LN   + + L+   V   +Y L    +  +   ++HRDLK SN+
Sbjct: 90  ENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNV 149

Query: 382 LLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC----FHTGKATPESD 437
            ++ D   R+ DFGLAR  ++E   Y          T  Y APE      H  +     D
Sbjct: 150 AVNEDCELRILDFGLARQADDEMTGYV--------ATRWYRAPEIMLNWMHYNQTV---D 198

Query: 438 VFGFGAVVLEVVCGRS--PGN 456
           ++  G ++ E++ G++  PGN
Sbjct: 199 IWSVGCIMAELLKGKALFPGN 219

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 49.3 bits (118), Expect = 3e-06
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 41/221 (18%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR--DSIKSKGDFLAELAIIHRLRHKHL 306
           +G G +GIV              N ++A+KK +   D+       L E+ ++  L H+++
Sbjct: 13  IGRGAYGIVCSAKNSET------NEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66

Query: 307 VHLVGWCHEKGK-----LLLVYDFMPNGSLEKYLYGTSEQVTLNWNH----RYKILTGVA 357
           + +        +     + +VY+ M +  L + +   S Q TL+ +H     Y++L G  
Sbjct: 67  IAIKDIMPPPHREAFNDVYIVYELM-DTDLHQII--RSSQ-TLSDDHCQYFLYQLLRG-- 120

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
                L+  +   V+HRDLK SN+LL+A+ + ++ DFGLAR   +E+  +    +V    
Sbjct: 121 -----LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVV---- 170

Query: 418 TMGYVAPE----CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           T  Y APE    C     A    DV+  G +  E++ GR P
Sbjct: 171 TRWYRAPELLLNCSEYTTAI---DVWSVGCIFAELL-GRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 49.3 bits (118), Expect = 3e-06
 Identities = 62/235 (26%), Positives = 95/235 (40%), Gaps = 49/235 (20%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAII 298
            +     LG+G +GIV        +    +   +A+KK +      I +K   L EL ++
Sbjct: 1   RYELIKELGQGAYGIV----CSARNAETSEEETVAIKKITNVFSKKILAK-RALRELKLL 55

Query: 299 HRLR-HKHLVHLVGWCHEKGKLLLVYDF---MPNGSLEKYLYGTSEQVTLNWNHR----- 349
              R HK++  L             YD     P    E YLY    +  L+   R     
Sbjct: 56  RHFRGHKNITCL-------------YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPL 102

Query: 350 ---------YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI 400
                    Y+IL G       L+  +   V+HRDLK  N+L++AD   ++ DFGLAR  
Sbjct: 103 TDAHFQSFIYQILCG-------LKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF 155

Query: 401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSP 454
                  A   +     T  Y APE   + ++ T   DV+  G ++ E++ GR P
Sbjct: 156 SENPGENAGF-MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKP 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 55/201 (27%)

Query: 291 FLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRY 350
           F    +++ ++ H HL  + G C    + ++V +F+ +G L+  L     +V + W  + 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120

Query: 351 KILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG------------DFG--- 395
            +   +ASA+ YL+   D+ +VH ++ A NILL     ARLG            D G   
Sbjct: 121 TVAQQLASALSYLE---DKNLVHGNVCAKNILL-----ARLGLAEGTSPFIKLSDPGVSF 172

Query: 396 --LARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVC-- 450
             L+R    ER          +P    ++APEC   G + +  +D + FG  +LE +C  
Sbjct: 173 TALSREERVER----------IP----WIAPECVPGGNSLSTAADKWSFGTTLLE-ICFD 217

Query: 451 ------GRSPGNMIPHQQHAY 465
                  R+P      ++  Y
Sbjct: 218 GEVPLKERTP----SEKERFY 234

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 40/146 (27%), Positives = 64/146 (43%), Gaps = 14/146 (9%)

Query: 314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVH 373
            ++  L LV D+   G L   L    +++  +    Y     +A  V  + + +    VH
Sbjct: 71  QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVIAIDSVHQLHYVH 125

Query: 374 RDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT---- 429
           RD+K  NIL+D + + RL DFG    +  E  +      VG P    Y++PE        
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSCLKLM-EDGTVQSSVAVGTP---DYISPEILQAMEDG 181

Query: 430 -GKATPESDVFGFGAVVLEVVCGRSP 454
            GK  PE D +  G  + E++ G +P
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 48.6 bits (115), Expect = 3e-06
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 34/221 (15%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLV 307
           +G G +G VYKG        HV   Q+A  K    +   + +   E+ ++ +   H+++ 
Sbjct: 14  VGNGTYGQVYKG-------RHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 66

Query: 308 HLVGWCHEKG------KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
              G   +K       +L LV +F   GS+   +  T    TL       I   +   + 
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-TLKEEWIAYICREILRGLS 125

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE---NERNSYAEHGLVGVPGT 418
           +L   +  KV+HRD+K  N+LL  +   +L DFG++  ++     RN++         GT
Sbjct: 126 HL---HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--------GT 174

Query: 419 MGYVAPE---CFHTGKATPE--SDVFGFGAVVLEVVCGRSP 454
             ++APE   C     AT +  SD++  G   +E+  G  P
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 41/220 (18%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLV 307
           +G G FG V    I+ +        ++ VK+   + S K + +FL +      L+H +++
Sbjct: 3   IGNGWFGKVLLSEIYTDTGV----ARVVVKELKANASSKEQNEFLQQGDPYRILQHPNIL 58

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYL------YGTSEQVTLNWNHRYKILTGVASAVY 361
             +G C E    LLV+++   G L+ YL         S+ + L      ++   +A+ V 
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVT 113

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA------IENERNSYAEHGLVGV 415
           ++   +    +H DL   N  L +D   ++GD+G+  +      IE E +          
Sbjct: 114 HM---HKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV------- 163

Query: 416 PGTMGYVAPEC---FHTGKATPE----SDVFGFGAVVLEV 448
              + ++APE    FH G  T E    S+V+  G  + E+
Sbjct: 164 --PLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 69/288 (23%), Positives = 110/288 (38%), Gaps = 46/288 (15%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS---RDSIKSKGDFLAELAII 298
             HE   +G G FG VY     H       N  +AVKK S   + + +   D + E+  +
Sbjct: 25  GLHE---IGHGSFGAVYFATNSHT------NEVVAVKKMSYSGKQTNEKWQDIIKEVKFL 75

Query: 299 HRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVAS 358
            +L+H + +   G   ++    LV ++   GS    L     +  L       I  G   
Sbjct: 76  QQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAITHGALQ 132

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
            + YL   +   ++HRD+KA NILL      +L DFG A +  +  NS+         GT
Sbjct: 133 GLAYL---HSHNMIHRDIKAGNILLTEPGQVKLADFGSA-SKSSPANSFV--------GT 180

Query: 419 MGYVAPE---CFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH 475
             ++APE       G+   + DV+  G   +E+   + P   +      Y          
Sbjct: 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---------- 230

Query: 476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
              HI       L  N   D  +  +     C   I  ERP + ++L+
Sbjct: 231 ---HIAQNDSPTLQSNEWTDSFRGFVDY---CLQKIPQERPASAELLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 66/267 (24%), Positives = 102/267 (38%), Gaps = 73/267 (27%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHND--QYHVDNTQIAVKKFSRDS---IKSKGDFLAEL 295
            +FH    +G+G FG V   ++   D  + +   T +  + F +D    +K++ D LAE 
Sbjct: 1   EDFHTVKVIGKGAFGEVR--LVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES 58

Query: 296 AIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGT-SEQVTLNWNHRYKI 352
                     +V L     +   L L+ +F+P G L   L  Y T SE VT     R+ +
Sbjct: 59  ------DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT-----RFYM 107

Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL---------------- 396
               A  V  ++  +    +HRD+K  NIL+D   + +L DFGL                
Sbjct: 108 ----AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKL 163

Query: 397 -----ARAIENERNSYA------------------------EHGLVGVPGTMGYVAPECF 427
                 +   + RNS A                         +  VG P    Y+APE F
Sbjct: 164 LQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTP---DYIAPEIF 220

Query: 428 HTGKATPESDVFGFGAVVLEVVCGRSP 454
                  E D +  GA++ E + G  P
Sbjct: 221 LQQGYGQECDWWSLGAIMFECLIGWPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 25/88 (28%), Positives = 48/88 (54%), Gaps = 3/88 (3%)

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
           + + ++HRD+K++NILL ++   +LGDFG ++      +        G P    YVAPE 
Sbjct: 160 HSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP---YYVAPEI 216

Query: 427 FHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +     + ++D+F  G ++ E++  + P
Sbjct: 217 WRRKPYSKKADMFSLGVLLYELLTLKRP 244

Length = 496

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.4 bits (118), Expect = 4e-06
 Identities = 58/233 (24%), Positives = 101/233 (43%), Gaps = 39/233 (16%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS---KGDFLAELAIIHRLRHKH 305
           +G+GG G VY     ++    V + ++A+KK   D  ++   K  FL E  I   L H  
Sbjct: 10  IGKGGMGEVYLA---YDP---VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 306 LVHLVGWCHEKGKLLLVYDFMP---NGSLEKYLYGTSEQVTLNWNHRYK--------ILT 354
           +V +   C +      VY  MP     +L+  L    ++ +L+     K        I  
Sbjct: 64  IVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE-----------NE 403
            + + + Y+   + + V+HRDLK  NILL       + D+G A   +           +E
Sbjct: 121 KICATIEYV---HSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 404 RNS-YAEHGLVG-VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           RN  Y+   + G + GT  Y+APE      A+  +D++  G ++ +++    P
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 31/107 (28%), Positives = 50/107 (46%), Gaps = 19/107 (17%)

Query: 372 VHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH--- 428
           VHRD+K  N+LLD + + RL DFG    +     +   +  VG P    Y++PE      
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRL-LADGTVQSNVAVGTP---DYISPEILQAME 179

Query: 429 --TGKATPESDVFGFGAVVLEVVCGRSP----------GNMIPHQQH 463
              G+  PE D +  G  + E++ G +P          G ++ H++H
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH 226

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 6/90 (6%)

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
           SA+ Y+  E    ++HRD+K  N+L++   +  LGDFG A       ++   +   G+ G
Sbjct: 271 SAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY---GIAG 324

Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLE 447
           T+   APE       TP  D++  G V+ E
Sbjct: 325 TVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 48/192 (25%), Positives = 89/192 (46%), Gaps = 33/192 (17%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA---ELAII 298
           +F    R+G G +G VYK         +V+  ++A  K  +  ++   DF     E+ ++
Sbjct: 10  DFELIQRIGSGTYGDVYKA-------RNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMM 60

Query: 299 HRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEK--YLYGTSEQVTLNWNHRYKILTGV 356
              +H ++V   G    + KL +  +F   GSL+   ++ G   +  + +  R  +    
Sbjct: 61  KDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL---- 116

Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE---NERNSYAEHGLV 413
              +YYL +   +  +HRD+K +NILL  + + +L DFG++  I     +R S+      
Sbjct: 117 -QGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI----- 167

Query: 414 GVPGTMGYVAPE 425
              GT  ++APE
Sbjct: 168 ---GTPYWMAPE 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 48.1 bits (114), Expect = 7e-06
 Identities = 59/257 (22%), Positives = 99/257 (38%), Gaps = 40/257 (15%)

Query: 245 ESMR-LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRH 303
           ES++ +G G FG V   ++   D  HV   +I ++K      +  G   AE  I+     
Sbjct: 4   ESLKVIGRGAFGEVR--LVQKKDTGHVYAMKI-LRKADMLEKEQVGHIRAERDILVEADS 60

Query: 304 KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYL 363
             +V +     +K  L L+ +F+P G +   L    + +T      Y     +A  V  +
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM-KKDTLTEEETQFY-----IAETVLAI 114

Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLA----RAIENERNSYAEHGL------- 412
            + +    +HRD+K  N+LLD+  + +L DFGL     +A   E      H L       
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 413 -------------------VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRS 453
                                  GT  Y+APE F         D +  G ++ E++ G  
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 454 PGNMIPHQQHAYTLVDW 470
           P      Q+    +++W
Sbjct: 235 PFCSETPQETYKKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 47.9 bits (114), Expect = 9e-06
 Identities = 41/185 (22%), Positives = 77/185 (41%), Gaps = 15/185 (8%)

Query: 270 VDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNG 329
               ++ VK     ++        E+ I+  + H+ +++L+     K  + +V   MP  
Sbjct: 117 EQRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKY 168

Query: 330 SLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA 389
             + + Y       L       I   +  A+ YL   + + ++HRD+K  NI LD   NA
Sbjct: 169 KCDLFTY-VDRSGPLPLEQAITIQRRLLEALAYL---HGRGIIHRDVKTENIFLDEPENA 224

Query: 390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
            LGDFG A  ++   ++   +G     GT+   +PE         ++D++  G V+ E+ 
Sbjct: 225 VLGDFGAACKLDAHPDTPQCYGWS---GTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281

Query: 450 CGRSP 454
                
Sbjct: 282 VKNVT 286

Length = 392

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 47.7 bits (113), Expect = 9e-06
 Identities = 29/77 (37%), Positives = 43/77 (55%), Gaps = 3/77 (3%)

Query: 372 VHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK 431
           VHRDL A N+LL      ++ DFGLAR I ++ N Y   G   +P  + ++APE      
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSN-YVSKGSTFLP--VKWMAPESIFDNL 315

Query: 432 ATPESDVFGFGAVVLEV 448
            T  SDV+ +G ++ E+
Sbjct: 316 YTTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 64/239 (26%)

Query: 249 LGEGGFGIV---YKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIHRLR 302
           +G G  GIV   Y  I+  N         +A+KK SR   +   +K  +  EL ++  + 
Sbjct: 32  IGSGAQGIVCAAYDAILERN---------VAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 81

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKY--LYGTSEQVTLNW--------NHR--- 349
           HK+++ L+              F P  SLE++  +Y   E +  N         +H    
Sbjct: 82  HKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS 129

Query: 350 ---YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
              Y++L G+       ++ +   ++HRDLK SNI++ +D   ++ DFGLAR        
Sbjct: 130 YLLYQMLCGI-------KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART------- 175

Query: 407 YAEHGLVGVPG--TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH 463
            A    +  P   T  Y APE           D++  G ++ E++ G   G + P   H
Sbjct: 176 -AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG---GVLFPGTDH 230

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 33/236 (13%)

Query: 234 KELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFL- 292
           + L   T+ +     +G+G +G VYK     N +   D +  AVK    D I    + + 
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVT---NKK---DGSLAAVKIL--DPISDVDEEIE 66

Query: 293 AELAIIHRL-RHKHLVHLVGWCHEK-----GKLLLVYDFMPNGSLEKYLYGTSEQVTLNW 346
           AE  I+  L  H ++V   G  ++      G+L LV +    GS+ + + G      L  
Sbjct: 67  AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL-----LIC 121

Query: 347 NHRYK---ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE 403
             R     I   +  A+  LQ+ ++ +++HRD+K +NILL  +   +L DFG++  + + 
Sbjct: 122 GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181

Query: 404 RNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-----DVFGFGAVVLEVVCGRSP 454
           R     +  VG P  M   APE     +    S     DV+  G   +E+  G  P
Sbjct: 182 R--LRRNTSVGTPFWM---APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 26/210 (12%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH 308
           +GEG +G V+K     N    V   ++ V+        S    +A L  +    H ++V 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 309 LVGWC-----HEKGKLLLVYDFMPNGSLEKYLYGTSE----QVTLNWNHRYKILTGVASA 359
           L   C       + KL LV++ + +  L  YL    E      T+  +  +++L G    
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK-DMMFQLLRG---- 122

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
              L   +  +VVHRDLK  NIL+ +    +L DFGLAR          +  L  V  T+
Sbjct: 123 ---LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS------FQMALTSVVVTL 173

Query: 420 GYVAPEC-FHTGKATPESDVFGFGAVVLEV 448
            Y APE    +  ATP  D++  G +  E+
Sbjct: 174 WYRAPEVLLQSSYATP-VDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 43/220 (19%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLV 307
           +G G FG+VY+ I     +      ++A+KK  +D   K++     EL I+  L H +++
Sbjct: 74  IGNGSFGVVYEAICIDTSE------KVAIKKVLQDPQYKNR-----ELLIMKNLNHINII 122

Query: 308 HLVGW----CHEKGK----LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILT----- 354
            L  +    C +K +    L +V +F+P  ++ KY+   +       NH   +       
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARN-----NHALPLFLVKLYS 176

Query: 355 -GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA-RLGDFGLARAIENERNSYAEHGL 412
             +  A+ Y+ +++   + HRDLK  N+L+D + +  +L DFG A      +N  A    
Sbjct: 177 YQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSA------KNLLAGQRS 227

Query: 413 VGVPGTMGYVAPEC-FHTGKATPESDVFGFGAVVLEVVCG 451
           V    +  Y APE        T   D++  G ++ E++ G
Sbjct: 228 VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 40/224 (17%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLV 307
           +G G +G VYKG        HV   Q+A  K    +   + +   E+ ++ +   H+++ 
Sbjct: 24  VGNGTYGQVYKG-------RHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIA 76

Query: 308 HLVGWCHEKG------KLLLVYDFMPNGSLEKYLYGTS-EQVTLNWNHRY--KILTGVAS 358
              G   +K       +L LV +F   GS+   +  T    +  +W      +IL G+A 
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA- 135

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE---NERNSYAEHGLVGV 415
                 + +  KV+HRD+K  N+LL  +   +L DFG++  ++     RN++        
Sbjct: 136 ------HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------- 182

Query: 416 PGTMGYVAPE---CFHTGKATPE--SDVFGFGAVVLEVVCGRSP 454
            GT  ++APE   C     AT +  SD++  G   +E+  G  P
Sbjct: 183 -GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 49/198 (24%)

Query: 275 IAVKKFSR---DSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSL 331
           +AVKK SR   +   +K  +  EL ++  + HK+++ L+              F P  SL
Sbjct: 49  VAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLNV------------FTPQKSL 95

Query: 332 EKY--LYGTSEQVTLNW--------NHR------YKILTGVASAVYYLQNEYDQKVVHRD 375
           E++  +Y   E +  N         +H       Y++L G+       ++ +   ++HRD
Sbjct: 96  EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGI-------KHLHSAGIIHRD 148

Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG--TMGYVAPECFHTGKAT 433
           LK SNI++ +D   ++ DFGLAR         A    +  P   T  Y APE        
Sbjct: 149 LKPSNIVVKSDCTLKILDFGLART--------ACTNFMMTPYVVTRYYRAPEVILGMGYK 200

Query: 434 PESDVFGFGAVVLEVVCG 451
              D++  G ++ E+V G
Sbjct: 201 ENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 8/99 (8%)

Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           +A  +++L +   + +++RDLK  N++LDA+ + ++ DFG+ +  EN           G 
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGT 164

Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           P    Y+APE           D + FG ++ E++ G+ P
Sbjct: 165 P---DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 61/253 (24%), Positives = 94/253 (37%), Gaps = 64/253 (25%)

Query: 245 ESMR-LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIH-RLR 302
           ES++ +G G FG V   ++   D  H+     A+K      I  K D L +  + H R  
Sbjct: 4   ESLKVIGRGAFGEVR--LVQKKDTGHI----YAMK------ILRKADMLEKEQVAHIRAE 51

Query: 303 HKHLVHLVG-WC-------HEKGKLLLVYDFMPNGSLEKYLYGT---SEQVTLNWNHRYK 351
              LV   G W         +K  L L+ +F+P G +   L      SE+ T  +     
Sbjct: 52  RDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFY----- 106

Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
               +A  V  +   +    +HRD+K  N+LLDA  + +L DFGL   ++    +     
Sbjct: 107 ----IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRN 162

Query: 412 LVGVP------------------------------GTMGYVAPECFHTGKATPESDVFGF 441
           L   P                              GT  Y+APE F         D +  
Sbjct: 163 LTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222

Query: 442 GAVVLEVVCGRSP 454
           G ++ E++ G  P
Sbjct: 223 GVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 31/102 (30%), Positives = 46/102 (45%), Gaps = 9/102 (8%)

Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA-RAIENERNSYAEH 410
           I   V  A+ YL      +++HRD+KA NI ++   +  LGDFG A   ++   N Y   
Sbjct: 187 IERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY--- 240

Query: 411 GLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGR 452
              G  GT+   APE        P  D++  G V+ E+    
Sbjct: 241 --YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 34/142 (23%), Positives = 63/142 (44%), Gaps = 15/142 (10%)

Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYY-----LQNEYDQKVV 372
           KLLL+ ++   G L K       Q+                 ++Y     L   + +K++
Sbjct: 139 KLLLIMEYGSGGDLNK-------QIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMM 191

Query: 373 HRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA 432
           HRDLK++NI L      +LGDFG ++   +  +        G P    Y+APE +   + 
Sbjct: 192 HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTP---YYLAPELWERKRY 248

Query: 433 TPESDVFGFGAVVLEVVCGRSP 454
           + ++D++  G ++ E++    P
Sbjct: 249 SKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 23/218 (10%)

Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRH 303
           +E  ++G G +G VYK       +   D+   A+K+     I        E+A++  L+H
Sbjct: 4   YEGCKVGRGTYGHVYKA----KRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKH 57

Query: 304 KHLVHL--VGWCHEKGKLLLVYDFMPNG-----SLEKYLYGTSEQVTLNWNHRYKILTGV 356
            +++ L  V   H   K+ L++D+  +         +      + V L       +L  +
Sbjct: 58  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117

Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR----LGDFGLARAIENERNSYAEHGL 412
              ++YL   +   V+HRDLK +NIL+  +   R    + D G AR   +     A+   
Sbjct: 118 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 413 VGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVV 449
           V V  T  Y APE     +  T   D++  G +  E++
Sbjct: 175 VVV--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 44.9 bits (106), Expect = 6e-05
 Identities = 54/238 (22%), Positives = 102/238 (42%), Gaps = 57/238 (23%)

Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDN---TQIAVKKFSRDSIKSK 288
           +Y++LK+          +G G +G V            +D     ++A+KK  R     +
Sbjct: 16  RYRDLKQ----------VGSGAYGTVC---------SALDRRTGAKVAIKKLYR---PFQ 53

Query: 289 GDFLA-----ELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF---MPN-----GSLEKYL 335
            +  A     EL ++  ++H++++ L+        L   +DF   MP      G L K+ 
Sbjct: 54  SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE 113

Query: 336 YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG 395
             + +++       Y++L G       L+  +   ++HRDLK  N+ ++ D   ++ DFG
Sbjct: 114 KLSEDRIQF---LVYQMLKG-------LKYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 163

Query: 396 LARAIENERNSYAEHGLVGVPGTMGYVAPEC-FHTGKATPESDVFGFGAVVLEVVCGR 452
           LAR  ++E   Y          T  Y APE   +    T   D++  G ++ E++ G+
Sbjct: 164 LARQTDSEMTGYVV--------TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 44.7 bits (105), Expect = 7e-05
 Identities = 51/218 (23%), Positives = 93/218 (42%), Gaps = 23/218 (10%)

Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRH 303
           +E  ++G G +G VYK       +   D  + A+K+     I        E+A++  L+H
Sbjct: 4   YEGCKVGRGTYGHVYKA----KRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKH 57

Query: 304 KHLVHL--VGWCHEKGKLLLVYDFMPNG-----SLEKYLYGTSEQVTLNWNHRYKILTGV 356
            +++ L  V   H   K+ L++D+  +         +      + + L  +    +L  +
Sbjct: 58  PNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117

Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR----LGDFGLARAIENERNSYAEHGL 412
              ++YL   +   V+HRDLK +NIL+  +   R    + D G AR   +     A+   
Sbjct: 118 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 413 VGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVV 449
           V V  T  Y APE     +  T   D++  G +  E++
Sbjct: 175 VVV--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 44.6 bits (105), Expect = 8e-05
 Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 39/229 (17%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA---ELAIIHRLR--- 302
           +G G +G VYK    H+  +      +A+K   R      G  L+   E+A++ RL    
Sbjct: 8   IGVGAYGTVYKARDPHSGHF------VALKSV-RVQTNEDGLPLSTVREVALLKRLEAFD 60

Query: 303 HKHLVHLVGWC-----HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
           H ++V L+  C       + K+ LV++ + +  L  YL    ++V         I   + 
Sbjct: 61  HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYL----DKVPPPGLPAETIKDLMR 115

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEH-GLVGVP 416
             +  L   +   +VHRDLK  NIL+ +    +L DFGLAR        Y+    L  V 
Sbjct: 116 QFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI-------YSCQMALTPVV 168

Query: 417 GTMGYVAPEC-FHTGKATPESDVFGFGAVVLE------VVCGRSPGNMI 458
            T+ Y APE    +  ATP  D++  G +  E      + CG S  + +
Sbjct: 169 VTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQL 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 41/172 (23%), Positives = 68/172 (39%), Gaps = 45/172 (26%)

Query: 319 LLLVYDFMPNGSLEKYL--YGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           L L+ +++P G +   L    T +E+ T     R+ I    A  +  + + +    +HRD
Sbjct: 76  LYLIMEYLPGGDMMTLLMKKDTFTEEET-----RFYI----AETILAIDSIHKLGYIHRD 126

Query: 376 LKASNILLDADFNARLGDFGLARAIE-NERNSYAE---HGLVGVP--------------- 416
           +K  N+LLDA  + +L DFGL   ++ + R  +     H L                   
Sbjct: 127 IKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAE 186

Query: 417 --------------GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                         GT  Y+APE F       E D +  G ++ E++ G  P
Sbjct: 187 TWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 31/107 (28%), Positives = 53/107 (49%), Gaps = 18/107 (16%)

Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G+     YL   +   ++HRD+K  N+L++++   ++ DFGLAR  E + + +  
Sbjct: 110 YQILRGLK----YL---HSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162

Query: 410 HGLVGVPGTMGYVAPE----CFHTGKATPESDVFGFGAVVLEVVCGR 452
             +V    T  Y APE      H   A    D++  G +  E++  R
Sbjct: 163 QEVV----TQYYRAPEILMGSRHYTSAV---DIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 21/209 (10%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAV-KKFSRDSIKSKGDFLA--ELAIIHRLRHK 304
           RLG+G FG VY       D+  V   ++ V K+     +       A  E  ++ +L H 
Sbjct: 7   RLGKGSFGTVYLVK----DKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYY 362
            +V       E+    ++ ++     L+  L     + + TL+ N   +    +   V+Y
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK-TLSENQVCEWFIQLLLGVHY 121

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
           +   + ++++HRDLKA NI L  +   ++GDFG++R +    +           GT  Y+
Sbjct: 122 M---HQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-----FTGTPYYM 172

Query: 423 APECF-HTGKATPESDVFGFGAVVLEVVC 450
           +PE   H G  + +SD++  G ++ E+ C
Sbjct: 173 SPEALKHQGYDS-KSDIWSLGCILYEMCC 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 26/104 (25%), Positives = 54/104 (51%), Gaps = 18/104 (17%)

Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           ++  +++L   + + +++RDLK  N++LD++ + ++ DFG+ +          EH + GV
Sbjct: 110 ISVGLFFL---HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK----------EHMVDGV 156

Query: 416 P-----GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                 GT  Y+APE           D + +G ++ E++ G+ P
Sbjct: 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 48/197 (24%), Positives = 93/197 (47%), Gaps = 33/197 (16%)

Query: 237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LA 293
           +   +++    R+G G +G VYK         ++   ++A  K  +  ++   DF     
Sbjct: 5   RNPQHDYELIQRVGSGTYGDVYKA-------RNLHTGELAAVKIIK--LEPGDDFSLIQQ 55

Query: 294 ELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEK--YLYGTSEQVTLNWNHRYK 351
           E+ ++   +H ++V   G    + KL +  ++   GSL+   ++ G   ++ + +  R +
Sbjct: 56  EIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-E 114

Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE---NERNSYA 408
            L G+A    YL   + +  +HRD+K +NILL  + + +L DFG+A  I     +R S+ 
Sbjct: 115 TLQGLA----YL---HSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI 167

Query: 409 EHGLVGVPGTMGYVAPE 425
                   GT  ++APE
Sbjct: 168 --------GTPYWMAPE 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 72/310 (23%), Positives = 113/310 (36%), Gaps = 88/310 (28%)

Query: 285 IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTL 344
           +K++ D LAE        ++ +V L     +K  L  V D++P G +   L     +V  
Sbjct: 48  VKAERDILAEA------DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL--IRMEVFP 99

Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
               R+ I    A     +++ +    +HRD+K  NIL+D D + +L DFGL        
Sbjct: 100 EVLARFYI----AELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155

Query: 405 NS-YAE--------------------------------------------HGLVGVPGTM 419
           NS Y +                                            H LVG P   
Sbjct: 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTP--- 212

Query: 420 GYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH 479
            Y+APE       T   D +  G ++ E++ G+ P       +    +++W   LH    
Sbjct: 213 NYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQ 272

Query: 480 IQ---DAVD----------QRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS 526
           ++   +AVD          +RL  N   D+ K         +HP  SE   + DI     
Sbjct: 273 VKLSPEAVDLITKLCCSAEERLGRNG-ADDIK---------AHPFFSEVDFSSDIR---- 318

Query: 527 GTSTVPYVPQ 536
            T   PYVP+
Sbjct: 319 -TQPAPYVPK 327

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 42.8 bits (100), Expect = 4e-04
 Identities = 56/225 (24%), Positives = 95/225 (42%), Gaps = 61/225 (27%)

Query: 249 LGEGGFGIV---YKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIHRLR 302
           +G G  GIV   Y  ++  N         +A+KK SR   +   +K  +  EL ++  + 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN---------VAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 74

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKY--LYGTSEQVTLNW--------NHR--- 349
           HK+++ L+              F P  SLE++  +Y   E +  N         +H    
Sbjct: 75  HKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMS 122

Query: 350 ---YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
              Y++L G+       ++ +   ++HRDLK SNI++ +D   ++ DFGLAR        
Sbjct: 123 YLLYQMLCGI-------KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART------- 168

Query: 407 YAEHGLVGVPG--TMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
            A    +  P   T  Y APE           D++  G ++ E+V
Sbjct: 169 -AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 33/221 (14%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFL-AELAIIHRLR-HKHL 306
           +G+G +G V+K  + +      + ++ AVK    D I    + + AE  I+  L  H ++
Sbjct: 26  IGKGTYGKVFK--VLNK----KNGSKAAVKIL--DPIHDIDEEIEAEYNILKALSDHPNV 77

Query: 307 VHLVGWCHEKG-----KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYK---ILTGVAS 358
           V   G  ++K      +L LV +    GS+   + G      L    R +   I   +  
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGF-----LKRGERMEEPIIAYILHE 132

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           A+  LQ+ +  K +HRD+K +NILL  +   +L DFG++  + + R     +  VG P  
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFW 190

Query: 419 MGYVAPE---CFHTGKATPES--DVFGFGAVVLEVVCGRSP 454
           M   APE   C     +T ++  DV+  G   +E+  G  P
Sbjct: 191 M---APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.0 bits (99), Expect = 6e-04
 Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 45/169 (26%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIHRLRHKH 305
           +G G  GIV            V    +A+KK SR   +   +K  +  EL ++  + HK+
Sbjct: 24  IGSGAQGIVCAA------YDTVTGQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKN 76

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKY--LYGTSE-------QVT-LNWNHR------ 349
           ++           LL V  F P  SLE++  +Y   E       QV  ++ +H       
Sbjct: 77  II----------GLLNV--FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLL 124

Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR 398
           Y++L G+     +L +     ++HRDLK SNI++ +D   ++ DFGLAR
Sbjct: 125 YQMLCGIK----HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 52/239 (21%), Positives = 86/239 (35%), Gaps = 66/239 (27%)

Query: 285 IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQV 342
           +K++ D LAE        ++ +V L     +K  L  V D++P G +   L   G   + 
Sbjct: 48  VKAERDILAEA------DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPE- 100

Query: 343 TLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA----- 397
             +    Y     +A     +++ +    +HRD+K  NIL+D D + +L DFGL      
Sbjct: 101 --DLARFY-----IAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153

Query: 398 -----------------------------------------RAIENERNSYAEHGLVGVP 416
                                                    RA    +   A H LVG P
Sbjct: 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLA-HSLVGTP 212

Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH 475
               Y+APE       T   D +  G ++ E++ G+ P       +    +++W   LH
Sbjct: 213 ---NYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLH 268

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 58/254 (22%), Positives = 95/254 (37%), Gaps = 67/254 (26%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK--FSRDS---IKSKGDFLAELAIIHRLRH 303
           +G G FG V   ++   D   +   +   K     R+    +K++ D LAE        +
Sbjct: 9   IGIGAFGEVC--LVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA------DN 60

Query: 304 KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVY 361
           + +V L     +K  L  V D++P G +   L   G  E+       R+ I   +  A+ 
Sbjct: 61  EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA----RFYI-AELTCAIE 115

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA---RAIENER-------------- 404
            +        +HRD+K  NIL+D D + +L DFGL    R   + +              
Sbjct: 116 SVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172

Query: 405 --NSYAE----------------------HGLVGVPGTMGYVAPECFHTGKATPESDVFG 440
               ++E                      H LVG P    Y+APE       T   D + 
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTP---NYIAPEVLLRTGYTQLCDWWS 229

Query: 441 FGAVVLEVVCGRSP 454
            G ++ E++ G+ P
Sbjct: 230 VGVILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 25/87 (28%), Positives = 42/87 (48%), Gaps = 15/87 (17%)

Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC---- 426
           ++HRDLK  N+ ++ D   ++ DFGLAR  + E   Y          T  Y APE     
Sbjct: 138 IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV--------TRWYRAPEVILNW 189

Query: 427 FHTGKATPESDVFGFGAVVLEVVCGRS 453
            H  +     D++  G ++ E++ G++
Sbjct: 190 MHYNQTV---DIWSVGCIMAEMLTGKT 213

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 32/110 (29%), Positives = 50/110 (45%), Gaps = 21/110 (19%)

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA-------------IENERN 405
           A+ YL N     +VHRDLK  N+L+ +  + +L DFGL++              IE +  
Sbjct: 113 ALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 406 SYAEHGLVGVPGTMGYVAPEC-FHTGKATPESDVFGFGAVVLEVVCGRSP 454
            + +  + G P    Y+APE     G   P  D +  G ++ E + G  P
Sbjct: 170 EFLDKQVCGTP---EYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	568
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06899	236	lectin_legume_LecRK_Arcelin_ConA legume lectins, l	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PF00139	236	Lectin_legB: Legume lectin domain; InterPro: IPR00	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.98
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.98
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
cd01951	223	lectin_L-type legume lectins. The L-type (legume-t	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.77
PRK10345	210	hypothetical protein; Provisional	99.76
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.76
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.73
PRK14879	211	serine/threonine protein kinase; Provisional	99.72
smart00090	237	RIO RIO-like kinase.	99.72
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.7
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.7
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.68
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.6
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.59
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.57
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.47
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.43
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.41
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.36
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.28
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.21
KOG1243	690	consensus Protein kinase [General function predict	99.15
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.11
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.08
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.01
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.92
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.92
cd07308	218	lectin_leg-like legume-like lectins: ERGIC-53, ERG	98.88
KOG3087	229	consensus Serine/threonine protein kinase [General	98.82
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.81
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.75
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.7
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.59
COG4248	637	Uncharacterized protein with protein kinase and he	98.54
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.47
PRK09902	216	hypothetical protein; Provisional	98.42
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.34
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.32
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.29
cd06902	225	lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 tran	98.19
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.04
PF01636	239	APH: Phosphotransferase enzyme family This family	97.99
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.99
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.98
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.87
PLN02876	822	acyl-CoA dehydrogenase	97.83
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.74
cd06901	248	lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembr	97.69
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.56
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.53
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.48
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.42
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.39
PRK10593	297	hypothetical protein; Provisional	97.36
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.36
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.29
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.24
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.12
cd06903	215	lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmem	97.12
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.08
PRK05231	319	homoserine kinase; Provisional	97.07
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.79
cd06900	255	lectin_VcfQ VcfQ bacterial pilus biogenesis protei	96.79
PLN02236	344	choline kinase	96.59
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.55
PF03388	229	Lectin_leg-like: Legume-like lectin family; InterP	96.52
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.03
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.02
KOG3839	351	consensus Lectin VIP36, involved in the transport	96.01
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.72
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	95.58
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	95.51
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.46
KOG3838	497	consensus Mannose lectin ERGIC-53, involved in gly	95.43
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.38
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.21
PLN02756	418	S-methyl-5-thioribose kinase	95.16
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.0

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-60  Score=490.91  Aligned_cols=290  Identities=44%  Similarity=0.754  Sum_probs=256.3

Q ss_pred             CCcccCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCce
Q 008374          227 MPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHL  306 (568)
Q Consensus       227 ~~~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI  306 (568)
                      ..+.|+|+|++.||++|...++||+|+||.||+|.+.       ++..||||++.....+..++|.+|++++.+++||||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-------~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nl  133 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-------DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNL  133 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-------CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCc
Confidence            4678999999999999999999999999999999997       468999999877654325569999999999999999


Q ss_pred             eeEEEEEEeCC-eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC
Q 008374          307 VHLVGWCHEKG-KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA  385 (568)
Q Consensus       307 v~l~g~~~~~~-~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~  385 (568)
                      |+|+|||.+.+ +.+||||||++|+|.++|+..... .|+|.+|++|+.++|+||+|||+.+.++|+||||||+|||||+
T Consensus       134 v~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~  212 (361)
T KOG1187|consen  134 VKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE  212 (361)
T ss_pred             ccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC
Confidence            99999999998 599999999999999999876554 8999999999999999999999998889999999999999999


Q ss_pred             CCcEEEeecCCcccccc-ccccccccccccC-CcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q 008374          386 DFNARLGDFGLARAIEN-ERNSYAEHGLVGV-PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH  463 (568)
Q Consensus       386 ~~~~kL~DFGla~~~~~-~~~~~~~~~~~~~-~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~  463 (568)
                      ++++||+|||+|+.... .....      .. .||.+|+|||++.++..+.|+|||||||+|+||+||+.|.+..... .
T Consensus       213 ~~~aKlsDFGLa~~~~~~~~~~~------~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~-~  285 (361)
T KOG1187|consen  213 DFNAKLSDFGLAKLGPEGDTSVS------TTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR-G  285 (361)
T ss_pred             CCCEEccCccCcccCCcccccee------eecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc-c
Confidence            99999999999976654 22211      12 7999999999999999999999999999999999999988743311 1


Q ss_pred             hhhHHHHHHHHhhcCchhhhhhhhcC-CCCcH-HHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC
Q 008374          464 AYTLVDWVWMLHREGHIQDAVDQRLN-INSVV-DEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTV  531 (568)
Q Consensus       464 ~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~  531 (568)
                      ...+++|++....++.+.+++|+++. ..+.. +++.++..+++.|++++|.+||+|.||+++|+.....
T Consensus       286 ~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  286 ELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             cccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            12599999999999999999999997 55554 7899999999999999999999999999999664433

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-48  Score=400.18  Aligned_cols=252  Identities=31%  Similarity=0.473  Sum_probs=209.4

Q ss_pred             cccceeccCCceeEEEEEEccCccccccCeE-EEEEEeccCCccc--chhhHHHHHHhhcCCCCceeeEEEEEEeCC-eE
Q 008374          244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQ-IAVKKFSRDSIKS--KGDFLAELAIIHRLRHKHLVHLVGWCHEKG-KL  319 (568)
Q Consensus       244 ~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~  319 (568)
                      ...+.||+|+||+||+|.+.        +.. ||||++.......  .++|.+|+.+|.+++|||||+++|.|.+.. .+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~--------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~  115 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWR--------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSL  115 (362)
T ss_pred             hhhhhcccCCceeEEEEEeC--------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence            33456999999999999996        445 9999997653322  568999999999999999999999999887 79


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCCEEEcCCC-cEEEeecCCc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQK-VVHRDLKASNILLDADF-NARLGDFGLA  397 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivHrDikp~NILld~~~-~~kL~DFGla  397 (568)
                      ++|||||++|+|.++|+.. ....+++..+++++.+||+||.|||   +++ ||||||||+|||++.++ ++||+|||++
T Consensus       116 ~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence            9999999999999999764 4568999999999999999999999   556 99999999999999997 9999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccc--cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFH--TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~--~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      +........     .+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||.......    ...      
T Consensus       192 r~~~~~~~~-----~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~----~~~------  256 (362)
T KOG0192|consen  192 REKVISKTS-----MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ----VAS------  256 (362)
T ss_pred             eeecccccc-----ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH----HHH------
Confidence            876543211     12468999999999999  6699999999999999999999999998654421    111      


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                            .++....+...+......+..++..||+.||..||++.+++..|+..
T Consensus       257 ------~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  257 ------AVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             ------HHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence                  12222233333444677788888899999999999999999999853

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-48  Score=401.57  Aligned_cols=252  Identities=31%  Similarity=0.530  Sum_probs=218.5

Q ss_pred             cccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEE
Q 008374          244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVY  323 (568)
Q Consensus       244 ~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  323 (568)
                      ...++||+|.||.||.|.++       ....||+|.++.. ....++|.+|+++|++|+|+|||+++|+|..++.++|||
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~-------~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWN-------GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             HHHHHhcCCccceEEEEEEc-------CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            34568999999999999997       3558999999765 334578999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccc
Q 008374          324 DFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE  403 (568)
Q Consensus       324 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~  403 (568)
                      |||+.|+|.+||.. .....+...+.+.++.|||+||+||+   ++++|||||.++|||++++..+||+||||||....+
T Consensus       281 E~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             EecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence            99999999999976 33567899999999999999999999   789999999999999999999999999999955443


Q ss_pred             cccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCchhh
Q 008374          404 RNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD  482 (568)
Q Consensus       404 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  482 (568)
                      .  ++...  ...-...|.|||.+..+.++.|||||||||+||||+| |+.|+..+...+                 +.+
T Consensus       357 ~--Y~~~~--~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-----------------v~~  415 (468)
T KOG0197|consen  357 E--YTASE--GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-----------------VLE  415 (468)
T ss_pred             c--eeecC--CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-----------------HHH
Confidence            2  22211  2234579999999999999999999999999999999 999988665443                 445


Q ss_pred             hhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       483 ~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      .++...+...+..++..+.+++..||+.+|++|||++.+...|+..
T Consensus       416 ~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  416 LLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             HHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            6677777888888999999999999999999999999999988764

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-49  Score=414.34  Aligned_cols=305  Identities=27%  Similarity=0.460  Sum_probs=252.2

Q ss_pred             ccCHHHHHHHhcCc---------cccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhh
Q 008374          230 EFKYKELKKATNNF---------HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIH  299 (568)
Q Consensus       230 ~~~~~el~~at~~f---------~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~  299 (568)
                      .++|++-..|..+|         .+++.||.|.||.||+|+++..++   ....||||.++... ++.+.+|+.|..||.
T Consensus       609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgk---re~~VAIKTLK~GytekqrrdFL~EAsIMG  685 (996)
T KOG0196|consen  609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGK---REITVAIKTLKAGYTEKQRRDFLSEASIMG  685 (996)
T ss_pred             CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCC---cceeEEEeeeccCccHHHHhhhhhhhhhcc
Confidence            57787766666555         455789999999999999986443   56789999998764 456789999999999


Q ss_pred             cCCCCceeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 008374          300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKAS  379 (568)
Q Consensus       300 ~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~  379 (568)
                      ++.||||++|.|...+....++|.|||+||+|+.||..+.  ..+++.+...++++||.||.||.   +.++|||||.++
T Consensus       686 QFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAAR  760 (996)
T KOG0196|consen  686 QFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAAR  760 (996)
T ss_pred             cCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhh
Confidence            9999999999999999999999999999999999997655  45999999999999999999999   679999999999


Q ss_pred             CEEEcCCCcEEEeecCCcccccccccc-ccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008374          380 NILLDADFNARLGDFGLARAIENERNS-YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNM  457 (568)
Q Consensus       380 NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~  457 (568)
                      |||++.+..+|++||||+|.++.+... +++.+   -.-.++|.|||.+..+++|.+||||||||++||+++ |.+|+-.
T Consensus       761 NILVNsnLvCKVsDFGLSRvledd~~~~ytt~G---GKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd  837 (996)
T KOG0196|consen  761 NILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLG---GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD  837 (996)
T ss_pred             heeeccceEEEeccccceeecccCCCccccccC---CccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc
Confidence            999999999999999999988776522 22211   112469999999999999999999999999999887 9999887


Q ss_pred             CCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCC---
Q 008374          458 IPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYV---  534 (568)
Q Consensus       458 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~p~~---  534 (568)
                      +.+++                 +...+++.++...+.+++..+.+|++.||++|-.+||++.|++..|++...-|..   
T Consensus       838 mSNQd-----------------VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~  900 (996)
T KOG0196|consen  838 MSNQD-----------------VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKT  900 (996)
T ss_pred             cchHH-----------------HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcc
Confidence            66654                 4566778888889999999999999999999999999999999999987666553   


Q ss_pred             -CCCCCccccCCCC--C----CCCCCCcccccccc
Q 008374          535 -PQFKPAFTWPSTS--P----PISMFDSILSSITL  562 (568)
Q Consensus       535 -p~~~~~~~~~~~~--~----~~~~~~~~~~~~~~  562 (568)
                       +...|...-+-.+  +    +-.++++||++|-|
T Consensus       901 ~~~~~~r~s~~lld~~~~~~~~f~sv~~WL~aIkm  935 (996)
T KOG0196|consen  901 IAPESPRPSQPLLDRSGSDFTPFRSVGDWLEAIKM  935 (996)
T ss_pred             cCCCCCCCcccccCCCCCCCcccCCHHHHHHHhhh
Confidence             2222222221111  1    22356688888876

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.1e-46  Score=404.38  Aligned_cols=267  Identities=27%  Similarity=0.446  Sum_probs=222.3

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-cchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .+....+.||+|.||+||+|....-. .....+.||||.++..... .+++|.+|++++..++|||||+|+|.|.+++.+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~-p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLL-PGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCC-CCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            34555678999999999999886422 1236789999999987655 788999999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCC-----------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSE-----------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN  388 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~  388 (568)
                      +||+|||.+|||.+||.....           ...|+-.+.+.||.|||.||.||.   ++.+|||||..+|+|+.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceE
Confidence            999999999999999964211           234889999999999999999999   679999999999999999999


Q ss_pred             EEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhH
Q 008374          389 ARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL  467 (568)
Q Consensus       389 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l  467 (568)
                      +||+||||+|.+......... .  ...-.++|||||.+..++||++||||||||+|||+++ |+.|+....+++     
T Consensus       642 VKIsDfGLsRdiYssDYYk~~-~--~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-----  713 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVR-G--NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-----  713 (774)
T ss_pred             EEecccccchhhhhhhhhccc-C--CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-----
Confidence            999999999987654321111 0  1223579999999999999999999999999999999 999998776655     


Q ss_pred             HHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC
Q 008374          468 VDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTV  531 (568)
Q Consensus       468 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~  531 (568)
                         |-+....|++         .+.+.+++..+..|++.||+.+|++||++.||-..|+.....
T Consensus       714 ---VIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  714 ---VIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             ---HHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence               2222233332         456778899999999999999999999999999999875443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-45  Score=362.10  Aligned_cols=249  Identities=25%  Similarity=0.347  Sum_probs=205.9

Q ss_pred             cccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC-eEEE
Q 008374          244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG-KLLL  321 (568)
Q Consensus       244 ~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~l  321 (568)
                      +....||+|..|+|||+.++.      +++.+|+|.+... .....+++.+|++++++.+||+||+++|.|...+ ...+
T Consensus        82 e~~~~lG~G~gG~V~kv~Hk~------t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI  155 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVRHKP------TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI  155 (364)
T ss_pred             hhhhhcccCCCcEEEEEEEcC------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence            345689999999999999986      7899999999544 3345678999999999999999999999999998 5999


Q ss_pred             EEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccc
Q 008374          322 VYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE  401 (568)
Q Consensus       322 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~  401 (568)
                      +||||.+|||++++..   .+.+++...-+|+.+|++||.|||+  +..|+||||||+|||++..|++||+|||.++.+.
T Consensus       156 ~mEYMDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv  230 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV  230 (364)
T ss_pred             ehhhcCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence            9999999999999943   3568999999999999999999996  4799999999999999999999999999999887


Q ss_pred             cccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC-CcccchhhHHHHHHHHhhcCch
Q 008374          402 NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMI-PHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       402 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~-~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      +..   .    .+.+||..|||||-+.+..|+.++||||||+.++|+++|+.|+... +.......+.+           
T Consensus       231 nS~---a----~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~-----------  292 (364)
T KOG0581|consen  231 NSI---A----NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC-----------  292 (364)
T ss_pred             hhh---c----ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH-----------
Confidence            652   1    2678999999999999999999999999999999999999998754 11221112222           


Q ss_pred             hhhhhhhcCCCCcH-HHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          481 QDAVDQRLNINSVV-DEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       481 ~~~~d~~l~~~~~~-~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       .+++... ...+. ....++..++-.|+++||.+|||++|+++
T Consensus       293 -~Iv~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  293 -AIVDEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             -HHhcCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             2233111 11112 24556677777999999999999999986

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-45  Score=360.86  Aligned_cols=204  Identities=25%  Similarity=0.487  Sum_probs=182.8

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ..+|...++||+|.||+||+|+++.      ++..||||.+.+.  ..+..+....|+.+|+.++|||||++++++..++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~------~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~   82 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKK------SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD   82 (429)
T ss_pred             cccceehhhccCcceEEEEEeEecc------CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence            3568888899999999999999986      6799999999876  4556677889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC------CcEEE
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD------FNARL  391 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~------~~~kL  391 (568)
                      .++||||||.+|+|..|++.   ...++......++.|+|.||++||   +++||||||||.||||+..      -.+||
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKI  156 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKI  156 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEe
Confidence            99999999999999999954   347999999999999999999999   7899999999999999765      46899


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQ  461 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~  461 (568)
                      +|||+||.+....-.      .+.+|++-|||||++...+|+.|+|+||.|++|||+++|+.||+.....
T Consensus       157 ADFGfAR~L~~~~~a------~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~  220 (429)
T KOG0595|consen  157 ADFGFARFLQPGSMA------ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK  220 (429)
T ss_pred             cccchhhhCCchhHH------HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence            999999998865322      2679999999999999999999999999999999999999999854433

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-44  Score=370.93  Aligned_cols=253  Identities=25%  Similarity=0.435  Sum_probs=208.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC---CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD---SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ..|...+.||+|||+.||+++..+      ++..||+|++.+.   .....+...+|+++.+.|+|||||+++++|++.+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~------tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~   91 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLD------TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN   91 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcC------CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence            458889999999999999999864      7899999999874   3345677899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      +.|||.|+|++++|..++.   ..+.+++.+...+..||+.||.|||   +.+|+|||||..|+||++++++||+|||||
T Consensus        92 nVYivLELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLA  165 (592)
T KOG0575|consen   92 NVYIVLELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLA  165 (592)
T ss_pred             ceEEEEEecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEeccccee
Confidence            9999999999999999994   4568999999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ..+..+....     .+.+||+.|+|||++....++..+||||+||++|-|++|+.||+...-.+   ..     .....
T Consensus       166 t~le~~~Erk-----~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke---ty-----~~Ik~  232 (592)
T KOG0575|consen  166 TQLEYDGERK-----KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE---TY-----NKIKL  232 (592)
T ss_pred             eeecCccccc-----ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH---HH-----HHHHh
Confidence            9987553221     26899999999999999999999999999999999999999998543322   11     00000


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCC
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISGT  528 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L~~~  528 (568)
                            .+-.+ ......++.+   |+-.+|++||.+|||+++|+.  ++.+.
T Consensus       233 ------~~Y~~-P~~ls~~A~d---LI~~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  233 ------NEYSM-PSHLSAEAKD---LIRKLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             ------cCccc-ccccCHHHHH---HHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence                  01111 1112234444   445778999999999999986  55443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-44  Score=353.36  Aligned_cols=251  Identities=23%  Similarity=0.349  Sum_probs=201.4

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc-------chhhHHHHHHhhcCCCCceeeEEEE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-------KGDFLAELAIIHRLRHKHLVHLVGW  312 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~nIv~l~g~  312 (568)
                      .+.|...+.||+|+||.|-+|.-+.      +++.||||++++.....       .....+|+++|++|+|||||+++++
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~------tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~  244 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKK------TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF  244 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcc------cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence            3457888999999999999999876      78999999997642211       1234699999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC---CcE
Q 008374          313 CHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD---FNA  389 (568)
Q Consensus       313 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~---~~~  389 (568)
                      +...+..|||||||.+|+|.+++-.   .+.+....-..+++|++.|+.|||   ++||+||||||+|||+..+   ..+
T Consensus       245 f~~~ds~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~ll  318 (475)
T KOG0615|consen  245 FEVPDSSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLL  318 (475)
T ss_pred             eecCCceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEE
Confidence            9999999999999999999999854   345677777889999999999999   7899999999999999655   789


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCccccccCCC---CccchhHHHHHHHHHHHhCCCCCCCCCcccchhh
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA---TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYT  466 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~---t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~  466 (568)
                      ||+|||+|+.......      +.+.+||+.|.|||++.+...   ..++|+||+||+||-++||..||.......   .
T Consensus       319 KItDFGlAK~~g~~sf------m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~---s  389 (475)
T KOG0615|consen  319 KITDFGLAKVSGEGSF------MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP---S  389 (475)
T ss_pred             Eecccchhhcccccee------hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc---c
Confidence            9999999998764322      237899999999999976543   347899999999999999999998544333   2


Q ss_pred             HHHHHHHHhhcCchhhhhhhhcCC--CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          467 LVDWVWMLHREGHIQDAVDQRLNI--NSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       467 l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      +.+.            +...++..  ..-.+..++.+.++-++|..||++|||+.|+++
T Consensus       390 l~eQ------------I~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  390 LKEQ------------ILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHHH------------HhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            2221            11222211  122344556677777999999999999999975

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-44  Score=340.75  Aligned_cols=259  Identities=25%  Similarity=0.364  Sum_probs=207.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEE-EEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGW-CHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~-~~~~~  317 (568)
                      .+|.+.++||+|.||+|||+....      ++..+|.|.+.-.  +.+.++++..|+.+|++|+|||||+++++ +.+++
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~------~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLL------DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeecc------CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            357778899999999999999875      7889999998743  44567789999999999999999999994 45555


Q ss_pred             e-EEEEEEecCCCChhhhhccC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCEEEcCCCcEEEeec
Q 008374          318 K-LLLVYDFMPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQ-KVVHRDLKASNILLDADFNARLGDF  394 (568)
Q Consensus       318 ~-~~lV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDikp~NILld~~~~~kL~DF  394 (568)
                      + ++||||||..|+|...+..- .+...++....++++.|++.||..+|..+.+ -|.||||||.||+|+++|.+||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence            5 89999999999999988652 3455789999999999999999999975433 3999999999999999999999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      ||++.+.+.... +    ...+||+.||+||.+....|+.||||||+||++|||+.-+.||.+..-    ..|..    .
T Consensus       173 GL~r~l~s~~tf-A----~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~----~~L~~----K  239 (375)
T KOG0591|consen  173 GLGRFLSSKTTF-A----HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL----LSLCK----K  239 (375)
T ss_pred             hhHhHhcchhHH-H----HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH----HHHHH----H
Confidence            999998876432 2    267899999999999999999999999999999999999999986411    12221    1


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                      ...+....+        .+.-....+.+++-.|+..||..||+.-.+++-+.
T Consensus       240 I~qgd~~~~--------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  240 IEQGDYPPL--------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             HHcCCCCCC--------cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            222211111        11334566777888999999999998555444443

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.8e-41  Score=396.63  Aligned_cols=263  Identities=25%  Similarity=0.429  Sum_probs=219.6

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ...|...+.||+|+||.||+|+...      ++..||||++.....    ....|++++++++||||++++|+|.+.+..
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~  758 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIK------NGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGA  758 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECC------CCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence            3457788899999999999999864      678999999865322    224568899999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++|||||++|+|.++++      .++|.++.+++.|+|+||+|||+.++++|+||||||+||+++.++..++. ||.+..
T Consensus       759 ~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~  831 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL  831 (968)
T ss_pred             EEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence            99999999999999993      38999999999999999999998878899999999999999999988876 666544


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      .....         ...||..|||||++.+..++.++|||||||++|||+||+.|++.....  ...+.+|+........
T Consensus       832 ~~~~~---------~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~  900 (968)
T PLN00113        832 LCTDT---------KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSDCH  900 (968)
T ss_pred             cccCC---------CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCccc
Confidence            32211         236889999999999999999999999999999999999998632221  2267788877666666


Q ss_pred             hhhhhhhhcCC--CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 008374          480 IQDAVDQRLNI--NSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST  530 (568)
Q Consensus       480 ~~~~~d~~l~~--~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~  530 (568)
                      ....+|+.+..  ....+++..+.+++.+||+.||++||||+||++.|++...
T Consensus       901 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            66677777643  3455777889999999999999999999999999998644

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=384.83  Aligned_cols=264  Identities=29%  Similarity=0.480  Sum_probs=217.1

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++....+.||+|.||.||+|...+.+.... ...||||.+++. +.++..+|++|..+|+.++|||||+++|+|.+....
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~-~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVS-PIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCcc-ceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            345566789999999999999986433211 567999999876 456778999999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCC----CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          320 LLVYDFMPNGSLEKYLYGTS----EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      ++++|||++|+|.+||.+.+    +...|+....+.++.|||+|+.||+   ++.+|||||.++|+||++...+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999997652    2456899999999999999999999   7899999999999999999999999999


Q ss_pred             CccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHH
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      |||.+..... +....  ...-..+|||||.+..+.++.|+|||||||+|||++| |..||......+   .+..+.   
T Consensus       848 lArDiy~~~y-yr~~~--~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---v~~~~~---  918 (1025)
T KOG1095|consen  848 LARDIYDKDY-YRKHG--EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---VLLDVL---  918 (1025)
T ss_pred             hhHhhhhchh-eeccC--ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---HHHHHH---
Confidence            9995544321 11111  1123469999999999999999999999999999999 889998655443   222121   


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                       ..|          +.+.+..++..+.++++.||+.+|++||++..+++.+...
T Consensus       919 -~gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  919 -EGG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             -hCC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence             111          3455667888999999999999999999999999987764

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1e-41  Score=353.42  Aligned_cols=266  Identities=25%  Similarity=0.425  Sum_probs=205.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcC-CCCceeeEEEEEEeC-
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRL-RHKHLVHLVGWCHEK-  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-  316 (568)
                      .++|...++||+|+||.||+|.....+. ...+..||||++..... ...+.+.+|+.++.++ +||||++++++|... 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDK-KSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCC-cccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            4678889999999999999998642111 12457899999975432 3346789999999999 899999999998765 


Q ss_pred             CeEEEEEEecCCCChhhhhccCCC--------------------------------------------------------
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSE--------------------------------------------------------  340 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~--------------------------------------------------------  340 (568)
                      +.+++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            468999999999999999864211                                                        


Q ss_pred             ---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccccccccccccCCc
Q 008374          341 ---QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG  417 (568)
Q Consensus       341 ---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~G  417 (568)
                         ...+++..+..++.|+++||.|||   +++|+||||||+|||+++++.+||+|||+++...........   ....+
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~---~~~~~  238 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK---GSARL  238 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcc---cCCCC
Confidence               134888999999999999999999   679999999999999999999999999999876433221111   13456


Q ss_pred             CCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHH
Q 008374          418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDE  496 (568)
Q Consensus       418 t~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  496 (568)
                      +..|+|||++.+..++.++|||||||++|||++ |+.||.......   .+.    .....+..         ...+...
T Consensus       239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~---~~~----~~~~~~~~---------~~~~~~~  302 (338)
T cd05102         239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE---EFC----QRLKDGTR---------MRAPENA  302 (338)
T ss_pred             CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH---HHH----HHHhcCCC---------CCCCCCC
Confidence            788999999999999999999999999999997 999987543222   111    11111110         0111223


Q ss_pred             HHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          497 AKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       497 ~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ...+.+++..||+.||.+|||+.|+++.|+..
T Consensus       303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         303 TPEIYRIMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            45677889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-42  Score=336.43  Aligned_cols=241  Identities=24%  Similarity=0.324  Sum_probs=198.1

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|+..++||+|+||+||.++-+.      +++.+|+|.+++...   .+.+...+|..+|.+++||+||+++-.|++.
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~d------t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~   97 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKD------TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE   97 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcc------cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC
Confidence            4679999999999999999998874      789999999987533   3456678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +.+|||+||+.||.|..+|.   ++..++.....-++..|+.||.|||   +++|+||||||+|||||++|.++|+||||
T Consensus        98 ~kLylVld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL  171 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGL  171 (357)
T ss_pred             CeEEEEEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEecccc
Confidence            99999999999999999994   4567888888888999999999999   78999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ++.........     .+.+||+.|||||++....|+..+|.||+|+++|||++|..||......       .+...   
T Consensus       172 ~k~~~~~~~~t-----~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-------~~~~~---  236 (357)
T KOG0598|consen  172 CKEDLKDGDAT-----RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-------KMYDK---  236 (357)
T ss_pred             chhcccCCCcc-----ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-------HHHHH---
Confidence            99654432221     2579999999999999999999999999999999999999999754322       22111   


Q ss_pred             cCchhhhhhhh-c-CCCCcHHHHHHHHHHHHhcCCCCCCCCC
Q 008374          477 EGHIQDAVDQR-L-NINSVVDEAKRLLLLGLACSHPIASERP  516 (568)
Q Consensus       477 ~~~~~~~~d~~-l-~~~~~~~~~~~l~~l~l~Cl~~dp~~RP  516 (568)
                            ++..+ . .......++.+++.   ..++.||++|.
T Consensus       237 ------I~~~k~~~~p~~ls~~ardll~---~LL~rdp~~RL  269 (357)
T KOG0598|consen  237 ------ILKGKLPLPPGYLSEEARDLLK---KLLKRDPRQRL  269 (357)
T ss_pred             ------HhcCcCCCCCccCCHHHHHHHH---HHhccCHHHhc
Confidence                  11111 1 11223344555444   56689999996

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=357.81  Aligned_cols=269  Identities=26%  Similarity=0.410  Sum_probs=213.5

Q ss_pred             HHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEE
Q 008374          234 KELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVG  311 (568)
Q Consensus       234 ~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g  311 (568)
                      ++.....+++....+||+|.||+||+|.|.+         .||||.+....  .+..+.|..|+..+++-+|.||+-+.|
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG  455 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMG  455 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc---------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeeh
Confidence            4555555667778899999999999999974         49999997653  346688999999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 008374          312 WCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL  391 (568)
Q Consensus       312 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL  391 (568)
                      ||..... .+|..+|++-+|+.+||...  ..++..+.++|++|||+||.|||   .++|||||||..||+|.+++++||
T Consensus       456 ~~~~p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkI  529 (678)
T KOG0193|consen  456 ACMNPPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKI  529 (678)
T ss_pred             hhcCCce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEE
Confidence            9998877 99999999999999998644  56888999999999999999999   789999999999999999999999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHH
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT---GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV  468 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~---~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~  468 (568)
                      +||||+..-.....   ........|...|||||++..   ..|+.++||||||+|+|||+||..||.....++    ++
T Consensus       530 gDFGLatvk~~w~g---~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq----Ii  602 (678)
T KOG0193|consen  530 GDFGLATVKTRWSG---EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ----II  602 (678)
T ss_pred             ecccceeeeeeecc---ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh----eE
Confidence            99999986544321   112234568889999999864   578999999999999999999999998322211    11


Q ss_pred             HHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-CCC
Q 008374          469 DWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST-VPY  533 (568)
Q Consensus       469 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~-~p~  533 (568)
                      -    ....|-  -..|..   ....+..+.+.+|+..||..++++||++.+++..|+...+ +|.
T Consensus       603 f----mVGrG~--l~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk  659 (678)
T KOG0193|consen  603 F----MVGRGY--LMPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPK  659 (678)
T ss_pred             E----Eecccc--cCccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence            0    011111  111111   1123456677788889999999999999999998877655 444

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-41  Score=343.30  Aligned_cols=275  Identities=23%  Similarity=0.313  Sum_probs=206.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeC--
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK--  316 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--  316 (568)
                      +.|+..++||+|.||.||||+...      +++.||+|++..+.  .....-..+||.+|++|+||||++|.+...+.  
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~------tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~  190 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLE------TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS  190 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecc------cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence            346777789999999999999875      78999999998764  33345568999999999999999999998877  


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      ..+|||+|||++ +|.-++..  ....++..++..+.+|++.||.|+|   .++|+|||||.+|||||.+|++||+||||
T Consensus       191 ~siYlVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGL  264 (560)
T KOG0600|consen  191 GSIYLVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGL  264 (560)
T ss_pred             ceEEEEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccc
Confidence            799999999976 78887743  3457899999999999999999999   78999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH------
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD------  469 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~------  469 (568)
                      |+.+.......    ++..+-|..|.|||++.+ ..|+.+.|+||.||||.||++|+..+.+..+-+....+..      
T Consensus       265 Ar~y~~~~~~~----~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~  340 (560)
T KOG0600|consen  265 ARFYTPSGSAP----YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT  340 (560)
T ss_pred             eeeccCCCCcc----cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC
Confidence            99887654332    225567999999999876 5799999999999999999999988875443321111110      


Q ss_pred             -HHHHHhhcCchh--hhhhh------hcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCCCCCCCCCC
Q 008374          470 -WVWMLHREGHIQ--DAVDQ------RLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISGTSTVPYVPQ  536 (568)
Q Consensus       470 -~~~~~~~~~~~~--~~~d~------~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L~~~~~~p~~p~  536 (568)
                       -.|.   ..++.  ..+.+      ++... ........+.|+-.+|..||.+|.|+.++++  .+ .+.++|.-|.
T Consensus       341 e~~W~---~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF-~t~p~~~~p~  413 (560)
T KOG0600|consen  341 EDYWP---VSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF-TTEPLPCDPS  413 (560)
T ss_pred             hhccc---cccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCccc-ccCCCCCCcc
Confidence             0111   00111  00000      00000 1112334566777788999999999999986  33 3445544443

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-42  Score=358.91  Aligned_cols=263  Identities=23%  Similarity=0.361  Sum_probs=210.6

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEecc---CCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      +....++||+|.||.||+|+++..+..  ....||||..+.   .......+|++|.++|++++|||||+++|++..+..
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~--~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGF--KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCc--eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            344557999999999999999864321  112399999875   235567899999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      +++|||+|+||+|++||.....  .++..+++.++.+.|.||+|||   +++++||||.++|+|+..++.+||+||||++
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence            9999999999999999965432  6999999999999999999999   7899999999999999999999999999988


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ....-.....     ...-...|+|||.+.++.++.++|||||||++||+++ |..|+.+....+    +..+       
T Consensus       311 ~~~~~~~~~~-----~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~----v~~k-------  374 (474)
T KOG0194|consen  311 AGSQYVMKKF-----LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE----VKAK-------  374 (474)
T ss_pred             CCcceeeccc-----cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH----HHHH-------
Confidence            7642111110     1124579999999999999999999999999999999 888988654432    2221       


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVP  532 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~p  532 (568)
                           ++-...+...+...+..+..++..||..+|++||||.++.+.|+......
T Consensus       375 -----I~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~  424 (474)
T KOG0194|consen  375 -----IVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK  424 (474)
T ss_pred             -----HHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence                 11222233333355566667777999999999999999999998654443

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.6e-41  Score=339.36  Aligned_cols=258  Identities=16%  Similarity=0.305  Sum_probs=203.6

Q ss_pred             cccCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc---chhhHHHHHHhhcCCCCc
Q 008374          229 REFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS---KGDFLAELAIIHRLRHKH  305 (568)
Q Consensus       229 ~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~n  305 (568)
                      +.++.+++     +......||+|++|.||+|.+        +++.||||+++......   .+.|.+|+.+|.+++|||
T Consensus        13 ~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n   79 (283)
T PHA02988         13 KCIESDDI-----DKYTSVLIKENDQNSIYKGIF--------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNN   79 (283)
T ss_pred             eecCHHHc-----CCCCCeEEeeCCceEEEEEEE--------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCC
Confidence            34455555     233346799999999999987        47899999997654333   467889999999999999


Q ss_pred             eeeEEEEEEe----CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 008374          306 LVHLVGWCHE----KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNI  381 (568)
Q Consensus       306 Iv~l~g~~~~----~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NI  381 (568)
                      |++++|++.+    ....++||||+++|+|.+++..   ...++|.....++.+++.||.|||.  ..+++||||||+||
T Consensus        80 Iv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~ni  154 (283)
T PHA02988         80 ILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSF  154 (283)
T ss_pred             EEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhE
Confidence            9999999977    3578999999999999999954   3468999999999999999999994  24788999999999


Q ss_pred             EEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 008374          382 LLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT--GKATPESDVFGFGAVVLEVVCGRSPGNMIP  459 (568)
Q Consensus       382 Lld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~t~~sDV~SfGvll~el~tG~~P~~~~~  459 (568)
                      |+++++.+||+|||+++.......        ...||..|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       155 ll~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~  226 (283)
T PHA02988        155 LVTENYKLKIICHGLEKILSSPPF--------KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT  226 (283)
T ss_pred             EECCCCcEEEcccchHhhhccccc--------cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence            999999999999999986643211        3458899999999976  689999999999999999999999998543


Q ss_pred             cccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          460 HQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       460 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ...    +...+   ...+       .++  ..+......+..++.+||+.||++|||++|+++.|+..
T Consensus       227 ~~~----~~~~i---~~~~-------~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        227 TKE----IYDLI---INKN-------NSL--KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             HHH----HHHHH---HhcC-------CCC--CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            222    11111   1010       111  11223345677788899999999999999999999764

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-41  Score=337.10  Aligned_cols=271  Identities=25%  Similarity=0.365  Sum_probs=204.2

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhc--CCCCceeeEEEEEEeCC--
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHR--LRHKHLVHLVGWCHEKG--  317 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~~--  317 (568)
                      .....++||+|+||.||||++.        ++.||||++..   ++.+.|.+|-+|.+.  ++|+||+++++.-....  
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~--------~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~  279 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD--------NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD  279 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc--------CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence            3455678999999999999985        68999999964   456778888887665  58999999999876555  


Q ss_pred             --eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCCEEEcCCCcE
Q 008374          318 --KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY------DQKVVHRDLKASNILLDADFNA  389 (568)
Q Consensus       318 --~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~ivHrDikp~NILld~~~~~  389 (568)
                        +++||+||.++|||.+||.    ...++|....+|+..+++||+|||++.      .++|+|||||++|||+.+|+++
T Consensus       280 ~~eywLVt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc  355 (534)
T KOG3653|consen  280 RMEYWLVTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC  355 (534)
T ss_pred             ccceeEEeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence              8999999999999999994    457999999999999999999999874      5679999999999999999999


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCccccccCC------CCccchhHHHHHHHHHHHhCCCCCC--CCCcc
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK------ATPESDVFGFGAVVLEVVCGRSPGN--MIPHQ  461 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~------~t~~sDV~SfGvll~el~tG~~P~~--~~~~~  461 (568)
                      .|+|||||..+.........   ...+||.+|||||++.+.-      .-.+.||||+|.|||||++...-..  ..++.
T Consensus       356 cIaDFGLAl~~~p~~~~~d~---~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y  432 (534)
T KOG3653|consen  356 CIADFGLALRLEPGKPQGDT---HGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY  432 (534)
T ss_pred             EeeccceeEEecCCCCCcch---hhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence            99999999998865443333   2578999999999986532      2247899999999999999765442  11111


Q ss_pred             cchh-------hHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC
Q 008374          462 QHAY-------TLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPY  533 (568)
Q Consensus       462 ~~~~-------~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~p~  533 (568)
                      +..+       .-.+-++......+....+-..+...   ..+..+.+.+..||++||+.|.|+.=|-+.+.....+.+
T Consensus       433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             cCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            1110       11122222222211111111111111   345667777889999999999999999998887766654

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=338.99  Aligned_cols=257  Identities=25%  Similarity=0.415  Sum_probs=201.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC--e
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG--K  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~  318 (568)
                      .++...+.||+|.||.||++...+      ++...|||.+...+....+.+.+|+.+|.+++|||||+++|.....+  .
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~------~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~   90 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKK------TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDE   90 (313)
T ss_pred             chhhhhccccCccceEEEEEEecC------CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence            346677889999999999999875      57899999987664333667899999999999999999999855444  6


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-CCcEEEeecCCc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA-DFNARLGDFGLA  397 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~-~~~~kL~DFGla  397 (568)
                      +++.|||+++|||.+++.....  .|+......+..||++||+|||   +++++||||||+|||++. ++.+||+|||++
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a  165 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLA  165 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccc
Confidence            9999999999999999965432  6999999999999999999999   789999999999999999 799999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      +........  ........||+.|||||++..+. ...++|||||||+++||+||+.||...   .   ...++......
T Consensus       166 ~~~~~~~~~--~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~---~~~~~~~~ig~  237 (313)
T KOG0198|consen  166 KKLESKGTK--SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---F---EEAEALLLIGR  237 (313)
T ss_pred             ccccccccc--ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---c---chHHHHHHHhc
Confidence            987741111  11122578999999999998643 335999999999999999999999753   0   11222221111


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII  525 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L  525 (568)
                      .+         .....+........+++..|+..||++|||+.++++.-
T Consensus       238 ~~---------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  238 ED---------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             cC---------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            11         11122233444556666799999999999999999844

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=332.87  Aligned_cols=265  Identities=22%  Similarity=0.290  Sum_probs=208.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-cchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .+.|+..+.||.|..++||+|+...      .++.||||++..+... ..+.+.+|+..|+.++||||++++..|..+..
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p------~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~   98 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIP------TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE   98 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecc------cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence            4568888999999999999999986      6789999999876443 35889999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      +++||.||.+||+.+.++..-. ..++...+..|++++++||.|||   .+|.||||||+.||||+++|.+||+|||.+-
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeee
Confidence            9999999999999999965432 34888999999999999999999   7899999999999999999999999999877


Q ss_pred             ccccccccccccccccCCcCCcccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHT--GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      .+........... ...+||+.|||||++..  ..|+.|+||||||+..+||++|..||...+.-.   .|..-     .
T Consensus       175 ~l~~~G~R~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk---vLl~t-----L  245 (516)
T KOG0582|consen  175 SLFDSGDRQVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK---VLLLT-----L  245 (516)
T ss_pred             eecccCceeeEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH---HHHHH-----h
Confidence            6644332222221 46789999999999643  579999999999999999999999998654322   11110     1


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .+......-..+..+........+.+++-.|++.||++|||+.++++
T Consensus       246 qn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  246 QNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            11110000001111112222336777888999999999999999986

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.7e-40  Score=332.48  Aligned_cols=259  Identities=24%  Similarity=0.399  Sum_probs=206.3

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...+.||+|+||.||+|+++...   ..+..||+|.++.... .....|.+|+.++.+++||||+++++++...+..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~---~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPS---KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCC---CceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            46788899999999999999876321   1467899999876532 3346789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++|+|.+++...  ...+++..++.++.|++.||+|||   +++++||||||+|||++.++.+|++|||.+..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            9999999999999999643  246899999999999999999999   67999999999999999999999999998765


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ........    .....++..|+|||.+....++.++|||||||++||+++ |+.||.......    +...+    ..+
T Consensus       157 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~----~~~~~----~~~  224 (266)
T cd05064         157 DKSEAIYT----TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD----VIKAV----EDG  224 (266)
T ss_pred             ccccchhc----ccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH----HHHHH----HCC
Confidence            43221111    012345678999999999999999999999999999775 999987543221    11111    111


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                               ............+.+++..||+.+|.+||+++++.+.|++.
T Consensus       225 ---------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 ---------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                     11112233455678888999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.9e-42  Score=325.73  Aligned_cols=264  Identities=23%  Similarity=0.315  Sum_probs=205.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      +.|+...++|+|+||.|||++.+.      +|+.||||++.....  .-.+-.++|+++|++++|+|+|.|+..|..+..
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~------TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk   75 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKD------TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK   75 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCC------cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce
Confidence            346777889999999999999886      789999999965422  233456899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      ++||+|||+..-|+++= .  ....++.....+++.|++.|+.|+|   +++++||||||+|||+..++.+||||||+||
T Consensus        76 lhLVFE~~dhTvL~eLe-~--~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR  149 (396)
T KOG0593|consen   76 LHLVFEYCDHTVLHELE-R--YPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFAR  149 (396)
T ss_pred             eEEEeeecchHHHHHHH-h--ccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhH
Confidence            99999999876555543 2  2345788899999999999999999   7899999999999999999999999999999


Q ss_pred             ccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      .+......++     ..+.|.+|.|||.+.+ .+|...+||||.||++.||++|..-|.+.++-+..+.+..-+..+.. 
T Consensus       150 ~L~~pgd~YT-----DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p-  223 (396)
T KOG0593|consen  150 TLSAPGDNYT-----DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP-  223 (396)
T ss_pred             hhcCCcchhh-----hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH-
Confidence            9875433343     5678999999999987 78999999999999999999999888765554433333322221111 


Q ss_pred             Cchhhhhhh----------hcCC-----CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 GHIQDAVDQ----------RLNI-----NSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~----------~l~~-----~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       +..++...          ....     ........-++.++..|++.||.+|++-+|++.
T Consensus       224 -rhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  224 -RHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             -HHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence             01111111          0000     011223446788999999999999999999875

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.6e-40  Score=349.42  Aligned_cols=266  Identities=26%  Similarity=0.396  Sum_probs=206.2

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcC-CCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  317 (568)
                      .++|...++||+|+||.||+|++..... ...+..||||+++... ....+.+.+|+.++..+ +||||++++++|...+
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~-~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFK-SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEecccc-CccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            4468888999999999999998632100 1246789999986542 23456788999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCC----------------------------------------------------------
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTS----------------------------------------------------------  339 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~----------------------------------------------------------  339 (568)
                      ..++|||||++|+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999985421                                                          


Q ss_pred             --------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccc
Q 008374          340 --------------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN  405 (568)
Q Consensus       340 --------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~  405 (568)
                                    ....++|..+..++.||++||.|||   +++++||||||+|||++.++.+||+|||+++.......
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                          0125789999999999999999999   67999999999999999999999999999987654322


Q ss_pred             cccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCchhhhh
Q 008374          406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV  484 (568)
Q Consensus       406 ~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  484 (568)
                      ....   ....++..|+|||.+....++.++|||||||++|||++ |..||.......   .+..+..    .+      
T Consensus       270 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---~~~~~~~----~~------  333 (375)
T cd05104         270 YVVK---GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---KFYKMIK----EG------  333 (375)
T ss_pred             cccc---CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---HHHHHHH----hC------
Confidence            1111   12345678999999999999999999999999999998 888887543322   1222111    11      


Q ss_pred             hhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       485 d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                         ............+.+++..|++.||++|||+.||++.|++.
T Consensus       334 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         334 ---YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ---ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence               11111111234677888899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.8e-40  Score=335.68  Aligned_cols=271  Identities=24%  Similarity=0.399  Sum_probs=205.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCcc----------ccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQ----------YHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHL  309 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~----------~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l  309 (568)
                      ++|...++||+|+||.||++.+.....          ....+..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467788899999999999998753221          11234579999987643 2345679999999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChhhhhccCC----------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 008374          310 VGWCHEKGKLLLVYDFMPNGSLEKYLYGTS----------------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVH  373 (568)
Q Consensus       310 ~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  373 (568)
                      ++++.+.+..++||||+++|+|.+++....                ....++|.....++.|++.||.|||   +.+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            999999999999999999999999985421                1135788999999999999999999   679999


Q ss_pred             cCCCCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh--C
Q 008374          374 RDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC--G  451 (568)
Q Consensus       374 rDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t--G  451 (568)
                      |||||+|||+++++.+||+|||+++..........   .....++..|+|||++..+.++.++||||||+++|||++  +
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRI---QGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEe---cCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence            99999999999999999999999987644322111   113456789999999988899999999999999999987  5


Q ss_pred             CCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          452 RSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       452 ~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      ..|+.......    ....+......... .     ............+.+++.+||+.||++|||+.||.+.|+.
T Consensus       239 ~~p~~~~~~~~----~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         239 EQPYGELTDEQ----VIENAGEFFRDQGR-Q-----VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCCCcCCHHH----HHHHHHHHhhhccc-c-----ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            56776443222    22222221111100 0     0001112234567889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.7e-40  Score=349.13  Aligned_cols=266  Identities=25%  Similarity=0.414  Sum_probs=206.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcC-CCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  317 (568)
                      .++|...+.||+|+||.||+|+....+. ..++..||||++.... ......+.+|+++++.+ +|+||++++++|...+
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGK-EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCc-ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            4568889999999999999998754221 1245689999997543 23345688999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCC----------------------------------------------------------
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTS----------------------------------------------------------  339 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~----------------------------------------------------------  339 (568)
                      ..++||||+++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999985321                                                          


Q ss_pred             ---------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccccccccccc
Q 008374          340 ---------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEH  410 (568)
Q Consensus       340 ---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  410 (568)
                               ....+++.+..+++.|++.||.|||   +++|+||||||+|||+++++.+||+|||+++........... 
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~-  271 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK-  271 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec-
Confidence                     1124788999999999999999999   679999999999999999999999999999876543221111 


Q ss_pred             ccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcC
Q 008374          411 GLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLN  489 (568)
Q Consensus       411 ~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  489 (568)
                        ....++..|||||++....++.++|||||||++|||++ |+.||.......   .+..             .+.....
T Consensus       272 --~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~-------------~~~~~~~  333 (374)
T cd05106         272 --GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYK-------------MVKRGYQ  333 (374)
T ss_pred             --cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHH-------------HHHcccC
Confidence              12345678999999998999999999999999999997 999987533222   1111             1111111


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          490 INSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       490 ~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ..........+.+++..||+.||++|||+.+|+++|++.
T Consensus       334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111111235677788899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-40  Score=332.48  Aligned_cols=255  Identities=31%  Similarity=0.546  Sum_probs=196.4

Q ss_pred             ccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEE
Q 008374          245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVY  323 (568)
Q Consensus       245 ~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  323 (568)
                      ..+.||.|.||.||+|.+...  ....+..|+||.++.... ...++|.+|++.+++++||||++++|+|...+..++|+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~--~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQK--DNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEEST--TTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcc--cCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccc
Confidence            456899999999999999831  122578999999965433 34788999999999999999999999999888899999


Q ss_pred             EecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccc
Q 008374          324 DFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE  403 (568)
Q Consensus       324 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~  403 (568)
                      ||+++|+|.++|... ....+++.++..|+.|+++||.|||   +.+++|+||+++||++++++.+||+|||+++.....
T Consensus        81 e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             E--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             ccccccccccccccc-ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            999999999999765 2356899999999999999999999   568999999999999999999999999999877332


Q ss_pred             cccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCchhh
Q 008374          404 RNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD  482 (568)
Q Consensus       404 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  482 (568)
                      .....   .....+...|+|||.+....++.++||||||+++|||++ |+.|+.......    +.+   .. .++    
T Consensus       157 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~----~~~---~~-~~~----  221 (259)
T PF07714_consen  157 SKYKN---DSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE----IIE---KL-KQG----  221 (259)
T ss_dssp             SSEEE---STTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH----HHH---HH-HTT----
T ss_pred             ccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccc----ccc---cc-ccc----
Confidence            21111   113456789999999999899999999999999999999 678876542221    111   11 111    


Q ss_pred             hhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 008374          483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII  525 (568)
Q Consensus       483 ~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L  525 (568)
                           .....+......+..++..||+.||++|||++++++.|
T Consensus       222 -----~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  222 -----QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -----EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -----ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                 11222233455677888899999999999999999987

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=345.85  Aligned_cols=241  Identities=24%  Similarity=0.425  Sum_probs=205.5

Q ss_pred             ccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEE
Q 008374          245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYD  324 (568)
Q Consensus       245 ~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  324 (568)
                      +.+-||+|+.|.||+|+++        ++.||||+++.-.       ..+|+-|++|+|+||+.+.|+|.....++||||
T Consensus       128 ELeWlGSGaQGAVF~Grl~--------netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiME  192 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH--------NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIME  192 (904)
T ss_pred             hhhhhccCcccceeeeecc--------CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeee
Confidence            3557999999999999995        6889999985432       357889999999999999999999999999999


Q ss_pred             ecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccccc
Q 008374          325 FMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER  404 (568)
Q Consensus       325 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~  404 (568)
                      ||+.|-|...|..   ...++......+..+||.||.|||   ...|||||||+-||||..+..+||+|||-++.+....
T Consensus       193 fCa~GqL~~VLka---~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S  266 (904)
T KOG4721|consen  193 FCAQGQLYEVLKA---GRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS  266 (904)
T ss_pred             ccccccHHHHHhc---cCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhhh
Confidence            9999999999953   446788889999999999999999   6799999999999999999999999999999876542


Q ss_pred             ccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhh
Q 008374          405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV  484 (568)
Q Consensus       405 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  484 (568)
                      +      ...++||..|||||++.....++|+||||||||||||+||..||.......                -+..+=
T Consensus       267 T------kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----------------IIwGVG  324 (904)
T KOG4721|consen  267 T------KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----------------IIWGVG  324 (904)
T ss_pred             h------hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----------------eEEecc
Confidence            2      126799999999999999999999999999999999999999987443221                011122


Q ss_pred             hhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       485 d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ...|....+..++..+..|+.+||+-.|..||++++++..|+-.
T Consensus       325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            33444556667788888899999999999999999999999864

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-41  Score=346.27  Aligned_cols=259  Identities=26%  Similarity=0.448  Sum_probs=221.0

Q ss_pred             HHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       237 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      +.-..+....++||-|.||.||.|+|+.      -...||||.++.+ ....++|+.|..+|+.++|||+|+|+|+|...
T Consensus       263 EmeRtdItMkhKLGGGQYGeVYeGvWKk------yslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E  335 (1157)
T KOG4278|consen  263 EMERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE  335 (1157)
T ss_pred             hccchheeeeeccCCCcccceeeeeeec------cceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence            3333455667899999999999999986      4678999999765 45678999999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      ..+|||.|||.+|+|.+||..... ..++-...+.++.||++||.||.   .+.+|||||.++|+|+.++..+|++||||
T Consensus       336 pPFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGL  411 (1157)
T KOG4278|consen  336 PPFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGL  411 (1157)
T ss_pred             CCeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccch
Confidence            999999999999999999977543 35777888999999999999999   68999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      +|++..+..  +.+.  ...-.+.|.|||.+....++.|+|||+|||+||||.| |-.|+.+.+-.+             
T Consensus       412 sRlMtgDTY--TAHA--GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------------  474 (1157)
T KOG4278|consen  412 SRLMTGDTY--TAHA--GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------  474 (1157)
T ss_pred             hhhhcCCce--eccc--CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------------
Confidence            999876543  2211  3344689999999999999999999999999999998 888887543222             


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                          +.+++...++.+.+..++..+.+|+.+||+.+|.+||+++|+-+.++.
T Consensus       475 ----VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt  522 (1157)
T KOG4278|consen  475 ----VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET  522 (1157)
T ss_pred             ----HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence                334556667777788899999999999999999999999999887663

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=342.57  Aligned_cols=250  Identities=21%  Similarity=0.369  Sum_probs=209.1

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ..|..-.+||+|..|.||.+.-..      +++.||||++........+-.++|+.+|+..+|+|||.++..+..+++++
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~------~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW  346 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKIS------TKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELW  346 (550)
T ss_pred             hhhcchhhhccccccceeeeeecc------CCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence            346667789999999999998875      67889999998776666677889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +|||||++|+|.+.+.    ...++..++..|+.++++||+|||   .++|+|||||.+||||+.++.+||+|||++..+
T Consensus       347 VVMEym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi  419 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQI  419 (550)
T ss_pred             EEEeecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecc
Confidence            9999999999999983    345999999999999999999999   789999999999999999999999999999988


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      .......     ...+||+.|||||++....|.+|.||||||++++||+-|..||-....       ..-.+.....|  
T Consensus       420 ~~~~~KR-----~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrAlyLIa~ng--  485 (550)
T KOG0578|consen  420 SEEQSKR-----STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATNG--  485 (550)
T ss_pred             ccccCcc-----ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHHHHHHhhcC--
Confidence            7665422     267899999999999999999999999999999999999999863211       11111111111  


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                            +............+.+++.+||+.|+.+||++.|+|+
T Consensus       486 ------~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  486 ------TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ------CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence                  1222233444556677778999999999999999986

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-40  Score=339.32  Aligned_cols=251  Identities=26%  Similarity=0.370  Sum_probs=204.1

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC----Cc-ccchhhHHHHHHhhcCC-CCceeeEEE
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD----SI-KSKGDFLAELAIIHRLR-HKHLVHLVG  311 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g  311 (568)
                      ...+.|...+.||+|.||+|+.|....      ++..||+|.+.+.    .. ...+...+|+.++++++ ||||++++.
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~------t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~e   87 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRL------TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLE   87 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeecc------CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEE
Confidence            345678899999999999999998875      6799999987664    11 23345668999999999 999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-CcEE
Q 008374          312 WCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD-FNAR  390 (568)
Q Consensus       312 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~-~~~k  390 (568)
                      ++.....+++||||+.+|+|.+++..   ...+.......++.|+++|++|+|   +++|+||||||+|||+|.+ +++|
T Consensus        88 v~~t~~~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~K  161 (370)
T KOG0583|consen   88 VFATPTKIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLK  161 (370)
T ss_pred             EEecCCeEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEE
Confidence            99999999999999999999999954   457888999999999999999999   7899999999999999999 9999


Q ss_pred             EeecCCccccc-cccccccccccccCCcCCcccCccccccCC-CC-ccchhHHHHHHHHHHHhCCCCCCCCCcccchhhH
Q 008374          391 LGDFGLARAIE-NERNSYAEHGLVGVPGTMGYVAPECFHTGK-AT-PESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTL  467 (568)
Q Consensus       391 L~DFGla~~~~-~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~t-~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l  467 (568)
                      |+|||++.... .+..      ....+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+......     
T Consensus       162 l~DFG~s~~~~~~~~~------l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-----  230 (370)
T KOG0583|consen  162 LSDFGLSAISPGEDGL------LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-----  230 (370)
T ss_pred             EeccccccccCCCCCc------ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-----
Confidence            99999999874 2211      22678999999999999877 76 78999999999999999999998632211     


Q ss_pred             HHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          468 VDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       468 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        ....         +....+....... ...+..++..|+..||.+|+|+.++++
T Consensus       231 --l~~k---------i~~~~~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  231 --LYRK---------IRKGEFKIPSYLL-SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             --HHHH---------HhcCCccCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence              1111         1111121111111 556677778999999999999999984

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-41  Score=342.98  Aligned_cols=264  Identities=28%  Similarity=0.448  Sum_probs=211.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc-chhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      +...+.++||+|.||+|.++...       .+..||||.++...... +++|.+|+++|.+++||||++|+|.|..++.+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeve-------g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi  610 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVE-------GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL  610 (807)
T ss_pred             hheehhhhhcCcccceeEEEEec-------CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence            34566788999999999999886       46899999998876554 58999999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++|+|||++|+|.+||..+.. ..+.-.....|+.|||+||+||.   +.++|||||.++|+|+|+++++||+|||++|-
T Consensus       611 cmI~EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRN  686 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccc
Confidence            999999999999999976532 22455667789999999999999   66999999999999999999999999999997


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHH--hCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV--CGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~--tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +.........   ...+-.++|||+|.+.-+++|+++|||+||+++||++  |..+||+...+++    .++-...+...
T Consensus       687 lysg~yy~vq---gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~----vven~~~~~~~  759 (807)
T KOG1094|consen  687 LYSGDYYRVQ---GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ----VVENAGEFFRD  759 (807)
T ss_pred             cccCCceeee---cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH----HHHhhhhhcCC
Confidence            7654322111   1344568999999999999999999999999999975  5778988554433    22222222211


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      +..      ......+.-++..++++++.||..+.++||+++++...|...
T Consensus       760 ~~~------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  760 QGR------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CCc------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            111      111223445677888999999999999999999999988764

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.4e-39  Score=323.40  Aligned_cols=252  Identities=27%  Similarity=0.462  Sum_probs=201.7

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|...+.||+|+||.||++.++       ++..+|+|.+.... ...++|.+|++++++++||||++++++|...+..+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-------~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-------AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY   75 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-------cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEE
Confidence            35777889999999999999886       45679999886442 33467899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++|+|.+++....  ..+++..+..++.|++.||.|||   +++++||||||+||++++++.+||+|||+++..
T Consensus        76 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~  150 (256)
T cd05114          76 IVTEFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV  150 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCcccc
Confidence            9999999999999986432  35899999999999999999999   679999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      ........    ....++..|+|||.+....++.++||||||+++|||++ |+.||......    .....+..    +.
T Consensus       151 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~----~~~~~i~~----~~  218 (256)
T cd05114         151 LDDEYTSS----SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY----EVVEMISR----GF  218 (256)
T ss_pred             CCCceecc----CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHC----CC
Confidence            43322111    13345678999999988889999999999999999999 89998643222    12221111    10


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                             +.  ..+......+..++.+||+.+|++||++.++++.|.
T Consensus       219 -------~~--~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         219 -------RL--YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             -------CC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                   00  011112346788889999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.5e-39  Score=328.07  Aligned_cols=263  Identities=27%  Similarity=0.485  Sum_probs=208.5

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...+.||+|+||.||+|....... ......||+|.+.... .....+|.+|+.++.+++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNE-RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCC-CcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            357778899999999999998864321 1244789999986543 23346789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCC-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC
Q 008374          320 LLVYDFMPNGSLEKYLYGTSE-------------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD  386 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~  386 (568)
                      +++|||+++++|.+++.....             ...+++.....++.|++.||.|||   +.+++||||||+||+++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCC
Confidence            999999999999999965321             145889999999999999999999   6799999999999999999


Q ss_pred             CcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchh
Q 008374          387 FNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAY  465 (568)
Q Consensus       387 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~  465 (568)
                      +.+||+|||+++..........   .....+++.|+|||.+....++.++|||||||++|||++ |..||.......   
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---  234 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRV---QSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---  234 (283)
T ss_pred             CcEEECCCcceeeccccccccc---cCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999986543221111   113456889999999988899999999999999999998 999987543321   


Q ss_pred             hHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          466 TLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       466 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                       +...             +...............+..++.+||+.||.+||+++||++.|++
T Consensus       235 -~~~~-------------i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 -VIEM-------------IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHH-------------HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence             1111             11111112233455778888899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-40  Score=336.86  Aligned_cols=256  Identities=23%  Similarity=0.304  Sum_probs=206.3

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcC-CCCceeeEEEEE
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRL-RHKHLVHLVGWC  313 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~  313 (568)
                      +...+|..++.||+|+|++|++|+.+.      +++.+|||++.+.-   +.-.+-...|-++|.+| .||.|++|+-.|
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~------t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF  143 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKA------TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF  143 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecC------CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence            344568888999999999999999886      78999999997642   22234466899999999 899999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEee
Q 008374          314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD  393 (568)
Q Consensus       314 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~D  393 (568)
                      ++...+|+|+||+++|+|.++|++   .+.++......++.+|+.||+|||   +.|||||||||+|||||+++.+||.|
T Consensus       144 QD~~sLYFvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITD  217 (604)
T KOG0592|consen  144 QDEESLYFVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITD  217 (604)
T ss_pred             ecccceEEEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEee
Confidence            999999999999999999999954   467898889999999999999999   78999999999999999999999999


Q ss_pred             cCCcccccccccc--------ccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchh
Q 008374          394 FGLARAIENERNS--------YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY  465 (568)
Q Consensus       394 FGla~~~~~~~~~--------~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~  465 (568)
                      ||-|+.+......        +........+||..|.+||++.....+..+|+|+|||+||+|+.|..||....+...  
T Consensus       218 FGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli--  295 (604)
T KOG0592|consen  218 FGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI--  295 (604)
T ss_pred             ccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH--
Confidence            9999988654222        111112368999999999999999999999999999999999999999986544321  


Q ss_pred             hHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          466 TLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       466 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                                    ...+++-.+  +++..-.+.+..|+.+.|..||.+|+|.+|+-+
T Consensus       296 --------------FqkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  296 --------------FQKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             --------------HHHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence                          111221111  122222234445555677899999999999876

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.3e-39  Score=324.51  Aligned_cols=254  Identities=25%  Similarity=0.457  Sum_probs=205.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|+..++||+|+||.||+|...       .+..||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-------~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-------NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-------CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            56888899999999999999875       45679999986543 24567999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      ++|||+++++|.+++.... ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus        78 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  153 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVI  153 (261)
T ss_pred             EEEecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceec
Confidence            9999999999999996532 346889999999999999999999   579999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      ........    ....++..|+|||++....++.++|||||||++|||++ |+.||.......    ......    .+ 
T Consensus       154 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~----~~~~~~----~~-  220 (261)
T cd05072         154 EDNEYTAR----EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD----VMSALQ----RG-  220 (261)
T ss_pred             CCCceecc----CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH----HHHHHH----cC-
Confidence            54322111    13346778999999988889999999999999999998 999986432221    111111    11 


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                              ............+.+++.+|++.+|++||+++++++.|+.
T Consensus       221 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         221 --------YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                    0111111233467788899999999999999999999985

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-39  Score=324.22  Aligned_cols=255  Identities=27%  Similarity=0.461  Sum_probs=206.1

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      .+|...++||+|+||.||+|....      .+..||+|.+... .....++.+|++++++++|+||++++++|...+..+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~------~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEec------CCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence            347778899999999999999875      5788999998754 334567999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++++|.+++.... ...+++..++.++.|+++||+|||   +++++||||||+||++++++.+||+|||+++..
T Consensus        79 lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~  154 (263)
T cd05052          79 IITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  154 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccc
Confidence            9999999999999985432 346899999999999999999999   679999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      ........    ....++..|+|||.+.+..++.++|||||||++|||++ |..|+.......    +    +...    
T Consensus       155 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----~----~~~~----  218 (263)
T cd05052         155 TGDTYTAH----AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----V----YELL----  218 (263)
T ss_pred             ccceeecc----CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----H----HHHH----
Confidence            54322111    12334678999999998999999999999999999998 899986432211    1    1111    


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                           ...............+.+++.+|++.+|++|||+.++++.|+.
T Consensus       219 -----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         219 -----EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             -----HCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence                 1111112222334567778889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.7e-39  Score=328.75  Aligned_cols=251  Identities=25%  Similarity=0.321  Sum_probs=199.9

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      |...+.||+|+||.||++....      +++.||+|.+....   ......+.+|+.++.+++|+||+++++++.+.+..
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~   75 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRA------TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDAL   75 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEec------CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeE
Confidence            6778899999999999999875      67899999986542   22334678999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++|+|..++.... ...+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++.
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~  151 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQ  151 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence            99999999999998885432 235899999999999999999999   67999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      .......      ....||..|+|||++.+..++.++|||||||++|||++|+.||........   . +-+.....   
T Consensus       152 ~~~~~~~------~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~-~~~~~~~~---  218 (285)
T cd05631         152 IPEGETV------RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---R-EEVDRRVK---  218 (285)
T ss_pred             cCCCCee------cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---H-HHHHHHhh---
Confidence            5432211      145689999999999999999999999999999999999999975433220   0 00011000   


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK-----TEDILQ  523 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt-----~~evl~  523 (568)
                           ..  ...........+..++..||+.||.+||+     ++++++
T Consensus       219 -----~~--~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         219 -----ED--QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             -----cc--cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence                 00  01112223345667788999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1e-39  Score=335.27  Aligned_cols=264  Identities=24%  Similarity=0.415  Sum_probs=206.3

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .+|+..+.||+|+||.||+|++..++.  .....||+|.+.... ....++|..|+.+++.++||||++++|+|... ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCC--ccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            358888999999999999999864322  124469999987543 34456799999999999999999999999764 57


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++|+||+++|+|.+++...  ...+++...+.++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++.
T Consensus        84 ~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          84 QLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccccc
Confidence            8999999999999999653  235889999999999999999999   67999999999999999999999999999998


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ..........   ....++..|+|||++....++.++||||||+++|||++ |+.|++......    +...    ... 
T Consensus       159 ~~~~~~~~~~---~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~----~~~~----~~~-  226 (316)
T cd05108         159 LGADEKEYHA---EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSI----LEK-  226 (316)
T ss_pred             ccCCCcceec---cCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----HHHH----HhC-
Confidence            7654332211   12335678999999999999999999999999999998 999987543221    1111    111 


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVP  532 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~p  532 (568)
                              .............+..++..||+.+|.+||++.++++.|......+
T Consensus       227 --------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         227 --------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             --------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence                    1111111123346778889999999999999999999988654433

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-39  Score=323.33  Aligned_cols=260  Identities=29%  Similarity=0.498  Sum_probs=208.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...+.||+|+||.||+|+++..+.   ....||||.+.... .....+|.+|+.++++++||||+++++++...+..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGK---KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCC---CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            568889999999999999999864211   35689999987543 33456799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++++|.+++....  ..+++..+..++.|++.||.|||   +.+++||||||+|||+++++.+||+|||+++.
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          81 MIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence            99999999999999996432  36899999999999999999999   67999999999999999999999999999998


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ..........   ....++..|+|||.+....++.++||||||++++||++ |+.||.......    +.+..    ..+
T Consensus       156 ~~~~~~~~~~---~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~----~~~~~----~~~  224 (266)
T cd05033         156 LEDSEATYTT---KGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD----VIKAV----EDG  224 (266)
T ss_pred             ccccccceec---cCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH----HHHHH----HcC
Confidence            7532222211   12345678999999998899999999999999999998 999986433221    11111    111


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                               ............+.+++..|++.+|++||++.||++.|++.
T Consensus       225 ---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         225 ---------YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                     11111223455678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-39  Score=321.94  Aligned_cols=255  Identities=30%  Similarity=0.478  Sum_probs=205.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .++|...+.||+|+||.||+|...       .+..||+|.++... ...++|.+|++++++++||||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-------NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI   76 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-------CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence            456888899999999999999875       45689999986543 3456799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++++|.+++.... ...+++..+..++.+++.||.|||   +++++||||||+||++++++.+||+|||+++.
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  152 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARV  152 (261)
T ss_pred             eeeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEE
Confidence            99999999999999996533 346899999999999999999999   67999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      .........    .....+..|+|||++....++.++||||||++++||++ |+.||.......    +..         
T Consensus       153 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~---------  215 (261)
T cd05068         153 IKEDIYEAR----EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE----VLQ---------  215 (261)
T ss_pred             ccCCccccc----CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH----HHH---------
Confidence            753221111    12233468999999998899999999999999999999 999987433221    111         


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                          .++..............+.+++.+|++.+|.+||++.++++.|+.
T Consensus       216 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         216 ----QVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ----HHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                111111111222345678889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.4e-39  Score=342.34  Aligned_cols=267  Identities=24%  Similarity=0.361  Sum_probs=208.0

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCC-CCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLR-HKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~  317 (568)
                      .++|...++||+|+||.||+|+...... ...+..||||++..... ...+.|.+|+++++++. ||||++++++|.+.+
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~-~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSR-SQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCC-CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            4578888999999999999998753211 11346799999975432 33467999999999996 999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCC---------------------------------------------------------
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSE---------------------------------------------------------  340 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~---------------------------------------------------------  340 (568)
                      ..+||||||++|+|.++|+....                                                         
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            99999999999999998864210                                                         


Q ss_pred             ------------------------------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc
Q 008374          341 ------------------------------------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD  384 (568)
Q Consensus       341 ------------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld  384 (568)
                                                          ...+++..+..++.|+++||.|||   +.+++||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence                                                124788899999999999999999   67999999999999999


Q ss_pred             CCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccc
Q 008374          385 ADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQH  463 (568)
Q Consensus       385 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~  463 (568)
                      +++.+||+|||+++..........   .....++..|+|||.+.+..++.++|||||||++|||++ |+.|+....... 
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-  347 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVS---KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-  347 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccc---cCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-
Confidence            999999999999987654322111   113456788999999998899999999999999999997 999987432211 


Q ss_pred             hhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          464 AYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       464 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                        .+..    ....+         ............+.+++.+||+.||++|||+.+|.++|+...
T Consensus       348 --~~~~----~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         348 --TFYN----KIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             --HHHH----HHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence              1111    11111         111122234557788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.2e-39  Score=325.91  Aligned_cols=262  Identities=24%  Similarity=0.414  Sum_probs=204.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|+..++||+|+||.||+|.+...+.  ..+..+++|.+.... .+...+|.+|++++++++||||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGM--DHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCC--CCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            457778899999999999998643211  146789999997543 23346789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCC--------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC
Q 008374          320 LLVYDFMPNGSLEKYLYGTS--------------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA  385 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~  385 (568)
                      ++||||+++++|.+++....              ....+++.+.+.++.|++.||.|||   +++++||||||+|||+++
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~  159 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGE  159 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcC
Confidence            99999999999999985321              1235889999999999999999999   679999999999999999


Q ss_pred             CCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccch
Q 008374          386 DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHA  464 (568)
Q Consensus       386 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~  464 (568)
                      ++.+||+|||+++..........   .....++..|+|||++.+..++.++||||||++++||++ |..||......   
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---  233 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRV---QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---  233 (283)
T ss_pred             CCcEEeccccccccccCCcceec---ccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence            99999999999987644322111   113446778999999988889999999999999999998 88898643221   


Q ss_pred             hhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          465 YTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       465 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                       .+.+.+             +..............+..++.+|++.||++||++.++.+.|.+
T Consensus       234 -~~~~~~-------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         234 -EVIEMV-------------RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHHHH-------------HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence             111111             1111111122234567778889999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.3e-39  Score=333.80  Aligned_cols=199  Identities=24%  Similarity=0.380  Sum_probs=174.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|+..++||+|+||.||+++...      ++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKP------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI   78 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECC------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            578889999999999999999875      67889999987642 23346799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        79 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  153 (331)
T cd06649          79 SICMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (331)
T ss_pred             EEEeecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence            999999999999999954   3458899999999999999999994  23699999999999999999999999999986


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNM  457 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~  457 (568)
                      ......       ....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       154 ~~~~~~-------~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         154 LIDSMA-------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             cccccc-------ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            643221       145689999999999998999999999999999999999999964

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-41  Score=336.08  Aligned_cols=268  Identities=21%  Similarity=0.311  Sum_probs=209.3

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc-chhhHHHHHHhhcCC-CCceeeEEEEEEeC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLAELAIIHRLR-HKHLVHLVGWCHEK  316 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~  316 (568)
                      ..++|...++||.|.||.||+|+-..      ++..||||++++..... .-.=++|+..|++|+ ||||++|...+.+.
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~------~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~   81 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKE------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDN   81 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecC------CCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence            34567888899999999999999876      67889999998754331 122368999999998 99999999999988


Q ss_pred             C-eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          317 G-KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       317 ~-~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      + .+++||||| ..+|.+++.+.  +..++...+..|+.||++||+|+|   .+|+.|||+||+|||+.....+||+|||
T Consensus        82 ~~~L~fVfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFG  155 (538)
T KOG0661|consen   82 DRILYFVFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFG  155 (538)
T ss_pred             CceEeeeHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccc
Confidence            7 999999999 55899998654  578999999999999999999999   6899999999999999999999999999


Q ss_pred             CccccccccccccccccccCCcCCcccCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH--
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFH-TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW--  472 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~--  472 (568)
                      |||.+... .+++     ..+.|.+|.|||++. .+.|+.+.|+||+||+++|+.+-+.-|.+..+-+..+.+++...  
T Consensus       156 LARev~Sk-pPYT-----eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP  229 (538)
T KOG0661|consen  156 LAREVRSK-PPYT-----EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTP  229 (538)
T ss_pred             cccccccC-CCcc-----hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCC
Confidence            99987654 2333     577899999999875 67899999999999999999999988876554443333333211  


Q ss_pred             --HHhhcC-chhhhhhhhcCC-------CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          473 --MLHREG-HIQDAVDQRLNI-------NSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       473 --~~~~~~-~~~~~~d~~l~~-------~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                        .-+.+| .+...+.-++..       ........+.++++..|+..||.+|||+.|++++
T Consensus       230 ~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  230 DKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             ccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence              111111 111111111110       0112356677888899999999999999999983

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.5e-39  Score=325.41  Aligned_cols=267  Identities=22%  Similarity=0.266  Sum_probs=201.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|...+.||+|+||.||+++.+.      +++.+|+|++....  ....+.+.+|++++++++||||+++++++...+.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKE------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK   74 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECC------CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence            368888999999999999999875      67889999987542  2334568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||++++++..+..   ....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++
T Consensus        75 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  148 (287)
T cd07848          75 LYLVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFAR  148 (287)
T ss_pred             EEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence            999999999887765542   2246889999999999999999999   6799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH--------H
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD--------W  470 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~--------~  470 (568)
                      ..........    ....||..|+|||++.+..++.++|||||||++|||++|+.||...........+..        +
T Consensus       149 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  224 (287)
T cd07848         149 NLSEGSNANY----TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQ  224 (287)
T ss_pred             cccccccccc----cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHH
Confidence            7654322111    145689999999999888899999999999999999999999975433221111110        0


Q ss_pred             HHHHhhcCchhhhhhhhcCCC------CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          471 VWMLHREGHIQDAVDQRLNIN------SVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       471 ~~~~~~~~~~~~~~d~~l~~~------~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ...............+.....      ........+.+++..|++.||++|||++|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         225 MKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000000000000000      00112345788889999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.3e-39  Score=324.80  Aligned_cols=265  Identities=26%  Similarity=0.449  Sum_probs=206.5

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++++|+..++||+|+||.||+|.+..... ...+..||+|++.... .....+|.+|+.+++.++||||+++++++...+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVK-DEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCC-CCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            46779999999999999999998753111 1245789999986532 234567899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEE
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSE-------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR  390 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~k  390 (568)
                      ..++||||+++++|.+++.....       ...+++..+..++.|++.||.|||   +.+++||||||+||++++++.+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEE
Confidence            99999999999999999864221       234688999999999999999999   67999999999999999999999


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHH
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~  469 (568)
                      |+|||+++..........   .....++..|+|||++....++.++|||||||++|||++ |..||.......    ..+
T Consensus       160 l~dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~----~~~  232 (277)
T cd05062         160 IGDFGMTRDIYETDYYRK---GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ----VLR  232 (277)
T ss_pred             ECCCCCccccCCcceeec---CCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH
Confidence            999999986644322111   012345788999999998899999999999999999999 788886443221    111


Q ss_pred             HHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          470 WVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       470 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      .+    ..+..         ..........+.+++.+|++.||++|||+.|+++.|+.
T Consensus       233 ~~----~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         233 FV----MEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HH----HcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            11    11111         01112234567888899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.6e-40  Score=336.62  Aligned_cols=247  Identities=26%  Similarity=0.389  Sum_probs=206.5

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|...+.||+|.||.||||+-+.      +.+.||+|.+.+..  .++.+...+|++++++++||||+.++++|+...+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~------t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~   75 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKY------TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH   75 (808)
T ss_pred             cchhHHHHhcCCccceeeeccccc------ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence            467788899999999999999875      78899999997653  3445678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      +++|.||+.+ +|..+|.   ....|+.+....|+.++++||.|||   +.+|+|||+||.||||+.++.+|++|||+||
T Consensus        76 ~~vVte~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar  148 (808)
T KOG0597|consen   76 LWVVTEYAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLAR  148 (808)
T ss_pred             EEEEehhhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhh
Confidence            9999999966 9999994   4567999999999999999999999   7899999999999999999999999999999


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ....+..-     .+.+.||+.|||||+..+..|+..+|.||+||++||++.|+.||...       .+...+.....  
T Consensus       149 ~m~~~t~v-----ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-------si~~Lv~~I~~--  214 (808)
T KOG0597|consen  149 AMSTNTSV-----LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-------SITQLVKSILK--  214 (808)
T ss_pred             hcccCcee-----eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------HHHHHHHHHhc--
Confidence            87664322     33788999999999999999999999999999999999999998632       22222222221  


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                            |+.   ..+......+..+....+.+||..|.|..++++
T Consensus       215 ------d~v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  215 ------DPV---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ------CCC---CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                  111   122244445566666778999999999999986

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=336.56  Aligned_cols=254  Identities=22%  Similarity=0.339  Sum_probs=203.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...++||+|+||.||+|+...      +++.||+|+++...   ....+.+..|++++.+++||||+++++++...+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~   74 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKD------TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE   74 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECC------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC
Confidence            368889999999999999999875      57899999997542   234456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++|+|.+++..   ...+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a  148 (333)
T cd05600          75 YLYLAMEYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLS  148 (333)
T ss_pred             EEEEEEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCC
Confidence            99999999999999999953   346889999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +.....        .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..|.      
T Consensus       149 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------  214 (333)
T cd05600         149 KGIVTY--------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK------  214 (333)
T ss_pred             cccccc--------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc------
Confidence            865441        124579999999999998999999999999999999999999997543322111111110      


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                          ..+...............+..++..|+..+|.+||+++++++.
T Consensus       215 ----~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         215 ----ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ----ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                0000000000011234456677779999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.2e-39  Score=322.68  Aligned_cols=256  Identities=26%  Similarity=0.465  Sum_probs=210.5

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ...+|...++||+|+||.||+|...       .+..+++|.+.........++.+|+.+++.++|+||+++++++...+.
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   76 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWK-------NRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP   76 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEec-------CCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCC
Confidence            3456888899999999999999987       467899999987665566789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++++|.+++.... ...+++..+..++.|++.||.|||   +++++||||||+||++++++.+||+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~  152 (261)
T cd05148          77 VYIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLAR  152 (261)
T ss_pred             eEEEEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchh
Confidence            999999999999999996543 346899999999999999999999   6799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ..........     ...++..|+|||.+....++.++||||||++++||++ |+.||.......    .....      
T Consensus       153 ~~~~~~~~~~-----~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~----~~~~~------  217 (261)
T cd05148         153 LIKEDVYLSS-----DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE----VYDQI------  217 (261)
T ss_pred             hcCCcccccc-----CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH----HHHHH------
Confidence            7644322111     3346778999999988899999999999999999998 899987543221    11111      


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                             ...............+.+++.+|++.||++|||+.++++.|+.
T Consensus       218 -------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         218 -------TAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             -------HhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence                   1111112223344567888899999999999999999999985

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=330.77  Aligned_cols=246  Identities=21%  Similarity=0.276  Sum_probs=199.7

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...++||+|+||.||+|....      +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   74 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRI------SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR   74 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcC------CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC
Confidence            367888999999999999999875      67899999986532   233456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++|+|.+++..   ...+++.....++.|++.||+|||   +++++||||||+|||++.++.+||+|||++
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~  148 (291)
T cd05612          75 FLYMLMEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFA  148 (291)
T ss_pred             eEEEEEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcc
Confidence            99999999999999999953   346889999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +......        ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    +.+.       
T Consensus       149 ~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~----~~~~-------  209 (291)
T cd05612         149 KKLRDRT--------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG----IYEK-------  209 (291)
T ss_pred             hhccCCc--------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHH-------
Confidence            8764321        13568999999999998889999999999999999999999997532211    1111       


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK-----TEDILQI  524 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt-----~~evl~~  524 (568)
                           +.....  ..+......+.+++..|++.||.+||+     +.++++.
T Consensus       210 -----i~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         210 -----ILAGKL--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -----HHhCCc--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                 111111  111112335667888999999999995     8887753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-39  Score=335.93  Aligned_cols=245  Identities=21%  Similarity=0.270  Sum_probs=199.5

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...+.||+|+||.||+|+...      +++.||+|.+....   ....+.+.+|+.++++++||||+++++++...+
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   91 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKG------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN   91 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECC------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence            568889999999999999999875      67899999986532   234467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++|+|.+++..   ...+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~  165 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFA  165 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCc
Confidence            99999999999999999953   346788889999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +.......        ...||+.|+|||++.+..++.++|||||||++|||++|+.||.......    ..    .....
T Consensus       166 ~~~~~~~~--------~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~----~~i~~  229 (329)
T PTZ00263        166 KKVPDRTF--------TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR----IY----EKILA  229 (329)
T ss_pred             eEcCCCcc--------eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH----HH----HHHhc
Confidence            87643221        3569999999999999999999999999999999999999997432211    11    11111


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK-----TEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt-----~~evl~  523 (568)
                      +        .+.  .+......+.+++..||+.||.+||+     ++++++
T Consensus       230 ~--------~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        230 G--------RLK--FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             C--------CcC--CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            1        111  11112234567888999999999997     677764

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.1e-39  Score=302.19  Aligned_cols=279  Identities=23%  Similarity=0.302  Sum_probs=212.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc--cchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK--SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|...++||+|.||.||+|+...      +++.||||+++.....  -....++|++.|+.++|+||+.|++++-..+.
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~------t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~   75 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTE------TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN   75 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecC------CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence            457778899999999999999875      7899999999765332  23457899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      +-||+|||+ .+|...+.+.  ...|+..++..++.++.+|++|+|   ++.|+||||||.|+|+++++.+||+|||+|+
T Consensus        76 l~lVfEfm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr  149 (318)
T KOG0659|consen   76 LSLVFEFMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLAR  149 (318)
T ss_pred             eEEEEEecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchh
Confidence            999999995 5899999653  457899999999999999999999   7799999999999999999999999999999


Q ss_pred             ccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH---
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML---  474 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~---  474 (568)
                      .+......++     ..+-|..|.|||.+.+ ..|....|+||.||++.||+.|..-|.+..+-+   .+..-...+   
T Consensus       150 ~f~~p~~~~~-----~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid---QL~~If~~LGTP  221 (318)
T KOG0659|consen  150 FFGSPNRIQT-----HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID---QLSKIFRALGTP  221 (318)
T ss_pred             ccCCCCcccc-----cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH---HHHHHHHHcCCC
Confidence            9876544333     3367899999999876 579999999999999999999886555443322   111111100   


Q ss_pred             ----hhc-Cchhhhh------hhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCCc
Q 008374          475 ----HRE-GHIQDAV------DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS-GTSTVPYVPQFKPA  540 (568)
Q Consensus       475 ----~~~-~~~~~~~------d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~-~~~~~p~~p~~~~~  540 (568)
                          |.+ ..+.+.+      .+.++. .........++++..++..||.+|+|+.|++++=- ...|.|..|.+-|.
T Consensus       222 ~~~~WP~~~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~  298 (318)
T KOG0659|consen  222 TPDQWPEMTSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPI  298 (318)
T ss_pred             CcccCccccccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcC
Confidence                000 0000000      111111 22234455688888999999999999999987432 23677776655554

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.4e-39  Score=319.15  Aligned_cols=252  Identities=27%  Similarity=0.477  Sum_probs=201.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|...+.||+|+||.||+|.+.       .+..+|+|.+.... ...++|.+|+.++.+++||||++++++|......+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-------GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY   75 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-------CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence            34677789999999999999875       34569999987543 33467999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++..
T Consensus        76 lv~e~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~  150 (256)
T cd05113          76 IVTEYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV  150 (256)
T ss_pred             EEEEcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceec
Confidence            9999999999999996432  26899999999999999999999   679999999999999999999999999999866


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      ........    ....++..|+|||.+....++.++||||||+++|||++ |+.||.......    ..+..    ..+.
T Consensus       151 ~~~~~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~----~~~~~----~~~~  218 (256)
T cd05113         151 LDDEYTSS----VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE----TVEKV----SQGL  218 (256)
T ss_pred             CCCceeec----CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH----HHHHH----hcCC
Confidence            44321111    12346678999999988889999999999999999998 999987443221    11111    1110


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                               ...........+.+++..||+.+|.+||++.++++.|+
T Consensus       219 ---------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         219 ---------RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                     00111123457788888999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.4e-39  Score=334.49  Aligned_cols=266  Identities=25%  Similarity=0.426  Sum_probs=205.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcC-CCCceeeEEEEEEeC-C
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRL-RHKHLVHLVGWCHEK-G  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-~  317 (568)
                      ++|+..+.||+|+||.||+|....... ..+++.||+|++..... ...+.+..|+.++.++ +|+||++++++|... .
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEK-SASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHhhhhcccccCcCceEEecccccccc-ccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            468888999999999999997653211 12467899999875432 2345688899999999 899999999988754 5


Q ss_pred             eEEEEEEecCCCChhhhhccCCC---------------------------------------------------------
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSE---------------------------------------------------------  340 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~---------------------------------------------------------  340 (568)
                      .++++|||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            78999999999999999854211                                                         


Q ss_pred             -cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCC
Q 008374          341 -QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM  419 (568)
Q Consensus       341 -~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~  419 (568)
                       ...++|..+..++.|++.||.|||   +++|+||||||+|||+++++.+||+|||+++.+.........   ....++.
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~---~~~~~~~  239 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK---GDARLPL  239 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhc---cCCCCCc
Confidence             126899999999999999999999   679999999999999999999999999999876543221111   1345678


Q ss_pred             cccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHH
Q 008374          420 GYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAK  498 (568)
Q Consensus       420 ~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  498 (568)
                      .|+|||++.+..++.++|||||||+++||++ |+.||......+   .+..    ....+         .....+.....
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~---------~~~~~~~~~~~  303 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EFCR----RLKEG---------TRMRAPEYATP  303 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HHHH----HHhcc---------CCCCCCccCCH
Confidence            8999999999999999999999999999998 999987432222   1111    11111         11111122345


Q ss_pred             HHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          499 RLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       499 ~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                      .+.+++.+|++.+|++||++.|+++.|+...
T Consensus       304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            6788899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6.2e-39  Score=322.88  Aligned_cols=263  Identities=25%  Similarity=0.454  Sum_probs=207.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-cchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...+.||+|+||.||+|....... ...+..||||.++..... ..+.|.+|++++++++|+||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEP-ENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccC-cCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            457778899999999999998754211 124678999999765444 457899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCC-----------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc
Q 008374          320 LLVYDFMPNGSLEKYLYGTS-----------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN  388 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~  388 (568)
                      ++||||+++++|.+++....           ....+++.+...++.|++.|+.|||   +++++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence            99999999999999996432           2345889999999999999999999   679999999999999999999


Q ss_pred             EEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhH
Q 008374          389 ARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL  467 (568)
Q Consensus       389 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l  467 (568)
                      +||+|||+++...........   ....++..|+|||++....++.++|||||||++|||++ |+.||.......    .
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~----~  233 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVG---GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE----V  233 (280)
T ss_pred             EEECCcccceecccCcceecC---CCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----H
Confidence            999999999865432211110   13346788999999999999999999999999999998 999986433221    2


Q ss_pred             HHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          468 VDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       468 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      .+...    .+..         ..........+.+++..||+.||.+||++.||++.|++
T Consensus       234 ~~~~~----~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         234 IECIT----QGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHHH----cCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            22111    1111         11112334567788889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.2e-39  Score=333.91  Aligned_cols=242  Identities=24%  Similarity=0.306  Sum_probs=195.3

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVY  323 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  323 (568)
                      +.||+|+||.||+++...      +++.||+|++....   ......+.+|+.++++++||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05571           1 KLLGKGTFGKVILVREKA------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEE
Confidence            369999999999998865      67899999997542   233456789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccc
Q 008374          324 DFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE  403 (568)
Q Consensus       324 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~  403 (568)
                      ||+++|+|.+++..   ...+++.....++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        75 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~  148 (323)
T cd05571          75 EYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD  148 (323)
T ss_pred             eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence            99999999999853   346899999999999999999999   679999999999999999999999999999854322


Q ss_pred             cccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhh
Q 008374          404 RNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDA  483 (568)
Q Consensus       404 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  483 (568)
                      ...     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +....    ..+     
T Consensus       149 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----~~~~~----~~~-----  210 (323)
T cd05571         149 GAT-----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELI----LME-----  210 (323)
T ss_pred             CCc-----ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH----HHHHH----HcC-----
Confidence            111     124579999999999999999999999999999999999999996432211    11111    001     


Q ss_pred             hhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          484 VDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       484 ~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                         ..  ..+......+.+++..|++.||++||     ++.++++
T Consensus       211 ---~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         211 ---EI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             ---CC--CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence               01  11122334566778899999999999     7998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=307.78  Aligned_cols=199  Identities=26%  Similarity=0.422  Sum_probs=179.7

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|+..+.||.|+||+|.+.+.+.      ++.-+|+|++++...   .+.+.-.+|..+|+.+.||+++++.+.|.+.+
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~------~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~  117 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKH------SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS  117 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEcc------CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence            467888999999999999999886      688999999987543   33455678999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .++|||||.++|.|..+|++   ...++.....-++.+|+.||+|||   +.+|++|||||+|||||.+|.+||.|||.|
T Consensus       118 ~lymvmeyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFA  191 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFA  191 (355)
T ss_pred             eEEEEEeccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccce
Confidence            99999999999999999954   456889999999999999999999   779999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIP  459 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~  459 (568)
                      +......  +      +.+||+.|+|||.+++..+..++|.|||||++|||+.|..||....
T Consensus       192 K~v~~rT--~------TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~  245 (355)
T KOG0616|consen  192 KRVSGRT--W------TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN  245 (355)
T ss_pred             EEecCcE--E------EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence            9876541  1      6799999999999999999999999999999999999999997543

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=8e-39  Score=324.59  Aligned_cols=266  Identities=25%  Similarity=0.453  Sum_probs=210.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      .+|...+.||+|+||.||+|+...... ..+...+++|.+........+.+.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSP-TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCC-CCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            357778899999999999998643211 1245679999987766656678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC
Q 008374          321 LVYDFMPNGSLEKYLYGTS-------------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF  387 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~  387 (568)
                      +||||+++++|.+++....             ....+++..++.++.|++.||+|||   +++++||||||+|||++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCC
Confidence            9999999999999996432             1235899999999999999999999   67999999999999999999


Q ss_pred             cEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhh
Q 008374          388 NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYT  466 (568)
Q Consensus       388 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~  466 (568)
                      .+||+|||+++..........   .....++..|+|||++....++.++||||||+++|||+| |+.||.......    
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----  233 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRV---GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----  233 (291)
T ss_pred             cEEECCCCcccccCCCceeec---CCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence            999999999986544321111   113456789999999998999999999999999999998 999986433221    


Q ss_pred             HHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 008374          467 LVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST  530 (568)
Q Consensus       467 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~  530 (568)
                      ..+    ....+...         .........+.+++.+|++.+|.+|||+++|+++|+....
T Consensus       234 ~~~----~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         234 VIE----CITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHH----HHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            111    11111111         1112234567788999999999999999999999988633

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.9e-39  Score=322.71  Aligned_cols=262  Identities=24%  Similarity=0.362  Sum_probs=201.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|+..+.||+|+||.||+|++..++..  ....+++|.+..... ....++..|+.++++++||||+++++++. ....
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~   83 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDS--IKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL   83 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCc--eeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence            3567788999999999999998643211  123588888864432 23467888899999999999999999885 4567


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++++||+++|+|.+++...  ...+++.....++.|++.||.|||   +++++||||||+|||+++++.+||+|||+++.
T Consensus        84 ~~i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            8999999999999999643  246899999999999999999999   67999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      .........   .....++..|+|||.+.++.++.++||||||+++||+++ |+.|+.......    +.+.+    ..+
T Consensus       159 ~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----~~~~~----~~~  227 (279)
T cd05111         159 LYPDDKKYF---YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE----VPDLL----EKG  227 (279)
T ss_pred             ccCCCcccc---cCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHH----HCC
Confidence            644322111   124557789999999998999999999999999999998 999987542221    11111    111


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST  530 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~  530 (568)
                      ...         .........+..++..|++.||++|||+.|+++.|.....
T Consensus       228 ~~~---------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         228 ERL---------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            100         0011123356778889999999999999999999987543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.1e-38  Score=319.02  Aligned_cols=262  Identities=27%  Similarity=0.491  Sum_probs=207.0

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .++|...+.||+|+||.||+|+....+.   ....+|+|.+.... ....+++..|++++++++|+|++++++++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGR---KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCC---CceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            3467888999999999999999874321   24579999987542 3345679999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++++|.+++...  ...+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++.
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~  155 (268)
T cd05063          81 AMIITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSR  155 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccce
Confidence            99999999999999999543  246899999999999999999999   6799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ...........  ......+..|+|||++....++.++|||||||++|||++ |+.||.......       +....   
T Consensus       156 ~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i---  223 (268)
T cd05063         156 VLEDDPEGTYT--TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAI---  223 (268)
T ss_pred             eccccccccee--ccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHH---
Confidence            76543221111  012223567999999988889999999999999999997 999986432211       11111   


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                             ..........+....+.+++.+|++.+|++||++.+|++.|++.
T Consensus       224 -------~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         224 -------NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -------hcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                   11111122223456678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-39  Score=330.36  Aligned_cols=242  Identities=22%  Similarity=0.225  Sum_probs=192.9

Q ss_pred             eccCCceeEEEEEEccCccccccCeEEEEEEeccC---CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 008374          249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD---SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       249 LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      ||+|+||.||+++...      +++.||+|.+...   .......+.+|+.++.+++||||+++++++...+..++||||
T Consensus         1 lg~G~~g~Vy~~~~~~------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   74 (312)
T cd05585           1 IGKGSFGKVMQVRKRD------TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAF   74 (312)
T ss_pred             CCcCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcC
Confidence            7999999999999864      6788999998653   233456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccc
Q 008374          326 MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN  405 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~  405 (568)
                      +++|+|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.......
T Consensus        75 ~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  148 (312)
T cd05585          75 INGGELFHHLQR---EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD  148 (312)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC
Confidence            999999999954   346899999999999999999999   67999999999999999999999999999986433221


Q ss_pred             cccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhh
Q 008374          406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVD  485 (568)
Q Consensus       406 ~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  485 (568)
                      .     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......       .....         ..
T Consensus       149 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~-------~~~~~---------~~  207 (312)
T cd05585         149 K-----TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE-------MYRKI---------LQ  207 (312)
T ss_pred             c-----cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH-------HHHHH---------Hc
Confidence            1     124579999999999999999999999999999999999999997432211       11111         11


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 008374          486 QRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII  525 (568)
Q Consensus       486 ~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L  525 (568)
                      ..+  ..+......+.+++..|++.||.+||+..++.+.|
T Consensus       208 ~~~--~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         208 EPL--RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             CCC--CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            111  11122234566777899999999998654444444

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9.7e-39  Score=316.52  Aligned_cols=250  Identities=26%  Similarity=0.431  Sum_probs=198.6

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      ++||+|+||.||+|+...      +++.+|+|.+.... ......|.+|++++++++||||++++++|...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   74 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL   74 (252)
T ss_pred             CccCcccCccEEEEEEec------CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEee
Confidence            369999999999999875      67889999886542 33456799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccc
Q 008374          326 MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN  405 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~  405 (568)
                      +++++|.+++...  ...+++..+..++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++.......
T Consensus        75 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  149 (252)
T cd05084          75 VQGGDFLTFLRTE--GPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY  149 (252)
T ss_pred             ccCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccc
Confidence            9999999998542  235889999999999999999999   67999999999999999999999999999986543211


Q ss_pred             cccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCchhhhh
Q 008374          406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV  484 (568)
Q Consensus       406 ~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  484 (568)
                      ....   ....++..|+|||.+..+.++.++||||||+++|||++ |..|+.......    ..             ..+
T Consensus       150 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~----~~-------------~~~  209 (252)
T cd05084         150 ASTG---GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ----TR-------------EAI  209 (252)
T ss_pred             cccC---CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH----HH-------------HHH
Confidence            1100   01223467999999999999999999999999999998 888886432211    11             111


Q ss_pred             hhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       485 d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      ...............+.+++.+|++.+|++|||+.+|+++|+.
T Consensus       210 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         210 EQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             HcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            1111112222334567888889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-39  Score=318.07  Aligned_cols=251  Identities=26%  Similarity=0.475  Sum_probs=200.5

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLL  321 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  321 (568)
                      +|...+.||+|+||.||+|.++       .+..+|+|.+.... ....+|.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-------~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-------GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI   76 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-------CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence            4677889999999999999875       35679999986432 234578899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccc
Q 008374          322 VYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE  401 (568)
Q Consensus       322 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~  401 (568)
                      ||||+++++|.+++....  ..+++..+..++.|++.||+|||   +++++||||||+||++++++.+||+|||+++...
T Consensus        77 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~  151 (256)
T cd05059          77 VTEYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL  151 (256)
T ss_pred             EEecCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecc
Confidence            999999999999996432  36899999999999999999999   6799999999999999999999999999998664


Q ss_pred             cccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          402 NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       402 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      .......    ....++..|+|||.+....++.++||||||+++|||++ |+.||.......    .....         
T Consensus       152 ~~~~~~~----~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~---------  214 (256)
T cd05059         152 DDQYTSS----QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE----VVESV---------  214 (256)
T ss_pred             ccccccc----CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH----HHHHH---------
Confidence            3221111    12234568999999998999999999999999999999 888987443221    11110         


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                          ...............+.+++.+|++.+|++|||+.|+++.|.
T Consensus       215 ----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         215 ----SAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             ----HcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence                111111112224557888999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.6e-39  Score=346.53  Aligned_cols=254  Identities=18%  Similarity=0.244  Sum_probs=202.5

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLL  321 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  321 (568)
                      .|...+.||+|+||.||+|....+     .+..||+|.+..........+.+|+.+++.++||||++++++|...+.++|
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~-----~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSD-----PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCC-----CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence            388889999999999999987541     267889998766555555678889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhccC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          322 VYDFMPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       322 V~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      ||||+++|+|.++|... .....+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            99999999999988642 22446889999999999999999999   679999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      ........   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +..   ... .+..
T Consensus       220 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~----~~~---~~~-~~~~  288 (478)
T PTZ00267        220 SDSVSLDV---ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE----IMQ---QVL-YGKY  288 (478)
T ss_pred             CCcccccc---ccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH---HHH-hCCC
Confidence            54321111   124579999999999999999999999999999999999999987432211    111   110 0110


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                          +     .........+..++..|++.||++||++.++++
T Consensus       289 ----~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 ----D-----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ----C-----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                0     111122345677888999999999999999864

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=9e-39  Score=333.51  Aligned_cols=248  Identities=22%  Similarity=0.376  Sum_probs=192.0

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      +|...++||+|+||.||+|+...      +++.||||.+..... ...+.+.+|++++++++|+||+++++++...+.++
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  148 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRP------TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ  148 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECC------CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence            34556789999999999998864      678999999865432 33467899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++|+|....       .+.+..+..++.||+.||.|||   +++|+||||||+|||+++++.+||+|||+++.+
T Consensus       149 lv~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~  218 (353)
T PLN00034        149 VLLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL  218 (353)
T ss_pred             EEEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence            999999999986543       3456778889999999999999   679999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHT-----GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      ......     .....||..|+|||.+..     ...+.++|||||||++|||++|+.||.......       |.....
T Consensus       219 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-------~~~~~~  286 (353)
T PLN00034        219 AQTMDP-----CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-------WASLMC  286 (353)
T ss_pred             cccccc-----ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-------HHHHHH
Confidence            543211     114579999999998743     223468999999999999999999997322211       111000


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                      .       +...............+.+++..||+.||++|||+.|+++.
T Consensus       287 ~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        287 A-------ICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             H-------HhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0       00000011112334467788889999999999999999873

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.3e-38  Score=316.93  Aligned_cols=250  Identities=26%  Similarity=0.433  Sum_probs=197.0

Q ss_pred             eeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 008374          248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       248 ~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      +||+|+||.||+|.++..    .++..+|+|+++....  ...+++..|+.++++++||||+++++++. .+..++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMK----KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEecC----CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEec
Confidence            589999999999987532    1567899999865432  23567899999999999999999999985 4567999999


Q ss_pred             cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccc
Q 008374          326 MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN  405 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~  405 (568)
                      +++|+|.+++..   ...+++.....++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++.......
T Consensus        77 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~  150 (257)
T cd05116          77 AELGPLNKFLQK---NKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN  150 (257)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCC
Confidence            999999999953   346889999999999999999999   67999999999999999999999999999987654432


Q ss_pred             cccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCchhhhh
Q 008374          406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV  484 (568)
Q Consensus       406 ~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  484 (568)
                      ....  .....++..|+|||.+....++.++||||||+++|||++ |+.||.......    +.+.+    ..+      
T Consensus       151 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~i----~~~------  214 (257)
T cd05116         151 YYKA--KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE----VTQMI----ESG------  214 (257)
T ss_pred             eeee--cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH----HCC------
Confidence            2111  112334678999999988889999999999999999998 999987542221    11111    111      


Q ss_pred             hhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       485 d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                         .....+......+.+++.+|++.||++||++++|++.|++
T Consensus       215 ---~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         215 ---ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence               1111122234556778889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.5e-39  Score=333.26  Aligned_cols=247  Identities=23%  Similarity=0.307  Sum_probs=198.7

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|...+.||+|+||.||+|+....     ....||+|++....   ....+.+.+|+.++..++||||+++++++.+.
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNE-----DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECC-----CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence            34688899999999999999987642     24689999986532   23345688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +..++||||+++|+|.+++..   ...+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~  177 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGF  177 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCC
Confidence            999999999999999999953   346889999999999999999999   67999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ++......        ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    .    .....
T Consensus       178 a~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~----~~~i~  241 (340)
T PTZ00426        178 AKVVDTRT--------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL----I----YQKIL  241 (340)
T ss_pred             CeecCCCc--------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH----H----HHHHh
Confidence            98764321        14579999999999998889999999999999999999999997432211    1    11111


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                      .+.        ..  .+......+..++..|++.||++|+     +++++++
T Consensus       242 ~~~--------~~--~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        242 EGI--------IY--FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             cCC--------CC--CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            111        10  1111223456677799999999995     8998876

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-39  Score=321.88  Aligned_cols=272  Identities=22%  Similarity=0.317  Sum_probs=207.4

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhc--CCCCceeeEEEEEEeC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHR--LRHKHLVHLVGWCHEK  316 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~  316 (568)
                      ...+....+.||+|.||+||+|.|+        |+.||||++...   +.+.+.+|.++...  |+|+||+.+++.-..+
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr--------Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR--------GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc--------CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            3456677788999999999999996        788999999643   45567888888775  4999999999876554


Q ss_pred             C----eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCEEEcCCC
Q 008374          317 G----KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY-----DQKVVHRDLKASNILLDADF  387 (568)
Q Consensus       317 ~----~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDikp~NILld~~~  387 (568)
                      +    .++||.+|.++|||.+||..    .+++-...++++..+|.||++||.+.     .+.|+|||||+.|||+..++
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~  353 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  353 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence            3    79999999999999999943    57999999999999999999999653     56799999999999999999


Q ss_pred             cEEEeecCCccccccccccccccccccCCcCCcccCccccccCC----C--CccchhHHHHHHHHHHHhCC---------
Q 008374          388 NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK----A--TPESDVFGFGAVVLEVVCGR---------  452 (568)
Q Consensus       388 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~----~--t~~sDV~SfGvll~el~tG~---------  452 (568)
                      .+.|+|+|||-......... ....+..+||.+|||||++...-    +  -..+||||||.++||++...         
T Consensus       354 ~C~IADLGLAv~h~~~t~~i-di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey  432 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTI-DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY  432 (513)
T ss_pred             cEEEeeceeeEEecccCCcc-cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence            99999999998877664322 22334668999999999985431    2  23689999999999998732         


Q ss_pred             -CCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC
Q 008374          453 -SPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTV  531 (568)
Q Consensus       453 -~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~  531 (568)
                       .||...-..+.  +. +-........++...++.++.   ..+.+..+.+++..||..||..|-|+-.+-+.|.+....
T Consensus       433 ~~Pyyd~Vp~DP--s~-eeMrkVVCv~~~RP~ipnrW~---s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  433 QLPYYDVVPSDP--SF-EEMRKVVCVQKLRPNIPNRWK---SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             cCCcccCCCCCC--CH-HHHhcceeecccCCCCCcccc---cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence             35543222110  11 111112222233333333332   347788899999999999999999999999988877655


Q ss_pred             C
Q 008374          532 P  532 (568)
Q Consensus       532 p  532 (568)
                      +
T Consensus       507 ~  507 (513)
T KOG2052|consen  507 D  507 (513)
T ss_pred             h
Confidence            4

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.1e-39  Score=324.92  Aligned_cols=267  Identities=27%  Similarity=0.457  Sum_probs=209.6

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcC-CCCceeeEEEEEEe
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHE  315 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~  315 (568)
                      ...++|...+.||+|+||.||++....... ......+|+|.+.... .+...++.+|++++.++ +|+||++++++|..
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~-~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDN-PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCC-CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            344568888999999999999998864221 1245789999987542 23446788999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccC-------------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGT-------------SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL  382 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIL  382 (568)
                      .+..+++|||+++|+|..++...             .....+++..++.++.|++.||.|||   +.+++||||||+|||
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEE
Confidence            99999999999999999998642             12346899999999999999999999   679999999999999


Q ss_pred             EcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 008374          383 LDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQ  461 (568)
Q Consensus       383 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~  461 (568)
                      ++.++.+||+|||+++.+.........   ....++..|+|||.+.+..++.++|||||||++|||++ |..|+......
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  241 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKT---TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  241 (293)
T ss_pred             EcCCCeEEeCccccccccccccceecc---CCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence            999999999999999876543221111   12345678999999988899999999999999999998 99898643322


Q ss_pred             cchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          462 QHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       462 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      .    +.+             .+...............+.+++..|++.||++|||+.|+++.|+..
T Consensus       242 ~----~~~-------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         242 E----LFK-------------LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             H----HHH-------------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            1    111             1111111122223455778899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.3e-38  Score=322.63  Aligned_cols=265  Identities=26%  Similarity=0.433  Sum_probs=208.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      .+|...+.||+|+||+||++...... ...++..+|+|.+........+.+.+|++++.+++||||++++++|...+..+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~-~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLC-PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCC-CCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            46788889999999999999864311 01145679999997766556678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCC----------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEE
Q 008374          321 LVYDFMPNGSLEKYLYGTS----------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR  390 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~k  390 (568)
                      +||||+++++|.+++....          ....+++.++..++.|++.||+|||   +++++||||||+|||+++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence            9999999999999986422          1235899999999999999999999   67999999999999999999999


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHH
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~  469 (568)
                      |+|||+++..........   .....++..|+|||.+....++.++|||||||+++||++ |+.||.......    ..+
T Consensus       161 l~dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~----~~~  233 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRV---GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE----VIE  233 (288)
T ss_pred             eccCCccccccCCceeec---CCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH
Confidence            999999986643321111   113346788999999988899999999999999999998 898986443221    111


Q ss_pred             HHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          470 WVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       470 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                      .    ...+....         ........+.+++.+|++.||.+|||+.+|.+.|+...
T Consensus       234 ~----i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         234 C----ITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             H----HHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            1    11111100         01122345788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2e-38  Score=328.31  Aligned_cols=199  Identities=25%  Similarity=0.394  Sum_probs=174.0

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|+..++||+|+||.||++....      ++..+|+|.+.... ......+.+|++++++++||||++++++|...+..
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKP------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI   78 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECC------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEE
Confidence            678889999999999999998874      67889999887542 23346789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++|+|.+++..   ...+++.....++.+++.||.|||+  ..+++||||||+|||++.++.+||+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  153 (333)
T cd06650          79 SICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (333)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence            999999999999999953   3458889999999999999999994  24799999999999999999999999999976


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNM  457 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~  457 (568)
                      ......       ....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       154 ~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         154 LIDSMA-------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             hhhhcc-------ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            543211       145689999999999988899999999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.6e-38  Score=320.74  Aligned_cols=272  Identities=25%  Similarity=0.385  Sum_probs=204.9

Q ss_pred             cccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeC--CeEE
Q 008374          244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEK--GKLL  320 (568)
Q Consensus       244 ~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~  320 (568)
                      ...+.||+|+||+||++......  ..++..||+|.+..... .....|.+|++++++++||||++++++|...  ...+
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPAN--DGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             eeceecccCCCcEEEEeeEcccc--CCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            67788999999999988754211  12577899999876432 3456788999999999999999999998754  4689


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++++|.+++..    ..+++.++..++.|++.||.|||   +++++||||||+|||+++++.+||+|||+++..
T Consensus        85 lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          85 LIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            99999999999999943    35899999999999999999999   679999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      .........  .....++..|+|||.+....++.++||||||++++||++|+.|+.......  .....+.........+
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~  233 (283)
T cd05080         158 PEGHEYYRV--REDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQGQMTVVRL  233 (283)
T ss_pred             CCcchhhcc--CCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcccccccchhhh
Confidence            543221110  012345677999999988889999999999999999999999986432211  0111111100011112


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      .+.++..............+..++..|++++|++|||+++|+++|+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            222222222222333456788889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.6e-38  Score=322.10  Aligned_cols=263  Identities=26%  Similarity=0.429  Sum_probs=205.5

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      +|...+.||+|+||.||+|+.....+. .....+++|.+..... ....++.+|+.+++.++||||+++++.|...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGR-AGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCC-CcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            366778999999999999987532211 1345789998875432 33567899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCC---------------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 008374          321 LVYDFMPNGSLEKYLYGTS---------------------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKAS  379 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~  379 (568)
                      +|+||+++++|.+++....                     ....+++..++.++.|++.||.|||   +.+++||||||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~  156 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAAR  156 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhh
Confidence            9999999999999985421                     1235889999999999999999999   679999999999


Q ss_pred             CEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 008374          380 NILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMI  458 (568)
Q Consensus       380 NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~  458 (568)
                      |||+++++.+||+|||+++...........   ....++..|+|||.+.+..++.++||||||++++||++ |+.||...
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~---~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKR---SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcc---cCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            999999999999999999876433221111   13346778999999988889999999999999999998 99998643


Q ss_pred             CcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          459 PHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       459 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ....    +.+    ..         ...............+.+++..|++.+|++||++.|+++.|++.
T Consensus       234 ~~~~----~~~----~~---------~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         234 APER----LFN----LL---------KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             CHHH----HHH----HH---------hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence            2211    111    11         11111122223345678889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=338.92  Aligned_cols=253  Identities=27%  Similarity=0.409  Sum_probs=217.1

Q ss_pred             cccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-cchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEE
Q 008374          244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       244 ~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      ...++||+|.||.|++|.|....+   +...||||.+..+... ...+|++|+.+|.+|+|||+++|+|...+ ....||
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psg---k~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSG---KHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCC---cEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            345689999999999999986332   5578999999877654 67899999999999999999999999987 788999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      +|+++.|||.+.|++ ..+..|-......++.|||.||.||.   .+++|||||.++|+||-....+||+||||.|.+..
T Consensus       189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            999999999999987 45567888889999999999999999   78999999999999999999999999999999987


Q ss_pred             ccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCchh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQ  481 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  481 (568)
                      +...+.....  ..-...|.|||.+..+.++.++|||+|||++|||++ |..||-+....+                 ++
T Consensus       265 ned~Yvm~p~--rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-----------------IL  325 (1039)
T KOG0199|consen  265 NEDMYVMAPQ--RKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-----------------IL  325 (1039)
T ss_pred             CCcceEecCC--CcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-----------------HH
Confidence            7666543222  223478999999999999999999999999999999 778887543322                 34


Q ss_pred             hhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          482 DAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       482 ~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      +.+|++-+...+..+.++++++++.||.++|++|||+..+.+
T Consensus       326 ~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  326 KNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             HhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            556666666677789999999999999999999999999974

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7.3e-39  Score=330.10  Aligned_cols=242  Identities=22%  Similarity=0.305  Sum_probs=194.2

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVY  323 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  323 (568)
                      +.||+|+||.||++....      ++..||+|.+....   ......+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05595           1 KLLGKGTFGKVILVREKA------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEE
Confidence            369999999999998764      67899999997542   233456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccc
Q 008374          324 DFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE  403 (568)
Q Consensus       324 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~  403 (568)
                      ||+++|+|..++..   ...+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        75 E~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  148 (323)
T cd05595          75 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  148 (323)
T ss_pred             eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence            99999999998843   346899999999999999999999   679999999999999999999999999998754322


Q ss_pred             cccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhh
Q 008374          404 RNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDA  483 (568)
Q Consensus       404 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  483 (568)
                      ...     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +...            +
T Consensus       149 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----~~~~------------~  207 (323)
T cd05595         149 GAT-----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFEL------------I  207 (323)
T ss_pred             CCc-----cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH----HHHH------------H
Confidence            111     114579999999999999999999999999999999999999987432221    1110            0


Q ss_pred             hhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          484 VDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       484 ~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                      ......  .+......+.+++..|++.||.+||     ++.++++
T Consensus       208 ~~~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         208 LMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             hcCCCC--CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            001110  1112234556777799999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2e-38  Score=317.54  Aligned_cols=262  Identities=26%  Similarity=0.453  Sum_probs=205.1

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      .|...+.||+|+||.||+|.+...+.   ....||||.+... ......+|..|+.++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGK---REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCC---CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            46778899999999999999875321   2357999998764 3344568999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++++|.+++...  ...+++.++..++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++..
T Consensus        82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          82 IITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             EEEecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence            999999999999999643  245899999999999999999999   679999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      .................+..|+|||++....++.++||||||+++||+++ |..||......    ...+++..      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~----~~~~~i~~------  226 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----DVINAIEQ------  226 (269)
T ss_pred             ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH----HHHHHHHc------
Confidence            54322111100001112457999999999999999999999999999886 99998643221    22222210      


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                             ........+.+..+.+++..|++.+|.+||++++|++.|++.
T Consensus       227 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         227 -------DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -------CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                   011111223345677888899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.9e-38  Score=322.87  Aligned_cols=261  Identities=25%  Similarity=0.420  Sum_probs=202.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  318 (568)
                      ++|...+.||+|+||.||+|+...++    ....+++|.++.. .....+.|.+|++++.++ +||||+++++++...+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDG----LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCC----CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            46788899999999999999886521    1245788888743 233456789999999999 79999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC
Q 008374          319 LLLVYDFMPNGSLEKYLYGTS-------------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA  385 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~  385 (568)
                      .++|+||+++++|.+++....             ....+++..+..++.|++.||+|||   +.+++||||||+|||+++
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~  154 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGE  154 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECC
Confidence            999999999999999996432             1135889999999999999999999   679999999999999999


Q ss_pred             CCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccch
Q 008374          386 DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHA  464 (568)
Q Consensus       386 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~  464 (568)
                      ++.+||+|||++.........      .....+..|+|||++....++.++|||||||++|||++ |+.||.......  
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--  226 (297)
T cd05089         155 NLASKIADFGLSRGEEVYVKK------TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--  226 (297)
T ss_pred             CCeEEECCcCCCccccceecc------CCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence            999999999998753321111      01223567999999988889999999999999999997 999987443221  


Q ss_pred             hhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC
Q 008374          465 YTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTV  531 (568)
Q Consensus       465 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~  531 (568)
                        +.+             .+...............+.+++..|++.+|.+|||+.++++.|+.....
T Consensus       227 --~~~-------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         227 --LYE-------------KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             --HHH-------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence              111             0111111111222335677888899999999999999999998765443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.9e-38  Score=315.49  Aligned_cols=253  Identities=28%  Similarity=0.459  Sum_probs=202.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|...++||+|+||.||+|++.       ....||+|+++... ...++|.+|++++++++||||+++++.+. ....+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-------~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY   76 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEec-------CCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence            45888899999999999999875       34569999987533 23457899999999999999999999875 45689


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++|+|.+++.... ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++..
T Consensus        77 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~  152 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI  152 (262)
T ss_pred             EEEEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeec
Confidence            9999999999999996432 345799999999999999999999   679999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      ........    ....++..|+|||+.....++.++||||||+++|||++ |+.||.......    +.    ...    
T Consensus       153 ~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~----~~----~~~----  216 (262)
T cd05071         153 EDNEYTAR----QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VL----DQV----  216 (262)
T ss_pred             cccccccc----cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH----HH----HHH----
Confidence            54322111    13456778999999988899999999999999999999 888886443221    11    101    


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                           ..........+....+.+++..|++.+|++||++.+++++|+.
T Consensus       217 -----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         217 -----ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             -----hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence                 1111111223455677899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-38  Score=316.40  Aligned_cols=260  Identities=25%  Similarity=0.436  Sum_probs=203.0

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe--
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK--  318 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~--  318 (568)
                      |...+.||+|+||.||+|++..+..   .+..||+|+++...  ......+.+|++.++.++||||+++++++.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDG---SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCC---CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            4567789999999999999864321   35789999987542  2334678999999999999999999999876554  


Q ss_pred             ----EEEEEEecCCCChhhhhccCC---CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 008374          319 ----LLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL  391 (568)
Q Consensus       319 ----~~lV~Ey~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL  391 (568)
                          .++++||+++|+|..++....   ....+++.....++.|++.||.|||   +++++||||||+||++++++.+||
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl  154 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCV  154 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEE
Confidence                799999999999999985432   2346899999999999999999999   679999999999999999999999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHH
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~  470 (568)
                      +|||+++...........   ....++..|+|||.+....++.++||||||+++|||++ |..||.......    +.++
T Consensus       155 ~dfg~~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~----~~~~  227 (273)
T cd05035         155 ADFGLSKKIYSGDYYRQG---RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE----IYDY  227 (273)
T ss_pred             CCccceeecccccccccc---ccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH
Confidence            999999876543221111   12345678999999988889999999999999999999 888886533221    2222


Q ss_pred             HHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          471 VWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       471 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ..    .+.         ...........+.+++.+|++.||++|||+.||++.|+..
T Consensus       228 ~~----~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         228 LR----HGN---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HH----cCC---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11    111         1111223445678888899999999999999999999763

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.7e-38  Score=315.01  Aligned_cols=253  Identities=29%  Similarity=0.483  Sum_probs=201.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|...++||+|+||.||+|...       .+..+|+|.+..... ..+.|.+|+.++++++|+|++++++++. .+..+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-------~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-------GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY   76 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-------CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence            45777889999999999999876       456799999876433 3467999999999999999999999885 45689


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      ++|||+++++|.+++.... ...+++.++..++.+++.||.|||   +.+++||||||+||++++++.+||+|||++...
T Consensus        77 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~  152 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLI  152 (260)
T ss_pred             EEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence            9999999999999996532 345899999999999999999999   579999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      ........    ....++..|+|||.+....++.++||||||++++||++ |+.||.......    ..+.         
T Consensus       153 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~----~~~~---------  215 (260)
T cd05070         153 EDNEYTAR----QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE----VLEQ---------  215 (260)
T ss_pred             cCcccccc----cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----HHHH---------
Confidence            44321111    12345678999999988889999999999999999999 888986432221    1111         


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                          +..........+....+.+++.+|++++|++|||++++.+.|+.
T Consensus       216 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         216 ----VERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ----HHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                11111112223344568889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=9.2e-39  Score=330.08  Aligned_cols=242  Identities=24%  Similarity=0.324  Sum_probs=194.9

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVY  323 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  323 (568)
                      +.||+|+||.||++....      ++..||+|.+....   ......+.+|+.+++.++||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   74 (328)
T cd05593           1 KLLGKGTFGKVILVREKA------SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVM   74 (328)
T ss_pred             CeeeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEE
Confidence            369999999999998865      67899999997542   234467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccc
Q 008374          324 DFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE  403 (568)
Q Consensus       324 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~  403 (568)
                      ||+++|+|..++..   ...+++.+...++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        75 Ey~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~  148 (328)
T cd05593          75 EYVNGGELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD  148 (328)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence            99999999998853   346899999999999999999999   679999999999999999999999999999864332


Q ss_pred             cccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhh
Q 008374          404 RNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDA  483 (568)
Q Consensus       404 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  483 (568)
                      ...     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +...   .. .+     
T Consensus       149 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~----~~~~---~~-~~-----  210 (328)
T cd05593         149 AAT-----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFEL---IL-ME-----  210 (328)
T ss_pred             ccc-----cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH----HHHH---hc-cC-----
Confidence            111     124579999999999998899999999999999999999999997432211    1110   00 00     


Q ss_pred             hhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          484 VDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       484 ~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                       +..+    +......+.+++..|++.||.+||     ++.|+++
T Consensus       211 -~~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         211 -DIKF----PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             -CccC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence             0111    112234566777799999999997     8999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.9e-38  Score=335.49  Aligned_cols=268  Identities=24%  Similarity=0.394  Sum_probs=207.8

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCC-CCceeeEEEEEEe
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLR-HKHLVHLVGWCHE  315 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~  315 (568)
                      ...++|...++||+|+||.||+|++.... ....+..||+|++..... ...+.+.+|++++.++. ||||++++++|..
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~-~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLS-HSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCC-CCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            34456778889999999999999976321 112467899999976432 23457889999999997 9999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCC--------------------------------------------------------
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTS--------------------------------------------------------  339 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~--------------------------------------------------------  339 (568)
                      .+..++|+||+++|+|.++++...                                                        
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            999999999999999999996431                                                        


Q ss_pred             ---------------------------------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 008374          340 ---------------------------------------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASN  380 (568)
Q Consensus       340 ---------------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~N  380 (568)
                                                             ....+++.....++.|++.||.|||   +++++||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcce
Confidence                                                   1124788889999999999999999   6799999999999


Q ss_pred             EEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 008374          381 ILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIP  459 (568)
Q Consensus       381 ILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~  459 (568)
                      ||+++++.+||+|||+++..........   .....++..|+|||.+....++.++||||||+++|||++ |+.|+....
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             EEEeCCCEEEEEecCcceeccccccccc---CCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999987643322111   113457889999999988889999999999999999998 888986543


Q ss_pred             cccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          460 HQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       460 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ...   .+.    .....+         .....+......+.+++..||+.+|.+||+++||++.|++.
T Consensus       347 ~~~---~~~----~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         347 MNE---QFY----NAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             chH---HHH----HHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            222   111    111111         11111122345677788899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.6e-38  Score=315.04  Aligned_cols=260  Identities=23%  Similarity=0.345  Sum_probs=207.5

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC---CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD---SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...++||+|+||.||+|+...      ++..||||.+...   .......+.+|++++++++||||+++++++...+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLL------DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN   75 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeC------CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence            468889999999999999999875      6789999987642   2233457889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTS-EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      ..++|+||+++++|.+++.... ....++......++.|++.||.|||   +++++|+||||+||+++.++.++|+|||+
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~  152 (267)
T cd08228          76 ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGL  152 (267)
T ss_pred             eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECcccc
Confidence            9999999999999999885322 2345788999999999999999999   67999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      +..........     ....|+..|+|||.+.+..++.++|+||||+++|||++|+.|+......     ..++.... .
T Consensus       153 ~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-----~~~~~~~~-~  221 (267)
T cd08228         153 GRFFSSKTTAA-----HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LFSLCQKI-E  221 (267)
T ss_pred             ceeccchhHHH-----hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-----HHHHHHHH-h
Confidence            98765432211     1346889999999998888999999999999999999999998633211     11111111 0


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ..        .............+.+++.+||+.+|++||++.+|++.|++.
T Consensus       222 ~~--------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         222 QC--------DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             cC--------CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            00        001111223445678888899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.7e-38  Score=320.51  Aligned_cols=262  Identities=24%  Similarity=0.392  Sum_probs=204.0

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-cchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      +|...++||+|+||.||+|....... ...+..||+|+++..... ..+.|.+|+.++.+++||||+++++++...+..+
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAP-GEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCC-CCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            35667789999999999998764211 114578999999765332 2456889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccC-------------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC
Q 008374          321 LVYDFMPNGSLEKYLYGT-------------SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF  387 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~  387 (568)
                      +++||+++++|.+++...             ..+..+++..+..++.|++.||.|||   +.+++||||||+|||+++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence            999999999999998532             11235889999999999999999999   67999999999999999999


Q ss_pred             cEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhh
Q 008374          388 NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYT  466 (568)
Q Consensus       388 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~  466 (568)
                      .+||+|||+++..........   .....+++.|+|||.+..+.++.++||||||+++|||++ |..|+.......    
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----  234 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKL---MGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD----  234 (283)
T ss_pred             ceEecccccccccccchheee---ccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH----
Confidence            999999999987643322111   113446789999999988899999999999999999998 888876432221    


Q ss_pred             HHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          467 LVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       467 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      +.+.    ...+.         ......+....+..++..|++.+|.+||++++|++.|+.
T Consensus       235 ~~~~----i~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         235 VIEM----IRNRQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHH----HHcCC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1111    11111         111223345567788899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.4e-38  Score=321.15  Aligned_cols=264  Identities=20%  Similarity=0.315  Sum_probs=197.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .++|...++||+|+||.||+|+...      +++.||||.+..... .....+.+|+.++++++||||+++++++.....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKV------NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECC------CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCe
Confidence            4678899999999999999999864      678999999875432 233467889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||++ ++|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||+++++.+||+|||+++
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  151 (303)
T cd07869          78 LTLVFEYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR  151 (303)
T ss_pred             EEEEEECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcce
Confidence            999999995 6888877542  245888999999999999999999   6799999999999999999999999999997


Q ss_pred             ccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      .........     ....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......   ...+........
T Consensus       152 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~  223 (303)
T cd07869         152 AKSVPSHTY-----SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ---DQLERIFLVLGT  223 (303)
T ss_pred             eccCCCccC-----CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH---HHHHHHHHHhCC
Confidence            654322111     14568999999998865 457889999999999999999999997543321   111111111000


Q ss_pred             C---chh------hhhhhhcC--CCCcH-------HHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 G---HIQ------DAVDQRLN--INSVV-------DEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~---~~~------~~~d~~l~--~~~~~-------~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .   ...      .....++.  .....       .....+.+++..|++.||++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         224 PNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             CChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0   000      00000000  00000       01234567778999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.5e-38  Score=326.44  Aligned_cols=263  Identities=24%  Similarity=0.334  Sum_probs=195.8

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeC---
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK---  316 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~---  316 (568)
                      +|...++||+|+||.||+|+...      ++..||||++...  .......+.+|++++++++||||+++++++...   
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   74 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTH------TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR   74 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECC------CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence            46778899999999999999875      6789999998653  223345688999999999999999999988643   


Q ss_pred             --CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 008374          317 --GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDF  394 (568)
Q Consensus       317 --~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DF  394 (568)
                        ..+++|||||. ++|.+++..   ...+++..+..++.|+++||.|||   +++|+||||||+|||++.++.+||+||
T Consensus        75 ~~~~~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Df  147 (338)
T cd07859          75 EFKDIYVVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDF  147 (338)
T ss_pred             CCceEEEEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccC
Confidence              35899999995 689888843   346899999999999999999999   679999999999999999999999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT--GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      |+++.........  .......||..|+|||++.+  ..++.++|||||||++|||++|+.||.......    ....+.
T Consensus       148 g~~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~----~~~~~~  221 (338)
T cd07859         148 GLARVAFNDTPTA--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH----QLDLIT  221 (338)
T ss_pred             ccccccccccCcc--ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH----HHHHHH
Confidence            9998654322111  11124578999999999865  678999999999999999999999997433211    111111


Q ss_pred             HHh-----------hcCchhhhh---hhhcCCCCc---HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          473 MLH-----------REGHIQDAV---DQRLNINSV---VDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       473 ~~~-----------~~~~~~~~~---d~~l~~~~~---~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ...           ......+.+   .+.......   ......+.+++..|++.||++|||++|+++
T Consensus       222 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         222 DLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            100           000000111   000000000   012345678888999999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-39  Score=321.14  Aligned_cols=260  Identities=22%  Similarity=0.312  Sum_probs=208.7

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc--------------cchhhHHHHHHhhcCCC
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK--------------SKGDFLAELAIIHRLRH  303 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~H  303 (568)
                      +..++|.....||+|.||.|-+|+...      +++.||||++.+....              ..+...+|+.+|++++|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~------~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H  167 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEV------DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH  167 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecC------CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence            445779999999999999999999875      7899999998653111              12467899999999999


Q ss_pred             CceeeEEEEEEeC--CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 008374          304 KHLVHLVGWCHEK--GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNI  381 (568)
Q Consensus       304 ~nIv~l~g~~~~~--~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NI  381 (568)
                      ||||+|+.+..+.  +.+|||+|||..|.+...-   .....|+..+..+++.++..||.|||   .++|+||||||+|+
T Consensus       168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNL  241 (576)
T KOG0585|consen  168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNL  241 (576)
T ss_pred             cCeeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhhe
Confidence            9999999998754  6899999999988775443   22233999999999999999999999   68999999999999


Q ss_pred             EEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCC
Q 008374          382 LLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK----ATPESDVFGFGAVVLEVVCGRSPGNM  457 (568)
Q Consensus       382 Lld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~----~t~~sDV~SfGvll~el~tG~~P~~~  457 (568)
                      ||++++++||+|||.+..................+||+.|||||...++.    ...+-||||+||+||.|+.|+.||-.
T Consensus       242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~  321 (576)
T KOG0585|consen  242 LLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD  321 (576)
T ss_pred             EEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence            99999999999999998764332222222233578999999999987743    24578999999999999999999974


Q ss_pred             CCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 008374          458 IPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII  525 (568)
Q Consensus       458 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L  525 (568)
                      .....                -...++...+......+..+++..|++.+|.+||+.|.+..+|....
T Consensus       322 ~~~~~----------------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  322 DFELE----------------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             chHHH----------------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            32221                12346666776666667778888888999999999999999997654

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.9e-38  Score=312.38  Aligned_cols=251  Identities=24%  Similarity=0.371  Sum_probs=204.8

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      +|...+.||+|+||.||+|+...      ++..|++|.+...  .....+++.+|++++++++||||+++++++.+.+..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKA------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKL   74 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcC------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence            46777899999999999999875      6789999998643  334567789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++++|.+++.... ...+++..+..++.+++.||.|||   +.+++|+||||+||+++.++.+||+|||+++.
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~  150 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL  150 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEccccccee
Confidence            99999999999999996532 346899999999999999999999   67999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      ........     ....|+..|+|||++.+..++.++||||||++++||++|+.||.......    ....    ...+.
T Consensus       151 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~----~~~~~  217 (256)
T cd08529         151 LSDNTNFA-----NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA----LILK----IIRGV  217 (256)
T ss_pred             ccCccchh-----hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH----HHHH----HHcCC
Confidence            65432221     13468899999999999999999999999999999999999997543211    1111    01110


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                               ...........+.+++.+|++.+|++||++.++++.
T Consensus       218 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         218 ---------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ---------CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                     111112344567888889999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.4e-38  Score=323.27  Aligned_cols=241  Identities=22%  Similarity=0.285  Sum_probs=188.9

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCeEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      +.||+|+||.||+|+...      +++.||+|.++...   ....+.+..|..++..+ +||||+++++++...+..++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv   74 (316)
T cd05592           1 KVLGKGSFGKVMLAELKG------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            369999999999999875      67889999987532   22334556677777654 899999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      |||+++|+|..++..   ...++......++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        75 ~e~~~gg~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~  148 (316)
T cd05592          75 MEYLNGGDLMFHIQS---SGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN  148 (316)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence            999999999999853   346888999999999999999999   67999999999999999999999999999986533


Q ss_pred             ccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD  482 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  482 (568)
                      ....     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    +.   ....       
T Consensus       149 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~----~~---~~i~-------  209 (316)
T cd05592         149 GEGK-----ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE----LF---DSIL-------  209 (316)
T ss_pred             CCCc-----cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH----HH---HHHH-------
Confidence            2211     124579999999999998899999999999999999999999997543221    11   1110       


Q ss_pred             hhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHH-HHH
Q 008374          483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTE-DIL  522 (568)
Q Consensus       483 ~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~-evl  522 (568)
                        ...  ...+......+.+++..|++.||.+||++. +++
T Consensus       210 --~~~--~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         210 --NDR--PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             --cCC--CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence              000  011112233456677799999999999976 454

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.2e-38  Score=325.90  Aligned_cols=252  Identities=22%  Similarity=0.309  Sum_probs=204.2

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      ..++|+....||+|+||.||+++-+.      +|..+|+|++++...   .+.+..+.|-.+|....+|+||+|+-.|++
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~------Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD  212 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKD------TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD  212 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEcc------CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC
Confidence            45789999999999999999999876      789999999988643   344567889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      .+.+||||||+|||++..+|.   ....|+.......+.+++-|+.-||   +.|+|||||||+|+|||..|.+||+|||
T Consensus       213 ~~~LYLiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFG  286 (550)
T KOG0605|consen  213 KEYLYLIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFG  286 (550)
T ss_pred             CCeeEEEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeecccc
Confidence            999999999999999999994   3457999999999999999999999   6799999999999999999999999999


Q ss_pred             Cccccccccc--------------------ccc-----c-----------------cccccCCcCCcccCccccccCCCC
Q 008374          396 LARAIENERN--------------------SYA-----E-----------------HGLVGVPGTMGYVAPECFHTGKAT  433 (568)
Q Consensus       396 la~~~~~~~~--------------------~~~-----~-----------------~~~~~~~Gt~~y~APE~~~~~~~t  433 (568)
                      |+.-+.....                    ...     .                 .-....+||+-|||||++.+..|.
T Consensus       287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~  366 (550)
T KOG0605|consen  287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG  366 (550)
T ss_pred             ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence            9965422000                    000     0                 001135799999999999999999


Q ss_pred             ccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCC
Q 008374          434 PESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIAS  513 (568)
Q Consensus       434 ~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~  513 (568)
                      ..+|.||+||++|||+.|.+||......+....++.|...+....              ......+..+|+..|+. ||.
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~  431 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPE  431 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHH
Confidence            999999999999999999999998777766667777754332211              11111334445556666 999


Q ss_pred             CCCC
Q 008374          514 ERPK  517 (568)
Q Consensus       514 ~RPt  517 (568)
                      +|..
T Consensus       432 ~RLG  435 (550)
T KOG0605|consen  432 NRLG  435 (550)
T ss_pred             HhcC
Confidence            9987

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.4e-38  Score=311.26  Aligned_cols=246  Identities=26%  Similarity=0.441  Sum_probs=197.3

Q ss_pred             eeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 008374          248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFM  326 (568)
Q Consensus       248 ~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  326 (568)
                      +||+|+||.||+|...       ++..+|+|.+..... .....|.+|++++++++||||++++++|...+..++||||+
T Consensus         2 ~ig~g~~g~vy~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   74 (250)
T cd05085           2 LLGKGNFGEVFKGTLK-------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELV   74 (250)
T ss_pred             ccCCCCCceEEEEEec-------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECC
Confidence            6899999999999865       567899999876543 23456889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccccccc
Q 008374          327 PNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS  406 (568)
Q Consensus       327 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~  406 (568)
                      ++++|.+++....  ..+++..+..++.+++.+|.|||   +++++||||||+||+++.++.+||+|||+++........
T Consensus        75 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          75 PGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence            9999999985432  35889999999999999999999   679999999999999999999999999999765433211


Q ss_pred             ccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhh
Q 008374          407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVD  485 (568)
Q Consensus       407 ~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  485 (568)
                      ...    ...++..|+|||++.+..++.++||||||+++||+++ |..||.......    ...    ....        
T Consensus       150 ~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~----~~~----~~~~--------  209 (250)
T cd05085         150 SSG----LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ----ARE----QVEK--------  209 (250)
T ss_pred             cCC----CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH----HHH----HHHc--------
Confidence            111    2234678999999998999999999999999999998 999986432221    111    1111        


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          486 QRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       486 ~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                       .............+..++.+|++.+|++||++.|+++.|.
T Consensus       210 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         210 -GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             -CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence             1111112234567888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2e-38  Score=321.40  Aligned_cols=266  Identities=20%  Similarity=0.294  Sum_probs=197.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...++||+|+||.||+|....      ++..||+|.++.... .....+.+|+.++++++||||+++++++...+..
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKL------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCL   78 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECC------CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            458888999999999999998764      678999999875432 2345678999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||++ ++|.+++...  ...+++.....++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++.
T Consensus        79 ~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~  152 (288)
T cd07871          79 TLVFEYLD-SDLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARA  152 (288)
T ss_pred             EEEEeCCC-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceee
Confidence            99999997 5899888532  235788999999999999999999   67999999999999999999999999999986


Q ss_pred             cccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH----HH
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW----ML  474 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~----~~  474 (568)
                      ........     ....||..|+|||.+.+ ..++.++||||+||++|||++|+.||...........+.....    ..
T Consensus       153 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  227 (288)
T cd07871         153 KSVPTKTY-----SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET  227 (288)
T ss_pred             ccCCCccc-----cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence            54332211     13468899999998865 5689999999999999999999999975433221111100000    00


Q ss_pred             hhc----CchhhhhhhhcCCCCc----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          475 HRE----GHIQDAVDQRLNINSV----VDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       475 ~~~----~~~~~~~d~~l~~~~~----~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      +..    ........+.......    ........+++..|++.||.+|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000    0000001111100000    011234567888999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.1e-38  Score=321.04  Aligned_cols=265  Identities=23%  Similarity=0.305  Sum_probs=194.7

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcC---CCCceeeEEEEEEe-
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRL---RHKHLVHLVGWCHE-  315 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~-  315 (568)
                      +|...++||+|+||.||+|+....     .+..||+|++.....  .....+.+|+.+++++   +||||++++++|.. 
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~   76 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKN-----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   76 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCC-----CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence            578889999999999999987531     467899999865432  2234566787777665   69999999999863 


Q ss_pred             ----CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 008374          316 ----KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL  391 (568)
Q Consensus       316 ----~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL  391 (568)
                          ...+++||||++ ++|.+++.... ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||
T Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl  151 (290)
T cd07862          77 RTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKL  151 (290)
T ss_pred             cCCCCCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEE
Confidence                356899999996 68999986433 235899999999999999999999   679999999999999999999999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      +|||+++.......      .....||..|+|||.+....++.++|||||||++|||++|+.||...........+.+..
T Consensus       152 ~Dfg~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~  225 (290)
T cd07862         152 ADFGLARIYSFQMA------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI  225 (290)
T ss_pred             ccccceEeccCCcc------cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence            99999987654311      124568999999999988899999999999999999999999998544332111111111


Q ss_pred             HHHhhcCchh-------hhhhhhcCC---CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          472 WMLHREGHIQ-------DAVDQRLNI---NSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       472 ~~~~~~~~~~-------~~~d~~l~~---~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .. .......       .........   ....+....+.+++.+|++.||++|||+.|+++
T Consensus       226 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         226 GL-PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CC-CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00 0000000       000000000   000112345567889999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.9e-38  Score=317.69  Aligned_cols=263  Identities=25%  Similarity=0.423  Sum_probs=205.5

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      +++....+||+|+||.||++...... ...++..+|+|.+........+.|.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLL-PEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCC-CCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            35666789999999999999764210 11246789999988766666778999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCC------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc
Q 008374          321 LVYDFMPNGSLEKYLYGTSE------------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN  388 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~  388 (568)
                      ++|||+++++|.+++.....            ...+++..+..++.|++.||+|||   +.+++||||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCC
Confidence            99999999999999865321            135899999999999999999999   679999999999999999999


Q ss_pred             EEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhH
Q 008374          389 ARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL  467 (568)
Q Consensus       389 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l  467 (568)
                      +||+|||+++..........   .....+++.|+|||.+....++.++|||||||++|||++ |+.||.......    .
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~  233 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRV---GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE----A  233 (280)
T ss_pred             EEECCCCceeEcCCCceeec---CCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH----H
Confidence            99999999986543221110   112345788999999998999999999999999999998 898986432221    1


Q ss_pred             HHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          468 VDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       468 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      .+.             +........+......+.+++.+||+.||++||++.+|++.|++
T Consensus       234 ~~~-------------~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         234 IEC-------------ITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHH-------------HHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            111             01111111111233456788889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.9e-38  Score=321.55  Aligned_cols=265  Identities=25%  Similarity=0.391  Sum_probs=207.8

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcC-CCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  317 (568)
                      .++|...+.||+|+||.||++...... ....+..||+|.++... ....+.+.+|+.+++++ +||||++++++|...+
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLS-KSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCC-CCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            457889999999999999999863211 11246689999987543 23346789999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++|+|.+++.... ...+++.++..++.+++.||.|||   +++++|+||||+|||++.++.+||+|||++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccc
Confidence            9999999999999999996432 234899999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      +...........   ....++..|+|||.+....++.++|||||||++|||++ |+.|+.......   .+...      
T Consensus       189 ~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---~~~~~------  256 (302)
T cd05055         189 RDIMNDSNYVVK---GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---KFYKL------  256 (302)
T ss_pred             ccccCCCceeec---CCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---HHHHH------
Confidence            876543221111   12346788999999999999999999999999999998 999987543322   11111      


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                             ++..............+.+++.+|++.+|++|||+.|+++.|+..
T Consensus       257 -------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         257 -------IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -------HHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                   111111111112235677888899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=331.85  Aligned_cols=246  Identities=22%  Similarity=0.311  Sum_probs=201.4

Q ss_pred             HHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc---cchhhHHHHHHhhcC-CCCceeeEEEE
Q 008374          237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK---SKGDFLAELAIIHRL-RHKHLVHLVGW  312 (568)
Q Consensus       237 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~H~nIv~l~g~  312 (568)
                      ....++|....+||+|.||+|+++.++.      +++.+|||.+++...-   +.+..+.|.+++... +||.|++|+.+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~------~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~  437 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKG------TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC  437 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcC------CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc
Confidence            3445789999999999999999999986      6789999999987543   345567888888777 59999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          313 CHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       313 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                      ++.++++++||||..+|++..+.    ....++.....-++..|+.||.|||   +++||+||||.+|||||.+|.+||+
T Consensus       438 fQT~~~l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiA  510 (694)
T KOG0694|consen  438 FQTKEHLFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIA  510 (694)
T ss_pred             cccCCeEEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEec
Confidence            99999999999999999965554    2356888889999999999999999   7899999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      ||||++........ +    .+.+||+.|||||++....|+.++|.|||||+||||+.|..||.+.++++....++    
T Consensus       511 DFGlcKe~m~~g~~-T----sTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~----  581 (694)
T KOG0694|consen  511 DFGLCKEGMGQGDR-T----STFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV----  581 (694)
T ss_pred             ccccccccCCCCCc-c----ccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh----
Confidence            99999975532221 1    27899999999999999999999999999999999999999998765544221111    


Q ss_pred             HHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH
Q 008374          473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKT  518 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~  518 (568)
                                 .|+.   .++.....+.+.++...+..||++|.-+
T Consensus       582 -----------~d~~---~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  582 -----------NDEV---RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -----------cCCC---CCCCcccHHHHHHHHHHhccCcccccCC
Confidence                       1221   2333444455566667889999999987

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.6e-38  Score=317.39  Aligned_cols=264  Identities=25%  Similarity=0.409  Sum_probs=204.5

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      .+++|...+.||+|+||.||+|.+...... .....||+|.+.... ......|..|+.++++++|+||+++++++.+.+
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGD-AVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCC-CCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            356788899999999999999998642110 146789999886543 233457999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC---cEE
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSE----QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF---NAR  390 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~---~~k  390 (568)
                      ..++||||+++++|.+++.....    ...++|..+..++.||+.||+|||   +++++||||||+||+++.++   .+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceE
Confidence            99999999999999999865321    235899999999999999999999   67999999999999998654   699


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHH
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~  469 (568)
                      |+|||+++..........   ......+..|+|||++.+..++.++|||||||++|||++ |+.||.......    +.+
T Consensus       160 l~dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~----~~~  232 (277)
T cd05036         160 IADFGMARDIYRASYYRK---GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE----VME  232 (277)
T ss_pred             eccCccccccCCccceec---CCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH
Confidence            999999987643221100   012234568999999999999999999999999999997 999987543221    111


Q ss_pred             HHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          470 WVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       470 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                      .             +........+......+.+++.+|++.+|++|||+.+|++.|+
T Consensus       233 ~-------------~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         233 F-------------VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             H-------------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1             1111111122233456778888999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.1e-38  Score=315.48  Aligned_cols=258  Identities=26%  Similarity=0.406  Sum_probs=199.0

Q ss_pred             cccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeC-----
Q 008374          244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK-----  316 (568)
Q Consensus       244 ~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----  316 (568)
                      ...++||+|+||.||+|++...+    ....+|+|.++..  +....+.|.+|++++++++|+||++++++|...     
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~----~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   77 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDD----SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG   77 (272)
T ss_pred             ccccccCcccCceEEEeEEccCC----CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence            45678999999999999986421    1246999988654  234456789999999999999999999988542     


Q ss_pred             -CeEEEEEEecCCCChhhhhccC---CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          317 -GKLLLVYDFMPNGSLEKYLYGT---SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       317 -~~~~lV~Ey~~~gsL~~~L~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                       ...++++||+++|+|.+++...   .....+++.....++.|++.||+|||   +++|+||||||+|||+++++.+||+
T Consensus        78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEEC
Confidence             2578999999999999987432   12345899999999999999999999   6799999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~  471 (568)
                      |||+++..........   .....++..|+|||++....++.++||||||+++|||++ |+.||.......    +.+  
T Consensus       155 Dfg~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~~--  225 (272)
T cd05075         155 DFGLSKKIYNGDYYRQ---GRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE----IYD--  225 (272)
T ss_pred             CCCcccccCcccceec---CCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH--
Confidence            9999987654322111   113346778999999999999999999999999999999 788886432211    111  


Q ss_pred             HHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       472 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                        ....+..       .  .........+.+++..||+.||++|||+.++++.|+..
T Consensus       226 --~~~~~~~-------~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         226 --YLRQGNR-------L--KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             --HHHcCCC-------C--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              1111111       0  11122344577888899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-38  Score=319.54  Aligned_cols=252  Identities=25%  Similarity=0.313  Sum_probs=200.6

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      +|+..++||+|+||+||++....      +++.||+|.+.....   .....+.+|+.++++++||||+++++++...+.
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRA------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcC------CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe
Confidence            36778899999999999998764      578999999865322   223457889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      +++||||+++|+|.+++.... ...+++.....++.|++.||.|||   +.+++||||||+||++++++.++|+|||+++
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~  150 (285)
T cd05605          75 LCLVLTLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAV  150 (285)
T ss_pred             EEEEEeccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCce
Confidence            999999999999999886432 346899999999999999999999   6799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ........      ....|+..|+|||++.+..++.++|||||||++|||++|+.||.......    ..+.+...    
T Consensus       151 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~----~~~~~~~~----  216 (285)
T cd05605         151 EIPEGETI------RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV----KREEVERR----  216 (285)
T ss_pred             ecCCCCcc------ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh----HHHHHHHH----
Confidence            76433211      13468999999999998899999999999999999999999997543322    11111110    


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                           +.. ............+.+++..|++.||.+||     ++.++++
T Consensus       217 -----~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         217 -----VKE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             -----hhh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence                 100 01111223345567788899999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.7e-38  Score=314.68  Aligned_cols=259  Identities=22%  Similarity=0.369  Sum_probs=203.1

Q ss_pred             HHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          236 LKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       236 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      ++.+++++.....||+|+||.||+|+...      ++..|++|.+........+.+.+|+.++++++|+||+++++++..
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   76 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLS------TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE   76 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecC------CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc
Confidence            45567778888899999999999998764      578899999887666667789999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-CCcEEEeec
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA-DFNARLGDF  394 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~-~~~~kL~DF  394 (568)
                      .+..++|+||+++++|.+++.........++..+..++.|++.||+|||   +++|+||||||+||+++. ++.+||+||
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~df  153 (268)
T cd06624          77 NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDF  153 (268)
T ss_pred             CCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecc
Confidence            9999999999999999999964322112278888899999999999999   679999999999999986 679999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK--ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~--~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      |++..........     ....|+..|+|||++....  ++.++||||||+++|||++|+.|+.......    ...+..
T Consensus       154 g~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~----~~~~~~  224 (268)
T cd06624         154 GTSKRLAGINPCT-----ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ----AAMFKV  224 (268)
T ss_pred             hhheecccCCCcc-----ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh----hhHhhh
Confidence            9998664322111     1345889999999986543  7889999999999999999999986432211    011100


Q ss_pred             HHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ...           +.....+......+..++.+|++.+|.+|||+.|+++
T Consensus       225 ~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         225 GMF-----------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hhh-----------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            000           0011112233455677888999999999999999975

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2e-38  Score=332.26  Aligned_cols=206  Identities=23%  Similarity=0.351  Sum_probs=175.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|+..+.||+|+||+||++....      +++.||+|++....   ......+..|+.++.+++|+||+++++.+.+..
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~   74 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKD------TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL   74 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECC------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            468888999999999999998764      67899999997532   223456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .+++||||+++|+|.+++..   ...+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla  148 (363)
T cd05628          75 NLYLIMEFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLC  148 (363)
T ss_pred             eEEEEEcCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCc
Confidence            99999999999999999954   346899999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccc------------------------------cccccccCCcCCcccCccccccCCCCccchhHHHHHHHHH
Q 008374          398 RAIENERNSY------------------------------AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLE  447 (568)
Q Consensus       398 ~~~~~~~~~~------------------------------~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~e  447 (568)
                      +.+.......                              .........||+.|+|||++.+..++.++|||||||++||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e  228 (363)
T cd05628         149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE  228 (363)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHH
Confidence            8653211000                              0000124579999999999999999999999999999999


Q ss_pred             HHhCCCCCCCC
Q 008374          448 VVCGRSPGNMI  458 (568)
Q Consensus       448 l~tG~~P~~~~  458 (568)
                      |++|+.||...
T Consensus       229 ll~G~~Pf~~~  239 (363)
T cd05628         229 MLIGYPPFCSE  239 (363)
T ss_pred             HHhCCCCCCCC
Confidence            99999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.8e-38  Score=324.11  Aligned_cols=245  Identities=22%  Similarity=0.301  Sum_probs=192.8

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHh---hcCCCCceeeEEEEEEeC
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAII---HRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~g~~~~~  316 (568)
                      |...+.||+|+||.||+|....      +++.||||.++...   ....+.+.+|++++   ++++||||+++++++...
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~   74 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKK------TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE   74 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC
Confidence            4567889999999999998875      67899999997542   22334566666554   567899999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +..++||||+++++|..++..    ..+++.....++.|++.||.|||   +++++||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~lv~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~  147 (324)
T cd05589          75 DHVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGL  147 (324)
T ss_pred             CEEEEEEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccC
Confidence            999999999999999988843    35899999999999999999999   67999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ++........     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    +..   .   
T Consensus       148 ~~~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~----~~~---~---  212 (324)
T cd05589         148 CKEGMGFGDR-----TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE----VFD---S---  212 (324)
T ss_pred             CccCCCCCCc-----ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH----HHH---H---
Confidence            8754322111     124679999999999999899999999999999999999999997543222    111   0   


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                            +.....  ..+......+.+++.+|++.||.+||     ++.++++
T Consensus       213 ------i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         213 ------IVNDEV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ------HHhCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                  011111  11112234567788899999999999     5666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2e-38  Score=334.35  Aligned_cols=257  Identities=24%  Similarity=0.331  Sum_probs=195.2

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .|...++||+|+||+||+|+...      +++.+|+|++....   ....+.+.+|++++.+++||||+++++++.+.+.
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~   75 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVD------THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE
Confidence            47788899999999999999875      67899999996542   2334578899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      +++||||+++|+|.+++..   ...+++.....++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        76 ~~lv~E~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~  149 (381)
T cd05626          76 LYFVMDYIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCT  149 (381)
T ss_pred             EEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence            9999999999999999954   345888888999999999999999   6799999999999999999999999999986


Q ss_pred             ccccccccc------------------------------------------cccccccCCcCCcccCccccccCCCCccc
Q 008374          399 AIENERNSY------------------------------------------AEHGLVGVPGTMGYVAPECFHTGKATPES  436 (568)
Q Consensus       399 ~~~~~~~~~------------------------------------------~~~~~~~~~Gt~~y~APE~~~~~~~t~~s  436 (568)
                      .+.......                                          .........||..|+|||.+....++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~  229 (381)
T cd05626         150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC  229 (381)
T ss_pred             ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcc
Confidence            442110000                                          00001135799999999999988899999


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCC-CCcHHHHHHHHHHHHhcCCCCCCCC
Q 008374          437 DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNI-NSVVDEAKRLLLLGLACSHPIASER  515 (568)
Q Consensus       437 DV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~l~Cl~~dp~~R  515 (568)
                      |||||||++|||++|+.||...........+..|      ...      ..+.. .....+...++.- +.|+.++|..|
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~------~~~------~~~~~~~~~s~~~~dli~~-ll~~~~~~~~R  296 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW------ENT------LHIPPQVKLSPEAVDLITK-LCCSAEERLGR  296 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcc------ccc------cCCCCCCCCCHHHHHHHHH-HccCcccccCC
Confidence            9999999999999999999754332211111111      000      00000 0111233333332 24778888889


Q ss_pred             CCHHHHHH
Q 008374          516 PKTEDILQ  523 (568)
Q Consensus       516 Pt~~evl~  523 (568)
                      |++.|+++
T Consensus       297 ~~~~~~l~  304 (381)
T cd05626         297 NGADDIKA  304 (381)
T ss_pred             CCHHHHhc
Confidence            99999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-39  Score=330.11  Aligned_cols=256  Identities=27%  Similarity=0.446  Sum_probs=214.2

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      .....++||+|-||.||+|++..-+  +...-.||||..+.+ .....+.|+.|..+|++++||||++|+|.|.+ +..+
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~--kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W  466 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPE--KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW  466 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccc--cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence            3445568999999999999997532  224567999999874 44567889999999999999999999999975 5789


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +|||.++-|.|..||...  ...|+......++.||+.||+|||   +..+|||||.++|||+...-.+||+||||+|.+
T Consensus       467 ivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYL  541 (974)
T ss_pred             EEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence            999999999999999654  346888899999999999999999   789999999999999999999999999999998


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      +.+..-..+    ...-.+.|||||.+...+++.+||||-|||++||++. |.+||....+.+                 
T Consensus       542 ed~~yYkaS----~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-----------------  600 (974)
T KOG4257|consen  542 EDDAYYKAS----RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-----------------  600 (974)
T ss_pred             cccchhhcc----ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-----------------
Confidence            876433222    2334679999999999999999999999999999987 999998665543                 


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                      +.-.+...-+...+..++..+..++.+||+.+|.+||++.|+...|.
T Consensus       601 VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  601 VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence            11222333345667788899999999999999999999999987665

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.5e-38  Score=314.79  Aligned_cols=261  Identities=30%  Similarity=0.487  Sum_probs=205.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .+|...+.||+|+||.||+|.+...+.   ....+|+|.++... ....+.|.+|+.++.+++||||+++++++...+..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGK---REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCC---CceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            467788999999999999998764221   34579999986543 23456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++++|.+++....  ..+++.+...++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRV  155 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence            99999999999999996432  35899999999999999999999   67999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ..........  .....++..|+|||++.+..++.++||||||++++|+++ |+.||.......    +....    ..+
T Consensus       156 ~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~----~~~~~----~~~  225 (267)
T cd05066         156 LEDDPEAAYT--TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD----VIKAI----EEG  225 (267)
T ss_pred             cccccceeee--cCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH----HHHHH----hCC
Confidence            7543221111  112234568999999998899999999999999999886 999987443221    11111    111


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                               .........+..+.+++.+|++.+|.+||+|.++++.|+..
T Consensus       226 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         226 ---------YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ---------CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                     11111223345677888899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.8e-38  Score=312.04  Aligned_cols=251  Identities=24%  Similarity=0.477  Sum_probs=197.1

Q ss_pred             eeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 008374          248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFM  326 (568)
Q Consensus       248 ~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  326 (568)
                      .||+|+||.||+|++...+    .+..||+|.+..... ...+.|.+|+.++++++||||++++++|. ....++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~----~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRK----KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecCC----CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeC
Confidence            4899999999999876321    356799999876533 23467899999999999999999999885 45789999999


Q ss_pred             CCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccccccc
Q 008374          327 PNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS  406 (568)
Q Consensus       327 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~  406 (568)
                      ++++|.+++...  ...+++..+..++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++........
T Consensus        77 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  151 (257)
T cd05115          77 SGGPLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY  151 (257)
T ss_pred             CCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence            999999998542  346899999999999999999999   679999999999999999999999999999866543322


Q ss_pred             ccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhh
Q 008374          407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVD  485 (568)
Q Consensus       407 ~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  485 (568)
                      ...  .....++..|+|||.+....++.++||||||+++||+++ |+.||.......    ....    ...+       
T Consensus       152 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~----~~~~-------  214 (257)
T cd05115         152 YKA--RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE----VMSF----IEQG-------  214 (257)
T ss_pred             eec--cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH----HHHH----HHCC-------
Confidence            111  112234678999999988889999999999999999996 999987543221    1111    1111       


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          486 QRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       486 ~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                        .....+......+.+++..||+.+|++||++.+|.+.|+.
T Consensus       215 --~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         215 --KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence              1112223345567778889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.9e-38  Score=311.42  Aligned_cols=253  Identities=28%  Similarity=0.464  Sum_probs=200.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|....+||+|+||.||+|.+.       .+..+|+|.+.... ...+.|.+|+.++++++|+|++++++++. .+..+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-------~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWN-------GTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY   76 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEc-------CCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence            45777889999999999999876       34569999886543 33467899999999999999999999875 45689


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++++|.+++.... ...+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++..
T Consensus        77 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~  152 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLI  152 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence            9999999999999996532 345899999999999999999999   679999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      ........    ....++..|+|||......++.++||||||+++|||++ |+.||.......    ...+.    ..+ 
T Consensus       153 ~~~~~~~~----~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~~----~~~-  219 (260)
T cd05069         153 EDNEYTAR----QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE----VLEQV----ERG-  219 (260)
T ss_pred             cCCccccc----CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH----HcC-
Confidence            43321111    13346788999999988899999999999999999999 898987533221    11111    111 


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                              ............+..++.+|+++||++||++++|+++|+.
T Consensus       220 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         220 --------YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             --------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                    1111122344567788889999999999999999999974

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.1e-38  Score=317.07  Aligned_cols=247  Identities=23%  Similarity=0.316  Sum_probs=195.8

Q ss_pred             eccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 008374          249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       249 LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      ||+|+||+||++....      +++.+|+|.+.....   ...+.+..|++++++++|+||+++.+++......++||||
T Consensus         1 lg~G~~g~Vy~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (280)
T cd05608           1 LGKGGFGEVSACQMRA------TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTI   74 (280)
T ss_pred             CCCCCceeEEEEEEcc------CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeC
Confidence            7999999999998875      678999999875422   2335678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccccc
Q 008374          326 MPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER  404 (568)
Q Consensus       326 ~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~  404 (568)
                      +++|+|..++... .....+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++.+....
T Consensus        75 ~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  151 (280)
T cd05608          75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ  151 (280)
T ss_pred             CCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC
Confidence            9999999888542 23456899999999999999999999   6799999999999999999999999999998765432


Q ss_pred             ccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhh
Q 008374          405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV  484 (568)
Q Consensus       405 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  484 (568)
                      ..     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......   ...... .        .+.
T Consensus       152 ~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~-~--------~~~  214 (280)
T cd05608         152 SK-----TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKELK-Q--------RIL  214 (280)
T ss_pred             cc-----ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch---hHHHHH-H--------hhc
Confidence            21     114578999999999999999999999999999999999999997433221   000100 0        011


Q ss_pred             hhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          485 DQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       485 d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                      ....  .........+.+++..|++.||++||     +++++++
T Consensus       215 ~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         215 NDSV--TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             ccCC--CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            1111  11223345567788899999999999     6777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-38  Score=331.40  Aligned_cols=288  Identities=24%  Similarity=0.338  Sum_probs=218.5

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      |..++.||+|+-|.|-.|+...      +|+.+|||++.+..   ........+|+.+|+-+.|||++++++.+.+..++
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~------TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l   87 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAE------TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL   87 (786)
T ss_pred             eeccccccCCCCceehhhhccc------ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence            6677889999999999998875      89999999997752   22345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      |||.||+++|-|.++|.   ..+.|...+..+++.||+.|+.|.|   ..+|+|||+||+|+|||..+++||+|||+|.+
T Consensus        88 ylvlEyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsL  161 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASL  161 (786)
T ss_pred             EEEEEecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeec
Confidence            99999999999999994   4567999999999999999999999   56999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKAT-PESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t-~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      -..+.--.      +-+|.+.|.|||++.+..|. .++||||.||+|+.|+||+.||++..-.    .|..-    ...|
T Consensus       162 e~~gklLe------TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir----~LLlK----V~~G  227 (786)
T KOG0588|consen  162 EVPGKLLE------TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR----VLLLK----VQRG  227 (786)
T ss_pred             ccCCcccc------ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH----HHHHH----HHcC
Confidence            65554322      56899999999999998885 6899999999999999999999843222    12111    1112


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCCCCCCCCCCCCCccccCCCC-C-CCCCCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISGTSTVPYVPQFKPAFTWPSTS-P-PISMFD  554 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L~~~~~~p~~p~~~~~~~~~~~~-~-~~~~~~  554 (568)
                      .. ++      ......+++.   |+-.|+..||++|.|++||++  .|.+-..+|..-...+....+-.+ + -++-.+
T Consensus       228 ~f-~M------Ps~Is~eaQd---LLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~~~~i~s~ps~~~IDp  297 (786)
T KOG0588|consen  228 VF-EM------PSNISSEAQD---LLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPPVSVPILSIPSIQEIDP  297 (786)
T ss_pred             cc-cC------CCcCCHHHHH---HHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcCCCcccceeecCCcccCCH
Confidence            11 00      1122334444   445888999999999999998  456654444321111111111111 1 122234


Q ss_pred             ccccccccCCCC
Q 008374          555 SILSSITLSSPG  566 (568)
Q Consensus       555 ~~~~~~~~~~~~  566 (568)
                      .++=+|++.|-+
T Consensus       298 ~Il~~l~iLwc~  309 (786)
T KOG0588|consen  298 LILQHLCILWCG  309 (786)
T ss_pred             HHHhhhhheeec
Confidence            667777776643

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-38  Score=311.70  Aligned_cols=253  Identities=27%  Similarity=0.487  Sum_probs=200.1

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      ++||+|+||.||+|++...+.   ....+|+|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSG---KEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCC---CcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence            369999999999998764321   247899999876543 24567999999999999999999999876 4568999999


Q ss_pred             cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccc
Q 008374          326 MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN  405 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~  405 (568)
                      +++|+|.+++...   ..+++..+..++.|++.+|+|||   ..+++||||||+|||++.++.+||+|||+++.......
T Consensus        77 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          77 APLGPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             CCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            9999999999543   36899999999999999999999   67999999999999999999999999999987754433


Q ss_pred             cccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCchhhhh
Q 008374          406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV  484 (568)
Q Consensus       406 ~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  484 (568)
                      ....  .....++..|+|||.+....++.++||||||+++|||++ |+.||......    .+..++..    +.     
T Consensus       151 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~----~~~~~~~~----~~-----  215 (257)
T cd05060         151 YYRA--TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA----EVIAMLES----GE-----  215 (257)
T ss_pred             cccc--ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH----HHHHHHHc----CC-----
Confidence            2211  112234568999999998999999999999999999998 99998754322    22222211    10     


Q ss_pred             hhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       485 d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                          ...........+.+++.+|++.+|.+||++.++++.|++.
T Consensus       216 ----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         216 ----RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             ----cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence                0111122345677888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.9e-38  Score=316.03  Aligned_cols=264  Identities=24%  Similarity=0.417  Sum_probs=206.0

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...++||+|+||.||+|++..++..  ....||+|.+.... .....++.+|+.++..++|+||++++++|.. ...
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~   83 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGEN--VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV   83 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCc--cceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence            4678889999999999999997653221  23468999987543 3345678899999999999999999999975 457


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++++||+++|+|.+++...  ...+++...+.++.|++.||+|||   +++++||||||+|||+++++.+||+|||+++.
T Consensus        84 ~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          84 QLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceee
Confidence            8999999999999999643  246899999999999999999999   67999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ..........   ....++..|+|||.+.+..++.++|||||||++|||++ |..|++.....    .+..++.    .+
T Consensus       159 ~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~----~~  227 (279)
T cd05109         159 LDIDETEYHA---DGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR----EIPDLLE----KG  227 (279)
T ss_pred             cccccceeec---CCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHH----CC
Confidence            7543222111   12345678999999988899999999999999999998 89998743322    1222111    11


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVP  532 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~p  532 (568)
                               ............+.+++..|++.||++||++.++++.|+.....|
T Consensus       228 ---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         228 ---------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             ---------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                     111111223456778888999999999999999999998765555

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.1e-38  Score=314.62  Aligned_cols=260  Identities=22%  Similarity=0.346  Sum_probs=206.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...+.||+|+||.||+++...      ++..+|||.+....   .....++.+|+.+++.++|+||+++++++.+.+
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLL------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN   75 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecC------CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence            467778899999999999999865      67899999886532   233467899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          318 KLLLVYDFMPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      ..+++|||+++++|.+++... .....+++.....++.+++.||.|||   +++++|+||||+||+++.++.++|+|||+
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~  152 (267)
T cd08229          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGL  152 (267)
T ss_pred             eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchh
Confidence            999999999999999998642 22356899999999999999999999   67999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ++.........     ....|+..|+|||++.+..++.++||||||+++|||++|..||.......     ......   
T Consensus       153 ~~~~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~---  219 (267)
T cd08229         153 GRFFSSKTTAA-----HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YSLCKK---  219 (267)
T ss_pred             hhccccCCccc-----ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-----HHHhhh---
Confidence            98765432211     13468899999999988889999999999999999999999986432211     111100   


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                         +.....+.+   ........+.+++.+|++.||++||||.+|++++++.
T Consensus       220 ---~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         220 ---IEQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             ---hhcCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence               000011111   1123445677788899999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6.7e-38  Score=312.17  Aligned_cols=253  Identities=27%  Similarity=0.482  Sum_probs=202.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|...++||+|+||.||+|..+       +++.+|+|.+.... ....+|.+|+.++++++|+||+++++++. .+..+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~-------~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYN-------GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             HHceeeeeeccCccceEEeeecC-------CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence            56788899999999999999875       56789999987543 33567999999999999999999999874 56789


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      ++|||+++++|.+++.... ...+++.++..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++...
T Consensus        77 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          77 IITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLI  152 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence            9999999999999986533 346899999999999999999999   679999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      ........    ....++..|+|||++....++.++||||||++++||++ |+.||.......    +....        
T Consensus       153 ~~~~~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~--------  216 (260)
T cd05067         153 EDNEYTAR----EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE----VIQNL--------  216 (260)
T ss_pred             CCCCcccc----cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH----HHHHH--------
Confidence            53322111    13346788999999988889999999999999999999 999997543221    11111        


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                           ...............+.+++.+|++.+|++|||+++++++|+.
T Consensus       217 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         217 -----ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -----HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                 1111111112234567888889999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-38  Score=316.37  Aligned_cols=263  Identities=25%  Similarity=0.433  Sum_probs=207.3

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...+.||+|+||.||+|....... ...+..||+|.+.... ......+.+|+.++..++||||+++++++......
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVK-GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCC-CCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            567888999999999999998864221 1245789999986543 23456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          320 LLVYDFMPNGSLEKYLYGTSE-------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                      ++||||+++|+|.+++.....       ...++|..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            999999999999999964321       234789999999999999999999   6799999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~  471 (568)
                      |||+++..........   .....++..|+|||.+....++.++|||||||++||+++ |+.||.......    +.++.
T Consensus       162 dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----~~~~~  234 (277)
T cd05032         162 DFGMTRDIYETDYYRK---GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE----VLKFV  234 (277)
T ss_pred             CcccchhhccCccccc---CCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH----HHHHH
Confidence            9999987654321110   113356789999999988889999999999999999998 898986433222    12211


Q ss_pred             HHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       472 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      .    .+.         ....+......+..++..|++.+|.+|||+.++++.|+.
T Consensus       235 ~----~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         235 I----DGG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             h----cCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            1    111         011112235677889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-39  Score=333.76  Aligned_cols=257  Identities=22%  Similarity=0.298  Sum_probs=203.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...++||+|+||+||+|+...      +++.||+|++....   ......+..|++++..++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKD------TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE   74 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECC------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC
Confidence            368888999999999999999875      67899999997542   234567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++++|.+++...   ..+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~  148 (350)
T cd05573          75 HLYLVMEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLC  148 (350)
T ss_pred             eEEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCC
Confidence            999999999999999999543   46899999999999999999999   689999999999999999999999999999


Q ss_pred             cccccccc------------------------cccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCC
Q 008374          398 RAIENERN------------------------SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRS  453 (568)
Q Consensus       398 ~~~~~~~~------------------------~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~  453 (568)
                      +.......                        ...........||+.|+|||.+.+..++.++|||||||++|||++|+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~  228 (350)
T cd05573         149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP  228 (350)
T ss_pred             ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence            87654320                        000011124579999999999999999999999999999999999999


Q ss_pred             CCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHH
Q 008374          454 PGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK-TEDILQI  524 (568)
Q Consensus       454 P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt-~~evl~~  524 (568)
                      ||...........+..|.              ..+...........+..++..|+. ||.+||+ +.++++.
T Consensus       229 Pf~~~~~~~~~~~i~~~~--------------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         229 PFYSDTLQETYNKIINWK--------------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCCHHHHHHHHhccC--------------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            997543222111111110              111111111134456667778997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-39  Score=334.58  Aligned_cols=256  Identities=22%  Similarity=0.309  Sum_probs=196.5

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...++||+|+||+||+|+...      +++.||||++....   ......+.+|+.++..++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKD------TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN   74 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence            468889999999999999999875      67899999997532   233456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++|+|.+++..   ...+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~lv~E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  148 (364)
T cd05599          75 YLYLIMEYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLC  148 (364)
T ss_pred             eEEEEECCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccc
Confidence            99999999999999999954   345899999999999999999999   679999999999999999999999999999


Q ss_pred             ccccccccccc---------------------------------ccccccCCcCCcccCccccccCCCCccchhHHHHHH
Q 008374          398 RAIENERNSYA---------------------------------EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAV  444 (568)
Q Consensus       398 ~~~~~~~~~~~---------------------------------~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvl  444 (568)
                      +.+........                                 ........||+.|+|||++....++.++|||||||+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i  228 (364)
T cd05599         149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI  228 (364)
T ss_pred             eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhH
Confidence            76532211000                                 000012469999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC---HHHH
Q 008374          445 VLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK---TEDI  521 (568)
Q Consensus       445 l~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt---~~ev  521 (568)
                      ++||++|+.||...........+..|              ...+...........+.+++..|+. +|.+|++   ++|+
T Consensus       229 l~el~~G~~Pf~~~~~~~~~~~i~~~--------------~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~l  293 (364)
T cd05599         229 MYEMLVGYPPFCSDNPQETYRKIINW--------------KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEI  293 (364)
T ss_pred             HHHhhcCCCCCCCCCHHHHHHHHHcC--------------CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHH
Confidence            99999999999754332211111111              0011111110112234455556775 8999998   8888


Q ss_pred             HH
Q 008374          522 LQ  523 (568)
Q Consensus       522 l~  523 (568)
                      ++
T Consensus       294 l~  295 (364)
T cd05599         294 KS  295 (364)
T ss_pred             hc
Confidence            76

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.9e-38  Score=316.22  Aligned_cols=274  Identities=23%  Similarity=0.367  Sum_probs=204.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeC--Ce
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK--GK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~  318 (568)
                      .+|...+.||+|+||.||++....-+  ...+..||+|++........+.|.+|++++++++||||+++++++...  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQ--DNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCc--CCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            35777889999999999999864211  125788999999776656667899999999999999999999987543  46


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      +++||||+++++|.+++...  ...+++..+..++.|++.||.|||   +++++||||||+||++++++.+||+|||+++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccc
Confidence            89999999999999999543  235899999999999999999999   6799999999999999999999999999999


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh--
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR--  476 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~--  476 (568)
                      ...........  .....++..|+|||++.+..++.++||||||++++||++|..|+.......     .........  
T Consensus       157 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-----~~~~~~~~~~~  229 (284)
T cd05081         157 VLPQDKEYYKV--REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-----MRMMGNDKQGQ  229 (284)
T ss_pred             cccCCCcceee--cCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh-----hhhcccccccc
Confidence            76543221111  011224456999999988899999999999999999999887654221100     000000000  


Q ss_pred             --cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          477 --EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       477 --~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                        ...+.+.+...............+.+++.+||+.+|++|||+.||++.|+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         230 MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence              0001111221111122223445688899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6.5e-38  Score=311.36  Aligned_cols=254  Identities=28%  Similarity=0.454  Sum_probs=203.2

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      ++||+|+||.||+|.+....   .....||+|.++.... ...++|.+|+.++++++||||+++++.+.. ...++||||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSG---GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCC---CCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence            36899999999999986421   1345799999987765 566789999999999999999999999988 899999999


Q ss_pred             cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccc
Q 008374          326 MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN  405 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~  405 (568)
                      +++++|.+++..... ..++|.....++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++.+.....
T Consensus        77 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          77 APLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             cCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEecccccccccccccc
Confidence            999999999965432 46899999999999999999999   67999999999999999999999999999998755332


Q ss_pred             cccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCchhhhh
Q 008374          406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV  484 (568)
Q Consensus       406 ~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  484 (568)
                      .+...  ....++..|+|||++.+..++.++||||||+++|||++ |+.|+.......    +.....   ...      
T Consensus       153 ~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~~~---~~~------  217 (257)
T cd05040         153 HYVME--EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ----ILKKID---KEG------  217 (257)
T ss_pred             ceecc--cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHH---hcC------
Confidence            22111  13457889999999998899999999999999999998 999986432221    111110   000      


Q ss_pred             hhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       485 d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                       .  ...........+.+++.+|++.+|++||++.++++.|.
T Consensus       218 -~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 -E--RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -C--cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence             0  01111233456788889999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-38  Score=326.47  Aligned_cols=245  Identities=24%  Similarity=0.299  Sum_probs=194.0

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC----cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS----IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      ++||+|+||.||+++...+.   ..++.||+|.+....    ......+..|+.++++++||||+++++++..++..++|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   78 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGA---DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLI   78 (323)
T ss_pred             ceeeecCCeEEEEEEEcccC---CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEE
Confidence            57999999999999865321   257899999987532    22345678899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      |||+++++|.+++..   ...+.+.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        79 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (323)
T cd05584          79 LEYLSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH  152 (323)
T ss_pred             EeCCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence            999999999999853   345788888899999999999999   67999999999999999999999999999875433


Q ss_pred             ccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD  482 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  482 (568)
                      ....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......       ...         .
T Consensus       153 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-------~~~---------~  211 (323)
T cd05584         153 EGTV-----THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-------TID---------K  211 (323)
T ss_pred             CCCc-----ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-------HHH---------H
Confidence            2211     114579999999999998889999999999999999999999997533211       111         1


Q ss_pred             hhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       483 ~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                      +......  .+......+.+++..|++.||++||     ++.++++
T Consensus       212 ~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         212 ILKGKLN--LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             HHcCCCC--CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            1111111  1112234567788899999999999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-38  Score=311.15  Aligned_cols=249  Identities=27%  Similarity=0.465  Sum_probs=204.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|...+.||+|+||.||+|..        .++.||+|.+..... ..+++.+|+.++++++|+||+++++++......+
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~--------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY--------RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY   76 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe--------cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence            4677888999999999999986        367899999976644 5678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++++|.+++.... ...+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus        77 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~  152 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEA  152 (256)
T ss_pred             EEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccc
Confidence            9999999999999996432 236899999999999999999999   679999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      .....        ...++..|+|||++..+.++.++||||||++++|+++ |+.||.......    +...+    .   
T Consensus       153 ~~~~~--------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~----~---  213 (256)
T cd05039         153 SQGQD--------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPHV----E---  213 (256)
T ss_pred             ccccc--------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHH----h---
Confidence            43221        2234678999999988899999999999999999997 999986442221    11111    1   


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                            ..............+.+++.+|+..+|++|||+.+++++|+.
T Consensus       214 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         214 ------KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ------cCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence                  111111122334667788889999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.4e-38  Score=320.54  Aligned_cols=269  Identities=27%  Similarity=0.465  Sum_probs=208.2

Q ss_pred             hcCccccceeccCCceeEEEEEEccCcc-ccccCeEEEEEEeccCC-cccchhhHHHHHHhhcC-CCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQ-YHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  316 (568)
                      .++|...+.||+|+||.||+|+....+. ....+..||+|.+.... ....+++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            4567888999999999999998642111 11245689999987542 33456789999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTS-------------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL  383 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl  383 (568)
                      ...++||||+++|+|.+++....             ....+++.++..++.|++.||.|||   +++++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            99999999999999999996532             1235889999999999999999999   6799999999999999


Q ss_pred             cCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 008374          384 DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQ  462 (568)
Q Consensus       384 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~  462 (568)
                      ++++.+||+|||+++...........   ....++..|+|||++.+..++.++||||||+++|||++ |..|+...+.. 
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-  246 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKT---TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-  246 (304)
T ss_pred             cCCCcEEECCCccceecccccccccc---cCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-
Confidence            99999999999999877543221111   12346678999999988889999999999999999998 78887643221 


Q ss_pred             chhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC
Q 008374          463 HAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTV  531 (568)
Q Consensus       463 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~  531 (568)
                            ++.... ..+         ............+..++..||+.+|.+|||+.|+++.|++..++
T Consensus       247 ------~~~~~~-~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         247 ------ELFKLL-KEG---------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             ------HHHHHH-HcC---------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence                  111111 111         11111223445677788899999999999999999999875443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.2e-38  Score=329.29  Aligned_cols=253  Identities=22%  Similarity=0.238  Sum_probs=198.7

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...++||+|+||.||++....      +++.||+|+++...   ....+.+..|+.+++.++|+||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~   74 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKA------TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD   74 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence            468888999999999999998875      67899999997642   234456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++|+|.+++...  ...+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a  149 (330)
T cd05601          75 NLYLVMEYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSA  149 (330)
T ss_pred             eEEEEECCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCC
Confidence            999999999999999999643  246899999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFH------TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~------~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      +.+........    ....||+.|+|||++.      ...++.++|||||||++|||++|+.||.......       ..
T Consensus       150 ~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~  218 (330)
T cd05601         150 ARLTANKMVNS----KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-------TY  218 (330)
T ss_pred             eECCCCCceee----ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-------HH
Confidence            87654332211    1456899999999986      4567889999999999999999999997433221       11


Q ss_pred             HHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       472 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ........       .+...........+..++..|++ +|.+|||+.++++
T Consensus       219 ~~i~~~~~-------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         219 NNIMNFQR-------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHHHcCCC-------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            11111000       01111111223345566667887 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.7e-38  Score=343.31  Aligned_cols=260  Identities=21%  Similarity=0.249  Sum_probs=204.5

Q ss_pred             HHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEE
Q 008374          236 LKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWC  313 (568)
Q Consensus       236 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~  313 (568)
                      .....++|...++||+|+||+||+|+...      +++.||||.+....  ......+.+|+.++..++|+||+++...+
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~  100 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVS------DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDF  100 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcC------CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecce
Confidence            34455789999999999999999998765      67899999986542  33456788999999999999999998877


Q ss_pred             EeCC--------eEEEEEEecCCCChhhhhccCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc
Q 008374          314 HEKG--------KLLLVYDFMPNGSLEKYLYGTS-EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD  384 (568)
Q Consensus       314 ~~~~--------~~~lV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld  384 (568)
                      ....        .+++||||+++|+|.+++.... ....+++.....++.|++.||.|||   +++|+||||||+|||++
T Consensus       101 ~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~  177 (496)
T PTZ00283        101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLC  177 (496)
T ss_pred             ecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEe
Confidence            5432        3789999999999999986432 2346889999999999999999999   67999999999999999


Q ss_pred             CCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccch
Q 008374          385 ADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHA  464 (568)
Q Consensus       385 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~  464 (568)
                      .++.+||+|||+++.+........   .....||+.|+|||++....++.++|||||||++|||++|+.||......   
T Consensus       178 ~~~~vkL~DFGls~~~~~~~~~~~---~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---  251 (496)
T PTZ00283        178 SNGLVKLGDFGFSKMYAATVSDDV---GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---  251 (496)
T ss_pred             CCCCEEEEecccCeeccccccccc---cccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---
Confidence            999999999999987654322111   12467999999999999999999999999999999999999999743221   


Q ss_pred             hhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          465 YTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       465 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                          +.+.... .+..         ...+......+..++..||+.||.+||++.++++.
T Consensus       252 ----~~~~~~~-~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        252 ----EVMHKTL-AGRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ----HHHHHHh-cCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                1111111 1110         01112234557778889999999999999999763

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=8.1e-38  Score=317.48  Aligned_cols=272  Identities=25%  Similarity=0.411  Sum_probs=208.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccc----------cccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceee
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQY----------HVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVH  308 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~----------~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~  308 (568)
                      ..+|+..++||+|+||.||++.....+..          ...+..||+|.+.... ....++|.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            34678889999999999999987642211          1134679999987653 234567899999999999999999


Q ss_pred             EEEEEEeCCeEEEEEEecCCCChhhhhccCC--------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 008374          309 LVGWCHEKGKLLLVYDFMPNGSLEKYLYGTS--------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASN  380 (568)
Q Consensus       309 l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~N  380 (568)
                      ++++|..++..++|+||+++++|.+++....        ....+++..++.++.|++.||+|||   +.+++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999996532        1226899999999999999999999   6799999999999


Q ss_pred             EEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCCC
Q 008374          381 ILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC--GRSPGNMI  458 (568)
Q Consensus       381 ILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t--G~~P~~~~  458 (568)
                      |+++.++.+||+|||+++..........   .....++..|+|||++....++.++|||||||++|||++  |..|+...
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRV---QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceee---cCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            9999999999999999986543321111   113456789999999988899999999999999999998  66777643


Q ss_pred             CcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          459 PHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       459 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      ....    ........+....      ..............+.+++.+|++.||++|||+.||++.|+.
T Consensus       238 ~~~~----~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         238 TDQQ----VIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             ChHH----HHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            3222    2222222211111      111111112233578889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.4e-37  Score=310.40  Aligned_cols=259  Identities=23%  Similarity=0.358  Sum_probs=208.5

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC---CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD---SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...+.||+|+||.||+|+...      +++.+|+|.++..   .....+.+.+|++++++++|+|++++++++...+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~   75 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLL------DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN   75 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcC------CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            578889999999999999999874      6788999988642   2233567899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          318 KLLLVYDFMPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      ..++||||+++++|.+++... .....+++.++..++.+++.||.|||   +.+++||||+|+||+++.++.++|+|||+
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~  152 (267)
T cd08224          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGL  152 (267)
T ss_pred             eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccce
Confidence            999999999999999998643 22345899999999999999999999   67999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ++.........     ....|+..|+|||.+.+..++.++||||||+++|||++|+.|+.....     .+.+..... .
T Consensus       153 ~~~~~~~~~~~-----~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~-~  221 (267)
T cd08224         153 GRFFSSKTTAA-----HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKI-E  221 (267)
T ss_pred             eeeccCCCccc-----ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-----cHHHHHhhh-h
Confidence            98765432211     134688999999999888899999999999999999999999864321     111111110 0


Q ss_pred             cCchhhhhhhhcCCCCc-HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          477 EGHIQDAVDQRLNINSV-VDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~-~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      .+         ...... ......+.+++.+|++.+|++|||+.+|+++|+..
T Consensus       222 ~~---------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         222 KC---------DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             cC---------CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            11         111111 13445677888899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.1e-38  Score=321.45  Aligned_cols=257  Identities=27%  Similarity=0.446  Sum_probs=200.3

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  318 (568)
                      ++|...+.||+|+||.||+|.+..++    ....+++|+++.. .......+.+|++++.++ +|+||+++++++...+.
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~   82 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   82 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCC----ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence            46778889999999999999986421    2245688887653 233456788999999999 89999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC
Q 008374          319 LLLVYDFMPNGSLEKYLYGTS-------------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA  385 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~  385 (568)
                      .++||||+++++|.+++....             ....+++.+++.++.|++.||+|||   +++++||||||+|||+++
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~  159 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGE  159 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecC
Confidence            999999999999999996432             1235889999999999999999999   679999999999999999


Q ss_pred             CCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccch
Q 008374          386 DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHA  464 (568)
Q Consensus       386 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~  464 (568)
                      ++.+||+|||+++........      ....++..|+|||++....++.++|||||||+++||+| |..||.......  
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--  231 (303)
T cd05088         160 NYVAKIADFGLSRGQEVYVKK------TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--  231 (303)
T ss_pred             CCcEEeCccccCcccchhhhc------ccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--
Confidence            999999999998743221110      12234678999999988889999999999999999998 999986433221  


Q ss_pred             hhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          465 YTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       465 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                        ..+.   .          ...............+.+++.+|++.+|++||++.++++.|+.
T Consensus       232 --~~~~---~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~  279 (303)
T cd05088         232 --LYEK---L----------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  279 (303)
T ss_pred             --HHHH---H----------hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence              1111   0          0111111111233456788889999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.1e-38  Score=322.81  Aligned_cols=237  Identities=22%  Similarity=0.296  Sum_probs=189.7

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCeEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      +.||+|+||.||+|+.+.      +++.||+|.+....   ....+.+..|..++..+ +||||+++++++...+.+++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv   74 (320)
T cd05590           1 RVLGKGSFGKVMLARLKE------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFV   74 (320)
T ss_pred             CeeeeCCCeEEEEEEEcC------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEE
Confidence            369999999999999875      67899999987532   23445677888888876 699999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      |||+++|+|..++..   ...+++..+..++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++....
T Consensus        75 ~Ey~~~g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~  148 (320)
T cd05590          75 MEFVNGGDLMFHIQK---SRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF  148 (320)
T ss_pred             EcCCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence            999999999998854   346889999999999999999999   67999999999999999999999999999876432


Q ss_pred             ccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD  482 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  482 (568)
                      ....     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    +...    ...+.   
T Consensus       149 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----~~~~----i~~~~---  212 (320)
T cd05590         149 NGKT-----TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD----LFEA----ILNDE---  212 (320)
T ss_pred             CCCc-----ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH----HHHH----HhcCC---
Confidence            2111     124579999999999998899999999999999999999999997543221    1111    11111   


Q ss_pred             hhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH
Q 008374          483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKT  518 (568)
Q Consensus       483 ~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~  518 (568)
                           .  ..+......+.+++..|++.||.+||++
T Consensus       213 -----~--~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         213 -----V--VYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             -----C--CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence                 0  0111123456677789999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.6e-38  Score=321.54  Aligned_cols=241  Identities=22%  Similarity=0.272  Sum_probs=190.1

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCeEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      ++||+|+||.||+|+.+.      ++..||+|.++...   ....+.+..|..++... +||||+++++++...+..++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   74 (316)
T cd05620           1 KVLGKGSFGKVLLAELKG------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEE
Confidence            369999999999999875      67899999997542   22345567788888754 899999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      |||+++|+|..++..   ...+++.+...++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        75 ~E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~  148 (316)
T cd05620          75 MEFLNGGDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF  148 (316)
T ss_pred             ECCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence            999999999999853   346889999999999999999999   67999999999999999999999999999875432


Q ss_pred             ccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD  482 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  482 (568)
                      ....     .....||..|+|||++.+..++.++|||||||++|||++|+.||.......    +.+..    ..+    
T Consensus       149 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~----~~~~~----~~~----  211 (316)
T cd05620         149 GDNR-----ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE----LFESI----RVD----  211 (316)
T ss_pred             CCCc-----eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHH----HhC----
Confidence            2111     124679999999999999999999999999999999999999997443221    11111    000    


Q ss_pred             hhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHH-HHH
Q 008374          483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTE-DIL  522 (568)
Q Consensus       483 ~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~-evl  522 (568)
                        .+.+    +......+.+++..|++.||++||++. +++
T Consensus       212 --~~~~----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         212 --TPHY----PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             --CCCC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence              0111    111223456677799999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-38  Score=311.66  Aligned_cols=254  Identities=25%  Similarity=0.372  Sum_probs=201.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-----ccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-----KSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      ++|...+.||+|+||.||++....      ++..+|+|.+.....     ...+.+.+|++++++++||||+++++++..
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~------~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   75 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVD------TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD   75 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcC------CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc
Confidence            568889999999999999998764      578999999864321     223568899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      .+..++|+||+++++|.+++..   ...+++.....++.|++.||.|||   +.+++||||+|+||++++++.+||+|||
T Consensus        76 ~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg  149 (263)
T cd06625          76 DETLSIFMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFG  149 (263)
T ss_pred             CCeEEEEEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence            9999999999999999999853   345888999999999999999999   6799999999999999999999999999


Q ss_pred             CccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      +++..........  ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......   ...    .  
T Consensus       150 ~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~----~--  218 (263)
T cd06625         150 ASKRLQTICSSGT--GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA---AIF----K--  218 (263)
T ss_pred             cceeccccccccc--cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH---HHH----H--
Confidence            9986643221111  1123567889999999999889999999999999999999999986432211   110    0  


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                             .................+..++..|++.+|.+|||+.|+++.
T Consensus       219 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         219 -------IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -------HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                   001111111222334456778889999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-38  Score=313.99  Aligned_cols=251  Identities=27%  Similarity=0.453  Sum_probs=195.9

Q ss_pred             eeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCeEEEEEEe
Q 008374          248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       248 ~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      .||+|+||.||+|++..++    ....+++|.++... ....+.+.+|++++.++ +||||++++++|...+..++||||
T Consensus         2 ~lg~g~~g~v~~~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   77 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   77 (270)
T ss_pred             cCCCCCCceEEEEEEcCCC----CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence            5899999999999987521    12457889887532 33456789999999999 799999999999999999999999


Q ss_pred             cCCCChhhhhccCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          326 MPNGSLEKYLYGTS-------------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       326 ~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                      +++|+|.+++....             ....+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+
T Consensus        78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEEC
Confidence            99999999986432             1235889999999999999999999   6799999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~  471 (568)
                      |||+++........      .....+..|+|||++....++.++||||||++++||++ |+.||.......    ...  
T Consensus       155 dfgl~~~~~~~~~~------~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~----~~~--  222 (270)
T cd05047         155 DFGLSRGQEVYVKK------TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYE--  222 (270)
T ss_pred             CCCCccccchhhhc------cCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH----HHH--
Confidence            99998643221111      02234567999999988889999999999999999997 999986432211    111  


Q ss_pred             HHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       472 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                       .          +...............+.+++..|++.||.+|||+.++++.|++.
T Consensus       223 -~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         223 -K----------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             -H----------HhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence             1          111111111122334677889999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.7e-38  Score=325.68  Aligned_cols=250  Identities=20%  Similarity=0.280  Sum_probs=194.4

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCeEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      +.||+|+||.||+++...      +++.+|+|.+.+..   ....+.+..|+.++.++ +||||+++++++...+..++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKK------TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEE
Confidence            369999999999999875      67899999997642   23345577898888777 899999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      |||+++|+|..++..   ...+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        75 ~E~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~  148 (329)
T cd05618          75 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  148 (329)
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence            999999999988843   346899999999999999999999   67999999999999999999999999999975432


Q ss_pred             ccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc-chhhHHHHHHHHhhcCchh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ-HAYTLVDWVWMLHREGHIQ  481 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~-~~~~l~~~~~~~~~~~~~~  481 (568)
                      ....     .....||..|+|||++.+..++.++|||||||++|||++|+.||....... ......++.........  
T Consensus       149 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--  221 (329)
T cd05618         149 PGDT-----TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--  221 (329)
T ss_pred             CCCc-----cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--
Confidence            2111     114579999999999999999999999999999999999999996321111 00122233333222111  


Q ss_pred             hhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC------HHHHHH
Q 008374          482 DAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK------TEDILQ  523 (568)
Q Consensus       482 ~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt------~~evl~  523 (568)
                            .  ..+......+..++..|++.||.+||+      +.++++
T Consensus       222 ------~--~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         222 ------I--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             ------C--CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence                  1  111223345667888999999999998      466643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.5e-38  Score=333.78  Aligned_cols=253  Identities=21%  Similarity=0.253  Sum_probs=198.8

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      ..++|...++||+|+||.||+++...      ++..+|+|.+....   ......+..|+.+++.++||||+++++++.+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~  114 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKS------SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD  114 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            45678999999999999999998875      67899999996532   2233457889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      .+..++||||+++|+|.+++..    ..++......++.|++.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG  187 (370)
T cd05596         115 DKYLYMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG  187 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEecc
Confidence            9999999999999999999843    34777888889999999999999   6799999999999999999999999999


Q ss_pred             CccccccccccccccccccCCcCCcccCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG----KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~----~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      +++..........    ....||+.|+|||.+...    .++.++|||||||++|||++|+.||.......    ..   
T Consensus       188 ~~~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~~---  256 (370)
T cd05596         188 TCMKMDANGMVRC----DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TY---  256 (370)
T ss_pred             ceeeccCCCcccC----CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH----HH---
Confidence            9987654322111    145799999999998653    47889999999999999999999997533211    00   


Q ss_pred             HHHhhcCchhhhhhh--hcCCCCcHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 008374          472 WMLHREGHIQDAVDQ--RLNINSVVDEAKRLLLLGLACSHPIASE--RPKTEDILQI  524 (568)
Q Consensus       472 ~~~~~~~~~~~~~d~--~l~~~~~~~~~~~l~~l~l~Cl~~dp~~--RPt~~evl~~  524 (568)
                               ..+++.  .+...........+.+++..|++.+|.+  |||+.|+++.
T Consensus       257 ---------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         257 ---------SKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ---------HHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                     111111  1111111122345566777899988987  9999999763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.1e-38  Score=315.45  Aligned_cols=264  Identities=20%  Similarity=0.337  Sum_probs=207.2

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEe-CC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE-KG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~  317 (568)
                      .++|...+.||+|+||.||+|.....+.  ..+..|++|++.... ....+.+.+|+.++++++|+||+++++++.. ..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~--~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKP--GKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCC--CceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            4678888999999999999999874211  136789999987542 3345678899999999999999999999876 46


Q ss_pred             eEEEEEEecCCCChhhhhccCCCc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQ-----VTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                      ..++++||+++++|.+++......     ..+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999998654322     46899999999999999999999   6799999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~  471 (568)
                      |||+++.+.........   ....++..|+|||++....++.++||||||+++||+++ |+.||......    .+..+.
T Consensus       160 d~g~~~~~~~~~~~~~~---~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~  232 (280)
T cd05043         160 DNALSRDLFPMDYHCLG---DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF----EMAAYL  232 (280)
T ss_pred             CCCCcccccCCceEEeC---CCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH----HHHHHH
Confidence            99999876433221111   12346778999999988889999999999999999999 99998753221    222211


Q ss_pred             HHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       472 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      .    .+         ............+.+++.+|++.||++|||+.+|++.|+..
T Consensus       233 ~----~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         233 K----DG---------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             H----cC---------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1    11         11111122345678899999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.6e-38  Score=325.25  Aligned_cols=255  Identities=22%  Similarity=0.254  Sum_probs=196.8

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC----cccchhhHHHHHHhhcC-CCCceeeEEEEEEeC
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS----IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEK  316 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  316 (568)
                      +|...++||+|+||.||+++...+.   .++..||+|.+.+..    ....+.+..|+.++.++ +|+||+++++++...
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGH---DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE   77 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccC---CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC
Confidence            4778899999999999999864321   257899999986532    22345678899999999 599999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +.+++||||+++|+|.+++..   ...+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~  151 (332)
T cd05614          78 AKLHLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGL  151 (332)
T ss_pred             CEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcC
Confidence            999999999999999999853   346889999999999999999999   67999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      ++..........    ....||..|+|||++.+. .++.++|||||||++|||++|+.||.......   .... +....
T Consensus       152 ~~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~-~~~~~  223 (332)
T cd05614         152 SKEFLSEEKERT----YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN---TQSE-VSRRI  223 (332)
T ss_pred             CccccccCCCcc----ccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC---CHHH-HHHHH
Confidence            986543322211    145799999999998765 47889999999999999999999997433222   1111 11111


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                      ..      .++.+    .......+..++..|++.||++||     +++++++
T Consensus       224 ~~------~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         224 LK------CDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             hc------CCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            00      01111    112234456777899999999999     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.6e-38  Score=319.99  Aligned_cols=265  Identities=26%  Similarity=0.457  Sum_probs=205.7

Q ss_pred             cCccccceeccCCceeEEEEEEccCcc-ccccCeEEEEEEeccCC-cccchhhHHHHHHhhcC-CCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQ-YHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  317 (568)
                      ++|...+.||+|+||.||++.....+. .......+|+|.+.... .....++..|++++.++ +||||++++++|...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            568899999999999999998753211 11134679999997542 33456788999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCC-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSE-------------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD  384 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld  384 (568)
                      ..++||||+++|+|.+++.....             ...++|.+++.++.|++.||+|||   +.+++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence            99999999999999999965321             235899999999999999999999   67999999999999999


Q ss_pred             CCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccc
Q 008374          385 ADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQH  463 (568)
Q Consensus       385 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~  463 (568)
                      .++.+||+|||+++...........   ....++..|+|||.+.+..++.++|||||||++|||++ |+.|+....... 
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~-  250 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKT---TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-  250 (307)
T ss_pred             CCCcEEECCCcccccccccchhhcc---ccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-
Confidence            9999999999999866432211111   12234578999999988889999999999999999998 888886432211 


Q ss_pred             hhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          464 AYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       464 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                         +..   .          +........+......+.+++..|++.+|.+||||.+|++.|+..
T Consensus       251 ---~~~---~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         251 ---LFK---L----------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             ---HHH---H----------HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence               111   1          111111122223345677788899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=8.1e-38  Score=316.72  Aligned_cols=267  Identities=25%  Similarity=0.427  Sum_probs=206.3

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      .+++|...++||+|+||.||+|..+.... ...+..||+|.+.... ......+.+|+.++++++||||+++++++...+
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCC-CCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45678889999999999999998653110 1135689999986543 223456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEE
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSE-------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR  390 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~k  390 (568)
                      ..++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||   +++++||||||+|||+++++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEE
Confidence            99999999999999999964211       234577888999999999999999   67999999999999999999999


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHH
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~  469 (568)
                      |+|||+++..........   .....++..|+|||.+.++.++.++|||||||++|||++ |..||.......    ..+
T Consensus       160 L~Dfg~~~~~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~----~~~  232 (288)
T cd05061         160 IGDFGMTRDIYETDYYRK---GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ----VLK  232 (288)
T ss_pred             ECcCCccccccccccccc---cCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH
Confidence            999999986543321111   112345678999999998899999999999999999998 788886432211    111


Q ss_pred             HHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          470 WVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       470 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                      ..    ..+..         ..........+.+++.+|++.||++|||+.++++.|+...
T Consensus       233 ~~----~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         233 FV----MDGGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HH----HcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            11    01100         1111223457888889999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1e-37  Score=317.43  Aligned_cols=250  Identities=19%  Similarity=0.331  Sum_probs=203.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      .+|...++||+|+||.||+|+...      ++..|++|.+........+.+.+|+.+++.++|+||+++++.+......+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~   93 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVA------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECC------CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence            467788899999999999998764      67899999998766556677899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++++|.+++..    ..+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~  166 (296)
T cd06654          94 VVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (296)
T ss_pred             EeecccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence            99999999999999843    35789999999999999999999   679999999999999999999999999998865


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      .......     ....|+..|+|||.+....++.++|||||||++|||++|+.||.......   .+..    ...    
T Consensus       167 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~---~~~~----~~~----  230 (296)
T cd06654         167 TPEQSKR-----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYL----IAT----  230 (296)
T ss_pred             ccccccc-----CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH---hHHH----Hhc----
Confidence            4332111     13468899999999988889999999999999999999999997433211   1111    000    


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                          +..............+.+++.+|+..+|++|||+.++++
T Consensus       231 ----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         231 ----NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ----CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence                000011112233455677888999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.6e-38  Score=327.88  Aligned_cols=243  Identities=24%  Similarity=0.325  Sum_probs=193.9

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVY  323 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  323 (568)
                      +.||+|+||.||++....      ++..||+|.+....   ......+..|++++..++||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~   74 (325)
T cd05594           1 KLLGKGTFGKVILVKEKA------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM   74 (325)
T ss_pred             CeeeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEE
Confidence            369999999999998764      67899999997542   233456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccc
Q 008374          324 DFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE  403 (568)
Q Consensus       324 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~  403 (568)
                      ||+++|+|..++..   ...+++.....++.|++.||.|||.  .++|+||||||+|||++.++.+||+|||+++.....
T Consensus        75 E~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~  149 (325)
T cd05594          75 EYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  149 (325)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC
Confidence            99999999998843   3468999999999999999999993  269999999999999999999999999998754322


Q ss_pred             cccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhh
Q 008374          404 RNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDA  483 (568)
Q Consensus       404 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  483 (568)
                      ...     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +.....    .+     
T Consensus       150 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~----~~~~i~----~~-----  211 (325)
T cd05594         150 GAT-----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELIL----ME-----  211 (325)
T ss_pred             Ccc-----cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH----HHHHHh----cC-----
Confidence            111     114569999999999999999999999999999999999999997433221    111110    00     


Q ss_pred             hhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          484 VDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       484 ~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                       ...+    +......+.+++.+|++.||++|+     ++.++++
T Consensus       212 -~~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         212 -EIRF----PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             -CCCC----CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence             0011    111233566777899999999996     8999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-37  Score=328.88  Aligned_cols=260  Identities=20%  Similarity=0.244  Sum_probs=195.7

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      .+|...++||+|+||.||++....      +++.||+|...      .+.+.+|++++++++||||+++++++......+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~------~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNK------TCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECC------CCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            468999999999999999999875      67899999753      235789999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +|+|++. ++|..++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus       160 lv~e~~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        160 LILPRYK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             EEEecCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            9999995 788888843   346889999999999999999999   679999999999999999999999999999754


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc---chhhHHHHHHHHhhc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ---HAYTLVDWVWMLHRE  477 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~---~~~~l~~~~~~~~~~  477 (568)
                      .......    .....||+.|+|||++....++.++|||||||++|||++|+.|+-......   ........+......
T Consensus       233 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~  308 (391)
T PHA03212        233 VDINANK----YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT  308 (391)
T ss_pred             ccccccc----cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence            3321111    124679999999999998899999999999999999999998864211100   000011111000000


Q ss_pred             ----------Cchhhhh---hhhc-C--C-----CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 ----------GHIQDAV---DQRL-N--I-----NSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ----------~~~~~~~---d~~l-~--~-----~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                                ..+....   .... .  .     ....+....+..++.+|++.||++|||+.|+++
T Consensus       309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                      0000000   0000 0  0     001123456778889999999999999999985

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=316.78  Aligned_cols=271  Identities=23%  Similarity=0.386  Sum_probs=204.1

Q ss_pred             cCccccceeccCCceeEEEEEEccCcc--------ccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQ--------YHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVG  311 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~--------~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g  311 (568)
                      ++|+..++||+|+||.||++.....+.        .......||+|.+.... ......|.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            468888999999999999988753211        01123468999987642 334567999999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhccCC---------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 008374          312 WCHEKGKLLLVYDFMPNGSLEKYLYGTS---------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL  382 (568)
Q Consensus       312 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIL  382 (568)
                      ++...+..++||||+++++|.+++....         ....+++..++.++.|++.||+|||   +.+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            9999999999999999999999985421         1124789999999999999999999   679999999999999


Q ss_pred             EcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCc
Q 008374          383 LDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC--GRSPGNMIPH  460 (568)
Q Consensus       383 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t--G~~P~~~~~~  460 (568)
                      +++++.+||+|||+++..........   .....++..|+|||.+..+.++.++|||||||+++||++  |..||.....
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRI---QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             EcCCCcEEecccccccccccCcceec---cCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            99999999999999986543221111   113345778999999988899999999999999999998  5567764332


Q ss_pred             ccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          461 QQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       461 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      ..    ............      +..............+.+++.+|++.||.+||||.+|++.|+.
T Consensus       239 ~~----~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         239 EQ----VIENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HH----HHHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            22    111111111100      0001011111234578889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=324.30  Aligned_cols=248  Identities=24%  Similarity=0.372  Sum_probs=204.0

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      .|...++||+|.||.||||....      +++.||+|++..+. ..+..+..+|+.++.+++++||.+++|.+..+..++
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~------t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lw   87 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNK------TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW   87 (467)
T ss_pred             ccccchhccccccceeeeeeecc------ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence            35566789999999999999875      78899999997654 345678899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      ++||||.+|++.+.|..   ...+......-|++++..||.|||   .++.+|||||+.|||+.++|.+||+|||++-.+
T Consensus        88 iiMey~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql  161 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQL  161 (467)
T ss_pred             HHHHHhcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeee
Confidence            99999999999999943   334577777788999999999999   679999999999999999999999999999887


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      .......     ...+||+.|||||++....|+.|+||||||++++||++|..|+.....-...+.             +
T Consensus       162 ~~~~~rr-----~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------------I  223 (467)
T KOG0201|consen  162 TNTVKRR-----KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------------I  223 (467)
T ss_pred             echhhcc-----ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------------c
Confidence            6653322     267899999999999988999999999999999999999999874322110000             0


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .+-.-+.+.+    .....+.+++-.|++.||+.||++.++++
T Consensus       224 pk~~PP~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  224 PKSAPPRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cCCCCCcccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            1111222322    33445667778999999999999999986

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=7.5e-38  Score=312.88  Aligned_cols=255  Identities=21%  Similarity=0.267  Sum_probs=200.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|...++||+|+||.||+|+...      +++.||+|++..........+.+|+.++.+++||||+++++++...+..+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~------~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLH------TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECC------CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence            468888999999999999999865      67899999997654445567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +|+||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus        83 iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~  156 (267)
T cd06646          83 ICMEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKI  156 (267)
T ss_pred             EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceee
Confidence            99999999999999853   346889999999999999999999   679999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFH---TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      .......     ....|+..|+|||.+.   ...++.++|||||||+++||++|+.|+........   ...+     ..
T Consensus       157 ~~~~~~~-----~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~---~~~~-----~~  223 (267)
T cd06646         157 TATIAKR-----KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLM-----SK  223 (267)
T ss_pred             ccccccc-----CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh---heee-----ec
Confidence            4322111     1346889999999874   34578899999999999999999999863322110   0000     00


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII  525 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L  525 (568)
                      ...   ..+.+..  .......+.+++..|++.+|++|||++++++.|
T Consensus       224 ~~~---~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         224 SNF---QPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCC---CCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            000   0011110  112235677888899999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-37  Score=309.77  Aligned_cols=255  Identities=30%  Similarity=0.508  Sum_probs=205.6

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .++|...++||+|+||.||+|...       ++..+|||.+.... ...+++.+|+.++++++|+||+++++++......
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-------~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-------GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI   76 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-------CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence            467888999999999999999875       45779999987543 3456799999999999999999999999988999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++++|.+++.... ...+++..+..++.+++.||.|||   +++++|+||||+||++++++.+||+|||+++.
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~  152 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARL  152 (261)
T ss_pred             EEEEeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECcccccee
Confidence            99999999999999996532 246899999999999999999999   67999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      +.........    ...++..|+|||.+.+..++.++||||||++++|+++ |+.||.......    ..+..       
T Consensus       153 ~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----~~~~~-------  217 (261)
T cd05034         153 IEDDEYTARE----GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE----VLEQV-------  217 (261)
T ss_pred             ccchhhhhhh----ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH-------
Confidence            6542211111    2335678999999998889999999999999999999 999986432221    11111       


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                            ........+.+....+.+++.+|++.+|++||+++++.+.|+.
T Consensus       218 ------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         218 ------ERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ------HcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                  1111111112234567888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.3e-38  Score=321.81  Aligned_cols=238  Identities=24%  Similarity=0.274  Sum_probs=187.4

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHH-HhhcCCCCceeeEEEEEEeCCeEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELA-IIHRLRHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      +.||+|+||+||+|+...      +++.||+|++....   ....+++..|.. +++.++||||+++++++...+..++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv   74 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKA------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFV   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEE
Confidence            369999999999999875      68899999987532   122344555554 56789999999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      |||+++|+|..++..   ...+++.....++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        75 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~  148 (323)
T cd05575          75 LDYVNGGELFFHLQR---ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE  148 (323)
T ss_pred             EcCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence            999999999999853   346888999999999999999999   67999999999999999999999999999975432


Q ss_pred             ccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD  482 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  482 (568)
                      ....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......       ....         
T Consensus       149 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~---------  207 (323)
T cd05575         149 HSKT-----TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-------MYDN---------  207 (323)
T ss_pred             CCCc-----cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-------HHHH---------
Confidence            2111     124579999999999999999999999999999999999999997532221       1111         


Q ss_pred             hhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 008374          483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTE  519 (568)
Q Consensus       483 ~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~  519 (568)
                      +....+.  ........+.+++..|++.||.+||+++
T Consensus       208 i~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         208 ILNKPLR--LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHcCCCC--CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            1111111  1112244566777899999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.1e-38  Score=324.22  Aligned_cols=242  Identities=23%  Similarity=0.298  Sum_probs=193.0

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCeEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      ++||+|+||.||+|+...      +++.||+|.+....   ....+.+..|.+++..+ +||||+++++++...+..++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv   74 (321)
T cd05591           1 KVLGKGSFGKVMLAELKG------TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFV   74 (321)
T ss_pred             CccccCCCeEEEEEEECC------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEE
Confidence            369999999999999864      67899999987642   23345677899998866 799999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      |||+++|+|..++..   ...+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        75 ~E~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~  148 (321)
T cd05591          75 MEYVNGGDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL  148 (321)
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence            999999999998853   346889999999999999999999   67999999999999999999999999999986433


Q ss_pred             ccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD  482 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  482 (568)
                      ....     .....||..|+|||++....++.++|||||||++|||++|+.||.......    +.+.   .. .+.   
T Consensus       149 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~----~~~~---i~-~~~---  212 (321)
T cd05591         149 NGVT-----TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD----LFES---IL-HDD---  212 (321)
T ss_pred             CCcc-----ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH----HHHH---HH-cCC---
Confidence            2211     124569999999999998899999999999999999999999997543322    1111   11 110   


Q ss_pred             hhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-------CHHHHHH
Q 008374          483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-------KTEDILQ  523 (568)
Q Consensus       483 ~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-------t~~evl~  523 (568)
                           .  ..+......+..++..|++.||++||       ++.++++
T Consensus       213 -----~--~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         213 -----V--LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             -----C--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence                 0  01111234566777899999999999       7888865

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-37  Score=321.93  Aligned_cols=266  Identities=27%  Similarity=0.446  Sum_probs=205.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCcc-ccccCeEEEEEEeccCC-cccchhhHHHHHHhhcC-CCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQ-YHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  317 (568)
                      .+|...+.||+|+||.||++.....+. .......||+|.+.... ....+++.+|++++.++ +||||++++++|...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            357788899999999999998653221 11134579999887542 23456899999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTS-------------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD  384 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld  384 (568)
                      ..++++||+++|+|.+++....             ....++|.++..++.|++.||.|||   +++++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence            9999999999999999986422             1235889999999999999999999   67999999999999999


Q ss_pred             CCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccc
Q 008374          385 ADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQH  463 (568)
Q Consensus       385 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~  463 (568)
                      +++.+||+|||+++..........   .....++..|+|||.+....++.++||||||+++|||++ |+.||....... 
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-  244 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKK---TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-  244 (334)
T ss_pred             CCCcEEECCcccceeccccccccc---ccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-
Confidence            999999999999987644321111   112334578999999999999999999999999999998 888886432221 


Q ss_pred             hhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          464 AYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       464 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                            +..... .         .............+.+++..|++.+|.+|||+.|+++.|+...
T Consensus       245 ------~~~~~~-~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         245 ------LFKLLK-E---------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             ------HHHHHH-c---------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence                  111111 1         1111112233456778889999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.1e-37  Score=312.25  Aligned_cols=251  Identities=25%  Similarity=0.362  Sum_probs=197.5

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      +|+..++||+|+||.||+|+...      ++..+|+|.+.... ....+++.+|++++.+++||||+++++++...+..+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   75 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLL------TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRIS   75 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcC------CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEE
Confidence            56777899999999999998764      67889999987542 334567899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++++|..+.       .+++.....++.|++.||.|||   +.+++|+||||+|||++.++.+||+|||++...
T Consensus        76 lv~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~  145 (279)
T cd06619          76 ICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL  145 (279)
T ss_pred             EEEecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence            999999999997653       3678888899999999999999   679999999999999999999999999999866


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      .....       ....||..|+|||++....++.++||||||+++|||++|+.||..............+.......   
T Consensus       146 ~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  215 (279)
T cd06619         146 VNSIA-------KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE---  215 (279)
T ss_pred             ccccc-------cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc---
Confidence            43321       14578999999999998899999999999999999999999987432221100111111000000   


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                         ..+.+.   .......+.+++..|++.+|++||+++|+++.
T Consensus       216 ---~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         216 ---DPPVLP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             ---CCCCCC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence               011111   11123456778889999999999999999863

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-39  Score=338.45  Aligned_cols=259  Identities=27%  Similarity=0.429  Sum_probs=218.5

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLL  321 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  321 (568)
                      +...++||+|+||+||||.|-.+++  .-+.+||+|.+... ..+..++++.|+.+|.+++||||++|+|+|.... +.|
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege--~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGE--NVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCc--eecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            3446789999999999999976432  24678999998664 4455688999999999999999999999998765 899


Q ss_pred             EEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccc
Q 008374          322 VYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE  401 (568)
Q Consensus       322 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~  401 (568)
                      |++|||.|+|.+|++.++  ..+.....+.+..|||+||.|||   +++++||||.++|||+.+-..+||.|||+|+.+.
T Consensus       775 vtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            999999999999997643  45778889999999999999999   7899999999999999999999999999999998


Q ss_pred             cccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          402 NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       402 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      .+...+....   ..-.+.|||-|.+....|+.++|||||||.+||++| |..|++..+..+                 +
T Consensus       850 ~d~~ey~~~~---gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-----------------I  909 (1177)
T KOG1025|consen  850 PDEKEYSAPG---GKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-----------------I  909 (1177)
T ss_pred             cccccccccc---cccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-----------------h
Confidence            8877665432   223578999999999999999999999999999999 999998765544                 2


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                      .+.+....+...+..+..++..+++.||..|+..||+++++...+..-+
T Consensus       910 ~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  910 PDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             hHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence            2233333344566677888999999999999999999999998887643

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.2e-38  Score=324.05  Aligned_cols=250  Identities=20%  Similarity=0.278  Sum_probs=195.4

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCeEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      +.||+|+||.||+++...      +++.||+|.++...   ....+.+..|..++.++ +||||+++++++...+.+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv   74 (329)
T cd05588           1 RVIGRGSYAKVLLVELKK------TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeEeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEE
Confidence            369999999999999875      67899999997642   23345678899999988 799999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      |||+++|+|..++..   ...+++..+..++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++....
T Consensus        75 ~e~~~~g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  148 (329)
T cd05588          75 IEFVSGGDLMFHMQR---QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR  148 (329)
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence            999999999998843   346899999999999999999999   67999999999999999999999999999975322


Q ss_pred             ccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc-chhhHHHHHHHHhhcCchh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ-HAYTLVDWVWMLHREGHIQ  481 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~-~~~~l~~~~~~~~~~~~~~  481 (568)
                      ....     .....||..|+|||++.+..++.++|||||||++|||++|+.||+...... ......++.......+.  
T Consensus       149 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--  221 (329)
T cd05588         149 PGDT-----TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--  221 (329)
T ss_pred             CCCc-----cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--
Confidence            1111     114579999999999999999999999999999999999999997322111 00122233332222211  


Q ss_pred             hhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC------HHHHHH
Q 008374          482 DAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK------TEDILQ  523 (568)
Q Consensus       482 ~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt------~~evl~  523 (568)
                            ..  .+......+..++..|++.||.+||+      ++++++
T Consensus       222 ------~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         222 ------IR--IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             ------CC--CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence                  11  11122345667778999999999997      677764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.2e-38  Score=323.88  Aligned_cols=242  Identities=19%  Similarity=0.285  Sum_probs=192.8

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCC-CceeeEEEEEEeCC
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRH-KHLVHLVGWCHEKG  317 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~  317 (568)
                      +|...+.||+|+||.||+|+...      +++.||||++....   ....+.+..|.+++..++| ++|+++++++...+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKG------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   74 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Confidence            47788899999999999999875      57889999987532   2345668889999999976 46888999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .+++||||+++|+|.+++..   ...+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~  148 (324)
T cd05587          75 RLYFVMEYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMC  148 (324)
T ss_pred             EEEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcc
Confidence            99999999999999999853   345889999999999999999999   679999999999999999999999999998


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +........     .....||..|+|||++.+..++.++|||||||++|||++|+.||.......    +...+      
T Consensus       149 ~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~----~~~~i------  213 (324)
T cd05587         149 KENIFGGKT-----TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----LFQSI------  213 (324)
T ss_pred             eecCCCCCc-----eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHH------
Confidence            753222111     124579999999999999999999999999999999999999997543222    11111      


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKT  518 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~  518 (568)
                            .....  ..+......+..++..|++.||.+||+.
T Consensus       214 ------~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         214 ------MEHNV--SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ------HcCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                  11111  1111223456677889999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.9e-38  Score=313.85  Aligned_cols=254  Identities=23%  Similarity=0.351  Sum_probs=199.3

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeEEEEEEeC
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEK  316 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  316 (568)
                      .+++.|...+.||+|+||.||+|....      +++.+|+|.+.... ....++..|+.++.++ +|+||+++++++...
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVK------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   75 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcC------CCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence            466778888999999999999998875      67899999986543 3456788999999998 799999999998753


Q ss_pred             ------CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEE
Q 008374          317 ------GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR  390 (568)
Q Consensus       317 ------~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~k  390 (568)
                            ...++||||+++++|.+++.... ...+++..+..++.|++.||+|||   +++++||||||+||++++++.+|
T Consensus        76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~  151 (272)
T cd06637          76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVK  151 (272)
T ss_pred             CCCCCCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEE
Confidence                  46899999999999999986532 346899999999999999999999   57999999999999999999999


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchh
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH-----TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY  465 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~  465 (568)
                      |+|||+++........     .....|+..|+|||++.     ...++.++|||||||++|||++|+.|+.......   
T Consensus       152 l~Dfg~~~~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~---  223 (272)
T cd06637         152 LVDFGVSAQLDRTVGR-----RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---  223 (272)
T ss_pred             EccCCCceeccccccc-----CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH---
Confidence            9999999876432211     12456899999999986     3457889999999999999999999986432211   


Q ss_pred             hHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          466 TLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       466 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                         .... . ....     ...+.   .......+.+++.+||+.+|.+|||+.++++
T Consensus       224 ---~~~~-~-~~~~-----~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         224 ---ALFL-I-PRNP-----APRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             ---HHHH-H-hcCC-----CCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence               1100 0 0000     11111   1122345677888999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.9e-38  Score=315.87  Aligned_cols=264  Identities=27%  Similarity=0.441  Sum_probs=205.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .++|+..+.||+|+||.||++...... ...++..+|+|.+.... ....++|.+|+.++++++||||++++++|.....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLL-PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccC-CCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            456888899999999999999875310 01246789999987543 2345679999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCC-------------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 008374          319 LLLVYDFMPNGSLEKYLYGTS-------------------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKAS  379 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~  379 (568)
                      .++||||+++|+|.+++....                   ....+++..++.++.|++.||.|||   +++++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHh
Confidence            999999999999999996321                   1235788999999999999999999   679999999999


Q ss_pred             CEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 008374          380 NILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMI  458 (568)
Q Consensus       380 NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~  458 (568)
                      ||++++++.+||+|||+++...........   ....++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKAS---ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             heEecCCCceEECccccceecccCcccccc---CCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999865433211111   12234678999999988899999999999999999998 88887643


Q ss_pred             CcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          459 PHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       459 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      ....       .... ...+...         .........+.+++.+|++.+|++|||+.|+++.|++
T Consensus       237 ~~~~-------~~~~-~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         237 AHEE-------VIYY-VRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CHHH-------HHHH-HhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            2211       1111 1111111         1112334567889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.9e-38  Score=330.59  Aligned_cols=254  Identities=22%  Similarity=0.264  Sum_probs=196.1

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC---CcccchhhHHHHHHhhcCCCCceeeEEEEEE
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD---SIKSKGDFLAELAIIHRLRHKHLVHLVGWCH  314 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~  314 (568)
                      ...++|...++||+|+||.||+++...      +++.+|+|.+.+.   .....+.+.+|+.+++.++||||+++++++.
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~  113 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKS------SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ  113 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            345678999999999999999999875      6789999998652   2223455789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 008374          315 EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDF  394 (568)
Q Consensus       315 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DF  394 (568)
                      ..+..++||||+++|+|.+++..    ..++......++.|++.||+|||   +++|+||||||+|||+++++.+||+||
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DF  186 (370)
T cd05621         114 DDKYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADF  186 (370)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEec
Confidence            99999999999999999999843    24788889999999999999999   679999999999999999999999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG----KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~----~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~  470 (568)
                      |+++.........    .....||+.|+|||++...    .++.++|||||||++|||++|+.||.......   ..   
T Consensus       187 G~a~~~~~~~~~~----~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~---~~---  256 (370)
T cd05621         187 GTCMKMDETGMVR----CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG---TY---  256 (370)
T ss_pred             ccceecccCCcee----cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH---HH---
Confidence            9998764322111    1246799999999998653    37889999999999999999999997432211   00   


Q ss_pred             HHHHhhcCchhhhhhhh--cCCCCcHHHHHHHHHHHHhcCCCCCC--CCCCHHHHHHH
Q 008374          471 VWMLHREGHIQDAVDQR--LNINSVVDEAKRLLLLGLACSHPIAS--ERPKTEDILQI  524 (568)
Q Consensus       471 ~~~~~~~~~~~~~~d~~--l~~~~~~~~~~~l~~l~l~Cl~~dp~--~RPt~~evl~~  524 (568)
                                ..+++..  +...........+..++..|+..++.  .||++.|+++.
T Consensus       257 ----------~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         257 ----------SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ----------HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                      1111111  11111112233444555667765443  48999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-37  Score=313.63  Aligned_cols=246  Identities=21%  Similarity=0.339  Sum_probs=190.4

Q ss_pred             eeccCCceeEEEEEEccCccc------------------cccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeE
Q 008374          248 RLGEGGFGIVYKGIIHHNDQY------------------HVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHL  309 (568)
Q Consensus       248 ~LG~G~fG~Vy~g~~~~~~~~------------------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l  309 (568)
                      +||+|+||.||+|.+...+..                  ......|++|.+.........+|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            699999999999987532110                  11235689999876544445678899999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC--
Q 008374          310 VGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF--  387 (568)
Q Consensus       310 ~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~--  387 (568)
                      +++|.+....++||||+++|+|+.++...  ...+++..+..++.|+++||+|||   +++|+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcc
Confidence            99999999999999999999999998542  346889999999999999999999   67999999999999997643  


Q ss_pred             -----cEEEeecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHH-hCCCCCCCCCc
Q 008374          388 -----NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVV-CGRSPGNMIPH  460 (568)
Q Consensus       388 -----~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~-tG~~P~~~~~~  460 (568)
                           .+|++|||++.......         ...++..|+|||.+.. ..++.++||||||+++|||+ +|+.|+.....
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~~---------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSRE---------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             cCccceeeecCCcccccccccc---------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence                 38999999986543221         2346788999998865 56899999999999999995 68988874332


Q ss_pred             ccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          461 QQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       461 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                      ..    ...+.             +......  ......+..++..||+.+|++|||+.+|++.|+
T Consensus       228 ~~----~~~~~-------------~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         228 SE----KERFY-------------EKKHRLP--EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HH----HHHHH-------------HhccCCC--CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            21    11110             1111100  111235778888999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-37  Score=307.64  Aligned_cols=254  Identities=30%  Similarity=0.550  Sum_probs=204.9

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc-chhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      +.||+|+||.||+|......   ..+..+++|.+....... .+.+.+|++++.+++|+||+++++++......++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD---GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCC---CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence            36999999999999987421   137889999997654433 67899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCC------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          326 MPNGSLEKYLYGTSE------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      +++++|.+++.....      ...+++..+..++.|++.||.|||   +++++||||||+||++++++.+||+|||.++.
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccccc
Confidence            999999999965421      267899999999999999999999   68999999999999999999999999999988


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      .........   .....++..|+|||.+....++.++||||+|++++||++ |+.||.......    +.+..    ..+
T Consensus       155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~----~~~  223 (262)
T cd00192         155 VYDDDYYRK---KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE----VLEYL----RKG  223 (262)
T ss_pred             ccccccccc---ccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHH----HcC
Confidence            765432111   124567889999999988899999999999999999999 699987553221    11111    111


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                               ............+.+++..|++.+|++|||+.|+++.|+
T Consensus       224 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 ---------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                     111122233567788888999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.4e-38  Score=323.05  Aligned_cols=242  Identities=19%  Similarity=0.283  Sum_probs=193.4

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcC-CCCceeeEEEEEEeCC
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKG  317 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  317 (568)
                      +|...+.||+|+||.||+|+...      ++..||+|.+.+..   ....+.+..|..++..+ +|++|+++++++...+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKG------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD   74 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC
Confidence            47778899999999999998875      67899999987642   22334567788888777 5899999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .+++||||+++|+|..++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||+++++.+||+|||++
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~  148 (323)
T cd05616          75 RLYFVMEYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC  148 (323)
T ss_pred             EEEEEEcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCc
Confidence            99999999999999999853   345889999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +........     .....||+.|+|||++....++.++|||||||++|||++|+.||.......    +...       
T Consensus       149 ~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~----~~~~-------  212 (323)
T cd05616         149 KENMWDGVT-----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQS-------  212 (323)
T ss_pred             eecCCCCCc-----cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH----HHHH-------
Confidence            754322111     124679999999999999999999999999999999999999997543222    1111       


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKT  518 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~  518 (568)
                           +.....  ..+......+..++..|++.||.+|++.
T Consensus       213 -----i~~~~~--~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         213 -----IMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -----HHhCCC--CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                 111111  1112234456778889999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-38  Score=338.53  Aligned_cols=264  Identities=23%  Similarity=0.286  Sum_probs=213.4

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-CCceeeEEEE-EEe--
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-HKHLVHLVGW-CHE--  315 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~-~~~--  315 (568)
                      ..+..+.+.|.+|||+.||.|....      .+.++|+|++-..+....+...+|+++|++|+ |+|||.+++. ...  
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~  109 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVK------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS  109 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecC------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence            3456778899999999999999874      34899999988778888899999999999996 9999999993 221  


Q ss_pred             ----CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 008374          316 ----KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL  391 (568)
Q Consensus       316 ----~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL  391 (568)
                          .-+.+|.||||++|+|-+++..... ..|+..++++|+.++++|+++||.. ..+|||||||.+||||..+++.||
T Consensus       110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKL  187 (738)
T ss_pred             CCCceeEEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEe
Confidence                1378999999999999999976443 3499999999999999999999976 888999999999999999999999


Q ss_pred             eecCCccccccccccccc----cccccCCcCCcccCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccch
Q 008374          392 GDFGLARAIENERNSYAE----HGLVGVPGTMGYVAPECF---HTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHA  464 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~----~~~~~~~Gt~~y~APE~~---~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~  464 (568)
                      ||||-|............    .......-|+.|+|||.+   .+...++|+|||+|||+||-|+....||+....    
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----  263 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----  263 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----
Confidence            999998765333211000    000112358899999987   456789999999999999999999999985421    


Q ss_pred             hhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC
Q 008374          465 YTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTV  531 (568)
Q Consensus       465 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~  531 (568)
                                      ..+++..+..........++..|+..||++||.+||++.||++.+......
T Consensus       264 ----------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  264 ----------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             ----------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                            234555555555567788888899999999999999999999987654433

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.9e-38  Score=332.23  Aligned_cols=205  Identities=24%  Similarity=0.331  Sum_probs=172.9

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .|...++||+|+||+||+|+...      +++.+|+|++....   ....+.+.+|+.++++++||||+++++.+.+.+.
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~   75 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVD------TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN   75 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECC------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE
Confidence            47888999999999999999875      67899999986532   2334578899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      +++|||||++|+|.+++..   ...++......++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        76 ~~lv~E~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~  149 (382)
T cd05625          76 LYFVMDYIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (382)
T ss_pred             EEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCc
Confidence            9999999999999999854   245788888999999999999999   6799999999999999999999999999986


Q ss_pred             cccccccc------------------------------------------ccccccccCCcCCcccCccccccCCCCccc
Q 008374          399 AIENERNS------------------------------------------YAEHGLVGVPGTMGYVAPECFHTGKATPES  436 (568)
Q Consensus       399 ~~~~~~~~------------------------------------------~~~~~~~~~~Gt~~y~APE~~~~~~~t~~s  436 (568)
                      .+......                                          ..........||+.|+|||++.+..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~  229 (382)
T cd05625         150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC  229 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCee
Confidence            43210000                                          000001135799999999999999999999


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCC
Q 008374          437 DVFGFGAVVLEVVCGRSPGNMI  458 (568)
Q Consensus       437 DV~SfGvll~el~tG~~P~~~~  458 (568)
                      |||||||++|||++|+.||...
T Consensus       230 DiwSlGvil~elltG~~Pf~~~  251 (382)
T cd05625         230 DWWSVGVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             eEEechHHHHHHHhCCCCCCCC
Confidence            9999999999999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-38  Score=331.93  Aligned_cols=206  Identities=24%  Similarity=0.341  Sum_probs=173.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...++||+|+||.||++....      +++.||||.+....   ....+.+.+|++++.+++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~   74 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKD------TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ   74 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECC------CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            368888999999999999998875      67899999986532   233456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++|+|.+++..   ...+++.....++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla  148 (377)
T cd05629          75 YLYLIMEFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLS  148 (377)
T ss_pred             eeEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccc
Confidence            99999999999999999953   346888889999999999999999   679999999999999999999999999999


Q ss_pred             ccccccccc-----------cc-------------------------------ccccccCCcCCcccCccccccCCCCcc
Q 008374          398 RAIENERNS-----------YA-------------------------------EHGLVGVPGTMGYVAPECFHTGKATPE  435 (568)
Q Consensus       398 ~~~~~~~~~-----------~~-------------------------------~~~~~~~~Gt~~y~APE~~~~~~~t~~  435 (568)
                      +........           ..                               ........||+.|+|||++....++.+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  228 (377)
T cd05629         149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE  228 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc
Confidence            743211000           00                               000012469999999999998899999


Q ss_pred             chhHHHHHHHHHHHhCCCCCCCC
Q 008374          436 SDVFGFGAVVLEVVCGRSPGNMI  458 (568)
Q Consensus       436 sDV~SfGvll~el~tG~~P~~~~  458 (568)
                      +|||||||++|||++|+.||...
T Consensus       229 ~DiwSlGvil~elltG~~Pf~~~  251 (377)
T cd05629         229 CDWWSLGAIMFECLIGWPPFCSE  251 (377)
T ss_pred             eeeEecchhhhhhhcCCCCCCCC
Confidence            99999999999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.4e-37  Score=312.38  Aligned_cols=263  Identities=23%  Similarity=0.403  Sum_probs=206.3

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-cchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|....+||+|+||.||+|+.+.... ......+++|.+...... ..+++.+|++++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEE-EGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCc-CCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            467888899999999999999864322 124578999998665433 456799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCc------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEee
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQ------VTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD  393 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~D  393 (568)
                      ++||||+++|+|.+++......      ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcc
Confidence            9999999999999999654322      26899999999999999999999   67999999999999999999999999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHH
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      ||+++.........    .....++..|+|||.+....++.++||||||++++||++ |..||.......    +...  
T Consensus       161 ~~~~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~----~~~~--  230 (275)
T cd05046         161 LSLSKDVYNSEYYK----LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE----VLNR--  230 (275)
T ss_pred             cccccccCcccccc----cCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH----HHHH--
Confidence            99987654322111    113456778999999988889999999999999999999 778886432221    1111  


Q ss_pred             HHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                        ...+.        +...........+.+++.+|++.+|++|||+.|+++.|.+
T Consensus       231 --~~~~~--------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         231 --LQAGK--------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             --HHcCC--------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence              11111        1111112234567788889999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.3e-37  Score=311.45  Aligned_cols=258  Identities=28%  Similarity=0.427  Sum_probs=200.9

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      +.||+|+||.||+|+..........+..+|+|.+.... .....+|.+|+.++++++||||++++++|...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36899999999999886432112245789999886543 23456799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCC----CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-----cEEEeecCC
Q 008374          326 MPNGSLEKYLYGTS----EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF-----NARLGDFGL  396 (568)
Q Consensus       326 ~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~-----~~kL~DFGl  396 (568)
                      +++++|.+++....    ....+++.++..++.|++.||.|||   +.+++|+||||+||+++.+.     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999996432    2245889999999999999999999   67999999999999999877     899999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      ++...........   ....++..|+|||++.++.++.++||||||+++|||++ |+.||.......    ....+    
T Consensus       158 ~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~----~~~~~----  226 (269)
T cd05044         158 ARDIYKSDYYRKE---GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE----VLQHV----  226 (269)
T ss_pred             ccccccccccccC---cccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH----HHHHH----
Confidence            9866433211111   12345788999999999999999999999999999998 999986432211    11111    


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                               +..............+.+++.+|+..+|++||++.+|++.|+.
T Consensus       227 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         227 ---------TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ---------hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                     1111111122334567788889999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.7e-37  Score=309.19  Aligned_cols=256  Identities=29%  Similarity=0.464  Sum_probs=194.7

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcCCCCceeeEEEEEEe-CCeEEEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE-KGKLLLVYD  324 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E  324 (568)
                      +.||+|+||.||+|.+...+   .....+|+|++... .....+.+.+|+.+++.++||||++++++|.. ++..++|+|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSD---GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCC---CceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence            36899999999999976422   14568999998643 23345678899999999999999999998764 456899999


Q ss_pred             ecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccccc
Q 008374          325 FMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER  404 (568)
Q Consensus       325 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~  404 (568)
                      |+++|+|.+++....  ..+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++......
T Consensus        78 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          78 YMKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            999999999996432  34678888999999999999999   6799999999999999999999999999998654321


Q ss_pred             ccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCC-CCCCCCCcccchhhHHHHHHHHhhcCchhhh
Q 008374          405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGR-SPGNMIPHQQHAYTLVDWVWMLHREGHIQDA  483 (568)
Q Consensus       405 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~-~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  483 (568)
                      .... .......++..|+|||++....++.++||||||+++|||++|. .|+......    .+...+.    .+.    
T Consensus       153 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~----~~~~~~~----~~~----  219 (262)
T cd05058         153 YYSV-HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF----DITVYLL----QGR----  219 (262)
T ss_pred             ceee-cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHh----cCC----
Confidence            1000 0011345677899999998889999999999999999999954 455432211    1222111    110    


Q ss_pred             hhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          484 VDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       484 ~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                         ..  ......+..+.+++..||+.+|++||++.||++.|+..
T Consensus       220 ---~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         220 ---RL--LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             ---CC--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence               00  11112235677899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.6e-37  Score=312.89  Aligned_cols=249  Identities=22%  Similarity=0.320  Sum_probs=194.4

Q ss_pred             eccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 008374          249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       249 LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      ||+|+||.||++..+.      +++.+|+|.+.....   ...+.+..|++++++++||||+++++++......++||||
T Consensus         1 lg~G~~g~Vy~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05607           1 LGKGGFGEVCAVQVKN------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSL   74 (277)
T ss_pred             CCCCCceEEEEEEEcc------CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEec
Confidence            7999999999999875      688999999865321   2234566799999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccc
Q 008374          326 MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN  405 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~  405 (568)
                      +++++|..++.... ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........
T Consensus        75 ~~g~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~  150 (277)
T cd05607          75 MNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT  150 (277)
T ss_pred             CCCCCHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce
Confidence            99999998885432 345889999999999999999999   67999999999999999999999999999987654321


Q ss_pred             cccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhh
Q 008374          406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVD  485 (568)
Q Consensus       406 ~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  485 (568)
                      .      ....||..|+|||++.+..++.++|||||||++|||++|+.||.......   ...+.....         +.
T Consensus       151 ~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~---~~~~~~~~~---------~~  212 (277)
T cd05607         151 I------TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV---AKEELKRRT---------LE  212 (277)
T ss_pred             e------eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh---hHHHHHHHh---------hc
Confidence            1      13568999999999998889999999999999999999999987433221   111111111         11


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          486 QRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       486 ~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                      ...... .......+.+++..|++.||++||+++|+++.+.
T Consensus       213 ~~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         213 DEVKFE-HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             cccccc-cccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            111000 0112334677788999999999999987765433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.2e-37  Score=307.71  Aligned_cols=248  Identities=30%  Similarity=0.457  Sum_probs=198.7

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEE-eCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCH-EKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~-~~~~~  319 (568)
                      ++|...+.||+|+||.||++...        +..+|+|.++...  ..+.|.+|+.++++++|+|++++++++. ..+..
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--------~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   75 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--------CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence            35778889999999999999763        6779999986542  3467899999999999999999999765 45678


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++|+||+++++|.+++.... ...+++..+..++.+++.||+|||   +++++||||||+||++++++.+||+|||+++.
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  151 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  151 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCcccee
Confidence            99999999999999986532 235889999999999999999999   67999999999999999999999999999886


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ......        ...++..|+|||++....++.++|||||||++|||++ |+.|+......    .+..++.    . 
T Consensus       152 ~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~----~~~~~~~----~-  214 (256)
T cd05082         152 ASSTQD--------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPRVE----K-  214 (256)
T ss_pred             ccccCC--------CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHh----c-
Confidence            543221        2345678999999988899999999999999999998 99998643221    1111111    0 


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                              .............+..++.+|++.+|.+|||+.++++.|+.
T Consensus       215 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         215 --------GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             --------CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence                    11111122334567788889999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-37  Score=301.42  Aligned_cols=281  Identities=20%  Similarity=0.260  Sum_probs=206.2

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc--cchhhHHHHHHhhcCCCCceeeEEEEEEeC-
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK--SKGDFLAELAIIHRLRHKHLVHLVGWCHEK-  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-  316 (568)
                      .++|+..++|++|.||.||+|+.+.      +++.||+|+++.+...  ---..++|+.+|.+++|||||.+..+.... 
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~------t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~  148 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKK------TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN  148 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCC------cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence            3568888999999999999999886      7889999999765321  123458999999999999999999887643 


Q ss_pred             -CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          317 -GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       317 -~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                       +..|||||||++ +|...+....  ..+...+...+..|+++|++|||   ...|+|||||++|+|+...|.+||+|||
T Consensus       149 ~d~iy~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFG  222 (419)
T KOG0663|consen  149 MDKIYIVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFG  222 (419)
T ss_pred             cceeeeeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccc
Confidence             579999999965 8999886543  46888899999999999999999   6799999999999999999999999999


Q ss_pred             CccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH----
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW----  470 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~----  470 (568)
                      |||.+......++     ..+-|..|.|||++.+ ..|++..|+||+||++.|+++++.-|.+..+-.....+...    
T Consensus       223 LAR~ygsp~k~~T-----~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtP  297 (419)
T KOG0663|consen  223 LAREYGSPLKPYT-----PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTP  297 (419)
T ss_pred             hhhhhcCCcccCc-----ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCC
Confidence            9999988755544     5677999999999876 56899999999999999999999877654332211111110    


Q ss_pred             ---HHHHhhcCchhhhhh---------hhcCCCCcHH-HHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-hCCCCCCCCCC
Q 008374          471 ---VWMLHREGHIQDAVD---------QRLNINSVVD-EAKRLLLLGLACSHPIASERPKTEDILQII-SGTSTVPYVPQ  536 (568)
Q Consensus       471 ---~~~~~~~~~~~~~~d---------~~l~~~~~~~-~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L-~~~~~~p~~p~  536 (568)
                         .|.-+.   ....+.         ..++..+... ..+.-+.++-..+..||.+|.|+.|.++.= =.+.|+|.-|.
T Consensus       298 te~iwpg~~---~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~  374 (419)
T KOG0663|consen  298 SEAIWPGYS---ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPS  374 (419)
T ss_pred             ccccCCCcc---ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChh
Confidence               010000   000000         0011111110 123334455566789999999999987631 23456666555


Q ss_pred             CCCc
Q 008374          537 FKPA  540 (568)
Q Consensus       537 ~~~~  540 (568)
                      +.|-
T Consensus       375 ~~Pt  378 (419)
T KOG0663|consen  375 MFPT  378 (419)
T ss_pred             hcCC
Confidence            5444

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.1e-37  Score=308.76  Aligned_cols=253  Identities=28%  Similarity=0.480  Sum_probs=202.3

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|...++||+|+||.||++.+.       .+..+|+|.+.... ...+.|.+|++++++++|+||+++.+.+.+ ...+
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~-------~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYN-------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             cceeEEeEecCccceEEEEEEec-------CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            56888899999999999999865       45679999886542 345678999999999999999999999887 7889


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      ++|||+++++|.+++.... ...+++..+..++.+++.||.|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus        77 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  152 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVI  152 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeec
Confidence            9999999999999996532 346889999999999999999999   579999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      .........    ...++..|+|||++....++.++|+|||||+++|+++ |+.||.......    +..+.    ..+ 
T Consensus       153 ~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~----~~~~~----~~~-  219 (260)
T cd05073         153 EDNEYTARE----GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----VIRAL----ERG-  219 (260)
T ss_pred             cCCCccccc----CCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH----HHHHH----hCC-
Confidence            543221111    2345678999999988889999999999999999999 899987432221    11111    111 


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                              ............+.+++.+|++.+|++||++.+++++|+.
T Consensus       220 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         220 --------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             --------CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                    1111112334567788889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=9.9e-38  Score=320.69  Aligned_cols=242  Identities=23%  Similarity=0.301  Sum_probs=190.9

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCeEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      +.||+|+||.||+|+...      +++.||||.++...   ....+.+..|..++..+ +||||+++++++.+.+.+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (316)
T cd05619           1 KMLGKGSFGKVFLAELKG------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFV   74 (316)
T ss_pred             CeeeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEE
Confidence            369999999999999875      57889999987642   22345567788888764 899999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      |||+++|+|.+++..   ...+++.+...++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++....
T Consensus        75 ~ey~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  148 (316)
T cd05619          75 MEYLNGGDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML  148 (316)
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence            999999999999853   346889999999999999999999   67999999999999999999999999999975432


Q ss_pred             ccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD  482 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  482 (568)
                      ....     .....||..|+|||++.+..++.++|||||||++|||++|+.||.......    +...+    ..+    
T Consensus       149 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----~~~~i----~~~----  211 (316)
T cd05619         149 GDAK-----TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE----LFQSI----RMD----  211 (316)
T ss_pred             CCCc-----eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH----HHHHH----HhC----
Confidence            2111     124579999999999998899999999999999999999999997543221    11111    000    


Q ss_pred             hhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHH
Q 008374          483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTE-DILQ  523 (568)
Q Consensus       483 ~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~-evl~  523 (568)
                        .+.+    +......+.+++..|++.||++||++. ++.+
T Consensus       212 --~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         212 --NPCY----PRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             --CCCC----CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence              0111    111223456777899999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.1e-37  Score=314.95  Aligned_cols=271  Identities=24%  Similarity=0.394  Sum_probs=204.3

Q ss_pred             cCccccceeccCCceeEEEEEEccCc----------cccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHND----------QYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHL  309 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~----------~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l  309 (568)
                      ++|+..++||+|+||.||++......          ........+|+|++.... ....++|.+|+.++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46888899999999999998654211          011134579999987543 3345689999999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChhhhhccCCC--------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 008374          310 VGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE--------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNI  381 (568)
Q Consensus       310 ~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NI  381 (568)
                      ++++...+..++||||+++++|.+++.....        ...+++.+...++.|++.||+|||   +.+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            9999999999999999999999999865321        235788999999999999999999   67999999999999


Q ss_pred             EEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCC
Q 008374          382 LLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC--GRSPGNMIP  459 (568)
Q Consensus       382 Lld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t--G~~P~~~~~  459 (568)
                      |++.++.+||+|||+++.+........   .....++..|+|||....+.++.++|||||||++|||++  |..|+....
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRI---QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceec---cCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            999999999999999986644321111   012344678999999888899999999999999999998  677876433


Q ss_pred             cccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          460 HQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       460 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      ...    ............      ...............+.+++.+||+.||.+||++.+|++.|+.
T Consensus       239 ~~~----~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         239 DEQ----VIENTGEFFRDQ------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             hHH----HHHHHHHHHhhc------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            222    111111111100      0000011112234677889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.5e-37  Score=318.93  Aligned_cols=267  Identities=25%  Similarity=0.465  Sum_probs=205.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCcc-ccccCeEEEEEEeccCC-cccchhhHHHHHHhhcC-CCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQ-YHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  316 (568)
                      .++|...++||+|+||.||+++...... .......+|+|.+.... .....++..|+++++++ +||||++++++|...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            3567888999999999999998643211 11245679999987542 23456788999999999 699999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTS-------------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL  383 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl  383 (568)
                      +..++||||+++|+|.+++....             ....++|.+...++.|++.||.|||   +.+++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence            99999999999999999996532             1245899999999999999999999   6799999999999999


Q ss_pred             cCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 008374          384 DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQ  462 (568)
Q Consensus       384 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~  462 (568)
                      ++++.+||+|||+++...........   ....++..|+|||.+....++.++||||||+++|||++ |+.||.......
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKT---SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             cCCCcEEEcccccccccccccccccc---ccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999876432211110   12234567999999988899999999999999999999 888886443221


Q ss_pred             chhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          463 HAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       463 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                          +.+.    ...+         ............+..++.+|++.+|++|||+.|+++.|++..
T Consensus       245 ----~~~~----~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         245 ----LFKL----LREG---------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             ----HHHH----HHcC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence                1111    1111         011112223446667888999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.6e-37  Score=308.63  Aligned_cols=256  Identities=25%  Similarity=0.398  Sum_probs=192.0

Q ss_pred             eeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 008374          248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFM  326 (568)
Q Consensus       248 ~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  326 (568)
                      .||+|+||.||+|.+..+.    .+..+|+|+++.... .....|.+|+.++++++||||+++++++.+....++||||+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGY----TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             cccccCCceEEEEEEcCCC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence            5899999999999876321    457899999876432 33457889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCC--CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccccc
Q 008374          327 PNGSLEKYLYGTS--EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER  404 (568)
Q Consensus       327 ~~gsL~~~L~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~  404 (568)
                      ++|+|.+++....  .....++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            9999999996532  2235677888899999999999999   6799999999999999999999999999997654322


Q ss_pred             ccccccccccCCcCCcccCccccccC-------CCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          405 NSYAEHGLVGVPGTMGYVAPECFHTG-------KATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       405 ~~~~~~~~~~~~Gt~~y~APE~~~~~-------~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ....   .....|+..|+|||++...       .++.++||||||+++|||++ |+.||......+    ......    
T Consensus       155 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~----~~~~~~----  223 (269)
T cd05087         155 YYVT---PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ----VLTYTV----  223 (269)
T ss_pred             eeec---CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH----HHHHHh----
Confidence            1111   1134578899999998532       35789999999999999996 999997543322    111110    


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                      .+......++.+..    .....+..++..|+ .+|++|||++||++.|+
T Consensus       224 ~~~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         224 REQQLKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             hcccCCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            01111111222211    12223455666888 68999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.9e-38  Score=332.51  Aligned_cols=206  Identities=24%  Similarity=0.326  Sum_probs=173.2

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      +|...++||+|+||.||+++...      +++.||||.+....   ......+.+|++++.+++|+||+++++.+.+.+.
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~   75 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVD------TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECC------CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE
Confidence            58888999999999999999875      67899999986532   2234568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      +++||||+++|+|.+++..   ...++......++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|.
T Consensus        76 ~~lv~E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~  149 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence            9999999999999999954   345788888899999999999999   6799999999999999999999999999985


Q ss_pred             cccccccc--------------------------------------ccccccccCCcCCcccCccccccCCCCccchhHH
Q 008374          399 AIENERNS--------------------------------------YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFG  440 (568)
Q Consensus       399 ~~~~~~~~--------------------------------------~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~S  440 (568)
                      .+......                                      ..........||+.|||||++....++.++||||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  229 (376)
T cd05598         150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  229 (376)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeee
Confidence            43210000                                      0000011357999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC
Q 008374          441 FGAVVLEVVCGRSPGNMIP  459 (568)
Q Consensus       441 fGvll~el~tG~~P~~~~~  459 (568)
                      |||++|||++|+.||....
T Consensus       230 lGvilyell~G~~Pf~~~~  248 (376)
T cd05598         230 VGVILYEMLVGQPPFLADT  248 (376)
T ss_pred             ccceeeehhhCCCCCCCCC
Confidence            9999999999999997543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.9e-37  Score=308.52  Aligned_cols=247  Identities=23%  Similarity=0.386  Sum_probs=191.7

Q ss_pred             ceeccCCceeEEEEEEccCcc------ccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQ------YHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      +.||+|+||.||+|++...+.      .......|++|.+..........|..|+.+++.++||||++++++|......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998753221      11234578999987655555567899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc-------EEEee
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN-------ARLGD  393 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~-------~kL~D  393 (568)
                      +||||+++|+|+.++...  ...+++..+..++.|+++||+|||   +++|+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999999988542  245899999999999999999999   689999999999999987664       89999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCccccc-cCCCCccchhHHHHHHHHHHH-hCCCCCCCCCcccchhhHHHHH
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH-TGKATPESDVFGFGAVVLEVV-CGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-~~~~t~~sDV~SfGvll~el~-tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      ||++.......         ...++..|+|||++. ...++.++|||||||++|||+ +|+.|+......+     ... 
T Consensus       156 ~g~~~~~~~~~---------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~-  220 (262)
T cd05077         156 PGIPITVLSRQ---------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-----KER-  220 (262)
T ss_pred             CCCCccccCcc---------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-----HHH-
Confidence            99987653221         345788999999886 467899999999999999998 5888876332111     000 


Q ss_pred             HHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       472 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                        .. .+..      ....    .....+..++..||+.||.+||++.++++.|+
T Consensus       221 --~~-~~~~------~~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         221 --FY-EGQC------MLVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             --HH-hcCc------cCCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence              00 0000      0111    11345677888999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-38  Score=295.12  Aligned_cols=250  Identities=22%  Similarity=0.337  Sum_probs=206.6

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      +.++|+.++.||+|.||.||.|+.++      +.-.||+|++.+...   +-..++.+|+++-+.|+||||+++++|+.+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekk------s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd   93 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKK------SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD   93 (281)
T ss_pred             chhhccccccccCCccccEeEeeecc------CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence            34679999999999999999999886      678899999876532   334678999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      ....||++||.+.|+|...|.... ...++......++.|+|.||.|+|   .++|+||||||+|+|++..+..||+|||
T Consensus        94 ~~riyLilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfG  169 (281)
T KOG0580|consen   94 SKRIYLILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFG  169 (281)
T ss_pred             cceeEEEEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCC
Confidence            999999999999999999997432 345777778889999999999999   7899999999999999999999999999


Q ss_pred             CccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      -+..-..++.       ...+||.-|++||...+..++..+|+|++|++.+|++.|..||+.....+...          
T Consensus       170 wsV~~p~~kR-------~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk----------  232 (281)
T KOG0580|consen  170 WSVHAPSNKR-------KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK----------  232 (281)
T ss_pred             ceeecCCCCc-------eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH----------
Confidence            8876543322       26799999999999999999999999999999999999999998654332111          


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                            .+..-++  ..+........+++..|+..+|.+|.+..||++
T Consensus       233 ------rI~k~~~--~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  233 ------RIRKVDL--KFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ------HHHHccc--cCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence                  1111111  112233344566777999999999999999976

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.1e-37  Score=327.52  Aligned_cols=261  Identities=20%  Similarity=0.265  Sum_probs=197.3

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC--
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG--  317 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--  317 (568)
                      +|+..++||+|+||.||++....      +++.||||++...  .....+.+.+|+++++.++||||+++++++...+  
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   74 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPR------DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID   74 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECC------CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence            47788899999999999998764      6789999998653  2234467889999999999999999999998776  


Q ss_pred             ---eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 008374          318 ---KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDF  394 (568)
Q Consensus       318 ---~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DF  394 (568)
                         ..++|+||+. ++|.+++..   ...+++..+..++.|++.||.|||   +++++||||||+|||++.++.+||+||
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Df  147 (372)
T cd07853          75 PFEEIYVVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDF  147 (372)
T ss_pred             ccceEEEEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccc
Confidence               8999999996 578887743   346899999999999999999999   679999999999999999999999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      |+++.........    .....+|..|+|||.+.+. .++.++|||||||+++||++|+.||...........+.    .
T Consensus       148 g~a~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~----~  219 (372)
T cd07853         148 GLARVEEPDESKH----MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT----D  219 (372)
T ss_pred             cceeecccCcccc----CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH----H
Confidence            9998764432211    1234688999999998764 57899999999999999999999997543322111111    0


Q ss_pred             HhhcCc----------hhhhhhh-hcCC-------CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          474 LHREGH----------IQDAVDQ-RLNI-------NSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       474 ~~~~~~----------~~~~~d~-~l~~-------~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ......          ....+.. ....       .........+.+++.+|++.||++|||+.|+++
T Consensus       220 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         220 LLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            000000          0000000 0000       001112345678888999999999999999987

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-37  Score=322.94  Aligned_cols=266  Identities=25%  Similarity=0.407  Sum_probs=202.2

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcC-CCCceeeEEEEEEeC-
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEK-  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-  316 (568)
                      .++|...++||+|+||.||+|+....+. ..+++.||||++.... ....+.+.+|+.++.++ +||||++++++|... 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCc-cccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            3568889999999999999998643211 1257889999997543 23345788999999999 689999999988654 


Q ss_pred             CeEEEEEEecCCCChhhhhccCCC--------------------------------------------------------
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSE--------------------------------------------------------  340 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~--------------------------------------------------------  340 (568)
                      ...++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            568999999999999999864210                                                        


Q ss_pred             --------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccccccccccccc
Q 008374          341 --------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL  412 (568)
Q Consensus       341 --------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~  412 (568)
                              ...+++..+..++.|+++||+|||   +++++||||||+|||+++++.+||+|||+++...........   
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~---  238 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK---  238 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc---
Confidence                    124788899999999999999999   679999999999999999999999999999876432211111   


Q ss_pred             ccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCC
Q 008374          413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNIN  491 (568)
Q Consensus       413 ~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  491 (568)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |..|+.......   .+..    ....+.         ...
T Consensus       239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~~~---------~~~  302 (343)
T cd05103         239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCR----RLKEGT---------RMR  302 (343)
T ss_pred             CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH---HHHH----HHhccC---------CCC
Confidence            12345678999999988899999999999999999997 888986432221   1111    111111         000


Q ss_pred             CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          492 SVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       492 ~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      .+......+.+++..||+.+|++|||+.||++.|+..
T Consensus       303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            0111224578888999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-37  Score=311.05  Aligned_cols=262  Identities=24%  Similarity=0.430  Sum_probs=205.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .+|...+.||+|+||.||+|.++..+.  .....+|+|.+..... ....++.+|+.++++++||||++++++|.. ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~--~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGE--KVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCC--CcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            456778899999999999999865321  1245799999876543 345678999999999999999999999987 789


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++|+||+++|+|.+++...  ...+++.....++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++.
T Consensus        84 ~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence            9999999999999999643  235899999999999999999999   67999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ..........   ....++..|+|||.+....++.++||||||++++|+++ |+.||.......    +.+.+.    .+
T Consensus       159 ~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~----~~  227 (279)
T cd05057         159 LDVDEKEYHA---EGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE----IPDLLE----KG  227 (279)
T ss_pred             ccCcccceec---CCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH----HHHHHh----CC
Confidence            7644332211   12234578999999988899999999999999999998 999987543221    111111    11


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST  530 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~  530 (568)
                               .....+......+..++..||..+|.+||++.++++.|+....
T Consensus       228 ---------~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         228 ---------ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                     0111111233456778889999999999999999999987533

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=9.2e-38  Score=321.20  Aligned_cols=242  Identities=21%  Similarity=0.267  Sum_probs=193.8

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCeEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      +.||+|+||.||++....      ++..||+|.+.+..   ......+..|.+++..+ +||||+++++++...+.+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv   74 (318)
T cd05570           1 KVLGKGSFGKVLLAELKG------TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFV   74 (318)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            369999999999999875      57889999997542   23445677899999888 799999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      |||+++|+|..++..   ...+++.+...++.|++.||.|||   +++++||||||+|||+++++.+||+|||+++....
T Consensus        75 ~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  148 (318)
T cd05570          75 MEYVNGGDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL  148 (318)
T ss_pred             EcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence            999999999998853   346899999999999999999999   67999999999999999999999999999875322


Q ss_pred             ccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD  482 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  482 (568)
                      ....     .....||..|+|||++.+..++.++|||||||++|||++|+.||.......    +...    ....    
T Consensus       149 ~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~----~~~~----i~~~----  211 (318)
T cd05570         149 GGVT-----TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE----LFQS----ILED----  211 (318)
T ss_pred             CCCc-----ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH----HHHH----HHcC----
Confidence            2111     114568999999999999999999999999999999999999997443221    1111    1111    


Q ss_pred             hhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHH
Q 008374          483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKT-----EDILQ  523 (568)
Q Consensus       483 ~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~-----~evl~  523 (568)
                          ..  ..+......+.+++..|++.||.+||++     .++++
T Consensus       212 ----~~--~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         212 ----EV--RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             ----CC--CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence                11  1111223456778889999999999999     88765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.6e-37  Score=306.86  Aligned_cols=252  Identities=25%  Similarity=0.494  Sum_probs=200.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      .+|...+.||+|+||.||+|.+.       .+..+|+|.+.... ....+|.+|++++++++|||++++++++......+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-------~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-------EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPIC   75 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-------CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceE
Confidence            35677889999999999999875       35679999986543 23457999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++++|.+++....  ..+++..+..++.+++.+|+|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus        76 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  150 (256)
T cd05112          76 LVFEFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV  150 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeec
Confidence            9999999999999985432  35789999999999999999999   679999999999999999999999999999866


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      ........    ....++.+|+|||++.++.++.++||||||+++|||++ |+.||.......    +.+   .. ..+ 
T Consensus       151 ~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~---~~-~~~-  217 (256)
T cd05112         151 LDDQYTSS----TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE----VVE---TI-NAG-  217 (256)
T ss_pred             ccCccccc----CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH----HHH---HH-hCC-
Confidence            43321111    12345678999999988899999999999999999998 999987432211    111   11 111 


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                              .....+......+.+++.+|++.+|++|||+.++++.|.
T Consensus       218 --------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         218 --------FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                    000001112456888899999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.5e-37  Score=315.39  Aligned_cols=262  Identities=23%  Similarity=0.313  Sum_probs=200.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...++||+|+||.||++....      ++..+|+|.+.... .....++.+|++++.+++||||++++++|...+.+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   74 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRP------SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEI   74 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcC------CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEE
Confidence            368889999999999999998764      57789999986542 22345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++++|.+++...   ..+++.....++.|+++||.|||+  ..+++||||||+|||++.++.+||+|||++..
T Consensus        75 ~lv~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  149 (308)
T cd06615          75 SICMEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  149 (308)
T ss_pred             EEEeeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccc
Confidence            9999999999999999543   458899999999999999999994  25899999999999999999999999999876


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC-
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG-  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~-  478 (568)
                      ......       ....|+..|+|||.+.+..++.++||||||+++|||++|+.|+.......    +..+........ 
T Consensus       150 ~~~~~~-------~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~  218 (308)
T cd06615         150 LIDSMA-------NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE----LEAMFGRPVSEGE  218 (308)
T ss_pred             cccccc-------ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh----HHHhhcCcccccc
Confidence            543211       14568899999999988889999999999999999999999986332111    111110000000 


Q ss_pred             -------------------chhhhhhhhcCC---CC-cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          479 -------------------HIQDAVDQRLNI---NS-VVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       479 -------------------~~~~~~d~~l~~---~~-~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                                         ...+..+.....   .. .......+.+++.+|++.+|++|||+.||++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         219 AKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                               000001100000   00 00123357788899999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-39  Score=297.67  Aligned_cols=268  Identities=20%  Similarity=0.237  Sum_probs=213.1

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeC---
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK---  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~---  316 (568)
                      .++|.+.++||+|||+-||.++.-.      ++..+|+|++...+.++.+..++|++..++++|||++++++++..+   
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s------~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D   93 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLS------TGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD   93 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccC------cccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence            3568889999999999999998544      6789999999888878888999999999999999999999987544   


Q ss_pred             --CeEEEEEEecCCCChhhhhccCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEee
Q 008374          317 --GKLLLVYDFMPNGSLEKYLYGTS-EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD  393 (568)
Q Consensus       317 --~~~~lV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~D  393 (568)
                        .+.||+++|...|||.+.+.... ++..++..+.+.|+.+|++||.+||+. ..+++||||||.|||+.+.+.++|.|
T Consensus        94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D  172 (302)
T KOG2345|consen   94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMD  172 (302)
T ss_pred             CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEe
Confidence              35999999999999999987543 344799999999999999999999965 45699999999999999999999999


Q ss_pred             cCCcccccccc----ccccccccccCCcCCcccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhh
Q 008374          394 FGLARAIENER----NSYAEHGLVGVPGTMGYVAPECFHT---GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYT  466 (568)
Q Consensus       394 FGla~~~~~~~----~~~~~~~~~~~~Gt~~y~APE~~~~---~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~  466 (568)
                      ||.+....-..    ....-........|..|.|||.+.-   ...++++|||||||+||+|+.|..||+....+...  
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS--  250 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS--  250 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe--
Confidence            99988653221    1111111123356889999999853   45688999999999999999999999843322210  


Q ss_pred             HHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          467 LVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       467 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                                  -...+....+.........+.+.+++.+|++.||.+||++.+++..++..
T Consensus       251 ------------laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  251 ------------LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ------------EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                        01122233443333334677888999999999999999999999998764

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.7e-38  Score=311.61  Aligned_cols=247  Identities=23%  Similarity=0.395  Sum_probs=192.4

Q ss_pred             ceeccCCceeEEEEEEccCccc-cccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQY-HVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      +.||+|+||.||+|.....+.. ......+++|.+........+.+..|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            3699999999999988643221 123556899998765555567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc--------EEEeecCCc
Q 008374          326 MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN--------ARLGDFGLA  397 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~--------~kL~DFGla  397 (568)
                      +++|+|.+++....  ..+++..+..++.|++.||.|||   +++++||||||+||+++.++.        +|++|||++
T Consensus        81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999999996532  36899999999999999999999   679999999999999987765        589999988


Q ss_pred             cccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCC-CCCCCCCcccchhhHHHHHHHHh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGR-SPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~-~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      .......         ...++..|+|||++.+ ..++.++||||||+++|||++|. .|+.......    ...      
T Consensus       156 ~~~~~~~---------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~----~~~------  216 (258)
T cd05078         156 ITVLPKE---------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK----KLQ------  216 (258)
T ss_pred             cccCCch---------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH----HHH------
Confidence            6543211         3457889999999976 45789999999999999999995 5554322111    000      


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                             ....+..  .+......+.+++..||+.||++|||++++++.|+
T Consensus       217 -------~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         217 -------FYEDRHQ--LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -------HHHcccc--CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                   0011111  11112245678888999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-38  Score=325.80  Aligned_cols=242  Identities=24%  Similarity=0.300  Sum_probs=191.9

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYD  324 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  324 (568)
                      +.||+|+||.||++....+.   ..++.+|+|++.....  .....+..|++++++++||||+++++++...+..++|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGP---DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            57999999999998764211   1578999999975432  234457789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccccc
Q 008374          325 FMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER  404 (568)
Q Consensus       325 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~  404 (568)
                      |+++|+|.+++..   ...+++.....++.|++.||.|||   +++|+||||||+|||+++++.+||+|||+++......
T Consensus        79 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  152 (318)
T cd05582          79 FLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  152 (318)
T ss_pred             CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence            9999999999843   346899999999999999999999   6799999999999999999999999999998654332


Q ss_pred             ccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhh
Q 008374          405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV  484 (568)
Q Consensus       405 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  484 (568)
                      ..     .....||..|+|||.+....++.++|||||||++|||++|+.||.......    ....            +.
T Consensus       153 ~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----~~~~------------i~  211 (318)
T cd05582         153 KK-----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE----TMTM------------IL  211 (318)
T ss_pred             Cc-----eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH----HHHH------------HH
Confidence            11     114579999999999988889999999999999999999999997532221    1111            11


Q ss_pred             hhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 008374          485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTED  520 (568)
Q Consensus       485 d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~e  520 (568)
                      ....  ..+......+.+++..|++.||++||++.+
T Consensus       212 ~~~~--~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         212 KAKL--GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             cCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            1111  111122345667778999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.8e-37  Score=312.52  Aligned_cols=276  Identities=24%  Similarity=0.387  Sum_probs=207.5

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-cchhhHHHHHHhhcCCCCceeeEEEEEEe--CCe
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHRLRHKHLVHLVGWCHE--KGK  318 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~  318 (568)
                      .|...+.||+|+||.||+|++....  ...+..+|||.+...... ..++|.+|++++++++|+||+++++++..  ...
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLG--DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCC--CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            4566788999999999999976321  125789999999765443 46789999999999999999999999987  557


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++++|.+++....  ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            999999999999999996432  35899999999999999999999   6799999999999999999999999999999


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ...........  .....++..|+|||.+....++.++||||||++++||++|+.|+..............  .......
T Consensus       158 ~~~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~  233 (284)
T cd05038         158 VLPEDKDYYYV--KEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA--QGQMIVT  233 (284)
T ss_pred             ccccCCcceec--cCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccc--cccccHH
Confidence            87643222111  1123455679999999888999999999999999999999999764322110000000  0000000


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      .+.+.+...............+.+++.+|++.+|++||||.||+++|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            01111111111122223346788899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.4e-37  Score=320.77  Aligned_cols=242  Identities=24%  Similarity=0.272  Sum_probs=188.9

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHH-HhhcCCCCceeeEEEEEEeCCeEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELA-IIHRLRHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      ++||+|+||+||+|+...      +++.+|+|++....   ......+..|.. +++.++||||+++++++...+..++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv   74 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKL------DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFV   74 (325)
T ss_pred             CceeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEE
Confidence            369999999999998764      67899999986532   223345566655 46778999999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      |||+++|+|..++..   ...+++.....++.||+.||.|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus        75 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~  148 (325)
T cd05604          75 LDFVNGGELFFHLQR---ERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA  148 (325)
T ss_pred             EcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence            999999999988843   346889999999999999999999   67999999999999999999999999999975432


Q ss_pred             ccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD  482 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  482 (568)
                      ....     .....||..|+|||++.+..++.++|||||||++|||++|+.||.......    +   ....        
T Consensus       149 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----~---~~~~--------  208 (325)
T cd05604         149 QSDT-----TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE----M---YDNI--------  208 (325)
T ss_pred             CCCC-----cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH----H---HHHH--------
Confidence            2111     124579999999999999999999999999999999999999997532221    1   1111        


Q ss_pred             hhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       483 ~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       ....+..  .......+.+++..|++.+|.+||++++.++
T Consensus       209 -~~~~~~~--~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         209 -LHKPLVL--RPGASLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             -HcCCccC--CCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence             1111100  1112334566778999999999999864433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-37  Score=308.99  Aligned_cols=248  Identities=23%  Similarity=0.355  Sum_probs=201.7

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      +|...+.||.|+||.||+|+...      ++..+|+|.+.... ......+.+|+.+++.++|+||+++++++.+....+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKR------TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLW   75 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECC------CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEE
Confidence            57777889999999999999875      67899999987653 344567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +|+||+++++|.+++...    .+++.....++.|++.||.|||   +++++||||+|+||++++++.++|+|||+++..
T Consensus        76 ~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  148 (274)
T cd06609          76 IIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQL  148 (274)
T ss_pred             EEEEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceee
Confidence            999999999999998532    6899999999999999999999   679999999999999999999999999999887


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      ......     .....|+..|+|||++.+..++.++||||||+++|||++|+.||.......    .   ... ...+  
T Consensus       149 ~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~----~---~~~-~~~~--  213 (274)
T cd06609         149 TSTMSK-----RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR----V---LFL-IPKN--  213 (274)
T ss_pred             cccccc-----cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH----H---HHH-hhhc--
Confidence            654211     114568899999999998889999999999999999999999987432111    0   000 0001  


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                         ..+.+...   .....+.+++..|++.+|++|||++++++
T Consensus       214 ---~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         214 ---NPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ---CCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence               01111111   03345677888999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-38  Score=324.07  Aligned_cols=252  Identities=23%  Similarity=0.344  Sum_probs=210.0

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|...+++|+|+||.++..+.+.      ++..+++|.+.-.  ....++..++|+.++++++|||||.+.+.+.+++.
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~------~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~   77 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKS------DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ   77 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhcc------CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc
Confidence            467778899999999999988775      6779999998654  33445578899999999999999999999999988


Q ss_pred             -EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          319 -LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       319 -~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                       ++|||+||+||+|.+.+.... ...+..+.+..++.|++.|+.|||   ++.|+|||||+.|||+..+..+||+|||+|
T Consensus        78 ~l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGla  153 (426)
T KOG0589|consen   78 LLCIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLA  153 (426)
T ss_pred             eEEEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhh
Confidence             999999999999999997644 456888999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +.+.......     ..+.||+.||.||.+.+.+|..|+||||+||++|||++-+.+|...+...    |+.        
T Consensus       154 K~l~~~~~~a-----~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~----Li~--------  216 (426)
T KOG0589|consen  154 KILNPEDSLA-----STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE----LIL--------  216 (426)
T ss_pred             hhcCCchhhh-----heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH----HHH--------
Confidence            9988765221     26889999999999999999999999999999999999999998654332    211        


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                          ++.. ......+......+..++..|++.+|+.||++.+++..
T Consensus       217 ----ki~~-~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  217 ----KINR-GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ----HHhh-ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                1111 11122334445566677779999999999999999863

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.1e-37  Score=313.17  Aligned_cols=259  Identities=20%  Similarity=0.329  Sum_probs=206.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      .+|...++||+|+||.||+|+...      ++..||+|.+........+.+.+|+.+++.++|+||+++++++...+..+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIA------TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   92 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECC------CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence            568888999999999999998764      67899999997765555677889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++++|.+++..    ..+++.++..++.|++.+|.|||   +.+++||||||+|||++.++.+||+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~  165 (297)
T cd06656          93 VVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (297)
T ss_pred             EeecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence            99999999999999843    35788999999999999999999   679999999999999999999999999999865


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      .......     ....++..|+|||.+.+..++.++|||||||++|+|++|+.||.......   .+.. .         
T Consensus       166 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~---~~~~-~---------  227 (297)
T cd06656         166 TPEQSKR-----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYL-I---------  227 (297)
T ss_pred             cCCccCc-----CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch---heee-e---------
Confidence            4432211     13468899999999998889999999999999999999999996432211   0000 0         


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCCCCCC
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISGTSTVP  532 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L~~~~~~p  532 (568)
                        .................+.+++.+|++.+|++||++.++++  .++...+.+
T Consensus       228 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (297)
T cd06656         228 --ATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS  279 (297)
T ss_pred             --ccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence              00000001112223345667888999999999999999987  444444433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2e-37  Score=311.86  Aligned_cols=246  Identities=22%  Similarity=0.365  Sum_probs=199.7

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLL  321 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  321 (568)
                      |...+.||+|+||.||+|....      .+..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNR------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcC------CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence            5566789999999999998864      57889999987543 3345678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccc
Q 008374          322 VYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE  401 (568)
Q Consensus       322 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~  401 (568)
                      ||||+++++|.+++..    ..+++.....++.|++.|+.|||   +++++|+||+|+||++++++.+||+|||+++.+.
T Consensus        80 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06642          80 IMEYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             EEEccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEcccccccccc
Confidence            9999999999999842    35889999999999999999999   6799999999999999999999999999998765


Q ss_pred             cccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchh
Q 008374          402 NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQ  481 (568)
Q Consensus       402 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  481 (568)
                      ......     ....|+..|+|||++.+..++.++||||||++++||++|+.|+.......    ...   .        
T Consensus       153 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~---~--------  212 (277)
T cd06642         153 DTQIKR-----NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR----VLF---L--------  212 (277)
T ss_pred             Ccchhh-----hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh----HHh---h--------
Confidence            432111     13468899999999998899999999999999999999999986432211    110   0        


Q ss_pred             hhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          482 DAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       482 ~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        +...............+.+++..|++.+|.+||+|.++++
T Consensus       213 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         213 --IPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             --hhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence              0111111112233456778888999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-37  Score=313.63  Aligned_cols=267  Identities=25%  Similarity=0.412  Sum_probs=203.6

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeC--Ce
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK--GK  318 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~  318 (568)
                      .|...++||+|+||.||++.+...+  ..++..||+|.+.... ......+.+|++++++++||||+++.+++...  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEG--DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCC--CCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            3677889999999999999864221  1257889999987543 33446799999999999999999999999875  57


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++++|.+++...  ...+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccc
Confidence            89999999999999998543  235899999999999999999999   6799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc--------chhhHHHH
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ--------HAYTLVDW  470 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~--------~~~~l~~~  470 (568)
                      .+.........  .....++..|+|||++.+..++.++||||||+++|||++++.|........        .......+
T Consensus       158 ~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05079         158 AIETDKEYYTV--KDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL  235 (284)
T ss_pred             ccccCccceee--cCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence            77543322111  113457788999999988889999999999999999999887643210000        00001111


Q ss_pred             HHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          471 VWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       471 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      + .         .+...............+.+++.+|++.+|++|||+.++++.|+.
T Consensus       236 ~-~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         236 V-R---------VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             H-H---------HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            1 0         111111111122345678889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.9e-37  Score=345.44  Aligned_cols=263  Identities=20%  Similarity=0.245  Sum_probs=202.0

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...++||+|+||.||+|+...      +++.||+|++.....   ...++|.+|++++++++||||+++++++.+.+
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~------tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~   75 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPV------CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD   75 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECC------CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence            468889999999999999998864      678999999975422   23457999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCC--------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcE
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTS--------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA  389 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~  389 (568)
                      ..++||||+++|+|.+++....        ....+++..++.++.|+++||+|||   +++|+||||||+|||++.++.+
T Consensus        76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~v  152 (932)
T PRK13184         76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEV  152 (932)
T ss_pred             EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCE
Confidence            9999999999999999986421        1234677888999999999999999   6799999999999999999999


Q ss_pred             EEeecCCccccccccccc-------------cccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008374          390 RLGDFGLARAIENERNSY-------------AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGN  456 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~-------------~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~  456 (568)
                      ||+|||+++.........             .........||+.|||||.+.+..++.++|||||||+++||+||+.||.
T Consensus       153 KLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~  232 (932)
T PRK13184        153 VILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR  232 (932)
T ss_pred             EEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence            999999998762211000             0000113569999999999999999999999999999999999999997


Q ss_pred             CCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhC
Q 008374          457 MIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-KTEDILQIISG  527 (568)
Q Consensus       457 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-t~~evl~~L~~  527 (568)
                      ......    +..   .    ...   .++. ......+....+.+++.+|++.||++|| +++++++.|+.
T Consensus       233 ~~~~~k----i~~---~----~~i---~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        233 RKKGRK----ISY---R----DVI---LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             Ccchhh----hhh---h----hhc---cChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            532211    000   0    000   0000 0001112334567788899999999996 56777776654

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.7e-37  Score=318.10  Aligned_cols=238  Identities=26%  Similarity=0.303  Sum_probs=186.8

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHH-HhhcCCCCceeeEEEEEEeCCeEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELA-IIHRLRHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      ++||+|+||.||+|+...      +++.||+|.+.+..   .....++..|.. +++.++||||+++++++.+.+..++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv   74 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKS------DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFV   74 (321)
T ss_pred             CeeeeCCCEEEEEEEECC------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEE
Confidence            369999999999999875      67899999986532   122344555654 57889999999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      |||+++|+|..++..   ...++......++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        75 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  148 (321)
T cd05603          75 LDYVNGGELFFHLQR---ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE  148 (321)
T ss_pred             EcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence            999999999988843   345788888999999999999999   67999999999999999999999999999875422


Q ss_pred             ccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD  482 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  482 (568)
                      ....     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    +.+   .         
T Consensus       149 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~---~---------  207 (321)
T cd05603         149 PEET-----TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ----MYD---N---------  207 (321)
T ss_pred             CCCc-----cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH----HHH---H---------
Confidence            2111     124578999999999998899999999999999999999999997532211    111   1         


Q ss_pred             hhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 008374          483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTE  519 (568)
Q Consensus       483 ~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~  519 (568)
                      +....+  ..+......+.+++.+|++.||.+||+..
T Consensus       208 i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         208 ILHKPL--QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HhcCCC--CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            111111  11122334567788899999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.9e-37  Score=332.44  Aligned_cols=260  Identities=21%  Similarity=0.286  Sum_probs=192.0

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeC---
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK---  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~---  316 (568)
                      .++|...++||+|+||.||+|+...      .++.||||++....    ....+|+.++++++||||+++++++...   
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~  134 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICID------TSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFK  134 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECC------CCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence            4579999999999999999999864      67899999985432    2345799999999999999999876432   


Q ss_pred             -----CeEEEEEEecCCCChhhhhccC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-cE
Q 008374          317 -----GKLLLVYDFMPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF-NA  389 (568)
Q Consensus       317 -----~~~~lV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~-~~  389 (568)
                           ..+++||||+++ +|.+++... .....+++.....++.|++.||.|||   +++|+||||||+|||++.++ .+
T Consensus       135 ~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~v  210 (440)
T PTZ00036        135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTL  210 (440)
T ss_pred             cCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCce
Confidence                 246799999975 676666431 23456899999999999999999999   67999999999999999664 79


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHH
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV  468 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~  468 (568)
                      ||+|||+|+.+......      ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......   .+.
T Consensus       211 kL~DFGla~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~---~~~  281 (440)
T PTZ00036        211 KLCDFGSAKNLLAGQRS------VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD---QLV  281 (440)
T ss_pred             eeeccccchhccCCCCc------ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHH
Confidence            99999999876543221      14568999999998865 468999999999999999999999997543322   111


Q ss_pred             HHHHHHhhcCchhh--hhh-------------hhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          469 DWVWMLHREGHIQD--AVD-------------QRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       469 ~~~~~~~~~~~~~~--~~d-------------~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .... .........  ...             ..+...++......+.+++..||+.||.+|||+.|+++
T Consensus       282 ~i~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        282 RIIQ-VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHH-HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            1111 000000000  000             00000011112346778888999999999999999985

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.7e-37  Score=326.70  Aligned_cols=193  Identities=24%  Similarity=0.314  Sum_probs=166.8

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLL  321 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  321 (568)
                      +|...+.||+|+||.||+|....      .++.||||...      ...+.+|++++++++|+||+++++++...+..++
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~------~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPD------YPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECC------CCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            58888999999999999999875      57889999642      2346789999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccc
Q 008374          322 VYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE  401 (568)
Q Consensus       322 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~  401 (568)
                      |||++ .++|..++...  ...++|.++..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       238 v~e~~-~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~  311 (461)
T PHA03211        238 VLPKY-RSDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR  311 (461)
T ss_pred             EEEcc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence            99999 57888888542  236999999999999999999999   6799999999999999999999999999998764


Q ss_pred             cccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008374          402 NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPG  455 (568)
Q Consensus       402 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~  455 (568)
                      .......   .....||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus       312 ~~~~~~~---~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        312 GSWSTPF---HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             ccccccc---ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            4322111   12457999999999999999999999999999999999988765

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.3e-37  Score=310.67  Aligned_cols=258  Identities=25%  Similarity=0.326  Sum_probs=204.0

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|+..++||+|+||+||++....      ++..+|+|.+.... ....+.+.+|+++++.++||||+++++++...+.+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIP------TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI   78 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcC------CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEE
Confidence            457777899999999999998864      57889999886543 33456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++++|.+++..   ...+++.....++.+++.+|.|||+  ..+++||||||+||++++++.++|+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~  153 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGE  153 (284)
T ss_pred             EEEEecCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence            999999999999998843   3468999999999999999999995  35799999999999999999999999999876


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc----chhhHHHHHHHHh
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ----HAYTLVDWVWMLH  475 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~----~~~~l~~~~~~~~  475 (568)
                      ......       ....|+..|+|||++.+..++.++|||||||++||+++|+.||.......    ....+.++.....
T Consensus       154 ~~~~~~-------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  226 (284)
T cd06620         154 LINSIA-------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV  226 (284)
T ss_pred             hhhhcc-------CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh
Confidence            533211       14568999999999988899999999999999999999999997433221    1111222221111


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII  525 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L  525 (568)
                               ..........+....+.+++.+|++.||.+|||+.|++++.
T Consensus       227 ---------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         227 ---------QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             ---------hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence                     11110001112345677788899999999999999999763

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.1e-37  Score=308.08  Aligned_cols=256  Identities=24%  Similarity=0.379  Sum_probs=189.9

Q ss_pred             eeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 008374          248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFM  326 (568)
Q Consensus       248 ~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  326 (568)
                      +||+|+||.||+|.....    .....+++|.+..... .....|.+|+++++.++|+||+++++.|......++||||+
T Consensus         2 ~lg~G~fg~v~~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRG----MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             cCCccCCceEEEEEEecC----CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence            589999999999976532    1456799998765432 33457889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccccc
Q 008374          327 PNGSLEKYLYGTSE--QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER  404 (568)
Q Consensus       327 ~~gsL~~~L~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~  404 (568)
                      ++|+|.+++.....  ....++.....++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence            99999999965432  234567888999999999999999   6799999999999999999999999999987643321


Q ss_pred             ccccccccccCCcCCcccCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          405 NSYAEHGLVGVPGTMGYVAPECFHT-------GKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       405 ~~~~~~~~~~~~Gt~~y~APE~~~~-------~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      .....   ....++..|+|||++..       ..++.++|||||||++|||++ |+.||.......   .+..    ...
T Consensus       155 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~----~~~  224 (269)
T cd05042         155 YYITK---DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLKQ----VVR  224 (269)
T ss_pred             heecc---CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHH----Hhh
Confidence            11111   13456778999998743       356789999999999999999 778886443222   1111    111


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                      .+ .....++.+    .......+..+...|+ .||++|||+++|+++|.
T Consensus       225 ~~-~~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         225 EQ-DIKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             cc-CccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            11 011111111    1123344455666787 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.4e-37  Score=305.56  Aligned_cols=252  Identities=21%  Similarity=0.384  Sum_probs=199.3

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc---------chhhHHHHHHhhcCCCCceeeEEEEE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS---------KGDFLAELAIIHRLRHKHLVHLVGWC  313 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~H~nIv~l~g~~  313 (568)
                      |.....||+|+||.||+|....      ++..+|+|.+.......         .+.+.+|+.++++++||||+++++++
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   75 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNAS------SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS   75 (267)
T ss_pred             ccccceeecCCCeEEEEEEecC------CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            5667899999999999998764      57889999886543221         24688999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEee
Q 008374          314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD  393 (568)
Q Consensus       314 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~D  393 (568)
                      .+.+..++|+||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+++||||+|+||++++++.+||+|
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~d  149 (267)
T cd06628          76 LDADHLNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISD  149 (267)
T ss_pred             EeCCccEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecc
Confidence            999999999999999999999943   346888999999999999999999   67999999999999999999999999


Q ss_pred             cCCccccccccccccc-cccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          394 FGLARAIENERNSYAE-HGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       394 FGla~~~~~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      ||+++........... .......|+..|+|||.+....++.++||||||+++|||++|+.||.......   .+.    
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~----  222 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---AIF----  222 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---HHH----
Confidence            9999877533211110 01113458899999999998889999999999999999999999997532211   110    


Q ss_pred             HHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .         +.. ......+......+..++.+||++||.+||++.|+++
T Consensus       223 ~---------~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         223 K---------IGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             H---------Hhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            0         000 0111112233456677888999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.7e-37  Score=309.34  Aligned_cols=250  Identities=22%  Similarity=0.327  Sum_probs=198.5

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      |+..+.||+|+||.||+|....      .+..+++|.+........+.+.+|+++++.++||||+++++++...+..++|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKE------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECC------CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence            4566789999999999998875      5778999999766656677899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      +||+++++|..++...  ...+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        81 ~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  155 (282)
T cd06643          81 IEFCAGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  155 (282)
T ss_pred             EEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccc
Confidence            9999999999988542  346899999999999999999999   67999999999999999999999999999976543


Q ss_pred             ccccccccccccCCcCCcccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFH-----TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ....     .....||..|+|||++.     ...++.++|||||||++|||++|+.||.......   ......    . 
T Consensus       156 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~----~-  222 (282)
T cd06643         156 TIQR-----RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR---VLLKIA----K-  222 (282)
T ss_pred             cccc-----cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH---HHHHHh----h-
Confidence            2211     11456899999999984     3457789999999999999999999987433221   111110    0 


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ..     .+.+  ..+......+.+++..||+.||.+||++.++++
T Consensus       223 ~~-----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         223 SE-----PPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             cC-----CCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00     0000  111122345677888999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.9e-37  Score=315.16  Aligned_cols=261  Identities=29%  Similarity=0.494  Sum_probs=202.1

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...+.||+|+||.||+|++..++..  ....+|+|.+..... ....++.+|+.++++++||||++++++|... ..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGET--VKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCc--ceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            4567778999999999999998653221  134689998865432 2334788999999999999999999999754 56


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++++||+++|+|.+++...  ...+++..+..++.|++.||.|||   +++++||||||+||++++++.+||+|||+++.
T Consensus        84 ~~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eeeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccccccc
Confidence            7999999999999998643  235889999999999999999999   67999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      .........   .....++..|+|||++.+..++.++||||||+++|||++ |+.|+......    .+.++.    ..+
T Consensus       159 ~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~----~~~~~~----~~~  227 (303)
T cd05110         159 LEGDEKEYN---ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR----EIPDLL----EKG  227 (303)
T ss_pred             ccCcccccc---cCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----HCC
Confidence            654322211   113446788999999988899999999999999999997 89998643221    122211    111


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                      .       .+  .........+..++..||..+|++||+++++++.|+...
T Consensus       228 ~-------~~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         228 E-------RL--PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             C-------CC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            0       01  111123346778889999999999999999999998753

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.1e-37  Score=312.42  Aligned_cols=250  Identities=20%  Similarity=0.349  Sum_probs=202.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      .+|...++||.|+||.||+|+...      +++.|++|.+........+.+.+|+.+++.++||||+++++++...+..+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVA------TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELF   92 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcC------CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence            358888999999999999998764      67899999997665555677899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +|+||+++++|..++..    ..+++.++..++.+++.||.|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~  165 (296)
T cd06655          93 VVMEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI  165 (296)
T ss_pred             EEEEecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhc
Confidence            99999999999999842    35899999999999999999999   679999999999999999999999999998876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      .......     ....|+..|+|||.+.+..++.++|||||||++|||++|+.||.......   .+.. ..   ... .
T Consensus       166 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~---~~~~-~~---~~~-~  232 (296)
T cd06655         166 TPEQSKR-----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYL-IA---TNG-T  232 (296)
T ss_pred             ccccccC-----CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH-HH---hcC-C
Confidence            5432211     13468899999999998889999999999999999999999987543221   1110 00   000 0


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                           +.  ..........+..++.+||+.||++|||+.++++
T Consensus       233 -----~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         233 -----PE--LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -----cc--cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                 00  1111223345667788999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.4e-37  Score=318.84  Aligned_cols=242  Identities=18%  Similarity=0.278  Sum_probs=192.7

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCC-CCceeeEEEEEEeCC
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLR-HKHLVHLVGWCHEKG  317 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~  317 (568)
                      +|+..+.||+|+||.||+|..+.      +++.||+|.+....   ....+.+..|..++..+. |++|+++++++...+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKG------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD   74 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence            36778899999999999998875      67899999987542   233456788999988885 577889999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .+++||||+++|+|..++..   ...+++.+...++.|++.||.|||   +++++||||||+|||++.++.+||+|||++
T Consensus        75 ~~~lv~Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~  148 (323)
T cd05615          75 RLYFVMEYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMC  148 (323)
T ss_pred             EEEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccc
Confidence            99999999999999999843   346899999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +........     .....||..|+|||++.+..++.++|||||||++|||++|+.||.......    +...+      
T Consensus       149 ~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~----~~~~i------  213 (323)
T cd05615         149 KEHMVDGVT-----TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE----LFQSI------  213 (323)
T ss_pred             cccCCCCcc-----ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHH------
Confidence            864332111     124569999999999998899999999999999999999999997543221    11111      


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKT  518 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~  518 (568)
                            .....  ..+......+.+++.+|++.+|.+|++.
T Consensus       214 ------~~~~~--~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         214 ------MEHNV--SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ------HhCCC--CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                  11111  1111223456778889999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.9e-37  Score=325.54  Aligned_cols=261  Identities=21%  Similarity=0.234  Sum_probs=199.5

Q ss_pred             HHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeE
Q 008374          233 YKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHL  309 (568)
Q Consensus       233 ~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l  309 (568)
                      ..++....++|...+.||+|+||.||++....      +++.+|+|.+....   ....+.+.+|+.+++.++||||+++
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~  108 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL  108 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECC------CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            44556667899999999999999999999875      67899999986422   2234557889999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcE
Q 008374          310 VGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA  389 (568)
Q Consensus       310 ~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~  389 (568)
                      ++++...+..++||||+++|+|.+++..    ..++......++.|++.||.|||   +++|+||||||+|||++.++.+
T Consensus       109 ~~~~~~~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~i  181 (371)
T cd05622         109 FYAFQDDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHL  181 (371)
T ss_pred             EEEEEcCCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCE
Confidence            9999999999999999999999999843    34788888899999999999999   6799999999999999999999


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchh
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG----KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY  465 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~----~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~  465 (568)
                      ||+|||+++..........    ....||+.|+|||++...    .++.++|||||||++|||++|+.||.......   
T Consensus       182 kL~DfG~a~~~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---  254 (371)
T cd05622         182 KLADFGTCMKMNKEGMVRC----DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---  254 (371)
T ss_pred             EEEeCCceeEcCcCCcccc----cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH---
Confidence            9999999987654321111    245799999999998653    37889999999999999999999997532211   


Q ss_pred             hHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 008374          466 TLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASE--RPKTEDILQI  524 (568)
Q Consensus       466 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~--RPt~~evl~~  524 (568)
                          .........       ..+...........+..++..|+..++.+  ||++.|+++.
T Consensus       255 ----~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         255 ----TYSKIMNHK-------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             ----HHHHHHcCC-------CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence                111111100       00111111122334555666788744433  7899988874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.2e-37  Score=304.32  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=202.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|+..++||+|+||.||+|+...      ++..+++|.+.....  .+++.+|++++++++|+||+++++++......+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKE------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLW   74 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcC------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEE
Confidence            568888899999999999999874      478899999875432  678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +++||+++++|.+++...  ...+++.....++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||++...
T Consensus        75 l~~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~  149 (256)
T cd06612          75 IVMEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL  149 (256)
T ss_pred             EEEecCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhc
Confidence            999999999999998532  346899999999999999999999   679999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      ......     .....|+..|+|||++.+..++.++||||||+++|||++|+.|+.......   ....     ...   
T Consensus       150 ~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~---~~~~-----~~~---  213 (256)
T cd06612         150 TDTMAK-----RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR---AIFM-----IPN---  213 (256)
T ss_pred             ccCccc-----cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh---hhhh-----hcc---
Confidence            543211     113458899999999988899999999999999999999999987433222   0000     000   


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        ...+.  ..........+.+++..|++.||.+|||+.||++
T Consensus       214 --~~~~~--~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         214 --KPPPT--LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             --CCCCC--CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence              00001  1112223346777888999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.5e-37  Score=301.91  Aligned_cols=249  Identities=27%  Similarity=0.451  Sum_probs=198.9

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-cchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      ++||+|+||.||++...       .++.|++|.+...... ....|.+|++++++++|+||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~-------~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   73 (251)
T cd05041           1 EKIGKGNFGDVYKGVLK-------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMEL   73 (251)
T ss_pred             CccccCCCceEEEEEEe-------CCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEc
Confidence            36999999999999876       3788999998765443 456799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccc
Q 008374          326 MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN  405 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~  405 (568)
                      +++++|.+++....  ..+++.....++.+++.+|.|||   +++++||||||+||+++.++.+||+|||+++.......
T Consensus        74 ~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  148 (251)
T cd05041          74 VPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY  148 (251)
T ss_pred             CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc
Confidence            99999999995432  35789999999999999999999   67999999999999999999999999999986653221


Q ss_pred             cccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCchhhhh
Q 008374          406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV  484 (568)
Q Consensus       406 ~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  484 (568)
                      ....   ....++..|+|||.+.++.++.++||||||++++||++ |..|+.......    ....             +
T Consensus       149 ~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~----~~~~-------------~  208 (251)
T cd05041         149 TVSD---GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ----TRER-------------I  208 (251)
T ss_pred             eecc---ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH----HHHH-------------H
Confidence            1110   12234667999999988899999999999999999999 888886443221    1111             1


Q ss_pred             hhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       485 d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      ...............+.+++.+|++.+|.+|||+.||++.|+.
T Consensus       209 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         209 ESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             hcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            1111111222334567888889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.2e-37  Score=309.03  Aligned_cols=251  Identities=24%  Similarity=0.304  Sum_probs=198.3

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      |...+.||+|+||+||+|....      +++.+|+|.+.....   .....+.+|++++++++|+|++++.+.+..++..
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~   75 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRA------TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDAL   75 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECC------CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEE
Confidence            5667889999999999999875      678999999865422   2234578899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++++|.+++.... ...+++.....++.|++.||.|||   +.+|+||||||+||++++++.+||+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~  151 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVK  151 (285)
T ss_pred             EEEEEeccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCccee
Confidence            99999999999999886432 346899999999999999999999   67999999999999999999999999999976


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      .......      ....|+..|+|||++.+..++.++|+||||+++|||++|+.||.......   ..... ....... 
T Consensus       152 ~~~~~~~------~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---~~~~~-~~~~~~~-  220 (285)
T cd05632         152 IPEGESI------RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---KREEV-DRRVLET-  220 (285)
T ss_pred             cCCCCcc------cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH-HHhhhcc-
Confidence            5432211      14568999999999998899999999999999999999999997543222   11111 1101100 


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK-----TEDILQ  523 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt-----~~evl~  523 (568)
                           .    ..........+.+++..|++.||++||+     +.++++
T Consensus       221 -----~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         221 -----E----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             -----c----cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                 0    0111122345567888999999999999     666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.2e-37  Score=317.55  Aligned_cols=244  Identities=20%  Similarity=0.283  Sum_probs=191.4

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCeEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      ++||+|+||+||++....      .++.+|+|++....   ....+.+..|+.++.++ +||||+++++++...+.+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   74 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKK------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLV   74 (327)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEE
Confidence            369999999999999875      67899999997642   23345688999999888 699999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      |||+++|+|..++..   ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        75 ~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~  148 (327)
T cd05617          75 IEYVNGGDLMFHMQR---QRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG  148 (327)
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence            999999999998843   346899999999999999999999   67999999999999999999999999999975332


Q ss_pred             ccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD  482 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  482 (568)
                      ....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....++.......     
T Consensus       149 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~-----  217 (327)
T cd05617         149 PGDT-----TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD-MNTEDYLFQVILE-----  217 (327)
T ss_pred             CCCc-----eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc-cccHHHHHHHHHh-----
Confidence            2111     1145799999999999999999999999999999999999999974322110 0122222222211     


Q ss_pred             hhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH
Q 008374          483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKT  518 (568)
Q Consensus       483 ~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~  518 (568)
                         ....  .+......+.+++..|++.||.+||++
T Consensus       218 ---~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         218 ---KPIR--IPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             ---CCCC--CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence               1111  111223445677789999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.3e-38  Score=309.41  Aligned_cols=247  Identities=27%  Similarity=0.426  Sum_probs=204.5

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccch---hhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      .+|++.+.||+|.||+|-+|....      .++.||||.++++.....+   .+.+|+++|+.|+||||++++.+|..++
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~------sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd  126 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHK------SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD  126 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhcc------CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence            357777889999999999998754      7899999999887555444   4678999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .+.|||||..+|.|.+|+   .+...|+..+...+++||.+|+.|.|   .++++|||||.+|||||.++++||+||||+
T Consensus       127 KIvivMEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLS  200 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLS  200 (668)
T ss_pred             eEEEEEEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchh
Confidence            999999999999999999   45667999999999999999999999   789999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKAT-PESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t-~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      .++.....      ..+++|.+-|.+||++.+..|. +.+|-||+||+||-|+.|..||++.+...    ++.       
T Consensus       201 Nly~~~kf------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~----lvr-------  263 (668)
T KOG0611|consen  201 NLYADKKF------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR----LVR-------  263 (668)
T ss_pred             hhhccccH------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH----HHH-------
Confidence            88765432      3378999999999999998885 78999999999999999999998653322    221       


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                           ++-...+........+..   |+.||+..||++|-|+.+|...
T Consensus       264 -----QIs~GaYrEP~~PSdA~g---LIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  264 -----QISRGAYREPETPSDASG---LIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             -----HhhcccccCCCCCchHHH---HHHHHHhcCcccchhHHHHhhh
Confidence                 111122222222233333   4457888999999999999764

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.1e-37  Score=319.27  Aligned_cols=193  Identities=21%  Similarity=0.303  Sum_probs=165.7

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ...+|...+.||+|+||.||+|+...      .+..||+|.....      ....|+.++++++||||+++++++...+.
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  131 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPG------QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAI  131 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECC------CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCe
Confidence            34579999999999999999999874      5678999975332      34679999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++|+||+ .++|.+++...  ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  205 (357)
T PHA03209        132 TCMVLPHY-SSDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ  205 (357)
T ss_pred             eEEEEEcc-CCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcccc
Confidence            99999999 56888888542  346899999999999999999999   6799999999999999999999999999997


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPG  455 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~  455 (568)
                      .......      .....||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       206 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        206 FPVVAPA------FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccCcc------cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            5432211      11456999999999999999999999999999999999966554

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.5e-36  Score=305.64  Aligned_cols=248  Identities=22%  Similarity=0.364  Sum_probs=202.5

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      .|...++||+|+||.||+|+...      .+..||+|.+.... ......+.+|+.++++++||||+++++.+.+.+..+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNR------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLW   78 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEcc------CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence            35667789999999999998864      57899999987543 344567899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++++|.+++..    ..+++.+...++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++...
T Consensus        79 lv~e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~  151 (277)
T cd06640          79 IIMEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQL  151 (277)
T ss_pred             EEEecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceec
Confidence            99999999999999843    35888999999999999999999   679999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      ......     .....++..|+|||++.+..++.++||||||+++|||++|+.|+.......    ..   .        
T Consensus       152 ~~~~~~-----~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~---~--------  211 (277)
T cd06640         152 TDTQIK-----RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VL---F--------  211 (277)
T ss_pred             cCCccc-----cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----Hh---h--------
Confidence            543211     113468889999999988889999999999999999999999987432221    00   0        


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                        .+...............+.+++..||+.+|++||++.++++.
T Consensus       212 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         212 --LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             --hhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence              011111112233455677889999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.3e-37  Score=309.50  Aligned_cols=253  Identities=23%  Similarity=0.375  Sum_probs=200.9

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      +|+..+.||+|+||.||++....      .+..+|+|.+... .......+.+|+.++.+++|+||+++++.+...+..+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   75 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRP------TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVY   75 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcC------CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEE
Confidence            57778899999999999998874      6789999998654 2233567899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++++|..++........+++..+..++.+++.||.|||+  +.+++||||||+||+++.++.+||+|||++...
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999999999999998654334478999999999999999999994  358999999999999999999999999999765


Q ss_pred             ccccccccccccccCCcCCcccCccccccCC------CCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGK------ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~------~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      .....       ....|+..|+|||.+.+..      ++.++|||||||++|||++|+.||.......    ...-    
T Consensus       154 ~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~----  218 (286)
T cd06622         154 VASLA-------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN----IFAQ----  218 (286)
T ss_pred             cCCcc-------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh----HHHH----
Confidence            43221       1346888999999985543      4789999999999999999999996432211    1110    


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                           +..+.+.. ......+....+..++.+|++.+|++||++.++++
T Consensus       219 -----~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         219 -----LSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             -----HHHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                 01111111 11122234556778888999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8e-37  Score=303.36  Aligned_cols=251  Identities=20%  Similarity=0.291  Sum_probs=201.2

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      +|...++||+|+||.||++....      ++..+|+|.+... .....+.+..|+.++++++|+||+++++.+...+.++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   74 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVN------SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLY   74 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcC------CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEE
Confidence            46778899999999999998875      6788999998643 2334567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++++|.+++.... ...++......++.|++.||.|||   +++++|+||||+||++++++.++|+|||+++..
T Consensus        75 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  150 (255)
T cd08219          75 IVMEYCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL  150 (255)
T ss_pred             EEEeeCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceee
Confidence            9999999999999885432 345788999999999999999999   679999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      .......     ....|+..|+|||++.+..++.++|+||||+++|+|++|+.||.......       ...... .+..
T Consensus       151 ~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~-~~~~  217 (255)
T cd08219         151 TSPGAYA-----CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN-------LILKVC-QGSY  217 (255)
T ss_pred             ccccccc-----ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH-------HHHHHh-cCCC
Confidence            5432211     14568899999999988889999999999999999999999997432211       111111 1111


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                      .         ..+......+.+++.+||+.||++|||+.+++..
T Consensus       218 ~---------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 K---------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             C---------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            0         1111223456678889999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=6.6e-37  Score=306.75  Aligned_cols=258  Identities=27%  Similarity=0.440  Sum_probs=202.5

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...++||+|+||.||+|+.....   .....|++|...... ....+.+.+|+.++++++||||++++++|.. +..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPE---NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCC---CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            35777889999999999999876421   134579999987654 3455689999999999999999999999875 567


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++|+|.+++...  ...+++..+..++.+++.||.|||   +.+++||||||+||+++.++.+||+|||+++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          82 WIVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeee
Confidence            8999999999999999543  235899999999999999999999   67999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ..........    ...++..|+|||.+....++.++||||||++++|+++ |+.||.......    ...+.    ..+
T Consensus       157 ~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~----~~~~~----~~~  224 (270)
T cd05056         157 LEDESYYKAS----KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND----VIGRI----ENG  224 (270)
T ss_pred             cccccceecC----CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHH----HcC
Confidence            6544221111    2334568999999988889999999999999999986 999987543322    11111    111


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      .       ++  .........+.+++.+|+..+|.+|||+.++++.|+..
T Consensus       225 ~-------~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         225 E-------RL--PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             C-------cC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0       11  11122345677788899999999999999999999763

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.3e-37  Score=310.52  Aligned_cols=251  Identities=25%  Similarity=0.341  Sum_probs=198.7

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      |+..+.||+|+||.||++....      +++.+|+|.+.....   .....+.+|+.++++++|+|++++++.+...+..
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~   75 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRA------TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDAL   75 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcC------CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEE
Confidence            6677889999999999999875      678999999865422   2234577899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++++|.+++.... ...+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+|||++..
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVH  151 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceee
Confidence            99999999999999985432 235889999999999999999999   67999999999999999999999999999976


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      .......      ....||..|+|||++.+..++.++||||||+++|||++|+.||.................       
T Consensus       152 ~~~~~~~------~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-------  218 (285)
T cd05630         152 VPEGQTI------KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-------  218 (285)
T ss_pred             cCCCccc------cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-------
Confidence            5433211      134689999999999999999999999999999999999999975332210001100000       


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK-----TEDILQ  523 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt-----~~evl~  523 (568)
                        . .....    .......+.+++..|++.||++|||     +.|+++
T Consensus       219 --~-~~~~~----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         219 --E-VQEEY----SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             --h-hhhhc----CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence              0 00111    1122334667788999999999999     888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.1e-36  Score=304.53  Aligned_cols=252  Identities=25%  Similarity=0.400  Sum_probs=193.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-----cccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-----IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      .+|...+.||+|+||.||+|....      ++..+++|++....     .+....+.+|+.++++++||||+++++++.+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   75 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVD------TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD   75 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcC------CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc
Confidence            368888999999999999998764      67899999986432     1234568899999999999999999998875


Q ss_pred             --CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEee
Q 008374          316 --KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD  393 (568)
Q Consensus       316 --~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~D  393 (568)
                        ....++++||+++++|.+++..   ...+++.....++.|++.||.|||   +.+++||||||+||+++.++.+||+|
T Consensus        76 ~~~~~~~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~d  149 (266)
T cd06651          76 RAEKTLTIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGD  149 (266)
T ss_pred             CCCCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEcc
Confidence              3578999999999999999953   235889999999999999999999   67999999999999999999999999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      ||+++..........  ......++..|+|||++.+..++.++|||||||++|||++|+.||.......   ..    ..
T Consensus       150 fg~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~---~~----~~  220 (266)
T cd06651         150 FGASKRLQTICMSGT--GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA---AI----FK  220 (266)
T ss_pred             CCCccccccccccCC--ccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH---HH----HH
Confidence            999986643211110  1123458899999999998889999999999999999999999987432211   11    00


Q ss_pred             HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       474 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ..         ........+...... ++.++.|+..+|++||+++||++
T Consensus       221 ~~---------~~~~~~~~~~~~~~~-~~~li~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         221 IA---------TQPTNPQLPSHISEH-ARDFLGCIFVEARHRPSAEELLR  260 (266)
T ss_pred             Hh---------cCCCCCCCchhcCHH-HHHHHHHhcCChhhCcCHHHHhc
Confidence            00         000011111111222 33334788899999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.8e-37  Score=308.81  Aligned_cols=267  Identities=21%  Similarity=0.307  Sum_probs=197.5

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      +|...+.||+|+||.||+|+...      ++..||+|++.....  ...+.+.+|+.++++++||||+++++++..++..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKK------TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL   74 (285)
T ss_pred             CceEeeEecccCceEEEEEEECC------CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence            46778899999999999999864      578999999865422  2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||++ ++|.+++........+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++.
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  150 (285)
T cd07861          75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARA  150 (285)
T ss_pred             EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceee
Confidence            99999997 689888865444467899999999999999999999   67999999999999999999999999999986


Q ss_pred             cccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH----HH
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW----ML  474 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~----~~  474 (568)
                      ........     ....++..|+|||.+.+ ..++.++||||||++++||+||+.||.................    ..
T Consensus       151 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (285)
T cd07861         151 FGIPVRVY-----THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDV  225 (285)
T ss_pred             cCCCcccc-----cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            54332111     13457889999998865 4578899999999999999999999875432211111000000    00


Q ss_pred             hhcCchhhhhhhhc---CCC----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          475 HREGHIQDAVDQRL---NIN----SVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       475 ~~~~~~~~~~d~~l---~~~----~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      +.............   ...    ........+.+++.+|++.||.+|||+.+|++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         226 WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000000000000   000    00012345567888999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.4e-37  Score=304.72  Aligned_cols=253  Identities=27%  Similarity=0.467  Sum_probs=199.6

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccch--hhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      |+..+.||+|+||+||+++...      +++.+|+|.+.........  ....|+.++++++||||+++++++......+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKK------NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLY   74 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETT------TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECC------CCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccc
Confidence            4567899999999999999885      6779999999876543332  3456999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++++|.+++.   ....+++..+..++.|+++||.|||   +.+++|+||||+||++++++.++|+|||.+...
T Consensus        75 ~v~~~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~  148 (260)
T PF00069_consen   75 IVMEYCPGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKL  148 (260)
T ss_dssp             EEEEEETTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred             cccccccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence            9999999999999995   3456899999999999999999999   569999999999999999999999999999864


Q ss_pred             ccccccccccccccCCcCCcccCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFH-TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~-~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      ..... .    .....+|..|+|||.+. ...++.++||||+|+++++|++|+.|+...........+..-.        
T Consensus       149 ~~~~~-~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~--------  215 (260)
T PF00069_consen  149 SENNE-N----FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL--------  215 (260)
T ss_dssp             TSTTS-E----BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH--------
T ss_pred             ccccc-c----cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc--------
Confidence            21111 1    12567899999999998 8889999999999999999999999998552111100111000        


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       .........  ........+.+++..|++.||++|||+.++++
T Consensus       216 -~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  216 -KRPLPSSSQ--QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -HTHHHHHTT--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -ccccccccc--ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000011100  00111267788888999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.3e-36  Score=311.20  Aligned_cols=266  Identities=20%  Similarity=0.327  Sum_probs=197.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...++||+|+||.||+|+...      ++..||+|.++.... .....+.+|+.++++++||||+++++++...+..
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKL------TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSL   79 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecC------CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence            468888999999999999998864      578899999875432 2334678999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++ +|.+++...  ...+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  153 (309)
T cd07872          80 TLVFEYLDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA  153 (309)
T ss_pred             EEEEeCCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcccccee
Confidence            999999975 888887543  235788999999999999999999   67999999999999999999999999999986


Q ss_pred             cccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH-------H
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW-------V  471 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~-------~  471 (568)
                      ........     ....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+...       .
T Consensus       154 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  228 (309)
T cd07872         154 KSVPTKTY-----SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET  228 (309)
T ss_pred             cCCCcccc-----ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            54332211     13467899999998864 56889999999999999999999999754322210000000       0


Q ss_pred             HHHhhcC-chhhhhhhhcCCC----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          472 WMLHREG-HIQDAVDQRLNIN----SVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       472 ~~~~~~~-~~~~~~d~~l~~~----~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      |...... .....-.+.....    ........+.+++..|++.||.+|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         229 WPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             HhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000000 0000000000000    00112334567888999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.8e-37  Score=303.81  Aligned_cols=248  Identities=27%  Similarity=0.438  Sum_probs=198.0

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|...+.||+|+||.||++..        .+..+|+|.+....  ..+.+.+|+.++++++|||++++++++... ..+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   74 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY   74 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence            3577888999999999999864        46789999986542  345789999999999999999999998754 579


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++++|.+++.... ...+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus        75 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~  150 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVG  150 (254)
T ss_pred             EEEECCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceec
Confidence            9999999999999996532 235889999999999999999999   679999999999999999999999999999764


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      .....        ....+..|+|||++.+..++.++||||||++++||++ |+.||.......    +..    ....  
T Consensus       151 ~~~~~--------~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~----~~~~--  212 (254)
T cd05083         151 SMGVD--------NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE----VKE----CVEK--  212 (254)
T ss_pred             cccCC--------CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH----HHH----HHhC--
Confidence            32211        2234578999999988899999999999999999998 999986432211    111    1111  


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                             .............+..++.+|++.+|++||++.++++.|+++
T Consensus       213 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  254 (254)
T cd05083         213 -------GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEKE  254 (254)
T ss_pred             -------CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHccC
Confidence                   111111223345677888899999999999999999999763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.3e-36  Score=308.36  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=200.7

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      +.|+..++||+|+||.||+|....      .+..+++|.+........+.+.+|+.++++++||||+++++.+..++..+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKE------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW   85 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECC------CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence            457788899999999999998875      57899999998776666778999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++++|..++...  ...+++..+..++.|++.+|.|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        86 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          86 IMIEFCPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             EEEecCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceec
Confidence            999999999999887543  245899999999999999999999   679999999999999999999999999998764


Q ss_pred             ccccccccccccccCCcCCcccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFH-----TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      .......     ....++..|+|||++.     ...++.++|||||||++|||++|+.|+.......   .....    .
T Consensus       161 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~~----~  228 (292)
T cd06644         161 VKTLQRR-----DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLLKI----A  228 (292)
T ss_pred             ccccccc-----ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH---HHHHH----h
Confidence            3322111     1346888999999984     3456889999999999999999999986432211   11110    0


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       ...     .+.+  .........+..++.+|++.+|++||++.++++
T Consensus       229 -~~~-----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         229 -KSE-----PPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             -cCC-----CccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             000     0000  111223345677888999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.5e-37  Score=317.84  Aligned_cols=203  Identities=24%  Similarity=0.340  Sum_probs=173.7

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC---CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD---SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...++||+|+||.||+++...      +++.||+|.+.+.   .......+.+|..++..++|+||+++++++.+.+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~   74 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKH------TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            468889999999999999998875      6788999998652   1223455888999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++|+|.+++...  ...+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~lv~Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a  149 (331)
T cd05624          75 YLYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSC  149 (331)
T ss_pred             EEEEEEeCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccce
Confidence            999999999999999999642  235888899999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHT-----GKATPESDVFGFGAVVLEVVCGRSPGNMI  458 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~t~~sDV~SfGvll~el~tG~~P~~~~  458 (568)
                      +..........    ....||+.|+|||++..     +.++.++|||||||++|||++|+.||...
T Consensus       150 ~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  211 (331)
T cd05624         150 LKMNQDGTVQS----SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             eeccCCCceee----ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence            87654322111    13569999999999865     56788999999999999999999999743

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.4e-37  Score=302.65  Aligned_cols=266  Identities=22%  Similarity=0.321  Sum_probs=203.8

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc--cchhhHHHHHHhhcCCCCc-eeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK--SKGDFLAELAIIHRLRHKH-LVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~  316 (568)
                      ...|...++||+|.||+||+|+.+.      +++.||+|++.....+  ......+|+.++++++|+| ||+|++++...
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~------~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~   83 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKR------TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTS   83 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEec------CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence            3446666789999999999999986      7789999999765442  3345689999999999999 99999999988


Q ss_pred             C------eEEEEEEecCCCChhhhhccCCCc-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcE
Q 008374          317 G------KLLLVYDFMPNGSLEKYLYGTSEQ-VTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA  389 (568)
Q Consensus       317 ~------~~~lV~Ey~~~gsL~~~L~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~  389 (568)
                      +      .++|||||+ .-+|.+++...... ..++...+..+..|++.||+|||   +.+|+||||||.|||+++.+.+
T Consensus        84 ~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~l  159 (323)
T KOG0594|consen   84 NNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVL  159 (323)
T ss_pred             ccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcE
Confidence            7      899999999 56999999654321 35677889999999999999999   7899999999999999999999


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHH
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV  468 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~  468 (568)
                      ||+|||+|+........++     ..++|..|.|||++.+. .|++..||||+||++.||++++.-|.+..+......  
T Consensus       160 KlaDFGlAra~~ip~~~yt-----~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~--  232 (323)
T KOG0594|consen  160 KLADFGLARAFSIPMRTYT-----PEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFR--  232 (323)
T ss_pred             eeeccchHHHhcCCccccc-----ccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHH--
Confidence            9999999997765544433     56789999999998875 799999999999999999999887876554331111  


Q ss_pred             HHHHHHhhc---Cch---hhhhhhhc-----C-CCC-cH---HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          469 DWVWMLHRE---GHI---QDAVDQRL-----N-INS-VV---DEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       469 ~~~~~~~~~---~~~---~~~~d~~l-----~-~~~-~~---~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                        +......   ..+   ....+-..     . ... ..   .......+++.+|++.+|.+|.|++.++++
T Consensus       233 --If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  233 --IFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             --HHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence              1111110   000   01111110     0 000 00   111366788889999999999999999874

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.2e-37  Score=325.91  Aligned_cols=206  Identities=23%  Similarity=0.347  Sum_probs=175.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|+..+.||+|+||.||+++...      +++.||+|.+....   ......+.+|+.++.+++||||+++++.+.+.+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   74 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKD------TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR   74 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            468888999999999999999875      67899999986532   233456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .+++||||+++|+|.+++..   ...++......++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~  148 (360)
T cd05627          75 NLYLIMEFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLC  148 (360)
T ss_pred             EEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCC
Confidence            99999999999999999953   346889999999999999999999   689999999999999999999999999998


Q ss_pred             cccccccccc------------------------------cccccccCCcCCcccCccccccCCCCccchhHHHHHHHHH
Q 008374          398 RAIENERNSY------------------------------AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLE  447 (568)
Q Consensus       398 ~~~~~~~~~~------------------------------~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~e  447 (568)
                      +.+.......                              .........||+.|+|||++.+..++.++|||||||++||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilye  228 (360)
T cd05627         149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE  228 (360)
T ss_pred             cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeee
Confidence            7653211000                              0000113579999999999999999999999999999999


Q ss_pred             HHhCCCCCCCC
Q 008374          448 VVCGRSPGNMI  458 (568)
Q Consensus       448 l~tG~~P~~~~  458 (568)
                      |++|+.||...
T Consensus       229 l~tG~~Pf~~~  239 (360)
T cd05627         229 MLIGYPPFCSE  239 (360)
T ss_pred             cccCCCCCCCC
Confidence            99999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=314.74  Aligned_cols=258  Identities=22%  Similarity=0.279  Sum_probs=194.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC---CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD---SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|+..+.||+|+||.||+++...      +++.||+|.+.+.   .....+.|.+|+.++..++|+||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKN------TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECC------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            468888999999999999999875      6789999998642   2233456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .+++||||+++|+|.+++...  ...++......++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  149 (331)
T cd05597          75 NLYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSC  149 (331)
T ss_pred             eEEEEEecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCce
Confidence            999999999999999999542  245888999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHT-----GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      ...........    ....||+.|+|||++..     ..++.++|||||||++|||++|+.||......+       ...
T Consensus       150 ~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~-------~~~  218 (331)
T cd05597         150 LRLLADGTVQS----NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYG  218 (331)
T ss_pred             eecCCCCCccc----cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH-------HHH
Confidence            76644322111    13469999999999863     457889999999999999999999997432211       111


Q ss_pred             HHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                      ........... .+  ......+....+++-+ .|...++..||+++++++.
T Consensus       219 ~i~~~~~~~~~-~~--~~~~~~~~~~~li~~l-l~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         219 KIMNHKEHFQF-PP--DVTDVSEEAKDLIRRL-ICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HHHcCCCcccC-CC--ccCCCCHHHHHHHHHH-ccCcccccCCCCHHHHhcC
Confidence            11111100000 00  0011223344444422 3566666679999999874

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.6e-36  Score=301.11  Aligned_cols=251  Identities=23%  Similarity=0.319  Sum_probs=203.5

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      +|+..+.||+|+||.||.+....      ++..+++|.+...  .....+++.+|++++++++|+||+++++++.+.+.+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   74 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTE------DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL   74 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcC------CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence            46778899999999999998764      6788999998654  334556789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      +++|||+++++|.+++.... ...+++.++..++.|++.+|.|||   +.+++|+||+|+||++++++.+||+|||+++.
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~  150 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI  150 (256)
T ss_pred             EEEEEecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEE
Confidence            99999999999999996532 346899999999999999999999   67999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      .......     .....|+..|+|||.+.+..++.++||||||+++|||++|+.||.......       ...... .+.
T Consensus       151 ~~~~~~~-----~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-------~~~~~~-~~~  217 (256)
T cd08221         151 LGSEYSM-----AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-------LVVKIV-QGN  217 (256)
T ss_pred             ccccccc-----ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHH-cCC
Confidence            6543321     114568999999999988889999999999999999999999987432211       111111 111


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                      ..         .........+..++..|++.+|.+||++.++++.
T Consensus       218 ~~---------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         218 YT---------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CC---------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            11         1112234557778889999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.8e-37  Score=305.54  Aligned_cols=253  Identities=22%  Similarity=0.311  Sum_probs=198.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|...++||+|+||.||+|+...      ++..+|+|.++.........+.+|+.+++.++||||+++++.+...+..+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVN------TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW   82 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcC------CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence            467777899999999999998864      67889999987665455567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +|+||+++++|.+++..   ...+++.+...++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++...
T Consensus        83 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd06645          83 ICMEFCGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQI  156 (267)
T ss_pred             EEEeccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence            99999999999999843   346899999999999999999999   579999999999999999999999999998766


Q ss_pred             ccccccccccccccCCcCCcccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFH---TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ......     .....|+..|+|||++.   ...++.++|||||||++|||++|+.|+.......   .+..    .. .
T Consensus       157 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~---~~~~----~~-~  223 (267)
T cd06645         157 TATIAK-----RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFL----MT-K  223 (267)
T ss_pred             cCcccc-----cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh---hHHh----hh-c
Confidence            432211     11456899999999874   4568889999999999999999999986432211   1100    00 0


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ....   .+.+..  .......+.+++.+|++.+|++|||++++++
T Consensus       224 ~~~~---~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         224 SNFQ---PPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cCCC---CCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0000   001100  0012234667888999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-36  Score=302.58  Aligned_cols=245  Identities=24%  Similarity=0.445  Sum_probs=191.7

Q ss_pred             ceeccCCceeEEEEEEccCccc----cccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQY----HVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      +.||+|+||.||+|.+......    ......+++|.+...... ...|.+|+.++++++||||++++++|.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            3689999999999999753211    112356888887654433 6789999999999999999999999988 778999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-------cEEEeecC
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF-------NARLGDFG  395 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~-------~~kL~DFG  395 (568)
                      |||+++|+|.+++....  ..+++..+..++.|++.||+|||   +++++||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999996532  26889999999999999999999   67999999999999999888       79999999


Q ss_pred             CccccccccccccccccccCCcCCcccCccccccC--CCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHH
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG--KATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~--~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      +++......         ...++..|+|||++...  .++.++||||||+++|||++ |..|+.......    ...+. 
T Consensus       154 ~a~~~~~~~---------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~----~~~~~-  219 (259)
T cd05037         154 IPITVLSRE---------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE----KERFY-  219 (259)
T ss_pred             ccccccccc---------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh----HHHHH-
Confidence            998754411         23467789999999776  78999999999999999999 577776432211    11110 


Q ss_pred             HHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                         ...       .....    .....+.+++..|++.+|.+|||+.+|++.|+
T Consensus       220 ---~~~-------~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         220 ---QDQ-------HRLPM----PDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ---hcC-------CCCCC----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               000       00000    11157778888999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-36  Score=317.73  Aligned_cols=199  Identities=24%  Similarity=0.330  Sum_probs=168.8

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      ..++|...+.||+|+||.||++....      ++..||+|++...  .......+.+|+.+++.++||||+++++++...
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   92 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTV------LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQ   92 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcC------CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence            45789999999999999999998764      6789999998654  223456788999999999999999999998654


Q ss_pred             C------eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEE
Q 008374          317 G------KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR  390 (568)
Q Consensus       317 ~------~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~k  390 (568)
                      +      ..++||||+++ +|.+.+.     ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+|
T Consensus        93 ~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~k  163 (359)
T cd07876          93 KSLEEFQDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK  163 (359)
T ss_pred             CCccccceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEE
Confidence            3      57999999965 5666652     24788889999999999999999   67999999999999999999999


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMI  458 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~  458 (568)
                      |+|||+++.......      .....||..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       164 l~Dfg~a~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         164 ILDFGLARTACTNFM------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             EecCCCccccccCcc------CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            999999986533211      11456899999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.8e-37  Score=318.59  Aligned_cols=243  Identities=25%  Similarity=0.293  Sum_probs=188.1

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHH-HhhcCCCCceeeEEEEEEeCCeEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELA-IIHRLRHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      +.||+|+||.||+++...      +++.+|+|.+....   ......+..|.. +++.++||||+++++++...+..++|
T Consensus         1 ~~lg~G~fg~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv   74 (325)
T cd05602           1 KVIGKGSFGKVLLARHKA------EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV   74 (325)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEE
Confidence            369999999999999875      57889999986532   122334455544 56788999999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      |||+++|+|.+++..   ...+.......++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        75 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~  148 (325)
T cd05602          75 LDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  148 (325)
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence            999999999999854   345777888889999999999999   67999999999999999999999999999975432


Q ss_pred             ccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD  482 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  482 (568)
                      ....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    ..+..           
T Consensus       149 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i-----------  208 (325)
T cd05602         149 HNGT-----TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNI-----------  208 (325)
T ss_pred             CCCC-----cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH----HHHHH-----------
Confidence            2111     124579999999999999999999999999999999999999997433221    11111           


Q ss_pred             hhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       483 ~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                       ....+.  ........+.+++..|++.||.+||++.+.++.
T Consensus       209 -~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         209 -LNKPLQ--LKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             -HhCCcC--CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence             111111  111223455667779999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-36  Score=301.33  Aligned_cols=254  Identities=20%  Similarity=0.291  Sum_probs=204.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|...+.||+|+||.||+|....      ++..+++|.+........+.+.+|++++++++||||+++++.+...+.++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   76 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIA------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW   76 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecC------CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence            578888999999999999998864      56789999998765556778999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      ++|||+++++|.+++...  ...++......++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||++...
T Consensus        77 l~~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  151 (262)
T cd06613          77 IVMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL  151 (262)
T ss_pred             EEEeCCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhh
Confidence            999999999999998543  246889999999999999999999   679999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTG---KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~---~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      .......     ....++..|+|||.+...   .++.++||||||+++|||++|+.|+.......   .....     ..
T Consensus       152 ~~~~~~~-----~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~---~~~~~-----~~  218 (262)
T cd06613         152 TATIAKR-----KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR---ALFLI-----SK  218 (262)
T ss_pred             hhhhhcc-----ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH-----Hh
Confidence            5432111     145688899999998776   88999999999999999999999987433222   11110     00


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ...   ....  ..........+.+++.+|++.+|.+|||+.+|+.
T Consensus       219 ~~~---~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         219 SNF---PPPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ccC---CCcc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000   0011  1112233456788899999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=7.7e-37  Score=309.04  Aligned_cols=265  Identities=22%  Similarity=0.276  Sum_probs=193.5

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc--cchhhHHHHHHhhcC---CCCceeeEEEEEEe-
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK--SKGDFLAELAIIHRL---RHKHLVHLVGWCHE-  315 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~-  315 (568)
                      +|...+.||+|+||.||+|....      +++.||+|.++.....  ....+.+|+.+++++   +||||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~   74 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPH------SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS   74 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECC------CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence            46778899999999999999875      6789999998754222  233566777777765   69999999998864 


Q ss_pred             ----CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 008374          316 ----KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL  391 (568)
Q Consensus       316 ----~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL  391 (568)
                          ....++||||++ ++|.+++.... ...+++..+..++.|++.||.|||   +++++||||||+|||++.++.+||
T Consensus        75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl  149 (288)
T cd07863          75 RTDRETKVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKL  149 (288)
T ss_pred             cCCCCceEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence                246899999997 58888885432 235899999999999999999999   679999999999999999999999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      +|||+++........      ....||..|+|||++.+..++.++|||||||+++||++|+.||...........+..+.
T Consensus       150 ~dfg~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~  223 (288)
T cd07863         150 ADFGLARIYSCQMAL------TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI  223 (288)
T ss_pred             CccCccccccCcccC------CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHh
Confidence            999999876533211      14568999999999988899999999999999999999999987543322111111110


Q ss_pred             H----HHhhcC-ch-hhhhhhhcC---CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          472 W----MLHREG-HI-QDAVDQRLN---INSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       472 ~----~~~~~~-~~-~~~~d~~l~---~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .    ..+... .. .....+...   .....+....+.+++..|++.||++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         224 GLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0    000000 00 000000000   0001122345678888999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.7e-36  Score=300.61  Aligned_cols=255  Identities=28%  Similarity=0.529  Sum_probs=202.2

Q ss_pred             cccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-cchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEE
Q 008374          244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       244 ~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      ...+.||.|+||.||+++....+.  ..+..||+|.+...... ..+.+..|+.++.+++|+||+++++++...+..+++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSG--EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCC--CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            456789999999999999875211  13488999999765433 567899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      |||+++++|.+++..... ..+++.++..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||+++....
T Consensus        80 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             EeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            999999999999964322 12899999999999999999999   67999999999999999999999999999987765


Q ss_pred             ccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCchh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQ  481 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  481 (568)
                      .......    ...++..|+|||.+....++.++||||+|++++||++ |+.|+......    .+.+.+    ..+.  
T Consensus       156 ~~~~~~~----~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~----~~~~~~----~~~~--  221 (258)
T smart00219      156 DDYYKKK----GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE----EVLEYL----KKGY--  221 (258)
T ss_pred             ccccccc----cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----hcCC--
Confidence            4221111    2237789999999988889999999999999999998 78887643221    111111    1111  


Q ss_pred             hhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 008374          482 DAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII  525 (568)
Q Consensus       482 ~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L  525 (568)
                             ...........+.+++.+|+..+|++|||+.|+++.|
T Consensus       222 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 -------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                   1111122445677788899999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.1e-36  Score=300.35  Aligned_cols=250  Identities=25%  Similarity=0.335  Sum_probs=200.1

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEe-CCe
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE-KGK  318 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~  318 (568)
                      +|+..+.||+|+||.||+++.+.      +++.+|+|++....  ....+.+.+|++++++++|+|++++++.+.. ...
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRT------DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL   74 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcC------CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence            47778899999999999999875      56789999986543  2345678899999999999999999998764 456


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      +++||||+++++|.+++.... ...+++.++..++.+++.|++|||   +.+++||||||+||+++.++.++|+|||++.
T Consensus        75 ~~lv~e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~  150 (257)
T cd08223          75 LYIVMGFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR  150 (257)
T ss_pred             EEEEecccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceE
Confidence            899999999999999996532 345899999999999999999999   6799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      .........     ....|++.|+|||.+.+..++.++||||||++++||++|+.||......       .+..... .+
T Consensus       151 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-------~~~~~~~-~~  217 (257)
T cd08223         151 VLENQCDMA-----STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-------SLVYRII-EG  217 (257)
T ss_pred             EecccCCcc-----ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHH-hc
Confidence            765432211     1456889999999999999999999999999999999999998743221       1111111 11


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ..         ..........+.+++.+|++.||++|||+.++++
T Consensus       218 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         218 KL---------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CC---------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            11         1112233456778888999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-37  Score=308.12  Aligned_cols=253  Identities=23%  Similarity=0.346  Sum_probs=202.0

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .++|...++||+|+||.||+|....      ++..+|+|.+........+.|.+|++++++++||||+++++.+......
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKE------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKL   77 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcC------CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeE
Confidence            3568888899999999999999864      5788999999776656667899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++++|.+++...  ...+++.....++.|++.||.|||   +++++|+||||+||+++.++.+||+|||++..
T Consensus        78 ~lv~e~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~  152 (280)
T cd06611          78 WILIEFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAK  152 (280)
T ss_pred             EEEeeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchh
Confidence            9999999999999998542  246899999999999999999999   67999999999999999999999999999876


Q ss_pred             cccccccccccccccCCcCCcccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFH-----TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      ........     ....||..|+|||.+.     ...++.++||||||+++|||++|+.||.......   .+..+    
T Consensus       153 ~~~~~~~~-----~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~---~~~~~----  220 (280)
T cd06611         153 NKSTLQKR-----DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR---VLLKI----  220 (280)
T ss_pred             hccccccc-----ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---HHHHH----
Confidence            54332211     1456899999999875     3456789999999999999999999987543221   11111    


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       ..+.     .+.+  .........+.+++..|++.+|.+||++.++++
T Consensus       221 -~~~~-----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         221 -LKSE-----PPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             -hcCC-----CCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence             0010     0011  111122345667788999999999999999976

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.3e-36  Score=306.67  Aligned_cols=266  Identities=23%  Similarity=0.336  Sum_probs=200.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|+...+||+|+||.||+|+.+.      +++.||+|++....  ....+.+.+|++++++++|+|++++++++.....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   74 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRE------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK   74 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECC------CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence            367788899999999999999874      57899999986542  2234568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++++|..++..   ...+++..+..++.|++.+|.|||   +++++||||||+||+++.++.+||+|||++.
T Consensus        75 ~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  148 (286)
T cd07847          75 LHLVFEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFAR  148 (286)
T ss_pred             EEEEEeccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccce
Confidence            9999999999998887743   335899999999999999999999   5799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH----
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM----  473 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~----  473 (568)
                      .........     ....++..|+|||++.+ ..++.++||||||+++|||++|+.||...........+......    
T Consensus       149 ~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  223 (286)
T cd07847         149 ILTGPGDDY-----TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR  223 (286)
T ss_pred             ecCCCcccc-----cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence            775533211     13457889999999865 56789999999999999999999999754332211111110000    


Q ss_pred             ---HhhcCch-hhhhhhhcCCCCc-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          474 ---LHREGHI-QDAVDQRLNINSV-----VDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       474 ---~~~~~~~-~~~~d~~l~~~~~-----~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                         .+..... .....+.......     ......+.+++..|++.+|++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence               0000000 0000000000000     112456788999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.2e-36  Score=317.72  Aligned_cols=265  Identities=20%  Similarity=0.228  Sum_probs=197.2

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      ...++|...+.||+|+||.||++....      .++.||||++....  ....+.+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   87 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAV------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP   87 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecC------CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeec
Confidence            345789999999999999999998764      67889999997542  2334678899999999999999999998864


Q ss_pred             C------CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcE
Q 008374          316 K------GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA  389 (568)
Q Consensus       316 ~------~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~  389 (568)
                      .      ...++||||+++ +|.+.+.     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+
T Consensus        88 ~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~  158 (355)
T cd07874          88 QKSLEEFQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL  158 (355)
T ss_pred             cccccccceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCE
Confidence            3      357999999964 6766662     24788899999999999999999   6799999999999999999999


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~  469 (568)
                      ||+|||+++.......      .....||..|+|||++.+..++.++|||||||++|||++|+.||.............+
T Consensus       159 kl~Dfg~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (355)
T cd07874         159 KILDFGLARTAGTSFM------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE  232 (355)
T ss_pred             EEeeCcccccCCCccc------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999986543221      1145689999999999988999999999999999999999999975432111000000


Q ss_pred             HH-------HHHhhcCchhhhhhhhcC------------------CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          470 WV-------WMLHREGHIQDAVDQRLN------------------INSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       470 ~~-------~~~~~~~~~~~~~d~~l~------------------~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                      ..       +... ...+...++....                  ..........+.+++.+|++.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         233 QLGTPCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HhCCCCHHHHHhh-cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            00       0000 0000001100000                  00011123456788889999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.1e-36  Score=300.94  Aligned_cols=255  Identities=25%  Similarity=0.387  Sum_probs=204.5

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEe--CC
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE--KG  317 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~  317 (568)
                      +|+..+.||.|+||.||++....      ++..+|+|.+....  ....+.+..|++++++++|+||+++++++..  ..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKS------DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ   74 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecC------CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence            36777899999999999998875      67889999986532  3345678899999999999999999998764  45


Q ss_pred             eEEEEEEecCCCChhhhhccC-CCcccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCEEEcCCCcEEEeec
Q 008374          318 KLLLVYDFMPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVASAVYYLQNEY--DQKVVHRDLKASNILLDADFNARLGDF  394 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDikp~NILld~~~~~kL~DF  394 (568)
                      ..+++|||+++++|.+++... .....+++.....++.+++.||.|||..+  +.+++|+||+|+||++++++.+||+||
T Consensus        75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~  154 (265)
T cd08217          75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF  154 (265)
T ss_pred             EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence            689999999999999998643 22457899999999999999999999554  679999999999999999999999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      |++..........     ....|+..|+|||.+....++.++||||||+++++|++|+.|+......    .+.+.+   
T Consensus       155 g~~~~~~~~~~~~-----~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~---  222 (265)
T cd08217         155 GLAKILGHDSSFA-----KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL----QLASKI---  222 (265)
T ss_pred             cccccccCCcccc-----cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH----HHHHHH---
Confidence            9999876543211     1356899999999999888999999999999999999999998754321    111111   


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                       ..+         ............+..++.+|++.+|.+||++.+|++.
T Consensus       223 -~~~---------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         223 -KEG---------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -hcC---------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence             111         1112223445677888899999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.6e-36  Score=316.24  Aligned_cols=264  Identities=21%  Similarity=0.239  Sum_probs=196.8

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      ..++|...+.||+|+||.||++....      .++.||||++....  ....+.+.+|+.+++.++||||+++++++...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~   95 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAI------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ   95 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECC------CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccc
Confidence            45689999999999999999998764      67889999997542  23446788999999999999999999987543


Q ss_pred             ------CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEE
Q 008374          317 ------GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR  390 (568)
Q Consensus       317 ------~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~k  390 (568)
                            ...++||||+++ +|.+++.     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+|
T Consensus        96 ~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~k  166 (364)
T cd07875          96 KSLEEFQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK  166 (364)
T ss_pred             ccccccCeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEE
Confidence                  357999999964 6777762     24788899999999999999999   67999999999999999999999


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH-
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD-  469 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~-  469 (568)
                      |+|||+++.......      .....||..|+|||++.+..++.++|||||||++|||++|+.||...........+.. 
T Consensus       167 L~DfG~a~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  240 (364)
T cd07875         167 ILDFGLARTAGTSFM------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ  240 (364)
T ss_pred             EEeCCCccccCCCCc------ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            999999986543221      1145689999999999999999999999999999999999999975432221000000 


Q ss_pred             ------HHHHHhhcCchhhhhhhhcC------------------CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          470 ------WVWMLHREGHIQDAVDQRLN------------------INSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       470 ------~~~~~~~~~~~~~~~d~~l~------------------~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                            ..+.... ..+......+..                  ..........+.+++.+|++.||.+|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         241 LGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             cCCCCHHHHHhhh-HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                  0000000 000000000000                  00011123456788889999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-37  Score=306.15  Aligned_cols=260  Identities=22%  Similarity=0.275  Sum_probs=196.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC---
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG---  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~---  317 (568)
                      -.|...+++|.|+||.||+|++..      +++.||||+.-.+.    +.--+|+++|+++.|||||+|+-++....   
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e------~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d   93 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRE------TEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESD   93 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcC------CCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCc
Confidence            346778899999999999999986      57899999985432    23347999999999999999998886532   


Q ss_pred             --eEEEEEEecCCCChhhhhccC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-CcEEEee
Q 008374          318 --KLLLVYDFMPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD-FNARLGD  393 (568)
Q Consensus       318 --~~~lV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~-~~~kL~D  393 (568)
                        .+.|||||||. +|.++++.- ..+..++.....-+..||.+||+|||   +.+|+||||||.|+|+|.+ +.+||+|
T Consensus        94 ~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicD  169 (364)
T KOG0658|consen   94 EVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICD  169 (364)
T ss_pred             hhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEecc
Confidence              35689999986 888888531 12345666677778999999999999   5799999999999999977 9999999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      ||.|+.+..+....      ....|..|.|||.+.+ ..|+.+.||||.||++.||+-|+.-|.+.+...   .+++-+.
T Consensus       170 FGSAK~L~~~epni------SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d---QL~eIik  240 (364)
T KOG0658|consen  170 FGSAKVLVKGEPNI------SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD---QLVEIIK  240 (364)
T ss_pred             CCcceeeccCCCce------eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH---HHHHHHH
Confidence            99999987764432      3456789999999876 679999999999999999999998887644433   3333322


Q ss_pred             HHhhc--Cch-------hhhhhhhcCC-----CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          473 MLHRE--GHI-------QDAVDQRLNI-----NSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       473 ~~~~~--~~~-------~~~~d~~l~~-----~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .+-..  ..+       .+...+.+..     -.......+.++++.++++.+|.+|.++.|++.
T Consensus       241 ~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  241 VLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            21100  000       0111111111     122334556788888999999999999999986

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-36  Score=308.82  Aligned_cols=257  Identities=23%  Similarity=0.267  Sum_probs=203.7

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc---cchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK---SKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...+.||+|+||.||++....      ++..+|+|.+......   ..+.+..|++++.+++|+||+++++.+...+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   74 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKG------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET   74 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcC------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC
Confidence            367888999999999999998874      5789999999765332   4457889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+.+++|.+++.... ...+++.....++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~  150 (316)
T cd05574          75 YLCLVMDYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLS  150 (316)
T ss_pred             EEEEEEEecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchh
Confidence            9999999999999999986432 346899999999999999999999   679999999999999999999999999998


Q ss_pred             ccccccccccc------------------------ccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCC
Q 008374          398 RAIENERNSYA------------------------EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRS  453 (568)
Q Consensus       398 ~~~~~~~~~~~------------------------~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~  453 (568)
                      ...........                        ........||..|+|||++.+..++.++||||||+++|||++|+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~  230 (316)
T cd05574         151 KQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT  230 (316)
T ss_pred             hcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCC
Confidence            86543221100                        001113468899999999998889999999999999999999999


Q ss_pred             CCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC----HHHHHH
Q 008374          454 PGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQ  523 (568)
Q Consensus       454 P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt----~~evl~  523 (568)
                      ||.......   .+             ..+.+..............+.+++.+|++.||++|||    ++|+++
T Consensus       231 pf~~~~~~~---~~-------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         231 PFKGSNRDE---TF-------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCCCchHH---HH-------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            997443322   11             1112222222222224567888888999999999999    666555

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2e-36  Score=303.49  Aligned_cols=260  Identities=24%  Similarity=0.409  Sum_probs=200.4

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC---
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG---  317 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~---  317 (568)
                      |...+.||+|+||.||+|.+..++.   .+..||||++....  ....+++.+|++++++++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDG---SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCC---CceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            4556789999999999999864321   47899999986542  234567899999999999999999999886532   


Q ss_pred             ---eEEEEEEecCCCChhhhhccCC---CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 008374          318 ---KLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL  391 (568)
Q Consensus       318 ---~~~lV~Ey~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL  391 (568)
                         ..++++||+++|+|..++....   ....+++.....++.|++.||+|||   +.+++||||||+||+++.++.+||
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl  154 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCV  154 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEE
Confidence               3478999999999998875321   2235788999999999999999999   579999999999999999999999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHH
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~  470 (568)
                      +|||+++...........   ....++..|++||.+....++.++||||||+++|||++ |+.|+......    .+..+
T Consensus       155 ~dfg~~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~----~~~~~  227 (273)
T cd05074         155 ADFGLSKKIYSGDYYRQG---CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS----EIYNY  227 (273)
T ss_pred             CcccccccccCCcceecC---CCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH----HHHHH
Confidence            999999876433211111   12345678999999988889999999999999999999 88888644322    12222


Q ss_pred             HHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          471 VWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       471 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ..    .+.       .+  .........+.+++.+|++.+|.+||++.++++.|++.
T Consensus       228 ~~----~~~-------~~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         228 LI----KGN-------RL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HH----cCC-------cC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11    110       01  11123345788899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=9.7e-37  Score=308.00  Aligned_cols=264  Identities=22%  Similarity=0.299  Sum_probs=203.8

Q ss_pred             cCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeE
Q 008374          231 FKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHL  309 (568)
Q Consensus       231 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l  309 (568)
                      +.+..+..++++|+..+.||+|+||.||+++...      .++.+|+|.+.... ....++.+|+.++.++ +||||+++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~   80 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKK------NGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKF   80 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECC------CCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeee
Confidence            4456677788999999999999999999999875      57889999886432 2345688899999999 69999999


Q ss_pred             EEEEE-----eCCeEEEEEEecCCCChhhhhccC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 008374          310 VGWCH-----EKGKLLLVYDFMPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL  383 (568)
Q Consensus       310 ~g~~~-----~~~~~~lV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl  383 (568)
                      ++++.     ..+..++||||+++++|.+++... .....+++..+..++.|++.||.|||   +.+++||||||+||++
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili  157 (286)
T cd06638          81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILL  157 (286)
T ss_pred             eeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEE
Confidence            99884     345789999999999999987532 22346888999999999999999999   6799999999999999


Q ss_pred             cCCCcEEEeecCCccccccccccccccccccCCcCCcccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008374          384 DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-----GKATPESDVFGFGAVVLEVVCGRSPGNMI  458 (568)
Q Consensus       384 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~t~~sDV~SfGvll~el~tG~~P~~~~  458 (568)
                      +.++.+||+|||+++.........     ....|+..|+|||++..     ..++.++|||||||++|||++|+.|+...
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~  232 (286)
T cd06638         158 TTEGGVKLVDFGVSAQLTSTRLRR-----NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL  232 (286)
T ss_pred             CCCCCEEEccCCceeecccCCCcc-----ccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence            999999999999998764432111     14468999999998753     45788999999999999999999998743


Q ss_pred             CcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          459 PHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       459 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                      ....   .+...     ....     .+.+.  ........+..++.+|++.||++|||+.|+++.
T Consensus       233 ~~~~---~~~~~-----~~~~-----~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         233 HPMR---ALFKI-----PRNP-----PPTLH--QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             chhH---HHhhc-----cccC-----CCccc--CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            2211   11110     0000     00110  011122357778889999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.2e-37  Score=310.48  Aligned_cols=266  Identities=23%  Similarity=0.335  Sum_probs=199.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|+..++||+|+||.||+|....      .++.+|+|++.....  ...+.+.+|++++++++||||+++++++...+.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKE------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR   74 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECC------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence            367788999999999999999864      578899999865432  234568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++++|..+...   ...+++.++..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++.
T Consensus        75 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~  148 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFAR  148 (286)
T ss_pred             EEEEEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeee
Confidence            9999999999999887743   235899999999999999999999   6799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH---
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML---  474 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~---  474 (568)
                      .........     ....++..|+|||++.+ ..++.++||||||+++|||++|+.||...........+..+....   
T Consensus       149 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (286)
T cd07846         149 TLAAPGEVY-----TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPR  223 (286)
T ss_pred             eccCCcccc-----CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchh
Confidence            765432211     13457899999999865 457889999999999999999999886433222111111111000   


Q ss_pred             ----hhcCchh-hhhhhhcCCC-----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          475 ----HREGHIQ-DAVDQRLNIN-----SVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       475 ----~~~~~~~-~~~d~~l~~~-----~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                          ....... ....+.....     ........+.+++..|++.+|++||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                0000000 0000000000     01123456788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.6e-36  Score=307.51  Aligned_cols=263  Identities=24%  Similarity=0.319  Sum_probs=205.7

Q ss_pred             cCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeE
Q 008374          231 FKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHL  309 (568)
Q Consensus       231 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l  309 (568)
                      +...++..++++|...+.||+|+||.||++....      +++.+|+|.+.... ....++.+|+.++.++ +|||++++
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~   84 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKK------DGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKF   84 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECC------CCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEE
Confidence            5566777789999999999999999999998864      67889999986532 2345678899999999 89999999


Q ss_pred             EEEEEeC-----CeEEEEEEecCCCChhhhhccC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 008374          310 VGWCHEK-----GKLLLVYDFMPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL  383 (568)
Q Consensus       310 ~g~~~~~-----~~~~lV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl  383 (568)
                      ++++...     +..++||||+++++|.+++... .....+++..+..++.|++.||.|||   +.+++||||||+||++
T Consensus        85 ~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili  161 (291)
T cd06639          85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILL  161 (291)
T ss_pred             EEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEE
Confidence            9998754     3689999999999999988542 22346899999999999999999999   6799999999999999


Q ss_pred             cCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008374          384 DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-----KATPESDVFGFGAVVLEVVCGRSPGNMI  458 (568)
Q Consensus       384 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-----~~t~~sDV~SfGvll~el~tG~~P~~~~  458 (568)
                      ++++.+||+|||+++.........     ....|+..|+|||.+...     .++.++|||||||++|||++|+.|+...
T Consensus       162 ~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~  236 (291)
T cd06639         162 TTEGGVKLVDFGVSAQLTSTRLRR-----NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM  236 (291)
T ss_pred             cCCCCEEEeecccchhcccccccc-----cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence            999999999999998765332111     134688999999998643     3688999999999999999999998754


Q ss_pred             CcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          459 PHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       459 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ....   .+..+.     .+..     +.+  .........+..++.+|++.+|++||++.|+++
T Consensus       237 ~~~~---~~~~~~-----~~~~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         237 HPVK---TLFKIP-----RNPP-----PTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             cHHH---HHHHHh-----cCCC-----CCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            3222   111110     0100     011  111223345778889999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.4e-36  Score=302.37  Aligned_cols=256  Identities=26%  Similarity=0.404  Sum_probs=199.9

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC----------cccchhhHHHHHHhhc-CCCCceeeEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS----------IKSKGDFLAELAIIHR-LRHKHLVHLV  310 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~H~nIv~l~  310 (568)
                      +|...+.||+|+||.||+|....+     .+..+|+|.+....          .....++.+|+.++.+ ++||||++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~-----~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~   75 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNN-----GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYY   75 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCC-----CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEE
Confidence            366778899999999999998742     36789999875421          1233457789988875 7999999999


Q ss_pred             EEEEeCCeEEEEEEecCCCChhhhhccC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcE
Q 008374          311 GWCHEKGKLLLVYDFMPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA  389 (568)
Q Consensus       311 g~~~~~~~~~lV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~  389 (568)
                      +++.+.+..++||||+++++|.+++... .....+++..++.++.|++.+|.|||.  ..+++|+||+|+||+++.++.+
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~  153 (269)
T cd08528          76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKV  153 (269)
T ss_pred             eeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcE
Confidence            9999999999999999999999988542 223468899999999999999999994  3589999999999999999999


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~  469 (568)
                      ||+|||++........      .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+.......    ...
T Consensus       154 ~l~dfg~~~~~~~~~~------~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~----~~~  223 (269)
T cd08528         154 TITDFGLAKQKQPESK------LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS----LAT  223 (269)
T ss_pred             EEecccceeecccccc------cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH----HHH
Confidence            9999999987654321      124568899999999998889999999999999999999999986432211    111


Q ss_pred             HHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          470 WVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       470 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                         .. ..+..        ...........+.+++.+|++.||.+||++.||.++|+
T Consensus       224 ---~~-~~~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         224 ---KI-VEAVY--------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ---HH-hhccC--------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence               10 01111        00001122345677888999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2e-36  Score=327.58  Aligned_cols=268  Identities=19%  Similarity=0.279  Sum_probs=193.5

Q ss_pred             HHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCC------Cceee
Q 008374          235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRH------KHLVH  308 (568)
Q Consensus       235 el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~nIv~  308 (568)
                      ++...+++|...++||+|+||+||+|....      .++.||||+++... ...+++..|+.++.+++|      .++++
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~------~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~  195 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRK------RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMK  195 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcC------CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceee
Confidence            344456789999999999999999998864      57889999996532 233445667777776654      45889


Q ss_pred             EEEEEEeC-CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC
Q 008374          309 LVGWCHEK-GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF  387 (568)
Q Consensus       309 l~g~~~~~-~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~  387 (568)
                      +++++... ...++|||++ +++|.+++..   ...+++..+..|+.||+.||.|||.  ..+|+||||||+|||++.++
T Consensus       196 i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~  269 (467)
T PTZ00284        196 IQRYFQNETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSD  269 (467)
T ss_pred             eEEEEEcCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCC
Confidence            99988754 5789999998 7788888853   3468999999999999999999994  25999999999999998765


Q ss_pred             ----------------cEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhC
Q 008374          388 ----------------NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCG  451 (568)
Q Consensus       388 ----------------~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG  451 (568)
                                      .+||+|||++......        .....||..|+|||++.+..++.++|||||||++|||++|
T Consensus       270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~--------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG  341 (467)
T PTZ00284        270 TVVDPVTNRALPPDPCRVRICDLGGCCDERHS--------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG  341 (467)
T ss_pred             cccccccccccCCCCceEEECCCCccccCccc--------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhC
Confidence                            4999999988643221        1256799999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccchhhHH--------HHHHH--------Hhh-cCchhhhhhhh----c-CCC--CcHHHHHHHHHHHHhc
Q 008374          452 RSPGNMIPHQQHAYTLV--------DWVWM--------LHR-EGHIQDAVDQR----L-NIN--SVVDEAKRLLLLGLAC  507 (568)
Q Consensus       452 ~~P~~~~~~~~~~~~l~--------~~~~~--------~~~-~~~~~~~~d~~----l-~~~--~~~~~~~~l~~l~l~C  507 (568)
                      +.||...........+.        +|...        ... .+.+....++.    + ...  ........+.+|+..|
T Consensus       342 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m  421 (467)
T PTZ00284        342 KLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGL  421 (467)
T ss_pred             CCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHh
Confidence            99997543322111110        11100        000 00000000000    0 000  0001124567888999


Q ss_pred             CCCCCCCCCCHHHHHH
Q 008374          508 SHPIASERPKTEDILQ  523 (568)
Q Consensus       508 l~~dp~~RPt~~evl~  523 (568)
                      |+.||.+|||++|+++
T Consensus       422 L~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        422 LHYDRQKRLNARQMTT  437 (467)
T ss_pred             CCcChhhCCCHHHHhc
Confidence            9999999999999987

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-37  Score=300.69  Aligned_cols=268  Identities=21%  Similarity=0.294  Sum_probs=201.4

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEe--
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE--  315 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--  315 (568)
                      ...|...+.||+|+||.|+.++.+.      +++.||||++.+.  .....++-.+|+++|+.++|+||+.+.+.+..  
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~------t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~   94 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKR------TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS   94 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcC------CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence            3445556789999999999999886      7899999999843  44456778899999999999999999998865  


Q ss_pred             ---CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          316 ---KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       316 ---~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                         -+.+|+|+|+| ..+|.+.++   .+..|+..+...++.|+++||.|+|   +.+|+||||||+|+|++.+..+||+
T Consensus        95 ~~~f~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~  167 (359)
T KOG0660|consen   95 RDKFNDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKIC  167 (359)
T ss_pred             ccccceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEec
Confidence               36899999999 678999984   3445999999999999999999999   7799999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH-
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW-  470 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~-  470 (568)
                      ||||||.....   .....++..+-|..|.|||++.. ..|+.+.||||.||++.||++|+.-|.+...-.....+.+. 
T Consensus       168 DFGLAR~~~~~---~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l  244 (359)
T KOG0660|consen  168 DFGLARYLDKF---FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL  244 (359)
T ss_pred             cccceeecccc---CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence            99999998654   11222346778999999998754 68999999999999999999999877654332211111111 


Q ss_pred             ------HHHHhhcCchhhhhhhhcC---CCC---cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          471 ------VWMLHREGHIQDAVDQRLN---INS---VVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       471 ------~~~~~~~~~~~~~~d~~l~---~~~---~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                            ........+....+.....   ..+   ........++|+.+++..||.+|+|++|.++
T Consensus       245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                  1111111111111111100   000   0122334566677899999999999999986

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-36  Score=319.51  Aligned_cols=265  Identities=20%  Similarity=0.238  Sum_probs=197.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      .+|...++||+|+||.||++.....    ..+..||+|.+...     ..+.+|++++++++||||+++++++...+..+
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~----~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGD----EQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCC----ccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            4688899999999999999976532    14678999988643     24568999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+. ++|.+++.   ....+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus       163 lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        163 MVMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            9999995 68888883   3356899999999999999999999   679999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh-----
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH-----  475 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~-----  475 (568)
                      ........   .....||..|+|||++....++.++|||||||++|||++|+.||...........+..-....-     
T Consensus       236 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~  312 (392)
T PHA03207        236 DAHPDTPQ---CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE  312 (392)
T ss_pred             Cccccccc---ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence            54322111   1246799999999999999999999999999999999999999864332211111111111000     


Q ss_pred             -hcCc---hhhh---hhhhcCCCCc-------HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          476 -REGH---IQDA---VDQRLNINSV-------VDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       476 -~~~~---~~~~---~d~~l~~~~~-------~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                       ....   +...   .....+....       ......+..++.+|++.||++|||+.|++..
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence             0000   0000   0000000000       0112345667789999999999999999864

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.6e-36  Score=300.63  Aligned_cols=256  Identities=19%  Similarity=0.323  Sum_probs=188.7

Q ss_pred             eeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 008374          248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFM  326 (568)
Q Consensus       248 ~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  326 (568)
                      .||+|+||.||+|......    ....+++|.+.... ....+.|.+|+.+++.++||||+++++.|......++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDT----GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcCC----CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            5999999999999865321    23457778776543 334568999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCC-cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccc
Q 008374          327 PNGSLEKYLYGTSE-QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN  405 (568)
Q Consensus       327 ~~gsL~~~L~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~  405 (568)
                      ++|+|.+++..... ...+++.....++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++........
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            99999999965322 234667778899999999999999   67999999999999999999999999999864322111


Q ss_pred             cccccccccCCcCCcccCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          406 SYAEHGLVGVPGTMGYVAPECFHT-------GKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       406 ~~~~~~~~~~~Gt~~y~APE~~~~-------~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ...   .....|+..|+|||++..       ..++.++||||||+++|||++ |..|+.......       ....... 
T Consensus       155 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~-  223 (268)
T cd05086         155 IET---EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-------VLNHVIK-  223 (268)
T ss_pred             hhc---ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHh-
Confidence            000   114567899999998743       245789999999999999997 566776433221       1111111 


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                      +......++.+...+    ...+.+++..|| .+|.+||++++|++.|.
T Consensus       224 ~~~~~~~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         224 DQQVKLFKPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             hcccccCCCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            111222333332222    234555666888 67999999999999884

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3e-36  Score=298.84  Aligned_cols=249  Identities=22%  Similarity=0.360  Sum_probs=200.5

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      +|...+.||+|+||.||++....      ++..+|+|.+....  ....+.+.+|++++++++||||+++++.+...+..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKA------DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL   74 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcC------CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence            46778899999999999998865      67889999987542  33456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-CcEEEeecCCcc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD-FNARLGDFGLAR  398 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~-~~~kL~DFGla~  398 (568)
                      ++||||+++++|.+++.... ...+++..+..++.+++.+|.|||   +++++|+||+|+||+++++ ..+||+|||++.
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~  150 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISK  150 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCce
Confidence            99999999999999996532 345899999999999999999999   6799999999999999855 568999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      .........      ...|+..|+|||.+....++.++||||||+++|+|++|+.|++......    .....   .. +
T Consensus       151 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~----~~~~~---~~-~  216 (256)
T cd08220         151 ILSSKSKAY------TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA----LVLKI---MS-G  216 (256)
T ss_pred             ecCCCcccc------ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH----HHHHH---Hh-c
Confidence            775432211      3468899999999998889999999999999999999999987432221    11111   00 0


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .         ...........+.+++..|++.+|.+|||+.|+++
T Consensus       217 ~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         217 T---------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             C---------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            0         01111123456778888999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.2e-36  Score=302.00  Aligned_cols=254  Identities=25%  Similarity=0.390  Sum_probs=197.5

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc------ccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI------KSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      +|...+.||+|+||+||+|...       ++..+|+|.+.....      .....+.+|++++++++|+||++++++|.+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   73 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD   73 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec
Confidence            3667789999999999999764       578899999864321      223568899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      .+..++||||+++++|.+++..   ...+++.....++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||
T Consensus        74 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg  147 (265)
T cd06631          74 DNTISIFMEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFG  147 (265)
T ss_pred             CCeEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccch
Confidence            9999999999999999999953   245789999999999999999999   6789999999999999999999999999


Q ss_pred             Ccccccccccc-ccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          396 LARAIENERNS-YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       396 la~~~~~~~~~-~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      +++........ ..........|+..|+|||++.+..++.++||||||++++||++|+.||.......   ....   ..
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~---~~  221 (265)
T cd06631         148 CARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA---AMFY---IG  221 (265)
T ss_pred             hhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH---HHHH---hh
Confidence            99865321110 00111124568999999999998889999999999999999999999997432211   1100   00


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ...+.     .+.+    .......+..++.+|++.+|.+||++.|+++
T Consensus       222 ~~~~~-----~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         222 AHRGL-----MPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             hccCC-----CCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000     0111    1123345677888999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.6e-36  Score=300.57  Aligned_cols=252  Identities=25%  Similarity=0.351  Sum_probs=194.5

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-----cccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-----IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      .+|...++||+|+||.||+|....      ++..||+|.+....     ....+.+.+|+.++++++||||+++++++.+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   75 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDAD------TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD   75 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcC------CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc
Confidence            468888999999999999998864      67899999875321     1234578889999999999999999998876


Q ss_pred             C--CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEee
Q 008374          316 K--GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD  393 (568)
Q Consensus       316 ~--~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~D  393 (568)
                      .  ..+++||||+++++|.+++..   ...+++....+++.|++.||.|||   +++++|+||||+||+++.++.+||+|
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~D  149 (265)
T cd06652          76 PMERTLSIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGD  149 (265)
T ss_pred             CCCceEEEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECc
Confidence            3  468899999999999999853   235788889999999999999999   67999999999999999999999999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      ||+++.........  .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......   .+.    .
T Consensus       150 fg~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~----~  220 (265)
T cd06652         150 FGASKRLQTICLSG--TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA---AIF----K  220 (265)
T ss_pred             Cccccccccccccc--cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH---HHH----H
Confidence            99998654321111  11124568899999999988889999999999999999999999987432111   110    0


Q ss_pred             HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       474 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                               ..........+......+..++..|+. +|++||+++|+++
T Consensus       221 ---------~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         221 ---------IATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ---------HhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                     000001111222333455566667774 8999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.1e-36  Score=300.15  Aligned_cols=248  Identities=25%  Similarity=0.398  Sum_probs=198.8

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-----cccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-----IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      +|...+.||+|+||+||+|+...      ++..|++|.+....     .+..+.+.+|+.++++++|+||+++++++...
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLD------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE   74 (258)
T ss_pred             CccccceeeecCCceEEEEEEcC------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC
Confidence            36667889999999999999864      57889999986543     22446789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      ...++|+||+++++|.+++..   ...+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||+
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~  148 (258)
T cd06632          75 DNLYIFLELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGM  148 (258)
T ss_pred             CeEEEEEEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCcc
Confidence            999999999999999999953   235889999999999999999999   67999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      +........      .....|+..|+|||.+.... ++.++|+||||+++|||++|+.||.......   .+    ....
T Consensus       149 ~~~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~---~~----~~~~  215 (258)
T cd06632         149 AKQVVEFSF------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA---AV----FKIG  215 (258)
T ss_pred             ceecccccc------ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH---HH----HHHH
Confidence            987654321      11456889999999987766 8999999999999999999999987543211   11    1111


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .....         ..........+.+++.+|++.+|.+||++.++++
T Consensus       216 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         216 RSKEL---------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             hcccC---------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            00000         0111122345667788999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9.4e-37  Score=309.83  Aligned_cols=246  Identities=26%  Similarity=0.373  Sum_probs=196.9

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      ...||+|+||.||++....      ++..||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||
T Consensus        27 ~~~lg~g~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKH------TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             hhcccCCCCeEEEEEEECC------CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            4569999999999998764      5789999998765555567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccc
Q 008374          326 MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN  405 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~  405 (568)
                      +++++|.+++..    ..+++.+...++.|++.||.|||   +++++||||||+||++++++.+||+|||++........
T Consensus       101 ~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658         101 LEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            999999998842    35889999999999999999999   67999999999999999999999999999976543321


Q ss_pred             cccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhh
Q 008374          406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVD  485 (568)
Q Consensus       406 ~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  485 (568)
                      ..     ....|+..|+|||.+....++.++||||||++++||++|+.||.......   .+..          +.....
T Consensus       174 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~----------~~~~~~  235 (292)
T cd06658         174 KR-----KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMRR----------IRDNLP  235 (292)
T ss_pred             cC-----ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----------HHhcCC
Confidence            11     13468899999999988889999999999999999999999987432211   1100          001111


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          486 QRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       486 ~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                      +.+...  ......+..++..|++.||++|||++|+++.
T Consensus       236 ~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         236 PRVKDS--HKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             Cccccc--cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            111111  1122345566778999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7.3e-36  Score=306.56  Aligned_cols=200  Identities=24%  Similarity=0.353  Sum_probs=161.7

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEe--CCeEEEEE
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE--KGKLLLVY  323 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~  323 (568)
                      .++||+|+||.||+|+....    ..++.+|+|.+....  ....+.+|+.++++++||||+++++++..  ....++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~----~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDG----KDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccC----CCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence            46899999999999987532    146789999986532  23457899999999999999999998854  45789999


Q ss_pred             EecCCCChhhhhccCC------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----cCCCcEEEee
Q 008374          324 DFMPNGSLEKYLYGTS------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL----DADFNARLGD  393 (568)
Q Consensus       324 Ey~~~gsL~~~L~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl----d~~~~~kL~D  393 (568)
                      ||+. ++|.+++....      ....+++.....++.|++.||.|||   +++|+||||||+|||+    +..+.+||+|
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07868          80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence            9995 57877764321      1235888999999999999999999   6799999999999999    4567899999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNM  457 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~  457 (568)
                      ||+++..........  ......||+.|+|||++.+ ..++.++||||+||+++||++|+.||..
T Consensus       156 fG~a~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         156 MGFARLFNSPLKPLA--DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cCceeccCCCCcccc--ccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            999987654322111  1224678999999999876 4588999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.9e-36  Score=305.33  Aligned_cols=261  Identities=22%  Similarity=0.338  Sum_probs=203.6

Q ss_pred             cCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeE
Q 008374          231 FKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHL  309 (568)
Q Consensus       231 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l  309 (568)
                      .++.++..+.+.|+..+.||+|+||.||+|....      .++.+|+|.+.... ....++..|+.++.++ +|+||+++
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~   78 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVK------TGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATY   78 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcC------CCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEE
Confidence            4566777788899999999999999999999875      57889999986543 3345688999999998 69999999


Q ss_pred             EEEEEe------CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 008374          310 VGWCHE------KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL  383 (568)
Q Consensus       310 ~g~~~~------~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl  383 (568)
                      ++++..      ....+++|||+++|+|.+++.... ...+++..+..++.|++.||.|||   +.+++|+||||+||++
T Consensus        79 ~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili  154 (282)
T cd06636          79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLL  154 (282)
T ss_pred             eeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEE
Confidence            999853      457899999999999999986432 235788889999999999999999   6799999999999999


Q ss_pred             cCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008374          384 DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH-----TGKATPESDVFGFGAVVLEVVCGRSPGNMI  458 (568)
Q Consensus       384 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~t~~sDV~SfGvll~el~tG~~P~~~~  458 (568)
                      ++++.++|+|||+++........     .....|+..|+|||.+.     ...++.++|||||||++|||++|+.||...
T Consensus       155 ~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~  229 (282)
T cd06636         155 TENAEVKLVDFGVSAQLDRTVGR-----RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM  229 (282)
T ss_pred             CCCCCEEEeeCcchhhhhccccC-----CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence            99999999999998866432211     11456899999999875     346788999999999999999999998643


Q ss_pred             CcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          459 PHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       459 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ....   .+..    .      .......+.   .......+.+++..||+.||.+|||+.|+++
T Consensus       230 ~~~~---~~~~----~------~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         230 HPMR---ALFL----I------PRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             CHHh---hhhh----H------hhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            2211   1100    0      000011111   1123346778888999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=307.16  Aligned_cols=266  Identities=24%  Similarity=0.312  Sum_probs=201.0

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      +|+..+.||+|+||.||+|+...      +++.||+|++...  .....+.+.+|++++++++|+||+++++++...+..
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKA------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRL   75 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCC------CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEE
Confidence            57888999999999999999875      5789999998653  233456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||++++.+..++..   ...+++.+...++.+++.||.|||   +++++||||+|+||++++++.+||+|||++..
T Consensus        76 ~iv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~  149 (288)
T cd07833          76 YLVFEYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARA  149 (288)
T ss_pred             EEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccc
Confidence            999999998777766532   345899999999999999999999   67999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH------
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW------  472 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~------  472 (568)
                      .........    ....++..|+|||++... .++.++||||||+++|||++|+.||...........+.....      
T Consensus       150 ~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (288)
T cd07833         150 LRARPASPL----TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSH  225 (288)
T ss_pred             cCCCccccc----cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            765432111    145678899999999887 889999999999999999999999874332211111110000      


Q ss_pred             -HHhh-cCch-----hhhhhhh-cCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          473 -MLHR-EGHI-----QDAVDQR-LNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       473 -~~~~-~~~~-----~~~~d~~-l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       .... ....     .+..+.. +...+.......+..++..|++.+|++|||++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             hhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence             0000 0000     0000000 000011112567888999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.2e-36  Score=314.92  Aligned_cols=203  Identities=24%  Similarity=0.339  Sum_probs=172.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC---CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD---SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...++||+|+||.||+++.+.      .++.+|+|.+.+.   .......|..|+.++..++|+||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKN------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN   74 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            468888999999999999999875      5788999998642   1223345888999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .+++||||+++|+|.+++...  ...+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a  149 (332)
T cd05623          75 NLYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC  149 (332)
T ss_pred             EEEEEEeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchh
Confidence            999999999999999999642  235888999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFH-----TGKATPESDVFGFGAVVLEVVCGRSPGNMI  458 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~t~~sDV~SfGvll~el~tG~~P~~~~  458 (568)
                      +..........    ....||+.|+|||++.     ...++.++|||||||++|||++|+.||...
T Consensus       150 ~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         150 LKLMEDGTVQS----SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             eecccCCccee----cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence            76543322111    1356999999999986     346789999999999999999999999743

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.6e-36  Score=301.56  Aligned_cols=256  Identities=22%  Similarity=0.371  Sum_probs=197.5

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc----------cchhhHHHHHHhhcCCCCceeeEEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK----------SKGDFLAELAIIHRLRHKHLVHLVG  311 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~H~nIv~l~g  311 (568)
                      +|...+.||+|+||.||+|....      +++.+|+|.+......          ..+.+.+|+.++++++|||++++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   75 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVT------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLG   75 (272)
T ss_pred             ceeecceecccCceEEEEEeecC------CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEE
Confidence            36677899999999999998764      5789999988542111          1235788999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 008374          312 WCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL  391 (568)
Q Consensus       312 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL  391 (568)
                      ++...+..++||||+++++|.+++...   ..+++..+..++.|++.||.|||   +++++||||+|+||+++.++.+||
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l  149 (272)
T cd06629          76 FETTEEYLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKI  149 (272)
T ss_pred             EeccCCceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEE
Confidence            999999999999999999999999543   46889999999999999999999   679999999999999999999999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK--ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~--~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~  469 (568)
                      +|||+++.........   ......|+..|+|||.+....  ++.++||||||+++||+++|+.|+.......   .+  
T Consensus       150 ~d~~~~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~--  221 (272)
T cd06629         150 SDFGISKKSDDIYDND---QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA---AM--  221 (272)
T ss_pred             eecccccccccccccc---ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH---HH--
Confidence            9999998654322111   112456889999999987654  7899999999999999999999986332211   11  


Q ss_pred             HHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          470 WVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       470 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                        ...... .....+.+    ....+....+.+++..|++++|.+|||+.+|++.
T Consensus       222 --~~~~~~-~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         222 --FKLGNK-RSAPPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             --HHhhcc-ccCCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence              111100 00001111    1111234567778889999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.5e-36  Score=301.45  Aligned_cols=247  Identities=23%  Similarity=0.375  Sum_probs=199.6

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLL  321 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  321 (568)
                      |...++||+|+||.||+|....      ++..+|+|.+.... ....+.+.+|+.++.+++||||+++++++..++..++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   79 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNR------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI   79 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECC------CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence            5667789999999999998764      57899999986543 2344678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccc
Q 008374          322 VYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE  401 (568)
Q Consensus       322 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~  401 (568)
                      ||||+++++|.+++..    ..+++.....++.+++.++.|||   +.+++|+||+|+||+++.++.++|+|||+++...
T Consensus        80 v~e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06641          80 IMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT  152 (277)
T ss_pred             EEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecc
Confidence            9999999999999842    35899999999999999999999   6899999999999999999999999999998765


Q ss_pred             cccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchh
Q 008374          402 NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQ  481 (568)
Q Consensus       402 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  481 (568)
                      .....     .....|+..|+|||.+.+..++.++|||||||++|||++|+.|+.......       +.... ..+   
T Consensus       153 ~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~-~~~---  216 (277)
T cd06641         153 DTQIK-----RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLFLI-PKN---  216 (277)
T ss_pred             cchhh-----hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-------HHHHH-hcC---
Confidence            43211     113468889999999988889999999999999999999999986432211       11110 000   


Q ss_pred             hhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          482 DAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       482 ~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                            ............+.+++..|++.+|.+||++.++++.
T Consensus       217 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         217 ------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ------CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                  0111122234556778889999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.8e-36  Score=299.08  Aligned_cols=260  Identities=22%  Similarity=0.340  Sum_probs=206.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|+..+.||.|+||.||+|....      ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+...+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLP------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDEL   74 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcC------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEE
Confidence            468888999999999999999764      57789999987543 23567899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++|+||+++++|.+++........+++.....++.|++.||+|||   +.+++||||+|+||++++++.+||+|||++..
T Consensus        75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~  151 (267)
T cd06610          75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSAS  151 (267)
T ss_pred             EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHH
Confidence            999999999999999965433356899999999999999999999   67999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      +........ .......|+..|+|||++... .++.++|+||||+++|||++|+.||.......   .+.+...    . 
T Consensus       152 ~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~~----~-  222 (267)
T cd06610         152 LADGGDRTR-KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLTLQ----N-  222 (267)
T ss_pred             hccCccccc-cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHHHhc----C-
Confidence            765432211 111245689999999998777 78999999999999999999999997543322   1111111    0 


Q ss_pred             chhhhhhhhcCCCC-cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          479 HIQDAVDQRLNINS-VVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       479 ~~~~~~d~~l~~~~-~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                           ..+.+.... .......+.+++..|++.||++||++.++++
T Consensus       223 -----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         223 -----DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             -----CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                 011111111 1133456678888999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.6e-36  Score=304.89  Aligned_cols=261  Identities=20%  Similarity=0.333  Sum_probs=206.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|...+.||+|+||.||++....      ++..+|+|.+........+.+.+|+.++++++|||++++++.|...+..+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   92 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVA------TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW   92 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcC------CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence            578888999999999999998754      56789999987655555677899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +|+||+++++|.+++..    ..+++..+..++.+++.||.|||   +++++||||||+||+++.++.+||+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~  165 (293)
T cd06647          93 VVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (293)
T ss_pred             EEEecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence            99999999999999843    35789999999999999999999   679999999999999999999999999998766


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      .......     ....|+..|+|||.+....++.++||||||+++||+++|+.||.......   .+.    ....    
T Consensus       166 ~~~~~~~-----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~---~~~----~~~~----  229 (293)
T cd06647         166 TPEQSKR-----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALY----LIAT----  229 (293)
T ss_pred             ccccccc-----ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh---hee----ehhc----
Confidence            4432211     13468899999999988889999999999999999999999997432221   000    0000    


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HhCCCCCCCC
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI--ISGTSTVPYV  534 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~--L~~~~~~p~~  534 (568)
                          ...............+.+++..||+.+|++||++.++++.  +....++-.+
T Consensus       230 ----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~  281 (293)
T cd06647         230 ----NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSL  281 (293)
T ss_pred             ----CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccc
Confidence                0111111122233456778889999999999999999874  4444444333

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.7e-36  Score=308.53  Aligned_cols=200  Identities=24%  Similarity=0.358  Sum_probs=161.6

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEe--CCeEEEEE
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE--KGKLLLVY  323 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~  323 (568)
                      ..+||+|+||.||+|+.....    .+..||+|.+....  ....+.+|++++++++||||+++++++..  ....++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~----~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGK----DEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCC----ccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence            468999999999999875421    46789999986542  23467899999999999999999999854  46789999


Q ss_pred             EecCCCChhhhhccC------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----cCCCcEEEee
Q 008374          324 DFMPNGSLEKYLYGT------SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL----DADFNARLGD  393 (568)
Q Consensus       324 Ey~~~gsL~~~L~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl----d~~~~~kL~D  393 (568)
                      ||+++ +|.+++...      .....+++..+..++.|++.||.|||   +++++||||||+|||+    ++++.+||+|
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07867          80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence            99864 777776421      12235889999999999999999999   6799999999999999    5667999999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNM  457 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~  457 (568)
                      ||+++..........  ......||..|+|||.+.+ ..++.++|||||||++|||+||+.||..
T Consensus       156 fG~a~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         156 MGFARLFNSPLKPLA--DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             ccceeccCCCccccc--ccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            999987654332211  1124568999999999876 4578999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.5e-36  Score=298.73  Aligned_cols=250  Identities=24%  Similarity=0.348  Sum_probs=201.7

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      +|...++||+|+||.+|++....      +++.+|+|++...  .....+++.+|+.++++++||||+++++++...+..
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKE------DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNL   74 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcC------CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence            47778899999999999998875      5788999998653  233456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++|+||+++++|.+++.... ...+++.+...++.|++.||.|||   +++++|+||+|+||+++.++.++|+|||++..
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~  150 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV  150 (256)
T ss_pred             EEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceee
Confidence            99999999999999985432 235789999999999999999999   67999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      ........     ....|+..|+|||++.+...+.++|||||||+++||++|+.|+.....       .+.+..... +.
T Consensus       151 ~~~~~~~~-----~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~~-~~  217 (256)
T cd08218         151 LNSTVELA-----RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKIIR-GS  217 (256)
T ss_pred             cCcchhhh-----hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHHhc-CC
Confidence            65432211     134588899999999888899999999999999999999999864321       111111111 10


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .         ..........+..++.+|++.+|.+||++.+|++
T Consensus       218 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         218 Y---------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             C---------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            0         1112233456778888999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.1e-36  Score=301.04  Aligned_cols=256  Identities=21%  Similarity=0.367  Sum_probs=201.5

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc------ccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI------KSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      +|...++||+|+||.||+|....      ++..+|+|.+.....      ...+.+.+|++++++++|+||+++++++.+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~------~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   74 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVK------TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE   74 (268)
T ss_pred             CccccceecCcCceEEEEEEEcC------CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc
Confidence            46778899999999999998764      678999999865331      134678999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-cEEEeec
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF-NARLGDF  394 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~-~~kL~DF  394 (568)
                      .+..++||||+++++|.+++..   ...+++.....++.|++.||.|||   +++++|+||+|+||+++.++ .+||+||
T Consensus        75 ~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~df  148 (268)
T cd06630          75 DSHFNLFVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADF  148 (268)
T ss_pred             CCeEEEEEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccc
Confidence            9999999999999999999953   346889999999999999999999   67999999999999998775 5999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      |++............ ......|+..|+|||.+.+..++.++||||+|++++||++|+.||.......    ....... 
T Consensus       149 g~~~~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~-  222 (268)
T cd06630         149 GAAARLAAKGTGAGE-FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN----HLALIFK-  222 (268)
T ss_pred             ccccccccccccCCc-cccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc----hHHHHHH-
Confidence            999877543211110 0113468899999999988889999999999999999999999986432221    1111111 


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                              ..........+......+.+++.+|++.+|.+||++.++++
T Consensus       223 --------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         223 --------IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --------HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                    00111112233344566778889999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-37  Score=317.90  Aligned_cols=246  Identities=26%  Similarity=0.440  Sum_probs=203.8

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFM  326 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  326 (568)
                      -+||+|.||+||.|+..+      +...+|||.+.....+..+-+..|+.+-++|+|+|||+++|.|.+.+.+-+.||.+
T Consensus       581 vVLGKGTYG~VYA~RD~~------tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqV  654 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMD------TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQV  654 (1226)
T ss_pred             EEeecCceeEEEeecccc------ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecC
Confidence            469999999999999875      67899999998877777788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCcccC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc-CCCcEEEeecCCccccccc
Q 008374          327 PNGSLEKYLYGTSEQVTL--NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD-ADFNARLGDFGLARAIENE  403 (568)
Q Consensus       327 ~~gsL~~~L~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld-~~~~~kL~DFGla~~~~~~  403 (568)
                      |+|||.++|...-  ++|  +..+.--+.+||++||.|||   ++.|||||||-.|||++ -.|.+||+|||-++.+..-
T Consensus       655 PGGSLSsLLrskW--GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi  729 (1226)
T KOG4279|consen  655 PGGSLSSLLRSKW--GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI  729 (1226)
T ss_pred             CCCcHHHHHHhcc--CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccC
Confidence            9999999996543  334  66777788999999999999   68999999999999996 4689999999999987643


Q ss_pred             cccccccccccCCcCCcccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchh
Q 008374          404 RNSYAEHGLVGVPGTMGYVAPECFHTG--KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQ  481 (568)
Q Consensus       404 ~~~~~~~~~~~~~Gt~~y~APE~~~~~--~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  481 (568)
                      ... +.    +..||..|||||++..+  .|..++|||||||.+.||.||+.||-.....+.+.         ..-|   
T Consensus       730 nP~-TE----TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---------FkVG---  792 (1226)
T KOG4279|consen  730 NPC-TE----TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---------FKVG---  792 (1226)
T ss_pred             Ccc-cc----ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---------hhhc---
Confidence            222 22    67799999999999765  58899999999999999999999997543322111         0111   


Q ss_pred             hhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          482 DAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       482 ~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                         --+...+.+.+.......++++|+.+||.+||++.++++
T Consensus       793 ---myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  793 ---MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ---ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence               112233456667777888999999999999999999987

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-36  Score=299.48  Aligned_cols=269  Identities=23%  Similarity=0.257  Sum_probs=214.4

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc---chhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS---KGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .|+..++||.|.-|+||++.+..      ++...|+|++.+.....   ..+...|-+||+.+.||.++.|+..++.+..
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~  151 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRG------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY  151 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecC------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence            46667789999999999999985      56899999998765433   3456779999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .+||||||+||+|...+++.. ...++.....-++..|+-||+|||   -.|||.|||||+||||.++|.+-|+||.|+.
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccc
Confidence            999999999999999987644 457888999999999999999999   5799999999999999999999999999986


Q ss_pred             cccccc---------------------------------c------------------cccccccccCCcCCcccCcccc
Q 008374          399 AIENER---------------------------------N------------------SYAEHGLVGVPGTMGYVAPECF  427 (568)
Q Consensus       399 ~~~~~~---------------------------------~------------------~~~~~~~~~~~Gt~~y~APE~~  427 (568)
                      .+....                                 .                  ..+.......+||-.|+|||++
T Consensus       228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI  307 (459)
T KOG0610|consen  228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI  307 (459)
T ss_pred             cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence            552200                                 0                  0001112356799999999999


Q ss_pred             ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhc
Q 008374          428 HTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLAC  507 (568)
Q Consensus       428 ~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~C  507 (568)
                      .+...+.++|.|+|||++|||+.|+.||.+....+   .             +..++-+.+......+....+.+|+...
T Consensus       308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~---T-------------l~NIv~~~l~Fp~~~~vs~~akDLIr~L  371 (459)
T KOG0610|consen  308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---T-------------LRNIVGQPLKFPEEPEVSSAAKDLIRKL  371 (459)
T ss_pred             ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh---h-------------HHHHhcCCCcCCCCCcchhHHHHHHHHH
Confidence            99999999999999999999999999999776655   2             2334444444444444445556666677


Q ss_pred             CCCCCCCCCC----HHHHHH---------HHhCCCCCCCCCC
Q 008374          508 SHPIASERPK----TEDILQ---------IISGTSTVPYVPQ  536 (568)
Q Consensus       508 l~~dp~~RPt----~~evl~---------~L~~~~~~p~~p~  536 (568)
                      |.+||++|..    +.||-+         .|-+...+|.+|.
T Consensus       372 LvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~  413 (459)
T KOG0610|consen  372 LVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPK  413 (459)
T ss_pred             hccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCC
Confidence            8999999998    777755         3334555666553

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.6e-36  Score=340.69  Aligned_cols=263  Identities=25%  Similarity=0.360  Sum_probs=201.6

Q ss_pred             HHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEE
Q 008374          236 LKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWC  313 (568)
Q Consensus       236 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~  313 (568)
                      .....++|...++||+|+||.||++....      .+..+|+|.+...  .......|..|+.++.+++||||+++++++
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~------tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f   81 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKR------TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRF   81 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECC------CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence            33455689999999999999999999875      6788999998653  223456789999999999999999999988


Q ss_pred             EeC--CeEEEEEEecCCCChhhhhccCC-CcccCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEecCCCCCCEEEcC-
Q 008374          314 HEK--GKLLLVYDFMPNGSLEKYLYGTS-EQVTLNWNHRYKILTGVASAVYYLQNEY----DQKVVHRDLKASNILLDA-  385 (568)
Q Consensus       314 ~~~--~~~~lV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~----~~~ivHrDikp~NILld~-  385 (568)
                      ...  ..++|||||+++|+|.++|.... ....+++..++.|+.||+.||.|||...    .++|+||||||+||||+. 
T Consensus        82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~  161 (1021)
T PTZ00266         82 LNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG  161 (1021)
T ss_pred             EecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence            643  57899999999999999996422 2346899999999999999999999642    256999999999999964 


Q ss_pred             ----------------CCcEEEeecCCccccccccccccccccccCCcCCcccCcccccc--CCCCccchhHHHHHHHHH
Q 008374          386 ----------------DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT--GKATPESDVFGFGAVVLE  447 (568)
Q Consensus       386 ----------------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~t~~sDV~SfGvll~e  447 (568)
                                      ...+||+|||+++.+......      ....||+.|+|||++..  ..++.++|||||||+|||
T Consensus       162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~------~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYE  235 (1021)
T PTZ00266        162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMA------HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE  235 (1021)
T ss_pred             ccccccccccccccCCCCceEEccCCccccccccccc------cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHH
Confidence                            345899999999876433211      14579999999999854  458899999999999999


Q ss_pred             HHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HH
Q 008374          448 VVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--II  525 (568)
Q Consensus       448 l~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L  525 (568)
                      |++|+.||.......      ..... ...+       +.+..   ......+..++..||+.+|.+||++.|+++  .+
T Consensus       236 LLTGk~PF~~~~~~~------qli~~-lk~~-------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i  298 (1021)
T PTZ00266        236 LCSGKTPFHKANNFS------QLISE-LKRG-------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGYQII  298 (1021)
T ss_pred             HHHCCCCCCcCCcHH------HHHHH-HhcC-------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence            999999997432211      11111 1111       11111   112345677888999999999999999984  45


Q ss_pred             hC
Q 008374          526 SG  527 (568)
Q Consensus       526 ~~  527 (568)
                      ..
T Consensus       299 k~  300 (1021)
T PTZ00266        299 KN  300 (1021)
T ss_pred             hh
Confidence            43

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.7e-36  Score=307.54  Aligned_cols=262  Identities=21%  Similarity=0.340  Sum_probs=197.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...++||+|+||.||+|+...      ++..||+|.+.... ......+.+|+.++++++||||+++++++...+..
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~   79 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKL------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   79 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcC------CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence            468888999999999999998864      67889999987543 22345678999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||++ ++|.+++...  ...+++.....++.|+++||.|||   +.+++||||||+||++++++.+||+|||+++.
T Consensus        80 ~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  153 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA  153 (301)
T ss_pred             EEEEeccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence            99999997 6898888543  235788999999999999999999   67999999999999999999999999999986


Q ss_pred             cccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh--
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR--  476 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~--  476 (568)
                      ........     ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......    ..........  
T Consensus       154 ~~~~~~~~-----~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~----~~~~~~~~~~~~  224 (301)
T cd07873         154 KSIPTKTY-----SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE----QLHFIFRILGTP  224 (301)
T ss_pred             cCCCCCcc-----cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHcCCC
Confidence            54332211     13457889999998865 457889999999999999999999997543221    1111111000  


Q ss_pred             -cCchhhhhh---------hhcCCCC----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          477 -EGHIQDAVD---------QRLNINS----VVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       477 -~~~~~~~~d---------~~l~~~~----~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       ......+.+         +......    .......+.+++.+|++.||.+|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         225 TEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             000000000         0000000    0112334567888999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4e-36  Score=312.18  Aligned_cols=260  Identities=20%  Similarity=0.284  Sum_probs=195.5

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      ...++|...+.||+|+||.||+|....      ++..||||++....  ....+.+.+|+.++++++||||+++++++..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTR------LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTP   85 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECC------CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcc
Confidence            345678889999999999999998764      67899999987542  2234567899999999999999999998754


Q ss_pred             C------CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcE
Q 008374          316 K------GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA  389 (568)
Q Consensus       316 ~------~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~  389 (568)
                      .      ...++++|++ +++|.+++.    ...+++..+..++.|++.||.|||   +++|+||||||+|||+++++.+
T Consensus        86 ~~~~~~~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~  157 (343)
T cd07878          86 ATSIENFNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCEL  157 (343)
T ss_pred             cccccccCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCE
Confidence            3      4579999998 789988873    245899999999999999999999   6799999999999999999999


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHH
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV  468 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~  468 (568)
                      ||+|||+++......        ....||..|+|||++.+ ..++.++|||||||+++||++|+.||.......   .+.
T Consensus       158 kl~Dfg~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~  226 (343)
T cd07878         158 RILDFGLARQADDEM--------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLK  226 (343)
T ss_pred             EEcCCccceecCCCc--------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHH
Confidence            999999998764321        14568999999999876 568899999999999999999999997433221   111


Q ss_pred             HHHHHH----------hhcCchhhhhhhhcCCCCc-------HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          469 DWVWML----------HREGHIQDAVDQRLNINSV-------VDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       469 ~~~~~~----------~~~~~~~~~~d~~l~~~~~-------~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .+....          .........+. .+.....       ......+.+++..|++.||.+|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         227 RIMEVVGTPSPEVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHHHhCCCCHHHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            110000          00000000000 0000000       011224567888999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.3e-35  Score=301.82  Aligned_cols=266  Identities=21%  Similarity=0.259  Sum_probs=198.7

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-----cchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-----SKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      +|...++||+|+||.||+|....      +++.||||++......     ....+..|++++++++|+||+++++++...
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKE------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK   74 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECC------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC
Confidence            36677889999999999999864      5789999999765332     234567899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +..++||||+ +++|.+++....  ..+++..+..++.|+++||.|||   +.+++|+||||+||+++.++.+||+|||+
T Consensus        75 ~~~~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~  148 (298)
T cd07841          75 SNINLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGL  148 (298)
T ss_pred             CEEEEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEcccee
Confidence            9999999999 999999995432  36899999999999999999999   67999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH---
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW---  472 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~---  472 (568)
                      ++.........     ....++..|+|||.+.+ ..++.++|||||||+++||++|..||...........+.....   
T Consensus       149 ~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~  223 (298)
T cd07841         149 ARSFGSPNRKM-----THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPT  223 (298)
T ss_pred             eeeccCCCccc-----cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCc
Confidence            98765432211     13356788999998854 4678999999999999999999777764332210000100000   


Q ss_pred             -HHh-hcCchhhhhhhhcCCCC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          473 -MLH-REGHIQDAVDQRLNINS-----VVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       473 -~~~-~~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                       ..+ ....+............     .......+.+++..|++.+|.+|||+.|+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             000 00000000000000011     11234567889999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.3e-36  Score=297.76  Aligned_cols=252  Identities=23%  Similarity=0.353  Sum_probs=206.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|+..+.||+|++|.||+|+...      +++.+++|++..... ...+.+.+|+..+.+++|+||+++++++...+..
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~------~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKP------TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEI   74 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcC------CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeE
Confidence            367788999999999999999875      588999999876544 4467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD-QKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      ++||||+++++|.+++...   ..++...+..++.|++++|.|||   + ++++||||+|+||+++.++.++|+|||++.
T Consensus        75 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~  148 (264)
T cd06623          75 SIVLEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISK  148 (264)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccce
Confidence            9999999999999999543   56899999999999999999999   6 899999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      .........     ....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ...+..+..      
T Consensus       149 ~~~~~~~~~-----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~------  216 (264)
T cd06623         149 VLENTLDQC-----NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-FFELMQAIC------  216 (264)
T ss_pred             ecccCCCcc-----cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC-HHHHHHHHh------
Confidence            775443221     13457899999999999999999999999999999999999987543211 112222211      


Q ss_pred             chhhhhhhhcCCCCcHH-HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          479 HIQDAVDQRLNINSVVD-EAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~-~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                            .... ...... ....+.+++..|++++|++||++.|+++
T Consensus       217 ------~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         217 ------DGPP-PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             ------cCCC-CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                  1000 111122 4467788888999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-36  Score=303.34  Aligned_cols=263  Identities=21%  Similarity=0.331  Sum_probs=196.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-cchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...+.||+|+||.||+|+.+.      +++.||+|.+...... ....+.+|++++++++|+||+++++++...+..
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKL------TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTL   78 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcC------CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeE
Confidence            568888999999999999999764      5788999998754322 234577899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||++ ++|.+++....  ..+++.....++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.
T Consensus        79 ~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  152 (291)
T cd07844          79 TLVFEYLD-TDLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARA  152 (291)
T ss_pred             EEEEecCC-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccc
Confidence            99999997 49999886432  36889999999999999999999   67999999999999999999999999999876


Q ss_pred             cccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc-
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE-  477 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~-  477 (568)
                      ........     ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......   ....-.+..... 
T Consensus       153 ~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~  224 (291)
T cd07844         153 KSVPSKTY-----SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE---DQLHKIFRVLGTP  224 (291)
T ss_pred             cCCCCccc-----cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH---HHHHHHHHhcCCC
Confidence            43221111     12346889999998865 458899999999999999999999997443211   111111111100 


Q ss_pred             --Cchhhhhh--------------hhcCCC-CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 --GHIQDAVD--------------QRLNIN-SVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 --~~~~~~~d--------------~~l~~~-~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        .....+.+              ..+... ........+.+++..|++.+|++|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         225 TEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence              00000000              000000 00111256678888999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.2e-36  Score=307.81  Aligned_cols=245  Identities=24%  Similarity=0.364  Sum_probs=196.8

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      ..+||+|+||.||++....      ++..||+|.+........+.+.+|+.++..++||||+++++++...+..++|+||
T Consensus        26 ~~~ig~g~~g~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKH------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             hhhcCCCCceeEEEEEEcC------CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            4479999999999998764      6789999998765555566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccc
Q 008374          326 MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN  405 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~  405 (568)
                      +++++|..++..    ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.......
T Consensus       100 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659         100 LQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            999999998732    45889999999999999999999   67999999999999999999999999999976544321


Q ss_pred             cccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhh
Q 008374          406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVD  485 (568)
Q Consensus       406 ~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  485 (568)
                      ..     ....|+..|+|||++.+..++.++||||||++++||++|+.||.......    .....    ....     .
T Consensus       173 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~~~----~~~~-----~  234 (297)
T cd06659         173 KR-----KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ----AMKRL----RDSP-----P  234 (297)
T ss_pred             cc-----cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHH----hccC-----C
Confidence            11     14568999999999988889999999999999999999999987432211    11110    0000     0


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          486 QRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       486 ~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ....  ........+.+++..|++.+|++||++.++++
T Consensus       235 ~~~~--~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         235 PKLK--NAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             CCcc--ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            0000  01112334667788999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-37  Score=316.56  Aligned_cols=241  Identities=27%  Similarity=0.310  Sum_probs=185.2

Q ss_pred             eccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcC---CCCceeeEEEEEEeCCeEEEE
Q 008374          249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRL---RHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       249 LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      ||+|+||+||+|+...      +++.||||++.....   .....+..|..++.+.   +||||+++++++...+..++|
T Consensus         1 lG~G~~g~Vy~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv   74 (330)
T cd05586           1 IGKGTFGQVYQVRKKD------TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLV   74 (330)
T ss_pred             CCCCCceEEEEEEECC------CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEE
Confidence            7999999999998864      678999999865321   2233455677777665   699999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      |||+++|+|..++..   ...+++.....++.||++||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        75 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~  148 (330)
T cd05586          75 TDYMSGGELFWHLQK---EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLT  148 (330)
T ss_pred             EcCCCCChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence            999999999999853   346899999999999999999999   67999999999999999999999999999976433


Q ss_pred             ccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQ  481 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  481 (568)
                      ....     .....||..|+|||.+.+. .++.++|||||||++|||++|+.||.......    +    ......+.  
T Consensus       149 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~----~----~~~i~~~~--  213 (330)
T cd05586         149 DNKT-----TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ----M----YRNIAFGK--  213 (330)
T ss_pred             CCCC-----ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH----H----HHHHHcCC--
Confidence            2211     1245799999999998754 47899999999999999999999987432211    1    11111111  


Q ss_pred             hhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC----CHHHHHH
Q 008374          482 DAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP----KTEDILQ  523 (568)
Q Consensus       482 ~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP----t~~evl~  523 (568)
                          .++...   .....+.+++..|++.||.+||    ++.++++
T Consensus       214 ----~~~~~~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         214 ----VRFPKN---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ----CCCCCc---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence                111111   1233456677799999999999    4555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.4e-36  Score=301.95  Aligned_cols=252  Identities=23%  Similarity=0.336  Sum_probs=193.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHH-hhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAI-IHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|...+.||+|+||.||+++...      ++..||+|+++.... ....++..|+.+ ++.++||||+++++++...+.
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~   74 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVP------TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD   74 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcC------CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc
Confidence            468888999999999999999875      688999999876432 234456667665 566789999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          319 LLLVYDFMPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQ-KVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      .++||||++ |+|.+++... .....+++.....++.|++.||.|||   ++ +++||||||+||+++.++.+||+|||+
T Consensus        75 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~  150 (283)
T cd06617          75 VWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGI  150 (283)
T ss_pred             EEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence            999999996 7888887542 23356899999999999999999999   44 899999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCcccccc----CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHT----GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~----~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      ++........      ....|+..|+|||.+..    ..++.++|+||||+++|||++|+.|+.......  ..+...  
T Consensus       151 ~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~--  220 (283)
T cd06617         151 SGYLVDSVAK------TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--QQLKQV--  220 (283)
T ss_pred             cccccccccc------ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--HHHHHH--
Confidence            9876432211      13468899999998854    456889999999999999999999986422111  011110  


Q ss_pred             HHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        .. +     ..+.+.   .......+..++..|+..+|.+||++.++++
T Consensus       221 --~~-~-----~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         221 --VE-E-----PSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             --Hh-c-----CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              00 0     011111   1112345777888999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-36  Score=300.47  Aligned_cols=256  Identities=24%  Similarity=0.349  Sum_probs=201.2

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeEEEEEEeC
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEK  316 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  316 (568)
                      .++++|+..+.||+|+||.||+|..+.      +++.+++|.+..... ..+++.+|+.+++++ +|+||+++++++...
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKK------TGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKK   75 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECC------CCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence            457889999999999999999999864      577899999876533 346789999999999 699999999999765


Q ss_pred             C------eEEEEEEecCCCChhhhhccCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcE
Q 008374          317 G------KLLLVYDFMPNGSLEKYLYGTS-EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA  389 (568)
Q Consensus       317 ~------~~~lV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~  389 (568)
                      .      ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~  152 (275)
T cd06608          76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEV  152 (275)
T ss_pred             CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeE
Confidence            4      4899999999999999986422 2356899999999999999999999   6799999999999999999999


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccch
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-----GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHA  464 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~  464 (568)
                      ||+|||++..........     ....|+..|+|||.+..     ..++.++||||||++++||++|+.||.......  
T Consensus       153 ~l~d~~~~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--  225 (275)
T cd06608         153 KLVDFGVSAQLDSTLGRR-----NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--  225 (275)
T ss_pred             EECCCccceecccchhhh-----cCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--
Confidence            999999998664432211     14568899999998753     346789999999999999999999987432211  


Q ss_pred             hhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          465 YTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       465 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       .+...     ..+.     .+.  ..........+.+++.+|+..||++|||+.|+++
T Consensus       226 -~~~~~-----~~~~-----~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         226 -ALFKI-----PRNP-----PPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -HHHHh-----hccC-----CCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             11110     0000     011  1112224456778888999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.1e-35  Score=296.29  Aligned_cols=255  Identities=24%  Similarity=0.422  Sum_probs=201.1

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc--cchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK--SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      +|...+.||+|+||.||+|+...      ++..+++|.+......  ..+.+..|++++++++|+||+++++.+...+..
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLD------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV   74 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECC------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence            46777899999999999998764      5789999998765443  567899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++|+||+++++|.+++..   ...+++..+..++.++++||.|||   +.+++|+||+|+||++++++.+||+|||++..
T Consensus        75 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~  148 (264)
T cd06626          75 YIFMEYCSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVK  148 (264)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccc
Confidence            999999999999999854   235788999999999999999999   67999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGK---ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~---~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      .......... ......++..|+|||++....   .+.++||||||++++|+++|+.||.......   ...   .....
T Consensus       149 ~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---~~~---~~~~~  221 (264)
T cd06626         149 LKNNTTTMGE-EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---QIM---FHVGA  221 (264)
T ss_pred             cCCCCCcccc-cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH---HHH---HHHhc
Confidence            7554322111 011356789999999998766   8899999999999999999999997432211   111   10000


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       +     ..+.+  .........+.+++..|++.+|.+|||+.+++.
T Consensus       222 -~-----~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         222 -G-----HKPPI--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             -C-----CCCCC--CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             0     00111  111122445667888999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.4e-35  Score=298.53  Aligned_cols=260  Identities=24%  Similarity=0.305  Sum_probs=201.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeC--C
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEK--G  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~  317 (568)
                      ++|...++||.|++|.||++....      .++.+|+|.+..... ....++.+|++++++++||||++++++|...  +
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   74 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKN------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS   74 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECC------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCC
Confidence            467888999999999999999875      678999999875432 3456789999999999999999999998654  4


Q ss_pred             eEEEEEEecCCCChhhhhccC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          318 KLLLVYDFMPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      .+++||||+++++|.+++... .....++......++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||+
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~  151 (287)
T cd06621          75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGV  151 (287)
T ss_pred             eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccc
Confidence            789999999999999987532 22345888999999999999999999   67999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc-cchhhHHHHHHHHh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQ-QHAYTLVDWVWMLH  475 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~-~~~~~l~~~~~~~~  475 (568)
                      +.........       ...++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .....+..+...  
T Consensus       152 ~~~~~~~~~~-------~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--  222 (287)
T cd06621         152 SGELVNSLAG-------TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN--  222 (287)
T ss_pred             cccccccccc-------cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc--
Confidence            8765432211       345788999999999899999999999999999999999999744221 111122222111  


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        ..... +.....  ........+.+++.+|++.+|.+|||+.|+++
T Consensus       223 --~~~~~-~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         223 --MPNPE-LKDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             --CCchh-hccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence              00001 111110  01123456788999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.1e-35  Score=303.98  Aligned_cols=247  Identities=25%  Similarity=0.361  Sum_probs=195.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      +.|...++||+|+||.||+|+...      +++.||+|.+.....   ...+++.+|+++++.++||||++++++|...+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~   88 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVR------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH   88 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcC------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence            447778899999999999999864      578999999865332   23457889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||++ |+|.+++...  ...+++..+..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||++
T Consensus        89 ~~~lv~e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~  162 (307)
T cd06607          89 TAWLVMEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSA  162 (307)
T ss_pred             eEEEEHHhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcc
Confidence            9999999996 6777776432  235899999999999999999999   679999999999999999999999999998


Q ss_pred             cccccccccccccccccCCcCCcccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFH---TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      .......         ...|+..|+|||.+.   ...++.++||||||+++|||++|+.|+.......       .....
T Consensus       163 ~~~~~~~---------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-------~~~~~  226 (307)
T cd06607         163 SLVSPAN---------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHI  226 (307)
T ss_pred             eecCCCC---------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-------HHHHH
Confidence            7654321         346788999999874   4568899999999999999999999986432221       01110


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                      ...         .............+..++..||+.+|++||++.++++.
T Consensus       227 ~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         227 AQN---------DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             hcC---------CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000         00001112234567888889999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.6e-36  Score=308.55  Aligned_cols=203  Identities=19%  Similarity=0.233  Sum_probs=165.8

Q ss_pred             cceeccC--CceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEE
Q 008374          246 SMRLGEG--GFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLL  321 (568)
Q Consensus       246 ~~~LG~G--~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  321 (568)
                      .++||+|  +|++||+++.+.      +++.||+|++.....  ...+.+.+|+++++.++||||++++++|..++..++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l   76 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKP------TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV   76 (327)
T ss_pred             hhhccccccceEEEEEEeecc------cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEE
Confidence            4679999  789999999875      688999999975422  233457789999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccc
Q 008374          322 VYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE  401 (568)
Q Consensus       322 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~  401 (568)
                      ||||+++|+|.+++.... ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.++++||+.+....
T Consensus        77 v~e~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~  152 (327)
T cd08227          77 VTSFMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  152 (327)
T ss_pred             EEeccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccc
Confidence            999999999999985432 235899999999999999999999   6799999999999999999999999998765432


Q ss_pred             cccccc--cccccccCCcCCcccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008374          402 NERNSY--AEHGLVGVPGTMGYVAPECFHT--GKATPESDVFGFGAVVLEVVCGRSPGNMI  458 (568)
Q Consensus       402 ~~~~~~--~~~~~~~~~Gt~~y~APE~~~~--~~~t~~sDV~SfGvll~el~tG~~P~~~~  458 (568)
                      ......  .........++..|+|||++..  ..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            211100  0000112356788999999875  45889999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.1e-35  Score=299.34  Aligned_cols=265  Identities=22%  Similarity=0.327  Sum_probs=196.5

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-cchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++++|...+.||+|+||.||+|....      ++..+|+|++...... ....+.+|+.++++++|+||+++.+++...+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   76 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRI------NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE   76 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcC------CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC
Confidence            45789999999999999999998875      5788999998754332 2346789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++|+||++ ++|.+++...  ...+.+.....++.|++.||.|||   ..+++||||||+|||++.++++||+|||++
T Consensus        77 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~  150 (291)
T cd07870          77 TLTFVFEYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLA  150 (291)
T ss_pred             eEEEEEeccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccc
Confidence            9999999995 6777776432  235788889999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      +.........     ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||+......   ....-.+....
T Consensus       151 ~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~  222 (291)
T cd07870         151 RAKSIPSQTY-----SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF---EQLEKIWTVLG  222 (291)
T ss_pred             cccCCCCCCC-----CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH---HHHHHHHHHcC
Confidence            8654322111     13457899999999875 357889999999999999999999997433211   11111111110


Q ss_pred             cC--ch-------hhhhhhhcCCC---------CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          477 EG--HI-------QDAVDQRLNIN---------SVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       477 ~~--~~-------~~~~d~~l~~~---------~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ..  ..       ...........         ........+.+++.+|++.||.+|||+.|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         223 VPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             CCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00  00       00000000000         00011345667788999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6.9e-36  Score=305.23  Aligned_cols=260  Identities=19%  Similarity=0.189  Sum_probs=201.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...+.||+|+||.||++....      .++.|++|.+....   ....+.+.+|+++++.++||||+++++.+...+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKE------TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR   74 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECC------CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC
Confidence            367888999999999999998875      67899999987643   233457889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++++|.+++..   ...+++.....++.+++.||.|||   +.+++||||||+||+++.++.+||+|||++
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~  148 (305)
T cd05609          75 HLCMVMEYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLS  148 (305)
T ss_pred             EEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCc
Confidence            99999999999999999943   346899999999999999999999   679999999999999999999999999998


Q ss_pred             ccccccccc----------ccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhH
Q 008374          398 RAIENERNS----------YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTL  467 (568)
Q Consensus       398 ~~~~~~~~~----------~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l  467 (568)
                      +........          ..........|+..|+|||.+....++.++|+||||+++|||++|+.||.......     
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-----  223 (305)
T cd05609         149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-----  223 (305)
T ss_pred             cccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence            742211000          00000113457889999999988889999999999999999999999986432211     


Q ss_pred             HHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          468 VDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       468 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                        +...... +.   ...+..    .......+.+++.+|++.+|++||++.++.+.|+.
T Consensus       224 --~~~~~~~-~~---~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         224 --LFGQVIS-DD---IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             --HHHHHHh-cc---cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence              1111100 00   000000    01233456788889999999999998888887776

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-36  Score=299.27  Aligned_cols=248  Identities=24%  Similarity=0.375  Sum_probs=198.1

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCC---CCceeeEEEEEEeCC
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLR---HKHLVHLVGWCHEKG  317 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~  317 (568)
                      .|+..+.||+|+||.||+|+...      ++..+|+|.+.... .....++.+|+.++++++   |||+++++++|....
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~   75 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVP------TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP   75 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcC------CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC
Confidence            36667789999999999999864      67899999986542 334567889999999996   999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++++|.+++..    ..+++.....++.+++.||.|||   +.+++|+||+|+||++++++.++|+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~  148 (277)
T cd06917          76 RLWIIMEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVA  148 (277)
T ss_pred             EEEEEEecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCce
Confidence            99999999999999999843    26899999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ..........     ....|+..|+|||.+.++ .++.++||||||+++|||++|+.||.......       +... ..
T Consensus       149 ~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------~~~~-~~  215 (277)
T cd06917         149 ALLNQNSSKR-----STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------AMML-IP  215 (277)
T ss_pred             eecCCCcccc-----ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-------hhhc-cc
Confidence            8775543211     145689999999998754 46889999999999999999999997432211       1100 00


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ..     ..+.+...   .....+.+++..|++.||.+||++.++++
T Consensus       216 ~~-----~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         216 KS-----KPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             cC-----CCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            00     01111111   13346677888999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.6e-35  Score=297.21  Aligned_cols=263  Identities=22%  Similarity=0.258  Sum_probs=200.4

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      +|...+.||+|+||.||+|+...      ++..||+|++....  ......+.+|+.++++++||||+++++++......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRE------TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF   74 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECC------CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence            46778899999999999999875      57899999987654  23356789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+ +++|.+++....  ..+++.++..++.|++++|.|||   +.+++|+||||+||+++.++.++|+|||++..
T Consensus        75 ~~v~e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~  148 (286)
T cd07832          75 VLVMEYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARL  148 (286)
T ss_pred             EEEeccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence            9999999 999999986433  46899999999999999999999   67999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ........    .....|+..|+|||.+.+. .++.++||||+|++++||++|+.|+.......    ...+........
T Consensus       149 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~----~~~~~~~~~~~~  220 (286)
T cd07832         149 FSEEEPRL----YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE----QLAIVFRTLGTP  220 (286)
T ss_pred             ccCCCCCc----cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH----HHHHHHHHcCCC
Confidence            75443211    1145688999999998654 46899999999999999999987776433221    111111111000


Q ss_pred             c------------hhhhhhhhcC----CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          479 H------------IQDAVDQRLN----INSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       479 ~------------~~~~~d~~l~----~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                      .            ...+..+.-.    .....+....+.+++.+|++.+|++|||++++++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         221 NEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             ChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0            0000000000    00001223677888889999999999999999853

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=9.9e-36  Score=300.31  Aligned_cols=262  Identities=21%  Similarity=0.292  Sum_probs=195.1

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      +|...++||+|+||.||+|+...      ++..+|+|++.....  .....+.+|++++++++||||+++++++.+.+..
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~------~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRE------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL   74 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECC------CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence            36777899999999999999875      678899999865422  2345678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++|+||++ ++|.+++...  ...+++.....++.||++||.|||   +++++||||||+||+++.++.+||+|||+++.
T Consensus        75 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~  148 (284)
T cd07839          75 TLVFEYCD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARA  148 (284)
T ss_pred             EEEEecCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhc
Confidence            99999996 5788877532  345899999999999999999999   67999999999999999999999999999986


Q ss_pred             cccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ........     ....++..|+|||.+.+. .++.++|||||||++|||++|+.|+.......   ...+.........
T Consensus       149 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~  220 (284)
T cd07839         149 FGIPVRCY-----SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGTP  220 (284)
T ss_pred             cCCCCCCc-----CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH---HHHHHHHHHhCCC
Confidence            64432221     134578899999998664 46899999999999999999999864322211   1111110000000


Q ss_pred             ------chhhhhhhhcCCC---------CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          479 ------HIQDAVDQRLNIN---------SVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       479 ------~~~~~~d~~l~~~---------~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                            ...+..+......         ........+.+++..|++.||.+|||+.++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         221 TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                  0000001000000         01112345667888999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.6e-35  Score=299.54  Aligned_cols=248  Identities=23%  Similarity=0.355  Sum_probs=199.2

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      |...++||+|++|.||++....      ++..+++|++........+.+.+|+.++++++||||+++++++...+..++|
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v   94 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKS------TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV   94 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECC------CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence            4445689999999999998764      5788999998765555566789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      +||+++++|.+++..    ..+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648          95 MEFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             EeccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence            999999999999854    45889999999999999999999   67999999999999999999999999999876544


Q ss_pred             ccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD  482 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  482 (568)
                      .....     ....|+..|+|||.+.+..++.++||||||++++||++|+.||......       ....... .+    
T Consensus       168 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-------~~~~~~~-~~----  230 (285)
T cd06648         168 EVPRR-----KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-------QAMKRIR-DN----  230 (285)
T ss_pred             CCccc-----ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-------HHHHHHH-hc----
Confidence            32111     1356889999999998888999999999999999999999998643211       1111110 00    


Q ss_pred             hhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       483 ~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       ..+.+.  ........+.+++.+|++.+|++|||+.++++
T Consensus       231 -~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         231 -LPPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             -CCCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence             001111  11123356788888999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=291.89  Aligned_cols=270  Identities=21%  Similarity=0.348  Sum_probs=221.1

Q ss_pred             HHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcCCCCceeeEEE
Q 008374          233 YKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLVHLVG  311 (568)
Q Consensus       233 ~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g  311 (568)
                      .++|....+++....++-+|.||.||+|.|++.+... +.+.|-||.++.. +.-+...|+.|.-.+..+.|||+.++.+
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n-~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYN-DCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcc-hHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            4556666778888899999999999999998654432 4567888888764 4445677999999999999999999999


Q ss_pred             EEEeC-CeEEEEEEecCCCChhhhhc-----cCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC
Q 008374          312 WCHEK-GKLLLVYDFMPNGSLEKYLY-----GTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA  385 (568)
Q Consensus       312 ~~~~~-~~~~lV~Ey~~~gsL~~~L~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~  385 (568)
                      .|.+. ...+.+|.++.-|+|..||.     +......++-.+...++.|++.|++|||   ..+|+|.||.++|++||+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehh
Confidence            99765 57899999999999999997     4444557888899999999999999999   679999999999999999


Q ss_pred             CCcEEEeecCCcccccccccc-ccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccc
Q 008374          386 DFNARLGDFGLARAIENERNS-YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQH  463 (568)
Q Consensus       386 ~~~~kL~DFGla~~~~~~~~~-~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~  463 (568)
                      ...+||+|=.|+|.+-..... ...    .-.....||+||.+....|+.++|||||||+||||+| |+.|+...+..+ 
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGD----nEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-  506 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGD----NENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-  506 (563)
T ss_pred             heeEEeccchhccccCcccccccCC----CCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-
Confidence            999999999999987543211 111    2234578999999999999999999999999999999 899987554433 


Q ss_pred             hhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          464 AYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       464 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                                      +...+.+..+...+.+++.+++.++.-||...|++||+.+|++..|..
T Consensus       507 ----------------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  507 ----------------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             ----------------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence                            112233444555677888999999999999999999999999998863

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=7.2e-36  Score=301.33  Aligned_cols=263  Identities=24%  Similarity=0.339  Sum_probs=197.1

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      +|+..+.||+|+||.||+|+...      ++..||||++.....  .....+.+|++++++++||||+++++++...+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKL------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL   74 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECC------CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcE
Confidence            47788899999999999999864      678999999865432  2335788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||++ ++|.+++.... ...+++.....++.|++.||+|||   +.+++||||+|+||+++.++.+||+|||+++.
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~  149 (284)
T cd07860          75 YLVFEFLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARA  149 (284)
T ss_pred             EEEeeccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhh
Confidence            99999995 68998886533 346899999999999999999999   67999999999999999999999999999986


Q ss_pred             cccccccccccccccCCcCCcccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ........     ....++..|+|||.+.+.. ++.++||||||+++|||+||+.||.......   .+...........
T Consensus       150 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~  221 (284)
T cd07860         150 FGVPVRTY-----THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPD  221 (284)
T ss_pred             cccCcccc-----ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCCC
Confidence            64432221     1345788999999886644 5889999999999999999999987543322   1111111000000


Q ss_pred             -c----hhhhhh-----hhcCCCC----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          479 -H----IQDAVD-----QRLNINS----VVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       479 -~----~~~~~d-----~~l~~~~----~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       .    .....+     +......    .......+.+++.+|++.||.+|||++++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         222 EVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence             0    000000     0000000    0012234567888999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-36  Score=331.52  Aligned_cols=268  Identities=25%  Similarity=0.425  Sum_probs=213.1

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccc-cccCeEEEEEEeccCCc-ccchhhHHHHHHhhcC-CCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQY-HVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRL-RHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  316 (568)
                      .++....+.||+|.||.|++|........ ......||||.++.... .+.+.+..|+++|+.+ +|+||+.++|+|.++
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            34445556899999999999998743322 11367899999986533 4667899999999999 599999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCC-----------Cc--ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTS-----------EQ--VTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL  383 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~-----------~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl  383 (568)
                      +.+++|.||+..|+|.++|...+           ..  ..|+..+.+.++.|||.|++||+   +.+++||||.++|||+
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLI  451 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEe
Confidence            99999999999999999997654           01  24899999999999999999999   6799999999999999


Q ss_pred             cCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 008374          384 DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQ  462 (568)
Q Consensus       384 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~  462 (568)
                      .++..+||+|||+||...+.......... .. -...|||||.+....|+.|||||||||+||||++ |..|+.......
T Consensus       452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~-~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~  529 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYNKDYYRTKSSA-GT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE  529 (609)
T ss_pred             cCCCEEEEccccceeccCCCCceEecCCC-Cc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence            99999999999999976654332211110 11 2457999999999999999999999999999999 888987533222


Q ss_pred             chhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          463 HAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       463 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                         .+.+    ...         +..+.+.+..+...+..++..||+.+|++||++.++++.|+..
T Consensus       530 ---~l~~----~l~---------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  530 ---ELLE----FLK---------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             ---HHHH----HHh---------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence               2222    222         2233344555567788999999999999999999999999884

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1e-35  Score=296.82  Aligned_cols=252  Identities=24%  Similarity=0.341  Sum_probs=201.8

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      +|+..+.||+|+||.||++..+.      +++.+|+|++.... ....+++.+|++++++++||||+++++.+...+..+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   75 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRP------TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDIS   75 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcC------CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEE
Confidence            56777889999999999999875      67889999987653 344567899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD-QKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      +++||+++++|.+++....  ..++......++.|++.+|.|||   + .+++|+||||+||++++++.+||+|||++..
T Consensus        76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~  150 (265)
T cd06605          76 ICMEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ  150 (265)
T ss_pred             EEEEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchh
Confidence            9999999999999996432  56888999999999999999999   5 7999999999999999999999999999876


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      .......       ...++..|+|||.+.+..++.++||||||+++++|++|+.|+.......  ....+......    
T Consensus       151 ~~~~~~~-------~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~----  217 (265)
T cd06605         151 LVNSLAK-------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP--DGIFELLQYIV----  217 (265)
T ss_pred             hHHHHhh-------cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc--ccHHHHHHHHh----
Confidence            6433211       2468889999999998899999999999999999999999987432111  01122111111    


Q ss_pred             hhhhhhhhcCCCCcHH-HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          480 IQDAVDQRLNINSVVD-EAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~-~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                           .... ...... ....+.+++..|+..||.+|||+.++++
T Consensus       218 -----~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         218 -----NEPP-PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             -----cCCC-CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence                 1100 011111 3445778888999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.1e-35  Score=298.47  Aligned_cols=254  Identities=25%  Similarity=0.375  Sum_probs=204.6

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ..++.|...+.||+|+||.||+|....      ++..+++|.+..... ..+.+.+|++++++++|+|++++++.+...+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   88 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRA------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGD   88 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEcc------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC
Confidence            355678888899999999999999874      578899999976544 5667899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++|+||+++++|.+++....  ..+++..+..++.+++.||.|||   +.+++|+||+|+||+++.++.+||+|||++
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~  163 (286)
T cd06614          89 ELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFA  163 (286)
T ss_pred             EEEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchh
Confidence            9999999999999999996532  37999999999999999999999   689999999999999999999999999998


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ..........     ....++..|+|||.+.+..++.++||||||+++|||++|+.|+.......   .....    . .
T Consensus       164 ~~~~~~~~~~-----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~---~~~~~----~-~  230 (286)
T cd06614         164 AQLTKEKSKR-----NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---ALFLI----T-T  230 (286)
T ss_pred             hhhccchhhh-----ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----H-h
Confidence            7654432111     13457889999999988889999999999999999999999987432221   11110    0 0


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ...       ............+..++.+|++.+|.+|||+.++++
T Consensus       231 ~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         231 KGI-------PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             cCC-------CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            000       001111113456777888999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3e-35  Score=298.24  Aligned_cols=245  Identities=25%  Similarity=0.297  Sum_probs=199.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...+.||+|+||.||++....      .++.+|+|.+....   ....+.+.+|++++++++||||+++++++...+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKG------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS   74 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence            367888999999999999999875      57889999986532   233466889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++++|.+++...   ..++...+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++
T Consensus        75 ~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~  148 (290)
T cd05580          75 NLYLVMEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFA  148 (290)
T ss_pred             eEEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCc
Confidence            999999999999999998543   46899999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +......        ....|++.|+|||.+.+...+.++||||||++++||++|+.||.......    ..    ..   
T Consensus       149 ~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~----~~---  209 (290)
T cd05580         149 KRVKGRT--------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ----IY----EK---  209 (290)
T ss_pred             cccCCCC--------CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----HH----HH---
Confidence            8765431        14568899999999988888999999999999999999999987433111    11    10   


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                           +.....  ..+......+.+++..|++.||.+||     +++|+++
T Consensus       210 -----~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         210 -----ILEGKV--RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             -----HhcCCc--cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence                 111111  11112245666788899999999999     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.4e-35  Score=300.79  Aligned_cols=266  Identities=21%  Similarity=0.265  Sum_probs=198.0

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc--cchhhHHHHHHhhcCCCCceeeEEEEEEeC--
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK--SKGDFLAELAIIHRLRHKHLVHLVGWCHEK--  316 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--  316 (568)
                      ++|...+.||+|+||.||+|..+.      +++.+++|.++.....  ....+.+|+.++.+++||||+++++++...  
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   78 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKK------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL   78 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECC------CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence            467788899999999999999875      5788999999754322  223567899999999999999999999877  


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +..++||||++ ++|.+++....  ..+++.....++.|++.||.|||   +++++|+||||+||+++.++.+||+|||+
T Consensus        79 ~~~~lv~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~  152 (293)
T cd07843          79 DKIYMVMEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGL  152 (293)
T ss_pred             CcEEEEehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCc
Confidence            89999999997 59988885432  36899999999999999999999   67999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH-----
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW-----  470 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~-----  470 (568)
                      ++.........     ....++..|+|||.+.+. .++.++|+||||++++||++|+.||...........+...     
T Consensus       153 ~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~  227 (293)
T cd07843         153 AREYGSPLKPY-----TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPT  227 (293)
T ss_pred             eeeccCCcccc-----ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence            98765532211     134578899999998654 4689999999999999999999999754332211111110     


Q ss_pred             --HHHHhhc------CchhhhhhhhcCCCCcHH-HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          471 --VWMLHRE------GHIQDAVDQRLNINSVVD-EAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       471 --~~~~~~~------~~~~~~~d~~l~~~~~~~-~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        .|.....      ..........+...+... ....+.+++..|++.+|++|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence              0110000      000000011111111111 2455677888999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=305.98  Aligned_cols=252  Identities=25%  Similarity=0.324  Sum_probs=207.0

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc---cchhhHHHHHHhhcCC-CCceeeEEEEEE
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK---SKGDFLAELAIIHRLR-HKHLVHLVGWCH  314 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-H~nIv~l~g~~~  314 (568)
                      ..+.|...+.||+|.||.||+++.+.      +++.+|+|.+.+....   ......+|+.+|+++. |||||.+.+.+.
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~------tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e  106 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKS------TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE  106 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecC------CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            34568888999999999999999885      6899999999876443   3358899999999998 999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC----CcEE
Q 008374          315 EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD----FNAR  390 (568)
Q Consensus       315 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~----~~~k  390 (568)
                      ....+++|||++.+|.|.+.+...    .++......++.|++.++.|||   +.+|+||||||+|+|+...    +.+|
T Consensus       107 ~~~~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik  179 (382)
T KOG0032|consen  107 DPDSVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIK  179 (382)
T ss_pred             cCCeEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEE
Confidence            999999999999999999999654    3899999999999999999999   6899999999999999543    4799


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~  470 (568)
                      ++|||++........      ....+||+.|+|||++....|+..+||||+||++|.|++|..||.........   .  
T Consensus       180 ~~DFGla~~~~~~~~------~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~---~--  248 (382)
T KOG0032|consen  180 LIDFGLAKFIKPGER------LHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF---L--  248 (382)
T ss_pred             EeeCCCceEccCCce------EeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH---H--
Confidence            999999998876211      22689999999999999999999999999999999999999999865443311   1  


Q ss_pred             HHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          471 VWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       471 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                         ....+..      .+..+.-.......-.++..|+..||.+|+|+.++++
T Consensus       249 ---~i~~~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  249 ---AILRGDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             ---HHHcCCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence               1111111      1122222233445555666899999999999999998

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2e-35  Score=297.89  Aligned_cols=264  Identities=23%  Similarity=0.362  Sum_probs=199.6

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-cchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      +|+..++||+|++|.||+|+...      ++..||||.+...... ....+.+|++++++++|+||+++++++...+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   74 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRT------TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLM   74 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECC------CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEE
Confidence            47788999999999999999875      6789999998765432 3456788999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||++ ++|.+++........+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++..
T Consensus        75 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~  150 (284)
T cd07836          75 LVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAF  150 (284)
T ss_pred             EEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence            9999997 488888865443456899999999999999999999   679999999999999999999999999999865


Q ss_pred             ccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH-------H
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV-------W  472 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~-------~  472 (568)
                      .......     ....++..|++||.+.+ ..++.++||||||+++|||++|+.||...........+.+..       +
T Consensus       151 ~~~~~~~-----~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (284)
T cd07836         151 GIPVNTF-----SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW  225 (284)
T ss_pred             cCCcccc-----ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence            4332211     13457889999998865 456889999999999999999999987543322111111100       0


Q ss_pred             HHhhcCchhhhhhhhcC-------CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          473 MLHREGHIQDAVDQRLN-------INSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~-------~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .....  . ........       ..........+.+++..|++.||.+||++.|+++
T Consensus       226 ~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         226 PGISQ--L-PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HHHhc--C-chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000  0 00000000       0001122455678888999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4.6e-35  Score=288.45  Aligned_cols=249  Identities=26%  Similarity=0.437  Sum_probs=202.8

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      |...+.||+|++|.||++....      ++..+++|++........+.+.+|++++++++|+|++++++++...+..+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~   75 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKR------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV   75 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECC------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            6677899999999999999875      5788999999776555667899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      +||+++++|.+++....  ..+++..+..++.+++.+|.|||   ..+++||||+|+||++++++.+||+|||.+.....
T Consensus        76 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  150 (253)
T cd05122          76 MEFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD  150 (253)
T ss_pred             EecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccccccccc
Confidence            99999999999985432  46899999999999999999999   68999999999999999999999999999987765


Q ss_pred             ccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD  482 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  482 (568)
                      ...      .....|+..|+|||.+....++.++||||||+++++|++|+.|+.......   .+..    ... ...  
T Consensus       151 ~~~------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~-~~~--  214 (253)
T cd05122         151 TKA------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK---ALFK----IAT-NGP--  214 (253)
T ss_pred             ccc------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---HHHH----HHh-cCC--
Confidence            432      114568899999999988889999999999999999999999987432211   1100    000 000  


Q ss_pred             hhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       483 ~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                         +.+  .........+.+++..|++.||++|||+.|+++
T Consensus       215 ---~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         215 ---PGL--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ---CCc--CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               000  001111456777888999999999999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.7e-35  Score=300.86  Aligned_cols=253  Identities=24%  Similarity=0.350  Sum_probs=198.1

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      |...+.||+|+||.||+|+...      ++..+|+|.+.....   ....++..|++++++++|||+++++++|......
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  100 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVR------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTA  100 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcC------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeE
Confidence            6677889999999999999864      578999999875422   2335688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||++ |+|.+++...  ...+++.++..++.+++.||.|||   +.+++||||+|+||+++.++.+||+|||++..
T Consensus       101 ~lv~e~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~  174 (317)
T cd06635         101 WLVMEYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASI  174 (317)
T ss_pred             EEEEeCCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccc
Confidence            99999996 5777777432  345899999999999999999999   67999999999999999999999999999875


Q ss_pred             cccccccccccccccCCcCCcccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFH---TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      .....         ...|+..|+|||++.   .+.++.++|||||||++|||++|+.|+.......   .+..+.     
T Consensus       175 ~~~~~---------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~-----  237 (317)
T cd06635         175 ASPAN---------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIA-----  237 (317)
T ss_pred             cCCcc---------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHH-----
Confidence            43321         346888999999974   4578899999999999999999999986432211   111110     


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVP  532 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~p  532 (568)
                              ...............+..++.+|++.+|.+||++.++++.+-.....|
T Consensus       238 --------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         238 --------QNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             --------hccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence                    000001111223345677888999999999999999998665444444

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-35  Score=296.10  Aligned_cols=261  Identities=23%  Similarity=0.322  Sum_probs=197.9

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeC--Ce
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK--GK  318 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~  318 (568)
                      |+..++||+|+||.||+|+...      ++..+|+|++....  ....+.+.+|++++++++|+|++++++++...  +.
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKK------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS   74 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECC------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence            4567789999999999999875      57899999997653  33345788999999999999999999999988  89


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++|+||+++ +|.+++....  ..+++..+..++.|++.||+|||   ..+++|+||+|+||++++++.+||+|||++.
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~  148 (287)
T cd07840          75 IYMVFEYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLAR  148 (287)
T ss_pred             EEEEeccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEcccccee
Confidence            9999999974 8988885432  46899999999999999999999   5799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ..........    ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......    ...........
T Consensus       149 ~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~----~~~~~~~~~~~  220 (287)
T cd07840         149 PYTKRNSADY----TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE----QLEKIFELCGS  220 (287)
T ss_pred             eccCCCcccc----cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCC
Confidence            7765432111    13457889999997754 467899999999999999999999987543221    11111110000


Q ss_pred             ---Cc---h-----h------hhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 ---GH---I-----Q------DAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ---~~---~-----~------~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                         ..   .     .      ......+.......+...+.+++..|++.+|++||++.++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         221 PTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             CchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               00   0     0      000000000000112567888999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=299.06  Aligned_cols=262  Identities=24%  Similarity=0.336  Sum_probs=197.0

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      |+..++||+|++|.||+|+...      ++..||+|++.....  .....+.+|++++++++|||++++++++.+.+..+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~   74 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKL------TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLY   74 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcC------CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence            4567789999999999999875      678999999875432  23356889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      ++|||++ ++|.+++..... ..+++..+..++.|++.||.|||   +++++||||+|+||+++.++.+||+|||+++..
T Consensus        75 iv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~  149 (283)
T cd07835          75 LVFEFLD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAF  149 (283)
T ss_pred             EEEeccC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence            9999994 689999854332 36899999999999999999999   679999999999999999999999999999865


Q ss_pred             ccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      .......     ....++..|+|||++.+. .++.++||||||+++|||++|+.||.......   .+.+..........
T Consensus       150 ~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~  221 (283)
T cd07835         150 GVPVRTY-----THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID---QLFRIFRTLGTPDE  221 (283)
T ss_pred             CCCcccc-----CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCh
Confidence            4332211     133568899999987654 57889999999999999999999987543322   11111111000000


Q ss_pred             -----hh---hhhhh--hcCC----CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          480 -----IQ---DAVDQ--RLNI----NSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       480 -----~~---~~~d~--~l~~----~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                           ..   +....  ....    .........+.+++.+|++++|++|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         222 DVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             HHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                 00   00000  0000    001112356778889999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.6e-35  Score=293.90  Aligned_cols=250  Identities=22%  Similarity=0.382  Sum_probs=199.9

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      +|...+.||+|+||.||+|..+.      ++..+|+|.+....  ....+.+.+|+.++++++|+||+++++.+...+..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~   74 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKS------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRL   74 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcC------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence            46778899999999999999875      57789999986542  23455788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-cEEEeecCCcc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF-NARLGDFGLAR  398 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~-~~kL~DFGla~  398 (568)
                      ++|+||+++++|.+++.... ...+++..+..++.|+++||.|||   +.+++|+||||+||++++++ .+||+|||.+.
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~  150 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR  150 (257)
T ss_pred             EEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccch
Confidence            99999999999999986532 235799999999999999999999   67999999999999999885 56999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      .........     ....|+..|+|||++....++.++||||||++++||++|+.|+.....       .+++..... +
T Consensus       151 ~~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~-~  217 (257)
T cd08225         151 QLNDSMELA-----YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKICQ-G  217 (257)
T ss_pred             hccCCcccc-----cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhc-c
Confidence            765432211     134588999999999888899999999999999999999999864321       222222111 1


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .        .. .........+.+++.+|++.+|++|||+.|+++
T Consensus       218 ~--------~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         218 Y--------FA-PISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             c--------CC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            1        10 011122345777888999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06899 lectin_legume_LecRK_Arcelin_ConA legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

Probab=100.00  E-value=6.3e-36  Score=292.22  Aligned_cols=157  Identities=44%  Similarity=0.774  Sum_probs=143.2

Q ss_pred             CCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC-C-CCCCCeeeEecCCccccccccCCC
Q 008374           10 DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG-F-DPDDNHLGLNINSVVSRKNVPLKD   87 (568)
Q Consensus        10 ~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~-~-d~~~~hvgidins~~s~~~~~~~~   87 (568)
                      ..+||||||||+|....++ ++.|++|||++.+++++..+++|||||||++|. + ||++||||||+|++.|..+..+..
T Consensus        77 ~~~gdGlAF~i~~~~~~~~-~~~G~~lG~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHigIdvn~~~S~~~~~~~~  155 (236)
T cd06899          77 SLGGDGLAFFLAPTDSLPP-ASSGGYLGLFNSSNNGNSSNHIVAVEFDTFQNPEFGDPDDNHVGIDVNSLVSVKAGYWDD  155 (236)
T ss_pred             CCCCCeEEEEEecCCCCCC-CCCcceeeeecCCCCCCcccceEEEEeecccCcccCCCCCCeEEEEcCCcccceeecccc
Confidence            5689999999999776655 589999999999877778899999999999998 3 999999999999999998888765


Q ss_pred             CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCcccccccccccccc
Q 008374           88 NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLD  167 (568)
Q Consensus        88 ~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~~~i~sWs~~  167 (568)
                       ..++|.+|+.++|||+||+.+++|+|+|++.+..+|..|+++..+||+.+|++++||||||+||. ..+.|++++|+|+
T Consensus       156 -~~~~l~~g~~~~v~I~Y~~~~~~L~V~l~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFSasTG~-~~~~h~i~sWsF~  233 (236)
T cd06899         156 -DGGKLKSGKPMQAWIDYDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGL-LTELHYILSWSFS  233 (236)
T ss_pred             -ccccccCCCeEEEEEEEcCCCCEEEEEEEeCCCCCCcCCEEEEeccHHHhCCCceEEEEEeEcCC-CcceEEEEEEEEE
Confidence             45568899999999999999999999999988778999999999999999999999999999997 8999999999998


Q ss_pred             cc
Q 008374          168 ID  169 (568)
Q Consensus       168 ~~  169 (568)
                      .+
T Consensus       234 s~  235 (236)
T cd06899         234 SN  235 (236)
T ss_pred             cC
Confidence            64

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by bindin

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.5e-35  Score=299.03  Aligned_cols=265  Identities=22%  Similarity=0.266  Sum_probs=195.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCC-CCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLR-HKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~  317 (568)
                      ++|+..+.||+|+||.||+|....      ++..||+|.+.....  .....+.+|+.++++++ ||||+++++++...+
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~------~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   74 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKN------TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE   74 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECC------CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence            468888999999999999999875      678999999865432  23456889999999995 699999999998766


Q ss_pred             e-----EEEEEEecCCCChhhhhccCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-CCcE
Q 008374          318 K-----LLLVYDFMPNGSLEKYLYGTSE--QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA-DFNA  389 (568)
Q Consensus       318 ~-----~~lV~Ey~~~gsL~~~L~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~-~~~~  389 (568)
                      .     .++||||+++ +|.+++.....  ...+++.....++.||+.||.|||   +++++||||||+||+++. ++.+
T Consensus        75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~  150 (295)
T cd07837          75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLL  150 (295)
T ss_pred             CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeE
Confidence            5     8999999985 89888854322  346899999999999999999999   679999999999999998 8999


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHH
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV  468 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~  468 (568)
                      ||+|||+++.+........     ...+++.|+|||++.+ ..++.++||||||+++|||++|..||.......   .+.
T Consensus       151 kl~dfg~~~~~~~~~~~~~-----~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~---~~~  222 (295)
T cd07837         151 KIADLGLGRAFSIPVKSYT-----HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ---QLL  222 (295)
T ss_pred             EEeecccceecCCCccccC-----CcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH---HHH
Confidence            9999999986644322211     3356889999998865 457899999999999999999999987543222   111


Q ss_pred             HHHHHHhhc-Cch-hhhhh-------hhcCC----CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          469 DWVWMLHRE-GHI-QDAVD-------QRLNI----NSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       469 ~~~~~~~~~-~~~-~~~~d-------~~l~~----~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ......... ... ....+       +....    .........+.+++..|+++||.+||++.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         223 HIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            110000000 000 00000       00000    001123455778889999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4e-35  Score=292.35  Aligned_cols=243  Identities=23%  Similarity=0.289  Sum_probs=195.9

Q ss_pred             eccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 008374          249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       249 LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      ||.|+||.||+++...      .+..+|+|.+.....   ...+.+.+|+.++++++||||+++++.+.+.+..++|+||
T Consensus         1 lg~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   74 (262)
T cd05572           1 LGVGGFGRVELVKVKS------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEY   74 (262)
T ss_pred             CCCCCceEEEEEEECC------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEec
Confidence            6999999999999874      578999999875432   3446789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccc
Q 008374          326 MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN  405 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~  405 (568)
                      +++++|.+++...   ..+++..+..++.|++.||.|||   +++++|+||+|+||+++.++.+||+|||+++.......
T Consensus        75 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~  148 (262)
T cd05572          75 CLGGELWTILRDR---GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK  148 (262)
T ss_pred             CCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc
Confidence            9999999999543   35889999999999999999999   68999999999999999999999999999987754421


Q ss_pred             cccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhh
Q 008374          406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVD  485 (568)
Q Consensus       406 ~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  485 (568)
                      .      ....|+..|+|||.+....++.++|+||||+++|||++|..|+.......     .+...         .+.+
T Consensus       149 ~------~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~---------~~~~  208 (262)
T cd05572         149 T------WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-----MEIYN---------DILK  208 (262)
T ss_pred             c------ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-----HHHHH---------HHhc
Confidence            1      13468899999999988889999999999999999999999997543211     11111         1111


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 008374          486 QRLNINSVVDEAKRLLLLGLACSHPIASERPK-----TEDILQ  523 (568)
Q Consensus       486 ~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt-----~~evl~  523 (568)
                      .......+......+..++..|++.+|++||+     ++|+++
T Consensus       209 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         209 GNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            11111222223567788888999999999999     666654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.2e-35  Score=303.08  Aligned_cols=272  Identities=22%  Similarity=0.320  Sum_probs=199.1

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcC-CCCceeeEEEEEEe
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHE  315 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~  315 (568)
                      ..++|...+.||+|+||.||+|....      ++..+|+|++...  .......+.+|+.++.++ +||||++++++|..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~   78 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRR------TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA   78 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcC------CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc
Confidence            35678888999999999999999864      5788999998543  223445678899999999 99999999999865


Q ss_pred             C--CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEee
Q 008374          316 K--GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD  393 (568)
Q Consensus       316 ~--~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~D  393 (568)
                      .  ...++||||++ ++|..++..    ..++|..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|
T Consensus        79 ~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d  150 (337)
T cd07852          79 ENDKDIYLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLAD  150 (337)
T ss_pred             CCCceEEEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEee
Confidence            4  46899999997 599888843    26889999999999999999999   67999999999999999999999999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH-
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV-  471 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~-  471 (568)
                      ||+++..................||..|+|||.+.. ..++.++||||||+++|||++|+.||...........+.... 
T Consensus       151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~  230 (337)
T cd07852         151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG  230 (337)
T ss_pred             ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            999987654432211111224568999999998754 567889999999999999999999987433222111111100 


Q ss_pred             ------HHHhhcCchhhhhhhhcCC------CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          472 ------WMLHREGHIQDAVDQRLNI------NSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       472 ------~~~~~~~~~~~~~d~~l~~------~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                            +...........++.....      .........+.+++.+|++.||++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                  0000000000111100000      0001134567888999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-35  Score=297.74  Aligned_cols=272  Identities=22%  Similarity=0.258  Sum_probs=197.8

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeC--
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK--  316 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--  316 (568)
                      +|...++||+|+||.||+|+....    ..+..||+|.+....   ....+.+.+|+.++.+++||||+++++++...  
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~----~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG----KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD   76 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC----CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC
Confidence            367788999999999999998642    146899999997743   33345678899999999999999999999988  


Q ss_pred             CeEEEEEEecCCCChhhhhccCC--CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC----CCcEE
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTS--EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA----DFNAR  390 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~----~~~~k  390 (568)
                      ..+++||||+++ +|.+++....  ....++......++.|++.||.|||   +.+++||||||+||+++.    ++.+|
T Consensus        77 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~k  152 (316)
T cd07842          77 KSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVK  152 (316)
T ss_pred             ceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEE
Confidence            789999999975 6666664322  2236888999999999999999999   679999999999999999    99999


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccch-----
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHA-----  464 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~-----  464 (568)
                      |+|||+++..........  ......+|..|+|||.+.+ ..++.++||||||++++||++|+.||.........     
T Consensus       153 l~Dfg~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~  230 (316)
T cd07842         153 IGDLGLARLFNAPLKPLA--DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ  230 (316)
T ss_pred             ECCCccccccCCCccccc--ccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhH
Confidence            999999987654332111  1124568899999998765 45789999999999999999999999744332100     


Q ss_pred             -hhHHHHHHHHhh-----------cCchhhhhhhhcCCCCc----H-------HHHHHHHHHHHhcCCCCCCCCCCHHHH
Q 008374          465 -YTLVDWVWMLHR-----------EGHIQDAVDQRLNINSV----V-------DEAKRLLLLGLACSHPIASERPKTEDI  521 (568)
Q Consensus       465 -~~l~~~~~~~~~-----------~~~~~~~~d~~l~~~~~----~-------~~~~~l~~l~l~Cl~~dp~~RPt~~ev  521 (568)
                       ..+...+..+..           ........+........    .       .....+.+++.+|++.||++|||+.|+
T Consensus       231 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei  310 (316)
T cd07842         231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA  310 (316)
T ss_pred             HHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence             011111100000           00000000000000000    1       223457889999999999999999999


Q ss_pred             HH
Q 008374          522 LQ  523 (568)
Q Consensus       522 l~  523 (568)
                      ++
T Consensus       311 l~  312 (316)
T cd07842         311 LE  312 (316)
T ss_pred             hc
Confidence            75

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-36  Score=314.28  Aligned_cols=248  Identities=21%  Similarity=0.381  Sum_probs=195.3

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEecc----CCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC--eE
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR----DSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG--KL  319 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~  319 (568)
                      ..+||+|.|-+||||....      +|.+||--.++.    .+....+.|..|+.+|+.|+||||++++.++.+..  .+
T Consensus        45 ~evLGrGafKtVYka~De~------~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i  118 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEE------EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI  118 (632)
T ss_pred             hhhcccccceeeeeccccc------cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence            4579999999999998864      677777655433    23445678999999999999999999999887654  48


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-CcEEEeecCCcc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD-FNARLGDFGLAR  398 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~-~~~kL~DFGla~  398 (568)
                      -+|+|.|..|+|..|+.+   ...++......+++||++||.|||.. .++|+|||||.+||+|+.+ |.+||||+|||.
T Consensus       119 n~iTEL~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt  194 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT  194 (632)
T ss_pred             eeeeecccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHH
Confidence            899999999999999954   34688889999999999999999975 8899999999999999876 899999999999


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ........       .+.||+.|||||... ..|.+..||||||++++||+|+..||..-....   .    ++.....|
T Consensus       195 l~r~s~ak-------svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A---Q----IYKKV~SG  259 (632)
T KOG0584|consen  195 LLRKSHAK-------SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA---Q----IYKKVTSG  259 (632)
T ss_pred             Hhhccccc-------eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH---H----HHHHHHcC
Confidence            87654321       578999999999986 889999999999999999999999987322211   1    22222222


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISG  527 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L~~  527 (568)
                      .--..+..    - ..   ..+.+++..|+.. ..+|||+.|+++  +|..
T Consensus       260 iKP~sl~k----V-~d---Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  260 IKPAALSK----V-KD---PEVREFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             CCHHHhhc----c-CC---HHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence            22221111    1 11   2345667799999 999999999987  5544

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.4e-35  Score=288.17  Aligned_cols=252  Identities=23%  Similarity=0.343  Sum_probs=204.5

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeC--C
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEK--G  317 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~  317 (568)
                      +|...+.||+|++|.||+|+...      ++..|++|.+.....  ...+.+.+|+.++++++|+||+++++.+...  +
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKD------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKN   74 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECC------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence            36777899999999999999874      578999999876543  4567899999999999999999999999988  8


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++|+||+++++|.+++...   ..+++..+..++.+++.+|.|||   +.+++|+||+|+||+++.++.+||+|||.+
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~  148 (260)
T cd06606          75 TLNIFLEYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCA  148 (260)
T ss_pred             eEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccE
Confidence            999999999999999999543   37899999999999999999999   579999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ...........   .....++..|+|||.+.....+.++||||||+++++|++|+.||.......      .-.+..   
T Consensus       149 ~~~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~---  216 (260)
T cd06606         149 KRLGDIETGEG---TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM------AALYKI---  216 (260)
T ss_pred             Eeccccccccc---ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHhc---
Confidence            87765432100   114568899999999988889999999999999999999999997543111      111111   


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                            ................+.+++.+|++.+|.+||++.|+++
T Consensus       217 ------~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         217 ------GSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ------cccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                  1111111122233567788888999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.8e-35  Score=290.75  Aligned_cols=249  Identities=24%  Similarity=0.344  Sum_probs=203.4

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      +|+..++||+|+||.||+++...      ++..+++|.+....  .....++.+|++++++++|+||+++++++......
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLS------DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL   74 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECC------CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence            46778899999999999998764      67889999987542  23456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          320 LLVYDFMPNGSLEKYLYGTS-EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      ++||||+++++|.+++.... ....+++.....++.+++.||.|||   +.+++|+||+|+||++++++.+||+|||+++
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~  151 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISK  151 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchh
Confidence            99999999999999985522 1346899999999999999999999   6799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      .......       ....++..|+|||.+.+..++.++|+||||+++|||++|+.||.......    +...+    .. 
T Consensus       152 ~~~~~~~-------~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~----~~~~~----~~-  215 (256)
T cd08530         152 VLKKNMA-------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD----LRYKV----QR-  215 (256)
T ss_pred             hhccCCc-------ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHH----hc-
Confidence            7765411       13457889999999998889999999999999999999999987543221    11110    11 


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                              .............+..++..|++.+|.+|||+.++++
T Consensus       216 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         216 --------GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             --------CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                    1111222344566888999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.2e-34  Score=296.41  Aligned_cols=268  Identities=22%  Similarity=0.286  Sum_probs=196.5

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc--cchhhHHHHHHhhcCCCCceeeEEEEEEeC-
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK--SKGDFLAELAIIHRLRHKHLVHLVGWCHEK-  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-  316 (568)
                      .++|...++||+|+||.||+|+...      ++..||+|.++.....  ....+.+|+.++++++|+||+++++++... 
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTT------SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH   79 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECC------CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC
Confidence            3578889999999999999999875      6789999998654322  233567899999999999999999998755 


Q ss_pred             -CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          317 -GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       317 -~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                       +..++||||+. ++|.+++...  ...+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+|||
T Consensus        80 ~~~~~lv~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg  153 (309)
T cd07845          80 LDSIFLVMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFG  153 (309)
T ss_pred             CCeEEEEEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccc
Confidence             57899999996 5888888543  246899999999999999999999   6799999999999999999999999999


Q ss_pred             CccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH----
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW----  470 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~----  470 (568)
                      +++.........     ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.++    
T Consensus       154 ~~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~  228 (309)
T cd07845         154 LARTYGLPAKPM-----TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP  228 (309)
T ss_pred             eeeecCCccCCC-----CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            998765432211     12345788999999865 45789999999999999999999999754332211111111    


Q ss_pred             ---HHHHhhcCchhhhhh-hhcCCCCc----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          471 ---VWMLHREGHIQDAVD-QRLNINSV----VDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       471 ---~~~~~~~~~~~~~~d-~~l~~~~~----~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                         .|.....-....... +.......    ......+.+++..|++.||++|||+.|+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence               000000000000000 00000000    0123455678889999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=5.4e-35  Score=294.88  Aligned_cols=243  Identities=23%  Similarity=0.283  Sum_probs=186.2

Q ss_pred             eeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhh---cCCCCceeeEEEEEEeCCeEEE
Q 008374          248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIH---RLRHKHLVHLVGWCHEKGKLLL  321 (568)
Q Consensus       248 ~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~H~nIv~l~g~~~~~~~~~l  321 (568)
                      .||+|+||.||++....      +++.+|+|.+.....   .....+.+|..++.   ..+||||+.+++++...+..++
T Consensus         1 ~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l   74 (279)
T cd05633           1 IIGRGGFGEVYGCRKAD------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCF   74 (279)
T ss_pred             CcccCCCeEEEEEEECC------CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEE
Confidence            48999999999998864      678999999865422   11223445544333   3479999999999999999999


Q ss_pred             EEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccc
Q 008374          322 VYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE  401 (568)
Q Consensus       322 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~  401 (568)
                      ||||+++++|.+++..   ...+++.....++.|++.||.|||   +++++||||||+|||+++++.+||+|||++....
T Consensus        75 v~e~~~~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~  148 (279)
T cd05633          75 ILDLMNGGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (279)
T ss_pred             EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence            9999999999999853   346999999999999999999999   6799999999999999999999999999997654


Q ss_pred             cccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          402 NERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       402 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      ....       ....||..|+|||.+.+ ..++.++|||||||+++||++|+.||.......    . .......     
T Consensus       149 ~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~-~~~~~~~-----  211 (279)
T cd05633         149 KKKP-------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----K-HEIDRMT-----  211 (279)
T ss_pred             ccCc-------cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC----H-HHHHHHh-----
Confidence            3211       13468999999999864 557899999999999999999999997432221    0 0111100     


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQI  524 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~~  524 (568)
                           .......+......+.+++..|++.||++||     +++++++.
T Consensus       212 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         212 -----LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -----hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence                 0011112223345667778899999999999     59999873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.8e-36  Score=281.93  Aligned_cols=252  Identities=25%  Similarity=0.384  Sum_probs=200.5

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc----cc----chhhHHHHHHhhcC-CCCceeeEE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI----KS----KGDFLAELAIIHRL-RHKHLVHLV  310 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~----~~----~~~~~~E~~~l~~l-~H~nIv~l~  310 (568)
                      -..|...+.||.|..+.|.+++.+.      ++.+.|+|++.....    +.    .+.-.+|+.+|+++ .||+|+++.
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~------t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~   89 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKE------TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ   89 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcc------cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence            3457788899999999999998875      678899999854221    11    23346799999998 699999999


Q ss_pred             EEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEE
Q 008374          311 GWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR  390 (568)
Q Consensus       311 g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~k  390 (568)
                      ++++....+++|+|.|+.|.|.++|.   ...+++.....+|.+|+..|++|||   .+.|+||||||+|||+|++.++|
T Consensus        90 D~yes~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~  163 (411)
T KOG0599|consen   90 DVYESDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIK  163 (411)
T ss_pred             eeccCcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceE
Confidence            99999999999999999999999994   4568999999999999999999999   67999999999999999999999


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccch
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT------GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHA  464 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~------~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~  464 (568)
                      |+|||.|..+..+..      .+..+||++|+|||.+..      ..|+...|.||.||++|.|+.|..||-...     
T Consensus       164 isDFGFa~~l~~Gek------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----  232 (411)
T KOG0599|consen  164 ISDFGFACQLEPGEK------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----  232 (411)
T ss_pred             EeccceeeccCCchh------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----
Confidence            999999998877643      347899999999998853      457889999999999999999999985211     


Q ss_pred             hhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          465 YTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       465 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       .++-  ..+..+|+.      .+..+.=.+.....-.|+.+|++.||++|.|++|+++
T Consensus       233 -QmlM--LR~ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  233 -QMLM--LRMIMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             -HHHH--HHHHHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence             1110  111112211      0111112234445666777999999999999999975

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-35  Score=301.41  Aligned_cols=265  Identities=22%  Similarity=0.299  Sum_probs=197.4

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeC--
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK--  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--  316 (568)
                      +++|...++||+|+||.||+|+...      ++..||+|.++... ......+.+|+.++++++|+||+++++++...  
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKP------TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF   77 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcC------CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence            4679999999999999999998865      67899999986432 23445688999999999999999999987654  


Q ss_pred             ---CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEee
Q 008374          317 ---GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD  393 (568)
Q Consensus       317 ---~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~D  393 (568)
                         ...++|+||++ ++|.+++.    ...+++.....++.|++.||.|||   +.+++||||||+|||++.++.+||+|
T Consensus        78 ~~~~~~~lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~d  149 (336)
T cd07849          78 ESFNDVYIVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICD  149 (336)
T ss_pred             cccceEEEEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECc
Confidence               35899999996 48877773    246899999999999999999999   67999999999999999999999999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      ||+++..........  ......||..|+|||.+.+ ..++.++|||||||+++||++|+.||.......    ......
T Consensus       150 fg~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~----~~~~~~  223 (336)
T cd07849         150 FGLARIADPEHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH----QLNLIL  223 (336)
T ss_pred             ccceeeccccccccC--CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHH
Confidence            999987644322111  1124568999999998754 568899999999999999999999986432211    111111


Q ss_pred             HHhhc---Cchhhhhhhh-------cCC--CC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          473 MLHRE---GHIQDAVDQR-------LNI--NS-----VVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       473 ~~~~~---~~~~~~~d~~-------l~~--~~-----~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                      .....   ..+..+.+..       ...  ..     .......+.+++.+|++.+|++|||+.|+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         224 GVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11110   0011111100       000  00     01124567889999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=287.19  Aligned_cols=248  Identities=25%  Similarity=0.410  Sum_probs=202.3

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      +|...+.||+|++|.||+++...      .+..+++|.+.....  ...+.+.+|++++.+++|+|++++++++...+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLE------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL   74 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcC------CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence            36678899999999999998864      577899999977644  3556799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++++|.+++...   ..+++..+..++.|++.+|.|||   +.+++||||+|+||+++.++.+||+|||++..
T Consensus        75 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  148 (254)
T cd06627          75 YIILEYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATK  148 (254)
T ss_pred             EEEEecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEecccccee
Confidence            9999999999999998543   56899999999999999999999   67999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      .......     .....++..|+|||......++.++||||+|++++||++|+.|+.......     ..|  .... . 
T Consensus       149 ~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-----~~~--~~~~-~-  214 (254)
T cd06627         149 LNDVSKD-----DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-----ALF--RIVQ-D-  214 (254)
T ss_pred             cCCCccc-----ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-----HHH--HHhc-c-
Confidence            7654321     114568899999999988888999999999999999999999987433211     011  1000 0 


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                              ............+..++.+|++.+|++|||+.+++.
T Consensus       215 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         215 --------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                    001111223456678888999999999999999974

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.3e-35  Score=296.45  Aligned_cols=244  Identities=24%  Similarity=0.363  Sum_probs=196.2

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFM  326 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  326 (568)
                      .+||+|+||.||++....      ++..||+|++..........+.+|+.++++++|+|++++++++...+..++||||+
T Consensus        26 ~~lg~g~~g~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          26 IKIGEGSTGIVCIATVKS------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             HHcCCCCCeEEEEEEEcC------CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence            579999999999998875      68899999986655555667999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccccccc
Q 008374          327 PNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS  406 (568)
Q Consensus       327 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~  406 (568)
                      ++++|.+++..    ..+++.....++.|++.+|+|||   +.+++|+||+|+||++++++.++|+|||++.........
T Consensus       100 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~  172 (292)
T cd06657         100 EGGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  172 (292)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc
Confidence            99999998732    35789999999999999999999   679999999999999999999999999998766443211


Q ss_pred             ccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhh
Q 008374          407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQ  486 (568)
Q Consensus       407 ~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  486 (568)
                           .....|+..|+|||.+.+..++.++||||||++++||++|+.||.......    ......         ....+
T Consensus       173 -----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~----~~~~~~---------~~~~~  234 (292)
T cd06657         173 -----RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMIR---------DNLPP  234 (292)
T ss_pred             -----ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHH---------hhCCc
Confidence                 114568899999999988889999999999999999999999987432211    111110         00111


Q ss_pred             hcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          487 RLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       487 ~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .+.  ........+..++.+|++.+|.+||++.++++
T Consensus       235 ~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         235 KLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            111  11122334566778999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.8e-35  Score=294.17  Aligned_cols=248  Identities=22%  Similarity=0.286  Sum_probs=200.9

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      +|...+.||.|+||.||++....      ++..+|+|.+....   ....+.+.+|++++++++||||+++++.+.....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRD------TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN   74 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEcc------CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe
Confidence            47788899999999999998864      57889999997543   2345689999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++|+||+++++|..++...   ..+++.....++.|+++||.|||   +++++|+||+|+||++++++.++|+|||++.
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~  148 (258)
T cd05578          75 MYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIAT  148 (258)
T ss_pred             EEEEEeCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeeccccc
Confidence            99999999999999999532   46889999999999999999999   6799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ........      ....|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+.......     .++....... 
T Consensus       149 ~~~~~~~~------~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~-  216 (258)
T cd05578         149 KVTPDTLT------TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-----RDQIRAKQET-  216 (258)
T ss_pred             ccCCCccc------cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-----HHHHHHHhcc-
Confidence            76543211      14568899999999988889999999999999999999999987543211     1111111110 


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH--HHHH
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKT--EDIL  522 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~--~evl  522 (568)
                               .....+......+.+++.+|++.||.+||++  +|++
T Consensus       217 ---------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 ---------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ---------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                     1111222334677788889999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.3e-35  Score=293.48  Aligned_cols=251  Identities=22%  Similarity=0.317  Sum_probs=197.8

Q ss_pred             eccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 008374          249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       249 LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      ||+|+||.||+++...      +++.+++|.+.....   ...+.+.+|++++.+++||||+++++.+......++||||
T Consensus         1 lg~g~~~~vy~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   74 (265)
T cd05579           1 ISKGAYGRVFLAKKKS------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEY   74 (265)
T ss_pred             CCCCCceEEEEEEECC------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEec
Confidence            6899999999999874      578999999876533   3456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccc
Q 008374          326 MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN  405 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~  405 (568)
                      +++++|.+++...   ..+++..+..++.|++.||+|||   +++++|+||+|+||++++++.+||+|||++........
T Consensus        75 ~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~  148 (265)
T cd05579          75 LPGGDLASLLENV---GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ  148 (265)
T ss_pred             CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcc
Confidence            9999999999542   36899999999999999999999   67999999999999999999999999999886544321


Q ss_pred             cc---cccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhh
Q 008374          406 SY---AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD  482 (568)
Q Consensus       406 ~~---~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  482 (568)
                      ..   .........++..|+|||.......+.++||||||++++||++|+.||.......       ......       
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~-------  214 (265)
T cd05579         149 INLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-------IFQNIL-------  214 (265)
T ss_pred             cccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHh-------
Confidence            00   0001124567889999999988889999999999999999999999987443221       111110       


Q ss_pred             hhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       483 ~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                        ...............+..++..|++.+|.+|||+.++.+.|+.
T Consensus       215 --~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         215 --NGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             --cCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence              0111111111124667788889999999999999777776653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=289.56  Aligned_cols=252  Identities=25%  Similarity=0.350  Sum_probs=195.7

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-----CcccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-----SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      .+|...+.||+|+||.||+|....      ++..+|+|.+...     ..+....+.+|++++++++|+||+++++++.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   75 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDAD------TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD   75 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcC------CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc
Confidence            468889999999999999998864      6789999987532     12334578899999999999999999999876


Q ss_pred             C--CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEee
Q 008374          316 K--GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD  393 (568)
Q Consensus       316 ~--~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~D  393 (568)
                      .  ..+++|+||+++++|.+++..   ...+++.....++.|++.||.|||   +++++|+||||+||+++.++.++|+|
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~d  149 (264)
T cd06653          76 PEEKKLSIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGD  149 (264)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECc
Confidence            4  468999999999999999843   235788999999999999999999   67999999999999999999999999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      ||+++..........  ......|+..|+|||++.+..++.++|||||||+++||++|+.||.......   ...     
T Consensus       150 fg~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~-----  219 (264)
T cd06653         150 FGASKRIQTICMSGT--GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---AIF-----  219 (264)
T ss_pred             cccccccccccccCc--cccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH---HHH-----
Confidence            999987643211110  1124568899999999988889999999999999999999999987432211   111     


Q ss_pred             HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       474 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                              +..........+......+..++..|++ +|..||+..+++.
T Consensus       220 --------~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         220 --------KIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --------HHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                    1111111111222333456667778998 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.3e-35  Score=295.76  Aligned_cols=255  Identities=25%  Similarity=0.354  Sum_probs=194.0

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCC-CCceeeEEEEEEeCCeE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLR-HKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~  319 (568)
                      +|...++||+|+||.||+++...      +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++...+..
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~   78 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKP------SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC   78 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECC------CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence            45556789999999999999875      67899999987543 234567889999999996 99999999999999999


Q ss_pred             EEEEEecCCCChhhhhcc--CCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          320 LLVYDFMPNGSLEKYLYG--TSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      +++|||+. ++|.++...  ......+++.....++.+++.||+|||+  ..+++||||||+||+++.++.+||+|||++
T Consensus        79 ~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  155 (288)
T cd06616          79 WICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS  155 (288)
T ss_pred             EEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchh
Confidence            99999985 455443321  1123568999999999999999999994  358999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTG---KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~---~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      +........      ....|+..|+|||.+...   .++.++|||||||++|||++|+.||.....      ..+-....
T Consensus       156 ~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~  223 (288)
T cd06616         156 GQLVDSIAK------TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS------VFDQLTQV  223 (288)
T ss_pred             HHhccCCcc------ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch------HHHHHhhh
Confidence            865433211      134588999999998766   688999999999999999999999864321      11111111


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .. +     ..+.+...........+.+++.+|++.+|++|||+.+|++
T Consensus       224 ~~-~-----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         224 VK-G-----DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             cC-C-----CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00 0     0111111111234456778888999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.8e-34  Score=292.01  Aligned_cols=266  Identities=17%  Similarity=0.210  Sum_probs=185.5

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccc-----------hhhHHHHHHhhcCCCCceeeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK-----------GDFLAELAIIHRLRHKHLVHL  309 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~nIv~l  309 (568)
                      ++|...++||+|+||.||+|....+..   ....+|+|..........           .....+...+..+.|+|++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~---~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHC---INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcc---cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            568889999999999999999864211   144566665432221111           112234445667789999999


Q ss_pred             EEEEEeCC----eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC
Q 008374          310 VGWCHEKG----KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA  385 (568)
Q Consensus       310 ~g~~~~~~----~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~  385 (568)
                      ++++....    ..++++|++. .++.+.+..   ....++..+..++.|++.||.|||   +++++||||||+|||++.
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~  161 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDG  161 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcC
Confidence            99776543    3467778763 356555532   223567888999999999999999   679999999999999999


Q ss_pred             CCcEEEeecCCccccccccccc--cccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q 008374          386 DFNARLGDFGLARAIENERNSY--AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH  463 (568)
Q Consensus       386 ~~~~kL~DFGla~~~~~~~~~~--~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~  463 (568)
                      ++.+||+|||+|+.+.......  .........||+.|+|||++.+..++.++|||||||+++||++|+.||....... 
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-  240 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-  240 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch-
Confidence            9999999999998764322111  1111123569999999999999999999999999999999999999998553322 


Q ss_pred             hhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          464 AYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       464 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                        .+..-...    +.+..+....+...   .....+.+++..|++.+|++||++.++++.|+
T Consensus       241 --~~~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        241 --NLIHAAKC----DFIKRLHEGKIKIK---NANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             --HHHHHhHH----HHHHHhhhhhhccC---CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence              11110000    00011111111111   22456777888999999999999999999874

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.2e-34  Score=289.89  Aligned_cols=258  Identities=21%  Similarity=0.246  Sum_probs=192.8

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCC-CCceeeEEEEEEeC--Ce
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLR-HKHLVHLVGWCHEK--GK  318 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~--~~  318 (568)
                      |...++||+|+||.||+|+...      ++..+|+|+++.... .......+|+.++.++. |+|++++++++.+.  +.
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   74 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRK------TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGR   74 (282)
T ss_pred             CceEeeccccccceEEEEEEcC------CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCc
Confidence            4556789999999999999864      678899999876422 22334567999999985 99999999999987  89


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      +++|+||++ ++|.+++...  ...++|..+..++.|++.||.|||   +.+++||||+|+||+++. +.+||+|||+++
T Consensus        75 ~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~  147 (282)
T cd07831          75 LALVFELMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCR  147 (282)
T ss_pred             EEEEEecCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccccc
Confidence            999999996 5888887542  246899999999999999999999   679999999999999999 999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ........      ....++..|+|||++.. ..++.++|||||||++|||++|+.||.......    ...+.......
T Consensus       148 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~----~~~~~~~~~~~  217 (282)
T cd07831         148 GIYSKPPY------TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD----QIAKIHDVLGT  217 (282)
T ss_pred             ccccCCCc------CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH----HHHHHHHHcCC
Confidence            76543221      13457889999997654 557889999999999999999999997543221    11211111100


Q ss_pred             -----------CchhhhhhhhcCC----CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 -----------GHIQDAVDQRLNI----NSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 -----------~~~~~~~d~~l~~----~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                                 ........+....    .........+.+++..|++++|++|||+.++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         218 PDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             CCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                       0000000000000    001123567888999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.6e-34  Score=294.13  Aligned_cols=265  Identities=24%  Similarity=0.299  Sum_probs=197.9

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      .+.++|+..+.||+|+||.||+|+.+.      +++.||+|+++....  .....+.+|++++++++||||+++++++.+
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~   77 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKD------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTD   77 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECC------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecC
Confidence            456788999999999999999999875      578899999875432  233567889999999999999999999876


Q ss_pred             CC----------eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC
Q 008374          316 KG----------KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA  385 (568)
Q Consensus       316 ~~----------~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~  385 (568)
                      ..          .+++|+||+++ +|..++...  ...+++..+..++.|++.||+|||   +.+++||||||+||++++
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~  151 (302)
T cd07864          78 KQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNN  151 (302)
T ss_pred             cchhhhccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence            54          79999999976 677776432  346899999999999999999999   679999999999999999


Q ss_pred             CCcEEEeecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccch
Q 008374          386 DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHA  464 (568)
Q Consensus       386 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~  464 (568)
                      ++.+||+|||++...........    ....++..|+|||.+.. ..++.++|||||||+++||++|+.||.......  
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--  225 (302)
T cd07864         152 KGQIKLADFGLARLYNSEESRPY----TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--  225 (302)
T ss_pred             CCcEEeCcccccccccCCccccc----ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--
Confidence            99999999999987754432111    12346788999998764 457889999999999999999999997543322  


Q ss_pred             hhHHHHHHHHhhcC---chhhh--------hhh------hcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          465 YTLVDWVWMLHREG---HIQDA--------VDQ------RLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       465 ~~l~~~~~~~~~~~---~~~~~--------~d~------~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       .+.. +.......   ....+        .+.      ++... .......+.+++..|++.+|.+|||+.++++
T Consensus       226 -~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         226 -QLEL-ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             -HHHH-HHHHhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             1111 11111000   00000        000      00000 0012456788888999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.3e-34  Score=302.09  Aligned_cols=264  Identities=20%  Similarity=0.253  Sum_probs=197.1

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      ..++|...+.||+|+||.||+|+...      ++..||+|.+...  .......+.+|+.++++++||||+++++++...
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTV------TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQ   87 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECC------CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccC
Confidence            45779999999999999999998875      6789999998653  223345678899999999999999999988643


Q ss_pred             ------CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEE
Q 008374          317 ------GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR  390 (568)
Q Consensus       317 ------~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~k  390 (568)
                            ...++||||+. ++|.+.+..     .++......++.|++.||+|||   +++++||||||+||+++.++.+|
T Consensus        88 ~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~k  158 (353)
T cd07850          88 KSLEEFQDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK  158 (353)
T ss_pred             CCccccCcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEE
Confidence                  35799999995 588887732     2888899999999999999999   67999999999999999999999


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHH--
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV--  468 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~--  468 (568)
                      |+|||+++.......      .....++..|+|||.+.+..++.++|||||||++++|++|+.||...........+.  
T Consensus       159 L~Dfg~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  232 (353)
T cd07850         159 ILDFGLARTAGTSFM------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQ  232 (353)
T ss_pred             EccCccceeCCCCCC------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence            999999987644321      113457899999999999999999999999999999999999987432211000000  


Q ss_pred             ------HHHH-------HHhhcC------chhhhhhhhcC----CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          469 ------DWVW-------MLHREG------HIQDAVDQRLN----INSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       469 ------~~~~-------~~~~~~------~~~~~~d~~l~----~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                            ++..       ......      ...+.....+.    ..........+.+++.+|++.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         233 LGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             cCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                  0000       000000      00001000000    0001123456778899999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.5e-34  Score=293.50  Aligned_cols=267  Identities=21%  Similarity=0.298  Sum_probs=195.1

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|+..++||+|+||.||+|+...      +++.||+|.+.....  ...+.+.+|++++++++||||+++++++...+.
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRV------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR   75 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecC------CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence            468888999999999999999865      678899999865432  234568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-CCcEEEeecCCc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA-DFNARLGDFGLA  397 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~-~~~~kL~DFGla  397 (568)
                      .++||||++ ++|.+++.... ...+++.....++.||+.||+|||   +++++||||+|+||+++. ++.+||+|||++
T Consensus        76 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~  150 (294)
T PLN00009         76 LYLVFEYLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLA  150 (294)
T ss_pred             EEEEEeccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccc
Confidence            999999995 58888774322 234678888899999999999999   679999999999999985 567999999999


Q ss_pred             cccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH---
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM---  473 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~---  473 (568)
                      +.........     ....++..|+|||++.+ ..++.++||||||+++|||++|+.||..............+...   
T Consensus       151 ~~~~~~~~~~-----~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  225 (294)
T PLN00009        151 RAFGIPVRTF-----THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNE  225 (294)
T ss_pred             cccCCCcccc-----ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            8654432211     13457889999998865 45789999999999999999999999754332211111100000   


Q ss_pred             -Hhhc-Cchhhhhh--hhcCCC----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          474 -LHRE-GHIQDAVD--QRLNIN----SVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       474 -~~~~-~~~~~~~d--~~l~~~----~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       .+.. ..+.....  +.....    ........+.+++.+|++.+|++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        226 ETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0000 00000000  000000    01112345677888999999999999999986

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.8e-34  Score=285.54  Aligned_cols=251  Identities=25%  Similarity=0.385  Sum_probs=203.6

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      +|...+.||+|+||.||++....      ++..+++|++.....  ...+++.+|++++++++|+|++++++.+......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~   74 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKS------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL   74 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcC------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence            46778899999999999999864      578999999976533  4556789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          320 LLVYDFMPNGSLEKYLYGTS-EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      ++|+||+++++|.+++.... ....+++..+..++.+++.||.|||   +.+++|+||+|+||+++.++.+||+|||++.
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~  151 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISK  151 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCcccee
Confidence            99999999999999996532 2357899999999999999999999   5699999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ....... ..    ....|+..|+|||.+....++.++||||+|+++++|++|+.|+.......    +.   .... ..
T Consensus       152 ~~~~~~~-~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~---~~~~-~~  218 (258)
T cd08215         152 VLSSTVD-LA----KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE----LA---LKIL-KG  218 (258)
T ss_pred             ecccCcc-ee----cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH----HH---HHHh-cC
Confidence            7655431 11    13468899999999988889999999999999999999999986432211    11   1111 11


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ..         ..........+.+++.+|++.+|++|||+.++++
T Consensus       219 ~~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         219 QY---------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            10         1111133456777888999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.5e-34  Score=292.65  Aligned_cols=259  Identities=22%  Similarity=0.253  Sum_probs=200.0

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC----cccchhhHHHHHHhhcC-CCCceeeEEEEEEeC
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS----IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEK  316 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  316 (568)
                      +|...+.||+|+||.||+++.....   .++..+|||.+.+..    ....+.+..|+.++.++ +||||+++++.+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~---~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~   77 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGH---DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD   77 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccc---cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC
Confidence            3667789999999999999865322   156789999986532    22345688999999999 599999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      ...++||||+++|+|.+++..   ...+++.....++.|++++|.|||   +.+++||||+|+||+++.++.++|+|||+
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~  151 (288)
T cd05583          78 TKLHLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGL  151 (288)
T ss_pred             CEEEEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcc
Confidence            999999999999999999853   345889999999999999999999   67999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK--ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~--~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      ++..........    ....|+..|+|||.+.+..  .+.++||||||++++||++|+.||.......   ...+.....
T Consensus       152 ~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~  224 (288)
T cd05583         152 SKEFLAEEEERA----YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSEISRRI  224 (288)
T ss_pred             cccccccccccc----ccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHHHHHHHH
Confidence            987654322111    1346889999999987655  7889999999999999999999986322211   111111111


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      .         ...  ..........+.+++.+|++.||++|||+.+|.+.|+.
T Consensus       225 ~---------~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         225 L---------KSK--PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             H---------ccC--CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            0         000  11111223456677889999999999999999888776

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=308.49  Aligned_cols=245  Identities=25%  Similarity=0.375  Sum_probs=199.8

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      -|...+.||.|+||.||-|+...      +...||||+++-...   +..++++.|+..|.+++|||++.+.||+.....
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~------n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T  100 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVR------NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT  100 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccC------ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch
Confidence            47778889999999999999876      678899999975433   345688999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .+|||||| -||-.++|.-  ..++|....+..|+.+.+.||+|||   +.+.||||||+.||||.+.+.+||+|||.|.
T Consensus       101 aWLVMEYC-lGSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAs  174 (948)
T KOG0577|consen  101 AWLVMEYC-LGSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSAS  174 (948)
T ss_pred             HHHHHHHH-hccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchh
Confidence            99999999 5677777632  2457888999999999999999999   6799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFH---TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      ......         .++||+.|||||++.   .+.|+-++||||+|++-.||.-.+.|.-.+..-...+-+        
T Consensus       175 i~~PAn---------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI--------  237 (948)
T KOG0577|consen  175 IMAPAN---------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------  237 (948)
T ss_pred             hcCchh---------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH--------
Confidence            765432         678999999999875   589999999999999999999999997544322211100        


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                           .+--.+.+.   ..+-...+..++-.|+++-|++|||..+++.
T Consensus       238 -----AQNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  238 -----AQNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -----HhcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence                 011112222   2345556777888999999999999998876

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-37  Score=292.82  Aligned_cols=248  Identities=24%  Similarity=0.347  Sum_probs=207.8

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLL  321 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  321 (568)
                      -|....+||+|+||.|||+..+.      +|..+|+|++.-+  ...++...|+.+|.+...|++|+++|.+.....+++
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~E------sG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI  105 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRE------SGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI  105 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhc------cCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence            36777899999999999999876      7899999998654  467889999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccc
Q 008374          322 VYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE  401 (568)
Q Consensus       322 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~  401 (568)
                      |||||..||..+.+..  ++++|+..++..+++..++||+|||.   ..-+|||||+.||||+.+|.+||+|||.|..+.
T Consensus       106 VMEYCGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT  180 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT  180 (502)
T ss_pred             ehhhcCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhh
Confidence            9999999999999854  45689999999999999999999995   478999999999999999999999999998876


Q ss_pred             cccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC-cccchhhHHHHHHHHhhcCch
Q 008374          402 NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIP-HQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       402 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~-~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      .....     ...+.||+.|||||++..-.|..++||||+|+...||..|+.|+...- ......               
T Consensus       181 DTMAK-----RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM---------------  240 (502)
T KOG0574|consen  181 DTMAK-----RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM---------------  240 (502)
T ss_pred             hhHHh-----hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe---------------
Confidence            54322     226889999999999999999999999999999999999999987421 111000               


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       ---.+......+..-...+-+++..|+-++|++|-|+.++++
T Consensus       241 -IPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  241 -IPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             -ccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence             000111122334555667778888999999999999999887

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=288.57  Aligned_cols=246  Identities=21%  Similarity=0.227  Sum_probs=190.6

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHh-hcCCCCceeeEEEEEEeCCeEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAII-HRLRHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      +.||+|+||.||+|+...      .++.||+|.+.....   .....+..|..++ ...+|+|++++++++...+..++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   75 (260)
T cd05611           2 KPISKGAFGSVYLAKKRS------TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLV   75 (260)
T ss_pred             ccCCcCCCeeEEEEEecC------CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEE
Confidence            468999999999998864      578999999865432   2223445555444 455899999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      +||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||+++....
T Consensus        76 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  149 (260)
T cd05611          76 MEYLNGGDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE  149 (260)
T ss_pred             EeccCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence            999999999999953   246888999999999999999999   67999999999999999999999999999876433


Q ss_pred             ccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhh
Q 008374          403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD  482 (568)
Q Consensus       403 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  482 (568)
                      .         ....|+..|+|||.+.+..++.++||||||++++||++|..||.......    .    +.....+..  
T Consensus       150 ~---------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~----~~~~~~~~~--  210 (260)
T cd05611         150 N---------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA----V----FDNILSRRI--  210 (260)
T ss_pred             c---------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH----H----HHHHHhccc--
Confidence            1         13468899999999988888999999999999999999999997432221    1    111111100  


Q ss_pred             hhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       483 ~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                          .............+..++..|++.+|++||++.++.+.|+.
T Consensus       211 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         211 ----NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             ----CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence                00111111234567888889999999999988877776654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-35  Score=317.88  Aligned_cols=207  Identities=21%  Similarity=0.350  Sum_probs=160.2

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccc-------------cCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCc
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHV-------------DNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKH  305 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~-------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n  305 (568)
                      ..++|...++||+|+||+||++.++.......             ....++.|.+.. .......+.+|+.+|++++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence            45689999999999999999998754211000             000111122211 1223456889999999999999


Q ss_pred             eeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 008374          306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE--QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL  383 (568)
Q Consensus       306 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl  383 (568)
                      |+++++++...+..++|+|++ .++|.+++.....  ...........++.|++.||.|||   +++|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence            999999999999999999998 4677777754221  122335567789999999999999   6799999999999999


Q ss_pred             cCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 008374          384 DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP  454 (568)
Q Consensus       384 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P  454 (568)
                      +.++.+||+|||+++.+........    ....||..|+|||++.+..++.++|||||||++|||++|+.+
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~  367 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFD----YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC  367 (501)
T ss_pred             CCCCCEEEEeCCCceecCccccccc----ccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            9999999999999987754432221    145799999999999999999999999999999999998754

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-34  Score=296.92  Aligned_cols=276  Identities=18%  Similarity=0.275  Sum_probs=199.2

Q ss_pred             CHHHHHHHh----cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCc
Q 008374          232 KYKELKKAT----NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKH  305 (568)
Q Consensus       232 ~~~el~~at----~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~n  305 (568)
                      ..+|+..++    ++|...+.||+|+||.||+|+...      ++..||+|++....  ......+.+|+.++++++|||
T Consensus         2 ~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n   75 (342)
T cd07879           2 YREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKR------TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN   75 (342)
T ss_pred             chhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCC------CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCC
Confidence            344555553    789899999999999999999764      67899999986532  223356889999999999999


Q ss_pred             eeeEEEEEEeC------CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 008374          306 LVHLVGWCHEK------GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKAS  379 (568)
Q Consensus       306 Iv~l~g~~~~~------~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~  379 (568)
                      |+++++++...      ...++|+||+.. +|..++     ...+++..+..++.|++.||+|||   +.+++||||||+
T Consensus        76 iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~  146 (342)
T cd07879          76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPG  146 (342)
T ss_pred             ccchhheecccccCCCCceEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHH
Confidence            99999998654      356999999964 777665     235889999999999999999999   679999999999


Q ss_pred             CEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008374          380 NILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMI  458 (568)
Q Consensus       380 NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~  458 (568)
                      ||+++.++.+||+|||+++......        ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       147 NIll~~~~~~kL~dfg~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~  218 (342)
T cd07879         147 NLAVNEDCELKILDFGLARHADAEM--------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  218 (342)
T ss_pred             HEEECCCCCEEEeeCCCCcCCCCCC--------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999998653321        13467889999999866 46889999999999999999999999753


Q ss_pred             CcccchhhHHHH-------HHHHhhcCchhhhhhh--hc-CCCC---cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--
Q 008374          459 PHQQHAYTLVDW-------VWMLHREGHIQDAVDQ--RL-NINS---VVDEAKRLLLLGLACSHPIASERPKTEDILQ--  523 (568)
Q Consensus       459 ~~~~~~~~l~~~-------~~~~~~~~~~~~~~d~--~l-~~~~---~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--  523 (568)
                      ........+...       .............+..  .. ....   .......+.+++..|++.||.+||++.++++  
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~  298 (342)
T cd07879         219 DYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHP  298 (342)
T ss_pred             CHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence            221100000000       0000000000000000  00 0000   0012345678888999999999999999985  


Q ss_pred             HHhCCCC
Q 008374          524 IISGTST  530 (568)
Q Consensus       524 ~L~~~~~  530 (568)
                      .+++..+
T Consensus       299 ~f~~~~~  305 (342)
T cd07879         299 YFDSFRD  305 (342)
T ss_pred             chhhccc
Confidence            3665443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.8e-34  Score=290.43  Aligned_cols=245  Identities=25%  Similarity=0.337  Sum_probs=192.3

Q ss_pred             eccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 008374          249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       249 LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      ||+|+||+||++....      +++.+|+|.+....   ......+..|++++++++||||+++++.+...+..++||||
T Consensus         1 lg~g~~g~vy~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05577           1 LGKGGFGEVCACQVKA------TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTL   74 (277)
T ss_pred             CCCCCceeEEEEEEcC------CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEec
Confidence            6999999999998765      67899999986532   22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccc
Q 008374          326 MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN  405 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~  405 (568)
                      +++++|.+++..... ..+++..+..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||+++.......
T Consensus        75 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  150 (277)
T cd05577          75 MNGGDLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK  150 (277)
T ss_pred             CCCCcHHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc
Confidence            999999999965432 36899999999999999999999   67999999999999999999999999999987644211


Q ss_pred             cccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhh
Q 008374          406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVD  485 (568)
Q Consensus       406 ~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  485 (568)
                      .      ....++..|+|||.+.+..++.++||||||++++||++|+.||...........+..    ..        ..
T Consensus       151 ~------~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~--------~~  212 (277)
T cd05577         151 I------KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR----RT--------LE  212 (277)
T ss_pred             c------ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh----cc--------cc
Confidence            1      134678899999999888899999999999999999999999975433211001100    00        00


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          486 QRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       486 ~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                      .  ...........+.+++..|++.||.+||     ++.++++
T Consensus       213 ~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         213 M--AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             c--cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            0  0111112244567788899999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.8e-34  Score=292.16  Aligned_cols=266  Identities=25%  Similarity=0.349  Sum_probs=193.3

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc--cchhhHHHHHHhhcCCCCceeeEEEEEEeCC-
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK--SKGDFLAELAIIHRLRHKHLVHLVGWCHEKG-  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-  317 (568)
                      ++|...++||+|+||.||+|+...      ++..||||.+......  ....+.+|++++++++||||++++++|...+ 
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   85 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKK------TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT   85 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECC------CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence            468889999999999999998875      6789999998654322  2335678999999999999999999987654 


Q ss_pred             -------eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEE
Q 008374          318 -------KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR  390 (568)
Q Consensus       318 -------~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~k  390 (568)
                             ..++||||+. ++|.+++...  ...+++.+...++.|++.||.|||   +.+++|+||||+||+++.++.+|
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~k  159 (310)
T cd07865          86 PYNRYKGSFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILK  159 (310)
T ss_pred             cccCCCceEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEE
Confidence                   4599999996 5888877432  236899999999999999999999   57999999999999999999999


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~  469 (568)
                      |+|||++........... .......++..|+|||.+.+. .++.++||||||++++||++|+.|+......... ....
T Consensus       160 l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~-~~~~  237 (310)
T cd07865         160 LADFGLARAFSLSKNSKP-NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL-TLIS  237 (310)
T ss_pred             ECcCCCcccccCCcccCC-CCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHH
Confidence            999999987654322110 111234578899999988654 4688999999999999999999998754322110 1111


Q ss_pred             HHHHHh-----hcC-------------chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          470 WVWMLH-----REG-------------HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       470 ~~~~~~-----~~~-------------~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ......     ...             ........++...   .....+.+++..|++.||.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            110000     000             0000000001000   01234567888999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.9e-34  Score=285.46  Aligned_cols=249  Identities=19%  Similarity=0.233  Sum_probs=190.8

Q ss_pred             HHHHHhcCcccccee--ccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeEEE
Q 008374          235 ELKKATNNFHESMRL--GEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHLVG  311 (568)
Q Consensus       235 el~~at~~f~~~~~L--G~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g  311 (568)
                      +.....++|...+.+  |+|+||.||+++.+.      ++..+|+|.+.......   .  |+.....+ +||||+++++
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~   76 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKP------TQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYY   76 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcC------CCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEE
Confidence            334445566666665  999999999998765      67889999986542221   1  22222222 7999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-cEE
Q 008374          312 WCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF-NAR  390 (568)
Q Consensus       312 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~-~~k  390 (568)
                      ++...+..++||||+++++|.+++...   ..+++.++..++.|+++||.|||   +.+++||||||+||+++.++ .++
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~  150 (267)
T PHA03390         77 SVTTLKGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIY  150 (267)
T ss_pred             EEecCCeeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEE
Confidence            999999999999999999999999543   37899999999999999999999   67899999999999999998 999


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~  470 (568)
                      |+|||+++......         ...|+..|+|||++.+..++.++||||||++++||++|+.||.......  ..+..+
T Consensus       151 l~dfg~~~~~~~~~---------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~  219 (267)
T PHA03390        151 LCDYGLCKIIGTPS---------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESL  219 (267)
T ss_pred             EecCccceecCCCc---------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHH
Confidence            99999987654321         3458899999999998899999999999999999999999997443322  122222


Q ss_pred             HHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHH
Q 008374          471 VWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK-TEDILQ  523 (568)
Q Consensus       471 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt-~~evl~  523 (568)
                      ....          ....  .........+..++..|++.+|.+||+ ++|+++
T Consensus       220 ~~~~----------~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        220 LKRQ----------QKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHhh----------cccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            2111          1111  111133445677778999999999996 688874

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.4e-34  Score=294.08  Aligned_cols=253  Identities=24%  Similarity=0.365  Sum_probs=193.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCC-CCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLR-HKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~  318 (568)
                      ++|...+.||+|+||.||+|....      ++..||||++..... ....++..|+.++.+.. ||||++++++|.....
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKK------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECC------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            457788899999999999999874      578999999976432 23456777887777775 9999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||++ ++|.+++...  ...+++..+..++.+++.||+|||.  ..+++||||+|+||++++++.+||+|||++.
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~  163 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISG  163 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence            999999985 4777766432  2368999999999999999999994  2589999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGK----ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~----~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      .+......      ....++..|+|||.+....    ++.++||||||+++|||++|+.||.......   ....   ..
T Consensus       164 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~---~~  231 (296)
T cd06618         164 RLVDSKAK------TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF---EVLT---KI  231 (296)
T ss_pred             hccCCCcc------cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH---HHHH---HH
Confidence            76433221      1335788999999987553    7889999999999999999999986422111   1111   11


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                      ....      .+.+  .........+.+++.+|++.||++||++.++++.
T Consensus       232 ~~~~------~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         232 LQEE------PPSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             hcCC------CCCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1100      0001  1111234567788889999999999999999854

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=282.34  Aligned_cols=252  Identities=23%  Similarity=0.369  Sum_probs=197.2

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      +++|+.-+.||+|.|+.||+.....      +++.+|+|.+...  +..+.+++.+|+++.+.|+||||++|.....+..
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~------tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~   83 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKT------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES   83 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhcc------chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence            4567777889999999999987764      7888999887543  3346678899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---CCcEEEeec
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA---DFNARLGDF  394 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~---~~~~kL~DF  394 (568)
                      ..+||+|+|.+++|..-+-.   ....+....-..++||+.+|.|.|   .++|+|||+||.|++|..   .--+||+||
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~F  157 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADF  157 (355)
T ss_pred             eeEEEEecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeeccc
Confidence            99999999999999776632   245677778889999999999999   789999999999999953   345899999


Q ss_pred             CCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      |+|..+......      ...+||++|||||++...+|+..+|||+.||+|+-|+.|+.||.......    +.+.    
T Consensus       158 GvAi~l~~g~~~------~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r----lye~----  223 (355)
T KOG0033|consen  158 GLAIEVNDGEAW------HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----LYEQ----  223 (355)
T ss_pred             ceEEEeCCcccc------ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH----HHHH----
Confidence            999988733221      26789999999999999999999999999999999999999997533322    2111    


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ...+...  ++. -..+...+++..+++   +|+..||.+|.|+.|.+.
T Consensus       224 I~~g~yd--~~~-~~w~~is~~Ak~Lvr---rML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  224 IKAGAYD--YPS-PEWDTVTPEAKSLIR---RMLTVNPKKRITADEALK  266 (355)
T ss_pred             HhccccC--CCC-cccCcCCHHHHHHHH---HHhccChhhhccHHHHhC
Confidence            1111100  011 012223345555544   788999999999998764

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.5e-34  Score=299.22  Aligned_cols=266  Identities=21%  Similarity=0.294  Sum_probs=199.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEe--
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE--  315 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--  315 (568)
                      .++|+..+.||+|+||.||+|+...      ++..||+|++....  ....+.+.+|+.++++++||||+++++++..  
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   77 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTR------SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG   77 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcC------CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC
Confidence            3678888999999999999998875      67899999987642  2344667889999999999999999998763  


Q ss_pred             --CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEee
Q 008374          316 --KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD  393 (568)
Q Consensus       316 --~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~D  393 (568)
                        ...+++||||+. ++|.+++..   ...+++.....++.|++.||.|||   +++++||||||+||++++++.+||+|
T Consensus        78 ~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~d  150 (334)
T cd07855          78 ADFKDVYVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGD  150 (334)
T ss_pred             CCCceEEEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecc
Confidence              357899999995 689998853   345899999999999999999999   67999999999999999999999999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      ||+++.......... .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||.......   .+ ....
T Consensus       151 fg~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~---~~-~~~~  225 (334)
T cd07855         151 FGMARGLSSSPTEHK-YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH---QL-KLIL  225 (334)
T ss_pred             cccceeecccCcCCC-cccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH---HH-HHHH
Confidence            999987654322111 11124578899999998865 468899999999999999999999997533211   11 0000


Q ss_pred             HH-----------hhcCchhhhhhhhc-CCCC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          473 ML-----------HREGHIQDAVDQRL-NINS-----VVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       473 ~~-----------~~~~~~~~~~d~~l-~~~~-----~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ..           ...+.+....+..- ....     .......+.+++..|++.+|.+|||+.++++
T Consensus       226 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         226 SVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             HHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00           00011111111000 0000     1123566788899999999999999999887

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-34  Score=287.39  Aligned_cols=261  Identities=24%  Similarity=0.301  Sum_probs=195.1

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcC---CCCceeeEEEEEEeCC
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRL---RHKHLVHLVGWCHEKG  317 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~  317 (568)
                      |+..+.||+|+||.||+|+.+.      ++..+|+|++.....  .....+.+|+.++.++   +|+|++++++++...+
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   74 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLN------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR   74 (287)
T ss_pred             CeEEEEecccCceEEEEEEECC------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence            4567889999999999999874      578999999974322  2234566788777666   5999999999998877


Q ss_pred             e-----EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          318 K-----LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       318 ~-----~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                      .     .+++|||++ ++|.+++.... ...+++..+..++.|+++||.|||   +.+++|+||+|+||+++.++.+||+
T Consensus        75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~  149 (287)
T cd07838          75 TDRELKLTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIA  149 (287)
T ss_pred             CCCCceeEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEe
Confidence            6     999999996 58988885432 235899999999999999999999   6799999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      |||++.........      ....++..|+|||.+....++.++||||||++++||++|+.||.......   .+.....
T Consensus       150 dfg~~~~~~~~~~~------~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~~~  220 (287)
T cd07838         150 DFGLARIYSFEMAL------TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKIFD  220 (287)
T ss_pred             ccCcceeccCCccc------ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHHHH
Confidence            99999876543221      13457889999999998899999999999999999999999987543322   1111111


Q ss_pred             HHhhcCch---------hhhhhhhcC---CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          473 MLHREGHI---------QDAVDQRLN---INSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       473 ~~~~~~~~---------~~~~d~~l~---~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ........         .........   .....+....+.+++..|++.||.+||++.|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         221 VIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             HcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            10000000         000000000   0111233456678889999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.6e-34  Score=294.11  Aligned_cols=246  Identities=25%  Similarity=0.362  Sum_probs=192.9

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC---CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD---SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .|...+.||+|+||.||+|+...      ++..+|+|.+...   .....+++.+|++++++++|+|++++++++.....
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   89 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVR------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT   89 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcC------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe
Confidence            36666789999999999999874      5788999998643   22334568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+. |+|.+++...  ...+++.++..++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||++.
T Consensus        90 ~~lv~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  163 (308)
T cd06634          90 AWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS  163 (308)
T ss_pred             eEEEEEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccce
Confidence            999999996 6887777432  235889999999999999999999   6799999999999999999999999999987


Q ss_pred             ccccccccccccccccCCcCCcccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFH---TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      ......         ...|+..|+|||.+.   ...++.++|||||||++|||++|+.|+.......   .+..+    .
T Consensus       164 ~~~~~~---------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~----~  227 (308)
T cd06634         164 IMAPAN---------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHI----A  227 (308)
T ss_pred             eecCcc---------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HHHHH----h
Confidence            654321         346888999999974   3567889999999999999999999986432211   11110    0


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                       .+..     +..   ........+..++.+||+.+|.+||++.++++.
T Consensus       228 -~~~~-----~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         228 -QNES-----PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             -hcCC-----CCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence             0000     111   111233456778889999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-35  Score=302.55  Aligned_cols=251  Identities=24%  Similarity=0.369  Sum_probs=200.7

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEecc--CCcccchhhHHHHHHhhcC-CCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR--DSIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  317 (568)
                      ..|++.++||+||.++||++...       +.+.+|+|++..  .+.+...-|..|+..|.+| .|.+|++|++|-..++
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s-------~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~  433 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNS-------DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG  433 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecC-------CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence            45788899999999999999765       467788888654  3556678899999999999 4999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .+||||||= .-+|.++|.+.... ...| .+..+..|++.|+.++|   ..+|||.||||.|+|+ -.|.+||+|||+|
T Consensus       434 ~lYmvmE~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLl-VkG~LKLIDFGIA  506 (677)
T KOG0596|consen  434 YLYMVMECG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLL-VKGRLKLIDFGIA  506 (677)
T ss_pred             eEEEEeecc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEE-EeeeEEeeeechh
Confidence            999999975 66999999764432 2335 67789999999999999   5699999999999998 4578999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCC-----------CCccchhHHHHHHHHHHHhCCCCCCCCCcccchhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK-----------ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYT  466 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-----------~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~  466 (568)
                      ..+..+......   ...+||+.||+||.+....           .++++||||+||+||+|+.|+.||.....      
T Consensus       507 ~aI~~DTTsI~k---dsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------  577 (677)
T KOG0596|consen  507 NAIQPDTTSIVK---DSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------  577 (677)
T ss_pred             cccCccccceee---ccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------
Confidence            999887655433   2678999999999885332           45789999999999999999999873321      


Q ss_pred             HHHHHHHHhhcCchhhhhhhhcCCCCcH-HHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          467 LVDWVWMLHREGHIQDAVDQRLNINSVV-DEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       467 l~~~~~~~~~~~~~~~~~d~~l~~~~~~-~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        .|       .++..+.|+.-..+++. .....++.++..||+.||.+|||+.++++
T Consensus       578 --~~-------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  578 --QI-------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             --HH-------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence              11       13455666655444322 12223888999999999999999999986

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.9e-34  Score=299.04  Aligned_cols=267  Identities=21%  Similarity=0.276  Sum_probs=197.8

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeC-
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK-  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-  316 (568)
                      .++|...+.||+|+||.||+|+...      ++..||||.+...  .......+.+|+.+++.++|+||+++++++... 
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   77 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSE------TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPH   77 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecC------CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence            3568888999999999999998764      6889999998653  223345678899999999999999999988644 


Q ss_pred             ----CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          317 ----GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       317 ----~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                          ...++||||+. ++|.+++..   ...+++.....++.|++.||.|||   +++++||||||+||+++.++.+||+
T Consensus        78 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~  150 (337)
T cd07858          78 REAFNDVYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKIC  150 (337)
T ss_pred             ccccCcEEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEC
Confidence                35899999995 789888843   346899999999999999999999   6799999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      |||+++........     .....++..|+|||.+.. ..++.++|||||||++|||++|+.||...........+.+..
T Consensus       151 Dfg~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  225 (337)
T cd07858         151 DFGLARTTSEKGDF-----MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELL  225 (337)
T ss_pred             cCccccccCCCccc-----ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence            99999876443211     113467889999998764 568899999999999999999999997543211110111000


Q ss_pred             -------HHHhhcCchhhhhhhhcCC------CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          472 -------WMLHREGHIQDAVDQRLNI------NSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       472 -------~~~~~~~~~~~~~d~~l~~------~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                             +...........+......      ....+....+.+++.+|++.+|++|||++|+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             CCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                   0000000111111000000      0011234567888999999999999999999875

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5e-34  Score=289.02  Aligned_cols=255  Identities=20%  Similarity=0.253  Sum_probs=195.3

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc----ccchhhHHHHHHhhcC-CCCceeeEEEEEEeC
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI----KSKGDFLAELAIIHRL-RHKHLVHLVGWCHEK  316 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  316 (568)
                      +|+..+.||+|+||.||++......   .++..||+|++.....    ...+.+..|+.++.++ +|+||+++++++...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~---~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGH---DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD   77 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCC---CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC
Confidence            3667889999999999999875321   1578899999875322    2345678899999999 599999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      ...++||||+++++|.+++..   ...+++.....++.|++.||.|||   +.+++||||+|+|||+++++.+||+|||+
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~  151 (290)
T cd05613          78 TKLHLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL  151 (290)
T ss_pred             CeEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCcc
Confidence            999999999999999999954   345888899999999999999999   67999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG--KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~--~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      ++..........    ....|+..|+|||.+...  .++.++||||||+++|||++|+.|+.......   ...+.....
T Consensus       152 ~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~~~~~~  224 (290)
T cd05613         152 SKEFHEDEVERA----YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN---SQAEISRRI  224 (290)
T ss_pred             ceeccccccccc----ccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc---cHHHHHHHh
Confidence            987644322111    135688999999998753  46789999999999999999999986432222   112221111


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                      ....           ...+......+..++..|++.||.+||     ++.++++
T Consensus       225 ~~~~-----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         225 LKSE-----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             hccC-----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            1100           111122334566788899999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.1e-34  Score=288.24  Aligned_cols=242  Identities=23%  Similarity=0.290  Sum_probs=185.9

Q ss_pred             eeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc---cchhhHHHHH---HhhcCCCCceeeEEEEEEeCCeEEE
Q 008374          248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK---SKGDFLAELA---IIHRLRHKHLVHLVGWCHEKGKLLL  321 (568)
Q Consensus       248 ~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~H~nIv~l~g~~~~~~~~~l  321 (568)
                      .||+|+||.||++....      +++.||+|.+......   ....+..|..   .++...||||+++++++...+..++
T Consensus         1 ~ig~g~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~   74 (278)
T cd05606           1 IIGRGGFGEVYGCRKAD------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   74 (278)
T ss_pred             CcccCCCeEEEEEEEec------CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEE
Confidence            48999999999998764      6789999998754322   1223444443   3444579999999999999999999


Q ss_pred             EEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccc
Q 008374          322 VYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE  401 (568)
Q Consensus       322 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~  401 (568)
                      ||||+++++|..++..   ...+++..+..++.|+++||.|||   +++++||||||+||++++++.+||+|||+++...
T Consensus        75 v~e~~~g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~  148 (278)
T cd05606          75 ILDLMNGGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (278)
T ss_pred             EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence            9999999999998843   346999999999999999999999   6799999999999999999999999999997654


Q ss_pred             cccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          402 NERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       402 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      ....       ....|+..|+|||.+.++ .++.++||||||++++||++|+.||........    .. ......    
T Consensus       149 ~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~----~~-~~~~~~----  212 (278)
T cd05606         149 KKKP-------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HE-IDRMTL----  212 (278)
T ss_pred             ccCC-------cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch----HH-HHHHhh----
Confidence            3211       134689999999998754 688999999999999999999999974422110    00 000000    


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                        ..+.    .........+..++..|++.+|.+||     ++.++++
T Consensus       213 --~~~~----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         213 --TMAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             --ccCC----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence              0011    11112245677777899999999999     9999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.7e-34  Score=293.77  Aligned_cols=267  Identities=22%  Similarity=0.269  Sum_probs=199.6

Q ss_pred             HHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEE
Q 008374          235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGW  312 (568)
Q Consensus       235 el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~  312 (568)
                      ++..++++|...+.||+|+||.||++....      ++..||+|++....  ....+.+.+|++++.+++||||+++.++
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   77 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQL------TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI   77 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECC------CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeee
Confidence            344578889999999999999999998775      67899999886432  2334678899999999999999999999


Q ss_pred             EEe-CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 008374          313 CHE-KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL  391 (568)
Q Consensus       313 ~~~-~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL  391 (568)
                      +.. .+..++|+||+ +++|.+++..    ..+++.....++.|+++||.|||   +++++||||+|+||++++++.+||
T Consensus        78 ~~~~~~~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l  149 (328)
T cd07856          78 FISPLEDIYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKI  149 (328)
T ss_pred             EecCCCcEEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEe
Confidence            875 56789999998 5689888842    35788888899999999999999   679999999999999999999999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~  470 (568)
                      +|||+++......        ....++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+.++
T Consensus       150 ~dfg~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~  221 (328)
T cd07856         150 CDFGLARIQDPQM--------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDL  221 (328)
T ss_pred             CccccccccCCCc--------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            9999998643321        13457889999998766 56899999999999999999999998744322111111111


Q ss_pred             --------HHHHhhcCchhhhhhh-hcCCCCcH-----HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          471 --------VWMLHREGHIQDAVDQ-RLNINSVV-----DEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       471 --------~~~~~~~~~~~~~~d~-~l~~~~~~-----~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                              .... ..+...+.+.. ........     .....+.+++..|++.+|++|||+.+++..
T Consensus       222 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         222 LGTPPDDVINTI-CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hCCCCHHHHHhc-cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                    1000 00111111100 00111111     123567788889999999999999999764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-34  Score=288.26  Aligned_cols=264  Identities=20%  Similarity=0.287  Sum_probs=196.3

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCC-CCceeeEEEEEEeCCeEE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLR-HKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~  320 (568)
                      |...+.||+|+||.||+|+...      +++.|++|++..... .......+|+..+.+++ |+||+++++++...+..+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   74 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKE------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELY   74 (283)
T ss_pred             CeeheeeccCCceEEEEEEECC------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEE
Confidence            4567789999999999999874      578899999876432 22334567999999999 999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+ +|+|.+++.... ...+++..+..++.|++.+|.|||   +++++|+||+|+||+++.++.++|+|||+++..
T Consensus        75 lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~  149 (283)
T cd07830          75 FVFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREI  149 (283)
T ss_pred             EEEecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceec
Confidence            999999 889999885433 246899999999999999999999   679999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH---------H
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFH-TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD---------W  470 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~-~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~---------~  470 (568)
                      ......      ....++..|+|||.+. ...++.++|+||||++++||++|+.||..............         |
T Consensus       150 ~~~~~~------~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (283)
T cd07830         150 RSRPPY------TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW  223 (283)
T ss_pred             cCCCCc------CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhh
Confidence            543221      1345788999999875 45678999999999999999999999864432221111111         1


Q ss_pred             HHHHhhcCchhhhhhhhcCC---CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          471 VWMLHREGHIQDAVDQRLNI---NSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       471 ~~~~~~~~~~~~~~d~~l~~---~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .............+......   .........+.+++..|++.+|++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         224 PEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            10000000000000000000   000112456888999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.7e-34  Score=296.41  Aligned_cols=275  Identities=20%  Similarity=0.287  Sum_probs=203.4

Q ss_pred             CcccCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCc
Q 008374          228 PREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKH  305 (568)
Q Consensus       228 ~~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~n  305 (568)
                      .+.....++..++++|...+.||+|+||.||+|....      ++..||+|++....  ....+.+.+|+.++.+++|||
T Consensus         4 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~   77 (345)
T cd07877           4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN   77 (345)
T ss_pred             chhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcC------CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCc
Confidence            4555667788889999999999999999999998764      67899999987542  223456889999999999999


Q ss_pred             eeeEEEEEEeC------CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 008374          306 LVHLVGWCHEK------GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKAS  379 (568)
Q Consensus       306 Iv~l~g~~~~~------~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~  379 (568)
                      |+++++++...      ...+++++++ +++|.+++..    ..+++..+..++.|+++||+|||   +++++||||||+
T Consensus        78 iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~  149 (345)
T cd07877          78 VIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPS  149 (345)
T ss_pred             ccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChH
Confidence            99999988643      3478888887 7899888742    35899999999999999999999   679999999999


Q ss_pred             CEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008374          380 NILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMI  458 (568)
Q Consensus       380 NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~  458 (568)
                      ||++++++.+||+|||+++......        ....|+..|+|||.+.+ ..++.++|||||||+++||++|+.||...
T Consensus       150 NIll~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  221 (345)
T cd07877         150 NLAVNEDCELKILDFGLARHTDDEM--------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  221 (345)
T ss_pred             HEEEcCCCCEEEecccccccccccc--------cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999998654321        13467899999998866 56788999999999999999999998643


Q ss_pred             CcccchhhHHHH-------HHHHhhcCchh---hhhhhhcCCCC---cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          459 PHQQHAYTLVDW-------VWMLHREGHIQ---DAVDQRLNINS---VVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       459 ~~~~~~~~l~~~-------~~~~~~~~~~~---~~~d~~l~~~~---~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                      ........+...       ...........   ..++......+   .......+.+++..|++.||.+||++.++++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         222 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            322111011110       00000000000   00000000000   00123456788889999999999999998763

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.5e-34  Score=291.04  Aligned_cols=245  Identities=25%  Similarity=0.371  Sum_probs=191.2

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      |...++||+|+||+||+|+...      .+..|++|++.....   ...+.+.+|++++++++|||++++++++.+....
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSH------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECC------CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            5556789999999999998764      678999999865422   2335688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||++ |+|.+++...  ...+++.++..++.|++.+|.|||   +.+++|+||+|+||+++.++.+||+|||++..
T Consensus        97 ~lv~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~  170 (313)
T cd06633          97 WLVMEYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASK  170 (313)
T ss_pred             EEEEecCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcc
Confidence            99999995 5777777432  245899999999999999999999   67999999999999999999999999999864


Q ss_pred             cccccccccccccccCCcCCcccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFH---TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ....         ....|+..|+|||++.   ...++.++|||||||++|||++|+.|+.......    ..   .....
T Consensus       171 ~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~----~~---~~~~~  234 (313)
T cd06633         171 SSPA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----AL---YHIAQ  234 (313)
T ss_pred             cCCC---------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----HH---HHHHh
Confidence            3221         1456889999999984   4568889999999999999999999986432211    11   11110


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                      . ..     +..   ........+..++.+|++.+|.+||++.++++.
T Consensus       235 ~-~~-----~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         235 N-DS-----PTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             c-CC-----CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0 00     001   011122346678889999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.5e-34  Score=299.87  Aligned_cols=201  Identities=21%  Similarity=0.280  Sum_probs=171.1

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-C-----CceeeEEEEEEe
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-H-----KHLVHLVGWCHE  315 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~g~~~~  315 (568)
                      +|...+.||+|.||+|-||...+      +++.||||++++.. .-..+-..|+.+|..|+ |     -|+|++++++..
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~------T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f  259 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHK------TGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF  259 (586)
T ss_pred             EEEEEEEecccccceeEEEEecC------CCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence            68889999999999999999875      78999999997653 23445567999999996 4     389999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC--CcEEEee
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD--FNARLGD  393 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~--~~~kL~D  393 (568)
                      ++++|||+|.+ ..+|.++|....- ..++......++.||+.||.+||   +.+|||+||||+||||.+-  ..+||+|
T Consensus       260 r~HlciVfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVID  334 (586)
T KOG0667|consen  260 RNHLCIVFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVID  334 (586)
T ss_pred             ccceeeeehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEe
Confidence            99999999998 6699999977544 45999999999999999999999   6799999999999999654  4799999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ  462 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~  462 (568)
                      ||.|.......-        ...-+..|.|||++.+.+|..+.|||||||++.||++|..-|.+..+.+
T Consensus       335 FGSSc~~~q~vy--------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D  395 (586)
T KOG0667|consen  335 FGSSCFESQRVY--------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD  395 (586)
T ss_pred             cccccccCCcce--------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence            999987654322        2334678999999999999999999999999999999987666554433

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.3e-34  Score=294.45  Aligned_cols=264  Identities=19%  Similarity=0.231  Sum_probs=193.1

Q ss_pred             ceeccC--CceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEE
Q 008374          247 MRLGEG--GFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       247 ~~LG~G--~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      ..||+|  +||+||++....      .++.||+|.+....  ....+.+.+|+.+++.++||||++++++|...+..++|
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v   77 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTP------TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI   77 (328)
T ss_pred             HHhCCcccCceeEEEEEEcC------CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEE
Confidence            356766  899999998764      68899999986542  22346788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      +||+++++|.+++.... ...+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+|++||+.+.....
T Consensus        78 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~  153 (328)
T cd08226          78 SPFMAYGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVR  153 (328)
T ss_pred             EecccCCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhc
Confidence            99999999999986532 235888999999999999999999   67999999999999999999999999986544322


Q ss_pred             ccccccc--cccccCCcCCcccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH-----
Q 008374          403 ERNSYAE--HGLVGVPGTMGYVAPECFHTG--KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM-----  473 (568)
Q Consensus       403 ~~~~~~~--~~~~~~~Gt~~y~APE~~~~~--~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~-----  473 (568)
                      .......  .......++..|+|||++.+.  .++.++|||||||+++||++|+.||.......   .+......     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~  230 (328)
T cd08226         154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ---MLLQKLKGPPYSP  230 (328)
T ss_pred             cCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH---HHHHHhcCCCCCC
Confidence            1111000  000012356679999998763  47899999999999999999999997543222   11110000     


Q ss_pred             ---------------------------HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          474 ---------------------------LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       474 ---------------------------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                                                 ....+....+.+..+...........+.+++..|++.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                                       00000000111112222223345567888999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-34  Score=286.24  Aligned_cols=264  Identities=22%  Similarity=0.300  Sum_probs=198.2

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc--cchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK--SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      |...+.||+|++|.||+|+...      +++.+++|++......  ....+.+|++++++++|+||+++++++...+..+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKL------TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY   74 (283)
T ss_pred             CccceeeecCCCceEEEEEcCC------CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence            3456789999999999999864      6788999998764332  3567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +|+||+++ +|.+++....  ..+++..+..++.+++.||.|||   +.+++|+||||+||+++.++.+||+|||.+...
T Consensus        75 ~v~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~  148 (283)
T cd05118          75 LVFEFMDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSF  148 (283)
T ss_pred             EEEeccCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence            99999975 8888885432  46899999999999999999999   679999999999999999999999999999877


Q ss_pred             ccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH-------HH
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW-------VW  472 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~-------~~  472 (568)
                      .......     ....++..|+|||.+.+. .++.++||||||+++++|++|+.||...........+.+.       .+
T Consensus       149 ~~~~~~~-----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (283)
T cd05118         149 GSPVRPY-----THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVW  223 (283)
T ss_pred             CCCcccc-----cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhc
Confidence            5543111     134578899999998776 7899999999999999999999998644322110011000       00


Q ss_pred             HHhhc---Cchhhhhhhhc-C-CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          473 MLHRE---GHIQDAVDQRL-N-INSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       473 ~~~~~---~~~~~~~d~~l-~-~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .....   .......+... . .....+....+.+++..|+++||.+||++.+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         224 PKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             ccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            00000   00000000000 0 0011234567888999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-35  Score=307.04  Aligned_cols=202  Identities=30%  Similarity=0.501  Sum_probs=177.1

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC----
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG----  317 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----  317 (568)
                      +...+.||+|+||.||+|+.+.      +|+.||||.+.... ....+...+|+++|++++|+|||++++.-.+..    
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnke------tG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~   88 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKE------TGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV   88 (732)
T ss_pred             eeehhhhcCCccceeeeecccc------cccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence            4556789999999999999875      89999999997753 345567889999999999999999999866544    


Q ss_pred             --eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc--C--CCcEEE
Q 008374          318 --KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD--A--DFNARL  391 (568)
Q Consensus       318 --~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld--~--~~~~kL  391 (568)
                        ...+|||||++|||+..|.+......|+..+.+.++.+++.||.|||   +.+|+||||||.||++-  +  .-..||
T Consensus        89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKL  165 (732)
T KOG4250|consen   89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKL  165 (732)
T ss_pred             cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEee
Confidence              57899999999999999998888889999999999999999999999   67999999999999993  2  234799


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIP  459 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~  459 (568)
                      +|||.||.++.+..      ...+.||..|++||.+.. +.|+..+|.|||||++||.+||..||....
T Consensus       166 tDfG~Arel~d~s~------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  166 TDFGAARELDDNSL------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             ecccccccCCCCCe------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            99999999887652      237899999999999984 889999999999999999999999998543

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.4e-34  Score=290.15  Aligned_cols=270  Identities=23%  Similarity=0.296  Sum_probs=195.2

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc--cchhhHHHHHHhhcCCCCceeeEEEEEEeC-
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK--SKGDFLAELAIIHRLRHKHLVHLVGWCHEK-  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-  316 (568)
                      .++|...++||+|+||.||+|+...      +++.+|+|++......  ....+.+|++++++++||||+++++++... 
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIK------TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERP   80 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECC------CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence            5789999999999999999999875      6788999998654322  234678899999999999999999987543 


Q ss_pred             -------CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcE
Q 008374          317 -------GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA  389 (568)
Q Consensus       317 -------~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~  389 (568)
                             ..+++|+||+.. +|...+...  ...+++.++..++.|+++||.|||   +++++||||||+||++++++.+
T Consensus        81 ~~~~~~~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~  154 (311)
T cd07866          81 DKSKRKRGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGIL  154 (311)
T ss_pred             ccccccCceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCE
Confidence                   357999999964 677776432  346899999999999999999999   6799999999999999999999


Q ss_pred             EEeecCCcccccccccccc------ccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 008374          390 RLGDFGLARAIENERNSYA------EHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ  462 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~------~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~  462 (568)
                      ||+|||+++..........      ........|+..|+|||.+.+ ..++.++||||||++++||++|+.||.......
T Consensus       155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~  234 (311)
T cd07866         155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID  234 (311)
T ss_pred             EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999987654322111      111124467889999998765 457899999999999999999999987433322


Q ss_pred             chhhHHHH-------HHHHhhcCchhhhh----hhhcCCC---CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          463 HAYTLVDW-------VWMLHREGHIQDAV----DQRLNIN---SVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       463 ~~~~l~~~-------~~~~~~~~~~~~~~----d~~l~~~---~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ....+...       .+..+.  .+....    .......   ........+.+++.+|++.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         235 QLHLIFKLCGTPTEETWPGWR--SLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHHHhCCCChhhchhhh--hcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            11111000       000000  000000    0000000   00112256778889999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.3e-34  Score=289.06  Aligned_cols=253  Identities=22%  Similarity=0.332  Sum_probs=201.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC---CcccchhhHHHHHHhhcCC-CCceeeEEEEEEeC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD---SIKSKGDFLAELAIIHRLR-HKHLVHLVGWCHEK  316 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~  316 (568)
                      ++|...+.||+|+||.||+|+...      ++..+|+|.+...   .....+.+..|++++.+++ ||||+++++++...
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   74 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKE------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE   74 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcC------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC
Confidence            367888899999999999999875      6789999998653   2233467889999999998 99999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +..++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~  148 (280)
T cd05581          75 ENLYFVLEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGT  148 (280)
T ss_pred             ceEEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCcc
Confidence            999999999999999999954   336999999999999999999999   67999999999999999999999999999


Q ss_pred             cccccccccccc---------------ccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 008374          397 ARAIENERNSYA---------------EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQ  461 (568)
Q Consensus       397 a~~~~~~~~~~~---------------~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~  461 (568)
                      +...........               ........|+..|+|||......++.++||||||++++|+++|+.|+......
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  228 (280)
T cd05581         149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY  228 (280)
T ss_pred             ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence            987654321100               01112456789999999998888999999999999999999999998754321


Q ss_pred             cchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH----HHHHH
Q 008374          462 QHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKT----EDILQ  523 (568)
Q Consensus       462 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~----~evl~  523 (568)
                      .    ...            .+.+.  ...........+.+++..|++.+|.+||++    +++++
T Consensus       229 ~----~~~------------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 L----TFQ------------KILKL--EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             H----HHH------------HHHhc--CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            1    111            01111  111122235567888889999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.1e-33  Score=292.86  Aligned_cols=265  Identities=22%  Similarity=0.260  Sum_probs=194.4

Q ss_pred             Ccc-ccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc--------------chhhHHHHHHhhcCCCCce
Q 008374          242 NFH-ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--------------KGDFLAELAIIHRLRHKHL  306 (568)
Q Consensus       242 ~f~-~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~nI  306 (568)
                      +|. ..+.||+|+||.||+|....      .++.||||.++......              ...+.+|++++++++|+||
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   82 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTL------TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI   82 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECC------CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence            444 34579999999999998764      67899999986543221              1247789999999999999


Q ss_pred             eeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC
Q 008374          307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD  386 (568)
Q Consensus       307 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~  386 (568)
                      +++++++...+..++||||++ |+|.+++..   ...+++.....++.|++.||.|||   +.+++||||+|+||+++.+
T Consensus        83 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~  155 (335)
T PTZ00024         83 MGLVDVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSK  155 (335)
T ss_pred             eeeeEEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCC
Confidence            999999999999999999996 689998843   345889999999999999999999   6799999999999999999


Q ss_pred             CcEEEeecCCcccccccccc---------ccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 008374          387 FNARLGDFGLARAIENERNS---------YAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGN  456 (568)
Q Consensus       387 ~~~kL~DFGla~~~~~~~~~---------~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~  456 (568)
                      +.+||+|||+++........         ..........++..|+|||.+.+. .++.++|||||||++|||++|+.||.
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~  235 (335)
T PTZ00024        156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP  235 (335)
T ss_pred             CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999876521100         001111133568899999998764 46889999999999999999999987


Q ss_pred             CCCcccchhhHHHHHHHHhhcCc---hhhhhh--------hhcCC---CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 008374          457 MIPHQQHAYTLVDWVWMLHREGH---IQDAVD--------QRLNI---NSVVDEAKRLLLLGLACSHPIASERPKTEDIL  522 (568)
Q Consensus       457 ~~~~~~~~~~l~~~~~~~~~~~~---~~~~~d--------~~l~~---~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl  522 (568)
                      ......    ....+........   +.+..+        .....   .........+.+++..|++.+|++|||++|++
T Consensus       236 ~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l  311 (335)
T PTZ00024        236 GENEID----QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL  311 (335)
T ss_pred             CCCHHH----HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence            544322    1111111111000   000000        00000   00011235577888899999999999999998


Q ss_pred             H
Q 008374          523 Q  523 (568)
Q Consensus       523 ~  523 (568)
                      .
T Consensus       312 ~  312 (335)
T PTZ00024        312 K  312 (335)
T ss_pred             c
Confidence            6

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-34  Score=297.36  Aligned_cols=276  Identities=19%  Similarity=0.279  Sum_probs=205.0

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC--
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG--  317 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--  317 (568)
                      +|...+.||+|+||.||+|+...      .+..+|+|++....  ....+.+.+|+.+++.++|+||+++++++....  
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKR------TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE   74 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCC------CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence            46778899999999999999764      57899999987643  334567999999999999999999999988765  


Q ss_pred             ---eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 008374          318 ---KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDF  394 (568)
Q Consensus       318 ---~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DF  394 (568)
                         .+++||||++ ++|.+++..   ...+++..+..++.+++.||.|||   +.+++||||||+|||++.++.++|+||
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~df  147 (330)
T cd07834          75 DFNDVYIVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDF  147 (330)
T ss_pred             cccceEEEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEccc
Confidence               7899999997 589888853   237899999999999999999999   679999999999999999999999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH--
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV--  471 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~--  471 (568)
                      |++..........  .......++..|+|||.+.+. .++.++||||||+++++|++|+.||...........+....  
T Consensus       148 g~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  225 (330)
T cd07834         148 GLARGVDPDEDEK--GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT  225 (330)
T ss_pred             CceEeeccccccc--ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCC
Confidence            9999876543110  011244678899999999887 78999999999999999999999997543322111111100  


Q ss_pred             -----HHHhhcCchhhhhhhhc-CCC-----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HhCCCCCC
Q 008374          472 -----WMLHREGHIQDAVDQRL-NIN-----SVVDEAKRLLLLGLACSHPIASERPKTEDILQI--ISGTSTVP  532 (568)
Q Consensus       472 -----~~~~~~~~~~~~~d~~l-~~~-----~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~--L~~~~~~p  532 (568)
                           +...........+...- ...     ........+.+++..||+.+|.+|||+.++++.  +++....+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~  299 (330)
T cd07834         226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE  299 (330)
T ss_pred             CChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence                 00000000111111000 000     011134567788889999999999999999983  55544333

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=304.06  Aligned_cols=252  Identities=23%  Similarity=0.350  Sum_probs=202.1

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      +.|.+...||.|+||+||||+.+.      .+...|.|.+...+....++|+-|++||....||+||+|++.+...+.++
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nke------t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw  105 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKE------TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW  105 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhccc------chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence            346667789999999999999874      56677889998888888999999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +..|||.||-.+..+..-  ...|+..++..++++++.||.|||   ++.|||||||+.|||+.-+|.++|+|||.+-..
T Consensus       106 iliEFC~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn  180 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN  180 (1187)
T ss_pred             EEEeecCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccc
Confidence            999999999999887543  347999999999999999999999   789999999999999999999999999997654


Q ss_pred             ccccccccccccccCCcCCcccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFH-----TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      ......     ...+.||+.|||||+..     ..+|..++||||||+.|.||..+..|......-.   .++..    .
T Consensus       181 ~~t~qk-----RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR---VllKi----a  248 (1187)
T KOG0579|consen  181 KSTRQK-----RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLLKI----A  248 (1187)
T ss_pred             hhHHhh-----hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH---HHHHH----h
Confidence            332211     12678999999999875     4678999999999999999999999854321111   11110    0


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ...      -+.+  -.+..-...+-+++..|+..||..||++.++++
T Consensus       249 KSe------PPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  249 KSE------PPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             hcC------CCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            000      0111  122334445667778999999999999999876

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-34  Score=290.36  Aligned_cols=248  Identities=22%  Similarity=0.343  Sum_probs=207.3

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .-|..++.||+|.|..|-+|+.--      +|..||||++.+...  -....+.+|++.|+.++|||||+|+.+......
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVF------TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK   91 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVF------TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK   91 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhc------ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence            346777889999999999987653      799999999976432  334568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc-CCCcEEEeecCCc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD-ADFNARLGDFGLA  397 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld-~~~~~kL~DFGla  397 (568)
                      +|||.|+-.+|+|.+|+-++.  ..|......+++.||..|+.|.|   +..+|||||||+||.+- .-|-+||.|||++
T Consensus        92 lyLiLELGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFS  166 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFS  166 (864)
T ss_pred             EEEEEEecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeecccc
Confidence            999999999999999996543  46889999999999999999999   56899999999999775 4588999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKAT-PESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t-~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ..+..+..-      ...+|...|-|||++.+..|. +++||||+||+||-|+||+.||+...+.+              
T Consensus       167 Nkf~PG~kL------~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE--------------  226 (864)
T KOG4717|consen  167 NKFQPGKKL------TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE--------------  226 (864)
T ss_pred             ccCCCcchh------hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh--------------
Confidence            887766442      367899999999999998885 68999999999999999999999766655              


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        .+..++|-++.  .+.-...++..|+..|+..||++|-+.+|++.
T Consensus       227 --TLTmImDCKYt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  227 --TLTMIMDCKYT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             --hhhhhhccccc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence              23344554442  23445556777777999999999999999864

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.6e-34  Score=283.75  Aligned_cols=250  Identities=22%  Similarity=0.307  Sum_probs=191.9

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-----CcccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-----SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      +|...++||+|+||.||++....      .+..+++|.++..     ......++..|+.++++++||||+++++++.+.
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKK------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER   74 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecC------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC
Confidence            36677899999999999998764      2333445544331     122334577899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      ...++||||+++++|.+++... .....+++..+..++.|++.||.|||   +.+++|+||+|+||+++. +.+||+|||
T Consensus        75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g  150 (260)
T cd08222          75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFG  150 (260)
T ss_pred             CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccC
Confidence            9999999999999999988642 22356899999999999999999999   679999999999999975 569999999


Q ss_pred             CccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      +++.........     ....|+..|+|||.+....++.++|+||||+++|+|++|+.|+.....       ........
T Consensus       151 ~~~~~~~~~~~~-----~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~~~~~~~  218 (260)
T cd08222         151 VSRLLMGSCDLA-----TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------LSVVLRIV  218 (260)
T ss_pred             ceeecCCCcccc-----cCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHH
Confidence            998764432211     135688899999999888889999999999999999999999863221       11111100


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       .+         ............+.+++.+|++.+|++||++.|+++
T Consensus       219 -~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         219 -EG---------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -cC---------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence             01         011112234456777888999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-33  Score=291.11  Aligned_cols=262  Identities=20%  Similarity=0.305  Sum_probs=195.5

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      ..++|...+.||+|+||.||++....      ++..||||++....  ......+.+|+.++++++||||+++++++...
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRR------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPD   86 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECC------CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCC
Confidence            45679899999999999999998765      67899999986532  22345688999999999999999999998755


Q ss_pred             C------eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEE
Q 008374          317 G------KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR  390 (568)
Q Consensus       317 ~------~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~k  390 (568)
                      .      ..++||||+ +++|.+++..    ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+|
T Consensus        87 ~~~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~k  158 (343)
T cd07880          87 LSLDRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELK  158 (343)
T ss_pred             ccccccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEE
Confidence            3      469999999 7799888742    45899999999999999999999   67999999999999999999999


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHH-
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV-  468 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~-  468 (568)
                      |+|||+++......        ....++..|+|||.+.. ..++.++|+||||+++++|++|+.||...........+. 
T Consensus       159 l~dfg~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~  230 (343)
T cd07880         159 ILDFGLARQTDSEM--------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK  230 (343)
T ss_pred             EeecccccccccCc--------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999998654321        13457889999999875 458899999999999999999999997443221100110 


Q ss_pred             -------HHHHHHhhcCchhhhhhh--hcCCC----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          469 -------DWVWMLHREGHIQDAVDQ--RLNIN----SVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       469 -------~~~~~~~~~~~~~~~~d~--~l~~~----~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                             ++... ............  .....    ........+.+++.+|++.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         231 VTGTPSKEFVQK-LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             hcCCCCHHHHHh-hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                   00000 000000000000  00000    00122335678888999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.9e-33  Score=288.15  Aligned_cols=261  Identities=20%  Similarity=0.212  Sum_probs=188.6

Q ss_pred             eeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 008374          248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       248 ~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      .+|.|+++.||++..        +++.||||++...  .....+.+..|++++++++|+||+++++++...+..+++|||
T Consensus         9 ~~~~~~~v~~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~   80 (314)
T cd08216           9 CFEDLMIVHLAKHKP--------TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL   80 (314)
T ss_pred             hhcCCceEEEEEecC--------CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence            344455555555432        5789999998764  334556799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccc
Q 008374          326 MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN  405 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~  405 (568)
                      +++|+|.+++.... ...+++.....++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||.+........
T Consensus        81 ~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~  156 (314)
T cd08216          81 MAYGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK  156 (314)
T ss_pred             cCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence            99999999996532 235888899999999999999999   67999999999999999999999999999876543211


Q ss_pred             c--ccccccccCCcCCcccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH----hhc
Q 008374          406 S--YAEHGLVGVPGTMGYVAPECFHT--GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML----HRE  477 (568)
Q Consensus       406 ~--~~~~~~~~~~Gt~~y~APE~~~~--~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~----~~~  477 (568)
                      .  ..........++..|+|||++..  ..++.++|||||||++|||++|+.||.......   .+.+-....    ...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~  233 (314)
T cd08216         157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKVRGTVPCLLDK  233 (314)
T ss_pred             cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhccCcccccc
Confidence            1  00001123457789999999865  357899999999999999999999997543222   111110000    000


Q ss_pred             -------Cchhh----hhhhh----cCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 -------GHIQD----AVDQR----LNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 -------~~~~~----~~d~~----l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                             ....+    ..+..    ............+..++..||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                   00000    00000    001111223456778888999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=328.38  Aligned_cols=256  Identities=25%  Similarity=0.347  Sum_probs=201.7

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      +-++.....||.|.||.||-|+...      +|...|||-++...  ....+...+|+.++..++|||+|+++|+-.+++
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~------tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLD------TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE 1307 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCC------ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH
Confidence            4466777889999999999999876      68889999886543  334467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..+|.||||.+|+|.+.+..   ...++......+..|++.|++|||   +.+||||||||.||+|+.+|.+|++|||.|
T Consensus      1308 kv~IFMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred             HHHHHHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccce
Confidence            99999999999999999943   234555556667889999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTG---KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~---~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      ..+....... ........||+-|||||++.+.   ....+.||||+|||++||+||++||...+..        |.-.+
T Consensus      1382 ~ki~~~~~~~-~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--------~aIMy 1452 (1509)
T KOG4645|consen 1382 VKIKNNAQTM-PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--------WAIMY 1452 (1509)
T ss_pred             eEecCchhcC-CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--------hHHHh
Confidence            9887663221 1233467899999999999653   3566899999999999999999999754432        32222


Q ss_pred             h-hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 008374          475 H-REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII  525 (568)
Q Consensus       475 ~-~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L  525 (568)
                      + .-|+.         ...+......-.+++-.|+..||.+|.++.|+++.=
T Consensus      1453 ~V~~gh~---------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1453 HVAAGHK---------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             HHhccCC---------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence            1 11211         122223333445566699999999999999887753

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-34  Score=286.87  Aligned_cols=264  Identities=23%  Similarity=0.330  Sum_probs=197.9

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      |+..+.||+|+||.||+|+...      +++.+|+|.+....  ....+.+..|+.++++++|+|++++++++...+..+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   74 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKK------TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY   74 (282)
T ss_pred             CeeehcccccCcceEEEeeecC------CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence            4456789999999999999875      57899999997653  233467889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||++ ++|.+++....  ..+++..+..++.+++.||.|||   +++++||||+|+||++++++.+||+|||+++..
T Consensus        75 ~v~e~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~  148 (282)
T cd07829          75 LVFEYCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAF  148 (282)
T ss_pred             EEecCcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCccccc
Confidence            9999997 59999996432  46899999999999999999999   579999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH-------HHH
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD-------WVW  472 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~-------~~~  472 (568)
                      .......     ....++..|+|||.+... .++.++||||||++++||++|+.||...........+..       ..|
T Consensus       149 ~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (282)
T cd07829         149 GIPLRTY-----THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW  223 (282)
T ss_pred             CCCcccc-----CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHH
Confidence            5433221     133467889999998766 789999999999999999999999875432211101110       001


Q ss_pred             HHhhcCchhhhhhhhcCC----CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          473 MLHREGHIQDAVDQRLNI----NSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~----~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .....-......-+....    .........+.+++..|++.||++||++.+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         224 PGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             HhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000000000000000000    000112456888999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.1e-33  Score=287.62  Aligned_cols=269  Identities=20%  Similarity=0.246  Sum_probs=192.7

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcC-CCCceeeEEEEEEeC--
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEK--  316 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~--  316 (568)
                      +|...+.||+|+||.||++......    .+..+|+|++....  ....+.+.+|++++.++ +||||+++++.+...  
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   76 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETS----EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG   76 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCC----cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence            4677889999999999999987421    26789999987532  22345688999999999 599999999976433  


Q ss_pred             --CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 008374          317 --GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDF  394 (568)
Q Consensus       317 --~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DF  394 (568)
                        ...++++||+. ++|.+++..   ...+++..+..++.|++.||.|||   .++++||||||+|||++.++.+||+||
T Consensus        77 ~~~~~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Df  149 (332)
T cd07857          77 NFNELYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDF  149 (332)
T ss_pred             cCCcEEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcC
Confidence              45788999985 689988843   346899999999999999999999   679999999999999999999999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHH-----
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV-----  468 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~-----  468 (568)
                      |+++.+......... ......||..|+|||++.+ ..++.++||||||+++++|++|+.||.............     
T Consensus       150 g~a~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  228 (332)
T cd07857         150 GLARGFSENPGENAG-FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT  228 (332)
T ss_pred             CCceecccccccccc-cccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCC
Confidence            999876543222111 1124568999999998765 468899999999999999999999987533211000000     


Q ss_pred             ---HHHHHHhhcCchhhhhhh---hcCCC---CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          469 ---DWVWMLHREGHIQDAVDQ---RLNIN---SVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       469 ---~~~~~~~~~~~~~~~~d~---~l~~~---~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                         ++...... .........   .-...   ........+.+++.+|++.||++|||+.|+++
T Consensus       229 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         229 PDEETLSRIGS-PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             CCHHHHHhhhh-hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence               00000000 000000000   00000   00012346778888999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.4e-34  Score=295.37  Aligned_cols=249  Identities=24%  Similarity=0.334  Sum_probs=202.5

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ...|....+||+|.|+.|.+|+...      ++..||+|.+.+...  ...+.+.+|+++|..++|||||+++.+.....
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~------t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~  128 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHIL------TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA  128 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecC------CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence            4568888999999999999999875      789999999987543  33456899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .+|+||||+.+|.+.+||....   .+.......++.|+.+|++|+|   ++.|+|||||++||||+.++++||+|||++
T Consensus       129 ~lylV~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS  202 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFS  202 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccc
Confidence            9999999999999999996543   4455777889999999999999   789999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ..+......      ...+|++.|.|||++.+..| .+++|+||+|++||-|++|..||++..-...             
T Consensus       203 ~~~~~~~~l------qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-------------  263 (596)
T KOG0586|consen  203 TFFDYGLML------QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-------------  263 (596)
T ss_pred             eeecccccc------cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------------
Confidence            988754332      26789999999999988776 5799999999999999999999985322210             


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                         -..++-.+++..+..  ..++-.++...+-++|.+|++++++.+-
T Consensus       264 ---r~rvl~gk~rIp~~m--s~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  264 ---RPRVLRGKYRIPFYM--SCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ---cchheeeeeccccee--echhHHHHHHhhccCccccCCHHHhhhh
Confidence               011222223333221  2233445557778999999999999873

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-33  Score=276.46  Aligned_cols=237  Identities=25%  Similarity=0.300  Sum_probs=192.4

Q ss_pred             eccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc---cchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 008374          249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK---SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       249 LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      ||+|+||.||+++...      +++.+++|.+......   ....+..|+.++++++|+||+++++.+...+..++||||
T Consensus         1 lg~G~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   74 (250)
T cd05123           1 LGKGSFGKVLLVRKKD------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEY   74 (250)
T ss_pred             CCCCCceEEEEEEECC------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEec
Confidence            6999999999999864      5789999998765332   345788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccc
Q 008374          326 MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN  405 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~  405 (568)
                      +++++|.+++...   ..+++.....++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++........
T Consensus        75 ~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~  148 (250)
T cd05123          75 APGGELFSHLSKE---GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS  148 (250)
T ss_pred             CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC
Confidence            9999999999543   36899999999999999999999   57999999999999999999999999999987654321


Q ss_pred             cccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhh
Q 008374          406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVD  485 (568)
Q Consensus       406 ~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  485 (568)
                      .     .....++..|+|||...+...+.++|+||||+++||+++|+.||.......    +...            +..
T Consensus       149 ~-----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~----~~~~------------~~~  207 (250)
T cd05123         149 R-----TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE----IYEK------------ILK  207 (250)
T ss_pred             c-----ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHH------------Hhc
Confidence            1     124568899999999988888999999999999999999999997443211    1111            111


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 008374          486 QRLNINSVVDEAKRLLLLGLACSHPIASERPKTED  520 (568)
Q Consensus       486 ~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~e  520 (568)
                      ..+  ..+......+.+++..|+..||++||++.+
T Consensus       208 ~~~--~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         208 DPL--RFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCC--CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            111  111222456677888999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.5e-33  Score=288.66  Aligned_cols=264  Identities=20%  Similarity=0.271  Sum_probs=193.3

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeC----
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK----  316 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~----  316 (568)
                      .+|...+.||.|+||.||+|+...      ++..||+|.+........+.+.+|++++++++||||+++++.+...    
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~------~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSD------CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECC------CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence            568889999999999999998875      6789999998776555667789999999999999999999766543    


Q ss_pred             ----------CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc-C
Q 008374          317 ----------GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD-A  385 (568)
Q Consensus       317 ----------~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld-~  385 (568)
                                ...++||||++ ++|.+++..    ..+++.....++.|++.||.|||   +.+++||||||+||+++ +
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~  150 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTE  150 (342)
T ss_pred             ccccccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCC
Confidence                      35799999997 589888732    35889999999999999999999   67999999999999997 4


Q ss_pred             CCcEEEeecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccch
Q 008374          386 DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHA  464 (568)
Q Consensus       386 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~  464 (568)
                      ++.+||+|||+++..........  ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||.......  
T Consensus       151 ~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--  226 (342)
T cd07854         151 DLVLKIGDFGLARIVDPHYSHKG--YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE--  226 (342)
T ss_pred             CceEEECCcccceecCCcccccc--ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence            56789999999987643211110  0113457889999998654 567889999999999999999999997443221  


Q ss_pred             hhHHHHHHHHhh-----cCchhhhhhhhc-----CCCC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          465 YTLVDWVWMLHR-----EGHIQDAVDQRL-----NINS-----VVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       465 ~~l~~~~~~~~~-----~~~~~~~~d~~l-----~~~~-----~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       ...........     ............     ....     .......+.+++..|++.||.+|||+.|+++
T Consensus       227 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         227 -QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             -HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence             11110000000     000000000000     0000     0112345678888999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-34  Score=270.77  Aligned_cols=247  Identities=24%  Similarity=0.355  Sum_probs=192.5

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCC-CCceeeEEEEEEeCCeEEEEE
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLR-HKHLVHLVGWCHEKGKLLLVY  323 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~  323 (568)
                      ...||.|..|.|++++.+.      ++..+|||.+.+... ++.+.++..+.++..-+ +|.||+.+|+|..+...++.|
T Consensus        97 l~dlGsGtcG~V~k~~~rs------~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRS------TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             HHhhcCCCccceEEEEEcc------cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            4569999999999999986      688999999987643 45567788888776664 899999999999999999999


Q ss_pred             EecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccc
Q 008374          324 DFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE  403 (568)
Q Consensus       324 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~  403 (568)
                      |.| ...++++|...  ..+++....-++...+.+||.||.+  ..+|+|||+||+|||+|+.|++||+|||++-.+...
T Consensus       171 elM-s~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  171 ELM-STCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHH-HHHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc
Confidence            998 45677777543  3457777778889999999999997  569999999999999999999999999999877654


Q ss_pred             cccccccccccCCcCCcccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          404 RNSYAEHGLVGVPGTMGYVAPECFH---TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       404 ~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      ...      +..+|-+.|||||-+.   ...|..++||||||+.|+||+||+.||..-..+-   ....-+         
T Consensus       246 kAh------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF---e~ltkv---------  307 (391)
T KOG0983|consen  246 KAH------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF---EVLTKV---------  307 (391)
T ss_pred             ccc------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH---HHHHHH---------
Confidence            332      2457889999999885   3568889999999999999999999998532221   111111         


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .+-.-+.+...  ..-...+.++...|+++|+.+||...++++
T Consensus       308 ln~ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  308 LNEEPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             HhcCCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            11011222221  113456777888999999999999999975

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.8e-34  Score=315.14  Aligned_cols=260  Identities=26%  Similarity=0.394  Sum_probs=190.5

Q ss_pred             HHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       237 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      .....+|++.+.||+||||.|||++.+-      +|+.+|||++... +........+|+.++++|+|||||+++..+.+
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKl------DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVE  548 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKL------DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVE  548 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecc------cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhc
Confidence            4456789999999999999999999875      8999999999765 33445678899999999999999999753210


Q ss_pred             C-------------------------------------------------------------------------------
Q 008374          316 K-------------------------------------------------------------------------------  316 (568)
Q Consensus       316 ~-------------------------------------------------------------------------------  316 (568)
                      .                                                                               
T Consensus       549 s~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~  628 (1351)
T KOG1035|consen  549 STAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGR  628 (1351)
T ss_pred             cCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccc
Confidence            0                                                                               


Q ss_pred             ----------------------------------------CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHH
Q 008374          317 ----------------------------------------GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGV  356 (568)
Q Consensus       317 ----------------------------------------~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~i  356 (568)
                                                              -.+||-||||+..+|.+++..+....  .-...++++++|
T Consensus       629 ~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreI  706 (1351)
T KOG1035|consen  629 NLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREI  706 (1351)
T ss_pred             ccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHH
Confidence                                                    01577788888877777775432111  356678899999


Q ss_pred             HHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccc----c---c------cccccccccccCCcCCcccC
Q 008374          357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE----N---E------RNSYAEHGLVGVPGTMGYVA  423 (568)
Q Consensus       357 a~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~----~---~------~~~~~~~~~~~~~Gt~~y~A  423 (568)
                      +.||+|+|   ++++|||||||.||+||++..+||+|||+|....    .   .      .........+..+||.-|+|
T Consensus       707 lEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA  783 (1351)
T KOG1035|consen  707 LEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA  783 (1351)
T ss_pred             HHHHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence            99999999   7899999999999999999999999999998721    0   0      00011112347789999999


Q ss_pred             ccccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHH
Q 008374          424 PECFHTG---KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRL  500 (568)
Q Consensus       424 PE~~~~~---~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  500 (568)
                      ||++...   +|+.|+|+||+||+++||+.   ||...-+..   ..+.    ..+.+.+..-      ..+..+++..-
T Consensus       784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa---~iL~----~LR~g~iP~~------~~f~~~~~~~e  847 (1351)
T KOG1035|consen  784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA---SILT----NLRKGSIPEP------ADFFDPEHPEE  847 (1351)
T ss_pred             HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHH---HHHH----hcccCCCCCC------cccccccchHH
Confidence            9999754   59999999999999999995   565321111   1111    1112221111      12234455555


Q ss_pred             HHHHHhcCCCCCCCCCCHHHHHH
Q 008374          501 LLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       501 ~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .+++.+++++||.+|||+.|++.
T Consensus       848 ~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  848 ASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHHHhcCCCccCCCHHHHhh
Confidence            67777999999999999999863

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-34  Score=286.00  Aligned_cols=202  Identities=29%  Similarity=0.412  Sum_probs=179.1

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      +.|..-++||+||||.||-++.+.      +|+.+|.|++.+..   .++....+.|-.+|.+++.+.||.+--.++.++
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvra------TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd  258 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRA------TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD  258 (591)
T ss_pred             cceeeeEEEecccccceeEEEEec------chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence            457888899999999999998876      78899999886543   234456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .++||+..|.+|+|.-+|+.... ..++.....-++.+|+.||++||   ..+||.||+||+|||||+.|+++|+|.|||
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLA  334 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLA  334 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceE
Confidence            99999999999999999976543 57899999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMI  458 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~  458 (568)
                      ..+......      +..+||.+|||||++.+..|+...|.||+||++|||+.|+.||...
T Consensus       335 vei~~g~~~------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~  389 (591)
T KOG0986|consen  335 VEIPEGKPI------RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR  389 (591)
T ss_pred             EecCCCCcc------ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence            988765432      1458999999999999999999999999999999999999999743

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-33  Score=292.00  Aligned_cols=264  Identities=19%  Similarity=0.287  Sum_probs=197.0

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      ...++|...+.||+|+||.||+|+...      ++..||+|++...  .....+.+.+|+.++++++||||+++++++..
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTK------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTP   85 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECC------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence            346678899999999999999999875      5788999998653  22234567889999999999999999988766


Q ss_pred             CCe------EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcE
Q 008374          316 KGK------LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA  389 (568)
Q Consensus       316 ~~~------~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~  389 (568)
                      .+.      .++|+||+ +++|.+++..    ..+++..+..++.|++.||.|||   +.+++||||||+||++++++.+
T Consensus        86 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~  157 (343)
T cd07851          86 ASSLEDFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCEL  157 (343)
T ss_pred             cccccccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCE
Confidence            554      89999999 6799998843    46899999999999999999999   6799999999999999999999


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHH
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV  468 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~  468 (568)
                      ||+|||++.......        ....++..|+|||.+.. ..++.++||||||++++||++|+.||...........+.
T Consensus       158 kL~dfg~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~  229 (343)
T cd07851         158 KILDFGLARHTDDEM--------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIM  229 (343)
T ss_pred             EEccccccccccccc--------cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            999999998764331        13467889999999865 467889999999999999999999987433221110111


Q ss_pred             HH-------HHHHhhcCchhhhhhhhc---CCCC---cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          469 DW-------VWMLHREGHIQDAVDQRL---NINS---VVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       469 ~~-------~~~~~~~~~~~~~~d~~l---~~~~---~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      +.       .+...........+....   ...+   .......+.+++..|++.+|++|||+.+|++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         230 NLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            10       000000000000000000   0000   0112456788999999999999999999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=269.79  Aligned_cols=270  Identities=21%  Similarity=0.333  Sum_probs=205.3

Q ss_pred             cCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeE
Q 008374          231 FKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHL  309 (568)
Q Consensus       231 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l  309 (568)
                      -+++++.+.|+     +.||+|+|+.|--++...      ++.++|||++.+.....+....+|++++.+. .|+||++|
T Consensus        73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~------t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqL  141 (463)
T KOG0607|consen   73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQ------TGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQL  141 (463)
T ss_pred             chHHHHHHhHH-----HHhcCccceeeeeeeeec------cchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHH
Confidence            34677777774     469999999999887764      7899999999988777788899999999998 59999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc-
Q 008374          310 VGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN-  388 (568)
Q Consensus       310 ~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~-  388 (568)
                      +.||+++...|||||-|.+|+|..++.+   +..++..+..++.++||.||.|||   .++|.|||+||+|||-..... 
T Consensus       142 iefFEdd~~FYLVfEKm~GGplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~v  215 (463)
T KOG0607|consen  142 IEFFEDDTRFYLVFEKMRGGPLLSHIQK---RKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKV  215 (463)
T ss_pred             HHHhcccceEEEEEecccCchHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCc
Confidence            9999999999999999999999999954   457899999999999999999999   789999999999999966543 


Q ss_pred             --EEEeecCCccccc--cccccccccccccCCcCCcccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 008374          389 --ARLGDFGLARAIE--NERNSYAEHGLVGVPGTMGYVAPECFH-----TGKATPESDVFGFGAVVLEVVCGRSPGNMIP  459 (568)
Q Consensus       389 --~kL~DFGla~~~~--~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~t~~sDV~SfGvll~el~tG~~P~~~~~  459 (568)
                        +||+||.|+.-+.  ++-....+....+.+|+..|||||+..     ...|..+.|.||+||+||-|++|..||.+..
T Consensus       216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C  295 (463)
T KOG0607|consen  216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC  295 (463)
T ss_pred             CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence              7999999886542  333344555566889999999999763     3567889999999999999999999997554


Q ss_pred             cccchhhHHHHHHHHhhcCchhhhhhhhcCCCC-------cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          460 HQQHAYTLVDWVWMLHREGHIQDAVDQRLNINS-------VVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       460 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~-------~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ...-.++--+ +.. .....+.+-+.+.. .++       ..+++.+++..++   ..++.+|.++.++++
T Consensus       296 g~dCGWdrGe-~Cr-~CQ~~LFesIQEGk-YeFPdkdWahIS~eakdlisnLl---vrda~~rlsa~~vln  360 (463)
T KOG0607|consen  296 GADCGWDRGE-VCR-VCQNKLFESIQEGK-YEFPDKDWAHISSEAKDLISNLL---VRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCcCCccCCC-ccH-HHHHHHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHH---hccHHhhhhhhhccC
Confidence            4321110000 000 00011112121111 122       2345555555444   599999999999876

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.2e-32  Score=306.89  Aligned_cols=147  Identities=25%  Similarity=0.383  Sum_probs=130.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...++||+|+||.||+|....      .++.||||++.....   .....+..|+.++..++||||+++++++...+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   77 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKN------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN   77 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECC------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence            578889999999999999999875      678999999875432   23467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..+|||||+++++|.+++..   ...+++...+.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls  151 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLS  151 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCC
Confidence            99999999999999999953   235788899999999999999999   569999999999999999999999999998


Q ss_pred             cc
Q 008374          398 RA  399 (568)
Q Consensus       398 ~~  399 (568)
                      +.
T Consensus       152 ~~  153 (669)
T cd05610         152 KV  153 (669)
T ss_pred             cc
Confidence            63

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.1e-32  Score=271.32  Aligned_cols=221  Identities=19%  Similarity=0.182  Sum_probs=176.0

Q ss_pred             CCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEecCCCCh
Q 008374          252 GGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSL  331 (568)
Q Consensus       252 G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  331 (568)
                      |.||.||+++...      +++.+|+|++....     .+..|...+....||||+++++++...+..++||||+++|+|
T Consensus         4 g~~~~v~~~~~~~------~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   72 (237)
T cd05576           4 GVIDKVLLVMDTR------TQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL   72 (237)
T ss_pred             cccceEEEEEEcc------CCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCH
Confidence            8899999999875      67899999997643     234455556666799999999999999999999999999999


Q ss_pred             hhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccccccccc
Q 008374          332 EKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG  411 (568)
Q Consensus       332 ~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~  411 (568)
                      .+++..   ...+++.....++.|++.||.|||   +++++||||||+||+++.++.++++|||++........      
T Consensus        73 ~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~------  140 (237)
T cd05576          73 WSHISK---FLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD------  140 (237)
T ss_pred             HHHHHH---hcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccccc------
Confidence            999854   235899999999999999999999   67999999999999999999999999998876543211      


Q ss_pred             cccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCC
Q 008374          412 LVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNIN  491 (568)
Q Consensus       412 ~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  491 (568)
                        ...++..|+|||.+....++.++||||+|++++||++|+.|+........                  ....    ..
T Consensus       141 --~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------------~~~~----~~  196 (237)
T cd05576         141 --GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------------THTT----LN  196 (237)
T ss_pred             --cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------------cccc----cC
Confidence              33456789999999888899999999999999999999988653211100                  0000    00


Q ss_pred             CcHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 008374          492 SVVDEAKRLLLLGLACSHPIASERPKTE  519 (568)
Q Consensus       492 ~~~~~~~~l~~l~l~Cl~~dp~~RPt~~  519 (568)
                      .+......+.+++.+|++.||++||++.
T Consensus       197 ~~~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         197 IPEWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             CcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence            1111234566778899999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.8e-32  Score=298.10  Aligned_cols=268  Identities=18%  Similarity=0.228  Sum_probs=169.5

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEE------
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGW------  312 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~------  312 (568)
                      ..++|...++||+|+||.||+|++..+..  ..+..||||++.....  .+.+..|  .+.+..+.++..++..      
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~--~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS--KKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCcc--ccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            56789999999999999999999875211  1278999999864321  1111111  1122222222222111      


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhccCCCc-----------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 008374          313 CHEKGKLLLVYDFMPNGSLEKYLYGTSEQ-----------------VTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD  375 (568)
Q Consensus       313 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  375 (568)
                      +......+|||||+++++|.+++......                 .......+..++.|++.||.|||   +++|+|||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRD  280 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRD  280 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCc
Confidence            34567899999999999999988643210                 01122345678999999999999   67999999


Q ss_pred             CCCCCEEEcC-CCcEEEeecCCccccccccccccccccccCCcCCcccCccccccC----------------------CC
Q 008374          376 LKASNILLDA-DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG----------------------KA  432 (568)
Q Consensus       376 ikp~NILld~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~----------------------~~  432 (568)
                      |||+|||+++ ++.+||+|||+|+.+........    ....||+.|||||.+...                      .+
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~----~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~  356 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP----KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL  356 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCC----cccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence            9999999986 58999999999987654322211    246789999999965322                      23


Q ss_pred             CccchhHHHHHHHHHHHhCCCCCCCCCcc------cchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHh
Q 008374          433 TPESDVFGFGAVVLEVVCGRSPGNMIPHQ------QHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLA  506 (568)
Q Consensus       433 t~~sDV~SfGvll~el~tG~~P~~~~~~~------~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~  506 (568)
                      ..++|||||||+||||+++..|.+.....      .....+..|.......  ...-+...+  +..........+|+..
T Consensus       357 ~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~--~~~d~~~~~~~dLi~~  432 (566)
T PLN03225        357 PDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR--ASPDLRRGF--EVLDLDGGAGWELLKS  432 (566)
T ss_pred             CCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc--cchhhhhhh--hhccccchHHHHHHHH
Confidence            44679999999999999987764421000      0001122221111000  000000000  0000112234468889


Q ss_pred             cCCCCCCCCCCHHHHHH
Q 008374          507 CSHPIASERPKTEDILQ  523 (568)
Q Consensus       507 Cl~~dp~~RPt~~evl~  523 (568)
                      |++.||++|||++|+++
T Consensus       433 mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        433 MMRFKGRQRISAKAALA  449 (566)
T ss_pred             HccCCcccCCCHHHHhC
Confidence            99999999999999986

>PF00139 Lectin_legB: Legume lectin domain; InterPro: IPR001220 Legume lectins are one of the largest lectin families with more than 70 lectins reported

Probab=100.00  E-value=1.7e-33  Score=275.77  Aligned_cols=157  Identities=43%  Similarity=0.719  Sum_probs=136.3

Q ss_pred             CCCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC--CCCCCCeeeEecCCccccccccC
Q 008374            8 AWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG--FDPDDNHLGLNINSVVSRKNVPL   85 (568)
Q Consensus         8 ~~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~--~d~~~~hvgidins~~s~~~~~~   85 (568)
                      ....+||||||||+|....+. ++.|++||+++.++++...++.|||||||++|.  .||++||||||+|++.|..+.++
T Consensus        76 ~~~~~~dGlAFvi~~~~~~~~-~~~g~~lG~~~~~~~~~~~~~~vAVEFDT~~N~~~~d~~~nHIgI~~n~~~s~~~~~~  154 (236)
T PF00139_consen   76 SSNNGGDGLAFVIQPDPNLPG-GSSGGYLGLFNSSTDGNGINNSVAVEFDTYKNPEYNDPDDNHIGIDVNSVVSNKTASA  154 (236)
T ss_dssp             SSSS-BEEEEEEEEETTSSTT-TSSGGGTTTSSSSSTTGGGGCEEEEEEETSTCGGGTTTSSSEEEEEESSSSESEEEE-
T ss_pred             CCccCCCceEEEEecCccccc-CCCCCccCccccccCCCccCcEEEEEEeeeecccccccCCCEEEEECCCCcccccccc
Confidence            446789999999999875544 489999999998877777899999999999987  69999999999999999988665


Q ss_pred             CC--CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCcccccccccc
Q 008374           86 KD--NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRS  163 (568)
Q Consensus        86 ~~--~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~~~i~s  163 (568)
                      ..  ....+|.+|+.++|||+||+.+++|+|+++... .+|..|+++..+||+.++++++||||||+||. ..+.|.|++
T Consensus       155 ~~~~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~~l~~~vdL~~~l~~~v~vGFsasTG~-~~~~h~I~s  232 (236)
T PF00139_consen  155 GYYSSPSFSLSDGKWHTVWIDYDASTKRLSVYLDDNS-SKPSSPVLSVNVDLSAVLPEQVYVGFSASTGG-SYQTHDILS  232 (236)
T ss_dssp             ---EEEEHHHGTTSEEEEEEEEETTTTEEEEEEEETT-TTSEEEEEEEE--HHHHSCSEEEEEEEEEESS-SSEEEEEEE
T ss_pred             cccccccccccCCcEEEEEEEEcCCccEEEEEEeccc-CCCcceeEEEEEchHHhcCCCcEEEEEeecCC-CcceEEEEE
Confidence            42  245688899999999999999999999999985 68999999999999999999999999999997 999999999


Q ss_pred             cccc
Q 008374          164 WTLD  167 (568)
Q Consensus       164 Ws~~  167 (568)
                      |+|+
T Consensus       233 W~F~  236 (236)
T PF00139_consen  233 WSFS  236 (236)
T ss_dssp             EEEE
T ss_pred             EEeC
Confidence            9985

Leguminous plant lectins resemble each other in their physicochemical properties although they differ in their carbohydrate specificities. They consist of two or four subunits with relative molecular mass of 30 kDa and each subunit has one carbohydrate-binding site. The interaction with sugars requires tightly bound calcium and manganese ions. The structural similarities of these lectins are reported by the primary structural analyses and X-ray crystallographic studies. X-ray studies have shown that the folding of the polypeptide chains in the region of the carbohydrate-binding sites is also similar, despite differences in the primary sequences. The carbohydrate-binding sites of these lectins consist of two conserved amino acids on beta pleated sheets. One of these loops contains transition metals, calcium and manganese, which keep the amino acid residues of the sugar-binding site at the required positions. Amino acid sequences of this loop play an important role in the carbohydrate-binding specificities of these lectins. These lectins bind either glucose/mannose or galactose. The exact function of legume lectins is not known but they may be involved in the attachment of nitrogen-fixing bacteria to legumes and in the protection against pathogens. Some legume lectins are proteolytically processed to produce two chains, beta (which corresponds to the N-terminal) and alpha (C-terminal) (IPR000985 from INTERPRO). The lectin concanavalin A (conA) from jack bean is exceptional in that the two chains are transposed and ligated (by formation of a new peptide bond). The N terminus of mature conA thus corresponds to that of the alpha chain and the C terminus to the beta chain.; GO: 0005488 binding; PDB: 1VLN_B 2GDF_C 2JE9_C 2JEC_C 1DGL_B 2P37_B 2CWM_A 2P34_D 2OW4_A 3IPV_B ....

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1e-32  Score=264.47  Aligned_cols=208  Identities=27%  Similarity=0.372  Sum_probs=170.7

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEe-CC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHE-KG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~  317 (568)
                      ..|+....||+|.||.||||+-+.....  ....+|+|+++....  .--....+|+.+++.++||||+.|..++.. +.
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~k--r~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDK--RTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcc--cchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            4577888999999999999976543211  245799999976422  122456799999999999999999998877 78


Q ss_pred             eEEEEEEecCCCChhhhhccC--CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC----CcEEE
Q 008374          318 KLLLVYDFMPNGSLEKYLYGT--SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD----FNARL  391 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~----~~~kL  391 (568)
                      .++|++||.+. +|...++-.  .....++......|+.||+.|+.|||   ++-|+||||||.|||+..+    |.+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence            99999999965 787777532  33457888999999999999999999   6789999999999999877    99999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGN  456 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~  456 (568)
                      +|||+||.+.+.-.+..+  ...++-|..|.|||++.+ ..||++.||||.||+..||+|-+.-|.
T Consensus       178 aDlGlaR~~~~plkpl~s--~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~  241 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLAS--LDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK  241 (438)
T ss_pred             ecccHHHHhhcccccccc--CCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence            999999998876554433  236678999999999876 578999999999999999999876665

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.98  E-value=7.4e-32  Score=263.57  Aligned_cols=238  Identities=27%  Similarity=0.364  Sum_probs=193.8

Q ss_pred             CceeEEEEEEccCccccccCeEEEEEEeccCCccc-chhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEecCCCCh
Q 008374          253 GFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSL  331 (568)
Q Consensus       253 ~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  331 (568)
                      +||.||+|+...      ++..+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|
T Consensus         1 ~~g~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   74 (244)
T smart00220        1 SFGKVYLARDKK------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDL   74 (244)
T ss_pred             CceEEEEEEECC------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence            589999999874      57899999997765544 67899999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccccccccc
Q 008374          332 EKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG  411 (568)
Q Consensus       332 ~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~  411 (568)
                      .+++....   .+++..+..++.+++.++.|||   ..+++|+||+|+||++++++.++|+|||++........      
T Consensus        75 ~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~------  142 (244)
T smart00220       75 FDLLKKRG---RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL------  142 (244)
T ss_pred             HHHHHhcc---CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeeccccc------
Confidence            99985432   3889999999999999999999   56999999999999999999999999999988765421      


Q ss_pred             cccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCC
Q 008374          412 LVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNIN  491 (568)
Q Consensus       412 ~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  491 (568)
                      .....++..|++||.+....++.++||||||++++||++|+.|+.......   .+.++..    .        ......
T Consensus       143 ~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~---~~~~~~~----~--------~~~~~~  207 (244)
T smart00220      143 LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL---ELFKKIG----K--------PKPPFP  207 (244)
T ss_pred             cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHh----c--------cCCCCc
Confidence            114568889999999988889999999999999999999999987532222   2222111    0        000000


Q ss_pred             CcHH-HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          492 SVVD-EAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       492 ~~~~-~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .... ....+.+++.+|+..+|.+||++.++++
T Consensus       208 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      208 PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            0000 4457788889999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=1.7e-34  Score=271.34  Aligned_cols=252  Identities=25%  Similarity=0.349  Sum_probs=192.6

Q ss_pred             ccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCeEEEE
Q 008374          245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGKLLLV  322 (568)
Q Consensus       245 ~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  322 (568)
                      ....||.|.||+|+|...+.      .++.+|||+++.... .+.++++.|.+...+- +.||||+++|.+..++..++-
T Consensus        68 dlg~iG~G~fG~V~KM~hk~------sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC  141 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKP------SGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC  141 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCc------cCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence            35579999999999998875      789999999986543 5667888898776555 799999999999999999999


Q ss_pred             EEecCCCChhhhhcc--CCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          323 YDFMPNGSLEKYLYG--TSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      ||.| .-||+.+...  ..++..++....-.|......||.||.+  ...|+|||+||+|||||..|.+||+|||++-.+
T Consensus       142 MELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  142 MELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             HHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence            9999 5677766432  1234467777777888889999999997  468999999999999999999999999999877


Q ss_pred             ccccccccccccccCCcCCcccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHT--GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ...-..      +..+|-..|||||-+..  ..|.-+|||||+|++|+|+.||+.|+....      ++.+.+.+... |
T Consensus       219 v~SiAk------T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~------svfeql~~Vv~-g  285 (361)
T KOG1006|consen  219 VDSIAK------TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD------SVFEQLCQVVI-G  285 (361)
T ss_pred             HHHHHh------hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH------HHHHHHHHHHc-C
Confidence            654221      24568889999998853  358899999999999999999999987322      12222222111 1


Q ss_pred             chhhhhhhhcC-CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          479 HIQDAVDQRLN-INSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       479 ~~~~~~d~~l~-~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .-     +.+. .....+....+..++-.|+.+|...||...++.+
T Consensus       286 dp-----p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  286 DP-----PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             CC-----CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            10     1111 1111234456677777899999999999999865

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=5.7e-33  Score=267.27  Aligned_cols=204  Identities=27%  Similarity=0.375  Sum_probs=176.1

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccch---hhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|...++||+|.||+|-+++-+.      +++.+|+|+++++-.-..+   .-+.|-++|...+||.+..|.-.++..
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKa------t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~  240 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKA------TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ  240 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecc------cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence            4678889999999999999998775      7899999999886443333   346789999999999999999899999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +++|+||||..+|.|.-+|..   ...++.....-.-..|+.||.|||   +++||.||||.+|.|||.+|.+||.||||
T Consensus       241 drlCFVMeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGL  314 (516)
T KOG0690|consen  241 DRLCFVMEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGL  314 (516)
T ss_pred             ceEEEEEEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeeccc
Confidence            999999999999999999943   456777777778889999999999   78999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPH  460 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~  460 (568)
                      ++.--.....     ....+||+.|+|||++....|..++|.|.+||++|||+|||.||...+.
T Consensus       315 CKE~I~~g~t-----~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh  373 (516)
T KOG0690|consen  315 CKEEIKYGDT-----TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH  373 (516)
T ss_pred             chhcccccce-----eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch
Confidence            9854322111     2378999999999999999999999999999999999999999975433

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-32  Score=283.45  Aligned_cols=240  Identities=26%  Similarity=0.312  Sum_probs=191.2

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  318 (568)
                      ++.|.....+|.|+|+.|-++....      +++..+||++.+.    ..+-.+|+.++.+. +||||+++.+.+.+..+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~------t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~  390 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSP------TDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKE  390 (612)
T ss_pred             chhhccccccCCCCccceeeeeccc------cccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCce
Confidence            5677778889999999999998875      6788999999765    22344567666555 79999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE-cCCCcEEEeecCCc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL-DADFNARLGDFGLA  397 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl-d~~~~~kL~DFGla  397 (568)
                      .++|||++.++-|.+.+....   ... .++..|+.+|+.|+.|||   +++|+||||||+|||+ ++.++++|+|||.+
T Consensus       391 ~~~v~e~l~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a  463 (612)
T KOG0603|consen  391 IYLVMELLDGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFW  463 (612)
T ss_pred             eeeeehhccccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechh
Confidence            999999999988877774322   223 677789999999999999   6899999999999999 58899999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +.....        +...+-|..|.|||++....+++++|+||||++||||++|+.|+...+.+.   .+..    ....
T Consensus       464 ~~~~~~--------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~---ei~~----~i~~  528 (612)
T KOG0603|consen  464 SELERS--------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI---EIHT----RIQM  528 (612)
T ss_pred             hhCchh--------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH---HHHH----hhcC
Confidence            987665        114566889999999999999999999999999999999999998665542   1111    1111


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      +...         ....+.+..   |+.+|++.||.+||+|.++..
T Consensus       529 ~~~s---------~~vS~~AKd---Ll~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  529 PKFS---------ECVSDEAKD---LLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             Cccc---------cccCHHHHH---HHHHhccCChhhCcChhhhcc
Confidence            1111         222344444   455899999999999999975

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=2.3e-31  Score=285.43  Aligned_cols=211  Identities=21%  Similarity=0.339  Sum_probs=158.0

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCcc----------ccccCeEEEEEEeccCCcccchh--------------hHHH
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQ----------YHVDNTQIAVKKFSRDSIKSKGD--------------FLAE  294 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~----------~~~~~~~vavK~~~~~~~~~~~~--------------~~~E  294 (568)
                      ..++|...++||+|+||.||+|.+...+.          ....++.||||++........++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            36789999999999999999998643211          11245789999987544333333              3457


Q ss_pred             HHHhhcCCCCce-----eeEEEEEEe--------CCeEEEEEEecCCCChhhhhccCC---------------------C
Q 008374          295 LAIIHRLRHKHL-----VHLVGWCHE--------KGKLLLVYDFMPNGSLEKYLYGTS---------------------E  340 (568)
Q Consensus       295 ~~~l~~l~H~nI-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~L~~~~---------------------~  340 (568)
                      +.++.+++|.++     ++++++|..        ++..+|||||+++++|.++|+...                     .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777876654     677888753        357899999999999999986421                     1


Q ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCc
Q 008374          341 QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG  420 (568)
Q Consensus       341 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~  420 (568)
                      ...++|..+..++.|++.+|.|||   +++|+||||||+|||++.++.+||+|||+++..........    ....+|+.
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~----~~g~~tp~  375 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP----LYGMLDPR  375 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCc----cccCCCcc
Confidence            123578889999999999999999   67999999999999999999999999999976543321111    12235789


Q ss_pred             ccCccccccCCC----------------------CccchhHHHHHHHHHHHhCCC-CCC
Q 008374          421 YVAPECFHTGKA----------------------TPESDVFGFGAVVLEVVCGRS-PGN  456 (568)
Q Consensus       421 y~APE~~~~~~~----------------------t~~sDV~SfGvll~el~tG~~-P~~  456 (568)
                      |+|||.+.....                      ..+.||||+||+++||++|.. |+.
T Consensus       376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~  434 (507)
T PLN03224        376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA  434 (507)
T ss_pred             eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence            999998754321                      134799999999999999875 654

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-32  Score=299.46  Aligned_cols=212  Identities=25%  Similarity=0.323  Sum_probs=184.1

Q ss_pred             ccCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC---CcccchhhHHHHHHhhcCCCCce
Q 008374          230 EFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD---SIKSKGDFLAELAIIHRLRHKHL  306 (568)
Q Consensus       230 ~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nI  306 (568)
                      .-...+++...++|.+.+.||+|+||.|...+.+.      +++.+|+|++++-   ......-|..|-.+|..-+.+-|
T Consensus        64 v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~------t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wi  137 (1317)
T KOG0612|consen   64 VKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKS------TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWI  137 (1317)
T ss_pred             HHHHHHHhCCHHhhHHHHHhcccccceeEEEEeec------cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHH
Confidence            34556777778999999999999999999999886      6888999999873   23345668899999999899999


Q ss_pred             eeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC
Q 008374          307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD  386 (568)
Q Consensus       307 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~  386 (568)
                      ++++-.|++.+++|||||||+||+|-.++...   ..++.....-++..|.-||.-||   +.|+|||||||+|||||..
T Consensus       138 v~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~  211 (1317)
T KOG0612|consen  138 VQLHYAFQDERYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKS  211 (1317)
T ss_pred             HHHHHHhcCccceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEeccc
Confidence            99999999999999999999999999999432   26888888888999999999999   6799999999999999999


Q ss_pred             CcEEEeecCCccccccccccccccccccCCcCCcccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008374          387 FNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-----GKATPESDVFGFGAVVLEVVCGRSPGNM  457 (568)
Q Consensus       387 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~t~~sDV~SfGvll~el~tG~~P~~~  457 (568)
                      |.+||+|||-+-.+..+..-...    ..+|||-|++||++..     +.|.+.+|.||+||++|||+.|..||..
T Consensus       212 GHikLADFGsClkm~~dG~V~s~----~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  212 GHIKLADFGSCLKMDADGTVRSS----VAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             CcEeeccchhHHhcCCCCcEEec----cccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            99999999999887755332222    6789999999999852     6789999999999999999999999964

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3e-31  Score=284.29  Aligned_cols=262  Identities=22%  Similarity=0.318  Sum_probs=213.6

Q ss_pred             cCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeE
Q 008374          231 FKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHL  309 (568)
Q Consensus       231 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l  309 (568)
                      ..++.+...++-|++.+.||.|.+|.||+++..+      +++..|+|++... ....++...|.++++.+ .|||++.+
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~------~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~f   81 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVK------TGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATF   81 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeee------cCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceE
Confidence            4455556667889999999999999999999876      6778888887554 34566788899999888 69999999


Q ss_pred             EEEEEe-----CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc
Q 008374          310 VGWCHE-----KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD  384 (568)
Q Consensus       310 ~g~~~~-----~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld  384 (568)
                      +|++..     ++.++||||||.+||..++++... ...+.|..+..|+..++.||.+||   ...++|||||-.||||+
T Consensus        82 yg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT  157 (953)
T KOG0587|consen   82 YGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLT  157 (953)
T ss_pred             EEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEe
Confidence            999864     368999999999999999997755 668999999999999999999999   67999999999999999


Q ss_pred             CCCcEEEeecCCccccccccccccccccccCCcCCcccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 008374          385 ADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-----GKATPESDVFGFGAVVLEVVCGRSPGNMIP  459 (568)
Q Consensus       385 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~t~~sDV~SfGvll~el~tG~~P~~~~~  459 (568)
                      +++.+||.|||++..++.....     ..+..||+.|||||++..     ..|+.++|+||+|++..||.-|..|+..+-
T Consensus       158 ~e~~VKLvDFGvSaQldsT~gr-----RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH  232 (953)
T KOG0587|consen  158 ENAEVKLVDFGVSAQLDSTVGR-----RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH  232 (953)
T ss_pred             ccCcEEEeeeeeeeeeeccccc-----ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc
Confidence            9999999999999987764322     125689999999999864     346779999999999999999999987432


Q ss_pred             cccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          460 HQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       460 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .-..          +     +.-.-.+......+..-.+.+..++..|+..|-++||++.++++
T Consensus       233 Pmra----------L-----F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  233 PMRA----------L-----FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             hhhh----------h-----ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            1110          0     00111333344446677888999999999999999999998875

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=265.52  Aligned_cols=205  Identities=22%  Similarity=0.351  Sum_probs=173.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchh---hHHHHHHhhcC-CCCceeeEEEEEEeC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELAIIHRL-RHKHLVHLVGWCHEK  316 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l-~H~nIv~l~g~~~~~  316 (568)
                      .+|....+||+|+||+|.+|.-+.      +.+.+|||+++++..-+.++   -+.|-++|... +-|.++++..+++.-
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkg------tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm  422 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKG------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM  422 (683)
T ss_pred             cccceEEEeccCccceeeeecccC------cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence            468888999999999999998765      67889999998864433332   34577777666 568999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +.+|+||||+.+|+|--++.+   -..+......-++..||-||-+||   +++|+.||||..|||||.+|.+||+|||+
T Consensus       423 DRLyFVMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGm  496 (683)
T KOG0696|consen  423 DRLYFVMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGM  496 (683)
T ss_pred             hheeeEEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccc
Confidence            999999999999999888843   345677788889999999999999   78999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ  462 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~  462 (568)
                      ++.---+...     ..+.+||+.|+|||++...+|...+|.|||||+||||+.|+.||++.++.+
T Consensus       497 cKEni~~~~T-----TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e  557 (683)
T KOG0696|consen  497 CKENIFDGVT-----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE  557 (683)
T ss_pred             ccccccCCcc-----eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence            9854333221     237899999999999999999999999999999999999999999765554

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=272.40  Aligned_cols=197  Identities=28%  Similarity=0.420  Sum_probs=171.0

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEE
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVY  323 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  323 (568)
                      .+.||+|.||+||-|+.++      +|+.||||.+.+.  .......+.+|+.||.+++||.||.+...|+..+..++||
T Consensus       569 devLGSGQFG~VYgg~hRk------tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM  642 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRK------TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM  642 (888)
T ss_pred             HhhccCCcceeeecceecc------cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence            4679999999999999886      7999999999764  3345577899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC---CcEEEeecCCcccc
Q 008374          324 DFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD---FNARLGDFGLARAI  400 (568)
Q Consensus       324 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~---~~~kL~DFGla~~~  400 (568)
                      |-+ +|++.+.+-. .+...|+...-.-++.||+.||.|||   -++|+|+||||+||||...   -.+||+|||.||.+
T Consensus       643 EKl-~GDMLEMILS-sEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI  717 (888)
T KOG4236|consen  643 EKL-HGDMLEMILS-SEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARII  717 (888)
T ss_pred             hhh-cchHHHHHHH-hhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeec
Confidence            999 4555554433 34567888888889999999999999   6799999999999999654   46999999999998


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIP  459 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~  459 (568)
                      ....-  .    +.++||+.|+|||++....|...-|+||.||++|--++|..||+..+
T Consensus       718 gEksF--R----rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE  770 (888)
T KOG4236|consen  718 GEKSF--R----RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE  770 (888)
T ss_pred             chhhh--h----hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence            76432  2    27899999999999999999999999999999999999999998543

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=5.5e-31  Score=251.54  Aligned_cols=262  Identities=22%  Similarity=0.284  Sum_probs=194.6

Q ss_pred             HhcCcccc-ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeEEEEEEe-
Q 008374          239 ATNNFHES-MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHE-  315 (568)
Q Consensus       239 at~~f~~~-~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~-  315 (568)
                      .|++|.+. .+||-|-.|+|..+..+.      +++.+|+|++...     ....+|+++--+. .|||||.+++++.. 
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~------T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs  127 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKR------TQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENS  127 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEecc------chhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence            45666555 469999999999998875      7889999998542     3456788775554 69999999998753 


Q ss_pred             ---CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---CCcE
Q 008374          316 ---KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA---DFNA  389 (568)
Q Consensus       316 ---~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~---~~~~  389 (568)
                         ...+++|||.|++|.|...+.+.. ...++..+.-.|.+||+.|+.|||   +.+|+||||||+|+|...   +-.+
T Consensus       128 ~~~rkcLLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~l  203 (400)
T KOG0604|consen  128 YQGRKCLLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPL  203 (400)
T ss_pred             ccCceeeEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcce
Confidence               468899999999999999996543 456999999999999999999999   679999999999999964   4568


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~  469 (568)
                      ||+|||+|+......      ...+.+-|+.|.|||++...+|....|+||+||++|-|+||..||...-....    . 
T Consensus       204 KLtDfGFAK~t~~~~------~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai----s-  272 (400)
T KOG0604|consen  204 KLTDFGFAKETQEPG------DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----S-  272 (400)
T ss_pred             EecccccccccCCCc------cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC----C-
Confidence            999999999765422      12367889999999999999999999999999999999999999974322211    0 


Q ss_pred             HHHHHhhcCchhhhhhhhcCCCCc--HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HhCCCCCCC
Q 008374          470 WVWMLHREGHIQDAVDQRLNINSV--VDEAKRLLLLGLACSHPIASERPKTEDILQI--ISGTSTVPY  533 (568)
Q Consensus       470 ~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~--L~~~~~~p~  533 (568)
                             .|.-..+....+....+  ....+..-+++...+..+|.+|.|+.|++..  +.+..-+|.
T Consensus       273 -------pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~  333 (400)
T KOG0604|consen  273 -------PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQ  333 (400)
T ss_pred             -------hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCC
Confidence                   11111111111111100  1223333445556678999999999999862  344444443

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-31  Score=233.54  Aligned_cols=197  Identities=25%  Similarity=0.433  Sum_probs=168.4

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      +|...++||+|.||+||||+...      +.+.||+|+++.+.  ..-....++|+-+++.++|+|||++++....++.+
T Consensus         3 ~ydkmekigegtygtvfkarn~~------t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkl   76 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRE------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL   76 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCC------ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence            35556789999999999998875      68899999987543  23345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      -||+||| ..+|.+|...  -++.++......++.|+.+||.|.|   +..+.|||+||.|.|++.+|++|++|||+++.
T Consensus        77 tlvfe~c-dqdlkkyfds--lng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglara  150 (292)
T KOG0662|consen   77 TLVFEFC-DQDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARA  150 (292)
T ss_pred             EEeHHHh-hHHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhh
Confidence            9999999 4588888743  3457888999999999999999999   77999999999999999999999999999998


Q ss_pred             cccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPG  455 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~  455 (568)
                      +.-....+.     ..+-|..|.+|+++.+. -|++..|+||.||++.|+....+|.
T Consensus       151 fgipvrcys-----aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl  202 (292)
T KOG0662|consen  151 FGIPVRCYS-----AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_pred             cCCceEeee-----ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence            876655544     34568999999998764 5889999999999999999855553

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-31  Score=262.44  Aligned_cols=257  Identities=25%  Similarity=0.371  Sum_probs=192.9

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEec--cCCcccc-----hhhHHHHHHhhcCCCCceeeEEEEEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS--RDSIKSK-----GDFLAELAIIHRLRHKHLVHLVGWCH  314 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~--~~~~~~~-----~~~~~E~~~l~~l~H~nIv~l~g~~~  314 (568)
                      +|-..++||+|||+.||||....      ..+.||||+-.  +....+.     +...+|..|-+.|.||.||++++++.
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~------EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs  537 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLT------EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS  537 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccc------hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence            45666789999999999998864      67889999853  3222222     23568999999999999999999987


Q ss_pred             e-CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---CCcEE
Q 008374          315 E-KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA---DFNAR  390 (568)
Q Consensus       315 ~-~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~---~~~~k  390 (568)
                      - ...+|-|.|||++.+|+-||.   ....++..+...|+.||+.||.||.+. +.+|||-||||.||||..   .|.+|
T Consensus       538 lDtdsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  538 LDTDSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             eccccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence            4 467899999999999999995   345789999999999999999999876 889999999999999954   47899


Q ss_pred             EeecCCcccccccccccc-c-cccccCCcCCcccCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCcccch
Q 008374          391 LGDFGLARAIENERNSYA-E-HGLVGVPGTMGYVAPECFHTG----KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHA  464 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~-~-~~~~~~~Gt~~y~APE~~~~~----~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~  464 (568)
                      |.||||++.++.+..... . .-....+||.+|++||++.-+    +.+.|+||||.||++|..+.|++||.....+.  
T Consensus       614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--  691 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--  691 (775)
T ss_pred             eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--
Confidence            999999999876543211 1 111256799999999988543    56889999999999999999999998544333  


Q ss_pred             hhHHHHHHHHhhcCchhhhhhhhcC-CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHH
Q 008374          465 YTLVDWVWMLHREGHIQDAVDQRLN-INSVVDEAKRLLLLGLACSHPIASERPKTEDI  521 (568)
Q Consensus       465 ~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~ev  521 (568)
                       .+++.       ..+..+-.-.+. ......++..   ++..|++.--++|....++
T Consensus       692 -dILqe-------NTIlkAtEVqFP~KPvVsseAka---FIRRCLaYRKeDR~DV~qL  738 (775)
T KOG1151|consen  692 -DILQE-------NTILKATEVQFPPKPVVSSEAKA---FIRRCLAYRKEDRIDVQQL  738 (775)
T ss_pred             -HHHhh-------hchhcceeccCCCCCccCHHHHH---HHHHHHHhhhhhhhhHHHH
Confidence             23321       122222111111 1122234444   4448999999999776655

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.8e-32  Score=253.65  Aligned_cols=264  Identities=27%  Similarity=0.410  Sum_probs=192.7

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeC----
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEK----  316 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~----  316 (568)
                      |....+||+|.||.||+|+.+.      +++.||+|++-.+.+  .--..-++|+++|..++|+|++.++..|...    
T Consensus        19 yek~~kigqGtfgeVFkAr~~n------~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKN------TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT   92 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcC------ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence            4455689999999999998875      677899988654322  2234568999999999999999999988643    


Q ss_pred             ----CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          317 ----GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       317 ----~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                          ..++|||++|+. +|.-+|..  ....++..++.++.+++..||.|+|   ...|+|||+||.|+||+.++.+||+
T Consensus        93 ~r~r~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             ccccceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEee
Confidence                358999999965 88888843  2356889999999999999999999   6799999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH--
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD--  469 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~--  469 (568)
                      |||++|.+....+... ...+..+-|..|.+||.+.+ ..|+++.|||..||++.||.||..-+....+++.. .++.  
T Consensus       167 DFGlar~fs~~~n~~k-prytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql-~~Is~L  244 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVK-PRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQL-HLISQL  244 (376)
T ss_pred             ccccccceecccccCC-CCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHH-HHHHHH
Confidence            9999998765543321 22334556999999998876 57899999999999999999998777654444311 1111  


Q ss_pred             ------HHHHHhhcCchhhhh-------------hhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          470 ------WVWMLHREGHIQDAV-------------DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       470 ------~~~~~~~~~~~~~~~-------------d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                            -+|.....-.+.+.+             ..+++.-.-.+++   +.|+..++..||.+||.+.+++.
T Consensus       245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a---~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEA---LDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhH---HHHHHHHhccCcccCcchHhhhc
Confidence                  122111111111111             1112111112233   44455677899999999999975

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-31  Score=282.75  Aligned_cols=247  Identities=24%  Similarity=0.394  Sum_probs=188.7

Q ss_pred             ccccceeccCCcee-EEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCeEE
Q 008374          243 FHESMRLGEGGFGI-VYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       243 f~~~~~LG~G~fG~-Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  320 (568)
                      |...+.+|.|.-|+ ||+|.+        +++.||||++-..   ...-..+|+..|+.- +|||||++++.-.++..+|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--------e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~Y  579 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--------EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLY  579 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--------CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEE
Confidence            55566799999885 999998        5789999998543   223456899998887 6999999999999999999


Q ss_pred             EEEEecCCCChhhhhccC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---C--CcEEEeec
Q 008374          321 LVYDFMPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA---D--FNARLGDF  394 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~---~--~~~kL~DF  394 (568)
                      +..|.| ..+|.+++... .+.....-...+.+..|+++||++||   +.+||||||||.||||+.   +  ..++|+||
T Consensus       580 IalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDf  655 (903)
T KOG1027|consen  580 IALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDF  655 (903)
T ss_pred             EEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccc
Confidence            999999 67999999663 11111111445678899999999999   579999999999999976   2  57899999


Q ss_pred             CCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCCCCcccchhhHHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCG-RSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG-~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      |+++.+..++.....  .....||-||+|||.+....-+.++||||+||++|..++| ..||+..-.++.  +++.    
T Consensus       656 glsKkl~~~~sS~~r--~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~----  727 (903)
T KOG1027|consen  656 GLSKKLAGGKSSFSR--LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILT----  727 (903)
T ss_pred             ccccccCCCcchhhc--ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhc----
Confidence            999999888766554  3478899999999999998888899999999999999996 889985433320  1111    


Q ss_pred             HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       474 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        ....+.       ......++  ...+|+-.|++++|..||++.+|+.
T Consensus       728 --~~~~L~-------~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  728 --GNYTLV-------HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             --Ccccee-------eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence              000000       00111111  4455666899999999999999974

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-30  Score=237.02  Aligned_cols=206  Identities=26%  Similarity=0.386  Sum_probs=171.2

Q ss_pred             HHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcC-CCCceeeEEEEEE
Q 008374          237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRL-RHKHLVHLVGWCH  314 (568)
Q Consensus       237 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~  314 (568)
                      ....+.......||+|++|.|=+.++..      +|...|+|++... ..+..++.+.|+.+..+- .+|.+|+++|...
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~------sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~  115 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQ------SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF  115 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeecc------CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence            3344555566789999999998888775      7899999999764 345567788899876655 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhccC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEee
Q 008374          315 EKGKLLLVYDFMPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD  393 (568)
Q Consensus       315 ~~~~~~lV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~D  393 (568)
                      .....++.||.| ..||+.+-.+- .....++....-+|+..+.+||.|||+  ...++|||+||+|||++.+|.+|++|
T Consensus       116 regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCD  192 (282)
T KOG0984|consen  116 REGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICD  192 (282)
T ss_pred             ccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcc
Confidence            999999999999 56888876432 334578888999999999999999997  57899999999999999999999999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCccccc----cCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH----TGKATPESDVFGFGAVVLEVVCGRSPGNM  457 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~----~~~~t~~sDV~SfGvll~el~tG~~P~~~  457 (568)
                      ||++-.+.+.....      ...|-..|||||.+.    ...|+-++||||+|+.+.||.+++.|++.
T Consensus       193 FGIsG~L~dSiAkt------~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  193 FGISGYLVDSIAKT------MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             cccceeehhhhHHH------HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            99998876543221      346778999999874    34789999999999999999999999873

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-30  Score=254.20  Aligned_cols=263  Identities=21%  Similarity=0.283  Sum_probs=201.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-C-C----ceeeEEEEE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-H-K----HLVHLVGWC  313 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~----nIv~l~g~~  313 (568)
                      +.+|....++|+|.||.|-++....      .+..||||+++... .-.+.-+-|++++.++. + |    -+|++.+|+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~------~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRE------TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecC------CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            6678888899999999999998775      57899999997542 23445677999999993 2 3    388999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc---------
Q 008374          314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD---------  384 (568)
Q Consensus       314 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld---------  384 (568)
                      .-.++.++|+|.| +-|+.++|..+. -.+++..++..|+.|++++++|||   +.+++|-||||+|||+-         
T Consensus       161 dyrghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~  235 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYN  235 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEec
Confidence            9999999999998 669999996543 346888999999999999999999   67999999999999982         


Q ss_pred             -----------CCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCC
Q 008374          385 -----------ADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRS  453 (568)
Q Consensus       385 -----------~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~  453 (568)
                                 ++..+||.|||-|+.-.....        .++.|..|.|||++.+-.++..+||||+||+|.|+.+|..
T Consensus       236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs--------~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~  307 (415)
T KOG0671|consen  236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHHS--------TIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET  307 (415)
T ss_pred             cCCccceeccCCCcceEEEecCCcceeccCcc--------eeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence                       134589999999987554432        5678999999999999999999999999999999999999


Q ss_pred             CCCCCCcccchhhHHHHH--------------HHHhhcCch-----------hhhhhhhc----CCCCcHHHHHHHHHHH
Q 008374          454 PGNMIPHQQHAYTLVDWV--------------WMLHREGHI-----------QDAVDQRL----NINSVVDEAKRLLLLG  504 (568)
Q Consensus       454 P~~~~~~~~~~~~l~~~~--------------~~~~~~~~~-----------~~~~d~~l----~~~~~~~~~~~l~~l~  504 (568)
                      -|...++.+.. .+.+-+              ......+++           ..+.+...    .......+...+++|+
T Consensus       308 LFqtHen~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl  386 (415)
T KOG0671|consen  308 LFQTHENLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL  386 (415)
T ss_pred             ecccCCcHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence            88865543311 111110              001111111           01111000    1122446777899999


Q ss_pred             HhcCCCCCCCCCCHHHHHH
Q 008374          505 LACSHPIASERPKTEDILQ  523 (568)
Q Consensus       505 l~Cl~~dp~~RPt~~evl~  523 (568)
                      ..++..||.+|+|++|+++
T Consensus       387 ~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  387 RRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHccCccccccHHHHhc
Confidence            9999999999999999975

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9.7e-30  Score=245.78  Aligned_cols=250  Identities=19%  Similarity=0.305  Sum_probs=192.1

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc---cchhhHHHHHHhhcC-CCCceeeEEEEEEeC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK---SKGDFLAELAIIHRL-RHKHLVHLVGWCHEK  316 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  316 (568)
                      .+|...++||+|+|.+|-.+.+++      +.+.+|+|+++++-..   ..+=...|-.+..+. +||.+|.|..+++..
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~------t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte  323 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKK------TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE  323 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcc------cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence            468889999999999999999886      6788999999875322   222245677777666 799999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      ..+++|.||+++|+|--++   .++..|+.+...-+...|.-||.|||   +++|+.||||..|||||.++.+||.|||+
T Consensus       324 srlffvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygm  397 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGM  397 (593)
T ss_pred             ceEEEEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccch
Confidence            9999999999999997776   44567999998889999999999999   78999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ++.--..... +    .+.+||+.|+|||++.+..|....|.|++||+++||+.|+.||+-...+....+-.++..+...
T Consensus       398 cke~l~~gd~-t----stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil  472 (593)
T KOG0695|consen  398 CKEGLGPGDT-T----STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL  472 (593)
T ss_pred             hhcCCCCCcc-c----ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh
Confidence            9864433221 1    2689999999999999999999999999999999999999999832222211233344333322


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK  517 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt  517 (568)
                              ...++.+.  ....+...+...-+++||.+|..
T Consensus       473 --------ekqiripr--slsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  473 --------EKQIRIPR--SLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             --------hhcccccc--eeehhhHHHHHHhhcCCcHHhcC
Confidence                    22222221  11122233444567888888753

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=8.3e-30  Score=263.40  Aligned_cols=229  Identities=24%  Similarity=0.372  Sum_probs=182.1

Q ss_pred             cCHHHHHHHh---cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc---cchhhHHHHHHhhcCCCC
Q 008374          231 FKYKELKKAT---NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK---SKGDFLAELAIIHRLRHK  304 (568)
Q Consensus       231 ~~~~el~~at---~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~  304 (568)
                      -.|--|+.|.   .-|-..+.||-|+||+|.+++-.+      +...+|+|.+.+.+.-   .......|-.||.....+
T Consensus       616 SnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvD------T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~  689 (1034)
T KOG0608|consen  616 SNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVD------TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNE  689 (1034)
T ss_pred             hhHHHHHHhhccccceEEEeeecccccceeEEEeecc------hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCc
Confidence            4455555553   347778889999999999987654      5678999999876443   233467899999999999


Q ss_pred             ceeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc
Q 008374          305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD  384 (568)
Q Consensus       305 nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld  384 (568)
                      -||+|+-.|++++.+|+||||+++|++-.+|.+   .+.+......-++..+..|+++.|   ..|+|||||||+|||||
T Consensus       690 WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILID  763 (1034)
T KOG0608|consen  690 WVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILID  763 (1034)
T ss_pred             ceEEEEEEeccCCceEEEEeccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEc
Confidence            999999999999999999999999999999843   345677777778889999999999   67999999999999999


Q ss_pred             CCCcEEEeecCCccccc--cccccc-----------------------------------cccccccCCcCCcccCcccc
Q 008374          385 ADFNARLGDFGLARAIE--NERNSY-----------------------------------AEHGLVGVPGTMGYVAPECF  427 (568)
Q Consensus       385 ~~~~~kL~DFGla~~~~--~~~~~~-----------------------------------~~~~~~~~~Gt~~y~APE~~  427 (568)
                      .+|.+||.||||+.-+.  ++...+                                   .+......+||..|+|||++
T Consensus       764 rdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl  843 (1034)
T KOG0608|consen  764 RDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVL  843 (1034)
T ss_pred             cCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHh
Confidence            99999999999986431  110000                                   00011245799999999999


Q ss_pred             ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          428 HTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       428 ~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      ....++..+|.||.||+|+||+.|+.||-.....+....+..|-
T Consensus       844 ~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~  887 (1034)
T KOG0608|consen  844 ARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWR  887 (1034)
T ss_pred             cccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehh
Confidence            99999999999999999999999999997544433334556663

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9.9e-31  Score=264.65  Aligned_cols=242  Identities=24%  Similarity=0.323  Sum_probs=193.2

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++.....||-||||.|=+.+.+.      ....+|+|.+++..   ..+.+....|-.+|...+.|.||+++-.+.+...
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~------~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky  494 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNS------QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY  494 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecc------cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence            34455679999999999998874      23358888887653   3344557789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .|+.||-|-+|.|...|.+   ...++.....-++..+.+|+.|||   +++||.|||||+|.|||.+|-+||.|||+|+
T Consensus       495 vYmLmEaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAK  568 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAK  568 (732)
T ss_pred             hhhhHHhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHH
Confidence            9999999999999999943   456777778888999999999999   7899999999999999999999999999999


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      .+..+....      +.+||+.|.|||++.+.....++|.||+|++++||++|+.||...+.-.. +++       ..+|
T Consensus       569 ki~~g~KTw------TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-Yn~-------ILkG  634 (732)
T KOG0614|consen  569 KIGSGRKTW------TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-YNL-------ILKG  634 (732)
T ss_pred             HhccCCcee------eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-HHH-------HHhh
Confidence            998776544      67999999999999999999999999999999999999999986433221 111       1111


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK  517 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt  517 (568)
                           +|.   ..++.........++...+..+|.+|..
T Consensus       635 -----id~---i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  635 -----IDK---IEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             -----hhh---hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence                 111   1122222333445555667889999987

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=4.7e-28  Score=230.51  Aligned_cols=211  Identities=30%  Similarity=0.523  Sum_probs=182.7

Q ss_pred             eccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-cchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 008374          249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMP  327 (568)
Q Consensus       249 LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  327 (568)
                      ||+|.+|.||++....      ++..+++|++...... ..+.+.+|++.+++++|++++++++++......++++||++
T Consensus         1 l~~g~~~~v~~~~~~~------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~   74 (215)
T cd00180           1 LGEGGFGTVYLARDKK------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCE   74 (215)
T ss_pred             CCcCCceEEEEEEecC------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCC
Confidence            6899999999999864      4789999999765432 34679999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-CCcEEEeecCCcccccccccc
Q 008374          328 NGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA-DFNARLGDFGLARAIENERNS  406 (568)
Q Consensus       328 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~-~~~~kL~DFGla~~~~~~~~~  406 (568)
                      +++|.+++....  ..+++..+..++.++++++.|||   +.+++|+||+|.||+++. ++.++|+|||.+.........
T Consensus        75 ~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~  149 (215)
T cd00180          75 GGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL  149 (215)
T ss_pred             CCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcch
Confidence            999999985432  36899999999999999999999   569999999999999999 899999999999876543210


Q ss_pred             ccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhh
Q 008374          407 YAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVD  485 (568)
Q Consensus       407 ~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  485 (568)
                           .....+...|++||..... .++.++|+|++|+++++|                                     
T Consensus       150 -----~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------  187 (215)
T cd00180         150 -----LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------  187 (215)
T ss_pred             -----hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------
Confidence                 1135578899999999877 888999999999999998                                     


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          486 QRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       486 ~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                                  ..+.+++..|++.+|.+||++.++++.
T Consensus       188 ------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                        466778889999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2e-30  Score=244.42  Aligned_cols=266  Identities=20%  Similarity=0.288  Sum_probs=196.8

Q ss_pred             cccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeC-----
Q 008374          244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK-----  316 (568)
Q Consensus       244 ~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----  316 (568)
                      +..+-||.|+||.||..+...      +++.||.|++...  +....+.+.+|+++|.-++|.|++..+++.+-.     
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPR------dgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfF  129 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPR------SGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFF  129 (449)
T ss_pred             CCCCcccccceeEEEeccCCC------CccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHH
Confidence            345679999999999998875      7899999998764  233457889999999999999999998887643     


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +++|+++|.| ..+|.+.+..   ...|+-....-++.||++||.|||   +.+|.||||||.|.|++.+-.+||+|||+
T Consensus       130 qEiYV~TELm-QSDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGL  202 (449)
T KOG0664|consen  130 QELYVLTELM-QSDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGL  202 (449)
T ss_pred             HHHHHHHHHH-Hhhhhheecc---CCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEeccccc
Confidence            3678899999 5588888843   346888888899999999999999   67999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH-----
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW-----  470 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~-----  470 (568)
                      ||..+.+.....+    ..+-|..|.|||++.+ ..|+.+.||||.||++.||+..+.-|.....-+....+.+.     
T Consensus       203 ARvee~d~~~hMT----qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs  278 (449)
T KOG0664|consen  203 ARTWDQRDRLNMT----HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPS  278 (449)
T ss_pred             ccccchhhhhhhH----HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCc
Confidence            9987765443333    4456889999999986 57899999999999999999988777643322211112221     


Q ss_pred             --HHHHhhcCchhhhhhhhcCCC---------CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          471 --VWMLHREGHIQDAVDQRLNIN---------SVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       471 --~~~~~~~~~~~~~~d~~l~~~---------~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                        ......+|.-..++....+..         .....-..-+.+.+.+++.||..|.+..+.++.+.
T Consensus       279 ~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  279 QEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence              111122333333333222111         01111122344555778999999999999987654

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=2e-27  Score=230.02  Aligned_cols=200  Identities=32%  Similarity=0.505  Sum_probs=172.5

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-cchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLL  321 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  321 (568)
                      |...+.||+|++|.||+++...      ++..+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   74 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYL   74 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEE
Confidence            4556789999999999999874      4788999999876554 56789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccc
Q 008374          322 VYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE  401 (568)
Q Consensus       322 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~  401 (568)
                      ++||+++++|.+++.....  .+++.....++.+++.++.|||   ..+++|+||+|+||+++.++.++|+|||++....
T Consensus        75 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~  149 (225)
T smart00221       75 VMEYCEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIH  149 (225)
T ss_pred             EEeccCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence            9999999999999854321  1889999999999999999999   5699999999999999999999999999998876


Q ss_pred             cccccccccccccCCcCCcccCcccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008374          402 NERNSYAEHGLVGVPGTMGYVAPECF-HTGKATPESDVFGFGAVVLEVVCGRSPGNM  457 (568)
Q Consensus       402 ~~~~~~~~~~~~~~~Gt~~y~APE~~-~~~~~t~~sDV~SfGvll~el~tG~~P~~~  457 (568)
                      ......    .....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       150 ~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      150 RDLAAL----LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             Cccccc----ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            543111    1144678899999998 667788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.2e-27  Score=245.93  Aligned_cols=196  Identities=23%  Similarity=0.379  Sum_probs=168.0

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc--------cchhhHHHHHHhhcCC---CCceeeEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK--------SKGDFLAELAIIHRLR---HKHLVHLV  310 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---H~nIv~l~  310 (568)
                      +|.....||+|+||.|+.++.+.      +...|+||.+.++..-        ..-..-.|+.||.+++   |+||++++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~------n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL  635 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKE------NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL  635 (772)
T ss_pred             cceeeeeccccccceEEEeeecc------cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence            57778899999999999999986      5778999998764221        1113557999999997   99999999


Q ss_pred             EEEEeCCeEEEEEEec-CCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcE
Q 008374          311 GWCHEKGKLLLVYDFM-PNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA  389 (568)
Q Consensus       311 g~~~~~~~~~lV~Ey~-~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~  389 (568)
                      ++|++++.+||+||-. ++-+|.+++.   ....++..+...|++||+.|+++||   +++|+|||||-+||.+|.+|-+
T Consensus       636 dfFEddd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~  709 (772)
T KOG1152|consen  636 DFFEDDDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFV  709 (772)
T ss_pred             heeecCCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeE
Confidence            9999999999999975 4568888883   3457899999999999999999999   8899999999999999999999


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCC
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKAT-PESDVFGFGAVVLEVVCGRSPGN  456 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t-~~sDV~SfGvll~el~tG~~P~~  456 (568)
                      ||+|||.|....++.-       ...+||..|.|||++.+.+|- ..-|||++|++||.++....||.
T Consensus       710 klidfgsaa~~ksgpf-------d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  710 KLIDFGSAAYTKSGPF-------DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEeeccchhhhcCCCc-------ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999987655432       267899999999999888875 45799999999999999888874

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=4.7e-27  Score=216.87  Aligned_cols=257  Identities=16%  Similarity=0.237  Sum_probs=189.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-CCceeeEEEEEEeC--
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-HKHLVHLVGWCHEK--  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~--  316 (568)
                      .++|+..+++|+|.|++||.|....      +.+.++||.++..   ..+...+|+.+|..|. ||||++|++...+.  
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~------~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINIT------NNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccC------CCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            4678888999999999999998664      6788999999753   3567889999999997 99999999998765  


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-CcEEEeecC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD-FNARLGDFG  395 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~-~~~kL~DFG  395 (568)
                      ....||+||..+.+...+.      ..|+...+...+.+++.||.|.|   ++||.|||+||.|+++|.. -.++|+|+|
T Consensus       108 ktpaLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWG  178 (338)
T KOG0668|consen  108 KTPSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWG  178 (338)
T ss_pred             cCchhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecc
Confidence            4678999999998877665      35777888889999999999999   7899999999999999965 679999999


Q ss_pred             CccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCC-CCCcccchhhHHHHHH-
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGN-MIPHQQHAYTLVDWVW-  472 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~-~~~~~~~~~~l~~~~~-  472 (568)
                      ||..+.....-.      ..+.+..|--||.+-. ..|...-|+|||||+|.+|+..+.||- +.++..   .++.-+. 
T Consensus       179 LAEFYHp~~eYn------VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D---QLVkIakV  249 (338)
T KOG0668|consen  179 LAEFYHPGKEYN------VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD---QLVKIAKV  249 (338)
T ss_pred             hHhhcCCCceee------eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH---HHHHHHHH
Confidence            999876654321      2234567888998865 557788999999999999999999986 333333   2332211 


Q ss_pred             -----------HH--hhcCchhhhhhhhcCC--------CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          473 -----------ML--HREGHIQDAVDQRLNI--------NSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       473 -----------~~--~~~~~~~~~~d~~l~~--------~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                                 ..  ....+...++....+.        +...-.....++++-..+..|.++|||++|.+.
T Consensus       250 LGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  250 LGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             hChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                       11  0111122222211111        000001133445555667899999999999864

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=8.7e-26  Score=228.52  Aligned_cols=132  Identities=23%  Similarity=0.371  Sum_probs=111.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-----C---CceeeEEEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-----H---KHLVHLVGW  312 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~nIv~l~g~  312 (568)
                      .+|...++||-|.|++||++....      ..+.||+|+.+.. ..-.+..+.||++|++++     |   ..||+|++.
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq------~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~  150 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQ------NKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH  150 (590)
T ss_pred             ceEEEEEeccccccceeEEEeecc------CCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence            568889999999999999998875      6889999998654 233456789999999983     3   369999999


Q ss_pred             EEeC----CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 008374          313 CHEK----GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL  383 (568)
Q Consensus       313 ~~~~----~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl  383 (568)
                      |...    .+++||+|++ +.+|..++..... ..++.....+|++||+.||.|||.+|  +|||-||||+||||
T Consensus       151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             ceecCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            9764    5899999999 7788888866443 45889999999999999999999854  99999999999998

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=8.2e-27  Score=267.84  Aligned_cols=199  Identities=17%  Similarity=0.229  Sum_probs=140.5

Q ss_pred             cCCC-CceeeEEEEE-------EeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 008374          300 RLRH-KHLVHLVGWC-------HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKV  371 (568)
Q Consensus       300 ~l~H-~nIv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  371 (568)
                      .++| +||++++++|       .+...+++++||+ .++|.++|...  ...+++.++..++.||++||.|||   +++|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAH---SQGI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            4566 6888899987       3334678889988 66999999642  345899999999999999999999   6899


Q ss_pred             EecCCCCCCEEEcC-------------------CCcEEEeecCCcccccccccc-----------ccccccccCCcCCcc
Q 008374          372 VHRDLKASNILLDA-------------------DFNARLGDFGLARAIENERNS-----------YAEHGLVGVPGTMGY  421 (568)
Q Consensus       372 vHrDikp~NILld~-------------------~~~~kL~DFGla~~~~~~~~~-----------~~~~~~~~~~Gt~~y  421 (568)
                      +||||||+||||+.                   ++.+|++|||+++........           ..........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   445666677766543210000           000001124589999


Q ss_pred             cCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHH
Q 008374          422 VAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLL  501 (568)
Q Consensus       422 ~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  501 (568)
                      ||||++.+..++.++|||||||+||||++|..|+....  .   .+......         .+.+.     .........
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~---~~~~~~~~---------~~~~~-----~~~~~~~~~  242 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--R---TMSSLRHR---------VLPPQ-----ILLNWPKEA  242 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--H---HHHHHHHh---------hcChh-----hhhcCHHHH
Confidence            99999999999999999999999999999988754211  0   11111000         01111     111223345


Q ss_pred             HHHHhcCCCCCCCCCCHHHHHH
Q 008374          502 LLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       502 ~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .++.+||+++|.+||+|.|+++
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhh
Confidence            6778999999999999999976

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=2.5e-26  Score=221.99  Aligned_cols=193  Identities=24%  Similarity=0.363  Sum_probs=159.5

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeC---
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK---  316 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~---  316 (568)
                      +|....-+|.|.- .|..+...      ..+++||+|++...  .....+...+|..++..++|+|+++++.++.-.   
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~------v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l   90 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQ------VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL   90 (369)
T ss_pred             eeeeecccCCCCc-eEEecchh------hccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence            3444556788877 56555543      36889999998654  334456778999999999999999999998643   


Q ss_pred             ---CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEee
Q 008374          317 ---GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD  393 (568)
Q Consensus       317 ---~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~D  393 (568)
                         .+.|+||||| ..+|...+.     ..++-.....|..|++.|+.|||   +.+|+||||||+||++..+..+||.|
T Consensus        91 ~~~~e~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~d  161 (369)
T KOG0665|consen   91 EEFQEVYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILD  161 (369)
T ss_pred             HHHHhHHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeecc
Confidence               4689999999 668888874     45777888899999999999999   67999999999999999999999999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGN  456 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~  456 (568)
                      ||+|+.-...      ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.
T Consensus       162 fg~ar~e~~~------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~  218 (369)
T KOG0665|consen  162 FGLARTEDTD------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP  218 (369)
T ss_pred             chhhcccCcc------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence            9999865443      11235678899999999999889999999999999999999998765

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=3.4e-27  Score=246.20  Aligned_cols=252  Identities=22%  Similarity=0.304  Sum_probs=200.6

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .++|....++|+|.||.|||++.+.      +++..|+|.++........-..+|+-+++..+||||+.++|.+.....+
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~------s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKR------SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccc------cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence            4568888899999999999999875      7889999999887666667778899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++.||||.+|+|.+.-+.   ...|+..++...++...+||+|||   +++-+|||||-.|||+.+.+.+|++|||.+-.
T Consensus        88 wicMEycgggslQdiy~~---TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaq  161 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQ  161 (829)
T ss_pred             EEEEEecCCCcccceeee---cccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhh
Confidence            999999999999998753   457899999999999999999999   78999999999999999999999999999876


Q ss_pred             cccccccccccccccCCcCCcccCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCC-CCCcccchhhHHHHHHHHh
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECF---HTGKATPESDVFGFGAVVLEVVCGRSPGN-MIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~---~~~~~t~~sDV~SfGvll~el~tG~~P~~-~~~~~~~~~~l~~~~~~~~  475 (568)
                      +..--..     .....||+.|||||+.   ..+.|..++|||+.|+...|+.--+.|.. ..+.+.         ..+.
T Consensus       162 itati~K-----rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~---------l~Lm  227 (829)
T KOG0576|consen  162 ITATIAK-----RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA---------LFLM  227 (829)
T ss_pred             hhhhhhh-----hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH---------HHHh
Confidence            6542211     1267899999999976   46789999999999999999988777643 222111         0011


Q ss_pred             hcCchhhhhh-hhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          476 REGHIQDAVD-QRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       476 ~~~~~~~~~d-~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .+.    ..+ ++++.  ...-.+.+-.++..|+..+|.+|||++.+++
T Consensus       228 TkS----~~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  228 TKS----GFQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             hcc----CCCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            110    011 11111  1233445667788899999999999987654

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=1.3e-26  Score=235.48  Aligned_cols=266  Identities=20%  Similarity=0.198  Sum_probs=201.0

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC------CCceeeEEEEE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR------HKHLVHLVGWC  313 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~nIv~l~g~~  313 (568)
                      -..|......|+|-|++|.+|....      .+..||||+|.+.. -..+.=+.|+++|++|+      --++++|+-.|
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~------r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F  503 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQA------RGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF  503 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccC------CCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence            3567777889999999999998875      56799999997653 33455678999999995      34799999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-CcEEEe
Q 008374          314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD-FNARLG  392 (568)
Q Consensus       314 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~-~~~kL~  392 (568)
                      ...+++|||||-+ ..+|.+.|..-.....|.......++.|+.-||..|.   ..+|+|.||||.|||+++. ..+|||
T Consensus       504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLC  579 (752)
T KOG0670|consen  504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLC  579 (752)
T ss_pred             hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeec
Confidence            9999999999977 6689999987666778899999999999999999999   4599999999999999887 457999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH--
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW--  470 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~--  470 (568)
                      |||.|.....+...       ...-...|.|||++.+..|...-|+||.||+||||.||+..|.+....+......+.  
T Consensus       580 DfGSA~~~~eneit-------PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG  652 (752)
T KOG0670|consen  580 DFGSASFASENEIT-------PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG  652 (752)
T ss_pred             cCcccccccccccc-------HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence            99999877554321       122345799999999999999999999999999999999888755443322111111  


Q ss_pred             --HHHHhhcCch-hhhhhhhcC--------------------------------C-----CCcHHHHHHHHHHHHhcCCC
Q 008374          471 --VWMLHREGHI-QDAVDQRLN--------------------------------I-----NSVVDEAKRLLLLGLACSHP  510 (568)
Q Consensus       471 --~~~~~~~~~~-~~~~d~~l~--------------------------------~-----~~~~~~~~~l~~l~l~Cl~~  510 (568)
                        ...+...|.+ .+-+|..++                                .     .........+..|+-.|+..
T Consensus       653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L  732 (752)
T KOG0670|consen  653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL  732 (752)
T ss_pred             CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence              0111112211 111222111                                0     11223455677788899999


Q ss_pred             CCCCCCCHHHHHH
Q 008374          511 IASERPKTEDILQ  523 (568)
Q Consensus       511 dp~~RPt~~evl~  523 (568)
                      ||++|.|..|+++
T Consensus       733 dP~KRit~nqAL~  745 (752)
T KOG0670|consen  733 DPEKRITVNQALK  745 (752)
T ss_pred             ChhhcCCHHHHhc
Confidence            9999999999875

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=3e-26  Score=229.17  Aligned_cols=272  Identities=23%  Similarity=0.317  Sum_probs=199.4

Q ss_pred             HHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeEEEEEE
Q 008374          236 LKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHLVGWCH  314 (568)
Q Consensus       236 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~  314 (568)
                      +....+.|...++||+|.|++||++++...   ......||+|.+...+  .......|+++|..+ .+.||+++.+++.
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~---~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQ---DTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhh---ccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhc
Confidence            344556788899999999999999998752   1256899999987643  455688999999999 5899999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-CcEEEee
Q 008374          315 EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD-FNARLGD  393 (568)
Q Consensus       315 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~-~~~kL~D  393 (568)
                      ..+...+|+||+++....+++.      .++..++...++.+..||.++|   .+|||||||||+|+|.+.. +.-.|.|
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvD  176 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVD  176 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEe
Confidence            9999999999999999999883      4678888899999999999999   7899999999999999755 6789999


Q ss_pred             cCCcccccccccc------------c--------------------cc-------cccccCCcCCcccCcccccc-CCCC
Q 008374          394 FGLARAIENERNS------------Y--------------------AE-------HGLVGVPGTMGYVAPECFHT-GKAT  433 (568)
Q Consensus       394 FGla~~~~~~~~~------------~--------------------~~-------~~~~~~~Gt~~y~APE~~~~-~~~t  433 (568)
                      ||||...+.....            .                    ..       ......+||+||.|||++.. ..-+
T Consensus       177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt  256 (418)
T KOG1167|consen  177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT  256 (418)
T ss_pred             chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence            9999833211100            0                    00       00013469999999999864 5678


Q ss_pred             ccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH---------HHhhcCc--hhh------hhhhh---------
Q 008374          434 PESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW---------MLHREGH--IQD------AVDQR---------  487 (568)
Q Consensus       434 ~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~---------~~~~~~~--~~~------~~d~~---------  487 (568)
                      ++.||||.||+++-+++++.||-...++..  .+.+.+.         .....|.  +.+      +.+.+         
T Consensus       257 taiDiws~GVI~Lslls~~~PFf~a~dd~~--al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~  334 (418)
T KOG1167|consen  257 TAIDIWSAGVILLSLLSRRYPFFKAKDDAD--ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIE  334 (418)
T ss_pred             CccceeeccceeehhhccccccccCccccc--hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChh
Confidence            999999999999999999999874443321  2222111         1111222  111      11100         


Q ss_pred             -cCC-CC--------cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          488 -LNI-NS--------VVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       488 -l~~-~~--------~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       +.. ..        ..-....++++.-+|+..||.+|.|+++.++
T Consensus       335 ~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  335 SIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             hcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence             000 00        0112235678888999999999999999985

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=6.1e-26  Score=214.38  Aligned_cols=254  Identities=24%  Similarity=0.363  Sum_probs=184.0

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeEEEE-EEeC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHLVGW-CHEK  316 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~-~~~~  316 (568)
                      ..+.|.+.+.||+|.||.+-++..+.      +.+.+++|.+.+.. ...++|.+|...--.| .|.||+.-++. ++..
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~------s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~   94 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQ------SKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS   94 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccC------CceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence            34678889999999999999998875      78899999987653 3567899998776566 58999877654 6667


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc-C-CCcEEEeec
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD-A-DFNARLGDF  394 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld-~-~~~~kL~DF  394 (568)
                      +..++++||+|.|+|.+-+..    ..+-.....+++.|+++||.|+|   ++++||||||.+|||+- . ...+||+||
T Consensus        95 d~YvF~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen   95 DAYVFVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             ceEEEeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeec
Confidence            788999999999999998733    45667778899999999999999   78999999999999993 3 357999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-----KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-----~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~  469 (568)
                      |+.+.......        ...-+..|.+||.....     ...+.+|||.||++++.++||+.||......    .-.-
T Consensus       168 G~t~k~g~tV~--------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~----d~~Y  235 (378)
T KOG1345|consen  168 GLTRKVGTTVK--------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM----DKPY  235 (378)
T ss_pred             ccccccCceeh--------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc----CchH
Confidence            99886543211        12234678999987542     3467899999999999999999999832211    1122


Q ss_pred             HHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          470 WVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       470 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                      |-|..|..+.....  ++.-.. ..+.+.+   +-.+-+.+++++|=...++.++
T Consensus       236 ~~~~~w~~rk~~~~--P~~F~~-fs~~a~r---~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  236 WEWEQWLKRKNPAL--PKKFNP-FSEKALR---LFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             HHHHHHhcccCccC--chhhcc-cCHHHHH---HHHHhcCCcccccchhHHHHHH
Confidence            34444444433211  111111 1233333   3446778999999555555443

>cd01951 lectin_L-type legume lectins

Probab=99.93  E-value=2e-25  Score=217.36  Aligned_cols=147  Identities=26%  Similarity=0.405  Sum_probs=118.1

Q ss_pred             CCCCCcEEEEEccCCCCCCCCCCC--cceecccCCCCCCCCCcEEEEEeeCCCCC--CCCCCCeeeEecCCccccc--cc
Q 008374           10 DISGHGLAFVIAPNDSFPPESSYG--QWLGLTNAFTDGNKANHFVAIEFDTVKQG--FDPDDNHLGLNINSVVSRK--NV   83 (568)
Q Consensus        10 ~~~~~G~aF~i~~~~~~~~~~~~g--~~lGl~~~~~~~~~~~~~~aVEfDt~~~~--~d~~~~hvgidins~~s~~--~~   83 (568)
                      ..+||||||+|+|....+.. ..|  ++||..       ..++.+||||||++|.  +||+.||||||+|+..+..  ..
T Consensus        69 ~~~gdG~aF~l~~~~~~~~~-~~g~~~~lG~~-------~~~~~~aVefDT~~N~~~~dp~~~higi~~n~~~~~~~~~~  140 (223)
T cd01951          69 TNGADGIAFVLQNDPAGALG-GGGGGGGLGYG-------GIGNSVAVEFDTYKNDDNNDPNGNHISIDVNGNGNNTALAT  140 (223)
T ss_pred             CCCCCcEEEEEecCCCCccc-cCCCCCccCcc-------ccCCeEEEEEeccccCCCCCCCCCEEEEEcCCCCCCccccc
Confidence            46899999999997654443 444  778863       3467899999999997  5999999999999997541  11


Q ss_pred             cCCC-CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCccccccccc
Q 008374           84 PLKD-NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVR  162 (568)
Q Consensus        84 ~~~~-~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~~~i~  162 (568)
                      .... .......+|+.++|||+||+.+++|+|+|+....  |..|.++..+||+..+++++||||+|+||. ..+.|+++
T Consensus       141 ~~~~~~~~~~~~~g~~~~v~I~Y~~~~~~L~v~l~~~~~--~~~~~l~~~~~l~~~~~~~~yvGFTAsTG~-~~~~h~V~  217 (223)
T cd01951         141 SLGSASLPNGTGLGNEHTVRITYDPTTNTLTVYLDNGST--LTSLDITIPVDLIQLGPTKAYFGFTASTGG-LTNLHDIL  217 (223)
T ss_pred             ccceeeCCCccCCCCEEEEEEEEeCCCCEEEEEECCCCc--cccccEEEeeeecccCCCcEEEEEEcccCC-CcceeEEE
Confidence            1111 0111222389999999999999999999987664  777899999999999999999999999997 99999999


Q ss_pred             ccccc
Q 008374          163 SWTLD  167 (568)
Q Consensus       163 sWs~~  167 (568)
                      +|+|.
T Consensus       218 ~wsf~  222 (223)
T cd01951         218 NWSFT  222 (223)
T ss_pred             EEEec
Confidence            99986

The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=3.8e-24  Score=200.22  Aligned_cols=166  Identities=19%  Similarity=0.136  Sum_probs=123.6

Q ss_pred             CChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccccccccc
Q 008374          329 GSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA  408 (568)
Q Consensus       329 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~  408 (568)
                      |+|.+++...  ...+++.++..++.|++.||.|||+.   +      ||+|||++.++.+|+  ||+++.....     
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----   62 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE-----   62 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc-----
Confidence            7899999542  34699999999999999999999953   3      999999999999999  9999876432     


Q ss_pred             ccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhc
Q 008374          409 EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRL  488 (568)
Q Consensus       409 ~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  488 (568)
                           ...||+.|||||++.+..++.++|||||||++|||++|+.||.......  ..+..+...... .      ++.-
T Consensus        63 -----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~-~------~~~~  128 (176)
T smart00750       63 -----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPA-D------DPRD  128 (176)
T ss_pred             -----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhcc-C------Cccc
Confidence                 2258899999999999999999999999999999999999986432211  011111111100 0      0000


Q ss_pred             CCCCcHHHH--HHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          489 NINSVVDEA--KRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       489 ~~~~~~~~~--~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                       ........  ..+.+++..|++.+|.+||++.|+++.+..
T Consensus       129 -~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      129 -RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             -cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence             01111122  258889999999999999999999998754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=9.4e-25  Score=206.19  Aligned_cols=247  Identities=18%  Similarity=0.322  Sum_probs=190.4

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEE
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVY  323 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  323 (568)
                      ..+|.+...|+.|+|+|.        +..+++|++.-...  .-.++|..|.-.|+-+.||||++++|.|....++.++.
T Consensus       195 ~tkl~e~hsgelwrgrwq--------gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ--------GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             hhhhccCCCccccccccc--------CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence            346888999999999996        44577777754322  23467999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccc
Q 008374          324 DFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE  403 (568)
Q Consensus       324 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~  403 (568)
                      .|||.|||...|++.. ....+-.+..+++.++|+|++|||+. ++-|.---|.+..|++|++.+++|+= +-++..-..
T Consensus       267 q~mp~gslynvlhe~t-~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsfqe  343 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQE  343 (448)
T ss_pred             eeccchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeeeec
Confidence            9999999999998754 34677788999999999999999976 55566667999999999999998851 111111100


Q ss_pred             cccccccccccCCcCCcccCccccccCCCC---ccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          404 RNSYAEHGLVGVPGTMGYVAPECFHTGKAT---PESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       404 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t---~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                               ....=.+.||+||.++..+..   .++|+|||++++|||.|...||...+.-+..                
T Consensus       344 ---------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg----------------  398 (448)
T KOG0195|consen  344 ---------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG----------------  398 (448)
T ss_pred             ---------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----------------
Confidence                     022235789999999876554   4799999999999999999999854432211                


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ..+.-+.++...+......+.+++.-|+..||.+||.+..|+-+|++.
T Consensus       399 mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  399 MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            122334444445555666777788889999999999999999999863

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=2.1e-23  Score=215.17  Aligned_cols=172  Identities=20%  Similarity=0.178  Sum_probs=131.2

Q ss_pred             HHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-----cccchhhHHHHHHhhcCCCCceeeEEE
Q 008374          237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-----IKSKGDFLAELAIIHRLRHKHLVHLVG  311 (568)
Q Consensus       237 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g  311 (568)
                      ....++|...+.||+|+||+||+|.....     +++.+|||++....     ....+.|.+|+++|++++|+|+++.+.
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~   88 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGD-----PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL   88 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCC-----CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence            34567799999999999999999987631     35668999875331     123456899999999999999985333


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCEEEcCCCcEE
Q 008374          312 WCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDL-KASNILLDADFNAR  390 (568)
Q Consensus       312 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDi-kp~NILld~~~~~k  390 (568)
                      .   .+..+|||||+++++|.. +.  . ..      ...++.+++++|.|||   +++|+|||| ||+|||++.++.+|
T Consensus        89 ~---~~~~~LVmE~~~G~~L~~-~~--~-~~------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ik  152 (365)
T PRK09188         89 A---TGKDGLVRGWTEGVPLHL-AR--P-HG------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAA  152 (365)
T ss_pred             E---cCCcEEEEEccCCCCHHH-hC--c-cc------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEE
Confidence            2   246899999999999963 21  1 11      1467889999999999   679999999 99999999999999


Q ss_pred             EeecCCcccccccccccc---ccccccCCcCCcccCcccccc
Q 008374          391 LGDFGLARAIENERNSYA---EHGLVGVPGTMGYVAPECFHT  429 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~---~~~~~~~~Gt~~y~APE~~~~  429 (568)
                      |+|||+|+.+........   ....+...++..|+|||++..
T Consensus       153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            999999998755432111   112235678999999999854

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.5e-21  Score=201.08  Aligned_cols=264  Identities=17%  Similarity=0.191  Sum_probs=192.8

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCC----CceeeEEEEE-EeC
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRH----KHLVHLVGWC-HEK  316 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~g~~-~~~  316 (568)
                      +|...++||+|+||.||++.....     ....+|+|............+..|..++..+..    +++..+++.. ...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~-----~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSE-----KNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCC-----CCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            789999999999999999987642     135788888766544333378889999998873    5788888888 467


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-----CcEEE
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD-----FNARL  391 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~-----~~~kL  391 (568)
                      ..-++||+.+ +-+|.++..... ...++..+.+.|+.|++.+|.+||   +.+++||||||.|+++...     ..+.|
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~l  168 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYL  168 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEE
Confidence            7889999988 889999775444 567999999999999999999999   6799999999999999755     46999


Q ss_pred             eecCCcc--cccccccc---ccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhh
Q 008374          392 GDFGLAR--AIENERNS---YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYT  466 (568)
Q Consensus       392 ~DFGla~--~~~~~~~~---~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~  466 (568)
                      .|||+++  ........   ..........||..|.++....+...+.+.|+||++.++.|+..|..||...........
T Consensus       169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~  248 (322)
T KOG1164|consen  169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK  248 (322)
T ss_pred             EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH
Confidence            9999999  43222211   111111245699999999999999999999999999999999999999975443321101


Q ss_pred             HHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          467 LVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       467 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      +......        .....  .....   ...+.++...+-..+..++|....+.+.|+..
T Consensus       249 ~~~~~~~--------~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  249 FEKDPRK--------LLTDR--FGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             HHHHhhh--------hcccc--ccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            1110000        00000  01112   22333344444558999999999999987654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.87  E-value=8.1e-21  Score=192.25  Aligned_cols=265  Identities=26%  Similarity=0.357  Sum_probs=194.8

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc---cchhhHHHHHHhhcCCCC-ceeeEEEEEEeCCe
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK---SKGDFLAELAIIHRLRHK-HLVHLVGWCHEKGK  318 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-nIv~l~g~~~~~~~  318 (568)
                      |.....||.|+||.||++...         ..+++|.+......   ....|.+|+.++..+.|+ +++++.+.+.....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   72 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS   72 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE
Confidence            556678999999999999864         57899998765433   367899999999999988 79999999977777


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-cEEEeecCCc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF-NARLGDFGLA  397 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~-~~kL~DFGla  397 (568)
                      .+++++|+.++++.+++........+.......+..+++.++.|+|   +.+++|||+||+||+++... .+++.|||++
T Consensus        73 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~  149 (384)
T COG0515          73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLA  149 (384)
T ss_pred             EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcc
Confidence            8999999999999977643221136888999999999999999999   66899999999999999998 7999999999


Q ss_pred             cccccccccccc-cccccCCcCCcccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          398 RAIENERNSYAE-HGLVGVPGTMGYVAPECFHT---GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       398 ~~~~~~~~~~~~-~~~~~~~Gt~~y~APE~~~~---~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      +........... .......||..|+|||.+..   ..+....|+||+|++++++++|..|+.............+.++.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  229 (384)
T COG0515         150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE  229 (384)
T ss_pred             eecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh
Confidence            866544322110 01236789999999999987   57889999999999999999999997643321000112222111


Q ss_pred             HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       474 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                      ....     .................+..+...|+..+|..|.++.+....
T Consensus       230 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         230 LPTP-----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cCCc-----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1100     000000000001223456667778888999999999987764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2.3e-21  Score=212.60  Aligned_cols=257  Identities=19%  Similarity=0.270  Sum_probs=182.0

Q ss_pred             cccceeccCCceeEEEEEEccCccccccCeEEEEEEec-----cCCccc-chhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS-----RDSIKS-KGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       244 ~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~-----~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ...+.+|.|.+|.|+......      .....+.|...     ...... ...+..|+.+=..++|+|++..+..+.+..
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~------~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~  394 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRS------DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID  394 (601)
T ss_pred             CccceeeecccCceEEEEecC------CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc
Confidence            345679999999777766553      22223333221     111111 112566778888899999988887777766


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ...-+||||+. +|..++..   ...+...++..+++|+..|+.|||   +.++.|||+|++|+++..++.+||+|||.+
T Consensus       395 ~~~~~mE~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~  467 (601)
T KOG0590|consen  395 GILQSMEYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAA  467 (601)
T ss_pred             cchhhhhcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcc
Confidence            66666999999 99999843   246788889999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCc-cchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATP-ESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~-~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      .......... ........|...|+|||.+....|.+ ..||||.|+++..|++|+.||.....+...+  .+   .. .
T Consensus       468 ~vf~~~~e~~-~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~~---~~-~  540 (601)
T KOG0590|consen  468 SVFRYPWEKN-IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--KT---NN-Y  540 (601)
T ss_pred             eeeccCcchh-hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--hh---hc-c
Confidence            8775543221 11223778999999999999988876 5899999999999999999997443332110  00   00 0


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .+. ..+..  -........+.+...++-.++++||.+|.||.+|++
T Consensus       541 ~~~-~~~~~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  541 SDQ-RNIFE--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccc-ccccc--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            000 00000  000112234556667778899999999999999975

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=2.6e-20  Score=176.61  Aligned_cols=142  Identities=17%  Similarity=0.170  Sum_probs=107.5

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc---------chhh-----------------HHHHHHhh
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS---------KGDF-----------------LAELAIIH  299 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~-----------------~~E~~~l~  299 (568)
                      ...||+|+||.||+|...       +++.||||+++......         ...|                 ..|++.+.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   74 (190)
T cd05147           2 NGCISTGKEANVYHATTA-------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLK   74 (190)
T ss_pred             CCccccccceEEEEEECC-------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHH
Confidence            357999999999999875       57899999997542211         1122                 24999999


Q ss_pred             cCCCCceeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 008374          300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKAS  379 (568)
Q Consensus       300 ~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~  379 (568)
                      ++.++++.....+..  ...+|||||++++++.....   ....++......++.|++.+|.|||+  +.+|+||||||+
T Consensus        75 ~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~  147 (190)
T cd05147          75 RLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEY  147 (190)
T ss_pred             HHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHH
Confidence            998777643333222  22389999999887765532   22468889999999999999999942  569999999999


Q ss_pred             CEEEcCCCcEEEeecCCcccccc
Q 008374          380 NILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       380 NILld~~~~~kL~DFGla~~~~~  402 (568)
                      |||++ ++.++|+|||+|....+
T Consensus       148 NIli~-~~~v~LiDFG~a~~~~~  169 (190)
T cd05147         148 NLLYH-DGKLYIIDVSQSVEHDH  169 (190)
T ss_pred             HEEEE-CCcEEEEEccccccCCC
Confidence            99998 47899999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=7.3e-20  Score=192.31  Aligned_cols=217  Identities=21%  Similarity=0.371  Sum_probs=161.6

Q ss_pred             hhcCCCCceeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 008374          298 IHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK  377 (568)
Q Consensus       298 l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDik  377 (568)
                      |+.+.|.|+.+++|.|.++...+.|.+||..|+|.+.+..  ....++|.....++++++.||.|||.  ++-..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeec
Confidence            4578999999999999999999999999999999999965  34579999999999999999999996  4444999999


Q ss_pred             CCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccC-------CCCccchhHHHHHHHHHHHh
Q 008374          378 ASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-------KATPESDVFGFGAVVLEVVC  450 (568)
Q Consensus       378 p~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-------~~t~~sDV~SfGvll~el~t  450 (568)
                      ++|+++|..+.+||+|||+......... ...  .....-..-|.|||.+...       ..+.+.||||||++++|+++
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~-~~~--~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~  153 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAE-PEA--HHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF  153 (484)
T ss_pred             cccceeeeeEEEEechhhhccccccccc-ccc--cchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence            9999999999999999999987743100 000  0011234579999998653       14678999999999999999


Q ss_pred             CCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          451 GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       451 G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      .+.||...........++..+..     ......-+.+...  .+....++.++..||..+|.+||++++|-..++..
T Consensus       154 r~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  154 RSGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             ccCccccccccCChHHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            99999853333311223333222     0011111111111  13344688899999999999999999998877653

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=1.6e-19  Score=168.42  Aligned_cols=207  Identities=22%  Similarity=0.295  Sum_probs=168.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCC-CceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRH-KHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~  318 (568)
                      ...|...++||+|+||.+|.|....      ++..||||.-+...  ...++..|.++.+.|+| ..|..+..+..++..
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~------~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y   85 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISIT------SGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY   85 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeecc------CCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence            3568889999999999999998875      78999999975432  34467889999999976 567777888888888


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC---CcEEEeecC
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD---FNARLGDFG  395 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~---~~~kL~DFG  395 (568)
                      -.||||.. +-||.+++.-.  ...++..+.+-++-|++.-++|+|   .++++||||||+|+|..-+   ..+.++|||
T Consensus        86 nvlVMdLL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             ceeeeecc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEecc
Confidence            99999998 78999887543  345788899999999999999999   6799999999999998644   568899999


Q ss_pred             Cccccccccccc--cccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 008374          396 LARAIENERNSY--AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPH  460 (568)
Q Consensus       396 la~~~~~~~~~~--~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~  460 (568)
                      ||+.+.......  .-..-+...||.+|.+--...+..-+.+.|+-|+|.+|...--|..||.+...
T Consensus       160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence            999875432211  11112367899999998888778888999999999999999999999986544

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=2.6e-19  Score=170.00  Aligned_cols=142  Identities=20%  Similarity=0.188  Sum_probs=109.5

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc--------------------------chhhHHHHHHhh
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--------------------------KGDFLAELAIIH  299 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~  299 (568)
                      ...||+|+||+||+|+..       +++.||||++.......                          ...+..|.+.+.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   74 (190)
T cd05145           2 NGCISTGKEANVYHARTG-------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLK   74 (190)
T ss_pred             CceeecCCCcEEEEEEcC-------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHH
Confidence            357999999999999865       57899999987642210                          011357889999


Q ss_pred             cCCCCceeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 008374          300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKAS  379 (568)
Q Consensus       300 ~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~  379 (568)
                      ++.|+++.....+...  ..+|||||++++++.....   ....++......++.+++.++.+||+  ..+|+||||||+
T Consensus        75 ~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~  147 (190)
T cd05145          75 RLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEY  147 (190)
T ss_pred             HHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChh
Confidence            9999987544443332  2489999999886544321   12357778889999999999999994  279999999999


Q ss_pred             CEEEcCCCcEEEeecCCcccccc
Q 008374          380 NILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       380 NILld~~~~~kL~DFGla~~~~~  402 (568)
                      |||++ ++.++|+|||+++...+
T Consensus       148 NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         148 NILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             hEEEE-CCCEEEEEcccceecCC
Confidence            99999 88999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=7.4e-20  Score=176.12  Aligned_cols=178  Identities=13%  Similarity=0.128  Sum_probs=134.3

Q ss_pred             CHHHHH--HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccch---h------hHHHHHHhhc
Q 008374          232 KYKELK--KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---D------FLAELAIIHR  300 (568)
Q Consensus       232 ~~~el~--~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~  300 (568)
                      .|.++.  ...++|...+.||.|+||.||....        ++..+|+|.+.........   .      |.+|+..+.+
T Consensus        20 ~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~--------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~r   91 (232)
T PRK10359         20 KYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT--------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDR   91 (232)
T ss_pred             cHHHHHHHHhhCceEEEEEecCCCceEEEEEec--------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHH
Confidence            344543  3467899999999999999998533        3557999999754332222   2      6799999999


Q ss_pred             CCCCceeeEEEEEEeC--------CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 008374          301 LRHKHLVHLVGWCHEK--------GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVV  372 (568)
Q Consensus       301 l~H~nIv~l~g~~~~~--------~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv  372 (568)
                      ++|++|..+..++...        +..+|||||+++.+|.++..       ++.    ....+++.+|..+|   ..+++
T Consensus        92 L~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH---~~gi~  157 (232)
T PRK10359         92 VRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLH---QHGMV  157 (232)
T ss_pred             HHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHH---HcCCc
Confidence            9999999998885533        35899999999999988741       221    34568999999999   67999


Q ss_pred             ecCCCCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHH
Q 008374          373 HRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV  449 (568)
Q Consensus       373 HrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~  449 (568)
                      |||+||+||+++.++ ++|+|||..+....+...                 ..+.....+..++|+|+||+.+.-..
T Consensus       158 H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~-----------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        158 SGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK-----------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             cCCCChHHEEEeCCC-EEEEECCCcccccchhhH-----------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999999999888 999999988765332111                 01334445667899999999987554

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=8e-19  Score=173.93  Aligned_cols=234  Identities=19%  Similarity=0.244  Sum_probs=151.3

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCC----------Cceee
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRH----------KHLVH  308 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H----------~nIv~  308 (568)
                      .+...+.||.|+|+.||.++...      +++++|||......   ....+++.+|.-.+..+.+          -.++-
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~------t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~   86 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVE------TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLV   86 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT------TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B--
T ss_pred             EEEEccccccCCceEEEEEEEcc------CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEe
Confidence            34567789999999999999875      78999999975433   2345667777766655432          12222


Q ss_pred             EEEEE---------EeCC--------eEEEEEEecCCCChhhhhcc---C-CCcccCCHHHHHHHHHHHHHHHHHHHhcC
Q 008374          309 LVGWC---------HEKG--------KLLLVYDFMPNGSLEKYLYG---T-SEQVTLNWNHRYKILTGVASAVYYLQNEY  367 (568)
Q Consensus       309 l~g~~---------~~~~--------~~~lV~Ey~~~gsL~~~L~~---~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~  367 (568)
                      .++..         ....        +.+++|+-+ .++|.+++.-   . .....+....++.+..|+++.+++||   
T Consensus        87 P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---  162 (288)
T PF14531_consen   87 PLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---  162 (288)
T ss_dssp             -SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred             eeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---
Confidence            22221         1111        347788877 6788877532   1 11234666778888899999999999   


Q ss_pred             CCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCcccccc--------CCCCccchhH
Q 008374          368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT--------GKATPESDVF  439 (568)
Q Consensus       368 ~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--------~~~t~~sDV~  439 (568)
                      ..+++|+||+|+|++++.+|.++|+||+...........        ...+..|.+||....        -.++.+.|.|
T Consensus       163 ~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW  234 (288)
T PF14531_consen  163 SYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAW  234 (288)
T ss_dssp             HTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHH
T ss_pred             hcceEecccceeeEEEcCCCCEEEcChHHHeecCceeec--------cCCCcccCChhhhhhhcccCcccceeeeccCHH
Confidence            579999999999999999999999999877654432211        124478999997644        2478899999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCC
Q 008374          440 GFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASER  515 (568)
Q Consensus       440 SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~R  515 (568)
                      ++|+++|.|.||+.||+........                    +..+.. +. +.++.+..|+...+++||.+|
T Consensus       235 ~LG~~ly~lWC~~lPf~~~~~~~~~--------------------~~~f~~-C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  235 QLGITLYSLWCGRLPFGLSSPEADP--------------------EWDFSR-CR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHHHSS-STCCCGGGSTS--------------------GGGGTT-SS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHHHHccCCCCCCCccccc--------------------cccchh-cC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999999999999854332200                    002222 22 666777777788999999988

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.78  E-value=5.5e-18  Score=164.98  Aligned_cols=205  Identities=19%  Similarity=0.294  Sum_probs=168.8

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCeEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  320 (568)
                      +|...++||+|.||..+.|+.--      .++.||||.-...+  ...++..|.+..+.| ..++|...+-+-.++.+-.
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~------nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni  100 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLY------NNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI  100 (449)
T ss_pred             cceeccccccCcceeeecccccc------cCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence            58899999999999999998763      68999999865543  345677888888887 4689988888888888889


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-----CCcEEEeecC
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA-----DFNARLGDFG  395 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~-----~~~~kL~DFG  395 (568)
                      ||+|.+ +-||+++..-.  ...++..+..-+|.|++.-++|+|   ++.+|.|||||+|+||..     ...+.|.|||
T Consensus       101 LVidLL-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG  174 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG  174 (449)
T ss_pred             hhhhhh-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEecc
Confidence            999998 77888876322  346888999999999999999999   679999999999999954     3458999999


Q ss_pred             Cccccccccccc--cccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 008374          396 LARAIENERNSY--AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPH  460 (568)
Q Consensus       396 la~~~~~~~~~~--~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~  460 (568)
                      +|+.+....+..  .-+......||.+||+--...+..-+.+.|.-|+|-+++..+-|..||.+...
T Consensus       175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            999886543221  11122367899999999999999999999999999999999999999986544

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=2.7e-18  Score=161.97  Aligned_cols=188  Identities=15%  Similarity=0.054  Sum_probs=136.8

Q ss_pred             cccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc----chhhHHHHHHhhcCC-CCceeeEEEEEEeCCe
Q 008374          244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS----KGDFLAELAIIHRLR-HKHLVHLVGWCHEKGK  318 (568)
Q Consensus       244 ~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~  318 (568)
                      .....|++|+||+||.+.-        .+.+++.+.+.....-.    ...|.+|+++|++|+ |+++.+++++    +.
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~   72 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DG   72 (218)
T ss_pred             ccceeecCCCcceEEEeec--------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cC
Confidence            3456899999999996543        46778877776543311    125789999999995 5889999886    45


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCEEEcCCCcEEEeecCCc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDL-KASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDi-kp~NILld~~~~~kL~DFGla  397 (568)
                      .+++|||+.+.+|...+..          ....++.+++.+|.++|   +++|+|||| ||+|||++.++.++|+|||+|
T Consensus        73 ~~lvmeyI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A  139 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRPPR----------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLA  139 (218)
T ss_pred             EEEEEeeecCccHHhhhhh----------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCc
Confidence            6999999999888654411          11356789999999999   679999999 799999999999999999999


Q ss_pred             cccccccccc---cccc-----cccCCcCCcccCccccccC-CCC-ccchhHHHHHHHHHHHhCCCCCC
Q 008374          398 RAIENERNSY---AEHG-----LVGVPGTMGYVAPECFHTG-KAT-PESDVFGFGAVVLEVVCGRSPGN  456 (568)
Q Consensus       398 ~~~~~~~~~~---~~~~-----~~~~~Gt~~y~APE~~~~~-~~t-~~sDV~SfGvll~el~tG~~P~~  456 (568)
                      ..........   ....     ..-...++.|++|+...-. ..+ ...+.++-|.-+|.++|++.|.-
T Consensus       140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            8654432100   0000     0011256778888754321 223 56789999999999999998864

>PRK10345 hypothetical protein; Provisional

Probab=99.76  E-value=6.8e-18  Score=161.82  Aligned_cols=136  Identities=19%  Similarity=0.207  Sum_probs=105.2

Q ss_pred             cccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-----CCCceeeEEEEEEeCC-
Q 008374          244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-----RHKHLVHLVGWCHEKG-  317 (568)
Q Consensus       244 ~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~g~~~~~~-  317 (568)
                      .....||+|+||.||.  .+.      ++.. +||++........+++.+|+.+++.+     .||||++++|++.++. 
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~------~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g   75 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPE------DAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG   75 (210)
T ss_pred             CCcceecCCCceEEEE--CCC------CcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence            4467899999999995  332      3334 69988765445567899999999999     5799999999998863 


Q ss_pred             --e-EEEEEEe--cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCCEEEcC----CC
Q 008374          318 --K-LLLVYDF--MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV-YYLQNEYDQKVVHRDLKASNILLDA----DF  387 (568)
Q Consensus       318 --~-~~lV~Ey--~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivHrDikp~NILld~----~~  387 (568)
                        . ..+|+||  +++++|.+++.+.    .++..  ..++.+++.++ .|||   +++|+||||||+|||++.    +.
T Consensus        76 ~g~v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~  146 (210)
T PRK10345         76 TGYVYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEV  146 (210)
T ss_pred             CeEEEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCC
Confidence              4 3478999  6689999999432    24444  35577777777 9999   679999999999999974    34


Q ss_pred             cEEEeecCCc
Q 008374          388 NARLGDFGLA  397 (568)
Q Consensus       388 ~~kL~DFGla  397 (568)
                      .++|+||+-+
T Consensus       147 ~~~LiDg~G~  156 (210)
T PRK10345        147 IPVVCDNIGE  156 (210)
T ss_pred             cEEEEECCCC
Confidence            8999995444

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.76  E-value=4.9e-19  Score=194.53  Aligned_cols=255  Identities=21%  Similarity=0.192  Sum_probs=179.4

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHH--hhcCCCCceeeEEEEEEeCCe
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAI--IHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++...+.||++.|=+|.+|+..       +|. |+||++-+.. .-..+.|.++++-  ...++|||.+++.-+-.....
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-------eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-------EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-------Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHH
Confidence            5667788999999999999876       344 9999986654 3345556554444  444589999999888777778


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .|||-+|..+ +|.+.|   ..+.-|...+..-|+.|+..||.-.|   ..+|+|+|||.+|||+..-.=+.|+||.--+
T Consensus        96 AylvRqyvkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFK  168 (1431)
T KOG1240|consen   96 AYLVRQYVKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFK  168 (1431)
T ss_pred             HHHHHHHHhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccC
Confidence            8999999855 788877   44556777888889999999999999   6799999999999999998889999998765


Q ss_pred             ccc--cccccccccccccCCcCCcccCccccccC-----------CCCccchhHHHHHHHHHHHh-CCCCCCCCCcccch
Q 008374          399 AIE--NERNSYAEHGLVGVPGTMGYVAPECFHTG-----------KATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHA  464 (568)
Q Consensus       399 ~~~--~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-----------~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~  464 (568)
                      ...  .+..........+-..-..|+|||-+...           ..+++-||||+||++.||++ |+.||+..      
T Consensus       169 PtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------  242 (1431)
T KOG1240|consen  169 PTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------  242 (1431)
T ss_pred             CccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------
Confidence            432  22111111111122334579999976431           25778999999999999998 67777522      


Q ss_pred             hhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          465 YTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       465 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                       .|..+...  .. ...+.+-+.+..       ..+..+++.|++.||.+|.++++.++.-.|.
T Consensus       243 -QL~aYr~~--~~-~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  243 -QLLAYRSG--NA-DDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             -HHHhHhcc--Cc-cCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence             22222111  00 011111111111       1566788899999999999999999875553

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.73  E-value=1.2e-18  Score=183.08  Aligned_cols=189  Identities=27%  Similarity=0.344  Sum_probs=153.6

Q ss_pred             eccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc--chhhHHHHHHhhcCC-CCceeeEEEEEEeCCeEEEEEEe
Q 008374          249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KGDFLAELAIIHRLR-HKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       249 LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      +|+|.||.|+...-...   ...+..+|+|.+++.....  ......|..++...+ ||.+|++.-.++.+..++++.+|
T Consensus         2 lg~g~~gkvfLvrk~~g---~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~   78 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGG---ADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF   78 (612)
T ss_pred             CCcCCCcchHHHHHhcc---ccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence            79999999987543221   1256778888887653322  224556788888887 99999999999999999999999


Q ss_pred             cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccc
Q 008374          326 MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN  405 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~  405 (568)
                      ..+|.|...+..   ....+..........++-++..+|   +.+++|||+|++||+++.+|.+|+.|||+++..-... 
T Consensus        79 ~rgg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-  151 (612)
T KOG0603|consen   79 LRGGDLFTRLSK---EVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-  151 (612)
T ss_pred             cccchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhh-
Confidence            999999998843   334555555566677888999999   6799999999999999999999999999998765432 


Q ss_pred             cccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008374          406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNM  457 (568)
Q Consensus       406 ~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~  457 (568)
                              ..+||..|||||++.  .....+|.||||++++||+||..||..
T Consensus       152 --------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  152 --------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             --------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence                    227999999999997  677889999999999999999999875

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=4.4e-17  Score=157.17  Aligned_cols=134  Identities=18%  Similarity=0.251  Sum_probs=112.3

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc--------cchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK--------SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      +.||+|++|.||+|..        .+..+++|+.......        ....+.+|++++..++|+++.....++...+.
T Consensus         2 ~~l~~G~~~~vy~~~~--------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~   73 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN   73 (211)
T ss_pred             cccccCceEEEEEEee--------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC
Confidence            4699999999999986        3567899986543211        12357889999999999999888888777788


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++++|.+++...      .+ .+..++.+++.+|.+||   ..+++|||++|.|||++ ++.++|+|||+++
T Consensus        74 ~~lv~e~~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~  142 (211)
T PRK14879         74 FIIVMEYIEGEPLKDLINSN------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAE  142 (211)
T ss_pred             CEEEEEEeCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence            99999999999999998432      22 78899999999999999   67999999999999999 7889999999987


Q ss_pred             c
Q 008374          399 A  399 (568)
Q Consensus       399 ~  399 (568)
                      .
T Consensus       143 ~  143 (211)
T PRK14879        143 F  143 (211)
T ss_pred             C
Confidence            5

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=4.5e-17  Score=159.77  Aligned_cols=144  Identities=17%  Similarity=0.234  Sum_probs=109.6

Q ss_pred             CccccceeccCCceeEEEEE-EccCccccccCeEEEEEEeccCCcc------------------------cchhhHHHHH
Q 008374          242 NFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSRDSIK------------------------SKGDFLAELA  296 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~-~~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~  296 (568)
                      .|...+.||+|+||.||+|+ ...      +++.||+|.+......                        ....+..|+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~------~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  102 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDG------SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR  102 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCC------CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence            47778899999999999998 332      6889999998754211                        0122568999


Q ss_pred             HhhcCCCCc--eeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEe
Q 008374          297 IIHRLRHKH--LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQK-VVH  373 (568)
Q Consensus       297 ~l~~l~H~n--Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivH  373 (568)
                      ++.++.+..  +.+++++    ...++||||+++++|......   ...+.......++.|++.++.+||   ..+ ++|
T Consensus       103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH  172 (237)
T smart00090      103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLY---KEGELVH  172 (237)
T ss_pred             HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHH---hcCCEEe
Confidence            999997533  3444443    235899999999888766522   223455567789999999999999   668 999


Q ss_pred             cCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          374 RDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       374 rDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      |||||+||+++ +++++|+|||++....+
T Consensus       173 ~Dikp~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      173 GDLSEYNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             CCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence            99999999999 88999999999875443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=8e-17  Score=177.04  Aligned_cols=141  Identities=19%  Similarity=0.216  Sum_probs=113.1

Q ss_pred             HHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEe-ccC-Cc------ccchhhHHHHHHhhcCCCCceee
Q 008374          237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF-SRD-SI------KSKGDFLAELAIIHRLRHKHLVH  308 (568)
Q Consensus       237 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~-~~~-~~------~~~~~~~~E~~~l~~l~H~nIv~  308 (568)
                      ......|...++||+|+||.||+|.+..        ..+++|+. .+. ..      ...+.+.+|++++.+++|++++.
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~--------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~  400 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYLG--------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT  400 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeecC--------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCe
Confidence            3344456678899999999999998753        23344332 111 11      12346889999999999999998


Q ss_pred             EEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc
Q 008374          309 LVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN  388 (568)
Q Consensus       309 l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~  388 (568)
                      ...++......++||||+++++|.+++.           ....++.+++.+|.|||   +.+++||||||+|||+ +++.
T Consensus       401 p~~~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~  465 (535)
T PRK09605        401 PVIYDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDR  465 (535)
T ss_pred             eEEEEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCc
Confidence            8888888778899999999999999883           35678999999999999   6799999999999999 6789


Q ss_pred             EEEeecCCcccc
Q 008374          389 ARLGDFGLARAI  400 (568)
Q Consensus       389 ~kL~DFGla~~~  400 (568)
                      ++|+|||+++..
T Consensus       466 ~~liDFGla~~~  477 (535)
T PRK09605        466 LYLIDFGLGKYS  477 (535)
T ss_pred             EEEEeCcccccC
Confidence            999999999764

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=7.1e-17  Score=154.29  Aligned_cols=130  Identities=22%  Similarity=0.305  Sum_probs=105.8

Q ss_pred             eeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc--------cchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK--------SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       248 ~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .||+|+||.||+|.+        .+..+++|........        ....+.+|++++..++|+++.....++...+..
T Consensus         1 ~ig~G~~~~vy~~~~--------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~   72 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNK   72 (199)
T ss_pred             CCCCCceEEEEEeec--------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCC
Confidence            389999999999985        4678999986542211        124577899999999988766655566667778


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++++|.+++....   .       .++.+++.+|.+||   ..+++|+|++|.||+++ ++.+++.|||+++.
T Consensus        73 ~lv~e~~~g~~l~~~~~~~~---~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        73 TIVMEYIEGKPLKDVIEEGN---D-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEEECCccHHHHHhhcH---H-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999999999998874311   0       78999999999999   67999999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.70  E-value=9.1e-17  Score=153.60  Aligned_cols=144  Identities=18%  Similarity=0.211  Sum_probs=110.1

Q ss_pred             HHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc----------------------cchhhHH
Q 008374          236 LKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK----------------------SKGDFLA  293 (568)
Q Consensus       236 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~  293 (568)
                      +...-..|...+.||+|+||.||++...       +++.||||++......                      ....+..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDP-------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQK   82 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcC-------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHH
Confidence            3333334777789999999999999875       5789999987543210                      0113567


Q ss_pred             HHHHhhcCCCC--ceeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 008374          294 ELAIIHRLRHK--HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKV  371 (568)
Q Consensus       294 E~~~l~~l~H~--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  371 (568)
                      |..++..+.|+  .+.+.++.    ...++||||+++++|......         .....++.+++.++.++|   ..++
T Consensus        83 E~~~l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh---~~gi  146 (198)
T cd05144          83 EFAALKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAY---KHGI  146 (198)
T ss_pred             HHHHHHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHH---HCCC
Confidence            88889888877  44455543    345899999999999776421         234578899999999999   5799


Q ss_pred             EecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          372 VHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       372 vHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      +||||||.||++++++.++|+|||++.....
T Consensus       147 ~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         147 IHGDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999999999999976554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=1.1e-16  Score=179.63  Aligned_cols=203  Identities=21%  Similarity=0.246  Sum_probs=158.9

Q ss_pred             CHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC---CCceee
Q 008374          232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR---HKHLVH  308 (568)
Q Consensus       232 ~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~  308 (568)
                      ...+++...+.|.+...||+|+||+||+|...       +++.||+|.-+....   -+|.-=.+++.||+   -+-|..
T Consensus       689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~-------~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~  758 (974)
T KOG1166|consen  689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHS-------NGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMH  758 (974)
T ss_pred             ccceeeecceeEEEEeeeccccceEEEEeecC-------CCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHH
Confidence            33455556677999999999999999999876       588999999765432   23333344555555   223444


Q ss_pred             EEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc----
Q 008374          309 LVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD----  384 (568)
Q Consensus       309 l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld----  384 (568)
                      +.....-.+.-+||+||.+.|+|.++++   ..+.++|.....++.|++..+..||   ..+|||+||||+|.||.    
T Consensus       759 ~~~a~~~~~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~  832 (974)
T KOG1166|consen  759 ISSAHVFQNASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREIC  832 (974)
T ss_pred             HHHHHccCCcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccC
Confidence            4444455667799999999999999996   4567999999999999999999999   67999999999999993    


Q ss_pred             ---CCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCC
Q 008374          385 ---ADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRS  453 (568)
Q Consensus       385 ---~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~  453 (568)
                         +...++|+|||.+..+.--... +  .....++|-.+-.+|...++.++.+.|.|.++.+++-|+.|+.
T Consensus       833 ~~~~~~~l~lIDfG~siDm~lfp~~-~--~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  833 ADSDSKGLYLIDFGRSIDMKLFPDG-T--KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             CCCcccceEEEecccceeeeEcCCC-c--EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence               3456899999999765432111 1  1236788999999999999999999999999999999999984

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.68  E-value=2.2e-16  Score=157.00  Aligned_cols=200  Identities=23%  Similarity=0.251  Sum_probs=138.5

Q ss_pred             CCCceeeEEEEEEe---------------------------CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHH
Q 008374          302 RHKHLVHLVGWCHE---------------------------KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILT  354 (568)
Q Consensus       302 ~H~nIv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~  354 (568)
                      +|||||++.+.|.+                           ...+|+||.-.+ .+|..||..    ...+...+.-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence            69999999987743                           235789998774 489999943    3466677778999


Q ss_pred             HHHHHHHHHHhcCCCCeEecCCCCCCEEE--cCC--CcEEEeecCCccccccc--cccccccccccCCcCCcccCccccc
Q 008374          355 GVASAVYYLQNEYDQKVVHRDLKASNILL--DAD--FNARLGDFGLARAIENE--RNSYAEHGLVGVPGTMGYVAPECFH  428 (568)
Q Consensus       355 ~ia~~L~yLH~~~~~~ivHrDikp~NILl--d~~--~~~kL~DFGla~~~~~~--~~~~~~~~~~~~~Gt~~y~APE~~~  428 (568)
                      |+++|+.|||   .++|.|||+|++|||+  |+|  -.+.|+|||++-.-+..  +-.+.+. ....-|.-.-||||+..
T Consensus       349 QlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~-~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  349 QLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESD-EVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccc-cccCCCcceecchhhhh
Confidence            9999999999   6799999999999999  333  45789999998654441  1122211 12445778899999985


Q ss_pred             cCC------CCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHH
Q 008374          429 TGK------ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLL  502 (568)
Q Consensus       429 ~~~------~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  502 (568)
                      ...      ...|+|.|+.|.+.||+++...||....+-.  .+...     +.+..+     +.    .+......+.+
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~--L~~r~-----Yqe~qL-----Pa----lp~~vpp~~rq  488 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML--LDTRT-----YQESQL-----PA----LPSRVPPVARQ  488 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe--echhh-----hhhhhC-----CC----CcccCChHHHH
Confidence            432      2358999999999999999999987421111  01111     111111     11    12233445566


Q ss_pred             HHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          503 LGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       503 l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                      ++...+++||.+|++.+-....|+
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHHH
Confidence            777778999999999877666654

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.68  E-value=1.1e-17  Score=172.80  Aligned_cols=127  Identities=25%  Similarity=0.439  Sum_probs=110.4

Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .+++.|++|...+|.+||.........+|.....++.|++.++.|      ++.+|||+||.||+...+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            589999999999999999876666778899999999999999998      58999999999999999999999999999


Q ss_pred             ccccccccc-ccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh
Q 008374          398 RAIENERNS-YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC  450 (568)
Q Consensus       398 ~~~~~~~~~-~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t  450 (568)
                      .......+. ......+...||..||+||.+.+..|+.|+||||+|++|+|++.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            877654311 11112336789999999999999999999999999999999997

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=2.3e-15  Score=135.90  Aligned_cols=135  Identities=19%  Similarity=0.128  Sum_probs=114.9

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCC--CceeeEEEEEEeCCeEEEEE
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRH--KHLVHLVGWCHEKGKLLLVY  323 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lV~  323 (568)
                      .+.||+|.++.||++...        +..+++|.......  ...+..|+.++..++|  .++.+++++....+..++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~--------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~   72 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTK--------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM   72 (155)
T ss_pred             ceecccccccceEEEEec--------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEE
Confidence            467999999999999874        36799999865433  5678999999999976  58999999888888999999


Q ss_pred             EecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          324 DFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       324 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      ||++++.+..+          +......++.++++++++||.....+++|+|++|+||++++.+.+++.|||+++..
T Consensus        73 e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          73 EWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             EecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            99988877654          55667788999999999999765568999999999999999999999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.60  E-value=8.7e-16  Score=169.20  Aligned_cols=174  Identities=25%  Similarity=0.331  Sum_probs=123.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ..+|...++|-.|+||.||..+.+.      ..+.+|+| +.+...     +.+-  ++.....|.+|            
T Consensus        82 e~df~~IklisngAygavylvrh~~------trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKE------TRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccc------cccchhhc-ccccch-----hhhc--cccccCCccee------------
Confidence            3578888999999999999998764      56778884 332211     1110  33333444444            


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                               |+=.+.+..   .+.+.-        +++.+++|||   ..+|+|||+||+|.+|..-|.+|+.|||+.+.
T Consensus       136 ---------gDc~tllk~---~g~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~  192 (1205)
T KOG0606|consen  136 ---------GDCATLLKN---IGPLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKK  192 (1205)
T ss_pred             ---------chhhhhccc---CCCCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhh
Confidence                     333333321   122322        2278999999   67999999999999999999999999999886


Q ss_pred             ccccccc---------c-cccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 008374          400 IENERNS---------Y-AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ  462 (568)
Q Consensus       400 ~~~~~~~---------~-~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~  462 (568)
                      .......         . ....-..++||+.|+|||++....|...+|.|++|+++||.+-|+.||.....++
T Consensus       193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee  265 (1205)
T KOG0606|consen  193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE  265 (1205)
T ss_pred             hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence            4321110         0 0111236789999999999999999999999999999999999999998665444

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.59  E-value=7e-15  Score=138.98  Aligned_cols=139  Identities=21%  Similarity=0.270  Sum_probs=97.1

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc--cchhh----------------------HHHHHHhhcC
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK--SKGDF----------------------LAELAIIHRL  301 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l  301 (568)
                      .+.||+|+||+||+|...       +++.||||++......  ....+                      ..|...+.++
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l   74 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRL   74 (187)
T ss_pred             CcccccccceeEEEEECC-------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHH
Confidence            357999999999999865       4788999998653221  11111                      2455556565


Q ss_pred             CCCc--eeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 008374          302 RHKH--LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKAS  379 (568)
Q Consensus       302 ~H~n--Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~  379 (568)
                      .+..  +.+.+++    ...++||||++++.+.......   .... .....++.+++.++.++|.  +++++||||||+
T Consensus        75 ~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~---~~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~  144 (187)
T cd05119          75 YEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKD---VRLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEY  144 (187)
T ss_pred             HHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhh---hhhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChh
Confidence            4432  4444443    2458999999996543221110   0011 5567889999999999994  279999999999


Q ss_pred             CEEEcCCCcEEEeecCCcccccc
Q 008374          380 NILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       380 NILld~~~~~kL~DFGla~~~~~  402 (568)
                      ||+++ ++.++|+|||.+.....
T Consensus       145 Nili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         145 NILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             hEEEE-CCcEEEEECcccccccC
Confidence            99999 99999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.57  E-value=2.2e-14  Score=141.00  Aligned_cols=136  Identities=19%  Similarity=0.208  Sum_probs=104.7

Q ss_pred             cceec-cCCceeEEEEEEccCccccccCeEEEEEEeccCC-------------cccchhhHHHHHHhhcCCCCce--eeE
Q 008374          246 SMRLG-EGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-------------IKSKGDFLAELAIIHRLRHKHL--VHL  309 (568)
Q Consensus       246 ~~~LG-~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~nI--v~l  309 (568)
                      ...|| .||.|+||+....        +..++||++....             ......+.+|++++.+++|+++  ++.
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~p  107 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRP  107 (239)
T ss_pred             CceeecCCCCccEEEEEeC--------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCcee
Confidence            35688 8999999998763        6789999885421             1223457889999999998875  677


Q ss_pred             EEEEEeCC----eEEEEEEecCC-CChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc
Q 008374          310 VGWCHEKG----KLLLVYDFMPN-GSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD  384 (568)
Q Consensus       310 ~g~~~~~~----~~~lV~Ey~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld  384 (568)
                      ++++....    ..++|+||+++ .+|.+++..    ..++..    .+.+++.+|.+||   +.+|+||||||.|||++
T Consensus       108 l~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~  176 (239)
T PRK01723        108 IAARVVRHGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLD  176 (239)
T ss_pred             EeeeeeecCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEc
Confidence            77654432    23599999997 689888743    234432    3678999999999   67999999999999999


Q ss_pred             CCCcEEEeecCCcccc
Q 008374          385 ADFNARLGDFGLARAI  400 (568)
Q Consensus       385 ~~~~~kL~DFGla~~~  400 (568)
                      .++.++|+|||.++..
T Consensus       177 ~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        177 PDGKFWLIDFDRGELR  192 (239)
T ss_pred             CCCCEEEEECCCcccC
Confidence            9899999999988753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.47  E-value=6.1e-15  Score=162.15  Aligned_cols=256  Identities=23%  Similarity=0.284  Sum_probs=181.8

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCC-CCceeeEEEEEEeCCe
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLR-HKHLVHLVGWCHEKGK  318 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~  318 (568)
                      .|...+.||+|.|+.|-......+     ....+|+|.+....  .........|..+=..+. |+|++++++...+.+.
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~-----~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~   95 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRD-----PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS   95 (601)
T ss_pred             cccccccccccccchhhhhhhcCC-----CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcc
Confidence            456666799999999987765432     45677787776543  112223334666666665 9999999999999999


Q ss_pred             EEEEEEecCCCChhhhhc-cCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-cEEEeecCC
Q 008374          319 LLLVYDFMPNGSLEKYLY-GTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF-NARLGDFGL  396 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~-~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~-~~kL~DFGl  396 (568)
                      .+++.||..++++.+.+. ...  ...+....-..+.|+..++.|+|.  ..++.||||||+|.+++..+ ..|++|||+
T Consensus        96 ~~~~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~  171 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGL  171 (601)
T ss_pred             cccccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchh
Confidence            999999999999988883 221  134445556779999999999994  46999999999999999999 999999999


Q ss_pred             cccccc-ccccccccccccCCc-CCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          397 ARAIEN-ERNSYAEHGLVGVPG-TMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       397 a~~~~~-~~~~~~~~~~~~~~G-t~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      |..+.. ......   ....+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.......  ....|...
T Consensus       172 At~~~~~~g~~~~---~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--~~~~~~~~  246 (601)
T KOG0590|consen  172 ATAYRNKNGAERS---LKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--RYSSWKSN  246 (601)
T ss_pred             hccccccCCccee---eecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc--cceeeccc
Confidence            998876 222111   225567 9999999998774 556789999999999999999999885433321  11122111


Q ss_pred             HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 008374          474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDIL  522 (568)
Q Consensus       474 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl  522 (568)
                      .   +.        .....-.........+...++..+|..|.+.+++.
T Consensus       247 ~---~~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  247 K---GR--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             c---cc--------cccCccccCChhhhhcccccccCCchhcccccccc
Confidence            0   00        00111112223345555677789999999988874

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.43  E-value=5.8e-13  Score=142.13  Aligned_cols=143  Identities=19%  Similarity=0.182  Sum_probs=99.4

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc--------------------------------------
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--------------------------------------  287 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~--------------------------------------  287 (568)
                      .+-||+|++|+||+|+++       +|+.||||+........                                      
T Consensus       122 ~~plasaSigQVh~A~l~-------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l  194 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTL  194 (437)
T ss_pred             CcceeeeehhheEEEEec-------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHH
Confidence            356999999999999987       68899999975432110                                      


Q ss_pred             --chhhHHHHHHhhcCC----CCceeeEEEEEE-eCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHH-H
Q 008374          288 --KGDFLAELAIIHRLR----HKHLVHLVGWCH-EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVAS-A  359 (568)
Q Consensus       288 --~~~~~~E~~~l~~l~----H~nIv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~-~  359 (568)
                        .-+|..|...+.+++    |.+-+.+-..+. .....+|||||+++++|.++......  ..   .+..++..++. .
T Consensus       195 ~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~  269 (437)
T TIGR01982       195 RRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSF  269 (437)
T ss_pred             HHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHH
Confidence              013555666665552    332233322222 23457999999999999887642111  12   23456666665 3


Q ss_pred             HHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccc
Q 008374          360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE  403 (568)
Q Consensus       360 L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~  403 (568)
                      +..+|   ..+++|+|++|.||+++.++.+++.|||++..+...
T Consensus       270 l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~  310 (437)
T TIGR01982       270 LNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE  310 (437)
T ss_pred             HHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence            56677   679999999999999999999999999999877543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=1.3e-13  Score=134.65  Aligned_cols=205  Identities=22%  Similarity=0.287  Sum_probs=140.0

Q ss_pred             HHhhcCCCCceeeEEEEEEeC-----CeEEEEEEecCCCChhhhhccCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 008374          296 AIIHRLRHKHLVHLVGWCHEK-----GKLLLVYDFMPNGSLEKYLYGTS-EQVTLNWNHRYKILTGVASAVYYLQNEYDQ  369 (568)
Q Consensus       296 ~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~  369 (568)
                      .-|-++-|-|||+++.|+.+.     .+..++.|||..|+|..+|++.. .+..+......+++.||.+||.|||.. .+
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            344556799999999987643     46789999999999999997643 355677777889999999999999975 89


Q ss_pred             CeEecCCCCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHH
Q 008374          370 KVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV  449 (568)
Q Consensus       370 ~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~  449 (568)
                      +++|+++..+-|++..++-+|++----.... ...............+-++|.|||+-...+.+..+|||+||...+||.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h-~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTH-PSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccc-hhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            9999999999999999998998632111110 000000001111334678999999998888899999999999999998


Q ss_pred             hCCCC-CCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          450 CGRSP-GNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       450 tG~~P-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      -+..- .+..........+..          ....+...+.           ..+...|++..|..||+|++++.
T Consensus       277 ilEiq~tnseS~~~~ee~ia~----------~i~~len~lq-----------r~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIAN----------VIIGLENGLQ-----------RGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HheeccCCCcceeehhhhhhh----------heeeccCccc-----------cCcCcccccCCCCCCcchhhhhc
Confidence            87643 221111110000000          0000011111           12344899999999999999864

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.36  E-value=1e-12  Score=138.76  Aligned_cols=251  Identities=25%  Similarity=0.274  Sum_probs=175.6

Q ss_pred             ccccceecc--CCceeEEEEEE--ccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcC-CCCceeeEEEEEEe
Q 008374          243 FHESMRLGE--GGFGIVYKGII--HHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHE  315 (568)
Q Consensus       243 f~~~~~LG~--G~fG~Vy~g~~--~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~  315 (568)
                      |.....+|.  |.+|.||.+..  ..      ++..+|+|+-+..  .......=.+|+....++ .|+|.++....+..
T Consensus       116 ~~~~~~~g~~~g~~~s~~~~~~~~~~------s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  116 FPISSRTGSLPGSKGSVFKSRCTNSE------SPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             cccccccccCCCCCceeecccCCccc------CCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence            556778999  99999999988  43      6788999984332  223333445677777777 49999998888889


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCCEEEcCC-CcEE
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVAS----AVYYLQNEYDQKVVHRDLKASNILLDAD-FNAR  390 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivHrDikp~NILld~~-~~~k  390 (568)
                      .+.+++-.|++ +.+|.++-+..  ...+.......+..+..+    ||..+|   ...++|-|+||.||++..+ ...+
T Consensus       190 ~~~lfiqtE~~-~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~  263 (524)
T KOG0601|consen  190 SGILFIQTELC-GESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCK  263 (524)
T ss_pred             CCcceeeeccc-cchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceee
Confidence            99999999998 47888877542  223444555566666666    988888   7899999999999999999 8999


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~  470 (568)
                      ++|||+...+....-...........|...|++||.. .+-++..+|+|++|.+.+|..++-.+...-...       .|
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------~W  335 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS-------SW  335 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-------Cc
Confidence            9999999988765422222222344678899999998 567888999999999999999987654311000       11


Q ss_pred             HHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          471 VWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       471 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        ...+.+-        +..++...-..++..+..++++.+|..|++.+.+..
T Consensus       336 --~~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  336 --SQLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             --ccccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence              1111110        111111111223333667888999999999877754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.28  E-value=2.3e-11  Score=112.78  Aligned_cols=130  Identities=19%  Similarity=0.097  Sum_probs=95.5

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCcee-eEEEEEEeCCeEEEEEEe
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV-HLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey  325 (568)
                      +.|+.|.++.||++..        .+..+++|....... ....+..|+.++..+.+.+++ +++.+.  ....++||||
T Consensus         4 ~~l~~G~~~~vy~~~~--------~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~   72 (170)
T cd05151           4 SPLKGGMTNKNYRVEV--------ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEF   72 (170)
T ss_pred             eecCCcccCceEEEEE--------CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEe
Confidence            4688999999999876        367899999755432 234578899999998765554 444443  2345899999


Q ss_pred             cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          326 MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY--DQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      +++.++....        .   ....++.+++++|+.||...  ...++|+|++|.||+++ ++.+++.||+.+..
T Consensus        73 i~G~~l~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          73 IEGSELLTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cCCCcccccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            9998876531        0   11245678999999999542  22369999999999999 66899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.21  E-value=1.2e-11  Score=133.78  Aligned_cols=149  Identities=15%  Similarity=0.205  Sum_probs=95.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc---------------------------------
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS---------------------------------  287 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~---------------------------------  287 (568)
                      ..|+. +-||+|++|+||+|+++.      +|+.||||+....-.+.                                 
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e  192 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKD------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAE  192 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECC------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHH
Confidence            45665 679999999999999974      48899999986431100                                 


Q ss_pred             -------chhhHHHHHHhhcCC----CCceeeEEEEEEe-CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHH
Q 008374          288 -------KGDFLAELAIIHRLR----HKHLVHLVGWCHE-KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG  355 (568)
Q Consensus       288 -------~~~~~~E~~~l~~l~----H~nIv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~  355 (568)
                             +-+|.+|...+.+++    +.+.+.+-..+.+ ....+|||||++++.+.++-.-..  ...+   +..++..
T Consensus       193 ~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~--~g~d---~~~la~~  267 (537)
T PRK04750        193 FEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA--AGTD---MKLLAER  267 (537)
T ss_pred             HHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh--cCCC---HHHHHHH
Confidence                   013455555555552    3333333333322 346789999999999987421111  1111   1122222


Q ss_pred             HHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC----cEEEeecCCccccccc
Q 008374          356 VASAVYYLQNEYDQKVVHRDLKASNILLDADF----NARLGDFGLARAIENE  403 (568)
Q Consensus       356 ia~~L~yLH~~~~~~ivHrDikp~NILld~~~----~~kL~DFGla~~~~~~  403 (568)
                      .+..  |++.....+++|+|+||.||+++.++    .+++.|||++..++..
T Consensus       268 ~v~~--~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        268 GVEV--FFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             HHHH--HHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            2221  22222256999999999999999888    9999999999887654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.15  E-value=3.7e-10  Score=120.63  Aligned_cols=165  Identities=19%  Similarity=0.261  Sum_probs=123.9

Q ss_pred             cCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHH
Q 008374          271 DNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRY  350 (568)
Q Consensus       271 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~  350 (568)
                      ++.+|.|..++...........+-++.|+.++||||++++.....++.+|||+|-+.  -|..++..      +.-....
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v~  107 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEVC  107 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHHH
Confidence            678899998877655334556778899999999999999999999999999999863  46666632      3344556


Q ss_pred             HHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccC
Q 008374          351 KILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG  430 (568)
Q Consensus       351 ~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~  430 (568)
                      -.+.||+.||.|||+  +.+++|++|.-..|++++.|..||++|.++.....-...  .   ....--..|..|+.+...
T Consensus       108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~---~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--A---KSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--c---ccchhhhcccChhhcCcc
Confidence            678999999999996  578999999999999999999999999887654322110  0   011112345666654322


Q ss_pred             CCCccchhHHHHHHHHHHHhCC
Q 008374          431 KATPESDVFGFGAVVLEVVCGR  452 (568)
Q Consensus       431 ~~t~~sDV~SfGvll~el~tG~  452 (568)
                      .  -..|.|-||++++|++.|.
T Consensus       181 ~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCcc
Confidence            2  3469999999999999993

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.11  E-value=9.4e-10  Score=106.43  Aligned_cols=142  Identities=17%  Similarity=0.243  Sum_probs=109.7

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCC--CceeeEEEEEEeC---CeEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRH--KHLVHLVGWCHEK---GKLL  320 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~---~~~~  320 (568)
                      +.|+.|..+.||++...       ++..+++|....... ....++..|.+++..+++  .++.+++.++...   +..+
T Consensus         4 ~~l~~G~~n~~~~v~~~-------~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~   76 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-------GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF   76 (223)
T ss_pred             eecCCCccceEEEEEec-------CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence            45899999999999864       357899999765432 245678999999999976  4467788877654   3668


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY---------------------------------  367 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------  367 (568)
                      +||||+++.++.+.+..    ..++..++..++.+++++|.+||...                                 
T Consensus        77 ~v~e~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (223)
T cd05154          77 YVMERVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTD  152 (223)
T ss_pred             EEEEEeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccc
Confidence            99999999988776521    34677777888888888888888421                                 


Q ss_pred             --------------------CCCeEecCCCCCCEEEcC--CCcEEEeecCCccc
Q 008374          368 --------------------DQKVVHRDLKASNILLDA--DFNARLGDFGLARA  399 (568)
Q Consensus       368 --------------------~~~ivHrDikp~NILld~--~~~~kL~DFGla~~  399 (568)
                                          ...++|+|+++.||+++.  ++.+.|.||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         153 EPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             ccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                256899999999999998  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.08  E-value=1.6e-09  Score=102.36  Aligned_cols=144  Identities=20%  Similarity=0.174  Sum_probs=97.5

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc----------------------ccchhhH----HHHHHhhc
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI----------------------KSKGDFL----AELAIIHR  300 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~----~E~~~l~~  300 (568)
                      ..||.|--+.||.|.-..+......+..+|||..+....                      ...+.+.    +|.+.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997542110111357899998642100                      0011222    78888888


Q ss_pred             CCC--CceeeEEEEEEeCCeEEEEEEecCCCChhh-hhccCCCcccCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCC
Q 008374          301 LRH--KHLVHLVGWCHEKGKLLLVYDFMPNGSLEK-YLYGTSEQVTLNWNHRYKILTGVASAVYYL-QNEYDQKVVHRDL  376 (568)
Q Consensus       301 l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~L~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivHrDi  376 (568)
                      +..  -++.+++++    ..-+|||||+.+..+.. .|.    ...++..+...+..+++.+|..| |   ..+++|+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence            853  455566654    45689999997654422 221    12344455667889999999998 6   569999999


Q ss_pred             CCCCEEEcCCCcEEEeecCCcccccc
Q 008374          377 KASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       377 kp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      ++.|||++ ++.+.|+|||.+...++
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCCC
Confidence            99999997 46799999998876554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.01  E-value=2.4e-10  Score=120.96  Aligned_cols=251  Identities=20%  Similarity=0.206  Sum_probs=170.4

Q ss_pred             HHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccch--hhHHHHHHhhcC-CCCceeeEEEE
Q 008374          236 LKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAIIHRL-RHKHLVHLVGW  312 (568)
Q Consensus       236 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~H~nIv~l~g~  312 (568)
                      ....+.+|.....||.|.|+.|++......     ++..+++|.+.+.......  .-..|+.+...+ .|.++++....
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~-----~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~  334 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPE-----GDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS  334 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCC-----CCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence            334466799999999999999999774421     5788999988765333222  223555555555 47888887666


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-CcEEE
Q 008374          313 CHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD-FNARL  391 (568)
Q Consensus       313 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~-~~~kL  391 (568)
                      +......++=-|||.++++...+   .....++...++++..+++.++.++|   ++.++|+|+||+||++..+ +..++
T Consensus       335 W~~~r~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~  408 (524)
T KOG0601|consen  335 WSQLRQGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKL  408 (524)
T ss_pred             ccccccccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhc
Confidence            66666777999999999987766   22345777888899999999999999   7899999999999999876 88999


Q ss_pred             eecCCccccccccccccccccccCCcCCcc-cCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGY-VAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y-~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~  470 (568)
                      +|||++..+......       ....+..| .+++......+-.+.|+||||.-+.|.+++..--+.         ...|
T Consensus       409 ~~~~~~t~~~~~~~~-------~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~---------~~~~  472 (524)
T KOG0601|consen  409 GDFGCWTRLAFSSGV-------FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES---------GVQS  472 (524)
T ss_pred             cccccccccceeccc-------ccccccccccchhhccccccccccccccccccccccccCcccCcc---------cccc
Confidence            999998753222110       11222333 355666677888999999999999999998753221         1111


Q ss_pred             HHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 008374          471 VWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII  525 (568)
Q Consensus       471 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L  525 (568)
                      ..  ...+.+     +  +.....+   .+..+...+..+++..||.+.+.....
T Consensus       473 ~~--i~~~~~-----p--~~~~~~~---~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  473 LT--IRSGDT-----P--NLPGLKL---QLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             ee--eecccc-----c--CCCchHH---hhhhhhhhhcCCccccchhhhhhcccc
Confidence            00  011100     1  1111113   333444456689999999988876544

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.92  E-value=8.7e-09  Score=94.42  Aligned_cols=130  Identities=22%  Similarity=0.269  Sum_probs=97.2

Q ss_pred             eeccCCceeEEEEEEccCccccccCeEEEEEE-eccCCc-c------cchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK-FSRDSI-K------SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       248 ~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~-~~~~~~-~------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .+++|+-+.+|.+.+.        +..+++|. +++.-. .      ....-.+|.+++.+++--.|....=+..+....
T Consensus         3 ~i~~GAEa~i~~~~~~--------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~   74 (204)
T COG3642           3 LIKQGAEAIIYLTDFL--------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG   74 (204)
T ss_pred             hhhCCcceeEEeeecc--------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC
Confidence            4788999999998764        44456654 333211 1      123456799999988655554444555677788


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      .|+|||.++-.|.+++...          +..++..+-..+.-||   ..+|+|+||.++||++..+. +.++||||+..
T Consensus        75 ~I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          75 LIVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999999998888433          3567888888888999   67999999999999997765 99999999874

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.92  E-value=1.3e-08  Score=105.90  Aligned_cols=169  Identities=17%  Similarity=0.315  Sum_probs=131.0

Q ss_pred             eeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEE----eCCeEEEEEEecCC-C
Q 008374          255 GIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCH----EKGKLLLVYDFMPN-G  329 (568)
Q Consensus       255 G~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~----~~~~~~lV~Ey~~~-g  329 (568)
                      .+.||+...-      +|..+++||+.....+.......-+++++++.|.|+|++...+.    .+..++|||+|.|+ +
T Consensus       290 ~Ttyk~~s~~------DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  290 ITTYKATSNV------DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             ceeEeeeecc------CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            4789998764      78899999995444444445566789999999999999998876    34578999999986 5


Q ss_pred             ChhhhhccC------------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          330 SLEKYLYGT------------SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       330 sL~~~L~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      +|.++-+..            .+....+....+.++.|+..||.++|   +.|+.-+-|.+++|+++.+.+++|+.+|..
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~  440 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIM  440 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccce
Confidence            676655432            12234667889999999999999999   679999999999999999999999999987


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP  454 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P  454 (568)
                      ..+..+...                   -+   .--.+-|.=.||.+++.|.||+.-
T Consensus       441 Dvl~~d~~~-------------------~l---e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  441 DVLQEDPTE-------------------PL---ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             eeecCCCCc-------------------ch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence            766554311                   01   112356888999999999999643

>cd07308 lectin_leg-like legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47

Probab=98.88  E-value=2.6e-08  Score=96.64  Aligned_cols=135  Identities=22%  Similarity=0.287  Sum_probs=81.4

Q ss_pred             CCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecC-Cccccc------c
Q 008374           10 DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNIN-SVVSRK------N   82 (568)
Q Consensus        10 ~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidin-s~~s~~------~   82 (568)
                      ..+||||||+|+|...     ..|..+|-.+       ..+-+||||||+.|. +-...+|.+=+| ...+..      .
T Consensus        72 ~~~gdG~af~~~~~~~-----~~g~~~G~~~-------~~~Glai~fdt~~n~-~~~~p~i~~~~Ndg~~~~~~~~d~~~  138 (218)
T cd07308          72 GLGGDGFAFWYTEEPG-----SDGPLFGGPD-------KFKGLAIFFDTYDND-GKGFPSISVFLNDGTKSYDYETDGEK  138 (218)
T ss_pred             CCCCCEEEEEEECCCC-----CCCcccccCC-------CCCEEEEEEEcCCCC-CCCCCeEEEEEeCCCceecccCCCcc
Confidence            4689999999998543     2344444422       224599999999985 223334333222 111111      1


Q ss_pred             ccCCCCcccccC-CCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccc-cCCCcccccccccCCCccccccc
Q 008374           83 VPLKDNYNITLS-DGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKD-YLKPESYFGFSASTGYPHIQLNC  160 (568)
Q Consensus        83 ~~~~~~~~~~l~-~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~-~l~~~~~vGfsastG~~~~~~~~  160 (568)
                      ..... -.+... ++..++++|.|+  .+.|.|.+....   +....  ...++.. .+++..|+||||+||. ..+.|.
T Consensus       139 ~~~~~-c~~~~~~~~~~~~~~I~y~--~~~l~v~i~~~~---~~~~~--~c~~~~~~~l~~~~y~G~sA~tg~-~~d~~d  209 (218)
T cd07308         139 LELAS-CSLKFRNSNAPTTLRISYL--NNTLKVDITYSE---GNNWK--ECFTVEDVILPSQGYFGFSAQTGD-LSDNHD  209 (218)
T ss_pred             ccccc-eeEecccCCCCeEEEEEEE--CCEEEEEEeCCC---CCCcc--EEEEcCCcccCCCCEEEEEeccCC-CcCcEE
Confidence            11111 111111 268999999999  678888887542   11111  2333333 4578899999999997 889999


Q ss_pred             cccccc
Q 008374          161 VRSWTL  166 (568)
Q Consensus       161 i~sWs~  166 (568)
                      +++|..
T Consensus       210 Ils~~~  215 (218)
T cd07308         210 ILSVHT  215 (218)
T ss_pred             EEEEEe
Confidence            988864

The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "ba

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.82  E-value=2.8e-08  Score=90.65  Aligned_cols=143  Identities=19%  Similarity=0.224  Sum_probs=101.6

Q ss_pred             ccceeccCCceeEEEEEEccCccccccCeEEEEEE-eccCC-------cccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK-FSRDS-------IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       245 ~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~-~~~~~-------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      ....|-+|+-+.|+++.+.        |+...||. ..+.-       .-..+...+|.+.+.+++--.|.-..-++.+.
T Consensus        11 ~l~likQGAEArv~~~~~~--------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~   82 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT   82 (229)
T ss_pred             cceeeeccceeeEeeeccC--------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec
Confidence            4567889999999999884        66666664 32221       11234677899999888654444444455566


Q ss_pred             CeEEEEEEecCC-CChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC---cEEEe
Q 008374          317 GKLLLVYDFMPN-GSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF---NARLG  392 (568)
Q Consensus       317 ~~~~lV~Ey~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~---~~kL~  392 (568)
                      ..-.|+|||.++ -++.+++...-+.. ..-.....++..|-+.+.-||   ..+++|+||..+||+|..++   .+.+.
T Consensus        83 ~~~~i~ME~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lI  158 (229)
T KOG3087|consen   83 YGGQIYMEFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILI  158 (229)
T ss_pred             CCCeEEEEeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEE
Confidence            667899999976 47888875432222 222233678899999999999   78999999999999996554   45899


Q ss_pred             ecCCccc
Q 008374          393 DFGLARA  399 (568)
Q Consensus       393 DFGla~~  399 (568)
                      |||++..
T Consensus       159 dfgls~~  165 (229)
T KOG3087|consen  159 DFGLSSV  165 (229)
T ss_pred             eecchhc
Confidence            9999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.81  E-value=2.1e-09  Score=119.64  Aligned_cols=212  Identities=20%  Similarity=0.206  Sum_probs=144.7

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC---CcccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD---SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      ..+.|...+-+-+|.++.++.+.-..      .+...+.|.....   .....+....+-.++-..+||.++...--+..
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~------sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~  875 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAG------SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC  875 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccc------cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC
Confidence            44566666677888999988765433      2222233332221   11223333444444444566777766555556


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      ....+||++|..+++|...|+...   .++.......+..+..++.|||   ...+.|||++|.|.+...++..+++|||
T Consensus       876 rsP~~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~  949 (1205)
T KOG0606|consen  876 RSPLPLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFG  949 (1205)
T ss_pred             CCCcchhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccc
Confidence            678999999999999999987543   2333333445566788899999   4568999999999999999999999998


Q ss_pred             Ccccccc------c----------------ccc--cc--ccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHH
Q 008374          396 LARAIEN------E----------------RNS--YA--EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV  449 (568)
Q Consensus       396 la~~~~~------~----------------~~~--~~--~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~  449 (568)
                      +.....-      .                +..  ..  ........||+.|.+||...+......+|.|++|++++|.+
T Consensus       950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen  950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred             cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence            4332210      0                000  00  01122567999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCccc
Q 008374          450 CGRSPGNMIPHQQ  462 (568)
Q Consensus       450 tG~~P~~~~~~~~  462 (568)
                      +|..||.....+.
T Consensus      1030 ~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQ 1042 (1205)
T ss_pred             cCCCCCCCcchhh
Confidence            9999998655444

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.75  E-value=1.8e-07  Score=93.27  Aligned_cols=139  Identities=17%  Similarity=0.097  Sum_probs=97.5

Q ss_pred             eccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-----------cchhhHHHHHHhhcCCCCc--eeeEEEEEEe
Q 008374          249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-----------SKGDFLAELAIIHRLRHKH--LVHLVGWCHE  315 (568)
Q Consensus       249 LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~  315 (568)
                      +-+.....|++..+        .|+.+.||+.......           ....+.+|...+.++...+  ..+++++...
T Consensus        30 v~~~~~rrvvr~~~--------~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~  101 (268)
T PRK15123         30 FRELEGRRTLRFEL--------AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGER  101 (268)
T ss_pred             EecCCCceEEEEEE--------CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEe
Confidence            33333344667655        4678999987443211           1113778999888884333  3345555543


Q ss_pred             -----CCeEEEEEEecCCC-ChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC----
Q 008374          316 -----KGKLLLVYDFMPNG-SLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA----  385 (568)
Q Consensus       316 -----~~~~~lV~Ey~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~----  385 (568)
                           ...-+||+|++++. +|.+++.... ....+...+..++.+++..+.-||   ..+|+|+|++++|||++.    
T Consensus       102 ~~~~~~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~  177 (268)
T PRK15123        102 GSNPATRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPG  177 (268)
T ss_pred             cCCCccceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccC
Confidence                 23578999999886 8988874321 123455677789999999999999   679999999999999975    


Q ss_pred             ---CCcEEEeecCCccc
Q 008374          386 ---DFNARLGDFGLARA  399 (568)
Q Consensus       386 ---~~~~kL~DFGla~~  399 (568)
                         +..+.|+||+.++.
T Consensus       178 ~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        178 REEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCCceEEEEECCcccc
Confidence               47899999998853

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.70  E-value=1.8e-07  Score=88.01  Aligned_cols=126  Identities=22%  Similarity=0.283  Sum_probs=79.3

Q ss_pred             eEEEEEEccCccccccCeEEEEEEeccCCc---------------------cc-----chhhHHHHHHhhcCCCC--cee
Q 008374          256 IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---------------------KS-----KGDFLAELAIIHRLRHK--HLV  307 (568)
Q Consensus       256 ~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---------------------~~-----~~~~~~E~~~l~~l~H~--nIv  307 (568)
                      .||.|...       ++..+|||..+....                     ..     .....+|.+.|.++..-  ++.
T Consensus         1 ~Vy~~~~~-------~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP   73 (188)
T PF01163_consen    1 DVYHAIDP-------DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVP   73 (188)
T ss_dssp             EEEEEEEC-------TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS-
T ss_pred             CEEEEECC-------CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            38888775       578999998743100                     00     01245799999999765  455


Q ss_pred             eEEEEEEeCCeEEEEEEecC--CCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCCEEEc
Q 008374          308 HLVGWCHEKGKLLLVYDFMP--NGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYY-LQNEYDQKVVHRDLKASNILLD  384 (568)
Q Consensus       308 ~l~g~~~~~~~~~lV~Ey~~--~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~ivHrDikp~NILld  384 (568)
                      +++.+-    .-+|||||++  +..+..+...     .++......++.+++..+.. +|   ..+++|+||.+.|||++
T Consensus        74 ~p~~~~----~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~  141 (188)
T PF01163_consen   74 KPYDYN----RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVD  141 (188)
T ss_dssp             -EEEEE----TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEE
T ss_pred             cEEEEe----CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEee
Confidence            665442    2379999998  5445443311     12234455677777775555 45   67999999999999999


Q ss_pred             CCCcEEEeecCCccccc
Q 008374          385 ADFNARLGDFGLARAIE  401 (568)
Q Consensus       385 ~~~~~kL~DFGla~~~~  401 (568)
                      ++ .+.|+|||.+....
T Consensus       142 ~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  142 DG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             TT-CEEE--GTTEEETT
T ss_pred             cc-eEEEEecCcceecC
Confidence            88 99999999887554

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.59  E-value=1.5e-08  Score=109.01  Aligned_cols=156  Identities=19%  Similarity=0.247  Sum_probs=103.0

Q ss_pred             HHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccc----cccccccccCCcCCcccCccccc
Q 008374          353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN----SYAEHGLVGVPGTMGYVAPECFH  428 (568)
Q Consensus       353 ~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~----~~~~~~~~~~~Gt~~y~APE~~~  428 (568)
                      +.+++.|+.|+|.  +.++||++|.|++|.+++++..||+.|+.+........    .+...-.....-...|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            4456699999996  78999999999999999999999999998765544211    11111111223456899999999


Q ss_pred             cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcC
Q 008374          429 TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACS  508 (568)
Q Consensus       429 ~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl  508 (568)
                      ....+.++|+||+|++++-+..|..+.-........+...             .-.+..-...+..+.+.++.+-+.+.+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-------------~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-------------RNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-------------hcccccccccccccCcHHHHHHHHHHh
Confidence            9888999999999999999996666543222211111100             000111111112334445555555778


Q ss_pred             CCCCCCCCCHHHHHH
Q 008374          509 HPIASERPKTEDILQ  523 (568)
Q Consensus       509 ~~dp~~RPt~~evl~  523 (568)
                      ..++.-||++.++..
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            899999998888754

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.54  E-value=2.2e-06  Score=87.48  Aligned_cols=259  Identities=17%  Similarity=0.182  Sum_probs=152.9

Q ss_pred             ccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeEEEEEE-------eC
Q 008374          245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHLVGWCH-------EK  316 (568)
Q Consensus       245 ~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~-------~~  316 (568)
                      .++-||+|+-+.+|---         +-...+-|++.........+-.   ..|... .||-+..-+.|-.       ..
T Consensus        15 ~gr~LgqGgea~ly~l~---------e~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~   82 (637)
T COG4248          15 PGRPLGQGGEADLYTLG---------EVRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRG   82 (637)
T ss_pred             CCccccCCccceeeecc---------hhhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCcc
Confidence            34569999999999532         1222345666544333322222   223333 4654433233321       12


Q ss_pred             CeEEEEEEecCCCC-hhhhhcc---CCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          317 GKLLLVYDFMPNGS-LEKYLYG---TSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       317 ~~~~lV~Ey~~~gs-L~~~L~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                      ...-+.|+.+++.- ...++..   ...-...+|...++.++.+|.+.+-||   ..|.+-+|+.++|+|+.++..+.|.
T Consensus        83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LV  159 (637)
T COG4248          83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLV  159 (637)
T ss_pred             ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEE
Confidence            23567777765542 2222221   122345789999999999999999999   5699999999999999999999998


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccc-----cCCCCccchhHHHHHHHHHHHhC-CCCCCCCCcccchhh
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH-----TGKATPESDVFGFGAVVLEVVCG-RSPGNMIPHQQHAYT  466 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~t~~sDV~SfGvll~el~tG-~~P~~~~~~~~~~~~  466 (568)
                      |=.--....++..      ....+|...|.+||.-.     +...+..+|-|.+|+++++++.| +.||.+.........
T Consensus       160 dsDsfqi~~ng~~------~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~  233 (637)
T COG4248         160 DSDSFQINANGTL------HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPN  233 (637)
T ss_pred             cccceeeccCCce------EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCC
Confidence            7443332222211      22567899999999753     34457789999999999999886 999985433221111


Q ss_pred             HHHHHHHHhhcCchhhhhhhhcCC-----CCc-HHHHHHHHHHHHhcCCC--CCCCCCCHHHHHHHHhC
Q 008374          467 LVDWVWMLHREGHIQDAVDQRLNI-----NSV-VDEAKRLLLLGLACSHP--IASERPKTEDILQIISG  527 (568)
Q Consensus       467 l~~~~~~~~~~~~~~~~~d~~l~~-----~~~-~~~~~~l~~l~l~Cl~~--dp~~RPt~~evl~~L~~  527 (568)
                      -.+   .....|.....-|.+...     ..+ .-....+.-+-.+|+..  ++.-|||++..+..|..
T Consensus       234 p~E---~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a  299 (637)
T COG4248         234 PLE---TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA  299 (637)
T ss_pred             cch---hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence            111   011123333333322211     111 11222333344466553  36789999998887754

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.47  E-value=1.9e-06  Score=82.76  Aligned_cols=124  Identities=23%  Similarity=0.246  Sum_probs=91.0

Q ss_pred             cCeEEEEEEeccCCc-------ccchhhHHHHHHhhcCCC--CceeeEEEEEEeCC----eEEEEEEecCCC-Chhhhhc
Q 008374          271 DNTQIAVKKFSRDSI-------KSKGDFLAELAIIHRLRH--KHLVHLVGWCHEKG----KLLLVYDFMPNG-SLEKYLY  336 (568)
Q Consensus       271 ~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~L~  336 (568)
                      ..+.+-+|.......       -......+|...+.++..  -...+.+++.....    .-+||+|++++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            355666665432111       234467788888887753  33556677666532    458999999874 7999885


Q ss_pred             cCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC---cEEEeecCCcccc
Q 008374          337 GTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF---NARLGDFGLARAI  400 (568)
Q Consensus       337 ~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~---~~kL~DFGla~~~  400 (568)
                      ...   .++...+..++.+++..+.-||   ..+|+|+|+++.|||++.+.   .+.++||+.++..
T Consensus       111 ~~~---~~~~~~~~~ll~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  111 QWE---QLDPSQRRELLRALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hhc---ccchhhHHHHHHHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            422   2556678889999999999999   67999999999999999887   8999999987754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.42  E-value=4.7e-06  Score=79.16  Aligned_cols=138  Identities=19%  Similarity=0.167  Sum_probs=102.4

Q ss_pred             eccCCceeEEEEEEccCccccccCeEEEEEEeccC---C---cccchhhHHHHHHhhcCCC--CceeeEEEEEE-eC---
Q 008374          249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD---S---IKSKGDFLAELAIIHRLRH--KHLVHLVGWCH-EK---  316 (568)
Q Consensus       249 LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~-~~---  316 (568)
                      -|+||-+.|++-.+.        |..+-+|+-...   +   +.....|.+|...|.++..  -.+.++. ++. .+   
T Consensus        26 ~~rgG~SgV~r~~~~--------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~   96 (216)
T PRK09902         26 YRRNGMSGVQCVERN--------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEG   96 (216)
T ss_pred             cCCCCcceEEEEEeC--------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCC
Confidence            477899999987663        457889986521   1   3356789999999999853  2344444 332 22   


Q ss_pred             -CeEEEEEEecCC-CChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc--EEEe
Q 008374          317 -GKLLLVYDFMPN-GSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN--ARLG  392 (568)
Q Consensus       317 -~~~~lV~Ey~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~--~kL~  392 (568)
                       -.-+||+|-+++ -+|.+++.... ....+...+..++.+++..+.-||   ..++.|+|+.+.|||++.++.  ++++
T Consensus        97 ~~rA~LVTe~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lI  172 (216)
T PRK09902         97 EWRALLVTEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFL  172 (216)
T ss_pred             ceEEEEEEEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEE
Confidence             246899997753 58888884432 224567778899999999999999   679999999999999986666  9999


Q ss_pred             ecCCccc
Q 008374          393 DFGLARA  399 (568)
Q Consensus       393 DFGla~~  399 (568)
                      ||.-++.
T Consensus       173 DlEk~r~  179 (216)
T PRK09902        173 DLEKSRR  179 (216)
T ss_pred             Ehhccch
Confidence            9987664

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.34  E-value=1.8e-06  Score=93.18  Aligned_cols=142  Identities=17%  Similarity=0.219  Sum_probs=92.2

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc---------------------------------------
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS---------------------------------------  287 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~---------------------------------------  287 (568)
                      .-|+.++-|+||+|+++       +|+.||||+....-.+.                                       
T Consensus       131 ~PiAsASIaQVH~A~L~-------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~  203 (517)
T COG0661         131 EPIASASIAQVHRAVLK-------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR  203 (517)
T ss_pred             CchhhhhHhhheeEEec-------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence            35889999999999998       68999999864321110                                       


Q ss_pred             -chhhHHHHHHhhcCC-----CCceeeEEEEE-EeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHH
Q 008374          288 -KGDFLAELAIIHRLR-----HKHLVHLVGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV  360 (568)
Q Consensus       288 -~~~~~~E~~~l~~l~-----H~nIv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L  360 (568)
                       .-+|.+|...+.+++     .+++ ++=..+ .-.+...|+|||++|-.+.+...-..  ...+   +..++..++++.
T Consensus       204 ~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d---~k~ia~~~~~~f  277 (517)
T COG0661         204 EELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGID---RKELAELLVRAF  277 (517)
T ss_pred             HHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCC---HHHHHHHHHHHH
Confidence             013444555555542     2333 222222 22456799999999999988852222  2344   223333333332


Q ss_pred             HHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccc
Q 008374          361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE  403 (568)
Q Consensus       361 ~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~  403 (568)
                        +......+++|.|..|-||+++.++.+.+.|||+...++..
T Consensus       278 --~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         278 --LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             --HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence              11112349999999999999999999999999998877554

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.32  E-value=3.5e-06  Score=81.98  Aligned_cols=136  Identities=22%  Similarity=0.268  Sum_probs=91.6

Q ss_pred             cccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc----------------------cchhhHHHHHHhhcC
Q 008374          244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK----------------------SKGDFLAELAIIHRL  301 (568)
Q Consensus       244 ~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l  301 (568)
                      ....+||.|--+.||.|...       ++.++|||.-+....+                      .+....+|.++|.+|
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~-------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L  166 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDP-------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRL  166 (304)
T ss_pred             hhccccccCccceEEEEECC-------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHh
Confidence            44578999999999999876       5889999964221000                      112346788999988


Q ss_pred             CCC--ceeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 008374          302 RHK--HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKAS  379 (568)
Q Consensus       302 ~H~--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~  379 (568)
                      .-.  .+.+.+++    +.-.+||||..+--|...-        ++-...-.++..|..-+.-+-   ..+++|+|+.+-
T Consensus       167 ~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSef  231 (304)
T COG0478         167 YPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEF  231 (304)
T ss_pred             hhcCCCCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchh
Confidence            644  56666654    3558999999886654432        112222233333333333222   469999999999


Q ss_pred             CEEEcCCCcEEEeecCCccccc
Q 008374          380 NILLDADFNARLGDFGLARAIE  401 (568)
Q Consensus       380 NILld~~~~~kL~DFGla~~~~  401 (568)
                      ||++++++.+.++||--+....
T Consensus       232 NIlV~~dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         232 NILVTEDGDIVVIDWPQAVPIS  253 (304)
T ss_pred             eEEEecCCCEEEEeCcccccCC
Confidence            9999999999999997665443

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.29  E-value=9.9e-06  Score=78.97  Aligned_cols=139  Identities=17%  Similarity=0.221  Sum_probs=84.7

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCc--eeeEEEEEEeCCeEEEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKH--LVHLVGWCHEKGKLLLVYD  324 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~E  324 (568)
                      ..||+|..+.||+.          .+..+++|......  ......+|.+++..+..-.  +.+.++++...+...+|||
T Consensus         7 ~~i~~G~t~~~y~~----------~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e   74 (226)
T TIGR02172         7 TQTGEGGNGESYTH----------KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYE   74 (226)
T ss_pred             eeecCCCCcceeEe----------cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeee
Confidence            46899999999983          23457788875432  3345688999998886433  4677888877788899999


Q ss_pred             ecCCCC-hhhhh---------------------ccCCCcccCCHHHHHH-HHH----------HHHH-HHHHHHhc-CCC
Q 008374          325 FMPNGS-LEKYL---------------------YGTSEQVTLNWNHRYK-ILT----------GVAS-AVYYLQNE-YDQ  369 (568)
Q Consensus       325 y~~~gs-L~~~L---------------------~~~~~~~~l~~~~~~~-i~~----------~ia~-~L~yLH~~-~~~  369 (568)
                      +++|.+ +...+                     |.-.. .......+.. +..          .+.. ...+|... ...
T Consensus        75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~  153 (226)
T TIGR02172        75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS  153 (226)
T ss_pred             ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence            998863 22111                     11000 0001000000 000          0111 12222211 134


Q ss_pred             CeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          370 KVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       370 ~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      .++|+|+.|.||++++++ +.|.||+.+..
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            678999999999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd06902 lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 transmembrane proteins, N-terminal lectin domain

Probab=98.19  E-value=2e-05  Score=76.26  Aligned_cols=139  Identities=20%  Similarity=0.248  Sum_probs=80.8

Q ss_pred             CCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEec-CCccccccc-c----
Q 008374           11 ISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNI-NSVVSRKNV-P----   84 (568)
Q Consensus        11 ~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidi-ns~~s~~~~-~----   84 (568)
                      .+||||||.++....     ..|..+|-.+.- +|      +||.|||+.|....+...|-+=+ ++....... .    
T Consensus        75 ~~gdG~a~W~t~~~~-----~~G~~~G~~~~f-~G------l~I~~Dt~~n~~~~~~p~i~~~~NDGt~~yd~~~D~~~~  142 (225)
T cd06902          75 IGADGLAIWYTKERG-----EEGPVFGSSDKW-NG------VGIFFDSFDNDGKKNNPAILVVGNDGTKSYDHQNDGLTQ  142 (225)
T ss_pred             CCCCEEEEEEECCCC-----CCCCccCCCCcc-cE------EEEEEECCCCCCCCCCcEEEEEECCCCeeccccCCCccc
Confidence            468999999997532     234444443321 22      79999999875333333443322 221221110 1    


Q ss_pred             -CCC-CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccc-cCCCcccccccccCCCcccccccc
Q 008374           85 -LKD-NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKD-YLKPESYFGFSASTGYPHIQLNCV  161 (568)
Q Consensus        85 -~~~-~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~-~l~~~~~vGfsastG~~~~~~~~i  161 (568)
                       ++. ...+. ....+.+++|.|+.  ..|.|.++...  .+.........++.. .||...|+||||+||. ..+-|-+
T Consensus       143 ~~~~C~~~~r-n~~~p~~~rI~Y~~--~~l~V~~d~~~--~~~~~~~~~Cf~~~~v~LP~~~yfGiSA~Tg~-l~d~hDI  216 (225)
T cd06902         143 ALGSCLRDFR-NKPYPVRAKITYYQ--NVLTVSINNGF--TPNKDDYELCTRVENMVLPPNGYFGVSAATGG-LADDHDV  216 (225)
T ss_pred             ccceEEEecc-CCCCCeEEEEEEEC--CeEEEEEeCCc--CCCCCcccEEEecCCeeCCCCCEEEEEecCCC-CCCcEeE
Confidence             111 01111 23567899999987  45888887432  222222334444444 4578899999999997 8888999


Q ss_pred             cccccc
Q 008374          162 RSWTLD  167 (568)
Q Consensus       162 ~sWs~~  167 (568)
                      ++|.+.
T Consensus       217 ls~~~~  222 (225)
T cd06902         217 LSFLTF  222 (225)
T ss_pred             EEEEEe
Confidence            887754

ERGIC-53 and ERGL, N-terminal carbohydrate recognition domain. ERGIC-53 and ERGL are eukaryotic mannose-binding type 1 transmembrane proteins of the early secretory pathway that transport newly synthesized glycoproteins from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC). ERGIC-53 and ERGL have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. ERGIC-53 functions as a 'cargo receptor' to facilitate the export of glycoproteins with different characteristics from the ER, while the ERGIC-53-like protein (ERGL) which may act as a regulator of ERGIC-53. In mammals, ERGIC-53 forms a complex with MCFD2 (multi-coagulation factor deficiency 2) which then recruits blood coagulation factors V and VIII. Mutations in either MCFD2 or ERGIC-53 cause a mild form of inherite

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.04  E-value=1.6e-05  Score=85.64  Aligned_cols=141  Identities=19%  Similarity=0.208  Sum_probs=90.6

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc-------------------------------------ch
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-------------------------------------KG  289 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~  289 (568)
                      +-||.-+.|+||+|+++       +|+.||||+-...-...                                     .-
T Consensus       167 ~piaaASlaQVhrA~L~-------~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~EL  239 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK-------NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQEL  239 (538)
T ss_pred             chhhhcchhheEEEEec-------CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhc
Confidence            45899999999999998       58999999853321110                                     11


Q ss_pred             hhHHHHHHhhcC----CCCc------eeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHH
Q 008374          290 DFLAELAIIHRL----RHKH------LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASA  359 (568)
Q Consensus       290 ~~~~E~~~l~~l----~H~n------Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~  359 (568)
                      +|..|.+-..+.    .|-+      |.+++-.+  .....|+||||+|..+.+.-.-.  ...++..   .++..+.++
T Consensus       240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~---~i~~~l~~~  312 (538)
T KOG1235|consen  240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAID--KRGISPH---DILNKLVEA  312 (538)
T ss_pred             chHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHH--HcCCCHH---HHHHHHHHH
Confidence            355555544433    3544      22333222  24679999999998887764321  1234433   334333333


Q ss_pred             HHHHHhcCCCCeEecCCCCCCEEEcC----CCcEEEeecCCccccccc
Q 008374          360 VYYLQNEYDQKVVHRDLKASNILLDA----DFNARLGDFGLARAIENE  403 (568)
Q Consensus       360 L~yLH~~~~~~ivHrDikp~NILld~----~~~~kL~DFGla~~~~~~  403 (568)
                        |++.....|++|+|-.|-||++..    ++.+.+-|||+...+.+.
T Consensus       313 --~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  313 --YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             --HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence              222222458999999999999983    678999999998877654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.99  E-value=9e-05  Score=71.83  Aligned_cols=143  Identities=18%  Similarity=0.209  Sum_probs=83.9

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCC--ceeeEEEEEEe---CCeEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHK--HLVHLVGWCHE---KGKLLL  321 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~g~~~~---~~~~~l  321 (568)
                      +.|+.|..+.||+....        +..+++|.....  .....+..|..++..+...  .+.+++.++..   ....++
T Consensus         3 ~~l~~G~~n~~~~v~~~--------~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~   72 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTD--------DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYL   72 (239)
T ss_dssp             EEEEESSSSEEEEEEET--------TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEE
T ss_pred             ccCCCCCeeeEEEEEEC--------CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceE
Confidence            46899999999998764        358999997544  3456677888888887433  35566665533   345799


Q ss_pred             EEEecCCCChhh----------------hh---ccC-CCcccCCHHH---------HHHH------------HHHHHH-H
Q 008374          322 VYDFMPNGSLEK----------------YL---YGT-SEQVTLNWNH---------RYKI------------LTGVAS-A  359 (568)
Q Consensus       322 V~Ey~~~gsL~~----------------~L---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-~  359 (568)
                      +|+++++..+..                .+   +.. .......+..         ....            ...+.+ .
T Consensus        73 ~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (239)
T PF01636_consen   73 LMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERL  152 (239)
T ss_dssp             EEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred             EEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHH
Confidence            999999988877                11   111 0001111100         0000            111222 3


Q ss_pred             HHHHHhc----CCCCeEecCCCCCCEEEc-CCCcEEEeecCCccc
Q 008374          360 VYYLQNE----YDQKVVHRDLKASNILLD-ADFNARLGDFGLARA  399 (568)
Q Consensus       360 L~yLH~~----~~~~ivHrDikp~NILld-~~~~~kL~DFGla~~  399 (568)
                      +..++..    ....++|+|+.+.|||++ +++.+.|.||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  153 LQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            3333322    356799999999999999 666668999987653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.99  E-value=3e-05  Score=73.18  Aligned_cols=106  Identities=19%  Similarity=0.197  Sum_probs=84.0

Q ss_pred             HHHHHhhcCCC-CceeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 008374          293 AELAIIHRLRH-KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKV  371 (568)
Q Consensus       293 ~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  371 (568)
                      .|.-++..+++ +++.+++|.|-    .++|.||.+.+++...-..-.+-..-+|..|.+|+.++++.+.+|++.....+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            47788888876 69999999993    36789999877664321000111247899999999999999999998766678


Q ss_pred             EecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          372 VHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       372 vHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      .-.|++++|+-+++++++|+.|...+...+.
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~~~  114 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVEDK  114 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchhHH
Confidence            8899999999999999999999987765543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.98  E-value=0.00013  Score=69.70  Aligned_cols=137  Identities=14%  Similarity=0.136  Sum_probs=87.7

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhh---------HHHHHHhhcCC---CCcee
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---------LAELAIIHRLR---HKHLV  307 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~---H~nIv  307 (568)
                      ..+|...+.+-......|.+-..        ++..+++|..+.......+.|         .+++..+.+++   .-...
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~  101 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPA  101 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccc
Confidence            45666666666666666655443        578899998765433222222         23444444442   22333


Q ss_pred             eEEEEEEe-----CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 008374          308 HLVGWCHE-----KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL  382 (568)
Q Consensus       308 ~l~g~~~~-----~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIL  382 (568)
                      .++..+..     ....+|+|||++|..|.++..       ++.    .++..+++++.-||   ..|++|+|+.|.|++
T Consensus       102 ~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFl  167 (229)
T PF06176_consen  102 DPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFL  167 (229)
T ss_pred             cceeeeeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEE
Confidence            33333322     235679999999988876641       221    24566777888899   679999999999999


Q ss_pred             EcCCCcEEEeecCCccc
Q 008374          383 LDADFNARLGDFGLARA  399 (568)
Q Consensus       383 ld~~~~~kL~DFGla~~  399 (568)
                      +.+++ +++.||+..+.
T Consensus       168 v~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  168 VSNNG-IRIIDTQGKRM  183 (229)
T ss_pred             EECCc-EEEEECccccc
Confidence            98655 99999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.98  E-value=9.3e-05  Score=72.93  Aligned_cols=140  Identities=16%  Similarity=0.156  Sum_probs=85.1

Q ss_pred             eccCCc-eeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-CCceeeEEEEEEeCCeEEEEEEec
Q 008374          249 LGEGGF-GIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-HKHLVHLVGWCHEKGKLLLVYDFM  326 (568)
Q Consensus       249 LG~G~f-G~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~  326 (568)
                      |-.|.. ..||+....        +..+.||+.....   ..+..+|++++..+. +--+.+++++....+..++|||++
T Consensus         6 ~~~g~~~~~v~~~~~~--------~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   74 (244)
T cd05150           6 VTEGQSGATVYRLDGK--------NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAV   74 (244)
T ss_pred             cCCCCCcCeEEEEcCC--------CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEee
Confidence            455555 678988542        3578888875443   445778999988874 334557788777666789999999


Q ss_pred             CCCChhhhh-------------------ccCCC-cccCC--HHHHHHHHH--------------------HHHHHHHHHH
Q 008374          327 PNGSLEKYL-------------------YGTSE-QVTLN--WNHRYKILT--------------------GVASAVYYLQ  364 (568)
Q Consensus       327 ~~gsL~~~L-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~ia~~L~yLH  364 (568)
                      ++.+|....                   |.... .....  +..+.....                    .+...+..|-
T Consensus        75 ~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  154 (244)
T cd05150          75 PGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELE  154 (244)
T ss_pred             CCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHH
Confidence            988776442                   11000 00110  001110000                    0111122221


Q ss_pred             hc----CCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          365 NE----YDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       365 ~~----~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ..    ....++|+|+.|.|||++++....|+||+.+..
T Consensus       155 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         155 ATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             hhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            11    135699999999999999988889999987753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.87  E-value=1.5e-06  Score=92.88  Aligned_cols=182  Identities=15%  Similarity=0.131  Sum_probs=128.6

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCc-eeeEEEEEEeCCeEEEEEEe
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKH-LVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey  325 (568)
                      +-+++|+++++||.+-..       .+...++.+...     ....-++++|.+++||| .+..++-+..+....+++++
T Consensus       248 h~fvK~altknpKkRpta-------eklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTA-------EKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             HHHHHHHhcCCCccCCCh-------hhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            347899999999976542       223334444322     34566899999999999 77777777777888999999


Q ss_pred             cCCC-ChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccccc
Q 008374          326 MPNG-SLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER  404 (568)
Q Consensus       326 ~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~  404 (568)
                      +..+ +-..-..  .....+...+...+...-.++++|||.   -.-+|||    ||+..+ ...|.+||+.+..+....
T Consensus       316 ~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  316 CSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             hcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc
Confidence            9776 2211110  111223333444556666788899984   3358888    776655 678999999998876654


Q ss_pred             ccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008374          405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGN  456 (568)
Q Consensus       405 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~  456 (568)
                      .      .+...+|+.|+|||......+..+.|+|+.|+-..++.-|-.|-.
T Consensus       386 ~------~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 K------PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             c------cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            2      125679999999999999999999999999987777777776643

>PLN02876 acyl-CoA dehydrogenase

Probab=97.83  E-value=0.00022  Score=82.80  Aligned_cols=152  Identities=13%  Similarity=0.251  Sum_probs=93.1

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCC-CCce--eeEEEEEEeC---Ce
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLR-HKHL--VHLVGWCHEK---GK  318 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nI--v~l~g~~~~~---~~  318 (568)
                      ..+++.|.+..+|+.....++    ....+++|+...... .....+.+|.++++.+. |.++  .+++.+|.+.   +.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~----~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGG----SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCC----cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            456899999999997664311    124677887654321 23356889999999995 6664  7888888764   46


Q ss_pred             EEEEEEecCCCChhhh-----------------------hccCCCc--------ccCC--------HHHHHHH-------
Q 008374          319 LLLVYDFMPNGSLEKY-----------------------LYGTSEQ--------VTLN--------WNHRYKI-------  352 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~-----------------------L~~~~~~--------~~l~--------~~~~~~i-------  352 (568)
                      .++||||+++..+.+-                       ||.-...        ....        |...+.-       
T Consensus       119 ~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~  198 (822)
T PLN02876        119 AFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKP  198 (822)
T ss_pred             ceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCC
Confidence            7999999987653221                       1110000        0001        1111111       


Q ss_pred             --HHHHHHHHHHHHhcCC--------CCeEecCCCCCCEEEcCC-C-cEEEeecCCccccc
Q 008374          353 --LTGVASAVYYLQNEYD--------QKVVHRDLKASNILLDAD-F-NARLGDFGLARAIE  401 (568)
Q Consensus       353 --~~~ia~~L~yLH~~~~--------~~ivHrDikp~NILld~~-~-~~kL~DFGla~~~~  401 (568)
                        ...+...+.+|.....        ..++|+|+++.||+++.+ . ..-|.||.++..-+
T Consensus       199 ~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        199 PRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN  259 (822)
T ss_pred             CCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence              1123344566643221        359999999999999853 3 35789999887643

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.74  E-value=0.00051  Score=66.49  Aligned_cols=155  Identities=20%  Similarity=0.222  Sum_probs=95.2

Q ss_pred             ccCHHHHHHHhcCccccce---eccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccc---------hhh------
Q 008374          230 EFKYKELKKATNNFHESMR---LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK---------GDF------  291 (568)
Q Consensus       230 ~~~~~el~~at~~f~~~~~---LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~---------~~~------  291 (568)
                      ..+++.|....++..+...   |.+|--+.||+|.-.       ++..+|||+++.......         ..|      
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~  106 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSN  106 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCC
Confidence            3455566666665555555   446777789998753       578999999854321111         111      


Q ss_pred             ---------HHHHHHhhcCC--CCceeeEEEEEEeCCeEEEEEEecCCCC-hhhhhccCCCcccCCHHHHHHHHHHHHHH
Q 008374          292 ---------LAELAIIHRLR--HKHLVHLVGWCHEKGKLLLVYDFMPNGS-LEKYLYGTSEQVTLNWNHRYKILTGVASA  359 (568)
Q Consensus       292 ---------~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gs-L~~~L~~~~~~~~l~~~~~~~i~~~ia~~  359 (568)
                               .+|..-|.++.  +-.+.+-+++.    +-.|||||+.... -.-.|.    ...+...+...+..++++.
T Consensus       107 rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~  178 (268)
T COG1718         107 RRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEY  178 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHH
Confidence                     23555565552  22333333332    3379999996541 111121    1222333455666667776


Q ss_pred             HHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       360 L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      +.-|-.  ..++||+||..-|||+. ++.+.|+|||-|....+
T Consensus       179 ~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         179 MRRLYK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             HHHHHH--hcCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence            666653  36999999999999999 88999999998876554

>cd06901 lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembrane proteins, lectin domain

Probab=97.69  E-value=0.00052  Score=67.45  Aligned_cols=134  Identities=22%  Similarity=0.275  Sum_probs=70.8

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCC---CCCCeeeEec-CCcccccc--
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFD---PDDNHLGLNI-NSVVSRKN--   82 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d---~~~~hvgidi-ns~~s~~~--   82 (568)
                      ...+||||||+++....     ..|..+|-.+. -+|      +||-|||+.|..-   ....-|-+=+ |+......  
T Consensus        72 ~~~~GdGlAfw~t~~~~-----~~G~~fG~~~~-f~G------l~I~~Dt~~n~~~~~~~~~P~i~~~~NDGt~~yd~~~  139 (248)
T cd06901          72 KNLFGDGFAIWYTKERM-----QPGPVFGSKDN-FHG------LAIFFDTYSNQNGEHEHVHPYISAMVNNGSLSYDHDR  139 (248)
T ss_pred             CCCCCCEEEEEEEcCCC-----ccCcccccCCC-Cce------EEEEEECCCCCCCcccCCCceEEEEEcCCCeeecccC
Confidence            35689999999998532     23333343221 112      8999999988521   1111221111 22122111  


Q ss_pred             ----ccCCC-CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccc-cCCCcccccccccCCCccc
Q 008374           83 ----VPLKD-NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKD-YLKPESYFGFSASTGYPHI  156 (568)
Q Consensus        83 ----~~~~~-~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~-~l~~~~~vGfsastG~~~~  156 (568)
                          ..++. ...+. ..+....++|.|...  .+.|.++..+.  ..   ......... .||...|+||||+||. ..
T Consensus       140 Dg~~~~~~~C~~~~r-n~~~~t~~rI~Y~~~--~l~v~vd~~~~--~~---w~~Cf~~~~v~LP~~~yfGiSA~Tg~-~s  210 (248)
T cd06901         140 DGTHTELAGCSAPFR-NKDHDTFVAIRYSKG--RLTVMTDIDGK--NE---WKECFDVTGVRLPTGYYFGASAATGD-LS  210 (248)
T ss_pred             CCchhhcCceeeecc-CCCCCeEEEEEEECC--eEEEEEecCCC--Cc---eeeeEEeCCeecCCCCEEEEEecCCC-CC
Confidence                01111 01111 235567899999864  57777765331  11   111222222 3477799999999997 66


Q ss_pred             ccccccc
Q 008374          157 QLNCVRS  163 (568)
Q Consensus       157 ~~~~i~s  163 (568)
                      +-|-+++
T Consensus       211 d~hdIls  217 (248)
T cd06901         211 DNHDIIS  217 (248)
T ss_pred             CcEEEEE
Confidence            7776654

The vesicular integral protein of 36 kDa (VIP36) is a type 1 transmembrane protein of the mammalian early secretory pathway that acts as a cargo receptor transporting high mannose type glycoproteins between the Golgi and the endoplasmic reticulum (ER). Lectins of the early secretory pathway are involved in the selective transport of newly synthesized glycoproteins from the ER to the ER-Golgi intermediate compartment (ERGIC). The most prominent cycling lectin is the mannose-binding type1 membrane protein ERGIC-53, which functions as a cargo receptor to facilitate export of glycoproteins from the ER. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded she

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.56  E-value=0.0011  Score=62.67  Aligned_cols=126  Identities=25%  Similarity=0.328  Sum_probs=89.1

Q ss_pred             hcCccccceeccCCc-eeEEEEEEccCccccccCeEEEEEEecc---CCc------------------ccchhhHHHHHH
Q 008374          240 TNNFHESMRLGEGGF-GIVYKGIIHHNDQYHVDNTQIAVKKFSR---DSI------------------KSKGDFLAELAI  297 (568)
Q Consensus       240 t~~f~~~~~LG~G~f-G~Vy~g~~~~~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~  297 (568)
                      +.+++..+.||.|.- |.|||..+        .++.+|+|..+.   ...                  ....-|..|.+.
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I--------~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRA  107 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEI--------DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRA  107 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEE--------CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHh
Confidence            377888999999999 99999987        478999999321   000                  112358899999


Q ss_pred             hhcCC---CCce--eeEEEEEEeC------------------CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHH
Q 008374          298 IHRLR---HKHL--VHLVGWCHEK------------------GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILT  354 (568)
Q Consensus       298 l~~l~---H~nI--v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~  354 (568)
                      ..+|+   +.++  |+.+||..-.                  ....||.||.+...            .++...    +.
T Consensus       108 fgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~  171 (207)
T PF13095_consen  108 FGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IP  171 (207)
T ss_pred             hHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HH
Confidence            88885   4456  9999997322                  12467888775533            222222    44


Q ss_pred             HHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       355 ~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      +|.+-|..+|   ..+|+-+|+++.|..     .-||+|||.+
T Consensus       172 ~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  172 QMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence            5555666777   679999999999974     4689999864

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.53  E-value=0.0014  Score=62.30  Aligned_cols=132  Identities=26%  Similarity=0.328  Sum_probs=90.0

Q ss_pred             ccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC----------------cccchhhHHHHHHhhcCC------
Q 008374          245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS----------------IKSKGDFLAELAIIHRLR------  302 (568)
Q Consensus       245 ~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------  302 (568)
                      ....||+|+.-.||.-  +       .+....||+.....                ....+++.+|+.....+.      
T Consensus         5 ~~~~i~~G~~R~cy~H--P-------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~   75 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQH--P-------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVD   75 (199)
T ss_pred             CCcccccCCCceEEEC--C-------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCc
Confidence            3457999999999963  2       45567888876654                223456777777666665      


Q ss_pred             CCceeeEEEEEEeCCeEEEEEEecCC--C----ChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 008374          303 HKHLVHLVGWCHEKGKLLLVYDFMPN--G----SLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDL  376 (568)
Q Consensus       303 H~nIv~l~g~~~~~~~~~lV~Ey~~~--g----sL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDi  376 (568)
                      +.+|.+++|+.....-+-+|+|...+  |    +|.+++..    ..++. ...+.   +-.-..||-   +..|+.+|+
T Consensus        76 ~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~---L~~f~~~l~---~~~Iv~~dl  144 (199)
T PF10707_consen   76 WSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQA---LDEFKRYLL---DHHIVIRDL  144 (199)
T ss_pred             ccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHH---HHHHHHHHH---HcCCeecCC
Confidence            78899999999999999999998643  2    47777732    23444 33333   333345555   568999999


Q ss_pred             CCCCEEEcCC--C--cEEEee-cCC
Q 008374          377 KASNILLDAD--F--NARLGD-FGL  396 (568)
Q Consensus       377 kp~NILld~~--~--~~kL~D-FGl  396 (568)
                      +|.||++...  +  .+.|.| ||-
T Consensus       145 ~~~NIv~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  145 NPHNIVVQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             CcccEEEEecCCCceEEEEEeCCCC
Confidence            9999999533  2  467777 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.48  E-value=0.00072  Score=66.28  Aligned_cols=32  Identities=25%  Similarity=0.296  Sum_probs=27.0

Q ss_pred             CCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          368 DQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       368 ~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ...++|+|+.+.||+++++...-|.||+.+..
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            34599999999999999876677999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.42  E-value=0.0024  Score=62.44  Aligned_cols=142  Identities=20%  Similarity=0.238  Sum_probs=79.8

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCce-eeEEEEEEeCCeEEEEEEe
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHL-VHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey  325 (568)
                      +.|..|-...+|+.....+     .+..+++|..... .....+-.+|+.++..+....+ .++++.+.  +  .++|||
T Consensus         4 ~~l~gG~tN~~~~v~~~~~-----~~~~~vlR~~~~~-~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~   73 (235)
T cd05157           4 KRFTGGITNKLVKVSNKED-----NQDAVLVRVYGNK-TELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEF   73 (235)
T ss_pred             EEcCCcccceEEEEEcCCC-----CCCeEEEEEccCC-ccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEe
Confidence            4577787889998864310     1467888876543 2222334578888888854333 44444332  2  479999


Q ss_pred             cCCCChhhh-----------------hccCCCc--------ccCC-HHHHHHHHH----------------------HHH
Q 008374          326 MPNGSLEKY-----------------LYGTSEQ--------VTLN-WNHRYKILT----------------------GVA  357 (568)
Q Consensus       326 ~~~gsL~~~-----------------L~~~~~~--------~~l~-~~~~~~i~~----------------------~ia  357 (568)
                      +++.++...                 +|.....        .... |.....+..                      .+.
T Consensus        74 i~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  153 (235)
T cd05157          74 IPGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLR  153 (235)
T ss_pred             eCCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHH
Confidence            998776322                 1111111        0111 222111111                      111


Q ss_pred             HHHHHH----Hhc-CCCCeEecCCCCCCEEEcC-CCcEEEeecCCcc
Q 008374          358 SAVYYL----QNE-YDQKVVHRDLKASNILLDA-DFNARLGDFGLAR  398 (568)
Q Consensus       358 ~~L~yL----H~~-~~~~ivHrDikp~NILld~-~~~~kL~DFGla~  398 (568)
                      ..+..|    ... ....++|+|+.+.|||+++ +..+.|.||..|.
T Consensus       154 ~~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         154 DEISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            111222    111 2357999999999999998 5789999998775

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.39  E-value=0.0015  Score=64.90  Aligned_cols=138  Identities=14%  Similarity=0.058  Sum_probs=78.8

Q ss_pred             eccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCce-eeEEEEEEeCCeEEEEEEecC
Q 008374          249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHL-VHLVGWCHEKGKLLLVYDFMP  327 (568)
Q Consensus       249 LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~  327 (568)
                      +..|-.+.+|+...        .+..+++|........-..+..+|.++++.+....+ .+++..+.    -.+||||++
T Consensus         4 ~~~G~tn~~y~~~~--------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~   71 (256)
T TIGR02721         4 LSGGLTNRSWRIEH--------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLE   71 (256)
T ss_pred             CCCcCcCCeEEEEe--------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEecc
Confidence            45677788998763        456788887654322221346789999988864333 34444432    368999999


Q ss_pred             CCChhhh-----------------hccCCC-cccCCHHHHH-HHHH---------HHHHHHHHHHhc-----CCCCeEec
Q 008374          328 NGSLEKY-----------------LYGTSE-QVTLNWNHRY-KILT---------GVASAVYYLQNE-----YDQKVVHR  374 (568)
Q Consensus       328 ~gsL~~~-----------------L~~~~~-~~~l~~~~~~-~i~~---------~ia~~L~yLH~~-----~~~~ivHr  374 (568)
                      +..+...                 ||.... ...++...+. ....         .+...+..+...     ....++|+
T Consensus        72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~  151 (256)
T TIGR02721        72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM  151 (256)
T ss_pred             CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence            8776432                 121111 1112221111 1111         111112222111     13468999


Q ss_pred             CCCCCCEEEcCCCcEEEeecCCccc
Q 008374          375 DLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       375 Dikp~NILld~~~~~kL~DFGla~~  399 (568)
                      |+.|.||++++++ ++|.||..|..
T Consensus       152 Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       152 DVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCCcCcEEEeCCC-CEEEeccccCc
Confidence            9999999999877 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=97.36  E-value=0.0031  Score=64.17  Aligned_cols=77  Identities=10%  Similarity=0.012  Sum_probs=55.3

Q ss_pred             ccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCC---CceeeEEEEEEe---CCe
Q 008374          245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRH---KHLVHLVGWCHE---KGK  318 (568)
Q Consensus       245 ~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~g~~~~---~~~  318 (568)
                      ..+.||.|..+.||+-...        +..+.+|..+..  .....|..|.+.|+.+.-   -.+.+++++|..   .+.
T Consensus        18 ~~~~i~~G~~~~vy~~~~~--------~~~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~   87 (297)
T PRK10593         18 RVECISEQPYAALWALYDS--------QGNPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP   87 (297)
T ss_pred             eeeecCCccceeEEEEEcC--------CCCEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence            3456999999999997543        234666764321  123578899999988853   367788888864   366


Q ss_pred             EEEEEEecCCCCh
Q 008374          319 LLLVYDFMPNGSL  331 (568)
Q Consensus       319 ~~lV~Ey~~~gsL  331 (568)
                      .+||||++++.++
T Consensus        88 ~~LVmE~i~G~~~  100 (297)
T PRK10593         88 DVLLLERLRGVSV  100 (297)
T ss_pred             eEEEEeccCCEec
Confidence            8999999998765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.36  E-value=0.00073  Score=77.49  Aligned_cols=196  Identities=16%  Similarity=0.137  Sum_probs=131.1

Q ss_pred             hHHHHHHhhcCCCCceeeEEEEEEeCCeE----EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhc
Q 008374          291 FLAELAIIHRLRHKHLVHLVGWCHEKGKL----LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE  366 (568)
Q Consensus       291 ~~~E~~~l~~l~H~nIv~l~g~~~~~~~~----~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~  366 (568)
                      -.-|++.+.++.|+|++.++.|-.++...    .+.-|++..-++...+.   .-..++....+.+..+...||.|+|..
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            34577788889999999999998765432    23456777777777773   334577788888899999999999954


Q ss_pred             CCCCeEecCCCCC---CEEEcCCCcEEEe--ecCCccccccccccccccccccCCcCCcccCccccccCCCCc--cchhH
Q 008374          367 YDQKVVHRDLKAS---NILLDADFNARLG--DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATP--ESDVF  439 (568)
Q Consensus       367 ~~~~ivHrDikp~---NILld~~~~~kL~--DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~--~sDV~  439 (568)
                         ...|.-+..+   +...+.++...++  ||+..+.+.......      ...-+..|.|+|......+..  ..|+|
T Consensus       306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~------~~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF------SDLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             ---ccceeEEecccccccccCccceeecchhhhcccccCCCcccch------hhcCccccccccccccccchhhhhhHHH
Confidence               4444444444   4445666777777  888887765543322      122345677888876655544  47999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 008374          440 GFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTE  519 (568)
Q Consensus       440 SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~  519 (568)
                      .+|.++..+..|..+-.....                   ....++.    ....    .+......|+..++++|++..
T Consensus       377 ~lgll~~~~~~~~~i~~~~~~-------------------~~~~l~~----~~~~----~~~d~~~~~~~~~~~~Rl~~~  429 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKSAV-------------------PVSLLDV----LSTS----ELLDALPKCLDEDSEERLSAL  429 (1351)
T ss_pred             HHHHHHhhhhhcCcccccccc-------------------hhhhhcc----ccch----hhhhhhhhhcchhhhhccchh
Confidence            999999999998765321100                   0011111    1111    345566689999999999999


Q ss_pred             HHHHHH
Q 008374          520 DILQII  525 (568)
Q Consensus       520 evl~~L  525 (568)
                      +++...
T Consensus       430 ~ll~~~  435 (1351)
T KOG1035|consen  430 ELLTHP  435 (1351)
T ss_pred             hhhhch
Confidence            998754

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.29  E-value=0.0035  Score=65.96  Aligned_cols=76  Identities=11%  Similarity=0.097  Sum_probs=51.8

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccC------C-cccchhhHHHHHHhhcCC---CCceeeEEEEEEeC
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD------S-IKSKGDFLAELAIIHRLR---HKHLVHLVGWCHEK  316 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~  316 (568)
                      +.||.|.+..||+.....      .++.++||.-...      + ....+.+..|.+.|..+.   -.++.+++.+.  .
T Consensus        32 ~elggGn~N~VyrV~~~~------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~  103 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTE------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--E  103 (401)
T ss_pred             eEcCCCceEEEEEEEeCC------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--C
Confidence            468999999999998752      2258999984321      1 123456677888887763   23566677663  3


Q ss_pred             CeEEEEEEecCCCC
Q 008374          317 GKLLLVYDFMPNGS  330 (568)
Q Consensus       317 ~~~~lV~Ey~~~gs  330 (568)
                      +..++||||+++..
T Consensus       104 ~~~~lVME~L~~~~  117 (401)
T PRK09550        104 ELAVTVMEDLSDHK  117 (401)
T ss_pred             CCCEEEEecCCCcc
Confidence            55789999998644

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.24  E-value=0.0016  Score=59.78  Aligned_cols=129  Identities=22%  Similarity=0.269  Sum_probs=86.7

Q ss_pred             ccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceee-EEEEEEeCCeEEEEE
Q 008374          245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH-LVGWCHEKGKLLLVY  323 (568)
Q Consensus       245 ~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~-l~g~~~~~~~~~lV~  323 (568)
                      ....|++|.+|.||+|.+.        +..+|+|.-..++  .+..+..|.++|..+.--++-+ ++.|-.    -++.|
T Consensus        26 v~~~L~KG~~s~Vyl~~~~--------~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~m   91 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR--------GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRM   91 (201)
T ss_pred             hhhhhhcccccEEEEeecc--------CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhh
Confidence            3456999999999999985        5689999876554  4567889999999887665543 344332    24559


Q ss_pred             EecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC-CCCEEEcCCCcEEEeecCCcccc
Q 008374          324 DFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK-ASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       324 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDik-p~NILld~~~~~kL~DFGla~~~  400 (568)
                      ||..+-.|.+.-...      +-.+    +..++..---|.   ..+|-|..|. |...+|-.+..+.|+||.-|+.-
T Consensus        92 e~i~G~~L~~~~~~~------~rk~----l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          92 EYIDGRPLGKLEIGG------DRKH----LLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhcCcchhhhhhcc------cHHH----HHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            999887887765221      2222    233444422233   4588888876 55555555669999999988743

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.12  E-value=0.0057  Score=62.03  Aligned_cols=143  Identities=18%  Similarity=0.188  Sum_probs=85.4

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCC--ceeeEEEE------EEeCC
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHK--HLVHLVGW------CHEKG  317 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~g~------~~~~~  317 (568)
                      .+.|..|....+|+....        +..+++|+...   ....+...|++++..+.+.  .+.+++..      ....+
T Consensus        19 i~~i~~G~~n~~y~v~~~--------~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~   87 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--------SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG   87 (296)
T ss_pred             eecccCccccceEEEEeC--------CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence            345677777899987543        34688888754   2334566778877777432  24444432      12345


Q ss_pred             eEEEEEEecCCCChhh----h----------hccCC--------CcccCCHHHHHH----------HHHHHHHHHHHHHh
Q 008374          318 KLLLVYDFMPNGSLEK----Y----------LYGTS--------EQVTLNWNHRYK----------ILTGVASAVYYLQN  365 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~----~----------L~~~~--------~~~~l~~~~~~~----------i~~~ia~~L~yLH~  365 (568)
                      ..++|++|+++..+..    .          +|...        ......|.....          ....+..++.++..
T Consensus        88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  167 (296)
T cd05153          88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA  167 (296)
T ss_pred             ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence            6789999999877643    0          01100        001123322211          11223344555543


Q ss_pred             ----cCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          366 ----EYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       366 ----~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                          ....+++|+|+.|.||+++++....|.||+.+..
T Consensus       168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence                1235799999999999999987789999987753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd06903 lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmembrane proteins, N-terminal lectin domain

Probab=97.12  E-value=0.0052  Score=59.12  Aligned_cols=126  Identities=18%  Similarity=0.221  Sum_probs=67.9

Q ss_pred             CCCCcEEEEEccCCCCCCCCCCC-cceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecCCcccccc-----cc
Q 008374           11 ISGHGLAFVIAPNDSFPPESSYG-QWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKN-----VP   84 (568)
Q Consensus        11 ~~~~G~aF~i~~~~~~~~~~~~g-~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidins~~s~~~-----~~   84 (568)
                      .+||||||.++......    .| ...|-.+. -+|      +||.|||+.|.. |  ..-++--++-.....     ..
T Consensus        74 ~~gdGla~W~t~~~~~~----~g~~~fG~~~~-f~G------l~I~~Dt~~n~~-p--~i~~~~NDGt~~yd~~~d~~~~  139 (215)
T cd06903          74 RSGGGLNFWLVKDGNAD----VGTSSIYGPSK-FDG------LQLLIDNNGGSG-G--SLRGFLNDGSKDYKNEDVDSLA  139 (215)
T ss_pred             cCCCEEEEEEECCCccc----CCccccCCCCC-CcE------EEEEEECCCCCC-c--eEEEEECCCCeeccccCCcccc
Confidence            57999999999753321    11 12222111 112      799999988621 1  111111122111111     11


Q ss_pred             CCC-CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeE-eeCccccCC-CcccccccccCCCcccccccc
Q 008374           85 LKD-NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKE-TINLKDYLK-PESYFGFSASTGYPHIQLNCV  161 (568)
Q Consensus        85 ~~~-~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~-~~dl~~~l~-~~~~vGfsastG~~~~~~~~i  161 (568)
                      ++. ... ...++.+.+++|.|......|.|.++..       .++.. .+.    || ...|+||||+||. ..+-|.+
T Consensus       140 ~g~C~~~-~rn~~~p~~iri~Y~~~~~~l~v~vd~~-------~Cf~~~~v~----lP~~~y~fGiSAaTg~-~~d~hdI  206 (215)
T cd06903         140 FGSCLFA-YQDSGVPSTIRLSYDALNSLFKVQVDNR-------LCFQTDKVQ----LPQGGYRFGITAANAD-NPESFEI  206 (215)
T ss_pred             cceeeEe-ccCCCCCEEEEEEEECCCCEEEEEECCC-------EEEecCCee----cCCCCCEEEEEEcCCC-CCCcEEE
Confidence            111 011 1234678899999988777888887531       22221 123    35 4456999999997 6677766


Q ss_pred             cc
Q 008374          162 RS  163 (568)
Q Consensus       162 ~s  163 (568)
                      ++
T Consensus       207 l~  208 (215)
T cd06903         207 LK  208 (215)
T ss_pred             EE
Confidence            53

EMP46 and EMP47, N-terminal carbohydrate recognition domain. EMP46 and EMP47 are fungal type-I transmembrane proteins that cycle between the endoplasmic reticulum and the golgi apparatus and are thought to function as cargo receptors that transport newly synthesized glycoproteins. EMP47 is a receptor for EMP46 responsible for the selective transport of EMP46 by forming hetero-oligomerization between the two proteins. EMP46 and EMP47 have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. EMP46 and EMP47 are 45% sequence-identical to one another and have sequence homology to a class of intracellular lectins defined by ERGIC-53 and VIP36. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat s

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.08  E-value=0.0054  Score=62.44  Aligned_cols=147  Identities=22%  Similarity=0.267  Sum_probs=83.9

Q ss_pred             eeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCce-eeEEEEEEeCCeEEEEEEec
Q 008374          248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHL-VHLVGWCHEKGKLLLVYDFM  326 (568)
Q Consensus       248 ~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~  326 (568)
                      .|..|-...+|+.........+..+..+++|...... ....+..+|.+++..+....+ .++++++. .   .+|+||+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence            4555666789988754211111235788898865543 233456788888888753333 35555553 2   3589999


Q ss_pred             CCCChhhh-----------------hccCCCcc--------cCCHHHHHH--------------------------HHHH
Q 008374          327 PNGSLEKY-----------------LYGTSEQV--------TLNWNHRYK--------------------------ILTG  355 (568)
Q Consensus       327 ~~gsL~~~-----------------L~~~~~~~--------~l~~~~~~~--------------------------i~~~  355 (568)
                      ++..+...                 +|......        ..-|.....                          +...
T Consensus        80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (302)
T cd05156          80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED  159 (302)
T ss_pred             CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence            88776432                 11111110        001111110                          1112


Q ss_pred             HHHHHHHHHh------cCCCCeEecCCCCCCEEEcCC----CcEEEeecCCccc
Q 008374          356 VASAVYYLQN------EYDQKVVHRDLKASNILLDAD----FNARLGDFGLARA  399 (568)
Q Consensus       356 ia~~L~yLH~------~~~~~ivHrDikp~NILld~~----~~~kL~DFGla~~  399 (568)
                      +...+.+|..      .....++|+|+.+.|||++++    +.++++||..|..
T Consensus       160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            2223334432      135679999999999999985    8899999988753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.07  E-value=0.017  Score=59.24  Aligned_cols=158  Identities=18%  Similarity=0.174  Sum_probs=83.1

Q ss_pred             cCHHHHHHHhcCccc-----cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCC-
Q 008374          231 FKYKELKKATNNFHE-----SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHK-  304 (568)
Q Consensus       231 ~~~~el~~at~~f~~-----~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~-  304 (568)
                      .+.+++......|..     .+.|+.|....+|+....        +..+++|+.....   .+....|..++..|... 
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~--------~g~~vLK~~~~~~---~~~l~~~~~~l~~L~~~g   75 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTT--------QGEYVLTLFERLT---AEDLPFFLGLMQHLAARG   75 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeC--------CCcEEEEEeccCC---hHHhHHHHHHHHHHHHCC
Confidence            344455544445543     234666777789987643        3368889875212   22333455555554211 


Q ss_pred             -ceeeEEE------EEEeCCeEEEEEEecCCCChhhh--------------hccCCC--------cccCCH-HHHHHH--
Q 008374          305 -HLVHLVG------WCHEKGKLLLVYDFMPNGSLEKY--------------LYGTSE--------QVTLNW-NHRYKI--  352 (568)
Q Consensus       305 -nIv~l~g------~~~~~~~~~lV~Ey~~~gsL~~~--------------L~~~~~--------~~~l~~-~~~~~i--  352 (568)
                       .+.+.+.      +....+..++++||+++..+...              +|....        ...+.| .....-  
T Consensus        76 lpvP~~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~  155 (319)
T PRK05231         76 VPVPAPVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLL  155 (319)
T ss_pred             CCCCcceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHh
Confidence             1233332      12235678999999988754210              111100        011222 111111  


Q ss_pred             ----------H-HHHHHHHHHHHhc----CCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          353 ----------L-TGVASAVYYLQNE----YDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       353 ----------~-~~ia~~L~yLH~~----~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                                + ..+...+..+...    ...+++|+|+.+.||+++.+...-|.||+.+..
T Consensus       156 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        156 PFLADEQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             hccChhHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence                      1 1111222333211    246899999999999999776668999998753

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.79  E-value=0.028  Score=57.39  Aligned_cols=156  Identities=17%  Similarity=0.179  Sum_probs=86.7

Q ss_pred             HHHHHHHhcCccc-----cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCC--c
Q 008374          233 YKELKKATNNFHE-----SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHK--H  305 (568)
Q Consensus       233 ~~el~~at~~f~~-----~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--n  305 (568)
                      -++|....+.|..     ...++.|.-..+|+....        +..+++|+.....  ..++...|.+++..|...  .
T Consensus         9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~--------~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~p   78 (307)
T TIGR00938         9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD--------VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLP   78 (307)
T ss_pred             HHHHHHHHHhcCCCCceeccccCCccccceEEEEeC--------CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCC
Confidence            3455554444533     234666666789987542        3357788764421  123445666777666322  2


Q ss_pred             eeeEEEEE------EeCCeEEEEEEecCCCChhhh--------------hccCCCc---------ccCCHHHHHH-----
Q 008374          306 LVHLVGWC------HEKGKLLLVYDFMPNGSLEKY--------------LYGTSEQ---------VTLNWNHRYK-----  351 (568)
Q Consensus       306 Iv~l~g~~------~~~~~~~lV~Ey~~~gsL~~~--------------L~~~~~~---------~~l~~~~~~~-----  351 (568)
                      +.+++...      ...+..++++||+++..+...              +|.....         ..-.|.....     
T Consensus        79 vp~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~  158 (307)
T TIGR00938        79 VPKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEA  158 (307)
T ss_pred             CCccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhc
Confidence            34444321      224567899999988654211              1110000         0112221111     


Q ss_pred             -------HHHHHHHHHHHHHh----cCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          352 -------ILTGVASAVYYLQN----EYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       352 -------i~~~ia~~L~yLH~----~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                             ....+...+.++..    ....+++|+|+.+.||+++++....|.||+.+.
T Consensus       159 ~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       159 APQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             ccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence                   11123344555542    235789999999999999998877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd06900 lectin_VcfQ VcfQ bacterial pilus biogenesis protein, lectin domain

Probab=96.79  E-value=0.013  Score=56.08  Aligned_cols=151  Identities=17%  Similarity=0.216  Sum_probs=80.0

Q ss_pred             CCCCCcEEEEEccCCCCCCCCCCCcceecccCCC-CCCCCCcEEEEEeeCCCCCCCCCC---CeeeEecCCcc---ccc-
Q 008374           10 DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFT-DGNKANHFVAIEFDTVKQGFDPDD---NHLGLNINSVV---SRK-   81 (568)
Q Consensus        10 ~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~-~~~~~~~~~aVEfDt~~~~~d~~~---~hvgidins~~---s~~-   81 (568)
                      ..++||+||||+--..-|..+..||-||+.-.+. ...-...++.|-||.|.|.-.++.   .-.|.--|+|.   |-. 
T Consensus        73 g~GADGia~vLsDasv~p~~G~fGGsLGYa~~~~~~~GfaGGwLGiGlDEyGNFsn~~eg~~~~~g~r~~sV~vRGsg~g  152 (255)
T cd06900          73 GNGADGVALVLSDASVTPQAGAFGGSLGYAQRNDGVPGFAGGWLGIGLDEYGNFSNPNEGRNGFSGRRPQSVTVRGSGSG  152 (255)
T ss_pred             CCCCceEEEEEeCCCcCCcCCCcCcccccccccCCCCccccceEEEEEeccccccCCCCCccCCcccccceEEEECCCCC
Confidence            5689999999995322234578999999977652 223467899999999988622221   11222222221   000 


Q ss_pred             ---cccCCC----CcccccC------CCceEEEEEEEcCc-ccEEEEEEeeCCCCCCCCCeeeE--eeCcc--ccCCCcc
Q 008374           82 ---NVPLKD----NYNITLS------DGTSYTVWVQYDGK-SKLIQVFMDREGETMPQKPLLKE--TINLK--DYLKPES  143 (568)
Q Consensus        82 ---~~~~~~----~~~~~l~------~g~~~~~~I~Yd~~-~~~l~v~~~~~~~~~~~~~~~~~--~~dl~--~~l~~~~  143 (568)
                         ...+..    ...++..      .+-.+++.||=... ...|+|.-+..+.-. ..+++..  .++.+  .-+|+..
T Consensus       153 ~~gY~yl~gt~~~~~~id~~~~~~~~~~hrY~i~Ids~~~~~~~vsV~R~~~~gg~-~~~~I~~~d~~~~~~q~avP~~f  231 (255)
T cd06900         153 YTGYKYITGTGVLPPGIDNNSTSTPAPGHRYRITIDSTNGDNAWLSVERDIGNGGA-YFVVILTFDALAEQNQDAIPENF  231 (255)
T ss_pred             CcCceEecccCCCCcccccCCCCCCCCceEEEEEEecCCCCceEEEEEEEccCCce-eEEeecceeeccccCCCCCCccE
Confidence               000000    0111101      12345555555422 235556555332111 1222211  12222  4678999


Q ss_pred             cccccccCCCccccccccc
Q 008374          144 YFGFSASTGYPHIQLNCVR  162 (568)
Q Consensus       144 ~vGfsastG~~~~~~~~i~  162 (568)
                      +++|+++||. ....|.|-
T Consensus       232 ~lS~TgSTGg-stN~HEId  249 (255)
T cd06900         232 YLSFTGSTGG-STNTHEID  249 (255)
T ss_pred             EEEEEecCCC-cccceeec
Confidence            9999999997 77777663

This family includes bacterial proteins homologous to the VcfQ (also known as MshQ) bacterial pilus biogenesis protein. VcfQ is encoded by the vcfQ gene of the type IV pilus gene cluster of Vibrio cholerae and is essential for type IV pilus assembly. VcfQ has a Laminin G-like domain as well as an L-type lectin domain.

>PLN02236 choline kinase

Probab=96.59  E-value=0.029  Score=58.35  Aligned_cols=145  Identities=16%  Similarity=0.176  Sum_probs=82.6

Q ss_pred             eeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCcee-eEEEEEEeCCeEEEEEEec
Q 008374          248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV-HLVGWCHEKGKLLLVYDFM  326 (568)
Q Consensus       248 ~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~  326 (568)
                      .|-.|-.-.+|+..+.....  ..+..+++|....... ..-+-.+|..++..+..-++. ++++.+.. +   .|+||+
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~--~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi  115 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEG--NLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFI  115 (344)
T ss_pred             EcCCcccceeEEEEeCCCCC--CCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEee
Confidence            35456677899987643211  1346788998765432 223347788888888544443 45565532 2   589999


Q ss_pred             CCCChhhh-----------------hccCCC--cc-cCCHHHHHHHHHH-----------------HHHHHHHHHh----
Q 008374          327 PNGSLEKY-----------------LYGTSE--QV-TLNWNHRYKILTG-----------------VASAVYYLQN----  365 (568)
Q Consensus       327 ~~gsL~~~-----------------L~~~~~--~~-~l~~~~~~~i~~~-----------------ia~~L~yLH~----  365 (568)
                      ++.+|...                 +|....  .. ...|.+..+...+                 +...+..|..    
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87676422                 121110  00 1112222222211                 1112222221    


Q ss_pred             -cCCCCeEecCCCCCCEEEcC-CCcEEEeecCCccc
Q 008374          366 -EYDQKVVHRDLKASNILLDA-DFNARLGDFGLARA  399 (568)
Q Consensus       366 -~~~~~ivHrDikp~NILld~-~~~~kL~DFGla~~  399 (568)
                       .....++|+|+++.|||+++ ++.++++||..|..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             22447999999999999986 47899999988764

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.55  E-value=0.0007  Score=79.32  Aligned_cols=160  Identities=14%  Similarity=0.017  Sum_probs=109.4

Q ss_pred             hHHHHHHhhcCCCCceeeEEEEEE--eCCeEEEEEEecCCCChhhhhccCCC-cccCCHHHHHHHHHHHHHHHHHHH--h
Q 008374          291 FLAELAIIHRLRHKHLVHLVGWCH--EKGKLLLVYDFMPNGSLEKYLYGTSE-QVTLNWNHRYKILTGVASAVYYLQ--N  365 (568)
Q Consensus       291 ~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~lV~Ey~~~gsL~~~L~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH--~  365 (568)
                      ...|...++...|+++.....-..  +..+.+.+++|+..|.+.+.+-+..+ ...++.......-.+......-.|  +
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            344555566678888776554332  33467889999999999998865432 222332222222222133333322  2


Q ss_pred             cCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHH
Q 008374          366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVV  445 (568)
Q Consensus       366 ~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll  445 (568)
                      ....-.+|+++|+-|.+|+.+.++|++++|+.+...+... ...    ...+++.|++|+....-.++.++|+|..|+.+
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-f~G----l~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-FFG----LELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHh-hhh----hhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence            2244588999999999999999999999999994433322 111    45678899999999988999999999999999


Q ss_pred             HHHHhCCCCC
Q 008374          446 LEVVCGRSPG  455 (568)
Q Consensus       446 ~el~tG~~P~  455 (568)
                      ++..-|..++
T Consensus      1431 y~rs~~n~~f 1440 (2724)
T KOG1826|consen 1431 YLRSDGNAYF 1440 (2724)
T ss_pred             HHHhcccHHH
Confidence            9988877654

>PF03388 Lectin_leg-like: Legume-like lectin family; InterPro: IPR005052 Lectins are structurally diverse proteins that bind to specific carbohydrates

Probab=96.52  E-value=0.011  Score=57.57  Aligned_cols=133  Identities=20%  Similarity=0.243  Sum_probs=67.8

Q ss_pred             CCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCC---CCCeeeEecCC-ccccccc--
Q 008374           10 DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDP---DDNHLGLNINS-VVSRKNV--   83 (568)
Q Consensus        10 ~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~---~~~hvgidins-~~s~~~~--   83 (568)
                      ...||||||.++.....     .|..+|-.+.- +|      +||=|||+.|...+   ....|.+-+|- -.+....  
T Consensus        75 ~~~g~G~a~W~t~~~~~-----~G~~fG~~~~f-~G------l~i~idt~~N~~~~~~~~~p~i~~~~NDGt~~~~~~~d  142 (229)
T PF03388_consen   75 GLGGDGMAFWYTKDPGS-----DGPVFGGPDKF-DG------LGIFIDTYDNDEGGHKRGFPYISAMLNDGTKSYDHDND  142 (229)
T ss_dssp             SS-S-EEEEEEESSSSS-----SCSBTTB-SS--EE------EEEEEEES-TTCTTCTSTSSEEEEEEEESSS---GGGT
T ss_pred             CcCCCeEEEEEEcCccc-----cccccCCCccc-ce------EEEEEEcccCCCcccccccceEEEEecCCCcccccccc
Confidence            45899999999975332     34444532221 12      78999999885322   22333332221 1111111  


Q ss_pred             ----cCCCCcccccC-CCceEEEEEEEcCcccEEEEEEeeC--CCCCCCCCeeeE-eeCccccCCCcccccccccCCCcc
Q 008374           84 ----PLKDNYNITLS-DGTSYTVWVQYDGKSKLIQVFMDRE--GETMPQKPLLKE-TINLKDYLKPESYFGFSASTGYPH  155 (568)
Q Consensus        84 ----~~~~~~~~~l~-~g~~~~~~I~Yd~~~~~l~v~~~~~--~~~~~~~~~~~~-~~dl~~~l~~~~~vGfsastG~~~  155 (568)
                          .++. =.+... .+.+.+++|.|...  .+.|.++..  .....-..++.. .+    .||...|+|+||+||. .
T Consensus       143 g~~~~~~~-C~~~~rn~~~p~~~ri~Y~~~--~l~v~id~~~~~~~~~~~~Cf~~~~v----~LP~~~yfGvSA~Tg~-~  214 (229)
T PF03388_consen  143 GKDQSLGS-CSADYRNSDVPTRIRISYSKN--TLTVSIDSNYLKNQDDWELCFTTDGV----DLPEGYYFGVSAATGE-L  214 (229)
T ss_dssp             TTTT-SEE-EE---BTESSEEEEEEEEETT--EEEEEEETSCCSECCTTEEEEEESTE----EGGSSBEEEEEEEESS-S
T ss_pred             Cccccccc-ceeccCcCCCCEEEEEEEECC--eEEEEEecccccCCcCCcEEEEcCCe----ecCCCCEEEEEecCCC-C
Confidence                0100 001111 35677899999775  466666532  111222334332 12    3578899999999997 6


Q ss_pred             ccccccc
Q 008374          156 IQLNCVR  162 (568)
Q Consensus       156 ~~~~~i~  162 (568)
                      .+.|-++
T Consensus       215 ~d~hdi~  221 (229)
T PF03388_consen  215 SDNHDIL  221 (229)
T ss_dssp             GGEEEEE
T ss_pred             CCcEEEE
Confidence            7777665

This family includes the VIP36 and ERGIC-53 lectins. These two proteins were the first members of the family of animal lectins similar to the leguminous plant lectins []. The alignment for this family is towards the N terminus, where the similarity of VIP36 and ERGIC-53 is greatest. Although they have been identified as a family of animal lectins, this alignment also includes yeast sequences[]. ERGIC-53 is a 53kDa protein, localised to the intermediate region between the endoplasmic reticulum and the Golgi apparatus (ER-Golgi-Intermediate Compartment, ERGIC). It was identified as a calcium-dependent, mannose-specific lectin []. Its dysfunction has been associated with combined factors V and VIII deficiency, suggesting an important and substrate-specific role for ERGIC-53 in the glycoprotein-secreting pathway [,]. The L-type lectin-like domain has an overall globular shape composed of a beta-sandwich of two major twisted antiparallel beta-sheets. The beta-sandwich comprises a major concave beta-sheet and a minor convex beta-sheet, in a variation of the jelly roll fold [, , , ]. ; GO: 0016020 membrane; PDB: 3A4U_A 3LCP_B 2A6Z_A 2A71_C 2A70_B 2A6Y_A 2A6X_A 2A6W_B 2A6V_B 2E6V_B ....

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.03  E-value=0.042  Score=55.45  Aligned_cols=75  Identities=17%  Similarity=0.236  Sum_probs=48.2

Q ss_pred             cccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC---CCceeeEEEEEEeCCeEE
Q 008374          244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR---HKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       244 ~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~  320 (568)
                      ...+.++.|....+|+...        ++..+.||.-.   ......|..|.+-|+.|.   --.+.+++++....+..+
T Consensus        20 ~~~~~v~GG~i~~a~~~~~--------~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~f   88 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLDT--------DGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAF   88 (288)
T ss_dssp             -EEEEE--SSSSEEEEEET--------TS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCE
T ss_pred             eeeEecCCCChhheEEEEC--------CCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCce
Confidence            3345688899999998762        57789999875   334567888988888873   345778899887777779


Q ss_pred             EEEEecCCC
Q 008374          321 LVYDFMPNG  329 (568)
Q Consensus       321 lV~Ey~~~g  329 (568)
                      ||+||++.+
T Consensus        89 Llle~l~~~   97 (288)
T PF03881_consen   89 LLLEFLEMG   97 (288)
T ss_dssp             EEEE-----
T ss_pred             EEEEeecCC
Confidence            999999877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.02  E-value=0.012  Score=62.49  Aligned_cols=48  Identities=21%  Similarity=0.382  Sum_probs=38.2

Q ss_pred             hhhHHHHHHhhcCCCCceeeEEEEEEeC-CeEEEEEEecCCCChhhhhcc
Q 008374          289 GDFLAELAIIHRLRHKHLVHLVGWCHEK-GKLLLVYDFMPNGSLEKYLYG  337 (568)
Q Consensus       289 ~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey~~~gsL~~~L~~  337 (568)
                      .+++....+++.+.|+|+.+.+.+.... ....+|+|++ +.||.+++..
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~   75 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT   75 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence            3466677888899999999999887644 4578899998 7799988843

>KOG3839 consensus Lectin VIP36, involved in the transport of glycoproteins carrying high mannose-type glycans [Intracellular trafficking, secretion, and vesicular transport]

Probab=96.01  E-value=0.015  Score=57.92  Aligned_cols=133  Identities=23%  Similarity=0.352  Sum_probs=75.1

Q ss_pred             CCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCC-C--CeeeE--ecCCcc-----c
Q 008374           10 DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPD-D--NHLGL--NINSVV-----S   79 (568)
Q Consensus        10 ~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~-~--~hvgi--dins~~-----s   79 (568)
                      ..-|||||+.++-...+|+     .-+|-++.-       +.+||=.||+.|..-|. -  .-+.+  ++++..     +
T Consensus       125 ~lfgdG~Aiw~t~Er~q~G-----PvFG~~dkF-------~GL~vfidtY~n~~g~~~~v~P~isvmv~~gs~sYD~~~D  192 (351)
T KOG3839|consen  125 NLFGDGMAIWYTKERAQPG-----PVFGSKDKF-------TGLAVFIDTYGNHNGPHEHVFPYISVMVNIGSLSYDHSKD  192 (351)
T ss_pred             cccccceEEEeecccccCC-----CCCCCcccc-------eeEEEEEeccCCcCCCcccceeeEEEEeccCCcccccCCC
Confidence            4579999999998665543     334443321       33789999988743111 1  11111  222221     0


Q ss_pred             cccccCCCCcccccCC-CceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCcccc-CCCcccccccccCCCcccc
Q 008374           80 RKNVPLKDNYNITLSD-GTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDY-LKPESYFGFSASTGYPHIQ  157 (568)
Q Consensus        80 ~~~~~~~~~~~~~l~~-g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~-l~~~~~vGfsastG~~~~~  157 (568)
                      -..+.+.+ =..++.+ --...+-|.|+.  +.|++..+..+   |..  +....++..+ +|..-|+|+||+||. ..+
T Consensus       193 g~~tel~g-c~a~~rn~~~dt~~~iry~~--~~l~~~~dl~~---~~~--~~~c~~~n~v~lp~g~~fg~SasTGd-lSd  263 (351)
T KOG3839|consen  193 GTHTELAG-CTANFRNLPHDTLVVIRYEK--KTLSISIDLEG---PNE--WIDCFSLNNVELPLGYFFGVSASTGD-LSD  263 (351)
T ss_pred             CCcccccc-ceeeeccCCCcceeEEEecC--CceEEEEecCC---Cce--eeeeeeecceecccceEEeeeeccCc-cch
Confidence            11111211 0011111 123458899988  66777777655   222  5566777664 477789999999996 777


Q ss_pred             cccccc
Q 008374          158 LNCVRS  163 (568)
Q Consensus       158 ~~~i~s  163 (568)
                      .|.+.+
T Consensus       264 ~HdivS  269 (351)
T KOG3839|consen  264 SHDIVS  269 (351)
T ss_pred             hhHHHH
Confidence            776654

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.72  E-value=0.1  Score=53.53  Aligned_cols=73  Identities=23%  Similarity=0.213  Sum_probs=56.8

Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      ...|++|++. ++.|..       ...-.|.+...++.+.++.+.-+..  .-+.-|||+.-.||||+ +|++-|+||-+
T Consensus       299 ~y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkl  367 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKL  367 (488)
T ss_pred             eEEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeee
Confidence            3456777764 444422       2345788999999998888877764  46788999999999999 99999999999


Q ss_pred             cccc
Q 008374          397 ARAI  400 (568)
Q Consensus       397 a~~~  400 (568)
                      +|.-
T Consensus       368 sRl~  371 (488)
T COG5072         368 SRLS  371 (488)
T ss_pred             eecc
Confidence            9953

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=95.58  E-value=0.16  Score=51.77  Aligned_cols=130  Identities=18%  Similarity=0.249  Sum_probs=76.4

Q ss_pred             CeEEEEEEecc--CCcccchhhHHHHHHhhcCCC--CceeeEEEEEEeCC--eEEEEEEecCCCChhhhhccCCC-----
Q 008374          272 NTQIAVKKFSR--DSIKSKGDFLAELAIIHRLRH--KHLVHLVGWCHEKG--KLLLVYDFMPNGSLEKYLYGTSE-----  340 (568)
Q Consensus       272 ~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~--~~~lV~Ey~~~gsL~~~L~~~~~-----  340 (568)
                      +++.++. ...  .......+..+|.++|+.+.-  --....+++|.++.  ..+.||+|+++..+.+.+.....     
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~  126 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA  126 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence            5667777 331  222344556778888887642  23445678887765  77999999988544333311100     


Q ss_pred             ------------------------------cccCCHHHHHHHH--------HHHHHHHHHHHhcC-----CCCeEecCCC
Q 008374          341 ------------------------------QVTLNWNHRYKIL--------TGVASAVYYLQNEY-----DQKVVHRDLK  377 (568)
Q Consensus       341 ------------------------------~~~l~~~~~~~i~--------~~ia~~L~yLH~~~-----~~~ivHrDik  377 (568)
                                                    ...-.|...++.+        -....-..||+...     ...++|+|+.
T Consensus       127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~  206 (321)
T COG3173         127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR  206 (321)
T ss_pred             HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence                                          0001122222111        01222234443321     3569999999


Q ss_pred             CCCEEEcCCCcEEEeecCCcccccc
Q 008374          378 ASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       378 p~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      +.|++++.+.-+=+.||+++..-+.
T Consensus       207 ~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         207 PGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             cCCEEEeCCCeeEEEeccccccCCc
Confidence            9999999988899999999886544

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=95.51  E-value=0.11  Score=52.10  Aligned_cols=32  Identities=34%  Similarity=0.440  Sum_probs=26.3

Q ss_pred             CCeEecCCCCCCEEEcCCCc-EEEeecCCcccc
Q 008374          369 QKVVHRDLKASNILLDADFN-ARLGDFGLARAI  400 (568)
Q Consensus       369 ~~ivHrDikp~NILld~~~~-~kL~DFGla~~~  400 (568)
                      ..++|+|+++.|||+++++. .-|.||+.+..-
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            45899999999999997554 569999987653

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.46  E-value=0.019  Score=57.87  Aligned_cols=149  Identities=17%  Similarity=0.183  Sum_probs=95.6

Q ss_pred             cCHHHHHHHhc---CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--------------------Ccc-
Q 008374          231 FKYKELKKATN---NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--------------------SIK-  286 (568)
Q Consensus       231 ~~~~el~~at~---~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--------------------~~~-  286 (568)
                      +.|-.|+....   -+...++||-|--+-+|.+...       .|.+.++|.-...                    +.. 
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~-------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWly  151 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADE-------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLY  151 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecC-------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhh
Confidence            45555555443   2567889999999999999876       5778888853211                    000 


Q ss_pred             -cchhhHHHHHHhhcCC-CC-ceeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHH
Q 008374          287 -SKGDFLAELAIIHRLR-HK-HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYL  363 (568)
Q Consensus       287 -~~~~~~~E~~~l~~l~-H~-nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yL  363 (568)
                       ++-...+|...|+.|. |. -+.+.++++    ..++|||++.+..|...-+      ..+..+.+.-+.+   .+.-|
T Consensus       152 LSRlaa~kEfafmkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~---~Iv~l  218 (465)
T KOG2268|consen  152 LSRLAATKEFAFMKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMG---LIVRL  218 (465)
T ss_pred             hHHHHHHHHHHHHHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeeee------cCChHHHHHHHHH---HHHHH
Confidence             0112346777777774 32 244445544    5589999998877765431      1233333333322   23333


Q ss_pred             HhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccc
Q 008374          364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN  402 (568)
Q Consensus       364 H~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~  402 (568)
                      .   ..|+||+|..-=||+++++..++++||--.....+
T Consensus       219 a---~~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~sh  254 (465)
T KOG2268|consen  219 A---NHGLIHGDFNEFNIMVKDDDKIVVIDFPQMVSTSH  254 (465)
T ss_pred             H---HcCceecccchheeEEecCCCEEEeechHhhccCC
Confidence            3   56999999999999999999999999976554444

>KOG3838 consensus Mannose lectin ERGIC-53, involved in glycoprotein traffic [Intracellular trafficking, secretion, and vesicular transport]

Probab=95.43  E-value=0.13  Score=52.16  Aligned_cols=135  Identities=19%  Similarity=0.356  Sum_probs=76.3

Q ss_pred             CCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecCC-ccccccc-c----
Q 008374           11 ISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINS-VVSRKNV-P----   84 (568)
Q Consensus        11 ~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidins-~~s~~~~-~----   84 (568)
                      .++|||||--+.....     -|.-+|-.+.= +|      +++=||.|.|...-|+.-|.+=.|. -.+.... +    
T Consensus       107 iGAdGlaiWYt~~~G~-----~GpVfGg~d~W-nG------igiffDSfdnD~qknnP~Is~~lndGt~~ydh~~DGasQ  174 (497)
T KOG3838|consen  107 IGADGLAIWYTRGRGH-----VGPVFGGLDSW-NG------IGIFFDSFDNDGQKNNPAISVLLNDGTIPYDHPGDGASQ  174 (497)
T ss_pred             ccCCceEEEEecCCCc-----ccccccccccc-cc------eEEEeecccccCCcCCccEEEEecCCcccccCCCccHHH
Confidence            3789999998764332     22222222211 12      6888999887533344444443322 1122111 1    


Q ss_pred             -CCC-CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccc-cCCCcccccccccCCCcccccccc
Q 008374           85 -LKD-NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKD-YLKPESYFGFSASTGYPHIQLNCV  161 (568)
Q Consensus        85 -~~~-~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~-~l~~~~~vGfsastG~~~~~~~~i  161 (568)
                       +.+ .+++. +---+..|+|+|  ..++|+|.+... + .|..+ ....++... .||...|+|.||+||. ...-|-+
T Consensus       175 ~LssCqrDFR-NkPyPvRarItY--~~nvLtv~innG-m-tp~d~-yE~C~rve~~~lp~nGyFGvSAATGg-LADDHDV  247 (497)
T KOG3838|consen  175 GLSSCQRDFR-NKPYPVRARITY--YGNVLTVMINNG-M-TPSDD-YEFCVRVENLLLPPNGYFGVSAATGG-LADDHDV  247 (497)
T ss_pred             HHHHhhHHhc-cCCCCceEEEEE--eccEEEEEEcCC-C-CCCCC-cceeEeccceeccCCCeeeeeecccc-cccccce
Confidence             000 01111 012457899999  668899888643 3 34433 355555555 4488899999999997 8888888


Q ss_pred             ccc
Q 008374          162 RSW  164 (568)
Q Consensus       162 ~sW  164 (568)
                      ++.
T Consensus       248 l~F  250 (497)
T KOG3838|consen  248 LSF  250 (497)
T ss_pred             eee
Confidence            754

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.38  E-value=0.19  Score=52.12  Aligned_cols=80  Identities=16%  Similarity=0.169  Sum_probs=48.4

Q ss_pred             eeccCCceeEEEEEEccCccccccCeEEEEEEecc-------CCcccchhhHHHHHHhhcCC--CCcee-eEEEEEEeCC
Q 008374          248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR-------DSIKSKGDFLAELAIIHRLR--HKHLV-HLVGWCHEKG  317 (568)
Q Consensus       248 ~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--H~nIv-~l~g~~~~~~  317 (568)
                      .||.|...-||++....      .++.|+||.-..       ...-..++..-|.+.|....  -|..+ +++.  .+.+
T Consensus         2 EigdGnlN~VfrV~~~~------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e   73 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQE------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTE   73 (370)
T ss_pred             cCCCCceEEEEEEEcCC------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccc
Confidence            47999999999998642      235799997421       11223345556777776653  34333 4443  2445


Q ss_pred             eEEEEEEecCCCC-hhhhh
Q 008374          318 KLLLVYDFMPNGS-LEKYL  335 (568)
Q Consensus       318 ~~~lV~Ey~~~gs-L~~~L  335 (568)
                      ...+|||+++... |.+.|
T Consensus        74 ~~~~vMEdL~~~~ilR~~L   92 (370)
T TIGR01767        74 MAVTVMEDLSHHKIARKGL   92 (370)
T ss_pred             cceehHhhCccchHHHHHH
Confidence            6679999996533 44444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.21  E-value=0.04  Score=52.92  Aligned_cols=31  Identities=35%  Similarity=0.458  Sum_probs=22.3

Q ss_pred             CCeEecCCCCCCEEE-cCCCcEEEeecCCccc
Q 008374          369 QKVVHRDLKASNILL-DADFNARLGDFGLARA  399 (568)
Q Consensus       369 ~~ivHrDikp~NILl-d~~~~~kL~DFGla~~  399 (568)
                      ..++|+|+.+.|||+ +.++.++++||..|..
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            468999999999999 8899999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.16  E-value=0.3  Score=51.53  Aligned_cols=80  Identities=15%  Similarity=0.161  Sum_probs=50.5

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccC----C---cccchhhHHHHHHhhcCC---CCceeeEEEEEEe
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD----S---IKSKGDFLAELAIIHRLR---HKHLVHLVGWCHE  315 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~  315 (568)
                      .+.||.|....||+....        +..++||+-...    .   ......-..|.+.|..+.   ..++.+++.+|. 
T Consensus        37 ~~eiggGn~N~VyrV~~~--------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-  107 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-  107 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-
Confidence            346899999999997642        346889985421    1   112333445566666553   247778898887 


Q ss_pred             CCeEEEEEEecCC--CChhhhh
Q 008374          316 KGKLLLVYDFMPN--GSLEKYL  335 (568)
Q Consensus       316 ~~~~~lV~Ey~~~--gsL~~~L  335 (568)
                       +.-+++|||+++  -.+.+.|
T Consensus       108 -d~~vlvME~L~~~~~ilr~~L  128 (418)
T PLN02756        108 -TMALIGMRYLEPPHIILRKGL  128 (418)
T ss_pred             -CCCEEEEeecCCcceehhhhh
Confidence             345788999976  2344433

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.00  E-value=0.29  Score=50.52  Aligned_cols=144  Identities=19%  Similarity=0.257  Sum_probs=79.9

Q ss_pred             eeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCcee-eEEEEEEeCCeEEEEEEec
Q 008374          248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV-HLVGWCHEKGKLLLVYDFM  326 (568)
Q Consensus       248 ~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~  326 (568)
                      .|..|=...+|+.......   .++..+++|....... ..-+-.+|..+++.+..-++- ++++++. .+   +|.+|+
T Consensus        21 ~l~gGlTN~~~~v~~~~~~---~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi   92 (330)
T PLN02421         21 RISGGITNLLLKVSVKEEN---GNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFI   92 (330)
T ss_pred             EeCCcccceEEEEEecCCC---CCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhh
Confidence            4544666789988654211   0234788888765432 233446888888888654443 5565552 22   589999


Q ss_pred             CCCChhhh-----------------hccCC--Ccc-cCCHHHHHHHHHH----------------------HHHHHHHHH
Q 008374          327 PNGSLEKY-----------------LYGTS--EQV-TLNWNHRYKILTG----------------------VASAVYYLQ  364 (568)
Q Consensus       327 ~~gsL~~~-----------------L~~~~--~~~-~l~~~~~~~i~~~----------------------ia~~L~yLH  364 (568)
                      ++-.|..-                 ||...  ... .--|....+...+                      +..-+..+.
T Consensus        93 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~  172 (330)
T PLN02421         93 NARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELK  172 (330)
T ss_pred             cCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHH
Confidence            77665321                 11111  000 1113222222211                      111122222


Q ss_pred             hc-----CCCCeEecCCCCCCEEEcC-CCcEEEeecCCccc
Q 008374          365 NE-----YDQKVVHRDLKASNILLDA-DFNARLGDFGLARA  399 (568)
Q Consensus       365 ~~-----~~~~ivHrDikp~NILld~-~~~~kL~DFGla~~  399 (568)
                      ..     .....+|+|+.+.|||+++ ++.++++||..|..
T Consensus       173 ~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        173 EITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            11     1235899999999999975 57899999998764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	568
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-44
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-43
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-35
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-35
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-34
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-34
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-34
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-32
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-19
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-17
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-15
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		9e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		9e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-14
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-14
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-14
1fny_A	237	Legume Lectin Of The Bark Of Robinia Pseudoacacia.		6e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-14
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		9e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-13
2pel_A	236	Peanut Lectin Length = 236		2e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-13
1bzw_A	232	Peanut Lectin Complexed With C-Lactose Length = 232		4e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-13
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		9e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		9e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-11
2eig_A	234	Lotus Tetragonolobus Seed Lectin (Isoform) Length =		1e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-11
2e7q_A	237	Crystal Structure Of Basic Winged Bean Lectin In Co		1e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-11
1wbf_A	242	Winged Bean Lectin, Saccharide Free Form Length = 2		1e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-11
1wbl_A	241	Winged Bean Lectin Complexed With Methyl-Alpha-D-Ga		1e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-11
3zvx_A	261	Structure Of The Lectin From Platypodium Elegans In		2e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-11
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-11
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		8e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		9e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-10
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-10
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-10
2sba_A	253	Soybean Agglutinin Complexed With 2,6-Pentasacchari		3e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-10
3usu_A	256	Crystal Structure Of Butea Monosperma Seed Lectin L		5e-10
3usu_B	242	Crystal Structure Of Butea Monosperma Seed Lectin L		5e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-09
1gsl_A	243	Lectin (Fourth Isolated From (Griffonia Simplicifol		4e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-09
1fat_A	252	Phytohemagglutinin-L Length = 252		7e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-09
1g8w_A	233	Improved Structure Of Phytohemagglutinin-L From The		7e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-09
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-09
1dbn_A	239	Maackia Amurensis Leukoagglutinin (Lectin) With Sia		9e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-08
3ujo_A	281	Galactose-Specific Seed Lectin From Dolichos Lablab		1e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-08
1gnz_A	257	Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)m		2e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-08
1hql_A	257	The Xenograft Antigen In Complex With The B4 Isolec		2e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-08
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		7e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		9e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-07
1n47_A	233	Isolectin B4 From Vicia Villosa In Complex With The		1e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-07
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-07
3ipv_B	239	Crystal Structure Of Spatholobus Parviflorus Seed L		2e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-07
1bjq_A	253	The Dolichos Biflorus Seed Lectin In Complex With A		3e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-07
2bqp_A	234	The Structure Of The Pea Lectin-D-Glucopyranose Com		4e-07
3ipv_A	251	Crystal Structure Of Spatholobus Parviflorus Seed L		4e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-07
1fay_A	238	Winged Bean Acidic Lectin Complexed With Methyl-Alp		6e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		9e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		9e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		9e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
3soa_A	444	Full-Length Human Camkii Length = 444		1e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-06
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-06
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-06
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-06
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-06
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-06
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-06
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-06
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-06
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-06
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		9e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		9e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		9e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		9e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-06
1gz9_A	239	High-Resolution Crystal Structure Of Erythrina Cris		9e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-06
1q8o_A	252	Pterocartpus Angolensis Lectin Pal In Complex With		1e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-05
1n3o_A	252	Pterocarcpus Angolensis Lectin In Complex With Alph		1e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-05
3n35_A	242	Erythrina Corallodendron Lectin Mutant (Y106g) With		2e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
1lte_A	239	Structure Of A Legume Lectin With An Ordered N-Link		2e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-05
2fmd_A	240	Structural Basis Of Carbohydrate Recognition By Bow		2e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-05
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-05
1sfy_A	239	Crystal Structure Of Recombinant Erythrina Corallod		3e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-05
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-05
1uzy_A	242	Erythrina Crystagalli Lectin Length = 242		4e-05
1fyu_A	255	Crystal Structure Of Erythrina Corallodendron Lecti		4e-05
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-05
1lul_A	253	Db58, A Legume Lectin From Dolichos Biflorus Length		4e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-05
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-05
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-05
1ax0_A	239	Erythrina Corallodendron Lectin In Complex With N-A		6e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		8e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		8e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-05
1qnw_A	242	Lectin Ii From Ulex Europaeus Length = 242		9e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-04
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-04
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-04
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-04
1lgc_A	181	Interaction Of A Legume Lectin With The N2 Fragment		3e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-04
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-04
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-04
1lgb_A	181	Interaction Of A Legume Lectin With The N2 Fragment		6e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-04
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-04
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-04
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		8e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		8e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		8e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  177 bits (448), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 110/341 (32%), Positives = 179/341 (52%), Gaps = 26/341 (7%)
Query: 214 EPHHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNT 273
           +P  +LG+L+       F  +EL+ A++NF     LG GGFG VYKG +        D T
Sbjct: 17  DPEVHLGQLK------RFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-------ADGT 63
Query: 274 QIAVKKFSRDSIKS-KGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLE 332
            +AVK+   +  +  +  F  E+ +I            G+C    + LLVY +M NGS+ 
Sbjct: 64  LVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 123
Query: 333 KYLYGTSE-QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL 391
             L    E Q  L+W  R +I  G A  + YL +  D K++HRD+KA+NILLD +F A +
Sbjct: 124 SCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 183
Query: 392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCG 451
           GDFGLA+ ++ +      H    V GT+G++APE   TGK++ ++DVFG+G ++LE++ G
Sbjct: 184 GDFGLAKLMDYK----DXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 239
Query: 452 RSPGNMIP-HQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHP 510
           +   ++          L+DWV  L +E  ++  VD  L  N   +E ++L+ + L C+  
Sbjct: 240 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQS 299
Query: 511 IASERPKTEDILQIISGTSTVPYVPQ------FKPAFTWPS 545
              ERPK  ++++++ G        +      F+  F +P+
Sbjct: 300 SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNYPT 340

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  172 bits (436), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 105/317 (33%), Positives = 170/317 (53%), Gaps = 20/317 (6%)
Query: 214 EPHHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNT 273
           +P  +LG+L+       F  +EL+ A++NF     LG GGFG VYKG +        D  
Sbjct: 9   DPEVHLGQLK------RFSLRELQVASDNFXNKNILGRGGFGKVYKGRL-------ADGX 55
Query: 274 QIAVKKFSRDSIKS-KGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLE 332
            +AVK+   +  +  +  F  E+ +I            G+C    + LLVY +M NGS+ 
Sbjct: 56  LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 115
Query: 333 KYLYGTSE-QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL 391
             L    E Q  L+W  R +I  G A  + YL +  D K++HRD+KA+NILLD +F A +
Sbjct: 116 SCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175
Query: 392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCG 451
           GDFGLA+ ++ +      H    V G +G++APE   TGK++ ++DVFG+G ++LE++ G
Sbjct: 176 GDFGLAKLMDYKDX----HVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 231
Query: 452 RSPGNMIP-HQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHP 510
           +   ++          L+DWV  L +E  ++  VD  L  N   +E ++L+ + L C+  
Sbjct: 232 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQS 291
Query: 511 IASERPKTEDILQIISG 527
              ERPK  ++++++ G
Sbjct: 292 SPMERPKMSEVVRMLEG 308

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 154/290 (53%), Gaps = 17/290 (5%)
Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAE 294
           +L++ATNNF     +G G FG VYKG++        D  ++A+K+ + +S +   +F  E
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLR-------DGAKVALKRRTPESSQGIEEFETE 85
Query: 295 LAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS-EQVTLNWNHRYKIL 353
           +  +            G+C E+ +++L+Y +M NG+L+++LYG+    ++++W  R +I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 354 TGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLV 413
            G A  ++YL   + + ++HRD+K+ NILLD +F  ++ DFG+++       +   H   
Sbjct: 146 IGAARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT---HLXX 199
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP-GNMIPHQQHAYTLVDWVW 472
            V GT+GY+ PE F  G+ T +SDV+ FG V+ EV+C RS     +P +     L +W  
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM--VNLAEWAV 257
Query: 473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDIL 522
             H  G ++  VD  L      +  ++     + C    + +RP   D+L
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  146 bits (369), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 154/290 (53%), Gaps = 17/290 (5%)
Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAE 294
           +L++ATNNF     +G G FG VYKG++        D  ++A+K+ + +S +   +F  E
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLR-------DGAKVALKRRTPESSQGIEEFETE 85
Query: 295 LAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS-EQVTLNWNHRYKIL 353
           +  +            G+C E+ +++L+Y +M NG+L+++LYG+    ++++W  R +I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 354 TGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLV 413
            G A  ++YL   + + ++HRD+K+ NILLD +F  ++ DFG+++       +   H   
Sbjct: 146 IGAARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQT---HLXX 199
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP-GNMIPHQQHAYTLVDWVW 472
            V GT+GY+ PE F  G+ T +SDV+ FG V+ EV+C RS     +P +     L +W  
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM--VNLAEWAV 257
Query: 473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDIL 522
             H  G ++  VD  L      +  ++     + C    + +RP   D+L
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  144 bits (364), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 157/306 (51%), Gaps = 30/306 (9%)
Query: 231 FKYKELKKATNNFHE------SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR-- 282
           F + ELK  TNNF E        ++GEGGFG+VYKG        +V+NT +AVKK +   
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG--------YVNNTTVAVKKLAAMV 66
Query: 283 --DSIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE 340
              + + K  F  E+ ++            G+  +   L LVY +MPNGSL   L     
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126
Query: 341 QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI 400
              L+W+ R KI  G A+ + +L   +    +HRD+K++NILLD  F A++ DFGLARA 
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPH 460
           E    +     +V   GT  Y+APE    G+ TP+SD++ FG V+LE++ G    +   H
Sbjct: 184 EKFAQTVMXSRIV---GTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD--EH 237
Query: 461 QQHAYTLVDWVWMLHREGHIQDAVDQRLN-INSVVDEAKRLLLLGLACSHPIASERPKTE 519
           ++    L     +   E  I+D +D+++N  +S   EA  +  +   C H   ++RP  +
Sbjct: 238 REPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEA--MYSVASQCLHEKKNKRPDIK 295
Query: 520 DILQII 525
            + Q++
Sbjct: 296 KVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  144 bits (364), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 157/306 (51%), Gaps = 30/306 (9%)
Query: 231 FKYKELKKATNNFHE------SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR-- 282
           F + ELK  TNNF E        ++GEGGFG+VYKG        +V+NT +AVKK +   
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG--------YVNNTTVAVKKLAAMV 66
Query: 283 --DSIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE 340
              + + K  F  E+ ++            G+  +   L LVY +MPNGSL   L     
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126
Query: 341 QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI 400
              L+W+ R KI  G A+ + +L   +    +HRD+K++NILLD  F A++ DFGLARA 
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPH 460
           E    +     +V   GT  Y+APE    G+ TP+SD++ FG V+LE++ G    +   H
Sbjct: 184 EKFAQTVMXXRIV---GTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD--EH 237
Query: 461 QQHAYTLVDWVWMLHREGHIQDAVDQRLN-INSVVDEAKRLLLLGLACSHPIASERPKTE 519
           ++    L     +   E  I+D +D+++N  +S   EA  +  +   C H   ++RP  +
Sbjct: 238 REPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEA--MYSVASQCLHEKKNKRPDIK 295
Query: 520 DILQII 525
            + Q++
Sbjct: 296 KVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 156/306 (50%), Gaps = 30/306 (9%)
Query: 231 FKYKELKKATNNFHE------SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR-- 282
           F + ELK  TNNF E        ++GEGGFG+VYKG        +V+NT +AVKK +   
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG--------YVNNTTVAVKKLAAMV 60
Query: 283 --DSIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE 340
              + + K  F  E+ ++            G+  +   L LVY +MPNGSL   L     
Sbjct: 61  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 120
Query: 341 QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI 400
              L+W+ R KI  G A+ + +L   +    +HRD+K++NILLD  F A++ DFGLARA 
Sbjct: 121 TPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARAS 177
Query: 401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPH 460
           E          +V   GT  Y+APE    G+ TP+SD++ FG V+LE++ G    +   H
Sbjct: 178 EKFAQXVMXXRIV---GTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD--EH 231
Query: 461 QQHAYTLVDWVWMLHREGHIQDAVDQRLN-INSVVDEAKRLLLLGLACSHPIASERPKTE 519
           ++    L     +   E  I+D +D+++N  +S   EA  +  +   C H   ++RP  +
Sbjct: 232 REPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEA--MYSVASQCLHEKKNKRPDIK 289
Query: 520 DILQII 525
            + Q++
Sbjct: 290 KVQQLL 295

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  135 bits (340), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 150/306 (49%), Gaps = 30/306 (9%)
Query: 231 FKYKELKKATNNFHE------SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR-- 282
           F + ELK  TNNF E        + GEGGFG+VYKG        +V+NT +AVKK +   
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG--------YVNNTTVAVKKLAAMV 57
Query: 283 --DSIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE 340
              + + K  F  E+ +             G+  +   L LVY + PNGSL   L     
Sbjct: 58  DITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDG 117
Query: 341 QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI 400
              L+W+ R KI  G A+ + +L   +    +HRD+K++NILLD  F A++ DFGLARA 
Sbjct: 118 TPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARAS 174
Query: 401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPH 460
           E          +V   GT  Y APE    G+ TP+SD++ FG V+LE++ G    +   H
Sbjct: 175 EKFAQXVXXSRIV---GTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD--EH 228
Query: 461 QQHAYTLVDWVWMLHREGHIQDAVDQRLN-INSVVDEAKRLLLLGLACSHPIASERPKTE 519
           ++    L     +   E  I+D +D++ N  +S   EA     +   C H   ++RP  +
Sbjct: 229 REPQLLLDIKEEIEDEEKTIEDYIDKKXNDADSTSVEAX--YSVASQCLHEKKNKRPDIK 286
Query: 520 DILQII 525
            + Q++
Sbjct: 287 KVQQLL 292

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 139/324 (42%), Gaps = 41/324 (12%)
Query: 216 HHNLGKLRLPGMPREFKYKELKKATNNFHESMR------------LGEGGFGIVYKGIIH 263
           H   G L+LPG+         +  T   HE  +            +G G FG V  G + 
Sbjct: 8   HFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLK 67
Query: 264 HNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLV 322
              +  +    +A+K      + K + DFL E +I+            G   +   +++V
Sbjct: 68  LPSKKEI---SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL 382
            ++M NGSL+ +L     Q T+       +L G+AS + YL    D   VHRDL A NIL
Sbjct: 125 TEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYLS---DMGYVHRDLAARNIL 179
Query: 383 LDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFG 442
           ++++   ++ DFGLAR +E++    A +   G    + + +PE     K T  SDV+ +G
Sbjct: 180 INSNLVCKVSDFGLARVLEDDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYG 237
Query: 443 AVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLL 501
            V+ EV+  G  P                 W +  +  I+ AVD+   +   +D    L 
Sbjct: 238 IVLWEVMSYGERP----------------YWEMSNQDVIK-AVDEGYRLPPPMDCPAALY 280
Query: 502 LLGLACSHPIASERPKTEDILQII 525
            L L C     + RPK E I+ I+
Sbjct: 281 QLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 86/324 (26%), Positives = 139/324 (42%), Gaps = 41/324 (12%)
Query: 216 HHNLGKLRLPGMPREFKYKELKKATNNFHESMR------------LGEGGFGIVYKGIIH 263
           H   G L+LPG+         +  T   HE  +            +G G FG V  G + 
Sbjct: 8   HFGNGHLKLPGLRTYVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLK 67
Query: 264 HNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLV 322
              +  +    +A+K      + K + DFL E +I+            G   +   +++V
Sbjct: 68  LPSKKEI---SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL 382
            ++M NGSL+ +L     Q T+       +L G+AS + YL    D   VHRDL A NIL
Sbjct: 125 TEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYLS---DMGYVHRDLAARNIL 179
Query: 383 LDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFG 442
           ++++   ++ DFGL+R +E++    A +   G    + + +PE     K T  SDV+ +G
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYG 237
Query: 443 AVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLL 501
            V+ EV+  G  P                 W +  +  I+ AVD+   +   +D    L 
Sbjct: 238 IVLWEVMSYGERP----------------YWEMSNQDVIK-AVDEGYRLPPPMDCPAALY 280
Query: 502 LLGLACSHPIASERPKTEDILQII 525
            L L C     + RPK E I+ I+
Sbjct: 281 QLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 86/324 (26%), Positives = 139/324 (42%), Gaps = 41/324 (12%)
Query: 216 HHNLGKLRLPGMPREFKYKELKKATNNFHESMR------------LGEGGFGIVYKGIIH 263
           H   G L+LPG+         +  T   HE  +            +G G FG V  G + 
Sbjct: 8   HFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLK 67
Query: 264 HNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLV 322
              +  +    +A+K      + K + DFL E +I+            G   +   +++V
Sbjct: 68  LPSKKEI---SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL 382
            ++M NGSL+ +L     Q T+       +L G+AS + YL    D   VHRDL A NIL
Sbjct: 125 TEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYLS---DMGFVHRDLAARNIL 179
Query: 383 LDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFG 442
           ++++   ++ DFGL+R +E++    A +   G    + + +PE     K T  SDV+ +G
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYG 237
Query: 443 AVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLL 501
            V+ EV+  G  P                 W +  +  I+ AVD+   +   +D    L 
Sbjct: 238 IVLWEVMSYGERP----------------YWEMSNQDVIK-AVDEGYRLPPPMDCPAALY 280
Query: 502 LLGLACSHPIASERPKTEDILQII 525
            L L C     + RPK E I+ I+
Sbjct: 281 QLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 86/324 (26%), Positives = 139/324 (42%), Gaps = 41/324 (12%)
Query: 216 HHNLGKLRLPGMPREFKYKELKKATNNFHESMR------------LGEGGFGIVYKGIIH 263
           H   G L+LPG+         +  T   HE  +            +G G FG V  G + 
Sbjct: 8   HFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLK 67
Query: 264 HNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLV 322
              +  +    +A+K      + K + DFL E +I+            G   +   +++V
Sbjct: 68  LPSKKEI---SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL 382
            ++M NGSL+ +L     Q T+       +L G+AS + YL    D   VHRDL A NIL
Sbjct: 125 TEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYLS---DMGYVHRDLAARNIL 179
Query: 383 LDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFG 442
           ++++   ++ DFGL+R +E++    A +   G    + + +PE     K T  SDV+ +G
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYG 237
Query: 443 AVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLL 501
            V+ EV+  G  P                 W +  +  I+ AVD+   +   +D    L 
Sbjct: 238 IVLWEVMSYGERP----------------YWEMSNQDVIK-AVDEGYRLPPPMDCPAALY 280
Query: 502 LLGLACSHPIASERPKTEDILQII 525
            L L C     + RPK E I+ I+
Sbjct: 281 QLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 86/324 (26%), Positives = 139/324 (42%), Gaps = 41/324 (12%)
Query: 216 HHNLGKLRLPGMPREFKYKELKKATNNFHESMR------------LGEGGFGIVYKGIIH 263
           H   G L+LPG+         +  T   HE  +            +G G FG V  G + 
Sbjct: 6   HFGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLK 65
Query: 264 HNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLV 322
              +  +    +A+K      + K + DFL E +I+            G   +   +++V
Sbjct: 66  LPSKKEI---SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 122
Query: 323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL 382
            ++M NGSL+ +L     Q T+       +L G+AS + YL    D   VHRDL A NIL
Sbjct: 123 TEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYLS---DMGYVHRDLAARNIL 177
Query: 383 LDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFG 442
           ++++   ++ DFGL+R +E++    A +   G    + + +PE     K T  SDV+ +G
Sbjct: 178 INSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYG 235
Query: 443 AVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLL 501
            V+ EV+  G  P                 W +  +  I+ AVD+   +   +D    L 
Sbjct: 236 IVLWEVMSYGERP----------------YWEMSNQDVIK-AVDEGYRLPPPMDCPAALY 278
Query: 502 LLGLACSHPIASERPKTEDILQII 525
            L L C     + RPK E I+ I+
Sbjct: 279 QLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 86/324 (26%), Positives = 138/324 (42%), Gaps = 41/324 (12%)
Query: 216 HHNLGKLRLPGMPREFKYKELKKATNNFHESMR------------LGEGGFGIVYKGIIH 263
           H   G L+LPG+         +  T   HE  +            +G G FG V  G + 
Sbjct: 8   HFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLK 67
Query: 264 HNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLV 322
              +  +    +A+K      + K + DFL E +I+            G   +   +++V
Sbjct: 68  LPSKKEI---SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL 382
            ++M NGSL+ +L     Q T+       +L G+AS + YL    D   VHRDL A NIL
Sbjct: 125 TEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYLS---DMGYVHRDLAARNIL 179
Query: 383 LDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFG 442
           ++++   ++ DFGL R +E++    A +   G    + + +PE     K T  SDV+ +G
Sbjct: 180 INSNLVCKVSDFGLGRVLEDDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYG 237
Query: 443 AVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLL 501
            V+ EV+  G  P                 W +  +  I+ AVD+   +   +D    L 
Sbjct: 238 IVLWEVMSYGERP----------------YWEMSNQDVIK-AVDEGYRLPPPMDCPAALY 280
Query: 502 LLGLACSHPIASERPKTEDILQII 525
            L L C     + RPK E I+ I+
Sbjct: 281 QLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 86/324 (26%), Positives = 139/324 (42%), Gaps = 41/324 (12%)
Query: 216 HHNLGKLRLPGMPREFKYKELKKATNNFHESMR------------LGEGGFGIVYKGIIH 263
           H   G L+LPG+         +  T   HE  +            +G G FG V  G + 
Sbjct: 8   HFGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLK 67
Query: 264 HNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLV 322
              +  +    +A+K      + K + DFL E +I+            G   +   +++V
Sbjct: 68  LPSKKEI---SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL 382
            ++M NGSL+ +L     Q T+       +L G+AS + YL    D   VHRDL A NIL
Sbjct: 125 TEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYLS---DMGYVHRDLAARNIL 179
Query: 383 LDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFG 442
           ++++   ++ DFGL+R +E++    A +   G    + + +PE     K T  SDV+ +G
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYG 237
Query: 443 AVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLL 501
            V+ EV+  G  P                 W +  +  I+ AVD+   +   +D    L 
Sbjct: 238 IVLWEVMSYGERP----------------YWEMSNQDVIK-AVDEGYRLPPPMDCPAALY 280
Query: 502 LLGLACSHPIASERPKTEDILQII 525
            L L C     + RPK E I+ I+
Sbjct: 281 QLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/324 (26%), Positives = 139/324 (42%), Gaps = 41/324 (12%)
Query: 216 HHNLGKLRLPGMPREFKYKELKKATNNFHESMR------------LGEGGFGIVYKGIIH 263
           H   G L+LPG+         +  T   HE  +            +G G FG V  G + 
Sbjct: 8   HFGNGHLKLPGLRTFVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLK 67
Query: 264 HNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLV 322
              +  +    +A+K      + K + DFL E +I+            G   +   +++V
Sbjct: 68  LPSKKEI---SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL 382
            ++M NGSL+ +L     Q T+       +L G+AS + YL    D   VHRDL A NIL
Sbjct: 125 TEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYLS---DMGYVHRDLAARNIL 179
Query: 383 LDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFG 442
           ++++   ++ DFGL+R +E++    A +   G    + + +PE     K T  SDV+ +G
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYG 237
Query: 443 AVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLL 501
            V+ EV+  G  P                 W +  +  I+ AVD+   +   +D    L 
Sbjct: 238 IVLWEVMSYGERP----------------YWEMSNQDVIK-AVDEGYRLPPPMDCPAALY 280
Query: 502 LLGLACSHPIASERPKTEDILQII 525
            L L C     + RPK E I+ I+
Sbjct: 281 QLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 136/307 (44%), Gaps = 34/307 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXX 307
           +G G FG VYKG++  +         +A+K      + K + DFL E  I+         
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKK--EVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G   +   ++++ ++M NG+L+K+L     + ++       +L G+A+ + YL N  
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL--QLVGMLRGIAAGMKYLAN-- 165
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
               VHRDL A NIL++++   ++ DFGL+R +E++    A +   G    + + APE  
Sbjct: 166 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE--ATYTTSGGKIPIRWTAPEAI 222
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQ 486
              K T  SDV+ FG V+ EV+  G  P                 W L     +  A++ 
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP----------------YWELSNH-EVMKAIND 265
Query: 487 RLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI----ISGTSTVPYVPQFKP--A 540
              + + +D    +  L + C     + RPK  DI+ I    I    ++  +  F P  +
Sbjct: 266 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVS 325
Query: 541 FTWPSTS 547
              PSTS
Sbjct: 326 IRLPSTS 332

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/324 (26%), Positives = 138/324 (42%), Gaps = 41/324 (12%)
Query: 216 HHNLGKLRLPGMPREFKYKELKKATNNFHESMR------------LGEGGFGIVYKGIIH 263
           H   G L+LPG+         +  T   HE  +            +G G FG V  G + 
Sbjct: 8   HFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLK 67
Query: 264 HNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLV 322
              +  +    +A+K      + K + DFL E +I+            G   +   +++V
Sbjct: 68  LPSKKEI---SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL 382
            + M NGSL+ +L     Q T+       +L G+AS + YL    D   VHRDL A NIL
Sbjct: 125 TEXMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYLS---DMGAVHRDLAARNIL 179
Query: 383 LDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFG 442
           ++++   ++ DFGL+R +E++    A +   G    + + +PE     K T  SDV+ +G
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYG 237
Query: 443 AVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLL 501
            V+ EV+  G  P                 W +  +  I+ AVD+   +   +D    L 
Sbjct: 238 IVLWEVMSYGERP----------------YWEMSNQDVIK-AVDEGYRLPPPMDCPAALY 280
Query: 502 LLGLACSHPIASERPKTEDILQII 525
            L L C     + RPK E I+ I+
Sbjct: 281 QLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 86/324 (26%), Positives = 138/324 (42%), Gaps = 41/324 (12%)
Query: 216 HHNLGKLRLPGMPREFKYKELKKATNNFHESMR------------LGEGGFGIVYKGIIH 263
           H   G L+LPG+         +  T   HE  +            +G G FG V  G + 
Sbjct: 8   HFGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLK 67
Query: 264 HNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLV 322
              +  +    +A+K      + K + DFL E +I+            G   +   +++V
Sbjct: 68  LPSKKEI---SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL 382
            + M NGSL+ +L     Q T+       +L G+AS + YL    D   VHRDL A NIL
Sbjct: 125 TEXMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYLS---DMGYVHRDLAARNIL 179
Query: 383 LDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFG 442
           ++++   ++ DFGL+R +E++    A +   G    + + +PE     K T  SDV+ +G
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYG 237
Query: 443 AVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLL 501
            V+ EV+  G  P                 W +  +  I+ AVD+   +   +D    L 
Sbjct: 238 IVLWEVMSYGERP----------------YWEMSNQDVIK-AVDEGYRLPPPMDCPAALY 280
Query: 502 LLGLACSHPIASERPKTEDILQII 525
            L L C     + RPK E I+ I+
Sbjct: 281 QLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 18/208 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           RLG G FG V+ G       Y+  +T++AVK   + S+ S   FLAE  ++         
Sbjct: 26  RLGAGQFGEVWMG-------YYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLV 77
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                  ++  + ++ ++M NGSL  +L  T   + L  N    +   +A  + +++   
Sbjct: 78  RLYAVVTQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIE--- 132
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           ++  +HRDL+A+NIL+    + ++ DFGLAR IE+   +  E    G    + + APE  
Sbjct: 133 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE----GAKFPIKWTAPEAI 188
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
           + G  T +SDV+ FG ++ E+V  GR P
Sbjct: 189 NYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 18/208 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           RLG G FG V+ G       Y+  +T++AVK   + S+ S   FLAE  ++         
Sbjct: 29  RLGAGQFGEVWMG-------YYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLV 80
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                  ++  + ++ ++M NGSL  +L  T   + L  N    +   +A  + +++   
Sbjct: 81  RLYAVVTQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIE--- 135
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           ++  +HRDL+A+NIL+    + ++ DFGLAR IE+   +  E    G    + + APE  
Sbjct: 136 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE----GAKFPIKWTAPEAI 191
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
           + G  T +SDV+ FG ++ E+V  GR P
Sbjct: 192 NYGTFTIKSDVWSFGILLTEIVTHGRIP 219

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 18/208 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           RLG G FG V+ G       Y+  +T++AVK   + S+ S   FLAE  ++         
Sbjct: 28  RLGAGQFGEVWMG-------YYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLV 79
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                  ++  + ++ ++M NGSL  +L  T   + L  N    +   +A  + +++   
Sbjct: 80  RLYAVVTQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIE--- 134
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           ++  +HRDL+A+NIL+    + ++ DFGLAR IE+   +  E    G    + + APE  
Sbjct: 135 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE----GAKFPIKWTAPEAI 190
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
           + G  T +SDV+ FG ++ E+V  GR P
Sbjct: 191 NYGTFTIKSDVWSFGILLTEIVTHGRIP 218

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 18/208 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           RLG G FG V+ G       Y+  +T++AVK   + S+ S   FLAE  ++         
Sbjct: 22  RLGAGQFGEVWMG-------YYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLV 73
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                  ++  + ++ ++M NGSL  +L  T   + L  N    +   +A  + +++   
Sbjct: 74  RLYAVVTQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIE--- 128
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           ++  +HRDL+A+NIL+    + ++ DFGLAR IE+   +  E    G    + + APE  
Sbjct: 129 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE----GAKFPIKWTAPEAI 184
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
           + G  T +SDV+ FG ++ E+V  GR P
Sbjct: 185 NYGTFTIKSDVWSFGILLTEIVTHGRIP 212

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 18/208 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           RLG G FG V+ G       Y+  +T++AVK   + S+ S   FLAE  ++         
Sbjct: 20  RLGAGQFGEVWMG-------YYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLV 71
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                  ++  + ++ ++M NGSL  +L  T   + L  N    +   +A  + +++   
Sbjct: 72  RLYAVVTQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIE--- 126
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           ++  +HRDL+A+NIL+    + ++ DFGLAR IE+   +  E    G    + + APE  
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE----GAKFPIKWTAPEAI 182
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
           + G  T +SDV+ FG ++ E+V  GR P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 18/208 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           RLG G FG V+ G       Y+  +T++AVK   + S+ S   FLAE  ++         
Sbjct: 21  RLGAGQFGEVWMG-------YYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLV 72
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                  ++  + ++ ++M NGSL  +L  T   + L  N    +   +A  + +++   
Sbjct: 73  RLYAVVTQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIE--- 127
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           ++  +HRDL+A+NIL+    + ++ DFGLAR IE+   +  E    G    + + APE  
Sbjct: 128 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE----GAKFPIKWTAPEAI 183
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
           + G  T +SDV+ FG ++ E+V  GR P
Sbjct: 184 NYGTFTIKSDVWSFGILLTEIVTHGRIP 211

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 18/208 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           RLG G FG V+ G       Y+  +T++AVK   + S+ S   FLAE  ++         
Sbjct: 20  RLGAGQFGEVWMG-------YYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLV 71
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                  ++  + ++ ++M NGSL  +L  T   + L  N    +   +A  + +++   
Sbjct: 72  RLYAVVTQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIE--- 126
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           ++  +HRDL+A+NIL+    + ++ DFGLAR IE+   +  E    G    + + APE  
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE----GAKFPIKWTAPEAI 182
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
           + G  T +SDV+ FG ++ E+V  GR P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 18/208 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           RLG G FG V+ G       Y+  +T++AVK   + S+ S   FLAE  ++         
Sbjct: 30  RLGAGQFGEVWMG-------YYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLV 81
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                  ++  + ++ ++M NGSL  +L  T   + L  N    +   +A  + +++   
Sbjct: 82  RLYAVVTQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIE--- 136
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           ++  +HRDL+A+NIL+    + ++ DFGLAR IE+   +  E    G    + + APE  
Sbjct: 137 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAI 192
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
           + G  T +SDV+ FG ++ E+V  GR P
Sbjct: 193 NYGTFTIKSDVWSFGILLTEIVTHGRIP 220

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 18/208 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           RLG G FG V+ G       Y+  +T++AVK   + S+ S   FLAE  ++         
Sbjct: 26  RLGAGQFGEVWMG-------YYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLV 77
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                  ++  + ++ ++M NGSL  +L  T   + L  N    +   +A  + +++   
Sbjct: 78  RLYAVVTQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIE--- 132
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           ++  +HRDL+A+NIL+    + ++ DFGLAR IE+   +  E    G    + + APE  
Sbjct: 133 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAI 188
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
           + G  T +SDV+ FG ++ E+V  GR P
Sbjct: 189 NYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 18/208 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           RLG G FG V+ G       Y+  +T++AVK   + S+ S   FLAE  ++         
Sbjct: 25  RLGAGQFGEVWMG-------YYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLV 76
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                  ++  + ++ ++M NGSL  +L  T   + L  N    +   +A  + +++   
Sbjct: 77  RLYAVVTQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIE--- 131
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           ++  +HRDL+A+NIL+    + ++ DFGLAR IE+   +  E    G    + + APE  
Sbjct: 132 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAI 187
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
           + G  T +SDV+ FG ++ E+V  GR P
Sbjct: 188 NYGTFTIKSDVWSFGILLTEIVTHGRIP 215

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 127/278 (45%), Gaps = 27/278 (9%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXX 307
           +G G FG V  G +    +  +    +A+K      + K + DFL E +I+         
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEI---SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G   +   +++V ++M NGSL+ +L     Q T+       +L G+AS + YL    
Sbjct: 98  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYLS--- 152
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           D   VHRDL A NIL++++   ++ DFGL+R +E++    A +   G    + + +PE  
Sbjct: 153 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEAI 210
Query: 428 HTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQR 487
              K T  SDV+ +G V+ EV         + + +  Y      W +  +  I+ AVD+ 
Sbjct: 211 AYRKFTSASDVWSYGIVLWEV---------MSYGERPY------WEMSNQDVIK-AVDEG 254
Query: 488 LNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
             +   +D    L  L L C     + RPK E I+ I+
Sbjct: 255 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 127/278 (45%), Gaps = 27/278 (9%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXX 307
           +G G FG V  G +    +  +    +A+K      + K + DFL E +I+         
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEI---SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G   +   +++V ++M NGSL+ +L     Q T+       +L G+AS + YL    
Sbjct: 81  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYLS--- 135
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           D   VHRDL A NIL++++   ++ DFGL+R +E++    A +   G    + + +PE  
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEAI 193
Query: 428 HTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQR 487
              K T  SDV+ +G V+ EV         + + +  Y      W +  +  I+ AVD+ 
Sbjct: 194 AYRKFTSASDVWSYGIVLWEV---------MSYGERPY------WEMSNQDVIK-AVDEG 237
Query: 488 LNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
             +   +D    L  L L C     + RPK E I+ I+
Sbjct: 238 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 115/243 (47%), Gaps = 34/243 (13%)
Query: 229 REFKYKELKKATNNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSRDS-IK 286
           R  K  ELK+          LG G FG VYKGI +   +   +    +A+K  +  +  K
Sbjct: 33  RILKETELKRVKV-------LGSGAFGTVYKGIWVPEGETVKIP---VAIKILNETTGPK 82
Query: 287 SKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQV 342
           +  +F+ E  I+            G C     + LV   MP+G L +Y++        Q+
Sbjct: 83  ANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQL 141
Query: 343 TLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN 402
            LNW         +A  + YL+   ++++VHRDL A N+L+ +  + ++ DFGLAR +E 
Sbjct: 142 LLNW------CVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 192
Query: 403 ERNSYAEHGLVGVPGTM--GYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIP 459
           +   Y   G     G M   ++A EC H  K T +SDV+ +G  + E++  G  P + IP
Sbjct: 193 DEKEYNADG-----GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 247
Query: 460 HQQ 462
            ++
Sbjct: 248 TRE 250

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 115/243 (47%), Gaps = 34/243 (13%)
Query: 229 REFKYKELKKATNNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSRDS-IK 286
           R  K  ELK+          LG G FG VYKGI +   +   +    +A+K  +  +  K
Sbjct: 10  RILKETELKRVK-------VLGSGAFGTVYKGIWVPEGETVKI---PVAIKILNETTGPK 59
Query: 287 SKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQV 342
           +  +F+ E  I+            G C     + LV   MP+G L +Y++        Q+
Sbjct: 60  ANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQL 118
Query: 343 TLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN 402
            LNW         +A  + YL+   ++++VHRDL A N+L+ +  + ++ DFGLAR +E 
Sbjct: 119 LLNW------CVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 169
Query: 403 ERNSYAEHGLVGVPGTM--GYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIP 459
           +   Y   G     G M   ++A EC H  K T +SDV+ +G  + E++  G  P + IP
Sbjct: 170 DEKEYNADG-----GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 224
Query: 460 HQQ 462
            ++
Sbjct: 225 TRE 227

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 18/208 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           RLG G FG V+ G       Y+  +T++AVK   + S+ S   FLAE  ++         
Sbjct: 20  RLGAGQFGEVWMG-------YYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLV 71
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                  ++  + ++ ++M NGSL  +L  T   + L  N    +   +A  + +++   
Sbjct: 72  RLYAVVTQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIE--- 126
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           ++  +HRDL+A+NIL+    + ++ DFGLAR IE+   +  E    G    + + APE  
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAI 182
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
           + G  T +SDV+ FG ++ E+V  GR P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 17/217 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK--GDFLAELAIIXXXXXXX 305
           ++G G FG V++   H +D        +AVK        ++   +FL E+AI+       
Sbjct: 44  KIGAGSFGTVHRAEWHGSD--------VAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                G   +   L +V +++  GSL + L+ +  +  L+   R  +   VA  + YL N
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
             +  +VHRDLK+ N+L+D  +  ++ DFGL+R    + + +         GT  ++APE
Sbjct: 156 R-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KASXFLXSKXAA--GTPEWMAPE 209
Query: 426 CFHTGKATPESDVFGFGAVVLEVVCGRSP-GNMIPHQ 461
                 +  +SDV+ FG ++ E+   + P GN+ P Q
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 18/208 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           RLG G FG V+ G       Y+  +T++AVK   + S+ S   FLAE  ++         
Sbjct: 15  RLGAGQFGEVWMG-------YYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLV 66
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                  ++  + ++ ++M NGSL  +L  T   + L  N    +   +A  + +++   
Sbjct: 67  RLYAVVTQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIE--- 121
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           ++  +HRDL+A+NIL+    + ++ DFGLAR IE+   +  E    G    + + APE  
Sbjct: 122 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAI 177
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
           + G  T +SDV+ FG ++ E+V  GR P
Sbjct: 178 NYGTFTIKSDVWSFGILLTEIVTHGRIP 205

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 17/217 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK--GDFLAELAIIXXXXXXX 305
           ++G G FG V++   H +D        +AVK        ++   +FL E+AI+       
Sbjct: 44  KIGAGSFGTVHRAEWHGSD--------VAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                G   +   L +V +++  GSL + L+ +  +  L+   R  +   VA  + YL N
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
             +  +VHR+LK+ N+L+D  +  ++ DFGL+R   +   S          GT  ++APE
Sbjct: 156 R-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-----GTPEWMAPE 209
Query: 426 CFHTGKATPESDVFGFGAVVLEVVCGRSP-GNMIPHQ 461
                 +  +SDV+ FG ++ E+   + P GN+ P Q
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 126/278 (45%), Gaps = 27/278 (9%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXX 307
           +G G FG V  G +    +  +    +A+K      + K + DFL E +I+         
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEI---SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G   +   +++V + M NGSL+ +L     Q T+       +L G+AS + YL    
Sbjct: 81  RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYLS--- 135
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           D   VHRDL A NIL++++   ++ DFGL+R +E++    A +   G    + + +PE  
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEAI 193
Query: 428 HTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQR 487
              K T  SDV+ +G V+ EV         + + +  Y      W +  +  I+ AVD+ 
Sbjct: 194 AYRKFTSASDVWSYGIVLWEV---------MSYGERPY------WEMSNQDVIK-AVDEG 237
Query: 488 LNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
             +   +D    L  L L C     + RPK E I+ I+
Sbjct: 238 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 127/279 (45%), Gaps = 29/279 (10%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXX 307
           +G G FG V  G +    +  V    +A+K      + K + DFL E +I+         
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDV---AVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G       +++V +FM NG+L+ +L     Q T+       +L G+A+ + YL    
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVI--QLVGMLRGIAAGMRYLA--- 162
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           D   VHRDL A NIL++++   ++ DFGL+R IE+  +  A +   G    + + APE  
Sbjct: 163 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIED--DPEAVYTTTGGKIPVRWTAPEAI 220
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQ 486
              K T  SDV+ +G V+ EV+  G  P                 W +  +  I+ A+++
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMSYGERP----------------YWDMSNQDVIK-AIEE 263
Query: 487 RLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
              + + +D    L  L L C     +ERPK E I+ I+
Sbjct: 264 GYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGIL 302

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 18/208 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           RLG G FG V+ G       Y+  +T++AVK   + S+ S   FLAE  ++         
Sbjct: 16  RLGAGQFGEVWMG-------YYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLV 67
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                  ++  + ++ ++M NGSL  +L  T   + L  N    +   +A  + +++   
Sbjct: 68  RLYAVVTQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIE--- 122
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           ++  +HR+L+A+NIL+    + ++ DFGLAR IE+   +  E    G    + + APE  
Sbjct: 123 ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAI 178
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
           + G  T +SDV+ FG ++ E+V  GR P
Sbjct: 179 NYGTFTIKSDVWSFGILLTEIVTHGRIP 206

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 126/279 (45%), Gaps = 27/279 (9%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF-SRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +G G FG V  G +    +  +    +A+K   S  + K + DFL+E +I+         
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREI---FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G   +   ++++ +FM NGSL+ +L     Q T+       +L G+A+ + YL    
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI--QLVGMLRGIAAGMKYLA--- 152
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           D   VHRDL A NIL++++   ++ DFGL+R +E++ +       +G    + + APE  
Sbjct: 153 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 212
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQ 486
              K T  SDV+ +G V+ EV+  G  P                 W +  +  I +A++Q
Sbjct: 213 QYRKFTSASDVWSYGIVMWEVMSYGERP----------------YWDMTNQDVI-NAIEQ 255
Query: 487 RLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
              +   +D    L  L L C     + RPK   I+  +
Sbjct: 256 DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 294

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIXXXX 302
           H +  +G G FG VY G +  ND   +     AVK  +R + I     FL E  I+    
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKI---HCAVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 303 XXXXXXXXGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG----VA 357
                   G C   +G  L+V  +M +G L  ++   +   T+      K L G    VA
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVA 143
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
             + YL +   +K VHRDL A N +LD  F  ++ DFGLAR +  ++  Y+ H   G   
Sbjct: 144 KGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKL 199
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            + ++A E   T K T +SDV+ FG ++ E++   +P
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIXXXX 302
           H +  +G G FG VY G +  ND   +     AVK  +R + I     FL E  I+    
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKI---HCAVKSLNRITDIGEVSQFLTEGIIMKDFS 108
Query: 303 XXXXXXXXGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG----VA 357
                   G C   +G  L+V  +M +G L  ++   +   T+      K L G    VA
Sbjct: 109 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVA 162
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
             + YL +   +K VHRDL A N +LD  F  ++ DFGLAR +  ++  Y+ H   G   
Sbjct: 163 KGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKL 218
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            + ++A E   T K T +SDV+ FG ++ E++   +P
Sbjct: 219 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIXXXX 302
           H +  +G G FG VY G +  ND   +     AVK  +R + I     FL E  I+    
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKI---HCAVKSLNRITDIGEVSQFLTEGIIMKDFS 107
Query: 303 XXXXXXXXGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG----VA 357
                   G C   +G  L+V  +M +G L  ++   +   T+      K L G    VA
Sbjct: 108 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVA 161
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
             + YL +   +K VHRDL A N +LD  F  ++ DFGLAR +  ++  Y+ H   G   
Sbjct: 162 KGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKL 217
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            + ++A E   T K T +SDV+ FG ++ E++   +P
Sbjct: 218 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 19/225 (8%)
Query: 228 PREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS 287
           P  F+ + LK+  +       LGEG FG V   +  ++ +      Q+AVK    +S  +
Sbjct: 15  PTHFEKRFLKRIRD-------LGEGHFGKVE--LCRYDPEGDNTGEQVAVKSLKPESGGN 65
Query: 288 K-GDFLAELAIIXXXXXXXXXXXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTL 344
              D   E+ I+            G C E G   + L+ +F+P+GSL++YL     ++ L
Sbjct: 66  HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL 125
Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
               +Y +   +   + YL +   ++ VHRDL A N+L++++   ++GDFGL +AIE ++
Sbjct: 126 KQQLKYAV--QICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
                      P  + + APEC    K    SDV+ FG  + E++
Sbjct: 181 EXXTVKDDRDSP--VFWYAPECLMQSKFYIASDVWSFGVTLHELL 223

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIXXXX 302
           H +  +G G FG VY G +  ND   +     AVK  +R + I     FL E  I+    
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKI---HCAVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 303 XXXXXXXXGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG----VA 357
                   G C   +G  L+V  +M +G L  ++   +   T+      K L G    VA
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVA 143
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
             + YL +   +K VHRDL A N +LD  F  ++ DFGLAR +  ++  Y+ H   G   
Sbjct: 144 KGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKL 199
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            + ++A E   T K T +SDV+ FG ++ E++   +P
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIXXXX 302
           H +  +G G FG VY G +  ND   +     AVK  +R + I     FL E  I+    
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKI---HCAVKSLNRITDIGEVSQFLTEGIIMKDFS 88
Query: 303 XXXXXXXXGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG----VA 357
                   G C   +G  L+V  +M +G L  ++   +   T+      K L G    VA
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVA 142
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
             + YL +   +K VHRDL A N +LD  F  ++ DFGLAR +  ++  Y+ H   G   
Sbjct: 143 KGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKL 198
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            + ++A E   T K T +SDV+ FG ++ E++   +P
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIXXXX 302
           H +  +G G FG VY G +  ND   +     AVK  +R + I     FL E  I+    
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKI---HCAVKSLNRITDIGEVSQFLTEGIIMKDFS 84
Query: 303 XXXXXXXXGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG----VA 357
                   G C   +G  L+V  +M +G L  ++   +   T+      K L G    VA
Sbjct: 85  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVA 138
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
             + YL +   +K VHRDL A N +LD  F  ++ DFGLAR +  ++  Y+ H   G   
Sbjct: 139 KGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKL 194
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            + ++A E   T K T +SDV+ FG ++ E++   +P
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIXXXX 302
           H +  +G G FG VY G +  ND   +     AVK  +R + I     FL E  I+    
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKI---HCAVKSLNRITDIGEVSQFLTEGIIMKDFS 86
Query: 303 XXXXXXXXGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG----VA 357
                   G C   +G  L+V  +M +G L  ++   +   T+      K L G    VA
Sbjct: 87  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVA 140
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
             + YL +   +K VHRDL A N +LD  F  ++ DFGLAR +  ++  Y+ H   G   
Sbjct: 141 KGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKL 196
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            + ++A E   T K T +SDV+ FG ++ E++   +P
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIXXXX 302
           H +  +G G FG VY G +  ND   +     AVK  +R + I     FL E  I+    
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKI---HCAVKSLNRITDIGEVSQFLTEGIIMKDFS 81
Query: 303 XXXXXXXXGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG----VA 357
                   G C   +G  L+V  +M +G L  ++   +   T+      K L G    VA
Sbjct: 82  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVA 135
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
             + YL +   +K VHRDL A N +LD  F  ++ DFGLAR +  ++  Y+ H   G   
Sbjct: 136 KGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKL 191
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            + ++A E   T K T +SDV+ FG ++ E++   +P
Sbjct: 192 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           RLG G  G V+ G       Y+  +T++AVK   + S+ S   FLAE  ++         
Sbjct: 20  RLGAGQAGEVWMG-------YYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLV 71
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                  ++  + ++ ++M NGSL  +L  T   + L  N    +   +A  + +++   
Sbjct: 72  RLYAVVTQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIE--- 126
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           ++  +HRDL+A+NIL+    + ++ DFGLAR IE+   +  E    G    + + APE  
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTARE----GAKFPIKWTAPEAI 182
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
           + G  T +SDV+ FG ++ E+V  GR P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 19/225 (8%)
Query: 228 PREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS 287
           P  F+ + LK+  +       LGEG FG V   +  ++ +      Q+AVK    +S  +
Sbjct: 3   PTHFEKRFLKRIRD-------LGEGHFGKV--ELCRYDPEGDNTGEQVAVKSLKPESGGN 53
Query: 288 K-GDFLAELAIIXXXXXXXXXXXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTL 344
              D   E+ I+            G C E G   + L+ +F+P+GSL++YL     ++ L
Sbjct: 54  HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL 113
Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
               +Y +   +   + YL +   ++ VHRDL A N+L++++   ++GDFGL +AIE ++
Sbjct: 114 KQQLKYAV--QICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 168
Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
                      P  + + APEC    K    SDV+ FG  + E++
Sbjct: 169 EXXTVKDDRDSP--VFWYAPECLMQSKFYIASDVWSFGVTLHELL 211

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIXXXX 302
           H +  +G G FG VY G +  ND   +     AVK  +R + I     FL E  I+    
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKI---HCAVKSLNRITDIGEVSQFLTEGIIMKDFS 87
Query: 303 XXXXXXXXGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG----VA 357
                   G C   +G  L+V  +M +G L  ++   +   T+      K L G    VA
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVA 141
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
             + YL +   +K VHRDL A N +LD  F  ++ DFGLAR +  ++  Y+ H   G   
Sbjct: 142 KGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKL 197
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            + ++A E   T K T +SDV+ FG ++ E++   +P
Sbjct: 198 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 128/279 (45%), Gaps = 29/279 (10%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXX 307
           +G G FG V  G +    +  +    +A+K      + K + DFL E +I+         
Sbjct: 30  IGAGEFGEVCSGRLKLPGKREL---PVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G   +   +++V ++M NGSL+ +L     Q T+       +L G+++ + YL    
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVI--QLVGMLRGISAGMKYLS--- 141
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           D   VHRDL A NIL++++   ++ DFGL+R +E++    A +   G    + + APE  
Sbjct: 142 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTAPEAI 199
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQ 486
              K T  SDV+ +G V+ EVV  G  P                 W +  +  I+ AV++
Sbjct: 200 AFRKFTSASDVWSYGIVMWEVVSYGERP----------------YWEMTNQDVIK-AVEE 242
Query: 487 RLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
              + S +D    L  L L C     + RPK ++I+ ++
Sbjct: 243 GYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 19/217 (8%)
Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIXXXX 302
           H +  +G G FG VY G +  ND   +     AVK  +R + I     FL E  I+    
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKI---HCAVKSLNRITDIGEVSQFLTEGIIMKDFS 88
Query: 303 XXXXXXXXGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG----VA 357
                   G C   +G  L+V  +M +G L  ++   +   T+      K L G    VA
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVA 142
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
             + YL +   +K VHRDL A N +LD  F  ++ DFGLAR +  ++   + H   G   
Sbjct: 143 KGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEXXSVHNKTGAKL 198
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            + ++A E   T K T +SDV+ FG ++ E++   +P
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF-SRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +G G FG V  G +    +  +    +A+K   S  + K + DFL+E +I+         
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREI---FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G   +   ++++ +FM NGSL+ +L     Q T+       +L G+A+ + YL    
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI--QLVGMLRGIAAGMKYLA--- 126
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           D   VHR L A NIL++++   ++ DFGL+R +E++ +       +G    + + APE  
Sbjct: 127 DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 428 HTGKATPESDVFGFGAVVLEVV 449
              K T  SDV+ +G V+ EV+
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVM 208

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 135/310 (43%), Gaps = 40/310 (12%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    +  +     +   +AVK    D+  K   D ++E+ ++        
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY-----GTSEQVTLNWNHRYKI-LTGVASA 359
                G C + G L ++ ++   G+L +YL      G      +N     ++    + S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 360 VYYLQN--EY--DQKVVHRDLKASNILLDADFNARLGDFGLARAIEN-ERNSYAEHGLVG 414
            Y L    EY   QK +HRDL A N+L+  +   ++ DFGLAR I N +      +G + 
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWVWM 473
           V     ++APE       T +SDV+ FG ++ E+   G SP   IP        V+ ++ 
Sbjct: 223 V----KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--------VEELFK 270
Query: 474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISGTS 529
           L +EGH  D      N          L ++   C H + S+RP      ED+ +I++ T+
Sbjct: 271 LLKEGHRMDKPANCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321
Query: 530 TVPYVPQFKP 539
              Y+   +P
Sbjct: 322 NEEYLDLSQP 331

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           LGEG FG V+    + N     D   +AVK     ++ ++ DF  E  ++          
Sbjct: 23  LGEGAFGKVFLAECY-NLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLY-----------GTSEQVT--LNWNHRYKILTG 355
             G C +   L++V+++M +G L K+L            G   Q    L  +    I + 
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           +AS + YL +   Q  VHRDL   N L+ A+   ++GDFG++R + +  + Y   G   +
Sbjct: 142 IASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST-DYYRVGGHTML 197
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           P  + ++ PE     K T ESDV+ FG ++ E+   G+ P
Sbjct: 198 P--IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXX 307
           LG+G FG+VY+G      +   + T++AVK  +   S++ + +FL E +++         
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAE-TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------WNHRYKILTGVASAV 360
              G   +    L+V + M +G L+ YL     +   N            ++   +A  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI-ENERNSYAEHGLVGVPGTM 419
            YL     +K VHRDL A N ++  DF  ++GDFG+ R I E +       GL+ V    
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV---- 196
Query: 420 GYVAPECFHTGKATPESDVFGFGAVVLEV 448
            ++APE    G  T  SD++ FG V+ E+
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 135/310 (43%), Gaps = 40/310 (12%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    +  +     +   +AVK    D+  K   D ++E+ ++        
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY-----GTSEQVTLNWNHRYKI-LTGVASA 359
                G C + G L ++ ++   G+L +YL      G      +N     ++    + S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 360 VYYLQN--EY--DQKVVHRDLKASNILLDADFNARLGDFGLARAIEN-ERNSYAEHGLVG 414
            Y L    EY   QK +HRDL A N+L+  +   ++ DFGLAR I N +      +G + 
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWVWM 473
           V     ++APE       T +SDV+ FG ++ E+   G SP   IP        V+ ++ 
Sbjct: 223 V----KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--------VEELFK 270
Query: 474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISGTS 529
           L +EGH  D      N          L ++   C H + S+RP      ED+ +I++ T+
Sbjct: 271 LLKEGHRMDKPANCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321
Query: 530 TVPYVPQFKP 539
              Y+   +P
Sbjct: 322 NEEYLDLSQP 331

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXX 307
           LG+G FG+VY+G      +   + T++AVK  +   S++ + +FL E +++         
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAE-TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------WNHRYKILTGVASAV 360
              G   +    L+V + M +G L+ YL     +   N            ++   +A  +
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI-ENERNSYAEHGLVGVPGTM 419
            YL     +K VHRDL A N ++  DF  ++GDFG+ R I E +       GL+ V    
Sbjct: 141 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV---- 193
Query: 420 GYVAPECFHTGKATPESDVFGFGAVVLEV 448
            ++APE    G  T  SD++ FG V+ E+
Sbjct: 194 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXX 307
           LG+G FG+VY+G      +   + T++AVK  +   S++ + +FL E +++         
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAE-TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------WNHRYKILTGVASAV 360
              G   +    L+V + M +G L+ YL     +   N            ++   +A  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI-ENERNSYAEHGLVGVPGTM 419
            YL     +K VHRDL A N ++  DF  ++GDFG+ R I E +       GL+ V    
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV---- 196
Query: 420 GYVAPECFHTGKATPESDVFGFGAVVLEV 448
            ++APE    G  T  SD++ FG V+ E+
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXX 307
           LG+G FG+VY+G      +   + T++AVK  +   S++ + +FL E +++         
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAE-TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------WNHRYKILTGVASAV 360
              G   +    L+V + M +G L+ YL     +   N            ++   +A  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            YL     +K VHRDL A N ++  DF  ++GDFG+ R I  E + Y + G   +P  + 
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLP--VR 197
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEV 448
           ++APE    G  T  SD++ FG V+ E+
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 25  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 77
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q  +N      + T ++SA+ YL+   
Sbjct: 78  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK-- 134
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    ++Y  H     P  + + APE  
Sbjct: 135 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP--IKWTAPESL 189
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 21/218 (9%)
Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIXXXX 302
           H +  +G G FG VY G +  ND   +     AVK  +R + I     FL E  I+    
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKI---HCAVKSLNRITDIGEVSQFLTEGIIMKDFS 90
Query: 303 XXXXXXXXGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG----VA 357
                   G C   +G  L+V  +M +G L  ++   +   T+      K L G    VA
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVA 144
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR-AIENERNSYAEHGLVGVP 416
             + +L +   +K VHRDL A N +LD  F  ++ DFGLAR  ++ E +S   H   G  
Sbjct: 145 KGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSV--HNKTGAK 199
Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             + ++A E   T K T +SDV+ FG ++ E++   +P
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 25  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 77
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q  +N      + T ++SA+ YL+   
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK-- 134
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    ++Y  H     P  + + APE  
Sbjct: 135 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP--IKWTAPESL 189
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXX 307
           LG+G FG+VY+G      +   + T++AVK  +   S++ + +FL E +++         
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAE-TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------WNHRYKILTGVASAV 360
              G   +    L+V + M +G L+ YL     +   N            ++   +A  +
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            YL     +K VHRDL A N ++  DF  ++GDFG+ R I  E + Y + G   +P  + 
Sbjct: 143 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLP--VR 196
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEV 448
           ++APE    G  T  SD++ FG V+ E+
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 24  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 76
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q  +N      + T ++SA+ YL+   
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK-- 133
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    ++Y  H     P  + + APE  
Sbjct: 134 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP--IKWTAPESL 188
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSP 216

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 17/223 (7%)
Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLA 293
           E + A      S  LG+G FG+VY+G+     +   + T++A+K  +   S++ + +FL 
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLN 62
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------W 346
           E +++            G   +    L++ + M  G L+ YL     ++  N        
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI-ENERN 405
           +   ++   +A  + YL      K VHRDL A N ++  DF  ++GDFG+ R I E +  
Sbjct: 123 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
                GL+ V     +++PE    G  T  SDV+ FG V+ E+
Sbjct: 180 RKGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 19/217 (8%)
Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIXXXX 302
           H +  +G G FG VY G +  ND   +     AVK  +R + I     FL E  I+    
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKI---HCAVKSLNRITDIGEVSQFLTEGIIMKDFS 87
Query: 303 XXXXXXXXGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG----VA 357
                   G C   +G  L+V  +M +G L  ++   +   T+      K L G    VA
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVA 141
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
             + +L +   +K VHRDL A N +LD  F  ++ DFGLAR + ++    + H   G   
Sbjct: 142 KGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD-SVHNKTGAKL 197
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            + ++A E   T K T +SDV+ FG ++ E++   +P
Sbjct: 198 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 20  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 72
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q  +N      + T ++SA+ YL+   
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK-- 129
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    ++Y  H     P  + + APE  
Sbjct: 130 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP--IKWTAPESL 184
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 19/217 (8%)
Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIXXXX 302
           H +  +G G FG VY G +  ND   +     AVK  +R + I     FL E  I+    
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKI---HCAVKSLNRITDIGEVSQFLTEGIIMKDFS 94
Query: 303 XXXXXXXXGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG----VA 357
                   G C   +G  L+V  +M +G L  ++   +   T+      K L G    VA
Sbjct: 95  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVA 148
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
             + +L +   +K VHRDL A N +LD  F  ++ DFGLAR + ++    + H   G   
Sbjct: 149 KGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD-SVHNKTGAKL 204
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            + ++A E   T K T +SDV+ FG ++ E++   +P
Sbjct: 205 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 25  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 77
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q  +N      + T ++SA+ YL+   
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK-- 134
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    ++Y  H     P  + + APE  
Sbjct: 135 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP--IKWTAPESL 189
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 15/222 (6%)
Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLA 293
           E + A      S  LG+G FG+VY+G+     +   + T++A+K  +   S++ + +FL 
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLN 77
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------W 346
           E +++            G   +    L++ + M  G L+ YL     ++  N        
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 137
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
           +   ++   +A  + YL      K VHRDL A N ++  DF  ++GDFG+ R I  E + 
Sbjct: 138 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDY 193
Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           Y + G   +P  + +++PE    G  T  SDV+ FG V+ E+
Sbjct: 194 YRKGGKGLLP--VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 22  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 74
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q  +N      + T ++SA+ YL+   
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK-- 131
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    ++Y  H     P  + + APE  
Sbjct: 132 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP--IKWTAPESL 186
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 187 AYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 19/217 (8%)
Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIXXXX 302
           H +  +G G FG VY G +  ND   +     AVK  +R + I     FL E  I+    
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKI---HCAVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 303 XXXXXXXXGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG----VA 357
                   G C   +G  L+V  +M +G L  ++   +   T+      K L G    VA
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVA 143
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
             + +L +   +K VHRDL A N +LD  F  ++ DFGLAR + ++    + H   G   
Sbjct: 144 KGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD-SVHNKTGAKL 199
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            + ++A E   T K T +SDV+ FG ++ E++   +P
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 132/303 (43%), Gaps = 46/303 (15%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    I  +       T++AVK    D+  K   D ++E+ ++        
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE---QVTLNWNHR----------YKI 352
                G C + G L ++ ++   G+L +YL        + + N +H              
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN-ERNSYAEHG 411
              VA  + YL +   +K +HRDL A N+L+  D   ++ DFGLAR I + +      +G
Sbjct: 156 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 412 LVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDW 470
            + V     ++APE       T +SDV+ FG ++ E+   G SP   +P        V+ 
Sbjct: 213 RLPV----KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--------VEE 260
Query: 471 VWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIIS 526
           ++ L +EGH  D      N          L ++   C H + S+RP      ED+ +I++
Sbjct: 261 LFKLLKEGHRMDKPSNCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 311
Query: 527 GTS 529
            TS
Sbjct: 312 LTS 314

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 15/222 (6%)
Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLA 293
           E + A      S  LG+G FG+VY+G+     +   + T++A+K  +   S++ + +FL 
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLN 64
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------W 346
           E +++            G   +    L++ + M  G L+ YL     ++  N        
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
           +   ++   +A  + YL      K VHRDL A N ++  DF  ++GDFG+ R I  E + 
Sbjct: 125 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDY 180
Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           Y + G   +P  + +++PE    G  T  SDV+ FG V+ E+
Sbjct: 181 YRKGGKGLLP--VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 20  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 72
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q  +N      + T ++SA+ YL+   
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK-- 129
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    ++Y  H     P  + + APE  
Sbjct: 130 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP--IKWTAPESL 184
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 19/217 (8%)
Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIXXXX 302
           H +  +G G FG VY G +  ND   +     AVK  +R + I     FL E  I+    
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKI---HCAVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 303 XXXXXXXXGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG----VA 357
                   G C   +G  L+V  +M +G L  ++   +   T+      K L G    VA
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVA 143
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
             + +L +   +K VHRDL A N +LD  F  ++ DFGLAR + ++    + H   G   
Sbjct: 144 KGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD-SVHNKTGAKL 199
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            + ++A E   T K T +SDV+ FG ++ E++   +P
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 22  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 74
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q  +N      + T ++SA+ YL+   
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK-- 131
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    ++Y  H     P  + + APE  
Sbjct: 132 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP--IKWTAPESL 186
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 187 AYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 15/222 (6%)
Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLA 293
           E + A      S  LG+G FG+VY+G+     +   + T++A+K  +   S++ + +FL 
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLN 71
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------W 346
           E +++            G   +    L++ + M  G L+ YL     ++  N        
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
           +   ++   +A  + YL      K VHRDL A N ++  DF  ++GDFG+ R I  E + 
Sbjct: 132 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDY 187
Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           Y + G   +P  + +++PE    G  T  SDV+ FG V+ E+
Sbjct: 188 YRKGGKGLLP--VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 15/222 (6%)
Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLA 293
           E + A      S  LG+G FG+VY+G+     +   + T++A+K  +   S++ + +FL 
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLN 70
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------W 346
           E +++            G   +    L++ + M  G L+ YL     ++  N        
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
           +   ++   +A  + YL      K VHRDL A N ++  DF  ++GDFG+ R I  E + 
Sbjct: 131 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDY 186
Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           Y + G   +P  + +++PE    G  T  SDV+ FG V+ E+
Sbjct: 187 YRKGGKGLLP--VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 15/222 (6%)
Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLA 293
           E + A      S  LG+G FG+VY+G+     +   + T++A+K  +   S++ + +FL 
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLN 70
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------W 346
           E +++            G   +    L++ + M  G L+ YL     ++  N        
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
           +   ++   +A  + YL      K VHRDL A N ++  DF  ++GDFG+ R I  E + 
Sbjct: 131 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDY 186
Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           Y + G   +P  + +++PE    G  T  SDV+ FG V+ E+
Sbjct: 187 YRKGGKGLLP--VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 17/223 (7%)
Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLA 293
           E + A      S  LG+G FG+VY+G+     +   + T++A+K  +   S++ + +FL 
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLN 71
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------W 346
           E +++            G   +    L++ + M  G L+ YL     ++  N        
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI-ENERN 405
           +   ++   +A  + YL      K VHRDL A N ++  DF  ++GDFG+ R I E +  
Sbjct: 132 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 188
Query: 406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
                GL+ V     +++PE    G  T  SDV+ FG V+ E+
Sbjct: 189 RKGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXX 307
           LG+G FG+VY+G      +   + T++AVK  +   S++ + +FL E +++         
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAE-TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------WNHRYKILTGVASAV 360
              G   +    L+V + M +G L+ YL     +   N            ++   +A  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            YL     +K VHRDL A N ++  DF  ++GDFG+ R I  E   Y + G   +P  + 
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETAYYRKGGKGLLP--VR 197
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEV 448
           ++APE    G  T  SD++ FG V+ E+
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 15/222 (6%)
Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLA 293
           E + A      S  LG+G FG+VY+G+     +   + T++A+K  +   S++ + +FL 
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLN 68
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------W 346
           E +++            G   +    L++ + M  G L+ YL     ++  N        
Sbjct: 69  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 128
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
           +   ++   +A  + YL      K VHRDL A N ++  DF  ++GDFG+ R I  E + 
Sbjct: 129 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDY 184
Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           Y + G   +P  + +++PE    G  T  SDV+ FG V+ E+
Sbjct: 185 YRKGGKGLLP--VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 19/217 (8%)
Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIXXXX 302
           H +  +G G FG VY G +  ND   +     AVK  +R + I     FL E  I+    
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKI---HCAVKSLNRITDIGEVSQFLTEGIIMKDFS 90
Query: 303 XXXXXXXXGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG----VA 357
                   G C   +G  L+V  +M +G L  ++   +   T+      K L G    VA
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVA 144
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
             + +L +   +K VHRDL A N +LD  F  ++ DFGLAR + ++    + H   G   
Sbjct: 145 KGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD-SVHNKTGAKL 200
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            + ++A E   T K T +SDV+ FG ++ E++   +P
Sbjct: 201 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 33  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 85
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q  +N      + T ++SA+ YL+   
Sbjct: 86  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK-- 142
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    ++Y  H     P  + + APE  
Sbjct: 143 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP--IKWTAPESL 197
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 198 AYNKFSIKSDVWAFGVLLWEIATYGMSP 225

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 116/248 (46%), Gaps = 26/248 (10%)
Query: 239 ATNNFHESMRLGEGGFGIVYKG-IIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAI 297
           A N      ++G+GGFG+V+KG ++       + +  +   +   + I+   +F  E+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
           +            G  H   +  +V +F+P G L   L   +  +   W+ + +++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPI--KWSVKLRLMLDIA 132
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILL-----DADFNARLGDFGLARAIENERNSYAEHGL 412
             + Y+QN+ +  +VHRDL++ NI L     +A   A++ DFGL++         + H +
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--------SVHSV 183
Query: 413 VGVPGTMGYVAPECFHTGKA--TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
            G+ G   ++APE     +   T ++D + F  ++  ++ G       P  +++Y  + +
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG-----PFDEYSYGKIKF 238
Query: 471 VWMLHREG 478
           + M+  EG
Sbjct: 239 INMIREEG 246

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 97/219 (44%), Gaps = 20/219 (9%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           LGEG FG V+    H N     D   +AVK     S  ++ DF  E  ++          
Sbjct: 26  LGEGAFGKVFLAECH-NLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKY---------LYGTSEQVT---LNWNHRYKILTGV 356
             G C E   LL+V+++M +G L ++         L    E V    L       + + V
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP 416
           A+ + YL   +    VHRDL   N L+      ++GDFG++R I +  + Y   G   +P
Sbjct: 145 AAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST-DYYRVGGRTMLP 200
Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
             + ++ PE     K T ESDV+ FG V+ E+   G+ P
Sbjct: 201 --IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 19/217 (8%)
Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIXXXX 302
           H +  +G G FG VY G +  ND   +     AVK  +R + I     FL E  I+    
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKI---HCAVKSLNRITDIGEVSQFLTEGIIMKDFS 148
Query: 303 XXXXXXXXGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG----VA 357
                   G C   +G  L+V  +M +G L  ++   +   T+      K L G    VA
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVA 202
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
             + +L +   +K VHRDL A N +LD  F  ++ DFGLAR + ++    + H   G   
Sbjct: 203 KGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD-SVHNKTGAKL 258
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            + ++A E   T K T +SDV+ FG ++ E++   +P
Sbjct: 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 97/219 (44%), Gaps = 20/219 (9%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           LGEG FG V+    H N     D   +AVK     S  ++ DF  E  ++          
Sbjct: 20  LGEGAFGKVFLAECH-NLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKY---------LYGTSEQVT---LNWNHRYKILTGV 356
             G C E   LL+V+++M +G L ++         L    E V    L       + + V
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP 416
           A+ + YL   +    VHRDL   N L+      ++GDFG++R I +  + Y   G   +P
Sbjct: 139 AAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST-DYYRVGGRTMLP 194
Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
             + ++ PE     K T ESDV+ FG V+ E+   G+ P
Sbjct: 195 --IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLA 293
           E + A      S  LG+G FG+VY+G+     +   + T++A+K  +   S++ + +FL 
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLN 77
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------W 346
           E +++            G   +    L++ + M  G L+ YL      +  N        
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
           +   ++   +A  + YL      K VHRDL A N ++  DF  ++GDFG+ R I  E + 
Sbjct: 138 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDY 193
Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           Y + G   +P  + +++PE    G  T  SDV+ FG V+ E+
Sbjct: 194 YRKGGKGLLP--VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 132/299 (44%), Gaps = 38/299 (12%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    +  +     +   +AVK    D+  K   D ++E+ ++        
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY-----GTSEQVTLNWNHRYKI-LTGVASA 359
                G C + G L ++ ++   G+L +YL      G      +N     ++    + S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 360 VYYLQN--EY--DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
            Y L    EY   QK +HRDL A N+L+  +   R+ DFGLAR I N  + Y +     +
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDI-NNIDYYKKTTNGRL 221
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWVWML 474
           P  + ++APE       T +SDV+ FG ++ E+   G SP   IP        V+ ++ L
Sbjct: 222 P--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--------VEELFKL 271
Query: 475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISGTS 529
            +EGH  D      N          L ++   C H + S+RP      ED+ +I++ T+
Sbjct: 272 LKEGHRMDKPANCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/307 (26%), Positives = 135/307 (43%), Gaps = 44/307 (14%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    I  +       T++AVK    D+  K   D ++E+ ++        
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYL-----------YGTSE--QVTLNWNHRYKI 352
                G C + G L ++ ++   G+L +YL           Y  S   +  L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
              VA  + YL +   +K +HRDL A N+L+  D   ++ DFGLAR I +  + Y +   
Sbjct: 156 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI-HHIDYYKKTTN 211
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWV 471
             +P  + ++APE       T +SDV+ FG ++ E+   G SP   +P        V+ +
Sbjct: 212 GRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--------VEEL 261
Query: 472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISG 527
           + L +EGH  D      N          L ++   C H + S+RP      ED+ +I++ 
Sbjct: 262 FKLLKEGHRMDKPSNCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 312
Query: 528 TSTVPYV 534
           TS   Y+
Sbjct: 313 TSNQEYL 319

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 25  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 77
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q        Y + T ++SA+ YL+   
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-MATQISSAMEYLEK-- 134
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    ++Y  H     P  + + APE  
Sbjct: 135 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP--IKWTAPESL 189
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 15/222 (6%)
Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLA 293
           E + A      S  LG+G FG+VY+G+     +   + T++A+K  +   S++ + +FL 
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLN 99
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------W 346
           E +++            G   +    L++ + M  G L+ YL     ++  N        
Sbjct: 100 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 159
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
           +   ++   +A  + YL      K VHRDL A N ++  DF  ++GDFG+ R I  E + 
Sbjct: 160 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDY 215
Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           Y + G   +P  + +++PE    G  T  SDV+ FG V+ E+
Sbjct: 216 YRKGGKGLLP--VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 97/219 (44%), Gaps = 20/219 (9%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           LGEG FG V+    H N     D   +AVK     S  ++ DF  E  ++          
Sbjct: 49  LGEGAFGKVFLAECH-NLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKY---------LYGTSEQVT---LNWNHRYKILTGV 356
             G C E   LL+V+++M +G L ++         L    E V    L       + + V
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP 416
           A+ + YL   +    VHRDL   N L+      ++GDFG++R I +  + Y   G   +P
Sbjct: 168 AAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST-DYYRVGGRTMLP 223
Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
             + ++ PE     K T ESDV+ FG V+ E+   G+ P
Sbjct: 224 --IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 20  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 72
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q        Y + T ++SA+ YL+   
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLY-MATQISSAMEYLEK-- 129
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    ++Y  H     P  + + APE  
Sbjct: 130 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP--IKWTAPESL 184
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 20  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 72
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q        Y + T ++SA+ YL+   
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLY-MATQISSAMEYLEK-- 129
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    ++Y  H     P  + + APE  
Sbjct: 130 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP--IKWTAPESL 184
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 20  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 72
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q        Y + T ++SA+ YL+   
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-MATQISSAMEYLEK-- 129
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    ++Y  H     P  + + APE  
Sbjct: 130 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP--IKWTAPESL 184
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXX 307
           LG+G FG+VY+G      +   + T++AVK  +   S++ + +FL E +++         
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAE-TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------WNHRYKILTGVASAV 360
              G   +    L+V + M +G L+ YL     +   N            ++   +A  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            YL     +K VHR+L A N ++  DF  ++GDFG+ R I  E + Y + G   +P  + 
Sbjct: 144 AYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLP--VR 197
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEV 448
           ++APE    G  T  SD++ FG V+ E+
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 20  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 72
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q        Y + T ++SA+ YL+   
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-MATQISSAMEYLEK-- 129
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    ++Y  H     P  + + APE  
Sbjct: 130 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP--IKWTAPESL 184
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 12/222 (5%)
Query: 229 REFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKS 287
           REF  KE+  +     E   +G G FG V +G +    +     + +A+K      + + 
Sbjct: 7   REFA-KEIDVSYVKIEEV--IGAGEFGEVCRGRLKAPGK---KESCVAIKTLKGGYTERQ 60
Query: 288 KGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWN 347
           + +FL+E +I+            G       ++++ +FM NG+L+ +L     Q T+   
Sbjct: 61  RREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI-- 118
Query: 348 HRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY 407
               +L G+AS + YL    +   VHRDL A NIL++++   ++ DFGL+R +E   +  
Sbjct: 119 QLVGMLRGIASGMRYLA---EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDP 175
Query: 408 AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
            E   +G    + + APE     K T  SD + +G V+ EV+
Sbjct: 176 TETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM 217

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLA 293
           E + A      S  LG+G FG+VY+G+     +   + T++A+K  +   S++ + +FL 
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLN 67
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------W 346
           E +++            G   +    L++ + M  G L+ YL      +  N        
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
           +   ++   +A  + YL      K VHRDL A N ++  DF  ++GDFG+ R I  E + 
Sbjct: 128 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDY 183
Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           Y + G   +P  + +++PE    G  T  SDV+ FG V+ E+
Sbjct: 184 YRKGGKGLLP--VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXX 307
           LG+G FG+VY+G      +   + T++AVK  +   S++ + +FL E +++         
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAE-TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------WNHRYKILTGVASAV 360
              G   +    L+V + M +G L+ YL     +   N            ++   +A  +
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            YL     +K VHR+L A N ++  DF  ++GDFG+ R I  E + Y + G   +P  + 
Sbjct: 145 AYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLP--VR 198
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEV 448
           ++APE    G  T  SD++ FG V+ E+
Sbjct: 199 WMAPESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 133/302 (44%), Gaps = 44/302 (14%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    I  +       T++AVK    D+  K   D ++E+ ++        
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE---QVTLNWNHR----------YKI 352
                G C + G L ++ ++   G+L +YL        + + N +H              
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
              VA  + YL +   +K +HRDL A N+L+  D   ++ DFGLAR I +  + Y +   
Sbjct: 145 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI-HHIDYYKKTTN 200
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWV 471
             +P  + ++APE       T +SDV+ FG ++ E+   G SP   +P        V+ +
Sbjct: 201 GRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--------VEEL 250
Query: 472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISG 527
           + L +EGH  D      N          L ++   C H + S+RP      ED+ +I++ 
Sbjct: 251 FKLLKEGHRMDKPSNCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 301
Query: 528 TS 529
           TS
Sbjct: 302 TS 303

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 22/226 (9%)
Query: 244 HESMRLGE----GGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KGDFLAELAI 297
           HE + LGE    G FG V+ G      +   DNT +AVK   R+++    K  FL E  I
Sbjct: 113 HEDLVLGEQIGRGNFGEVFSG------RLRADNTLVAVKS-CRETLPPDLKAKFLQEARI 165
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
           +            G C +K  + +V + +  G    +L   +E   L      +++   A
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAA 223
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
           + + YL+++     +HRDL A N L+      ++ DFG++R  E +    A  GL  VP 
Sbjct: 224 AGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVXAASGGLRQVP- 278
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSPGNMIPHQQ 462
            + + APE  + G+ + ESDV+ FG ++ E    G SP   + +QQ
Sbjct: 279 -VKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLA 293
           E + A      S  LG+G FG+VY+G+     +   + T++A+K  +   S++ + +FL 
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLN 64
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN-------W 346
           E +++            G   +    L++ + M  G L+ YL     ++  N        
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
           +   ++   +A  + YL      K VHRDL A N  +  DF  ++GDFG+ R I  E + 
Sbjct: 125 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDI-YETDY 180
Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           Y + G   +P  + +++PE    G  T  SDV+ FG V+ E+
Sbjct: 181 YRKGGKGLLP--VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 136/298 (45%), Gaps = 30/298 (10%)
Query: 229 REFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKS 287
           REF  KE+  +     + + +GE  FG V  G +    +  +    +A+K      + K 
Sbjct: 20  REFA-KEIDASCIKIEKVIGVGE--FGEVCSGRLKVPGKREI---CVAIKTLKAGYTDKQ 73
Query: 288 KGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWN 347
           + DFL+E +I+            G   +   ++++ ++M NGSL+ +L     + T+   
Sbjct: 74  RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI-- 131
Query: 348 HRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY 407
               +L G+ S + YL    D   VHRDL A NIL++++   ++ DFG++R +E+  +  
Sbjct: 132 QLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLED--DPE 186
Query: 408 AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTL 467
           A +   G    + + APE     K T  SDV+ +G V+ EV         + + +  Y  
Sbjct: 187 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV---------MSYGERPY-- 235
Query: 468 VDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
               W +  +  I+ A+++   +   +D    L  L L C     S+RPK   I+ ++
Sbjct: 236 ----WDMSNQDVIK-AIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 288

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 133/302 (44%), Gaps = 44/302 (14%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    I  +       T++AVK    D+  K   D ++E+ ++        
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE---QVTLNWNHR----------YKI 352
                G C + G L ++ ++   G+L +YL        + + N +H              
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
              VA  + YL +   +K +HRDL A N+L+  D   ++ DFGLAR I +  + Y +   
Sbjct: 156 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI-HHIDYYKKTTN 211
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWV 471
             +P  + ++APE       T +SDV+ FG ++ E+   G SP   +P        V+ +
Sbjct: 212 GRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--------VEEL 261
Query: 472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISG 527
           + L +EGH  D      N          L ++   C H + S+RP      ED+ +I++ 
Sbjct: 262 FKLLKEGHRMDKPSNCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 312
Query: 528 TS 529
           TS
Sbjct: 313 TS 314

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +G G FG+V+ G       Y ++  ++A+K   R+   S+ DF+ E  ++          
Sbjct: 15  IGSGQFGLVHLG-------YWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G C E+  + LV++FM +G L  YL   +++          +   V   + YL+   +
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---E 121
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
             V+HRDL A N L+  +   ++ DFG+ R + +++ + +     G    + + +PE F 
Sbjct: 122 ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS----TGTKFPVKWASPEVFS 177
Query: 429 TGKATPESDVFGFGAVVLEV 448
             + + +SDV+ FG ++ EV
Sbjct: 178 FSRYSSKSDVWSFGVLMWEV 197

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 133/302 (44%), Gaps = 44/302 (14%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    I  +       T++AVK    D+  K   D ++E+ ++        
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE---QVTLNWNHR----------YKI 352
                G C + G L ++ ++   G+L +YL        + + N +H              
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
              VA  + YL +   +K +HRDL A N+L+  D   ++ DFGLAR I +  + Y +   
Sbjct: 149 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI-HHIDYYKKTTN 204
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWV 471
             +P  + ++APE       T +SDV+ FG ++ E+   G SP   +P        V+ +
Sbjct: 205 GRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--------VEEL 254
Query: 472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISG 527
           + L +EGH  D      N          L ++   C H + S+RP      ED+ +I++ 
Sbjct: 255 FKLLKEGHRMDKPSNCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 305
Query: 528 TS 529
           TS
Sbjct: 306 TS 307

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 133/302 (44%), Gaps = 44/302 (14%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    I  +       T++AVK    D+  K   D ++E+ ++        
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE---QVTLNWNHR----------YKI 352
                G C + G L ++ ++   G+L +YL        + + N +H              
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
              VA  + YL +   +K +HRDL A N+L+  D   ++ DFGLAR I +  + Y +   
Sbjct: 156 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI-HHIDYYKKTTN 211
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWV 471
             +P  + ++APE       T +SDV+ FG ++ E+   G SP   +P        V+ +
Sbjct: 212 GRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--------VEEL 261
Query: 472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISG 527
           + L +EGH  D      N          L ++   C H + S+RP      ED+ +I++ 
Sbjct: 262 FKLLKEGHRMDKPSNCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 312
Query: 528 TS 529
           TS
Sbjct: 313 TS 314

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 132/299 (44%), Gaps = 38/299 (12%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    +  +     +   +AVK    D+  K   D ++E+ ++        
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY-----GTSEQVTLNWNHRYKI-LTGVASA 359
                G C + G L ++ ++   G+L +YL      G      +N     ++    + S 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 360 VYYLQN--EY--DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
            Y L    EY   QK +HRDL A N+L+  +   ++ DFGLAR I N  + Y +     +
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTNGRL 221
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWVWML 474
           P  + ++APE       T +SDV+ FG ++ E+   G SP   IP        V+ ++ L
Sbjct: 222 P--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--------VEELFKL 271
Query: 475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISGTS 529
            +EGH  D      N          L ++   C H + S+RP      ED+ +I++ T+
Sbjct: 272 LKEGHRMDKPANCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 133/302 (44%), Gaps = 44/302 (14%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    I  +       T++AVK    D+  K   D ++E+ ++        
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYL-----------YGTSE--QVTLNWNHRYKI 352
                G C + G L ++ ++   G+L +YL           Y  S   +  L+       
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
              VA  + YL +   +K +HRDL A N+L+  D   ++ DFGLAR I +  + Y +   
Sbjct: 141 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI-HHIDYYKKTTN 196
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWV 471
             +P  + ++APE       T +SDV+ FG ++ E+   G SP   +P        V+ +
Sbjct: 197 GRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--------VEEL 246
Query: 472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISG 527
           + L +EGH  D      N          L ++   C H + S+RP      ED+ +I++ 
Sbjct: 247 FKLLKEGHRMDKPSNCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
Query: 528 TS 529
           TS
Sbjct: 298 TS 299

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 133/302 (44%), Gaps = 44/302 (14%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    I  +       T++AVK    D+  K   D ++E+ ++        
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE---QVTLNWNHR----------YKI 352
                G C + G L ++ ++   G+L +YL        + + N +H              
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
              VA  + YL +   +K +HRDL A N+L+  D   ++ DFGLAR I +  + Y +   
Sbjct: 197 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI-HHIDYYKKTTN 252
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWV 471
             +P  + ++APE       T +SDV+ FG ++ E+   G SP   +P        V+ +
Sbjct: 253 GRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--------VEEL 302
Query: 472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISG 527
           + L +EGH  D      N          L ++   C H + S+RP      ED+ +I++ 
Sbjct: 303 FKLLKEGHRMDKPSNCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353
Query: 528 TS 529
           TS
Sbjct: 354 TS 355

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 132/299 (44%), Gaps = 38/299 (12%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    +  +     +   +AVK    D+  K   D ++E+ ++        
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY-----GTSEQVTLNWNHRYKI-LTGVASA 359
                G C + G L ++ ++   G+L +YL      G      +N     ++    + S 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 360 VYYLQN--EY--DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
            Y L    EY   QK +HRDL A N+L+  +   ++ DFGLAR I N  + Y +     +
Sbjct: 209 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTNGRL 267
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWVWML 474
           P  + ++APE       T +SDV+ FG ++ E+   G SP   IP        V+ ++ L
Sbjct: 268 P--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--------VEELFKL 317
Query: 475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISGTS 529
            +EGH  D      N          L ++   C H + S+RP      ED+ +I++ T+
Sbjct: 318 LKEGHRMDKPANCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 133/302 (44%), Gaps = 44/302 (14%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    I  +       T++AVK    D+  K   D ++E+ ++        
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE---QVTLNWNHR----------YKI 352
                G C + G L ++ ++   G+L +YL        + + N +H              
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
              VA  + YL +   +K +HRDL A N+L+  D   ++ DFGLAR I +  + Y +   
Sbjct: 148 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI-HHIDYYKKTTN 203
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWV 471
             +P  + ++APE       T +SDV+ FG ++ E+   G SP   +P        V+ +
Sbjct: 204 GRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--------VEEL 253
Query: 472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISG 527
           + L +EGH  D      N          L ++   C H + S+RP      ED+ +I++ 
Sbjct: 254 FKLLKEGHRMDKPSNCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 304
Query: 528 TS 529
           TS
Sbjct: 305 TS 306

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 22/226 (9%)
Query: 244 HESMRLGE----GGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KGDFLAELAI 297
           HE + LGE    G FG V+ G      +   DNT +AVK   R+++    K  FL E  I
Sbjct: 113 HEDLVLGEQIGRGNFGEVFSG------RLRADNTLVAVKS-CRETLPPDLKAKFLQEARI 165
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
           +            G C +K  + +V + +  G    +L   +E   L      +++   A
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAA 223
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
           + + YL+++     +HRDL A N L+      ++ DFG++R  E +    A  GL  VP 
Sbjct: 224 AGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVP- 278
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSPGNMIPHQQ 462
            + + APE  + G+ + ESDV+ FG ++ E    G SP   + +QQ
Sbjct: 279 -VKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +G G FG+V+ G       Y ++  ++A+K   R+   S+ DF+ E  ++          
Sbjct: 18  IGSGQFGLVHLG-------YWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 69
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G C E+  + LV++FM +G L  YL   +++          +   V   + YL+   +
Sbjct: 70  LYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---E 124
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
             V+HRDL A N L+  +   ++ DFG+ R + +++ + +     G    + + +PE F 
Sbjct: 125 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS----TGTKFPVKWASPEVFS 180
Query: 429 TGKATPESDVFGFGAVVLEV 448
             + + +SDV+ FG ++ EV
Sbjct: 181 FSRYSSKSDVWSFGVLMWEV 200

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 138/321 (42%), Gaps = 33/321 (10%)
Query: 213 AEPHHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDN 272
           AEPH        PG       +E++   +  H    +G G  G V  G +    Q  V  
Sbjct: 27  AEPH----TYEEPGRAGRSFTREIE--ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDV-- 78
Query: 273 TQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSL 331
             +A+K      + + + DFL+E +I+            G        ++V ++M NGSL
Sbjct: 79  -PVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL 137
Query: 332 EKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL 391
           + +L     Q T+       +L GV + + YL    D   VHRDL A N+L+D++   ++
Sbjct: 138 DTFLRTHDGQFTIM--QLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKV 192
Query: 392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCG 451
            DFGL+R +E++ +  A +   G    + + APE       +  SDV+ FG V+ EV+  
Sbjct: 193 SDFGLSRVLEDDPD--AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL-- 248
Query: 452 RSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPI 511
                       AY    +  M +R+  +  +V++   + + +     L  L L C H  
Sbjct: 249 ------------AYGERPYWNMTNRD--VISSVEEGYRLPAPMGCPHALHQLMLDCWHKD 294
Query: 512 ASERPKTEDILQIISGTSTVP 532
            ++RP+   I+ ++      P
Sbjct: 295 RAQRPRFSQIVSVLDALIRSP 315

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +G G FG+V+ G       Y ++  ++A+K   R+   S+ DF+ E  ++          
Sbjct: 13  IGSGQFGLVHLG-------YWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G C E+  + LV++FM +G L  YL   +++          +   V   + YL+   +
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---E 119
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
             V+HRDL A N L+  +   ++ DFG+ R + +++ + +     G    + + +PE F 
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS----TGTKFPVKWASPEVFS 175
Query: 429 TGKATPESDVFGFGAVVLEV 448
             + + +SDV+ FG ++ EV
Sbjct: 176 FSRYSSKSDVWSFGVLMWEV 195

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 132/299 (44%), Gaps = 38/299 (12%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    +  +     +   +AVK    D+  K   D ++E+ ++        
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY-----GTSEQVTLNWNHRYKI-LTGVASA 359
                G C + G L ++ ++   G+L +YL      G      +N     ++    + S 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 360 VYYLQN--EY--DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
            Y L    EY   QK +HRDL A N+L+  +   ++ DFGLAR I N  + Y +     +
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTNGRL 221
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWVWML 474
           P  + ++APE       T +SDV+ FG ++ E+   G SP   IP        V+ ++ L
Sbjct: 222 P--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--------VEELFKL 271
Query: 475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISGTS 529
            +EGH  D      N          L ++   C H + S+RP      ED+ +I++ T+
Sbjct: 272 LKEGHRMDKPANCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G FG V+    + +       T++AVK     S+  +  FLAE  ++         
Sbjct: 22  KLGAGQFGEVWMATYNKH-------TKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLV 73
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLY---GTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                   K  + ++ +FM  GSL  +L    G+ + +    +   +I  G+A   +  Q
Sbjct: 74  KLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA---FIEQ 129
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
             Y    +HRDL+A+NIL+ A    ++ DFGLAR IE+   +  E    G    + + AP
Sbjct: 130 RNY----IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAP 181
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           E  + G  T +SDV+ FG +++E+V  GR P
Sbjct: 182 EAINFGSFTIKSDVWSFGILLMEIVTYGRIP 212

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +G G FG+V+ G       Y ++  ++A+K   R+   S+ DF+ E  ++          
Sbjct: 15  IGSGQFGLVHLG-------YWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G C E+  + LV++FM +G L  YL   +++          +   V   + YL+   +
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---E 121
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
             V+HRDL A N L+  +   ++ DFG+ R + +++ + +     G    + + +PE F 
Sbjct: 122 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS----TGTKFPVKWASPEVFS 177
Query: 429 TGKATPESDVFGFGAVVLEV 448
             + + +SDV+ FG ++ EV
Sbjct: 178 FSRYSSKSDVWSFGVLMWEV 197

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 111/230 (48%), Gaps = 17/230 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 266 KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 318
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q  +N      + T ++SA+ YL+   
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK-- 375
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HR+L A N L+  +   ++ DFGL+R +    ++Y  H     P  + + APE  
Sbjct: 376 -KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP--IKWTAPESL 430
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHR 476
              K + +SDV+ FG ++ E+   G SP   I   Q  Y L++  + + R
Sbjct: 431 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMER 479

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 131/300 (43%), Gaps = 40/300 (13%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    +  +     +   +AVK    D+  K   D ++E+ ++        
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY-----GTSEQVTLNWNHRYKI-LTGVASA 359
                G C + G L ++ ++   G+L +YL      G      +N     ++    + S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 360 VYYLQN--EY--DQKVVHRDLKASNILLDADFNARLGDFGLARAIEN-ERNSYAEHGLVG 414
            Y L    EY   QK +HRDL A N+L+  +   ++ DFGLAR I N +      +G + 
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLP 222
Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWVWM 473
           V     ++APE       T +SDV+ FG ++ E+   G SP   IP        V+ ++ 
Sbjct: 223 V----KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--------VEELFK 270
Query: 474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISGTS 529
           L +EGH  D      N          L ++   C H + S+RP      ED+ +I++ T+
Sbjct: 271 LLKEGHRMDKPANCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 18  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 70
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q        Y + T ++SA+ YL+   
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-MATQISSAMEYLEK-- 127
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    +++  H     P  + + APE  
Sbjct: 128 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTFTAHAGAKFP--IKWTAPESL 182
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/248 (22%), Positives = 115/248 (46%), Gaps = 26/248 (10%)
Query: 239 ATNNFHESMRLGEGGFGIVYKG-IIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAI 297
           A N      ++G+GGFG+V+KG ++       + +  +   +   + I+   +F  E+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
           +            G  H   +  +V +F+P G L   L   +  +   W+ + +++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPI--KWSVKLRLMLDIA 132
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILL-----DADFNARLGDFGLARAIENERNSYAEHGL 412
             + Y+QN+ +  +VHRDL++ NI L     +A   A++ DFG ++         + H +
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ--------SVHSV 183
Query: 413 VGVPGTMGYVAPECFHTGKA--TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
            G+ G   ++APE     +   T ++D + F  ++  ++ G       P  +++Y  + +
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG-----PFDEYSYGKIKF 238
Query: 471 VWMLHREG 478
           + M+  EG
Sbjct: 239 INMIREEG 246

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/248 (22%), Positives = 116/248 (46%), Gaps = 26/248 (10%)
Query: 239 ATNNFHESMRLGEGGFGIVYKG-IIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAI 297
           A N      ++G+GGFG+V+KG ++       + +  +   +   + I+   +F  E+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
           +            G  H   +  +V +F+P G L   L   +  +   W+ + +++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPI--KWSVKLRLMLDIA 132
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILL-----DADFNARLGDFGLARAIENERNSYAEHGL 412
             + Y+QN+ +  +VHRDL++ NI L     +A   A++ DF L++         + H +
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ--------SVHSV 183
Query: 413 VGVPGTMGYVAPECFHTGKA--TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
            G+ G   ++APE     +   T ++D + F  ++  ++ G  P +     +++Y  + +
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-----EYSYGKIKF 238
Query: 471 VWMLHREG 478
           + M+  EG
Sbjct: 239 INMIREEG 246

>pdb|1FNY|A Chain A, Legume Lectin Of The Bark Of Robinia Pseudoacacia. Length = 237

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/170 (34%), Positives = 91/170 (53%), Gaps = 20/170 (11%)
Query: 3   RDPRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDG--NKANHFVAIEFDTVK 60
           + P PA   +  GLAF +AP D+ P +   G  LG+   F DG  NK+N  VA+EFDT  
Sbjct: 78  QAPNPA--TTADGLAFFLAPVDTQPLD--LGGMLGI---FKDGYFNKSNQIVAVEFDTFS 130
Query: 61  QG-FDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDRE 119
            G +DP   HLG+N+NS+ S K VP    +N T  +G    V++ Y+  +K +   +   
Sbjct: 131 NGDWDPKGRHLGINVNSIESIKTVP----WNWT--NGEVANVFISYEASTKSLTASLVY- 183
Query: 120 GETMPQKPLLKETINLKDYLKPESYFGFSASTGYP--HIQLNCVRSWTLD 167
             ++    ++   +++K  L     FGFSA+TG    ++Q N V SW+ +
Sbjct: 184 -PSLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFE 232

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G FG VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 18  KLGGGQFGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 70
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q        Y + T ++SA+ YL+   
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-MATQISSAMEYLEK-- 127
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    ++   H     P  + + APE  
Sbjct: 128 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTXTAHAGAKFP--IKWTAPESL 182
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 132/299 (44%), Gaps = 38/299 (12%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    +  +     +   +AVK    D+  K   D ++E+ ++        
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY-----GTSEQVTLNWNHRYKI-LTGVASA 359
                G C + G L ++ ++   G+L +YL      G      +N     ++    + S 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 360 VYYLQN--EY--DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
            Y L    EY   QK +HRDL A N+L+  +   ++ DFGLAR I N  + Y +     +
Sbjct: 150 TYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTNGRL 208
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWVWML 474
           P  + ++APE       T +SDV+ FG ++ E+   G SP   IP        V+ ++ L
Sbjct: 209 P--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--------VEELFKL 258
Query: 475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISGTS 529
            +EGH  D      N          L ++   C H + S+RP      ED+ +I++ T+
Sbjct: 259 LKEGHRMDKPANCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 308

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +G G FG+V+ G       Y ++  ++A+K     S+ S+ DF+ E  ++          
Sbjct: 35  IGSGQFGLVHLG-------YWLNKDKVAIKTIKEGSM-SEDDFIEEAEVMMKLSHPKLVQ 86
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G C E+  + LV++FM +G L  YL   +++          +   V   + YL+   +
Sbjct: 87  LYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---E 141
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
             V+HRDL A N L+  +   ++ DFG+ R + +++ + +     G    + + +PE F 
Sbjct: 142 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS----TGTKFPVKWASPEVFS 197
Query: 429 TGKATPESDVFGFGAVVLEV 448
             + + +SDV+ FG ++ EV
Sbjct: 198 FSRYSSKSDVWSFGVLMWEV 217

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 79/321 (24%), Positives = 138/321 (42%), Gaps = 33/321 (10%)
Query: 213 AEPHHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDN 272
           AEPH        PG       +E++   +  H    +G G  G V  G +    Q  V  
Sbjct: 27  AEPH----TYEEPGRAGRSFTREIE--ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDV-- 78
Query: 273 TQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSL 331
             +A+K      + + + DFL+E +I+            G        ++V ++M NGSL
Sbjct: 79  -PVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL 137
Query: 332 EKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL 391
           + +L     Q T+       +L GV + + YL    D   VHRDL A N+L+D++   ++
Sbjct: 138 DTFLRTHDGQFTIM--QLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKV 192
Query: 392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCG 451
            DFGL+R +E++ ++        +P  + + APE       +  SDV+ FG V+ EV+  
Sbjct: 193 SDFGLSRVLEDDPDAAXTTTGGKIP--IRWTAPEAIAFRTFSSASDVWSFGVVMWEVL-- 248
Query: 452 RSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPI 511
                       AY    +  M +R+  +  +V++   + + +     L  L L C H  
Sbjct: 249 ------------AYGERPYWNMTNRD--VISSVEEGYRLPAPMGCPHALHQLMLDCWHKD 294
Query: 512 ASERPKTEDILQIISGTSTVP 532
            ++RP+   I+ ++      P
Sbjct: 295 RAQRPRFSQIVSVLDALIRSP 315

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 136/298 (45%), Gaps = 30/298 (10%)
Query: 229 REFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKS 287
           REF  KE+  +     + + +GE  FG V  G +    +  +    +A+K      + K 
Sbjct: 5   REFA-KEIDASCIKIEKVIGVGE--FGEVCSGRLKVPGKREI---CVAIKTLKAGYTDKQ 58
Query: 288 KGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWN 347
           + DFL+E +I+            G   +   ++++ ++M NGSL+ +L     + T+   
Sbjct: 59  RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI-- 116
Query: 348 HRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY 407
               +L G+ S + YL    D   VHRDL A NIL++++   ++ DFG++R +E++    
Sbjct: 117 QLVGMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE-- 171
Query: 408 AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTL 467
           A +   G    + + APE     K T  SDV+ +G V+ EV         + + +  Y  
Sbjct: 172 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV---------MSYGERPY-- 220
Query: 468 VDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
               W +  +  I+ A+++   +   +D    L  L L C     S+RPK   I+ ++
Sbjct: 221 ----WDMSNQDVIK-AIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 273

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 25  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 77
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q  +N      + T ++SA+ YL+   
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK-- 134
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    ++   H     P  + + APE  
Sbjct: 135 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTXTAHAGAKFP--IKWTAPESL 189
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 227 KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 279
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q        Y + T ++SA+ YL+   
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-MATQISSAMEYLEK-- 336
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HR+L A N L+  +   ++ DFGL+R +    ++Y  H     P  + + APE  
Sbjct: 337 -KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP--IKWTAPESL 391
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSP 419

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 132/299 (44%), Gaps = 38/299 (12%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    +  +     +   +AVK    D+  K   D ++E+ ++        
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY-----GTSEQVTLNWNHRYKI-LTGVASA 359
                G C + G L ++ ++   G+L +YL      G      +N     ++    + S 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 360 VYYLQN--EY--DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
            Y L    EY   QK +HRDL A N+L+  +   ++ DFGLAR I N  + Y +     +
Sbjct: 152 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTNGRL 210
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWVWML 474
           P  + ++APE       T +SDV+ FG ++ E+   G SP   IP        V+ ++ L
Sbjct: 211 P--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--------VEELFKL 260
Query: 475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISGTS 529
            +EGH  D      N          L ++   C H + S+RP      ED+ +I++ T+
Sbjct: 261 LKEGHRMDKPANCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 310

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 132/299 (44%), Gaps = 38/299 (12%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    +  +     +   +AVK    D+  K   D ++E+ ++        
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY-----GTSEQVTLNWNHRYKI-LTGVASA 359
                G C + G L ++ ++   G+L +YL      G      +N     ++    + S 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 360 VYYLQN--EY--DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
            Y L    EY   QK +HRDL A N+L+  +   ++ DFGLAR I N  + Y +     +
Sbjct: 155 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTNGRL 213
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWVWML 474
           P  + ++APE       T +SDV+ FG ++ E+   G SP   IP        V+ ++ L
Sbjct: 214 P--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--------VEELFKL 263
Query: 475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISGTS 529
            +EGH  D      N          L ++   C H + S+RP      ED+ +I++ T+
Sbjct: 264 LKEGHRMDKPANCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 313

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 21  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 73
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q  +N      + T ++SA+ YL+   
Sbjct: 74  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK-- 130
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    ++   H     P  + + APE  
Sbjct: 131 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTXTAHAGAKFP--IKWTAPESL 185
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 186 AYNKFSIKSDVWAFGVLLWEIATYGMSP 213

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 132/299 (44%), Gaps = 38/299 (12%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK-GDFLAELAIIXXX-XXXX 305
           LGEG FG +V    +  +     +   +AVK    D+ +    D ++E+ ++        
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY-----GTSEQVTLNWNHRYKI-LTGVASA 359
                G C + G L ++ ++   G+L +YL      G      +N     ++    + S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 360 VYYLQN--EY--DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
            Y L    EY   QK +HRDL A N+L+  +   ++ DFGLAR I N  + Y +     +
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTNGRL 221
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWVWML 474
           P  + ++APE       T +SDV+ FG ++ E+   G SP   IP        V+ ++ L
Sbjct: 222 P--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--------VEELFKL 271
Query: 475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISGTS 529
            +EGH  D      N          L ++   C H + S+RP      ED+ +I++ T+
Sbjct: 272 LKEGHRMDKPANCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG+G FG V   +  ++         +AVKK    + +   DF  E+ I+         
Sbjct: 20  QLGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 77
Query: 308 XXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G C+  G+  L L+ +F+P GSL +YL    E++        K+L   +     ++ 
Sbjct: 78  KYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERID-----HIKLLQYTSQICKGMEY 132
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT--MGYVA 423
              ++ +HRDL   NIL++ +   ++GDFGL + +  ++    E   V  PG   + + A
Sbjct: 133 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EXXKVKEPGESPIFWYA 188
Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE     K +  SDV+ FG V+ E+
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYEL 213

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G FG V+    + +       T++AVK     S+  +  FLAE  ++         
Sbjct: 195 KLGAGQFGEVWMATYNKH-------TKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLV 246
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLY---GTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                   K  + ++ +FM  GSL  +L    G+ + +    +   +I  G+A   +  Q
Sbjct: 247 KLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA---FIEQ 302
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
             Y    +HRDL+A+NIL+ A    ++ DFGLAR IE+  N Y        P  + + AP
Sbjct: 303 RNY----IHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFP--IKWTAP 354
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           E  + G  T +SDV+ FG +++E+V  GR P
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 127/278 (45%), Gaps = 27/278 (9%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXX 307
           +G G FG V  G +    +  +    +A+K      + K + DFL+E +I+         
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREI---CVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G   +   ++++ ++M NGSL+ +L     + T+       +L G+ S + YL    
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI--QLVGMLRGIGSGMKYLS--- 127
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           D   VHRDL A NIL++++   ++ DFG++R +E++    A +   G    + + APE  
Sbjct: 128 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE--AAYTTRGGKIPIRWTAPEAI 185
Query: 428 HTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQR 487
              K T  SDV+ +G V+ EV         + + +  Y      W +  +  I+ A+++ 
Sbjct: 186 AYRKFTSASDVWSYGIVMWEV---------MSYGERPY------WDMSNQDVIK-AIEEG 229
Query: 488 LNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
             +   +D    L  L L C     S+RPK   I+ ++
Sbjct: 230 YRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 267

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 131/299 (43%), Gaps = 38/299 (12%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXXXX-XX 305
           LGEG FG +V    +  +     +   +AVK    D+  K   D ++E+ ++        
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY-----GTSEQVTLNWNHRYKI-LTGVASA 359
                G C + G L ++  +   G+L +YL      G      +N     ++    + S 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 360 VYYLQN--EY--DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
            Y L    EY   QK +HRDL A N+L+  +   ++ DFGLAR I N  + Y +     +
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTNGRL 221
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWVWML 474
           P  + ++APE       T +SDV+ FG ++ E+   G SP   IP        V+ ++ L
Sbjct: 222 P--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--------VEELFKL 271
Query: 475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISGTS 529
            +EGH  D      N          L ++   C H + S+RP      ED+ +I++ T+
Sbjct: 272 LKEGHRMDKPANCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 131/299 (43%), Gaps = 38/299 (12%)
Query: 249 LGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIXXX-XXXX 305
           LGEG FG +V    +  +     +   +AVK    D+  K   D ++E+ ++        
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY-----GTSEQVTLNWNHRYKI-LTGVASA 359
                G C + G L ++  +   G+L +YL      G      +N     ++    + S 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 360 VYYLQN--EY--DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
            Y L    EY   QK +HRDL A N+L+  +   ++ DFGLAR I N  + Y +     +
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTNGRL 221
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSPGNMIPHQQHAYTLVDWVWML 474
           P  + ++APE       T +SDV+ FG ++ E+   G SP   IP        V+ ++ L
Sbjct: 222 P--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--------VEELFKL 271
Query: 475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK----TEDILQIISGTS 529
            +EGH  D      N          L ++   C H + S+RP      ED+ +I++ T+
Sbjct: 272 LKEGHRMDKPANCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 21  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 73
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q  +N      + T ++SA+ YL+   
Sbjct: 74  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK-- 130
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +  +  +       G    + + APE  
Sbjct: 131 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT----APAGAKFPIKWTAPESL 185
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 186 AYNKFSIKSDVWAFGVLLWEIATYGMSP 213

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 18/217 (8%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           LGEG FG V+    + N     D   +AVK     S  ++ DF  E  ++          
Sbjct: 21  LGEGAFGKVFLAECY-NLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 79
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVT----------LNWNHRYKILTGVAS 358
             G C E   L++V+++M +G L K+L                  L  +    I   +A+
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
            + YL +   Q  VHRDL   N L+  +   ++GDFG++R + +  + Y   G   +P  
Sbjct: 140 GMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST-DYYRVGGHTMLP-- 193
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           + ++ PE     K T ESDV+  G V+ E+   G+ P
Sbjct: 194 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 22  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 74
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q  +N      + T ++SA+ YL+   
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK-- 131
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +  +  +       G    + + APE  
Sbjct: 132 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT----APAGAKFPIKWTAPESL 186
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 187 AYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 9/202 (4%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXX 307
           +G G FG V +G +    +     + +A+K      + + + +FL+E +I+         
Sbjct: 22  IGAGEFGEVCRGRLKAPGK---KESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G       ++++ +FM NG+L+ +L     Q T+       +L G+AS + YL    
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI--QLVGMLRGIASGMRYLA--- 133
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           +   VHRDL A NIL++++   ++ DFGL+R +E   +       +G    + + APE  
Sbjct: 134 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193
Query: 428 HTGKATPESDVFGFGAVVLEVV 449
              K T  SD + +G V+ EV+
Sbjct: 194 AFRKFTSASDAWSYGIVMWEVM 215

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY+G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 18  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 70
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    ++ +FM  G+L  YL   + Q        Y + T ++SA+ YL+   
Sbjct: 71  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLY-MATQISSAMEYLEK-- 127
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    ++   H     P  + + APE  
Sbjct: 128 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTXTAHAGAKFP--IKWTAPESL 182
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 16/208 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G VY G+      +   +  +AVK    D+++ + +FL E A++         
Sbjct: 39  KLGGGQYGEVYVGV------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 91
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C  +    +V ++MP G+L  YL   + +        Y + T ++SA+ YL+   
Sbjct: 92  QLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLY-MATQISSAMEYLEK-- 148
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +    ++Y  H     P  + + APE  
Sbjct: 149 -KNFIHRDLAARNCLVGENHVVKVADFGLSRLMTG--DTYTAHAGAKFP--IKWTAPESL 203
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
                + +SDV+ FG ++ E+   G SP
Sbjct: 204 AYNTFSIKSDVWAFGVLLWEIATYGMSP 231

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG+G FG V   +  ++         +AVKK    + +   DF  E+ I+         
Sbjct: 20  QLGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 77
Query: 308 XXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G C+  G+  L L+ +++P GSL  YL   +E++        K+L   +     ++ 
Sbjct: 78  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERID-----HIKLLQYTSQICKGMEY 132
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT--MGYVA 423
              ++ +HRDL   NIL++ +   ++GDFGL + +  ++    E   V  PG   + + A
Sbjct: 133 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EXXKVKEPGESPIFWYA 188
Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE     K +  SDV+ FG V+ E+
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYEL 213

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +G G FG+V+ G       Y ++  ++A+K   R+   S+ DF+ E  ++          
Sbjct: 16  IGSGQFGLVHLG-------YWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G C E+  + LV +FM +G L  YL   +++          +   V   + YL+   +
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---E 122
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
             V+HRDL A N L+  +   ++ DFG+ R + +++ + +     G    + + +PE F 
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS----TGTKFPVKWASPEVFS 178
Query: 429 TGKATPESDVFGFGAVVLEV 448
             + + +SDV+ FG ++ EV
Sbjct: 179 FSRYSSKSDVWSFGVLMWEV 198

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 129/295 (43%), Gaps = 36/295 (12%)
Query: 247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXX 306
           ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  ++        
Sbjct: 190 VKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKL 241
Query: 307 XXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
                   E+  + +V ++M  GSL  +L G + +  L       +   +AS + Y++  
Sbjct: 242 VQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER- 298
Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
                VHRDL+A+NIL+  +   ++ DFGLAR IE+  N Y        P  + + APE 
Sbjct: 299 --MNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP--IKWTAPEA 352
Query: 427 FHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVD 485
              G+ T +SDV+ FG ++ E+   GR P               +  M++RE  + D V+
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNRE--VLDQVE 395
Query: 486 QRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPA 540
           +   +    +  + L  L   C      ERP T + LQ           PQ++P 
Sbjct: 396 RGYRMPCPPECPESLHDLMCQCWRKEPEERP-TFEYLQAFLEDYFTSTEPQYQPG 449

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 108/226 (47%), Gaps = 18/226 (7%)
Query: 228 PREFKYKEL-KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQI--AVKKFSRDS 284
           P E K K+L  K  N     + LG G FG V +G+      Y +   QI  A+K   + +
Sbjct: 322 PEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGV------YRMRKKQIDVAIKVLKQGT 375
Query: 285 IKSKGD-FLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVT 343
            K+  +  + E  I+            G C  +  L+LV +    G L K+L G  E++ 
Sbjct: 376 EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIP 434
Query: 344 LNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE 403
           ++  +  ++L  V+  + YL+   ++  VHR+L A N+LL     A++ DFGL++A+  +
Sbjct: 435 VS--NVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489
Query: 404 RNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
            + Y        P  + + APEC +  K +  SDV+ +G  + E +
Sbjct: 490 DSYYTARSAGKWP--LKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 101/228 (44%), Gaps = 21/228 (9%)
Query: 225 PGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS 284
           PG P  F  + LKK  +       LGEG FG V   +  ++         +AVK    D+
Sbjct: 22  PGDPTVFHKRYLKKIRD-------LGEGHFGKV--SLYCYDPTNDGTGEMVAVKALKADA 72
Query: 285 -IKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKG--KLLLVYDFMPNGSLEKYLYGTSEQ 341
             + +  +  E+ I+            G C + G   L LV +++P GSL  YL   S  
Sbjct: 73  GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIG 132
Query: 342 VTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE 401
           +        +I  G+A    YL   + Q  +HRDL A N+LLD D   ++GDFGLA+A+ 
Sbjct: 133 LAQLLLFAQQICEGMA----YL---HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185
Query: 402 NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
                Y        P  + + APEC    K    SDV+ FG  + E++
Sbjct: 186 EGHEXYRVREDGDSP--VFWYAPECLKEYKFYYASDVWSFGVTLYELL 231

>pdb|2PEL|A Chain A, Peanut Lectin Length = 236

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 15  GLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG--FDPDDNHLGL 72
           G+ F IAP D+  P  S G   G T   +D   A HFV +EFDT       DP  +H+G+
Sbjct: 84  GIIFFIAPEDTQIPAGSIG---GGTLGVSDTKGAGHFVGVEFDTYSNSEYNDPPTDHVGI 140
Query: 73  NINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKET 132
           ++NSV S K VP           G    V V YD  +K + V +  +   +     + + 
Sbjct: 141 DVNSVDSVKTVPWNS------VSGAVVKVTVIYDSSTKTLSVAVTNDNGDITT---IAQV 191
Query: 133 INLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEK 177
           ++LK  L     FGFSAS      Q++ +RSW+    +I T +  
Sbjct: 192 VDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTSTLITTTRRS 236

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG+G FG V   +  ++         +AVKK    + +   DF  E+ I+         
Sbjct: 16  QLGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 73
Query: 308 XXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G C+  G+  L L+ +++P GSL  YL    E++        K+L   +     ++ 
Sbjct: 74  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGMEY 128
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT--MGYVA 423
              ++ +HRDL   NIL++ +   ++GDFGL + +  ++    E   V  PG   + + A
Sbjct: 129 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EXXKVKEPGESPIFWYA 184
Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE     K +  SDV+ FG V+ E+
Sbjct: 185 PESLTESKFSVASDVWSFGVVLYEL 209

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG+G FG V   +  ++         +AVKK    + +   DF  E+ I+         
Sbjct: 17  QLGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 308 XXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G C+  G+  L L+ +++P GSL  YL    E++        K+L   +     ++ 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGMEY 129
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT--MGYVA 423
              ++ +HRDL   NIL++ +   ++GDFGL + +  ++    E   V  PG   + + A
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EXXKVKEPGESPIFWYA 185
Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE     K +  SDV+ FG V+ E+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYEL 210

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 103/227 (45%), Gaps = 23/227 (10%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           RLG G FG V+ G       Y+ ++T++AVK     ++  +  FL E  ++         
Sbjct: 20  RLGAGQFGEVWMG-------YYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLV 71
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                   +  + ++ ++M  GSL  +L  + E   +           +A  + Y++   
Sbjct: 72  RLYAVVTREEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIER-- 128
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL+A+N+L+      ++ DFGLAR IE+   +  E    G    + + APE  
Sbjct: 129 -KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAI 183
Query: 428 HTGKATPESDVFGFGAVVLEVVC-------GRSPGNMIPHQQHAYTL 467
           + G  T +SDV+ FG ++ E+V        GR+  +++      Y +
Sbjct: 184 NFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRM 230

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG+G FG V   +  ++         +AVKK    + +   DF  E+ I+         
Sbjct: 15  QLGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 72
Query: 308 XXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G C+  G+  L L+ +++P GSL  YL    E++        K+L   +     ++ 
Sbjct: 73  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGMEY 127
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT--MGYVA 423
              ++ +HRDL   NIL++ +   ++GDFGL + +  ++    E   V  PG   + + A
Sbjct: 128 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EXXKVKEPGESPIFWYA 183
Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE     K +  SDV+ FG V+ E+
Sbjct: 184 PESLTESKFSVASDVWSFGVVLYEL 208

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXX 306
           ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  ++        
Sbjct: 190 VKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKL 241
Query: 307 XXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
                   E+  + +V ++M  GSL  +L G + +  L       +   +AS + Y++  
Sbjct: 242 VQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER- 298
Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
                VHRDL+A+NIL+  +   ++ DFGLAR IE+  N Y        P  + + APE 
Sbjct: 299 --MNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP--IKWTAPEA 352
Query: 427 FHTGKATPESDVFGFGAVVLEVVC-GRSP 454
              G+ T +SDV+ FG ++ E+   GR P
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG+G FG V   +  ++         +AVKK    + +   DF  E+ I+         
Sbjct: 21  QLGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 78
Query: 308 XXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G C+  G+  L L+ +++P GSL  YL    E++        K+L   +     ++ 
Sbjct: 79  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGMEY 133
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT--MGYVA 423
              ++ +HRDL   NIL++ +   ++GDFGL + +  ++    E   V  PG   + + A
Sbjct: 134 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EXXKVKEPGESPIFWYA 189
Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE     K +  SDV+ FG V+ E+
Sbjct: 190 PESLTESKFSVASDVWSFGVVLYEL 214

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +G+G FG V  G    N        ++AVK    D+      FLAE +++          
Sbjct: 201 IGKGEFGDVMLGDYRGN--------KVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQ 250
Query: 309 XXG-WCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
             G    EKG L +V ++M  GSL  YL      V L  +   K    V  A+ YL+   
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG-- 307
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
               VHRDL A N+L+  D  A++ DFGL +    E +S  + G + V  T    APE  
Sbjct: 308 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT----APEAL 358
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSPGNMIP 459
              K + +SDV+ FG ++ E+   GR P   IP
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 129/295 (43%), Gaps = 36/295 (12%)
Query: 246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXX 305
            ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  ++       
Sbjct: 16  EVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEK 67
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                    E+  + +V ++M  GSL  +L G + +  L       +   +AS + Y++ 
Sbjct: 68  LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER 125
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
                 VHRDL+A+NIL+  +   ++ DFGLAR IE+  N Y        P  + + APE
Sbjct: 126 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP--IKWTAPE 178
Query: 426 CFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV 484
               G+ T +SDV+ FG ++ E+   GR P               +  M++RE  + D V
Sbjct: 179 AALYGRFTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNRE--VLDQV 221
Query: 485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKP 539
           ++   +    +  + L  L   C      ERP T + LQ           PQ++P
Sbjct: 222 ERGYRMPCPPECPESLHDLMCQCWRKEPEERP-TFEYLQAFLEDYFTSTEPQYQP 275

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG+G FG V   +  ++         +AVKK    + +   DF  E+ I+         
Sbjct: 17  QLGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 308 XXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G C+  G+  L L+ +++P GSL  YL    E++        K+L   +     ++ 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGMEY 129
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT--MGYVA 423
              ++ +HRDL   NIL++ +   ++GDFGL + +  ++    E   V  PG   + + A
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EXXKVKEPGESPIFWYA 185
Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE     K +  SDV+ FG V+ E+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYEL 210

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG+G FG V   +  ++         +AVKK    + +   DF  E+ I+         
Sbjct: 17  QLGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 308 XXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G C+  G+  L L+ +++P GSL  YL    E++        K+L   +     ++ 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGMEY 129
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT--MGYVA 423
              ++ +HRDL   NIL++ +   ++GDFGL + +  ++  +     V  PG   + + A
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK----VKEPGESPIFWYA 185
Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE     K +  SDV+ FG V+ E+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYEL 210

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 108/223 (48%), Gaps = 28/223 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAI 297
           +++ F +  +LG G +  VYKG+      Y      +A+K+   DS + +    + E+++
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVY------VALKEVKLDSEEGTPSTAIREISL 56
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG-----TSEQVTLNW--NHRY 350
           +               H + KL LV++FM N  L+KY+       T   + LN     ++
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 351 KILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEH 410
           ++L G+A         ++ K++HRDLK  N+L++     +LGDFGLARA     N+++  
Sbjct: 116 QLLQGLAFC-------HENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE 168
Query: 411 GLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGR 452
            +     T+ Y AP+     +    S D++  G ++ E++ G+
Sbjct: 169 VV-----TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG+G FG V   +  ++         +AVKK    + +   DF  E+ I+         
Sbjct: 20  QLGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 77
Query: 308 XXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G C+  G+  L L+ +++P GSL  YL    E++        K+L   +     ++ 
Sbjct: 78  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGMEY 132
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT--MGYVA 423
              ++ +HRDL   NIL++ +   ++GDFGL + +  ++    E   V  PG   + + A
Sbjct: 133 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EXXKVKEPGESPIFWYA 188
Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE     K +  SDV+ FG V+ E+
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYEL 213

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG+G FG V   +  ++         +AVKK    + +   DF  E+ I+         
Sbjct: 35  QLGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 92
Query: 308 XXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G C+  G+  L L+ +++P GSL  YL    E++        K+L   +     ++ 
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGMEY 147
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT--MGYVA 423
              ++ +HRDL   NIL++ +   ++GDFGL + +  ++    E   V  PG   + + A
Sbjct: 148 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EXXKVKEPGESPIFWYA 203
Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE     K +  SDV+ FG V+ E+
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYEL 228

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG+G FG V   +  ++         +AVKK    + +   DF  E+ I+         
Sbjct: 18  QLGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 75
Query: 308 XXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G C+  G+  L L+ +++P GSL  YL    E++        K+L   +     ++ 
Sbjct: 76  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGMEY 130
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT--MGYVA 423
              ++ +HR+L   NIL++ +   ++GDFGL + +  ++  Y     V  PG   + + A
Sbjct: 131 LGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYK----VKEPGESPIFWYA 186
Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE     K +  SDV+ FG V+ E+
Sbjct: 187 PESLTESKFSVASDVWSFGVVLYEL 211

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG+G FG V   +  ++         +AVKK    + +   DF  E+ I+         
Sbjct: 22  QLGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 79
Query: 308 XXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G C+  G+  L L+ +++P GSL  YL    E++        K+L   +     ++ 
Sbjct: 80  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGMEY 134
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT--MGYVA 423
              ++ +HRDL   NIL++ +   ++GDFGL + +  ++    E   V  PG   + + A
Sbjct: 135 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EXXKVKEPGESPIFWYA 190
Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE     K +  SDV+ FG V+ E+
Sbjct: 191 PESLTESKFSVASDVWSFGVVLYEL 215

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           LG G FG+V  G      QY V     AVK     S+ S+ +F  E   +          
Sbjct: 16  LGSGQFGVVKLG--KWKGQYDV-----AVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVK 67
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G C ++  + +V +++ NG L  YL   S    L  +   ++   V   + +L++   
Sbjct: 68  FYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLES--- 122
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
            + +HRDL A N L+D D   ++ DFG+ R + +++   +    VG    + + APE FH
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPEVFH 178
Query: 429 TGKATPESDVFGFGAVVLEVV-CGRSPGNM 457
             K + +SDV+ FG ++ EV   G+ P ++
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG+G FG V   +  ++         +AVKK    + +   DF  E+ I+         
Sbjct: 24  QLGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 81
Query: 308 XXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G C+  G+  L L+ +++P GSL  YL    E++        K+L   +     ++ 
Sbjct: 82  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGMEY 136
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT--MGYVA 423
              ++ +HRDL   NIL++ +   ++GDFGL + +  ++    E   V  PG   + + A
Sbjct: 137 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EXXKVKEPGESPIFWYA 192
Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE     K +  SDV+ FG V+ E+
Sbjct: 193 PESLTESKFSVASDVWSFGVVLYEL 217

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG+G FG V   +  ++         +AVKK    + +   DF  E+ I+         
Sbjct: 48  QLGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 308 XXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G C+  G+  L L+ +++P GSL  YL    E++        K+L   +     ++ 
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGMEY 160
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT--MGYVA 423
              ++ +HRDL   NIL++ +   ++GDFGL + +  ++    E   V  PG   + + A
Sbjct: 161 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EXXKVKEPGESPIFWYA 216
Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE     K +  SDV+ FG V+ E+
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYEL 241

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXX 306
           ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  ++        
Sbjct: 273 VKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKL 324
Query: 307 XXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
                   E+  + +V ++M  GSL  +L G + +  L       +   +AS + Y++  
Sbjct: 325 VQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER- 381
Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
                VHRDL+A+NIL+  +   ++ DFGLAR IE+  N Y        P  + + APE 
Sbjct: 382 --MNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP--IKWTAPEA 435
Query: 427 FHTGKATPESDVFGFGAVVLEVVC-GRSP 454
              G+ T +SDV+ FG ++ E+   GR P
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG+G FG V   +  ++         +AVKK    + +   DF  E+ I+         
Sbjct: 23  QLGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 80
Query: 308 XXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G C+  G+  L L+ +++P GSL  YL    E++        K+L   +     ++ 
Sbjct: 81  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGMEY 135
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT--MGYVA 423
              ++ +HRDL   NIL++ +   ++GDFGL + +  ++    E   V  PG   + + A
Sbjct: 136 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EXXKVKEPGESPIFWYA 191
Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE     K +  SDV+ FG V+ E+
Sbjct: 192 PESLTESKFSVASDVWSFGVVLYEL 216

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +G+G FG V  G    N        ++AVK    D+      FLAE +++          
Sbjct: 14  IGKGEFGDVMLGDYRGN--------KVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQ 63
Query: 309 XXG-WCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
             G    EKG L +V ++M  GSL  YL      V L  +   K    V  A+ YL+   
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG-- 120
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
               VHRDL A N+L+  D  A++ DFGL +    E +S  + G + V  T    APE  
Sbjct: 121 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT----APEAL 171
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSPGNMIP 459
              K + +SDV+ FG ++ E+   GR P   IP
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +G+G FG V  G    N        ++AVK    D+      FLAE +++          
Sbjct: 29  IGKGEFGDVMLGDYRGN--------KVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQ 78
Query: 309 XXG-WCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
             G    EKG L +V ++M  GSL  YL      V L  +   K    V  A+ YL+   
Sbjct: 79  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG-- 135
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
               VHRDL A N+L+  D  A++ DFGL +    E +S  + G + V  T    APE  
Sbjct: 136 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT----APEAL 186
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSPGNMIP 459
              K + +SDV+ FG ++ E+   GR P   IP
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG+G FG V   +  ++         +AVKK    + +   DF  E+ I+         
Sbjct: 35  QLGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 92
Query: 308 XXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G C+  G+  L L+ +++P GSL  YL    E++        K+L   +     ++ 
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGMEY 147
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT--MGYVA 423
              ++ +HRDL   NIL++ +   ++GDFGL + +  ++    E   V  PG   + + A
Sbjct: 148 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EXXKVKEPGESPIFWYA 203
Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE     K +  SDV+ FG V+ E+
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYEL 228

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 129/296 (43%), Gaps = 36/296 (12%)
Query: 246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXX 305
            ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  ++       
Sbjct: 20  EVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEK 71
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                    E+  + +V ++M  GSL  +L G + +  L       +   +AS + Y++ 
Sbjct: 72  LVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVER 129
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
                 VHRDL+A+NIL+  +   ++ DFGLAR IE+  N Y        P  + + APE
Sbjct: 130 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP--IKWTAPE 182
Query: 426 CFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV 484
               G+ T +SDV+ FG ++ E+   GR P               +  M++RE  + D V
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNRE--VLDQV 225
Query: 485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPA 540
           ++   +    +  + L  L   C      ERP T + LQ           PQ++P 
Sbjct: 226 ERGYRMPCPPECPESLHDLMCQCWRKEPEERP-TFEYLQAFLEDYFTSTEPQYQPG 280

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQI--AVKKFSRDSIKSKGD-FLAE 294
           K  N     + LG G FG V +G+      Y +   QI  A+K   + + K+  +  + E
Sbjct: 7   KRDNLLIADIELGCGNFGSVRQGV------YRMRKKQIDVAIKVLKQGTEKADTEEMMRE 60
Query: 295 LAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILT 354
             I+            G C  +  L+LV +    G L K+L G  E++ ++  +  ++L 
Sbjct: 61  AQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLH 117
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
            V+  + YL+   ++  VHRDL A N+LL     A++ DFGL++A+  + + Y       
Sbjct: 118 QVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
            P  + + APEC +  K +  SDV+ +G  + E +  G+ P
Sbjct: 175 WP--LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 106/252 (42%), Gaps = 30/252 (11%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIX 299
           NN      +GEG FG V++        Y    T +AVK    + S   + DF  E A++ 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYE-PFTMVAVKMLKEEASADMQADFQREAALMA 105
Query: 300 XXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNH----------- 348
                      G C     + L++++M  G L ++L   S     + +H           
Sbjct: 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 349 ----------RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR 398
                     +  I   VA+ + YL    ++K VHRDL   N L+  +   ++ DFGL+R
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNM 457
            I +  + Y   G   +P  + ++ PE     + T ESDV+ +G V+ E+   G  P   
Sbjct: 223 NIYSA-DYYKADGNDAIP--IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 458 IPHQQHAYTLVD 469
           + H++  Y + D
Sbjct: 280 MAHEEVIYYVRD 291

>pdb|1BZW|A Chain A, Peanut Lectin Complexed With C-Lactose Length = 232

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 76/161 (47%), Gaps = 14/161 (8%)
Query: 15  GLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG--FDPDDNHLGL 72
           G+ F IAP D+  P  S G   G T   +D   A HFV +EFDT       DP  +H+G+
Sbjct: 84  GIIFFIAPEDTQIPAGSIG---GGTLGVSDTKGAGHFVGVEFDTYSNSEYNDPPTDHVGI 140
Query: 73  NINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKET 132
           ++NSV S K VP           G    V V YD  +K + V +  +   +     + + 
Sbjct: 141 DVNSVDSVKTVPWNS------VSGAVVKVTVIYDSSTKTLSVAVTNDNGDITT---IAQV 191
Query: 133 INLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQT 173
           ++LK  L     FGFSAS      Q++ +RSW+    +I T
Sbjct: 192 VDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTSTLITT 232

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXX 306
           ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  ++        
Sbjct: 190 VKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKL 241
Query: 307 XXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
                   E+  + +V ++M  GSL  +L G + +  L       +   +AS + Y++  
Sbjct: 242 VQLYAVVSEE-PIYIVGEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER- 298
Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
                VHRDL+A+NIL+  +   ++ DFGLAR IE+  N Y        P  + + APE 
Sbjct: 299 --MNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP--IKWTAPEA 352
Query: 427 FHTGKATPESDVFGFGAVVLEVVC-GRSP 454
              G+ T +SDV+ FG ++ E+   GR P
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXX 305
            ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  ++       
Sbjct: 13  EVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEK 64
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                    E+  + +V ++M  GSL  +L G + +  L       +   +AS + Y++ 
Sbjct: 65  LVQLYAVVSEE-PIXIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER 122
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
                 VHRDL+A+NIL+  +   ++ DFGLAR IE+   +  +    G    + + APE
Sbjct: 123 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQ----GAKFPIKWTAPE 175
Query: 426 CFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
               G+ T +SDV+ FG ++ E+   GR P
Sbjct: 176 AALYGRFTIKSDVWSFGILLTELTTKGRVP 205

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 36/296 (12%)
Query: 246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXX 305
            ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  ++       
Sbjct: 14  EVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEK 65
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                    E+  + +V ++M  GSL  +L G   +  L       +   +AS + Y++ 
Sbjct: 66  LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVER 123
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
                 VHRDL+A+NIL+  +   ++ DFGLAR IE+  N Y        P  + + APE
Sbjct: 124 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP--IKWTAPE 176
Query: 426 CFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV 484
               G+ T +SDV+ FG ++ E+   GR P               +  M++RE  + D V
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNRE--VLDQV 219
Query: 485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPA 540
           ++   +    +  + L  L   C      ERP T + LQ           PQ++P 
Sbjct: 220 ERGYRMPCPPECPESLHDLMCQCWRKDPEERP-TFEYLQAFLEDYFTSTEPQYQPG 274

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 36/296 (12%)
Query: 246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXX 305
            ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  ++       
Sbjct: 23  EVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKIRHEK 74
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                    E+  + +V ++M  GSL  +L G   +  L       +   +AS + Y++ 
Sbjct: 75  LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVER 132
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
                 VHRDL+A+NIL+  +   ++ DFGLAR IE+  N Y        P  + + APE
Sbjct: 133 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP--IKWTAPE 185
Query: 426 CFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV 484
               G+ T +SDV+ FG ++ E+   GR P               +  M++RE  + D V
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNRE--VLDQV 228
Query: 485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPA 540
           ++   +    +  + L  L   C      ERP T + LQ           PQ++P 
Sbjct: 229 ERGYRMPCPPECPESLHDLMCQCWRKDPEERP-TFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 36/296 (12%)
Query: 246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXX 305
            ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  ++       
Sbjct: 23  EVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEK 74
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                    E+  + +V ++M  GSL  +L G   +  L       +   +AS + Y++ 
Sbjct: 75  LVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVER 132
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
                 VHRDL+A+NIL+  +   ++ DFGLAR IE+  N Y        P  + + APE
Sbjct: 133 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP--IKWTAPE 185
Query: 426 CFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV 484
               G+ T +SDV+ FG ++ E+   GR P               +  M++RE  + D V
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNRE--VLDQV 228
Query: 485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPA 540
           ++   +    +  + L  L   C      ERP T + LQ           PQ++P 
Sbjct: 229 ERGYRMPCPPECPESLHDLMCQCWRKDPEERP-TFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 36/296 (12%)
Query: 246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXX 305
            ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  ++       
Sbjct: 12  EVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEK 63
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                    E+  + +V ++M  GSL  +L G   +  L       +   +AS + Y++ 
Sbjct: 64  LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVER 121
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
                 VHRDL+A+NIL+  +   ++ DFGLAR IE+  N Y        P  + + APE
Sbjct: 122 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP--IKWTAPE 174
Query: 426 CFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV 484
               G+ T +SDV+ FG ++ E+   GR P               +  M++RE  + D V
Sbjct: 175 AALYGRFTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNRE--VLDQV 217
Query: 485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPA 540
           ++   +    +  + L  L   C      ERP T + LQ           PQ++P 
Sbjct: 218 ERGYRMPCPPECPESLHDLMCQCWRKDPEERP-TFEYLQAFLEDYFTSTEPQYQPG 272

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF--SRDSIKSKGDFLAELAIIXXXXXXX 305
           R+G G FG VYKG      ++H D   +AVK    +  + +    F  E+ ++       
Sbjct: 31  RIGSGSFGTVYKG------KWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                G+   K +L +V  +    SL  +L+ +  +  +       I    A  + YL  
Sbjct: 82  ILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHASETKFEMK--KLIDIARQTARGMDYL-- 136
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            + + ++HRDLK++NI L  D   ++GDFGL  A E  R S   H    + G++ ++APE
Sbjct: 137 -HAKSIIHRDLKSNNIFLHEDNTVKIGDFGL--ATEKSRWS-GSHQFEQLSGSILWMAPE 192
Query: 426 CFHTGKATP---ESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD 482
                 + P   +SDV+ FG V+ E++ G+ P + I ++         + M+ R     D
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IEMVGRGSLSPD 246
Query: 483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
               R N        KR+  L   C      ERP    IL  I
Sbjct: 247 LSKVRSNC------PKRMKRLMAECLKKKRDERPSFPRILAEI 283

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 36/296 (12%)
Query: 246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXX 305
            ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  ++       
Sbjct: 23  EVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEK 74
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                    E+  + +V ++M  GSL  +L G   +  L       +   +AS + Y++ 
Sbjct: 75  LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVER 132
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
                 VHRDL+A+NIL+  +   ++ DFGLAR IE+  N Y        P  + + APE
Sbjct: 133 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP--IKWTAPE 185
Query: 426 CFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV 484
               G+ T +SDV+ FG ++ E+   GR P               +  M++RE  + D V
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNRE--VLDQV 228
Query: 485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPA 540
           ++   +    +  + L  L   C      ERP T + LQ           PQ++P 
Sbjct: 229 ERGYRMPCPPECPESLHDLMCQCWRKDPEERP-TFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 36/296 (12%)
Query: 246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXX 305
            ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  ++       
Sbjct: 23  EVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEK 74
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                    E+  + +V ++M  GSL  +L G   +  L       +   +AS + Y++ 
Sbjct: 75  LVQLYAVVSEE-PIYIVCEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVER 132
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
                 VHRDL+A+NIL+  +   ++ DFGLAR IE+  N Y        P  + + APE
Sbjct: 133 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP--IKWTAPE 185
Query: 426 CFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV 484
               G+ T +SDV+ FG ++ E+   GR P               +  M++RE  + D V
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNRE--VLDQV 228
Query: 485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPA 540
           ++   +    +  + L  L   C      ERP T + LQ           PQ++P 
Sbjct: 229 ERGYRMPCPPECPESLHDLMCQCWRKDPEERP-TFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           RLG G FG V+ G  +        NT++A+K     ++ S   FL E  I+         
Sbjct: 16  RLGNGQFGEVWMGTWN-------GNTKVAIKTLKPGTM-SPESFLEEAQIMKKLKHDKLV 67
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                  E+  + +V ++M  GSL  +L    E   L   +   +   VA+ + Y++   
Sbjct: 68  QLYAVVSEE-PIYIVTEYMNKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIER-- 123
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
               +HRDL+++NIL+      ++ DFGLAR IE+   +  +    G    + + APE  
Sbjct: 124 -MNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQ----GAKFPIKWTAPEAA 178
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
             G+ T +SDV+ FG ++ E+V  GR P
Sbjct: 179 LYGRFTIKSDVWSFGILLTELVTKGRVP 206

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 104/227 (45%), Gaps = 23/227 (10%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G FG V+ G       Y+ ++T++AVK     ++  +  FL E  ++         
Sbjct: 19  KLGAGQFGEVWMG-------YYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLV 70
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                  ++  + ++ +FM  GSL  +L  + E   +           +A  + Y++   
Sbjct: 71  RLYAVVTKEEPIYIITEFMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIER-- 127
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL+A+N+L+      ++ DFGLAR IE+   +  E    G    + + APE  
Sbjct: 128 -KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAI 182
Query: 428 HTGKATPESDVFGFGAVVLEVVC-------GRSPGNMIPHQQHAYTL 467
           + G  T +S+V+ FG ++ E+V        GR+  +++      Y +
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRM 229

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 128/296 (43%), Gaps = 36/296 (12%)
Query: 246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXX 305
            ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  ++       
Sbjct: 23  EVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEK 74
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                    E+  + +V ++M  GSL  +L G   +  L       +   +AS + Y++ 
Sbjct: 75  LVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVER 132
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
                 VHRDL+A+NIL+  +   ++ DFGLAR IE+   +  +    G    + + APE
Sbjct: 133 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQ----GAKFPIKWTAPE 185
Query: 426 CFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV 484
               G+ T +SDV+ FG ++ E+   GR P               +  M++RE  + D V
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNRE--VLDQV 228
Query: 485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPA 540
           ++   +    +  + L  L   C      ERP T + LQ           PQ++P 
Sbjct: 229 ERGYRMPCPPECPESLHDLMCQCWRKDPEERP-TFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 95/213 (44%), Gaps = 24/213 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +G+G FG V  G    N        ++AVK    D+      FLAE +++          
Sbjct: 20  IGKGEFGDVMLGDYRGN--------KVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQ 69
Query: 309 XXG-WCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
             G    EKG L +V ++M  GSL  YL      V L  +   K    V  A+ YL+   
Sbjct: 70  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG-- 126
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
               VHRDL A N+L+  D  A++ DFGL +    E +S  + G + V     + APE  
Sbjct: 127 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVK----WTAPEAL 177
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSPGNMIP 459
                + +SDV+ FG ++ E+   GR P   IP
Sbjct: 178 REAAFSTKSDVWSFGILLWEIYSFGRVPYPRIP 210

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF--SRDSIKSKGDFLAELAIIXXXXXXX 305
           ++GEG FG   K I+  + +   D  Q  +K+   SR S K + +   E+A++       
Sbjct: 31  KIGEGSFG---KAILVKSTE---DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                    E G L +V D+   G L K +    + V    +   +IL         L++
Sbjct: 85  IVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQED---QILDWFVQICLALKH 140
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            +D+K++HRD+K+ NI L  D   +LGDFG+AR +    NS  E     + GT  Y++PE
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL----NSTVELARACI-GTPYYLSPE 195
Query: 426 CFHTGKATPESDVFGFGAVVLEVV 449
                    +SD++  G V+ E+ 
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELC 219

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 75
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 76  ASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 128
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 129 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 185
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 186 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 236

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 120/283 (42%), Gaps = 35/283 (12%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF--SRDSIKSKGDFLAELAIIXXXXXXX 305
           R+G G FG VYKG      ++H D   +AVK    +  + +    F  E+ ++       
Sbjct: 19  RIGSGSFGTVYKG------KWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 69
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                G+   K +L +V  +    SL  +L+ +  +  +       I    A  + YL  
Sbjct: 70  ILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHASETKFEMK--KLIDIARQTARGMDYL-- 124
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            + + ++HRDLK++NI L  D   ++GDFGLA        S   H    + G++ ++APE
Sbjct: 125 -HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGS---HQFEQLSGSILWMAPE 180
Query: 426 CFHTGKATP---ESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD 482
                 + P   +SDV+ FG V+ E++ G+ P + I ++         + M+ R     D
Sbjct: 181 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IEMVGRGSLSPD 234
Query: 483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
               R N        KR+  L   C      ERP    IL  I
Sbjct: 235 LSKVRSNC------PKRMKRLMAECLKKKRDERPSFPRILAEI 271

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 123/281 (43%), Gaps = 40/281 (14%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 81
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 82  ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 134
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 135 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 191
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL----- 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L     
Sbjct: 192 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 247
Query: 468 --------VDWVWMLHREGHIQDAVDQRLNINSVVDEAKRL 500
                   +D V+M+ R+  + DA D R     ++ E  ++
Sbjct: 248 LPQPPICTID-VYMIMRKCWMIDA-DSRPKFRELIIEFSKM 286

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 127/296 (42%), Gaps = 36/296 (12%)
Query: 246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXX 305
            ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  ++       
Sbjct: 23  EVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEK 74
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                    E+  + +V ++M  GSL  +L G   +  L       +   +AS + Y++ 
Sbjct: 75  LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVER 132
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
                 VHRDL A+NIL+  +   ++ DFGLAR IE+  N Y        P  + + APE
Sbjct: 133 ---MNYVHRDLAAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP--IKWTAPE 185
Query: 426 CFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV 484
               G+ T +SDV+ FG ++ E+   GR P               +  M++RE  + D V
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNRE--VLDQV 228
Query: 485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPA 540
           ++   +    +  + L  L   C      ERP T + LQ           PQ++P 
Sbjct: 229 ERGYRMPCPPECPESLHDLMCQCWRKDPEERP-TFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 112/227 (49%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 53
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++F+ +  L+K++     T   + L  ++ +++
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 113 LQGLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEV 164
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 165 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 111/225 (49%), Gaps = 29/225 (12%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAI 297
            NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+++
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREISL 55
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKILT 354
           +               H + KL LV++F+ +  L+K++     T   + L  ++ +++L 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +V 
Sbjct: 115 GLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVV- 165
Query: 415 VPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
              T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 166 ---TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 112/227 (49%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 54
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++F+ +  L+K++     T   + L  ++ +++
Sbjct: 55  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 114 LQGLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEV 165
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 166 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 112/227 (49%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 53
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++F+ +  L+K++     T   + L  ++ +++
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 113 LQGLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEV 164
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 165 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 112/227 (49%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 53
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++F+ +  L+K++     T   + L  ++ +++
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 113 LQGLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEV 164
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 165 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 111/225 (49%), Gaps = 29/225 (12%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAI 297
            NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+++
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREISL 54
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKILT 354
           +               H + KL LV++F+ +  L+K++     T   + L  ++ +++L 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +V 
Sbjct: 114 GLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVV- 164
Query: 415 VPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
              T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 165 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 71
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 72  ASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 124
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 182 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 72
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 73  ASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 125
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 126 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 183 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 233

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 111/225 (49%), Gaps = 29/225 (12%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAI 297
            NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+++
Sbjct: 7   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREISL 59
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKILT 354
           +               H + KL LV++F+ +  L+K++     T   + L  ++ +++L 
Sbjct: 60  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 118
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +V 
Sbjct: 119 GLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVV- 169
Query: 415 VPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
              T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 170 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 211

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 111/225 (49%), Gaps = 29/225 (12%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAI 297
            NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+++
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREISL 55
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKILT 354
           +               H + KL LV++F+ +  L+K++     T   + L  ++ +++L 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +V 
Sbjct: 115 GLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVV- 165
Query: 415 VPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
              T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 166 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 111/225 (49%), Gaps = 29/225 (12%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAI 297
            NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+++
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREISL 54
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKILT 354
           +               H + KL LV++F+ +  L+K++     T   + L  ++ +++L 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +V 
Sbjct: 114 GLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVV- 164
Query: 415 VPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
              T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 165 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 127/296 (42%), Gaps = 36/296 (12%)
Query: 246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXX 305
            ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  ++       
Sbjct: 23  EVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEK 74
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                    E+  + +V ++M  G L  +L G   +  L       +   +AS + Y++ 
Sbjct: 75  LVQLYAVVSEE-PIYIVMEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVER 132
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
                 VHRDL+A+NIL+  +   ++ DFGLAR IE+  N Y        P  + + APE
Sbjct: 133 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP--IKWTAPE 185
Query: 426 CFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV 484
               G+ T +SDV+ FG ++ E+   GR P               +  M++RE  + D V
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNRE--VLDQV 228
Query: 485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPA 540
           ++   +    +  + L  L   C      ERP T + LQ           PQ++P 
Sbjct: 229 ERGYRMPCPPECPESLHDLMCQCWRKDPEERP-TFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 111/225 (49%), Gaps = 29/225 (12%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAI 297
            NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+++
Sbjct: 10  ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREISL 62
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKILT 354
           +               H + KL LV++F+ +  L+K++     T   + L  ++ +++L 
Sbjct: 63  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 121
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +V 
Sbjct: 122 GLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVV- 172
Query: 415 VPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
              T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 173 ---TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGD 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 73
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 74  ASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 126
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 127 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 183
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 184 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 71
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 72  ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 124
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 182 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 112/227 (49%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 55
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++F+ +  L+K++     T   + L  ++ +++
Sbjct: 56  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 114
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 115 LQGLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEV 166
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 167 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 74
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 75  ASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 127
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 128 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 185 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 72
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 73  ASVDNPHVCRLLGICL-TSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNW------CV 125
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 126 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 183 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 233

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 123/281 (43%), Gaps = 40/281 (14%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 74
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 75  ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 127
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 128 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL----- 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L     
Sbjct: 185 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 240
Query: 468 --------VDWVWMLHREGHIQDAVDQRLNINSVVDEAKRL 500
                   +D V+M+ R+  + DA D R     ++ E  ++
Sbjct: 241 LPQPPICTID-VYMIMRKCWMIDA-DSRPKFRELIIEFSKM 279

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 112/227 (49%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 56
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++F+ +  L+K++     T   + L  ++ +++
Sbjct: 57  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 115
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 116 LQGLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEV 167
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 168 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 112/227 (49%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 55
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++F+ +  L+K++     T   + L  ++ +++
Sbjct: 56  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 114
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 115 LQGLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEV 166
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 167 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 123/281 (43%), Gaps = 40/281 (14%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 71
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 72  ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 124
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL----- 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L     
Sbjct: 182 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 237
Query: 468 --------VDWVWMLHREGHIQDAVDQRLNINSVVDEAKRL 500
                   +D V+M+ R+  + DA D R     ++ E  ++
Sbjct: 238 LPQPPICTID-VYMIMRKCWMIDA-DSRPKFRELIIEFSKM 276

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 111/225 (49%), Gaps = 29/225 (12%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAI 297
            NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+++
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREISL 55
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKILT 354
           +               H + KL LV++F+ +  L+K++     T   + L  ++ +++L 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +V 
Sbjct: 115 GLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVV- 165
Query: 415 VPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
              T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 166 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 127/296 (42%), Gaps = 36/296 (12%)
Query: 246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXX 305
            ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  ++       
Sbjct: 23  EVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEK 74
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                    E+  + +V ++M  G L  +L G   +  L       +   +AS + Y++ 
Sbjct: 75  LVQLYAVVSEE-PIYIVTEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVER 132
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
                 VHRDL+A+NIL+  +   ++ DFGLAR IE+  N Y        P  + + APE
Sbjct: 133 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP--IKWTAPE 185
Query: 426 CFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV 484
               G+ T +SDV+ FG ++ E+   GR P               +  M++RE  + D V
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNRE--VLDQV 228
Query: 485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPA 540
           ++   +    +  + L  L   C      ERP T + LQ           PQ++P 
Sbjct: 229 ERGYRMPCPPECPESLHDLMCQCWRKDPEERP-TFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 111/225 (49%), Gaps = 29/225 (12%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAI 297
            NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+++
Sbjct: 10  ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREISL 62
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKILT 354
           +               H + KL LV++F+ +  L+K++     T   + L  ++ +++L 
Sbjct: 63  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 121
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +V 
Sbjct: 122 GLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVV- 172
Query: 415 VPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
              T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 173 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 214

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 112/227 (49%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 55
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++F+ +  L+K++     T   + L  ++ +++
Sbjct: 56  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 114
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 115 LQGLAFC-------HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX-HEV 166
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 167 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 129/296 (43%), Gaps = 36/296 (12%)
Query: 246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXX 305
            ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  ++       
Sbjct: 20  EVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEK 71
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                    E+  + +V ++M  GSL  +L G + +  L       +   +AS + Y++ 
Sbjct: 72  LVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVER 129
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
                 VHRDL+A+NIL+  +   ++ DFGLAR IE+  N +        P  + + APE
Sbjct: 130 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEWTARQGAKFP--IKWTAPE 182
Query: 426 CFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV 484
               G+ T +SDV+ FG ++ E+   GR P               +  M++RE  + D V
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNRE--VLDQV 225
Query: 485 DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPA 540
           ++   +    +  + L  L   C      ERP T + LQ           PQ++P 
Sbjct: 226 ERGYRMPCPPECPESLHDLMCQCWRKEPEERP-TFEYLQAFLEDYFTSTEPQYQPG 280

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 112/227 (49%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 56
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++F+ +  L+K++     T   + L  ++ +++
Sbjct: 57  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQL 115
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 116 LQGLAFC-------HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX-HEV 167
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 168 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 13/214 (6%)
Query: 244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAIIXXXX 302
           H    +G+G FG+VY G   + DQ   +  Q A+K  SR   ++    FL E  ++    
Sbjct: 24  HSDRVIGKGHFGVVYHG--EYIDQAQ-NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 303 XXXXXXXXG-WCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
                   G     +G   ++  +M +G L +++       T+     + +   VA  + 
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL--QVARGME 138
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI-ENERNSYAEHGLVGVPGTMG 420
           YL    +QK VHRDL A N +LD  F  ++ DFGLAR I + E  S  +H    +P  + 
Sbjct: 139 YLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP--VK 193
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           + A E   T + T +SDV+ FG ++ E++   +P
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 111/225 (49%), Gaps = 29/225 (12%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAI 297
            NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+++
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREISL 54
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKILT 354
           +               H + KL LV++F+ +  L+K++     T   + L  ++ +++L 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +V 
Sbjct: 114 GLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVV- 164
Query: 415 VPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
              T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 165 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 111/225 (49%), Gaps = 29/225 (12%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAI 297
            NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+++
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREISL 54
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKILT 354
           +               H + KL LV++F+ +  L+K++     T   + L  ++ +++L 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +V 
Sbjct: 114 GLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVV- 164
Query: 415 VPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
              T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 165 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 112/227 (49%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 57
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++F+ +  L+K++     T   + L  ++ +++
Sbjct: 58  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 116
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 117 LQGLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEV 168
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 169 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 211

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 73
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 74  ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 126
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 127 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 183
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 184 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 74
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 75  ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 127
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 128 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 185 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 71
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 72  ASVDNPHVCRLLGICL-TSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNW------CV 124
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 182 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 96
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 97  ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 149
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 150 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 206
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 207 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 257

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 112/227 (49%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 54
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++F+ +  L+K++     T   + L  ++ +++
Sbjct: 55  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 114 LQGLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEV 165
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 166 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 74
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 75  ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 127
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 128 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 185 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKEILDEAYVM 65
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 66  ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 118
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 119 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 176 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 112/227 (49%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 54
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++F+ +  L+K++     T   + L  ++ +++
Sbjct: 55  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 114 LQGLAFC-------HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX-HEV 165
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 166 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 112/227 (49%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 56
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++F+ +  L+K++     T   + L  ++ +++
Sbjct: 57  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 115
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 116 LQGLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEV 167
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 168 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 68
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 69  ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 121
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 122 QIAEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 178
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 179 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 229

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 112/227 (49%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 54
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++F+ +  L+K++     T   + L  ++ +++
Sbjct: 55  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 114 LQGLAFC-------HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX-HEV 165
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 166 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 111/225 (49%), Gaps = 29/225 (12%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAI 297
            NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+++
Sbjct: 4   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREISL 56
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKILT 354
           +               H + KL LV++F+ +  L+K++     T   + L  ++ +++L 
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +V 
Sbjct: 116 GLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVV- 166
Query: 415 VPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
              T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 167 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 23/234 (9%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIX 299
             F +   LG G FG VYKG+ I   ++  +    + +++ +  S K+  + L E  ++ 
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREAT--SPKANKEILDEAYVMA 106
Query: 300 XXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILTG 355
                      G C     + L+   MP G L  Y+         Q  LNW         
Sbjct: 107 SVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 159
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLVG 414
           +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V 
Sbjct: 160 IAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 216
Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
           +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 217 I----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 266

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 124/296 (41%), Gaps = 47/296 (15%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK-GDFLAELAIIXXXXXXXXX 307
           LGEG FG V K    H  +     T +AVK    ++  S+  D L+E  ++         
Sbjct: 31  LGEGEFGKVVKATAFHL-KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---------------------EQVTLNW 346
              G C + G LLL+ ++   GSL  +L  +                      ++  L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
                    ++  + YL    + K+VHRDL A NIL+      ++ DFGL+R +  E +S
Sbjct: 150 GDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE-DS 205
Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAY 465
           Y +     +P  + ++A E       T +SDV+ FG ++ E+V  G +P   IP ++   
Sbjct: 206 YVKRSQGRIP--VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER--- 260
Query: 466 TLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDI 521
                ++ L + GH  +  D      +  +E  RL+   L C      +RP   DI
Sbjct: 261 -----LFNLLKTGHRMERPD------NCSEEMYRLM---LQCWKQEPDKRPVFADI 302

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 112/227 (49%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 53
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++F+ +  L+K++     T   + L  ++ +++
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 113 LQGLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEV 164
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 165 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 77
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 78  ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 130
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 131 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 187
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 188 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 238

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 78
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 79  ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 131
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 132 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 189 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 121/283 (42%), Gaps = 35/283 (12%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF--SRDSIKSKGDFLAELAIIXXXXXXX 305
           R+G G FG VYKG      ++H D   +AVK    +  + +    F  E+ ++       
Sbjct: 31  RIGSGSFGTVYKG------KWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                G+     +L +V  +    SL  +L+ +  +  +       I    A  + YL  
Sbjct: 82  ILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMK--KLIDIARQTARGMDYL-- 136
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            + + ++HRDLK++NI L  D   ++GDFGL  A E  R S   H    + G++ ++APE
Sbjct: 137 -HAKSIIHRDLKSNNIFLHEDNTVKIGDFGL--ATEKSRWS-GSHQFEQLSGSILWMAPE 192
Query: 426 CFHTGKATP---ESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD 482
                 + P   +SDV+ FG V+ E++ G+ P + I ++         + M+ R     D
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IEMVGRGSLSPD 246
Query: 483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
               R N        KR+  L   C      ERP    IL  I
Sbjct: 247 LSKVRSNC------PKRMKRLMAECLKKKRDERPSFPRILAEI 283

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXX 306
           ++LG+G FG V+ G  +         T++A+K     ++  +  FL E  ++        
Sbjct: 191 VKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGNMSPEA-FLQEAQVMKKLRHEKL 242
Query: 307 XXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
                   E+  + +V ++M  GSL  +L G   +  L       +   +AS + Y++  
Sbjct: 243 VQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVER- 299
Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
                VHRDL+A+NIL+  +   ++ DFGL R IE+  N Y        P  + + APE 
Sbjct: 300 --MNYVHRDLRAANILVGENLVCKVADFGLGRLIED--NEYTARQGAKFP--IKWTAPEA 353
Query: 427 FHTGKATPESDVFGFGAVVLEVVC-GRSP 454
              G+ T +SDV+ FG ++ E+   GR P
Sbjct: 354 ALYGRFTIKSDVWSFGILLTELTTKGRVP 382

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF--SRDSIKSKGDFLAELAIIXXXXXXX 305
           R+G G FG VYKG      ++H D   +AVK    +  + +    F  E+ ++       
Sbjct: 35  RIGSGSFGTVYKG------KWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 85
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                G+   K +L +V  +    SL  +L+    +  +       I    A  + YL  
Sbjct: 86  ILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYL-- 140
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            + + ++HRDLK++NI L  D   ++GDFGL  A E  R S   H    + G++ ++APE
Sbjct: 141 -HAKSIIHRDLKSNNIFLHEDLTVKIGDFGL--ATEKSRWS-GSHQFEQLSGSILWMAPE 196
Query: 426 CFHTGKATP---ESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV 468
                   P   +SDV+ FG V+ E++ G+ P + I ++     +V
Sbjct: 197 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 242

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 111/225 (49%), Gaps = 29/225 (12%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAI 297
            NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+++
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREISL 55
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKILT 354
           +               H + KL LV++F+ +  L+K++     T   + L  ++ +++L 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           G++         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +V 
Sbjct: 115 GLSFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVV- 165
Query: 415 VPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
              T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 166 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 100/225 (44%), Gaps = 21/225 (9%)
Query: 228 PREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IK 286
           P  F  + LKK  +       LGEG FG V   +  ++         +AVK    D   +
Sbjct: 8   PTVFHKRYLKKIRD-------LGEGHFGKV--SLYCYDPTNDGTGEMVAVKALKADCGPQ 58
Query: 287 SKGDFLAELAIIXXXXXXXXXXXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTL 344
            +  +  E+ I+            G C ++G+  L LV +++P GSL  YL   S  +  
Sbjct: 59  HRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQ 118
Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
                 +I  G+A    YL +   Q  +HR+L A N+LLD D   ++GDFGLA+A+    
Sbjct: 119 LLLFAQQICEGMA----YLHS---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH 171
Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
             Y        P  + + APEC    K    SDV+ FG  + E++
Sbjct: 172 EYYRVREDGDSP--VFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF--SRDSIKSKGDFLAELAIIXXXXXXX 305
           R+G G FG VYKG      ++H D   +AVK    +  + +    F  E+ ++       
Sbjct: 15  RIGSGSFGTVYKG------KWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                G+   K +L +V  +    SL  +L+    +  +       I    A  + YL  
Sbjct: 66  ILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYL-- 120
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            + + ++HRDLK++NI L  D   ++GDFGL  A E  R S   H    + G++ ++APE
Sbjct: 121 -HAKSIIHRDLKSNNIFLHEDLTVKIGDFGL--ATEKSRWS-GSHQFEQLSGSILWMAPE 176
Query: 426 CFHTGKATP---ESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV 468
                   P   +SDV+ FG V+ E++ G+ P + I ++     +V
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 110/242 (45%), Gaps = 32/242 (13%)
Query: 229 REFKYKELKKATNNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSRD-SIK 286
           R  K  EL+K          LG G FG VYKGI I   +   +    +A+K    + S K
Sbjct: 12  RILKETELRKVKV-------LGSGAFGTVYKGIWIPDGENVKI---PVAIKVLRENTSPK 61
Query: 287 SKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGT----SEQV 342
           +  + L E  ++            G C     + LV   MP G L  ++         Q 
Sbjct: 62  ANKEILDEAYVMAGVGSPYVSRLLGICL-TSTVQLVTQLMPYGCLLDHVRENRGRLGSQD 120
Query: 343 TLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN 402
            LNW  +      +A  + YL+   D ++VHRDL A N+L+ +  + ++ DFGLAR ++ 
Sbjct: 121 LLNWCMQ------IAKGMSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 171
Query: 403 ERNSY-AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPH 460
           +   Y A+ G V +     ++A E     + T +SDV+ +G  V E++  G  P + IP 
Sbjct: 172 DETEYHADGGKVPI----KWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 227
Query: 461 QQ 462
           ++
Sbjct: 228 RE 229

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 34/211 (16%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G FG V+    + +       T++AVK     S+  +  FLAE  ++         
Sbjct: 189 KLGAGQFGEVWMATYNKH-------TKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLV 240
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLY---GTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                   K  + ++ +FM  GSL  +L    G+ + +    +   +I  G+A   +  Q
Sbjct: 241 KLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA---FIEQ 296
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
             Y    +HRDL+A+NIL+ A    ++ DFGLAR              VG    + + AP
Sbjct: 297 RNY----IHRDLRAANILVSASLVCKIADFGLAR--------------VGAKFPIKWTAP 338
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           E  + G  T +SDV+ FG +++E+V  GR P
Sbjct: 339 EAINFGSFTIKSDVWSFGILLMEIVTYGRIP 369

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF--SRDSIKSKGDFLAELAIIXXXXXXX 305
           R+G G FG VYKG      ++H D   +AVK    +  + +    F  E+ ++       
Sbjct: 43  RIGSGSFGTVYKG------KWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 93
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                G+   K +L +V  +    SL  +L+    +  +       I    A  + YL  
Sbjct: 94  ILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYL-- 148
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            + + ++HRDLK++NI L  D   ++GDFGL  A E  R S   H    + G++ ++APE
Sbjct: 149 -HAKSIIHRDLKSNNIFLHEDLTVKIGDFGL--ATEKSRWS-GSHQFEQLSGSILWMAPE 204
Query: 426 CFHTGKATP---ESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV 468
                   P   +SDV+ FG V+ E++ G+ P + I ++     +V
Sbjct: 205 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXX 307
           LGEG FG VY+G+  ++     +   +AVK   +D ++ +K  F++E  I+         
Sbjct: 16  LGEGFFGEVYEGVYTNHKG---EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G   E+   +++ +  P G L  YL      + +     Y +   +  A+ YL++  
Sbjct: 73  KLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES-- 127
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
               VHRD+   NIL+ +    +LGDFGL+R IE+E   Y +  +  +P  + +++PE  
Sbjct: 128 -INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE--DYYKASVTRLP--IKWMSPESI 182
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
           +  + T  SDV+ F   + E++  G+ P
Sbjct: 183 NFRRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXX 307
           LGEG FG VY+G+  ++     +   +AVK   +D ++ +K  F++E  I+         
Sbjct: 32  LGEGFFGEVYEGVYTNHKG---EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G   E+   +++ +  P G L  YL      + +     Y +   +  A+ YL++  
Sbjct: 89  KLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES-- 143
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
               VHRD+   NIL+ +    +LGDFGL+R IE+E   Y +  +  +P  + +++PE  
Sbjct: 144 -INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE--DYYKASVTRLP--IKWMSPESI 198
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
           +  + T  SDV+ F   + E++  G+ P
Sbjct: 199 NFRRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 100/225 (44%), Gaps = 21/225 (9%)
Query: 228 PREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IK 286
           P  F  + LKK  +       LGEG FG V   +  ++         +AVK    D   +
Sbjct: 8   PTVFHKRYLKKIRD-------LGEGHFGKV--SLYCYDPTNDGTGEMVAVKALKADCGPQ 58
Query: 287 SKGDFLAELAIIXXXXXXXXXXXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTL 344
            +  +  E+ I+            G C ++G+  L LV +++P GSL  YL   S  +  
Sbjct: 59  HRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQ 118
Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
                 +I  G+A    YL   + Q  +HR+L A N+LLD D   ++GDFGLA+A+    
Sbjct: 119 LLLFAQQICEGMA----YL---HAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH 171
Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
             Y        P  + + APEC    K    SDV+ FG  + E++
Sbjct: 172 EYYRVREDGDSP--VFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 22/228 (9%)
Query: 225 PGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS 284
           P  P  F+ + LK  +        LG+G FG V   +  ++         +AVK+     
Sbjct: 2   PQDPTIFEERHLKYISQ-------LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSG 52
Query: 285 IKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQV 342
              + DF  E+ I+            G  +  G+  L LV +++P+G L  +L     + 
Sbjct: 53  PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRA 110
Query: 343 TLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN 402
            L+ +      + +   + YL +   ++ VHRDL A NIL++++ + ++ DFGLA+ +  
Sbjct: 111 RLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 167
Query: 403 ERNSYAEHGLVGVPGT--MGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           +++ Y    +V  PG   + + APE       + +SDV+ FG V+ E+
Sbjct: 168 DKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG+G FG V   +  ++         +AVK+        + DF  E+ I+         
Sbjct: 17  QLGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 74
Query: 308 XXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G  +  G+  L LV +++P+G L  +L     +  L+ +      + +   + YL +
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS 132
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT--MGYVA 423
              ++ VHRDL A NIL++++ + ++ DFGLA+ +  +++ Y    +V  PG   + + A
Sbjct: 133 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYA 185
Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE       + +SDV+ FG V+ E+
Sbjct: 186 PESLSDNIFSRQSDVWSFGVVLYEL 210

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 18/217 (8%)
Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK---FSRDSIKSKGDFLAELAII 298
           NF    ++G G F  VY+          +D   +A+KK   F     K++ D + E+ ++
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACL------LDGVPVALKKVQIFDLMDAKARADCIKEIDLL 86
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR-YKILTGVA 357
                           E  +L +V +    G L + +    +Q  L      +K    + 
Sbjct: 87  KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
           SA   L++ + ++V+HRD+K +N+ + A    +LGD GL R   ++  + A H LVG P 
Sbjct: 147 SA---LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTP- 200
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
              Y++PE  H      +SD++  G ++ E+   +SP
Sbjct: 201 --YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 110/225 (48%), Gaps = 29/225 (12%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAI 297
            NF +  ++GEG +G+VYK       +  +    +A+ K   D+ +++G     + E+++
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALXKIRLDT-ETEGVPSTAIREISL 55
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKILT 354
           +               H + KL LV++F+ +  L+K++     T   + L  ++ +++L 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +V 
Sbjct: 115 GLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVV- 165
Query: 415 VPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
              T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 166 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 110/225 (48%), Gaps = 29/225 (12%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAI 297
            NF +  ++GEG +G+VYK       +  +    +A+ K   D+ +++G     + E+++
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALXKIRLDT-ETEGVPSTAIREISL 54
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKILT 354
           +               H + KL LV++F+ +  L+K++     T   + L  ++ +++L 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +V 
Sbjct: 114 GLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVV- 164
Query: 415 VPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
              T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 165 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 75
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 76  ASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 128
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFG A+ +  E   Y AE G V
Sbjct: 129 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 185
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 186 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 236

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXXX 307
           LGEG FG VY+G+  ++     +   +AVK   +D ++ +K  F++E  I+         
Sbjct: 20  LGEGFFGEVYEGVYTNHKG---EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G   E+   +++ +  P G L  YL      + +     Y +   +  A+ YL++  
Sbjct: 77  KLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES-- 131
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
               VHRD+   NIL+ +    +LGDFGL+R IE+E   Y +  +  +P  + +++PE  
Sbjct: 132 -INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE--DYYKASVTRLP--IKWMSPESI 186
Query: 428 HTGKATPESDVFGFGAVVLEVVC-GRSP 454
           +  + T  SDV+ F   + E++  G+ P
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 111/227 (48%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 53
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++F+ +  L+ ++     T   + L  ++ +++
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQL 112
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 113 LQGLAFC-------HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX-HEV 164
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 165 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 122/281 (43%), Gaps = 40/281 (14%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 73
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 74  ASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 126
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFG A+ +  E   Y AE G V
Sbjct: 127 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL----- 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L     
Sbjct: 184 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 239
Query: 468 --------VDWVWMLHREGHIQDAVDQRLNINSVVDEAKRL 500
                   +D V+M+ R+  + DA D R     ++ E  ++
Sbjct: 240 LPQPPICTID-VYMIMRKCWMIDA-DSRPKFRELIIEFSKM 278

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 111/227 (48%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 56
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++F+ +  L+ ++     T   + L  ++ +++
Sbjct: 57  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQL 115
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 116 LQGLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEV 167
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 168 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   L  G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 78
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 79  ASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 131
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 132 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 189 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 111/227 (48%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 56
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++F+ +  L+ ++     T   + L  ++ +++
Sbjct: 57  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQL 115
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 116 LQGLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEV 167
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 168 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   L  G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 71
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 72  ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 124
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 182 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/277 (23%), Positives = 121/277 (43%), Gaps = 33/277 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           LG G FG+V  G      QY V     A+K     S+ S+ +F+ E  ++          
Sbjct: 32  LGTGQFGVVKYG--KWRGQYDV-----AIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQ 83
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G C ++  + ++ ++M NG L  YL     +         ++   V  A+ YL++   
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES--- 138
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           ++ +HRDL A N L++     ++ DFGL+R + ++  + +    VG    + +  PE   
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSS----VGSKFPVRWSPPEVLM 194
Query: 429 TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRL 488
             K + +SD++ FG ++ E+    S G M P+++                   + + Q L
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIY---SLGKM-PYERFT------------NSETAEHIAQGL 238
Query: 489 NINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
            +      ++++  +  +C H  A ERP  + +L  I
Sbjct: 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG+G FG V   +  ++         +AVK+        + DF  E+ I+         
Sbjct: 30  QLGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 308 XXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G  +  G+  L LV +++P+G L  +L     +  L+ +      + +   + YL +
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT--MGYVA 423
              ++ VHRDL A NIL++++ + ++ DFGLA+ +  +++ Y    +V  PG   + + A
Sbjct: 146 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYA 198
Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE       + +SDV+ FG V+ E+
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 32/189 (16%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           + LV+D M  G L  YL   +E+V L+      I+  +  AV +L   +   +VHRDLK 
Sbjct: 175 MFLVFDLMRKGELFDYL---TEKVALSEKETRSIMRSLLEAVSFL---HANNIVHRDLKP 228
Query: 379 SNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF-------HTGK 431
            NILLD +   RL DFG +  +E          L  + GT GY+APE         H G 
Sbjct: 229 ENILLDDNMQIRLSDFGFSCHLE------PGEKLRELCGTPGYLAPEILKCSMDETHPGY 282
Query: 432 ATPESDVFGFGAVVLEVVCGRSPG---------NMIPHQQHAYTLVDWVWMLHREGHIQD 482
              E D++  G ++  ++ G  P           MI   Q+ ++  +W     R   ++D
Sbjct: 283 GK-EVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD---DRSSTVKD 338
Query: 483 AVDQRLNIN 491
            + + L ++
Sbjct: 339 LISRLLQVD 347

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 111/227 (48%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 55
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++F+ +  L+ ++     T   + L  ++ +++
Sbjct: 56  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQL 114
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 115 LQGLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEV 166
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 167 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 73
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 74  ASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 126
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFG A+ +  E   Y AE G V
Sbjct: 127 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 184 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 122/281 (43%), Gaps = 40/281 (14%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 73
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 74  ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 126
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFG A+ +  E   Y AE G V
Sbjct: 127 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL----- 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L     
Sbjct: 184 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 239
Query: 468 --------VDWVWMLHREGHIQDAVDQRLNINSVVDEAKRL 500
                   +D V+M+ R+  + DA D R     ++ E  ++
Sbjct: 240 LPQPPICTID-VYMIMRKCWMIDA-DSRPKFRELIIEFSKM 278

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 71
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 72  ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 124
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFG A+ +  E   Y AE G V
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 181
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 182 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF--SRDSIKSKGDFLAELAIIXXXXXXX 305
           R+G G FG VYKG      ++H D   +AVK    +  + +    F  E+ ++       
Sbjct: 17  RIGSGSFGTVYKG------KWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 67
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                G+   K +L +V  +    SL  +L+    +  +       I    A  + YL  
Sbjct: 68  ILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYL-- 122
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            + + ++HRDLK++NI L  D   ++GDFGLA        S   H    + G++ ++APE
Sbjct: 123 -HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS---HQFEQLSGSILWMAPE 178
Query: 426 CFHTGKATP---ESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV 468
                   P   +SDV+ FG V+ E++ G+ P + I ++     +V
Sbjct: 179 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 224

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   L  G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 78
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 79  ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 131
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V
Sbjct: 132 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 189 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|2EIG|A Chain A, Lotus Tetragonolobus Seed Lectin (Isoform) Length = 234

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 82/155 (52%), Gaps = 15/155 (9%)
Query: 15  GLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDD---NHLG 71
           G+ F +AP  +  P +S G +LG+T++    N  N FVA+EFD+    +DP     +H+G
Sbjct: 81  GVVFFLAPWGTEIPPNSQGGYLGITDS---SNSQNQFVAVEFDSHPNVWDPKSLRSSHIG 137
Query: 72  LNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKE 131
           +++NS++S K V    N+N     G+     + YD  +K++ V M  +     Q   + +
Sbjct: 138 IDVNSIMSLKAV----NWNRV--SGSLEKATIIYDSDTKILTVVMTHQNG---QITTISQ 188
Query: 132 TINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTL 166
            I+LK  L  +   GFSA+T  P  + + + SW+ 
Sbjct: 189 EIDLKTVLPEKVSVGFSATTWNPERERHDIYSWSF 223

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF--SRDSIKSKGDFLAELAIIXXXXXXX 305
           R+G G FG VYKG      ++H D   +AVK    +  + +    F  E+ ++       
Sbjct: 42  RIGSGSFGTVYKG------KWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 92
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                G+   K +L +V  +    SL  +L+    +  +       I    A  + YL  
Sbjct: 93  ILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYL-- 147
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            + + ++HRDLK++NI L  D   ++GDFGLA        S   H    + G++ ++APE
Sbjct: 148 -HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS---HQFEQLSGSILWMAPE 203
Query: 426 CFHTGKATP---ESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV 468
                   P   +SDV+ FG V+ E++ G+ P + I ++     +V
Sbjct: 204 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 249

>pdb|2E7Q|A Chain A, Crystal Structure Of Basic Winged Bean Lectin In Complex With B Blood Group Trisaccharide Length = 237

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 76/150 (50%), Gaps = 17/150 (11%)
Query: 5   PRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFD 64
           PRP       GL F IAP ++   E   G + G+ N  +       FVA+EFDT +  +D
Sbjct: 81  PRPH---PADGLVFFIAPPNTQTGEG--GGYFGIYNPLS----PYPFVAVEFDTFRNTWD 131
Query: 65  PDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMP 124
           P   H+G+++NSV+S K VP       TL +G    V ++YD  +K++ V +     ++ 
Sbjct: 132 PQIPHIGIDVNSVISTKTVPF------TLDNGGIANVVIKYDASTKILHVVL--VFPSLG 183
Query: 125 QKPLLKETINLKDYLKPESYFGFSASTGYP 154
               + + ++LK  L      GFSA+TG P
Sbjct: 184 TIYTIADIVDLKQVLPESVNVGFSAATGDP 213

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF--SRDSIKSKGDFLAELAIIXXXXXXX 305
           R+G G FG VYKG      ++H D   +AVK    +  + +    F  E+ ++       
Sbjct: 20  RIGSGSFGTVYKG------KWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 70
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                G+   K +L +V  +    SL  +L+    +  +       I    A  + YL  
Sbjct: 71  ILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYL-- 125
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            + + ++HRDLK++NI L  D   ++GDFGLA        S   H    + G++ ++APE
Sbjct: 126 -HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS---HQFEQLSGSILWMAPE 181
Query: 426 CFHTGKATP---ESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV 468
                   P   +SDV+ FG V+ E++ G+ P + I ++     +V
Sbjct: 182 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF--SRDSIKSKGDFLAELAIIXXXXXXX 305
           R+G G FG VYKG      ++H D   +AVK    +  + +    F  E+ ++       
Sbjct: 15  RIGSGSFGTVYKG------KWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                G+   K +L +V  +    SL  +L+    +  +       I    A  + YL  
Sbjct: 66  ILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYL-- 120
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            + + ++HRDLK++NI L  D   ++GDFGLA        S   H    + G++ ++APE
Sbjct: 121 -HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS---HQFEQLSGSILWMAPE 176
Query: 426 CFHTGKATP---ESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV 468
                   P   +SDV+ FG V+ E++ G+ P + I ++     +V
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/277 (23%), Positives = 121/277 (43%), Gaps = 33/277 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           LG G FG+V  G      QY V     A+K     S+ S+ +F+ E  ++          
Sbjct: 16  LGTGQFGVVKYG--KWRGQYDV-----AIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQ 67
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G C ++  + ++ ++M NG L  YL     +         ++   V  A+ YL++   
Sbjct: 68  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES--- 122
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           ++ +HRDL A N L++     ++ DFGL+R + ++  + +    VG    + +  PE   
Sbjct: 123 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLM 178
Query: 429 TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRL 488
             K + +SD++ FG ++ E+    S G M P+++                   + + Q L
Sbjct: 179 YSKFSSKSDIWAFGVLMWEIY---SLGKM-PYERFT------------NSETAEHIAQGL 222
Query: 489 NINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
            +      ++++  +  +C H  A ERP  + +L  I
Sbjct: 223 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 259

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 25/235 (10%)
Query: 241 NNFHESMRLGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAII 298
             F +   LG G FG VYKG+ I   ++  +    +A+K+     S K+  + L E  ++
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 78
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLY----GTSEQVTLNWNHRYKILT 354
                       G C     + L+   MP G L  Y+         Q  LNW        
Sbjct: 79  ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 131
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLV 413
            +A  + YL+   D+++VHRDL A N+L+    + ++ DFG A+ +  E   Y AE G V
Sbjct: 132 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 188
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL 467
            +     ++A E       T +SDV+ +G  V E++  G  P + IP  + +  L
Sbjct: 189 PI----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF--SRDSIKSKGDFLAELAIIXXXXXXX 305
           R+G G FG VYKG      ++H D   +AVK    +  + +    F  E+ ++       
Sbjct: 20  RIGSGSFGTVYKG------KWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 70
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                G+   K +L +V  +    SL  +L+    +  +       I    A  + YL  
Sbjct: 71  ILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYL-- 125
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            + + ++HRDLK++NI L  D   ++GDFGLA        S   H    + G++ ++APE
Sbjct: 126 -HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS---HQFEQLSGSILWMAPE 181
Query: 426 CFHTGKATP---ESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV 468
                   P   +SDV+ FG V+ E++ G+ P + I ++     +V
Sbjct: 182 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|1WBF|A Chain A, Winged Bean Lectin, Saccharide Free Form Length = 242

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 76/150 (50%), Gaps = 17/150 (11%)
Query: 5   PRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFD 64
           PRP       GL F IAP ++   E   G + G+ N  +       FVA+EFDT +  +D
Sbjct: 82  PRPH---PADGLVFFIAPPNTQTGEG--GGYFGIYNPLS----PYPFVAVEFDTFRNTWD 132
Query: 65  PDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMP 124
           P   H+G+++NSV+S K VP       TL +G    V ++YD  +K++ V +     ++ 
Sbjct: 133 PQIPHIGIDVNSVISTKTVPF------TLDNGGIANVVIKYDASTKILHVVL--VFPSLG 184
Query: 125 QKPLLKETINLKDYLKPESYFGFSASTGYP 154
               + + ++LK  L      GFSA+TG P
Sbjct: 185 TIYTIADIVDLKQVLPESVNVGFSAATGDP 214

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/277 (23%), Positives = 121/277 (43%), Gaps = 33/277 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           LG G FG+V  G      QY V     A+K     S+ S+ +F+ E  ++          
Sbjct: 17  LGTGQFGVVKYG--KWRGQYDV-----AIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQ 68
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G C ++  + ++ ++M NG L  YL     +         ++   V  A+ YL++   
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES--- 123
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           ++ +HRDL A N L++     ++ DFGL+R + ++  + +    VG    + +  PE   
Sbjct: 124 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLM 179
Query: 429 TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRL 488
             K + +SD++ FG ++ E+    S G M P+++                   + + Q L
Sbjct: 180 YSKFSSKSDIWAFGVLMWEIY---SLGKM-PYERFT------------NSETAEHIAQGL 223
Query: 489 NINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
            +      ++++  +  +C H  A ERP  + +L  I
Sbjct: 224 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 260

>pdb|1WBL|A Chain A, Winged Bean Lectin Complexed With Methyl-Alpha-D-Galactose Length = 241

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 76/150 (50%), Gaps = 17/150 (11%)
Query: 5   PRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFD 64
           PRP       GL F IAP ++   E   G + G+ N  +       FVA+EFDT +  +D
Sbjct: 81  PRPH---PADGLVFFIAPPNTQTGEG--GGYFGIYNPLS----PYPFVAVEFDTFRNTWD 131
Query: 65  PDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMP 124
           P   H+G+++NSV+S K VP       TL +G    V ++YD  +K++ V +     ++ 
Sbjct: 132 PQIPHIGIDVNSVISTKTVPF------TLDNGGIANVVIKYDASTKILHVVL--VFPSLG 183
Query: 125 QKPLLKETINLKDYLKPESYFGFSASTGYP 154
               + + ++LK  L      GFSA+TG P
Sbjct: 184 TIYTIADIVDLKQVLPESVNVGFSAATGDP 213

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/277 (23%), Positives = 121/277 (43%), Gaps = 33/277 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           LG G FG+V  G      QY V     A+K     S+ S+ +F+ E  ++          
Sbjct: 32  LGTGQFGVVKYG--KWRGQYDV-----AIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQ 83
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G C ++  + ++ ++M NG L  YL     +         ++   V  A+ YL++   
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES--- 138
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           ++ +HRDL A N L++     ++ DFGL+R + ++  + +    VG    + +  PE   
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLM 194
Query: 429 TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRL 488
             K + +SD++ FG ++ E+    S G M P+++                   + + Q L
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIY---SLGKM-PYERFT------------NSETAEHIAQGL 238
Query: 489 NINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
            +      ++++  +  +C H  A ERP  + +L  I
Sbjct: 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 29/230 (12%)
Query: 225 PGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS 284
           PG PRE+          NF   +++GEG  GIV      H  +      Q+AVKK     
Sbjct: 40  PGDPREY--------LANF---IKIGEGSTGIVCIATEKHTGK------QVAVKKMDLRK 82
Query: 285 IKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTL 344
            + +     E+ I+                   +L +V +F+  G+L   +  T     +
Sbjct: 83  QQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTR----M 138
Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
           N      +   V  A+ YL N   Q V+HRD+K+ +ILL +D   +L DFG    +  E 
Sbjct: 139 NEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 195
Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                  LVG P    ++APE         E D++  G +V+E++ G  P
Sbjct: 196 PK--RKXLVGTP---YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXX 304
           E   LG G FG V KG             +I   + +  ++K   + LAE  ++      
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNP 430
Query: 305 XXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                 G C E    +LV +    G L KYL    +   +   +  +++  V+  + YL+
Sbjct: 431 YIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLE 486
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
              +   VHRDL A N+LL     A++ DFGL++A+  + N Y        P  + + AP
Sbjct: 487 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP--VKWYAP 541
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           EC +  K + +SDV+ FG ++ E    G+ P
Sbjct: 542 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF--SRDSIKSKGDFLAELAIIXXXXXXX 305
           R+G G FG VYKG      ++H D   +AVK    +  + +    F  E+ ++       
Sbjct: 43  RIGSGSFGTVYKG------KWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 93
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                G+   K +L +V  +    SL  +L+    +  +       I    A  + YL  
Sbjct: 94  ILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYL-- 148
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            + + ++HRDLK++NI L  D   ++GDFGLA        S   H    + G++ ++APE
Sbjct: 149 -HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS---HQFEQLSGSILWMAPE 204
Query: 426 CFHTGKATP---ESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV 468
                   P   +SDV+ FG V+ E++ G+ P + I ++     +V
Sbjct: 205 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 21/211 (9%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +G G FG+V K      D        +A+K+   +S   +  F+ EL  +          
Sbjct: 17  VGRGAFGVVCKAKWRAKD--------VAIKQIESES--ERKAFIVELRQLSRVNHPNIVK 66
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G C     + LV ++   GSL   L+G          H        +  V YL +   
Sbjct: 67  LYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 369 QKVVHRDLKASNILLDADFNA-RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           + ++HRDLK  N+LL A     ++ DFG A  I+          +    G+  ++APE F
Sbjct: 125 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--------MTNNKGSAAWMAPEVF 176
Query: 428 HTGKATPESDVFGFGAVVLEVVCGRSPGNMI 458
                + + DVF +G ++ EV+  R P + I
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVITRRKPFDEI 207

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXX 304
           E   LG G FG V KG             +I   + +  ++K   + LAE  ++      
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNP 431
Query: 305 XXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                 G C E    +LV +    G L KYL    +   +   +  +++  V+  + YL+
Sbjct: 432 YIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLE 487
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
              +   VHRDL A N+LL     A++ DFGL++A+  + N Y        P  + + AP
Sbjct: 488 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP--VKWYAP 542
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           EC +  K + +SDV+ FG ++ E    G+ P
Sbjct: 543 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/277 (23%), Positives = 121/277 (43%), Gaps = 33/277 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           LG G FG+V  G      QY V     A+K     S+ S+ +F+ E  ++          
Sbjct: 12  LGTGQFGVVKYG--KWRGQYDV-----AIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQ 63
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G C ++  + ++ ++M NG L  YL     +         ++   V  A+ YL++   
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES--- 118
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           ++ +HRDL A N L++     ++ DFGL+R + ++  + +    VG    + +  PE   
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLM 174
Query: 429 TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRL 488
             K + +SD++ FG ++ E+    S G M P+++                   + + Q L
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIY---SLGKM-PYERFT------------NSETAEHIAQGL 218
Query: 489 NINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
            +      ++++  +  +C H  A ERP  + +L  I
Sbjct: 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/277 (23%), Positives = 121/277 (43%), Gaps = 33/277 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           LG G FG+V  G      QY V     A+K     S+ S+ +F+ E  ++          
Sbjct: 23  LGTGQFGVVKYG--KWRGQYDV-----AIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQ 74
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G C ++  + ++ ++M NG L  YL     +         ++   V  A+ YL++   
Sbjct: 75  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES--- 129
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           ++ +HRDL A N L++     ++ DFGL+R + ++  + +    VG    + +  PE   
Sbjct: 130 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLM 185
Query: 429 TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRL 488
             K + +SD++ FG ++ E+    S G M P+++                   + + Q L
Sbjct: 186 YSKFSSKSDIWAFGVLMWEIY---SLGKM-PYERFT------------NSETAEHIAQGL 229
Query: 489 NINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
            +      ++++  +  +C H  A ERP  + +L  I
Sbjct: 230 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 266

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 21/211 (9%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +G G FG+V K      D        +A+K+   +S   +  F+ EL  +          
Sbjct: 16  VGRGAFGVVCKAKWRAKD--------VAIKQIESES--ERKAFIVELRQLSRVNHPNIVK 65
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G C     + LV ++   GSL   L+G          H        +  V YL +   
Sbjct: 66  LYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 369 QKVVHRDLKASNILLDADFNA-RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           + ++HRDLK  N+LL A     ++ DFG A  I+          +    G+  ++APE F
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--------MTNNKGSAAWMAPEVF 175
Query: 428 HTGKATPESDVFGFGAVVLEVVCGRSPGNMI 458
                + + DVF +G ++ EV+  R P + I
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206

>pdb|3ZVX|A Chain A, Structure Of The Lectin From Platypodium Elegans In Complex With A Trimannoside Length = 261

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 15  GLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNK-ANHFVAIEFDTV----KQGFDPDDNH 69
           G+AF IAP D+  P  S G  LGL N  T  N+ AN  +A+EFDT        +DP+  H
Sbjct: 96  GIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNSNTWDPNYQH 155
Query: 70  LGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMP--QKP 127
           +G+++NS+ S K V  +        +G +  V V Y+  ++ I V       T P  Q+ 
Sbjct: 156 IGIDVNSIRSSKVVRWERR------EGKTLNVLVTYNPSTRTIDVVA-----TYPDGQRY 204
Query: 128 LLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEKD 178
            L   ++L   L      GFSA++G    Q + + SW+    ++ T +++D
Sbjct: 205 QLSHVVDLTTILPEWVRVGFSAASG-EQFQTHNLESWSFTSTLLYTAQKED 254

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXX 304
           E   LG G FG V KG             +I   + +  ++K   + LAE  ++      
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNP 72
Query: 305 XXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                 G C E    +LV +    G L KYL    +   +   +  +++  V+  + YL+
Sbjct: 73  YIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLE 128
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
              +   VHRDL A N+LL     A++ DFGL++A+  + N Y        P  + + AP
Sbjct: 129 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWP--VKWYAP 183
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           EC +  K + +SDV+ FG ++ E    G+ P
Sbjct: 184 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 123/296 (41%), Gaps = 47/296 (15%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK-GDFLAELAIIXXXXXXXXX 307
           LGEG FG V K    H  +     T +AVK    ++  S+  D L+E  ++         
Sbjct: 31  LGEGEFGKVVKATAFHL-KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---------------------EQVTLNW 346
              G C + G LLL+ ++   GSL  +L  +                      ++  L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
                    ++  + YL    + K+VHRDL A NIL+      ++ DFGL+R +  E +S
Sbjct: 150 GDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE-DS 205
Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAY 465
             +     +P  + ++A E       T +SDV+ FG ++ E+V  G +P   IP ++   
Sbjct: 206 XVKRSQGRIP--VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER--- 260
Query: 466 TLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDI 521
                ++ L + GH  +  D      +  +E  RL+   L C      +RP   DI
Sbjct: 261 -----LFNLLKTGHRMERPD------NCSEEMYRLM---LQCWKQEPDKRPVFADI 302

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXX 304
           E   LG G FG V KG             +I   + +  ++K   + LAE  ++      
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNP 88
Query: 305 XXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                 G C E    +LV +    G L KYL    +   +   +  +++  V+  + YL+
Sbjct: 89  YIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLE 144
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
              +   VHRDL A N+LL     A++ DFGL++A+  + N Y        P  + + AP
Sbjct: 145 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP--VKWYAP 199
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           EC +  K + +SDV+ FG ++ E    G+ P
Sbjct: 200 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXX 304
           E   LG G FG V KG             +I   + +  ++K   + LAE  ++      
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNP 88
Query: 305 XXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                 G C E    +LV +    G L KYL    +   +   +  +++  V+  + YL+
Sbjct: 89  YIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLE 144
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
              +   VHRDL A N+LL     A++ DFGL++A+  + N Y        P  + + AP
Sbjct: 145 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP--VKWYAP 199
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           EC +  K + +SDV+ FG ++ E    G+ P
Sbjct: 200 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 111/227 (48%), Gaps = 29/227 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           +  NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 56
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKI 352
           +++               H + KL LV++ + +  L+K++     T   + L  ++ +++
Sbjct: 57  SLLKELNHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQL 115
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +
Sbjct: 116 LQGLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEV 167
Query: 413 VGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
           V    T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 168 V----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 112/253 (44%), Gaps = 24/253 (9%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVK--KFSRDSIKSKGDFLAELAIIXXXXXXXX 306
           LGEG FG V +G +   D     + ++AVK  K    S +   +FL+E A +        
Sbjct: 42  LGEGEFGSVMEGNLKQEDG---TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 307 XXXXGWCHEKG-----KLLLVYDFMPNGSLEKYLYGTSEQVT---LNWNHRYKILTGVAS 358
               G C E       K +++  FM  G L  YL  +  +     +      K +  +A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
            + YL N   +  +HRDL A N +L  D    + DFGL++ I +  + Y +  +  +P  
Sbjct: 159 GMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG-DYYRQGRIAKMP-- 212
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHRE 477
           + ++A E       T +SDV+ FG  + E+   G +P    P  Q+ + + D++   HR 
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP---YPGVQN-HEMYDYLLHGHRL 268
Query: 478 GHIQDAVDQRLNI 490
              +D +D+   I
Sbjct: 269 KQPEDCLDELYEI 281

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXX 304
           E   LG G FG V KG             +I   + +  ++K   + LAE  ++      
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNP 86
Query: 305 XXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                 G C E    +LV +    G L KYL    +   +   +  +++  V+  + YL+
Sbjct: 87  YIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLE 142
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
              +   VHRDL A N+LL     A++ DFGL++A+  + N Y        P  + + AP
Sbjct: 143 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP--VKWYAP 197
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           EC +  K + +SDV+ FG ++ E    G+ P
Sbjct: 198 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXX 304
           E   LG G FG V KG             +I   + +  ++K   + LAE  ++      
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNP 72
Query: 305 XXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                 G C E    +LV +    G L KYL    +   +   +  +++  V+  + YL+
Sbjct: 73  YIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLE 128
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
              +   VHRDL A N+LL     A++ DFGL++A+  + N Y        P  + + AP
Sbjct: 129 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP--VKWYAP 183
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           EC +  K + +SDV+ FG ++ E    G+ P
Sbjct: 184 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXX 304
           E   LG G FG V KG             +I   + +  ++K   + LAE  ++      
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNP 78
Query: 305 XXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                 G C E    +LV +    G L KYL    +   +   +  +++  V+  + YL+
Sbjct: 79  YIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLE 134
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
              +   VHRDL A N+LL     A++ DFGL++A+  + N Y        P  + + AP
Sbjct: 135 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP--VKWYAP 189
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           EC +  K + +SDV+ FG ++ E    G+ P
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXX 304
           E   LG G FG V KG             +I   + +  ++K   + LAE  ++      
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNP 68
Query: 305 XXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                 G C E    +LV +    G L KYL    +   +   +  +++  V+  + YL+
Sbjct: 69  YIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLE 124
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
              +   VHRDL A N+LL     A++ DFGL++A+  + N Y        P  + + AP
Sbjct: 125 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP--VKWYAP 179
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           EC +  K + +SDV+ FG ++ E    G+ P
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXX 304
           E   LG G FG V KG             +I   + +  ++K   + LAE  ++      
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNP 66
Query: 305 XXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                 G C E    +LV +    G L KYL    +   +   +  +++  V+  + YL+
Sbjct: 67  YIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLE 122
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
              +   VHRDL A N+LL     A++ DFGL++A+  + N Y        P  + + AP
Sbjct: 123 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP--VKWYAP 177
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           EC +  K + +SDV+ FG ++ E    G+ P
Sbjct: 178 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 100/245 (40%), Gaps = 43/245 (17%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXX-XXX 307
           +GEG FG V K  I   D   +D     +K+++  S     DF  EL ++          
Sbjct: 33  IGEGNFGQVLKARIK-KDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNII 89
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYL-------------YGTSEQVTLNWNHRYKILT 354
              G C  +G L L  ++ P+G+L  +L                S   TL+         
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
            VA  + YL     ++ +HRDL A NIL+  ++ A++ DFGL+R  E           V 
Sbjct: 150 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE-----------VY 195
Query: 415 VPGTMG-----YVAPECFHTGKATPESDVFGFGAVVLEVV-------CGRSPGNMIPHQQ 462
           V  TMG     ++A E  +    T  SDV+ +G ++ E+V       CG +   +     
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255
Query: 463 HAYTL 467
             Y L
Sbjct: 256 QGYRL 260

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 100/245 (40%), Gaps = 43/245 (17%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXX-XXX 307
           +GEG FG V K  I   D   +D     +K+++  S     DF  EL ++          
Sbjct: 23  IGEGNFGQVLKARIK-KDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNII 79
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYL-------------YGTSEQVTLNWNHRYKILT 354
              G C  +G L L  ++ P+G+L  +L                S   TL+         
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
            VA  + YL     ++ +HRDL A NIL+  ++ A++ DFGL+R  E           V 
Sbjct: 140 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE-----------VY 185
Query: 415 VPGTMG-----YVAPECFHTGKATPESDVFGFGAVVLEVV-------CGRSPGNMIPHQQ 462
           V  TMG     ++A E  +    T  SDV+ +G ++ E+V       CG +   +     
Sbjct: 186 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 245
Query: 463 HAYTL 467
             Y L
Sbjct: 246 QGYRL 250

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 96/240 (40%), Gaps = 35/240 (14%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS----RDSIKSKGDFLAELAIIXXXXXX 304
           +G G +G VYKG         +D   +AVK FS    ++ I  K  +   L         
Sbjct: 21  IGRGRYGAVYKG--------SLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARF 72
Query: 305 XXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                      + + LLV ++ PNGSL KYL       T +W    ++   V   + YL 
Sbjct: 73  IVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGLAYLH 128
Query: 365 NE------YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE---RNSYAEHGLVGV 415
            E      Y   + HRDL + N+L+  D    + DFGL+  +      R    ++  +  
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 416 PGTMGYVAPECFHTG-------KATPESDVFGFGAVVLEVVCGRS---PGNMIPHQQHAY 465
            GT+ Y+APE             A  + D++  G +  E+    +   PG  +P  Q A+
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG+G FG V   +  ++         +AVK+        + DF  E+ I+         
Sbjct: 14  QLGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 71
Query: 308 XXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
              G  +  G+  L LV +++P+G L  +L     +  L+ +      + +   + YL +
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS 129
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT--MGYVA 423
              ++ VHRDL A NIL++++ + ++ DFGLA+ +  +++      +V  PG   + + A
Sbjct: 130 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXX----VVREPGQSPIFWYA 182
Query: 424 PECFHTGKATPESDVFGFGAVVLEV 448
           PE       + +SDV+ FG V+ E+
Sbjct: 183 PESLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 21/227 (9%)
Query: 246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXX 305
           S R+G G FG VYKG      ++H D   + + K    + +    F  E+A++       
Sbjct: 41  STRIGSGSFGTVYKG------KWHGD-VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVN 93
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                G+   K  L +V  +    SL K+L+   ++          I    A  + YL  
Sbjct: 94  ILLFMGYM-TKDNLAIVTQWCEGSSLYKHLH--VQETKFQMFQLIDIARQTAQGMDYL-- 148
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP-GTMGYVAP 424
            + + ++HRD+K++NI L      ++GDFGLA      ++ ++    V  P G++ ++AP
Sbjct: 149 -HAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATV----KSRWSGSQQVEQPTGSVLWMAP 203
Query: 425 ECFHTGKATP---ESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV 468
           E        P   +SDV+ +G V+ E++ G  P + I ++     +V
Sbjct: 204 EVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/277 (22%), Positives = 120/277 (43%), Gaps = 33/277 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           LG G FG+V  G      QY V     A+K     S+ S+ +F+ E  ++          
Sbjct: 17  LGTGQFGVVKYG--KWRGQYDV-----AIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQ 68
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G C ++  + ++ ++M NG L  YL     +         ++   V  A+ YL++   
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES--- 123
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           ++ +HRDL A N L++     ++ DFGL+R + ++  + +     G    + +  PE   
Sbjct: 124 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSR----GSKFPVRWSPPEVLM 179
Query: 429 TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRL 488
             K + +SD++ FG ++ E+    S G M P+++                   + + Q L
Sbjct: 180 YSKFSSKSDIWAFGVLMWEIY---SLGKM-PYERFT------------NSETAEHIAQGL 223
Query: 489 NINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
            +      ++++  +  +C H  A ERP  + +L  I
Sbjct: 224 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 260

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF--SRDSIKSKGDFLAELAIIXXXXXXX 305
           R+G G FG VYKG      ++H D   +AVK    +  + +    F  E+ ++       
Sbjct: 15  RIGSGSFGTVYKG------KWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                G+     +L +V  +    SL  +L+    +  +       I    A  + YL  
Sbjct: 66  ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYL-- 120
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            + + ++HRDLK++NI L  D   ++GDFGLA        S   H    + G++ ++APE
Sbjct: 121 -HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS---HQFEQLSGSILWMAPE 176
Query: 426 CFHTGKATP---ESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV 468
                   P   +SDV+ FG V+ E++ G+ P + I ++     +V
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS----IKSKGDFLAELA 296
             + +  ++GEG +G+VYK     + Q  +    +A+K+   D+    I S    + E++
Sbjct: 21  EKYQKLEKVGEGTYGVVYKA---KDSQGRI----VALKRIRLDAEDEGIPSTA--IREIS 71
Query: 297 IIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILT 354
           ++               H +  L LV++FM    L+K L    T  Q +    + Y++L 
Sbjct: 72  LLKELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           GVA         +  +++HRDLK  N+L+++D   +L DFGLARA      SY  H +V 
Sbjct: 131 GVAHC-------HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT-HEVV- 181
Query: 415 VPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGR 452
              T+ Y AP+     K    S D++  G +  E++ G+
Sbjct: 182 ---TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS----IKSKGDFLAELA 296
             + +  ++GEG +G+VYK     + Q  +    +A+K+   D+    I S    + E++
Sbjct: 21  EKYQKLEKVGEGTYGVVYKA---KDSQGRI----VALKRIRLDAEDEGIPSTA--IREIS 71
Query: 297 IIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILT 354
           ++               H +  L LV++FM    L+K L    T  Q +    + Y++L 
Sbjct: 72  LLKELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           GVA         +  +++HRDLK  N+L+++D   +L DFGLARA      SY  H +V 
Sbjct: 131 GVAHC-------HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT-HEVV- 181
Query: 415 VPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGR 452
              T+ Y AP+     K    S D++  G +  E++ G+
Sbjct: 182 ---TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           LG+G FG   K  + H +   V    + +K+  R   +++  FL E+ ++          
Sbjct: 18  LGKGCFGQAIK--VTHRETGEV----MVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G  ++  +L  + +++  G+L   +     Q    W+ R      +AS + YL   + 
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP--WSQRVSFAKDIASGMAYL---HS 126
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENER------------NSYAEHGLVGVP 416
             ++HRDL + N L+  + N  + DFGLAR + +E+            +    + +VG P
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
               ++APE  +      + DVF FG V+ E++
Sbjct: 187 ---YWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 77/140 (55%), Gaps = 13/140 (9%)
Query: 316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           +GKL L+ DF+  G L   L   S++V          L  +A A+ +L +     +++RD
Sbjct: 98  EGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRD 151
Query: 376 LKASNILLDADFNARLGDFGLAR-AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATP 434
           LK  NILLD + + +L DFGL++ +I++E+ +Y+        GT+ Y+APE  +    T 
Sbjct: 152 LKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS------FCGTVEYMAPEVVNRRGHTQ 205
Query: 435 ESDVFGFGAVVLEVVCGRSP 454
            +D + FG ++ E++ G  P
Sbjct: 206 SADWWSFGVLMFEMLTGTLP 225

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 24/211 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS---KGDFLAELAIIXXXXXXX 305
           LG G FG V  G      ++ +   ++AVK  +R  I+S    G    E+  +       
Sbjct: 24  LGVGTFGKVKVG------KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                        + +V +++  G L  Y+        L+     ++   + S V Y   
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCHR 134
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
                VVHRDLK  N+LLDA  NA++ DFGL+  + +         L    G+  Y APE
Sbjct: 135 ---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE------FLRXSCGSPNYAAPE 185
Query: 426 CFHTGK--ATPESDVFGFGAVVLEVVCGRSP 454
              +G+  A PE D++  G ++  ++CG  P
Sbjct: 186 VI-SGRLYAGPEVDIWSSGVILYALLCGTLP 215

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 122/296 (41%), Gaps = 47/296 (15%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK-GDFLAELAIIXXXXXXXXX 307
           LGEG FG V K    H  +     T +AVK    ++  S+  D L+E  ++         
Sbjct: 31  LGEGEFGKVVKATAFHL-KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---------------------EQVTLNW 346
              G C + G LLL+ ++   GSL  +L  +                      ++  L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
                    ++  + YL    +  +VHRDL A NIL+      ++ DFGL+R +  E +S
Sbjct: 150 GDLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMKISDFGLSRDV-YEEDS 205
Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAY 465
             +     +P  + ++A E       T +SDV+ FG ++ E+V  G +P   IP ++   
Sbjct: 206 XVKRSQGRIP--VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER--- 260
Query: 466 TLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDI 521
                ++ L + GH  +  D      +  +E  RL+   L C      +RP   DI
Sbjct: 261 -----LFNLLKTGHRMERPD------NCSEEMYRLM---LQCWKQEPDKRPVFADI 302

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 77/140 (55%), Gaps = 13/140 (9%)
Query: 316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           +GKL L+ DF+  G L   L   S++V          L  +A A+ +L   +   +++RD
Sbjct: 98  EGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHL---HSLGIIYRD 151
Query: 376 LKASNILLDADFNARLGDFGLAR-AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATP 434
           LK  NILLD + + +L DFGL++ +I++E+ +Y+        GT+ Y+APE  +    T 
Sbjct: 152 LKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS------FCGTVEYMAPEVVNRRGHTQ 205
Query: 435 ESDVFGFGAVVLEVVCGRSP 454
            +D + FG ++ E++ G  P
Sbjct: 206 SADWWSFGVLMFEMLTGTLP 225

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 249 LGEGGFGIVYKGIIH--HNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAIIXXXXXXX 305
           LG G FG VY+G +    ND   +   Q+AVK      S + + DFL E  II       
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPL---QVAVKTLPEVCSEQDELDFLMEALIISKLNHQN 95
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGT----SEQVTLNWNHRYKILTGVASAVY 361
                G   +     ++ + M  G L+ +L  T    S+  +L       +   +A    
Sbjct: 96  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           YL+  +    +HRD+ A N LL        A++GDFG+AR I    + Y + G   +P  
Sbjct: 156 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLP-- 209
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           + ++ PE F  G  T ++D + FG ++ E+
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 77/140 (55%), Gaps = 13/140 (9%)
Query: 316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           +GKL L+ DF+  G L   L   S++V          L  +A A+ +L   +   +++RD
Sbjct: 99  EGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHL---HSLGIIYRD 152
Query: 376 LKASNILLDADFNARLGDFGLAR-AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATP 434
           LK  NILLD + + +L DFGL++ +I++E+ +Y+        GT+ Y+APE  +    T 
Sbjct: 153 LKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS------FCGTVEYMAPEVVNRRGHTQ 206
Query: 435 ESDVFGFGAVVLEVVCGRSP 454
            +D + FG ++ E++ G  P
Sbjct: 207 SADWWSFGVLMFEMLTGTLP 226

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 249 LGEGGFGIVYKGIIH--HNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAIIXXXXXXX 305
           LG G FG VY+G +    ND   +   Q+AVK      S + + DFL E  II       
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPL---QVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 95
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGT----SEQVTLNWNHRYKILTGVASAVY 361
                G   +     ++ + M  G L+ +L  T    S+  +L       +   +A    
Sbjct: 96  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           YL+  +    +HRD+ A N LL        A++GDFG+AR I    + Y + G   +P  
Sbjct: 156 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLP-- 209
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           + ++ PE F  G  T ++D + FG ++ E+
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +GEG FG V++GI    +   +       K  + DS++ K  FL E   +          
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 75
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G   E   + ++ +    G L  +L     + +L+          +++A+ YL++   
Sbjct: 76  LIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLES--- 129
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           ++ VHRD+ A N+L+ ++   +LGDFGL+R +E+     A  G + +     ++APE  +
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPI----KWMAPESIN 185
Query: 429 TGKATPESDVFGFGAVVLEVV 449
             + T  SDV+ FG  + E++
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 76/140 (54%), Gaps = 18/140 (12%)
Query: 321 LVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK 377
           LV +++   +L +Y+      S    +N+ ++  IL G+  A       +D ++VHRD+K
Sbjct: 88  LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQ--ILDGIKHA-------HDMRIVHRDIK 138
Query: 378 ASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE-S 436
             NIL+D++   ++ DFG+A+A+     +   H L    GT+ Y +PE    G+AT E +
Sbjct: 139 PQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL----GTVQYFSPEQAK-GEATDECT 193
Query: 437 DVFGFGAVVLEVVCGRSPGN 456
           D++  G V+ E++ G  P N
Sbjct: 194 DIYSIGIVLYEMLVGEPPFN 213

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 249 LGEGGFGIVYKGIIH--HNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAIIXXXXXXX 305
           LG G FG VY+G +    ND   +   Q+AVK      S + + DFL E  II       
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPL---QVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 111
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGT----SEQVTLNWNHRYKILTGVASAVY 361
                G   +     ++ + M  G L+ +L  T    S+  +L       +   +A    
Sbjct: 112 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 171
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           YL+  +    +HRD+ A N LL        A++GDFG+AR I    + Y + G   +P  
Sbjct: 172 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLP-- 225
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           + ++ PE F  G  T ++D + FG ++ E+
Sbjct: 226 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 255

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 249 LGEGGFGIVYKGIIH--HNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAIIXXXXXXX 305
           LG G FG VY+G +    ND   +   Q+AVK      S + + DFL E  II       
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPL---QVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 101
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGT----SEQVTLNWNHRYKILTGVASAVY 361
                G   +     ++ + M  G L+ +L  T    S+  +L       +   +A    
Sbjct: 102 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 161
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           YL+  +    +HRD+ A N LL        A++GDFG+AR I    + Y + G   +P  
Sbjct: 162 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLP-- 215
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           + ++ PE F  G  T ++D + FG ++ E+
Sbjct: 216 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 245

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 109/225 (48%), Gaps = 29/225 (12%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAI 297
            NF +  ++GEG +G+VYK       +  +    +A+KK   D+ +++G     + E+++
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREISL 54
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKILT 354
           +               H + KL LV++ + +  L+ ++     T   + L  ++ +++L 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
           G+A         +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +V 
Sbjct: 114 GLAFC-------HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVV- 164
Query: 415 VPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRS--PGN 456
              T+ Y APE     K  +   D++  G +  E+V  R+  PG+
Sbjct: 165 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 249 LGEGGFGIVYKGIIH--HNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAIIXXXXXXX 305
           LG G FG VY+G +    ND   +   Q+AVK      S + + DFL E  II       
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPL---QVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 121
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGT----SEQVTLNWNHRYKILTGVASAVY 361
                G   +     ++ + M  G L+ +L  T    S+  +L       +   +A    
Sbjct: 122 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 181
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           YL+  +    +HRD+ A N LL        A++GDFG+AR I    + Y + G   +P  
Sbjct: 182 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLP-- 235
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           + ++ PE F  G  T ++D + FG ++ E+
Sbjct: 236 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 265

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 249 LGEGGFGIVYKGIIH--HNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAIIXXXXXXX 305
           LG G FG VY+G +    ND   +   Q+AVK      S + + DFL E  II       
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPL---QVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGT----SEQVTLNWNHRYKILTGVASAVY 361
                G   +     ++ + M  G L+ +L  T    S+  +L       +   +A    
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           YL+  +    +HRD+ A N LL        A++GDFG+AR I    + Y + G   +P  
Sbjct: 155 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLP-- 208
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           + ++ PE F  G  T ++D + FG ++ E+
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 249 LGEGGFGIVYKGIIH--HNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAIIXXXXXXX 305
           LG G FG VY+G +    ND   +   Q+AVK      S + + DFL E  II       
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPL---QVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGT----SEQVTLNWNHRYKILTGVASAVY 361
                G   +     ++ + M  G L+ +L  T    S+  +L       +   +A    
Sbjct: 95  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           YL+  +    +HRD+ A N LL        A++GDFG+AR I    + Y + G   +P  
Sbjct: 155 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLP-- 208
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           + ++ PE F  G  T ++D + FG ++ E+
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 111/260 (42%), Gaps = 29/260 (11%)
Query: 228 PREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IK 286
           P  F  + LKK  +       LGEG FG V   +  ++         +AVK        +
Sbjct: 3   PTVFHKRYLKKIRD-------LGEGHFGKV--SLYCYDPTNDGTGEMVAVKALKEGCGPQ 53
Query: 287 SKGDFLAELAIIXXXXXXXXXXXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTL 344
            +  +  E+ I+            G C ++G+  + LV +++P GSL  YL      +  
Sbjct: 54  LRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQ 113
Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
                 +I  G+A    YL   + Q  +HR L A N+LLD D   ++GDFGLA+A+    
Sbjct: 114 LLLFAQQICEGMA----YL---HAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH 166
Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV--C--GRSP----GN 456
             Y        P  + + APEC    K    SDV+ FG  + E++  C   +SP      
Sbjct: 167 EYYRVREDGDSP--VFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTE 224
Query: 457 MIPHQQHAYTLVDWVWMLHR 476
           +I H Q   T++    +L R
Sbjct: 225 LIGHTQGQMTVLRLTELLER 244

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 249 LGEGGFGIVYKGIIH--HNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAIIXXXXXXX 305
           LG G FG VY+G +    ND   +   Q+AVK      S + + DFL E  II       
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPL---QVAVKTLPEVCSEQDELDFLMEALIISKLNHQN 109
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGT----SEQVTLNWNHRYKILTGVASAVY 361
                G   +     ++ + M  G L+ +L  T    S+  +L       +   +A    
Sbjct: 110 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           YL+  +    +HRD+ A N LL        A++GDFG+AR I    + Y + G   +P  
Sbjct: 170 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLP-- 223
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           + ++ PE F  G  T ++D + FG ++ E+
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 111/246 (45%), Gaps = 31/246 (12%)
Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KG 289
           K  ELK   ++F +   LG G  G+V+K         H  +  +  +K     IK   + 
Sbjct: 18  KVGELK--DDDFEKISELGAGNGGVVFK-------VSHKPSGLVMARKLIHLEIKPAIRN 68
Query: 290 DFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNW 346
             + EL ++            G  +  G++ +  + M  GSL++ L       EQ+    
Sbjct: 69  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL--- 125
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA-RAIENERN 405
               K+   V   + YL+ ++  K++HRD+K SNIL+++    +L DFG++ + I++  N
Sbjct: 126 ---GKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 180
Query: 406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY 465
           S+         GT  Y++PE       + +SD++  G  ++E+  GR P          +
Sbjct: 181 SFV--------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIF 232
Query: 466 TLVDWV 471
            L+D++
Sbjct: 233 ELLDYI 238

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 65/138 (47%), Gaps = 15/138 (10%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           L L+ ++   G +  YL             +++    + SAV Y    + +++VHRDLKA
Sbjct: 89  LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQYC---HQKRIVHRDLKA 142
Query: 379 SNILLDADFNARLGDFGLARAIENERNSYAEHG-LVGVPGTMGYVAPECFHTGKAT-PES 436
            N+LLDAD N ++ DFG +       N +   G L    G   Y APE F   K   PE 
Sbjct: 143 ENLLLDADMNIKIADFGFS-------NEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEV 195
Query: 437 DVFGFGAVVLEVVCGRSP 454
           DV+  G ++  +V G  P
Sbjct: 196 DVWSLGVILYTLVSGSLP 213

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 249 LGEGGFGIVYKGIIH--HNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAIIXXXXXXX 305
           LG G FG VY+G +    ND   +   Q+AVK      S + + DFL E  II       
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPL---QVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 86
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGT----SEQVTLNWNHRYKILTGVASAVY 361
                G   +     ++ + M  G L+ +L  T    S+  +L       +   +A    
Sbjct: 87  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 146
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           YL+  +    +HRD+ A N LL        A++GDFG+AR I    + Y + G   +P  
Sbjct: 147 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLP-- 200
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           + ++ PE F  G  T ++D + FG ++ E+
Sbjct: 201 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 230

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 111/260 (42%), Gaps = 29/260 (11%)
Query: 228 PREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IK 286
           P  F  + LKK  +       LGEG FG V   +  ++         +AVK        +
Sbjct: 2   PTVFHKRYLKKIRD-------LGEGHFGKV--SLYCYDPTNDGTGEMVAVKALKEGCGPQ 52
Query: 287 SKGDFLAELAIIXXXXXXXXXXXXGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTL 344
            +  +  E+ I+            G C ++G+  + LV +++P GSL  YL      +  
Sbjct: 53  LRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQ 112
Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
                 +I  G+A    YL   + Q  +HR L A N+LLD D   ++GDFGLA+A+    
Sbjct: 113 LLLFAQQICEGMA----YL---HAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH 165
Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV--C--GRSP----GN 456
             Y        P  + + APEC    K    SDV+ FG  + E++  C   +SP      
Sbjct: 166 EYYRVREDGDSP--VFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTE 223
Query: 457 MIPHQQHAYTLVDWVWMLHR 476
           +I H Q   T++    +L R
Sbjct: 224 LIGHTQGQMTVLRLTELLER 243

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 249 LGEGGFGIVYKGIIH--HNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAIIXXXXXXX 305
           LG G FG VY+G +    ND   +   Q+AVK      S + + DFL E  II       
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPL---QVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 109
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGT----SEQVTLNWNHRYKILTGVASAVY 361
                G   +     ++ + M  G L+ +L  T    S+  +L       +   +A    
Sbjct: 110 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           YL+  +    +HRD+ A N LL        A++GDFG+AR I    + Y + G   +P  
Sbjct: 170 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLP-- 223
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           + ++ PE F  G  T ++D + FG ++ E+
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 15/138 (10%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           L L+ ++   G +  YL             +++    + SAV Y    + +++VHRDLKA
Sbjct: 86  LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQYC---HQKRIVHRDLKA 139
Query: 379 SNILLDADFNARLGDFGLARAIENERNSYAEHG-LVGVPGTMGYVAPECFHTGKAT-PES 436
            N+LLDAD N ++ DFG +       N +   G L    G+  Y APE F   K   PE 
Sbjct: 140 ENLLLDADMNIKIADFGFS-------NEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEV 192
Query: 437 DVFGFGAVVLEVVCGRSP 454
           DV+  G ++  +V G  P
Sbjct: 193 DVWSLGVILYTLVSGSLP 210

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 100/245 (40%), Gaps = 43/245 (17%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXX-XXX 307
           +GEG FG V K  I   D   +D     +K+++  S     DF  EL ++          
Sbjct: 30  IGEGNFGQVLKARIK-KDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNII 86
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYL-------------YGTSEQVTLNWNHRYKILT 354
              G C  +G L L  ++ P+G+L  +L                S   TL+         
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
            VA  + YL     ++ +HR+L A NIL+  ++ A++ DFGL+R  E           V 
Sbjct: 147 DVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSRGQE-----------VY 192
Query: 415 VPGTMG-----YVAPECFHTGKATPESDVFGFGAVVLEVV-------CGRSPGNMIPHQQ 462
           V  TMG     ++A E  +    T  SDV+ +G ++ E+V       CG +   +     
Sbjct: 193 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 252
Query: 463 HAYTL 467
             Y L
Sbjct: 253 QGYRL 257

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 66/139 (47%), Gaps = 17/139 (12%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           L LV ++   G +  YL             +++    + SAV Y   +Y   +VHRDLKA
Sbjct: 89  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQKY---IVHRDLKA 142
Query: 379 SNILLDADFNARLGDFGLAR--AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKAT-PE 435
            N+LLD D N ++ DFG +    + N+ +++         G+  Y APE F   K   PE
Sbjct: 143 ENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC--------GSPPYAAPELFQGKKYDGPE 194
Query: 436 SDVFGFGAVVLEVVCGRSP 454
            DV+  G ++  +V G  P
Sbjct: 195 VDVWSLGVILYTLVSGSLP 213

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 25/217 (11%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXX 306
           RLG GGFG V + I  H D       Q+A+K+  ++ S K++  +  E+ I+        
Sbjct: 22  RLGTGGFGYVLRWI--HQD----TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 75
Query: 307 XXXXGWCHEKGKL------LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
                      KL      LL  ++   G L KYL        L       +L+ ++SA+
Sbjct: 76  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 135
Query: 361 YYLQNEYDQKVVHRDLKASNILLD---ADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
            YL   ++ +++HRDLK  NI+L         ++ D G A+ ++               G
Sbjct: 136 RYL---HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG------ELCTEFVG 186
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           T+ Y+APE     K T   D + FG +  E + G  P
Sbjct: 187 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 25/217 (11%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXXX 306
           RLG GGFG V + I  H D       Q+A+K+  ++ S K++  +  E+ I+        
Sbjct: 21  RLGTGGFGYVLRWI--HQD----TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 307 XXXXGWCHEKGKL------LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
                      KL      LL  ++   G L KYL        L       +L+ ++SA+
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 361 YYLQNEYDQKVVHRDLKASNILLD---ADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
            YL   ++ +++HRDLK  NI+L         ++ D G A+ ++               G
Sbjct: 135 RYL---HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG------ELCTEFVG 185
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           T+ Y+APE     K T   D + FG +  E + G  P
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 67/143 (46%), Gaps = 20/143 (13%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
             LV+D M  G L  YL   +E+VTL+     KI+  +   +  L   +   +VHRDLK 
Sbjct: 99  FFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICAL---HKLNIVHRDLKP 152
Query: 379 SNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF-------HTGK 431
            NILLD D N +L DFG +  ++          L  V GT  Y+APE         H G 
Sbjct: 153 ENILLDDDMNIKLTDFGFSCQLDPGEK------LRSVCGTPSYLAPEIIECSMNDNHPGY 206
Query: 432 ATPESDVFGFGAVVLEVVCGRSP 454
              E D++  G ++  ++ G  P
Sbjct: 207 GK-EVDMWSTGVIMYTLLAGSPP 228

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 31/229 (13%)
Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KG 289
           K  ELK   ++F +   LG G  G+V+K         H  +  +  +K     IK   + 
Sbjct: 61  KVGELKD--DDFEKISELGAGNGGVVFK-------VSHKPSGLVMARKLIHLEIKPAIRN 111
Query: 290 DFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNW 346
             + EL ++            G  +  G++ +  + M  GSL++ L       EQ+    
Sbjct: 112 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL--- 168
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA-RAIENERN 405
               K+   V   + YL+ ++  K++HRD+K SNIL+++    +L DFG++ + I++  N
Sbjct: 169 ---GKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 223
Query: 406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           S+         GT  Y++PE       + +SD++  G  ++E+  GR P
Sbjct: 224 SFV--------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +GEG FG V++GI    +   +       K  + DS++ K  FL E   +          
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 75
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G   E   + ++ +    G L  +L     + +L+          +++A+ YL++   
Sbjct: 76  LIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLES--- 129
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           ++ VHRD+ A N+L+ A    +LGDFGL+R +E+     A  G + +     ++APE  +
Sbjct: 130 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPI----KWMAPESIN 185
Query: 429 TGKATPESDVFGFGAVVLEVV 449
             + T  SDV+ FG  + E++
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 249 LGEGGFGIVYKGIIH--HNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAIIXXXXXXX 305
           LG G FG VY+G +    ND   +   Q+AVK      S + + DFL E  II       
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPL---QVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGT----SEQVTLNWNHRYKILTGVASAVY 361
                G   +     ++ + M  G L+ +L  T    S+  +L       +   +A    
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           YL+  +    +HRD+ A N LL        A++GDFG+AR I      Y + G   +P  
Sbjct: 196 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-GYYRKGGCAMLP-- 249
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           + ++ PE F  G  T ++D + FG ++ E+
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 249 LGEGGFGIVYKGIIHH--NDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAIIXXXXXXX 305
           LG G FG VY+G +    ND   +   Q+AVK      S + + DFL E  II       
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPL---QVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 112
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGT----SEQVTLNWNHRYKILTGVASAVY 361
                G   +     ++ + M  G L+ +L  T    S+  +L       +   +A    
Sbjct: 113 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 172
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           YL+  +    +HRD+ A N LL        A++GDFG+AR I      Y + G   +P  
Sbjct: 173 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-GYYRKGGCAMLP-- 226
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           + ++ PE F  G  T ++D + FG ++ E+
Sbjct: 227 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 256

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 249 LGEGGFGIVYKGIIH--HNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIXXXXXXX 305
           LG G FG VY+G +    ND   +   Q+AVK      S + + DFL E  II       
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPL---QVAVKTLPEVYSEQDELDFLMEALIISKFNHQN 109
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGT----SEQVTLNWNHRYKILTGVASAVY 361
                G   +     ++ + M  G L+ +L  T    S+  +L       +   +A    
Sbjct: 110 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           YL+  +    +HRD+ A N LL        A++GDFG+AR I    + Y + G   +P  
Sbjct: 170 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLP-- 223
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           + ++ PE F  G  T ++D + FG ++ E+
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 33/231 (14%)
Query: 227 MPREFKYKELKKATNNFHESMRLGEGGFGIVYKGI-IHHNDQYHVD-NTQIAVKKFSRDS 284
           + R FK  EL+K          LG G FG V+KG+ I   +   +    ++   K  R S
Sbjct: 6   LARIFKETELRKLKV-------LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS 58
Query: 285 IKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSL----EKYLYGTSE 340
            ++  D    +  I            G C     L LV  ++P GSL     ++      
Sbjct: 59  FQAVTD---HMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGP 114
Query: 341 QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI 400
           Q+ LNW         +A  +YYL+   +  +VHR+L A N+LL +    ++ DFG+A  +
Sbjct: 115 QLLLNWG------VQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165
Query: 401 --ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
             ++++  Y+E         + ++A E  H GK T +SDV+ +G  V E++
Sbjct: 166 PPDDKQLLYSE-----AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 23/213 (10%)
Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXX 302
           +H   ++GEG +G+VYK   ++ + + +   ++  +    + I S    + E++I+    
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIPSTT--IREISILKELK 58
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYL---YGTSEQVTLNWNHRYKILTGVASA 359
                      H K +L+LV++ + +  L+K L    G  E VT   +   ++L G+A  
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAK-SFLLQLLNGIAYC 116
Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
                  +D++V+HRDLK  N+L++ +   ++ DFGLARA       Y  H +V    T+
Sbjct: 117 -------HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIV----TL 164
Query: 420 GYVAPECFH-TGKATPESDVFGFGAVVLEVVCG 451
            Y AP+    + K +   D++  G +  E+V G
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 33/231 (14%)
Query: 227 MPREFKYKELKKATNNFHESMRLGEGGFGIVYKGI-IHHNDQYHVD-NTQIAVKKFSRDS 284
           + R FK  EL+K          LG G FG V+KG+ I   +   +    ++   K  R S
Sbjct: 24  LARIFKETELRKLKV-------LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS 76
Query: 285 IKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSL----EKYLYGTSE 340
            ++  D    +  I            G C     L LV  ++P GSL     ++      
Sbjct: 77  FQAVTD---HMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGP 132
Query: 341 QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI 400
           Q+ LNW         +A  +YYL+   +  +VHR+L A N+LL +    ++ DFG+A  +
Sbjct: 133 QLLLNWG------VQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 183
Query: 401 --ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
             ++++  Y+E         + ++A E  H GK T +SDV+ +G  V E++
Sbjct: 184 PPDDKQLLYSE-----AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 229

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 106 KLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 157
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A+  
Sbjct: 158 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV---GTAQYVSPELLTEKSASKS 214
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 215 SDLWALGCIIYQLVAGLPP 233

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS---KGDFLAELAIIXXXXXXX 305
           LG G FG V  G      ++ +   ++AVK  +R  I+S    G    E+  +       
Sbjct: 19  LGVGTFGKVKIG------EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYL 363
                          +V +++  G L  Y+  +G  E++        ++   + SAV Y 
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-----RLFQQILSAVDYC 127
Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI---ENERNSYAEHGLVGVPGTMG 420
                  VVHRDLK  N+LLDA  NA++ DFGL+  +   E  R+S          G+  
Sbjct: 128 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---------CGSPN 175
Query: 421 YVAPECFHTGK--ATPESDVFGFGAVVLEVVCGRSP 454
           Y APE   +G+  A PE D++  G ++  ++CG  P
Sbjct: 176 YAAPEVI-SGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 101/241 (41%), Gaps = 35/241 (14%)
Query: 238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAI 297
           +  ++F E   LG+G FG V K       +  +D+   A+KK  R + +     L+E+ +
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKI-RHTEEKLSTILSEVML 55
Query: 298 IXXXX-XXXXXXXXGWCH------------EKGKLLLVYDFMPNGSLEKYLYGTSEQVTL 344
           +              W              +K  L +  ++  NG+L   ++  SE +  
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH--SENLNQ 113
Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
             +  +++   +  A+ Y+   + Q ++HRDLK  NI +D   N ++GDFGLA+ +    
Sbjct: 114 QRDEYWRLFRQILEALSYI---HSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 405 NSY---------AEHGLVGVPGTMGYVAPECFH-TGKATPESDVFGFGAVVLEVVCGRSP 454
           +           +   L    GT  YVA E    TG    + D++  G +  E++   S 
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST 230
Query: 455 G 455
           G
Sbjct: 231 G 231

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 67/143 (46%), Gaps = 20/143 (13%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
             LV+D M  G L  YL   +E+VTL+     KI+  +   +  L   +   +VHRDLK 
Sbjct: 86  FFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICAL---HKLNIVHRDLKP 139
Query: 379 SNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF-------HTGK 431
            NILLD D N +L DFG +  ++          L  V GT  Y+APE         H G 
Sbjct: 140 ENILLDDDMNIKLTDFGFSCQLD------PGEKLREVCGTPSYLAPEIIECSMNDNHPGY 193
Query: 432 ATPESDVFGFGAVVLEVVCGRSP 454
              E D++  G ++  ++ G  P
Sbjct: 194 GK-EVDMWSTGVIMYTLLAGSPP 215

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 23/213 (10%)
Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXX 302
           +H   ++GEG +G+VYK   ++ + + +   ++  +    + I S    + E++I+    
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIPSTT--IREISILKELK 58
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYL---YGTSEQVTLNWNHRYKILTGVASA 359
                      H K +L+LV++ + +  L+K L    G  E VT   +   ++L G+A  
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAK-SFLLQLLNGIAYC 116
Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
                  +D++V+HRDLK  N+L++ +   ++ DFGLARA       Y  H +V    T+
Sbjct: 117 -------HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEVV----TL 164
Query: 420 GYVAPECFH-TGKATPESDVFGFGAVVLEVVCG 451
            Y AP+    + K +   D++  G +  E+V G
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS---KGDFLAELAIIXXXXXXX 305
           LG G FG V  G      ++ +   ++AVK  +R  I+S    G    E+  +       
Sbjct: 19  LGVGTFGKVKIG------EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYL 363
                          +V +++  G L  Y+  +G  E++        ++   + SAV Y 
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-----RLFQQILSAVDYC 127
Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
                  VVHRDLK  N+LLDA  NA++ DFGL+  + +         L    G+  Y A
Sbjct: 128 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF------LRTSCGSPNYAA 178
Query: 424 PECFHTGK--ATPESDVFGFGAVVLEVVCGRSP 454
           PE   +G+  A PE D++  G ++  ++CG  P
Sbjct: 179 PEVI-SGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KGDFLAELAII 298
           ++F +   LG G  G+V+K         H  +  +  +K     IK   +   + EL ++
Sbjct: 6   DDFEKISELGAGNGGVVFK-------VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKILTG 355
                       G  +  G++ +  + M  GSL++ L       EQ+        K+   
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIA 112
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA-RAIENERNSYAEHGLVG 414
           V   + YL+ ++  K++HRD+K SNIL+++    +L DFG++ + I++  NS+       
Sbjct: 113 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------ 164
Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             GT  Y++PE       + +SD++  G  ++E+  GR P
Sbjct: 165 --GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 23/213 (10%)
Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXX 302
           +H   ++GEG +G+VYK   ++ + + +   ++  +    + I S    + E++I+    
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIPSTT--IREISILKELK 58
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYL---YGTSEQVTLNWNHRYKILTGVASA 359
                      H K +L+LV++ + +  L+K L    G  E VT   +   ++L G+A  
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAK-SFLLQLLNGIAYC 116
Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
                  +D++V+HRDLK  N+L++ +   ++ DFGLARA       Y  H +V    T+
Sbjct: 117 -------HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEVV----TL 164
Query: 420 GYVAPECFH-TGKATPESDVFGFGAVVLEVVCG 451
            Y AP+    + K +   D++  G +  E+V G
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 31/229 (13%)
Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KG 289
           K  ELK   ++F +   LG G  G+V+K         H  +  +  +K     IK   + 
Sbjct: 26  KVGELK--DDDFEKISELGAGNGGVVFK-------VSHKPSGLVMARKLIHLEIKPAIRN 76
Query: 290 DFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNW 346
             + EL ++            G  +  G++ +  + M  GSL++ L       EQ+    
Sbjct: 77  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL--- 133
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA-RAIENERN 405
               K+   V   + YL+ ++  K++HRD+K SNIL+++    +L DFG++ + I++  N
Sbjct: 134 ---GKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 188
Query: 406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           S+         GT  Y++PE       + +SD++  G  ++E+  GR P
Sbjct: 189 SFV--------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 67/143 (46%), Gaps = 20/143 (13%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
             LV+D M  G L  YL   +E+VTL+     KI+  +   +  L   +   +VHRDLK 
Sbjct: 99  FFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICAL---HKLNIVHRDLKP 152
Query: 379 SNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF-------HTGK 431
            NILLD D N +L DFG +  ++          L  V GT  Y+APE         H G 
Sbjct: 153 ENILLDDDMNIKLTDFGFSCQLDPGEK------LREVCGTPSYLAPEIIECSMNDNHPGY 206
Query: 432 ATPESDVFGFGAVVLEVVCGRSP 454
              E D++  G ++  ++ G  P
Sbjct: 207 GK-EVDMWSTGVIMYTLLAGSPP 228

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 104 KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 155
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV---GTAQYVSPELLTEKSACKS 212
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 213 SDLWALGCIIYQLVAGLPP 231

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +GEG FG V++GI    +   +       K  + DS++ K  FL E   +          
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 75
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G   E   + ++ +    G L  +L     + +L+          +++A+ YL++   
Sbjct: 76  LIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES--- 129
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           ++ VHRD+ A N+L+ ++   +LGDFGL+R +E+     A  G + +     ++APE  +
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI----KWMAPESIN 185
Query: 429 TGKATPESDVFGFGAVVLEVV 449
             + T  SDV+ FG  + E++
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +GEG FG V++GI    +   +       K  + DS++ K  FL E   +          
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 75
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G   E   + ++ +    G L  +L     + +L+          +++A+ YL++   
Sbjct: 76  LIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES--- 129
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           ++ VHRD+ A N+L+ ++   +LGDFGL+R +E+     A  G + +     ++APE  +
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI----KWMAPESIN 185
Query: 429 TGKATPESDVFGFGAVVLEVV 449
             + T  SDV+ FG  + E++
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +GEG FG V++GI    +   +       K  + DS++ K  FL E   +          
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 72
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G   E   + ++ +    G L  +L     + +L+          +++A+ YL++   
Sbjct: 73  LIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES--- 126
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           ++ VHRD+ A N+L+ ++   +LGDFGL+R +E+     A  G + +     ++APE  +
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI----KWMAPESIN 182
Query: 429 TGKATPESDVFGFGAVVLEVV 449
             + T  SDV+ FG  + E++
Sbjct: 183 FRRFTSASDVWMFGVCMWEIL 203

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 52/99 (52%), Gaps = 2/99 (2%)
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           +A A   L   +   ++HRD+K +NIL+ A    ++ DFG+ARAI +  NS  +     V
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQ--TAAV 179
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            GT  Y++PE          SDV+  G V+ EV+ G  P
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 71/139 (51%), Gaps = 9/139 (6%)
Query: 319 LLLVYDFMPNGSLEKYLY-GTSEQVTLNWNHRYKILTGVASAVYYLQNEYD--QKVVHRD 375
           L +V ++   G L   +  GT E+  L+     +++T +  A+       D    V+HRD
Sbjct: 82  LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 141
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK +N+ LD   N +LGDFGLAR I N   S+A+   VG P    Y++PE  +      +
Sbjct: 142 LKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAK-AFVGTP---YYMSPEQMNRMSYNEK 196
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ E +C   P
Sbjct: 197 SDIWSLGCLLYE-LCALMP 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 66/139 (47%), Gaps = 17/139 (12%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           L LV ++   G +  YL             +++    + SAV Y   ++   +VHRDLKA
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQKF---IVHRDLKA 141
Query: 379 SNILLDADFNARLGDFGLARAIE--NERNSYAEHGLVGVPGTMGYVAPECFHTGKAT-PE 435
            N+LLDAD N ++ DFG +      N+ +++         G+  Y APE F   K   PE
Sbjct: 142 ENLLLDADMNIKIADFGFSNEFTFGNKLDTFC--------GSPPYAAPELFQGKKYDGPE 193
Query: 436 SDVFGFGAVVLEVVCGRSP 454
            DV+  G ++  +V G  P
Sbjct: 194 VDVWSLGVILYTLVSGSLP 212

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 66/139 (47%), Gaps = 17/139 (12%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           L LV ++   G +  YL             +++    + SAV Y   ++   +VHRDLKA
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQKF---IVHRDLKA 141
Query: 379 SNILLDADFNARLGDFGLARAIE--NERNSYAEHGLVGVPGTMGYVAPECFHTGKAT-PE 435
            N+LLDAD N ++ DFG +      N+ +++         G+  Y APE F   K   PE
Sbjct: 142 ENLLLDADMNIKIADFGFSNEFTFGNKLDTFC--------GSPPYAAPELFQGKKYDGPE 193
Query: 436 SDVFGFGAVVLEVVCGRSP 454
            DV+  G ++  +V G  P
Sbjct: 194 VDVWSLGVILYTLVSGSLP 212

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 95/229 (41%), Gaps = 31/229 (13%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAIIXXXXXXXX 306
           +G GGFG VY+        +  D   +   +   D   S+   +   E  +         
Sbjct: 15  IGIGGFGKVYRAF------WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 307 XXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG--TSEQVTLNWNHRYKILTGVASAVYYLQ 364
               G C ++  L LV +F   G L + L G      + +NW         +A  + YL 
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWA------VQIARGMNYLH 122
Query: 365 NEYDQKVVHRDLKASNILL-----DADFN---ARLGDFGLARAIENERNSYAEHGLVGVP 416
           +E    ++HRDLK+SNIL+     + D +    ++ DFGLAR  E  R +      +   
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTK-----MSAA 175
Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY 465
           G   ++APE       +  SDV+ +G ++ E++ G  P   I     AY
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY 224

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 107 KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 158
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 159 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV---GTAQYVSPELLTEKSACKS 215
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 216 SDLWALGCIIYQLVAGLPP 234

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 25/231 (10%)
Query: 227 MPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK 286
           + ++ K  ELK   ++F     LG G  G+V K         H  +  I  +K     IK
Sbjct: 4   LTQKAKVGELKD--DDFERISELGAGNGGVVTK-------VQHRPSGLIMARKLIHLEIK 54
Query: 287 S--KGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTL 344
              +   + EL ++            G  +  G++ +  + M  GSL++ L    E   +
Sbjct: 55  PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRI 111
Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA-RAIENE 403
                 K+   V   + YL+ ++  +++HRD+K SNIL+++    +L DFG++ + I++ 
Sbjct: 112 PEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 169
Query: 404 RNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            NS+         GT  Y+APE       + +SD++  G  ++E+  GR P
Sbjct: 170 ANSFV--------GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 84  KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 135
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 136 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV---GTAQYVSPELLTEKSACKS 192
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 193 SDLWALGCIIYQLVAGLPP 211

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +GEG FG V++GI    +   +       K  + DS++ K  FL E   +          
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 103
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G   E   + ++ +    G L  +L     + +L+          +++A+ YL++   
Sbjct: 104 LIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES--- 157
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           ++ VHRD+ A N+L+ ++   +LGDFGL+R +E+     A  G + +     ++APE  +
Sbjct: 158 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI----KWMAPESIN 213
Query: 429 TGKATPESDVFGFGAVVLEVV 449
             + T  SDV+ FG  + E++
Sbjct: 214 FRRFTSASDVWMFGVCMWEIL 234

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 83  KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 134
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 135 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV---GTAQYVSPELLTEKSACKS 191
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 192 SDLWALGCIIYQLVAGLPP 210

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 29/230 (12%)
Query: 225 PGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS 284
           PG PR +         +NF   +++GEG  GIV    +  + +       +AVKK     
Sbjct: 146 PGDPRSY--------LDNF---IKIGEGSTGIVCIATVRSSGKL------VAVKKMDLRK 188
Query: 285 IKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTL 344
            + +     E+ I+                   +L +V +F+  G+L   +  T     +
Sbjct: 189 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----M 244
Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
           N      +   V  A+  L   + Q V+HRD+K+ +ILL  D   +L DFG    +  E 
Sbjct: 245 NEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE- 300
Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                  LVG P    ++APE        PE D++  G +V+E+V G  P
Sbjct: 301 -VPRRKXLVGTP---YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 66/139 (47%), Gaps = 17/139 (12%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           L LV ++   G +  YL             +++    + SAV Y   ++   +VHRDLKA
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQKF---IVHRDLKA 141
Query: 379 SNILLDADFNARLGDFGLARAIE--NERNSYAEHGLVGVPGTMGYVAPECFHTGKAT-PE 435
            N+LLDAD N ++ DFG +      N+ +++         G+  Y APE F   K   PE
Sbjct: 142 ENLLLDADMNIKIADFGFSNEFTFGNKLDTFC--------GSPPYAAPELFQGKKYDGPE 193
Query: 436 SDVFGFGAVVLEVVCGRSP 454
            DV+  G ++  +V G  P
Sbjct: 194 VDVWSLGVILYTLVSGSLP 212

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +GEG FG V++GI    +   +       K  + DS++ K  FL E   +          
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 80
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G   E   + ++ +    G L  +L     + +L+          +++A+ YL++   
Sbjct: 81  LIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES--- 134
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           ++ VHRD+ A N+L+ ++   +LGDFGL+R +E+     A  G + +     ++APE  +
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPESIN 190
Query: 429 TGKATPESDVFGFGAVVLEVV 449
             + T  SDV+ FG  + E++
Sbjct: 191 FRRFTSASDVWMFGVCMWEIL 211

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 249 LGEGGFGIVYKGIIH--HNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAIIXXXXXXX 305
           LG G FG VY+G +    ND   +   Q+AVK      S + + DFL E  II       
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPL---QVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 95
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGT----SEQVTLNWNHRYKILTGVASAVY 361
                G   +     ++ + M  G L+ +L  T    S+  +L       +   +A    
Sbjct: 96  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           YL+  +    +HRD+ A N LL        A++GDFG+A+ I    + Y + G   +P  
Sbjct: 156 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRA-SYYRKGGCAMLP-- 209
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           + ++ PE F  G  T ++D + FG ++ E+
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +GEG FG V++GI    +   +       K  + DS++ K  FL E   +          
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 78
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G   E   + ++ +    G L  +L     + +L+          +++A+ YL++   
Sbjct: 79  LIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES--- 132
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           ++ VHRD+ A N+L+ ++   +LGDFGL+R +E+     A  G + +     ++APE  +
Sbjct: 133 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPESIN 188
Query: 429 TGKATPESDVFGFGAVVLEVV 449
             + T  SDV+ FG  + E++
Sbjct: 189 FRRFTSASDVWMFGVCMWEIL 209

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +GEG FG V++GI    +   +       K  + DS++ K  FL E   +          
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 77
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G   E   + ++ +    G L  +L     + +L+          +++A+ YL++   
Sbjct: 78  LIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES--- 131
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           ++ VHRD+ A N+L+ ++   +LGDFGL+R +E+     A  G + +     ++APE  +
Sbjct: 132 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI----KWMAPESIN 187
Query: 429 TGKATPESDVFGFGAVVLEVV 449
             + T  SDV+ FG  + E++
Sbjct: 188 FRRFTSASDVWMFGVCMWEIL 208

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 82  KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 133
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 134 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV---GTAQYVSPELLTEKSACKS 190
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 191 SDLWALGCIIYQLVAGLPP 209

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 29/230 (12%)
Query: 225 PGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS 284
           PG PR +         +NF   +++GEG  GIV    +  + +       +AVKK     
Sbjct: 26  PGDPRSY--------LDNF---IKIGEGSTGIVCIATVRSSGKL------VAVKKMDLRK 68
Query: 285 IKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTL 344
            + +     E+ I+                   +L +V +F+  G+L   +  T     +
Sbjct: 69  QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----M 124
Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
           N      +   V  A+  L   + Q V+HRD+K+ +ILL  D   +L DFG    +  E 
Sbjct: 125 NEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 181
Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                  LVG P    ++APE        PE D++  G +V+E+V G  P
Sbjct: 182 PR--RKXLVGTP---YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 103 KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 154
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 155 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV---GTAQYVSPELLTEKSACKS 211
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 212 SDLWALGCIIYQLVAGLPP 230

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +GEG FG V++GI    +   +       K  + DS++ K  FL E   +          
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 455
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G   E   + ++ +    G L  +L     + +L+          +++A+ YL++   
Sbjct: 456 LIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLES--- 509
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           ++ VHRD+ A N+L+ A    +LGDFGL+R +E+     A  G + +     ++APE  +
Sbjct: 510 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPI----KWMAPESIN 565
Query: 429 TGKATPESDVFGFGAVVLEVV 449
             + T  SDV+ FG  + E++
Sbjct: 566 FRRFTSASDVWMFGVCMWEIL 586

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 81  KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 132
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 133 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV---GTAQYVSPELLTEKSACKS 189
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 190 SDLWALGCIIYQLVAGLPP 208

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 2/99 (2%)
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           +A A   L   +   ++HRD+K +NI++ A    ++ DFG+ARAI +  NS  +     V
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ--TAAV 179
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            GT  Y++PE          SDV+  G V+ EV+ G  P
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXX 306
           +++GEG  GIV      H+ +      Q+AVK       + +     E+ I+        
Sbjct: 51  VKIGEGSTGIVCLAREKHSGR------QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV 104
Query: 307 XXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
                      +L ++ +F+  G+L   +     QV LN      +   V  A+ YL   
Sbjct: 105 VEMYKSYLVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYL--- 157
Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
           + Q V+HRD+K+ +ILL  D   +L DFG    I   ++      LVG P    ++APE 
Sbjct: 158 HAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKXLVGTP---YWMAPEV 212
Query: 427 FHTGKATPESDVFGFGAVVLEVVCGRSP 454
                   E D++  G +V+E+V G  P
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 2/99 (2%)
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           +A A   L   +   ++HRD+K +NI++ A    ++ DFG+ARAI +  NS  +     V
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ--TAAV 179
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            GT  Y++PE          SDV+  G V+ EV+ G  P
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 29/230 (12%)
Query: 225 PGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS 284
           PG PR +         +NF   +++GEG  GIV    +  + +       +AVKK     
Sbjct: 24  PGDPRSY--------LDNF---IKIGEGSTGIVCIATVRSSGKL------VAVKKMDLRK 66
Query: 285 IKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTL 344
            + +     E+ I+                   +L +V +F+  G+L   +  T     +
Sbjct: 67  QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----M 122
Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
           N      +   V  A+  L   + Q V+HRD+K+ +ILL  D   +L DFG    +  E 
Sbjct: 123 NEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 179
Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                  LVG P    ++APE        PE D++  G +V+E+V G  P
Sbjct: 180 PR--RKXLVGTP---YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 104 KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 155
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV---GTAQYVSPELLTEKSACKS 212
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 213 SDLWALGCIIYQLVAGLPP 231

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 104 KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 155
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV---GTAQYVSPELLTEKSACKS 212
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 213 SDLWALGCIIYQLVAGLPP 231

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KGDFLAELAII 298
           ++F +   LG G  G+V+K         H  +  +  +K     IK   +   + EL ++
Sbjct: 6   DDFEKISELGAGNGGVVFK-------VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKILTG 355
                       G  +  G++ +  + M  GSL++ L       EQ+        K+   
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIA 112
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA-RAIENERNSYAEHGLVG 414
           V   + YL+ ++  K++HRD+K SNIL+++    +L DFG++ + I++  NS+       
Sbjct: 113 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------ 164
Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             GT  Y++PE       + +SD++  G  ++E+  GR P
Sbjct: 165 --GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 2/99 (2%)
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           +A A   L   +   ++HRD+K +NI++ A    ++ DFG+ARAI +  NS  +     V
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ--TAAV 179
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            GT  Y++PE          SDV+  G V+ EV+ G  P
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 2/99 (2%)
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           +A A   L   +   ++HRD+K +NI++ A    ++ DFG+ARAI +  NS  +     V
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ--TAAV 179
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            GT  Y++PE          SDV+  G V+ EV+ G  P
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 28/223 (12%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQ----IAVKKFSRDSIKSK-GDFLAELAI-IXXXX 302
           LG G FG V +      D + +D T     +AVK     +  S+    ++EL I I    
Sbjct: 35  LGRGAFGQVIEA-----DAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 303 XXXXXXXXGWCHEKG-KLLLVYDFMPNGSLEKYLYGTSEQVT---------LNWNHRYKI 352
                   G C + G  L+++ +F   G+L  YL     +           L   H    
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
              VA  + +L +   +K +HRDL A NILL      ++ DFGLAR I  + + Y   G 
Sbjct: 150 SFQVAKGMEFLAS---RKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPD-YVRKGD 205
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
             +P  + ++APE       T +SDV+ FG ++ E+   G SP
Sbjct: 206 ARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 20/223 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIXXXXXX 304
           +LG+G FG+V +G     D        +AVK    D +   ++  DF+ E+  +      
Sbjct: 15  KLGDGSFGVVRRG---EWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 305 XXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                 G       + +V +  P GSL   L        L    RY +   VA  + YL+
Sbjct: 72  NLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE 128
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
           +   ++ +HRDL A N+LL      ++GDFGL RA+    + Y       VP    + AP
Sbjct: 129 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP--FAWCAP 183
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP-----GNMIPHQ 461
           E   T   +  SD + FG  + E+   G+ P     G+ I H+
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 226

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 104 KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 155
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV---GTAQYVSPELLTEKSACKS 212
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 213 SDLWALGCIIYQLVAGLPP 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 157
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 158 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV---GTAQYVSPELLTEKSACKS 214
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 215 SDLWALGCIIYQLVAGLPP 233

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 29/230 (12%)
Query: 225 PGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS 284
           PG PR +         +NF   +++GEG  GIV    +  + +       +AVKK     
Sbjct: 15  PGDPRSY--------LDNF---IKIGEGSTGIVCIATVRSSGKL------VAVKKMDLRK 57
Query: 285 IKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTL 344
            + +     E+ I+                   +L +V +F+  G+L   +  T     +
Sbjct: 58  QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----M 113
Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
           N      +   V  A+  L   + Q V+HRD+K+ +ILL  D   +L DFG    +  E 
Sbjct: 114 NEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 170
Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                  LVG P    ++APE        PE D++  G +V+E+V G  P
Sbjct: 171 PR--RKXLVGTP---YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 2/99 (2%)
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           +A A   L   +   ++HRD+K +NI++ A    ++ DFG+ARAI +  NS  +     V
Sbjct: 139 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ--TAAV 196
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            GT  Y++PE          SDV+  G V+ EV+ G  P
Sbjct: 197 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 88  KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 139
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 140 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV---GTAQYVSPELLTEKSACKS 196
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 197 SDLWALGCIIYQLVAGLPP 215

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 115/246 (46%), Gaps = 22/246 (8%)
Query: 214 EPHHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVY-KGIIHHNDQYHVDN 272
           +P  + G L+   +    K    K   ++F     LG+G FG V+    +   D  H+  
Sbjct: 1   QPSKDEGVLKEISITHHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYA 60
Query: 273 TQIAVKKFS---RDSIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNG 329
            ++ +KK +   RD +++K     E  I+                 +GKL L+ DF+  G
Sbjct: 61  MKV-LKKATLKVRDRVRTK----MERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGG 115
Query: 330 SLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA 389
            L   L   S++V          L  +A  + +L +     +++RDLK  NILLD + + 
Sbjct: 116 DLFTRL---SKEVMFTEEDVKFYLAELALGLDHLHS---LGIIYRDLKPENILLDEEGHI 169
Query: 390 RLGDFGLAR-AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
           +L DFGL++ AI++E+ +Y+        GT+ Y+APE  +    +  +D + +G ++ E+
Sbjct: 170 KLTDFGLSKEAIDHEKKAYS------FCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEM 223
Query: 449 VCGRSP 454
           + G  P
Sbjct: 224 LTGSLP 229

>pdb|2SBA|A Chain A, Soybean Agglutinin Complexed With 2,6-Pentasaccharide Length = 253

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 69/138 (50%), Gaps = 13/138 (9%)
Query: 15  GLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNI 74
           GLAF +AP D+ P   ++  +LGL   F +    +  VA+EFDT +  +DP + H+G+N+
Sbjct: 89  GLAFFLAPIDTKP--QTHAGYLGL---FNENESGDQVVAVEFDTFRNSWDPPNPHIGINV 143
Query: 75  NSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETIN 134
           NS+ S K           L++     V + YD  + L+   +    +      +L + ++
Sbjct: 144 NSIRSIKTTSWD------LANNKVAKVLITYDASTSLLVASLVYPSQRTSN--ILSDVVD 195
Query: 135 LKDYLKPESYFGFSASTG 152
           LK  L      GFSA+TG
Sbjct: 196 LKTSLPEWVRIGFSAATG 213

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KGDFLAELAII 298
           ++F +   LG G  G+V+K         H  +  +  +K     IK   +   + EL ++
Sbjct: 6   DDFEKISELGAGNGGVVFK-------VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKILTG 355
                       G  +  G++ +  + M  GSL++ L       EQ+        K+   
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIA 112
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA-RAIENERNSYAEHGLVG 414
           V   + YL+ ++  K++HRD+K SNIL+++    +L DFG++ + I++  NS+       
Sbjct: 113 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------ 164
Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             GT  Y++PE       + +SD++  G  ++E+  GR P
Sbjct: 165 --GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 20/223 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIXXXXXX 304
           +LG+G FG+V +G     D        +AVK    D +   ++  DF+ E+  +      
Sbjct: 19  KLGDGSFGVVRRG---EWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 75
Query: 305 XXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                 G       + +V +  P GSL   L        L    RY +   VA  + YL+
Sbjct: 76  NLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE 132
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
           +   ++ +HRDL A N+LL      ++GDFGL RA+    + Y       VP    + AP
Sbjct: 133 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP--FAWCAP 187
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP-----GNMIPHQ 461
           E   T   +  SD + FG  + E+   G+ P     G+ I H+
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 230

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 96/225 (42%), Gaps = 21/225 (9%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHND-QYHVDNTQIAVKKFSRDSIKSKGDFLAEL---A 296
            +F     LG GGFG+V++     +D  Y +   ++  ++ +R+ +  +   LA+L    
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 297 IIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR---YKIL 353
           I+                     + +Y  M     E      + + T+    R     I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 354 TGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN-------- 405
             +A AV +L   + + ++HRDLK SNI    D   ++GDFGL  A++ +          
Sbjct: 125 LQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 406 -SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
            +YA H   G  GT  Y++PE  H    + + D+F  G ++ E++
Sbjct: 182 PAYARH--TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 107 KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 158
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 159 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV---GTAQYVSPELLTEKSACKS 215
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 216 SDLWALGCIIYQLVAGLPP 234

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 157
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 158 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV---GTAQYVSPELLTEKSACKS 214
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 215 SDLWALGCIIYQLVAGLPP 233

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KGDFLAELAII 298
           ++F +   LG G  G+V+K         H  +  +  +K     IK   +   + EL ++
Sbjct: 6   DDFEKISELGAGNGGVVFK-------VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKILTG 355
                       G  +  G++ +  + M  GSL++ L       EQ+        K+   
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIA 112
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA-RAIENERNSYAEHGLVG 414
           V   + YL+ ++  K++HRD+K SNIL+++    +L DFG++ + I++  NS+       
Sbjct: 113 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------ 164
Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             GT  Y++PE       + +SD++  G  ++E+  GR P
Sbjct: 165 --GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 157
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 158 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV---GTAQYVSPELLTEKSACKS 214
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 215 SDLWALGCIIYQLVAGLPP 233

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KGDFLAELAII 298
           ++F +   LG G  G+V+K         H  +  +  +K     IK   +   + EL ++
Sbjct: 6   DDFEKISELGAGNGGVVFK-------VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKILTG 355
                       G  +  G++ +  + M  GSL++ L       EQ+        K+   
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIA 112
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA-RAIENERNSYAEHGLVG 414
           V   + YL+ ++  K++HRD+K SNIL+++    +L DFG++ + I++  NS+       
Sbjct: 113 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------ 164
Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             GT  Y++PE       + +SD++  G  ++E+  GR P
Sbjct: 165 --GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +GEG FG V++GI    +   +       K  + DS++ K  FL E   +          
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 455
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G   E   + ++ +    G L  +L     + +L+          +++A+ YL++   
Sbjct: 456 LIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLES--- 509
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           ++ VHRD+ A N+L+ ++   +LGDFGL+R +E+     A  G + +     ++APE  +
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI----KWMAPESIN 565
Query: 429 TGKATPESDVFGFGAVVLEVV 449
             + T  SDV+ FG  + E++
Sbjct: 566 FRRFTSASDVWMFGVCMWEIL 586

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 111 KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 162
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 163 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV---GTAQYVSPELLTEKSACKS 219
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 220 SDLWALGCIIYQLVAGLPP 238

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 92/212 (43%), Gaps = 21/212 (9%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
            LG+G FG VYK       +        A K     S +   D++ E+ I+         
Sbjct: 18  ELGDGAFGKVYKA------KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIV 71
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G  +  GKL ++ +F P G+++  +      +T       +I       +  L   +
Sbjct: 72  KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT-----EPQIQVVCRQMLEALNFLH 126
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            ++++HRDLKA N+L+  + + RL DFG++   +N +        +G P    ++APE  
Sbjct: 127 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTP---YWMAPEVV 181
Query: 428 --HTGKATP---ESDVFGFGAVVLEVVCGRSP 454
              T K TP   ++D++  G  ++E+     P
Sbjct: 182 MCETMKDTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 29/230 (12%)
Query: 225 PGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS 284
           PG PR +         +NF   +++GEG  GIV    +  + +       +AVKK     
Sbjct: 19  PGDPRSY--------LDNF---IKIGEGSTGIVCIATVRSSGKL------VAVKKMDLRK 61
Query: 285 IKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTL 344
            + +     E+ I+                   +L +V +F+  G+L   +  T     +
Sbjct: 62  QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----M 117
Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
           N      +   V  A+  L   + Q V+HRD+K+ +ILL  D   +L DFG    +  E 
Sbjct: 118 NEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 174
Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                  LVG P    ++APE        PE D++  G +V+E+V G  P
Sbjct: 175 PR--RKXLVGTP---YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 157
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 158 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV---GTAQYVSPELLTEKSACKS 214
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 215 SDLWALGCIIYQLVAGLPP 233

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 109 KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 160
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 161 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV---GTAQYVSPELLTEKSACKS 217
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 218 SDLWALGCIIYQLVAGLPP 236

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 65/139 (46%), Gaps = 17/139 (12%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           L LV ++   G +  YL             +++    + SAV Y   ++   +VHRDLKA
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQKF---IVHRDLKA 141
Query: 379 SNILLDADFNARLGDFGLARAIE--NERNSYAEHGLVGVPGTMGYVAPECFHTGKAT-PE 435
            N+LLDAD N ++ DFG +      N+ + +         G+  Y APE F   K   PE
Sbjct: 142 ENLLLDADMNIKIADFGFSNEFTFGNKLDEFC--------GSPPYAAPELFQGKKYDGPE 193
Query: 436 SDVFGFGAVVLEVVCGRSP 454
            DV+  G ++  +V G  P
Sbjct: 194 VDVWSLGVILYTLVSGSLP 212

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 71/139 (51%), Gaps = 9/139 (6%)
Query: 319 LLLVYDFMPNGSLEKYLY-GTSEQVTLNWNHRYKILTGVASAVYYLQNEYD--QKVVHRD 375
           L +V ++   G L   +  GT E+  L+     +++T +  A+       D    V+HRD
Sbjct: 82  LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 141
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK +N+ LD   N +LGDFGLAR I N   S+A+   VG P    Y++PE  +      +
Sbjct: 142 LKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAK-TFVGTP---YYMSPEQMNRMSYNEK 196
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ E +C   P
Sbjct: 197 SDIWSLGCLLYE-LCALMP 214

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 65/139 (46%), Gaps = 17/139 (12%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           L LV ++   G +  YL             +++    + SAV Y   ++   +VHRDLKA
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQKF---IVHRDLKA 141
Query: 379 SNILLDADFNARLGDFGLARAIE--NERNSYAEHGLVGVPGTMGYVAPECFHTGKAT-PE 435
            N+LLDAD N ++ DFG +      N+ +++         G   Y APE F   K   PE
Sbjct: 142 ENLLLDADMNIKIADFGFSNEFTFGNKLDAFC--------GAPPYAAPELFQGKKYDGPE 193
Query: 436 SDVFGFGAVVLEVVCGRSP 454
            DV+  G ++  +V G  P
Sbjct: 194 VDVWSLGVILYTLVSGSLP 212

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 21/211 (9%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           LG+G FG VYK       +        A K     S +   D++ E+ I+          
Sbjct: 27  LGDGAFGKVYKA------KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
             G  +  GKL ++ +F P G+++  +      +T       +I       +  L   + 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT-----EPQIQVVCRQMLEALNFLHS 135
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF- 427
           ++++HRDLKA N+L+  + + RL DFG+  + +N +        +G P    ++APE   
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGV--SAKNLKTLQKRDSFIGTP---YWMAPEVVM 190
Query: 428 -HTGKATP---ESDVFGFGAVVLEVVCGRSP 454
             T K TP   ++D++  G  ++E+     P
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 20/223 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIXXXXXX 304
           +LG+G FG+V +G     D        +AVK    D +   ++  DF+ E+  +      
Sbjct: 15  KLGDGSFGVVRRG---EWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 305 XXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                 G       + +V +  P GSL   L        L    RY +   VA  + YL+
Sbjct: 72  NLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE 128
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
           +   ++ +HRDL A N+LL      ++GDFGL RA+    + Y       VP    + AP
Sbjct: 129 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP--FAWCAP 183
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP-----GNMIPHQ 461
           E   T   +  SD + FG  + E+   G+ P     G+ I H+
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 226

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 103 KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 154
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 155 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV---GTAQYVSPELLTEKSACKS 211
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 212 SDLWALGCIIYQLVAGLPP 230

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 318 KLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           KL     +  NG L KY+   G+ ++    +         + SA+ YL     + ++HRD
Sbjct: 106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----YTAEIVSALEYLHG---KGIIHRD 157
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  NILL+ D + ++ DFG A+ +  E      +  V   GT  YV+PE      A   
Sbjct: 158 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV---GTAQYVSPELLTEKSAXKS 214
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ ++V G  P
Sbjct: 215 SDLWALGCIIYQLVAGLPP 233

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 20/223 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIXXXXXX 304
           +LG+G FG+V +G     D        +AVK    D +   ++  DF+ E+  +      
Sbjct: 25  KLGDGSFGVVRRG---EWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 305 XXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                 G       + +V +  P GSL   L        L    RY +   VA  + YL+
Sbjct: 82  NLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE 138
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
           +   ++ +HRDL A N+LL      ++GDFGL RA+    + Y       VP    + AP
Sbjct: 139 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP--FAWCAP 193
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP-----GNMIPHQ 461
           E   T   +  SD + FG  + E+   G+ P     G+ I H+
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 236

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 32/224 (14%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKFSRDSIKSK-GDFLA----- 293
           N+F     +G GGFG VY            D  ++ A+K   +  IK K G+ LA     
Sbjct: 188 NDFSVHRIIGRGGFGEVYGC-------RKADTGKMYAMKCLDKKRIKMKQGETLALNERI 240
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYK 351
            L+++               H   KL  + D M  G L  +L  +G   +  + +     
Sbjct: 241 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY---- 296
Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
                A  +  L++ +++ VV+RDLK +NILLD   + R+ D GLA     ++     H 
Sbjct: 297 ----AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHA 348
Query: 412 LVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGRSP 454
            V   GT GY+APE    G A   S D F  G ++ +++ G SP
Sbjct: 349 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 32/224 (14%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKFSRDSIKSK-GDFLA----- 293
           N+F     +G GGFG VY            D  ++ A+K   +  IK K G+ LA     
Sbjct: 189 NDFSVHRIIGRGGFGEVYGC-------RKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYK 351
            L+++               H   KL  + D M  G L  +L  +G   +  + +     
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY---- 297
Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
                A  +  L++ +++ VV+RDLK +NILLD   + R+ D GLA     ++     H 
Sbjct: 298 ----AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHA 349
Query: 412 LVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGRSP 454
            V   GT GY+APE    G A   S D F  G ++ +++ G SP
Sbjct: 350 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 32/224 (14%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKFSRDSIKSK-GDFLA----- 293
           N+F     +G GGFG VY            D  ++ A+K   +  IK K G+ LA     
Sbjct: 189 NDFSVHRIIGRGGFGEVYGC-------RKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYK 351
            L+++               H   KL  + D M  G L  +L  +G   +  + +     
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY---- 297
Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
                A  +  L++ +++ VV+RDLK +NILLD   + R+ D GLA     ++     H 
Sbjct: 298 ----AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHA 349
Query: 412 LVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGRSP 454
            V   GT GY+APE    G A   S D F  G ++ +++ G SP
Sbjct: 350 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 32/224 (14%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKFSRDSIKSK-GDFLA----- 293
           N+F     +G GGFG VY            D  ++ A+K   +  IK K G+ LA     
Sbjct: 189 NDFSVHRIIGRGGFGEVYGC-------RKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYK 351
            L+++               H   KL  + D M  G L  +L  +G   +  + +     
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY---- 297
Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
                A  +  L++ +++ VV+RDLK +NILLD   + R+ D GLA     ++     H 
Sbjct: 298 ----AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHA 349
Query: 412 LVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGRSP 454
            V   GT GY+APE    G A   S D F  G ++ +++ G SP
Sbjct: 350 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 20/223 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIXXXXXX 304
           +LG+G FG+V +G     D        +AVK    D +   ++  DF+ E+  +      
Sbjct: 19  KLGDGSFGVVRRG---EWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 75
Query: 305 XXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                 G       + +V +  P GSL   L        L    RY +   VA  + YL+
Sbjct: 76  NLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE 132
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
           +   ++ +HRDL A N+LL      ++GDFGL RA+    + Y       VP    + AP
Sbjct: 133 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP--FAWCAP 187
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP-----GNMIPHQ 461
           E   T   +  SD + FG  + E+   G+ P     G+ I H+
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 230

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKFSRDSIKSKGDFLAELAIIXXXXXXXX 306
           +LGEG +G VYK I       H +  QI A+K+   +S     + + E++I+        
Sbjct: 36  KLGEGSYGSVYKAI-------HKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHV 86
Query: 307 XXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
               G   +   L +V ++   GS+   +   ++  TL  +    IL      + YL   
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYL--- 141
Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN---ERNSYAEHGLVGVPGTMGYVA 423
           +  + +HRD+KA NILL+ + +A+L DFG+A  + +   +RN         V GT  ++A
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNX--------VIGTPFWMA 193
Query: 424 PECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           PE          +D++  G   +E+  G+ P
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 29/230 (12%)
Query: 225 PGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS 284
           PG PR +         +NF   +++GEG  GIV    +  + +       +AVKK     
Sbjct: 69  PGDPRSY--------LDNF---IKIGEGSTGIVCIATVRSSGKL------VAVKKMDLRK 111
Query: 285 IKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTL 344
            + +     E+ I+                   +L +V +F+  G+L   +  T     +
Sbjct: 112 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----M 167
Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
           N      +   V  A+  L   + Q V+HRD+K+ +ILL  D   +L DFG    +  E 
Sbjct: 168 NEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE- 223
Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                  LVG P    ++APE        PE D++  G +V+E+V G  P
Sbjct: 224 -VPRRKXLVGTP---YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|3USU|A Chain A, Crystal Structure Of Butea Monosperma Seed Lectin Length = 256

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 81/158 (51%), Gaps = 15/158 (9%)
Query: 13  GHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG--FDPDDNHL 70
             GLAF +AP  S PP++  G +LGL ++    N +   VA+EFDT +     DP D H+
Sbjct: 88  ADGLAFFLAPVSS-PPKAGAG-FLGLFDSAV-FNSSYQTVAVEFDTYENTVFLDPPDTHI 144
Query: 71  GLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLK 130
           G+++NS+ S K V         L++G +  V + YD  +KL+   +           +L 
Sbjct: 145 GIDVNSIKSIKTVKWD------LANGEAAKVLITYDSSAKLLVAALVYPSSKTSF--ILS 196
Query: 131 ETINLKDYLKPESYFGFSASTGYP--HIQLNCVRSWTL 166
           + ++LK  L      GFSA+TG    +I+ + V SW+ 
Sbjct: 197 DVVDLKSVLPEWVSIGFSAATGASSGYIETHDVFSWSF 234

>pdb|3USU|B Chain B, Crystal Structure Of Butea Monosperma Seed Lectin Length = 242

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 81/158 (51%), Gaps = 15/158 (9%)
Query: 13  GHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG--FDPDDNHL 70
             GLAF +AP  S PP++  G +LGL ++    N +   VA+EFDT +     DP D H+
Sbjct: 88  ADGLAFFLAPVSS-PPKAGAG-FLGLFDSAV-FNSSYQTVAVEFDTYENTVFLDPPDTHI 144
Query: 71  GLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLK 130
           G+++NS+ S K V         L++G +  V + YD  +KL+   +           +L 
Sbjct: 145 GIDVNSIKSIKTVKWD------LANGEAAKVLITYDSSAKLLVAALVYPSSKTSF--ILS 196
Query: 131 ETINLKDYLKPESYFGFSASTGYP--HIQLNCVRSWTL 166
           + ++LK  L      GFSA+TG    +I+ + V SW+ 
Sbjct: 197 DVVDLKSVLPEWVSIGFSAATGASSGYIETHDVFSWSF 234

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 70/139 (50%), Gaps = 9/139 (6%)
Query: 319 LLLVYDFMPNGSLEKYLY-GTSEQVTLNWNHRYKILTGVASAVYYLQNEYD--QKVVHRD 375
           L +V ++   G L   +  GT E+  L+     +++T +  A+       D    V+HRD
Sbjct: 82  LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 141
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK +N+ LD   N +LGDFGLAR + ++ +   E   VG P    Y++PE  +      +
Sbjct: 142 LKPANVFLDGKQNVKLGDFGLARILNHDEDFAKE--FVGTP---YYMSPEQMNRMSYNEK 196
Query: 436 SDVFGFGAVVLEVVCGRSP 454
           SD++  G ++ E +C   P
Sbjct: 197 SDIWSLGCLLYE-LCALMP 214

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 54/102 (52%), Gaps = 14/102 (13%)
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE--NERNSYAEHGLV 413
           + SAV Y   ++   +VHRDLKA N+LLDAD N ++ DFG +      N+ +++      
Sbjct: 115 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----- 166
Query: 414 GVPGTMGYVAPECFHTGKAT-PESDVFGFGAVVLEVVCGRSP 454
              G+  Y APE F   K   PE DV+  G ++  +V G  P
Sbjct: 167 ---GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 205

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 96/236 (40%), Gaps = 25/236 (10%)
Query: 225 PGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS 284
           P + +E    ++K    +F     LG+G FG V+       +Q+       A+K   +D 
Sbjct: 2   PELNKERPSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQF------FAIKALKKDV 55
Query: 285 IKSKGDFLAELAIIXXXXXXXXXXXXGWCH------EKGKLLLVYDFMPNGSLEKYLYGT 338
           +    D   E  ++               H       K  L  V +++  G L  Y   +
Sbjct: 56  VLMDDD--VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL-MYHIQS 112
Query: 339 SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR 398
             +  L+    Y      A  +  LQ  + + +V+RDLK  NILLD D + ++ DFG+ +
Sbjct: 113 CHKFDLSRATFY-----AAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK 167
Query: 399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             EN       +   G P    Y+APE     K     D + FG ++ E++ G+SP
Sbjct: 168 --ENMLGDAKTNEFCGTP---DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 28/223 (12%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQ----IAVKKFSRDSIKSK-GDFLAELAI-IXXXX 302
           LG G FG V +      D + +D T     +AVK     +  S+    ++EL I I    
Sbjct: 35  LGRGAFGQVIEA-----DAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 303 XXXXXXXXGWCHEKG-KLLLVYDFMPNGSLEKYLYGTSEQVT---------LNWNHRYKI 352
                   G C + G  L+++ +F   G+L  YL     +           L   H    
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
              VA  + +L +   +K +HRDL A NILL      ++ DFGLAR I  + + Y   G 
Sbjct: 150 SFQVAKGMEFLAS---RKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGD 205
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
             +P  + ++APE       T +SDV+ FG ++ E+   G SP
Sbjct: 206 ARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 21/222 (9%)
Query: 237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LA 293
           +   +NF     LG+G FG V    +      +      AVK   +D I    D    + 
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLY------AVKVLKKDVILQDDDVECTMT 72
Query: 294 ELAIIXXXXXXXXXXXXGWCHEK-GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKI 352
           E  I+              C +   +L  V +F+  G L   ++   +    +       
Sbjct: 73  EKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFY 129
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
              + SA+ +L   +D+ +++RDLK  N+LLD + + +L DFG+ +  E   N       
Sbjct: 130 AAEIISALMFL---HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATF 184
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            G P    Y+APE        P  D +  G ++ E++CG +P
Sbjct: 185 CGTP---DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 65/139 (46%), Gaps = 17/139 (12%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           L LV ++   G +  YL             +++    + SAV Y   ++   +VHRDLKA
Sbjct: 88  LYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR---QIVSAVQYCHQKF---IVHRDLKA 141
Query: 379 SNILLDADFNARLGDFGLARAIE--NERNSYAEHGLVGVPGTMGYVAPECFHTGKAT-PE 435
            N+LLDAD N ++ DFG +      N+ +++         G   Y APE F   K   PE
Sbjct: 142 ENLLLDADXNIKIADFGFSNEFTFGNKLDAFC--------GAPPYAAPELFQGKKYDGPE 193
Query: 436 SDVFGFGAVVLEVVCGRSP 454
            DV+  G ++  +V G  P
Sbjct: 194 VDVWSLGVILYTLVSGSLP 212

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 106/240 (44%), Gaps = 25/240 (10%)
Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF--LAELAI 297
            + + +  ++G+G FG V+K       ++     ++A+KK   ++ K       L E+ I
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKA------RHRKTGQKVALKKVLMENEKEGFPITALREIKI 69
Query: 298 IXXXXXXXXXXXXGWCHEK--------GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR 349
           +              C  K        G + LV+DF  +  L   L     + TL+   R
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 128
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
             ++  + + +YY+      K++HRD+KA+N+L+  D   +L DFGLARA    +NS   
Sbjct: 129 --VMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 410 HGLVGVPGTMGYVAPECFHTGKAT-PESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV 468
                V  T+ Y  PE     +   P  D++G G ++ E +  RSP      +QH   L+
Sbjct: 184 RYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAE-MWTRSPIMQGNTEQHQLALI 241

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 107/240 (44%), Gaps = 25/240 (10%)
Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF--LAELAI 297
            + + +  ++G+G FG V+K       ++     ++A+KK   ++ K       L E+ I
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKA------RHRKTGQKVALKKVLMENEKEGFPITALREIKI 70
Query: 298 IXXXXXXXXXXXXGWCHEK--------GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR 349
           +              C  K        G + LV+DF  +  L   L     + TL+   R
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 129
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
             ++  + + +YY+   +  K++HRD+KA+N+L+  D   +L DFGLARA    +NS   
Sbjct: 130 --VMQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 410 HGLVGVPGTMGYVAPECFHTGKAT-PESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV 468
                V  T+ Y  PE     +   P  D++G G ++ E +  RSP      +QH   L+
Sbjct: 185 RYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAE-MWTRSPIMQGNTEQHQLALI 242

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 107/240 (44%), Gaps = 25/240 (10%)
Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF--LAELAI 297
            + + +  ++G+G FG V+K       ++     ++A+KK   ++ K       L E+ I
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKA------RHRKTGQKVALKKVLMENEKEGFPITALREIKI 70
Query: 298 IXXXXXXXXXXXXGWCHEK--------GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR 349
           +              C  K        G + LV+DF  +  L   L     + TL+   R
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 129
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
             ++  + + +YY+   +  K++HRD+KA+N+L+  D   +L DFGLARA    +NS   
Sbjct: 130 --VMQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 410 HGLVGVPGTMGYVAPECFHTGKAT-PESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV 468
                V  T+ Y  PE     +   P  D++G G ++ E +  RSP      +QH   L+
Sbjct: 185 RYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAE-MWTRSPIMQGNTEQHQLALI 242

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELAIIXXXXXXX 305
           LG+G FG     +I   D+  +   + AVK  S+  +K K D    L E+ ++       
Sbjct: 40  LGKGSFG----EVILCKDK--ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                 +  +KG   LV +    G L   +        ++     +I+  V S + Y+  
Sbjct: 94  IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSGITYM-- 148
Query: 366 EYDQKVVHRDLKASNILLDA---DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
            +  K+VHRDLK  N+LL++   D N R+ DFGL+   E      A   +    GT  Y+
Sbjct: 149 -HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE------ASKKMKDKIGTAYYI 201
Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSPGN 456
           APE  H G    + DV+  G ++  ++ G  P N
Sbjct: 202 APEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 234

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 96/236 (40%), Gaps = 25/236 (10%)
Query: 225 PGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS 284
           P + +E    ++K    +F     LG+G FG V+       +Q+       A+K   +D 
Sbjct: 1   PELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQF------FAIKALKKDV 54
Query: 285 IKSKGDFLAELAIIXXXXXXXXXXXXGWCH------EKGKLLLVYDFMPNGSLEKYLYGT 338
           +    D   E  ++               H       K  L  V +++  G L  Y   +
Sbjct: 55  VLMDDD--VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL-MYHIQS 111
Query: 339 SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR 398
             +  L+    Y      A  +  LQ  + + +V+RDLK  NILLD D + ++ DFG+ +
Sbjct: 112 CHKFDLSRATFY-----AAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK 166
Query: 399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             EN       +   G P    Y+APE     K     D + FG ++ E++ G+SP
Sbjct: 167 --ENMLGDAKTNXFCGTP---DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/241 (22%), Positives = 100/241 (41%), Gaps = 35/241 (14%)
Query: 238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAI 297
           +  ++F E   LG+G FG V K       +  +D+   A+KK  R + +     L+E+ +
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKI-RHTEEKLSTILSEVML 55
Query: 298 IXXXX-XXXXXXXXGWCH------------EKGKLLLVYDFMPNGSLEKYLYGTSEQVTL 344
           +              W              +K  L +  ++  N +L   ++  SE +  
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIH--SENLNQ 113
Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
             +  +++   +  A+ Y+   + Q ++HRDLK  NI +D   N ++GDFGLA+ +    
Sbjct: 114 QRDEYWRLFRQILEALSYI---HSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 405 NSY---------AEHGLVGVPGTMGYVAPECFH-TGKATPESDVFGFGAVVLEVVCGRSP 454
           +           +   L    GT  YVA E    TG    + D++  G +  E++   S 
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST 230
Query: 455 G 455
           G
Sbjct: 231 G 231

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 99/226 (43%), Gaps = 31/226 (13%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQ----IAVKKFSRDSIKSK-GDFLAELAI-IXXXX 302
           LG G FG V +      D + +D T     +AVK     +  S+    ++EL I I    
Sbjct: 36  LGRGAFGQVIEA-----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 90
Query: 303 XXXXXXXXGWCHEKG-KLLLVYDFMPNGSLEKYL---------YGTSEQVT---LNWNHR 349
                   G C + G  L+++ +F   G+L  YL         Y T E +    L   H 
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
                 VA  + +L +   +K +HRDL A NILL      ++ DFGLAR I  + +    
Sbjct: 151 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX-VR 206
Query: 410 HGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
            G   +P  + ++APE       T +SDV+ FG ++ E+   G SP
Sbjct: 207 KGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 97/227 (42%), Gaps = 32/227 (14%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQ----IAVKKFSRDSIKSK-GDFLAELAI-IXXXX 302
           LG G FG V +      D + +D T     +AVK     +  S+    ++EL I I    
Sbjct: 35  LGRGAFGQVIEA-----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 303 XXXXXXXXGWCHEKG-KLLLVYDFMPNGSLEKYLYGTSEQVT-------------LNWNH 348
                   G C + G  L+++ +F   G+L  YL     +               L   H
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
                  VA  + +L +   +K +HRDL A NILL      ++ DFGLAR I  + + Y 
Sbjct: 150 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YV 205
Query: 409 EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
             G   +P  + ++APE       T +SDV+ FG ++ E+   G SP
Sbjct: 206 RKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KGDFLAELAII 298
           ++F +   LG G  G+V+K         H  +  +  +K     IK   +   + EL ++
Sbjct: 9   DDFEKISELGAGNGGVVFK-------VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 61
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKILTG 355
                       G  +  G++ +  + M  GSL++ L       EQ+        K+   
Sbjct: 62  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIA 115
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA-RAIENERNSYAEHGLVG 414
           V   + YL+ ++  K++HRD+K SNIL+++    +L DFG++ + I+   N +       
Sbjct: 116 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV------ 167
Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             GT  Y++PE       + +SD++  G  ++E+  GR P
Sbjct: 168 --GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 106/243 (43%), Gaps = 30/243 (12%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD-FLAELAIIXXX-XXXXX 306
           LG G FG V     +   +  V + Q+AVK     +  S+ +  ++EL ++         
Sbjct: 53  LGSGAFGKVMNATAYGISKTGV-SIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 307 XXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVT-----------LNWNHRYKILT- 354
               G C   G + L++++   G L  YL    E+ +           L       +LT 
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 355 --------GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
                    VA  + +L+    +  VHRDL A N+L+      ++ DFGLAR I ++ N 
Sbjct: 172 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN- 227
Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSPGNMIPHQQHAY 465
           Y   G   +P  + ++APE    G  T +SDV+ +G ++ E+   G +P   IP   + Y
Sbjct: 228 YVVRGNARLP--VKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 285
Query: 466 TLV 468
            L+
Sbjct: 286 KLI 288

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 32/235 (13%)
Query: 230 EFKYKELKKAT-NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK 288
           ++K+ E +  T N F +   LG+GGFG V    +    + +        K   +   K K
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYA-----CKKLEKKRIKKRK 226
Query: 289 GDFLA--ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNW 346
           G+ +A  E  I+                 K  L LV   M  G L+ ++Y          
Sbjct: 227 GEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY---------- 276
Query: 347 NHRYKILTGVASAVYY-------LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA 399
            H  +     A AV+Y       L++ + +++V+RDLK  NILLD   + R+ D GLA  
Sbjct: 277 -HMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH 335
Query: 400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +   +       + G  GT+GY+APE     + T   D +  G ++ E++ G+SP
Sbjct: 336 VPEGQT------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 97/227 (42%), Gaps = 32/227 (14%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQ----IAVKKFSRDSIKSK-GDFLAELAI-IXXXX 302
           LG G FG V +      D + +D T     +AVK     +  S+    ++EL I I    
Sbjct: 37  LGRGAFGQVIEA-----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 91
Query: 303 XXXXXXXXGWCHEKG-KLLLVYDFMPNGSLEKYLYGTSEQVT-------------LNWNH 348
                   G C + G  L+++ +F   G+L  YL     +               L   H
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEH 151
Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
                  VA  + +L +   +K +HRDL A NILL      ++ DFGLAR I  + + Y 
Sbjct: 152 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YV 207
Query: 409 EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
             G   +P  + ++APE       T +SDV+ FG ++ E+   G SP
Sbjct: 208 RKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 252

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 32/235 (13%)
Query: 230 EFKYKELKKAT-NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK 288
           ++K+ E +  T N F +   LG+GGFG V    +    + +        K   +   K K
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYA-----CKKLEKKRIKKRK 226
Query: 289 GDFLA--ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNW 346
           G+ +A  E  I+                 K  L LV   M  G L+ ++Y          
Sbjct: 227 GEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY---------- 276
Query: 347 NHRYKILTGVASAVYY-------LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA 399
            H  +     A AV+Y       L++ + +++V+RDLK  NILLD   + R+ D GLA  
Sbjct: 277 -HMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH 335
Query: 400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +   +       + G  GT+GY+APE     + T   D +  G ++ E++ G+SP
Sbjct: 336 VPEGQT------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELAIIXXXXXXX 305
           LG+G FG     +I   D+  +   + AVK  S+  +K K D    L E+ ++       
Sbjct: 34  LGKGSFG----EVILCKDK--ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                 +  +KG   LV +    G L   +        ++     +I+  V S + Y+  
Sbjct: 88  IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSGITYM-- 142
Query: 366 EYDQKVVHRDLKASNILLDA---DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
            +  K+VHRDLK  N+LL++   D N R+ DFGL+   E      A   +    GT  Y+
Sbjct: 143 -HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE------ASKKMKDKIGTAYYI 195
Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSPGN 456
           APE  H G    + DV+  G ++  ++ G  P N
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 97/227 (42%), Gaps = 32/227 (14%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQ----IAVKKFSRDSIKSK-GDFLAELAI-IXXXX 302
           LG G FG V +      D + +D T     +AVK     +  S+    ++EL I I    
Sbjct: 26  LGRGAFGQVIEA-----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 80
Query: 303 XXXXXXXXGWCHEKG-KLLLVYDFMPNGSLEKYLYGTSEQVT-------------LNWNH 348
                   G C + G  L+++ +F   G+L  YL     +               L   H
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
                  VA  + +L +   +K +HRDL A NILL      ++ DFGLAR I  + + Y 
Sbjct: 141 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YV 196
Query: 409 EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
             G   +P  + ++APE       T +SDV+ FG ++ E+   G SP
Sbjct: 197 RKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 97/227 (42%), Gaps = 32/227 (14%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQ----IAVKKFSRDSIKSK-GDFLAELAI-IXXXX 302
           LG G FG V +      D + +D T     +AVK     +  S+    ++EL I I    
Sbjct: 72  LGRGAFGQVIEA-----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 126
Query: 303 XXXXXXXXGWCHEKG-KLLLVYDFMPNGSLEKYLYGTSEQVT-------------LNWNH 348
                   G C + G  L+++ +F   G+L  YL     +               L   H
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 186
Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
                  VA  + +L +   +K +HRDL A NILL      ++ DFGLAR I  + + Y 
Sbjct: 187 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YV 242
Query: 409 EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
             G   +P  + ++APE       T +SDV+ FG ++ E+   G SP
Sbjct: 243 RKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 27/219 (12%)
Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA----ELAI 297
           N+     LGEG FG V          YH    Q    K     + +K D       E++ 
Sbjct: 5   NYQIVKTLGEGSFGKVKLA-------YHTTTGQKVALKIINKKVLAKSDMQGRIEREISY 57
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
           +                 K ++++V ++  N  L  Y+    ++  ++     +    + 
Sbjct: 58  LRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIV---QRDKMSEQEARRFFQQII 113
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
           SAV Y       K+VHRDLK  N+LLD   N ++ DFGL+  + +       + L    G
Sbjct: 114 SAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD------GNFLKTSCG 164
Query: 418 TMGYVAPECFHTGK--ATPESDVFGFGAVVLEVVCGRSP 454
           +  Y APE   +GK  A PE DV+  G ++  ++C R P
Sbjct: 165 SPNYAAPEVI-SGKLYAGPEVDVWSCGVILYVMLCRRLP 202

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 97/227 (42%), Gaps = 32/227 (14%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQ----IAVKKFSRDSIKSK-GDFLAELAI-IXXXX 302
           LG G FG V +      D + +D T     +AVK     +  S+    ++EL I I    
Sbjct: 26  LGRGAFGQVIEA-----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 80
Query: 303 XXXXXXXXGWCHEKG-KLLLVYDFMPNGSLEKYLYGTSEQVT-------------LNWNH 348
                   G C + G  L+++ +F   G+L  YL     +               L   H
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
                  VA  + +L +   +K +HRDL A NILL      ++ DFGLAR I  + + Y 
Sbjct: 141 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YV 196
Query: 409 EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
             G   +P  + ++APE       T +SDV+ FG ++ E+   G SP
Sbjct: 197 RKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 110/262 (41%), Gaps = 33/262 (12%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAIIXXXXXXX 305
           LG+G F  VY+    H         ++A+K   + ++   G       E+ I        
Sbjct: 19  LGKGSFAGVYRAESIHT------GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRY--KILTGVASAVYYL 363
                 +  +   + LV +   NG + +YL    +  + N    +  +I+TG+     YL
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM----LYL 128
Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
              +   ++HRDL  SN+LL  + N ++ DFGLA  ++     +  + L G P    Y++
Sbjct: 129 ---HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH--YTLCGTP---NYIS 180
Query: 424 PECFHTGKATPESDVFGFGAVVLEVVCGRSP--GNMIPHQQHAYTLVDWVWMLHREGHIQ 481
           PE         ESDV+  G +   ++ GR P   + + +  +   L D+          +
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAK 240
Query: 482 DAVDQ--------RLNINSVVD 495
           D + Q        RL+++SV+D
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLD 262

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/120 (33%), Positives = 58/120 (48%), Gaps = 17/120 (14%)
Query: 344 LNWNHRYKILTGVASAVYYL-------QNEYDQKVVHRDLKASNILLDADFNARLGDFGL 396
           L  + R K LT    A YYL       Q  +  +V+HRDLK  N+ L+ D   ++GDFGL
Sbjct: 105 LELHKRRKALTE-PEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 163
Query: 397 ARAIE--NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           A  +E   ER          + GT  Y+APE       + E DV+  G ++  ++ G+ P
Sbjct: 164 ATKVEYDGERKK-------TLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 27/219 (12%)
Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA----ELAI 297
           N+     LGEG FG V          YH    Q    K     + +K D       E++ 
Sbjct: 15  NYQIVKTLGEGSFGKVKLA-------YHTTTGQKVALKIINKKVLAKSDMQGRIEREISY 67
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
           +                 K ++++V ++  N  L  Y+    ++  ++     +    + 
Sbjct: 68  LRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIV---QRDKMSEQEARRFFQQII 123
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
           SAV Y       K+VHRDLK  N+LLD   N ++ DFGL+  + +       + L    G
Sbjct: 124 SAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD------GNFLKTSCG 174
Query: 418 TMGYVAPECFHTGK--ATPESDVFGFGAVVLEVVCGRSP 454
           +  Y APE   +GK  A PE DV+  G ++  ++C R P
Sbjct: 175 SPNYAAPEVI-SGKLYAGPEVDVWSCGVILYVMLCRRLP 212

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
            LG+G FG VYK       Q    +   A K     S +   D++ E+ I+         
Sbjct: 44  ELGDGAFGKVYKA------QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 97
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                 + +  L ++ +F   G+++  +      +T   +    +      A+ YL   +
Sbjct: 98  KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT--ESQIQVVCKQTLDALNYL---H 152
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           D K++HRDLKA NIL   D + +L DFG++   +N R        +G P  M      C 
Sbjct: 153 DNKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMC- 209
Query: 428 HTGKATP---ESDVFGFGAVVLEV 448
            T K  P   ++DV+  G  ++E+
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 27/219 (12%)
Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA----ELAI 297
           N+     LGEG FG V          YH    Q    K     + +K D       E++ 
Sbjct: 14  NYQIVKTLGEGSFGKVKLA-------YHTTTGQKVALKIINKKVLAKSDMQGRIEREISY 66
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
           +                 K ++++V ++  N  L  Y+    ++  ++     +    + 
Sbjct: 67  LRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIV---QRDKMSEQEARRFFQQII 122
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
           SAV Y       K+VHRDLK  N+LLD   N ++ DFGL+  + +       + L    G
Sbjct: 123 SAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD------GNFLKTSCG 173
Query: 418 TMGYVAPECFHTGK--ATPESDVFGFGAVVLEVVCGRSP 454
           +  Y APE   +GK  A PE DV+  G ++  ++C R P
Sbjct: 174 SPNYAAPEVI-SGKLYAGPEVDVWSCGVILYVMLCRRLP 211

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/120 (33%), Positives = 58/120 (48%), Gaps = 17/120 (14%)
Query: 344 LNWNHRYKILTGVASAVYYL-------QNEYDQKVVHRDLKASNILLDADFNARLGDFGL 396
           L  + R K LT    A YYL       Q  +  +V+HRDLK  N+ L+ D   ++GDFGL
Sbjct: 127 LELHKRRKALTE-PEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 185
Query: 397 ARAIE--NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           A  +E   ER          + GT  Y+APE       + E DV+  G ++  ++ G+ P
Sbjct: 186 ATKVEYDGERKKV-------LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 238

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/120 (33%), Positives = 58/120 (48%), Gaps = 17/120 (14%)
Query: 344 LNWNHRYKILTGVASAVYYL-------QNEYDQKVVHRDLKASNILLDADFNARLGDFGL 396
           L  + R K LT    A YYL       Q  +  +V+HRDLK  N+ L+ D   ++GDFGL
Sbjct: 105 LELHKRRKALTE-PEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 163
Query: 397 ARAIE--NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           A  +E   ER          + GT  Y+APE       + E DV+  G ++  ++ G+ P
Sbjct: 164 ATKVEYDGERKK-------TLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 27/219 (12%)
Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA----ELAI 297
           N+     LGEG FG V          YH    Q    K     + +K D       E++ 
Sbjct: 9   NYQIVKTLGEGSFGKVKLA-------YHTTTGQKVALKIINKKVLAKSDMQGRIEREISY 61
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
           +                 K ++++V ++  N  L  Y+    ++  ++     +    + 
Sbjct: 62  LRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIV---QRDKMSEQEARRFFQQII 117
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
           SAV Y       K+VHRDLK  N+LLD   N ++ DFGL+  + +       + L    G
Sbjct: 118 SAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD------GNFLKTSCG 168
Query: 418 TMGYVAPECFHTGK--ATPESDVFGFGAVVLEVVCGRSP 454
           +  Y APE   +GK  A PE DV+  G ++  ++C R P
Sbjct: 169 SPNYAAPEVI-SGKLYAGPEVDVWSCGVILYVMLCRRLP 206

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/120 (33%), Positives = 58/120 (48%), Gaps = 17/120 (14%)
Query: 344 LNWNHRYKILTGVASAVYYL-------QNEYDQKVVHRDLKASNILLDADFNARLGDFGL 396
           L  + R K LT    A YYL       Q  +  +V+HRDLK  N+ L+ D   ++GDFGL
Sbjct: 129 LELHKRRKALTE-PEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 187
Query: 397 ARAIE--NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           A  +E   ER          + GT  Y+APE       + E DV+  G ++  ++ G+ P
Sbjct: 188 ATKVEYDGERKKV-------LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/120 (33%), Positives = 58/120 (48%), Gaps = 17/120 (14%)
Query: 344 LNWNHRYKILTGVASAVYYL-------QNEYDQKVVHRDLKASNILLDADFNARLGDFGL 396
           L  + R K LT    A YYL       Q  +  +V+HRDLK  N+ L+ D   ++GDFGL
Sbjct: 103 LELHKRRKALTE-PEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 161
Query: 397 ARAIE--NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           A  +E   ER          + GT  Y+APE       + E DV+  G ++  ++ G+ P
Sbjct: 162 ATKVEYDGERKKV-------LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 30/225 (13%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQ----IAVKKFSRDSIKSK-GDFLAELAI-IXXXX 302
           LG G FG V +      D + +D T     +AVK     +  S+    ++EL I I    
Sbjct: 37  LGRGAFGQVIEA-----DAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 91
Query: 303 XXXXXXXXGWCHEKG-KLLLVYDFMPNGSLEKYLYGTSEQVT-----------LNWNHRY 350
                   G C + G  L+++ +F   G+L  YL     +             L   H  
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 351 KILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEH 410
                VA  + +L +   +K +HRDL A NILL      ++ DFGLAR I  + +     
Sbjct: 152 XYSFQVAKGMEFLAS---RKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX-VRK 207
Query: 411 GLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
           G   +P  + ++APE       T +SDV+ FG ++ E+   G SP
Sbjct: 208 GDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/120 (33%), Positives = 58/120 (48%), Gaps = 17/120 (14%)
Query: 344 LNWNHRYKILTGVASAVYYL-------QNEYDQKVVHRDLKASNILLDADFNARLGDFGL 396
           L  + R K LT    A YYL       Q  +  +V+HRDLK  N+ L+ D   ++GDFGL
Sbjct: 109 LELHKRRKALTE-PEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 167
Query: 397 ARAIE--NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           A  +E   ER          + GT  Y+APE       + E DV+  G ++  ++ G+ P
Sbjct: 168 ATKVEYDGERKK-------TLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 220

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 20/223 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIXXXXXX 304
           +LG+G FG+V +G     D        +AVK    D +   ++  DF+ E+  +      
Sbjct: 15  KLGDGSFGVVRRG---EWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 305 XXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                 G       + +V +  P GSL   L        L    RY +   VA  + YL+
Sbjct: 72  NLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE 128
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
           +   ++ +HRDL A N+LL      ++GDFGL RA+    +         VP    + AP
Sbjct: 129 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVP--FAWCAP 183
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP-----GNMIPHQ 461
           E   T   +  SD + FG  + E+   G+ P     G+ I H+
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 226

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/245 (22%), Positives = 110/245 (44%), Gaps = 32/245 (13%)
Query: 217 HNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIA 276
           H+   +++PGM       E       F +  R+G+G FG V+KGI +   Q       +A
Sbjct: 4   HSPVAVQVPGMQNNIADPE-----ELFTKLERIGKGSFGEVFKGIDNRTQQV------VA 52
Query: 277 VKKFSRDSIKSKGDFLA-ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGS-LEKY 334
           +K    +  + + + +  E+ ++            G   +  KL ++ +++  GS L+  
Sbjct: 53  IKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLL 112
Query: 335 LYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDF 394
             G  ++        ++I T +   +  L   + +K +HRD+KA+N+LL    + +L DF
Sbjct: 113 RAGPFDE--------FQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADF 164
Query: 395 GLARAIEN---ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCG 451
           G+A  + +   +RN++         GT  ++APE         ++D++  G   +E+  G
Sbjct: 165 GVAGQLTDTQIKRNTFV--------GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG 216
Query: 452 RSPGN 456
             P +
Sbjct: 217 EPPNS 221

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 63/145 (43%), Gaps = 20/145 (13%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE--------YDQ 369
           +L L+  F   GSL  YL G      + WN    +   ++  + YL  +        +  
Sbjct: 87  ELWLITAFHDKGSLTDYLKGN----IITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKP 142
Query: 370 KVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT 429
            + HRD K+ N+LL +D  A L DFGLA   E  +     HG V   GT  Y+APE    
Sbjct: 143 SIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV---GTRRYMAPEVLEG 199
Query: 430 G-----KATPESDVFGFGAVVLEVV 449
                  A    D++  G V+ E+V
Sbjct: 200 AINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELAIIXXXXXXX 305
           LG+G FG V    I   D+  +   + AVK  S+  +K K D    L E+ ++       
Sbjct: 57  LGKGSFGEV----ILCKDK--ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                 +  +KG   LV +    G L   +        ++     +I+  V S + Y+  
Sbjct: 111 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSGITYM-- 165
Query: 366 EYDQKVVHRDLKASNILLDA---DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
            +  K+VHRDLK  N+LL++   D N R+ DFGL+   E      A   +    GT  Y+
Sbjct: 166 -HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE------ASKKMKDKIGTAYYI 218
Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSPGN 456
           APE  H G    + DV+  G ++  ++ G  P N
Sbjct: 219 APEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 251

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 7/139 (5%)
Query: 316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           K  L LV   M  G +  ++Y   E        R    T  A  V  L++ + + +++RD
Sbjct: 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT--AQIVSGLEHLHQRNIIYRD 314
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  N+LLD D N R+ D GL  A+E +       G  G P   G++APE     +    
Sbjct: 315 LKPENVLLDDDGNVRISDLGL--AVELKAGQTKTKGYAGTP---GFMAPELLLGEEYDFS 369
Query: 436 SDVFGFGAVVLEVVCGRSP 454
            D F  G  + E++  R P
Sbjct: 370 VDYFALGVTLYEMIAARGP 388

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 10/137 (7%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK 377
           +L  V ++   G L  + + + E+V      R+     + SA+ YL +E  + VV+RDLK
Sbjct: 225 RLCFVMEYANGGEL--FFHLSRERVFSEDRARF-YGAEIVSALDYLHSE--KNVVYRDLK 279
Query: 378 ASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESD 437
             N++LD D + ++ DFGL +  E  ++        G P    Y+APE           D
Sbjct: 280 LENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTP---EYLAPEVLEDNDYGRAVD 334
Query: 438 VFGFGAVVLEVVCGRSP 454
            +G G V+ E++CGR P
Sbjct: 335 WWGLGVVMYEMMCGRLP 351

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 7/139 (5%)
Query: 316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           K  L LV   M  G +  ++Y   E        R    T  A  V  L++ + + +++RD
Sbjct: 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT--AQIVSGLEHLHQRNIIYRD 314
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  N+LLD D N R+ D GL  A+E +       G  G P   G++APE     +    
Sbjct: 315 LKPENVLLDDDGNVRISDLGL--AVELKAGQTKTKGYAGTP---GFMAPELLLGEEYDFS 369
Query: 436 SDVFGFGAVVLEVVCGRSP 454
            D F  G  + E++  R P
Sbjct: 370 VDYFALGVTLYEMIAARGP 388

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 10/137 (7%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK 377
           +L  V ++   G L  + + + E+V      R+     + SA+ YL +E  + VV+RDLK
Sbjct: 222 RLCFVMEYANGGEL--FFHLSRERVFSEDRARF-YGAEIVSALDYLHSE--KNVVYRDLK 276
Query: 378 ASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESD 437
             N++LD D + ++ DFGL +  E  ++        G P    Y+APE           D
Sbjct: 277 LENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTP---EYLAPEVLEDNDYGRAVD 331
Query: 438 VFGFGAVVLEVVCGRSP 454
            +G G V+ E++CGR P
Sbjct: 332 WWGLGVVMYEMMCGRLP 348

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 7/139 (5%)
Query: 316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           K  L LV   M  G +  ++Y   E        R    T  A  V  L++ + + +++RD
Sbjct: 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT--AQIVSGLEHLHQRNIIYRD 314
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  N+LLD D N R+ D GL  A+E +       G  G P   G++APE     +    
Sbjct: 315 LKPENVLLDDDGNVRISDLGL--AVELKAGQTKTKGYAGTP---GFMAPELLLGEEYDFS 369
Query: 436 SDVFGFGAVVLEVVCGRSP 454
            D F  G  + E++  R P
Sbjct: 370 VDYFALGVTLYEMIAARGP 388

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
            LG+G FG VYK       Q    +   A K     S +   D++ E+ I+         
Sbjct: 44  ELGDGAFGKVYKA------QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 97
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                 + +  L ++ +F   G+++  +      +T   +    +      A+ YL   +
Sbjct: 98  KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT--ESQIQVVCKQTLDALNYL---H 152
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           D K++HRDLKA NIL   D + +L DFG++   +N R        +G P  M      C 
Sbjct: 153 DNKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDSFIGTPYWMAPEVVMC- 209
Query: 428 HTGKATP---ESDVFGFGAVVLEV 448
            T K  P   ++DV+  G  ++E+
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 20/223 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIXXXXXX 304
           +LG+G FG+V +G     D        +AVK    D +   ++  DF+ E+  +      
Sbjct: 25  KLGDGSFGVVRRG---EWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 305 XXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
                 G       + +V +  P GSL   L        L    RY +   VA  + YL+
Sbjct: 82  NLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE 138
Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
           +   ++ +HRDL A N+LL      ++GDFGL RA+    +         VP    + AP
Sbjct: 139 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVP--FAWCAP 193
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVC-GRSP-----GNMIPHQ 461
           E   T   +  SD + FG  + E+   G+ P     G+ I H+
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 236

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELAIIXXXXXXX 305
           LG+G FG V    I   D+  +   + AVK  S+  +K K D    L E+ ++       
Sbjct: 58  LGKGSFGEV----ILCKDK--ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                 +  +KG   LV +    G L   +        ++     +I+  V S + Y+  
Sbjct: 112 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSGITYM-- 166
Query: 366 EYDQKVVHRDLKASNILLDA---DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
            +  K+VHRDLK  N+LL++   D N R+ DFGL+   E      A   +    GT  Y+
Sbjct: 167 -HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE------ASKKMKDKIGTAYYI 219
Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSPGN 456
           APE  H G    + DV+  G ++  ++ G  P N
Sbjct: 220 APEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 252

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA-ELAIIXXXXXXXX 306
           R+G+G FG VYKGI +H  +       +A+K    +  + + + +  E+ ++        
Sbjct: 26  RIGKGSFGEVYKGIDNHTKEV------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 79
Query: 307 XXXXGWCHEKGKLLLVYDFMPNGS-LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
               G   +  KL ++ +++  GS L+    G  E+  +       IL  +   + YL +
Sbjct: 80  TRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHS 134
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN---ERNSYAEHGLVGVPGTMGYV 422
           E   + +HRD+KA+N+LL    + +L DFG+A  + +   +RN +         GT  ++
Sbjct: 135 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV--------GTPFWM 183
Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSPGN 456
           APE         ++D++  G   +E+  G  P +
Sbjct: 184 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNS 217

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 25/240 (10%)
Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF--LAELAI 297
            + + +  ++G+G FG V+K       ++     ++A+KK   ++ K       L E+ I
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKA------RHRKTGQKVALKKVLMENEKEGFPITALREIKI 70
Query: 298 IXXXXXXXXXXXXGWCHEKGK--------LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR 349
           +              C  K          + LV+DF  +  L   L     + TL+   R
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 129
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
             ++  + + +YY+   +  K++HRD+KA+N+L+  D   +L DFGLARA    +NS   
Sbjct: 130 --VMQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 410 HGLVGVPGTMGYVAPECFHTGKAT-PESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV 468
                V  T+ Y  PE     +   P  D++G G ++ E +  RSP      +QH   L+
Sbjct: 185 RYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAE-MWTRSPIMQGNTEQHQLALI 242

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 7/139 (5%)
Query: 316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           K  L LV   M  G +  ++Y   E        R    T  A  V  L++ + + +++RD
Sbjct: 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT--AQIVSGLEHLHQRNIIYRD 314
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  N+LLD D N R+ D GL  A+E +       G  G P   G++APE     +    
Sbjct: 315 LKPENVLLDDDGNVRISDLGL--AVELKAGQTKTKGYAGTP---GFMAPELLLGEEYDFS 369
Query: 436 SDVFGFGAVVLEVVCGRSP 454
            D F  G  + E++  R P
Sbjct: 370 VDYFALGVTLYEMIAARGP 388

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 105/223 (47%), Gaps = 27/223 (12%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIXXXXXXXX 306
           +LGEG +  VYKG      +  + +  +A+K+   +  + +    + E++++        
Sbjct: 9   KLGEGTYATVYKG------KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 307 XXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR---YKILTGVASAVYYL 363
                  H +  L LV++++ +  L++YL      + ++ N +   +++L G+A      
Sbjct: 63  VTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMH-NVKLFLFQLLRGLAYC---- 116
Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
              + QKV+HRDLK  N+L++     +L DFGLARA      +Y    +     T+ Y  
Sbjct: 117 ---HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-----TLWYRP 168
Query: 424 PE-CFHTGKATPESDVFGFGAVVLEVVCGRS--PGNMIPHQQH 463
           P+    +   + + D++G G +  E+  GR   PG+ +  Q H
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH 211

>pdb|1GSL|A Chain A, Lectin (Fourth Isolated From (Griffonia Simplicifolia)) Complex With Y Human Blood Group Determinant Length = 243

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 78/156 (50%), Gaps = 13/156 (8%)
Query: 12  SGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKA-NHFVAIEFDT--VKQGFDPDDN 68
           +  GLAF +AP DS      YG +LGL    T  + + N  VA+EFDT   K   DP   
Sbjct: 87  TADGLAFFLAPVDS--SVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYP 144
Query: 69  HLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPL 128
           H+G+++NS+VS      +++     S  T++   + YD +SK++ V +  E     +  +
Sbjct: 145 HIGIDVNSIVSVATTRWENDDAYGSSIATAH---ITYDARSKILTVLLSYE---HGRDYI 198
Query: 129 LKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSW 164
           L   ++L   L  +   GFSA  GY   ++  + SW
Sbjct: 199 LSHVVDLAKVLPQKVRIGFSAGVGYD--EVTYILSW 232

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 10/137 (7%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK 377
           +L  V ++   G L  + + + E+V      R+     + SA+ YL +E  + VV+RDLK
Sbjct: 84  RLCFVMEYANGGEL--FFHLSRERVFSEDRARF-YGAEIVSALDYLHSE--KNVVYRDLK 138
Query: 378 ASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESD 437
             N++LD D + ++ DFGL +  E  ++        G P    Y+APE           D
Sbjct: 139 LENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTP---EYLAPEVLEDNDYGRAVD 193
Query: 438 VFGFGAVVLEVVCGRSP 454
            +G G V+ E++CGR P
Sbjct: 194 WWGLGVVMYEMMCGRLP 210

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 10/137 (7%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK 377
           +L  V ++   G L  + + + E+V      R+     + SA+ YL +E  + VV+RDLK
Sbjct: 82  RLCFVMEYANGGEL--FFHLSRERVFSEDRARF-YGAEIVSALDYLHSE--KNVVYRDLK 136
Query: 378 ASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESD 437
             N++LD D + ++ DFGL +  E  ++        G P    Y+APE           D
Sbjct: 137 LENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTP---EYLAPEVLEDNDYGRAVD 191
Query: 438 VFGFGAVVLEVVCGRSP 454
            +G G V+ E++CGR P
Sbjct: 192 WWGLGVVMYEMMCGRLP 208

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 32/227 (14%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQ----IAVKKFSRDSIKSK-GDFLAELAI-IXXXX 302
           LG G FG V +      D + +D T     +AVK     +  S+    ++EL I I    
Sbjct: 35  LGRGAFGQVIEA-----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 303 XXXXXXXXGWCHEKG-KLLLVYDFMPNGSLEKYLYGTSEQVT-------------LNWNH 348
                   G C + G  L+++ +F   G+L  YL     +               L   H
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
                  VA  + +L +   +K +HRDL A NILL      ++ DFGLAR I  + +   
Sbjct: 150 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX-V 205
Query: 409 EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
             G   +P  + ++APE       T +SDV+ FG ++ E+   G SP
Sbjct: 206 RKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
            LG+G FG VYK       Q    +   A K     S +   D++ E+ I+         
Sbjct: 44  ELGDGAFGKVYKA------QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 97
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                 + +  L ++ +F   G+++  +      +T   +    +      A+ YL   +
Sbjct: 98  KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT--ESQIQVVCKQTLDALNYL---H 152
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           D K++HRDLKA NIL   D + +L DFG++   +N R        +G P  M      C 
Sbjct: 153 DNKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDXFIGTPYWMAPEVVMC- 209
Query: 428 HTGKATP---ESDVFGFGAVVLEV 448
            T K  P   ++DV+  G  ++E+
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 10/137 (7%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK 377
           +L  V ++   G L  + + + E+V      R+     + SA+ YL +E  + VV+RDLK
Sbjct: 83  RLCFVMEYANGGEL--FFHLSRERVFSEDRARF-YGAEIVSALDYLHSE--KNVVYRDLK 137
Query: 378 ASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESD 437
             N++LD D + ++ DFGL +  E  ++        G P    Y+APE           D
Sbjct: 138 LENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTP---EYLAPEVLEDNDYGRAVD 192
Query: 438 VFGFGAVVLEVVCGRSP 454
            +G G V+ E++CGR P
Sbjct: 193 WWGLGVVMYEMMCGRLP 209

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 20/221 (9%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF-SRDSIKSKGDFLAELAIIX 299
           NN      LG G FG V +       +      ++AVK   S      K   ++EL I+ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDA-VLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 300 XX-XXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQV-----------TLNWN 347
                       G C   G +L++ ++   G L  +L   S  +           TL+  
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTR 164
Query: 348 HRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY 407
                 + VA  + +L +   +  +HRD+ A N+LL     A++GDFGLAR I N+ N Y
Sbjct: 165 DLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN-Y 220
Query: 408 AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
              G   +P  + ++APE       T +SDV+ +G ++ E+
Sbjct: 221 IVKGNARLP--VKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 23/219 (10%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAIIXXXXXXXX 306
           LG+G FG V +  +   D   V   ++AVK    D I S    +FL E A +        
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFV---KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 307 XXXXG---WCHEKGKL---LLVYDFMPNGSLEKYLYGT---SEQVTLNWNHRYKILTGVA 357
               G       KG+L   +++  FM +G L  +L  +        L      + +  +A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG-VP 416
             + YL +   +  +HRDL A N +L  D    + DFGL+R I +    Y   G    +P
Sbjct: 148 CGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS--GDYYRQGCASKLP 202
Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
             + ++A E       T  SDV+ FG  + E++  G++P
Sbjct: 203 --VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE--NERNSYAEHGLVGVP 416
            V YL N    +V+HRDLK  N+ L+ D + ++GDFGLA  IE   ER          + 
Sbjct: 138 GVQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKK-------DLC 187
Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           GT  Y+APE       + E D++  G ++  ++ G+ P
Sbjct: 188 GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|1FAT|A Chain A, Phytohemagglutinin-L Length = 252

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 80/156 (51%), Gaps = 18/156 (11%)
Query: 15  GLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKAN-HFVAIEFDTV-KQGFDPDDNHLGL 72
           GLAF + P  S P +   G +LGL     DG+ +N H VA+EFDT+  + +DP + H+G+
Sbjct: 87  GLAFALVPVGSQPKDK--GGFLGLF----DGSNSNFHTVAVEFDTLYNKDWDPTERHIGI 140
Query: 73  NINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKET 132
           ++NS+ S K             +G +  V + YD  + L+   +    +      ++ +T
Sbjct: 141 DVNSIRSIKTTRWD------FVNGENAEVLITYDSSTNLLVASLVYPSQ--KTSFIVSDT 192
Query: 133 INLKDYLKPESYFGFSASTGYP--HIQLNCVRSWTL 166
           ++LK  L      GFSA+TG    +++ N V SW+ 
Sbjct: 193 VDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSF 228

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 32/227 (14%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQ----IAVKKFSRDSIKSK-GDFLAELAI-IXXXX 302
           LG G FG V +      D + +D T     +AVK     +  S+    ++EL I I    
Sbjct: 26  LGRGAFGQVIEA-----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 80
Query: 303 XXXXXXXXGWCHEKG-KLLLVYDFMPNGSLEKYLYGTSEQVT-------------LNWNH 348
                   G C + G  L+++ +F   G+L  YL     +               L   H
Sbjct: 81  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
                  VA  + +L +   +K +HRDL A NILL      ++ DFGLAR I  + +   
Sbjct: 141 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX-V 196
Query: 409 EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
             G   +P  + ++APE       T +SDV+ FG ++ E+   G SP
Sbjct: 197 RKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           ++G+G  G VY  +     Q      ++A+++ +      K   + E+ ++         
Sbjct: 27  KIGQGASGTVYTAMDVATGQ------EVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                     +L +V +++  GSL       ++ VT       +I       +  L+  +
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
             +V+HRD+K+ NILL  D + +L DFG    I  E++  +E  +VG P    ++APE  
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSE--MVGTP---YWMAPEVV 188
Query: 428 HTGKATPESDVFGFGAVVLEVVCGRSP 454
                 P+ D++  G + +E++ G  P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 32/227 (14%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQ----IAVKKFSRDSIKSK-GDFLAELAI-IXXXX 302
           LG G FG V +      D + +D T     +AVK     +  S+    ++EL I I    
Sbjct: 26  LGRGAFGQVIEA-----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 80
Query: 303 XXXXXXXXGWCHEKG-KLLLVYDFMPNGSLEKYLYGTSEQVT-------------LNWNH 348
                   G C + G  L+++ +F   G+L  YL     +               L   H
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
                  VA  + +L +   +K +HRDL A NILL      ++ DFGLAR I  + +   
Sbjct: 141 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX-V 196
Query: 409 EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
             G   +P  + ++APE       T +SDV+ FG ++ E+   G SP
Sbjct: 197 RKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|1G8W|A Chain A, Improved Structure Of Phytohemagglutinin-L From The Kidney Bean Length = 233

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 80/156 (51%), Gaps = 18/156 (11%)
Query: 15  GLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKAN-HFVAIEFDTV-KQGFDPDDNHLGL 72
           GLAF + P  S P +   G +LGL     DG+ +N H VA+EFDT+  + +DP + H+G+
Sbjct: 87  GLAFALVPVGSQPKDK--GGFLGLF----DGSNSNFHTVAVEFDTLYNKDWDPTERHIGI 140
Query: 73  NINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKET 132
           ++NS+ S K             +G +  V + YD  + L+   +    +      ++ +T
Sbjct: 141 DVNSIRSIKTTRWD------FVNGENAEVLITYDSSTNLLVASLVYPSQ--KTSFIVSDT 192
Query: 133 INLKDYLKPESYFGFSASTGYP--HIQLNCVRSWTL 166
           ++LK  L      GFSA+TG    +++ N V SW+ 
Sbjct: 193 VDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSF 228

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE--NERNSYAEHGLVGVP 416
            V YL N    +V+HRDLK  N+ L+ D + ++GDFGLA  IE   ER          + 
Sbjct: 154 GVQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKK-------DLC 203
Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           GT  Y+APE       + E D++  G ++  ++ G+ P
Sbjct: 204 GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE--NERNSYAEHGLVGVP 416
            V YL N    +V+HRDLK  N+ L+ D + ++GDFGLA  IE   ER       L G P
Sbjct: 154 GVQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKK----TLCGTP 206
Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
               Y+APE       + E D++  G ++  ++ G+ P
Sbjct: 207 ---NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 16/217 (7%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF-SRDSIKSKGDFLAELAIIX 299
           NN      LG G FG V +       +      ++AVK   S      K   ++EL I+ 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDA-VLKVAVKMLKSTAHADEKEALMSELKIMS 96
Query: 300 XX-XXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQ-------VTLNWNHRYK 351
                       G C   G +L++ ++   G L  +L   +E          L       
Sbjct: 97  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH 156
Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
             + VA  + +L +   +  +HRD+ A N+LL     A++GDFGLAR I N+ N Y   G
Sbjct: 157 FSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN-YIVKG 212
Query: 412 LVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
              +P  + ++APE       T +SDV+ +G ++ E+
Sbjct: 213 NARLP--VKWMAPESIFDCVYTVQSDVWSYGILLWEI 247

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE--NERNSYAEHGLVGVP 416
            V YL N    +V+HRDLK  N+ L+ D + ++GDFGLA  IE   ER          + 
Sbjct: 154 GVQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKX-------LC 203
Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           GT  Y+APE       + E D++  G ++  ++ G+ P
Sbjct: 204 GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 28/222 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY      N ++      +A+K   +  ++  G       E+
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAR-EKNSKF-----ILALKVLFKAQLEKAGVEHQLRREV 59
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 60  EIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 113
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + +KV+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 114 ITELANALSYC---HSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA------ 164
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             + GT+ Y+ PE         + D++  G +  E + G+ P
Sbjct: 165 -ALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 32/227 (14%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQ----IAVKKFSRDSIKSK-GDFLAELAI-IXXXX 302
           LG G FG V +      D + +D T     +AVK     +  S+    ++EL I I    
Sbjct: 35  LGRGAFGQVIEA-----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 303 XXXXXXXXGWCHEKG-KLLLVYDFMPNGSLEKYLYGTSEQVT-------------LNWNH 348
                   G C + G  L+++ +F   G+L  YL     +               L   H
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
                  VA  + +L +   +K +HRDL A NILL      ++ DFGLAR I  + +   
Sbjct: 150 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDX-V 205
Query: 409 EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
             G   +P  + ++APE       T +SDV+ FG ++ E+   G SP
Sbjct: 206 RKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 16/217 (7%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF-SRDSIKSKGDFLAELAIIX 299
           NN      LG G FG V +       +      ++AVK   S      K   ++EL I+ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDA-VLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 300 XX-XXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQ-------VTLNWNHRYK 351
                       G C   G +L++ ++   G L  +L   +E          L       
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH 164
Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
             + VA  + +L +   +  +HRD+ A N+LL     A++GDFGLAR I N+ N Y   G
Sbjct: 165 FSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN-YIVKG 220
Query: 412 LVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
              +P  + ++APE       T +SDV+ +G ++ E+
Sbjct: 221 NARLP--VKWMAPESIFDCVYTVQSDVWSYGILLWEI 255

>pdb|1DBN|A Chain A, Maackia Amurensis Leukoagglutinin (Lectin) With Sialyllactose Length = 239

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 84/169 (49%), Gaps = 16/169 (9%)
Query: 3   RDPRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTV--- 59
           + P P  DI+  GLAF +AP DS  P  S  ++LGL N  ++ + +N  VA+EFDT    
Sbjct: 78  KAPNP--DITSDGLAFYLAPPDSQIPSGSVSKYLGLFNN-SNSDSSNQIVAVEFDTYFAH 134
Query: 60  -KQGFDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDR 118
               +DP+  H+G+++N + S K V         ++ G ++           LI   +  
Sbjct: 135 SYDPWDPNYRHIGIDVNGIESIKTVQWD-----WINGGVAFATITYLAPNKTLIASLVYP 189
Query: 119 EGETMPQKPLLKETINLKDYLKPESYFGFSASTGYP-HIQLNCVRSWTL 166
             +T      +  +++LK+ L      GFSA+TGYP  ++ + V SW+ 
Sbjct: 190 SNQTTFS---VAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWSF 235

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 22/211 (10%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK--FSRDSIKSKGDFLAELAIIXXXXXXXX 306
           +G+G FG V   I+  ND   +   +   K+    R+ ++   +   EL I+        
Sbjct: 23  IGKGSFGKV--CIVQKNDTKKMYAMKYMNKQKCVERNEVR---NVFKELQIMQGLEHPFL 77
Query: 307 XXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
                   ++  + +V D +  G L    Y   + V          +  +  A+ YLQN 
Sbjct: 78  VNLWYSFQDEEDMFMVVDLLLGGDLR---YHLQQNVHFKEETVKLFICELVMALDYLQN- 133
Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
             Q+++HRD+K  NILLD   +  + DF +A  +  E        +  + GT  Y+APE 
Sbjct: 134 --QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ------ITTMAGTKPYMAPEM 185
Query: 427 FHTGKATPES---DVFGFGAVVLEVVCGRSP 454
           F + K    S   D +  G    E++ GR P
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAI 297
           ++FH    +G+G FG V         ++  +    AVK   + +I   K +   ++E  +
Sbjct: 38  SDFHFLKVIGKGSFGKVLLA------RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV 91
Query: 298 IXXXXXXXXXXXXGWCHEKG-KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGV 356
           +             +  +   KL  V D++  G L  + +   E+  L    R+     +
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARF-YAAEI 148
Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP 416
           ASA+ YL   +   +V+RDLK  NILLD+  +  L DFGL +  EN  ++       G P
Sbjct: 149 ASALGYL---HSLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTP 203
Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
               Y+APE  H        D +  GAV+ E++ G  P
Sbjct: 204 ---EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|3UJO|A Chain A, Galactose-Specific Seed Lectin From Dolichos Lablab In Complex With Adenine And Galactose Length = 281

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 18/171 (10%)
Query: 15  GLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKA--NHFVAIEFDTV-KQGFDPDDNHLG 71
           GLAF + P  S P +   G +LGL   F   N A  N  VA+EFDT    G+DP + H+G
Sbjct: 109 GLAFALVPVGSQPKDK--GGFLGL---FDSKNYASSNQTVAVEFDTFYNGGWDPTERHIG 163
Query: 72  LNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKE 131
           +++NS+ S K            ++G +  V + YD  + L+   +    +      ++ E
Sbjct: 164 IDVNSIKSIKTTSWD------FANGENAEVLITYDSSTNLLVASLVHPSQ--KTSFIVSE 215
Query: 132 TINLKDYLKPESYFGFSASTGYP--HIQLNCVRSWTLDIDVIQTKKEKDWK 180
            ++L   L      GFSA+TG    +++ N V SW+    +   K++++ K
Sbjct: 216 RVDLTSVLPEWVSVGFSATTGLSKGYVETNEVLSWSFASKLSINKEDEENK 266

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 98/241 (40%), Gaps = 35/241 (14%)
Query: 238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAI 297
           +  ++F E   LG+G FG V K       +  +D+   A+KK  R + +     L+E+ +
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKI-RHTEEKLSTILSEVXL 55
Query: 298 IXXXX-XXXXXXXXGWCH------------EKGKLLLVYDFMPNGSLEKYLYGTSEQVTL 344
           +              W              +K  L +  ++  N +L   ++  SE +  
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIH--SENLNQ 113
Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
             +  +++   +  A+ Y+   + Q ++HR+LK  NI +D   N ++GDFGLA+ +    
Sbjct: 114 QRDEYWRLFRQILEALSYI---HSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 405 NSY---------AEHGLVGVPGTMGYVAPECFH-TGKATPESDVFGFGAVVLEVVCGRSP 454
           +           +   L    GT  YVA E    TG    + D +  G +  E +   S 
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFST 230
Query: 455 G 455
           G
Sbjct: 231 G 231

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/230 (23%), Positives = 98/230 (42%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY   +    Q       +A+K   +  ++  G       E+
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY---LAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G + K L   S   EQ T  +      
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY------ 118
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 119 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------ 169
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 170 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 18/220 (8%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF-SRDSIKSKGDFLAELAIIX 299
           NN      LG G FG V +       +      ++AVK   S      K   ++EL I+ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDA-VLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 300 XX-XXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVAS 358
                       G C   G +L++ ++   G L  +L   S    L  +  + I    AS
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR--VLETDPAFAIANSTAS 162
Query: 359 A--VYYLQNEYDQ--------KVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
              + +  ++  Q          +HRD+ A N+LL     A++GDFGLAR I N+ N Y 
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN-YI 221
Query: 409 EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
             G   +P  + ++APE       T +SDV+ +G ++ E+
Sbjct: 222 VKGNARLP--VKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELAIIXXXXXXX 305
           LG+G FG V    I   D+  +   + AVK  S+  +K K D    L E+ ++       
Sbjct: 34  LGKGSFGEV----ILCKDK--ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                 +  +KG   LV +    G L   +        ++     +I+  V S + Y   
Sbjct: 88  IXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSGITY--- 141
Query: 366 EYDQKVVHRDLKASNILLDA---DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
            +  K+VHRDLK  N+LL++   D N R+ DFGL+   E  +    +       GT  Y+
Sbjct: 142 XHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK------IGTAYYI 195
Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSPGN 456
           APE  H G    + DV+  G ++  ++ G  P N
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/299 (22%), Positives = 127/299 (42%), Gaps = 54/299 (18%)
Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXX 301
           +F E   +G GGFG V+K       ++ +D     +K+   ++ K++ +  A   +    
Sbjct: 12  DFKEIELIGSGGFGQVFKA------KHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVN 65
Query: 302 XXXXXXXXXGWCHE-----------KGKLLLV-YDFMPNGSLEKYLYGTSEQVTLNWNHR 349
                    G+ ++           K K L +  +F   G+LE+++     +  L+    
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLA 124
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
            ++   +   V Y+   + +K+++RDLK SNI L      ++GDFGL  +++N+      
Sbjct: 125 LELFEQITKGVDYI---HSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS 181
Query: 410 HGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV--VCGRSPGNMIPHQQHAYTL 467
                  GT+ Y++PE   +     E D++  G ++ E+  VC             A+  
Sbjct: 182 ------KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC-----------DTAFET 224
Query: 468 VDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS 526
             +   L R+G I D          + D+ ++ LL  L    P   +RP T +IL+ ++
Sbjct: 225 SKFFTDL-RDGIISD----------IFDKKEKTLLQKLLSKKP--EDRPNTSEILRTLT 270

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 14/107 (13%)
Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN------ 405
           I   +A AV +L   + + ++HRDLK SNI    D   ++GDFGL  A++ +        
Sbjct: 169 IFIQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 406 ---SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
              +YA H   G  GT  Y++PE  H    + + D+F  G ++ E++
Sbjct: 226 PMPAYATH--XGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA-ELAIIXXX 301
           F +  ++G+G FG V+KGI +   +       +A+K    +  + + + +  E+ ++   
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKV------VAIKIIDLEEAEDEIEDIQQEITVLSQC 62
Query: 302 XXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
                    G   +  KL ++ +++  GS    L    E   L+      IL  +   + 
Sbjct: 63  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLD 118
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN---ERNSYAEHGLVGVPGT 418
           YL +E   K +HRD+KA+N+LL      +L DFG+A  + +   +RN++         GT
Sbjct: 119 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--------GT 167
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             ++APE         ++D++  G   +E+  G  P
Sbjct: 168 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 121/302 (40%), Gaps = 48/302 (15%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY   +    Q       +A+K   +  ++  G       E+
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY---LAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G + K L   S   EQ T  +      
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY------ 118
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R        
Sbjct: 119 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRX------ 169
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW 472
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+  Y  +  V 
Sbjct: 170 -XLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRV- 226
Query: 473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI--ISGTST 530
                                V E  R L+  L   +P  S+RP   ++L+   I+  S+
Sbjct: 227 --------------EFTFPDFVTEGARDLISRLLKHNP--SQRPMLREVLEHPWITANSS 270
Query: 531 VP 532
            P
Sbjct: 271 KP 272

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY   +    Q       +A+K   +  ++  G       E+
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY---LAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREV 59
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 113
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 114 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA------ 164
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 165 -ALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA-ELAIIXXX 301
           F +  ++G+G FG V+KGI +   +       +A+K    +  + + + +  E+ ++   
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKV------VAIKIIDLEEAEDEIEDIQQEITVLSQC 82
Query: 302 XXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
                    G   +  KL ++ +++  GS    L    E   L+      IL  +   + 
Sbjct: 83  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLD 138
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN---ERNSYAEHGLVGVPGT 418
           YL +E   K +HRD+KA+N+LL      +L DFG+A  + +   +RN++         GT
Sbjct: 139 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--------GT 187
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             ++APE         ++D++  G   +E+  G  P
Sbjct: 188 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA-ELAIIXXX 301
           F +  ++G+G FG V+KGI +   +       +A+K    +  + + + +  E+ ++   
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKV------VAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 302 XXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
                    G   +  KL ++ +++  GS    L    E   L+      IL  +   + 
Sbjct: 78  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLD 133
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN---ERNSYAEHGLVGVPGT 418
           YL +E   K +HRD+KA+N+LL      +L DFG+A  + +   +RN +         GT
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV--------GT 182
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             ++APE         ++D++  G   +E+  G  P
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|1GNZ|A Chain A, Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)metal Free Form Length = 257

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 13/156 (8%)
Query: 13  GHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKA-NHFVAIEFDT-VKQGF-DPDDNH 69
             GLAF +AP DS   ++  G++LGL N  T    + N  VA+EFDT     F +P   H
Sbjct: 87  ADGLAFFLAPPDSDVKDA--GEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRH 144
Query: 70  LGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDR-EGETMPQKPL 128
           +G+N+NS+VS      +D+    +  G   T  + YDG ++++ V +   +G       +
Sbjct: 145 IGINVNSIVSVATKRWEDS---DIFSGKIATARISYDGSAEILTVVLSYPDGSDY----I 197
Query: 129 LKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSW 164
           L  +++++  L      G SASTG        + SW
Sbjct: 198 LSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSW 233

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 36/210 (17%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           L +  +F   G+LE+++     +  L+     ++   +   V Y+   + +K++HRDLK 
Sbjct: 109 LFIQMEFCDKGTLEQWIEKRRGE-KLDKVLALELFEQITKGVDYI---HSKKLIHRDLKP 164
Query: 379 SNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDV 438
           SNI L      ++GDFGL  +++N+             GT+ Y++PE   +     E D+
Sbjct: 165 SNIFLVDTKQVKIGDFGLVTSLKNDGKR------TRSKGTLRYMSPEQISSQDYGKEVDL 218
Query: 439 FGFGAVVLEV--VCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDE 496
           +  G ++ E+  VC             A+    +   L R+G I D          + D+
Sbjct: 219 YALGLILAELLHVC-----------DTAFETSKFFTDL-RDGIISD----------IFDK 256
Query: 497 AKRLLLLGLACSHPIASERPKTEDILQIIS 526
            ++ LL  L    P   +RP T +IL+ ++
Sbjct: 257 KEKTLLQKLLSKKP--EDRPNTSEILRTLT 284

>pdb|1HQL|A Chain A, The Xenograft Antigen In Complex With The B4 Isolectin Of Griffonia Simplicifolia Lectin-1 Length = 257

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 13/156 (8%)
Query: 13  GHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKA-NHFVAIEFDT-VKQGF-DPDDNH 69
             GLAF +AP DS   ++  G++LGL N  T    + N  VA+EFDT     F +P   H
Sbjct: 87  ADGLAFFLAPPDSDVKDA--GEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRH 144
Query: 70  LGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDR-EGETMPQKPL 128
           +G+N+NS+VS      +D+    +  G   T  + YDG ++++ V +   +G       +
Sbjct: 145 IGINVNSIVSVATKRWEDS---DIFSGKIATARISYDGSAEILTVVLSYPDGSDY----I 197
Query: 129 LKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSW 164
           L  +++++  L      G SASTG        + SW
Sbjct: 198 LSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSW 233

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/308 (22%), Positives = 125/308 (40%), Gaps = 48/308 (15%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY   +    Q       +A+K   +  ++  G       E+
Sbjct: 7   ALEDFEIGRPLGKGKFGNVY---LAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 114
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 115 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRT------ 165
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW 472
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+  Y  +  V 
Sbjct: 166 -TLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRV- 222
Query: 473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISGTST 530
                                V E  R L+  L   +P  S+RP   ++L+   I+  S+
Sbjct: 223 --------------EFTFPDFVTEGARDLISRLLKHNP--SQRPMLREVLEHPWITANSS 266
Query: 531 VPYVPQFK 538
            P   Q K
Sbjct: 267 KPSNSQNK 274

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYH---VDNTQIAVKKFSRDSIKSKGDFLA 293
           K +  +F     LG G FG V+     HN +Y+   V   +I V+      ++   D   
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR---LKQVEHTNDERL 58
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKIL 353
            L+I+            G   +  ++ ++ D++  G L   L     Q   N   ++   
Sbjct: 59  MLSIVTHPFIIRMW---GTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKF-YA 112
Query: 354 TGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLV 413
             V  A+ YL +   + +++RDLK  NILLD + + ++ DFG A+ + +       + L 
Sbjct: 113 AEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLC 164
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           G P    Y+APE   T       D + FG ++ E++ G +P
Sbjct: 165 GTP---DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY  +        +    +A+K   +  ++  G       E+
Sbjct: 32  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFI----LALKVLFKAQLEKAGVEHQLRREV 85
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 86  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 139
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 140 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------ 190
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 191 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 239

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY   +    Q       +A+K   +  ++  G       E+
Sbjct: 5   ALEDFEIGRPLGKGKFGNVY---LAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREV 58
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 59  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 112
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 113 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------ 163
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 164 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 212

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY   +    Q       +A+K   +  ++  G       E+
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY---LAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 116
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 117 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA------ 167
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 168 -ALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA---ELAIIXXXXXXX 305
           LGEG FG V K   H+  Q      ++A+K  SR  +K     +    E++ +       
Sbjct: 17  LGEGSFGKV-KLATHYKTQ-----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                        +++V ++   G L  Y+    E+  +  +   +    +  A+ Y   
Sbjct: 71  IIKLYDVITTPTDIVMVIEY-AGGELFDYIV---EKKRMTEDEGRRFFQQIICAIEYCHR 126
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
               K+VHRDLK  N+LLD + N ++ DFGL+  + +       + L    G+  Y APE
Sbjct: 127 ---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD------GNFLKTSCGSPNYAAPE 177
Query: 426 CFHTGK--ATPESDVFGFGAVVLEVVCGRSP 454
             + GK  A PE DV+  G V+  ++ GR P
Sbjct: 178 VIN-GKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 100/230 (43%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY  +     +  +    +A+K   +  ++  G       E+
Sbjct: 3   ALEDFEIGRPLGKGKFGNVY--LAREKQRKFI----LALKVLFKAQLEKAGVEHQLRREV 56
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 57  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 110
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 111 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------ 161
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 162 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 210

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY   +    Q       +A+K   +  ++  G       E+
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY---LAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 116
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 117 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------ 167
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 168 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 98/230 (42%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY        +       +A+K   +  ++  G       E+
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREV 59
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 113
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 114 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------ 164
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 165 -DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA-ELAIIXXX 301
           F +  ++G+G FG V+KGI +   +       +A+K    +  + + + +  E+ ++   
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKV------VAIKIIDLEEAEDEIEDIQQEITVLSQC 62
Query: 302 XXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
                    G   +  KL ++ +++  GS    L    E   L+      IL  +   + 
Sbjct: 63  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLD 118
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN---ERNSYAEHGLVGVPGT 418
           YL +E   K +HRD+KA+N+LL      +L DFG+A  + +   +RN +         GT
Sbjct: 119 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV--------GT 167
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             ++APE         ++D++  G   +E+  G  P
Sbjct: 168 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 98/230 (42%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY        +       +A+K   +  ++  G       E+
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 118
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 119 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------ 169
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 170 -DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY   +    Q       +A+K   +  ++  G       E+
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY---LAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 116
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 117 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------ 167
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 168 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY   +    Q       +A+K   +  ++  G       E+
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY---LAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREV 59
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 113
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 114 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------ 164
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 165 -XLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 98/230 (42%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY        +       +A+K   +  ++  G       E+
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 114
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 115 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------ 165
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 166 -DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/302 (21%), Positives = 122/302 (40%), Gaps = 48/302 (15%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY        +       +A+K   +  ++  G       E+
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 118
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 119 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------ 169
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW 472
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+  Y  +  V 
Sbjct: 170 -TLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRV- 226
Query: 473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI--ISGTST 530
                                V E  R L+  L   +P  S+RP   ++L+   I+  S+
Sbjct: 227 --------------EFTFPDFVTEGARDLISRLLKHNP--SQRPXLREVLEHPWITANSS 270
Query: 531 VP 532
            P
Sbjct: 271 KP 272

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 96/223 (43%), Gaps = 33/223 (14%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAIIXXXXXXX 305
           LG+G FG VY        +       +A+K   +  ++  G       E+ I        
Sbjct: 20  LGKGKFGNVYLA------RERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKILTGVASAVYY 362
                G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      +T +A+A+ Y
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY------ITELANALSY 127
Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
               + ++V+HRD+K  N+LL ++   ++ DFG +    + R +        + GT+ Y+
Sbjct: 128 C---HSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRT-------TLCGTLDYL 177
Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY 465
            PE         + D++  G +  E + G     M P + H Y
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-----MPPFEAHTY 215

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 98/230 (42%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY        +       +A+K   +  ++  G       E+
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREV 59
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 113
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 114 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------ 164
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 165 -DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY  +        +    +A+K   +  ++  G       E+
Sbjct: 23  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFI----LALKVLFKAQLEKAGVEHQLRREV 76
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 77  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 130
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 131 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------ 181
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 182 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 230

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY   +    Q       +A+K   +  ++  G       E+
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY---LAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREV 59
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 113
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 114 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------ 164
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 165 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY   +    Q       +A+K   +  ++  G       E+
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY---LAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 118
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 119 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------ 169
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 170 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY   +    Q       +A+K   +  ++  G       E+
Sbjct: 10  ALEDFEIGRPLGKGKFGNVY---LAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREV 63
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 64  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 117
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 118 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------ 168
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 169 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 217

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/302 (21%), Positives = 122/302 (40%), Gaps = 48/302 (15%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY  +        +    +A+K   +  ++  G       E+
Sbjct: 32  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFI----LALKVLFKAQLEKAGVEHQLRREV 85
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 86  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 139
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R        
Sbjct: 140 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD------ 190
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW 472
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+  Y  +  V 
Sbjct: 191 -DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRV- 247
Query: 473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI--ISGTST 530
                                V E  R L+  L   +P  S+RP   ++L+   I+  S+
Sbjct: 248 --------------EFTFPDFVTEGARDLISRLLKHNP--SQRPMLREVLEHPWITANSS 291
Query: 531 VP 532
            P
Sbjct: 292 KP 293

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY   +    Q       +A+K   +  ++  G       E+
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY---LAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREV 59
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 113
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +      
Sbjct: 114 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------ 164
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 165 -ELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 11/137 (8%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK 377
           +L  V ++   G L  + + + E+V      R+     + SA+ YL +   + VV+RD+K
Sbjct: 84  RLCFVMEYANGGEL--FFHLSRERVFTEERARF-YGAEIVSALEYLHS---RDVVYRDIK 137
Query: 378 ASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESD 437
             N++LD D + ++ DFGL +  E   +        G P    Y+APE           D
Sbjct: 138 LENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTP---EYLAPEVLEDNDYGRAVD 192
Query: 438 VFGFGAVVLEVVCGRSP 454
            +G G V+ E++CGR P
Sbjct: 193 WWGLGVVMYEMMCGRLP 209

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 11/137 (8%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK 377
           +L  V ++   G L  + + + E+V      R+     + SA+ YL +   + VV+RD+K
Sbjct: 79  RLCFVMEYANGGEL--FFHLSRERVFTEERARF-YGAEIVSALEYLHS---RDVVYRDIK 132
Query: 378 ASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESD 437
             N++LD D + ++ DFGL +  E   +        G P    Y+APE           D
Sbjct: 133 LENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTP---EYLAPEVLEDNDYGRAVD 187
Query: 438 VFGFGAVVLEVVCGRSP 454
            +G G V+ E++CGR P
Sbjct: 188 WWGLGVVMYEMMCGRLP 204

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 90/207 (43%), Gaps = 18/207 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           ++G+G  G VY  +     Q      ++A+++ +      K   + E+ ++         
Sbjct: 27  KIGQGASGTVYTAMDVATGQ------EVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                     +L +V +++  GSL       ++ VT       +I       +  L+  +
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
             +V+HRD+K+ NILL  D + +L DFG    I  E++  +   +VG P    ++APE  
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTP---YWMAPEVV 188
Query: 428 HTGKATPESDVFGFGAVVLEVVCGRSP 454
                 P+ D++  G + +E++ G  P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 90/207 (43%), Gaps = 18/207 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           ++G+G  G VY  +     Q      ++A+++ +      K   + E+ ++         
Sbjct: 27  KIGQGASGTVYTAMDVATGQ------EVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                     +L +V +++  GSL       ++ VT       +I       +  L+  +
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
             +V+HRD+K+ NILL  D + +L DFG    I  E++  +   +VG P    ++APE  
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGTP---YWMAPEVV 188
Query: 428 HTGKATPESDVFGFGAVVLEVVCGRSP 454
                 P+ D++  G + +E++ G  P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 40/239 (16%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF------SRDSIKSKGDFLAELAIIXXX 301
           +LG+G +GIV+K I     +       +AVKK       S D+ ++  + +  L  +   
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEV------VAVKKIFDAFQNSTDAQRTFREIMI-LTELSGH 68
Query: 302 XXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
                            + LV+D+M     E  L+       L   H+  ++  +   + 
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIKVIK 123
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER----------NSYAEHG 411
           YL   +   ++HRD+K SNILL+A+ + ++ DFGL+R+  N R          N   E+ 
Sbjct: 124 YL---HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 412 ------LVGVPGTMGYVAPEC-FHTGKATPESDVFGFGAVVLEVVCGRS--PGNMIPHQ 461
                 L     T  Y APE    + K T   D++  G ++ E++CG+   PG+   +Q
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 11/137 (8%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK 377
           +L  V ++   G L  + + + E+V      R+     + SA+ YL +   + VV+RD+K
Sbjct: 79  RLCFVMEYANGGEL--FFHLSRERVFTEERARF-YGAEIVSALEYLHS---RDVVYRDIK 132
Query: 378 ASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESD 437
             N++LD D + ++ DFGL +  E   +        G P    Y+APE           D
Sbjct: 133 LENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTP---EYLAPEVLEDNDYGRAVD 187
Query: 438 VFGFGAVVLEVVCGRSP 454
            +G G V+ E++CGR P
Sbjct: 188 WWGLGVVMYEMMCGRLP 204

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 20/221 (9%)
Query: 237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LA 293
           K   N+F     LG+G FG V         +Y+      A+K   ++ I +K +    + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYY------AMKILRKEVIIAKDEVAHTVT 54
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKIL 353
           E  ++                   +L  V ++   G L  + + + E+V      R+   
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF-YG 111
Query: 354 TGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLV 413
             + SA+ YL +   + VV+RD+K  N++LD D + ++ DFGL +  E   +        
Sbjct: 112 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC 166
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           G P    Y+APE           D +G G V+ E++CGR P
Sbjct: 167 GTP---EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 90/207 (43%), Gaps = 18/207 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           ++G+G  G VY  +     Q      ++A+++ +      K   + E+ ++         
Sbjct: 28  KIGQGASGTVYTAMDVATGQ------EVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                     +L +V +++  GSL       ++ VT       +I       +  L+  +
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH 134
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
             +V+HRD+K+ NILL  D + +L DFG    I  E++  +   +VG P    ++APE  
Sbjct: 135 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGTP---YWMAPEVV 189
Query: 428 HTGKATPESDVFGFGAVVLEVVCGRSP 454
                 P+ D++  G + +E++ G  P
Sbjct: 190 TRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 11/137 (8%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK 377
           +L  V ++   G L  + + + E+V      R+     + SA+ YL +   + VV+RD+K
Sbjct: 79  RLCFVMEYANGGEL--FFHLSRERVFTEERARF-YGAEIVSALEYLHS---RDVVYRDIK 132
Query: 378 ASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESD 437
             N++LD D + ++ DFGL +  E   +        G P    Y+APE           D
Sbjct: 133 LENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTP---EYLAPEVLEDNDYGRAVD 187
Query: 438 VFGFGAVVLEVVCGRSP 454
            +G G V+ E++CGR P
Sbjct: 188 WWGLGVVMYEMMCGRLP 204

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 11/137 (8%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK 377
           +L  V ++   G L  + + + E+V      R+     + SA+ YL +   + VV+RD+K
Sbjct: 82  RLCFVMEYANGGEL--FFHLSRERVFTEERARF-YGAEIVSALEYLHS---RDVVYRDIK 135
Query: 378 ASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESD 437
             N++LD D + ++ DFGL +  E   +        G P    Y+APE           D
Sbjct: 136 LENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTP---EYLAPEVLEDNDYGRAVD 190
Query: 438 VFGFGAVVLEVVCGRSP 454
            +G G V+ E++CGR P
Sbjct: 191 WWGLGVVMYEMMCGRLP 207

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 11/137 (8%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK 377
           +L  V ++   G L  + + + E+V      R+     + SA+ YL +   + VV+RD+K
Sbjct: 79  RLCFVMEYANGGEL--FFHLSRERVFTEERARF-YGAEIVSALEYLHS---RDVVYRDIK 132
Query: 378 ASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESD 437
             N++LD D + ++ DFGL +  E   +        G P    Y+APE           D
Sbjct: 133 LENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTP---EYLAPEVLEDNDYGRAVD 187
Query: 438 VFGFGAVVLEVVCGRSP 454
            +G G V+ E++CGR P
Sbjct: 188 WWGLGVVMYEMMCGRLP 204

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 95/223 (42%), Gaps = 33/223 (14%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAIIXXXXXXX 305
           LG+G FG VY        +       +A+K   +  ++  G       E+ I        
Sbjct: 20  LGKGKFGNVYLA------RERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKILTGVASAVYY 362
                G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      +T +A+A+ Y
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY------ITELANALSY 127
Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
               + ++V+HRD+K  N+LL ++   ++ DFG +    + R          + GT+ Y+
Sbjct: 128 C---HSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRD-------TLCGTLDYL 177
Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY 465
            PE         + D++  G +  E + G     M P + H Y
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-----MPPFEAHTY 215

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 97/230 (42%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY        +       +A+K   +  ++  G       E+
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 116
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R        
Sbjct: 117 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD------ 167
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 168 -DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 98/230 (42%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY   +    Q       +A+K   +  ++  G       E+
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY---LAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREV 59
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 113
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R        
Sbjct: 114 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRX------ 164
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 165 -XLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 98/230 (42%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY   +    Q       +A+K   +  ++  G       E+
Sbjct: 8   ALEDFEIGRPLGKGKFGNVY---LAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREV 61
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 115
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R        
Sbjct: 116 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRX------ 166
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 167 -XLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 215

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 97/230 (42%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY        +       +A+K   +  ++  G       E+
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 114
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R        
Sbjct: 115 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD------ 165
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 166 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 98/230 (42%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY   +    Q       +A+K   +  ++  G       E+
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY---LAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 116
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R        
Sbjct: 117 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRX------ 167
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 168 -XLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 22/223 (9%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF-SRDSIKSKGDFLAELAIIX 299
           NN      LG G FG V +       +      ++AVK   S      K   ++EL I+ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAV-LKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 300 XX-XXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYL-----------YGTSEQVTLNWN 347
                       G C   G +L++ ++   G L  +L           Y  S       +
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLS 164
Query: 348 HR--YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN 405
            R      + VA  + +L +   +  +HRD+ A N+LL     A++GDFGLAR I N+ N
Sbjct: 165 SRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 221
Query: 406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV 448
            Y   G   +P  + ++APE       T +SDV+ +G ++ E+
Sbjct: 222 -YIVKGNARLP--VKWMAPESIFDCVYTVQSDVWSYGILLWEI 261

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 99/244 (40%), Gaps = 30/244 (12%)
Query: 228 PREFKYKE-LKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF-SRDSI 285
           P +  Y E  +   NN      LG G FG V +       +      ++AVK   S    
Sbjct: 17  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDA-VLKVAVKMLKSTAHA 75
Query: 286 KSKGDFLAELAIIXXXXX-XXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVT- 343
             K   ++EL I+             G C   G +L++ ++   G L  +L   +E +  
Sbjct: 76  DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLG 135
Query: 344 -------------------LNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD 384
                              L         + VA  + +L +   +  +HRD+ A N+LL 
Sbjct: 136 PSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLT 192
Query: 385 ADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAV 444
               A++GDFGLAR I N+ N Y   G   +P  + ++APE       T +SDV+ +G +
Sbjct: 193 NGHVAKIGDFGLARDIMNDSN-YIVKGNARLP--VKWMAPESIFDCVYTVQSDVWSYGIL 249
Query: 445 VLEV 448
           + E+
Sbjct: 250 LWEI 253

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 71/162 (43%), Gaps = 25/162 (15%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE-------YDQKV 371
           L L+  F   GSL  +L        ++WN    I   +A  + YL  +       +   +
Sbjct: 97  LWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAI 152
Query: 372 VHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG- 430
            HRD+K+ N+LL  +  A + DFGLA   E  +++   HG V   GT  Y+APE      
Sbjct: 153 SHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV---GTRRYMAPEVLEGAI 209
Query: 431 ----KATPESDVFGFGAVVLEVV--CGRSPG----NMIPHQQ 462
                A    D++  G V+ E+   C  + G     M+P ++
Sbjct: 210 NFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/236 (21%), Positives = 96/236 (40%), Gaps = 22/236 (9%)
Query: 237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLA 293
           K   ++F     LG+G FG VY      N         +A+K   +  ++ +G       
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQN------KFIMALKVLFKSQLEKEGVEHQLRR 64
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKIL 353
           E+ I              + H++ ++ L+ +F P G L K L    +    +       +
Sbjct: 65  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFM 121
Query: 354 TGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLV 413
             +A A++Y    +++KV+HRD+K  N+L+      ++ DFG +    + R         
Sbjct: 122 EELADALHYC---HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR------- 171
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD 469
            + GT+ Y+ PE         + D++  G +  E + G  P +   H +    +V+
Sbjct: 172 XMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN 227

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/224 (21%), Positives = 92/224 (41%), Gaps = 22/224 (9%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAIIXXXXXXX 305
           LG+G FG VY      N         +A+K   +  ++ +G       E+ I        
Sbjct: 22  LGKGKFGNVYLAREKQN------KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
                 + H++ ++ L+ +F P G L K L    +    +       +  +A A++Y   
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYC-- 130
Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            +++KV+HRD+K  N+L+      ++ DFG +    + R          + GT+ Y+ PE
Sbjct: 131 -HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-------XMCGTLDYLPPE 182
Query: 426 CFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD 469
                    + D++  G +  E + G  P +   H +    +V+
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN 226

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY   +    Q       +A+K   +  ++  G       E+
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY---LAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 116
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ +FG +    + R +      
Sbjct: 117 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT------ 167
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 168 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 15/217 (6%)
Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQ-YHVDNTQIAVKKFSRDSIKSKGDFLA 293
           ++K     + +   LGEG F  VYK    + +Q   +   ++  +  ++D I      L 
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTA--LR 61
Query: 294 ELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKIL 353
           E+ ++                 K  + LV+DFM    LE  +   S  +T +    Y ++
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 354 TGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLV 413
           T     + YL   +   ++HRDLK +N+LLD +   +L DFGLA++  +   +Y  H +V
Sbjct: 121 T--LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYX-HQVV 174
Query: 414 GVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
               T  Y APE     +      D++  G ++ E++
Sbjct: 175 ----TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 106/252 (42%), Gaps = 32/252 (12%)
Query: 229 REFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS- 287
           ++ K KE+  +   F E   LGE  FG VYKG  H       + TQ    K  +D  +  
Sbjct: 16  KQAKLKEISLSAVRFMEE--LGEDRFGKVYKG--HLFGPAPGEQTQAVAIKTLKDKAEGP 71
Query: 288 -KGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE------ 340
            + +F  E  +             G   +   L +++ +  +G L ++L   S       
Sbjct: 72  LREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGS 131
Query: 341 -------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD 393
                  +  L       ++  +A+ + YL + +   VVH+DL   N+L+    N ++ D
Sbjct: 132 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISD 188
Query: 394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV---- 449
            GL R +    + Y   G   +P  + ++APE    GK + +SD++ +G V+ EV     
Sbjct: 189 LGLFREV-YAADYYKLLGNSLLP--IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 245
Query: 450 ---CGRSPGNMI 458
              CG S  +++
Sbjct: 246 QPYCGYSNQDVV 257

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAEL 295
           A  +F     LG+G FG VY   +    Q       +A+K   +  ++  G       E+
Sbjct: 8   ALEDFEIGRPLGKGKFGNVY---LAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREV 61
Query: 296 AIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKI 352
            I             G+ H+  ++ L+ ++ P G++ + L   S   EQ T  +      
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 115
Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +T +A+A+ Y    + ++V+HRD+K  N+LL +    ++ +FG +    + R +      
Sbjct: 116 ITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT------ 166
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
             + GT+ Y+ PE         + D++  G +  E + G+ P     +Q+
Sbjct: 167 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 215

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 8/99 (8%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAI-----ENERNSYAEHGLVGVPGTMGYVAPE 425
           V+HRDLK SN+L++++ + ++ DFGLAR I     +N   +  + G+V    T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
Query: 426 CFHT-GKATPESDVFGFGAVVLEVVCGRS--PGNMIPHQ 461
              T  K +   DV+  G ++ E+   R   PG    HQ
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231

>pdb|1N47|A Chain A, Isolectin B4 From Vicia Villosa In Complex With The Tn Antigen Length = 233

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 75/174 (43%), Gaps = 34/174 (19%)
Query: 15  GLAFVIAPNDSFPPESSYGQWLGLTNAFTDG--NKANHFVAIEFDTVKQGFDPDDNHLGL 72
           GLAF +AP D+ P   + G +LGL   F D   + +   VA+EFDT    +DP+  H+G+
Sbjct: 86  GLAFFLAPPDTQP--QARGGFLGL---FADRAHDASYQTVAVEFDTYSNAWDPNYTHIGI 140
Query: 73  NINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPL---L 129
           + N + S+K  P    Y      G    + + Y   +K +   +       P       +
Sbjct: 141 DTNGIESKKTTPFDMVY------GEKANIVITYQASTKALAASL-----VFPVSQTSYAV 189
Query: 130 KETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEKDWKWLV 183
              ++L+D L      GFSA+TG             L+  V++T     W + V
Sbjct: 190 SARVDLRDILPEYVRVGFSATTG-------------LNAGVVETHDIVSWSFAV 230

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAI 297
            +F+  M LG+G FG V        D+ +      AVK   +D +    D    + E  +
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELY------AVKILKKDVVIQDDDVECTMVEKRV 73
Query: 298 IXXXXXXXXXXXXGWCHEK-GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGV 356
           +              C +   +L  V +++  G L   +Y   +       H       +
Sbjct: 74  LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEI 130
Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP 416
           A  +++LQ+   + +++RDLK  N++LD++ + ++ DFG+ +  EN  +        G P
Sbjct: 131 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTP 185
Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
               Y+APE           D + FG ++ E++ G++P
Sbjct: 186 ---DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 124/302 (41%), Gaps = 34/302 (11%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           +LG G +G V   ++  +   HV+     ++K S  S  S    L E+A++         
Sbjct: 44  KLGSGAYGEV---LLCRDKVTHVERAIKIIRKTSV-STSSNSKLLEEVAVLKLLDHPNIM 99
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
               +  +K    LV +    G L   +     ++  N      I+  V S V YL   +
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYL---H 153
Query: 368 DQKVVHRDLKASNILLDA---DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
              +VHRDLK  N+LL++   D   ++ DFGL+   EN++       +    GT  Y+AP
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK------MKERLGTAYYIAP 207
Query: 425 ECFHTGKATPESDVFGFGAVVLEVVCGRSP-GNMIPH------QQHAYTLVDWVWMLHRE 477
           E     K   + DV+  G ++  ++ G  P G           ++  YT     W    E
Sbjct: 208 EVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE 266
Query: 478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHP-IASERPKTEDILQIISGTSTVPYVPQ 536
           G  +D + Q L  +S     +R +    A  HP I     K E  +++ S  + +  + +
Sbjct: 267 G-AKDLIKQMLQFDS-----QRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRK 320
Query: 537 FK 538
           F+
Sbjct: 321 FQ 322

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 59/114 (51%), Gaps = 7/114 (6%)
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           VA  + +L +   +  +HRDL A NILL      ++ DFGLAR I+N+ N Y   G   +
Sbjct: 177 VAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARL 232
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSPGNMIPHQQHAYTLV 468
           P  + ++APE       T ESDV+ +G  + E+   G SP   +P     Y ++
Sbjct: 233 P--VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 284

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 59/114 (51%), Gaps = 7/114 (6%)
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           VA  + +L +   +  +HRDL A NILL      ++ DFGLAR I+N+ N Y   G   +
Sbjct: 170 VAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARL 225
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSPGNMIPHQQHAYTLV 468
           P  + ++APE       T ESDV+ +G  + E+   G SP   +P     Y ++
Sbjct: 226 P--VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 277

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 92/221 (41%), Gaps = 28/221 (12%)
Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIX 299
           T+ +     +G G + +  + I      +   N + AVK       KSK D   E+ I+ 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCI------HKATNMEFAVKIID----KSKRDPTEEIEILL 70
Query: 300 XXXXXXXXXXXGWCHEKGKLL-LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVAS 358
                         ++ GK + +V + M  G L   L     Q   +      +L  +  
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL---LDKILRQKFFSEREASAVLFTITK 127
Query: 359 AVYYLQNEYDQKVVHRDLKASNIL-LDADFN---ARLGDFGLARAIENERNSYAEHGLVG 414
            V YL   + Q VVHRDLK SNIL +D   N    R+ DFG A+ +       AE+GL+ 
Sbjct: 128 TVEYL---HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR------AENGLLM 178
Query: 415 VPG-TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            P  T  +VAPE           D++  G ++  ++ G +P
Sbjct: 179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 59/114 (51%), Gaps = 7/114 (6%)
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           VA  + +L +   +  +HRDL A NILL      ++ DFGLAR I+N+ N Y   G   +
Sbjct: 172 VAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARL 227
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSPGNMIPHQQHAYTLV 468
           P  + ++APE       T ESDV+ +G  + E+   G SP   +P     Y ++
Sbjct: 228 P--VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 279

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/207 (21%), Positives = 90/207 (43%), Gaps = 18/207 (8%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           ++G+G  G VY  +     Q      ++A+++ +      K   + E+ ++         
Sbjct: 28  KIGQGASGTVYTAMDVATGQ------EVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                     +L +V +++  GSL       ++ VT       +I       +  L+  +
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH 134
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
             +V+HR++K+ NILL  D + +L DFG    I  E++  +   +VG P    ++APE  
Sbjct: 135 SNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTP---YWMAPEVV 189
Query: 428 HTGKATPESDVFGFGAVVLEVVCGRSP 454
                 P+ D++  G + +E++ G  P
Sbjct: 190 TRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 59/114 (51%), Gaps = 7/114 (6%)
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           VA  + +L +   +  +HRDL A NILL      ++ DFGLAR I+N+ N Y   G   +
Sbjct: 177 VAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSN-YVVKGNARL 232
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSPGNMIPHQQHAYTLV 468
           P  + ++APE       T ESDV+ +G  + E+   G SP   +P     Y ++
Sbjct: 233 P--VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 284

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 69/143 (48%), Gaps = 11/143 (7%)
Query: 316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           + +L  V +++  G L   ++    Q  L   H       ++ A+ YL   +++ +++RD
Sbjct: 78  ESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYL---HERGIIYRD 131
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  N+LLD++ + +L D+G+ +  E  R         G P    Y+APE          
Sbjct: 132 LKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTP---NYIAPEILRGEDYGFS 186
Query: 436 SDVFGFGAVVLEVVCGRSPGNMI 458
            D +  G ++ E++ GRSP +++
Sbjct: 187 VDWWALGVLMFEMMAGRSPFDIV 209

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 69/143 (48%), Gaps = 11/143 (7%)
Query: 316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           + +L  V +++  G L   ++    Q  L   H       ++ A+ YL   +++ +++RD
Sbjct: 82  ESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYL---HERGIIYRD 135
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  N+LLD++ + +L D+G+ +  E  R         G P    Y+APE          
Sbjct: 136 LKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTP---NYIAPEILRGEDYGFS 190
Query: 436 SDVFGFGAVVLEVVCGRSPGNMI 458
            D +  G ++ E++ GRSP +++
Sbjct: 191 VDWWALGVLMFEMMAGRSPFDIV 213

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 59/114 (51%), Gaps = 7/114 (6%)
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           VA  + +L +   +  +HRDL A NILL      ++ DFGLAR I+N+ N Y   G   +
Sbjct: 154 VAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARL 209
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSPGNMIPHQQHAYTLV 468
           P  + ++APE       T ESDV+ +G  + E+   G SP   +P     Y ++
Sbjct: 210 P--VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 69/143 (48%), Gaps = 11/143 (7%)
Query: 316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           + +L  V +++  G L   ++    Q  L   H       ++ A+ YL   +++ +++RD
Sbjct: 93  ESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYL---HERGIIYRD 146
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  N+LLD++ + +L D+G+ +  E  R         G P    Y+APE          
Sbjct: 147 LKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTP---NYIAPEILRGEDYGFS 201
Query: 436 SDVFGFGAVVLEVVCGRSPGNMI 458
            D +  G ++ E++ GRSP +++
Sbjct: 202 VDWWALGVLMFEMMAGRSPFDIV 224

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAI 297
            +F+  M LG+G FG V        D+ +      AVK   +D +    D    + E  +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELY------AVKILKKDVVIQDDDVECTMVEKRV 394
Query: 298 IXXXXXXXXXXXXGWCHEK-GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGV 356
           +              C +   +L  V +++  G L   +Y   +       H       +
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEI 451
Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP 416
           A  +++LQ+   + +++RDLK  N++LD++ + ++ DFG+ +  EN  +        G P
Sbjct: 452 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTP 506
Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
               Y+APE           D + FG ++ E++ G++P
Sbjct: 507 ---DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 96/244 (39%), Gaps = 49/244 (20%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF--SRDSIKSKGDFLAELAIIXXXXXXXX 306
           +GEG +G+V K    + D   +    +A+KKF  S D    K   + E+ ++        
Sbjct: 33  VGEGSYGMVMK--CRNKDTGRI----VAIKKFLESDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 307 XXXXGWCHEKGKLLLVYDFMPN---GSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYL 363
                 C +K +  LV++F+ +     LE +  G   QV     + ++I+ G+       
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVV--QKYLFQIINGIGFC---- 140
Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
              +   ++HRD+K  NIL+      +L DFG AR +      Y +        T  Y A
Sbjct: 141 ---HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE-----VATRWYRA 192
Query: 424 PECF----HTGKATPESDVFGFGAVVLEVVCGR-----------------SPGNMIPHQQ 462
           PE        GKA    DV+  G +V E+  G                    GN+IP  Q
Sbjct: 193 PELLVGDVKYGKAV---DVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249
Query: 463 HAYT 466
             + 
Sbjct: 250 ELFN 253

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 69/143 (48%), Gaps = 11/143 (7%)
Query: 316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           + +L  V +++  G L   ++    Q  L   H       ++ A+ YL   +++ +++RD
Sbjct: 125 ESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYL---HERGIIYRD 178
Query: 376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
           LK  N+LLD++ + +L D+G+ +  E  R         G P    Y+APE          
Sbjct: 179 LKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTP---NYIAPEILRGEDYGFS 233
Query: 436 SDVFGFGAVVLEVVCGRSPGNMI 458
            D +  G ++ E++ GRSP +++
Sbjct: 234 VDWWALGVLMFEMMAGRSPFDIV 256

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 104/249 (41%), Gaps = 32/249 (12%)
Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KG 289
           K KE+  +   F E   LGE  FG VYKG  H       + TQ    K  +D  +   + 
Sbjct: 2   KLKEISLSAVRFMEE--LGEDRFGKVYKG--HLFGPAPGEQTQAVAIKTLKDKAEGPLRE 57
Query: 290 DFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE--------- 340
           +F  E  +             G   +   L +++ +  +G L ++L   S          
Sbjct: 58  EFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117
Query: 341 ----QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL 396
               +  L       ++  +A+ + YL + +   VVH+DL   N+L+    N ++ D GL
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGL 174
Query: 397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV------- 449
            R +    + Y   G   +P  + ++APE    GK + +SD++ +G V+ EV        
Sbjct: 175 FREV-YAADYYKLLGNSLLP--IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231
Query: 450 CGRSPGNMI 458
           CG S  +++
Sbjct: 232 CGYSNQDVV 240

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 29/211 (13%)
Query: 234 KELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQ--YHVDNTQIAVKKFSRD-------- 283
           KE  K  N++     L +G F    K I+   D   Y +   + ++ +  RD        
Sbjct: 24  KEKDKYINDYRIIRTLNQGKFN---KIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 284 -SIKSK-GDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSL---EKYLYGT 338
            SIKSK  DF  EL II            G      ++ ++Y++M N S+   ++Y +  
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 339 SEQVT--LNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL 396
            +  T  +       I+  V ++  Y+ NE  + + HRD+K SNIL+D +   +L DFG 
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFG- 197
Query: 397 ARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
                 E     +  + G  GT  ++ PE F
Sbjct: 198 ------ESEYMVDKKIKGSRGTYEFMPPEFF 222

>pdb|3IPV|B Chain B, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 239

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 76/156 (48%), Gaps = 15/156 (9%)
Query: 15  GLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGF--DPDDNHLGL 72
           GLAF +AP  S P   S G +LGL ++   G+     VA+EFDT +     DP   H+G 
Sbjct: 89  GLAFFLAPVASAP--DSGGGFLGLFDSAV-GDTTYQTVAVEFDTYENTVFTDPPYTHIGF 145
Query: 73  NINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKET 132
           ++NS+ S K V        +L++G +  V + Y+   KL+   +           +L + 
Sbjct: 146 DVNSISSIKTV------KWSLANGEAAKVLITYNSAVKLLVASLVYPSSK--TSFILADI 197
Query: 133 INLKDYLKPESYFGFSASTGYP--HIQLNCVRSWTL 166
           ++L   L      GFSA+TG    +I+ + V SW+ 
Sbjct: 198 VDLSSVLPEWVRVGFSAATGASKGYIETHDVFSWSF 233

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 110/269 (40%), Gaps = 40/269 (14%)
Query: 314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVH 373
            ++  L LV D+   G L   L    +++  +    Y     +   V  + + +    VH
Sbjct: 160 QDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY-----IGEMVLAIDSIHQLHYVH 214
Query: 374 RDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT---- 429
           RD+K  N+LLD + + RL DFG    + N+  +      VG P    Y++PE        
Sbjct: 215 RDIKPDNVLLDVNGHIRLADFGSCLKM-NDDGTVQSSVAVGTP---DYISPEILQAMEDG 270
Query: 430 -GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD-WVWMLHREGHIQDAVDQR 487
            GK  PE D +  G  + E++ G +P        +A +LV+ +  +++ E   Q      
Sbjct: 271 MGKYGPECDWWSLGVCMYEMLYGETPF-------YAESLVETYGKIMNHEERFQFPS--- 320
Query: 488 LNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISGTS-------TVPYVPQFK 538
            ++  V +EAK  L+  L CS      +   ED  +     G +         PY+P   
Sbjct: 321 -HVTDVSEEAKD-LIQRLICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLEAPYIPDVS 378
Query: 539 PAFTWPSTSPPISMFDSILSSITLSSPGS 567
                PS +    + D +L +  +  PGS
Sbjct: 379 S----PSDTSNFDVDDDVLRNTEILPPGS 403

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 110/269 (40%), Gaps = 40/269 (14%)
Query: 314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVH 373
            ++  L LV D+   G L   L    +++  +    Y     +   V  + + +    VH
Sbjct: 144 QDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY-----IGEMVLAIDSIHQLHYVH 198
Query: 374 RDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT---- 429
           RD+K  N+LLD + + RL DFG    + N+  +      VG P    Y++PE        
Sbjct: 199 RDIKPDNVLLDVNGHIRLADFGSCLKM-NDDGTVQSSVAVGTP---DYISPEILQAMEDG 254
Query: 430 -GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD-WVWMLHREGHIQDAVDQR 487
            GK  PE D +  G  + E++ G +P        +A +LV+ +  +++ E   Q      
Sbjct: 255 MGKYGPECDWWSLGVCMYEMLYGETPF-------YAESLVETYGKIMNHEERFQFPS--- 304
Query: 488 LNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISGTS-------TVPYVPQFK 538
            ++  V +EAK  L+  L CS      +   ED  +     G +         PY+P   
Sbjct: 305 -HVTDVSEEAKD-LIQRLICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLEAPYIPDVS 362
Query: 539 PAFTWPSTSPPISMFDSILSSITLSSPGS 567
                PS +    + D +L +  +  PGS
Sbjct: 363 S----PSDTSNFDVDDDVLRNTEILPPGS 387

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/82 (39%), Positives = 44/82 (53%), Gaps = 4/82 (4%)
Query: 373 HRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA 432
           HRD+K  NIL+ AD  A L DFG+A A  +E+ +     L    GT+ Y APE F    A
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ----LGNTVGTLYYXAPERFSESHA 212
Query: 433 TPESDVFGFGAVVLEVVCGRSP 454
           T  +D++    V+ E + G  P
Sbjct: 213 TYRADIYALTCVLYECLTGSPP 234

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 91/222 (40%), Gaps = 30/222 (13%)
Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIX 299
           T+ +     +G G + +  + I      +   N + AVK       KSK D   E+ I+ 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCI------HKATNXEFAVKIID----KSKRDPTEEIEILL 70
Query: 300 XXXXXXXXXXXGWCHEKGKLLLVYDFMPNGS--LEKYLYGTSEQVTLNWNHRYKILTGVA 357
                         ++ GK + V   +  G   L+K L     Q   +      +L  + 
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKIL----RQKFFSEREASAVLFTIT 126
Query: 358 SAVYYLQNEYDQKVVHRDLKASNIL-LDADFN---ARLGDFGLARAIENERNSYAEHGLV 413
             V YL   + Q VVHRDLK SNIL +D   N    R+ DFG A+ +       AE+GL+
Sbjct: 127 KTVEYL---HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR------AENGLL 177
Query: 414 GVPG-TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             P  T  +VAPE           D++  G ++   + G +P
Sbjct: 178 XTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 241 NNFH--ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAII 298
           NNF+   S  LG G F +V + I     Q +       +KK  R     + + L E+A++
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK---FLKKRRRGQ-DCRAEILHEIAVL 82
Query: 299 XXXXXXXXXXXXGWCHEK-GKLLLVYDFMPNGSL-EKYLYGTSEQVTLNWNHRYKILTGV 356
                          +E   +++L+ ++   G +    L   +E V+   N   +++  +
Sbjct: 83  ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS--ENDVIRLIKQI 140
Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADF---NARLGDFGLARAIENERNSYAEHGLV 413
              VYYL   +   +VH DLK  NILL + +   + ++ DFG++R I +         L 
Sbjct: 141 LEGVYYL---HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE------LR 191
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            + GT  Y+APE  +    T  +D++  G +   ++   SP
Sbjct: 192 EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 80/189 (42%), Gaps = 26/189 (13%)
Query: 275 IAVKKFSRDSIKSK-GDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSL-- 331
           +A+K  ++++++ K G    E+A++                  G L L+   +  G L  
Sbjct: 46  VAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFD 105
Query: 332 ---EKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL---LDA 385
              EK  Y   +   L +         V  AV YL   +D  +VHRDLK  N+L   LD 
Sbjct: 106 RIVEKGFYTERDASRLIFQ--------VLDAVKYL---HDLGIVHRDLKPENLLYYSLDE 154
Query: 386 DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVV 445
           D    + DFGL++ +E+  +      L    GT GYVAPE       +   D +  G + 
Sbjct: 155 DSKIMISDFGLSK-MEDPGSV-----LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 208
Query: 446 LEVVCGRSP 454
             ++CG  P
Sbjct: 209 YILLCGYPP 217

>pdb|1BJQ|A Chain A, The Dolichos Biflorus Seed Lectin In Complex With Adenine Length = 253

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 14/155 (9%)
Query: 15  GLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVK-QGFDPDDNHLGLN 73
           G+AF + P  S P  +  G +LG+ ++    N A   VA+EFDT+   G+DP   H+G++
Sbjct: 86  GIAFALVPVGSEPRRN--GGYLGVFDSDVYNNSA-QTVAVEFDTLSNSGWDPSMKHIGID 142
Query: 74  INSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETI 133
           +NS+ S   V         L++G +  + + Y+  + L+   +           +L E +
Sbjct: 143 VNSIKSIATVSWD------LANGENAEILITYNAATSLLVASLVHPSRRTSY--ILSERV 194
Query: 134 NLKDYLKPESYFGFSASTGYP--HIQLNCVRSWTL 166
           ++ + L      GFSA+TG    +I+ + V SW+ 
Sbjct: 195 DITNELPEYVSVGFSATTGLSEGYIETHDVLSWSF 229

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 80/189 (42%), Gaps = 26/189 (13%)
Query: 275 IAVKKFSRDSIKSK-GDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSL-- 331
           +A+K  ++++++ K G    E+A++                  G L L+   +  G L  
Sbjct: 46  VAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFD 105
Query: 332 ---EKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL---LDA 385
              EK  Y   +   L +         V  AV YL   +D  +VHRDLK  N+L   LD 
Sbjct: 106 RIVEKGFYTERDASRLIFQ--------VLDAVKYL---HDLGIVHRDLKPENLLYYSLDE 154
Query: 386 DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVV 445
           D    + DFGL++ +E+  +      L    GT GYVAPE       +   D +  G + 
Sbjct: 155 DSKIMISDFGLSK-MEDPGSV-----LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 208
Query: 446 LEVVCGRSP 454
             ++CG  P
Sbjct: 209 YILLCGYPP 217

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 80/189 (42%), Gaps = 26/189 (13%)
Query: 275 IAVKKFSRDSIKSK-GDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSL-- 331
           +A+K  ++++++ K G    E+A++                  G L L+   +  G L  
Sbjct: 46  VAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFD 105
Query: 332 ---EKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL---LDA 385
              EK  Y   +   L +         V  AV YL   +D  +VHRDLK  N+L   LD 
Sbjct: 106 RIVEKGFYTERDASRLIFQ--------VLDAVKYL---HDLGIVHRDLKPENLLYYSLDE 154
Query: 386 DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVV 445
           D    + DFGL++ +E+  +      L    GT GYVAPE       +   D +  G + 
Sbjct: 155 DSKIMISDFGLSK-MEDPGSV-----LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 208
Query: 446 LEVVCGRSP 454
             ++CG  P
Sbjct: 209 YILLCGYPP 217

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 99/242 (40%), Gaps = 36/242 (14%)
Query: 224 LPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQ--IAVKKFS 281
           +PG     ++K+ +   + +     LG G F  V    I   D+     TQ  +A+K  +
Sbjct: 1   MPGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEV----ILAEDK----RTQKLVAIKCIA 52
Query: 282 RDSIKSK-GDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSL-----EKYL 335
           + +++ K G    E+A++                  G L L+   +  G L     EK  
Sbjct: 53  KKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF 112
Query: 336 YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL---LDADFNARLG 392
           Y   +   L +         V  AV YL   +D  +VHRDLK  N+L   LD D    + 
Sbjct: 113 YTERDASRLIFQ--------VLDAVKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMIS 161
Query: 393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGR 452
           DFGL++ +E+  +      L    GT GYVAPE       +   D +  G +   ++CG 
Sbjct: 162 DFGLSK-MEDPGSV-----LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 215
Query: 453 SP 454
            P
Sbjct: 216 PP 217

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 8/99 (8%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAI-----ENERNSYAEHGLVGVPGTMGYVAPE 425
           V+HRDLK SN+L++++ + ++ DFGLAR I     +N   +  + G+     T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPE 192
Query: 426 CFHT-GKATPESDVFGFGAVVLEVVCGRS--PGNMIPHQ 461
              T  K +   DV+  G ++ E+   R   PG    HQ
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           LG+G +GIVY G    N        +IA+K+      +       E+A+           
Sbjct: 30  LGKGTYGIVYAGRDLSN------QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGT-----SEQVTLNWNHRYKILTGVASAVYYL 363
             G   E G + +  + +P GSL   L          + T+ + +  +IL G+     YL
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-YTKQILEGLK----YL 138
Query: 364 QNEYDQKVVHRDLKASNILLDADFNA-RLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
              +D ++VHRD+K  N+L++      ++ DFG ++ +    N   E       GT+ Y+
Sbjct: 139 ---HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG-INPCTET----FTGTLQYM 190
Query: 423 APECFHTGKA--TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI 480
           APE    G       +D++  G  ++E+  G+ P   +   Q A   V  ++ +H E   
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV-GMFKVHPE--- 246
Query: 481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDIL 522
                      S+  EAK  +   L C  P   +R    D+L
Sbjct: 247 --------IPESMSAEAKAFI---LKCFEPDPDKRACANDLL 277

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 8/99 (8%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAI-----ENERNSYAEHGLVGVPGTMGYVAPE 425
           V+HRDLK SN+L++++ + ++ DFGLAR I     +N   +  + G+     T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPE 192
Query: 426 CFHT-GKATPESDVFGFGAVVLEVVCGRS--PGNMIPHQ 461
              T  K +   DV+  G ++ E+   R   PG    HQ
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231

>pdb|2BQP|A Chain A, The Structure Of The Pea Lectin-D-Glucopyranose Complex Length = 234

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 15  GLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTV-KQGFDPD--DNHLG 71
           G  F IAP D+ P     G +LG+ N+  + +K    VA+EFDT     +DP   D H+G
Sbjct: 82  GFTFFIAPVDTKPQTG--GGYLGVFNS-AEYDKTTQTVAVEFDTFYNAAWDPSNRDRHIG 138
Query: 72  LNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPL--- 128
           +++NS+ S      K      L +G    V + ++  + ++ V +     ++ ++     
Sbjct: 139 IDVNSIKSVNTKSWK------LQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYT 192
Query: 129 LKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTL 166
           L + ++LKD +      GFSA+TG  +   + V SW+ 
Sbjct: 193 LSDVVSLKDVVPEWVRIGFSATTGAEY-AAHEVLSWSF 229

>pdb|3IPV|A Chain A, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 251

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 76/156 (48%), Gaps = 15/156 (9%)
Query: 15  GLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGF--DPDDNHLGL 72
           GLAF +AP  S P   S G +LGL ++   G+     VA+EFDT +     DP   H+G 
Sbjct: 89  GLAFFLAPVASAP--DSGGGFLGLFDSAVSGSTYQT-VAVEFDTYENTVFTDPPYTHIGF 145
Query: 73  NINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKET 132
           ++NS+ S K V        +L++G +  V + Y+   KL+   +     +     +L + 
Sbjct: 146 DVNSISSIKTV------KWSLANGEAAKVLITYNSAVKLLVASLVY--PSSKTSFILADI 197
Query: 133 INLKDYLKPESYFGFSASTGYP--HIQLNCVRSWTL 166
           ++L   L      GFSA+TG     I+ + V SW+ 
Sbjct: 198 VDLSSVLPEWVRVGFSAATGASGGKIETHDVFSWSF 233

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 65/143 (45%), Gaps = 14/143 (9%)
Query: 315 EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHR 374
           E+G   L++D +  G L + +         + +H    +  +  AV +    +   VVHR
Sbjct: 92  EEGHHYLIFDLVTGGELFEDIVAREYYSEADASH---CIQQILEAVLHC---HQMGVVHR 145
Query: 375 DLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK 431
           DLK  N+LL +       +L DFGLA  +E E+ ++      G  GT GY++PE      
Sbjct: 146 DLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW-----FGFAGTPGYLSPEVLRKDP 200
Query: 432 ATPESDVFGFGAVVLEVVCGRSP 454
                D++  G ++  ++ G  P
Sbjct: 201 YGKPVDLWACGVILYILLVGYPP 223

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           LG+G +GIVY G    N        +IA+K+      +       E+A+           
Sbjct: 16  LGKGTYGIVYAGRDLSN------QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ 69
Query: 309 XXGWCHEKGKLLLVYDFMPNGSLEKYLYGT-----SEQVTLNWNHRYKILTGVASAVYYL 363
             G   E G + +  + +P GSL   L          + T+ + +  +IL G+     YL
Sbjct: 70  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-YTKQILEGLK----YL 124
Query: 364 QNEYDQKVVHRDLKASNILLDADFNA-RLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
              +D ++VHRD+K  N+L++      ++ DFG ++ +    N   E       GT+ Y+
Sbjct: 125 ---HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG-INPCTET----FTGTLQYM 176
Query: 423 APECFHTGKA--TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI 480
           APE    G       +D++  G  ++E+  G+ P   +   Q A   V  ++ +H E   
Sbjct: 177 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG-MFKVHPE--- 232
Query: 481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDIL 522
                      S+  EAK  +   L C  P   +R    D+L
Sbjct: 233 --------IPESMSAEAKAFI---LKCFEPDPDKRACANDLL 263

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 91/233 (39%), Gaps = 21/233 (9%)
Query: 226 GMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS-RDS 284
           G   EF      K ++N+     LG+G F +V +  +H           I  KK S RD 
Sbjct: 14  GRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSARDF 72
Query: 285 IKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTL 344
            K       E  I                 E+    LV+D +  G L + +         
Sbjct: 73  QK----LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA 128
Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA---RLGDFGLARAIE 401
           + +H    +  +  ++ Y    +   +VHR+LK  N+LL +       +L DFGLA  + 
Sbjct: 129 DASH---CIQQILESIAYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182
Query: 402 NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +   S A HG  G P   GY++PE       +   D++  G ++  ++ G  P
Sbjct: 183 D---SEAWHGFAGTP---GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 12/102 (11%)
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDA---DFNARLGDFGLARAIENERNSYAEHGL 412
           +  AV YL   ++  +VHRDLK  N+L      D   ++ DFGL++ +E++        +
Sbjct: 157 ILEAVAYL---HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL------M 207
Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             V GT GY APE        PE D++  G +   ++CG  P
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|1FAY|A Chain A, Winged Bean Acidic Lectin Complexed With Methyl-Alpha-D-Galactose (Monoclinic Form) Length = 238

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 82/173 (47%), Gaps = 23/173 (13%)
Query: 5   PRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFD 64
           P PA      GL F + P +S  P+   G  LG+   F      N F A+EFDT +  +D
Sbjct: 84  PEPA-----DGLTFFMVPPNS--PQGEDGGNLGV---FKPPEGDNAF-AVEFDTFQNTWD 132
Query: 65  PDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMP 124
           P   H+G+++NS+VS K +  +      L +G    V ++YD  +K++ V +     ++ 
Sbjct: 133 PQVPHIGIDVNSIVSSKTLHFQ------LENGGVANVVIKYDSPTKILNVVLAF--HSVG 184
Query: 125 QKPLLKETINLKDYLKPESY--FGFSASTGYPH--IQLNCVRSWTLDIDVIQT 173
               L   ++LK       +   G SA+TGY    ++ + + SW+    + +T
Sbjct: 185 TVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFTSSLQET 237

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 98/245 (40%), Gaps = 49/245 (20%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKF--SRDSIKSKGDFLAELAIIXXXXXX 304
           ++GEG +G+V+K         + D  QI A+KKF  S D    K   L E+ ++      
Sbjct: 10  KIGEGSYGVVFKC-------RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 305 XXXXXXGWCHEKGKLLLVYDFMPNG---SLEKYLYGTSEQV--TLNWNHRYKILTGVASA 359
                      K +L LV+++  +     L++Y  G  E +  ++ W            A
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ--------TLQA 114
Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
           V +    +    +HRD+K  NIL+      +L DFG AR +    + Y +        T 
Sbjct: 115 VNFC---HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-----ATR 166
Query: 420 GYVAPECF-HTGKATPESDVFGFGAVVLEVVCG-----------------RSPGNMIPHQ 461
            Y +PE      +  P  DV+  G V  E++ G                 ++ G++IP  
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH 226
Query: 462 QHAYT 466
           Q  ++
Sbjct: 227 QQVFS 231

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/225 (22%), Positives = 94/225 (41%), Gaps = 22/225 (9%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAI 297
           ++F     LG+G FG VY   +    + H     +A+K   +  I+ +G       E+ I
Sbjct: 23  DDFEIGRPLGKGKFGNVY---LAREKKSHFI---VALKVLFKSQIEKEGVEHQLRREIEI 76
Query: 298 IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
                         + +++ ++ L+ ++ P G L K L    +  T +      I+  +A
Sbjct: 77  QAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELA 133
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
            A+ Y    + +KV+HRD+K  N+LL      ++ DFG +    + R          + G
Sbjct: 134 DALMYC---HGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRK-------TMCG 183
Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
           T+ Y+ PE         + D++  G +  E++ G  P     H +
Sbjct: 184 TLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNE 228

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 249 LGEGGFGIVYKGIIHHND-QYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           LG G F +V K        QY     +    K SR  + S+ D   E++I+         
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV-SREDIEREVSILKEIQHPNVI 77
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                   K  ++L+ + +  G L  +L   +E+ +L      + L  + + VYYL   +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYL---H 131
Query: 368 DQKVVHRDLKASNILLDADFNA-----RLGDFGLARAIE--NERNSYAEHGLVGVPGTMG 420
             ++ H DLK  NI+L  D N      ++ DFGLA  I+  NE           + GT  
Sbjct: 132 SLQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPA 182
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +VAPE  +      E+D++  G +   ++ G SP
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 22/220 (10%)
Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS-RDSIKSKGDFLAELAII 298
           T+++     LG+G F +V + +     Q +     I  KK S RD  K +     E  I 
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKI-INTKKLSARDHQKLE----REARIC 84
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR-YKILTGVA 357
                           E+G   LV+D +  G L + +         + +H  ++IL  V 
Sbjct: 85  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESV- 143
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLVG 414
                  + +   +VHRDLK  N+LL +       +L DFGLA  ++ E+ ++      G
Sbjct: 144 ------NHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAW-----FG 192
Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             GT GY++PE           D++  G ++  ++ G  P
Sbjct: 193 FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 13/206 (6%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD-FLAELAIIXXXXXXXXX 307
           +GEG +G+V     H      V  T++A+KK S    ++     L E+ I+         
Sbjct: 51  IGEGAYGMVSSAYDH------VRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                        +   ++    +E  LY   +   L+ +H    L  +   + Y+   +
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYI---H 161
Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
              V+HRDLK SN+L++   + ++ DFGLAR  + E +      L     T  Y APE  
Sbjct: 162 SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTG--FLTEXVATRWYRAPEIM 219
Query: 428 HTGKATPES-DVFGFGAVVLEVVCGR 452
              K   +S D++  G ++ E++  R
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 87/219 (39%), Gaps = 33/219 (15%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIXXXXXX-X 305
           +G G +G V       N   H  + QI   K  R ++  K +   L +L ++        
Sbjct: 30  IGRGAYGSV-------NKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY 82
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNG--SLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYL 363
                G    +G   +  + M        KY+Y   + V +      KI      A+ +L
Sbjct: 83  IVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV-IPEEILGKITLATVKALNHL 141
Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFG----LARAIENERNSYAEHGLVGVPGTM 419
           +   + K++HRD+K SNILLD   N +L DFG    L  +I   R++          G  
Sbjct: 142 KE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA----------GCR 189
Query: 420 GYVAPECFHTGKATP----ESDVFGFGAVVLEVVCGRSP 454
            Y+APE      +       SDV+  G  + E+  GR P
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 12/139 (8%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK 377
           KL L+ D++  G L  +L    E+ T    H  +I  G    V  L++ +   +++RD+K
Sbjct: 133 KLHLILDYINGGELFTHL-SQRERFT---EHEVQIYVG--EIVLALEHLHKLGIIYRDIK 186
Query: 378 ASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESD 437
             NILLD++ +  L DFGL++    +    A        GT+ Y+AP+    G +  +  
Sbjct: 187 LENILLDSNGHVVLTDFGLSKEFVADETERA----YDFCGTIEYMAPDIVRGGDSGHDKA 242
Query: 438 V--FGFGAVVLEVVCGRSP 454
           V  +  G ++ E++ G SP
Sbjct: 243 VDWWSLGVLMYELLTGASP 261

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYS--DW 220

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 89/227 (39%), Gaps = 34/227 (14%)
Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXX 300
            +F    RLG G +G V+K     + + +     ++  +  +D  +     LAE+     
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARK----LAEVGSHEK 112
Query: 301 XXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVAS 358
                         E+G +L +   +   SL+++   +G S      W +    L  +A 
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA- 171
Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV--- 415
                 + + Q +VH D+K +NI L      +LGDFGL            E G  G    
Sbjct: 172 ------HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGL----------LVELGTAGAGEV 215
Query: 416 -PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNM-IPH 460
             G   Y+APE       T  +DVF  G  +LEV C     NM +PH
Sbjct: 216 QEGDPRYMAPELLQGSYGT-AADVFSLGLTILEVAC-----NMELPH 256

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 115/284 (40%), Gaps = 35/284 (12%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +G+G F +V + I     Q       + V KF+     S  D   E +I           
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKI-VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 309 XXGWCHEKGKLLLVYDFMPNGSL---------EKYLYGTSEQVTLNWNHRYKILTGVASA 359
                   G L +V++FM    L           ++Y  SE V  ++      +  +  A
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY--SEAVASHY------MRQILEA 142
Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNA---RLGDFGLARAIENERNSYAEHGLV--G 414
           + Y    +D  ++HRD+K  N+LL +  N+   +LGDFG+A  +        E GLV  G
Sbjct: 143 LRYC---HDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL-------GESGLVAGG 192
Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML 474
             GT  ++APE           DV+G G ++  ++ G  P      +     +     M 
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMN 252
Query: 475 HRE-GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK 517
            R+  HI ++    +    ++D A+R+ +   A +HP   ER +
Sbjct: 253 PRQWSHISESAKDLVRRMLMLDPAERITVYE-ALNHPWLKERDR 295

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 249 LGEGGFGIVYKGIIHHND-QYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           LG G F +V K        QY     +    K SR  + S+ D   E++I+         
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV-SREDIEREVSILKEIQHPNVI 77
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                   K  ++L+ + +  G L  +L   +E+ +L      + L  + + VYYL   +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYL---H 131
Query: 368 DQKVVHRDLKASNILLDADFNA-----RLGDFGLARAIE--NERNSYAEHGLVGVPGTMG 420
             ++ H DLK  NI+L  D N      ++ DFGLA  I+  NE           + GT  
Sbjct: 132 SLQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPE 182
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +VAPE  +      E+D++  G +   ++ G SP
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 249 LGEGGFGIVYKGIIHHND-QYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           LG G F +V K        QY     +    K SR  + S+ D   E++I+         
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV-SREDIEREVSILKEIQHPNVI 77
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                   K  ++L+ + +  G L  +L   +E+ +L      + L  + + VYYL   +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYL---H 131
Query: 368 DQKVVHRDLKASNILLDADFNA-----RLGDFGLARAIE--NERNSYAEHGLVGVPGTMG 420
             ++ H DLK  NI+L  D N      ++ DFGLA  I+  NE           + GT  
Sbjct: 132 SLQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPE 182
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +VAPE  +      E+D++  G +   ++ G SP
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           VA  + +L +   +K +HRDL A NILL      ++ DFGLAR I  + + Y   G   +
Sbjct: 207 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARL 262
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           P  + ++APE       T +SDV+ FG ++ E+   G SP
Sbjct: 263 P--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 300

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           VA  + +L +   +K +HRDL A NILL      ++ DFGLAR I  + + Y   G   +
Sbjct: 209 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARL 264
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           P  + ++APE       T +SDV+ FG ++ E+   G SP
Sbjct: 265 P--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 302

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           VA  + +L +   +K +HRDL A NILL      ++ DFGLAR I  + + Y   G   +
Sbjct: 202 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARL 257
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
           P  + ++APE       T +SDV+ FG ++ E+   G SP
Sbjct: 258 P--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 65/143 (45%), Gaps = 14/143 (9%)
Query: 315 EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHR 374
           E+G   L++D +  G L + +         + +H    +  +  AV +    +   VVHR
Sbjct: 81  EEGHHYLIFDLVTGGELFEDIVAREYYSEADASH---CIQQILEAVLHC---HQMGVVHR 134
Query: 375 DLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK 431
           +LK  N+LL +       +L DFGLA  +E E+ ++      G  GT GY++PE      
Sbjct: 135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW-----FGFAGTPGYLSPEVLRKDP 189
Query: 432 ATPESDVFGFGAVVLEVVCGRSP 454
                D++  G ++  ++ G  P
Sbjct: 190 YGKPVDLWACGVILYILLVGYPP 212

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           VA  + +L +   +K +HRDL A NILL      ++ DFGLAR I  + + Y   G   +
Sbjct: 200 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARL 255
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
           P  + ++APE       T +SDV+ FG ++ E+   G SP
Sbjct: 256 P--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 293

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 249 LGEGGFGIVYKGIIHHND-QYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           LG G F +V K        QY     +    K SR  + S+ D   E++I+         
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV-SREDIEREVSILKEIQHPNVI 76
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                   K  ++L+ + +  G L  +L   +E+ +L      + L  + + VYYL   +
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYL---H 130
Query: 368 DQKVVHRDLKASNILLDADFNA-----RLGDFGLARAIE--NERNSYAEHGLVGVPGTMG 420
             ++ H DLK  NI+L  D N      ++ DFGLA  I+  NE           + GT  
Sbjct: 131 SLQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPE 181
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +VAPE  +      E+D++  G +   ++ G SP
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/230 (23%), Positives = 90/230 (39%), Gaps = 24/230 (10%)
Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD- 290
           K ++L+    ++     +G G FG V   ++ H     V     A+K  S+  +  + D 
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEV--QLVRHKSTRKV----YAMKLLSKFEMIKRSDS 113
Query: 291 --FLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNH 348
             F  E  I+                +   L +V ++MP G L   +  ++  V   W  
Sbjct: 114 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWAR 171
Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
            Y      A  V  L   +    +HRD+K  N+LLD   + +L DFG    +  E     
Sbjct: 172 FY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226
Query: 409 EHGLVGVPGTMGYVAPECFHT----GKATPESDVFGFGAVVLEVVCGRSP 454
           +  +    GT  Y++PE   +    G    E D +  G  + E++ G +P
Sbjct: 227 DTAV----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 249 LGEGGFGIVYKGIIHHND-QYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           LG G F +V K        QY     +    K SR  + S+ D   E++I+         
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV-SREDIEREVSILKEIQHPNVI 76
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                   K  ++L+ + +  G L  +L   +E+ +L      + L  + + VYYL   +
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYL---H 130
Query: 368 DQKVVHRDLKASNILLDADFNA-----RLGDFGLARAIE--NERNSYAEHGLVGVPGTMG 420
             ++ H DLK  NI+L  D N      ++ DFGLA  I+  NE           + GT  
Sbjct: 131 SLQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPE 181
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +VAPE  +      E+D++  G +   ++ G SP
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMXGTLPYVAPELLKRR 182
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 221

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 249 LGEGGFGIVYKGIIHHND-QYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           LG G F +V K        QY     +    K SR  + S+ D   E++I+         
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV-SREDIEREVSILKEIQHPNVI 77
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                   K  ++L+ + +  G L  +L   +E+ +L      + L  + + VYYL   +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYL---H 131
Query: 368 DQKVVHRDLKASNILLDADFNA-----RLGDFGLARAIE--NERNSYAEHGLVGVPGTMG 420
             ++ H DLK  NI+L  D N      ++ DFGLA  I+  NE           + GT  
Sbjct: 132 SLQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPE 182
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +VAPE  +      E+D++  G +   ++ G SP
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/230 (23%), Positives = 90/230 (39%), Gaps = 24/230 (10%)
Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD- 290
           K ++L+    ++     +G G FG V   ++ H     V     A+K  S+  +  + D 
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEV--QLVRHKSTRKV----YAMKLLSKFEMIKRSDS 118
Query: 291 --FLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNH 348
             F  E  I+                +   L +V ++MP G L   +  ++  V   W  
Sbjct: 119 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWAR 176
Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
            Y      A  V  L   +    +HRD+K  N+LLD   + +L DFG    +  E     
Sbjct: 177 FY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 231
Query: 409 EHGLVGVPGTMGYVAPECFHT----GKATPESDVFGFGAVVLEVVCGRSP 454
           +  +    GT  Y++PE   +    G    E D +  G  + E++ G +P
Sbjct: 232 DTAV----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/230 (23%), Positives = 90/230 (39%), Gaps = 24/230 (10%)
Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD- 290
           K ++L+    ++     +G G FG V   ++ H     V     A+K  S+  +  + D 
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEV--QLVRHKSTRKV----YAMKLLSKFEMIKRSDS 118
Query: 291 --FLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNH 348
             F  E  I+                +   L +V ++MP G L   +  ++  V   W  
Sbjct: 119 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWAR 176
Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
            Y      A  V  L   +    +HRD+K  N+LLD   + +L DFG    +  E     
Sbjct: 177 FY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 231
Query: 409 EHGLVGVPGTMGYVAPECFHT----GKATPESDVFGFGAVVLEVVCGRSP 454
           +  +    GT  Y++PE   +    G    E D +  G  + E++ G +P
Sbjct: 232 DTAV----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 69/164 (42%), Gaps = 26/164 (15%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY-----DQKVV 372
           +L L+ D+  NGSL  YL  T    TL+     K+     S + +L  E         + 
Sbjct: 109 QLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA 164
Query: 373 HRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP-----GTMGYVAPECF 427
           HRDLK+ NIL+  +    + D GLA    ++ N       V +P     GT  Y+ PE  
Sbjct: 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE------VDIPPNTRVGTKRYMPPEVL 218
Query: 428 HTG------KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY 465
                    ++   +D++ FG ++ EV      G ++   Q  Y
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 81/189 (42%), Gaps = 22/189 (11%)
Query: 272 NTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGK-LLLVYDFMPNGS 330
           N + AVK       KSK D   E+ I+               ++ GK + LV + M  G 
Sbjct: 52  NMEYAVKVID----KSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGE 107
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL-LDADFNA 389
           L   L     Q   +      +L  +   V YL   + Q VVHRDLK SNIL +D   N 
Sbjct: 108 L---LDKILRQKFFSEREASFVLHTIGKTVEYL---HSQGVVHRDLKPSNILYVDESGNP 161
Query: 390 ---RLGDFGLARAIENERNSYAEHGLVGVPG-TMGYVAPECFHTGKATPESDVFGFGAVV 445
              R+ DFG A+ +       AE+GL+  P  T  +VAPE           D++  G ++
Sbjct: 162 ECLRICDFGFAKQLR------AENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILL 215
Query: 446 LEVVCGRSP 454
             ++ G +P
Sbjct: 216 YTMLAGYTP 224

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 81/189 (42%), Gaps = 22/189 (11%)
Query: 272 NTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXXXXGWCHEKGK-LLLVYDFMPNGS 330
           N + AVK       KSK D   E+ I+               ++ GK + LV + M  G 
Sbjct: 52  NMEYAVKVID----KSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGE 107
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL-LDADFNA 389
           L   L     Q   +      +L  +   V YL   + Q VVHRDLK SNIL +D   N 
Sbjct: 108 L---LDKILRQKFFSEREASFVLHTIGKTVEYL---HSQGVVHRDLKPSNILYVDESGNP 161
Query: 390 ---RLGDFGLARAIENERNSYAEHGLVGVPG-TMGYVAPECFHTGKATPESDVFGFGAVV 445
              R+ DFG A+ +       AE+GL+  P  T  +VAPE           D++  G ++
Sbjct: 162 ECLRICDFGFAKQLR------AENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILL 215
Query: 446 LEVVCGRSP 454
             ++ G +P
Sbjct: 216 YTMLAGYTP 224

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 249 LGEGGFGIVYKGIIHHND-QYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           LG G F +V K        QY     +    K SR  + S+ D   E++I+         
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV-SREDIEREVSILKEIQHPNVI 77
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                   K  ++L+ + +  G L  +L   +E+ +L      + L  + + VYYL   +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYL---H 131
Query: 368 DQKVVHRDLKASNILLDADFNA-----RLGDFGLARAIE--NERNSYAEHGLVGVPGTMG 420
             ++ H DLK  NI+L  D N      ++ DFGLA  I+  NE           + GT  
Sbjct: 132 SLQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPE 182
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +VAPE  +      E+D++  G +   ++ G SP
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 219

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 221

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 249 LGEGGFGIVYKGIIHHND-QYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           LG G F +V K        QY     +    K SR  + S+ D   E++I+         
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV-SREDIEREVSILKEIQHPNVI 77
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                   K  ++L+ + +  G L  +L   +E+ +L      + L  + + VYYL   +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYL---H 131
Query: 368 DQKVVHRDLKASNILLDADFNA-----RLGDFGLARAIE--NERNSYAEHGLVGVPGTMG 420
             ++ H DLK  NI+L  D N      ++ DFGLA  I+  NE           + GT  
Sbjct: 132 SLQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPE 182
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +VAPE  +      E+D++  G +   ++ G SP
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 249 LGEGGFGIVYKGIIHHND-QYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           LG G F +V K        QY     +    K SR  + S+ D   E++I+         
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV-SREDIEREVSILKEIQHPNVI 77
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                   K  ++L+ + +  G L  +L   +E+ +L      + L  + + VYYL   +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYL---H 131
Query: 368 DQKVVHRDLKASNILLDADFNA-----RLGDFGLARAIE--NERNSYAEHGLVGVPGTMG 420
             ++ H DLK  NI+L  D N      ++ DFGLA  I+  NE           + GT  
Sbjct: 132 SLQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPE 182
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +VAPE  +      E+D++  G +   ++ G SP
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 249 LGEGGFGIVYKGIIHHND-QYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           LG G F +V K        QY     +    K SR  + S+ D   E++I+         
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV-SREDIEREVSILKEIQHPNVI 77
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                   K  ++L+ + +  G L  +L   +E+ +L      + L  + + VYYL   +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYL---H 131
Query: 368 DQKVVHRDLKASNILLDADFNA-----RLGDFGLARAIE--NERNSYAEHGLVGVPGTMG 420
             ++ H DLK  NI+L  D N      ++ DFGLA  I+  NE           + GT  
Sbjct: 132 SLQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPE 182
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +VAPE  +      E+D++  G +   ++ G SP
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 221

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 249 LGEGGFGIVYKGIIHHND-QYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           LG G F +V K        QY     +    K SR  + S+ D   E++I+         
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV-SREDIEREVSILKEIQHPNVI 77
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                   K  ++L+ + +  G L  +L   +E+ +L      + L  + + VYYL   +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYL---H 131
Query: 368 DQKVVHRDLKASNILLDADFNA-----RLGDFGLARAIE--NERNSYAEHGLVGVPGTMG 420
             ++ H DLK  NI+L  D N      ++ DFGLA  I+  NE           + GT  
Sbjct: 132 SLQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPE 182
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +VAPE  +      E+D++  G +   ++ G SP
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 249 LGEGGFGIVYKGIIHHND-QYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           LG G F +V K        QY     +    K SR  + S+ D   E++I+         
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV-SREDIEREVSILKEIQHPNVI 77
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                   K  ++L+ + +  G L  +L   +E+ +L      + L  + + VYYL   +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYL---H 131
Query: 368 DQKVVHRDLKASNILLDADFNA-----RLGDFGLARAIE--NERNSYAEHGLVGVPGTMG 420
             ++ H DLK  NI+L  D N      ++ DFGLA  I+  NE           + GT  
Sbjct: 132 SLQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPE 182
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +VAPE  +      E+D++  G +   ++ G SP
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 54/106 (50%), Gaps = 13/106 (12%)
Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNIL-LDADFNARL--GDFGLARAIENERNSYA 408
           ++  V SAV YL   ++  +VHRDLK  N+L L  + N+++   DFGL++  +N   S A
Sbjct: 111 VIQQVLSAVKYL---HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA 167
Query: 409 EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                   GT GYVAPE       +   D +  G +   ++CG  P
Sbjct: 168 -------CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 22/149 (14%)
Query: 314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY-----D 368
           H   +L L+  +   GSL  YL  T    TL+     +I+  +AS + +L  E       
Sbjct: 76  HSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE--- 425
             + HRDLK+ NIL+  +    + D GLA  + ++  +  + G     GT  Y+APE   
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190
Query: 426 ------CFHTGKATPESDVFGFGAVVLEV 448
                 CF + K     D++ FG V+ EV
Sbjct: 191 ETIQVDCFDSYKRV---DIWAFGLVLWEV 216

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 60/128 (46%), Gaps = 13/128 (10%)
Query: 371 VVHRDLKASNILLD-----ADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
           +VHRDLK  NIL+          A + DFGL + +   R+S++     GVPGT G++APE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS--GVPGTEGWIAPE 196
Query: 426 CF-HTGKATP--ESDVFGFGAVVLEVVC-GRSP-GNMIPHQQHAYTLVDWVWMLHREGHI 480
                 K  P    D+F  G V   V+  G  P G  +  Q +       +  LH E H 
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH- 255
Query: 481 QDAVDQRL 488
           +D + + L
Sbjct: 256 EDVIAREL 263

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 221

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 249 LGEGGFGIVYKGIIHHND-QYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           LG G F +V K        QY     +    K SR  + S+ D   E++I+         
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV-SREDIEREVSILKEIQHPNVI 77
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                   K  ++L+ + +  G L  +L   +E+ +L      + L  + + VYYL   +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYL---H 131
Query: 368 DQKVVHRDLKASNILLDADFNA-----RLGDFGLARAIE--NERNSYAEHGLVGVPGTMG 420
             ++ H DLK  NI+L  D N      ++ DFGLA  I+  NE           + GT  
Sbjct: 132 SLQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPE 182
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +VAPE  +      E+D++  G +   ++ G SP
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 22/149 (14%)
Query: 314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY-----D 368
           H   +L L+  +   GSL  YL  T    TL+     +I+  +AS + +L  E       
Sbjct: 76  HSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE--- 425
             + HRDLK+ NIL+  +    + D GLA  + ++  +  + G     GT  Y+APE   
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190
Query: 426 ------CFHTGKATPESDVFGFGAVVLEV 448
                 CF + K     D++ FG V+ EV
Sbjct: 191 ETIQVDCFDSYKRV---DIWAFGLVLWEV 216

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 221

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 221

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 221

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           + HRD+K  N+LLD   N ++ DFGLA      R +  E  L  + GT+ YVAPE     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 431 KATPES-DVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW 470
           +   E  DV+  G V+  ++ G  P +        Y+  DW
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 221

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 24/212 (11%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KGDFLAELAIIXXXXXXX 305
           ++GEG +G V+K     N + H     +A+K+   D          L E+ ++       
Sbjct: 9   KIGEGTYGTVFKA---KNRETH---EIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQV--TLNWNHRYKILTGVASAVYYL 363
                   H   KL LV++F  +  L+KY    +  +   +  +  +++L G+       
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC---- 117
Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
              + + V+HRDLK  N+L++ +   +L DFGLARA       Y+   +     T+ Y  
Sbjct: 118 ---HSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-----TLWYRP 169
Query: 424 PECFHTGKATPES-DVFGFGAVVLEVVCGRSP 454
           P+     K    S D++  G +  E+     P
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 56/110 (50%), Gaps = 15/110 (13%)
Query: 351 KILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA-RAIENERNSYAE 409
           K+   +  A+YYL+ ++   V+HRD+K SNILLD     +L DFG++ R ++++    + 
Sbjct: 128 KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS- 184
Query: 410 HGLVGVPGTMGYVAPECFHTGKATP-----ESDVFGFGAVVLEVVCGRSP 454
                  G   Y+APE       T       +DV+  G  ++E+  G+ P
Sbjct: 185 ------AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 22/149 (14%)
Query: 314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY-----D 368
           H   +L L+  +   GSL  YL  T    TL+     +I+  +AS + +L  E       
Sbjct: 105 HSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 160
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE--- 425
             + HRDLK+ NIL+  +    + D GLA  + ++  +  + G     GT  Y+APE   
Sbjct: 161 PAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 219
Query: 426 ------CFHTGKATPESDVFGFGAVVLEV 448
                 CF + K     D++ FG V+ EV
Sbjct: 220 ETIQVDCFDSYKRV---DIWAFGLVLWEV 245

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 16/143 (11%)
Query: 316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           K  ++L+ + +  G L  +L   +E+ +L  +   + L  +   V+YL   + +++ H D
Sbjct: 80  KTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYL---HSKRIAHFD 133
Query: 376 LKASNI-LLDADF---NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK 431
           LK  NI LLD +      +L DFG+A  IE      A +    + GT  +VAPE  +   
Sbjct: 134 LKPENIMLLDKNVPNPRIKLIDFGIAHKIE------AGNEFKNIFGTPEFVAPEIVNYEP 187
Query: 432 ATPESDVFGFGAVVLEVVCGRSP 454
              E+D++  G +   ++ G SP
Sbjct: 188 LGLEADMWSIGVITYILLSGASP 210

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 16/143 (11%)
Query: 316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           K  ++L+ + +  G L  +L   +E+ +L  +   + L  +   V+YL   + +++ H D
Sbjct: 87  KTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYL---HSKRIAHFD 140
Query: 376 LKASNI-LLDADF---NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK 431
           LK  NI LLD +      +L DFG+A  IE      A +    + GT  +VAPE  +   
Sbjct: 141 LKPENIMLLDKNVPNPRIKLIDFGIAHKIE------AGNEFKNIFGTPEFVAPEIVNYEP 194
Query: 432 ATPESDVFGFGAVVLEVVCGRSP 454
              E+D++  G +   ++ G SP
Sbjct: 195 LGLEADMWSIGVITYILLSGASP 217

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 249 LGEGGFGIVYKGIIHHND-QYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXX 307
           LG G F +V K        QY     +    K SR  + S+ D   E++I+         
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV-SREDIEREVSILKEIQHPNVI 77
Query: 308 XXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                   K  ++L+ + +  G L  +L   +E+ +L      + L  + + VYYL   +
Sbjct: 78  TLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYL---H 131
Query: 368 DQKVVHRDLKASNILLDADFNA-----RLGDFGLARAIE--NERNSYAEHGLVGVPGTMG 420
             ++ H DLK  NI+L  D N      ++ DFGLA  I+  NE           + GT  
Sbjct: 132 SLQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPE 182
Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +VAPE  +      E+D++  G +   ++ G SP
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 21/221 (9%)
Query: 238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS-RDSIKSKGDFLAELA 296
           K ++N+     LG+G F +V +  +H           I  KK S RD  K +     E  
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSARDFQKLE----REAR 57
Query: 297 IIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGV 356
           I                 E+    LV+D +  G L + +         + +H    +  +
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQI 114
Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLV 413
             ++ Y  +     +VHR+LK  N+LL +       +L DFGLA  +    +S A HG  
Sbjct: 115 LESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFA 168
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           G P   GY++PE       +   D++  G ++  ++ G  P
Sbjct: 169 GTP---GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KGDFLAELA 296
           + + +    +LGEG +G VYK I        V N  +A+K+   +  +    G  + E++
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAI------DTVTNETVAIKRIRLEHEEEGVPGTAIREVS 85
Query: 297 IIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE-QVTLNWNHRYKILTG 355
           ++               H   +L L++++  N  L+KY+    +  + +  +  Y+++ G
Sbjct: 86  LLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLING 144
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNA-----RLGDFGLARA 399
           V          + ++ +HRDLK  N+LL     +     ++GDFGLARA
Sbjct: 145 VNFC-------HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 16/143 (11%)
Query: 316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           K  ++L+ + +  G L  +L   +E+ +L  +   + L  +   V+YL   + +++ H D
Sbjct: 101 KTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYL---HSKRIAHFD 154
Query: 376 LKASNI-LLDADF---NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK 431
           LK  NI LLD +      +L DFG+A  IE      A +    + GT  +VAPE  +   
Sbjct: 155 LKPENIMLLDKNVPNPRIKLIDFGIAHKIE------AGNEFKNIFGTPEFVAPEIVNYEP 208
Query: 432 ATPESDVFGFGAVVLEVVCGRSP 454
              E+D++  G +   ++ G SP
Sbjct: 209 LGLEADMWSIGVITYILLSGASP 231

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 27/222 (12%)
Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS--KGDFLAELAIIXXXXXXX 305
           ++GEG +G V+K     N + H     +A+K+   D          L E+ ++       
Sbjct: 9   KIGEGTYGTVFKA---KNRETH---EIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 306 XXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQV--TLNWNHRYKILTGVASAVYYL 363
                   H   KL LV++F  +  L+KY    +  +   +  +  +++L G+       
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC---- 117
Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
              + + V+HRDLK  N+L++ +   +L +FGLARA       Y+   +     T+ Y  
Sbjct: 118 ---HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-----TLWYRP 169
Query: 424 PECFHTGKATPES-DVFGFGAVVLEVV-CGRS--PGNMIPHQ 461
           P+     K    S D++  G +  E+   GR   PGN +  Q
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 21/221 (9%)
Query: 238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS-RDSIKSKGDFLAELA 296
           K ++N+     LG+G F +V +  +H           I  KK S RD  K +     E  
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSARDFQKLE----REAR 57
Query: 297 IIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGV 356
           I                 E+    LV+D +  G L + +         + +H    +  +
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQI 114
Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLV 413
             ++ Y  +     +VHR+LK  N+LL +       +L DFGLA  +    +S A HG  
Sbjct: 115 LESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFA 168
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           G P   GY++PE       +   D++  G ++  ++ G  P
Sbjct: 169 GTP---GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 91/230 (39%), Gaps = 24/230 (10%)
Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD- 290
           K + L+    ++     +G G FG V   ++ H     V     A+K  S+  +  + D 
Sbjct: 66  KIRGLQMKAEDYDVVKVIGRGAFGEVQ--LVRHKASQKV----YAMKLLSKFEMIKRSDS 119
Query: 291 --FLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNH 348
             F  E  I+                +   L +V ++MP G L   +  ++  V   W  
Sbjct: 120 AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAK 177
Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
            Y      A  V  L   +   ++HRD+K  N+LLD   + +L DFG    ++     + 
Sbjct: 178 FY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHC 232
Query: 409 EHGLVGVPGTMGYVAPECFHT----GKATPESDVFGFGAVVLEVVCGRSP 454
           +  +    GT  Y++PE   +    G    E D +  G  + E++ G +P
Sbjct: 233 DTAV----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 63/120 (52%), Gaps = 12/120 (10%)
Query: 343 TLNWNHRYKILTGVA----SAVYYLQNEYDQKVVHRDLKASNILLDAD--FNARLGDFGL 396
           +L++  R K+++ +     SA++YL N   Q + HRD+K  N L   +  F  +L DFGL
Sbjct: 160 SLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGL 216
Query: 397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKAT--PESDVFGFGAVVLEVVCGRSP 454
           ++    + N+   +G+    GT  +VAPE  +T   +  P+ D +  G ++  ++ G  P
Sbjct: 217 SKEFY-KLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 54/110 (49%), Gaps = 18/110 (16%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 410 HGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE         ++ D++  G ++ E++ GR+  PG 
Sbjct: 184 -------ATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 21/221 (9%)
Query: 238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS-RDSIKSKGDFLAELA 296
           K ++N+     LG+G F +V +  +H           I  KK S RD  K +     E  
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSARDFQKLE----REAR 56
Query: 297 IIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGV 356
           I                 E+    LV+D +  G L + +         + +H    +  +
Sbjct: 57  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQI 113
Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLV 413
             ++ Y  +     +VHR+LK  N+LL +       +L DFGLA  +    +S A HG  
Sbjct: 114 LESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFA 167
Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           G P   GY++PE       +   D++  G ++  ++ G  P
Sbjct: 168 GTP---GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 65/143 (45%), Gaps = 14/143 (9%)
Query: 315 EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHR 374
           E+G   LV+D +  G L + +         + +H    +  +  AV +    +   VVHR
Sbjct: 74  EEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIQQILEAVLHC---HQMGVVHR 127
Query: 375 DLKASNILLDADFNA---RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK 431
           DLK  N+LL +       +L DFGLA  ++ ++ ++      G  GT GY++PE      
Sbjct: 128 DLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAW-----FGFAGTPGYLSPEVLRKEA 182
Query: 432 ATPESDVFGFGAVVLEVVCGRSP 454
                D++  G ++  ++ G  P
Sbjct: 183 YGKPVDIWACGVILYILLVGYPP 205

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 62/146 (42%), Gaps = 14/146 (9%)
Query: 314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVH 373
            +   L LV D+   G L   L    +++       Y     +A  V  + + +    VH
Sbjct: 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY-----LAEMVIAIDSVHQLHYVH 198
Query: 374 RDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT---- 429
           RD+K  NIL+D + + RL DFG    +  E  +      VG P    Y++PE        
Sbjct: 199 RDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGTP---DYISPEILQAMEGG 254
Query: 430 -GKATPESDVFGFGAVVLEVVCGRSP 454
            G+  PE D +  G  + E++ G +P
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 99/221 (44%), Gaps = 20/221 (9%)
Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD--FLAELAI 297
            ++    M LG G +G+V K         HV + QI   K  R ++ S+     L +L I
Sbjct: 50  ADDLEPIMELGRGAYGVVEK-------MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI 102
Query: 298 -IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQ-VTLNWNHRYKILTG 355
            +            G    +G + +  + M + SL+K+     ++  T+  +   KI   
Sbjct: 103 SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVS 161
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           +  A+ +L ++    V+HRD+K SN+L++A    ++ DFG++  +    +S A+    G 
Sbjct: 162 IVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDSVAKTIDAGC 216
Query: 416 PGTMG--YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
              M    + PE    G +  +SD++  G  ++E+   R P
Sbjct: 217 KPYMAPERINPELNQKGYSV-KSDIWSLGITMIELAILRFP 256

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 93/231 (40%), Gaps = 61/231 (26%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS-RD------------SIKSKGDFLAEL 295
           +G+G +G V++G+ H           +AVK FS RD            ++  + D +  L
Sbjct: 16  VGKGRYGEVWRGLWH--------GESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNI--L 65
Query: 296 AIIXXXXXXXXXXXXGWC----HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYK 351
             I             W     HE G L   YDF+   +LE +L               +
Sbjct: 66  GFIASDMTSRNSSTQLWLITHYHEHGSL---YDFLQRQTLEPHLA-------------LR 109
Query: 352 ILTGVASAVYYLQNEY-----DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
           +    A  + +L  E         + HRD K+ N+L+ ++    + D GLA  + ++ + 
Sbjct: 110 LAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSD 168
Query: 407 YAEHGLVGVPGTMGYVAPE---------CFHTGKATPESDVFGFGAVVLEV 448
           Y + G     GT  Y+APE         CF + K T   D++ FG V+ E+
Sbjct: 169 YLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWT---DIWAFGLVLWEI 216

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 61/144 (42%), Gaps = 25/144 (17%)
Query: 319 LLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVH 373
           L LV   +  G L     EK  Y   +  TL        +  V  AVYYL       +VH
Sbjct: 95  LYLVMQLVSGGELFDRIVEKGFYTEKDASTL--------IRQVLDAVYYLHR---MGIVH 143
Query: 374 RDLKASNILL---DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           RDLK  N+L    D +    + DFGL++ +E + +      +    GT GYVAPE     
Sbjct: 144 RDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGDV-----MSTACGTPGYVAPEVLAQK 197
Query: 431 KATPESDVFGFGAVVLEVVCGRSP 454
             +   D +  G +   ++CG  P
Sbjct: 198 PYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           VA  + +L +   +K +HRDL A NILL  +   ++ DFGLAR I    + Y   G   +
Sbjct: 208 VARGMEFLSS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPD-YVRKGDTRL 263
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           P  + ++APE       + +SDV+ +G ++ E+   G SP
Sbjct: 264 P--LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSP 301

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 33/235 (14%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF--SRDSIKSKGDFLAELAIIXXXXXXXX 306
           +G G +G+V         +  +   Q+A+KK   + D + +    L EL I+        
Sbjct: 62  IGNGAYGVVSSA------RRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNI 115
Query: 307 XXXXGWCH------EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR--YKILTGVAS 358
                         E   + +V D M    L + ++ +S+ +TL       Y++L G   
Sbjct: 116 IAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIH-SSQPLTLEHVRYFLYQLLRG--- 170
Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG--LVGVP 416
               L+  +  +V+HRDLK SN+L++ +   ++GDFG+AR +     S AEH   +    
Sbjct: 171 ----LKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL---CTSPAEHQYFMTEYV 223
Query: 417 GTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRS--PGNMIPHQQHAYTLV 468
            T  Y APE   +  + T   D++  G +  E++  R   PG    HQ     +V
Sbjct: 224 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 108 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLK 164
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 165 IXDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222
Query: 450 CGR 452
             R
Sbjct: 223 SNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 108 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLK 164
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 165 ICDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222
Query: 450 CGR 452
             R
Sbjct: 223 SNR 225

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV- 183
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 184 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 226

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 138 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 189
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 190 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 232

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 108 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLK 164
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 165 ICDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222
Query: 450 CGR 452
             R
Sbjct: 223 SNR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 112 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLK 168
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 169 ICDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 450 CGR 452
             R
Sbjct: 227 SNR 229

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 99/228 (43%), Gaps = 34/228 (14%)
Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD--FLAELAI 297
            ++    M LG G +G+V K         HV + QI   K  R ++ S+     L +L I
Sbjct: 6   ADDLEPIMELGRGAYGVVEK-------MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI 58
Query: 298 -IXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQ-VTLNWNHRYKILTG 355
            +            G    +G + +  + M + SL+K+     ++  T+  +   KI   
Sbjct: 59  SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVS 117
Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           +  A+ +L ++    V+HRD+K SN+L++A    ++ DFG++  + ++     +      
Sbjct: 118 IVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID------ 169
Query: 416 PGTMGYVAPECFHTGKATPE---------SDVFGFGAVVLEVVCGRSP 454
            G   Y+APE     +  PE         SD++  G  ++E+   R P
Sbjct: 170 AGCKPYMAPE-----RINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 112 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLK 168
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 169 ICDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 450 CGR 452
             R
Sbjct: 227 SNR 229

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 108 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLK 164
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 165 ICDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222
Query: 450 CGR 452
             R
Sbjct: 223 SNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 110 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLK 166
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 167 ICDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 224
Query: 450 CGR 452
             R
Sbjct: 225 SNR 227

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 137 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV- 188
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 189 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 231

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 184 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 226

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 113 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLK 169
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 170 ICDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 227
Query: 450 CGR 452
             R
Sbjct: 228 SNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 114 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLK 170
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 171 ICDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 228
Query: 450 CGR 452
             R
Sbjct: 229 SNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 105 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLK 161
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 162 ICDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 219
Query: 450 CGR 452
             R
Sbjct: 220 SNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 112 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLK 168
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 169 ICDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 450 CGR 452
             R
Sbjct: 227 SNR 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 128 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLK 184
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 185 ICDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 242
Query: 450 CGR 452
             R
Sbjct: 243 SNR 245

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 106 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLK 162
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 163 ICDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 220
Query: 450 CGR 452
             R
Sbjct: 221 SNR 223

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 100/235 (42%), Gaps = 33/235 (14%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR--DSIKSKGDFLAELAIIXXXXXXXX 306
           +G G +G+V         +  +   Q+A+KK     D + +    L EL I+        
Sbjct: 63  IGNGAYGVVSSA------RRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNI 116
Query: 307 XXXXGWCH------EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR--YKILTGVAS 358
                         E   + +V D M    L + ++ +S+ +TL       Y++L G   
Sbjct: 117 IAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIH-SSQPLTLEHVRYFLYQLLRG--- 171
Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG--LVGVP 416
               L+  +  +V+HRDLK SN+L++ +   ++GDFG+AR +     S AEH   +    
Sbjct: 172 ----LKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL---CTSPAEHQYFMTEYV 224
Query: 417 GTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRS--PGNMIPHQQHAYTLV 468
            T  Y APE   +  + T   D++  G +  E++  R   PG    HQ     +V
Sbjct: 225 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 279

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 137 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV- 188
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 189 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 231

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 106 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLK 162
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 163 ICDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 220
Query: 450 CGR 452
             R
Sbjct: 221 SNR 223

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 112 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLK 168
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 169 ICDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 450 CGR 452
             R
Sbjct: 227 SNR 229

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 184 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 226

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 138 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 189
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 190 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 232

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 137 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 188
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 189 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 231

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 184 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 226

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E      
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------ 178
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
             + G   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 179 --MAGFVATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 226

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 184 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 226

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 144 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 195
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 196 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 238

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 143 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV- 194
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 195 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 237

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 54/110 (49%), Gaps = 18/110 (16%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 410 HGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE         ++ D++  G ++ E++ GR+  PG 
Sbjct: 184 -------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 139 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 190
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 191 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 233

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 116 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLK 172
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 173 ICDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 230
Query: 450 CGR 452
             R
Sbjct: 231 SNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 108 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLK 164
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 165 ICDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222
Query: 450 CGR 452
             R
Sbjct: 223 SNR 225

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 138 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 189
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 190 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 232

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 184 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 226

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 110 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLK 166
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 167 ICDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 224
Query: 450 CGR 452
             R
Sbjct: 225 SNR 227

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E      
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------ 178
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
             + G   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 179 --MAGFVATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 226

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 54/110 (49%), Gaps = 18/110 (16%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 128 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 179
Query: 410 HGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE         ++ D++  G ++ E++ GR+  PG 
Sbjct: 180 -------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 144 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 195
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 196 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 238

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 134 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 185
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 186 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 228

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 184 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 226

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 144 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 195
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 196 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 238

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 184 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 226

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 54/110 (49%), Gaps = 18/110 (16%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 129 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 180
Query: 410 HGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE         ++ D++  G ++ E++ GR+  PG 
Sbjct: 181 -------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 223

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 112 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLK 168
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 169 ICDFGLARVADPDHDHTG--FLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 450 CGR 452
             R
Sbjct: 227 SNR 229

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 18/110 (16%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E      
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------ 178
Query: 410 HGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGRS--PGN 456
             + G   T  Y APE         ++ D++  G ++ E++ GR+  PG 
Sbjct: 179 --MTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 113 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLK 169
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 170 ICDFGLARVADPDHDHTG--FLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 227
Query: 450 CGR 452
             R
Sbjct: 228 SNR 230

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 137 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 188
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 189 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 231

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 134 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 185
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 186 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 228

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 131 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 182
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 183 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 225

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 155 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 206
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 207 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 249

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 54/110 (49%), Gaps = 18/110 (16%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 129 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 180
Query: 410 HGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE         ++ D++  G ++ E++ GR+  PG 
Sbjct: 181 -------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 223

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 152 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 203
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 204 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 246

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 142 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 193
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 194 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 236

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 134 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 185
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 186 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 228

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 54/110 (49%), Gaps = 18/110 (16%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 128 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 179
Query: 410 HGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE         ++ D++  G ++ E++ GR+  PG 
Sbjct: 180 -------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 152 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 203
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 204 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 246

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 151 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 202
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 203 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 245

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 54/110 (49%), Gaps = 18/110 (16%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 128 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 179
Query: 410 HGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE         ++ D++  G ++ E++ GR+  PG 
Sbjct: 180 -------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 18/110 (16%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E      
Sbjct: 128 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------ 174
Query: 410 HGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGRS--PGN 456
             + G   T  Y APE         ++ D++  G ++ E++ GR+  PG 
Sbjct: 175 --MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 143 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 194
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 195 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 237

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 184 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 226

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 54/110 (49%), Gaps = 18/110 (16%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 130 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 181
Query: 410 HGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE         ++ D++  G ++ E++ GR+  PG 
Sbjct: 182 -------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 224

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 138 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV- 189
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 190 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 232

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 151 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 202
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 203 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 245

>pdb|1GZ9|A Chain A, High-Resolution Crystal Structure Of Erythrina Cristagalli Lectin In Complex With 2'-Alpha-L-Fucosyllactose Length = 239

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 64/145 (44%), Gaps = 16/145 (11%)
Query: 11  ISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHF--VAIEFDTVKQGFDPDD- 67
           +   GL F + P  S P      Q  G    F +  + N +  +A+EFDT    +DP   
Sbjct: 86  LPADGLVFFMGPTKSKP-----AQGYGYLGVFNNSKQDNSYQTLAVEFDTFSNPWDPPQV 140
Query: 68  NHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKP 127
            H+G+++NS+ S K  P +      L +G    V ++YD  SK++ V +           
Sbjct: 141 PHIGIDVNSIRSIKTQPFQ------LDNGQVANVVIKYDAPSKILHVVLVYPSSGAIYT- 193
Query: 128 LLKETINLKDYLKPESYFGFSASTG 152
            + E +++K  L      G S +TG
Sbjct: 194 -IAEIVDVKQVLPDWVDVGLSGATG 217

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 134 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV- 185
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 186 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 228

>pdb|1Q8O|A Chain A, Pterocartpus Angolensis Lectin Pal In Complex With The Dimmanoside Man(Alpha1-2)man Length = 252

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 76/170 (44%), Gaps = 15/170 (8%)
Query: 13  GHGLAFVIAPND-SFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTV----KQGFDPDD 67
             G+AF IAP D + P  S  G              AN  +A+EFDT        +DP+ 
Sbjct: 85  ADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQDSNTWDPNY 144
Query: 68  NHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKP 127
            H+G+++NS+ S K V           DG S  V V ++  ++ + V       T  +  
Sbjct: 145 PHIGIDVNSIRSVKTVKWDRR------DGQSLNVLVTFNPSTRNLDVVATYSDGTRYE-- 196
Query: 128 LLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEK 177
            +   ++++  L      GFSA++G  + Q + + SW+    ++ T ++K
Sbjct: 197 -VSYEVDVRSVLPEWVRVGFSAASGEQY-QTHTLESWSFTSTLLYTAQKK 244

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 112 METDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLK 168
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 169 ICDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 450 CGR 452
             R
Sbjct: 227 SNR 229

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   V+HRDLK SN+LL+   + ++ DFGLAR  + + +    
Sbjct: 151 YQILRG-------LKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTG- 202
Query: 410 HGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGR 452
             L     T  Y APE     K   +S D++  G ++ E++  R
Sbjct: 203 -FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1N3O|A Chain A, Pterocarcpus Angolensis Lectin In Complex With Alpha-Methyl Glucose Length = 252

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 76/170 (44%), Gaps = 15/170 (8%)
Query: 13  GHGLAFVIAPND-SFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTV----KQGFDPDD 67
             G+AF IAP D + P  S  G              AN  +A+EFDT        +DP+ 
Sbjct: 85  ADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQDSNTWDPNY 144
Query: 68  NHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKP 127
            H+G+++NS+ S K V           DG S  V V ++  ++ + V       T  +  
Sbjct: 145 PHIGIDVNSIRSVKTVKWDRR------DGQSLNVLVTFNPSTRNLDVVATYSDGTRYE-- 196
Query: 128 LLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQTKKEK 177
            +   ++++  L      GFSA++G  + Q + + SW+    ++ T ++K
Sbjct: 197 -VSYEVDVRSVLPEWVRVGFSAASGEQY-QTHTLESWSFTSTLLYTAQKK 244

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +E  LY   +   L+ +H    L  +   + Y+ +     V+HRDLK SN+LL+   + +
Sbjct: 110 METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTSDLK 166
Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVV 449
           + DFGLAR  + + +      L     T  Y APE     K   +S D++  G ++ E++
Sbjct: 167 ICDFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 224
Query: 450 CGR 452
             R
Sbjct: 225 SNR 227

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E      
Sbjct: 161 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------ 207
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
             + G   T  Y APE      H        D++  G ++ E++ GR+  PG 
Sbjct: 208 --MTGYVATRWYRAPEIMLNWMHYNMTV---DIWSVGCIMAELLTGRTLFPGT 255

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E   Y  
Sbjct: 155 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYV- 206
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 207 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 249

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR  ++E      
Sbjct: 152 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------ 198
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
             + G   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 199 --MXGXVATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 246

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 13/106 (12%)
Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD---FNARLGDFGLARAIENERNSYA 408
           I+  + S + YL   +   +VHRD+K  NILL+      N ++ DFGL+           
Sbjct: 151 IMKQILSGICYL---HKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS------K 201
Query: 409 EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           ++ L    GT  Y+APE     K   + DV+  G ++  ++CG  P
Sbjct: 202 DYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 27/231 (11%)
Query: 228 PREFKYKE-LKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK 286
           P +++Y+E +  AT+     +RLG G FG V      H  +      Q AVKK   +  +
Sbjct: 83  PVDYEYREEVHWATHQ----LRLGRGSFGEV------HRMEDKQTGFQCAVKKVRLEVFR 132
Query: 287 SKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNW 346
           ++     EL               G   E   + +  + +  GSL + +    EQ  L  
Sbjct: 133 AE-----ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV---KEQGCLPE 184
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD-FNARLGDFGLARAIENERN 405
           +     L      + YL   + ++++H D+KA N+LL +D  +A L DFG A  ++   +
Sbjct: 185 DRALYYLGQALEGLEYL---HSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQP--D 239
Query: 406 SYAEHGLVG--VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
              +  L G  +PGT  ++APE         + DV+    ++L ++ G  P
Sbjct: 240 GLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 53/113 (46%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR   +E   Y  
Sbjct: 139 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV- 190
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 191 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 233

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 53/113 (46%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR   +E   Y  
Sbjct: 139 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV- 190
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 191 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 233

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 53/113 (46%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGLAR   +E   Y  
Sbjct: 139 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV- 190
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 191 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 233

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 27/231 (11%)
Query: 228 PREFKYKE-LKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK 286
           P +++Y+E +  AT+     +RLG G FG V      H  +      Q AVKK   +  +
Sbjct: 64  PVDYEYREEVHWATHQ----LRLGRGSFGEV------HRMEDKQTGFQCAVKKVRLEVFR 113
Query: 287 SKGDFLAELAIIXXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNW 346
           ++     EL               G   E   + +  + +  GSL + +    EQ  L  
Sbjct: 114 AE-----ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV---KEQGCLPE 165
Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD-FNARLGDFGLARAIENERN 405
           +     L      + YL   + ++++H D+KA N+LL +D  +A L DFG A  ++   +
Sbjct: 166 DRALYYLGQALEGLEYL---HSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQP--D 220
Query: 406 SYAEHGLVG--VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
              +  L G  +PGT  ++APE         + DV+    ++L ++ G  P
Sbjct: 221 GLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 62/144 (43%), Gaps = 14/144 (9%)
Query: 314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVH 373
           H K  LL++ + M  G L   +    +Q         +I+  + +A+ +L   +   + H
Sbjct: 77  HGKRCLLIIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIGTAIQFL---HSHNIAH 132
Query: 374 RDLKASNILL---DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           RD+K  N+L    + D   +L DFG A+          ++ L     T  YVAPE     
Sbjct: 133 RDVKPENLLYTSKEKDAVLKLTDFGFAKET-------TQNALQTPCYTPYYVAPEVLGPE 185
Query: 431 KATPESDVFGFGAVVLEVVCGRSP 454
           K     D++  G ++  ++CG  P
Sbjct: 186 KYDKSCDMWSLGVIMYILLCGFPP 209

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 62/144 (43%), Gaps = 14/144 (9%)
Query: 314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVH 373
           H K  LL++ + M  G L   +    +Q         +I+  + +A+ +L   +   + H
Sbjct: 96  HGKRCLLIIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIGTAIQFL---HSHNIAH 151
Query: 374 RDLKASNILL---DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           RD+K  N+L    + D   +L DFG A+          ++ L     T  YVAPE     
Sbjct: 152 RDVKPENLLYTSKEKDAVLKLTDFGFAKET-------TQNALQTPCYTPYYVAPEVLGPE 204
Query: 431 KATPESDVFGFGAVVLEVVCGRSP 454
           K     D++  G ++  ++CG  P
Sbjct: 205 KYDKSCDMWSLGVIMYILLCGFPP 228

>pdb|3N35|A Chain A, Erythrina Corallodendron Lectin Mutant (Y106g) With N- Acetylgalactosamine Length = 242

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 77/174 (44%), Gaps = 23/174 (13%)
Query: 5   PRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHF--VAIEFDTVKQG 62
           P PA      GL F + P  S P +   G +LG+   F +  + N +  + +EFDT    
Sbjct: 85  PLPA-----DGLVFFMGPTKSKPAQG--GGYLGI---FNNSKQDNSYQTLGVEFDTFSNQ 134
Query: 63  FDPDD-NHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGE 121
           +DP    H+G+++NS+ S K  P +      L +G    V ++YD  SK++   +     
Sbjct: 135 WDPPQVPHIGIDVNSIRSIKTQPFQ------LDNGQVANVVIKYDASSKILHAVLVYPSS 188
Query: 122 TMPQKPLLKETINLKDYLKPESYFGFSASTGYPH--IQLNCVRSWTLDIDVIQT 173
                  + E +++K  L      G S +TG      + + V SW+    + +T
Sbjct: 189 GAIYT--IAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSWSFQASLPET 240

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ D+GLAR  ++E   Y  
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYV- 183
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 184 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 226

>pdb|1LTE|A Chain A, Structure Of A Legume Lectin With An Ordered N-Linked Carbohydrate In Complex With Lactose Length = 239

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 12/143 (8%)
Query: 11  ISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDD-NH 69
           +   GL F + P  S P +  YG +LG+ N     N +   + +EFDT    +DP    H
Sbjct: 86  LPADGLVFFMGPTKSKPAQG-YG-YLGIFNQSKQDN-SYQTLGVEFDTFSNPWDPPQVPH 142
Query: 70  LGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLL 129
           +G+++NS+ S K  P +      L +G    V ++YD  SKL+   +            +
Sbjct: 143 IGIDVNSIRSIKTQPFQ------LDNGQVANVVIKYDASSKLLHAVLVYPSSGAIYT--I 194
Query: 130 KETINLKDYLKPESYFGFSASTG 152
            E +++K  L      G S +TG
Sbjct: 195 AEIVDVKQVLPEWVDVGLSGATG 217

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/259 (22%), Positives = 96/259 (37%), Gaps = 30/259 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK--------GDFLAELAIIXX 300
           LG G FG V+  +          N ++ VK   ++ +           G    E+AI+  
Sbjct: 32  LGSGAFGFVWTAVDKEK------NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 301 XXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
                          +G   LV +   +GS             L+      I   + SAV
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVME--KHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            YL+    + ++HRD+K  NI++  DF  +L DFG A  +E  +  Y         GT+ 
Sbjct: 144 GYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT------FCGTIE 194
Query: 421 YVAPECFHTGKAT-PESDVFGFGAVVLEVVCGRSP----GNMIPHQQHAYTLVDWVWMLH 475
           Y APE         PE +++  G  +  +V   +P       +    H   LV    M  
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSL 254
Query: 476 REGHIQDAVDQRLNINSVV 494
             G +Q   ++R  +  +V
Sbjct: 255 VSGLLQPVPERRTTLEKLV 273

>pdb|2FMD|A Chain A, Structural Basis Of Carbohydrate Recognition By Bowringia Milbraedii Seed Agglutinin Length = 240

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 12/153 (7%)
Query: 16  LAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG--FDPDDNHLGLN 73
           L F IA  D+  P  S G+ LGL  +  +    N  V++EFDT       DP+  H+G++
Sbjct: 88  LTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIGDPNYRHIGID 147
Query: 74  INSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETI 133
           +NS+  R     K ++     +G + T  + Y+  SK + V       +     ++   +
Sbjct: 148 VNSI--RSKAASKWDWQ----NGKTATAHISYNSASKRLSVVSSYPNSS---PVVVSFDV 198
Query: 134 NLKDYLKPESYFGFSASTGYPHIQLNCVRSWTL 166
            L +        GFSA+TG  + Q N + +W+ 
Sbjct: 199 ELNNVXPXWVRVGFSATTG-QYTQTNNILAWSF 230

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 17/92 (18%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC---- 426
           ++HRDLK SN+ ++ D   R+ DFGLAR  + E   Y          T  Y APE     
Sbjct: 144 IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYV--------ATRWYRAPEIMLNW 195
Query: 427 FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
            H  +     D++  G ++ E++ G++  PG+
Sbjct: 196 MHYNQTV---DIWSVGCIMAELLQGKALFPGS 224

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DFGL R  ++E   Y  
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYV- 183
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 184 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 226

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 17/154 (11%)
Query: 316 KGKLLLVYDFMPNGS---LEKYLYGTSEQVT--LNWNHRYKILTGVASAVYYLQNEYDQK 370
           K +L LV   +  GS   + K++    E  +  L+ +    IL  V   + YL   +   
Sbjct: 85  KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL---HKNG 141
Query: 371 VVHRDLKASNILLDADFNARLGDFG----LARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
            +HRD+KA NILL  D + ++ DFG    LA   +  RN       VG P    ++APE 
Sbjct: 142 QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK-VRKTFVGTP---CWMAPEV 197
Query: 427 FHTGKATP-ESDVFGFGAVVLEVVCGRSPGNMIP 459
               +    ++D++ FG   +E+  G +P +  P
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/211 (21%), Positives = 92/211 (43%), Gaps = 10/211 (4%)
Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQY-HVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXX 301
           F+ES  LG+G F  ++KG+      Y  +  T++ +K   +        F    +++   
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 302 XXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
                    G C    + +LV +F+  GSL+ YL      + + W  + ++   +A A++
Sbjct: 70  SHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMH 127
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGY 421
           +L+   +  ++H ++ A NILL  + + + G+    + + +   S        +   + +
Sbjct: 128 FLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIK-LSDPGISITVLPKDILQERIPW 183
Query: 422 VAPECFHTGK-ATPESDVFGFGAVVLEVVCG 451
           V PEC    K     +D + FG  + E+  G
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 17/92 (18%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC---- 426
           ++HRDLK SN+ ++ D   R+ DFGLAR  + E   Y          T  Y APE     
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV--------ATRWYRAPEIMLNW 203
Query: 427 FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
            H  +     D++  G ++ E++ G++  PG+
Sbjct: 204 MHYNQTV---DIWSVGCIMAELLQGKALFPGS 232

>pdb|1SFY|A Chain A, Crystal Structure Of Recombinant Erythrina Corallodandron Lectin Length = 239

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 67/145 (46%), Gaps = 16/145 (11%)
Query: 11  ISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHF--VAIEFDTVKQGFDPDD- 67
           +   GL F + P  S P +  YG +LG+   F +  + N +  + +EFDT    +DP   
Sbjct: 86  LPADGLVFFMGPTKSKPAQG-YG-YLGI---FNNSKQDNSYQTLGVEFDTFSNQWDPPQV 140
Query: 68  NHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKP 127
            H+G+++NS+ S K  P +      L +G    V ++YD  SKL+   +           
Sbjct: 141 PHIGIDVNSIRSIKTQPFQ------LDNGQVANVVIKYDASSKLLHAVLVYPSSGAIYT- 193
Query: 128 LLKETINLKDYLKPESYFGFSASTG 152
            + E +++K  L      G S +TG
Sbjct: 194 -IAEIVDVKQVLPEWVDVGLSGATG 217

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 90/225 (40%), Gaps = 33/225 (14%)
Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIX 299
           ++ +    +LG G +G V   ++  +     +     +KK S  +  + G  L E+A++ 
Sbjct: 20  SDRYQRVKKLGSGAYGEV---LLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 300 XXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSL--EKYLYGTSEQVTLNWNHRYKILTGVA 357
                       +  +K    LV +    G L  E  L     +V         I+  V 
Sbjct: 77  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-----IMKQVL 131
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDA---DFNARLGDFGLARAIE-----NERNSYAE 409
           S   YL   +   +VHRDLK  N+LL++   D   ++ DFGL+   E      ER     
Sbjct: 132 SGTTYL---HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER----- 183
Query: 410 HGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                  GT  Y+APE     K   + DV+  G ++  ++CG  P
Sbjct: 184 ------LGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPP 221

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 70/154 (45%), Gaps = 17/154 (11%)
Query: 316 KGKLLLVYDFMPNGS---LEKYLYGTSEQVT--LNWNHRYKILTGVASAVYYLQNEYDQK 370
           K +L LV   +  GS   + K++    E  +  L+ +    IL  V   + YL       
Sbjct: 80  KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ-- 137
Query: 371 VVHRDLKASNILLDADFNARLGDFG----LARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
            +HRD+KA NILL  D + ++ DFG    LA   +  RN       VG P    ++APE 
Sbjct: 138 -IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK-VRKTFVGTP---CWMAPEV 192
Query: 427 FHTGKATP-ESDVFGFGAVVLEVVCGRSPGNMIP 459
               +    ++D++ FG   +E+  G +P +  P
Sbjct: 193 MEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 226

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 68/138 (49%), Gaps = 11/138 (7%)
Query: 317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDL 376
           GKL L+ +++  G L  ++    E + +     +  L  ++ A+ +L   + + +++RDL
Sbjct: 94  GKLYLILEYLSGGEL--FMQLEREGIFMEDTACF-YLAEISMALGHL---HQKGIIYRDL 147
Query: 377 KASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES 436
           K  NI+L+   + +L DFGL +  E+  +    H      GT+ Y+APE           
Sbjct: 148 KPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFC---GTIEYMAPEILMRSGHNRAV 202
Query: 437 DVFGFGAVVLEVVCGRSP 454
           D +  GA++ +++ G  P
Sbjct: 203 DWWSLGALMYDMLTGAPP 220

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 17/92 (18%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC---- 426
           ++HRDLK SN+ ++ D   R+ DFGLAR  + E   Y          T  Y APE     
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV--------ATRWYRAPEIMLNW 203
Query: 427 FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
            H  +     D++  G ++ E++ G++  PG+
Sbjct: 204 MHYNQTV---DIWSVGCIMAELLQGKALFPGS 232

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 68/138 (49%), Gaps = 11/138 (7%)
Query: 317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDL 376
           GKL L+ +++  G L  ++    E + +     +  L  ++ A+ +L   + + +++RDL
Sbjct: 94  GKLYLILEYLSGGEL--FMQLEREGIFMEDTACF-YLAEISMALGHL---HQKGIIYRDL 147
Query: 377 KASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES 436
           K  NI+L+   + +L DFGL +  E+  +    H      GT+ Y+APE           
Sbjct: 148 KPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFC---GTIEYMAPEILMRSGHNRAV 202
Query: 437 DVFGFGAVVLEVVCGRSP 454
           D +  GA++ +++ G  P
Sbjct: 203 DWWSLGALMYDMLTGAPP 220

>pdb|1UZY|A Chain A, Erythrina Crystagalli Lectin Length = 242

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 72/168 (42%), Gaps = 18/168 (10%)
Query: 11  ISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHF--VAIEFDTVKQGFDPDD- 67
           +   GL F + P  S P      Q  G    F +  + N +  +A+EFDT    +DP   
Sbjct: 86  LPADGLVFFMGPTKSKP-----AQGYGYLGVFNNSKQDNSYQTLAVEFDTFSNPWDPPQV 140
Query: 68  NHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKP 127
            H+G+++NS+ S K  P +      L +G    V ++YD  SK++   +           
Sbjct: 141 PHIGIDVNSIRSIKTQPFQ------LDNGQVANVVIKYDASSKILLAVLVYPSSGAIYT- 193
Query: 128 LLKETINLKDYLKPESYFGFSASTGYPH--IQLNCVRSWTLDIDVIQT 173
            + E +++K  L      G S +TG      + + V SW+    + +T
Sbjct: 194 -IAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSWSFHASLPET 240

>pdb|1FYU|A Chain A, Crystal Structure Of Erythrina Corallodendron Lectin In Hexagonal Crystal Form Length = 255

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 18/169 (10%)
Query: 11  ISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHF--VAIEFDTVKQGFDPDD- 67
           +   GL F + P  S P +  YG +LG+   F +  + N +  + +EFDT    +DP   
Sbjct: 86  LPADGLVFFMGPTKSKPAQG-YG-YLGI---FNNSKQDNSYQTLGVEFDTFSNPWDPPQV 140
Query: 68  NHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKP 127
            H+G+++NS+ S K  P +      L +G    V ++YD  SK++   +           
Sbjct: 141 PHIGIDVNSIRSIKTQPFQ------LDNGQVANVVIKYDASSKILHAVLVYPSSGAIYT- 193
Query: 128 LLKETINLKDYLKPESYFGFSASTGYPH--IQLNCVRSWTLDIDVIQTK 174
            + E +++K  L      G S +TG      + + V SW+    + +T 
Sbjct: 194 -IAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSWSFQASLPETN 241

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK--GDFLAELAIIXXXXXXXX 306
           LG+G FG V K       +  +   + AVK  ++ S K+K     L E+ ++        
Sbjct: 30  LGKGSFGEVLKC------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 307 XXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
                   +     +V +    G L   +    ++   + +   +I+  V S + Y+   
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYM--- 137
Query: 367 YDQKVVHRDLKASNILLDA---DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
           +   +VHRDLK  NILL++   D + ++ DFGL+     ++N+  +  +    GT  Y+A
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRI----GTAYYIA 191
Query: 424 PECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           PE    G    + DV+  G ++  ++ G  P
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1LUL|A Chain A, Db58, A Legume Lectin From Dolichos Biflorus Length = 253

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 75/158 (47%), Gaps = 14/158 (8%)
Query: 12  SGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG-FDPDDNHL 70
           S  G+AF + P  S P  +S   +LG+ ++    N A   VA+EFDT     +DP   H+
Sbjct: 83  SADGIAFALVPVGSEPKSNS--GFLGVFDSDVYDNSA-QTVAVEFDTFSNTDWDPTSRHI 139
Query: 71  GLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLK 130
           G+++NS+ S +           L++G +  + + Y+  + L+   +           ++ 
Sbjct: 140 GIDVNSIKSIRTASWG------LANGQNAEILITYNAATSLLVASLVHPSRRTSY--IVS 191
Query: 131 ETINLKDYLKPESYFGFSASTGYP--HIQLNCVRSWTL 166
           E +++ + L      GFSA+TG    + + + V SW+ 
Sbjct: 192 ERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSF 229

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 88/219 (40%), Gaps = 20/219 (9%)
Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS-RDSIKSKGDFLAELAII 298
           T+ +     LG+G F +V + +     Q +     I  KK S RD  K +     E  I 
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKI-INTKKLSARDHQKLE----REARIC 57
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVAS 358
                           E+G   LV+D +  G L + +         + +H       +  
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH------CIQQ 111
Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLVGV 415
            +  + + +   +VHRDLK  N+LL +       +L DFGLA  ++ ++ ++      G 
Sbjct: 112 ILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW-----FGF 166
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            GT GY++PE           D++  G ++  ++ G  P
Sbjct: 167 AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK--GDFLAELAIIXXXXXXXX 306
           LG+G FG V K       +  +   + AVK  ++ S K+K     L E+ ++        
Sbjct: 30  LGKGSFGEVLKC------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 307 XXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
                   +     +V +    G L   +    ++   + +   +I+  V S + Y+   
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYM--- 137
Query: 367 YDQKVVHRDLKASNILLDA---DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
           +   +VHRDLK  NILL++   D + ++ DFGL+     ++N+  +  +    GT  Y+A
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRI----GTAYYIA 191
Query: 424 PECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           PE    G    + DV+  G ++  ++ G  P
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK--GDFLAELAIIXXXXXXXX 306
           LG+G FG V K       +  +   + AVK  ++ S K+K     L E+ ++        
Sbjct: 30  LGKGSFGEVLKC------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 307 XXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
                   +     +V +    G L   +    ++   + +   +I+  V S + Y+   
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYM--- 137
Query: 367 YDQKVVHRDLKASNILLDA---DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
           +   +VHRDLK  NILL++   D + ++ DFGL+     ++N+  +  +    GT  Y+A
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRI----GTAYYIA 191
Query: 424 PECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           PE    G    + DV+  G ++  ++ G  P
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/250 (19%), Positives = 101/250 (40%), Gaps = 47/250 (18%)
Query: 214 EPHHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNT 273
           +P +NL +++L                 +F+  M LG+G FG V        ++ +    
Sbjct: 8   QPSNNLDRVKL----------------TDFNFLMVLGKGSFGKVMLADRKGTEELY---- 47
Query: 274 QIAVKKFSRDSIKSKGDF---LAELAIIXXXXXXXXXXXXGWCHEK-GKLLLVYDFMPNG 329
             A+K   +D +    D    + E  ++              C +   +L  V +++  G
Sbjct: 48  --AIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGG 105
Query: 330 SLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA 389
            L   +Y   +               ++  +++L   + + +++RDLK  N++LD++ + 
Sbjct: 106 DL---MYHIQQVGKFKEPQAVFYAAEISIGLFFL---HKRGIIYRDLKLDNVMLDSEGHI 159
Query: 390 RLGDFGLARAIENERNSYAEHGLVGVP-----GTMGYVAPECFHTGKATPESDVFGFGAV 444
           ++ DFG+ +          EH + GV      GT  Y+APE           D + +G +
Sbjct: 160 KIADFGMCK----------EHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVL 209
Query: 445 VLEVVCGRSP 454
           + E++ G+ P
Sbjct: 210 LYEMLAGQPP 219

>pdb|1AX0|A Chain A, Erythrina Corallodendron Lectin In Complex With N-Actylgalactosamine Length = 239

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 16/145 (11%)
Query: 11  ISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHF--VAIEFDTVKQGFDPDD- 67
           +   GL F + P  S P +  YG +LG+   F +  + N +  + +EFDT    +DP   
Sbjct: 86  LPADGLVFFMGPTKSKPAQG-YG-YLGI---FNNSKQDNSYQTLGVEFDTFSNPWDPPQV 140
Query: 68  NHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKP 127
            H+G+++NS+ S K  P +      L +G    V ++YD  SK++   +           
Sbjct: 141 PHIGIDVNSIRSIKTQPFQ------LDNGQVANVVIKYDASSKILHAVLVYPSSGAIYT- 193
Query: 128 LLKETINLKDYLKPESYFGFSASTG 152
            + E +++K  L      G S +TG
Sbjct: 194 -IAEIVDVKQVLPEWVDVGLSGATG 217

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 88/219 (40%), Gaps = 20/219 (9%)
Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS-RDSIKSKGDFLAELAII 298
           T+ +     LG+G F +V + +     Q +     I  KK S RD  K +     E  I 
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKI-INTKKLSARDHQKLE----REARIC 57
Query: 299 XXXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVAS 358
                           E+G   LV+D +  G L + +         + +H       +  
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH------CIQQ 111
Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNA---RLGDFGLARAIENERNSYAEHGLVGV 415
            +  + + +   +VHRDLK  N+LL +       +L DFGLA  ++ ++ ++      G 
Sbjct: 112 ILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW-----FGF 166
Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            GT GY++PE           D++  G ++  ++ G  P
Sbjct: 167 AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 61/148 (41%), Gaps = 16/148 (10%)
Query: 314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVH 373
            ++  L LV ++   G L   L    E++       Y     +A  V  + + +    VH
Sbjct: 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY-----LAEIVMAIDSVHRLGYVH 185
Query: 374 RDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT---- 429
           RD+K  NILLD   + RL DFG    +   R       LV V GT  Y++PE        
Sbjct: 186 RDIKPDNILLDRCGHIRLADFGSCLKL---RADGTVRSLVAV-GTPDYLSPEILQAVGGG 241
Query: 430 ---GKATPESDVFGFGAVVLEVVCGRSP 454
              G   PE D +  G    E+  G++P
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++  FGLAR  ++E   Y  
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYV- 183
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 184 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 226

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 34/220 (15%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR----------DSIKSKGDFLAELAII 298
           LG+GGFG V+ G          D  Q+A+K   R          DS+    +      + 
Sbjct: 39  LGKGGFGTVFAG------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 299 XXXXXXXXXXXXGWCH-EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
                        W   ++G +L++   +P   L  Y+   +E+  L           V 
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI---TEKGPLGEGPSRCFFGQVV 149
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFN-ARLGDFGLARAIENERNSYAEHGLVGVP 416
           +A+   Q+ + + VVHRD+K  NIL+D     A+L DFG    + +E  +  +       
Sbjct: 150 AAI---QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD------- 199
Query: 417 GTMGYVAPECF--HTGKATPESDVFGFGAVVLEVVCGRSP 454
           GT  Y  PE    H   A P + V+  G ++ ++VCG  P
Sbjct: 200 GTRVYSPPEWISRHQYHALPAT-VWSLGILLYDMVCGDIP 238

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 90/225 (40%), Gaps = 33/225 (14%)
Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIX 299
           ++ +    +LG G +G V   ++  +     +     +KK S  +  + G  L E+A++ 
Sbjct: 3   SDRYQRVKKLGSGAYGEV---LLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 59
Query: 300 XXXXXXXXXXXGWCHEKGKLLLVYDFMPNGSL--EKYLYGTSEQVTLNWNHRYKILTGVA 357
                       +  +K    LV +    G L  E  L     +V         I+  V 
Sbjct: 60  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-----IMKQVL 114
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDA---DFNARLGDFGLARAIE-----NERNSYAE 409
           S   YL   +   +VHRDLK  N+LL++   D   ++ DFGL+   E      ER     
Sbjct: 115 SGTTYL---HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER----- 166
Query: 410 HGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                  GT  Y+APE     K   + DV+  G ++  ++CG  P
Sbjct: 167 ------LGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPP 204

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ DF LAR  ++E   Y  
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYV- 183
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 184 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 226

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 28/216 (12%)
Query: 249 LGEGGFGIVYK------GIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXX 302
           LG G F IV K      G+ +         ++ + +  SR+ I+       E++I+    
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER------EVSILRQVL 73
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYY 362
                        +  ++L+ + +  G L  +L   +++ +L+       +  +   V Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNY 130
Query: 363 LQNEYDQKVVHRDLKASNI-LLDADF---NARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           L   + +K+ H DLK  NI LLD +    + +L DFGLA  IE+            + GT
Sbjct: 131 L---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE------FKNIFGT 181
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             +VAPE  +      E+D++  G +   ++ G SP
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 64/239 (26%)
Query: 249 LGEGGFGIV---YKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIXXXX 302
           +G G  GIV   Y  I+  N         +A+KK SR   +   +K  +  EL ++    
Sbjct: 32  IGSGAQGIVVAAYDAILERN---------VAIKKLSRPFQNQTHAKRAY-RELVLMKV-- 79
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKY--LY--------GTSEQVTLNWNHR--- 349
                      + K  + L+  F P  SLE++  +Y          S+ + +  +H    
Sbjct: 80  ----------VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS 129
Query: 350 ---YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
              Y++L G+       ++ +   ++HRDLK SNI++ +D   ++ DFGLAR        
Sbjct: 130 YLLYQMLVGI-------KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART------- 175
Query: 407 YAEHGLVGVP--GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH 463
            A    +  P   T  Y APE           D++  G ++ E++ G   G + P   H
Sbjct: 176 -AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG---GVLFPGTDH 230

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK--SKGDFLAELAIIXXXXXXXX 306
           LG G F IV K         +    +   K+ SR S +  S+ +   E++I+        
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYA--AKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 307 XXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
                    +  ++L+ + +  G L  +L   +++ +L+       +  +   V YL   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYL--- 131
Query: 367 YDQKVVHRDLKASNI-LLDADF---NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
           + +K+ H DLK  NI LLD +    + +L DFGLA  IE+            + GT  +V
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE------FKNIFGTPEFV 185
Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           APE  +      E+D++  G +   ++ G SP
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 28/216 (12%)
Query: 249 LGEGGFGIVYK------GIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXX 302
           LG G F IV K      G+ +         ++ + +  SR+ I+       E++I+    
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER------EVSILRQVL 73
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYY 362
                        +  ++L+ + +  G L  +L   +++ +L+       +  +   V Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNY 130
Query: 363 LQNEYDQKVVHRDLKASNI-LLDADF---NARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           L   + +K+ H DLK  NI LLD +    + +L DFGLA  IE+            + GT
Sbjct: 131 L---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE------FKNIFGT 181
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             +VAPE  +      E+D++  G +   ++ G SP
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 61/228 (26%)
Query: 249 LGEGGFGIV---YKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIXXXX 302
           +G G  GIV   Y  I+  N         +A+KK SR   +   +K  +  EL ++    
Sbjct: 32  IGSGAQGIVCAAYDAILERN---------VAIKKLSRPFQNQTHAKRAY-RELVLMK--- 78
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKY--LYGTSEQ--------VTLNWNHR--- 349
                      + K  + L+  F P  SLE++  +Y   E         + +  +H    
Sbjct: 79  ---------CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS 129
Query: 350 ---YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
              Y++L G+       ++ +   ++HRDLK SNI++ +D   ++ DFGLAR        
Sbjct: 130 YLLYQMLCGI-------KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART------- 175
Query: 407 YAEHGLVGVPG--TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGR 452
            A    +  P   T  Y APE           D++  G ++ E+VC +
Sbjct: 176 -AGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 109/274 (39%), Gaps = 44/274 (16%)
Query: 247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS---RDSIKSKGDFLAELA---IIXX 300
           + +G G F  VYKG+        V   ++  +K +   R   K + + L  L    I+  
Sbjct: 32  IEIGRGSFKTVYKGL-DTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
Query: 301 XXXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYG---TSEQVTLNWNHRYKILTGVA 357
                       C     ++LV +   +G+L+ YL        +V  +W    +IL G+ 
Sbjct: 91  YDSWESTVKGKKC-----IVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCR--QILKGLQ 143
Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADF-NARLGDFGLARAIENERNSYAEHGLVGVP 416
               +L       ++HRDLK  NI +     + ++GD GLA     +R S+A+     V 
Sbjct: 144 ----FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAK----AVI 191
Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV-------- 468
           GT  + APE +   K     DV+ FG   LE      P +   +    Y  V        
Sbjct: 192 GTPEFXAPEXYEE-KYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPAS 250
Query: 469 -DWVWMLHR----EGHIQDAVDQRLNINSVVDEA 497
            D V +       EG I+   D+R +I  +++ A
Sbjct: 251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ D GLAR  ++E   Y  
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYV- 183
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 184 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 226

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 64/239 (26%)
Query: 249 LGEGGFGIV---YKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIXXXX 302
           +G G  GIV   Y  I+  N         +A+KK SR   +   +K  +  EL ++    
Sbjct: 32  IGSGAQGIVCAAYDAILERN---------VAIKKLSRPFQNQTHAKRAY-RELVLMKV-- 79
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKY--LY--------GTSEQVTLNWNHR--- 349
                      + K  + L+  F P  SLE++  +Y          S+ + +  +H    
Sbjct: 80  ----------VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS 129
Query: 350 ---YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
              Y++L G+       ++ +   ++HRDLK SNI++ +D   ++ DFGLAR        
Sbjct: 130 YLLYQMLVGI-------KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART------- 175
Query: 407 YAEHGLVGVP--GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH 463
            A    +  P   T  Y APE           D++  G ++ E++ G   G + P   H
Sbjct: 176 -AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG---GVLFPGTDH 230

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 84/215 (39%), Gaps = 22/215 (10%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +G G +G VYKG        HV   Q+A  K    +   + +   E+ ++          
Sbjct: 32  VGNGTYGQVYKG-------RHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 309 XXGWCHEK-------GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
                  K        +L LV +F   GS+   +  T    TL       I   +   + 
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-TLKEEWIAYICREILRGLS 143
Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGY 421
           +L   +  KV+HRD+K  N+LL  +   +L DFG++  +  +R     +  +G P  M  
Sbjct: 144 HL---HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAP 198
Query: 422 VAPECFHTGKATPE--SDVFGFGAVVLEVVCGRSP 454
               C     AT +  SD++  G   +E+  G  P
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 64/239 (26%)
Query: 249 LGEGGFGIV---YKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIXXXX 302
           +G G  GIV   Y  I+  N         +A+KK SR   +   +K  +  EL ++    
Sbjct: 32  IGSGAQGIVCAAYDAILERN---------VAIKKLSRPFQNQTHAKRAY-RELVLMKV-- 79
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKY--LY--------GTSEQVTLNWNHR--- 349
                      + K  + L+  F P  SLE++  +Y          S+ + +  +H    
Sbjct: 80  ----------VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS 129
Query: 350 ---YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
              Y++L G+       ++ +   ++HRDLK SNI++ +D   ++ DFGLAR        
Sbjct: 130 YLLYQMLVGI-------KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART------- 175
Query: 407 YAEHGLVGVP--GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH 463
            A    +  P   T  Y APE           D++  G ++ E++ G   G + P   H
Sbjct: 176 -AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG---GVLFPGTDH 230

>pdb|1QNW|A Chain A, Lectin Ii From Ulex Europaeus Length = 242

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 14/155 (9%)
Query: 15  GLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDT----VKQGFDPDDNHL 70
           GLAF +AP +S  P  S     GL ++ +D   +N  +A+EFDT        +DPD  H+
Sbjct: 87  GLAFFLAPANSQIPSGSSAGMFGLFSS-SDSKSSNQIIAVEFDTYFGKAYNPWDPDFKHI 145
Query: 71  GLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLK 130
           G+++NS+ S K V   D  N  ++D     V + Y   +K + V +    +      ++ 
Sbjct: 146 GIDVNSIKSIKTVKW-DWRNGEVAD-----VVITYRAPTKSLTVCLSYPSDGTSN--IIT 197
Query: 131 ETINLKDYLKPESYFGFSASTG-YPHIQLNCVRSW 164
            +++LK  L      GFS   G     + + V SW
Sbjct: 198 ASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSW 232

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ D GLAR  ++E   Y  
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYV- 183
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 184 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 226

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 28/216 (12%)
Query: 249 LGEGGFGIVYK------GIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXX 302
           LG G F IV K      G+ +         ++ + +  SR+ I+       E++I+    
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER------EVSILRQVL 73
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYY 362
                        +  ++L+ + +  G L  +L   +++ +L+       +  +   V Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNY 130
Query: 363 LQNEYDQKVVHRDLKASNI-LLDADF---NARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           L   + +K+ H DLK  NI LLD +    + +L DFGLA  IE+            + GT
Sbjct: 131 L---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE------FKNIFGT 181
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             +VAPE  +      E+D++  G +   ++ G SP
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/83 (36%), Positives = 42/83 (50%), Gaps = 8/83 (9%)
Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
           +  +VVHRDLK  NIL+ +    +L DFGLAR          +  L  V  T+ Y APE 
Sbjct: 137 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS------FQMALTSVVVTLWYRAPEV 190
Query: 427 -FHTGKATPESDVFGFGAVVLEV 448
              +  ATP  D++  G +  E+
Sbjct: 191 LLQSSYATP-VDLWSVGCIFAEM 212

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 61/228 (26%)
Query: 249 LGEGGFGIV---YKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIXXXX 302
           +G G  GIV   Y  I+  N         +A+KK SR   +   +K  +  EL ++    
Sbjct: 26  IGSGAQGIVCAAYDAILERN---------VAIKKLSRPFQNQTHAKRAY-RELVLMK--- 72
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKY--LYGTSEQ--------VTLNWNHR--- 349
                      + K  + L+  F P  SLE++  +Y   E         + +  +H    
Sbjct: 73  ---------CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS 123
Query: 350 ---YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
              Y++L G+       ++ +   ++HRDLK SNI++ +D   ++ DFGLAR        
Sbjct: 124 YLLYQMLCGI-------KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART------- 169
Query: 407 YAEHGLVGVP--GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGR 452
            A    +  P   T  Y APE           D++  G ++ E+VC +
Sbjct: 170 -AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 61/228 (26%)
Query: 249 LGEGGFGIV---YKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIXXXX 302
           +G G  GIV   Y  I+  N         +A+KK SR   +   +K  +  EL ++    
Sbjct: 37  IGSGAQGIVCAAYDAILERN---------VAIKKLSRPFQNQTHAKRAY-RELVLMK--- 83
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKY--LYGTSEQ--------VTLNWNHR--- 349
                      + K  + L+  F P  SLE++  +Y   E         + +  +H    
Sbjct: 84  ---------CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS 134
Query: 350 ---YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
              Y++L G+       ++ +   ++HRDLK SNI++ +D   ++ DFGLAR        
Sbjct: 135 YLLYQMLCGI-------KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART------- 180
Query: 407 YAEHGLVGVP--GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGR 452
            A    +  P   T  Y APE           D++  G ++ E+VC +
Sbjct: 181 -AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 28/216 (12%)
Query: 249 LGEGGFGIVYK------GIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXX 302
           LG G F IV K      G+ +         ++ + +  SR+ I+       E++I+    
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER------EVSILRQVL 73
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYY 362
                        +  ++L+ + +  G L  +L   +++ +L+       +  +   V Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNY 130
Query: 363 LQNEYDQKVVHRDLKASNI-LLDADF---NARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           L   + +K+ H DLK  NI LLD +    + +L DFGLA  IE+            + GT
Sbjct: 131 L---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE------FKNIFGT 181
Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             +VAPE  +      E+D++  G +   ++ G SP
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/84 (29%), Positives = 45/84 (53%), Gaps = 9/84 (10%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC-FHT 429
           ++HRDLK  N+ ++ D   ++ DFGLAR  ++E        + G   T  Y APE   + 
Sbjct: 149 IIHRDLKPGNLAVNEDCELKILDFGLARQADSE--------MXGXVVTRWYRAPEVILNW 200
Query: 430 GKATPESDVFGFGAVVLEVVCGRS 453
            + T   D++  G ++ E++ G++
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGKT 224

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 60/140 (42%), Gaps = 15/140 (10%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           LL+V + +  G L   +    +Q         +I+  +  A+ YL   +   + HRD+K 
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYL---HSINIAHRDVKP 189
Query: 379 SNILLDADF-NA--RLGDFGLARAIENERNSYAEHGLVGVPG-TMGYVAPECFHTGKATP 434
            N+L  +   NA  +L DFG A+           H  +  P  T  YVAPE     K   
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKET-------TSHNSLTTPCYTPYYVAPEVLGPEKYDK 242
Query: 435 ESDVFGFGAVVLEVVCGRSP 454
             D++  G ++  ++CG  P
Sbjct: 243 SCDMWSLGVIMYILLCGYPP 262

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 96/235 (40%), Gaps = 56/235 (23%)
Query: 249 LGEGGFGIV---YKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIXXXX 302
           +G G  GIV   Y  I+  N         +A+KK SR   +   +K  +  EL ++    
Sbjct: 34  IGSGAQGIVCAAYDAILERN---------VAIKKLSRPFQNQTHAKRAY-RELVLMK--- 80
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKY--LYGTSE----------QVTLNWNHRY 350
                      + K  + L+  F P  SLE++  +Y   E          Q+ L+     
Sbjct: 81  ---------CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS 131
Query: 351 KILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEH 410
            +L  +   + +L   +   ++HRDLK SNI++ +D   ++ DFGLAR         A  
Sbjct: 132 YLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--------AGT 180
Query: 411 GLVGVP--GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH 463
             + VP   T  Y APE           D++  G ++ E++ G   G + P   H
Sbjct: 181 SFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG---GVLFPGTDH 232

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/83 (36%), Positives = 42/83 (50%), Gaps = 8/83 (9%)
Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
           +  +VVHRDLK  NIL+ +    +L DFGLAR          +  L  V  T+ Y APE 
Sbjct: 137 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS------FQMALTSVVVTLWYRAPEV 190
Query: 427 -FHTGKATPESDVFGFGAVVLEV 448
              +  ATP  D++  G +  E+
Sbjct: 191 LLQSSYATP-VDLWSVGCIFAEM 212

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 64/239 (26%)
Query: 249 LGEGGFGIV---YKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIXXXX 302
           +G G  GIV   Y  I+  N         +A+KK SR   +   +K  +  EL ++    
Sbjct: 32  IGSGAQGIVCAAYDAILERN---------VAIKKLSRPFQNQTHAKRAY-RELVLMK--- 78
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKY--LY--------GTSEQVTLNWNHR--- 349
                      + K  + L+  F P  SLE++  +Y          S+ + +  +H    
Sbjct: 79  ---------CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS 129
Query: 350 ---YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
              Y++L G+       ++ +   ++HRDLK SNI++ +D   ++ DFGLAR        
Sbjct: 130 YLLYQMLCGI-------KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART------- 175
Query: 407 YAEHGLVGVP--GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH 463
            A    +  P   T  Y APE           D++  G ++ E++ G   G + P   H
Sbjct: 176 -AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG---GVLFPGTDH 230

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 64/239 (26%)
Query: 249 LGEGGFGIV---YKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIXXXX 302
           +G G  GIV   Y  I+  N         +A+KK SR   +   +K  +  EL ++    
Sbjct: 32  IGSGAQGIVCAAYDAILERN---------VAIKKLSRPFQNQTHAKRAY-RELVLMKV-- 79
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKY--LY--------GTSEQVTLNWNHR--- 349
                      + K  + L+  F P  SLE++  +Y          S+ + +  +H    
Sbjct: 80  ----------VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS 129
Query: 350 ---YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
              Y++L G+       ++ +   ++HRDLK SNI++ +D   ++ DFGLAR        
Sbjct: 130 YLLYQMLCGI-------KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART------- 175
Query: 407 YAEHGLVGVP--GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH 463
            A    +  P   T  Y APE           D++  G ++ E++ G   G + P   H
Sbjct: 176 -AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG---GVLFPGTDH 230

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 60/140 (42%), Gaps = 15/140 (10%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           LL+V + +  G L   +    +Q         +I+  +  A+ YL   +   + HRD+K 
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYL---HSINIAHRDVKP 195
Query: 379 SNILLDADF-NA--RLGDFGLARAIENERNSYAEHGLVGVPG-TMGYVAPECFHTGKATP 434
            N+L  +   NA  +L DFG A+           H  +  P  T  YVAPE     K   
Sbjct: 196 ENLLYTSKRPNAILKLTDFGFAKET-------TSHNSLTTPCYTPYYVAPEVLGPEKYDK 248
Query: 435 ESDVFGFGAVVLEVVCGRSP 454
             D++  G ++  ++CG  P
Sbjct: 249 SCDMWSLGVIMYILLCGYPP 268

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 61/139 (43%), Gaps = 13/139 (9%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           LL+V + +  G L   +    +Q         +I+  +  A+ YL   +   + HRD+K 
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYL---HSINIAHRDVKP 145
Query: 379 SNILLDADF-NA--RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
            N+L  +   NA  +L DFG A+       + + + L     T  YVAPE     K    
Sbjct: 146 ENLLYTSKRPNAILKLTDFGFAK------ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 199
Query: 436 SDVFGFGAVVLEVVCGRSP 454
            D++  G ++  ++CG  P
Sbjct: 200 CDMWSLGVIMYILLCGYPP 218

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/83 (36%), Positives = 42/83 (50%), Gaps = 8/83 (9%)
Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
           +  +VVHRDLK  NIL+ +    +L DFGLAR          +  L  V  T+ Y APE 
Sbjct: 137 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS------FQMALTSVVVTLWYRAPEV 190
Query: 427 -FHTGKATPESDVFGFGAVVLEV 448
              +  ATP  D++  G +  E+
Sbjct: 191 LLQSSYATP-VDLWSVGCIFAEM 212

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 61/139 (43%), Gaps = 13/139 (9%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           LL+V + +  G L   +    +Q         +I+  +  A+ YL   +   + HRD+K 
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYL---HSINIAHRDVKP 150
Query: 379 SNILLDADF-NA--RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
            N+L  +   NA  +L DFG A+       + + + L     T  YVAPE     K    
Sbjct: 151 ENLLYTSKRPNAILKLTDFGFAK------ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 204
Query: 436 SDVFGFGAVVLEVVCGRSP 454
            D++  G ++  ++CG  P
Sbjct: 205 CDMWSLGVIMYILLCGYPP 223

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 64/239 (26%)
Query: 249 LGEGGFGIV---YKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIXXXX 302
           +G G  GIV   Y  I+  N         +A+KK SR   +   +K  +  EL ++    
Sbjct: 32  IGSGAQGIVCAAYDAILERN---------VAIKKLSRPFQNQTHAKRAY-RELVLMK--- 78
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKY--LY--------GTSEQVTLNWNHR--- 349
                      + K  + L+  F P  SLE++  +Y          S+ + +  +H    
Sbjct: 79  ---------CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS 129
Query: 350 ---YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
              Y++L G+       ++ +   ++HRDLK SNI++ +D   ++ DFGLAR        
Sbjct: 130 YLLYQMLCGI-------KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART------- 175
Query: 407 YAEHGLVGVP--GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH 463
            A    +  P   T  Y APE           D++  G ++ E++ G   G + P   H
Sbjct: 176 -AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG---GVLFPGTDH 230

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 61/139 (43%), Gaps = 13/139 (9%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           LL+V + +  G L   +    +Q         +I+  +  A+ YL   +   + HRD+K 
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYL---HSINIAHRDVKP 149
Query: 379 SNILLDADF-NA--RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
            N+L  +   NA  +L DFG A+       + + + L     T  YVAPE     K    
Sbjct: 150 ENLLYTSKRPNAILKLTDFGFAK------ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 203
Query: 436 SDVFGFGAVVLEVVCGRSP 454
            D++  G ++  ++CG  P
Sbjct: 204 CDMWSLGVIMYILLCGYPP 222

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 24/113 (21%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y+IL G       L+  +   ++HRDLK SN+ ++ D   ++ D GLAR  ++E   Y  
Sbjct: 132 YQILRG-------LKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYV- 183
Query: 410 HGLVGVPGTMGYVAPEC----FHTGKATPESDVFGFGAVVLEVVCGRS--PGN 456
                   T  Y APE      H  +     D++  G ++ E++ GR+  PG 
Sbjct: 184 -------ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLFPGT 226

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 53/224 (23%)
Query: 249 LGEGGFGIV---YKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIXXXX 302
           +G G  GIV   Y  I+  N         +A+KK SR   +   +K  +  EL ++    
Sbjct: 32  IGSGAQGIVCAAYDAILERN---------VAIKKLSRPFQNQTHAKRAY-RELVLMK--- 78
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKY--LYGTSE----------QVTLNWNHRY 350
                      + K  + L+  F P  SLE++  +Y   E          Q+ L+     
Sbjct: 79  ---------CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS 129
Query: 351 KILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEH 410
            +L  +   + +L   +   ++HRDLK SNI++ +D   ++ DFGLAR         A  
Sbjct: 130 YLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--------AGT 178
Query: 411 GLVGVPG--TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGR 452
             +  P   T  Y APE           D++  G ++ E+VC +
Sbjct: 179 SFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 61/139 (43%), Gaps = 13/139 (9%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           LL+V + +  G L   +    +Q         +I+  +  A+ YL   +   + HRD+K 
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYL---HSINIAHRDVKP 151
Query: 379 SNILLDADF-NA--RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
            N+L  +   NA  +L DFG A+       + + + L     T  YVAPE     K    
Sbjct: 152 ENLLYTSKRPNAILKLTDFGFAK------ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 205
Query: 436 SDVFGFGAVVLEVVCGRSP 454
            D++  G ++  ++CG  P
Sbjct: 206 CDMWSLGVIMYILLCGYPP 224

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 61/139 (43%), Gaps = 13/139 (9%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           LL+V + +  G L   +    +Q         +I+  +  A+ YL   +   + HRD+K 
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYL---HSINIAHRDVKP 143
Query: 379 SNILLDADF-NA--RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
            N+L  +   NA  +L DFG A+       + + + L     T  YVAPE     K    
Sbjct: 144 ENLLYTSKRPNAILKLTDFGFAK------ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 197
Query: 436 SDVFGFGAVVLEVVCGRSP 454
            D++  G ++  ++CG  P
Sbjct: 198 CDMWSLGVIMYILLCGYPP 216

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 60/140 (42%), Gaps = 15/140 (10%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           LL+V + +  G L   +    +Q         +I+  +  A+ YL   +   + HRD+K 
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYL---HSINIAHRDVKP 145
Query: 379 SNILLDADF-NA--RLGDFGLARAIENERNSYAEHGLVGVPG-TMGYVAPECFHTGKATP 434
            N+L  +   NA  +L DFG A+           H  +  P  T  YVAPE     K   
Sbjct: 146 ENLLYTSKRPNAILKLTDFGFAKET-------TSHNSLTTPCYTPYYVAPEVLGPEKYDK 198
Query: 435 ESDVFGFGAVVLEVVCGRSP 454
             D++  G ++  ++CG  P
Sbjct: 199 SCDMWSLGVIMYILLCGYPP 218

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 61/139 (43%), Gaps = 13/139 (9%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           LL+V + +  G L   +    +Q         +I+  +  A+ YL   +   + HRD+K 
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYL---HSINIAHRDVKP 144
Query: 379 SNILLDADF-NA--RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
            N+L  +   NA  +L DFG A+       + + + L     T  YVAPE     K    
Sbjct: 145 ENLLYTSKRPNAILKLTDFGFAK------ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 198
Query: 436 SDVFGFGAVVLEVVCGRSP 454
            D++  G ++  ++CG  P
Sbjct: 199 CDMWSLGVIMYILLCGYPP 217

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 113/284 (39%), Gaps = 35/284 (12%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +G+G F +V + I     Q       + V KF+     S  D   E +I           
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKI-VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 309 XXGWCHEKGKLLLVYDFMPNGSL---------EKYLYGTSEQVTLNWNHRYKILTGVASA 359
                   G L +V++FM    L           ++Y  SE V  ++      +  +  A
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY--SEAVASHY------MRQILEA 142
Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNA---RLGDFGLARAIENERNSYAEHGLV--G 414
           + Y    +D  ++HRD+K   +LL +  N+   +LG FG+A  +        E GLV  G
Sbjct: 143 LRYC---HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-------GESGLVAGG 192
Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML 474
             GT  ++APE           DV+G G ++  ++ G  P      +     +     M 
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMN 252
Query: 475 HRE-GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK 517
            R+  HI ++    +    ++D A+R+ +   A +HP   ER +
Sbjct: 253 PRQWSHISESAKDLVRRMLMLDPAERITVYE-ALNHPWLKERDR 295

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 67/140 (47%), Gaps = 16/140 (11%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           ++L+ + +  G L  +L   +++ +L+       +  +   V YL   + +K+ H DLK 
Sbjct: 90  VVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYL---HTKKIAHFDLKP 143
Query: 379 SNI-LLDADF---NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATP 434
            NI LLD +    + +L DFGLA  IE+            + GT  +VAPE  +      
Sbjct: 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE------FKNIFGTPEFVAPEIVNYEPLGL 197
Query: 435 ESDVFGFGAVVLEVVCGRSP 454
           E+D++  G +   ++ G SP
Sbjct: 198 EADMWSIGVITYILLSGASP 217

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 61/139 (43%), Gaps = 13/139 (9%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           LL+V + +  G L   +    +Q         +I+  +  A+ YL   +   + HRD+K 
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYL---HSINIAHRDVKP 143
Query: 379 SNILLDADF-NA--RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
            N+L  +   NA  +L DFG A+       + + + L     T  YVAPE     K    
Sbjct: 144 ENLLYTSKRPNAILKLTDFGFAK------ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKS 197
Query: 436 SDVFGFGAVVLEVVCGRSP 454
            D++  G ++  ++CG  P
Sbjct: 198 CDMWSLGVIMYILLCGYPP 216

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH 428
           QK++HRD+K SN+L+  D + ++ DFG++   +      ++  L    GT  ++APE   
Sbjct: 156 QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG-----SDALLSNTVGTPAFMAPESLS 210
Query: 429 ------TGKATPESDVFGFGAVVLEVVCGRSP 454
                 +GKA    DV+  G  +   V G+ P
Sbjct: 211 ETRKIFSGKAL---DVWAMGVTLYCFVFGQCP 239

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 61/139 (43%), Gaps = 13/139 (9%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           LL+V + +  G L   +    +Q         +I+  +  A+ YL   +   + HRD+K 
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYL---HSINIAHRDVKP 159
Query: 379 SNILLDADF-NA--RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE 435
            N+L  +   NA  +L DFG A+       + + + L     T  YVAPE     K    
Sbjct: 160 ENLLYTSKRPNAILKLTDFGFAK------ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 213
Query: 436 SDVFGFGAVVLEVVCGRSP 454
            D++  G ++  ++CG  P
Sbjct: 214 CDMWSLGVIMYILLCGYPP 232

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 113/284 (39%), Gaps = 35/284 (12%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXXXXXXXXX 308
           +G+G F +V + I     Q       + V KF+     S  D   E +I           
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKI-VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 309 XXGWCHEKGKLLLVYDFMPNGSL---------EKYLYGTSEQVTLNWNHRYKILTGVASA 359
                   G L +V++FM    L           ++Y  SE V  ++      +  +  A
Sbjct: 93  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY--SEAVASHY------MRQILEA 144
Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNA---RLGDFGLARAIENERNSYAEHGLV--G 414
           + Y    +D  ++HRD+K   +LL +  N+   +LG FG+A  +        E GLV  G
Sbjct: 145 LRYC---HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-------GESGLVAGG 194
Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML 474
             GT  ++APE           DV+G G ++  ++ G  P      +     +     M 
Sbjct: 195 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMN 254
Query: 475 HRE-GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK 517
            R+  HI ++    +    ++D A+R+ +   A +HP   ER +
Sbjct: 255 PRQWSHISESAKDLVRRMLMLDPAERITVYE-ALNHPWLKERDR 297

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 97/239 (40%), Gaps = 64/239 (26%)
Query: 249 LGEGGFGIV---YKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIXXXX 302
           +G G  GIV   Y  I+  N         +A+KK SR   +   +K  +  EL ++    
Sbjct: 32  IGSGAQGIVCAAYDAILERN---------VAIKKLSRPFQNQTHAKRAY-RELVLMK--- 78
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKY--LYGTSEQ--------VTLNWNHR--- 349
                      + K  + L+  F P  SLE++  +Y   E         + +  +H    
Sbjct: 79  ---------CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS 129
Query: 350 ---YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
              Y++L G+       ++ +   ++HRDLK SNI++ +D   ++ DFGLAR        
Sbjct: 130 YLLYQMLCGI-------KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART------- 175
Query: 407 YAEHGLVGVPG--TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH 463
            A    +  P   T  Y APE           D++  G ++ E++ G   G + P   H
Sbjct: 176 -AGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG---GVLFPGTDH 230

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/36 (47%), Positives = 28/36 (77%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
           ++HRDLK +N LL+ D + ++ DFGLAR I +E+++
Sbjct: 150 IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 9/84 (10%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           VVHRDLK  N+ ++ D   ++ DFGLAR        +A+  + G   T  Y APE   + 
Sbjct: 147 VVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVTRWYRAPEVILSW 198
Query: 431 KATPES-DVFGFGAVVLEVVCGRS 453
               ++ D++  G ++ E++ G++
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGKT 222

>pdb|1LGC|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 12/103 (11%)
Query: 15  GLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTV-KQGFDPD--DNHLG 71
           G  F IAP D+ P     G +LG+ N+  D +K +  VA+EFDT     +DP   D H+G
Sbjct: 82  GFTFFIAPVDTKPQTG--GGYLGVFNS-KDYDKTSQTVAVEFDTFYNTAWDPSNGDRHIG 138
Query: 72  LNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQV 114
           +++NS+ S      K      L +G    V + ++G + ++ V
Sbjct: 139 IDVNSIKSINTKSWK------LQNGKEANVVIAFNGATNVLTV 175

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 43/94 (45%), Gaps = 12/94 (12%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           +VHRDLK  NIL+ +    +L DFGLAR       SY +  L  V  T+ Y APE     
Sbjct: 141 IVHRDLKPENILVTSGGTVKLADFGLARIY-----SY-QMALTPVVVTLWYRAPEVLLQS 194
Query: 431 KATPESDVFGFGAVVLE------VVCGRSPGNMI 458
                 D++  G +  E      + CG S  + +
Sbjct: 195 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 228

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 43/94 (45%), Gaps = 12/94 (12%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           +VHRDLK  NIL+ +    +L DFGLAR       SY +  L  V  T+ Y APE     
Sbjct: 133 IVHRDLKPENILVTSGGTVKLADFGLARIY-----SY-QMALAPVVVTLWYRAPEVLLQS 186
Query: 431 KATPESDVFGFGAVVLE------VVCGRSPGNMI 458
                 D++  G +  E      + CG S  + +
Sbjct: 187 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 220

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 9/84 (10%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           VVHRDLK  N+ ++ D   ++ DFGLAR        +A+  + G   T  Y APE   + 
Sbjct: 165 VVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVTRWYRAPEVILSW 216
Query: 431 KATPES-DVFGFGAVVLEVVCGRS 453
               ++ D++  G ++ E++ G++
Sbjct: 217 MHYNQTVDIWSVGCIMAEMLTGKT 240

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 97/239 (40%), Gaps = 64/239 (26%)
Query: 249 LGEGGFGIV---YKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIXXXX 302
           +G G  GIV   Y  I+  N         +A+KK SR   +   +K  +  EL ++    
Sbjct: 32  IGSGAQGIVCAAYDAILERN---------VAIKKLSRPFQNQTHAKRAY-RELVLMK--- 78
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKY--LYGTSEQ--------VTLNWNHR--- 349
                      + K  + L+  F P  SLE++  +Y   E         + +  +H    
Sbjct: 79  ---------CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS 129
Query: 350 ---YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
              Y++L G+       ++ +   ++HRDLK SNI++ +D   ++ DFGLAR        
Sbjct: 130 YLLYQMLCGI-------KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART------- 175
Query: 407 YAEHGLVGVP--GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH 463
            A    +  P   T  Y APE           D++  G ++ E++ G   G + P   H
Sbjct: 176 -AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG---GVLFPGTDH 230

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 43/94 (45%), Gaps = 12/94 (12%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           +VHRDLK  NIL+ +    +L DFGLAR       SY +  L  V  T+ Y APE     
Sbjct: 133 IVHRDLKPENILVTSGGTVKLADFGLARIY-----SY-QMALFPVVVTLWYRAPEVLLQS 186
Query: 431 KATPESDVFGFGAVVLE------VVCGRSPGNMI 458
                 D++  G +  E      + CG S  + +
Sbjct: 187 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 220

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 97/239 (40%), Gaps = 64/239 (26%)
Query: 249 LGEGGFGIV---YKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIXXXX 302
           +G G  GIV   Y  I+  N         +A+KK SR   +   +K  +  EL ++    
Sbjct: 32  IGSGAQGIVCAAYDAILERN---------VAIKKLSRPFQNQTHAKRAY-RELVLMK--- 78
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKY--LYGTSEQ--------VTLNWNHR--- 349
                      + K  + L+  F P  SLE++  +Y   E         + +  +H    
Sbjct: 79  ---------CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS 129
Query: 350 ---YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
              Y++L G+       ++ +   ++HRDLK SNI++ +D   ++ DFGLAR        
Sbjct: 130 YLLYQMLCGI-------KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART------- 175
Query: 407 YAEHGLVGVP--GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH 463
            A    +  P   T  Y APE           D++  G ++ E++ G   G + P   H
Sbjct: 176 -AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG---GVLFPGTDH 230

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 97/239 (40%), Gaps = 64/239 (26%)
Query: 249 LGEGGFGIV---YKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIXXXX 302
           +G G  GIV   Y  I+  N         +A+KK SR   +   +K  +  EL ++    
Sbjct: 33  IGSGAQGIVCAAYDAILERN---------VAIKKLSRPFQNQTHAKRAY-RELVLMK--- 79
Query: 303 XXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKY--LYGTSEQ--------VTLNWNHR--- 349
                      + K  + L+  F P  SLE++  +Y   E         + +  +H    
Sbjct: 80  ---------CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS 130
Query: 350 ---YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
              Y++L G+       ++ +   ++HRDLK SNI++ +D   ++ DFGLAR        
Sbjct: 131 YLLYQMLCGI-------KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART------- 176
Query: 407 YAEHGLVGVP--GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH 463
            A    +  P   T  Y APE           D++  G ++ E++ G   G + P   H
Sbjct: 177 -AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG---GVLFPGTDH 231

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 90/232 (38%), Gaps = 30/232 (12%)
Query: 234 KELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF-- 291
           KE +   + +     LG GGFG VY GI         DN  +A+K   +D I   G+   
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGI------RVSDNLPVAIKHVEKDRISDWGELPN 54
Query: 292 ----LAELAIIXXXXX--XXXXXXXGWCHEKGKLLLVYDFM-PNGSLEKYLYGTSEQVTL 344
                 E+ ++               W       +L+ + M P   L  ++   +E+  L
Sbjct: 55  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFI---TERGAL 111
Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA-RLGDFGLARAIENE 403
                      V  AV +  N     V+HRD+K  NIL+D +    +L DFG    +++ 
Sbjct: 112 QEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD- 167
Query: 404 RNSYAEHGLVGVPGTMGYVAPECFHTGKATPES-DVFGFGAVVLEVVCGRSP 454
              Y +       GT  Y  PE     +    S  V+  G ++ ++VCG  P
Sbjct: 168 -TVYTDFD-----GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 213

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 67/163 (41%), Gaps = 24/163 (14%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY-----DQKVV 372
           +L LV D+  +GSL  YL     + T+      K+    AS + +L  E         + 
Sbjct: 114 QLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169
Query: 373 HRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP----GTMGYVAPECFH 428
           HRDLK+ NIL+  +    + D GLA      R+  A   +   P    GT  Y+APE   
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLA-----VRHDSATDTIDIAPNHRVGTKRYMAPEVLD 224
Query: 429 TG------KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY 465
                   ++   +D++  G V  E+    S G +    Q  Y
Sbjct: 225 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 67/163 (41%), Gaps = 24/163 (14%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY-----DQKVV 372
           +L LV D+  +GSL  YL     + T+      K+    AS + +L  E         + 
Sbjct: 75  QLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 130
Query: 373 HRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP----GTMGYVAPECFH 428
           HRDLK+ NIL+  +    + D GLA      R+  A   +   P    GT  Y+APE   
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLA-----VRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 429 TG------KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY 465
                   ++   +D++  G V  E+    S G +    Q  Y
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 67/163 (41%), Gaps = 24/163 (14%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY-----DQKVV 372
           +L LV D+  +GSL  YL     + T+      K+    AS + +L  E         + 
Sbjct: 101 QLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 156
Query: 373 HRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP----GTMGYVAPECFH 428
           HRDLK+ NIL+  +    + D GLA      R+  A   +   P    GT  Y+APE   
Sbjct: 157 HRDLKSKNILVKKNGTCCIADLGLA-----VRHDSATDTIDIAPNHRVGTKRYMAPEVLD 211
Query: 429 TG------KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY 465
                   ++   +D++  G V  E+    S G +    Q  Y
Sbjct: 212 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 254

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 67/163 (41%), Gaps = 24/163 (14%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY-----DQKVV 372
           +L LV D+  +GSL  YL     + T+      K+    AS + +L  E         + 
Sbjct: 76  QLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 131
Query: 373 HRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP----GTMGYVAPECFH 428
           HRDLK+ NIL+  +    + D GLA      R+  A   +   P    GT  Y+APE   
Sbjct: 132 HRDLKSKNILVKKNGTCCIADLGLA-----VRHDSATDTIDIAPNHRVGTKRYMAPEVLD 186
Query: 429 TG------KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY 465
                   ++   +D++  G V  E+    S G +    Q  Y
Sbjct: 187 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 229

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 67/163 (41%), Gaps = 24/163 (14%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY-----DQKVV 372
           +L LV D+  +GSL  YL     + T+      K+    AS + +L  E         + 
Sbjct: 81  QLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 136
Query: 373 HRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP----GTMGYVAPECFH 428
           HRDLK+ NIL+  +    + D GLA      R+  A   +   P    GT  Y+APE   
Sbjct: 137 HRDLKSKNILVKKNGTCCIADLGLA-----VRHDSATDTIDIAPNHRVGTKRYMAPEVLD 191
Query: 429 TG------KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY 465
                   ++   +D++  G V  E+    S G +    Q  Y
Sbjct: 192 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 234

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 67/163 (41%), Gaps = 24/163 (14%)
Query: 318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY-----DQKVV 372
           +L LV D+  +GSL  YL     + T+      K+    AS + +L  E         + 
Sbjct: 78  QLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 133
Query: 373 HRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP----GTMGYVAPECFH 428
           HRDLK+ NIL+  +    + D GLA      R+  A   +   P    GT  Y+APE   
Sbjct: 134 HRDLKSKNILVKKNGTCCIADLGLA-----VRHDSATDTIDIAPNHRVGTKRYMAPEVLD 188
Query: 429 TG------KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY 465
                   ++   +D++  G V  E+    S G +    Q  Y
Sbjct: 189 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 231

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 36/223 (16%)
Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIXXX------- 301
           LG GG G+V+  + +  D+      ++A+KK      +S    L E+ II          
Sbjct: 19  LGCGGNGLVFSAVDNDCDK------RVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 302 -------XXXXXXXXXGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILT 354
                           G   E   + +V ++M     E  L    EQ  L   H    + 
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARLFMY 127
Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDA-DFNARLGDFGLARAIE--NERNSYAEHG 411
            +   + Y+   +   V+HRDLK +N+ ++  D   ++GDFGLAR ++       +   G
Sbjct: 128 QLLRGLKYI---HSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 412 LVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRS 453
           LV    T  Y +P    +    T   D++  G +  E++ G++
Sbjct: 185 LV----TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>pdb|1LGB|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 56/103 (54%), Gaps = 12/103 (11%)
Query: 15  GLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTV-KQGFDPD--DNHLG 71
           G  F IAP D+ P     G +LG+ N+  D +K +  VA+EFDT     +DP   D H+G
Sbjct: 82  GFTFFIAPVDTKPQTG--GGYLGVFNS-KDYDKTSQTVAVEFDTFYNTAWDPSNGDRHIG 138
Query: 72  LNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQV 114
           +++NS+   K++  K   +  L +G    V + ++G + ++ V
Sbjct: 139 IDVNSI---KSINTK---SWALQNGKEANVVIAFNGATNVLTV 175

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 49/102 (48%), Gaps = 15/102 (14%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           +VH DLK +N L+  D   +L DFG+A  ++ +  S  +   VG   T+ Y+ PE     
Sbjct: 148 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVG---TVNYMPPEAIKDM 203
Query: 431 KATPES-----------DVFGFGAVVLEVVCGRSPGNMIPHQ 461
            ++ E+           DV+  G ++  +  G++P   I +Q
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 48/102 (47%), Gaps = 13/102 (12%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y++L G+       ++ +   ++HRDLK SNI++ +D   ++ DFGLA      R +   
Sbjct: 133 YQMLCGI-------KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTACTN 179
Query: 410 HGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCG 451
             +     T  Y APE           D++  G ++ E+V G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 17/42 (40%), Positives = 30/42 (71%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           ++HRDLK +N LL+ D + ++ DFGLAR I ++++ +  + L
Sbjct: 152 IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDL 193

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 63/127 (49%), Gaps = 13/127 (10%)
Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL-DADFNA 389
           LE+ +   +    L+  +  +++  + +A+ Y    + Q VVH+DLK  NIL  D   ++
Sbjct: 108 LERIVSAQARGKALSEGYVAELMKQMMNALAYF---HSQHVVHKDLKPENILFQDTSPHS 164
Query: 390 --RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLE 447
             ++ DFGLA   +++ +S          GT  Y+APE F     T + D++  G V+  
Sbjct: 165 PIKIIDFGLAELFKSDEHS------TNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYF 217
Query: 448 VVCGRSP 454
           ++ G  P
Sbjct: 218 LLTGCLP 224

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 69/159 (43%), Gaps = 29/159 (18%)
Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA-------------DFNARLGDFGLAR 398
           +L  +AS V +L   +  K++HRDLK  NIL+               +    + DFGL +
Sbjct: 120 LLRQIASGVAHL---HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTG-------KATPESDVFGFGAVVLEVVC- 450
            +++ ++S+  + L    GT G+ APE            + T   D+F  G V   ++  
Sbjct: 177 KLDSGQSSFRTN-LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 451 GRSP-GNMIPHQQHAYTLV---DWVWMLHREGHIQDAVD 485
           G+ P G+    + +    +   D +  LH    I +A D
Sbjct: 236 GKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATD 274

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 43/94 (45%), Gaps = 12/94 (12%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           +VHRDLK  NIL+ +    +L DFGLAR       SY +  L  V  T+ Y APE     
Sbjct: 133 IVHRDLKPENILVTSGGTVKLADFGLARIY-----SY-QMALDPVVVTLWYRAPEVLLQS 186
Query: 431 KATPESDVFGFGAVVLE------VVCGRSPGNMI 458
                 D++  G +  E      + CG S  + +
Sbjct: 187 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 220

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 49/102 (48%), Gaps = 15/102 (14%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           +VH DLK +N L+  D   +L DFG+A  ++ +  S  +   VG   T+ Y+ PE     
Sbjct: 132 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVG---TVNYMPPEAIKDM 187
Query: 431 KATPES-----------DVFGFGAVVLEVVCGRSPGNMIPHQ 461
            ++ E+           DV+  G ++  +  G++P   I +Q
Sbjct: 188 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 229

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 49/104 (47%), Gaps = 17/104 (16%)
Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           Y++L G+       ++ +   ++HRDLK SNI++ +D   ++ DFGLAR         A 
Sbjct: 131 YQMLCGI-------KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--------AS 175
Query: 410 HGLVGVP--GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCG 451
              +  P   T  Y APE           D++  G ++ E+V G
Sbjct: 176 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 57/140 (40%), Gaps = 15/140 (10%)
Query: 319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           LL+V + +  G L   +    +Q         +I   +  A+ YL   +   + HRD+K 
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQA-FTEREASEIXKSIGEAIQYL---HSINIAHRDVKP 189
Query: 379 SNILLDADF-NA--RLGDFGLARAIENERNSYAEHGLVGVPG-TMGYVAPECFHTGKATP 434
            N+L  +   NA  +L DFG A+           H  +  P  T  YVAPE     K   
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKET-------TSHNSLTTPCYTPYYVAPEVLGPEKYDK 242
Query: 435 ESDVFGFGAVVLEVVCGRSP 454
             D +  G +   ++CG  P
Sbjct: 243 SCDXWSLGVIXYILLCGYPP 262

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 49/102 (48%), Gaps = 15/102 (14%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           +VH DLK +N L+  D   +L DFG+A  ++ +  S  +   VG   T+ Y+ PE     
Sbjct: 129 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVG---TVNYMPPEAIKDM 184
Query: 431 KATPES-----------DVFGFGAVVLEVVCGRSPGNMIPHQ 461
            ++ E+           DV+  G ++  +  G++P   I +Q
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 66/155 (42%), Gaps = 25/155 (16%)
Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA-------------DFNARLGDFGLAR 398
           +L  +AS V +L   +  K++HRDLK  NIL+               +    + DFGL +
Sbjct: 138 LLRQIASGVAHL---HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194
Query: 399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTG---KATPESDVFGFGAVVLEVVC-GRSP 454
            +++ +  +    L    GT G+ APE        + T   D+F  G V   ++  G+ P
Sbjct: 195 KLDSGQXXF-RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253
Query: 455 -GNMIPHQQHAYTLV---DWVWMLHREGHIQDAVD 485
            G+    + +    +   D +  LH    I +A D
Sbjct: 254 FGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATD 288

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 49/102 (48%), Gaps = 15/102 (14%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           +VH DLK +N L+  D   +L DFG+A  ++ +  S  +   VG   T+ Y+ PE     
Sbjct: 176 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVG---TVNYMPPEAIKDM 231
Query: 431 KATPES-----------DVFGFGAVVLEVVCGRSPGNMIPHQ 461
            ++ E+           DV+  G ++  +  G++P   I +Q
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 49/102 (48%), Gaps = 15/102 (14%)
Query: 371 VVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG 430
           +VH DLK +N L+  D   +L DFG+A  ++ +  S  +   VG   T+ Y+ PE     
Sbjct: 128 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVG---TVNYMPPEAIKDM 183
Query: 431 KATPES-----------DVFGFGAVVLEVVCGRSPGNMIPHQ 461
            ++ E+           DV+  G ++  +  G++P   I +Q
Sbjct: 184 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 225

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 66/155 (42%), Gaps = 25/155 (16%)
Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA-------------DFNARLGDFGLAR 398
           +L  +AS V +L   +  K++HRDLK  NIL+               +    + DFGL +
Sbjct: 138 LLRQIASGVAHL---HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194
Query: 399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTG---KATPESDVFGFGAVVLEVVC-GRSP 454
            +++ +  +    L    GT G+ APE        + T   D+F  G V   ++  G+ P
Sbjct: 195 KLDSGQXXF-RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253
Query: 455 -GNMIPHQQHAYTLV---DWVWMLHREGHIQDAVD 485
            G+    + +    +   D +  LH    I +A D
Sbjct: 254 FGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATD 288

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	568
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-112
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-107
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-103
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-62
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-51
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-50
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-50
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-49
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-47
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-45
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-45
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-44
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-44
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-43
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-41
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-41
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-41
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-41
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-40
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-40
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-40
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-40
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-39
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-39
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-39
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-39
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-39
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-39
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-38
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-38
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-38
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-37
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-37
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-37
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-37
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-37
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-37
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-37
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-37
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-37
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-37
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	9e-37
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-36
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-36
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-35
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-35
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-35
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	3e-35
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-35
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-34
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-34
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-34
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-34
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	9e-34
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	1e-33
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-33
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-33
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-33
1gsl_A	243	Griffonia simplicifolia lectin 4; glycoprotein, ma	4e-33
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	4e-33
1hql_A	257	Lectin; xenograft antigen, sugar BI protein; HET:	1e-32
1g7y_A	253	Stem/LEAF lectin DB58; jelly roll fold, sugar bind	1e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-32
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	2e-32
1qnw_A	242	Chitin binding lectin, UEA-II; carbohydrate bindin	3e-32
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	3e-32
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	5e-32
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	8e-32
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	1e-31
1wbf_A	242	Protein (agglutinin); lectin (agglutinin), legume	2e-31
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	4e-31
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	8e-31
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	9e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-30
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-30
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-30
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-30
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-29
2bqp_A	234	Protein (PEA lectin); D-glucopyranose complex, sug	2e-29
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-29
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-29
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	5e-29
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-29
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-28
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-28
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-28
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-28
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-28
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	7e-28
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	1e-27
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-27
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-27
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-27
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-27
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	8e-27
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	1e-04
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-27
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-27
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	3e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-25
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-25
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	9e-25
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-24
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-24
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-23
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-23
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-23
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-23
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-22
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-22
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	3e-22
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-22
2ltn_A	181	PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO	9e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-21
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-21
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-21
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-21
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-21
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	8e-21
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-20
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-20
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-20
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-20
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-20
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-20
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-20
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-20
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-20
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-20
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-19
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-19
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-19
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-19
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-19
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-19
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-19
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-18
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-18
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-18
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-18
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-17
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-17
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-17
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-17
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-17
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-17
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-16
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-16
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-16
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-14
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-14
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-12
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-11
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-10
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-10
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	9e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-06
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-05
1qmo_A	113	Mannose binding lectin, FRIL; crosslink, hematopoi	3e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-05
2ltn_B	52	PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP	6e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  336 bits (863), Expect = e-112
 Identities = 107/305 (35%), Positives = 172/305 (56%), Gaps = 14/305 (4%)

Query: 226 GMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI 285
           G  + F  +EL+ A++NF     LG GGFG VYKG +        D T +AVK+   +  
Sbjct: 15  GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-------DGTLVAVKRLKEERT 67

Query: 286 K-SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE-QVT 343
           +  +  F  E+ +I    H++L+ L G+C    + LLVY +M NGS+   L    E Q  
Sbjct: 68  QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 127

Query: 344 LNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE 403
           L+W  R +I  G A  + YL +  D K++HRD+KA+NILLD +F A +GDFGLA+ ++ +
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187

Query: 404 RNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNM-IPHQQ 462
                 H    V GT+G++APE   TGK++ ++DVFG+G ++LE++ G+   ++      
Sbjct: 188 DT----HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243

Query: 463 HAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDIL 522
               L+DWV  L +E  ++  VD  L  N   +E ++L+ + L C+     ERPK  +++
Sbjct: 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303

Query: 523 QIISG 527
           +++ G
Sbjct: 304 RMLEG 308

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  322 bits (828), Expect = e-107
 Identities = 94/319 (29%), Positives = 162/319 (50%), Gaps = 15/319 (4%)

Query: 206 KKRRSRVAEPHHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHN 265
           K  ++  +          +P         +L++ATNNF     +G G FG VYKG++   
Sbjct: 4   KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-- 61

Query: 266 DQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDF 325
                D  ++A+K+ + +S +   +F  E+  +   RH HLV L+G+C E+ +++L+Y +
Sbjct: 62  -----DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY 116

Query: 326 MPNGSLEKYLYGTSEQVT-LNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD 384
           M NG+L+++LYG+      ++W  R +I  G A  ++YL       ++HRD+K+ NILLD
Sbjct: 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLD 173

Query: 385 ADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAV 444
            +F  ++ DFG+++       +   H    V GT+GY+ PE F  G+ T +SDV+ FG V
Sbjct: 174 ENFVPKITDFGISKKGTELDQT---HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVV 230

Query: 445 VLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLG 504
           + EV+C RS       ++    L +W    H  G ++  VD  L      +  ++     
Sbjct: 231 LFEVLCARSAIVQSLPREMVN-LAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTA 289

Query: 505 LACSHPIASERPKTEDILQ 523
           + C    + +RP   D+L 
Sbjct: 290 VKCLALSSEDRPSMGDVLW 308

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  312 bits (803), Expect = e-103
 Identities = 100/314 (31%), Positives = 164/314 (52%), Gaps = 30/314 (9%)

Query: 228 PREFKYKELKKATNNFHESM------RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS 281
              F + ELK  TNNF E        ++GEGGFG+VYKG +        +NT +AVKK +
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--------NNTTVAVKKLA 63

Query: 282 RDSIKS--KGD--FLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYG 337
                +  +    F  E+ ++ + +H++LV L+G+  +   L LVY +MPNGSL   L  
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123

Query: 338 TSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA 397
                 L+W+ R KI  G A+ + +L   ++   +HRD+K++NILLD  F A++ DFGLA
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFL---HENHHIHRDIKSANILLDEAFTAKISDFGLA 180

Query: 398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNM 457
           RA E    +        + GT  Y+APE    G+ TP+SD++ FG V+LE++ G    + 
Sbjct: 181 RASEKFAQT---VMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE 236

Query: 458 IPHQQHAYTLVDWVWMLHRE-GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP 516
               Q    L+D    +  E   I+D +D+++N ++     + +  +   C H   ++RP
Sbjct: 237 HREPQL---LLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRP 292

Query: 517 KTEDILQIISGTST 530
             + + Q++   + 
Sbjct: 293 DIKKVQQLLQEMTA 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  207 bits (528), Expect = 2e-62
 Identities = 65/320 (20%), Positives = 120/320 (37%), Gaps = 39/320 (12%)

Query: 229 REFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK 288
            +   + L   +           G FG V+K  +         N  +AVK F     +S 
Sbjct: 12  VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--------NEYVAVKIFPIQDKQSW 63

Query: 289 GDFLAELAIIHRLRHKHLVHLVGWC----HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTL 344
                E+  +  ++H++++  +G           L L+  F   GSL  +L        +
Sbjct: 64  -QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VV 118

Query: 345 NWNHRYKILTGVASAVYYL-------QNEYDQKVVHRDLKASNILLDADFNARLGDFGLA 397
           +WN    I   +A  + YL       ++ +   + HRD+K+ N+LL  +  A + DFGLA
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178

Query: 398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-----KATPESDVFGFGAVVLEVVCGR 452
              E  +++   HG V   GT  Y+APE           A    D++  G V+ E+    
Sbjct: 179 LKFEAGKSAGDTHGQV---GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235

Query: 453 SPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVD---QRLNINSVVDEAKRLLLLG---LA 506
           +  +  P  ++     + +        +Q+ V    +R  +     +   + +L      
Sbjct: 236 TAADG-PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE 294

Query: 507 CSHPIASERPKTEDILQIIS 526
           C    A  R     + + I+
Sbjct: 295 CWDHDAEARLSAGCVGERIT 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  177 bits (451), Expect = 2e-51
 Identities = 72/324 (22%), Positives = 139/324 (42%), Gaps = 34/324 (10%)

Query: 205 VKKRRSRVAEPHHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHH 264
           +K          +++               ++     + +   ++G G FG V++     
Sbjct: 1   MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAE--- 57

Query: 265 NDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLV 322
              +H   + +AVK        ++   +FL E+AI+ RLRH ++V  +G   +   L +V
Sbjct: 58  ---WH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112

Query: 323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL 382
            +++  GSL + L+ +  +  L+   R  +   VA  + YL N  +  +VHR+LK+ N+L
Sbjct: 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLL 171

Query: 383 LDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFG 442
           +D  +  ++ DFGL+R   +   S          GT  ++APE      +  +SDV+ FG
Sbjct: 172 VDKKYTVKVCDFGLSRLKASTFLS-----SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFG 226

Query: 443 AVVLEVVCGRSP-GNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLL 501
            ++ E+   + P GN+ P Q         V  +  +        +RL I   ++     +
Sbjct: 227 VILWELATLQQPWGNLNPAQ--------VVAAVGFKC-------KRLEIPRNLNPQVAAI 271

Query: 502 LLGLACSHPIASERPKTEDILQII 525
           +    C      +RP    I+ ++
Sbjct: 272 I--EGCWTNEPWKRPSFATIMDLL 293

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  174 bits (442), Expect = 5e-50
 Identities = 57/306 (18%), Positives = 113/306 (36%), Gaps = 44/306 (14%)

Query: 229 REFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK 288
           R F+  +L            LG+G FG   K        +      + +K+  R   +++
Sbjct: 5   RIFRPSDLIHGE-------VLGKGCFGQAIKVT------HRETGEVMVMKELIRFDEETQ 51

Query: 289 GDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNH 348
             FL E+ ++  L H +++  +G  ++  +L  + +++  G+L   +     Q    W+ 
Sbjct: 52  RTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQ 109

Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
           R      +AS + YL       ++HRDL + N L+  + N  + DFGLAR + +E+    
Sbjct: 110 RVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166

Query: 409 EHGLVGVP---------GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP-GNMI 458
               +  P         G   ++APE  +      + DVF FG V+ E++   +   + +
Sbjct: 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226

Query: 459 PHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKT 518
           P                 +  +                +     + + C      +RP  
Sbjct: 227 PRTM--------------DFGLNVRGFLDRYCPPNCPPS--FFPITVRCCDLDPEKRPSF 270

Query: 519 EDILQI 524
             +   
Sbjct: 271 VKLEHW 276

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  174 bits (442), Expect = 5e-50
 Identities = 67/280 (23%), Positives = 115/280 (41%), Gaps = 38/280 (13%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
            +G G FG+V K        +      +A+K+   +S +    F+ EL  + R+ H ++V
Sbjct: 15  VVGRGAFGVVCKAK------WR--AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 64

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L G C     + LV ++   GSL   L+G          H        +  V YL +  
Sbjct: 65  KLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 368 DQKVVHRDLKASNILLDADFN-ARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
            + ++HRDLK  N+LL A     ++ DFG A  I+          +    G+  ++APE 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--------MTNNKGSAAWMAPEV 174

Query: 427 FHTGKATPESDVFGFGAVVLEVVCGRSP-GNMIPHQQHAYTLVDWVWMLHREGHIQDAVD 485
           F     + + DVF +G ++ EV+  R P   +             +W +H          
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI------MWAVHN--------G 220

Query: 486 QRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
            R  +   + +    L+    C     S+RP  E+I++I+
Sbjct: 221 TRPPLIKNLPKPIESLM--TRCWSKDPSQRPSMEEIVKIM 258

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  171 bits (436), Expect = 5e-49
 Identities = 72/330 (21%), Positives = 120/330 (36%), Gaps = 50/330 (15%)

Query: 230 EFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG 289
           E    E     +N      +G G +G VYKG +            +AVK FS  + ++  
Sbjct: 2   EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--------ERPVAVKVFSFANRQN-- 51

Query: 290 DFLAELAI--IHRLRHKHLVHLVGWCHE-----KGKLLLVYDFMPNGSLEKYLYGTSEQV 342
            F+ E  I  +  + H ++   +          + + LLV ++ PNGSL KYL       
Sbjct: 52  -FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---- 106

Query: 343 TLNWNHRYKILTGVASAVYYLQNEYDQ------KVVHRDLKASNILLDADFNARLGDFGL 396
           T +W    ++   V   + YL  E  +       + HRDL + N+L+  D    + DFGL
Sbjct: 107 TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166

Query: 397 ARAIEN---ERNSYAEHGLVGVPGTMGYVAPE-------CFHTGKATPESDVFGFGAVVL 446
           +  +      R    ++  +   GT+ Y+APE             A  + D++  G +  
Sbjct: 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226

Query: 447 EVV---CGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV---DQRLNINSVVDEAKRL 500
           E+        PG  +P  Q A+     V        +Q  V    QR        E    
Sbjct: 227 EIFMRCTDLFPGESVPEYQMAFQ--TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLA 284

Query: 501 LL----LGLACSHPIASERPKTEDILQIIS 526
           +         C    A  R   +   + ++
Sbjct: 285 VRSLKETIEDCWDQDAEARLTAQXAEERMA 314

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  164 bits (418), Expect = 8e-47
 Identities = 67/311 (21%), Positives = 130/311 (41%), Gaps = 56/311 (18%)

Query: 230 EFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG 289
                E++     + +  ++G+GGFG+V+KG          D + +A+K       + + 
Sbjct: 15  TLADNEIE-----YEK--QIGKGGFGLVHKGR------LVKDKSVVAIKSLILGDSEGET 61

Query: 290 -------DFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQV 342
                  +F  E+ I+  L H ++V L G  H      +V +F+P G L   L   +   
Sbjct: 62  EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP- 118

Query: 343 TLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD-----ADFNARLGDFGLA 397
            + W+ + +++  +A  + Y+QN+ +  +VHRDL++ NI L      A   A++ DFGL+
Sbjct: 119 -IKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176

Query: 398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA--TPESDVFGFGAVVLEVVCGRSP- 454
           +           H + G+ G   ++APE     +   T ++D + F  ++  ++ G  P 
Sbjct: 177 QQS--------VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

Query: 455 GNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASE 514
                 +      + ++ M+  EG        R  I         L  +   C      +
Sbjct: 229 DEYSYGK------IKFINMIREEG-------LRPTIPEDCPPR--LRNVIELCWSGDPKK 273

Query: 515 RPKTEDILQII 525
           RP    I++ +
Sbjct: 274 RPHFSYIVKEL 284

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  160 bits (406), Expect = 2e-45
 Identities = 66/290 (22%), Positives = 109/290 (37%), Gaps = 49/290 (16%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKF----SRDSIKSKGDFLAELAIIHRLRH 303
            +G GGFG VY+        +     ++AVK        D  ++  +   E  +   L+H
Sbjct: 14  IIGIGGFGKVYRAF------WI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 304 KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYL 363
            +++ L G C ++  L LV +F   G L + L G      +  +        +A  + YL
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYL 121

Query: 364 QNEYDQKVVHRDLKASNILLDADFNAR--------LGDFGLARAIENERNSYAEHGLVGV 415
            +E    ++HRDLK+SNIL+               + DFGLAR              +  
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-------TKMSA 174

Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP-GNMIPHQQHAYTLVDWVWML 474
            G   ++APE       +  SDV+ +G ++ E++ G  P   +              + +
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA--------VAYGV 226

Query: 475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI 524
                        L I S   E    L+    C +P    RP   +IL  
Sbjct: 227 AMNK-------LALPIPSTCPEPFAKLM--EDCWNPDPHSRPSFTNILDQ 267

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  159 bits (404), Expect = 7e-45
 Identities = 75/284 (26%), Positives = 123/284 (43%), Gaps = 37/284 (13%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAIIHRLRHKH 305
           R+G G FG VYKG       +H D   +AVK  +  +   +    F  E+ ++ + RH +
Sbjct: 31  RIGSGSFGTVYKGK------WHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           ++  +G+     +L +V  +    SL  +L+  + +          I    A  + YL  
Sbjct: 82  ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHA 138

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
              + ++HRDLK++NI L  D   ++GDFGLA     +      H    + G++ ++APE
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATE---KSRWSGSHQFEQLSGSILWMAPE 192

Query: 426 CFHTGKATP---ESDVFGFGAVVLEVVCGRSP-GNMIPHQQHAYTLVDWVWMLHREGHIQ 481
                 + P   +SDV+ FG V+ E++ G+ P  N+    Q        + M+ R     
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-------IEMVGRGSLSP 245

Query: 482 DAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
           D    R N    +   KRL+     C      ERP    IL  I
Sbjct: 246 DLSKVRSNCPKRM---KRLM---AECLKKKRDERPSFPRILAEI 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  158 bits (402), Expect = 3e-44
 Identities = 46/226 (20%), Positives = 86/226 (38%), Gaps = 27/226 (11%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAIIHRLRHKH 305
            +G+G FG VY G       +H    ++A++    +         F  E+    + RH++
Sbjct: 40  LIGKGRFGQVYHGR------WH---GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           +V  +G C     L ++       +L   +     ++ L+ N   +I   +   + YL  
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVR--DAKIVLDVNKTRQIAQEIVKGMGYL-- 146

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            + + ++H+DLK+ N+  D +    + DFGL       +    E  L    G + ++APE
Sbjct: 147 -HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204

Query: 426 CFHTGKA---------TPESDVFGFGAVVLEVVCGRSP-GNMIPHQ 461
                           +  SDVF  G +  E+     P        
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA 250

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  153 bits (390), Expect = 5e-43
 Identities = 53/304 (17%), Positives = 107/304 (35%), Gaps = 52/304 (17%)

Query: 230 EFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG 289
              +K+L      F    +L E   G ++KG       +      I VK        ++ 
Sbjct: 6   GIDFKQLN-----FLT--KLNENHSGELWKGR------WQ--GNDIVVKVLKVRDWSTRK 50

Query: 290 --DFLAELAIIHRLRHKHLVHLVGWCHE--KGKLLLVYDFMPNGSLEKYLYGTSEQVTLN 345
             DF  E   +    H +++ ++G C         L+  +MP GSL   L+       ++
Sbjct: 51  SRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVD 109

Query: 346 WNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN 405
            +   K    +A  + +L    +  +    L + ++++D D  AR+    +  + ++   
Sbjct: 110 QSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-- 166

Query: 406 SYAEHGLVGVPGTMGYVAPECF---HTGKATPESDVFGFGAVVLEVVCGRSP-GNMIPHQ 461
                   G      +VAPE             +D++ F  ++ E+V    P  ++   +
Sbjct: 167 --------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME 218

Query: 462 QHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDI 521
                       +  EG        R  I   +      L+    C +   ++RPK + I
Sbjct: 219 --------IGMKVALEG-------LRPTIPPGISPHVSKLM--KICMNEDPAKRPKFDMI 261

Query: 522 LQII 525
           + I+
Sbjct: 262 VPIL 265

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  151 bits (384), Expect = 1e-41
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 15/210 (7%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHL 306
            LG G FG VYKG+     +       +A+K+    +  K+  + L E  ++  + + H+
Sbjct: 22  VLGSGAFGTVYKGLWIPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
             L+G C     + L+   MP G L  Y+    + +     +       +A  + YL+  
Sbjct: 80  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQIAKGMNYLE-- 134

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLVGVPGTMGYVAPE 425
            D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V +       A E
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALE 189

Query: 426 CFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
                  T +SDV+ +G  V E++  G  P
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  150 bits (382), Expect = 1e-41
 Identities = 71/304 (23%), Positives = 116/304 (38%), Gaps = 45/304 (14%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIH--RLRHKH 305
            +G+G +G V++G              +AVK FS    KS   +  E  + +   LRH++
Sbjct: 15  CVGKGRYGEVWRGSWQ--------GENVAVKIFSSRDEKS---WFRETELYNTVMLRHEN 63

Query: 306 LVHLVGWC----HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
           ++  +       H   +L L+  +   GSL  YL  T    TL+     +I+  +AS + 
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLA 119

Query: 362 YLQNEYDQ-----KVVHRDLKASNILLDADFNARLGDFGLARAIENERNS--YAEHGLVG 414
           +L  E         + HRDLK+ NIL+  +    + D GLA       N      +  V 
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV- 178

Query: 415 VPGTMGYVAPE------CFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV 468
             GT  Y+APE            +    D++ FG V+ EV        ++   +  +   
Sbjct: 179 --GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY-- 234

Query: 469 DWVWMLHREGHIQDAV---DQRLNINSVVDEAKRLLLLGL---ACSHPIASERPKTEDIL 522
           D V        ++  V    QR NI +       L  L      C +   S R     I 
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294

Query: 523 QIIS 526
           + ++
Sbjct: 295 KTLT 298

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  148 bits (377), Expect = 5e-41
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 15/209 (7%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHL 306
            LGEG FG VY+G+  ++     +   +AVK   +D ++ +K  F++E  I+  L H H+
Sbjct: 19  ILGEGFFGEVYEGVYTNHKG---EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
           V L+G   E+    ++ +  P G L  YL      + +           +  A+ YL+  
Sbjct: 76  VKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSLQICKAMAYLE-- 130

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
                VHRD+   NIL+ +    +LGDFGL+R IE+E    A    + +       +PE 
Sbjct: 131 -SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPES 185

Query: 427 FHTGKATPESDVFGFGAVVLEVV-CGRSP 454
            +  + T  SDV+ F   + E++  G+ P
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQP 214

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  149 bits (379), Expect = 7e-41
 Identities = 60/248 (24%), Positives = 107/248 (43%), Gaps = 23/248 (9%)

Query: 212 VAEPHHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVD 271
           +   HH+  +L     P  F+ + LK  +       +LG+G FG V              
Sbjct: 1   MGHHHHHHAQLYACQDPTIFEERHLKYIS-------QLGKGNFGSVELCRYDPLGDN--T 51

Query: 272 NTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK--LLLVYDFMPNG 329
              +AVK+        + DF  E+ I+  L    +V   G  +  G+  L LV +++P+G
Sbjct: 52  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 111

Query: 330 SLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA 389
            L  +L     ++  +        + +   + YL     ++ VHRDL A NIL++++ + 
Sbjct: 112 CLRDFLQRHRARLDAS--RLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHV 166

Query: 390 RLGDFGLARAIENERNSY--AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLE 447
           ++ DFGLA+ +  +++ Y   E G   +       APE       + +SDV+ FG V+ E
Sbjct: 167 KIADFGLAKLLPLDKDYYVVREPGQSPIFWY----APESLSDNIFSRQSDVWSFGVVLYE 222

Query: 448 VV-CGRSP 454
           +       
Sbjct: 223 LFTYCDKS 230

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  147 bits (373), Expect = 2e-40
 Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 19/213 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVK---KFSRDSIKSKGDFLAELAIIHRLRHK 304
           +LG+G FG+V +G              +AVK          ++  DF+ E+  +H L H+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSG---KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
           +L+ L G       + +V +  P GSL   L        L      +    VA  + YL+
Sbjct: 82  NLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLE 138

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY--AEHGLVGVPGTMGYV 422
               ++ +HRDL A N+LL      ++GDFGL RA+    + Y   EH  V         
Sbjct: 139 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC---- 191

Query: 423 APECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
           APE   T   +  SD + FG  + E+   G+ P
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  146 bits (370), Expect = 5e-40
 Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 18/212 (8%)

Query: 247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKH 305
           + LG G FG V +G+             +A+K   + +      + + E  I+H+L + +
Sbjct: 16  IELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY 71

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           +V L+G C  +  L+LV +    G L K+L G  E++ ++  +  ++L  V+  + YL+ 
Sbjct: 72  IVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLE- 127

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY--AEHGLVGVPGTMGYVA 423
             ++  VHRDL A N+LL     A++ DFGL++A+  + + Y     G   +       A
Sbjct: 128 --EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----A 181

Query: 424 PECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
           PEC +  K +  SDV+ +G  + E +  G+ P
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  147 bits (373), Expect = 5e-40
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 16/211 (7%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHL 306
            +G G  G V  G +    Q    +  +A+K        + + DFL+E +I+ +  H ++
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQ---RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
           + L G        ++V ++M NGSL+ +L     Q T+       +L GV + + YL   
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYLS-- 168

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY--AEHGLVGVPGTMGYVAP 424
            D   VHRDL A N+L+D++   ++ DFGL+R +E++ ++      G + +  T    AP
Sbjct: 169 -DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----AP 223

Query: 425 ECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
           E       +  SDV+ FG V+ EV+  G  P
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  146 bits (371), Expect = 1e-39
 Identities = 67/326 (20%), Positives = 126/326 (38%), Gaps = 48/326 (14%)

Query: 224 LPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD 283
           LP + +    K+++          ++G+G +G V+ G       +     ++AVK F   
Sbjct: 27  LPLLVQRTIAKQIQMVK-------QIGKGRYGEVWMGK------WR--GEKVAVKVFFTT 71

Query: 284 SIKSKGDFLAELAIIH--RLRHKHLVHLVGWCHEKG----KLLLVYDFMPNGSLEKYLYG 337
              S   +  E  I     +RH++++  +    +      +L L+ D+  NGSL  YL  
Sbjct: 72  EEAS---WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS 128

Query: 338 TSEQVTLNWNHRYKILTGVASAVYYLQNEYDQ-----KVVHRDLKASNILLDADFNARLG 392
           T    TL+     K+     S + +L  E         + HRDLK+ NIL+  +    + 
Sbjct: 129 T----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184

Query: 393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPE------CFHTGKATPESDVFGFGAVVL 446
           D GLA    ++ N   +       GT  Y+ PE        +  ++   +D++ FG ++ 
Sbjct: 185 DLGLAVKFISDTNE-VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243

Query: 447 EVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV---DQRLNINSVVDEAKRLLLL 503
           EV      G ++   Q  Y   D V        +++ V     R +  +     + L  +
Sbjct: 244 EVARRCVSGGIVEEYQLPYH--DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQM 301

Query: 504 GL---ACSHPIASERPKTEDILQIIS 526
           G     C     + R     + + ++
Sbjct: 302 GKLMTECWAHNPASRLTALRVKKTLA 327

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  147 bits (374), Expect = 1e-39
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 22/212 (10%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLAELAIIHRLRHKHL 306
           ++G G FG V+ G          DNT +AVK          K  FL E  I+ +  H ++
Sbjct: 121 QIGRGNFGEVFSGR------LRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
           V L+G C +K  + +V + +  G    +L   +E   L      +++   A+ + YL+  
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLE-- 230

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV---A 423
             +  +HRDL A N L+      ++ DFG++R    +    A  GL  VP     V   A
Sbjct: 231 -SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVP-----VKWTA 283

Query: 424 PECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
           PE  + G+ + ESDV+ FG ++ E    G SP
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASP 315

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  145 bits (369), Expect = 2e-39
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 15/210 (7%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHL 306
            LG G FG VYKG+     +       +A+K+    +  K+  + L E  ++  + + H+
Sbjct: 22  VLGSGAFGTVYKGLWIPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
             L+G C     + L+   MP G L  Y+    + +     +       +A  + YL+  
Sbjct: 80  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQIAKGMNYLE-- 134

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY-AEHGLVGVPGTMGYVAPE 425
            D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y AE G V +       A E
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALE 189

Query: 426 CFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
                  T +SDV+ +G  V E++  G  P
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  146 bits (370), Expect = 2e-39
 Identities = 71/304 (23%), Positives = 122/304 (40%), Gaps = 45/304 (14%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIH--RLRHKH 305
            +G+G FG V++G             ++AVK FS    +S   +  E  I     LRH++
Sbjct: 49  SIGKGRFGEVWRGKWR--------GEEVAVKIFSSREERS---WFREAEIYQTVMLRHEN 97

Query: 306 LVHLVGWCHEKG----KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
           ++  +   ++      +L LV D+  +GSL  YL     + T+      K+    AS + 
Sbjct: 98  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLA 153

Query: 362 YLQNEYDQ-----KVVHRDLKASNILLDADFNARLGDFGLARAIENERNS--YAEHGLVG 414
           +L  E         + HRDLK+ NIL+  +    + D GLA   ++  ++   A +  V 
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV- 212

Query: 415 VPGTMGYVAPE------CFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV 468
             GT  Y+APE           ++   +D++  G V  E+    S G +    Q  Y   
Sbjct: 213 --GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-- 268

Query: 469 DWVWMLHREGHIQDAV---DQRLNINSVVDEAKRLLLLGL---ACSHPIASERPKTEDIL 522
           D V        ++  V     R NI +     + L ++      C +   + R     I 
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328

Query: 523 QIIS 526
           + +S
Sbjct: 329 KTLS 332

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  144 bits (366), Expect = 4e-39
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 22/230 (9%)

Query: 228 PREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IK 286
            R FK  EL+K          LG G FG V+KG+     +       + +K     S  +
Sbjct: 7   ARIFKETELRKLK-------VLGSGVFGTVHKGVWIPEGE--SIKIPVCIKVIEDKSGRQ 57

Query: 287 SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNW 346
           S       +  I  L H H+V L+G C     L LV  ++P GSL  ++      +    
Sbjct: 58  SFQAVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQ- 115

Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
                    +A  +YYL+   +  +VHR+L A N+LL +    ++ DFG+A  +  +   
Sbjct: 116 -LLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171

Query: 407 Y-AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
                    +       A E  H GK T +SDV+ +G  V E++  G  P
Sbjct: 172 LLYSEAKTPIKWM----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  143 bits (363), Expect = 4e-39
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 15/209 (7%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHL 306
            +GEG FG V++GI    +        +A+K      S   +  FL E   + +  H H+
Sbjct: 22  CIGEGQFGDVHQGIYMSPEN---PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
           V L+G    +  + ++ +    G L  +L      + L           +++A+ YL+  
Sbjct: 79  VKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLE-- 133

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
             ++ VHRD+ A N+L+ ++   +LGDFGL+R +E+     A  G + +       APE 
Sbjct: 134 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APES 188

Query: 427 FHTGKATPESDVFGFGAVVLEVV-CGRSP 454
            +  + T  SDV+ FG  + E++  G  P
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKP 217

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  143 bits (363), Expect = 5e-39
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 22/226 (9%)

Query: 228 PREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS 287
           P +F+ + LK          +LG+G FG V       +         +AVKK    + + 
Sbjct: 4   PTQFEERHLKFLQ-------QLGKGNFGSVEMCRY--DPLQDNTGEVVAVKKLQHSTEEH 54

Query: 288 KGDFLAELAIIHRLRHKHLVHLVGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLN 345
             DF  E+ I+  L+H ++V   G C+  G+  L L+ +++P GSL  YL    E++   
Sbjct: 55  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 114

Query: 346 WNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN 405
                +  + +   + YL     ++ +HRDL   NIL++ +   ++GDFGL + +  ++ 
Sbjct: 115 --KLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169

Query: 406 SY--AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
            +   E G   +       APE     K +  SDV+ FG V+ E+ 
Sbjct: 170 FFKVKEPGESPIFWY----APESLTESKFSVASDVWSFGVVLYELF 211

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  142 bits (360), Expect = 1e-38
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 20/212 (9%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVK--KFSRDSIKSKGDFLAELAIIHRLRHKH 305
            LG G FG V KG              +AVK  K   +    K + LAE  ++ +L + +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKV----VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           +V ++G C E    +LV +    G L KYL        +   +  +++  V+  + YL+ 
Sbjct: 80  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE- 134

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY--AEHGLVGVPGTMGYVA 423
             +   VHRDL A N+LL     A++ DFGL++A+  + N Y    HG   V       A
Sbjct: 135 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----A 188

Query: 424 PECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
           PEC +  K + +SDV+ FG ++ E    G+ P
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  142 bits (361), Expect = 1e-38
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 25/228 (10%)

Query: 228 PREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-K 286
           P  F+ + LK+          LGEG FG V                Q+AVK    +S   
Sbjct: 15  PTHFEKRFLKRIR-------DLGEGHFGKVELCRYDPEGDN--TGEQVAVKSLKPESGGN 65

Query: 287 SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTL 344
              D   E+ I+  L H+++V   G C E G   + L+ +F+P+GSL++YL     ++ L
Sbjct: 66  HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL 125

Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
               + K    +   + YL     ++ VHRDL A N+L++++   ++GDFGL +AIE ++
Sbjct: 126 K--QQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180

Query: 405 NSYAEHGLVGVPGTMGYV---APECFHTGKATPESDVFGFGAVVLEVV 449
             Y        P     V   APEC    K    SDV+ FG  + E++
Sbjct: 181 EYYTVKDDRDSP-----VFWYAPECLMQSKFYIASDVWSFGVTLHELL 223

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  144 bits (365), Expect = 1e-38
 Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 16/211 (7%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHL 306
            +G G FG V  G +    +       +A+K        K + DFL E +I+ +  H ++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSK---KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
           + L G   +   +++V ++M NGSL+ +L     Q T+       +L G+AS + YL   
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYLS-- 164

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY--AEHGLVGVPGTMGYVAP 424
            D   VHRDL A NIL++++   ++ DFGL R +E++  +      G + +  T    +P
Sbjct: 165 -DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SP 219

Query: 425 ECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
           E     K T  SDV+ +G V+ EV+  G  P
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  142 bits (360), Expect = 3e-38
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 22/226 (9%)

Query: 228 PREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS 287
           P +F+ + LK          +LG+G FG V      ++         +AVKK    + + 
Sbjct: 35  PTQFEERHLKFLQ-------QLGKGNFGSVEMCR--YDPLQDNTGEVVAVKKLQHSTEEH 85

Query: 288 KGDFLAELAIIHRLRHKHLVHLVGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLN 345
             DF  E+ I+  L+H ++V   G C+  G+  L L+ +++P GSL  YL    E++   
Sbjct: 86  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 145

Query: 346 WNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN 405
                +  + +   + YL     ++ +HRDL   NIL++ +   ++GDFGL + +  ++ 
Sbjct: 146 --KLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200

Query: 406 SY--AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
            Y   E G   +       APE     K +  SDV+ FG V+ E+ 
Sbjct: 201 YYKVKEPGESPIFWY----APESLTESKFSVASDVWSFGVVLYELF 242

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  140 bits (354), Expect = 6e-38
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 18/208 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
            +G G FG+V+ G          +  ++A+K   R+   S+ DF+ E  ++ +L H  LV
Sbjct: 15  EIGSGQFGLVHLGYWL-------NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L G C E+  + LV +FM +G L  YL                +   V   + YL+   
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLE--- 121

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           +  V+HRDL A N L+  +   ++ DFG+ R + +++ + +      V       +PE F
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVF 177

Query: 428 HTGKATPESDVFGFGAVVLEVV-CGRSP 454
              + + +SDV+ FG ++ EV   G+ P
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIP 205

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  140 bits (356), Expect = 7e-38
 Identities = 68/214 (31%), Positives = 100/214 (46%), Gaps = 22/214 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLV 307
           +G G FG VY G +  ND         AVK  +R   I     FL E  I+    H +++
Sbjct: 33  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 308 HLVGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
            L+G C   +G  L+V  +M +G L  ++   +   T+           VA  + YL   
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYLA-- 145

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG--VPGTMGYV-- 422
             +K VHRDL A N +LD  F  ++ DFGLAR +  ++  Y+ H   G  +P     V  
Sbjct: 146 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLP-----VKW 198

Query: 423 -APECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
            A E   T K T +SDV+ FG ++ E++  G  P
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  139 bits (353), Expect = 1e-37
 Identities = 50/218 (22%), Positives = 97/218 (44%), Gaps = 25/218 (11%)

Query: 248 RLGEGGFGIVYKGIIHH-NDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHL 306
            LG+G F  ++KG+     D   +  T++ +K   +        F    +++ +L HKHL
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
           V   G C    + +LV +F+  GSL+ YL      + + W  + ++   +A+A+++L+  
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLE-- 130

Query: 367 YDQKVVHRDLKASNILLDADFNAR--------LGDFGLARAIENERNSYAEHGLVGVPGT 418
            +  ++H ++ A NILL  + + +        L D G++  +  +     +     +P  
Sbjct: 131 -ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-----DILQERIPWV 184

Query: 419 MGYVAPECFHTGKA-TPESDVFGFGAVVLEVV-CGRSP 454
                PEC    K     +D + FG  + E+   G  P
Sbjct: 185 ----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  140 bits (354), Expect = 1e-37
 Identities = 66/236 (27%), Positives = 104/236 (44%), Gaps = 18/236 (7%)

Query: 225 PGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD- 283
             +  E K   +       H    +G+G FG+VY G      Q   +  Q A+K  SR  
Sbjct: 5   SALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQ---NRIQCAIKSLSRIT 61

Query: 284 SIKSKGDFLAELAIIHRLRHKHLVHLVGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQV 342
            ++    FL E  ++  L H +++ L+G     +G   ++  +M +G L +++       
Sbjct: 62  EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP 121

Query: 343 TLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN 402
           T+           VA  + YL    +QK VHRDL A N +LD  F  ++ DFGLAR I +
Sbjct: 122 TVK--DLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176

Query: 403 E---RNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
                     H  + V  T    A E   T + T +SDV+ FG ++ E++  G  P
Sbjct: 177 REYYSVQQHRHARLPVKWT----ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  138 bits (351), Expect = 2e-37
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 18/208 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
            LG G FG+V  G              +AVK   ++   S+ +F  E   + +L H  LV
Sbjct: 15  ELGSGQFGVVKLGKWK-------GQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
              G C ++  + +V +++ NG L  YL   S    L  +   ++   V   + +L+   
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLE--- 121

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
             + +HRDL A N L+D D   ++ DFG+ R + +++   +      V  +    APE F
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVF 177

Query: 428 HTGKATPESDVFGFGAVVLEVV-CGRSP 454
           H  K + +SDV+ FG ++ EV   G+ P
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  144 bits (364), Expect = 2e-37
 Identities = 59/208 (28%), Positives = 107/208 (51%), Gaps = 16/208 (7%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           +LG G +G VY+G+      +   +  +AVK    D++    +FL E A++  ++H +LV
Sbjct: 227 KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLV 279

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L+G C  +    ++ +FM  G+L  YL     +  ++      + T ++SA+ YL+   
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLE--- 335

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HR+L A N L+  +   ++ DFGL+R +    ++Y  H     P  + + APE  
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP--IKWTAPESL 391

Query: 428 HTGKATPESDVFGFGAVVLEVV-CGRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSP 419

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  140 bits (355), Expect = 2e-37
 Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 15/211 (7%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHL 306
            +G G FG VYKG++            +A+K        K + DFL E  I+ +  H ++
Sbjct: 51  VIGAGEFGEVYKGML--KTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
           + L G   +   ++++ ++M NG+L+K+L     + ++       +L G+A+ + YL   
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV--LQLVGMLRGIAAGMKYLA-- 164

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY--AEHGLVGVPGTMGYVAP 424
            +   VHRDL A NIL++++   ++ DFGL+R +E++  +      G + +  T    AP
Sbjct: 165 -NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----AP 219

Query: 425 ECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
           E     K T  SDV+ FG V+ EV+  G  P
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  139 bits (352), Expect = 3e-37
 Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 26/221 (11%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVK--KFSRDSIKSKGDFLAELAIIHRLRHKH 305
            LGEG FG V +G +   D     + ++AVK  K    S +   +FL+E A +    H +
Sbjct: 41  ILGEGEFGSVMEGNLKQEDG---TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 306 LVHLVGWC-----HEKGKLLLVYDFMPNGSLEKYL---YGTSEQVTLNWNHRYKILTGVA 357
           ++ L+G C         K +++  FM  G L  YL      +    +      K +  +A
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
             + YL    ++  +HRDL A N +L  D    + DFGL++ I    + Y +  +  +P 
Sbjct: 158 LGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY-SGDYYRQGRIAKMP- 212

Query: 418 TMGYV---APECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
               V   A E       T +SDV+ FG  + E+   G +P
Sbjct: 213 ----VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  145 bits (367), Expect = 3e-37
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 15/209 (7%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHL 306
            +GEG FG V++GI    +        +A+K      S   +  FL E   + +  H H+
Sbjct: 397 CIGEGQFGDVHQGIYMSPEN---PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
           V L+G    +  + ++ +    G L  +L      + L           +++A+ YL+  
Sbjct: 454 VKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLA--SLILYAYQLSTALAYLE-- 508

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
             ++ VHRD+ A N+L+ ++   +LGDFGL+R +E+     A  G + +       APE 
Sbjct: 509 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APES 563

Query: 427 FHTGKATPESDVFGFGAVVLEVV-CGRSP 454
            +  + T  SDV+ FG  + E++  G  P
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVKP 592

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  138 bits (349), Expect = 4e-37
 Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 18/208 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
            LG G FG+V  G              +A+K     S+ S+ +F+ E  ++  L H+ LV
Sbjct: 31  ELGTGQFGVVKYGKWR-------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLV 82

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L G C ++  + ++ ++M NG L  YL     +         ++   V  A+ YL+   
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLE--- 137

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            ++ +HRDL A N L++     ++ DFGL+R + ++  + +      V  +     PE  
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVL 193

Query: 428 HTGKATPESDVFGFGAVVLEVV-CGRSP 454
              K + +SD++ FG ++ E+   G+ P
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  138 bits (350), Expect = 4e-37
 Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 29/225 (12%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
            LGEG FG V+    + N     D   +AVK     ++ ++ DF  E  ++  L+H+H+V
Sbjct: 22  ELGEGAFGKVFLAECY-NLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYL-------------YGTSEQVTLNWNHRYKILT 354
              G C +   L++V+++M +G L K+L                  +  L  +    I +
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
            +AS + YL     Q  VHRDL   N L+ A+   ++GDFG++R +    + Y   G   
Sbjct: 141 QIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY-STDYYRVGGHTM 196

Query: 415 VPGTMGYV---APECFHTGKATPESDVFGFGAVVL-EVV-CGRSP 454
           +P     +    PE     K T ESDV+ FG V+L E+   G+ P
Sbjct: 197 LP-----IRWMPPESIMYRKFTTESDVWSFG-VILWEIFTYGKQP 235

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  138 bits (349), Expect = 5e-37
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 16/208 (7%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           +LG G +G VY+G+      +   +  +AVK    D++    +FL E A++  ++H +LV
Sbjct: 20  KLGGGQYGEVYEGV------WKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLV 72

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L+G C  +    ++ +FM  G+L  YL     +  ++      + T ++SA+ YL+   
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLE--- 128

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL A N L+  +   ++ DFGL+R +  +  +        +  T    APE  
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESL 184

Query: 428 HTGKATPESDVFGFGAVVLEVV-CGRSP 454
              K + +SDV+ FG ++ E+   G SP
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  139 bits (351), Expect = 5e-37
 Identities = 70/231 (30%), Positives = 100/231 (43%), Gaps = 25/231 (10%)

Query: 224 LPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD 283
            PG P  F  + LKK          LGEG FG V       +         +AVK    D
Sbjct: 21  GPGDPTVFHKRYLKKIR-------DLGEGHFGKVSLYCY--DPTNDGTGEMVAVKALKAD 71

Query: 284 -SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSE 340
              + +  +  E+ I+  L H+H++   G C + G   L LV +++P GSL  YL     
Sbjct: 72  AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----P 127

Query: 341 QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI 400
           + ++           +   + YL     Q  +HRDL A N+LLD D   ++GDFGLA+A+
Sbjct: 128 RHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184

Query: 401 ENERNSY--AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
                 Y   E G   V       APEC    K    SDV+ FG  + E++
Sbjct: 185 PEGHEYYRVREDGDSPVFWY----APECLKEYKFYYASDVWSFGVTLYELL 231

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  138 bits (351), Expect = 6e-37
 Identities = 67/224 (29%), Positives = 99/224 (44%), Gaps = 28/224 (12%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
            LGEG FG V+    H+      D   +AVK     S  ++ DF  E  ++  L+H+H+V
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQ-DKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYL------------YGTSEQVTLNWNHRYKILTG 355
              G C E   LL+V+++M +G L ++L                    L       + + 
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           VA+ + YL        VHRDL   N L+      ++GDFG++R I    + Y   G   +
Sbjct: 167 VAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-STDYYRVGGRTML 222

Query: 416 PGTMGYV---APECFHTGKATPESDVFGFGAVVL-EVV-CGRSP 454
           P     +    PE     K T ESDV+ FG VVL E+   G+ P
Sbjct: 223 P-----IRWMPPESILYRKFTTESDVWSFG-VVLWEIFTYGKQP 260

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  143 bits (363), Expect = 8e-37
 Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 18/212 (8%)

Query: 247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKH 305
           + LG G FG V +G+     +       +A+K   + +      + + E  I+H+L + +
Sbjct: 342 IELGCGNFGSVRQGVYRMRKK----QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY 397

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           +V L+G C  +  L+LV +    G L K+L G  E++ ++  +  ++L  V+  + YL+ 
Sbjct: 398 IVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLE- 453

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY--AEHGLVGVPGTMGYVA 423
             ++  VHR+L A N+LL     A++ DFGL++A+  + + Y     G   +       A
Sbjct: 454 --EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----A 507

Query: 424 PECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
           PEC +  K +  SDV+ +G  + E +  G+ P
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  139 bits (352), Expect = 9e-37
 Identities = 66/213 (30%), Positives = 98/213 (46%), Gaps = 20/213 (9%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLV 307
           +G G FG VY G +  ND         AVK  +R   I     FL E  I+    H +++
Sbjct: 97  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 308 HLVGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
            L+G C   +G  L+V  +M +G L  ++   +   T+           VA  + +L   
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFLA-- 209

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAI-ENERNSYAEHGLVGVPGTMGYV--- 422
             +K VHRDL A N +LD  F  ++ DFGLAR + + E +S        +P     V   
Sbjct: 210 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP-----VKWM 263

Query: 423 APECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           A E   T K T +SDV+ FG ++ E++  G  P
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  137 bits (348), Expect = 1e-36
 Identities = 57/222 (25%), Positives = 89/222 (40%), Gaps = 27/222 (12%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVK--KFSRDSIKSKGDFLAELAIIHRLRHKH 305
            LG+G FG V +  +   D       ++AVK  K    +     +FL E A +    H H
Sbjct: 30  MLGKGEFGSVREAQLKQEDG---SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86

Query: 306 LVHLVGWCHEKG------KLLLVYDFMPNGSLEKYL---YGTSEQVTLNWNHRYKILTGV 356
           +  LVG              +++  FM +G L  +L           L      + +  +
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP 416
           A  + YL     +  +HRDL A N +L  D    + DFGL+R I    + Y +     +P
Sbjct: 147 ACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY-SGDYYRQGCASKLP 202

Query: 417 GTMGYV---APECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
                V   A E       T  SDV+ FG  + E++  G++P
Sbjct: 203 -----VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  136 bits (344), Expect = 2e-36
 Identities = 66/208 (31%), Positives = 111/208 (53%), Gaps = 18/208 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           RLG G FG V+ G  +        +T++AVK   + S+ S   FLAE  ++ +L+H+ LV
Sbjct: 20  RLGAGQFGEVWMGYYN-------GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLV 71

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L     ++  + ++ ++M NGSL  +L  T   + L  N    +   +A  + +++   
Sbjct: 72  RLYAVVTQEP-IYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIE--- 126

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
           ++  +HRDL+A+NIL+    + ++ DFGLAR IE+   +  E     +  T    APE  
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAI 182

Query: 428 HTGKATPESDVFGFGAVVLEVV-CGRSP 454
           + G  T +SDV+ FG ++ E+V  GR P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  137 bits (347), Expect = 2e-36
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 22/219 (10%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHL 306
            LG+G FG+VY+G+     +     T++A+K  +   S++ + +FL E +++      H+
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDE-PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYL-------YGTSEQVTLNWNHRYKILTGVASA 359
           V L+G   +    L++ + M  G L+ YL                + +   ++   +A  
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
           + YL      K VHRDL A N ++  DF  ++GDFG+ R I    + Y + G   +P   
Sbjct: 151 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET-DYYRKGGKGLLP--- 203

Query: 420 GYV---APECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
             V   +PE    G  T  SDV+ FG V+ E+      P
Sbjct: 204 --VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  138 bits (350), Expect = 8e-36
 Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 18/208 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           +LG+G FG V+ G  +         T++A+K     ++ S   FL E  ++ +LRH+ LV
Sbjct: 191 KLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLV 242

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L     E+  + +V ++M  GSL  +L        L       +   +AS + Y++   
Sbjct: 243 QLYAVVSEEP-IYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVE--- 297

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
               VHRDL+A+NIL+  +   ++ DFGLAR IE+  N Y        P  + + APE  
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP--IKWTAPEAA 353

Query: 428 HTGKATPESDVFGFGAVVLEVV-CGRSP 454
             G+ T +SDV+ FG ++ E+   GR P
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVP 381

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  135 bits (341), Expect = 1e-35
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 22/219 (10%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHL 306
            LG G FG VY+G +           Q+AVK      S + + DFL E  II +  H+++
Sbjct: 37  GLGHGAFGEVYEGQVSGMPN-DPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYL----YGTSEQVTLNWNHRYKILTGVASAVYY 362
           V  +G   +     ++ + M  G L+ +L       S+  +L       +   +A    Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 363 LQNEYDQKVVHRDLKASNILLDA---DFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
           L+   +   +HRD+ A N LL        A++GDFG+AR I    + Y + G   +P   
Sbjct: 156 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLP--- 208

Query: 420 GYV---APECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
             V    PE F  G  T ++D + FG ++ E+   G  P
Sbjct: 209 --VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  133 bits (338), Expect = 2e-35
 Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 28/225 (12%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHL 306
            LGE  FG VYKG +            +A+K          + +F  E  +  RL+H ++
Sbjct: 16  ELGEDRFGKVYKGHLF-GPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYL-------------YGTSEQVTLNWNHRYKIL 353
           V L+G   +   L +++ +  +G L ++L                + +  L       ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 354 TGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLV 413
             +A+ + YL       VVH+DL   N+L+    N ++ D GL R +    + Y   G  
Sbjct: 135 AQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA-DYYKLLGNS 190

Query: 414 GVPGTMGYV---APECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
            +P     +   APE    GK + +SD++ +G V+ EV   G  P
Sbjct: 191 LLP-----IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  138 bits (349), Expect = 3e-35
 Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 18/208 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           +LG+G FG V+ G  +         T++A+K     ++ S   FL E  ++ +LRH+ LV
Sbjct: 274 KLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLV 325

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L     E+  + +V ++M  GSL  +L        L       +   +AS + Y++   
Sbjct: 326 QLYAVVSEEP-IYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVE--- 380

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
               VHRDL+A+NIL+  +   ++ DFGLAR IE+  N Y        P  + + APE  
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP--IKWTAPEAA 436

Query: 428 HTGKATPESDVFGFGAVVLEVV-CGRSP 454
             G+ T +SDV+ FG ++ E+   GR P
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVP 464

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232

 Score =  131 bits (331), Expect = 3e-35
 Identities = 49/158 (31%), Positives = 70/158 (44%), Gaps = 14/158 (8%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGF--DPDD 67
                G+ F IAP D+  P  S G      +   D   A HFV +EFDT       DP  
Sbjct: 79  YDPADGIIFFIAPEDTQIPAGSIGGGTLGVS---DTKGAGHFVGVEFDTYSNSEYNDPPT 135

Query: 68  NHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKP 127
           +H+G+++NSV S K VP           G    V V YD  +K + V +  +        
Sbjct: 136 DHVGIDVNSVDSVKTVPW------NSVSGAVVKVTVIYDSSTKTLSVAVTNDN---GDIT 186

Query: 128 LLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWT 165
            + + ++LK  L     FGFSAS      Q++ +RSW+
Sbjct: 187 TIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWS 224

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  136 bits (344), Expect = 5e-35
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 18/208 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           +LG G FG V+    +        +T++AVK     S+ S   FLAE  ++  L+H  LV
Sbjct: 195 KLGAGQFGEVWMATYN-------KHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLV 246

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
            L     ++  + ++ +FM  GSL  +L  + E               +A  + +++   
Sbjct: 247 KLHAVVTKEP-IYIITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGMAFIE--- 301

Query: 368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF 427
            +  +HRDL+A+NIL+ A    ++ DFGLAR IE+   +  E     +  T    APE  
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAI 357

Query: 428 HTGKATPESDVFGFGAVVLEVV-CGRSP 454
           + G  T +SDV+ FG +++E+V  GR P
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  134 bits (338), Expect = 7e-35
 Identities = 69/277 (24%), Positives = 114/277 (41%), Gaps = 34/277 (12%)

Query: 202 IAYVKKRRSRVAEPHHNLGKLRLPGMP----REFKYKELKKATNNFHESMR--------L 249
           + +     S +  P + L KLR   +       + +     + ++  E  R        L
Sbjct: 20  LYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGL 79

Query: 250 GEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLVH 308
           G G FG VY+G +           Q+AVK      S + + DFL E  II +  H+++V 
Sbjct: 80  GHGAFGEVYEGQVSGMPN-DPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 309 LVGWCHEKGKLLLVYDFMPNGSLEKYL----YGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
            +G   +     ++ + M  G L+ +L       S+  +L       +   +A    YL+
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198

Query: 365 NEYDQKVVHRDLKASNILLDA---DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGY 421
              +   +HRD+ A N LL        A++GDFG+AR I      Y + G   +P     
Sbjct: 199 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RAGYYRKGGCAMLP----- 249

Query: 422 V---APECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
           V    PE F  G  T ++D + FG ++ E+   G  P
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  131 bits (331), Expect = 1e-34
 Identities = 68/209 (32%), Positives = 104/209 (49%), Gaps = 24/209 (11%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
            +G+G FG V  G             ++AVK    D+  +   FLAE +++ +LRH +LV
Sbjct: 28  TIGKGEFGDVMLGDYR--------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLV 77

Query: 308 HLVGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
            L+G    EKG L +V ++M  GSL  YL  +  +  L  +   K    V  A+ YL+  
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLE-- 134

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
                VHRDL A N+L+  D  A++ DFGL +   + +++    G + V  T    APE 
Sbjct: 135 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWT----APEA 185

Query: 427 FHTGKATPESDVFGFGAVVLEVV-CGRSP 454
               K + +SDV+ FG ++ E+   GR P
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  130 bits (330), Expect = 3e-34
 Identities = 68/232 (29%), Positives = 103/232 (44%), Gaps = 34/232 (14%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHL 306
            LGEG FG V K    H        T +AVK    + S     D L+E  ++ ++ H H+
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRA-GYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYL------------YGTSEQVTLNWNHRYKILT 354
           + L G C + G LLL+ ++   GSL  +L             G S   +   +   + LT
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 355 G---------VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN 405
                     ++  + YL    + K+VHRDL A NIL+      ++ DFGL+R +  E +
Sbjct: 149 MGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDV-YEED 204

Query: 406 SY--AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
           SY     G + V       A E       T +SDV+ FG ++ E+V  G +P
Sbjct: 205 SYVKRSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  130 bits (330), Expect = 3e-34
 Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 31/228 (13%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRL-RHKH 305
            LG G FG V +   +   +       +AVK       +  +   ++EL ++  L  H +
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSD-AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG---------- 355
           +V+L+G C   G  L++ ++   G L  +L    +    +      +             
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 356 -----VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEH 410
                VA  + +L     +  +HRDL A NILL      ++ DFGLAR I+N+ ++Y   
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKND-SNYVVK 204

Query: 411 GLVGVPGTMGYV---APECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
           G   +P     V   APE       T ESDV+ +G  + E+   G SP
Sbjct: 205 GNARLP-----VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  130 bits (329), Expect = 5e-34
 Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 30/227 (13%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRL-RHKH 305
            LG G FG V +      D+       +AVK      +       ++EL I+  +  H +
Sbjct: 34  PLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 306 LVHLVGWCHEKGK-LLLVYDFMPNGSLEKYL----YGTSEQVTLNWNHRYKILTG----- 355
           +V+L+G C + G  L+++ +F   G+L  YL               +     LT      
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 356 ----VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
               VA  + +L     +K +HRDL A NILL      ++ DFGLAR I  +   Y   G
Sbjct: 153 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI-YKDPDYVRKG 208

Query: 412 LVGVPGTMGYV---APECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
              +P     +   APE       T +SDV+ FG ++ E+   G SP
Sbjct: 209 DARLP-----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  130 bits (329), Expect = 7e-34
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 31/228 (13%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDN-TQIAVKKFSRD-SIKSKGDFLAELAIIHRL-RHK 304
            LGEG FG V        D+        +AVK    D + K   D ++E+ ++  + +HK
Sbjct: 42  PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL-------------YGTSEQVTLNWNHRYK 351
           ++++L+G C + G L ++ ++   G+L +YL                  +  + +     
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161

Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
               +A  + YL     QK +HRDL A N+L+  +   ++ DFGLAR I N  + Y +  
Sbjct: 162 CTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI-DYYKKTT 217

Query: 412 LVGVPGTMGYV---APECFHTGKATPESDVFGFGAVVL-EVV-CGRSP 454
              +P     V   APE       T +SDV+ FG V++ E+   G SP
Sbjct: 218 NGRLP-----VKWMAPEALFDRVYTHQSDVWSFG-VLMWEIFTLGGSP 259

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  130 bits (329), Expect = 8e-34
 Identities = 62/234 (26%), Positives = 105/234 (44%), Gaps = 31/234 (13%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRL-RHKH 305
            LG G FG V +       +      ++AVK          K   ++EL I+  L +H++
Sbjct: 53  TLGAGAFGKVVEATAFGLGK-EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYL-----------YGTSEQVTLNWNHRYKILT 354
           +V+L+G C   G +L++ ++   G L  +L                  T +        +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
            VA  + +L     +  +HRD+ A N+LL     A++GDFGLAR I N+ ++Y   G   
Sbjct: 172 QVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND-SNYIVKGNAR 227

Query: 415 VPGTMGYV---APECFHTGKATPESDVFGFGAVVL-EVV-CGRSP--GNMIPHQ 461
           +P     V   APE       T +SDV+ +G ++L E+   G +P  G ++  +
Sbjct: 228 LP-----VKWMAPESIFDCVYTVQSDVWSYG-ILLWEIFSLGLNPYPGILVNSK 275

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237

 Score =  127 bits (320), Expect = 9e-34
 Identities = 51/159 (32%), Positives = 79/159 (49%), Gaps = 14/159 (8%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG-FDPDDN 68
             +  GLAF +AP D+ P     G  LG+       NK+N  VA+EFDT   G +DP   
Sbjct: 83  ATTADGLAFFLAPVDTQPL--DLGGMLGIFKD-GYFNKSNQIVAVEFDTFSNGDWDPKGR 139

Query: 69  HLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPL 128
           HLG+N+NS+ S K VP         ++G    V++ Y+  +K +   +      +    +
Sbjct: 140 HLGINVNSIESIKTVPW------NWTNGEVANVFISYEASTKSLTASLVYPS--LETSFI 191

Query: 129 LKETINLKDYLKPESYFGFSASTGYP--HIQLNCVRSWT 165
           +   +++K  L     FGFSA+TG    ++Q N V SW+
Sbjct: 192 IDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWS 230

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234

 Score =  127 bits (319), Expect = 1e-33
 Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 15/162 (9%)

Query: 7   PAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPD 66
                   G+ F +AP  +  P +S G +LG+T+     N  N FVA+EFD+    +DP 
Sbjct: 73  VQRYPPTDGVVFFLAPWGTEIPPNSQGGYLGITD---SSNSQNQFVAVEFDSHPNVWDPK 129

Query: 67  D---NHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETM 123
               +H+G+++NS++S K V            G+     + YD  +K++ V M       
Sbjct: 130 SLRSSHIGIDVNSIMSLKAVNW------NRVSGSLEKATIIYDSDTKILTVVM---THQN 180

Query: 124 PQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWT 165
            Q   + + I+LK  L  +   GFSA+T  P  + + + SW+
Sbjct: 181 GQITTISQEIDLKTVLPEKVSVGFSATTWNPERERHDIYSWS 222

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  130 bits (329), Expect = 2e-33
 Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 31/228 (13%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDN-TQIAVKKFSRD-SIKSKGDFLAELAIIHRL-RHK 304
            LGEG FG V        D+        +AVK    D + K   D ++E+ ++  + +HK
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG--------- 355
           ++++L+G C + G L ++ ++   G+L +YL               ++            
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207

Query: 356 ----VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
               +A  + YL     QK +HRDL A N+L+  +   ++ DFGLAR I N  + Y +  
Sbjct: 208 CTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI-DYYKKTT 263

Query: 412 LVGVPGTMGYV---APECFHTGKATPESDVFGFGAVVL-EVVC-GRSP 454
              +P     V   APE       T +SDV+ FG V++ E+   G SP
Sbjct: 264 NGRLP-----VKWMAPEALFDRVYTHQSDVWSFG-VLMWEIFTLGGSP 305

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  129 bits (327), Expect = 3e-33
 Identities = 67/228 (29%), Positives = 110/228 (48%), Gaps = 31/228 (13%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDN-TQIAVKKFSRD-SIKSKGDFLAELAIIHRL-RHK 304
            LGEG FG V        D+   +  T++AVK    D + K   D ++E+ ++  + +HK
Sbjct: 76  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL----YGTSEQVTLNWNHRYKILTG----- 355
           ++++L+G C + G L ++ ++   G+L +YL        E      ++  + L+      
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195

Query: 356 ----VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
               VA  + YL     +K +HRDL A N+L+  D   ++ DFGLAR I +  + Y +  
Sbjct: 196 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI-DYYKKTT 251

Query: 412 LVGVPGTMGYV---APECFHTGKATPESDVFGFGAVVL-EVV-CGRSP 454
              +P     V   APE       T +SDV+ FG V+L E+   G SP
Sbjct: 252 NGRLP-----VKWMAPEALFDRIYTHQSDVWSFG-VLLWEIFTLGGSP 293

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  128 bits (325), Expect = 3e-33
 Identities = 63/234 (26%), Positives = 101/234 (43%), Gaps = 38/234 (16%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHL 306
            +GEG FG V++        Y    T +AVK    + S   + DF  E A++    + ++
Sbjct: 54  DIGEGAFGRVFQARAPGLLPYE-PFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRY---------------- 350
           V L+G C     + L++++M  G L ++L   S     + +H                  
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 351 -----KILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN 405
                 I   VA+ + YL    ++K VHRDL   N L+  +   ++ DFGL+R I +  +
Sbjct: 173 CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA-D 228

Query: 406 SYAEHGLVGVPGTMGYV---APECFHTGKATPESDVFGFGAVVL-EVV-CGRSP 454
            Y   G   +P     +    PE     + T ESDV+ +G VVL E+   G  P
Sbjct: 229 YYKADGNDAIP-----IRWMPPESIFYNRYTTESDVWAYG-VVLWEIFSYGLQP 276

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  130 bits (330), Expect = 3e-33
 Identities = 70/209 (33%), Positives = 104/209 (49%), Gaps = 24/209 (11%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
            +G+G FG V  G             ++AVK    D+  +   FLAE +++ +LRH +LV
Sbjct: 200 TIGKGEFGDVMLGDYR--------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLV 249

Query: 308 HLVGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
            L+G    EKG L +V ++M  GSL  YL  +  +  L  +   K    V  A+ YL+  
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLE-- 306

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
                VHRDL A N+L+  D  A++ DFGL +    E +S  + G + V  T    APE 
Sbjct: 307 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT----APEA 357

Query: 427 FHTGKATPESDVFGFGAVVLEVV-CGRSP 454
               K + +SDV+ FG ++ E+   GR P
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* Length = 243

 Score =  126 bits (316), Expect = 4e-33
 Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 13/159 (8%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKA-NHFVAIEFDTVKQGF--DPD 66
             +  GLAF +AP DS      YG +LGL    T  + + N  VA+EFDT       DP 
Sbjct: 85  APTADGLAFFLAPVDSSVK--DYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPP 142

Query: 67  DNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQK 126
             H+G+++NS+VS          N      +  T  + YD +SK++ V +        + 
Sbjct: 143 YPHIGIDVNSIVSVATTRW---ENDDAYGSSIATAHITYDARSKILTVLL---SYEHGRD 196

Query: 127 PLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWT 165
            +L   ++L   L  +   GFSA  GY   ++  + SW 
Sbjct: 197 YILSHVVDLAKVLPQKVRIGFSAGVGY--DEVTYILSWH 233

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242

 Score =  125 bits (316), Expect = 4e-33
 Identities = 41/165 (24%), Positives = 65/165 (39%), Gaps = 12/165 (7%)

Query: 4   DPRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG- 62
           +       +  GL F +AP DS  P    G + GL N  T  + +   VA+EFDT+    
Sbjct: 77  ETSANPKAATDGLTFFLAPPDS--PLRRAGGYFGLFN-DTKCDSSYQTVAVEFDTIGSPV 133

Query: 63  --FDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREG 120
             +DP   H+G+++N V S          N          V + Y+  SK +   +    
Sbjct: 134 NFWDPGFPHIGIDVNCVKSINAERW----NKRYGLNNVANVEIIYEASSKTLTASLTYPS 189

Query: 121 ETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWT 165
           +       +   ++LK+ L      GFS ST       + V +W 
Sbjct: 190 D--QTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWY 232

>1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257

 Score =  124 bits (313), Expect = 1e-32
 Identities = 45/163 (27%), Positives = 73/163 (44%), Gaps = 11/163 (6%)

Query: 6   RPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKA-NHFVAIEFDTVKQGF- 63
           +   +    GLAF +AP DS       G++LGL N  T    + N  VA+EFDT      
Sbjct: 80  KITGNGPADGLAFFLAPPDSDVK--DAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNF 137

Query: 64  -DPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGET 122
            +P   H+G+N+NS+VS      +   +  +  G   T  + YDG ++++ V +      
Sbjct: 138 PEPSYRHIGINVNSIVSVATKRWE---DSDIFSGKIATARISYDGSAEILTVVLSYPD-- 192

Query: 123 MPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWT 165
                +L  +++++  L      G SASTG        + SW 
Sbjct: 193 -GSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWR 234

>1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* Length = 253

 Score =  124 bits (312), Expect = 1e-32
 Identities = 39/159 (24%), Positives = 75/159 (47%), Gaps = 14/159 (8%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQ-GFDPDDN 68
             S  G+AF + P  S P   S   +LG+ ++    N +   VA+EFDT     +DP   
Sbjct: 81  SSSADGIAFALVPVGSEPK--SNSGFLGVFDSDVYDN-SAQTVAVEFDTFSNTDWDPTSR 137

Query: 69  HLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPL 128
           H+G+++NS+ S +           L++G +  + + Y+  + L+   +     +     +
Sbjct: 138 HIGIDVNSIKSIRTASWG------LANGQNAEILITYNAATSLLVASLV--HPSRRTSYI 189

Query: 129 LKETINLKDYLKPESYFGFSASTGYP--HIQLNCVRSWT 165
           + E +++ + L      GFSA+TG    + + + V SW+
Sbjct: 190 VSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWS 228

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  126 bits (319), Expect = 2e-32
 Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 29/223 (13%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRL-RHKH 305
            +GEG FG V K  I  +          A+K+     S     DF  EL ++ +L  H +
Sbjct: 32  VIGEGNFGQVLKARIKKDGL----RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYL-------------YGTSEQVTLNWNHRYKI 352
           +++L+G C  +G L L  ++ P+G+L  +L                S   TL+       
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
              VA  + YL     ++ +HRDL A NIL+  ++ A++ DFGL+R  E         G 
Sbjct: 148 AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGR 202

Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
           + V       A E  +    T  SDV+ +G ++ E+V  G +P
Sbjct: 203 LPVRWM----AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  126 bits (319), Expect = 2e-32
 Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 38/234 (16%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRL-RHKH 305
            LG G FG V     +   +    + Q+AVK          +   ++EL ++ +L  H++
Sbjct: 52  VLGSGAFGKVMNATAYGISK-TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYL-----------YGTSEQVTLNWNHRYKILT 354
           +V+L+G C   G + L++++   G L  YL                Q  L       +LT
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 355 G---------VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN 405
                     VA  + +L+    +  VHRDL A N+L+      ++ DFGLAR I    +
Sbjct: 171 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI-MSDS 226

Query: 406 SYAEHGLVGVPGTMGYV---APECFHTGKATPESDVFGFGAVVL-EVV-CGRSP 454
           +Y   G   +P     V   APE    G  T +SDV+ +G ++L E+   G +P
Sbjct: 227 NYVVRGNARLP-----VKWMAPESLFEGIYTIKSDVWSYG-ILLWEIFSLGVNP 274

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240

 Score =  123 bits (310), Expect = 2e-32
 Identities = 40/161 (24%), Positives = 67/161 (41%), Gaps = 12/161 (7%)

Query: 7   PAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGF--D 64
                    L F IA  D+  P  S G+ LGL  +  +    N  V++EFDT       D
Sbjct: 79  QGSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIGD 138

Query: 65  PDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMP 124
           P+  H+G+++NS+ S+              +G + T  + Y+  SK + V          
Sbjct: 139 PNYRHIGIDVNSIRSKAASKW------DWQNGKTATAHISYNSASKRLSVVSSYPN---S 189

Query: 125 QKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWT 165
              ++   + L +        GFSA+TG  + Q N + +W+
Sbjct: 190 SPVVVSFDVELNNVBPBWVRVGFSATTG-QYTQTNNILAWS 229

>1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* Length = 242

 Score =  123 bits (309), Expect = 3e-32
 Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 14/165 (8%)

Query: 6   RPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVK----Q 61
           +        GLAF +AP +S  P  S     GL ++ +D   +N  +A+EFDT       
Sbjct: 78  KADKSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSS-SDSKSSNQIIAVEFDTYFGKAYN 136

Query: 62  GFDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGE 121
            +DPD  H+G+++NS+ S K V           +G    V + Y   +K + V +    +
Sbjct: 137 PWDPDFKHIGIDVNSIKSIKTVK------WDWRNGEVADVVITYRAPTKSLTVCLSYPSD 190

Query: 122 TMPQKPLLKETINLKDYLKPESYFGFSASTG-YPHIQLNCVRSWT 165
                 ++  +++LK  L      GFS   G     + + V SW 
Sbjct: 191 GT--SNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWY 233

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261

 Score =  123 bits (310), Expect = 3e-32
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 15/165 (9%)

Query: 6   RPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGN-KANHFVAIEFDTVK---- 60
                    G+AF IAP D+  P  S G  LGL N  T  N  AN  +A+EFDT      
Sbjct: 87  SSPLSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNS 146

Query: 61  QGFDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREG 120
             +DP+  H+G+++NS+ S K V           +G +  V V Y+  ++ I V      
Sbjct: 147 NTWDPNYQHIGIDVNSIRSSKVVRW------ERREGKTLNVLVTYNPSTRTIDVVATYPD 200

Query: 121 ETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWT 165
               Q+  L   ++L   L      GFSA++G    Q + + SW+
Sbjct: 201 ---GQRYQLSHVVDLTTILPEWVRVGFSAASG-EQFQTHNLESWS 241

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233

 Score =  122 bits (307), Expect = 5e-32
 Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 13/158 (8%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNH 69
                GLAF +AP D+ P   + G +LGL       + +   VA+EFDT    +DP+  H
Sbjct: 81  AAVADGLAFFLAPPDTQPQ--ARGGFLGLFA-DRAHDASYQTVAVEFDTYSNAWDPNYTH 137

Query: 70  LGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLL 129
           +G++ N + S+K  P        +  G    + + Y   +K +   +            +
Sbjct: 138 IGIDTNGIESKKTTPF------DMVYGEKANIVITYQASTKALAASLV--FPVSQTSYAV 189

Query: 130 KETINLKDYLKPESYFGFSASTGYPH--IQLNCVRSWT 165
              ++L+D L      GFSA+TG     ++ + + SW+
Sbjct: 190 SARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWS 227

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253

 Score =  122 bits (307), Expect = 8e-32
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 14/157 (8%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNH 69
                GLAF +AP D+     ++  +LGL N    G+     VA+EFDT +  +DP + H
Sbjct: 84  KRLADGLAFFLAPIDT--KPQTHAGYLGLFNENESGD---QVVAVEFDTFRNSWDPPNPH 138

Query: 70  LGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLL 129
           +G+N+NS+ S K           L++     V + YD  + L+   +    +      +L
Sbjct: 139 IGINVNSIRSIKTTSW------DLANNKVAKVLITYDASTSLLVASLVYPSQ--RTSNIL 190

Query: 130 KETINLKDYLKPESYFGFSASTG-YPHIQLNCVRSWT 165
            + ++LK  L      GFSA+TG     + + V SW+
Sbjct: 191 SDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWS 227

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252

 Score =  122 bits (306), Expect = 1e-31
 Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 16/159 (10%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVK-QGFDPDDN 68
                GLAF + P  S P     G +LGL +     N   H VA+EFDT+  + +DP + 
Sbjct: 82  AGPADGLAFALVPVGSQP--KDKGGFLGLFD---GSNSNFHTVAVEFDTLYNKDWDPTER 136

Query: 69  HLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPL 128
           H+G+++NS+ S K             +G +  V + YD  + L+   +    +      +
Sbjct: 137 HIGIDVNSIRSIKTTRW------DFVNGENAEVLITYDSSTNLLVASLVYPSQ--KTSFI 188

Query: 129 LKETINLKDYLKPESYFGFSASTGYP--HIQLNCVRSWT 165
           + +T++LK  L      GFSA+TG    +++ N V SW+
Sbjct: 189 VSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWS 227

>1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* Length = 242

 Score =  121 bits (304), Expect = 2e-31
 Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 20/168 (11%)

Query: 4   DPRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGF 63
                      GL F IAP ++       G + G+ N          FVA+EFDT +  +
Sbjct: 78  RQPFPRPHPADGLVFFIAPPNT--QTGEGGGYFGIYN----PLSPYPFVAVEFDTFRNTW 131

Query: 64  DPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETM 123
           DP   H+G+++NSV+S K VP       TL +G    V ++YD  +K++ V +     ++
Sbjct: 132 DPQIPHIGIDVNSVISTKTVPF------TLDNGGIANVVIKYDASTKILHVVLV--FPSL 183

Query: 124 PQKPLLKETINLKDYLKPESYFGFSASTGYP------HIQLNCVRSWT 165
                + + ++LK  L      GFSA+TG P        + + + SW+
Sbjct: 184 GTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWS 231

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251

 Score =  120 bits (302), Expect = 4e-31
 Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 15/160 (9%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGF--DPDD 67
                GLAF +AP  S P   S G +LGL ++   G+     VA+EFDT +     DP  
Sbjct: 84  ATIADGLAFFLAPVASAPD--SGGGFLGLFDSAVSGST-YQTVAVEFDTYENTVFTDPPY 140

Query: 68  NHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKP 127
            H+G ++NS+ S K V        +L++G +  V + Y+   KL+   +           
Sbjct: 141 THIGFDVNSISSIKTVKW------SLANGEAAKVLITYNSAVKLLVASLVYPSS--KTSF 192

Query: 128 LLKETINLKDYLKPESYFGFSASTGY--PHIQLNCVRSWT 165
           +L + ++L   L      GFSA+TG     I+ + V SW+
Sbjct: 193 ILADIVDLSSVLPEWVRVGFSAATGASGGKIETHDVFSWS 232

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239

 Score =  119 bits (299), Expect = 8e-31
 Identities = 49/164 (29%), Positives = 80/164 (48%), Gaps = 14/164 (8%)

Query: 7   PAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVK----QG 62
           P  DI+  GLAF +AP DS  P  S  ++LGL N  ++ + +N  VA+EFDT        
Sbjct: 80  PNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFN-NSNSDSSNQIVAVEFDTYFAHSYDP 138

Query: 63  FDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGET 122
           +DP+  H+G+++N + S K V           +G      + Y   +K +   +      
Sbjct: 139 WDPNYRHIGIDVNGIESIKTVQ------WDWINGGVAFATITYLAPNKTLIASLVYPSN- 191

Query: 123 MPQKPLLKETINLKDYLKPESYFGFSASTGYPH-IQLNCVRSWT 165
                 +  +++LK+ L      GFSA+TGYP  ++ + V SW+
Sbjct: 192 -QTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWS 234

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239

 Score =  119 bits (298), Expect = 9e-31
 Identities = 41/165 (24%), Positives = 70/165 (42%), Gaps = 14/165 (8%)

Query: 4   DPRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGF 63
           +      +   GL F + P  S P       +LG+ N     N +   +A+EFDT    +
Sbjct: 79  EQPYTRPLPADGLVFFMGPTKSKPA--QGYGYLGVFNNSKQDN-SYQTLAVEFDTFSNPW 135

Query: 64  -DPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGET 122
             P   H+G+++NS+ S K  P        L +G    V ++YD  SK++ V +     +
Sbjct: 136 DPPQVPHIGIDVNSIRSIKTQPF------QLDNGQVANVVIKYDAPSKILHVVLV--YPS 187

Query: 123 MPQKPLLKETINLKDYLKPESYFGFSASTGYPH--IQLNCVRSWT 165
                 + E +++K  L      G S +TG      + + V SW+
Sbjct: 188 SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWS 232

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  120 bits (304), Expect = 1e-30
 Identities = 64/312 (20%), Positives = 119/312 (38%), Gaps = 61/312 (19%)

Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIH 299
            ++F E   LG+G FG V K    +     +D+   A+KK      K     L+E+ ++ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKAR--NA----LDSRYYAIKKIRHTEEKLS-TILSEVMLLA 57

Query: 300 RLRHKHLVHLVG-WCHE------------KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNW 346
            L H+++V     W               K  L +  ++  NG+L   +   SE +    
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQR 115

Query: 347 NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
           +  +++   +  A+ Y+   + Q ++HRDLK  NI +D   N ++GDFGLA+ +    + 
Sbjct: 116 DEYWRLFRQILEALSYI---HSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172

Query: 407 YAEHGLVGVP---------GTMGYVAPE-CFHTGKATPESDVFGFGAVVLEVVCGRSPGN 456
                              GT  YVA E    TG    + D++  G +  E++   S G 
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM 232

Query: 457 MIPH-----QQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPI 511
              +     +  +                          ++ +   K+++ L +    P 
Sbjct: 233 ERVNILKKLRSVSIEFPPDFD------------------DNKMKVEKKIIRLLI-DHDP- 272

Query: 512 ASERPKTEDILQ 523
            ++RP    +L 
Sbjct: 273 -NKRPGARTLLN 283

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  120 bits (302), Expect = 2e-30
 Identities = 71/289 (24%), Positives = 107/289 (37%), Gaps = 49/289 (16%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAIIH 299
           +F    RLG G +G V+K      +    D    AVK+        K     LAE+    
Sbjct: 58  SFQRLSRLGHGSYGEVFKVR--SKE----DGRLYAVKRSMSPFRGPKDRARKLAEVGSHE 111

Query: 300 RL-RHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGT--SEQVTLNWNHRYKILT 354
           ++ +H   V L     E G L L  +     SL+++   +G    E     +      L 
Sbjct: 112 KVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGY------LR 164

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
               A+ +L   + Q +VH D+K +NI L      +LGDFGL   +        +     
Sbjct: 165 DTLLALAHL---HSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---- 217

Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML 474
             G   Y+APE    G     +DVF  G  +LEV C        PH         W  + 
Sbjct: 218 --GDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMEL----PHGGE-----GWQQL- 264

Query: 475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
            R+G++       L   S   E + +L++      P    R   E +L 
Sbjct: 265 -RQGYLPPEFTAGL---S--SELRSVLVM---MLEPDPKLRATAEALLA 304

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  120 bits (302), Expect = 4e-30
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 27/221 (12%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK--FSRDSIKSKGDFLAELAII 298
             +    ++GEG FG           +   D  Q  +K+   SR S K + +   E+A++
Sbjct: 24  EKYVRLQKIGEGSFGKAILV------KSTEDGRQYVIKEINISRMSSKEREESRREVAVL 77

Query: 299 HRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGT-----SEQVTLNWNHRYKIL 353
             ++H ++V       E G L +V D+   G L K +         E   L+W       
Sbjct: 78  ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------F 131

Query: 354 TGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLV 413
             +  A+ ++    D+K++HRD+K+ NI L  D   +LGDFG+AR + +     A    +
Sbjct: 132 VQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-VELA-RACI 186

Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           G P    Y++PE         +SD++  G V+ E+   +  
Sbjct: 187 GTP---YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  118 bits (299), Expect = 5e-30
 Identities = 54/233 (23%), Positives = 101/233 (43%), Gaps = 40/233 (17%)

Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK---FSRDSIKSK 288
            ++  KK          +G G F  VY+           D   +A+KK   F     K++
Sbjct: 33  NFRIEKK----------IGRGQFSEVYRAA--CLL----DGVPVALKKVQIFDLMDAKAR 76

Query: 289 GDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGT-------SEQ 341
            D + E+ ++ +L H +++       E  +L +V +    G L + +           E+
Sbjct: 77  ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPER 136

Query: 342 VTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIE 401
               +         + SA+ ++     ++V+HRD+K +N+ + A    +LGD GL R   
Sbjct: 137 TVWKY------FVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187

Query: 402 NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           ++  + A H LVG P    Y++PE  H      +SD++  G ++ E+   +SP
Sbjct: 188 SK-TTAA-HSLVGTP---YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  118 bits (297), Expect = 1e-29
 Identities = 50/254 (19%), Positives = 107/254 (42%), Gaps = 35/254 (13%)

Query: 216 HHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQI 275
           HH+   + L      F+   +K     +    ++G GG   V++ +       +      
Sbjct: 5   HHHSSGVDLGTENLYFQSMSVKG--RIYSILKQIGSGGSSKVFQVL-------NEKKQIY 55

Query: 276 AVKKFSRDSIKSKG--DFLAELAIIHRLRHK--HLVHLVGWCHEKGKLLLVYDFMPNGSL 331
           A+K  + +   ++    +  E+A +++L+     ++ L  +      + +V +   N  L
Sbjct: 56  AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDL 114

Query: 332 EKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL 391
             +L    ++ +++   R      +  AV+ +   +   +VH DLK +N L+  D   +L
Sbjct: 115 NSWL---KKKKSIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIV-DGMLKL 167

Query: 392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF-----------HTGKATPESDVFG 440
            DFG+A  ++ +  S  +   V   GT+ Y+ PE                K +P+SDV+ 
Sbjct: 168 IDFGIANQMQPDTTSVVKDSQV---GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 224

Query: 441 FGAVVLEVVCGRSP 454
            G ++  +  G++P
Sbjct: 225 LGCILYYMTYGKTP 238

>2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 Length = 234

 Score =  115 bits (288), Expect = 2e-29
 Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 16/162 (9%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGF---DPD 66
                G  F IAP D+     + G +LG+ N+  + +K    VA+EFDT           
Sbjct: 77  YNVADGFTFFIAPVDT--KPQTGGGYLGVFNS-AEYDKTTQTVAVEFDTFYNAAWDPSNR 133

Query: 67  DNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQK 126
           D H+G+++NS+ S             L +G    V + ++  + ++ V +     ++ ++
Sbjct: 134 DRHIGIDVNSIKSVNTKSW------KLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEE 187

Query: 127 ---PLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWT 165
                L + ++LKD +      GFSA+TG      + V SW+
Sbjct: 188 VTSYTLSDVVSLKDVVPEWVRIGFSATTG-AEYAAHEVLSWS 228

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  115 bits (291), Expect = 3e-29
 Identities = 55/242 (22%), Positives = 101/242 (41%), Gaps = 41/242 (16%)

Query: 227 MP-REFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK--FSRD 283
           MP R   Y+ L            +G G +G   K       +   D   +  K+  +   
Sbjct: 1   MPSRAEDYEVLYT----------IGTGSYGRCQKI------RRKSDGKILVWKELDYGSM 44

Query: 284 SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK--GKLLLVYDFMPNGSLEKYLYGT--- 338
           +   K   ++E+ ++  L+H ++V       ++    L +V ++   G L   +      
Sbjct: 45  TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE 104

Query: 339 ----SEQVTLNWNHRYKILTGVASAVYYL--QNEYDQKVVHRDLKASNILLDADFNARLG 392
                E+  L        +T +  A+     +++    V+HRDLK +N+ LD   N +LG
Sbjct: 105 RQYLDEEFVLRV------MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158

Query: 393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGR 452
           DFGLAR + ++  S+A    VG P    Y++PE  +      +SD++  G ++ E+    
Sbjct: 159 DFGLARILNHD-TSFA-KTFVGTP---YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213

Query: 453 SP 454
            P
Sbjct: 214 PP 215

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  116 bits (293), Expect = 4e-29
 Identities = 48/225 (21%), Positives = 81/225 (36%), Gaps = 33/225 (14%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           +LGEGGF  V         +   D    A+K+      + + +   E  +     H +++
Sbjct: 36  KLGEGGFSYVDLV------EGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 308 HLVGWCHE----KGKLLLVYDFMPNGSLEKYLYGT-------SEQVTLNWNHRYKILTGV 356
            LV +C      K +  L+  F   G+L   +          +E   L       +L G+
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL------WLLLGI 143

Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP 416
              +  +   + +   HRDLK +NILL  +    L D G             +   +   
Sbjct: 144 CRGLEAI---HAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200

Query: 417 ----GTMGYVAPECFHT---GKATPESDVFGFGAVVLEVVCGRSP 454
                T+ Y APE F           +DV+  G V+  ++ G  P
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238

 Score =  114 bits (285), Expect = 5e-29
 Identities = 42/166 (25%), Positives = 75/166 (45%), Gaps = 18/166 (10%)

Query: 4   DPRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGF 63
               A+     GL F + P +S  P+   G  LG+        + ++  A+EFDT +  +
Sbjct: 78  TQPYAYPEPADGLTFFMVPPNS--PQGEDGGNLGVFK----PPEGDNAFAVEFDTFQNTW 131

Query: 64  DPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETM 123
           DP   H+G+++NS+VS K +         L +G    V ++YD  +K++ V +      +
Sbjct: 132 DPQVPHIGIDVNSIVSSKTLHF------QLENGGVANVVIKYDSPTKILNVVLAFHS--V 183

Query: 124 PQKPLLKETINLKDYL--KPESYFGFSASTGYPH--IQLNCVRSWT 165
                L   ++LK           G SA+TGY    ++ + + SW+
Sbjct: 184 GTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWS 229

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  120 bits (303), Expect = 6e-29
 Identities = 62/235 (26%), Positives = 96/235 (40%), Gaps = 41/235 (17%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVD-NTQIAVKKFSRDSIKSKGDFLA-ELAIIHRLRHKH 305
           RLG GGFG V + I       H D   Q+A+K+  ++      +    E+ I+ +L H +
Sbjct: 21  RLGTGGFGYVLRWI-------HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73

Query: 306 LVHLV------GWCHEKGKLLLVYDFMPNGSLEKYL------YGTSEQVTLNWNHRYKIL 353
           +V                  LL  ++   G L KYL       G  E           +L
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR------TLL 127

Query: 354 TGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR---LGDFGLARAIENERNSYAEH 410
           + ++SA+ YL   ++ +++HRDLK  NI+L          + D G A+ ++         
Sbjct: 128 SDISSALRYL---HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ------GE 178

Query: 411 GLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP--GNMIPHQQH 463
                 GT+ Y+APE     K T   D + FG +  E + G  P   N  P Q H
Sbjct: 179 LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH 233

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  115 bits (289), Expect = 1e-28
 Identities = 59/303 (19%), Positives = 109/303 (35%), Gaps = 48/303 (15%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS-RDSIKSKGDFLAELAIIH 299
            +F     LG GGFG+V++       +  VD+   A+K+    +   ++   + E+  + 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEA------KNKVDDCNYAIKRIRLPNRELAREKVMREVKALA 58

Query: 300 RLRHKHLVHLVGWCHEK------------GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWN 347
           +L H  +V       EK              L +        +L+ ++ G         +
Sbjct: 59  KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118

Query: 348 HRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY 407
               I   +A AV +L   + + ++HRDLK SNI    D   ++GDFGL  A++ +    
Sbjct: 119 VCLHIFLQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175

Query: 408 AEHGLVGVP-------GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPH 460
                +          GT  Y++PE  H    + + D+F  G ++ E++   S       
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVR 235

Query: 461 QQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTED 520
                          R         Q+            ++        P   ERP+  +
Sbjct: 236 ----------TLTDVRNLKFPPLFTQKY------PCEYVMV---QDMLSPSPMERPEAIN 276

Query: 521 ILQ 523
           I++
Sbjct: 277 IIE 279

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  115 bits (290), Expect = 1e-28
 Identities = 45/221 (20%), Positives = 96/221 (43%), Gaps = 33/221 (14%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAIIHRLRHK-- 304
           +G GG   V++ +       +      A+K  + +   ++    +  E+A +++L+    
Sbjct: 17  IGSGGSSKVFQVL-------NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
            ++ L  +      + +V +   N  L  +L    ++ +++   R      +  AV+ + 
Sbjct: 70  KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI- 124

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
             +   +VH DLK +N L+  D   +L DFG+A  ++ +  S  +   V   GT+ Y+ P
Sbjct: 125 --HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV---GTVNYMPP 178

Query: 425 ECF-----------HTGKATPESDVFGFGAVVLEVVCGRSP 454
           E                K +P+SDV+  G ++  +  G++P
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  114 bits (288), Expect = 2e-28
 Identities = 54/223 (24%), Positives = 86/223 (38%), Gaps = 32/223 (14%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVD-NTQIAVKKFSRDSIKSKGDFLA-ELAIIHRLRHKH 305
            LG+G    V++G        H       A+K F+  S     D    E  ++ +L HK+
Sbjct: 16  ILGQGATANVFRGR-------HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 306 LVHL--VGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYL 363
           +V L  +         +L+ +F P GSL   L   S    L  +    +L  V   + +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 364 QNEYDQKVVHRDLKASNILL----DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
               +  +VHR++K  NI+     D     +L DFG AR +E++         V + GT 
Sbjct: 129 ---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ------FVSLYGTE 179

Query: 420 GYVAPE--------CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            Y+ P+          H  K     D++  G        G  P
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  113 bits (286), Expect = 2e-28
 Identities = 66/312 (21%), Positives = 123/312 (39%), Gaps = 76/312 (24%)

Query: 237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK--FSRDSIKSKGDFLAE 294
           K+   +F E   +G GGFG V+K    H     +D     +K+  ++ +  +       E
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAK--HR----IDGKTYVIKRVKYNNEKAER------E 54

Query: 295 LAIIHRLRHKHLVHLVG----------------WCHEKGKLLLVYDFMPNGSLEKYLYGT 338
           +  + +L H ++VH  G                   +   L +  +F   G+LE+++   
Sbjct: 55  VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114

Query: 339 -----SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD 393
                 + + L           +   V Y+   + +K+++RDLK SNI L      ++GD
Sbjct: 115 RGEKLDKVLALEL------FEQITKGVDYI---HSKKLINRDLKPSNIFLVDTKQVKIGD 165

Query: 394 FGLARAIEN--ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCG 451
           FGL  +++N  +R            GT+ Y++PE   +     E D++  G ++ E++  
Sbjct: 166 FGLVTSLKNDGKRTRSK--------GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV 217

Query: 452 RSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPI 511
                    +          +   R+G I D  D++           + LL  L    P 
Sbjct: 218 CDT----AFETSK------FFTDLRDGIISDIFDKKE----------KTLLQKLLSKKP- 256

Query: 512 ASERPKTEDILQ 523
             +RP T +IL+
Sbjct: 257 -EDRPNTSEILR 267

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  114 bits (287), Expect = 5e-28
 Identities = 34/241 (14%), Positives = 70/241 (29%), Gaps = 20/241 (8%)

Query: 227 MPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK 286
           +P      E +  +   +    LGEG F  VY+     +     +  +  +K     +  
Sbjct: 51  LPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEAT-QGDLNDAKNKQKFVLKVQKPANPW 109

Query: 287 SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTL 344
                   +  +        +        +   +LV +    G+L   +  Y  + +  +
Sbjct: 110 EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVM 169

Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL-----------DADFNARLGD 393
                      +   +  +    D +++H D+K  N +L           D      L D
Sbjct: 170 PQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226

Query: 394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRS 453
            G +  ++                T G+   E         + D FG  A V  ++ G  
Sbjct: 227 LGQSIDMKLFPKG---TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283

Query: 454 P 454
            
Sbjct: 284 M 284

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  114 bits (288), Expect = 6e-28
 Identities = 44/221 (19%), Positives = 95/221 (42%), Gaps = 33/221 (14%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK--GDFLAELAIIHRLRHK-- 304
           +G GG   V++ +       +      A+K  + +   ++    +  E+A +++L+    
Sbjct: 64  IGSGGSSKVFQVL-------NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
            ++ L  +      + +V +   N  L  +L    ++ +++   R      +  AV+ + 
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI- 171

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
             +   +VH DLK +N L+  D   +L DFG+A  ++ +  S  +   V   G + Y+ P
Sbjct: 172 --HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV---GAVNYMPP 225

Query: 425 ECF-----------HTGKATPESDVFGFGAVVLEVVCGRSP 454
           E                K +P+SDV+  G ++  +  G++P
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226

 Score =  110 bits (276), Expect = 7e-28
 Identities = 40/158 (25%), Positives = 72/158 (45%), Gaps = 18/158 (11%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNH 69
           + S +GLAF + P  S P     G++LGL N  T+ ++  H VA+ FDT         N 
Sbjct: 79  ENSAYGLAFALVPVGSRPK--LKGRYLGLFNT-TNYDRDAHTVAVVFDT-------VSNR 128

Query: 70  LGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLL 129
           + +++NS+            N   ++G    V + YD     ++V +     +  +K  +
Sbjct: 129 IEIDVNSIRPIATESC----NFGHNNGEKAEVRITYDSPKNDLRVSLL--YPSSEEKCHV 182

Query: 130 KETINLKDYLKPESYFGFSASTGYPH--IQLNCVRSWT 165
             T+ L+  ++     GFSA++G      + + V SW+
Sbjct: 183 SATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWS 220

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240

 Score =  110 bits (276), Expect = 1e-27
 Identities = 37/158 (23%), Positives = 64/158 (40%), Gaps = 18/158 (11%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNH 69
            IS +GLAF + P +S  P     ++LG+ N   +       VA+ F+T K   D D N 
Sbjct: 81  SISAYGLAFALVPVNS--PPQKKQEFLGIFNT-NNPEPNARTVAVVFNTFKNRIDFDKNF 137

Query: 70  LGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLL 129
           +   +N                   +G    V + YD  +  ++VF+         K  +
Sbjct: 138 IKPYVNENCD-----------FHKYNGEKTDVQITYDSSNNDLRVFLH--FTVSQVKCSV 184

Query: 130 KETINLKDYLKPESYFGFSASTGYPH--IQLNCVRSWT 165
             T++L+  +      GFS ++G      + + V SW+
Sbjct: 185 SATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWS 222

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  112 bits (282), Expect = 2e-27
 Identities = 36/311 (11%), Positives = 74/311 (23%), Gaps = 62/311 (19%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELAIIHRLRHK 304
            L  G   +V+        +        A+K F+  +  S+ +            RL  +
Sbjct: 69  PLRVGDRSVVFLVRDVERLE------DFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 305 HLVHLVGWCH-----------------------EKGKLLLVYDFMP--NGSLEKYL---- 335
                                            +   +      MP  +  LE       
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 336 YGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG 395
           +    +        + +   +      LQ    + +VH      N+ +  D    LGD  
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVS 239

Query: 396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA--TPESDVFGFGAVVLEVVCGRS 453
               +     + +          + Y   E  +   A  T   + +  G  +  V C   
Sbjct: 240 ALWKVGTRGPASS--------VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291

Query: 454 P-GNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIA 512
           P G + P  + ++                           + D  K  L+          
Sbjct: 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTP-------LPDFVKT-LIGRFLNFDR-- 341

Query: 513 SERPKTEDILQ 523
             R    + ++
Sbjct: 342 RRRLLPLEAME 352

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  113 bits (284), Expect = 2e-27
 Identities = 52/222 (23%), Positives = 85/222 (38%), Gaps = 32/222 (14%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVD-NTQIAVKKFSRDSIKSKGDFLA-ELAIIHRLRHKHL 306
           LG+G    V++G        H       A+K F+  S     D    E  ++ +L HK++
Sbjct: 17  LGQGATANVFRGR-------HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 307 VHL--VGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
           V L  +         +L+ +F P GSL   L   S    L  +    +L  V   + +L 
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL- 128

Query: 365 NEYDQKVVHRDLKASNILL----DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
              +  +VHR++K  NI+     D     +L DFG AR +E++         V + GT  
Sbjct: 129 --RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ------FVSLYGTEE 180

Query: 421 YVAPECFHTGKA--------TPESDVFGFGAVVLEVVCGRSP 454
           Y+ P+ +                 D++  G        G  P
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  110 bits (278), Expect = 2e-27
 Identities = 65/286 (22%), Positives = 108/286 (37%), Gaps = 46/286 (16%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK--GDFLAELAIIHRLRHKH 305
            +G G F  VYKG+    D       ++A  +     +       F  E  ++  L+H +
Sbjct: 33  EIGRGSFKTVYKGL----DT--ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86

Query: 306 LVHLVG----WCHEKGKLLLVYDFMPNGSLEKYL--YGT-SEQVTLNWNHRYKILTGVAS 358
           +V            K  ++LV + M +G+L+ YL  +     +V  +W    +IL G+  
Sbjct: 87  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR--QILKGLQ- 143

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDA-DFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
              +L       ++HRDLK  NI +     + ++GD GLA                 V G
Sbjct: 144 ---FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-------AVIG 192

Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE 477
           T  ++APE +   K     DV+ FG  +LE+     P +   +    Y  V         
Sbjct: 193 TPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV-------TS 244

Query: 478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
           G    + D+         E K ++     C      ER   +D+L 
Sbjct: 245 GVKPASFDKVAI-----PEVKEIIEG---CIRQNKDERYSIKDLLN 282

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  110 bits (278), Expect = 6e-27
 Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 28/213 (13%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKFSRDSIKSKGD---FLAELAIIHRLRHK 304
           LG+GGF   ++           D  ++ A K   +  +           E++I   L H+
Sbjct: 49  LGKGGFAKCFEIS-------DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGT-SEQVTLNWNHRYKILTGVASAVY 361
           H+V   G+  +   + +V +     SL +        +E        RY  L  +     
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----RY-YLRQIVLGCQ 155

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGY 421
           YL      +V+HRDLK  N+ L+ D   ++GDFGLA  +E +           + GT  Y
Sbjct: 156 YLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-----KKVLCGTPNY 207

Query: 422 VAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +APE       + E DV+  G ++  ++ G+ P
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237

 Score =  108 bits (269), Expect = 8e-27
 Identities = 30/134 (22%), Positives = 52/134 (38%), Gaps = 12/134 (8%)

Query: 48  ANHFVAIEFDTVK--QGFDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQY 105
           A+  VA+E DT       DP   H+G++I SV S+K           + +G   T  + Y
Sbjct: 1   ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW------NMQNGKVGTAHIIY 54

Query: 106 DGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWT 165
           +   K +   +            +   ++L + L      G SASTG  + + N + SW+
Sbjct: 55  NSVDKRLSAVVSYPN---ADSATVSYDVDLDNVLPEWVRVGLSASTG-LYKETNTILSWS 110

Query: 166 LDIDVIQTKKEKDW 179
               +      +  
Sbjct: 111 FTSKLKSNSTHETN 124

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237

 Score = 43.3 bits (101), Expect = 1e-04
 Identities = 12/30 (40%), Positives = 15/30 (50%)

Query: 12  SGHGLAFVIAPNDSFPPESSYGQWLGLTNA 41
              G+AF I+  DS  P  S G+ LGL   
Sbjct: 206 PADGIAFFISNIDSSIPSGSTGRLLGLFPD 235

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  110 bits (276), Expect = 9e-27
 Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 26/212 (12%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDN-TQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHL 306
           R+G G FG V++               Q AVKK   +  + +     EL     L    +
Sbjct: 65  RVGRGSFGEVHRMK-------DKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRI 112

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGT-SEQVTLNWNHRYKILTGVASAVYYL 363
           V L G   E   + +  + +  GSL + +   G   E   L +    + L G+     YL
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYL--GQALEGLE----YL 166

Query: 364 QNEYDQKVVHRDLKASNILLDAD-FNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
              + ++++H D+KA N+LL +D   A L DFG A  ++ +    +      +PGT  ++
Sbjct: 167 ---HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223

Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           APE         + D++    ++L ++ G  P
Sbjct: 224 APEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  109 bits (274), Expect = 9e-27
 Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 28/213 (13%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKFSRDSIKSKGD---FLAELAIIHRLRHK 304
           LG+GGF   ++           D  ++ A K   +  +           E++I   L H+
Sbjct: 23  LGKGGFAKCFEIS-------DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGT-SEQVTLNWNHRYKILTGVASAVY 361
           H+V   G+  +   + +V +     SL +        +E        RY  L  +     
Sbjct: 76  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----RY-YLRQIVLGCQ 129

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGY 421
           YL      +V+HRDLK  N+ L+ D   ++GDFGLA  +E +           + GT  Y
Sbjct: 130 YLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-----KKVLCGTPNY 181

Query: 422 VAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +APE       + E DV+  G ++  ++ G+ P
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 133

 Score =  103 bits (257), Expect = 3e-26
 Identities = 39/142 (27%), Positives = 60/142 (42%), Gaps = 18/142 (12%)

Query: 49  NHFVAIEFDTVK--QGFDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYD 106
           ++ VA+EFDT       DP+  H+G+++NS+ S+              +G   T  + Y+
Sbjct: 1   SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKWD------WQNGKIATAHISYN 54

Query: 107 GKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSW-- 164
             SK + V     G    +   L   I L   L      G SASTG    + N V SW  
Sbjct: 55  SVSKRLSVTSYYAG---SKPATLSYDIELHTVLPEWVRVGLSASTG-QDKERNTVHSWSF 110

Query: 165 --TLDIDVIQTKKEKDWKWLVI 184
             +L  +    KKE + K++  
Sbjct: 111 TSSLWTN--VAKKENENKYITR 130

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  108 bits (272), Expect = 3e-26
 Identities = 60/317 (18%), Positives = 111/317 (35%), Gaps = 52/317 (16%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-HKHLV 307
           L EGGF  VY+       Q      + A+K+   +  +     + E+  + +L  H ++V
Sbjct: 36  LAEGGFAFVYEA------QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 308 HLVGWC--------HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASA 359
                           + + LL+ +    G L ++L     +  L+ +   KI      A
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTEL-CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP--- 416
           V ++  +    ++HRDLK  N+LL      +L DFG A  I +  +         +    
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 417 ----GTMGYVAPECFHTGK---ATPESDVFGFGAVVLEVVCGRSP---GNMIPHQQHAYT 466
                T  Y  PE            + D++  G ++  +   + P   G  +      Y+
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYS 267

Query: 467 LVDWV-----------WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASER 515
           +                ML          ++RL+I  VV + +      +A +  +  + 
Sbjct: 268 IPPHDTQYTVFHSLIRAMLQVN------PEERLSIAEVVHQLQE-----IAAARNVNPKS 316

Query: 516 PKTEDILQIISGTSTVP 532
           P TE + Q     S   
Sbjct: 317 PITELLEQNGGYGSATL 333

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  104 bits (262), Expect = 5e-25
 Identities = 51/214 (23%), Positives = 86/214 (40%), Gaps = 32/214 (14%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH 308
           LG G F  V+                 A+K   +           E+A++ +++H+++V 
Sbjct: 17  LGSGAFSEVFLVK--QRL----TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 309 LVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVASAVYYL 363
           L           LV   +  G L     E+ +Y  +E+          ++  V SAV YL
Sbjct: 71  LEDIYESTTHYYLVMQLVSGGELFDRILERGVY--TEKDA------SLVIQQVLSAVKYL 122

Query: 364 QNEYDQKVVHRDLKASNILL---DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
              ++  +VHRDLK  N+L    + +    + DFGL++  +N         +    GT G
Sbjct: 123 ---HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-------MSTACGTPG 172

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           YVAPE       +   D +  G +   ++CG  P
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  104 bits (261), Expect = 5e-25
 Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 31/216 (14%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQ-IAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           LG+G +GIVY G         + N   IA+K+      +       E+A+   L+HK++V
Sbjct: 30  LGKGTYGIVYAGR-------DLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV 82

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYL---YGT---SEQVTLNWNHRYKILTGVASAVY 361
             +G   E G + +  + +P GSL   L   +G    +EQ    +    +IL G+     
Sbjct: 83  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT--KQILEGLK---- 136

Query: 362 YLQNEYDQKVVHRDLKASNILLDA-DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
           YL   +D ++VHRD+K  N+L++      ++ DFG ++ +                GT+ 
Sbjct: 137 YL---HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC-----TETFTGTLQ 188

Query: 421 YVAPECFHTGK--ATPESDVFGFGAVVLEVVCGRSP 454
           Y+APE    G       +D++  G  ++E+  G+ P
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  106 bits (265), Expect = 9e-25
 Identities = 48/215 (22%), Positives = 84/215 (39%), Gaps = 27/215 (12%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLV 307
           LG G  G +    +        DN  +AVK+   +          E+ ++     H +++
Sbjct: 32  LGHGAEGTIVYRGMF-------DNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVI 81

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
                  ++    +  +     +L++Y+    +           +L    S + +L   +
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHL---H 135

Query: 368 DQKVVHRDLKASNILL-----DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
              +VHRDLK  NIL+          A + DFGL + +   R+S++     GVPGT G++
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR--RSGVPGTEGWI 193

Query: 423 APE---CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           APE          T   D+F  G V   V+   S 
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  102 bits (257), Expect = 1e-24
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 21/210 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELAIIHRLRHKH 305
           LG+G F  VY+     +    V     A+K   + ++   G       E+ I  +L+H  
Sbjct: 19  LGKGSFAGVYRAE-SIHTGLEV-----AIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           ++ L  +  +   + LV +   NG + +YL    +  + N    +  +  + + + YL  
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIITGMLYL-- 128

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            +   ++HRDL  SN+LL  + N ++ DFGLA  ++             + GT  Y++PE
Sbjct: 129 -HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK-----HYTLCGTPNYISPE 182

Query: 426 CFHTGKA-TPESDVFGFGAVVLEVVCGRSP 454
              T  A   ESDV+  G +   ++ GR P
Sbjct: 183 IA-TRSAHGLESDVWSLGCMFYTLLIGRPP 211

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  101 bits (255), Expect = 2e-24
 Identities = 48/209 (22%), Positives = 95/209 (45%), Gaps = 22/209 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAIIHRLRHKH 305
           LG+G FG VY      +         +A+K   +  ++  G       E+ I   LRH +
Sbjct: 17  LGKGKFGNVYLAREKQSKFI------LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           ++ L G+ H+  ++ L+ ++ P G++ + L    +    +       +T +A+A+ Y   
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC-- 125

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
            + ++V+HRD+K  N+LL +    ++ DFG +    + R          + GT+ Y+ PE
Sbjct: 126 -HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-------RTDLCGTLDYLPPE 177

Query: 426 CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                    + D++  G +  E + G+ P
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  104 bits (261), Expect = 5e-24
 Identities = 63/234 (26%), Positives = 100/234 (42%), Gaps = 39/234 (16%)

Query: 236 LKKATNNFHE----SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD- 290
           ++ +T  F +       LG+G FG V                + AVK  S+  +K K D 
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCK--DKI----TGQECAVKVISKRQVKQKTDK 70

Query: 291 --FLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVT 343
              L E+ ++ +L H +++ L  +  +KG   LV +    G L      +  +  SE   
Sbjct: 71  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVDA 128

Query: 344 LNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL---DADFNARLGDFGLARAI 400
                  +I+  V S + Y+      K+VHRDLK  N+LL     D N R+ DFGL+   
Sbjct: 129 ------ARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179

Query: 401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           E  +       +    GT  Y+APE  H G    + DV+  G ++  ++ G  P
Sbjct: 180 EASKK------MKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  101 bits (253), Expect = 1e-23
 Identities = 48/234 (20%), Positives = 101/234 (43%), Gaps = 49/234 (20%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA--------------- 293
           L +G F  +       ++++       A+KK+ +  ++ K DF                 
Sbjct: 39  LNQGKFNKIILCE--KDNKF------YALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90

Query: 294 --ELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYK 351
             EL II  +++++ +   G      ++ ++Y++M N S+ K+         L+ N+   
Sbjct: 91  KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD---EYFFVLDKNYTCF 147

Query: 352 ILTGVA--------SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE 403
           I   V         ++  Y+ NE +  + HRD+K SNIL+D +   +L DFG +  + ++
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205

Query: 404 RNSYAEHGLVGVPGTMGYVAPECFHTGKAT---PESDVFGFGAVVLEVVCGRSP 454
           +       + G  GT  ++ PE F + +++    + D++  G  +  +     P
Sbjct: 206 K-------IKGSRGTYEFMPPEFF-SNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  100 bits (251), Expect = 1e-23
 Identities = 49/218 (22%), Positives = 91/218 (41%), Gaps = 30/218 (13%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVD-NTQIAVKKFSRDSIKSKGDFLA----ELAIIHRLRH 303
           LGEG +G V + +         +   + AVK   +  ++   +  A    E+ ++ RLRH
Sbjct: 13  LGEGSYGKVKEVL-------DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 304 KHLVHL--VGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRY--KILTGVASA 359
           K+++ L  V +  EK K+ +V ++   G  E       ++  +   H Y  +++      
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI----DG 121

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
           + YL +   Q +VH+D+K  N+LL      ++   G+A A+             G P   
Sbjct: 122 LEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP--- 175

Query: 420 GYVAPECFHTGK--ATPESDVFGFGAVVLEV-VCGRSP 454
            +  PE  +     +  + D++  G V L     G  P
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAG-VTLYNITTGLYP 212

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  100 bits (250), Expect = 1e-23
 Identities = 59/308 (19%), Positives = 98/308 (31%), Gaps = 62/308 (20%)

Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK--FSRDSIKSKGDFLAELAI 297
           T  FHE  ++G G FG V+K +         D    A+K+          + + L E+  
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCV--KRL----DGCIYAIKRSKKPLAGSVDEQNALREVYA 63

Query: 298 IHRL-RHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL-YGTSEQVTLNWNHRYKILTG 355
              L +H H+V       E   +L+  ++   GSL   +                 +L  
Sbjct: 64  HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123

Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDAD-------------------FNARLGDFGL 396
           V   + Y+   +   +VH D+K SNI +                         ++GD G 
Sbjct: 124 VGRGLRYI---HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSPG 455
              I +              G   ++A E         P++D+F     V+         
Sbjct: 181 VTRISS-PQVEE--------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL- 230

Query: 456 NMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASER 515
              P            W   R+G +   + Q L   S   E   LL +     HP    R
Sbjct: 231 ---PRNGDQ-------WHEIRQGRLPR-IPQVL---S--QEFTELLKV---MIHPDPERR 271

Query: 516 PKTEDILQ 523
           P    +++
Sbjct: 272 PSAMALVK 279

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  102 bits (256), Expect = 2e-23
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 36/218 (16%)

Query: 249 LGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAIIHRLRHKH 305
           LG+G F +V + + +    +Y       A    +   + ++       E  I   L+H +
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEY-------AAMIINTKKLSARDHQKLEREARICRLLKHPN 71

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVASAV 360
           +V L     E+G   L++D +  G L      +  Y  SE            +  +  AV
Sbjct: 72  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYY--SEADA------SHCIQQILEAV 123

Query: 361 YYLQNEYDQKVVHRDLKASNILL---DADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
            +    +   VVHR+LK  N+LL         +L DFGLA  +E E     +    G  G
Sbjct: 124 LHC---HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-----QQAWFGFAG 175

Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSP 454
           T GY++PE           D++  G V+L + + G  P
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACG-VILYILLVGYPP 212

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  102 bits (254), Expect = 2e-23
 Identities = 32/245 (13%), Positives = 56/245 (22%), Gaps = 51/245 (20%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELAIIHRLRH- 303
            LG+       +       +         V                   E+  +  LR  
Sbjct: 85  VLGQEDPYAYLEATDQETGE------SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138

Query: 304 -----------------------KHLVHLVGWCHEKGKLLLVYDFMP-----NGSLEKYL 335
                                  K  +  V        +L  +   P       +  + L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198

Query: 336 YG-TSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDF 394
              +S   +L  + R ++   V   +  L       +VH  L+  +I+LD      L  F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGF 255

Query: 395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECF-----HTGKATPESDVFGFGAVVLEVV 449
                 +              P      A         H    T   D +  G  +  + 
Sbjct: 256 EHLVR-DGASAVSPIGRGFAPP---ETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311

Query: 450 CGRSP 454
           C   P
Sbjct: 312 CADLP 316

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  102 bits (257), Expect = 2e-23
 Identities = 55/233 (23%), Positives = 94/233 (40%), Gaps = 38/233 (16%)

Query: 236 LKKATNNFHE----SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK--G 289
           +     +  E      +LG G +G V              + + A+K   + S+ +    
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCR--DKV----THVERAIKIIRKTSVSTSSNS 81

Query: 290 DFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTL 344
             L E+A++  L H +++ L  +  +K    LV +    G L      +  +  +E    
Sbjct: 82  KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF--NEVDAA 139

Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL---DADFNARLGDFGLARAIE 401
                  I+  V S V YL       +VHRDLK  N+LL   + D   ++ DFGL+   E
Sbjct: 140 ------VIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190

Query: 402 NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           N++       +    GT  Y+APE     K   + DV+  G ++  ++ G  P
Sbjct: 191 NQKK------MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP 236

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 99.2 bits (248), Expect = 2e-23
 Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 28/212 (13%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELAIIHRLRHKH 305
           LG+G FG VY      N         +A+K   +  ++ +G       E+ I   LRH +
Sbjct: 22  LGKGKFGNVYLAREKQNKFI------MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGT---SEQVTLNWNHRYKILTGVASAVYY 362
           ++ +  + H++ ++ L+ +F P G L K L       EQ +      +  +  +A A++Y
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS----ATF--MEELADALHY 129

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
               +++KV+HRD+K  N+L+      ++ DFG +    + R          + GT+ Y+
Sbjct: 130 C---HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-------RRTMCGTLDYL 179

Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            PE         + D++  G +  E + G  P
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 98.0 bits (245), Expect = 4e-23
 Identities = 55/215 (25%), Positives = 83/215 (38%), Gaps = 34/215 (15%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH 308
           +G G +G V                + A KK  +  ++    F  E+ I+  L H +++ 
Sbjct: 17  IGRGSWGEVKIA------VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70

Query: 309 LVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVASAVYYL 363
           L     +   + LV +    G L      K ++   E          +I+  V SAV Y 
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVF--RESDA------ARIMKDVLSAVAYC 122

Query: 364 QNEYDQKVVHRDLKASNILL---DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
              +   V HRDLK  N L      D   +L DFGLA   +          +    GT  
Sbjct: 123 ---HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP------GKMMRTKVGTPY 173

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSP 454
           YV+P+    G   PE D +  G V++ V +CG  P
Sbjct: 174 YVSPQVLE-GLYGPECDEWSAG-VMMYVLLCGYPP 206

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 99.6 bits (248), Expect = 5e-23
 Identities = 57/342 (16%), Positives = 105/342 (30%), Gaps = 81/342 (23%)

Query: 241 NNFHESMRLGEGGFGIVY-------------KGIIHHNDQYHVDNTQIAVKKFSR----- 282
            +F     +G GGFG+V+             K I   N +   +     VK  ++     
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 283 ----------------------------------DSIKSKGDFLAELAIIHRLRHKHLVH 308
                                              S         ++  +     K+ V 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 309 LVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYD 368
            +     K  L +        +L+ ++                I   +A AV +L   + 
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL---HS 182

Query: 369 QKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP-------GTMGY 421
           + ++HRDLK SNI    D   ++GDFGL  A++ +         +          GT  Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 422 VAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQ 481
           ++PE  H    + + D+F  G ++ E++   S                 +    R     
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR----------IITDVRNLKFP 292

Query: 482 DAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
               Q+        +   ++        P  +ERP+  DI++
Sbjct: 293 LLFTQK------YPQEHMMVQD---MLSPSPTERPEATDIIE 325

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 99.7 bits (249), Expect = 5e-23
 Identities = 56/217 (25%), Positives = 89/217 (41%), Gaps = 27/217 (12%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH 308
           +G+G F +V + I +           + V KF+     S  D   E +I H L+H H+V 
Sbjct: 32  IGKGPFSVVRRCI-NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 309 LVGWCHEKGKLLLVYDFMPNGSL-------EKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
           L+      G L +V++FM    L           +  SE V          +  +  A+ 
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA------SHYMRQILEALR 144

Query: 362 YLQNEYDQKVVHRDLKASNILL---DADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           Y    +D  ++HRD+K   +LL   +     +LG FG+A  +          G VG P  
Sbjct: 145 YC---HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGTP-- 197

Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
             ++APE           DV+G G V+L ++  G  P
Sbjct: 198 -HFMAPEVVKREPYGKPVDVWGCG-VILFILLSGCLP 232

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 99.3 bits (248), Expect = 6e-23
 Identities = 61/236 (25%), Positives = 97/236 (41%), Gaps = 42/236 (17%)

Query: 234 KELKKATNNFHE----SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG 289
           ++L + +  F +       +G G + +  + I  H       N + AVK       KSK 
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCI--HKA----TNMEFAVKIID----KSKR 60

Query: 290 DFLAELAIIHRL-RHKHLVHLVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVT 343
           D   E+ I+ R  +H +++ L     +   + +V + M  G L      +  +  SE+  
Sbjct: 61  DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF--SEREA 118

Query: 344 LNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL-DADFNA---RLGDFGLARA 399
                   +L  +   V YL   + Q VVHRDLK SNIL  D   N    R+ DFG A+ 
Sbjct: 119 ------SAVLFTITKTVEYL---HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169

Query: 400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
           +  E        L+    T  +VAPE           D++  G V+L  +  G +P
Sbjct: 170 LRAE-----NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLG-VLLYTMLTGYTP 219

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 98.1 bits (245), Expect = 7e-23
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAIIHRLRHKHL 306
           LG+G FG V K       Q      + AVK  ++ S K+K     L E+ ++ +L H ++
Sbjct: 30  LGKGSFGEVLKCKDRITQQ------EYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
           + L     +     +V +    G L     ++  +  SE          +I+  V S + 
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF--SEHDA------ARIIKQVFSGIT 135

Query: 362 YLQNEYDQKVVHRDLKASNILL---DADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           Y+       +VHRDLK  NILL   + D + ++ DFGL+   +          +    GT
Sbjct: 136 YMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK------MKDRIGT 186

Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
             Y+APE    G    + DV+  G V+L ++  G  P
Sbjct: 187 AYYIAPEVLR-GTYDEKCDVWSAG-VILYILLSGTPP 221

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 98.4 bits (245), Expect = 1e-22
 Identities = 47/247 (19%), Positives = 94/247 (38%), Gaps = 46/247 (18%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH 308
           +G+G +G+V   I  +  +       +   K  + + K       E+ ++ +L H ++  
Sbjct: 34  IGQGSYGVVRVAI-ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92

Query: 309 LVGWCHEKGKLLLVYDFMPNGSL-------------------------------EKYLYG 337
           L     ++  + LV +    G L                               E+ + G
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152

Query: 338 TSEQVTLNWNHRY------KILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL 391
           +      + +          I+  + SA++YL   ++Q + HRD+K  N L   + +  +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYL---HNQGICHRDIKPENFLFSTNKSFEI 209

Query: 392 --GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA--TPESDVFGFGAVVLE 447
              DFGL++      N    +G+    GT  +VAPE  +T      P+ D +  G ++  
Sbjct: 210 KLVDFGLSKEFYKLNNG-EYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268

Query: 448 VVCGRSP 454
           ++ G  P
Sbjct: 269 LLMGAVP 275

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  101 bits (252), Expect = 1e-22
 Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 28/222 (12%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAE--- 294
           N+F     +G GGFG VY        + +      A+K   +  IK K      L E   
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMY------AMKCLDKKRIKMKQGETLALNERIM 242

Query: 295 LAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILT 354
           L+++       +V +    H   KL  + D M  G L  +L     Q  +      +   
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYA 298

Query: 355 G-VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLV 413
             +   + ++ N   + VV+RDLK +NILLD   + R+ D GLA     ++     H  V
Sbjct: 299 AEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASV 351

Query: 414 GVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSP 454
              GT GY+APE    G A    +D F  G ++ +++ G SP
Sbjct: 352 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 99.1 bits (247), Expect = 1e-22
 Identities = 56/219 (25%), Positives = 90/219 (41%), Gaps = 36/219 (16%)

Query: 227 MPREFKYK---ELKKATNNFH-ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR 282
           M  +FK K   E ++  + F  E  ++G G +G VYK           D+   A+K+   
Sbjct: 3   MDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDG----KDDKDYALKQIEG 58

Query: 283 DSIKSKGDFLAELAIIHRLRHKHLVHL--VGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE 340
             I        E+A++  L+H +++ L  V   H   K+ L++D+  +  L   +     
Sbjct: 59  TGISMSA--CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRA 115

Query: 341 QVTLNWNHR----------YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
                   +          Y+IL G+     YL   +   V+HRDLK +NIL+  +   R
Sbjct: 116 SKANKKPVQLPRGMVKSLLYQILDGIH----YL---HANWVLHRDLKPANILVMGEGPER 168

Query: 391 ----LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
               + D G AR   +     A+   V V  T  Y APE
Sbjct: 169 GRVKIADMGFARLFNSPLKPLADLDPVVV--TFWYRAPE 205

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 98.0 bits (244), Expect = 2e-22
 Identities = 59/275 (21%), Positives = 111/275 (40%), Gaps = 23/275 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK-GDFLAELAIIHRLRHKHL 306
            LG G  G+V+K    H          +A K    +   +     + EL ++H     ++
Sbjct: 40  ELGAGNGGVVFKVS--HKP----SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
           V   G  +  G++ +  + M  GSL++ L    +   +      K+   V   + YL+ +
Sbjct: 94  VGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREK 150

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN-ERNSYAEHGLVGVPGTMGYVAPE 425
           +  K++HRD+K SNIL+++    +L DFG++  + +   NS+         GT  Y++PE
Sbjct: 151 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--------GTRSYMSPE 200

Query: 426 CFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVD 485
                  + +SD++  G  ++E+  GR P      ++        V     E   +    
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260

Query: 486 QRLNINSVVDEAKRLLLLGLACSHPIASERPKTED 520
            R      +D    + +  L     I +E P    
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLDY--IVNEPPPKLP 293

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 99.4 bits (248), Expect = 2e-22
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 34/216 (15%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAIIHRLRHKHL 306
           LG+G FG V K              + AVK  ++ S K+K     L E+ ++ +L H ++
Sbjct: 30  LGKGSFGEVLKCK--DRI----TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
           + L     +     +V +    G L     ++  +  SE          +I+  V S + 
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF--SEHDAA------RIIKQVFSGIT 135

Query: 362 YLQNEYDQKVVHRDLKASNILL---DADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           Y+       +VHRDLK  NILL   + D + ++ DFGL+   +          +    GT
Sbjct: 136 YMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK------MKDRIGT 186

Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             Y+APE    G    + DV+  G ++  ++ G  P
Sbjct: 187 AYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 50/218 (22%), Positives = 87/218 (39%), Gaps = 37/218 (16%)

Query: 249 LGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAIIHRLRHKH 305
           LG+G F +V + +      ++       A K  +   + ++       E  I  +L+H +
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEF-------AAKIINTKKLSARDFQKLEREARICRKLQHPN 66

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVASAV 360
           +V L     E+    LV+D +  G L      +  Y  SE            +  +  ++
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY--SEADA------SHCIQQILESI 118

Query: 361 YYLQNEYDQKVVHRDLKASNILL---DADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
            Y    +   +VHR+LK  N+LL         +L DFGLA  + +           G  G
Sbjct: 119 AYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND------SEAWHGFAG 169

Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
           T GY++PE       +   D++  G V+L ++  G  P
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACG-VILYILLVGYPP 206

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 99.9 bits (249), Expect = 2e-22
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 19/230 (8%)

Query: 230 EFKYKELKKAT-NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK 288
           ++K+ E +    + F +   LG GGFG V+   +    + +      A KK ++  +K +
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLY------ACKKLNKKRLKKR 226

Query: 289 GDF---LAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN 345
             +   + E  I+ ++  + +V L      K  L LV   M  G +  ++Y   E     
Sbjct: 227 KGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF 286

Query: 346 WNHRYKILTG-VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
              R    T  + S + +L     + +++RDLK  N+LLD D N R+ D GLA   E + 
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKA 341

Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                 G     GT G++APE     +     D F  G  + E++  R P
Sbjct: 342 GQTKTKGYA---GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223

 Score = 94.4 bits (234), Expect = 3e-22
 Identities = 27/174 (15%), Positives = 61/174 (35%), Gaps = 27/174 (15%)

Query: 1   MWRDPRPAWDISGHGLA-------FVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVA 53
            +  P    D +   +A         I        +++    L               V 
Sbjct: 44  FYSAPIQIRDSTTGNVASFDTNFTMNIRT----HRQANSAVGLDFVLVPVQPESKGDTVT 99

Query: 54  IEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQ 113
           +EFDT         + + +++N+   +        +++   DG +  V + Y+  +K+  
Sbjct: 100 VEFDTFL-------SRISIDVNNNDIKSV-----PWDVHDYDGQNAEVRITYNSSTKVFS 147

Query: 114 VFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTG--YPHIQLNCVRSWT 165
           V +     +  +   +  T+ L+  +      GFSA++G      + + V SW+
Sbjct: 148 VSLS--NPSTGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWS 199

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 98.7 bits (246), Expect = 3e-22
 Identities = 48/231 (20%), Positives = 85/231 (36%), Gaps = 40/231 (17%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLV 307
           LG G  G V         Q       +AVK+   D        L E+ ++     H +++
Sbjct: 23  LGYGSSGTVVF-------QGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVI 72

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRY--KILTGVASAVYYL 363
                      L +  +   N +L+  +     S++            +L  +AS V +L
Sbjct: 73  RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131

Query: 364 QNEYDQKVVHRDLKASNILLD-------------ADFNARLGDFGLARAIENERNSYAEH 410
              +  K++HRDLK  NIL+               +    + DFGL + +++ ++S+  +
Sbjct: 132 ---HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188

Query: 411 GLVGVPGTMGYVAPECF-------HTGKATPESDVFGFGAVVLEVVCGRSP 454
            L    GT G+ APE            + T   D+F  G V   ++     
Sbjct: 189 -LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 35/217 (16%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK--GDFLAELAIIHRLRHKHL 306
           LG+G F +V + +  H         + A K  +   + ++       E  I  +L+H ++
Sbjct: 37  LGKGAFSVVRRCV--HKT----TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
           V L     E+    LV+D +  G L      +  Y  SE            +  +  ++ 
Sbjct: 91  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY--SEADA------SHCIQQILESIA 142

Query: 362 YLQNEYDQKVVHRDLKASNILL---DADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           Y    +   +VHR+LK  N+LL         +L DFGLA  + +           G  GT
Sbjct: 143 YC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND------SEAWHGFAGT 193

Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
            GY++PE       +   D++  G V+L ++  G  P
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACG-VILYILLVGYPP 229

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 95.8 bits (239), Expect = 7e-22
 Identities = 60/252 (23%), Positives = 105/252 (41%), Gaps = 41/252 (16%)

Query: 212 VAEPHHNLGKLRLPGMPREF-----KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHND 266
           +   HH+       G    +     KY+ L            +GEG +G+V K       
Sbjct: 1   MGHHHHHHSSGVDLGTENLYFQSMEKYENLGL----------VGEGSYGMVMKCR----- 45

Query: 267 QYHVDNTQI-AVKKFSRDSIKSKGDFLA--ELAIIHRLRHKHLVHLVGWCHEKGKLLLVY 323
             + D  +I A+KKF           +A  E+ ++ +LRH++LV+L+  C +K +  LV+
Sbjct: 46  --NKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103

Query: 324 DFMPNGSLEKYLYGTSEQVTLNW--NHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNI 381
           +F+ + ++   L      +       + ++I+ G+     +    +   ++HRD+K  NI
Sbjct: 104 EFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIG----FC---HSHNIIHRDIKPENI 155

Query: 382 LLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE-CFHTGKATPESDVFG 440
           L+      +L DFG AR +      Y    +     T  Y APE      K     DV+ 
Sbjct: 156 LVSQSGVVKLCDFGFARTLAAPGEVYD-DEVA----TRWYRAPELLVGDVKYGKAVDVWA 210

Query: 441 FGAVVLEVVCGR 452
            G +V E+  G 
Sbjct: 211 IGCLVTEMFMGE 222

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 95.3 bits (238), Expect = 7e-22
 Identities = 47/198 (23%), Positives = 86/198 (43%), Gaps = 33/198 (16%)

Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF 291
           KY+++ K          +GEG +G+V+K       Q       +A+KKF           
Sbjct: 4   KYEKIGK----------IGEGSYGVVFKCRNRDTGQI------VAIKKFLESEDDPVIKK 47

Query: 292 LA--ELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNW--N 347
           +A  E+ ++ +L+H +LV+L+     K +L LV+++  + ++   L      V  +   +
Sbjct: 48  IALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKS 106

Query: 348 HRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY 407
             ++ L  V     +    +    +HRD+K  NIL+      +L DFG AR +    + Y
Sbjct: 107 ITWQTLQAVN----FC---HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159

Query: 408 AEHGLVGVPGTMGYVAPE 425
               +     T  Y +PE
Sbjct: 160 D-DEVA----TRWYRSPE 172

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 97.8 bits (244), Expect = 9e-22
 Identities = 52/244 (21%), Positives = 93/244 (38%), Gaps = 49/244 (20%)

Query: 236 LKKATNNFHE----SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG-- 289
           ++K      E      +LG G +G V        +     +++ A+K   +         
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCK--EKN----GHSEKAIKVIKKSQFDKGRYS 80

Query: 290 -----------DFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSL-----EK 333
                      +   E++++  L H +++ L     +K    LV +F   G L      +
Sbjct: 81  DDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR 140

Query: 334 YLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL---DADFNAR 390
           + +   E           I+  + S + YL       +VHRD+K  NILL   ++  N +
Sbjct: 141 HKF--DECDAA------NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK 189

Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC 450
           + DFGL+     +        L    GT  Y+APE     K   + DV+  G ++  ++C
Sbjct: 190 IVDFGLSSFFSKDYK------LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLC 242

Query: 451 GRSP 454
           G  P
Sbjct: 243 GYPP 246

>2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* Length = 181

 Score = 92.0 bits (228), Expect = 9e-22
 Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 12/110 (10%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQ-GFDPD-- 66
                G  F IAP D+     + G +LG+ N+  + +K    VA+EFDT     +DP   
Sbjct: 77  YNVADGFTFFIAPVDT--KPQTGGGYLGVFNS-AEYDKTTQTVAVEFDTFYNAAWDPSNR 133

Query: 67  DNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFM 116
           D H+G+++NS+ S             L +G    V + ++  + ++ V +
Sbjct: 134 DRHIGIDVNSIKSVNTKSW------KLQNGEEANVVIAFNAATNVLTVSL 177

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 95.5 bits (238), Expect = 1e-21
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 35/215 (16%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH 308
           LG G   IVY+       + +      A+K   +     K     E+ ++ RL H +++ 
Sbjct: 61  LGRGATSIVYRCKQKGTQKPY------ALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIK 112

Query: 309 LVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVASAVYYL 363
           L        ++ LV + +  G L     EK  Y  SE+           +  +  AV YL
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYY--SERDA------ADAVKQILEAVAYL 164

Query: 364 QNEYDQKVVHRDLKASNILL---DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
              ++  +VHRDLK  N+L      D   ++ DFGL++ +E++        +  V GT G
Sbjct: 165 ---HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL------MKTVCGTPG 215

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSP 454
           Y APE        PE D++  G ++  ++ CG  P
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVG-IITYILLCGFEP 249

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 97.2 bits (242), Expect = 2e-21
 Identities = 63/230 (27%), Positives = 102/230 (44%), Gaps = 22/230 (9%)

Query: 230 EFKYKELKKAT-NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK 288
           ++K+ E +  T N F +   LG+GGFG V    +    + +      A KK  +  IK +
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMY------ACKKLEKKRIKKR 225

Query: 289 GDF---LAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN 345
                 L E  I+ ++  + +V L      K  L LV   M  G L+ ++Y   +     
Sbjct: 226 KGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE 285

Query: 346 WNHRYKILTG-VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
              R       +   +  L     +++V+RDLK  NILLD   + R+ D GLA  +   +
Sbjct: 286 --ARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340

Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                 G V   GT+GY+APE     + T   D +  G ++ E++ G+SP
Sbjct: 341 TI---KGRV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 95.5 bits (237), Expect = 2e-21
 Identities = 32/252 (12%), Positives = 60/252 (23%), Gaps = 64/252 (25%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHV-DNTQIAVKKFSRDSIKSKGD---------------- 290
            LG+       +                  V                             
Sbjct: 80  VLGQEDPYAYLEAT-------DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 132

Query: 291 ------------FLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFM-PNGSL----EK 333
                       F+    ++   + K ++ +     +   L   + +     +L    E 
Sbjct: 133 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 192

Query: 334 YLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD 393
            L  +S   +L  + R ++   V   +  L       +VH  L+  +I+LD      L  
Sbjct: 193 LLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTG 249

Query: 394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECF-----------HTGKATPESDVFGFG 442
           F           S           + G+  PE                  T   D +  G
Sbjct: 250 FEHLVRDGARVVS---------SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300

Query: 443 AVVLEVVCGRSP 454
            V+  + C   P
Sbjct: 301 LVIYWIWCADLP 312

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 93.7 bits (234), Expect = 2e-21
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 24/212 (11%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA--ELAIIHRLRHKH 305
           ++GEG +G V+K       +       +A+K+   D         A  E+ ++  L+HK+
Sbjct: 9   KIGEGTYGTVFKAKNRETHEI------VALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRY--KILTGVASAVYYL 363
           +V L    H   KL LV++F     L+KY    +  +       +  ++L G+     + 
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLG----FC 117

Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
              + + V+HRDLK  N+L++ +   +L +FGLARA       Y+   +V    T+ Y  
Sbjct: 118 ---HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS-AEVV----TLWYRP 169

Query: 424 PE-CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           P+  F     +   D++  G +  E+     P
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 43/189 (22%), Positives = 87/189 (46%), Gaps = 30/189 (15%)

Query: 249 LGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-HKHL 306
           LGEG    V   I +  + +Y       AVK   +     +     E+ ++++ + H+++
Sbjct: 21  LGEGAHARVQTCINLITSQEY-------AVKIIEKQPGHIRSRVFREVEMLYQCQGHRNV 73

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
           + L+ +  E+ +  LV++ M  GS+     ++  +  +E           ++  VASA+ 
Sbjct: 74  LELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHF--NELEA------SVVVQDVASALD 125

Query: 362 YLQNEYDQKVVHRDLKASNILL---DADFNARLGDFGLARAIE--NERNSYAEHGLVGVP 416
           +L   +++ + HRDLK  NIL    +     ++ DF L   I+   + +  +   L+   
Sbjct: 126 FL---HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182

Query: 417 GTMGYVAPE 425
           G+  Y+APE
Sbjct: 183 GSAEYMAPE 191

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 48/212 (22%), Positives = 90/212 (42%), Gaps = 23/212 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLAELAIIHRLRHKHLV 307
           LG G FG V+      +        +  +K  ++D  +       AE+ ++  L H +++
Sbjct: 30  LGSGAFGDVHLVEERSSGL------ERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSL-EKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
            +     +   + +V +    G L E+ +   +    L+  +  +++  + +A+ Y    
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH-- 141

Query: 367 YDQKVVHRDLKASNILL---DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
             Q VVH+DLK  NIL          ++ DFGLA   +++ +           GT  Y+A
Sbjct: 142 -SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH------STNAAGTALYMA 194

Query: 424 PECFHTGKATPESDVFGFGAVVLEV-VCGRSP 454
           PE F     T + D++  G VV+   + G  P
Sbjct: 195 PEVFK-RDVTFKCDIWSAG-VVMYFLLTGCLP 224

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 58/218 (26%), Positives = 83/218 (38%), Gaps = 35/218 (16%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVK----KFSRDSIKSKGDFLA----ELAIIH 299
            +G GG G VY+          V    +A+K      S D       F      E     
Sbjct: 41  LVGRGGMGDVYEA--ED----TVRERIVALKLMSETLSSDP-----VFRTRMQREARTAG 89

Query: 300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASA 359
           RL+  H+V +  +    G+L +    +    L   L     Q  L       I+  + SA
Sbjct: 90  RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSA 146

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG---VP 416
              L   +     HRD+K  NIL+ AD  A L DFG+A A         +  L       
Sbjct: 147 ---LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASAT-------TDEKLTQLGNTV 196

Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           GT+ Y+APE F    AT  +D++    V+ E + G  P
Sbjct: 197 GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 93.2 bits (232), Expect = 5e-21
 Identities = 62/243 (25%), Positives = 101/243 (41%), Gaps = 30/243 (12%)

Query: 221 KLRLPGMPREFKYKELKKATNN------FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQ 274
             +   +  E     L+   +           +++GEG  GIV      H+ +      Q
Sbjct: 19  YFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGR------Q 72

Query: 275 IAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKY 334
           +AVK       + +     E+ I+   +H ++V +        +L ++ +F+  G+L   
Sbjct: 73  VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI 132

Query: 335 LYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDF 394
           +     QV LN      +   V  A+ YL   + Q V+HRD+K+ +ILL  D   +L DF
Sbjct: 133 V----SQVRLNEEQIATVCEAVLQALAYL---HAQGVIHRDIKSDSILLTLDGRVKLSDF 185

Query: 395 GLARAIENE---RNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCG 451
           G    I  +   R S     LVG P  M   APE         E D++  G +V+E+V G
Sbjct: 186 GFCAQISKDVPKRKS-----LVGTPYWM---APEVISRSLYATEVDIWSLGIMVIEMVDG 237

Query: 452 RSP 454
             P
Sbjct: 238 EPP 240

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 92.7 bits (231), Expect = 5e-21
 Identities = 57/209 (27%), Positives = 84/209 (40%), Gaps = 44/209 (21%)

Query: 237 KKATNNFHESMR----LGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSRDSIKS---- 287
             +T+ F+E+      LG G   +V + I      +Y       AVK        S    
Sbjct: 9   SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEY-------AVKIIDVTGGGSFSAE 61

Query: 288 -----KGDFLAELAIIHRL-RHKHLVHLVGWCHEKGKLLLVYDFMPNGSL-----EKYLY 336
                +   L E+ I+ ++  H +++ L           LV+D M  G L     EK   
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121

Query: 337 GTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL 396
             SE+ T       KI+  +   +  L   +   +VHRDLK  NILLD D N +L DFG 
Sbjct: 122 --SEKET------RKIMRALLEVICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFGF 170

Query: 397 ARAIENERNSYAEHGLVGVPGTMGYVAPE 425
           +  ++          L  V GT  Y+APE
Sbjct: 171 SCQLDP------GEKLREVCGTPSYLAPE 193

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 92.7 bits (231), Expect = 5e-21
 Identities = 61/225 (27%), Positives = 93/225 (41%), Gaps = 26/225 (11%)

Query: 237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LA 293
           KK   +F     LGEG F  V         + +      A+K   +  I  +        
Sbjct: 26  KKRPEDFKFGKILGEGSFSTVVLARELATSREY------AIKILEKRHIIKENKVPYVTR 79

Query: 294 ELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGT---SEQVTLNWNHRY 350
           E  ++ RL H   V L     +  KL     +  NG L KY+       E  T       
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------- 132

Query: 351 KILTG-VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
           +  T  + SA+ YL   + + ++HRDLK  NILL+ D + ++ DFG A+ +  E      
Sbjct: 133 RFYTAEIVSALEYL---HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189

Query: 410 HGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           +  V   GT  YV+PE      A   SD++  G ++ ++V G  P
Sbjct: 190 NSFV---GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 94.0 bits (234), Expect = 6e-21
 Identities = 50/263 (19%), Positives = 103/263 (39%), Gaps = 39/263 (14%)

Query: 206 KKRRSRVAEPHHNLGKLRLPGMPREFKYKELKKATNNFHE----SMRLGEGGFGIVYKGI 261
            K R +   P  N        + +++  + ++    + ++       LG G FG+V++ +
Sbjct: 12  SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71

Query: 262 -IHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL 320
                  +         K  +      K     E++I+++L H  L++L     +K +++
Sbjct: 72  EKATGRVF-------VAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124

Query: 321 LVYDFMPNGSL------EKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHR 374
           L+ +F+  G L      E Y    SE   +N       +      + ++   ++  +VH 
Sbjct: 125 LILEFLSGGELFDRIAAEDYKM--SEAEVIN------YMRQACEGLKHM---HEHSIVHL 173

Query: 375 DLKASNILLDADFNARL--GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA 432
           D+K  NI+ +    + +   DFGLA  +  +        +     T  + APE       
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDEI------VKVTTATAEFAAPEIVDREPV 227

Query: 433 TPESDVFGFGAVVLEV-VCGRSP 454
              +D++  G V+  V + G SP
Sbjct: 228 GFYTDMWAIG-VLGYVLLSGLSP 249

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 93.2 bits (232), Expect = 7e-21
 Identities = 51/258 (19%), Positives = 90/258 (34%), Gaps = 49/258 (18%)

Query: 215 PHHNLGKLRLPGMPREFKYKELKKATNNFHE-----SMRLGEGGFGIVYKGIIHHNDQYH 269
            HH+           E  ++  +       +        LG G  G V +    H     
Sbjct: 2   AHHH----HHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECF--HRR--- 52

Query: 270 VDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHLVGWC----HEKGKLLLVYD 324
               + A+K      +        E+    +     H+V ++       H K  LL++ +
Sbjct: 53  -TGQKCALK-----LLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME 106

Query: 325 FMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKAS 379
            M  G L     E+     +E+         +I+  + +A+ +L   +   + HRD+K  
Sbjct: 107 CMEGGELFSRIQERGDQAFTEREA------AEIMRDIGTAIQFL---HSHNIAHRDVKPE 157

Query: 380 NILL---DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES 436
           N+L    + D   +L DFG A+             L     T  YVAPE     K     
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKETTQNA-------LQTPCYTPYYVAPEVLGPEKYDKSC 210

Query: 437 DVFGFGAVVLEVVCGRSP 454
           D++  G ++  ++CG  P
Sbjct: 211 DMWSLGVIMYILLCGFPP 228

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 93.6 bits (233), Expect = 7e-21
 Identities = 53/191 (27%), Positives = 80/191 (41%), Gaps = 37/191 (19%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA--------ELAIIHR 300
           +G G   +V + +  H         + AVK     + +   + L         E  I+ +
Sbjct: 102 IGRGVSSVVRRCV--HRA----TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 301 LR-HKHLVHLVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILT 354
           +  H H++ L+        + LV+D M  G L     EK     SE+ T        I+ 
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL--SEKET------RSIMR 207

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
            +  AV +L   +   +VHRDLK  NILLD +   RL DFG +  +E          L  
Sbjct: 208 SLLEAVSFL---HANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP------GEKLRE 258

Query: 415 VPGTMGYVAPE 425
           + GT GY+APE
Sbjct: 259 LCGTPGYLAPE 269

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 92.2 bits (230), Expect = 8e-21
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 30/212 (14%)

Query: 216 HHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQI 275
           HH+ G+  L       KY++L+K          +GEG +G+VYK               +
Sbjct: 6   HHSSGRENLYFQGLMEKYQKLEK----------VGEGTYGVVYKAK-------DSQGRIV 48

Query: 276 AVKKFSRDSIKSKGDFLA--ELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEK 333
           A+K+   D+        A  E++++  L H ++V L+   H +  L LV++FM    L+K
Sbjct: 49  ALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKK 107

Query: 334 YLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD 393
            L     +  L  +     L  +   V +    +  +++HRDLK  N+L+++D   +L D
Sbjct: 108 VL--DENKTGLQDSQIKIYLYQLLRGVAHC---HQHRILHRDLKPQNLLINSDGALKLAD 162

Query: 394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
           FGLARA      SY  H +V    T+ Y AP+
Sbjct: 163 FGLARAFGIPVRSYT-HEVV----TLWYRAPD 189

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 49/215 (22%), Positives = 95/215 (44%), Gaps = 29/215 (13%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVK----KFSRDSIKSKGDFLA----ELAIIH 299
           +LG GG   VY       D   + N ++A+K               + L     E+    
Sbjct: 18  KLGGGGMSTVYLAE----D--TILNIKVAIKAIFIPPREKE-----ETLKRFEREVHNSS 66

Query: 300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASA 359
           +L H+++V ++    E     LV +++   +L +Y+        L+ +        +   
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDG 123

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
              +++ +D ++VHRD+K  NIL+D++   ++ DFG+A+A+     +   H L    GT+
Sbjct: 124 ---IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL----GTV 176

Query: 420 GYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            Y +PE          +D++  G V+ E++ G  P
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 91.8 bits (229), Expect = 1e-20
 Identities = 53/184 (28%), Positives = 92/184 (50%), Gaps = 26/184 (14%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA--ELAIIHRLRHKH 305
           ++GEG +G+VYK       +       +A+KK   D+        A  E++++  L H +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEV------VALKKIRLDTETEGVPSTAIREISLLKELNHPN 63

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR----YKILTGVASAVY 361
           +V L+   H + KL LV++F+    L+K++   S    +         +++L G+A    
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD-ASALTGIPLPLIKSYLFQLLQGLA---- 117

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGY 421
           +    +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y  H +V    T+ Y
Sbjct: 118 FC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVV----TLWY 169

Query: 422 VAPE 425
            APE
Sbjct: 170 RAPE 173

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 92.5 bits (230), Expect = 2e-20
 Identities = 55/263 (20%), Positives = 104/263 (39%), Gaps = 39/263 (14%)

Query: 207 KRRSRVAEPHHNLGKLRLPGMPREFKYKELKKATNNFHE------SMRLGEGGFGIVYKG 260
             R  V     +   + +P  P  F ++ +       +       +  LG G FG V+K 
Sbjct: 49  TERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC 108

Query: 261 IIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL 320
                        ++A K      +K K +   E++++++L H +L+ L      K  ++
Sbjct: 109 E--ETA----TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV 162

Query: 321 LVYDFMPNGSL------EKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHR 374
           LV +++  G L      E Y    +E  T+        +  +   + ++   +   ++H 
Sbjct: 163 LVMEYVDGGELFDRIIDESYNL--TELDTIL------FMKQICEGIRHM---HQMYILHL 211

Query: 375 DLKASNILLDADFNARL--GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA 432
           DLK  NIL       ++   DFGLAR  +          L    GT  ++APE  +    
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREK------LKVNFGTPEFLAPEVVNYDFV 265

Query: 433 TPESDVFGFGAVVLEV-VCGRSP 454
           +  +D++  G V+  + + G SP
Sbjct: 266 SFPTDMWSVG-VIAYMLLSGLSP 287

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 34/219 (15%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHV-DNTQIAVKKFSRDSIKSKGDFLA------ELAIIHRL 301
           LG GGFG VY GI        V DN  +A+K   +D I   G+         E+ ++ ++
Sbjct: 51  LGSGGFGSVYSGI-------RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 302 RHK--HLVHLVGWCHEKGKLLLVYDF-MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVAS 358
                 ++ L+ W       +L+ +   P   L  ++   +E+  L           V  
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLE 160

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDAD-FNARLGDFGLARAIENERNSYAEHGLVGVPG 417
           AV +    ++  V+HRD+K  NIL+D +    +L DFG    +++   +  +       G
Sbjct: 161 AVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-------G 210

Query: 418 TMGYVAPECFHTGK-ATPESDVFGFGAVVLEV-VCGRSP 454
           T  Y  PE     +     + V+  G ++L   VCG  P
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLG-ILLYDMVCGDIP 248

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 89.9 bits (224), Expect = 4e-20
 Identities = 53/186 (28%), Positives = 89/186 (47%), Gaps = 32/186 (17%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQ--IAVKKFSRDSIKSKGDFLA--ELAIIHRLRH 303
           ++GEG +G+VYK           +N     A+KK   +            E++I+  L+H
Sbjct: 9   KIGEGTYGVVYKAQ---------NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59

Query: 304 KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR----YKILTGVASA 359
            ++V L    H K +L+LV++ +    L+K L     +  L          ++L G+A  
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIA-- 114

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
             Y    +D++V+HRDLK  N+L++ +   ++ DFGLARA       Y  H +V    T+
Sbjct: 115 --YC---HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIV----TL 164

Query: 420 GYVAPE 425
            Y AP+
Sbjct: 165 WYRAPD 170

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 90.4 bits (225), Expect = 5e-20
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 36/216 (16%)

Query: 249 LGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-HKHL 306
           LGEG F I  K +    N  +       AVK  S+   + + +   E+  +     H ++
Sbjct: 19  LGEGSFSICRKCVHKKSNQAF-------AVKIISK---RMEANTQKEITALKLCEGHPNI 68

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
           V L    H++    LV + +  G L     +K  +  SE           I+  + SAV 
Sbjct: 69  VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHF--SETEA------SYIMRKLVSAVS 120

Query: 362 YLQNEYDQKVVHRDLKASNILL---DADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           ++   +D  VVHRDLK  N+L    + +   ++ DFG AR    +        L     T
Sbjct: 121 HM---HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-----NQPLKTPCFT 172

Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           + Y APE  +        D++  G ++  ++ G+ P
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 92.6 bits (230), Expect = 5e-20
 Identities = 50/258 (19%), Positives = 97/258 (37%), Gaps = 32/258 (12%)

Query: 205 VKKRRSRVAEPHHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHH 264
           V+ + +  +   + +  +     P+  + K      +++     LG G FG+V++     
Sbjct: 122 VRGKGTVSSNYDNYVFDIWKQYYPQPVEIKH-DHVLDHYDIHEELGTGAFGVVHRVT--E 178

Query: 265 NDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYD 324
                      A K         K     E+  +  LRH  LV+L     +  +++++Y+
Sbjct: 179 RA----TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234

Query: 325 FMPNGSL------EKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKA 378
           FM  G L      E      SE   +        +  V   + ++   ++   VH DLK 
Sbjct: 235 FMSGGELFEKVADEHNKM--SEDEAVE------YMRQVCKGLCHM---HENNYVHLDLKP 283

Query: 379 SNILLDADFNARL--GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPES 436
            NI+     +  L   DFGL   ++ +++      +    GT  + APE          +
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLDPKQS------VKVTTGTAEFAAPEVAEGKPVGYYT 337

Query: 437 DVFGFGAVVLEVVCGRSP 454
           D++  G +   ++ G SP
Sbjct: 338 DMWSVGVLSYILLSGLSP 355

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 90.0 bits (224), Expect = 5e-20
 Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 31/219 (14%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVK----KFSRDSIKSKGDFLA----ELAIIH 299
            LG GG   V+       D    D+  +AVK      +RD       F      E     
Sbjct: 19  ILGFGGMSEVHLAR----D--LRDHRDVAVKVLRADLARDP-----SFYLRFRREAQNAA 67

Query: 300 RLRHKHLVHL--VGWCHEKGKLL--LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG 355
            L H  +V +   G        L  +V +++   +L   +     +  +      +++  
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIAD 124

Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
              A   L   +   ++HRD+K +NI++ A    ++ DFG+ARAI +  NS  +     V
Sbjct: 125 ACQA---LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA--V 179

Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            GT  Y++PE          SDV+  G V+ EV+ G  P
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 90.0 bits (224), Expect = 6e-20
 Identities = 45/226 (19%), Positives = 80/226 (35%), Gaps = 45/226 (19%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--------DFLAELAIIHR 300
           LG G  G V                ++A+K  S+               +   E+ I+ +
Sbjct: 18  LGSGACGEVKLAF--ERK----TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 301 LRHKHLVHLVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTG 355
           L H  ++ +  +  +     +V + M  G L             E               
Sbjct: 72  LNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRL--KEATC------KLYFYQ 122

Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILL---DADFNARLGDFGLARAIENERNSYAEHGL 412
           +  AV YL   ++  ++HRDLK  N+LL   + D   ++ DFG ++ +           +
Sbjct: 123 MLLAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE------TSLM 173

Query: 413 VGVPGTMGYVAPECFHTGKA---TPESDVFGFGAVVLEV-VCGRSP 454
             + GT  Y+APE   +          D +  G V+L + + G  P
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VILFICLSGYPP 218

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 90.0 bits (224), Expect = 6e-20
 Identities = 56/219 (25%), Positives = 104/219 (47%), Gaps = 29/219 (13%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD------FLAE 294
             + +  +LGEG +  VYKG     D        +A+K+     I+ + +       + E
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNL------VALKE-----IRLEHEEGAPCTAIRE 50

Query: 295 LAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILT 354
           ++++  L+H ++V L    H +  L LV++++    L++YL        +N ++    L 
Sbjct: 51  VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLF 107

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
            +   + Y    + QKV+HRDLK  N+L++     +L DFGLARA      +Y  + +V 
Sbjct: 108 QLLRGLAYC---HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD-NEVV- 162

Query: 415 VPGTMGYVAPE-CFHTGKATPESDVFGFGAVVLEVVCGR 452
              T+ Y  P+    +   + + D++G G +  E+  GR
Sbjct: 163 ---TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 89.2 bits (222), Expect = 6e-20
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 38/218 (17%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVD-NTQIAVKKFSRDSIKSKGDFLA---ELAIIHRLRHK 304
           LG G FG V  G        H     ++AVK  +R  I+S         E+  +   RH 
Sbjct: 19  LGVGTFGKVKIGE-------HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71

Query: 305 HLVHLVGWCHE----KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
           H++ L    ++         +V +++  G L  Y+    +   +      ++   + SAV
Sbjct: 72  HIIKL----YQVISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILSAV 124

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP-GTM 419
            Y    +   VVHRDLK  N+LLDA  NA++ DFGL+       N  ++   +    G+ 
Sbjct: 125 DYC---HRHMVVHRDLKPENVLLDAHMNAKIADFGLS-------NMMSDGEFLRTSCGSP 174

Query: 420 GYVAPECFHTGK--ATPESDVFGFGAVVLEV-VCGRSP 454
            Y APE   +G+  A PE D++  G V+L   +CG  P
Sbjct: 175 NYAAPEVI-SGRLYAGPEVDIWSCG-VILYALLCGTLP 210

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 89.9 bits (224), Expect = 7e-20
 Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 30/200 (15%)

Query: 235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---F 291
           ++K     + +   LGEG F  VYK    + +Q       +A+KK          D    
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQI------VAIKKIKLGHRSEAKDGINR 57

Query: 292 LA--ELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR 349
            A  E+ ++  L H +++ L+     K  + LV+DFM    LE  +      + L  +H 
Sbjct: 58  TALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLTPSHI 114

Query: 350 ----YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN 405
                  L G+     YL   +   ++HRDLK +N+LLD +   +L DFGLA++  +   
Sbjct: 115 KAYMLMTLQGLE----YL---HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167

Query: 406 SYAEHGLVGVPGTMGYVAPE 425
           +Y  H +V    T  Y APE
Sbjct: 168 AYT-HQVV----TRWYRAPE 182

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 90.9 bits (226), Expect = 8e-20
 Identities = 42/227 (18%), Positives = 80/227 (35%), Gaps = 47/227 (20%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--------DFLAELAIIHR 300
           LG G  G V                ++A++  S+               +   E+ I+ +
Sbjct: 143 LGSGACGEVKLAF--ERK----TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196

Query: 301 LRHKHLVHLVGWCHEKGKLLLVYDFMPNGSL-------EKYLYGTSEQVTLNWNHRYKIL 353
           L H  ++ +  +  +     +V + M  G L       ++      E             
Sbjct: 197 LNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRL----KEATC------KLYF 245

Query: 354 TGVASAVYYLQNEYDQKVVHRDLKASNILL---DADFNARLGDFGLARAIENERNSYAEH 410
             +  AV YL   ++  ++HRDLK  N+LL   + D   ++ DFG ++ +          
Sbjct: 246 YQMLLAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE------TS 296

Query: 411 GLVGVPGTMGYVAPECFHTGKA---TPESDVFGFGAVVLEVVCGRSP 454
            +  + GT  Y+APE   +          D +  G ++   + G  P
Sbjct: 297 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 89.3 bits (222), Expect = 8e-20
 Identities = 47/215 (21%), Positives = 97/215 (45%), Gaps = 24/215 (11%)

Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR 302
           +    ++G+G  G VY  +     Q      ++A+++ +      K   + E+ ++   +
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQ------EVAIRQMNLQQQPKKELIINEILVMRENK 75

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYY 362
           + ++V+ +       +L +V +++  GSL   +     +  ++      +      A+ +
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEF 131

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE---RNSYAEHGLVGVPGTM 419
           L   +  +V+HRD+K+ NILL  D + +L DFG    I  E   R++     +VG P  M
Sbjct: 132 L---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-----MVGTPYWM 183

Query: 420 GYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
              APE        P+ D++  G + +E++ G  P
Sbjct: 184 ---APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 88.8 bits (221), Expect = 9e-20
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 28/217 (12%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKFSRDSIKSK-GDFLAELAIIHRL-RHK 304
            LG G +G+V K         HV + QI AVK+        +    L +L I  R     
Sbjct: 14  ELGRGAYGVVEKMR-------HVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEK-YLYGTSEQVTLNWNHRYKILTGVASAVYYL 363
             V   G    +G + +  + M + SL+K Y     +  T+  +   KI   +  A+ +L
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125

Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN--ERNSYAEHGLVGVPGTMGY 421
            ++    V+HRD+K SN+L++A    ++ DFG++  + +   ++  A        G   Y
Sbjct: 126 HSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--------GCKPY 175

Query: 422 VAPECFHTGKATPE----SDVFGFGAVVLEVVCGRSP 454
           +APE  +           SD++  G  ++E+   R P
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 55/190 (28%), Positives = 96/190 (50%), Gaps = 35/190 (18%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-----IKSKGDFLAELAIIHRLR 302
           +LG G +  VYKG+      Y      +A+K+   DS       +    + E++++  L+
Sbjct: 12  KLGNGTYATVYKGLNKTTGVY------VALKEVKLDSEEGTPSTA----IREISLMKELK 61

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR-------YKILTG 355
           H+++V L    H + KL LV++FM N  L+KY+   +   T             +++L G
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120

Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           +A    +    ++ K++HRDLK  N+L++     +LGDFGLARA     N+++   +V  
Sbjct: 121 LA----FC---HENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFS-SEVV-- 170

Query: 416 PGTMGYVAPE 425
             T+ Y AP+
Sbjct: 171 --TLWYRAPD 178

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 34/219 (15%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHV-DNTQIAVKKFSRDSIKSKGDFLA--------ELAIIH 299
           LG G FG V+  +           N ++ VK   ++ +                E+AI+ 
Sbjct: 32  LGSGAFGFVWTAV-------DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASA 359
           R+ H +++ ++     +G   LV +   +G L+ + +       L+      I   + SA
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAF-IDRHPRLDEPLASYIFRQLVSA 142

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP-GT 418
           V YL+    + ++HRD+K  NI++  DF  +L DFG A              L     GT
Sbjct: 143 VGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSA-------AYLERGKLFYTFCGT 192

Query: 419 MGYVAPECFHTGK--ATPESDVFGFGAVVLEV-VCGRSP 454
           + Y APE    G     PE +++  G V L   V   +P
Sbjct: 193 IEYCAPEVL-MGNPYRGPELEMWSLG-VTLYTLVFEENP 229

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 54/241 (22%), Positives = 95/241 (39%), Gaps = 57/241 (23%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHV-DNTQIAVKKFSRDSIKSKGDFLA-------------- 293
           +G+G +G+V          Y+  DNT  A+K  S+  +  +  F                
Sbjct: 21  IGKGSYGVVKLA-------YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 294 ------------ELAIIHRLRHKHLVHL--VGWCHEKGKLLLVYDFMPNGSLEKYLYGT- 338
                       E+AI+ +L H ++V L  V     +  L +V++ +  G + +      
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133

Query: 339 -SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA 397
            SE     +         +   + YL     QK++HRD+K SN+L+  D + ++ DFG++
Sbjct: 134 LSEDQARFYFQD------LIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS 184

Query: 398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKAT---PESDVFGFGAVVLEV-VCGRS 453
              +       +  L    GT  ++APE     +        DV+  G V L   V G+ 
Sbjct: 185 NEFKGS-----DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMG-VTLYCFVFGQC 238

Query: 454 P 454
           P
Sbjct: 239 P 239

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 51/220 (23%), Positives = 95/220 (43%), Gaps = 27/220 (12%)

Query: 215 PHHNLGKLRLPGMPREFKYKELKKATN--NFHESMRLGEGGFGIVYKGIIHHNDQYHVDN 272
            HH          P          AT+   +    +LGEG +G VYK I    ++     
Sbjct: 6   HHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNET---- 61

Query: 273 TQIAVKKFSRDSIKSKGDFLA--ELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGS 330
             +A+K+   +  +      A  E++++  L+H++++ L    H   +L L++++  N  
Sbjct: 62  --VAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-D 118

Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           L+KY+    +   ++       L  + + V +    + ++ +HRDLK  N+LL     + 
Sbjct: 119 LKKYM---DKNPDVSMRVIKSFLYQLINGVNFC---HSRRCLHRDLKPQNLLLSVSDASE 172

Query: 391 -----LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
                +GDFGLARA       +  H ++    T+ Y  PE
Sbjct: 173 TPVLKIGDFGLARAFGIPIRQFT-HEII----TLWYRPPE 207

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 90.3 bits (224), Expect = 4e-19
 Identities = 43/214 (20%), Positives = 80/214 (37%), Gaps = 32/214 (14%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVK--KFSRDSIKSKGDFLAELAIIHRLRHKH 305
            +  GG G +Y  +    D+ +V+   + +K    S D+ +++   +AE   +  + H  
Sbjct: 87  CIAHGGLGWIYLAL----DR-NVNGRPVVLKGLVHSGDA-EAQAMAMAERQFLAEVVHPS 140

Query: 306 LV--HLVG---WCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
           +V           H      +V +++   SL++          L        L  +  A+
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPAL 195

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            YL   +   +V+ DLK  NI+L  +   +L D G    I N            + GT G
Sbjct: 196 SYL---HSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI-NSFGY--------LYGTPG 242

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           + APE       T  +D++  G  +  +      
Sbjct: 243 FQAPEIV-RTGPTVATDIYTVGRTLAALTLDLPT 275

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 25/216 (11%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKFSRDSIKSK-GDFLAELAIIHRL-RHK 304
            +G G +G V K +       H  + QI AVK+      + +    L +L ++ R     
Sbjct: 29  EIGRGAYGSVNKMV-------HKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTLNWNHRYKILTGVASAVYY 362
           ++V   G    +G   +  + M + S +K+     +     +      KI      A+ +
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
           L+     K++HRD+K SNILLD   N +L DFG++  +    +S A+       G   Y+
Sbjct: 141 LKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDA---GCRPYM 192

Query: 423 APECFHTGKATPE----SDVFGFGAVVLEVVCGRSP 454
           APE      +       SDV+  G  + E+  GR P
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHV-DNTQIAVKKFSRDSIKSKGDFLA------ELAIIHRL 301
           LG+GGFG V+ G         + D  Q+A+K   R+ +              E+A++ ++
Sbjct: 39  LGKGGFGTVFAGH-------RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 302 R----HKHLVHLVGWCHEKGKLLLVYDF-MPNGSLEKYLYGTSEQVTLNWNHRYKILTGV 356
                H  ++ L+ W   +   +LV +  +P   L  Y+   +E+  L           V
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI---TEKGPLGEGPSRCFFGQV 148

Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNA-RLGDFGLARAIENERNSYAEHGLVGV 415
            +A+ +    + + VVHRD+K  NIL+D      +L DFG    + +E  +  +      
Sbjct: 149 VAAIQHC---HSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD------ 199

Query: 416 PGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEV-VCGRSP 454
            GT  Y  PE     +     + V+  G ++L   VCG  P
Sbjct: 200 -GTRVYSPPEWISRHQYHALPATVWSLG-ILLYDMVCGDIP 238

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 87.4 bits (217), Expect = 8e-19
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 26/213 (12%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAIIHRLRHKH 305
           +G+G FG V     +   + +      A+K  ++     + +      EL I+  L H  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMY------AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG-VASAVYYLQ 364
           LV+L     ++  + +V D +  G L  +L    + V        K+    +  A+ YLQ
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFK-EETVKLFICELVMALDYLQ 132

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAP 424
              +Q+++HRD+K  NILLD   +  + DF +A  +  E           + GT  Y+AP
Sbjct: 133 ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT------MAGTKPYMAP 183

Query: 425 ECFHTGKATPES---DVFGFGAVVLEVVCGRSP 454
           E F + K    S   D +  G    E++ GR P
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 87.4 bits (217), Expect = 9e-19
 Identities = 58/247 (23%), Positives = 101/247 (40%), Gaps = 62/247 (25%)

Query: 226 GMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI 285
           G  RE  Y   K           +G G FG+V++          V++ ++A+KK  +D  
Sbjct: 35  GEQREIAYTNCKV----------IGNGSFGVVFQAK-------LVESDEVAIKKVLQD-- 75

Query: 286 KSKGDFLAELAIIHRLRH------KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YG 337
             K     EL I+  ++H      K   +  G   ++  L LV +++P  ++ +    Y 
Sbjct: 76  --KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYA 132

Query: 338 TSEQVTLNWNH----RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA-RLG 392
             +Q T+         Y++L  +A    Y+ +     + HRD+K  N+LLD      +L 
Sbjct: 133 KLKQ-TMPMLLIKLYMYQLLRSLA----YIHS---IGICHRDIKPQNLLLDPPSGVLKLI 184

Query: 393 DFGLARAIENERNSYAEHGLVGVPGTMGYV------APE-CFHTGKATPESDVFGFGAVV 445
           DFG A+             L+     + Y+      APE  F     T   D++  G V+
Sbjct: 185 DFGSAKI------------LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVM 232

Query: 446 LEVVCGR 452
            E++ G+
Sbjct: 233 AELMQGQ 239

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 86.2 bits (214), Expect = 9e-19
 Identities = 50/205 (24%), Positives = 96/205 (46%), Gaps = 25/205 (12%)

Query: 227 MPREFKYKELKKATN---NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD 283
           M +  +Y+ +++  +    +     LG+G FG VYK    + +         A K     
Sbjct: 2   MRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAK--NKE----TGALAAAKVIETK 55

Query: 284 SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVT 343
           S +   D++ E+ I+    H ++V L+G  +  GKL ++ +F P G+++  +        
Sbjct: 56  SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRG 113

Query: 344 LNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA---RAI 400
           L       +   +  A+ +L +   ++++HRDLKA N+L+  + + RL DFG++      
Sbjct: 114 LTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170

Query: 401 ENERNSYAEHGLVGVPGTMGYVAPE 425
             +R+S+     +G P  M   APE
Sbjct: 171 LQKRDSF-----IGTPYWM---APE 187

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 60/217 (27%), Positives = 90/217 (41%), Gaps = 37/217 (17%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVD-NTQIAVKKFSRDSIKSK--GDFLAELAIIHRLRHKH 305
           +G+G F  V           H+    ++A+K   +  +          E+ I+  L H +
Sbjct: 23  IGKGNFAKVKLAR-------HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 306 LVHLVGWCHE----KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
           +V L     E    +  L L+ ++   G +  YL        +           + SAV 
Sbjct: 76  IVKL----FEVIETEKTLYLIMEYASGGEVFDYL---VAHGRMKEKEARSKFRQIVSAVQ 128

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP-GTMG 420
           Y      +++VHRDLKA N+LLDAD N ++ DFG +       N +   G +    G   
Sbjct: 129 YCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFS-------NEFTVGGKLDAFCGAPP 178

Query: 421 YVAPECFHTGK--ATPESDVFGFGAVVLEV-VCGRSP 454
           Y APE F  GK    PE DV+  G V+L   V G  P
Sbjct: 179 YAAPELF-QGKKYDGPEVDVWSLG-VILYTLVSGSLP 213

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 85.3 bits (212), Expect = 1e-18
 Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 40/222 (18%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVK------KFSRDSIKSKGDFLAELAIIHRLR 302
           LG G F IV K              + A K        S     S+ +   E+ I+  +R
Sbjct: 13  LGSGQFAIVRKCR--QKG----TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVA 357
           H +++ L      K  ++L+ + +  G L     EK     +E          + L  + 
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL--TEDEA------TQFLKQIL 118

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILL----DADFNARLGDFGLARAIENERNSYAEHGLV 413
             V+YL   + +++ H DLK  NI+L      +   +L DFG+A  IE            
Sbjct: 119 DGVHYL---HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE------FK 169

Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSP 454
            + GT  +VAPE  +      E+D++  G V+  + + G SP
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASP 210

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 87.5 bits (217), Expect = 2e-18
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 38/218 (17%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVD-NTQIAVKKFSRDSIKSKGDFLA---ELAIIHRLRHK 304
           LG G FG V  G        H     ++AVK  +R  I+S         E+  +   RH 
Sbjct: 24  LGVGTFGKVKVGK-------HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 305 HLVHLVGWCHE----KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
           H++ L    ++       + +V +++  G L  Y+    +   L+     ++   + S V
Sbjct: 77  HIIKL----YQVISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSGV 129

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP-GTM 419
            Y    +   VVHRDLK  N+LLDA  NA++ DFGL+       N  ++   +    G+ 
Sbjct: 130 DYC---HRHMVVHRDLKPENVLLDAHMNAKIADFGLS-------NMMSDGEFLRTSCGSP 179

Query: 420 GYVAPECFHTGK--ATPESDVFGFGAVVLEV-VCGRSP 454
            Y APE   +G+  A PE D++  G V+L   +CG  P
Sbjct: 180 NYAAPEVI-SGRLYAGPEVDIWSSG-VILYALLCGTLP 215

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 49/211 (23%), Positives = 78/211 (36%), Gaps = 23/211 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVD-NTQIAVKKFSRDSIKSKGDFLA-ELAIIHRLRHKHL 306
           LGEG +G V   +       +      +AVK           + +  E+ I   L H+++
Sbjct: 15  LGEGAYGEVQLAV-------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
           V   G   E     L  ++   G L   +      + +      +    + + V YL   
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG- 123

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
               + HRD+K  N+LLD   N ++ DFGLA            + + G      YVAPE 
Sbjct: 124 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL---PYVAPEL 178

Query: 427 FHTGK--ATPESDVFGFGAVVLEV-VCGRSP 454
               +       DV+  G +VL   + G  P
Sbjct: 179 L-KRREFHAEPVDVWSCG-IVLTAMLAGELP 207

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 52/222 (23%), Positives = 92/222 (41%), Gaps = 40/222 (18%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG------DFLAELAIIHRLR 302
           LG G F IV K              + A K   +   ++        +   E++I+ ++ 
Sbjct: 20  LGSGQFAIVKKCR--EKS----TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVA 357
           H +++ L      +  ++L+ + +  G L     +K     SE+   +       +  + 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESL--SEEEATS------FIKQIL 125

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILL-DADFNA---RLGDFGLARAIENERNSYAEHGLV 413
             V YL   + +K+ H DLK  NI+L D +      +L DFGLA  IE+           
Sbjct: 126 DGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE------FK 176

Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSP 454
            + GT  +VAPE  +      E+D++  G V+  + + G SP
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASP 217

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 86.3 bits (214), Expect = 3e-18
 Identities = 62/250 (24%), Positives = 106/250 (42%), Gaps = 61/250 (24%)

Query: 223 RLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR 282
           + P  P+E  Y + K           +G G FG+VY+  +  +         +A+KK  +
Sbjct: 46  QGPDRPQEVSYTDTKV----------IGNGSFGVVYQAKLCDS------GELVAIKKVLQ 89

Query: 283 DSIKSKGDFLAELAIIHRLRH------KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL- 335
           D  + K     EL I+ +L H      ++  +  G   ++  L LV D++P  ++ +   
Sbjct: 90  DK-RFK---NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVAR 144

Query: 336 -YGTSEQVTLNWNH----RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA- 389
            Y  ++Q TL   +     Y++   +A    Y+ +     + HRD+K  N+LLD D    
Sbjct: 145 HYSRAKQ-TLPVIYVKLYMYQLFRSLA----YIHS---FGICHRDIKPQNLLLDPDTAVL 196

Query: 390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYV------APE-CFHTGKATPESDVFGFG 442
           +L DFG A+ +             G P    Y+      APE  F     T   DV+  G
Sbjct: 197 KLCDFGSAKQLVR-----------GEPNV-SYICSRYYRAPELIFGATDYTSSIDVWSAG 244

Query: 443 AVVLEVVCGR 452
            V+ E++ G+
Sbjct: 245 CVLAELLLGQ 254

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 85.5 bits (212), Expect = 4e-18
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 40/222 (18%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG------DFLAELAIIHRLR 302
           LG G F IV K              + A K   +   ++        +   E++I+ ++ 
Sbjct: 20  LGSGQFAIVKKCR--EKS----TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVA 357
           H +++ L      +  ++L+ + +  G L     +K     SE+   +       +  + 
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL--SEEEATS------FIKQIL 125

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILL----DADFNARLGDFGLARAIENERNSYAEHGLV 413
             V YL   + +K+ H DLK  NI+L        + +L DFGLA  IE+           
Sbjct: 126 DGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE------FK 176

Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSP 454
            + GT  +VAPE  +      E+D++  G V+  + + G SP
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASP 217

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 85.6 bits (212), Expect = 4e-18
 Identities = 44/204 (21%), Positives = 77/204 (37%), Gaps = 41/204 (20%)

Query: 249 LGEGGFGIVYKGI-IHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHL 306
           LG G  G V +       +++       A+K      ++       E+ +  R  +  H+
Sbjct: 70  LGLGINGKVLQIFNKRTQEKF-------ALK-----MLQDCPKARREVELHWRASQCPHI 117

Query: 307 VHLVGWCHE----KGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVA 357
           V +V         +  LL+V + +  G L     ++     +E+         +I+  + 
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA------SEIMKSIG 171

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILL-DADFNA--RLGDFGLARAIENERNSYAEHGLVG 414
            A+ YL   +   + HRD+K  N+L      NA  +L DFG A+         + + L  
Sbjct: 172 EAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------SHNSLTT 222

Query: 415 VPGTMGYVAPECFHTGKATPESDV 438
              T  YVAPE     K     D+
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKSCDM 246

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 83.9 bits (208), Expect = 7e-18
 Identities = 49/211 (23%), Positives = 78/211 (36%), Gaps = 23/211 (10%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVD-NTQIAVKKFSRDSIKSKGDFLA-ELAIIHRLRHKHL 306
           LGEG +G V   +       +      +AVK           + +  E+ I   L H+++
Sbjct: 15  LGEGAYGEVQLAV-------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
           V   G   E     L  ++   G L   +      + +      +    + + V YL   
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG- 123

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
               + HRD+K  N+LLD   N ++ DFGLA            + + G      YVAPE 
Sbjct: 124 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL---PYVAPEL 178

Query: 427 FHTGK--ATPESDVFGFGAVVLEV-VCGRSP 454
               +       DV+  G +VL   + G  P
Sbjct: 179 L-KRREFHAEPVDVWSCG-IVLTAMLAGELP 207

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 83.8 bits (208), Expect = 7e-18
 Identities = 41/219 (18%), Positives = 89/219 (40%), Gaps = 42/219 (19%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG----DFLAELAIIHRLRHK 304
           LG G FGIV++ +                K      +K KG        E++I++  RH+
Sbjct: 13  LGRGEFGIVHRCV--ETS----SKKTYMAK-----FVKVKGTDQVLVKKEISILNIARHR 61

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSL------EKYLYGTSEQVTLNWNHRYKILTGVAS 358
           +++HL        +L+++++F+    +        +    +E+  ++       +  V  
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFEL--NEREIVS------YVHQVCE 113

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARL--GDFGLARAIENERNSYAEHGLVGVP 416
           A+ +L   +   + H D++  NI+     ++ +   +FG AR ++   N         + 
Sbjct: 114 ALQFL---HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN------FRLLF 164

Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSP 454
               Y APE       +  +D++  G  ++ V + G +P
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLG-TLVYVLLSGINP 202

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 49/224 (21%), Positives = 88/224 (39%), Gaps = 30/224 (13%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKFSRDSIKSK-GDFLAELAII 298
           N+      +G G  G V+K               + AVK+  R   K +    L +L ++
Sbjct: 25  NDLENLGEMGSGTCGQVWKMR-------FRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77

Query: 299 HRL-RHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
            +     ++V   G       + +  + M   + +           +      K+   + 
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG---PIPERILGKMTVAIV 134

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN--ERNSYAEHGLVGV 415
            A+YYL+ +    V+HRD+K SNILLD     +L DFG++  + +   ++  A       
Sbjct: 135 KALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA------- 185

Query: 416 PGTMGYVAPECFHTGKATPE-----SDVFGFGAVVLEVVCGRSP 454
            G   Y+APE       T       +DV+  G  ++E+  G+ P
Sbjct: 186 -GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 83.8 bits (208), Expect = 1e-17
 Identities = 47/172 (27%), Positives = 86/172 (50%), Gaps = 28/172 (16%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKF----SRDSIKSKGDFLAEL 295
           + + +  ++G+G FG V+K         H    Q  A+KK      ++        L E+
Sbjct: 17  SKYEKLAKIGQGTFGEVFKAR-------HRKTGQKVALKKVLMENEKEGFPITA--LREI 67

Query: 296 AIIHRLRHKHLVHLVGWCHEK--------GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWN 347
            I+  L+H+++V+L+  C  K        G + LV+DF  +  L   L  ++  V    +
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLVKFTLS 124

Query: 348 HRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA 399
              +++  + + +YY+   +  K++HRD+KA+N+L+  D   +L DFGLARA
Sbjct: 125 EIKRVMQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLARA 173

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 27/212 (12%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKFSRDSIKSK-GDFLAELAIIHRLRHKH 305
           ++G+G FG V+KGI            ++ A+K    +  + +  D   E+ ++ +    +
Sbjct: 29  KIGKGSFGEVFKGI-------DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQN 365
           +    G   +  KL ++ +++  GS    L    E   L+      IL  +   + YL +
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS 137

Query: 366 EYDQKVVHRDLKASNILLDADFNARLGDFGLA---RAIENERNSYAEHGLVGVPGTMGYV 422
              +K +HRD+KA+N+LL      +L DFG+A      + +RN++     VG P  M   
Sbjct: 138 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-----VGTPFWM--- 186

Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           APE         ++D++  G   +E+  G  P
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 83.0 bits (205), Expect = 3e-17
 Identities = 52/254 (20%), Positives = 89/254 (35%), Gaps = 38/254 (14%)

Query: 216 HHNLGKLRLPGM----PREFKYKELKKATNNFHESMRLGEG--GFGIVYKGIIHHNDQYH 269
           HH++  L   GM    P    Y+ L            +G+G      V          Y 
Sbjct: 6   HHHMENLYFQGMSSFLPEGGCYELLTV----------IGKGFEDLMTVNLAR------YK 49

Query: 270 VDNTQIAVKKFSRDSIKSKG--DFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMP 327
                + V++ + ++  ++       EL +     H ++V          +L +V  FM 
Sbjct: 50  PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 109

Query: 328 NGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF 387
            GS +  L  T     +N      IL GV  A+ Y+   +    VHR +KAS+IL+  D 
Sbjct: 110 YGSAKD-LICTHFMDGMNELAIAYILQGVLKALDYI---HHMGYVHRSVKASHILISVDG 165

Query: 388 NARLGDFGLARAIENE---RNSYAE--HGLVGVPGTMGYVAPECFHTGKA--TPESDVFG 440
              L       ++ +    +    +     V V   +   +PE           +SD++ 
Sbjct: 166 KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL---SPEVLQQNLQGYDAKSDIYS 222

Query: 441 FGAVVLEVVCGRSP 454
            G    E+  G  P
Sbjct: 223 VGITACELANGHVP 236

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 83.3 bits (206), Expect = 3e-17
 Identities = 54/235 (22%), Positives = 95/235 (40%), Gaps = 23/235 (9%)

Query: 228 PREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS 287
           P   K K+++    +F     +G G FG V    + + D+        A+K  ++  +  
Sbjct: 61  PFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVF------AMKILNKWEMLK 114

Query: 288 KGD---FLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTL 344
           + +   F  E  ++     K +  L     +   L LV D+   G L   L    +++  
Sbjct: 115 RAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPE 174

Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
                Y  L  +  A+  +   +    VHRD+K  NIL+D + + RL DFG    +  + 
Sbjct: 175 EMARFY--LAEMVIAIDSV---HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229

Query: 405 NSYAEHGLVGVPGTMGYVAPE-----CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
              +    V   GT  Y++PE         G+  PE D +  G  + E++ G +P
Sbjct: 230 TVQS-SVAV---GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 61/247 (24%), Positives = 111/247 (44%), Gaps = 33/247 (13%)

Query: 218 NLGKLRLPGMPREFKYKELKKATNN------FHESMRLGEGGFGIVYKGIIHHNDQYHVD 271
           +L  ++L   PR  + K+L + +        F    +LGEG +G VYK    H +     
Sbjct: 1   SLETVQLRNPPRR-QLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKA--IHKE----T 53

Query: 272 NTQIAVKKFS-RDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGS 330
              +A+K+      ++   + + E++I+ +    H+V   G   +   L +V ++   GS
Sbjct: 54  GQIVAIKQVPVESDLQ---EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS 110

Query: 331 LEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
           +   +   ++  TL  +    IL      + YL      + +HRD+KA NILL+ + +A+
Sbjct: 111 VSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAK 165

Query: 391 LGDFGLARAIENE---RNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLE 447
           L DFG+A  + +    RN+      +G P  M   APE          +D++  G   +E
Sbjct: 166 LADFGVAGQLTDTMAKRNTV-----IGTPFWM---APEVIQEIGYNCVADIWSLGITAIE 217

Query: 448 VVCGRSP 454
           +  G+ P
Sbjct: 218 MAEGKPP 224

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 81.9 bits (203), Expect = 4e-17
 Identities = 48/218 (22%), Positives = 90/218 (41%), Gaps = 34/218 (15%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVK--KFSRDSIKSKGDFLAELAIIHRLRH-KH 305
           LG G F +V + I            + A K  K  R     + + L E+A++   +    
Sbjct: 37  LGRGKFAVVRQCI--SKS----TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR 90

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVASAV 360
           +++L        +++L+ ++   G +      +     SE          +++  +   V
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV------IRLIKQILEGV 144

Query: 361 YYLQNEYDQKVVHRDLKASNILL---DADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
           YYL   +   +VH DLK  NILL       + ++ DFG++R I +         L  + G
Sbjct: 145 YYL---HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE------LREIMG 195

Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSP 454
           T  Y+APE  +    T  +D++  G ++  + +   SP
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIG-IIAYMLLTHTSP 232

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 81.9 bits (203), Expect = 4e-17
 Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 40/222 (18%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVK------KFSRDSIKSKGDFLAELAIIHRLR 302
           LG G F +V K              Q A K        S     S+ D   E++I+  ++
Sbjct: 19  LGSGQFAVVKKCR--EKS----TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVA 357
           H +++ L      K  ++L+ + +  G L     EK     +E+           L  + 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL--TEEEATE------FLKQIL 124

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILL----DADFNARLGDFGLARAIENERNSYAEHGLV 413
           + VYYL   +  ++ H DLK  NI+L          ++ DFGLA  I+            
Sbjct: 125 NGVYYL---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE------FK 175

Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEV-VCGRSP 454
            + GT  +VAPE  +      E+D++  G V+  + + G SP
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASP 216

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 81.2 bits (201), Expect = 7e-17
 Identities = 50/258 (19%), Positives = 90/258 (34%), Gaps = 37/258 (14%)

Query: 207 KRRSRVAEPHHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHND 266
           K+ S        L K +   + +     +     + F     LG G FG V       + 
Sbjct: 7   KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66

Query: 267 QYHVDNTQIAVKKFSRDSIKSKGDF---LAELAIIHRLRHKHLVHLVGWCHEKGKLLLVY 323
            ++      A+K   +  +         L E  I+  +    LV L     +   L +V 
Sbjct: 67  NHY------AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120

Query: 324 DFMPNGSLEKYLYGT---SEQVTLNWNHRYKILTG-VASAVYYLQNEYDQKVVHRDLKAS 379
           +++  G +  +L      SE          +     +     YL       +++RDLK  
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHA-------RFYAAQIVLTFEYLH---SLDLIYRDLKPE 170

Query: 380 NILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT---GKATPES 436
           N+L+D     ++ DFG A+ ++    +          GT   +APE   +    KA    
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWTLC--------GTPEALAPEIILSKGYNKAV--- 219

Query: 437 DVFGFGAVVLEVVCGRSP 454
           D +  G ++ E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 80.8 bits (200), Expect = 8e-17
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 39/218 (17%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVD-NTQIAVKKFSRDSIKSKGDFLA---ELAIIHRLRHK 304
           LGEG FG V           H     ++A+K  SR  +K     +    E++ +  LRH 
Sbjct: 17  LGEGSFGKVKLAT-------HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 305 HLVHLVGWCHE----KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
           H++ L    ++       +++V ++   G L  Y+    E+  +  +   +    +  A+
Sbjct: 70  HIIKL----YDVITTPTDIVMVIEYA-GGELFDYI---VEKKRMTEDEGRRFFQQIICAI 121

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP-GTM 419
            Y    +  K+VHRDLK  N+LLD + N ++ DFGL+       N   +   +    G+ 
Sbjct: 122 EYC---HRHKIVHRDLKPENLLLDDNLNVKIADFGLS-------NIMTDGNFLKTSCGSP 171

Query: 420 GYVAPECFHTGK--ATPESDVFGFGAVVLEV-VCGRSP 454
            Y APE    GK  A PE DV+  G +VL V + GR P
Sbjct: 172 NYAAPEVI-NGKLYAGPEVDVWSCG-IVLYVMLVGRLP 207

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 80.9 bits (200), Expect = 9e-17
 Identities = 54/218 (24%), Positives = 83/218 (38%), Gaps = 37/218 (16%)

Query: 223 RLPGMPREFKYKELKKA-----------TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVD 271
            +  MP   +   LK                F +   +G G FG VY           V 
Sbjct: 25  AMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFAR-------DVR 77

Query: 272 NTQI-AVKKFSRDSIKSKGDF---LAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMP 327
           N+++ A+KK S    +S   +   + E+  + +LRH + +   G    +    LV ++  
Sbjct: 78  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137

Query: 328 NGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF 387
             + +           L       +  G    + YL +     ++HRD+KA NILL    
Sbjct: 138 GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPG 191

Query: 388 NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
             +LGDFG A +I    NS      VG P  M   APE
Sbjct: 192 LVKLGDFGSA-SIMAPANS-----FVGTPYWM---APE 220

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 24/218 (11%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQI-AVKKFSRDSIK-SKGDFLAELAIIHRLRHKH 305
            +G G   +V                +  A+K+ + +  + S  + L E+  + +  H +
Sbjct: 22  VIGSGATAVVQAAY-------CAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVASAV 360
           +V        K +L LV   +  GS+          G  +   L+ +    IL  V   +
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE---HGLVGVPG 417
            YL   +    +HRD+KA NILL  D + ++ DFG++  +    +          VG P 
Sbjct: 135 EYL---HKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 418 TMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSP 454
            M   APE     +    ++D++ FG   +E+  G +P
Sbjct: 192 WM---APEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 35/191 (18%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQI-AVK--KFSRDSIKSKGDFLAELAIIHRL-RH 303
            +G G +G VYKG        HV   Q+ A+K    + D  +   +   E+ ++ +   H
Sbjct: 31  LVGNGTYGQVYKGR-------HVKTGQLAAIKVMDVTGDEEE---EIKQEINMLKKYSHH 80

Query: 304 KHLVHLVG------WCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
           +++    G            +L LV +F   GS+   L   ++  TL       I   + 
Sbjct: 81  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREIL 139

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE---RNSYAEHGLVG 414
             + +L      KV+HRD+K  N+LL  +   +L DFG++  ++     RN++     +G
Sbjct: 140 RGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-----IG 191

Query: 415 VPGTMGYVAPE 425
            P  M   APE
Sbjct: 192 TPYWM---APE 199

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 51/268 (19%), Positives = 90/268 (33%), Gaps = 58/268 (21%)

Query: 226 GMPREFKYKELKKATNNFHESMR------LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK 279
           GM  + +                      +  G +G V  G+         +   +A+K+
Sbjct: 1   GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGV-------DSEGIPVAIKR 53

Query: 280 FSRDSIKSKGDF-----------LAELAIIHRLRHKHLVHLV-----GWCHEKGKLLLVY 323
                   +              L E+ +++   H +++ L             KL LV 
Sbjct: 54  VFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVT 113

Query: 324 DFMPNGSLEKYLYGTSEQVTLNWNHR----YKILTGVA---SAVYYLQNEYDQKVVHRDL 376
           + M    L + ++   +++ ++  H     Y IL G+     A           VVHRDL
Sbjct: 114 ELMRT-DLAQVIH--DQRIVISPQHIQYFMYHILLGLHVLHEA----------GVVHRDL 160

Query: 377 KASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE-CFHTGKATPE 435
              NILL  + +  + DF LAR    + N               Y APE        T  
Sbjct: 161 HPGNILLADNNDITICDFNLAREDTADAN------KTHYVTHRWYRAPELVMQFKGFTKL 214

Query: 436 SDVFGFGAVVLEVVCGRS--PGNMIPHQ 461
            D++  G V+ E+   ++   G+   +Q
Sbjct: 215 VDMWSAGCVMAEMFNRKALFRGSTFYNQ 242

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 79.4 bits (196), Expect = 5e-16
 Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 25/233 (10%)

Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD- 290
           + KE++   ++F     +G G F  V    +    Q +      A+K  ++  +  +G+ 
Sbjct: 52  RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVY------AMKIMNKWDMLKRGEV 105

Query: 291 --FLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNH 348
             F  E  ++     + +  L     ++  L LV ++   G L   L    E++      
Sbjct: 106 SCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR 165

Query: 349 RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA 408
            Y  L  +  A+  +   +    VHRD+K  NILLD   + RL DFG    +  +    +
Sbjct: 166 FY--LAEIVMAIDSV---HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220

Query: 409 EHGLVGVPGTMGYVAPE-------CFHTGKATPESDVFGFGAVVLEVVCGRSP 454
               V   GT  Y++PE          TG   PE D +  G    E+  G++P
Sbjct: 221 -LVAV---GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 79.0 bits (195), Expect = 7e-16
 Identities = 54/233 (23%), Positives = 90/233 (38%), Gaps = 30/233 (12%)

Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD- 290
           K ++L+    ++     +G G FG V         + +      A+K  S+  +  + D 
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVY------AMKLLSKFEMIKRSDS 113

Query: 291 --FLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL--YGTSEQVTLNW 346
             F  E  I+       +V L     +   L +V ++MP G L   +  Y   E+     
Sbjct: 114 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA--- 170

Query: 347 NHR-YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN 405
             R Y     V  A+  +   +    +HRD+K  N+LLD   + +L DFG    +  E  
Sbjct: 171 --RFY--TAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223

Query: 406 SYAEHGLVGVPGTMGYVAPECF----HTGKATPESDVFGFGAVVLEVVCGRSP 454
                  V   GT  Y++PE        G    E D +  G  + E++ G +P
Sbjct: 224 VRC-DTAV---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 24/176 (13%)

Query: 237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF----- 291
             AT+ +     +G G +G VYK    H+  +      +A+K     +    G       
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHF------VALKSVRVPNGGGGGGGLPIST 58

Query: 292 LAELAIIHRLR---HKHLVHLVGWCH-----EKGKLLLVYDFMPNGSLEKYLYGTSEQVT 343
           + E+A++ RL    H ++V L+  C       + K+ LV++ +    L  YL   +    
Sbjct: 59  VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD-KAPPPG 116

Query: 344 LNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA 399
           L       ++      + +L   +   +VHRDLK  NIL+ +    +L DFGLAR 
Sbjct: 117 LPAETIKDLMRQFLRGLDFL---HANCIVHRDLKPENILVTSGGTVKLADFGLARI 169

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 75.3 bits (186), Expect = 4e-15
 Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 37/216 (17%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAIIHRLRHKH 305
           LG G FG V+     HN +Y+      A+K   ++ +           E  ++  + H  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYY------AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGT---SEQVTLNWNHR-YKILTGVASAVY 361
           ++ + G   +  ++ ++ D++  G L   L  +      V      + Y     V  A+ 
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-----KFY--AAEVCLALE 120

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGY 421
           YL     + +++RDLK  NILLD + + ++ DFG A+ + +   +          GT  Y
Sbjct: 121 YLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC--------GTPDY 169

Query: 422 VAPECFHT---GKATPESDVFGFGAVVLEVVCGRSP 454
           +APE   T    K+    D + FG ++ E++ G +P
Sbjct: 170 IAPEVVSTKPYNKSI---DWWSFGILIYEMLAGYTP 202

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 75.4 bits (186), Expect = 7e-15
 Identities = 49/252 (19%), Positives = 90/252 (35%), Gaps = 57/252 (22%)

Query: 237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK-FSRDSIKSKGDFLAEL 295
           +K  + F      G+G FG V  G              +A+KK       +++     EL
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKST------GMSVAIKKVIQDPRFRNR-----EL 67

Query: 296 AIIHRLRH---------KHLVHLVGWCHEKG-KLLLVYDFMPNGSLEKYL--YGTSEQVT 343
            I+  L           +   + +G    +   L +V +++P+ +L +    Y   +   
Sbjct: 68  QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQV-A 125

Query: 344 LNWNH----RYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD-ADFNARLGDFGLAR 398
                     ++++  +      L +     V HRD+K  N+L++ AD   +L DFG A+
Sbjct: 126 PPPILIKVFLFQLIRSIG----CL-HLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180

Query: 399 AIENERNSYAEHGLVGVPGTMGYV------APE-CFHTGKATPESDVFGFGAVVLEVVCG 451
            +               P    Y+      APE  F     T   D++  G +  E++ G
Sbjct: 181 KLSPSE-----------PNV-AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

Query: 452 RS--PGNMIPHQ 461
                G+    Q
Sbjct: 229 EPIFRGDNSAGQ 240

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 75.6 bits (186), Expect = 1e-14
 Identities = 49/228 (21%), Positives = 92/228 (40%), Gaps = 50/228 (21%)

Query: 201 AIAYVKKRRSRVAEPHHNLGKLRLPGMPREF----KYKELKKATNNFHESMRLGEGGFGI 256
            ++  ++   +  + H +     +P    ++    +Y+              +G G +G 
Sbjct: 19  TVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHL----------IGTGSYGH 68

Query: 257 VYKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIHRLRHKHLVHLV--- 310
           V +               +A+KK  R   D I  K   L E+AI++RL H H+V ++   
Sbjct: 69  VCEAYDKLE------KRVVAIKKILRVFEDLIDCKR-ILREIAILNRLNHDHVVKVLDIV 121

Query: 311 --GWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR----YKILTGVA---SAVY 361
                 +  +L +V +   +   +K     +    L   H     Y +L GV    SA  
Sbjct: 122 IPKDVEKFDELYVVLEIADS-DFKKLFR--TPV-YLTELHIKTLLYNLLVGVKYVHSA-- 175

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
                    ++HRDLK +N L++ D + ++ DFGLAR ++   N  ++
Sbjct: 176 --------GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 51/220 (23%), Positives = 77/220 (35%), Gaps = 44/220 (20%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVD-NTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           +G G FG+                   +AVK   R +   +     E+     LRH ++V
Sbjct: 28  IGSGNFGVARLMR-------DKLTKELVAVKYIERGAAIDENVQR-EIINHRSLRHPNIV 79

Query: 308 HLVGWCHE----KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYL 363
                  E       L ++ ++   G L + +         + +        + S V Y 
Sbjct: 80  RF----KEVILTPTHLAIIMEYASGGELYERI---CNAGRFSEDEARFFFQQLLSGVSYC 132

Query: 364 QNEYDQKVVHRDLKASNILLDADFNARL--GDFGLARAIENERNSYAEHGL----VGVPG 417
            +    ++ HRDLK  N LLD     RL   DFG +        S   H      VG P 
Sbjct: 133 HS---MQICHRDLKLENTLLDGSPAPRLKICDFGYS-------KSSVLHSQPKSTVGTP- 181

Query: 418 TMGYVAPECFHTGK--ATPESDVFGFGAVVLEV-VCGRSP 454
              Y+APE     +      +DV+  G V L V + G  P
Sbjct: 182 --AYIAPEVL-LRQEYDGKIADVWSCG-VTLYVMLVGAYP 217

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 55/258 (21%), Positives = 100/258 (38%), Gaps = 50/258 (19%)

Query: 227 MPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS--RDS 284
           MP+   Y         F     LGEG +G+V          +      +A+KK       
Sbjct: 1   MPKRIVYNISSD----FQLKSLLGEGAYGVVCSAT------HKPTGEIVAIKKIEPFDKP 50

Query: 285 IKSKGDFLAELAIIHRLRHKHLVHLV-----GWCHEKGKLLLVYDFMPNGSLEKYLYGTS 339
           + +    L E+ I+   +H++++ +             ++ ++ + M     +  L+   
Sbjct: 51  LFALR-TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVI 104

Query: 340 EQVTLNWNHR----YKILTGVA---SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG 392
               L+ +H     Y+ L  V     +           V+HRDLK SN+L++++ + ++ 
Sbjct: 105 STQMLSDDHIQYFIYQTLRAVKVLHGS----------NVIHRDLKPSNLLINSNCDLKVC 154

Query: 393 DFGLARAIENERNSYAEHGLVGVPGTMGYV------APE-CFHTGKATPESDVFGFGAVV 445
           DFGLAR I+      +E           +V      APE    + K +   DV+  G ++
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMV-EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCIL 213

Query: 446 LEVVCGRS--PGNMIPHQ 461
            E+   R   PG    HQ
Sbjct: 214 AELFLRRPIFPGRDYRHQ 231

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 42/184 (22%), Positives = 70/184 (38%), Gaps = 42/184 (22%)

Query: 237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS------------ 284
            +A   +     +GEG +G V+K               +A+K+    +            
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKAR-----DLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61

Query: 285 IKSKGDFLAELAIIHRLRHKHLVHLVGWCH-----EKGKLLLVYDFMPNGSLEKYLYGTS 339
           +      L  L       H ++V L   C       + KL LV++ +    L  YL    
Sbjct: 62  VA----VLRHL---ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKV 112

Query: 340 EQVTLNWNHR----YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG 395
            +  +         +++L G+     +L   +  +VVHRDLK  NIL+ +    +L DFG
Sbjct: 113 PEPGVPTETIKDMMFQLLRGLD----FL---HSHRVVHRDLKPQNILVTSSGQIKLADFG 165

Query: 396 LARA 399
           LAR 
Sbjct: 166 LARI 169

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 23/219 (10%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAI 297
           N F     LG+G FG V         +Y+      A+K   ++ I +K +    L E  +
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYY------AMKILKKEVIVAKDEVAHTLTENRV 201

Query: 298 IHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG-V 356
           +   RH  L  L        +L  V ++   G L  +L   S +   +   R +     +
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFS-EDRARFYGAEI 257

Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR-AIENERNSYAEHGLVGV 415
            SA+ YL +E +  VV+RDLK  N++LD D + ++ DFGL +  I++             
Sbjct: 258 VSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT------F 309

Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            GT  Y+APE           D +G G V+ E++CGR P
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 71.4 bits (176), Expect = 1e-13
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 44/222 (19%)

Query: 249 LGEGGFGIVY---KGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF--LAELAIIHRLRH 303
           LG+G FG V+   K       Q +      A+K   + ++K +       E  I+  + H
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLY------AMKVLKKATLKVRDRVRTKMERDILVEVNH 85

Query: 304 KHLVHLVGWCH----EKGKLLLVYDFMPNGSLEKYLYGT---SEQVTLNWNHRYKILTG- 355
             +V L    H     +GKL L+ DF+  G L   L      +E+         K     
Sbjct: 86  PFIVKL----HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-------DVKFYLAE 134

Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR-AIENER--NSYAEHGL 412
           +A A+ +L   +   +++RDLK  NILLD + + +L DFGL++ +I++E+   S+     
Sbjct: 135 LALALDHL---HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---- 187

Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
               GT+ Y+APE  +    T  +D + FG ++ E++ G  P
Sbjct: 188 ----GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 7/100 (7%)

Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           VA  + +L +   +K +HRDL A NILL      ++ DFGLAR I  + + Y   G   +
Sbjct: 202 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARL 257

Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP 454
           P  + ++APE       T +SDV+ FG ++ E+   G SP
Sbjct: 258 P--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 36/175 (20%), Positives = 66/175 (37%), Gaps = 14/175 (8%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAI-IHRLRHKH 305
            LG G FG V +      D+       +AVK      +       ++EL I IH   H +
Sbjct: 29  PLGRGAFGQVIEADAFGIDKTA-TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 306 LVHLVGWC-HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ 364
           +V+L+G C    G L+++ +F   G+L  YL           + R + +        + Q
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137

Query: 365 NEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
            +     +  DLK     + +  ++    F   +++ +     A   L     T+
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTL 192

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 33/162 (20%), Positives = 62/162 (38%), Gaps = 33/162 (20%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLV 307
           LG G  G V +    +         + A+K      ++       E+ +  R  +  H+V
Sbjct: 26  LGLGINGKVLQIF--NKR----TQEKFALK-----MLQDCPKARREVELHWRASQCPHIV 74

Query: 308 HLVGWCHE----KGKLLLVYDFMPNGSL-----EKYLYGTSEQVTLNWNHRYKILTGVAS 358
            +V         +  LL+V + +  G L     ++     +E+         +I+  +  
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA------SEIMKSIGE 128

Query: 359 AVYYLQNEYDQKVVHRDLKASNILL---DADFNARLGDFGLA 397
           A+ YL   +   + HRD+K  N+L      +   +L DFG A
Sbjct: 129 AIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 51/241 (21%), Positives = 96/241 (39%), Gaps = 49/241 (20%)

Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELA 296
              + +   +G G +G V   +            ++A+KK  R     + +K     EL 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAV------DGRTGAKVAIKKLYRPFQSELFAKR-AYRELR 76

Query: 297 IIHRLRHKHLVHLV------GWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR- 349
           ++  +RH++++ L+          +     LV  FM        L    +   L  +   
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQ 131

Query: 350 ---YKILTGVA---SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE 403
              Y++L G+    +A           ++HRDLK  N+ ++ D   ++ DFGLAR  ++E
Sbjct: 132 FLVYQMLKGLRYIHAA----------GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181

Query: 404 RNSYAEHGLVGVPGTMGYVAPE-CFHTGKATPESDVFGFGAVVLEVVCGRS--PGNMIPH 460
              Y          T  Y APE   +  + T   D++  G ++ E++ G++   G+    
Sbjct: 182 MTGYV--------VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 233

Query: 461 Q 461
           Q
Sbjct: 234 Q 234

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 54/240 (22%), Positives = 89/240 (37%), Gaps = 48/240 (20%)

Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELA 296
              +     +G G +G V   I            ++A+KK SR     I +K     EL 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAI------DKRSGEKVAIKKLSRPFQSEIFAKR-AYRELL 75

Query: 297 IIHRLRHKHLVHLV------GWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR- 349
           ++  ++H++++ L+                LV  FM     +  L             + 
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQY 130

Query: 350 --YKILTGVA---SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
             Y++L G+    SA           VVHRDLK  N+ ++ D   ++ DFGLAR  + E 
Sbjct: 131 LVYQMLKGLKYIHSA----------GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180

Query: 405 NSYAEHGLVGVPGTMGYVAPE-CFHTGKATPESDVFGFGAVVLEVVCGRS--PGNMIPHQ 461
             Y          T  Y APE            D++  G ++ E++ G++   G     Q
Sbjct: 181 TGYV--------VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 232

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 53/237 (22%), Positives = 94/237 (39%), Gaps = 41/237 (17%)

Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELA 296
              +     +G G  GIV            +    +A+KK SR   +   +K     EL 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAY------DAILERNVAIKKLSRPFQNQTHAKR-AYRELV 76

Query: 297 IIHRLRHKHLVHLV------GWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR- 349
           ++  + HK+++ L+          E   + +V + M   +L + +     Q+ L+     
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI-----QMELDHERMS 130

Query: 350 ---YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
              Y++L G+     +L   +   ++HRDLK SNI++ +D   ++ DFGLAR        
Sbjct: 131 YLLYQMLCGIK----HL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---- 179

Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRS--PGNMIPHQ 461
                +     T  Y APE           D++  G ++ E++ G    PG     Q
Sbjct: 180 --SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ 234

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 51/232 (21%), Positives = 87/232 (37%), Gaps = 59/232 (25%)

Query: 232 KYKELKKATNNFHESMR------LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR--- 282
           +     +   N H          +G G +G VY                +A+KK +R   
Sbjct: 11  RENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAY------DKNTEKNVAIKKVNRMFE 64

Query: 283 DSIKSKGDFLAELAIIHRLRHKHLVHLV-----GWCHEKGKLLLVYDFMPNGSLEKYLYG 337
           D I  K   L E+ I++RL+  +++ L          +  +L +V +   +  L+K    
Sbjct: 65  DLIDCKR-ILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFK- 121

Query: 338 TSEQVTLNWNHR----YKILTGVA---SAVYYLQNEYDQKVVHRDLKASNILLDADFNAR 390
            +    L   H     Y +L G      +           ++HRDLK +N LL+ D + +
Sbjct: 122 -TPI-FLTEEHIKTILYNLLLGENFIHES----------GIIHRDLKPANCLLNQDCSVK 169

Query: 391 LGDFGLARAIENERNSYAEHGLVGVPGTM-----------GYV------APE 425
           + DFGLAR I +E+++   + L                   +V      APE
Sbjct: 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPE 221

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 69.9 bits (172), Expect = 4e-13
 Identities = 49/224 (21%), Positives = 90/224 (40%), Gaps = 46/224 (20%)

Query: 249 LGEGGFGIVY---KGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD----FLAELAIIHRL 301
           LG+GG+G V+   K    +  +        A+K   +  I           AE  I+  +
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIF------AMKVLKKAMIVRNAKDTAHTKAERNILEEV 78

Query: 302 RHKHLVHLVGWCH----EKGKLLLVYDFMPNGSLEKYLYGT---SEQVTLNWNHRYKILT 354
           +H  +V L           GKL L+ +++  G L   L       E              
Sbjct: 79  KHPFIVDL----IYAFQTGGKLYLILEYLSGGELFMQLEREGIFME-------DTACFYL 127

Query: 355 G-VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA--IENER-NSYAEH 410
             ++ A+ +L   + + +++RDLK  NI+L+   + +L DFGL +    +    +++   
Sbjct: 128 AEISMALGHL---HQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-- 182

Query: 411 GLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
                 GT+ Y+APE           D +  GA++ +++ G  P
Sbjct: 183 ------GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 69.9 bits (171), Expect = 8e-13
 Identities = 54/237 (22%), Positives = 92/237 (38%), Gaps = 41/237 (17%)

Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELA 296
              +     +G G  GIV            V +  +A+KK SR   +   +K     EL 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAY------DAVLDRNVAIKKLSRPFQNQTHAKRA-YRELV 113

Query: 297 IIHRLRHKHLVHLV------GWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR- 349
           ++  + HK+++ L+          E   + LV + M     +  L    +   L+     
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQM-ELDHERMS 167

Query: 350 ---YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
              Y++L G+     +L   +   ++HRDLK SNI++ +D   ++ DFGLAR        
Sbjct: 168 YLLYQMLCGIK----HL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---- 216

Query: 407 YAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRS--PGNMIPHQ 461
                +     T  Y APE           D++  G ++ E+V  +   PG     Q
Sbjct: 217 --SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 59/239 (24%), Positives = 102/239 (42%), Gaps = 41/239 (17%)

Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS--RDSIKSKGDFLAELAI 297
              +     +GEG +G+V           +++  ++A+KK S        +   L E+ I
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAY------DNLNKVRVAIKKISPFEHQTYCQR-TLREIKI 78

Query: 298 IHRLRHKHLVHLV-----GWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR--- 349
           + R RH++++ +          +   + +V D M     E  LY   +   L+ +H    
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYF 133

Query: 350 -YKILTGVA---SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN 405
            Y+IL G+    SA           V+HRDLK SN+LL+   + ++ DFGLAR  + + +
Sbjct: 134 LYQILRGLKYIHSA----------NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183

Query: 406 SYAEHGLVGVPGTMGYVAPE-CFHTGKATPESDVFGFGAVVLEVVCGRS--PGNMIPHQ 461
                 L     T  Y APE   ++   T   D++  G ++ E++  R   PG     Q
Sbjct: 184 H--TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 240

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 67.6 bits (166), Expect = 2e-12
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 34/216 (15%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAIIHRLRHKH 305
           LG+G FG V         +Y+      A+K   ++ I +K +    + E  ++   RH  
Sbjct: 13  LGKGTFGKVILVREKATGRYY------AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGT---SEQVTLNWNHRYKILTG-VASAVY 361
           L  L        +L  V ++   G L  +L      +E+       R +     + SA+ 
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-------RARFYGAEIVSALE 119

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA--IENER-NSYAEHGLVGVPGT 418
           YL   + + VV+RD+K  N++LD D + ++ DFGL +    +     ++         GT
Sbjct: 120 YL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--------GT 168

Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             Y+APE           D +G G V+ E++CGR P
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 58/254 (22%), Positives = 101/254 (39%), Gaps = 62/254 (24%)

Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIH 299
            + + +   LG GG G+V+  +       +  + ++A+KK      +S    L E+ II 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAV------DNDCDKRVAIKKIVLTDPQSVKHALREIKIIR 63

Query: 300 RLRHKHLVHL--------------VGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLN 345
           RL H ++V +              VG   E   + +V ++M     E  L    EQ  L 
Sbjct: 64  RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLL 118

Query: 346 WNHR----YKILTGVA---SAVYYLQNEYDQKVVHRDLKASNILLDA-DFNARLGDFGLA 397
             H     Y++L G+    SA           V+HRDLK +N+ ++  D   ++GDFGLA
Sbjct: 119 EEHARLFMYQLLRGLKYIHSA----------NVLHRDLKPANLFINTEDLVLKIGDFGLA 168

Query: 398 RAIENERNSYAEHGLVGVPGTM-GYV------APE-CFHTGKATPESDVFGFGAVVLEVV 449
           R ++   +           G +   +      +P         T   D++  G +  E++
Sbjct: 169 RIMDPHYSH---------KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219

Query: 450 CGRS--PGNMIPHQ 461
            G++   G     Q
Sbjct: 220 TGKTLFAGAHELEQ 233

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 57/284 (20%), Positives = 99/284 (34%), Gaps = 95/284 (33%)

Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF 291
           KY   K           LG G FGIV +     +        + A+KK  +D        
Sbjct: 8   KYSLGKT----------LGTGSFGIVCEVFDIES------GKRFALKKVLQDPRYK---- 47

Query: 292 LAELAIIHRLRHKHLVHLVGWCHEKGK--------------------------------- 318
             EL I+  L H +++ LV + +  G                                  
Sbjct: 48  NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNP 107

Query: 319 -----LLLVYDFMPNGSLEKYL--YGTSEQVTLNWNH----RYKILTGVASAVYYLQNEY 367
                L ++ +++P+ +L K L  +  S + ++  N      Y++   V     ++ +  
Sbjct: 108 SQNKYLNVIMEYVPD-TLHKVLKSFIRSGR-SIPMNLISIYIYQLFRAVG----FIHS-- 159

Query: 368 DQKVVHRDLKASNILLDA-DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV---- 422
              + HRD+K  N+L+++ D   +L DFG A+ +               P    Y+    
Sbjct: 160 -LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-----------PSV-AYICSRF 206

Query: 423 --APECFHTGKA-TPESDVFGFGAVVLEVVCGRS--PGNMIPHQ 461
             APE        TP  D++  G V  E++ G+    G     Q
Sbjct: 207 YRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQ 250

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 26/214 (12%), Positives = 62/214 (28%), Gaps = 57/214 (26%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNT---QIAVK----KFSRDSIKSKGDFLAELAIIHR 300
             G       ++          +D     Q+A+     +          + L+    + R
Sbjct: 38  FHGGVPPLQFWQA---------LDTALDRQVALTFVDPQGVLPD-DVLQETLSRTLRLSR 87

Query: 301 LRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
           +    +  ++   H +   L+V +++  GSL++    +      +     + +  +A+A 
Sbjct: 88  IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAA- 141

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
                 +   V       S + +  D +  L                             
Sbjct: 142 --ADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------------------- 174

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            +         A P+ D+ G GA +  ++  R P
Sbjct: 175 TMPD-------ANPQDDIRGIGASLYALLVNRWP 201

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 67.0 bits (163), Expect = 9e-12
 Identities = 49/263 (18%), Positives = 102/263 (38%), Gaps = 36/263 (13%)

Query: 204 YVKKRRSRVAEPHHNLGKLRLPGMPREFKYKELKKAT-NNFHESMRLGEGGFGIVYKGII 262
             K  R+++ +      +     + +        +    +F+  M LG+G FG V     
Sbjct: 303 RQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSER 362

Query: 263 HHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAII-HRLRHKHLVHLVGWCHEKGK 318
              D+ +      AVK   +D +    D    + E  ++    +   L  L        +
Sbjct: 363 KGTDELY------AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416

Query: 319 LLLVYDFMPNGSLEKYLYGT---SEQVTLNWNHRYKILTG-VASAVYYLQNEYDQKVVHR 374
           L  V +++  G L  ++       E                +A  +++L     + +++R
Sbjct: 417 LYFVMEYVNGGDLMYHIQQVGRFKEP-------HAVFYAAEIAIGLFFL---QSKGIIYR 466

Query: 375 DLKASNILLDADFNARLGDFGLARA-IENER--NSYAEHGLVGVPGTMGYVAPECFHTGK 431
           DLK  N++LD++ + ++ DFG+ +  I +     ++         GT  Y+APE      
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC--------GTPDYIAPEIIAYQP 518

Query: 432 ATPESDVFGFGAVVLEVVCGRSP 454
                D + FG ++ E++ G++P
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAP 541

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 65.3 bits (158), Expect = 1e-11
 Identities = 36/205 (17%), Positives = 65/205 (31%), Gaps = 53/205 (25%)

Query: 239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKK--------FSRDSIKSKGD 290
            T       ++GEG FG V++ I         D+T +A+K          +    K+  +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA--------DHTPVAIKIIAIEGPDLVNGSHQKTFEE 69

Query: 291 FLAELAIIHRL---------RHKHLVHLVGWCHEKGK----LLLVYDFM----------P 327
            L E+ I   L         R +  + L      +G     LL  +D            P
Sbjct: 70  ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129

Query: 328 NGSLEKYLYGTSE------------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD 375
           +   +  L+   E                +      IL  + +++   +     +  HRD
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRD 187

Query: 376 LKASNILLDADFNARLGDFGLARAI 400
           L   N+LL      +L      ++ 
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSS 212

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 58/241 (24%), Positives = 94/241 (39%), Gaps = 49/241 (20%)

Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELA 296
              +     +G G +G V                ++AVKK SR     I +K     EL 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAF------DTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 80

Query: 297 IIHRLRHKHLVHLV------GWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR- 349
           ++  ++H++++ L+          E   + LV   M        L    +   L  +H  
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQ 135

Query: 350 ---YKILTGVA---SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE 403
              Y+IL G+    SA           ++HRDLK SN+ ++ D   ++ DFGLAR   +E
Sbjct: 136 FLIYQILRGLKYIHSA----------DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185

Query: 404 RNSYAEHGLVGVPGTMGYVAPE-CFHTGKATPESDVFGFGAVVLEVVCGRS--PGNMIPH 460
              Y          T  Y APE   +        D++  G ++ E++ GR+  PG     
Sbjct: 186 MTGYV--------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 237

Query: 461 Q 461
           Q
Sbjct: 238 Q 238

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 36/221 (16%)

Query: 249 LGEGGFGIVY---KGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF----LAELAIIHRL 301
           LG G +G V+   K   H   + +      A+K   + +I  K         E  ++  +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLY------AMKVLKKATIVQKAKTTEHTRTERQVLEHI 115

Query: 302 RHKH-LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG-VASA 359
           R    LV L      + KL L+ D++  G L  +L   S++      H  +I  G +  A
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL---SQRERFT-EHEVQIYVGEIVLA 171

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR---AIENER-NSYAEHGLVGV 415
           + +L   +   +++RD+K  NILLD++ +  L DFGL++   A E ER   +        
Sbjct: 172 LEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC------- 221

Query: 416 PGTMGYVAPECFHTGKA--TPESDVFGFGAVVLEVVCGRSP 454
            GT+ Y+AP+    G +      D +  G ++ E++ G SP
Sbjct: 222 -GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 63.8 bits (156), Expect = 4e-11
 Identities = 57/244 (23%), Positives = 100/244 (40%), Gaps = 41/244 (16%)

Query: 225 PGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS 284
           P + +E    ++K    +F     LG+G FG V+       +Q+       A+K   +D 
Sbjct: 1   PELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFF------AIKALKKDV 54

Query: 285 IKSKGDF---LAELAI-IHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE 340
           +    D    + E  +      H  L H+      K  L  V +++  G L  ++     
Sbjct: 55  VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----- 109

Query: 341 QVTLNWNHRYKILTGVASAVYY-------LQNEYDQKVVHRDLKASNILLDADFNARLGD 393
                          ++ A +Y       LQ  + + +V+RDLK  NILLD D + ++ D
Sbjct: 110 -------QSCHKFD-LSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIAD 161

Query: 394 FGLAR-AIENER--NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC 450
           FG+ +  +  +   N++         GT  Y+APE     K     D + FG ++ E++ 
Sbjct: 162 FGMCKENMLGDAKTNTFC--------GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213

Query: 451 GRSP 454
           G+SP
Sbjct: 214 GQSP 217

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 35/217 (16%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAELAI-IHRLRHK 304
           +G+G FG V        + ++      AVK   + +I  K +    ++E  + +  ++H 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFY------AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGT---SEQVTLNWNHRYKILTG-VASAV 360
            LV L        KL  V D++  G L  +L       E        R +     +ASA+
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE-------PRARFYAAEIASAL 152

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA--IENER-NSYAEHGLVGVPG 417
            YL   +   +V+RDLK  NILLD+  +  L DFGL +     N   +++         G
Sbjct: 153 GYL---HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC--------G 201

Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           T  Y+APE  H        D +  GAV+ E++ G  P
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 39/219 (17%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAE---LAIIHRLR 302
           LG+G FG V    +      +      AVK   +D I    D    + E   L++     
Sbjct: 31  LGKGSFGKVMLARVKETGDLY------AVKVLKKDVILQDDDVECTMTEKRILSLA--RN 82

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGT---SEQVTLNWNHRYKILTG-VAS 358
           H  L  L        +L  V +F+  G L  ++  +    E        R +     + S
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-------RARFYAAEIIS 135

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA--IENER-NSYAEHGLVGV 415
           A+ +L   +D+ +++RDLK  N+LLD + + +L DFG+ +          ++        
Sbjct: 136 ALMFL---HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC------- 185

Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            GT  Y+APE        P  D +  G ++ E++CG +P
Sbjct: 186 -GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 46/219 (21%), Positives = 88/219 (40%), Gaps = 39/219 (17%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAE---LAIIHRLR 302
           LG+G FG V        D+ +      AVK   +D +    D    + E   LA+  +  
Sbjct: 28  LGKGSFGKVMLSERKGTDELY------AVKILKKDVVIQDDDVECTMVEKRVLALPGK-- 79

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGT---SEQVTLNWNHRYKILTG-VAS 358
              L  L        +L  V +++  G L  ++       E                +A 
Sbjct: 80  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-------HAVFYAAEIAI 132

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA--IENER-NSYAEHGLVGV 415
            +++L     + +++RDLK  N++LD++ + ++ DFG+ +    +     ++        
Sbjct: 133 GLFFL---QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC------- 182

Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            GT  Y+APE           D + FG ++ E++ G++P
Sbjct: 183 -GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 51/207 (24%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR---DSIKSKGDFLAELAIIHRLR-H 303
           +LG+G +GIV+K I             +AVKK      +S  ++     E+ I+  L  H
Sbjct: 16  KLGKGAYGIVWKSI------DRRTGEVVAVKKIFDAFQNSTDAQ-RTFREIMILTELSGH 68

Query: 304 KHLVHLVGWCHEKGK--LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR----YKILTGVA 357
           +++V+L+          + LV+D+M    L   +        L   H+    Y+++  + 
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN----ILEPVHKQYVVYQLIKVIK 123

Query: 358 ---SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
              S            ++HRD+K SNILL+A+ + ++ DFGL+R+  N R       L  
Sbjct: 124 YLHSG----------GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173

Query: 415 VPGTM----------GYV------APE 425
              T            YV      APE
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPE 200

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 43/219 (19%), Positives = 90/219 (41%), Gaps = 39/219 (17%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAE---LAIIHRLR 302
           +G G +  V    +   D+ +      A++   ++ +    D      E           
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIY------AMRVVKKELVNDDEDIDWVQTEKHVFEQA--SN 111

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGT---SEQVTLNWNHRYKILTG-VAS 358
           H  LV L      + +L  V +++  G L  ++       E+         +  +  ++ 
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-------HARFYSAEISL 164

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA--IENER-NSYAEHGLVGV 415
           A+ YL   +++ +++RDLK  N+LLD++ + +L D+G+ +      +  +++        
Sbjct: 165 ALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC------- 214

Query: 416 PGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
            GT  Y+APE           D +  G ++ E++ GRSP
Sbjct: 215 -GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 46/216 (21%), Positives = 88/216 (40%), Gaps = 33/216 (15%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF---LAE---LAIIHRLR 302
           +G G +  V    +   D+ +      A+K   ++ +    D      E           
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIY------AMKVVKKELVNDDEDIDWVQTEKHVFEQA--SN 68

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGT---SEQVTLNWNHRYKILTG-VAS 358
           H  LV L      + +L  V +++  G L  ++       E+         +  +  ++ 
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-------HARFYSAEISL 121

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           A+ YL   +++ +++RDLK  N+LLD++ + +L D+G+ +  E  R            GT
Sbjct: 122 ALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFC---GT 173

Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             Y+APE           D +  G ++ E++ GRSP
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 59.6 bits (145), Expect = 8e-10
 Identities = 47/244 (19%), Positives = 90/244 (36%), Gaps = 47/244 (19%)

Query: 227 MPREF-KYKELKKA---TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR 282
            PRE+  Y+         +++    +LG G +  V++ I   N      N ++ VK    
Sbjct: 18  RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN------NEKVVVKILKP 71

Query: 283 DSIKSKGDFLAELAIIHRLR-HKHLVHL--VGWCHEKGKLLLVYDFMPNGSLEKYLYGTS 339
              K       E+ I+  LR   +++ L  +          LV++ + N   ++      
Sbjct: 72  VKKKK---IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--- 125

Query: 340 EQVTLNWNH----RYKILTGVA---SAVYYLQNEYDQKVVHRDLKASNILLDADFNA-RL 391
              TL         Y+IL  +    S            ++HRD+K  N+++D +    RL
Sbjct: 126 ---TLTDYDIRFYMYEILKALDYCHSM----------GIMHRDVKPHNVMIDHEHRKLRL 172

Query: 392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVC 450
            D+GLA      +  Y     V    +  +  PE     +      D++  G ++  ++ 
Sbjct: 173 IDWGLAEFYHPGQ-EYNVR--V---ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 226

Query: 451 GRSP 454
            + P
Sbjct: 227 RKEP 230

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 34/246 (13%), Positives = 85/246 (34%), Gaps = 54/246 (21%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF----LAELAIIHRLR-- 302
           LG G F  V+      N+ +      +A+K      ++    +      E+ ++ R+   
Sbjct: 27  LGWGHFSTVWLAKDMVNNTH------VAMK-----IVRGDKVYTEAAEDEIKLLQRVNDA 75

Query: 303 ---------HKHLVHLVGWCHEKGK----LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR 349
                      H++ L+   + KG     +++V++ +   +L   +     +  +   + 
Sbjct: 76  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG-IPLIYV 133

Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD------ADFNARLGDFGLARAIENE 403
            +I   +   + Y+       ++H D+K  N+L++           ++ D G A   +  
Sbjct: 134 KQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191

Query: 404 RNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCG------RSPGNM 457
             +  +        T  Y +PE          +D++    ++ E++ G          + 
Sbjct: 192 YTNSIQ--------TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243

Query: 458 IPHQQH 463
                H
Sbjct: 244 TKDDDH 249

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 36/167 (21%), Positives = 58/167 (34%), Gaps = 25/167 (14%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           ++G GGFG++Y               + A      +  +  G   +EL    R+  K   
Sbjct: 44  KIGSGGFGLIYLAF------PTNKPEKDARHVVKVEY-QENGPLFSELKFYQRVAKKD-- 94

Query: 308 HLVGWCHEKGKLLL----VYDFMPNGSLEKY-------LYGTSEQVTLNWNHRYKILTGV 356
            +  W   K    L     Y         +          G   Q     N  +K  T +
Sbjct: 95  CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVL 154

Query: 357 ASAVYYLQN-EY--DQKVVHRDLKASNILLDADFNAR--LGDFGLAR 398
              +  L   EY  + + VH D+KA+N+LL      +  L D+GL+ 
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 32/171 (18%), Positives = 70/171 (40%), Gaps = 28/171 (16%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF----LAELAIIHRLRHK 304
           +G+G FG V K   H   Q+      +A+K      ++++  F      E+ I+  LR +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQH------VALK-----MVRNEKRFHRQAAEEIRILEHLRKQ 153

Query: 305 ------HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVAS 358
                 +++H++     +  + + ++ + + +L + +     Q   +     K    +  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQ-GFSLPLVRKFAHSILQ 211

Query: 359 AVYYLQNEYDQKVVHRDLKASNILL--DADFNARLGDFGLARAIENERNSY 407
            +  L   +  +++H DLK  NILL        ++ DFG +        +Y
Sbjct: 212 CLDAL---HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTY 259

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 50.1 bits (120), Expect = 9e-07
 Identities = 38/171 (22%), Positives = 73/171 (42%), Gaps = 26/171 (15%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF----LAELAIIHRLRH- 303
           +G+G FG V K       ++      +A+K      IK+K  F      E+ ++  +   
Sbjct: 62  IGKGSFGQVVKAYDRVEQEW------VAIK-----IIKNKKAFLNQAQIEVRLLELMNKH 110

Query: 304 -----KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVAS 358
                 ++VHL      +  L LV++ + + +L   L  T+ +  ++ N   K    + +
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFR-GVSLNLTRKFAQQMCT 168

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNA--RLGDFGLARAIENERNSY 407
           A+ +L    +  ++H DLK  NILL     +  ++ DFG +  +      Y
Sbjct: 169 ALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY 218

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 36/170 (21%), Positives = 62/170 (36%), Gaps = 28/170 (16%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
            +G+GGFG +Y   ++ + +    +    VK    D+    G    EL    R      +
Sbjct: 42  PIGQGGFGCIYLADMN-SSESVGSDAPCVVKVEPSDN----GPLFTELKFYQRAAKPEQI 96

Query: 308 HLVGWCHEKGKLLL--VYDFMPNGSLE-KY------LYGTSEQVTLNWNHRYKILTGVA- 357
                  +   L +   +    +      Y       +G+  Q     N +      V  
Sbjct: 97  QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQ 156

Query: 358 ------SAVYYL-QNEYDQKVVHRDLKASNILLDADFNAR--LGDFGLAR 398
                   + Y+ ++EY    VH D+KASN+LL+     +  L D+GLA 
Sbjct: 157 LSLRILDILEYIHEHEY----VHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 26/170 (15%), Positives = 60/170 (35%), Gaps = 28/170 (16%)

Query: 248 RLGEGGFGIVYKG--IIHHNDQYHVDNTQIAVKKFSRDS----------IKSKGDFLAEL 295
                  GI+Y+                + ++K  ++D             +K   + + 
Sbjct: 49  FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108

Query: 296 AIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYK---- 351
             ++      +   +G+   + K    Y F+    L     G S Q  L+ + ++     
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDK----YRFL---VLP--SLGRSLQSALDVSPKHVLSER 159

Query: 352 -ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR--LGDFGLAR 398
            +L      +  L+  ++ + VH ++ A NI +D +  ++  L  +G A 
Sbjct: 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.1 bits (116), Expect = 4e-06
 Identities = 46/268 (17%), Positives = 86/268 (32%), Gaps = 63/268 (23%)

Query: 263 HHND------QYHV-DNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLVHLVGWCH 314
           HH D      QY   D   +    F  +   K   D    +     L  + + H++    
Sbjct: 5   HHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSI-----LSKEEIDHIIMSKD 59

Query: 315 EKGKLLLVYDFM---PNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQK- 370
                L ++  +       ++K++     ++   +         + S    ++ E  Q  
Sbjct: 60  AVSGTLRLFWTLLSKQEEMVQKFV-EEVLRINYKF---------LMSP---IKTEQRQPS 106

Query: 371 ------VVHRD-LKASNILLDADFNARLGDF-GLARAIENERNSYAEHGLVGVPGTMGYV 422
                 +  RD L   N +      +RL  +  L +A+   R        V + G +G  
Sbjct: 107 MMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRP----AKNVLIDGVLG-- 160

Query: 423 APECFHTGKATPESDV---------FGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM 473
                 +GK     DV           F    L +    SP  ++   Q     +D  W 
Sbjct: 161 ------SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWT 214

Query: 474 LHREGHIQDAVDQRLNINSVVDEAKRLL 501
              +     + + +L I+S+  E +RLL
Sbjct: 215 SRSDH----SSNIKLRIHSIQAELRRLL 238

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 32/176 (18%), Positives = 68/176 (38%), Gaps = 41/176 (23%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF----LAELAIIHRLRHK 304
           LGEG FG V + + H   +  V     A+K      I++ G +      E+ ++ +++ K
Sbjct: 27  LGEGTFGKVVECLDHARGKSQV-----ALK-----IIRNVGKYREAARLEINVLKKIKEK 76

Query: 305 ------HLVHLVGWCHEKGKLLLV--------YDFMPNGSLEKYLYGTSEQVTLNWNHRY 350
                   V +  W +  G + +         ++F     L++  +           H  
Sbjct: 77  DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEF-----LKENNF-----QPYPLPHVR 126

Query: 351 KILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
            +   +  A+ +L   ++ ++ H DLK  NIL        L +   +   ++ +N+
Sbjct: 127 HMAYQLCHALRFL---HENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179

>1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 113

 Score = 42.6 bits (100), Expect = 3e-05
 Identities = 13/32 (40%), Positives = 15/32 (46%), Gaps = 2/32 (6%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNA 41
                GLAF IAP DS      +G +LGL   
Sbjct: 82  SRIADGLAFFIAPPDSVIS--YHGGFLGLFPN 111

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 28/152 (18%), Positives = 51/152 (33%), Gaps = 41/152 (26%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF----LAELAIIHRLRH- 303
           +G+G FG V       N +Y       AVK      +++   +      E  I+ ++++ 
Sbjct: 43  MGDGTFGRVLLCQHIDNKKY------YAVK-----VVRNIKKYTRSAKIEADILKKIQND 91

Query: 304 ----KHLVHLVGWCHEKGKLLLV--------YDFMPNGSLEKYLYGTSEQVTLNWNHRYK 351
                ++V   G       + L+        Y+      + +  Y        +      
Sbjct: 92  DINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEI-----ITRNNY-----NGFHIEDIKL 141

Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILL 383
               +  A+ YL       + H DLK  NILL
Sbjct: 142 YCIEILKALNYL---RKMSLTHTDLKPENILL 170

>2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B Length = 52

 Score = 39.8 bits (93), Expect = 6e-05
 Identities = 13/37 (35%), Positives = 20/37 (54%), Gaps = 1/37 (2%)

Query: 129 LKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWT 165
           L + ++LKD +      GFSA+TG      + V SW+
Sbjct: 6   LSDVVSLKDVVPEWVRIGFSATTGA-EYAAHEVLSWS 41

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 44.2 bits (105), Expect = 7e-05
 Identities = 38/176 (21%), Positives = 64/176 (36%), Gaps = 41/176 (23%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDF----LAELAIIHRLRHK 304
           LGEG FG V + I H     HV     AVK      +K+   +     +E+ ++  L   
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHV-----AVK-----IVKNVDRYCEAARSEIQVLEHLNTT 71

Query: 305 ------HLVHLVGWCHEKGKLLLV--------YDFMPNGSLEKYLYGTSEQVTLNWNHRY 350
                   V ++ W    G + +V        YDF     +++  +     +    +H  
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDF-----IKENGF-----LPFRLDHIR 121

Query: 351 KILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNS 406
           K+   +  +V +L   +  K+ H DLK  NIL          +  + R      N 
Sbjct: 122 KMAYQICKSVNFL---HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 41.6 bits (98), Expect = 5e-04
 Identities = 35/169 (20%), Positives = 72/169 (42%), Gaps = 30/169 (17%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHR 300
            ++    R+GEG FG++++G         ++N Q+A+K    +  +S    L +    ++
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGT------NLLNNQQVAIK---FEPRRSDAPQLRDEYRTYK 60

Query: 301 LRH--KHLVHLVGWCHEKGKLLLVYDFMPNG-SLEKYLYGTSEQVTLNWNHRYKILTGVA 357
           L      + ++  +  E    +LV D +  G SLE  L             ++ + T   
Sbjct: 61  LLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLC--------GRKFSVKTVAM 110

Query: 358 SAVYYLQN-EY--DQKVVHRDLKASNILLDADFNAR-----LGDFGLAR 398
           +A   L   +   ++ +V+RD+K  N L+    +       + DFG+ +
Sbjct: 111 AAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 40.8 bits (96), Expect = 8e-04
 Identities = 39/166 (23%), Positives = 69/166 (41%), Gaps = 26/166 (15%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLA-ELAIIH 299
           N +    ++G G FG +Y G             ++A+K    + +K+K   L  E  I  
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGT------DIAAGEEVAIK---LECVKTKHPQLHIESKIYK 59

Query: 300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTS-EQVTLNWNHRYKILTGVAS 358
            ++    +  + WC  +G     Y+ M    +E  L G S E +    + ++ + T +  
Sbjct: 60  MMQGGVGIPTIRWCGAEGD----YNVM---VME--LLGPSLEDLFNFCSRKFSLKTVLLL 110

Query: 359 AVYYLQN-EY--DQKVVHRDLKASNILLDADFNA---RLGDFGLAR 398
           A   +   EY   +  +HRD+K  N L+          + DFGLA+
Sbjct: 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	568
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3ujo_A	281	Legume lectin; carbohydrate-binding, galactose, ad	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1qnw_A	242	Chitin binding lectin, UEA-II; carbohydrate bindin	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	100.0
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	100.0
2bqp_A	234	Protein (PEA lectin); D-glucopyranose complex, sug	100.0
1g7y_A	253	Stem/LEAF lectin DB58; jelly roll fold, sugar bind	100.0
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	100.0
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	100.0
1wbf_A	242	Protein (agglutinin); lectin (agglutinin), legume	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1hql_A	257	Lectin; xenograft antigen, sugar BI protein; HET:	100.0
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1gsl_A	243	Griffonia simplicifolia lectin 4; glycoprotein, ma	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	100.0
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	100.0
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	99.97
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	99.97
2ltn_A	181	PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO	99.96
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
2dur_A	253	VIP36;, vesicular integral-membrane protein VIP36;	99.87
1gv9_A	260	P58/ergic-53; lectin, carbohydrate binding; 1.46A	99.84
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.77
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.6
2a6y_A	256	EMP47P (FORM1); beta sandwich, carbohydrate bindin	99.47
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.15
2ltn_B	52	PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP	99.06
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.03
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.8
2a6z_A	222	EMP47P (FORM2); beta sandwich, carbohydrate bindin	98.63
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.46
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.37
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.36
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.24
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.23
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.2
1qmo_A	113	Mannose binding lectin, FRIL; crosslink, hematopoi	98.16
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.86
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.76
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.6
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.55
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.34
2a6v_A	226	EMP46P; beta sandwich, carbohydrate binding protei	97.18
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.16
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.8
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.75
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.7
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.62
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.61
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.56
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.29
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.58
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.34
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.2
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.52
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	86.39
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.26
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	81.72
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	81.39
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	80.86
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	80.58

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3e-56  Score=457.49  Aligned_cols=269  Identities=25%  Similarity=0.433  Sum_probs=212.1

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|...++||+|+||+||+|+++.... ..+++.||||+++..+....++|.+|+++|++++|||||+++|+|.+.+.++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~-~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLP-EQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC----CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCccc-CCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            467778899999999999999863110 1257899999998877777789999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCC------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc
Q 008374          321 LVYDFMPNGSLEKYLYGTSE------------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN  388 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~  388 (568)
                      ||||||++|+|.++|+....            ...++|.+++.|+.|||+||+|||   +++|+||||||+||||+++++
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCc
Confidence            99999999999999975421            246999999999999999999999   579999999999999999999


Q ss_pred             EEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhH
Q 008374          389 ARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTL  467 (568)
Q Consensus       389 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l  467 (568)
                      +||+|||+|+..........   .....||+.|||||++.+..++.++|||||||+||||+| |+.||......+    +
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~---~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~----~  269 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRV---GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE----A  269 (329)
T ss_dssp             EEECCCC-------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH----H
T ss_pred             EEEcccccceeccCCCccee---cCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH----H
Confidence            99999999997754332211   125679999999999999999999999999999999999 899997543322    2


Q ss_pred             HHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC
Q 008374          468 VDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPY  533 (568)
Q Consensus       468 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~p~  533 (568)
                      ...+    ..+         .....+......+.+++.+||+.||++||||+||++.|+...+.|+
T Consensus       270 ~~~i----~~g---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp  322 (329)
T 4aoj_A          270 IDCI----TQG---------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP  322 (329)
T ss_dssp             HHHH----HHT---------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred             HHHH----HcC---------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence            2111    111         1112223345567888899999999999999999999998766553

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.8e-56  Score=450.66  Aligned_cols=264  Identities=25%  Similarity=0.444  Sum_probs=214.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|...++||+|+||+||+|++..... ..++..||||+++..+....++|.+|+++|++++|||||+++|+|.+.+.++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~-~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCP-EQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC-----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCccc-CCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            467888999999999999999863111 1257899999998877777789999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCC----------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEE
Q 008374          321 LVYDFMPNGSLEKYLYGTS----------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR  390 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~k  390 (568)
                      ||||||++|+|.++|+...          ....++|.+++.++.|||+||.|||   +++|+||||||+||||++++++|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEE
Confidence            9999999999999996532          2347999999999999999999999   57999999999999999999999


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHH
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~  469 (568)
                      |+|||+|+...........   ....||+.|||||++.+..++.++|||||||+||||+| |+.||......+    +..
T Consensus       169 i~DFGla~~~~~~~~~~~~---~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~----~~~  241 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVG---GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE----VIE  241 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEET---TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----HHH
T ss_pred             ECCcccceecCCCCceeec---CceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH
Confidence            9999999976544322111   14569999999999999999999999999999999998 899998654322    221


Q ss_pred             HHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          470 WVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       470 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      .+    ..+.         ....+......+.+++..||+.||++||||+||++.|+..
T Consensus       242 ~i----~~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          242 CI----TQGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             HH----HHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH----HcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            11    1111         1122233456678889999999999999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.3e-55  Score=448.68  Aligned_cols=263  Identities=25%  Similarity=0.396  Sum_probs=211.7

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++...++||+|+||+||+|++..... ..+++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+.+.++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~-~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAP-GEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC--------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCcc-CCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            45567899999999999999853111 12578999999976533 34578999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC
Q 008374          321 LVYDFMPNGSLEKYLYGTS-------------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF  387 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~  387 (568)
                      ||||||++|+|.++|....             ....++|.++++|+.|||+||+|||   +++|+||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence            9999999999999996532             1346999999999999999999999   57999999999999999999


Q ss_pred             cEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhh
Q 008374          388 NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYT  466 (568)
Q Consensus       388 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~  466 (568)
                      ++||+|||+|+..........   .....||+.|||||++.++.++.++|||||||+||||+| |+.||......+    
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~---~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~----  255 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKL---LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD----  255 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCS---SSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH----
T ss_pred             CEEECCcccceeccCCCceeE---ecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH----
Confidence            999999999997754432211   125679999999999999999999999999999999998 899998654322    


Q ss_pred             HHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          467 LVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       467 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      +...+    ..+         ...+.+.+.+..+.+++..||+.||++||||.||++.|+.-
T Consensus       256 ~~~~i----~~~---------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          256 VVEMI----RNR---------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHH----HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHH----HcC---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            22211    111         11223334556788899999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-54  Score=437.90  Aligned_cols=258  Identities=26%  Similarity=0.420  Sum_probs=201.1

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      +++...++||+|+||+||+|++.         ..||||+++..  +.+..++|.+|+++|++++|||||+++|+|.+ +.
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~---------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~  105 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH---------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN  105 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS---------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC---------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence            46777889999999999999864         25899998654  33455789999999999999999999999865 56


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      ++||||||++|+|.++|+..  ...++|.+++.|+.|||+||+|||   +++|+||||||+||||++++++||+|||+|+
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  180 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLAT  180 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred             EEEEEEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCce
Confidence            89999999999999999653  346999999999999999999999   5799999999999999999999999999999


Q ss_pred             ccccccccccccccccCCcCCcccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHT---GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~---~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      ..........   ....+||+.|||||++..   +.|+.++|||||||+||||+||+.||.......   .+..    ..
T Consensus       181 ~~~~~~~~~~---~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~---~~~~----~~  250 (307)
T 3omv_A          181 VKSRWSGSQQ---VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD---QIIF----MV  250 (307)
T ss_dssp             C---------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHH----HH
T ss_pred             ecccCCccee---ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH---HHHH----HH
Confidence            7654322211   225689999999999863   468999999999999999999999997543322   1111    11


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ..+.    ..+.+ .....+....+.+++..||+.||++||||.||++.|+..
T Consensus       251 ~~~~----~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          251 GRGY----ASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             HTTC----CCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             hcCC----CCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            1111    11111 112223455677888999999999999999999888753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.5e-52  Score=428.68  Aligned_cols=250  Identities=23%  Similarity=0.356  Sum_probs=208.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      +.|+..++||+|+||+||+|+.+.      +++.||||++........+.+.+|+++|++++|||||++++++.+.+.+|
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  147 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRS------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  147 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECC------CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            458888999999999999999875      68899999998766666778999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      ||||||++|+|.+++..    ..+++.+...++.||+.||.|||   +++|+||||||+||||+.++.+||+|||+|+.+
T Consensus       148 ivmEy~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  220 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV  220 (346)
T ss_dssp             EEECCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceec
Confidence            99999999999999953    45999999999999999999999   679999999999999999999999999999987


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      .......     ...+||+.|||||++....|+.++|||||||++|||++|+.||.......    +...+.    .+  
T Consensus       221 ~~~~~~~-----~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~i~----~~--  285 (346)
T 4fih_A          221 SKEVPRR-----KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMIR----DN--  285 (346)
T ss_dssp             CSSSCCB-----CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHH----HS--
T ss_pred             CCCCCcc-----cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHH----cC--
Confidence            6543221     25789999999999999999999999999999999999999997543222    111110    00  


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                         ..+.+  .........+.+++..||+.||++|||+.|+++
T Consensus       286 ---~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          286 ---LPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             ---SCCCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCCCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               11111  111223345667788999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.2e-53  Score=437.72  Aligned_cols=270  Identities=24%  Similarity=0.386  Sum_probs=215.8

Q ss_pred             HHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCC-CceeeEEEEE
Q 008374          236 LKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRH-KHLVHLVGWC  313 (568)
Q Consensus       236 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H-~nIv~l~g~~  313 (568)
                      .+...++|...++||+|+||+||+|++...+. ...++.||||++..... ...++|.+|+++|.+++| ||||+++|+|
T Consensus        59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~-~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~  137 (353)
T 4ase_A           59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC  137 (353)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEETSSS-TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cEecHHHeEEeeEEecCCCeEEEEEEEcCCCc-ccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence            33445789999999999999999999875322 12457899999976543 345679999999999965 9999999999


Q ss_pred             EeC-CeEEEEEEecCCCChhhhhccCCC-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 008374          314 HEK-GKLLLVYDFMPNGSLEKYLYGTSE-------------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKAS  379 (568)
Q Consensus       314 ~~~-~~~~lV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~  379 (568)
                      .+. +.++||||||++|+|.++|+....             ...++|.+++.++.|||+||+|||   +++|+||||||+
T Consensus       138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~  214 (353)
T 4ase_A          138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAAR  214 (353)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred             EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCcc
Confidence            765 578999999999999999975321             345899999999999999999999   679999999999


Q ss_pred             CEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 008374          380 NILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMI  458 (568)
Q Consensus       380 NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~  458 (568)
                      ||||++++.+||+|||+|+.+........   .....||+.|||||++.+..|+.++|||||||+||||+| |+.||...
T Consensus       215 NILl~~~~~vKi~DFGlar~~~~~~~~~~---~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          215 NILLSEKNVVKICDFGLARDIYKDPDYVR---KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEE---ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ceeeCCCCCEEECcchhhhhcccCCCcee---eccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999997755432211   124679999999999999999999999999999999998 99999865


Q ss_pred             CcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          459 PHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       459 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ....   .+...             +....+...+......+.+++..||+.||++|||+.||++.|+..
T Consensus       292 ~~~~---~~~~~-------------i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          292 KIDE---EFCRR-------------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             CCSH---HHHHH-------------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHH---HHHHH-------------HHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            4332   11111             111112222233445677888999999999999999999998753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.5e-52  Score=425.52  Aligned_cols=256  Identities=20%  Similarity=0.203  Sum_probs=203.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .+.|...++||+|+||+||+|+.+.      +++.||||+++...     .+.+|+.++++++|||||++++++.+.+.+
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~------~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~  125 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQ------TGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWV  125 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECC------CCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3568888899999999999999875      68999999997542     235799999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-cEEEeecCCcc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF-NARLGDFGLAR  398 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~-~~kL~DFGla~  398 (568)
                      |||||||++|+|.++|..   ...+++.+...++.||+.||.|||   +++|+||||||+||||+.++ .+||+|||+|+
T Consensus       126 ~ivmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~  199 (336)
T 4g3f_A          126 NIFMELLEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHAL  199 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred             EEEEeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence            999999999999999953   356999999999999999999999   78999999999999999987 59999999999


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      .+...............+||+.|||||++.+..|+.++|||||||++|||+||+.||...........+.       ...
T Consensus       200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~-------~~~  272 (336)
T 4g3f_A          200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA-------SEP  272 (336)
T ss_dssp             EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH-------HSC
T ss_pred             EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH-------cCC
Confidence            8765432211111225689999999999999999999999999999999999999998544333111111       000


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      .       .+ ..........+.+++.+||+.||.+|||+.|+++.|..
T Consensus       273 ~-------~~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          273 P-------PI-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             C-------GG-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C-------Cc-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            0       00 01112233456677889999999999999999988764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.9e-52  Score=421.32  Aligned_cols=270  Identities=23%  Similarity=0.293  Sum_probs=200.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC---
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG---  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~---  317 (568)
                      +++...++||+|+||+||+|++        .++.||||+++.... ....+..|+..+.+++|||||+++|+|.+.+   
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--------~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~   73 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--------RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTW   73 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--------TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--------CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCc
Confidence            4577788999999999999987        368899999965422 1223345667778899999999999998764   


Q ss_pred             -eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCCEEEcCCCcEEE
Q 008374          318 -KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE-----YDQKVVHRDLKASNILLDADFNARL  391 (568)
Q Consensus       318 -~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivHrDikp~NILld~~~~~kL  391 (568)
                       .++||||||++|+|.++|+.    ..++|..+.+++.|+++||+|||+.     +.++|+||||||+|||||+++++||
T Consensus        74 ~~~~lV~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki  149 (303)
T 3hmm_A           74 TQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             EEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             eEEEEEecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEE
Confidence             68999999999999999953    4599999999999999999999954     2459999999999999999999999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCccccccC------CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchh
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG------KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY  465 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~------~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~  465 (568)
                      +|||+|+........... .....+||+.|||||++.+.      .++.++|||||||+||||+||+.|+.........+
T Consensus       150 ~DFGla~~~~~~~~~~~~-~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~  228 (303)
T 3hmm_A          150 ADLGLAVRHDSATDTIDI-APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             CCCTTCEEEETTTTEESC-C-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EeCCCCccccCCCCceee-ecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence            999999987654332211 12246799999999998654      46789999999999999999988775322211100


Q ss_pred             -------hHHHHHHHHhhcCchhhhhhhhcCCC-CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          466 -------TLVDWVWMLHREGHIQDAVDQRLNIN-SVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       466 -------~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                             ...+........+.    .++.+... ...+....+.+++.+||+.||++||||.||++.|+..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          229 YDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhcccccchHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence                   01111111111111    11111111 1235667788999999999999999999999999764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.4e-52  Score=429.45  Aligned_cols=251  Identities=23%  Similarity=0.353  Sum_probs=201.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|...++||+|+||+||+|+.+.      +++.||||++....  ....+.|.+|+++|++++|||||++++++.+.+.
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   97 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTE------DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGS   97 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETT------TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cceEEeEEEecCCCeEEEEEEECC------CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence            579999999999999999999875      68999999997643  3345679999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      +|||||||++|+|.++|.... ...+++.+...++.||+.||.|||   +++|+||||||+||||++++.+||+|||+|+
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~  173 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIAR  173 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEES
T ss_pred             EEEEEeCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccce
Confidence            999999999999999996432 345788999999999999999999   6799999999999999999999999999999


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      .+......     ....+||+.|||||++.+..|+.++|||||||+||||+||+.||.......       ...... .+
T Consensus       174 ~~~~~~~~-----~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~-~~  240 (350)
T 4b9d_A          174 VLNSTVEL-----ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-------LVLKII-SG  240 (350)
T ss_dssp             CCCHHHHH-----HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHH-HT
T ss_pred             eecCCccc-----ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHH-cC
Confidence            87543221     124679999999999999999999999999999999999999997543222       111111 11


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ..     +.    ........+.+++.+||+.||++|||++|+++
T Consensus       241 ~~-----~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          241 SF-----PP----VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CC-----CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CC-----CC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11     01    11122345667788999999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-51  Score=415.22  Aligned_cols=245  Identities=22%  Similarity=0.355  Sum_probs=195.2

Q ss_pred             cccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEe----CC
Q 008374          244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE----KG  317 (568)
Q Consensus       244 ~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~  317 (568)
                      ...++||+|+||+||+|+...      ++..||+|++...  .....+.|.+|+++|++++|||||+++++|..    ++
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~  102 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTE------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred             EeeeEEecCcCcEEEEEEECC------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence            556789999999999999875      6889999999654  23345679999999999999999999999865    35


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEEcC-CCcEEEeec
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQK--VVHRDLKASNILLDA-DFNARLGDF  394 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDikp~NILld~-~~~~kL~DF  394 (568)
                      .++||||||++|+|.++|..   ...+++..+..++.||+.||+|||   +++  |+||||||+||||+. ++.+||+||
T Consensus       103 ~~~lvmEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DF  176 (290)
T 3fpq_A          103 CIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred             EEEEEEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeC
Confidence            68999999999999999953   356999999999999999999999   455  999999999999984 799999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      |+|+......       ....+||+.|||||++. +.|+.++|||||||++|||+||+.||.......   .+.    ..
T Consensus       177 Gla~~~~~~~-------~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~---~~~----~~  241 (290)
T 3fpq_A          177 GLATLKRASF-------AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA---QIY----RR  241 (290)
T ss_dssp             TGGGGCCTTS-------BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH---HHH----HH
T ss_pred             cCCEeCCCCc-------cCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH---HHH----HH
Confidence            9998644321       12568999999999886 469999999999999999999999997433222   111    11


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ...+......        +......+.+++..||+.||++|||++|+++
T Consensus       242 i~~~~~~~~~--------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          242 VTSGVKPASF--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HTTTCCCGGG--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHcCCCCCCC--------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111110111        1111234667788999999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.3e-51  Score=429.59  Aligned_cols=250  Identities=24%  Similarity=0.364  Sum_probs=208.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      +.|+..++||+|+||.||+|+.+.      +++.||||++........+.+.+|+.+|++++|||||++++++.+.+.+|
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRS------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECC------CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence            468899999999999999999875      68999999998776666778999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      ||||||++|+|.+++..    ..+++.+...++.||+.||.|||   +++|+||||||+||||+.++.+||+|||+|+.+
T Consensus       225 iVmEy~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~  297 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV  297 (423)
T ss_dssp             EEEECCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred             EEEeCCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceEC
Confidence            99999999999999943    45899999999999999999999   679999999999999999999999999999987


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      .......     ...+||+.|||||++....|+.++|||||||++|||++|+.||.......    +...+    ..   
T Consensus       298 ~~~~~~~-----~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~i----~~---  361 (423)
T 4fie_A          298 SKEVPRR-----KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMI----RD---  361 (423)
T ss_dssp             CSSCCCB-----CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHH----HH---
T ss_pred             CCCCccc-----cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHH----Hc---
Confidence            6543221     25789999999999999999999999999999999999999997543222    11111    00   


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        ...+.+.  ........+..++..||+.||++|||+.|+++
T Consensus       362 --~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          362 --NLPPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             --SCCCCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CCCCCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              0111111  11122345667778999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.8e-51  Score=413.60  Aligned_cols=251  Identities=24%  Similarity=0.305  Sum_probs=196.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|+..++||+|+||+||+|+...+.   .+++.||||++++..  ......+.+|+++|++++|||||++++++.+.+.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGS---DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSST---TTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCC---CCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            56999999999999999999875321   257899999997643  2334568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      ++||||||++|+|.++|..   ...+++.+...++.||+.||.|||   +++|+||||||+|||+++++.+||+|||+|+
T Consensus       101 ~~ivmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~  174 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK  174 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred             EEEEEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccce
Confidence            9999999999999999953   456999999999999999999999   6799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ........     ....+||+.|||||++.+..|+.++|||||||++|||+||+.||......+    +...        
T Consensus       175 ~~~~~~~~-----~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----~~~~--------  237 (304)
T 3ubd_A          175 ESIDHEKK-----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE----TMTM--------  237 (304)
T ss_dssp             C-----CC-----CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH--------
T ss_pred             eccCCCcc-----ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH----HHHH--------
Confidence            76443221     125689999999999999999999999999999999999999998543322    1111        


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK-----TEDILQ  523 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt-----~~evl~  523 (568)
                          +....+  ..+......+.+++..||+.||++|||     ++|+++
T Consensus       238 ----i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          238 ----ILKAKL--GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             ----HHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             ----HHcCCC--CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                111111  111122345667788999999999998     467764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3e-51  Score=414.61  Aligned_cols=249  Identities=23%  Similarity=0.295  Sum_probs=205.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|+..++||+|+||+||+|+.+.      +++.||||++.+..   ....+.+.+|+++|++++|||||++++++.+.+
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  105 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELA------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE  105 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cccEEEEEEecccCeEEEEEEECC------CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            579999999999999999999875      78899999997542   234567899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .+|||||||++|+|.+++..   ...+++.+...++.||+.||.|||   +++|+||||||+||||++++.+||+|||+|
T Consensus       106 ~~yivmEy~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla  179 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA  179 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCc
Confidence            99999999999999999953   356999999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +.+........   ....+||+.|||||++.+..|+.++||||+||++|||+||+.||.......    +..-       
T Consensus       180 ~~~~~~~~~~~---~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~-------  245 (311)
T 4aw0_A          180 KVLSPESKQAR---ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL----IFAK-------  245 (311)
T ss_dssp             EECCTTTTCCC---BCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH-------
T ss_pred             eecCCCCCccc---ccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHH-------
Confidence            98754322111   126789999999999999999999999999999999999999997543222    1111       


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDIL  522 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl  522 (568)
                           ++...+  .++......+.+++.+|++.||++|||++|++
T Consensus       246 -----i~~~~~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          246 -----IIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -----HHHTCC--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -----HHcCCC--CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                 111111  11112233456777899999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.4e-50  Score=400.40  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=191.3

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|+..++||+|+||+||+|+...      +++.||||++.+..   ....+.+.+|++++++++|||||++++++.+.+
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   86 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTT------TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD   86 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTT------TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             eCeEEEEEEecCcCeEEEEEEECC------CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            679999999999999999998765      68999999997643   223457899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .+++||||| +|+|.+++..   ...+++.+...++.||+.||+|||   +++|+||||||+|||+++++++||+|||+|
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla  159 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLS  159 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC
T ss_pred             EEEEEEeCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCC
Confidence            999999999 6899999854   346999999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      +........      ...+||+.|||||++.+..+ +.++||||+||++|||+||+.||.......    +..   . ..
T Consensus       160 ~~~~~~~~~------~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~----~~~---~-i~  225 (275)
T 3hyh_A          160 NIMTDGNFL------KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV----LFK---N-IS  225 (275)
T ss_dssp             ---------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH---H-HH
T ss_pred             eecCCCCcc------CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH----HHH---H-HH
Confidence            876543221      25689999999999988776 579999999999999999999997543221    111   1 11


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhC
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISG  527 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L~~  527 (568)
                      .+        ...  .+......+.+++.+|++.||++|||++|+++  .++.
T Consensus       226 ~~--------~~~--~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          226 NG--------VYT--LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HT--------CCC--CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             cC--------CCC--CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            11        111  11122345567788999999999999999987  4543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9.8e-50  Score=404.08  Aligned_cols=255  Identities=23%  Similarity=0.370  Sum_probs=190.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCC--
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG--  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--  317 (568)
                      ++|+..+.||+|+||+||+|+.+.      +++.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+  
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~   78 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKV------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT   78 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETT------TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred             hhCEEeeEEecCCCeEEEEEEECC------CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence            468899999999999999999875      688999999976543 34567999999999999999999999987654  


Q ss_pred             ----------eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC
Q 008374          318 ----------KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF  387 (568)
Q Consensus       318 ----------~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~  387 (568)
                                .+++|||||++|+|.+++..........+.....++.||++||+|||   +++|+||||||+||||+.++
T Consensus        79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~  155 (299)
T 4g31_A           79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDD  155 (299)
T ss_dssp             --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTC
T ss_pred             ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCC
Confidence                      37999999999999999976554455677888999999999999999   67999999999999999999


Q ss_pred             cEEEeecCCcccccccccccc-------ccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 008374          388 NARLGDFGLARAIENERNSYA-------EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPH  460 (568)
Q Consensus       388 ~~kL~DFGla~~~~~~~~~~~-------~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~  460 (568)
                      .+||+|||+|+.+........       .......+||+.|||||++.+..|+.++|||||||++|||++   ||....+
T Consensus       156 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~  232 (299)
T 4g31_A          156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME  232 (299)
T ss_dssp             CEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH
Confidence            999999999998765432211       011224679999999999999999999999999999999996   7652111


Q ss_pred             ccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          461 QQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       461 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                            ....... .......         ....+.......++.+||+.||++|||+.|+++
T Consensus       233 ------~~~~~~~-~~~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          233 ------RVRTLTD-VRNLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             ------HHHHHHH-HHTTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------HHHHHHH-HhcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  0110000 1111111         111222334567888999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.1e-47  Score=390.61  Aligned_cols=297  Identities=35%  Similarity=0.641  Sum_probs=253.2

Q ss_pred             CcccCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCce
Q 008374          228 PREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHL  306 (568)
Q Consensus       228 ~~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nI  306 (568)
                      .+.+++.++..++++|...+.||+|+||.||+|...       +++.||||++..... .....+.+|++++++++||||
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i   89 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-------DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL   89 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-------SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTB
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEec-------CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCc
Confidence            567999999999999999999999999999999754       578899999976543 234578999999999999999


Q ss_pred             eeEEEEEEeCCeEEEEEEecCCCChhhhhccCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC
Q 008374          307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTS-EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA  385 (568)
Q Consensus       307 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~  385 (568)
                      ++++++|...+..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||..+..+|+||||||+|||++.
T Consensus        90 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~  169 (326)
T 3uim_A           90 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE  169 (326)
T ss_dssp             CCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT
T ss_pred             cceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC
Confidence            999999999999999999999999999997643 2345999999999999999999999655559999999999999999


Q ss_pred             CCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC-cccch
Q 008374          386 DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIP-HQQHA  464 (568)
Q Consensus       386 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~-~~~~~  464 (568)
                      ++.+||+|||+++...........    ...||+.|+|||.+.+..++.++||||||+++|||++|+.||+... .....
T Consensus       170 ~~~~kl~Dfg~~~~~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  245 (326)
T 3uim_A          170 EFEAVVGDFGLAKLMDYKDTHVTT----AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD  245 (326)
T ss_dssp             TCCEEECCCSSCEECCSSSSCEEC----CCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSC
T ss_pred             CCCEEeccCccccccCcccccccc----cccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccc
Confidence            999999999999877544332222    4569999999999998899999999999999999999999996211 11112


Q ss_pred             hhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCC
Q 008374          465 YTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVP  535 (568)
Q Consensus       465 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~p~~p  535 (568)
                      ..+.+|+........+....+..+......+....+.+++..|++.||.+|||+.||++.|++.......+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~  316 (326)
T 3uim_A          246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE  316 (326)
T ss_dssp             SBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC
T ss_pred             hhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhh
Confidence            25777877777777788888888888888999999999999999999999999999999999876665543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.4e-46  Score=383.37  Aligned_cols=287  Identities=32%  Similarity=0.618  Sum_probs=244.3

Q ss_pred             cccCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceee
Q 008374          229 REFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH  308 (568)
Q Consensus       229 ~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~  308 (568)
                      .++.+.++..++++|...+.||+|+||.||+|++.       +++.||||++........+.+.+|+.++++++||||++
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   99 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVS   99 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEEC-------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEee
Confidence            45566677778899999999999999999999865       57899999998776667788999999999999999999


Q ss_pred             EEEEEEeCCeEEEEEEecCCCChhhhhccCCC-cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC
Q 008374          309 LVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE-QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF  387 (568)
Q Consensus       309 l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~  387 (568)
                      ++++|.+.+..++||||+++|+|.+++..... ...++|..+..++.|++.||.|||   +++++||||||+|||++.++
T Consensus       100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~  176 (321)
T 2qkw_B          100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENF  176 (321)
T ss_dssp             EEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTC
T ss_pred             EEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCC
Confidence            99999999999999999999999999965432 346999999999999999999999   57999999999999999999


Q ss_pred             cEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhH
Q 008374          388 NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTL  467 (568)
Q Consensus       388 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l  467 (568)
                      .+||+|||+++..........   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ...+
T Consensus       177 ~~kl~Dfg~~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~-~~~~  252 (321)
T 2qkw_B          177 VPKITDFGISKKGTELDQTHL---STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVNL  252 (321)
T ss_dssp             CEEECCCTTCEECSSSSCCCC---BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS-CCCH
T ss_pred             CEEEeeccccccccccccccc---ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH-HHHH
Confidence            999999999987543322111   124568999999999998999999999999999999999999997433322 2356


Q ss_pred             HHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          468 VDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       468 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                      ..|.......+.+.+.+++.+......+....+.+++..|++.||++|||+.||++.|+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             HHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            77777777777777788887777778889999999999999999999999999999998653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-46  Score=391.25  Aligned_cols=269  Identities=19%  Similarity=0.255  Sum_probs=199.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEe---
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE---  315 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~---  315 (568)
                      ++|...++||+|+||+||+|+.+.      +++.||||+++...  ....+.+.+|+++|++++|||||++++++..   
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~------t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  127 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRL------TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP  127 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred             CCeEEEEEEecccCeEEEEEEECC------CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence            579999999999999999999875      78999999997643  2334678899999999999999999999764   


Q ss_pred             ---CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          316 ---KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       316 ---~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                         .+.+|||||||+ |+|.+++..   ...+++.+...++.||+.||.|||   +++|+||||||+|||++.++.+||+
T Consensus       128 ~~~~~~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~  200 (398)
T 4b99_A          128 YGEFKSVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIG  200 (398)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEEC
T ss_pred             cccCCEEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEe
Confidence               368999999995 789999953   457999999999999999999999   6799999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      |||+|+.+....... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...........+....
T Consensus       201 DFGla~~~~~~~~~~-~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~  279 (398)
T 4b99_A          201 DFGMARGLCTSPAEH-QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL  279 (398)
T ss_dssp             CCTTCBCC--------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred             ecceeeecccCcccc-ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence            999999765432111 1112367899999999998765 56899999999999999999999998654333111111110


Q ss_pred             HH-------HhhcCchhhhhhhhc-CCCCcH-----HHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          472 WM-------LHREGHIQDAVDQRL-NINSVV-----DEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       472 ~~-------~~~~~~~~~~~d~~l-~~~~~~-----~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ..       ..........+.... ......     .....+.+|+.+||+.||.+|||++|+++
T Consensus       280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00       000000000000000 000000     11235667888999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.8e-45  Score=382.67  Aligned_cols=208  Identities=22%  Similarity=0.334  Sum_probs=173.4

Q ss_pred             HHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeEEEEEEe
Q 008374          237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHE  315 (568)
Q Consensus       237 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~  315 (568)
                      ....+.|+..++||+|+||+||+|+.+.+.   .+++.||||++....  ...++.+|+++|..+ +||||+++++++.+
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~---~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQV---GPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTT---SCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccC---CCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            345678999999999999999999875321   157899999986543  345688999999998 69999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-CcEEEeec
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD-FNARLGDF  394 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~-~~~kL~DF  394 (568)
                      .+.++||||||++|+|.+++.      .+++.+...++.|++.||.|||   +++|+||||||+|||++.+ +.+||+||
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence            999999999999999999982      4889999999999999999999   6799999999999999877 79999999


Q ss_pred             CCcccccccccccc-----------------------ccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHh
Q 008374          395 GLARAIENERNSYA-----------------------EHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVC  450 (568)
Q Consensus       395 Gla~~~~~~~~~~~-----------------------~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~t  450 (568)
                      |+|+..........                       .......+||+.|||||++.+. .++.++||||+||+++||+|
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence            99986643221100                       0112245799999999998765 58999999999999999999


Q ss_pred             CCCCCCCC
Q 008374          451 GRSPGNMI  458 (568)
Q Consensus       451 G~~P~~~~  458 (568)
                      |+.||...
T Consensus       243 G~~Pf~~~  250 (361)
T 4f9c_A          243 GRYPFYKA  250 (361)
T ss_dssp             TCSSSSCC
T ss_pred             CCCCCCCC
Confidence            99999643

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.4e-45  Score=403.93  Aligned_cols=253  Identities=18%  Similarity=0.258  Sum_probs=208.6

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .++|...++||+|+||.||+|+.+.      +++.||+|.+........+.+.+|+++|+.++|||||++++++.+.+.+
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~------tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  229 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERA------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM  229 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECC------CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            4679999999999999999999875      7889999999877666677899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC--CcEEEeecCCc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD--FNARLGDFGLA  397 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~--~~~kL~DFGla  397 (568)
                      +||||||++|+|.++|...  ...+++.+...++.||+.||.|||   +++|+||||||+|||++.+  +.+||+|||+|
T Consensus       230 ~iv~E~~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a  304 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLT  304 (573)
T ss_dssp             EEEEECCCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSC
T ss_pred             EEEEeecCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccce
Confidence            9999999999999999532  346899999999999999999999   6799999999999999854  89999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +.+......      ...+||+.|||||++.+..|+.++||||+||++|||++|+.||.......    ...   . ...
T Consensus       305 ~~~~~~~~~------~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~----~~~---~-i~~  370 (573)
T 3uto_A          305 AHLDPKQSV------KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----TLR---N-VKS  370 (573)
T ss_dssp             EECCTTSEE------EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHH---H-HHT
T ss_pred             eEccCCCce------eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHH---H-HHh
Confidence            987654322      24579999999999999999999999999999999999999997543322    111   1 111


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      +.      ..+...........+.+|+..||+.||.+|||+.|+++
T Consensus       371 ~~------~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          371 CD------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             TC------CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            10      01111111122344567788999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.7e-45  Score=399.42  Aligned_cols=264  Identities=21%  Similarity=0.274  Sum_probs=205.8

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhh---HHHHHHhhcCCCCceeeEEEEE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDF---LAELAIIHRLRHKHLVHLVGWC  313 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~H~nIv~l~g~~  313 (568)
                      .++|...++||+|+||+||+|+.+.      +++.||||++.+...   ......   ..++.+++.++|||||++++++
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~------tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f  261 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKAD------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF  261 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECC------CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE
Confidence            3679999999999999999999875      789999999965321   112223   3446777888999999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEee
Q 008374          314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD  393 (568)
Q Consensus       314 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~D  393 (568)
                      .+.+.+|||||||++|+|.++|..   ...+++.....++.||+.||.|||   +++|+||||||+||||+.++.+||+|
T Consensus       262 ~~~~~lylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~D  335 (689)
T 3v5w_A          262 HTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISD  335 (689)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             EECCEEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecc
Confidence            999999999999999999999953   456999999999999999999999   78999999999999999999999999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      ||+|+.+.....       ...+||+.|||||++.. ..|+.++||||+||++|||++|+.||........ ..+...  
T Consensus       336 FGlA~~~~~~~~-------~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-~~i~~~--  405 (689)
T 3v5w_A          336 LGLACDFSKKKP-------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRM--  405 (689)
T ss_dssp             CTTCEECSSCCC-------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-HHHHHH--
T ss_pred             cceeeecCCCCC-------CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHh--
Confidence            999987754322       25689999999999975 5799999999999999999999999974322220 011111  


Q ss_pred             HHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH-----------HHhCCCCCCCCCC
Q 008374          473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK-----TEDILQ-----------IISGTSTVPYVPQ  536 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt-----~~evl~-----------~L~~~~~~p~~p~  536 (568)
                                +....+  ..+......+..++..||+.||.+|++     ++||++           .+.+..+.|..|+
T Consensus       406 ----------i~~~~~--~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~  473 (689)
T 3v5w_A          406 ----------TLTMAV--ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPP  473 (689)
T ss_dssp             ----------HHHCCC--CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred             ----------hcCCCC--CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCC
Confidence                      111111  111122344566777999999999998     688764           3344556665554


Q ss_pred             C
Q 008374          537 F  537 (568)
Q Consensus       537 ~  537 (568)
                      .
T Consensus       474 ~  474 (689)
T 3v5w_A          474 R  474 (689)
T ss_dssp             T
T ss_pred             C
Confidence            3

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=7.7e-44  Score=361.97  Aligned_cols=282  Identities=35%  Similarity=0.625  Sum_probs=231.4

Q ss_pred             CcccCHHHHHHHhcCcccc------ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC----cccchhhHHHHHH
Q 008374          228 PREFKYKELKKATNNFHES------MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS----IKSKGDFLAELAI  297 (568)
Q Consensus       228 ~~~~~~~el~~at~~f~~~------~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~  297 (568)
                      ...|++.++..++++|...      ++||+|+||.||+|..        .+..||||++....    ....+.+.+|+.+
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~   83 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--------NNTTVAVKKLAAMVDITTEELKQQFDQEIKV   83 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--------SSCEEEEEEECCCTTSCTTTHHHHHHHHHHH
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--------CCceEEEEEEecccCcchHHHHHHHHHHHHH
Confidence            4679999999999999888      8999999999999985        46789999986532    2335678999999


Q ss_pred             hhcCCCCceeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 008374          298 IHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK  377 (568)
Q Consensus       298 l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDik  377 (568)
                      +++++||||+++++++.+.+..++||||+++++|.+++........+++..+..++.|++.||.|||   +++++|||||
T Consensus        84 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlk  160 (307)
T 2nru_A           84 MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIK  160 (307)
T ss_dssp             HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred             HHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCC
Confidence            9999999999999999999999999999999999999976544567999999999999999999999   5799999999


Q ss_pred             CCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008374          378 ASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNM  457 (568)
Q Consensus       378 p~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~  457 (568)
                      |+|||+++++.+||+|||+++..........   .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||..
T Consensus       161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~  236 (307)
T 2nru_A          161 SANILLDEAFTAKISDFGLARASEKFAQTVM---TSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDE  236 (307)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSCSSCEE---CSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred             HHHEEEcCCCcEEEeeccccccccccccccc---ccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCccc
Confidence            9999999999999999999987654322211   124579999999998854 589999999999999999999999986


Q ss_pred             CCcccchhhHHHHHHHHhh-cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          458 IPHQQHAYTLVDWVWMLHR-EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       458 ~~~~~~~~~l~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ......   +..+...... ...+.+.+++.+. .........+.+++..|++.||.+|||+.+|++.|+..
T Consensus       237 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          237 HREPQL---LLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             TBSSSB---TTHHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CcchHH---HHHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            544432   2222222222 2234445555443 34567788899999999999999999999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.5e-44  Score=368.50  Aligned_cols=261  Identities=25%  Similarity=0.403  Sum_probs=203.4

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      ...++|...++||+|+||.||+|+.        .+..||||++....  ....++|.+|++++++++||||+++++++..
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  105 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ  105 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--------TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--------CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            3456789999999999999999976        46789999987653  2334679999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEEcCCCcEEEee
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQK--VVHRDLKASNILLDADFNARLGD  393 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDikp~NILld~~~~~kL~D  393 (568)
                      .+..++||||+++|+|.+++........+++..+..++.|++.||+|||   +++  |+||||||+|||++.++.+||+|
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~D  182 (309)
T 3p86_A          106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCD  182 (309)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred             CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECC
Confidence            9999999999999999999976544446999999999999999999999   567  99999999999999999999999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      ||+++........     .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......    ....+. 
T Consensus       183 fg~a~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~----~~~~~~-  252 (309)
T 3p86_A          183 FGLSRLKASTFLS-----SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ----VVAAVG-  252 (309)
T ss_dssp             CC----------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH----HHHHHH-
T ss_pred             CCCCccccccccc-----cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHH-
Confidence            9999865443211     124579999999999999999999999999999999999999997543322    111110 


Q ss_pred             HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 008374          474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST  530 (568)
Q Consensus       474 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~  530 (568)
                        .         .......+......+.+++..||+.||.+|||+.|+++.|+....
T Consensus       253 --~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          253 --F---------KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             --H---------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             --h---------cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence              0         001111222333457778889999999999999999999987543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2e-43  Score=362.22  Aligned_cols=263  Identities=24%  Similarity=0.330  Sum_probs=215.3

Q ss_pred             CcccCHHHHHHHhcC----------ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHH
Q 008374          228 PREFKYKELKKATNN----------FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAI  297 (568)
Q Consensus       228 ~~~~~~~el~~at~~----------f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~  297 (568)
                      +..+++++++.+++.          |...++||+|+||.||+|+...      +++.||||++........+.+.+|+.+
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~   95 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKH------SGRQVAVKMMDLRKQQRRELLFNEVVI   95 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEETTTCCSHHHHHHHHHH
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECC------CCcEEEEEEEeccchhHHHHHHHHHHH
Confidence            346899999999875          6777899999999999999874      688999999987666667789999999


Q ss_pred             hhcCCCCceeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 008374          298 IHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK  377 (568)
Q Consensus       298 l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDik  377 (568)
                      +++++||||+++++++...+..++||||+++++|.+++..    ..+++..+..++.|++.||.|||   +.+|+|||||
T Consensus        96 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlk  168 (321)
T 2c30_A           96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIK  168 (321)
T ss_dssp             HTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred             HHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence            9999999999999999999999999999999999999843    46999999999999999999999   5799999999


Q ss_pred             CCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008374          378 ASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNM  457 (568)
Q Consensus       378 p~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~  457 (568)
                      |+|||++.++.+||+|||+++.........     ....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       169 p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~  243 (321)
T 2c30_A          169 SDSILLTLDGRVKLSDFGFCAQISKDVPKR-----KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS  243 (321)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSSSCCB-----CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             HHHEEECCCCcEEEeeeeeeeecccCcccc-----ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999998765432211     256799999999999999999999999999999999999999975


Q ss_pred             CCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          458 IPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       458 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .....    ......    .     ...+.+.  ........+.+++..|++.||++|||+.|+++
T Consensus       244 ~~~~~----~~~~~~----~-----~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          244 DSPVQ----AMKRLR----D-----SPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             SCHHH----HHHHHH----H-----SSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCHHH----HHHHHh----c-----CCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            43221    111110    0     0011111  11122345677888999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.5e-44  Score=363.37  Aligned_cols=263  Identities=20%  Similarity=0.363  Sum_probs=211.1

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .++|...++||+|+||+||+|+...      +++.||+|++........+.|.+|++++++++||||+++++++.+.+..
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~------~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   82 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRE------TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL   82 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETT------TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECC------CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence            3568889999999999999999875      6889999999776667778899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++|+|.+++...  ...+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  157 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARL  157 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeeccccee
Confidence            9999999999999999653  346899999999999999999999   57999999999999999999999999999987


Q ss_pred             ccccccccc---------ccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH
Q 008374          400 IENERNSYA---------EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       400 ~~~~~~~~~---------~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~  470 (568)
                      .........         ........||+.|+|||.+.+..++.++||||||+++|||++|..|+...........    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~----  233 (310)
T 3s95_A          158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG----  233 (310)
T ss_dssp             CC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS----
T ss_pred             cccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh----
Confidence            654322110         0011145799999999999999999999999999999999999999864322211000    


Q ss_pred             HHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          471 VWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       471 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                             .......+....    ......+.+++..||+.||++|||+.++++.|+..
T Consensus       234 -------~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          234 -------LNVRGFLDRYCP----PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             -------BCHHHHHHHTCC----TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------hhhhccccccCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                   001111111111    12224567788899999999999999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.6e-43  Score=358.88  Aligned_cols=251  Identities=20%  Similarity=0.354  Sum_probs=207.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .++|...++||+|+||+||+|....      +++.||||++........+.+.+|+.++++++||||+++++++...+..
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVA------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTT------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECC------CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence            3578899999999999999998764      6889999999776656667799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++|+|.+++..    ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  165 (297)
T ss_dssp             EEEEECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCcee
Confidence            999999999999999953    35899999999999999999999   57999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      ........     ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......   .+    ......+ 
T Consensus       166 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~----~~~~~~~-  232 (297)
T 3fxz_A          166 ITPEQSKR-----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---AL----YLIATNG-  232 (297)
T ss_dssp             CCSTTCCB-----CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH----HHHHHHC-
T ss_pred             cCCccccc-----CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHHhCC-
Confidence            65543221     24679999999999999999999999999999999999999997543221   11    1111100 


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                             .............+.+++..||+.||.+|||+.|+++
T Consensus       233 -------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          233 -------TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             -------SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -------CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                   1111112233455677888999999999999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.6e-44  Score=367.59  Aligned_cols=265  Identities=26%  Similarity=0.467  Sum_probs=211.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...++||+|+||.||+|++...+.   .+..||||++... .....+.|.+|+.++++++||||+++++++.+.+..
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQ---RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTS---CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCC---CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            457778999999999999999875322   4567999999765 334456799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus       126 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            9999999999999999543  346999999999999999999999   57999999999999999999999999999998


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ..........  .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......    +..         
T Consensus       201 ~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~---------  265 (325)
T 3kul_A          201 LEDDPDAAYT--TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD----VIS---------  265 (325)
T ss_dssp             CC----CCEE--CC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH----HHH---------
T ss_pred             cccCccceee--ccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH----HHH---------
Confidence            7654322111  113456889999999998999999999999999999999 999997543322    111         


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVP  532 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~p  532 (568)
                          .+...............+.+++..||+.||.+|||+.||++.|+.....|
T Consensus       266 ----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          266 ----SVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             ----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             ----HHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence                11111122223334456778888999999999999999999999864443

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.9e-43  Score=369.65  Aligned_cols=266  Identities=26%  Similarity=0.454  Sum_probs=213.2

Q ss_pred             hcCccccceeccCCceeEEEEEEccCcc-ccccCeEEEEEEeccCC-cccchhhHHHHHHhhcC-CCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQ-YHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  316 (568)
                      .++|...+.||+|+||.||+|+....+. ....+..||||++.... ....+++.+|+.+++++ +||||++++++|.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            4678899999999999999998753211 12256789999997653 23456799999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCC-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSE-------------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL  383 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl  383 (568)
                      +.+++||||+++|+|.+++.....             ...+++.++..++.||+.||.|||   +++|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            999999999999999999965321             235899999999999999999999   5799999999999999


Q ss_pred             cCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 008374          384 DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQ  462 (568)
Q Consensus       384 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~  462 (568)
                      +.++.+||+|||+++..........   .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKK---TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCT---TTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             CCCCCEEEccccCCcccCcccceec---ccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            9999999999999987654322111   124567889999999999999999999999999999999 999997654332


Q ss_pred             chhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          463 HAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       463 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                          +...             +........+......+.+++..||+.||.+|||+.|+++.|+..
T Consensus       314 ----~~~~-------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          314 ----LFKL-------------LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             ----HHHH-------------HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HHHH-------------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                1111             111111122223445677888899999999999999999999864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.1e-43  Score=371.87  Aligned_cols=262  Identities=29%  Similarity=0.480  Sum_probs=200.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...+.||+|+||.||+|++...+   ..+..||||+++... ....++|.+|+.++++++||||++++++|.+.+..
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPS---KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTT---SCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCC---CCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            57888999999999999999876321   146789999997653 34456899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++|+|.+++...  ...+++.++..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus       122 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            9999999999999999643  346899999999999999999999   56999999999999999999999999999988


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ..........  .....+|..|+|||++....++.++||||||+++|||++ |+.||.......    +.          
T Consensus       197 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~----~~----------  260 (373)
T 2qol_A          197 LEDDPEAAYT--TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----VI----------  260 (373)
T ss_dssp             -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH----HH----------
T ss_pred             cccCCcccee--ccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----HH----------
Confidence            7654221111  112346788999999999999999999999999999998 999997543221    11          


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                         +.++..............+.+++..||+.||.+||++.||++.|+...
T Consensus       261 ---~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~  308 (373)
T 2qol_A          261 ---KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI  308 (373)
T ss_dssp             ---HHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence               112222222223344567888999999999999999999999998653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=9.8e-44  Score=372.73  Aligned_cols=257  Identities=25%  Similarity=0.403  Sum_probs=208.8

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .++|...++||+|+||.||+|++..      +++.||||.+.... ....++|.+|++++++++||||++++++|...+.
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  186 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRA------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP  186 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEec------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence            4578889999999999999999875      67899999987543 2345689999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++|+|.+++...  ...+++..+..++.|++.||+|||   +++++||||||+|||++.++.+||+|||+++
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSR  261 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             cEEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence            99999999999999999642  346899999999999999999999   5799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ..........   .....++..|+|||.+....++.++|||||||++|||++ |+.||.......    ..+.       
T Consensus       262 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~----~~~~-------  327 (377)
T 3cbl_A          262 EEADGVYAAS---GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ----TREF-------  327 (377)
T ss_dssp             ECTTSEEECC---SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH----HHHH-------
T ss_pred             ecCCCceeec---CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH-------
Confidence            6543321111   012235778999999998999999999999999999998 999987543322    1111       


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                            +........+......+.+++..||+.||++|||++++++.|+.
T Consensus       328 ------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  371 (377)
T 3cbl_A          328 ------VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS  371 (377)
T ss_dssp             ------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------HHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence                  11111112222334567788889999999999999999999975

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.2e-43  Score=381.82  Aligned_cols=260  Identities=26%  Similarity=0.444  Sum_probs=215.6

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ..++|...++||+|+||.||+|++..      .+..||||.+.... ...++|.+|+.+|++++||||++++++|...+.
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  290 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP  290 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGG------GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcC------CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            35678889999999999999999874      57899999997643 346789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .+||||||++|+|.+++.... ...+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus       291 ~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  366 (495)
T 1opk_A          291 FYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSR  366 (495)
T ss_dssp             CEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred             EEEEEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccce
Confidence            999999999999999996532 346899999999999999999999   5799999999999999999999999999999


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ..........    ....+|..|+|||.+....++.++|||||||++|||++ |+.||.......    +.+        
T Consensus       367 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~----~~~--------  430 (495)
T 1opk_A          367 LMTGDTYTAH----AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYE--------  430 (495)
T ss_dssp             CCTTCCEECC----TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HHH--------
T ss_pred             eccCCceeec----CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH----HHH--------
Confidence            7754322111    14457789999999999999999999999999999999 999997554332    111        


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST  530 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~  530 (568)
                           .+........+......+.+++..||+.||.+|||+.+|++.|+....
T Consensus       431 -----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          431 -----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             -----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             -----HHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                 122222222333445667788899999999999999999999998643

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.3e-43  Score=360.62  Aligned_cols=266  Identities=23%  Similarity=0.305  Sum_probs=204.7

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC--
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG--  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--  317 (568)
                      .++|...++||+|+||+||+|++.        ++.||||++.... .....+..|+.++.+++||||+++++++....  
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--------NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--------TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             hhhchhhheecccCceEEEEEEEC--------CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            467899999999999999999864        6889999996543 33445677999999999999999999998754  


Q ss_pred             --eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCC----------CeEecCCCCCCEEEcC
Q 008374          318 --KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQ----------KVVHRDLKASNILLDA  385 (568)
Q Consensus       318 --~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~----------~ivHrDikp~NILld~  385 (568)
                        .+++||||+++|+|.+++..    ..+++..+..++.|++.||.|||   +.          +|+||||||+|||++.
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~  166 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKN  166 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECT
T ss_pred             CceEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECC
Confidence              47999999999999999953    35899999999999999999999   55          9999999999999999


Q ss_pred             CCcEEEeecCCccccccccccccccccccCCcCCcccCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 008374          386 DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-----KATPESDVFGFGAVVLEVVCGRSPGNMIPH  460 (568)
Q Consensus       386 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-----~~t~~sDV~SfGvll~el~tG~~P~~~~~~  460 (568)
                      ++.+||+|||+++..........   .....||+.|+|||++.+.     .++.++|||||||++|||++|+.||.....
T Consensus       167 ~~~~kL~DFg~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~  243 (322)
T 3soc_A          167 NLTACIADFGLALKFEAGKSAGD---THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD  243 (322)
T ss_dssp             TCCEEECCCTTCEEECTTSCCCC---CTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred             CCeEEEccCCcccccccccCccc---cccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence            99999999999987765432211   1246799999999999763     456688999999999999999999974332


Q ss_pred             ccchh---------hHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          461 QQHAY---------TLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       461 ~~~~~---------~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      .....         ...++..... .......+....   ........+.+++..||+.||++|||+.||++.|+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          244 EYMLPFEEEIGQHPSLEDMQEVVV-HKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHT-TSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhccchhhhhccCCchhhhhhhhh-cccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            21100         1111111111 110000011100   1224556788899999999999999999999999853

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.4e-43  Score=377.68  Aligned_cols=260  Identities=27%  Similarity=0.450  Sum_probs=212.2

Q ss_pred             HHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          236 LKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       236 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      .....++|...++||+|+||.||+|.+.       .+..||||+++... ...++|.+|+.+|++++||||+++++++. 
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-  253 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYN-------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-  253 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEET-------TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEEC-------CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-
Confidence            3445678899999999999999999986       46789999997653 45678999999999999999999999986 


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      .+..++|||||++|+|.+++.... ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus       254 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG  329 (454)
T 1qcf_A          254 KEPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFG  329 (454)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred             CCccEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCC
Confidence            667899999999999999996431 235889999999999999999999   5799999999999999999999999999


Q ss_pred             CccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHH
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      +++..........    ....+|..|+|||++....++.++|||||||++|||++ |+.||......+    +...    
T Consensus       330 ~a~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~----~~~~----  397 (454)
T 1qcf_A          330 LARVIEDNEYTAR----EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----VIRA----  397 (454)
T ss_dssp             GGGGBCCHHHHTT----CSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHH----
T ss_pred             CceEcCCCceecc----CCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH----HHHH----
Confidence            9987654321111    13457889999999999999999999999999999999 999997543322    1111    


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                               +........+......+.+++..||+.||++|||+++|++.|+...
T Consensus       398 ---------i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          398 ---------LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             ---------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             ---------HHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence                     1111122222334566788889999999999999999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.1e-43  Score=348.67  Aligned_cols=254  Identities=24%  Similarity=0.453  Sum_probs=207.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|...++||+|+||.||+|+..       ++..||+|++.... ...+++.+|++++++++||||+++++++.+.+..+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   81 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-------TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hhceeeheecCCCccEEEEEEec-------CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence            56888899999999999999986       46789999997653 34567999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++++|.+++...  ...+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++..
T Consensus        82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  156 (269)
T ss_dssp             EEEECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             EEEEeCCCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccc
Confidence            999999999999999643  346899999999999999999999   579999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      ........    ....+|..|+|||.+....++.++||||||++++||++ |+.||.......    +..   ..     
T Consensus       157 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~----~~~---~~-----  220 (269)
T 4hcu_A          157 LDDQYTSS----TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----VVE---DI-----  220 (269)
T ss_dssp             CCHHHHST----TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHH---HH-----
T ss_pred             cccccccc----cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH----HHH---HH-----
Confidence            54322111    24567889999999999999999999999999999999 999987543322    111   10     


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                           ........+......+.+++..|++.||++|||+.|+++.|+..
T Consensus       221 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          221 -----STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             -----HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----hcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence                 11111111122244577788899999999999999999999753

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.4e-43  Score=360.48  Aligned_cols=262  Identities=24%  Similarity=0.423  Sum_probs=204.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...++||+|+||.||+|++..++..  ...+||+|.+.... ....++|.+|+.++++++||||++++++|.... .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   91 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCce--EEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence            5688899999999999999998653211  23467999886543 345578999999999999999999999998754 7


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++|+||+++|+|.+++...  ...+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        92 ~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            8999999999999999653  346899999999999999999999   56999999999999999999999999999988


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ..........   ....||..|+|||++.+..++.++|||||||++|||++ |+.||.......    +.          
T Consensus       167 ~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~----------  229 (327)
T 3poz_A          167 LGAEEKEYHA---EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----IS----------  229 (327)
T ss_dssp             HTTTCC----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HH----------
T ss_pred             ccCCcccccc---cCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----HH----------
Confidence            7554332211   24457889999999999999999999999999999999 999998654332    11          


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST  530 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~  530 (568)
                         ..+...............+..++..||+.||.+|||+.|+++.|+....
T Consensus       230 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          230 ---SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ---HHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             ---HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence               1112222222223344567888899999999999999999999986543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.3e-42  Score=356.42  Aligned_cols=255  Identities=23%  Similarity=0.326  Sum_probs=202.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .++|...++||+|+||.||+|+...      +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   79 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRV------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECC------CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence            3578999999999999999999875      678999999865432 334678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++|+|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        80 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~  153 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLAT  153 (323)
T ss_dssp             EEEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccc
Confidence            9999999999999999943   346999999999999999999999   5799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ..........   .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||........  ....|..     
T Consensus       154 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~-----  223 (323)
T 3tki_A          154 VFRYNNRERL---LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKE-----  223 (323)
T ss_dssp             ECEETTEECC---BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HHHHHHT-----
T ss_pred             eeccCCcccc---cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHhc-----
Confidence            7654322111   125679999999999987775 7789999999999999999999975433221  1111110     


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                              ..............+.+++..|++.||.+|||+.|+++.
T Consensus       224 --------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          224 --------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             --------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --------ccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                    001111111233455678889999999999999999863

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.5e-43  Score=358.66  Aligned_cols=248  Identities=25%  Similarity=0.362  Sum_probs=204.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      .++|...+.||+|+||.||+|+...      +++.||||++...  .....+.+.+|++++++++||||+++++++...+
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   87 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHIL------TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK   87 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            4579999999999999999999864      6889999999764  2334567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++|+|.+++..   ...+++.....++.|++.||.|||   +++|+||||||+|||++.++++||+|||++
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  161 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS  161 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCC
T ss_pred             EEEEEEECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCc
Confidence            99999999999999999954   346899999999999999999999   579999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKAT-PESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t-~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      +.......      .....||+.|+|||++.+..+. .++|||||||++|||++|+.||.......    +..   .   
T Consensus       162 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~---~---  225 (328)
T 3fe3_A          162 NEFTVGGK------LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE----LRE---R---  225 (328)
T ss_dssp             GGGSSSCG------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH---H---
T ss_pred             eecCCCCc------cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH----HHH---H---
Confidence            87654322      1256799999999999887775 79999999999999999999997543221    111   1   


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                            +......  .+......+..++..|++.||.+|||++|+++
T Consensus       226 ------i~~~~~~--~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          226 ------VLRGKYR--IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             ------HHHCCCC--CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             ------HHhCCCC--CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                  1111111  11122345667788999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7e-43  Score=353.02  Aligned_cols=274  Identities=21%  Similarity=0.360  Sum_probs=207.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeC--Ce
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK--GK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~  318 (568)
                      ++|+..++||+|+||.||+|++....  ..+++.||||++........+.|.+|++++++++||||++++++|...  ..
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQ--DNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTC--SSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             HHhhhhheeeccCCEEEEEEEEeccc--CCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            56888999999999999999864211  126889999999877666678899999999999999999999999653  56


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             eEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            89999999999999999653  235899999999999999999999   5799999999999999999999999999999


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH----
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML----  474 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~----  474 (568)
                      ...........  .....+|..|+|||.+.+..++.++||||||+++|||++|..|+......     ........    
T Consensus       163 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~  235 (295)
T 3ugc_A          163 VLPQDKEFFKV--KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQ  235 (295)
T ss_dssp             ---------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCCTH
T ss_pred             cccCCcceeee--ccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccccc
Confidence            87554322111  11345788899999999999999999999999999999999997632111     00000000    


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      .....+.+.+........+......+.+++..||+.||++|||+.|+++.|+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            000011111222222223334456778888999999999999999999999753

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-42  Score=351.21  Aligned_cols=275  Identities=21%  Similarity=0.273  Sum_probs=215.1

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC--
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG--  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--  317 (568)
                      ++|...++||+|+||+||+|+...      +++.||||++.... ....+.+.+|++++++++||||+++++++....  
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKK------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCEEEEEEecCCCCeEEEEEEECC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence            568889999999999999999875      67899999997643 234567889999999999999999999998765  


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----cCCCcEEEee
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL----DADFNARLGD  393 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl----d~~~~~kL~D  393 (568)
                      ..++||||+++++|.+++........+++..+..++.|++.||.|||   +++|+||||||+|||+    +.++.+||+|
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence            78999999999999999976544445999999999999999999999   5799999999999999    8888999999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCccccc--------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchh
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH--------TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY  465 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~--------~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~  465 (568)
                      ||+++........      ....||..|+|||++.        ...++.++|||||||++|||++|+.||..........
T Consensus       160 fg~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  233 (319)
T 4euu_A          160 FGAARELEDDEQF------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (319)
T ss_dssp             CTTCEECCTTCCB------CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH
T ss_pred             CCCceecCCCCce------eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH
Confidence            9999877554321      1457999999999986        5788999999999999999999999997543322111


Q ss_pred             hHHHHHHHHhhcCchhhhh-----------hhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 008374          466 TLVDWVWMLHREGHIQDAV-----------DQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST  530 (568)
Q Consensus       466 ~l~~~~~~~~~~~~~~~~~-----------d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~  530 (568)
                      .+..-+........+..+.           +-.............+..++..|++.||++|||++|+++..+.++-
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            1211111111111000000           0011123345677788889999999999999999999998876543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.6e-43  Score=366.12  Aligned_cols=275  Identities=24%  Similarity=0.382  Sum_probs=215.9

Q ss_pred             cCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcC-CCCceee
Q 008374          231 FKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRL-RHKHLVH  308 (568)
Q Consensus       231 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~  308 (568)
                      +...+.....++|...++||+|+||.||+|++.... ...+++.||||++..... ...+.+.+|++++.++ +||||++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID-KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS-STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEecccc-ccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            445566667789999999999999999999875321 123678999999976433 3456799999999999 7999999


Q ss_pred             EEEEEEeCC-eEEEEEEecCCCChhhhhccCCC-----------------------------------------------
Q 008374          309 LVGWCHEKG-KLLLVYDFMPNGSLEKYLYGTSE-----------------------------------------------  340 (568)
Q Consensus       309 l~g~~~~~~-~~~lV~Ey~~~gsL~~~L~~~~~-----------------------------------------------  340 (568)
                      ++++|.+.+ ..++||||+++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999998765 48999999999999999975432                                               


Q ss_pred             ----------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccccc
Q 008374          341 ----------------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER  404 (568)
Q Consensus       341 ----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~  404 (568)
                                      ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                            112899999999999999999999   5799999999999999999999999999998765432


Q ss_pred             ccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCchhhh
Q 008374          405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDA  483 (568)
Q Consensus       405 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  483 (568)
                      ....   .....||+.|+|||++.+..++.++||||||+++|||++ |+.||.......   .+...             
T Consensus       248 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~-------------  308 (359)
T 3vhe_A          248 DYVR---KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCRR-------------  308 (359)
T ss_dssp             TCEE---C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---HHHHH-------------
T ss_pred             cchh---ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH---HHHHH-------------
Confidence            2211   124568999999999999999999999999999999998 999997543332   11111             


Q ss_pred             hhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          484 VDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       484 ~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      +...............+.+++..|++.||.+|||+.||++.|+..
T Consensus       309 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          309 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            111111111222334577788899999999999999999999753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.1e-42  Score=346.40  Aligned_cols=257  Identities=26%  Similarity=0.467  Sum_probs=209.1

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .++|...+.||+|+||.||+|...       .+..||+|++.... ...+++.+|++++.+++||||+++++++.+.+..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-------GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-------TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-------CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            457888999999999999999876       46789999997653 3456799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++.
T Consensus        79 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY  153 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred             EEEEEccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence            9999999999999999542  345899999999999999999999   57999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      .........    ....+|+.|+|||.+.+..++.++||||||++++||++ |+.||.......    ..   ... ..+
T Consensus       154 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~---~~~-~~~  221 (268)
T 3sxs_A          154 VLDDQYVSS----VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE----VV---LKV-SQG  221 (268)
T ss_dssp             CCTTCEEEC----CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH----HH---HHH-HTT
T ss_pred             cchhhhhcc----cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH----HH---HHH-HcC
Confidence            655432211    14557788999999998899999999999999999999 999997543322    11   110 111


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST  530 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~  530 (568)
                               .....+......+.+++..|++.||.+|||+.|+++.|+...+
T Consensus       222 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          222 ---------HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             ---------CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             ---------CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence                     0011111123457778889999999999999999999987543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.9e-42  Score=355.33  Aligned_cols=263  Identities=23%  Similarity=0.356  Sum_probs=206.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...++||+|+||.||+|++..++..  ...+||+|.+.... ....+.+.+|+.++++++||||++++++|. .+..
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   89 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGES--IKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL   89 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCS--CCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCce--EEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence            4688889999999999999998753221  23468999886543 345578899999999999999999999986 5678


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence            9999999999999999643  347899999999999999999999   56999999999999999999999999999998


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      .........   .....||..|+|||.+.+..++.++||||||+++|||++ |+.||.......    +.+.+       
T Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~-------  230 (325)
T 3kex_A          165 LPPDDKQLL---YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE----VPDLL-------  230 (325)
T ss_dssp             SCCCTTCCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH----HHHHH-------
T ss_pred             cCccccccc---ccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH----HHHHH-------
Confidence            755432221   124568889999999999999999999999999999999 999998543322    11111       


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTV  531 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~  531 (568)
                            ...............+..++..||+.||.+|||+.|+++.|+.....
T Consensus       231 ------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          231 ------EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             ------HTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             ------HcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                  11111111112233566788899999999999999999999876543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=353.98  Aligned_cols=253  Identities=27%  Similarity=0.453  Sum_probs=198.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|...+.||+|+||.||+|++.        ++.||||++...  ...+.|.+|++++++++||||+++++++.  +..+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~   75 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--------AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVC   75 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--------TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--------CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcE
Confidence            46888899999999999999874        678999998643  34578999999999999999999999887  3479


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc-EEEeecCCccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN-ARLGDFGLARA  399 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~-~kL~DFGla~~  399 (568)
                      +||||+++|+|.+++........+++..++.++.|+++||.|||+.+.++|+||||||+|||++.++. +||+|||+++.
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            99999999999999976554456889999999999999999999654489999999999999998876 79999999986


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      .....        ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......     ....+.... + 
T Consensus       156 ~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~-~-  220 (307)
T 2eva_A          156 IQTHM--------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-----FRIMWAVHN-G-  220 (307)
T ss_dssp             -----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-----HHHHHHHHT-T-
T ss_pred             ccccc--------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-----HHHHHHHhc-C-
Confidence            54321        13468999999999999999999999999999999999999997543222     111111111 1 


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                              ............+.+++..|++.||.+|||++++++.|+..
T Consensus       221 --------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  261 (307)
T 2eva_A          221 --------TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL  261 (307)
T ss_dssp             --------CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                    01111122334567788899999999999999999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=371.00  Aligned_cols=268  Identities=25%  Similarity=0.388  Sum_probs=210.1

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...++||+|+||.||+|++.... ....+..||||++... ......++.+|+.++++++||||+++++++...+..
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMP-NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCC-CCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            56888999999999999999975321 1125789999999654 334456799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCC----CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC---cEEEe
Q 008374          320 LLVYDFMPNGSLEKYLYGTS----EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF---NARLG  392 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~---~~kL~  392 (568)
                      ++||||+++|+|.+++....    ....+++.+++.++.|+++||.|||   +++|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999996532    2246899999999999999999999   57999999999999999554   59999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~  471 (568)
                      |||+++..........   .....||+.|+|||.+.+..++.++|||||||++|||++ |+.||.......    +... 
T Consensus       227 DFG~a~~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~----~~~~-  298 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRK---GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----VLEF-  298 (367)
T ss_dssp             CCHHHHHHHHHSSCTT---CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHH-
T ss_pred             CCcccccccccccccc---CCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH-
Confidence            9999986644322111   114568899999999999999999999999999999998 999997543322    1111 


Q ss_pred             HHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC
Q 008374          472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVP  532 (568)
Q Consensus       472 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~p  532 (568)
                                  +...............+.+++..||+.||.+|||+.+|++.|+.....|
T Consensus       299 ------------i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          299 ------------VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             ------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             ------------HHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence                        1111111122233456778888999999999999999999998654433

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.5e-42  Score=370.55  Aligned_cols=249  Identities=29%  Similarity=0.455  Sum_probs=204.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC-e
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG-K  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~  318 (568)
                      .++|...++||+|+||.||+|.+.        ++.||||.++...  ..+.|.+|+.+|++++||||++++++|.+.+ .
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            457888899999999999999874        5789999997653  5678999999999999999999999987765 7


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++|||||++|+|.+++.... ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  337 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK  337 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             eEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence            999999999999999996532 234789999999999999999999   5799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      .......        ...+|..|+|||.+....++.++|||||||++|||++ |+.||.......    +...       
T Consensus       338 ~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----~~~~-------  398 (450)
T 1k9a_A          338 EASSTQD--------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPR-------  398 (450)
T ss_dssp             ECC--------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT----HHHH-------
T ss_pred             ccccccc--------CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH-------
Confidence            5433211        2357889999999999999999999999999999998 999998554332    1111       


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                            +........+......+.+++..||+.||.+|||+.++++.|+.
T Consensus       399 ------i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~  442 (450)
T 1k9a_A          399 ------VEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH  442 (450)
T ss_dssp             ------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------HHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                  11111222233445677788889999999999999999999875

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.8e-42  Score=355.06  Aligned_cols=249  Identities=22%  Similarity=0.315  Sum_probs=203.8

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC---CcccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD---SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|...+.||+|+||+||+++.+.      +++.||+|++.+.   .......+.+|+.++++++||||+++++++...
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~   77 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKA------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH   77 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECC------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC
Confidence            3578999999999999999999875      6889999999754   223456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +.+++||||+++|+|..++..   ...+++.....++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~  151 (337)
T 1o6l_A           78 DRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGL  151 (337)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccc
Confidence            999999999999999999953   346899999999999999999999   57999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ++........     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +..   .   
T Consensus       152 a~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~---~---  216 (337)
T 1o6l_A          152 CKEGISDGAT-----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFE---L---  216 (337)
T ss_dssp             CBCSCCTTCC-----BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH---H---
T ss_pred             hhhcccCCCc-----ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH----HHH---H---
Confidence            9864332211     125679999999999999999999999999999999999999997543221    111   1   


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                            +....+.  .+......+..++..|++.||.+||     +++|+++
T Consensus       217 ------i~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          217 ------ILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ------HHHCCCC--CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------HHcCCCC--CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                  1111111  1112234566777899999999999     8999976

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.8e-42  Score=347.32  Aligned_cols=265  Identities=23%  Similarity=0.314  Sum_probs=202.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhc--CCCCceeeEEEEEEeC-
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHR--LRHKHLVHLVGWCHEK-  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~-  316 (568)
                      .++|...++||+|+||+||+|+.        +++.||||++...   ....+..|.+++..  ++||||+++++++... 
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--------QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--------TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--------CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            46789999999999999999986        4788999998643   34556667777666  7999999999997653 


Q ss_pred             ---CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCEEEcCCCc
Q 008374          317 ---GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY-----DQKVVHRDLKASNILLDADFN  388 (568)
Q Consensus       317 ---~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDikp~NILld~~~~  388 (568)
                         ...++||||+++|+|.+++.    ...+++..+..++.|++.||.|||...     +++|+||||||+|||++.++.
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~  151 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ  151 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred             CCCceeEEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC
Confidence               46899999999999999994    246999999999999999999999422     579999999999999999999


Q ss_pred             EEEeecCCccccccccccccccccccCCcCCcccCccccccC------CCCccchhHHHHHHHHHHHhC----------C
Q 008374          389 ARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG------KATPESDVFGFGAVVLEVVCG----------R  452 (568)
Q Consensus       389 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~------~~t~~sDV~SfGvll~el~tG----------~  452 (568)
                      +||+|||+++........... ......||+.|+|||.+...      .++.++|||||||++|||++|          +
T Consensus       152 ~kl~Dfg~a~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          152 CCIADLGLAVMHSQSTNQLDV-GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             EEECCCTTCEEEETTTTEEEC-CCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             EEEeeCCCeeecccccccccc-cccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            999999999876554322111 11245799999999999776      455799999999999999999          7


Q ss_pred             CCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcC-CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          453 SPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLN-INSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       453 ~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      .||........  ..............     .+.+. ..........+.+++..||+.||++|||+.||++.|++
T Consensus       231 ~pf~~~~~~~~--~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          231 PPFYDVVPNDP--SFEDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             CTTTTTSCSSC--CHHHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccccCCCCc--chhhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            77764322221  11111111111110     11111 11233567788899999999999999999999999975

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.7e-42  Score=348.39  Aligned_cols=250  Identities=23%  Similarity=0.329  Sum_probs=196.4

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--------------------------ccchhhHH
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--------------------------KSKGDFLA  293 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~  293 (568)
                      .++|...+.||+|+||.||+|+...      +++.||||++.....                          ...+.+.+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNEN------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQ   85 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETT------TTEEEEEEEEECC-------------------------------CHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECC------CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHH
Confidence            3578999999999999999998865      688999999865431                          12356899


Q ss_pred             HHHHhhcCCCCceeeEEEEEEe--CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 008374          294 ELAIIHRLRHKHLVHLVGWCHE--KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKV  371 (568)
Q Consensus       294 E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  371 (568)
                      |++++++++||||+++++++.+  .+..++||||+++++|.+++.    ...+++..+..++.|++.||.|||   +++|
T Consensus        86 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i  158 (298)
T 2zv2_A           86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLH---YQKI  158 (298)
T ss_dssp             HHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            9999999999999999999986  568999999999999998763    346999999999999999999999   5699


Q ss_pred             EecCCCCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCC---CCccchhHHHHHHHHHH
Q 008374          372 VHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK---ATPESDVFGFGAVVLEV  448 (568)
Q Consensus       372 vHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~---~t~~sDV~SfGvll~el  448 (568)
                      +||||||+|||++.++.+||+|||+++.........     ....||+.|+|||.+....   ++.++|||||||++|||
T Consensus       159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l  233 (298)
T 2zv2_A          159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL-----SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF  233 (298)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEE-----CCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHH
T ss_pred             eccCCCHHHEEECCCCCEEEecCCCccccccccccc-----cCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHH
Confidence            999999999999999999999999998765432211     1457999999999997655   37889999999999999


Q ss_pred             HhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          449 VCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       449 ~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ++|+.||......       .+....         ....+...........+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~g~~pf~~~~~~-------~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          234 VFGQCPFMDERIM-------CLHSKI---------KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHSSCSSCCSSHH-------HHHHHH---------HHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHCCCCCCCccHH-------HHHHHH---------hcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            9999999743221       111111         1111111111123345677888999999999999999974

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.4e-42  Score=351.21  Aligned_cols=264  Identities=20%  Similarity=0.300  Sum_probs=206.6

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|...++||+|+||.||+|+...      .+..||+|.+.....   ...+.|.+|+.++.+++||||+++++++.+.
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~   83 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTI------LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED   83 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETT------TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECC------CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence            3568899999999999999998764      678999999865432   3346789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +..++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        84 ~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  157 (294)
T 4eqm_A           84 DCYYLVMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGI  157 (294)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSS
T ss_pred             CeEEEEEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCC
Confidence            999999999999999999953   346899999999999999999999   57999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ++..........    ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......       .......
T Consensus       158 ~~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-------~~~~~~~  226 (294)
T 4eqm_A          158 AKALSETSLTQT----NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-------IAIKHIQ  226 (294)
T ss_dssp             STTC-----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH-------HHHHHHS
T ss_pred             cccccccccccc----CccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHhh
Confidence            987754332221    14579999999999999999999999999999999999999997543221       1111111


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhCCCCCC
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-KTEDILQIISGTSTVP  532 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-t~~evl~~L~~~~~~p  532 (568)
                      . ..... ....    ..+....+..++.+|++.||.+|| +++++.+.|+......
T Consensus       227 ~-~~~~~-~~~~----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          227 D-SVPNV-TTDV----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             S-CCCCH-HHHS----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             c-cCCCc-chhc----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            1 11000 0111    112335677788899999999999 9999999998764433

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.3e-43  Score=376.08  Aligned_cols=264  Identities=22%  Similarity=0.273  Sum_probs=208.8

Q ss_pred             cCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCcee
Q 008374          231 FKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLV  307 (568)
Q Consensus       231 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv  307 (568)
                      +.+++++..+++|...++||+|+||+||+|+.+.      +++.||||++.+..   ......+.+|..++..++||||+
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv  137 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWIT  137 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBC
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcC------CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEE
Confidence            3456666678899999999999999999999875      67899999997532   22345589999999999999999


Q ss_pred             eEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC
Q 008374          308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF  387 (568)
Q Consensus       308 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~  387 (568)
                      +++++|.+.+.++||||||++|+|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++
T Consensus       138 ~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g  212 (437)
T 4aw2_A          138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNG  212 (437)
T ss_dssp             CEEEEEECSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTS
T ss_pred             EEEEEEeeCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCC
Confidence            9999999999999999999999999999642  346899999999999999999999   57999999999999999999


Q ss_pred             cEEEeecCCccccccccccccccccccCCcCCcccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 008374          388 NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH-----TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ  462 (568)
Q Consensus       388 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~  462 (568)
                      .+||+|||+|+..........    ...+||+.|+|||++.     ...++.++|||||||++|||++|+.||.......
T Consensus       213 ~vkL~DFGla~~~~~~~~~~~----~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~  288 (437)
T 4aw2_A          213 HIRLADFGSCLKLMEDGTVQS----SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE  288 (437)
T ss_dssp             CEEECCCTTCEECCTTSCEEC----CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             CEEEcchhhhhhcccCCCccc----ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH
Confidence            999999999987654432221    1468999999999987     5678999999999999999999999998543332


Q ss_pred             chhhHHHHHHHHhhcCchhhhhhhhcCCC-CcHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHH
Q 008374          463 HAYTLVDWVWMLHREGHIQDAVDQRLNIN-SVVDEAKRLLLLGLACSHPIASE--RPKTEDILQ  523 (568)
Q Consensus       463 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~l~Cl~~dp~~--RPt~~evl~  523 (568)
                      ....+..+.              .++... ........+.+++..|+..+|++  ||+++|+++
T Consensus       289 ~~~~i~~~~--------------~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          289 TYGKIMNHK--------------ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHHHHHTHH--------------HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             HHHhhhhcc--------------ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            111111110              011100 00112234555666788777777  999999987

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.1e-42  Score=347.16  Aligned_cols=255  Identities=25%  Similarity=0.456  Sum_probs=205.9

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ..++|...++||+|+||.||+|.+.       .+..||+|++.... ...+++.+|++++.+++||||+++++++.+.+.
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-------GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-------TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-------CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence            3467888999999999999999876       56789999997653 335679999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++++|.+++...  ...+++.++..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  168 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR  168 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred             eEEEEeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccc
Confidence            99999999999999999642  346999999999999999999999   5799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ..........    ....+|+.|+|||.+....++.++||||||+++|||++ |+.||.......    ...   .    
T Consensus       169 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~----~~~---~----  233 (283)
T 3gen_A          169 YVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----TAE---H----  233 (283)
T ss_dssp             GBCCHHHHST----TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----HHH---H----
T ss_pred             cccccccccc----cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH----HHH---H----
Confidence            7654322111    14567889999999998999999999999999999998 999997543322    111   0    


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                            +...............+.+++..||+.||.+|||++|+++.|+.
T Consensus       234 ------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  277 (283)
T 3gen_A          234 ------IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  277 (283)
T ss_dssp             ------HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------HhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence                  11111111112223567788889999999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-42  Score=362.44  Aligned_cols=267  Identities=26%  Similarity=0.436  Sum_probs=213.4

Q ss_pred             hcCccccceeccCCceeEEEEEEccCcc-ccccCeEEEEEEeccCC-cccchhhHHHHHHhhcC-CCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQ-YHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  316 (568)
                      .++|...++||+|+||.||+|+....+. ....+..||||++.... ....+++.+|+++++++ +||||++++++|...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            4678899999999999999999754221 11245789999997653 33457799999999999 999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCC-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSE-------------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL  383 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl  383 (568)
                      +..++||||+++|+|.+++.....             ...+++..+..++.|++.||.|||   +++|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            999999999999999999965321             245999999999999999999999   5799999999999999


Q ss_pred             cCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 008374          384 DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQ  462 (568)
Q Consensus       384 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~  462 (568)
                      ++++.+||+|||+++..........   .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKK---TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCC---CTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             cCCCcEEEcccCccccccccccccc---ccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999987654322111   124567899999999999999999999999999999999 999987543221


Q ss_pred             chhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          463 HAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       463 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                          +...    .         ...............+.+++..||+.||++|||++||++.|+...
T Consensus       302 ----~~~~----~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          302 ----LFKL----L---------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             ----HHHH----H---------HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHHH----H---------HcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                1111    1         111111122233456778888999999999999999999998753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-42  Score=357.60  Aligned_cols=270  Identities=26%  Similarity=0.417  Sum_probs=214.2

Q ss_pred             HHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       237 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      ....++|...+.||+|+||.||+|+...... ..+++.||||.+.... ....+.|.+|+.++++++||||++++++|..
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLP-YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSST-TSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCC-CCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            3446789999999999999999999863211 1145899999997653 3345679999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCC---------------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSE---------------------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHR  374 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  374 (568)
                      .+..++||||+++|+|.+++.....                     ...+++.+++.++.|+++||.|||   +++|+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence            9999999999999999999965321                     156899999999999999999999   5799999


Q ss_pred             CCCCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCC
Q 008374          375 DLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRS  453 (568)
Q Consensus       375 Dikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~  453 (568)
                      ||||+|||++.++.+||+|||+++..........   .....||+.|+|||.+....++.++||||||+++|||++ |+.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKA---DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC-------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccc---cCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999987654321111   124568899999999999999999999999999999999 999


Q ss_pred             CCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 008374          454 PGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST  530 (568)
Q Consensus       454 P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~  530 (568)
                      ||.......    +..    ....+..         ...+......+.+++..||+.||.+|||+.++++.|+....
T Consensus       276 p~~~~~~~~----~~~----~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          276 PYYGMAHEE----VIY----YVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             TTTTSCHHH----HHH----HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cCCCCChHH----HHH----HHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            997543222    111    1111111         11122334567788889999999999999999999998643

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.8e-43  Score=356.96  Aligned_cols=273  Identities=22%  Similarity=0.350  Sum_probs=196.8

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      ..++|...+.||+|+||.||+|+....+.   ....||||.+...  .....+++.+|++++++++||||+++++++...
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDG---SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC----------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCC---cceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            45679999999999999999998864211   1238999999764  334567899999999999999999999999877


Q ss_pred             CeE------EEEEEecCCCChhhhhccCC---CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC
Q 008374          317 GKL------LLVYDFMPNGSLEKYLYGTS---EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF  387 (568)
Q Consensus       317 ~~~------~lV~Ey~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~  387 (568)
                      ...      ++||||+++|+|.+++....   ....+++..+..++.|++.||.|||   +++|+||||||+|||+++++
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTS
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCC
Confidence            655      99999999999999995432   1225899999999999999999999   57999999999999999999


Q ss_pred             cEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhh
Q 008374          388 NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYT  466 (568)
Q Consensus       388 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~  466 (568)
                      .+||+|||+++..........   .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......    
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----  247 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQ---GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE----  247 (323)
T ss_dssp             CEEECCCCC--------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----
T ss_pred             CEEEeeccccccccccccccc---cccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH----
Confidence            999999999987654322111   113457889999999999999999999999999999999 999998654332    


Q ss_pred             HHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCC
Q 008374          467 LVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQF  537 (568)
Q Consensus       467 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~p~~p~~  537 (568)
                      +....    ..         .............+.+++..|++.||++|||+.++++.|+....-|.+...
T Consensus       248 ~~~~~----~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          248 IYNYL----IG---------GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             HHHHH----HT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             HHHHH----hc---------CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            11110    00         111112223345677888899999999999999999999987666655433

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.8e-42  Score=371.88  Aligned_cols=258  Identities=29%  Similarity=0.468  Sum_probs=204.9

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ..++|...++||+|+||.||+|.+.       .+..||||++.... ...++|.+|+++|++++||||+++++++.+ +.
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~  252 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  252 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-------TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             ChhHceeeeeecCCCCeEEEEEEEC-------CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence            4567888999999999999999986       35679999997653 345689999999999999999999999976 67


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++|||||++|+|.+++... ....+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  328 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLAR  328 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             eEEEehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccce
Confidence            89999999999999999532 1245899999999999999999999   5799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ..........    ....+|..|+|||.+....++.++||||||+++|||++ |+.||......+    +...       
T Consensus       329 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----~~~~-------  393 (452)
T 1fmk_A          329 LIEDNEYTAR----QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQ-------  393 (452)
T ss_dssp             ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHH-------
T ss_pred             ecCCCceecc----cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH----HHHH-------
Confidence            7654322111    13457889999999999999999999999999999999 999997543322    1111       


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST  530 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~  530 (568)
                            +........+......+.+++..||+.||++|||++++++.|+....
T Consensus       394 ------i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          394 ------VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             ------HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ------HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence                  11111122233445667888899999999999999999999998643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.3e-42  Score=344.51  Aligned_cols=252  Identities=25%  Similarity=0.396  Sum_probs=194.0

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc----ccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI----KSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      ++|...++||+|+||.||+|+..        +..||||++.....    ...+.+.+|++++++++||||+++++++...
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI--------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE   78 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET--------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC
T ss_pred             hheeeeeeeccCCCeEEEEEEEc--------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            57888999999999999999863        67899999875432    2346788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC--------CCc
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA--------DFN  388 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~--------~~~  388 (568)
                      +..++||||+++++|.+++.    ...+++..+..++.|++.||.|||.....+++||||||+|||++.        ++.
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~  154 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI  154 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred             CceEEEEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence            99999999999999999994    346899999999999999999999542223999999999999986        778


Q ss_pred             EEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHH
Q 008374          389 ARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV  468 (568)
Q Consensus       389 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~  468 (568)
                      +||+|||+++........       ...||+.|+|||.+.+..++.++||||||++++||++|+.||.......    . 
T Consensus       155 ~kl~Dfg~~~~~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~-  222 (271)
T 3dtc_A          155 LKITDFGLAREWHRTTKM-------SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA----V-  222 (271)
T ss_dssp             EEECCCCC--------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH----H-
T ss_pred             eEEccCCccccccccccc-------CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----H-
Confidence            999999999876543221       4568999999999999999999999999999999999999997543322    0 


Q ss_pred             HHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          469 DWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       469 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                        ...         .................+.+++..|++.||.+|||+.|+++.|+.
T Consensus       223 --~~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          223 --AYG---------VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             --HHH---------HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             --HHh---------hhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence              011         111111122223334567788889999999999999999999975

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=8.6e-42  Score=355.67  Aligned_cols=253  Identities=21%  Similarity=0.304  Sum_probs=204.5

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc------cchhhHHHHHHhhcCCCCceeeEEEE
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK------SKGDFLAELAIIHRLRHKHLVHLVGW  312 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~g~  312 (568)
                      ..+.|...+.||+|+||.||+|+.+.      +++.||+|.+......      ..+.+.+|+.++.+++||||++++++
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~------~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~   83 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKS------TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDV   83 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECC------CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEE
Confidence            34678999999999999999999875      6889999999765332      23578999999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC----c
Q 008374          313 CHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF----N  388 (568)
Q Consensus       313 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~----~  388 (568)
                      +.+.+..++||||+++|+|.+++..   ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++    .
T Consensus        84 ~~~~~~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~  157 (361)
T 2yab_A           84 YENRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPH  157 (361)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCC
T ss_pred             EEeCCEEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccC
Confidence            9999999999999999999999943   356999999999999999999999   57999999999999998877    7


Q ss_pred             EEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHH
Q 008374          389 ARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV  468 (568)
Q Consensus       389 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~  468 (568)
                      +||+|||+++.......      .....||+.|+|||++....++.++|||||||++|||++|+.||.......    +.
T Consensus       158 vkl~DFG~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~----~~  227 (361)
T 2yab_A          158 IKLIDFGLAHEIEDGVE------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TL  227 (361)
T ss_dssp             EEECCCSSCEECCTTCC------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HH
T ss_pred             EEEEecCCceEcCCCCc------cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----HH
Confidence            99999999987655322      125679999999999999899999999999999999999999997543322    11


Q ss_pred             HHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          469 DWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       469 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .   . ...+...  .++..    .......+.+++..|++.||.+|||+.|+++
T Consensus       228 ~---~-i~~~~~~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          228 A---N-ITAVSYD--FDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             H---H-HHTTCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             H---H-HHhcCCC--CCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1   0 0111000  00000    0112345667888999999999999999975

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.8e-42  Score=350.27  Aligned_cols=266  Identities=27%  Similarity=0.430  Sum_probs=212.5

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ..++|...+.||+|+||.||+|+...... ..++..||||.+.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKG-RAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGG-CSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCc-ccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            35678899999999999999998753211 1246899999997643 344577899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCC---------------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSE---------------------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDL  376 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDi  376 (568)
                      ..++||||+++++|.+++.....                     ...+++.++..++.|++.||.|||   +++|+||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCccccc
Confidence            99999999999999999965322                     235899999999999999999999   579999999


Q ss_pred             CCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCC
Q 008374          377 KASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPG  455 (568)
Q Consensus       377 kp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~  455 (568)
                      ||+|||+++++.+||+|||+++..........   .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVK---RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEEC---SSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             chheEEEcCCCCEEEcccccccccccccccee---ccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999987654332211   114457889999999998899999999999999999999 99999


Q ss_pred             CCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          456 NMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       456 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      .......    +...             +...............+.+++..|++.||.+|||+.|+++.|++.
T Consensus       254 ~~~~~~~----~~~~-------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          254 PGIPPER----LFNL-------------LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             TTCCGGG----HHHH-------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCHHH----HHHH-------------hhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            7554332    1111             111111112223345677888899999999999999999999763

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-42  Score=356.01  Aligned_cols=270  Identities=23%  Similarity=0.397  Sum_probs=212.3

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcC-CCCceeeEEEEEEe
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHE  315 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~  315 (568)
                      ...++|...+.||+|+||.||+|+...... ...+..||||.+... .....+.+.+|+.++.++ +||||+++++++..
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISK-TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSS-SSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeecccc-CCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            345789999999999999999999742111 125678999999754 234567899999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCc--------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQ--------------------VTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRD  375 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~--------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  375 (568)
                      .+..++||||+++|+|.+++......                    ..+++..+..++.|++.||.|||   +++|+|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCC
Confidence            99999999999999999999754321                    34899999999999999999999   57999999


Q ss_pred             CCCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCC
Q 008374          376 LKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSP  454 (568)
Q Consensus       376 ikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P  454 (568)
                      |||+|||++.++.+||+|||+++...........   ....||+.|+|||.+.+..++.++||||||+++|||+| |+.|
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR---GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEE---TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceec---cCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999999877554322111   14457889999999999999999999999999999998 9999


Q ss_pred             CCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 008374          455 GNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST  530 (568)
Q Consensus       455 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~  530 (568)
                      |.......   .+...             +........+......+..++..||+.||.+|||+.|+++.|+....
T Consensus       275 ~~~~~~~~---~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          275 YPGIPVDA---NFYKL-------------IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             STTCCCSH---HHHHH-------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cccCCcHH---HHHHH-------------HhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            97654332   11111             11111122222334567778889999999999999999999987543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.9e-42  Score=351.54  Aligned_cols=252  Identities=24%  Similarity=0.320  Sum_probs=204.0

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc------cchhhHHHHHHhhcCCCCceeeEEEEE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK------SKGDFLAELAIIHRLRHKHLVHLVGWC  313 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~g~~  313 (568)
                      .+.|...+.||+|+||.||+|+...      ++..||+|.+......      ..+.+.+|+.++++++||||+++++++
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   83 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKS------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY   83 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETT------TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECC------CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3568899999999999999999875      6889999998764322      346789999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC----cE
Q 008374          314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF----NA  389 (568)
Q Consensus       314 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~----~~  389 (568)
                      ...+..++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++    .+
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~  157 (326)
T 2y0a_A           84 ENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRI  157 (326)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCE
T ss_pred             EeCCEEEEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCE
Confidence            999999999999999999999943   356899999999999999999999   57999999999999999887    89


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~  469 (568)
                      ||+|||+++........      ....||+.|+|||++....++.++|||||||++|||++|+.||.......   .+..
T Consensus       158 kl~Dfg~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~  228 (326)
T 2y0a_A          158 KIIDFGLAHKIDFGNEF------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLAN  228 (326)
T ss_dssp             EECCCTTCEECCTTSCC------CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHH
T ss_pred             EEEECCCCeECCCCCcc------ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHH
Confidence            99999999877543221      24579999999999998999999999999999999999999997543322   1111


Q ss_pred             HHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          470 WVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       470 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       +.   . .      ...............+.+++..|++.||.+|||+.|+++
T Consensus       229 -~~---~-~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          229 -VS---A-V------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             -HH---H-T------CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -HH---h-c------CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             00   0 0      000000000112345677888999999999999999987

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.5e-43  Score=356.15  Aligned_cols=245  Identities=26%  Similarity=0.332  Sum_probs=193.1

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcC-CCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  317 (568)
                      ++|...++||+|+||+||+|+...      +++.||||++.....  ....++..|+..+.++ +||||++++++|.+.+
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~  130 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKE------DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG  130 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT------TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hheeeeheeccCCCeEEEEEEECC------CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence            679999999999999999999875      688999999865432  2334566666666655 8999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .+++||||+ +++|.+++...  ...++|..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a  204 (311)
T 3p1a_A          131 ILYLQTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLL  204 (311)
T ss_dssp             EEEEEEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred             EEEEEEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceee
Confidence            999999999 77999988543  346999999999999999999999   569999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +........      ....||+.|+|||++.+ .++.++|||||||++|||++|+.|+....         .|  .....
T Consensus       205 ~~~~~~~~~------~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---------~~--~~~~~  266 (311)
T 3p1a_A          205 VELGTAGAG------EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---------GW--QQLRQ  266 (311)
T ss_dssp             EECC------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---------HH--HHHTT
T ss_pred             eecccCCCC------cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HH--HHHhc
Confidence            876543221      14569999999999865 79999999999999999999977654211         11  11111


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      +......        .......+.+++..|++.||++|||++|+++
T Consensus       267 ~~~~~~~--------~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          267 GYLPPEF--------TAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             TCCCHHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCCccc--------ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            1111111        1122356778888999999999999999985

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6e-42  Score=351.09  Aligned_cols=256  Identities=22%  Similarity=0.357  Sum_probs=200.7

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC-
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG-  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-  317 (568)
                      .++|...++||+|+||.||+|+...      +++.||||++.... ....+.+.+|++++++++||||++++++|.+.. 
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   78 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKV------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPP   78 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETT------TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcC------CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence            4578999999999999999999875      68899999997543 334577999999999999999999999986543 


Q ss_pred             --------------------------------------------------------eEEEEEEecCCCChhhhhccCCCc
Q 008374          318 --------------------------------------------------------KLLLVYDFMPNGSLEKYLYGTSEQ  341 (568)
Q Consensus       318 --------------------------------------------------------~~~lV~Ey~~~gsL~~~L~~~~~~  341 (568)
                                                                              ..++||||+++++|.+++......
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  158 (332)
T 3qd2_B           79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL  158 (332)
T ss_dssp             CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred             chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence                                                                    389999999999999999876656


Q ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccccccccc-------cccccc
Q 008374          342 VTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYA-------EHGLVG  414 (568)
Q Consensus       342 ~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~-------~~~~~~  414 (568)
                      ....+..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++..........       ......
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG  235 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred             cchhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccc
Confidence            66788889999999999999999   57999999999999999999999999999998765422111       011124


Q ss_pred             CCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcH
Q 008374          415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVV  494 (568)
Q Consensus       415 ~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  494 (568)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|..|+.         ..... .........         .....
T Consensus       236 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~---------~~~~~-~~~~~~~~~---------~~~~~  296 (332)
T 3qd2_B          236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---------ERVRI-ITDVRNLKF---------PLLFT  296 (332)
T ss_dssp             CC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH---------HHHHH-HHHHHTTCC---------CHHHH
T ss_pred             cCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh---------HHHHH-HHHhhccCC---------Ccccc
Confidence            579999999999999999999999999999999999876632         00110 000111111         11112


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          495 DEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       495 ~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .....+.+++..|++.||.+|||+.|+++
T Consensus       297 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          297 QKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             cCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            33445677888999999999999999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.8e-41  Score=357.02  Aligned_cols=252  Identities=19%  Similarity=0.289  Sum_probs=198.8

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcC-CCCceeeEEEEEEe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHE  315 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~  315 (568)
                      .++|...++||+|+||+||+|+.+.      +++.||+|++++..   ....+.+..|..++.++ +||||+++++++.+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~------~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~  124 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKK------TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT  124 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE
Confidence            4579999999999999999999875      68899999997642   23445688999999887 89999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      .+.+++||||+++|+|..++..   ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus       125 ~~~~~lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG  198 (396)
T 4dc2_A          125 ESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYG  198 (396)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecc
Confidence            9999999999999999999953   346999999999999999999999   5799999999999999999999999999


Q ss_pred             CccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccc-hhhHHHHHHHH
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH-AYTLVDWVWML  474 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~-~~~l~~~~~~~  474 (568)
                      +++........     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+.....
T Consensus       199 la~~~~~~~~~-----~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~  273 (396)
T 4dc2_A          199 MCKEGLRPGDT-----TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV  273 (396)
T ss_dssp             TCBCCCCTTCC-----BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH
T ss_pred             eeeecccCCCc-----cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH
Confidence            99864332211     1256899999999999999999999999999999999999999974321110 00111111111


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKT  518 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~  518 (568)
                      .        ....+.  .+......+..++..||+.||.+||++
T Consensus       274 i--------~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          274 I--------LEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             H--------HHCCCC--CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             H--------hccccC--CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            1        111111  122233456677889999999999995

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.3e-41  Score=342.12  Aligned_cols=253  Identities=25%  Similarity=0.460  Sum_probs=202.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc-------chhhHHHHHHhhcCCCCceeeEEEE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-------KGDFLAELAIIHRLRHKHLVHLVGW  312 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~nIv~l~g~  312 (568)
                      .++|...+.||+|+||.||+|+...      +++.||+|++.......       .+.+.+|+.++++++||||++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   91 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVK------DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL   91 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETT------TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hccceehhccccCCceeEEEEEEcC------CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence            3578899999999999999999875      67899999986543221       2678999999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEEcCCCc--
Q 008374          313 CHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQK--VVHRDLKASNILLDADFN--  388 (568)
Q Consensus       313 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDikp~NILld~~~~--  388 (568)
                      +.+..  ++||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +++  ++||||||+|||++.++.  
T Consensus        92 ~~~~~--~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~  164 (287)
T 4f0f_A           92 MHNPP--RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENA  164 (287)
T ss_dssp             ETTTT--EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTC
T ss_pred             ecCCC--eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCC
Confidence            97655  6999999999999988653  346899999999999999999999   567  999999999999988776  


Q ss_pred             ---EEEeecCCccccccccccccccccccCCcCCcccCcccc--ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q 008374          389 ---ARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF--HTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH  463 (568)
Q Consensus       389 ---~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~--~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~  463 (568)
                         +||+|||+++......        ....||+.|+|||.+  ....++.++||||||+++|||++|+.||........
T Consensus       165 ~~~~kl~Dfg~~~~~~~~~--------~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  236 (287)
T 4f0f_A          165 PVCAKVADFGLSQQSVHSV--------SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI  236 (287)
T ss_dssp             SCCEEECCCTTCBCCSSCE--------ECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH
T ss_pred             ceeEEeCCCCccccccccc--------cccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH
Confidence               9999999998544321        146799999999998  445678999999999999999999999975433221


Q ss_pred             hhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          464 AYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       464 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                        .....            .................+.+++..||+.||.+|||+.|+++.|+.
T Consensus       237 --~~~~~------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          237 --KFINM------------IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             --HHHHH------------HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             --HHHHH------------HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence              11111            111112222223344567788889999999999999999999986

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-41  Score=347.94  Aligned_cols=246  Identities=22%  Similarity=0.287  Sum_probs=203.1

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|...+.||+|+||+||+++...      +++.||+|.+.+..   ....+.+.+|..+++.++||||+++++++.+.
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~   78 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRH------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA   78 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC
Confidence            3578899999999999999999875      68899999997542   23445678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +.+++||||+++|+|.+++..   ...+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        79 ~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~  152 (318)
T 1fot_A           79 QQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGF  152 (318)
T ss_dssp             SEEEEEECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             CEEEEEEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCc
Confidence            999999999999999999954   346899999999999999999999   78999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ++......        ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    .   ..    
T Consensus       153 a~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~---~~----  213 (318)
T 1fot_A          153 AKYVPDVT--------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----T---YE----  213 (318)
T ss_dssp             CEECSSCB--------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----H---HH----
T ss_pred             ceecCCcc--------ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----H---HH----
Confidence            98754321        14679999999999999999999999999999999999999997543221    1   11    


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                           .++...+.  .+......+.+++..|++.||++||     +++|+++
T Consensus       214 -----~i~~~~~~--~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          214 -----KILNAELR--FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -----HHHHCCCC--CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----HHHhCCCC--CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                 11111111  1112234566777799999999999     8999874

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-42  Score=350.54  Aligned_cols=250  Identities=18%  Similarity=0.268  Sum_probs=204.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .++|...+.||+|+||.||+|+...      ++..+|+|.+... ......+.+|+.++++++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETS------SKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECC------CCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEE
Confidence            4678999999999999999999875      6889999998654 33456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC--CCcEEEeecCCc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA--DFNARLGDFGLA  397 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~--~~~~kL~DFGla  397 (568)
                      ++||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.  ++.+||+|||++
T Consensus        77 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a  151 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA  151 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred             EEEEEeCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence            9999999999999999542  246899999999999999999999   579999999999999987  789999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +........      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +...       
T Consensus       152 ~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~-------  214 (321)
T 1tki_A          152 RQLKPGDNF------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----IIEN-------  214 (321)
T ss_dssp             EECCTTCEE------EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHH-------
T ss_pred             eECCCCCcc------ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH----HHHH-------
Confidence            877543221      14568999999999988889999999999999999999999997543322    1111       


Q ss_pred             CchhhhhhhhcCCCC--cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 GHIQDAVDQRLNINS--VVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~--~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                           +.........  .......+.+++..|++.||.+|||+.|+++
T Consensus       215 -----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          215 -----IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -----HHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----HHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 1111111000  0112345677888999999999999999998

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.2e-42  Score=345.85  Aligned_cols=258  Identities=24%  Similarity=0.385  Sum_probs=196.1

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .++|...+.||+|+||.||+|+....+.   .+..||+|++.... ....+.+.+|+.++++++||||+++++++. .+.
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   89 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPEN---PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCC---CceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence            4578889999999999999999864321   45789999987643 334567999999999999999999999984 567


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++++|.+++...  ...+++..+..++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             cEEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECcccccc
Confidence            89999999999999999643  246899999999999999999999   5799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ..........    ....+|+.|+|||.+....++.++||||||+++|||++ |+.||.......    +...+    ..
T Consensus       165 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~----~~~~i----~~  232 (281)
T 1mp8_A          165 YMEDSTYYKA----SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRI----EN  232 (281)
T ss_dssp             ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHH----HT
T ss_pred             ccCccccccc----ccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH----HHHHH----Hc
Confidence            7754332111    13457789999999998999999999999999999996 999997544332    11111    11


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      +         ............+.+++..|++.||.+|||+.|+++.|+.
T Consensus       233 ~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  273 (281)
T 1mp8_A          233 G---------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  273 (281)
T ss_dssp             T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            1         0111122334567778889999999999999999999975

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-42  Score=355.30  Aligned_cols=263  Identities=27%  Similarity=0.480  Sum_probs=201.5

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...+.||+|+||.||+|+....+.  ..+..||||.+.... .....++.+|+.++++++||||+++++++...+..
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSG--KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCC--CccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            346667899999999999999874321  134679999997643 23456799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus       122 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            9999999999999999643  246899999999999999999999   56999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ..........  .....+|..|+|||.+....++.++||||||+++|||++ |+.||.......    +..    ...  
T Consensus       197 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~----~~~----~~~--  264 (333)
T 1mqb_A          197 LEDDPEATYT--TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----VMK----AIN--  264 (333)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHH----HHH--
T ss_pred             hccccccccc--cCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH----HHH----HHH--
Confidence            7543221111  113456889999999999999999999999999999999 999997543221    111    111  


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                             ..............+.+++..||+.||.+||++.++++.|+...
T Consensus       265 -------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          265 -------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             -------TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -------CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                   11111122234456778888999999999999999999998653

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.3e-42  Score=357.34  Aligned_cols=270  Identities=25%  Similarity=0.396  Sum_probs=213.1

Q ss_pred             HHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcC-CCCceeeEEEEE
Q 008374          236 LKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRL-RHKHLVHLVGWC  313 (568)
Q Consensus       236 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~  313 (568)
                      +....++|...+.||+|+||.||+|.....+. ......||+|.+..... ...+.+.+|+.+++++ +||||++++++|
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGK-EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSS-SCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCc-ccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            33446789999999999999999999865321 12346899999976532 3456799999999999 899999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhccCCC-----------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 008374          314 HEKGKLLLVYDFMPNGSLEKYLYGTSE-----------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL  382 (568)
Q Consensus       314 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIL  382 (568)
                      ...+..++||||+++|+|.+++.....           ...+++..+..++.|++.||.|||   +++|+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEE
Confidence            999999999999999999999964211           235799999999999999999999   579999999999999


Q ss_pred             EcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 008374          383 LDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQ  461 (568)
Q Consensus       383 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~  461 (568)
                      ++.++.+||+|||+++...........   ....||+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  273 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVK---GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN  273 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEEC---SSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred             ECCCCeEEECccccccccccccceeec---CCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence            999999999999999876544322111   13457889999999999999999999999999999998 99998754333


Q ss_pred             cchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          462 QHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       462 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      .   .+...             +........+......+..++..||+.||.+|||+.||++.|+..
T Consensus       274 ~---~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          274 S---KFYKL-------------VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             H---HHHHH-------------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H---HHHHH-------------HhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence            2   11111             111111111222345677788899999999999999999999753

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2e-42  Score=348.16  Aligned_cols=258  Identities=26%  Similarity=0.450  Sum_probs=213.4

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ...++|...++||+|+||.||+|+...      .+..||+|.+... ....+.+.+|++++++++||||+++++++.+.+
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   82 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGG------GTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ccccceeEEeecCCCCceeEEEeEecC------CCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            345678999999999999999999875      6889999999754 345678999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++++|.+++.... ...+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||++
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~  158 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS  158 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred             CEEEEEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccc
Confidence            9999999999999999996532 346899999999999999999999   569999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      +..........    ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......    +.+       
T Consensus       159 ~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~----~~~-------  223 (288)
T 3kfa_A          159 RLMTGDTYTAH----AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYE-------  223 (288)
T ss_dssp             GTSCSSSSEEE----TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HHH-------
T ss_pred             eeccCCccccc----cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH-------
Confidence            87765432221    14457889999999999999999999999999999999 999987543322    111       


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                            .+...............+.+++..|++.||.+|||+.|+++.|+.
T Consensus       224 ------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~  268 (288)
T 3kfa_A          224 ------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET  268 (288)
T ss_dssp             ------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------HHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence                  111122222223334567788889999999999999999999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.2e-42  Score=349.75  Aligned_cols=267  Identities=25%  Similarity=0.384  Sum_probs=213.1

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcC-CCCceeeEEEEEEeC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRL-RHKHLVHLVGWCHEK  316 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  316 (568)
                      ..++|...+.||+|+||.||+|++.... ...+++.||||++..... ...+.+.+|+.++.++ +||||+++++++...
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLI-KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSS-STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeecc-ccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            3467899999999999999999864210 012578999999976533 3457799999999999 999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCC---------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSE---------------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNI  381 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NI  381 (568)
                      +..++||||+++|+|.+++.....               ...+++..+..++.|++.||.|||   +++++||||||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Ni  176 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI  176 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceE
Confidence            999999999999999999965432               225899999999999999999999   57999999999999


Q ss_pred             EEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 008374          382 LLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPH  460 (568)
Q Consensus       382 Lld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~  460 (568)
                      |++.++.+||+|||+++...........   ....||+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVK---GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEEC---SSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             EEcCCCCEEEccccccccccccccceec---cCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            9999999999999999877654322111   13457889999999999999999999999999999999 9999975543


Q ss_pred             ccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          461 QQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       461 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ..   .+...             +...............+.+++..|++.||.+|||+.|+++.|++.
T Consensus       254 ~~---~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          254 DS---KFYKM-------------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             SH---HHHHH-------------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hh---HHHHH-------------hccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            32   11111             111111111223345677788899999999999999999999864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.5e-42  Score=356.12  Aligned_cols=278  Identities=20%  Similarity=0.311  Sum_probs=214.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEE--eCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCH--EKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~  318 (568)
                      ++|...++||+|+||.||+|++...+.  ..++.||||++........+.+.+|++++++++||||+++++++.  +.+.
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGD--NTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSS--SCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCC--CcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            568889999999999999998642211  268899999998776666778999999999999999999999987  4567


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++++|.+++...  ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             EEEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccce
Confidence            99999999999999999542  245899999999999999999999   5799999999999999999999999999999


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ...........  .....||..|+|||.+.+..++.++||||||+++|||++|+.|+........  ....+........
T Consensus       176 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~  251 (327)
T 3lxl_A          176 LLPLDKDYYVV--REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL--RMMGCERDVPALS  251 (327)
T ss_dssp             ECCTTCSEEEC--SSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH--HHCC----CCHHH
T ss_pred             ecccCCcccee--eccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhh--hhcccccccccHH
Confidence            77544322111  1245688899999999988999999999999999999999999763211100  0000000000001


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                      .+.+.+...............+.+++..|++.||++|||+.|+++.|+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            112222333333334445567788888999999999999999999998753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.7e-42  Score=356.65  Aligned_cols=250  Identities=22%  Similarity=0.308  Sum_probs=199.3

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcC-CCCceeeEEEEEE
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRL-RHKHLVHLVGWCH  314 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~  314 (568)
                      ..++|...++||+|+||+||+|+.+.      +++.||||++.+..   ....+.+.+|..++..+ +||||+++++++.
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~------~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~   94 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKE------TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ   94 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcC------CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence            35689999999999999999999875      68899999997542   23445678999999988 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 008374          315 EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDF  394 (568)
Q Consensus       315 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DF  394 (568)
                      +.+.+++||||+++|+|..++..   ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+||
T Consensus        95 ~~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DF  168 (353)
T 3txo_A           95 TPDRLFFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADF  168 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccc
Confidence            99999999999999999999954   346899999999999999999999   579999999999999999999999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      |+++........     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +..     
T Consensus       169 G~a~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~-----  234 (353)
T 3txo_A          169 GMCKEGICNGVT-----TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD----LFE-----  234 (353)
T ss_dssp             TTCBCSCC--------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH-----
T ss_pred             cceeecccCCcc-----ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH----HHH-----
Confidence            999864332221     125679999999999998889999999999999999999999997543322    111     


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKT------EDILQ  523 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~------~evl~  523 (568)
                             .+....+  .++......+..++..|++.||.+||++      +|+++
T Consensus       235 -------~i~~~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          235 -------AILNDEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -------HHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -------HHHcCCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                   1111111  1112233456677789999999999998      67764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=356.73  Aligned_cols=249  Identities=21%  Similarity=0.255  Sum_probs=198.2

Q ss_pred             cccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEE
Q 008374          244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVY  323 (568)
Q Consensus       244 ~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  323 (568)
                      ...+.||+|+||.||+|+...      +++.||+|++........+++.+|++++++++||||+++++++...+..+|||
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  165 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETA------TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM  165 (373)
T ss_dssp             EEEEECC-----CEEEEEETT------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ecceEEecCcCEEEEEEEEcC------CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            445689999999999999875      68899999998776666778999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE--cCCCcEEEeecCCccccc
Q 008374          324 DFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL--DADFNARLGDFGLARAIE  401 (568)
Q Consensus       324 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl--d~~~~~kL~DFGla~~~~  401 (568)
                      ||+++++|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||+  +.++.+||+|||+++...
T Consensus       166 E~~~~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          166 EYVDGGELFDRIIDE--SYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK  240 (373)
T ss_dssp             ECCTTCEEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred             eCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence            999999999988542  346899999999999999999999   5799999999999999  677899999999998775


Q ss_pred             cccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchh
Q 008374          402 NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQ  481 (568)
Q Consensus       402 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  481 (568)
                      .....      ....||+.|+|||++....++.++|||||||++|||++|+.||.......   .+....    .. .. 
T Consensus       241 ~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~i~----~~-~~-  305 (373)
T 2x4f_A          241 PREKL------KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE---TLNNIL----AC-RW-  305 (373)
T ss_dssp             TTCBC------CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHH----HT-CC-
T ss_pred             Ccccc------ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hc-cC-
Confidence            43221      14569999999999998899999999999999999999999997543322   111111    00 00 


Q ss_pred             hhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          482 DAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       482 ~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                           .+...........+.+++..|++.||.+|||+.|+++
T Consensus       306 -----~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          306 -----DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             -----CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                 0000011122346677888999999999999999987

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.6e-42  Score=364.08  Aligned_cols=260  Identities=21%  Similarity=0.249  Sum_probs=206.6

Q ss_pred             HHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeE
Q 008374          233 YKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHL  309 (568)
Q Consensus       233 ~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l  309 (568)
                      +.+++...++|...++||+|+||+||+|+.+.      +++.||+|++.+..   ....+.+.+|+.++..++||||+++
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~------~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l  134 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL  134 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCE
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECC------CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            34455567889999999999999999999875      67899999996532   2334568899999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcE
Q 008374          310 VGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA  389 (568)
Q Consensus       310 ~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~  389 (568)
                      +++|.+.+.++||||||++|+|.+++..    ..+++.....++.||+.||.|||   +++|+||||||+|||++.++.+
T Consensus       135 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~i  207 (410)
T 3v8s_A          135 FYAFQDDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHL  207 (410)
T ss_dssp             EEEEECSSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred             EEEEEECCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCE
Confidence            9999999999999999999999999953    35889999999999999999999   5799999999999999999999


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCCCCcccchh
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK----ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY  465 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~----~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~  465 (568)
                      ||+|||+|+..........    ...+||+.|+|||++....    ++.++|||||||++|||++|+.||..........
T Consensus       208 kL~DFG~a~~~~~~~~~~~----~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~  283 (410)
T 3v8s_A          208 KLADFGTCMKMNKEGMVRC----DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS  283 (410)
T ss_dssp             EECCCTTCEECCTTSEEEC----CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             EEeccceeEeeccCCcccc----cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH
Confidence            9999999987654432111    2568999999999997655    7899999999999999999999997543322111


Q ss_pred             hHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHH
Q 008374          466 TLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASE--RPKTEDILQ  523 (568)
Q Consensus       466 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~--RPt~~evl~  523 (568)
                      .+..+.              ..+...........+..++..|++.+|.+  ||+++||++
T Consensus       284 ~i~~~~--------------~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          284 KIMNHK--------------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHTHH--------------HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             HHHhcc--------------ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            111100              00111111112344566677899988988  999999987

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.6e-41  Score=344.98  Aligned_cols=263  Identities=16%  Similarity=0.153  Sum_probs=207.4

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  318 (568)
                      .++|...++||+|+||.||+|+...      +++.||||.+....  ..+.+.+|+++++++ +||||+++++++...+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   79 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLY------TNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY   79 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETT------TTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECC------CCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence            3578899999999999999999764      68899999987543  345789999999999 99999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc-----EEEee
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN-----ARLGD  393 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~-----~kL~D  393 (568)
                      .++||||+ +++|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.     +||+|
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~D  153 (330)
T 2izr_A           80 NAMVLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIID  153 (330)
T ss_dssp             EEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECC
T ss_pred             cEEEEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEE
Confidence            99999999 99999999643  346999999999999999999999   569999999999999999887     99999


Q ss_pred             cCCcccccccccccc--ccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          394 FGLARAIENERNSYA--EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       394 FGla~~~~~~~~~~~--~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      ||+++..........  ........||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... 
T Consensus       154 Fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i-  232 (330)
T 2izr_A          154 FALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI-  232 (330)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH-
T ss_pred             cccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH-
Confidence            999997654322110  01122567999999999999999999999999999999999999999865433211111111 


Q ss_pred             HHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       472 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      .......     ..+.+...    .. .+..++..|++.||.+||++.+|++.|+.
T Consensus       233 ~~~~~~~-----~~~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~  278 (330)
T 2izr_A          233 GDTKRAT-----PIEVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD  278 (330)
T ss_dssp             HHHHHHS-----CHHHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             HhhhccC-----CHHHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence            0000000     00001111    12 67778889999999999999999998864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.6e-41  Score=353.96  Aligned_cols=254  Identities=20%  Similarity=0.315  Sum_probs=204.8

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      ...++|...+.||+|+||.||+|+...      +++.||+|++....  ....+.+.+|+.++++++||||+++++++.+
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   99 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKT------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE   99 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECC------CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            345789999999999999999999875      68899999997643  2345678999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC---CcEEEe
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD---FNARLG  392 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~---~~~kL~  392 (568)
                      .+..++||||+++|+|.+++..   ...+++..+..++.||+.||.|||   +++|+||||||+|||++.+   +.+||+
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~  173 (362)
T 2bdw_A          100 ESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLA  173 (362)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred             CCEEEEEEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEe
Confidence            9999999999999999999853   346899999999999999999999   5799999999999999865   459999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      |||+++.......      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +...  
T Consensus       174 DfG~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----~~~~--  241 (362)
T 2bdw_A          174 DFGLAIEVNDSEA------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----LYAQ--  241 (362)
T ss_dssp             CCTTCBCCTTCCS------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH--
T ss_pred             ecCcceEecCCcc------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHH--
Confidence            9999987654322      124679999999999999899999999999999999999999997543221    1111  


Q ss_pred             HHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        ...+..      .............+.+++..||+.||.+|||+.|+++
T Consensus       242 --i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          242 --IKAGAY------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             --HHHTCC------CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --HHhCCC------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              111110      0000001122345677888999999999999999976

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.6e-41  Score=340.15  Aligned_cols=263  Identities=23%  Similarity=0.315  Sum_probs=200.0

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|...++||+|+||+||+|+...      +++.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   75 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRE------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCceeeeEecCCCCeEEEEEEECC------CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE
Confidence            468889999999999999999875      678999999976432  234678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++ +|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        76 ~~lv~e~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  149 (292)
T 3o0g_A           76 LTLVFEFCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLAR  149 (292)
T ss_dssp             EEEEEECCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence            9999999975 555555332  346999999999999999999999   5799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      .........     ....||+.|+|||.+.+.. ++.++|||||||+++||++|+.|+.......   .....+......
T Consensus       150 ~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~---~~~~~i~~~~~~  221 (292)
T 3o0g_A          150 AFGIPVRCY-----SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGT  221 (292)
T ss_dssp             ECCSCCSCC-----CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH---HHHHHHHHHHCC
T ss_pred             ecCCccccc-----cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCC
Confidence            765432221     2457899999999997765 7999999999999999999998864322221   122222211111


Q ss_pred             C---chhhhh---hhh---------cCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 G---HIQDAV---DQR---------LNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~---~~~~~~---d~~---------l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .   ......   +..         ............+.+++..|++.||++|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0   000000   000         000111123345667888999999999999999985

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.2e-41  Score=351.30  Aligned_cols=245  Identities=21%  Similarity=0.254  Sum_probs=203.1

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...+.||+|+||.||+++...      +++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  114 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKE------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             HHCEEEEEeecCcCcEEEEEEECC------CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            578899999999999999999875      68899999996542   234467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .+++||||+++|+|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a  188 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA  188 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccc
Confidence            99999999999999999953   346899999999999999999999   579999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +......        ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +..   .    
T Consensus       189 ~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~---~----  249 (350)
T 1rdq_E          189 KRVKGRT--------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----IYE---K----  249 (350)
T ss_dssp             EECSSCB--------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH---H----
T ss_pred             eeccCCc--------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH----HHH---H----
Confidence            8765432        14579999999999999999999999999999999999999997543221    111   1    


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK-----TEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt-----~~evl~  523 (568)
                           +....+.  .+......+..++..|++.||.+||+     ++|+++
T Consensus       250 -----i~~~~~~--~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          250 -----IVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----HHHCCCC--CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----HHcCCCC--CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                 1111111  11122345677888999999999998     888875

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.3e-42  Score=345.83  Aligned_cols=260  Identities=22%  Similarity=0.384  Sum_probs=205.5

Q ss_pred             hcCccccceeccCCceeEEEEEEccCcc-ccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQ-YHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .++|...++||+|+||.||+|+....++ ....+..||+|.+........+.+.+|+.++++++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3568889999999999999999875321 111246899999977666667889999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc--------EE
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN--------AR  390 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~--------~k  390 (568)
                      .++||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999643  234899999999999999999999   579999999999999998887        99


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCC-CCCCcccchhhHH
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPG-NMIPHQQHAYTLV  468 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~-~~~~~~~~~~~l~  468 (568)
                      |+|||+++......         ...||..|+|||.+.+ ..++.++||||||+++|||++|..|+ .......    ..
T Consensus       162 l~Dfg~~~~~~~~~---------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~----~~  228 (289)
T 4fvq_A          162 LSDPGISITVLPKD---------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR----KL  228 (289)
T ss_dssp             ECCCCSCTTTSCHH---------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----HH
T ss_pred             eccCcccccccCcc---------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH----HH
Confidence            99999997654321         3357889999999987 77899999999999999999965554 3322111    11


Q ss_pred             HHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC
Q 008374          469 DWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVP  532 (568)
Q Consensus       469 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~p  532 (568)
                      ..   ....        ..+..    .....+.+++..||+.||.+|||+.|+++.|+...+..
T Consensus       229 ~~---~~~~--------~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          229 QF---YEDR--------HQLPA----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             HH---HHTT--------CCCCC----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             HH---hhcc--------CCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            10   0000        00111    11234677888999999999999999999999876643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.2e-41  Score=338.71  Aligned_cols=250  Identities=19%  Similarity=0.298  Sum_probs=202.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeC--
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK--  316 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--  316 (568)
                      ++|...++||+|+||.||+|++.        +..||||++....  ....+.|.+|+.++++++||||+++++++...  
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ--------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA   81 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET--------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC--------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence            46888999999999999999873        6789999997643  33456799999999999999999999999877  


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEEcCCCcEEEeec
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQK--VVHRDLKASNILLDADFNARLGDF  394 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDikp~NILld~~~~~kL~DF  394 (568)
                      +..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||   +++  ++||||||+|||++.++.+||+||
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~  157 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMA  157 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred             CCeEeeecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEec
Confidence            78899999999999999996532 236899999999999999999999   567  999999999999999999999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCccccccCCCCc---cchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATP---ESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~---~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      |++......          ...||+.|+|||.+.+..++.   ++||||||+++|||++|+.||.......       ..
T Consensus       158 ~~~~~~~~~----------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~  220 (271)
T 3kmu_A          158 DVKFSFQSP----------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-------IG  220 (271)
T ss_dssp             GSCCTTSCT----------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-------HH
T ss_pred             cceeeeccc----------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-------HH
Confidence            887653221          346899999999998765544   7999999999999999999997543322       11


Q ss_pred             HHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       472 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ...         ................+.+++..||+.||++|||++|+++.|+..
T Consensus       221 ~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          221 MKV---------ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             HHH---------HHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH---------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            111         111111122223345677788899999999999999999999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=377.16  Aligned_cols=257  Identities=25%  Similarity=0.453  Sum_probs=202.5

Q ss_pred             Cccccc-eeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          242 NFHESM-RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       242 ~f~~~~-~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++.... +||+|+||.||+|++....    .+..||||+++.... ...++|.+|+++|++++||||++++++|.. +.+
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSS----CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCC----CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence            344344 7999999999999886421    467899999976533 356789999999999999999999999976 569


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++|||||++|+|.+++...  ...+++..+..++.||+.||.|||   +++|+||||||+|||+++++.+||+|||+++.
T Consensus       411 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~  485 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKA  485 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred             EEEEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence            9999999999999999643  346999999999999999999999   57999999999999999999999999999998


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ..........  .....+|+.|+|||++....++.++|||||||++|||++ |+.||......+    +...        
T Consensus       486 ~~~~~~~~~~--~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----~~~~--------  551 (613)
T 2ozo_A          486 LGADDSYYTA--RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMAF--------  551 (613)
T ss_dssp             CC----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH----HHHH--------
T ss_pred             ccCCCceeee--ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHH--------
Confidence            7544322211  112346789999999999999999999999999999998 999998654322    1111        


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                           +........+......+.+++..||+.||.+||++.+|++.|+.
T Consensus       552 -----i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  595 (613)
T 2ozo_A          552 -----IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  595 (613)
T ss_dssp             -----HHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred             -----HHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                 11111222233445677888899999999999999999999975

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.5e-41  Score=352.64  Aligned_cols=255  Identities=23%  Similarity=0.303  Sum_probs=202.4

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-----cccchhhHHHHHHhhcCCCCceeeEEEEEE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-----IKSKGDFLAELAIIHRLRHKHLVHLVGWCH  314 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~  314 (568)
                      .+.|...+.||+|+||.||+|+.+.      +++.||||++....     ....+.+.+|+.++++++||||+++++++.
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~   96 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRE------TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS   96 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECC------CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            3568999999999999999999875      68899999986421     223567899999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhccCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc---EE
Q 008374          315 EKGKLLLVYDFMPNGSLEKYLYGTS-EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN---AR  390 (568)
Q Consensus       315 ~~~~~~lV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~---~k  390 (568)
                      +.+..++|||||++++|.+++.... ....+++..+..++.|++.||.|||   +++|+||||||+|||++.++.   +|
T Consensus        97 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vk  173 (351)
T 3c0i_A           97 SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVK  173 (351)
T ss_dssp             ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEE
T ss_pred             eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEE
Confidence            9999999999999999988885432 2335899999999999999999999   579999999999999987655   99


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~  470 (568)
                      |+|||+++........     .....||+.|+|||++....++.++|||||||++|||++|+.||.....     .+...
T Consensus       174 l~Dfg~a~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~  243 (351)
T 3c0i_A          174 LGGFGVAIQLGESGLV-----AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEG  243 (351)
T ss_dssp             ECCCTTCEECCTTSCB-----CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-----HHHHH
T ss_pred             EecCcceeEecCCCee-----ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-----HHHHH
Confidence            9999999877543221     1245799999999999999999999999999999999999999975321     11111


Q ss_pred             HHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          471 VWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       471 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                          ...+...  ..+..    .......+.+++..||+.||++|||+.|+++
T Consensus       244 ----i~~~~~~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          244 ----IIKGKYK--MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             ----HHHTCCC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----HHcCCCC--CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                1111100  00000    0012345677888999999999999999986

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-41  Score=350.95  Aligned_cols=263  Identities=22%  Similarity=0.291  Sum_probs=203.3

Q ss_pred             HHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-----CcccchhhHHHHHHhhcCCCCceeeE
Q 008374          235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-----SIKSKGDFLAELAIIHRLRHKHLVHL  309 (568)
Q Consensus       235 el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l  309 (568)
                      ++....++|...++||+|+||.||+|+...      ++..||+|++...     .....+.+.+|++++++++||||+++
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~   93 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQ------TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL   93 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECC------CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCccee
Confidence            456677889999999999999999999865      6789999998653     23455789999999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChhhhhccCC-------------------------------------CcccCCHHHHHHH
Q 008374          310 VGWCHEKGKLLLVYDFMPNGSLEKYLYGTS-------------------------------------EQVTLNWNHRYKI  352 (568)
Q Consensus       310 ~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~-------------------------------------~~~~l~~~~~~~i  352 (568)
                      ++++.+.+..++||||+++|+|.+++....                                     ....+++..+..+
T Consensus        94 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  173 (345)
T 3hko_A           94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI  173 (345)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred             ehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence            999999999999999999999999985210                                     0123456778899


Q ss_pred             HHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC--cEEEeecCCccccccccccccccccccCCcCCcccCcccccc-
Q 008374          353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF--NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-  429 (568)
Q Consensus       353 ~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-  429 (568)
                      +.|++.||.|||   +++|+||||||+|||++.++  .+||+|||+++.+........ .......||+.|+|||.+.. 
T Consensus       174 ~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~  249 (345)
T 3hko_A          174 MRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY-YGMTTKAGTPYFVAPEVLNTT  249 (345)
T ss_dssp             HHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------CCCGGGCCHHHHTCS
T ss_pred             HHHHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCcccc-ccccccCCCccccCchhhccC
Confidence            999999999999   56999999999999998776  899999999987654322110 11125679999999999865 


Q ss_pred             -CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCC--CCcHHHHHHHHHHHHh
Q 008374          430 -GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNI--NSVVDEAKRLLLLGLA  506 (568)
Q Consensus       430 -~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~l~  506 (568)
                       ..++.++||||||+++|||++|+.||.......   .+    ..         ++......  .........+.+++..
T Consensus       250 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~----~~---------~~~~~~~~~~~~~~~~~~~~~~li~~  313 (345)
T 3hko_A          250 NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD---TI----SQ---------VLNKKLCFENPNYNVLSPLARDLLSN  313 (345)
T ss_dssp             SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HH---------HHHCCCCTTSGGGGGSCHHHHHHHHH
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH---HH----HH---------HHhcccccCCcccccCCHHHHHHHHH
Confidence             678999999999999999999999997543322   11    11         11111111  1111223456778889


Q ss_pred             cCCCCCCCCCCHHHHHH
Q 008374          507 CSHPIASERPKTEDILQ  523 (568)
Q Consensus       507 Cl~~dp~~RPt~~evl~  523 (568)
                      |++.||.+|||+.|+++
T Consensus       314 ~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          314 LLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HSCSCTTTSCCHHHHHH
T ss_pred             HcCCChhHCCCHHHHhc
Confidence            99999999999999987

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3e-41  Score=352.01  Aligned_cols=276  Identities=17%  Similarity=0.196  Sum_probs=209.6

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc-----------chhhHHHHHHhhcCCCCcee
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-----------KGDFLAELAIIHRLRHKHLV  307 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~nIv  307 (568)
                      ..++|...++||+|+||.||+|.+..+.. ...++.||||++.......           ...+..|+..+..++||||+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSES-VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSC-CCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccc-cccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            34579999999999999999998875321 1236789999987653211           12344566677888999999


Q ss_pred             eEEEEEEeC----CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 008374          308 HLVGWCHEK----GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL  383 (568)
Q Consensus       308 ~l~g~~~~~----~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl  383 (568)
                      ++++++...    ...+|||||+ +++|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill  185 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLL  185 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEE
Confidence            999998765    4589999999 99999999653  346999999999999999999999   5699999999999999


Q ss_pred             c--CCCcEEEeecCCcccccccccccc--ccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 008374          384 D--ADFNARLGDFGLARAIENERNSYA--EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIP  459 (568)
Q Consensus       384 d--~~~~~kL~DFGla~~~~~~~~~~~--~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~  459 (568)
                      +  .++.+||+|||+++.+........  ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            9  889999999999987754422111  111124569999999999999999999999999999999999999998432


Q ss_pred             cccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          460 HQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       460 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ...   ....+..... ...+.+.+++.+....   ....+.+++..||+.||.+||++.++++.|+..
T Consensus       266 ~~~---~~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          266 KDP---KYVRDSKIRY-RENIASLMDKCFPAAN---APGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             TCH---HHHHHHHHHH-HHCHHHHHHHHSCTTC---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cCH---HHHHHHHHHh-hhhHHHHHHHhccccc---CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            222   2222222222 1234455555543222   234566777799999999999999999998753

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-41  Score=355.65  Aligned_cols=254  Identities=17%  Similarity=0.246  Sum_probs=207.0

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .++|...++||+|+||.||+|+...      +++.||+|.+..........+.+|+.++++++||||+++++++.+.+..
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKA------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECC------CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence            4679999999999999999999875      6789999999876555667899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC--CCcEEEeecCCc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA--DFNARLGDFGLA  397 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~--~~~~kL~DFGla  397 (568)
                      ++||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.  ++.+||+|||++
T Consensus       124 ~lv~E~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a  198 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLA  198 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccc
Confidence            9999999999999999542  346899999999999999999999   579999999999999974  478999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +........      ....||+.|+|||++....++.++|||||||++|||++|+.||.......    ....+   .. 
T Consensus       199 ~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----~~~~i---~~-  264 (387)
T 1kob_A          199 TKLNPDEIV------KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----TLQNV---KR-  264 (387)
T ss_dssp             EECCTTSCE------EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHH---HH-
T ss_pred             eecCCCcce------eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH----HHHHH---Hh-
Confidence            877543221      13479999999999999999999999999999999999999997543222    11111   00 


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                      ..      ..............+.+++..||+.||.+|||+.|+++.
T Consensus       265 ~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          265 CD------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CC------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CC------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            00      001111111233456778889999999999999999873

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=361.57  Aligned_cols=254  Identities=22%  Similarity=0.310  Sum_probs=204.0

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      ..++|...++||+|+||.||+|+...      +++.+|+|.+.....  ...+.+.+|+.++++++||||+++++++.+.
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~------~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~   82 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVL------AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE   82 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETT------TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECC------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC
Confidence            45679999999999999999998875      688999999976432  3456789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc---CCCcEEEee
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD---ADFNARLGD  393 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld---~~~~~kL~D  393 (568)
                      +..++||||+++|+|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++   .++.+||+|
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~D  156 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLAD  156 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECC
T ss_pred             CEEEEEEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEcc
Confidence            999999999999999999854   346899999999999999999999   57999999999999998   568899999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      ||+++.........     ....||+.|+|||++....++.++|||||||++|||++|+.||.......    +...   
T Consensus       157 FG~a~~~~~~~~~~-----~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~----~~~~---  224 (444)
T 3soa_A          157 FGLAIEVEGEQQAW-----FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR----LYQQ---  224 (444)
T ss_dssp             CSSCBCCCTTCCBC-----CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHH---
T ss_pred             CceeEEecCCCcee-----ecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH----HHHH---
Confidence            99998776543221     25679999999999999999999999999999999999999997543222    1111   


Q ss_pred             HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       474 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       ...+..      .+...........+.+++..|++.||.+|||+.|+++
T Consensus       225 -i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          225 -IKAGAY------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             -HHHTCC------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -HHhCCC------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence             111110      0000001122345667888999999999999999987

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.7e-41  Score=346.12  Aligned_cols=262  Identities=22%  Similarity=0.329  Sum_probs=200.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      .++|...++||+|+||+||+|+..       +++.||+|++.....  ...+.+.+|++++++++||||+++++++...+
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   92 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER   92 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence            467899999999999999999875       578999999975432  23467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||++ ++|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        93 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  166 (311)
T 3niz_A           93 CLTLVFEFME-KDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLA  166 (311)
T ss_dssp             CEEEEEECCS-EEHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEcCCC-CCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCc
Confidence            9999999997 5888887543  345899999999999999999999   579999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      +.........     ....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......   .+.... ....
T Consensus       167 ~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~-~~~~  237 (311)
T 3niz_A          167 RAFGIPVRSY-----THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---QLPKIF-SILG  237 (311)
T ss_dssp             EETTSCCC--------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---HHHHHH-HHHC
T ss_pred             eecCCCcccc-----cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHH-HHHC
Confidence            8765432221     24578999999999876 568999999999999999999999998654443   222211 1111


Q ss_pred             cCc---hhhh------hhhhcC--CCC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          477 EGH---IQDA------VDQRLN--INS-----VVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       477 ~~~---~~~~------~d~~l~--~~~-----~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ...   ....      .+....  ...     .......+.+++..|++.||.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          238 TPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            000   0000      000000  000     0112245677888999999999999999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9e-42  Score=353.34  Aligned_cols=251  Identities=23%  Similarity=0.274  Sum_probs=202.2

Q ss_pred             HHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcC-CCCceeeEEEE
Q 008374          237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRL-RHKHLVHLVGW  312 (568)
Q Consensus       237 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~  312 (568)
                      ....++|...+.||+|+||+||+|+.+.      +++.||||++++..   ....+.+..|..++..+ +||||++++++
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~   86 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKK------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT   86 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETT------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEE
Confidence            4456789999999999999999999875      68899999997642   23345678899999877 99999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          313 CHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       313 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                      +.+.+.+++||||+++|+|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~  160 (345)
T 1xjd_A           87 FQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIA  160 (345)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEe
Confidence            9999999999999999999999953   346899999999999999999999   5799999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      |||+++........     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +...  
T Consensus       161 DFG~a~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~--  229 (345)
T 1xjd_A          161 DFGMCKENMLGDAK-----TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----LFHS--  229 (345)
T ss_dssp             CCTTCBCCCCTTCC-----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH--
T ss_pred             EChhhhhcccCCCc-----ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH----HHHH--
Confidence            99999865432211     125689999999999999999999999999999999999999997543222    1111  


Q ss_pred             HHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHH-HHH
Q 008374          473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTE-DIL  522 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~-evl  522 (568)
                        ...+        ..  ..+......+..++..|++.||++||++. +++
T Consensus       230 --i~~~--------~~--~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          230 --IRMD--------NP--FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             --HHHC--------CC--CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             --HHhC--------CC--CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence              1001        11  11112234566778899999999999997 664

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.8e-41  Score=351.32  Aligned_cols=250  Identities=23%  Similarity=0.350  Sum_probs=202.7

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...+.||+|+||.||++....      +++.||+|.+....   ....+.+.+|+.++.+++||||+++++++.+.+
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   88 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKND------TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE   88 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            578999999999999999999875      67899999986532   234567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .+++||||+++|+|..++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a  162 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIA  162 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEecccee
Confidence            99999999999999999954   346999999999999999999999   579999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHT---GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~---~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      +........      ....||+.|+|||++..   ..++.++|||||||++|||++|+.||.......    ........
T Consensus       163 ~~~~~~~~~------~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~----~~~~~~~~  232 (384)
T 4fr4_A          163 AMLPRETQI------TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS----SKEIVHTF  232 (384)
T ss_dssp             EECCTTCCB------CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC----HHHHHHHH
T ss_pred             eeccCCCce------eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc----HHHHHHHH
Confidence            876543221      25679999999999864   458999999999999999999999997433222    11111110


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK-TEDILQ  523 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt-~~evl~  523 (568)
                      .         ...  ...+......+..++..||+.||.+||+ ++++++
T Consensus       233 ~---------~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          233 E---------TTV--VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             H---------HCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             h---------hcc--cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            0         000  1112223456677888999999999998 777764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-41  Score=338.86  Aligned_cols=254  Identities=24%  Similarity=0.447  Sum_probs=207.0

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|...+.||+|+||.||+|...       ++..||+|++..... ..+++.+|++++++++||||+++++++.+.+..+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-------TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeEecCCCceeEEEEEec-------CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence            56888899999999999999986       467899999976543 3467999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++++|.+++...  ...+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++..
T Consensus        80 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  154 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  154 (267)
T ss_dssp             EEECCCTTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             EEEeCCCCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccc
Confidence            999999999999999643  245899999999999999999999   579999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      .......    .....||..|+|||.+....++.++||||||+++|||++ |+.||.......    ...   . ...+ 
T Consensus       155 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~---~-i~~~-  221 (267)
T 3t9t_A          155 LDDQYTS----STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----VVE---D-ISTG-  221 (267)
T ss_dssp             CCHHHHS----TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHH---H-HHTT-
T ss_pred             ccccccc----cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH----HHH---H-HhcC-
Confidence            5432111    114567889999999998999999999999999999999 899987543221    111   1 1111 


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                              .....+......+.+++..|++.||++|||+.++++.|+..
T Consensus       222 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          222 --------FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                    11111112234567788899999999999999999999753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.5e-42  Score=351.32  Aligned_cols=275  Identities=25%  Similarity=0.410  Sum_probs=215.6

Q ss_pred             CHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEE
Q 008374          232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLV  310 (568)
Q Consensus       232 ~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~  310 (568)
                      ..+++....++|...+.||+|+||.||+|+..... ....+..||||.+.... ......|.+|+.++++++||||++++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVV-KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEE-TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             ChhhhcchhhheeeeeEeccCCceEEEeeeecCcc-CCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            33445566788999999999999999999876210 00146889999997543 23456789999999999999999999


Q ss_pred             EEEEeCCeEEEEEEecCCCChhhhhccCC-------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 008374          311 GWCHEKGKLLLVYDFMPNGSLEKYLYGTS-------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL  383 (568)
Q Consensus       311 g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl  383 (568)
                      +++.+.+..++||||+++|+|.+++....       ....+++..++.++.|++.||.|||   +++|+||||||+|||+
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEE
Confidence            99999999999999999999999996421       1245789999999999999999999   5699999999999999


Q ss_pred             cCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 008374          384 DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQ  462 (568)
Q Consensus       384 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~  462 (568)
                      +.++.+||+|||+++..........   .....||+.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  248 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRK---GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ  248 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEG---GGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred             cCCCeEEECcCcccccccccccccc---ccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH
Confidence            9999999999999987654322111   113457889999999999999999999999999999999 888987543221


Q ss_pred             chhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 008374          463 HAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST  530 (568)
Q Consensus       463 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~  530 (568)
                          +...    ...+..         ..........+.+++..|++.||.+|||+.|+++.|+....
T Consensus       249 ----~~~~----~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          249 ----VLRF----VMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             ----HHHH----HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ----HHHH----HHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence                1111    111111         11122334557778889999999999999999999998644

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.9e-42  Score=350.84  Aligned_cols=264  Identities=25%  Similarity=0.422  Sum_probs=203.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...++||+|+||.||+|+....+..  -..+||+|.+... .....+.+.+|+.++++++||||++++++|.... .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~   91 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCS--CCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCce--EEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence            5688999999999999999998753321  2346788888654 3345678999999999999999999999998754 8


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++|+||+++|+|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        92 ~~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             eEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            8999999999999999653  346899999999999999999999   57999999999999999999999999999988


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ..........   ....||+.|+|||.+.+..++.++|||||||++|||++ |+.||.......    +..         
T Consensus       167 ~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~---------  230 (327)
T 3lzb_A          167 LGAEEKEYHA---EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISS---------  230 (327)
T ss_dssp             ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHH---------
T ss_pred             ccCccccccc---cCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHH---------
Confidence            7544322211   13457889999999999999999999999999999999 999998654432    111         


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVP  532 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~p  532 (568)
                          .+...............+.+++..||+.||.+|||+.|+++.|+.....|
T Consensus       231 ----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          231 ----ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             ----HHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             ----HHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence                11111112222233446777888999999999999999999999865443

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=8.8e-42  Score=349.26  Aligned_cols=273  Identities=25%  Similarity=0.397  Sum_probs=210.5

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeC--CeE
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK--GKL  319 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~  319 (568)
                      |...++||+|+||.||++++.....  .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.  ...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTND--GTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC----CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCC--CCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence            4888999999999999998753221  268899999997653 23456799999999999999999999999874  688


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++|+|.+++..    ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus       111 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence            999999999999999953    34899999999999999999999   57999999999999999999999999999998


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      ..........  .....||..|+|||.+.+..++.++||||||+++|||++|+.||.......  .....+.........
T Consensus       184 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~  259 (318)
T 3lxp_A          184 VPEGHEYYRV--REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF--LELIGIAQGQMTVLR  259 (318)
T ss_dssp             CCTTCSEEEC-----CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HHHHCSCCHHHHHHH
T ss_pred             cccccccccc--ccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh--hhhhcccccchhHHH
Confidence            7654322111  124568889999999999899999999999999999999999986321110  000000000000111


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      +.+.++..............+.+++..||+.||.+|||+.|+++.|+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            2233333333333444556788888999999999999999999999863

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-40  Score=341.00  Aligned_cols=261  Identities=22%  Similarity=0.376  Sum_probs=190.7

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .++|...++||+|+||.||+|+...      +++.||+|++..... ...+.+.+|+.++++++||||+++++++...+.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   77 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKT------TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENK   77 (317)
T ss_dssp             ---------------CEEEEEECSS------SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECC------CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCe
Confidence            4578889999999999999998764      688999999976533 344678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccC---CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          319 LLLVYDFMPNGSLEKYLYGT---SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      .++||||++ |+|.+++...   .....+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus        78 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  153 (317)
T 2pmi_A           78 LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFG  153 (317)
T ss_dssp             EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCS
T ss_pred             EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCc
Confidence            999999997 6999988542   12245899999999999999999999   5799999999999999999999999999


Q ss_pred             CccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      +++.........     ....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......    ....+...
T Consensus       154 ~~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~  224 (317)
T 2pmi_A          154 LARAFGIPVNTF-----SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE----QLKLIFDI  224 (317)
T ss_dssp             SCEETTSCCCCC-----CCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHH
T ss_pred             cceecCCCcccC-----CCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHH
Confidence            998765432221     14578999999999876 468999999999999999999999998554332    11111111


Q ss_pred             hhc--C----------------------chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          475 HRE--G----------------------HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       475 ~~~--~----------------------~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ...  .                      .+.+.+.+....    .....+.+++..|++.||++|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKE----PLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             HCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSS----CCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccc----cCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            110  0                      000111111111    12345778888999999999999999975

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.3e-41  Score=364.54  Aligned_cols=250  Identities=24%  Similarity=0.323  Sum_probs=195.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC---CcccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD---SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|...++||+|+||.||+|+...      +++.||||++...   .......+.+|+.++++++||||++++++|...
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~  220 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKA------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH  220 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcC------CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC
Confidence            4679999999999999999999875      6889999999753   333456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +.+++|||||++|+|.+++..   ...+++..+..++.|++.||.|||.  .++|+||||||+|||++.++.+||+|||+
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~  295 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGL  295 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCC
T ss_pred             CEEEEEEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCC
Confidence            999999999999999999953   3468999999999999999999994  26899999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ++........     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +...+     
T Consensus       296 a~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i-----  361 (446)
T 4ejn_A          296 CKEGIKDGAT-----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELI-----  361 (446)
T ss_dssp             CCTTCC----------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH-----
T ss_pred             ceeccCCCcc-----cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH----HHHHH-----
Confidence            9865433221     125689999999999999999999999999999999999999997543322    11111     


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                             ....+  ..+......+.+++..||+.||.+||     +++|+++
T Consensus       362 -------~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          362 -------LMEEI--RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             -------HHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -------HhCCC--CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                   11111  11112234567788899999999999     9999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.1e-41  Score=337.67  Aligned_cols=250  Identities=22%  Similarity=0.323  Sum_probs=204.8

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ..++|...++||+|+||.||+|+...      ++..+|+|++........+.+.+|++++++++||||+++++++.+.+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKG------TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD   80 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCC------CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence            34678999999999999999999875      678999999987666667889999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---cCCCcEEEeecC
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL---DADFNARLGDFG  395 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl---d~~~~~kL~DFG  395 (568)
                      .++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +++++||||||+|||+   +.++.+||+|||
T Consensus        81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg  154 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFG  154 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence            9999999999999999853   346899999999999999999999   5799999999999999   888999999999


Q ss_pred             CccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      ++.........      ....||+.|+|||.+.+ .++.++||||||++++||++|+.||.......    ...   . .
T Consensus       155 ~~~~~~~~~~~------~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~---~-~  219 (277)
T 3f3z_A          155 LAARFKPGKMM------RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE----VML---K-I  219 (277)
T ss_dssp             TCEECCTTSCB------CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH---H-H
T ss_pred             cceeccCccch------hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH----HHH---H-H
Confidence            99876543321      14579999999999854 58999999999999999999999997543322    111   0 1


Q ss_pred             hcCchhhhhhhhcCCCCc--HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          476 REGHIQDAVDQRLNINSV--VDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~--~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ..+.        ......  ......+.+++..|++.||.+|||+.|+++
T Consensus       220 ~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          220 REGT--------FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHCC--------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HhCC--------CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1110        000000  012346677888999999999999999975

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.3e-42  Score=375.69  Aligned_cols=258  Identities=28%  Similarity=0.460  Sum_probs=209.8

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ...++|...++||+|+||.||+|++.       .+..||||++.... ...++|.+|+++|++++||||++++++|.+ +
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~  334 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  334 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             cchhhhhhheecccCCCeEEEEEEEC-------CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence            34567888999999999999999986       45679999997654 345689999999999999999999999976 6


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..+||||||++|+|.++|... ....+++.+++.++.||+.||.|||   +++|+||||||+|||+++++.+||+|||++
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  410 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLA  410 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred             cceEeeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence            789999999999999999532 1235899999999999999999999   579999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      +.........    .....+|..|+|||.+....++.++|||||||++|||++ |+.||......+    +.+.      
T Consensus       411 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~----~~~~------  476 (535)
T 2h8h_A          411 RLIEDNEYTA----RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQ------  476 (535)
T ss_dssp             TTCCCHHHHT----TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH----HHHH------
T ss_pred             eecCCCceec----ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH------
Confidence            8765432111    113457889999999999999999999999999999999 999997543322    1111      


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                             +...............+.+++..||+.||++|||+++|+++|+...
T Consensus       477 -------i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          477 -------VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             -------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             -------HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                   1111112222334556778889999999999999999999999864

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.4e-41  Score=340.53  Aligned_cols=255  Identities=27%  Similarity=0.477  Sum_probs=205.8

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .++|...+.||+|+||.||+|...       .+..||||.+.... ...+.+.+|++++++++||||+++++++. .+..
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   82 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN-------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPI   82 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc-------CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCc
Confidence            457888999999999999999875       46789999997543 34567999999999999999999999986 4568


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++++|.+++... ....+++..+..++.|++.||.|||   +++++||||||+|||+++++.+||+|||+++.
T Consensus        83 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARL  158 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence            9999999999999999532 1236899999999999999999999   57999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      .........    ....+|..|+|||.+....++.++||||||++++||++ |+.||.......    +...    ... 
T Consensus       159 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~~~----~~~-  225 (279)
T 1qpc_A          159 IEDNEYTAR----EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----VIQN----LER-  225 (279)
T ss_dssp             CSSSCEECC----TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHH----HHT-
T ss_pred             ccCcccccc----cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH----HHHH----Hhc-
Confidence            754332211    14567889999999988899999999999999999999 899987543221    1111    111 


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                              .............+.+++..|++.||++|||+.++++.|+..
T Consensus       226 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          226 --------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence                    111111223345677888899999999999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=351.40  Aligned_cols=252  Identities=23%  Similarity=0.286  Sum_probs=189.0

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ..++|...++||+|+||.||+|+...      +++.||||++....  ..+.+.+|++++++++||||++++++|...+.
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  122 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKG------TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE  122 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECC------CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCe
Confidence            45679999999999999999999875      57899999997643  34668899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---CCcEEEeecC
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA---DFNARLGDFG  395 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~---~~~~kL~DFG  395 (568)
                      .++||||+++|+|.+++..   ...+++.++..++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||
T Consensus       123 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg  196 (349)
T 2w4o_A          123 ISLVLELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFG  196 (349)
T ss_dssp             EEEEECCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred             EEEEEEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCc
Confidence            9999999999999999953   346899999999999999999999   569999999999999975   8999999999


Q ss_pred             CccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      +++........      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .+..    ..
T Consensus       197 ~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~----~i  263 (349)
T 2w4o_A          197 LSKIVEHQVLM------KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ---FMFR----RI  263 (349)
T ss_dssp             ----------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH---HHHH----HH
T ss_pred             cccccCccccc------ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH---HHHH----HH
Confidence            99876543211      14579999999999999999999999999999999999999997443322   1111    11


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .....      ........+....+.+++..|++.||++|||+.|+++
T Consensus       264 ~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          264 LNCEY------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HTTCC------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HhCCC------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11100      0001111123345677888999999999999999987

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-41  Score=339.09  Aligned_cols=259  Identities=25%  Similarity=0.462  Sum_probs=206.3

Q ss_pred             cCccccc-eeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESM-RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~-~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|.... .||+|+||.||+|++....    .+..||||.+.... ....+++.+|++++++++||||+++++++ ..+.
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA   83 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred             HHhhhhhccccccCceeEEEeEeccCC----CcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence            4455555 8999999999999875321    57889999997653 33467799999999999999999999999 5667


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++++|.+++...  ...+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             cEEEEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECccccee
Confidence            99999999999999999542  346899999999999999999999   5799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ...........  .....||+.|+|||.+.+..++.++||||||+++|||++ |+.||.......    +...+    ..
T Consensus       159 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~i----~~  228 (287)
T 1u59_A          159 ALGADDSYYTA--RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMAFI----EQ  228 (287)
T ss_dssp             ECTTCSCEECC--CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH----HHHHH----HT
T ss_pred             eeccCcceeec--cccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH----HHHHH----hc
Confidence            87544322111  113457899999999988889999999999999999998 999997543322    11111    11


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      +         .....+......+.+++..||+.||.+||++.++++.|+..
T Consensus       229 ~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          229 G---------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             T---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C---------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1         11122223445677888899999999999999999999864

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.3e-41  Score=338.16  Aligned_cols=265  Identities=17%  Similarity=0.203  Sum_probs=209.2

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  318 (568)
                      .++|...+.||+|+||.||+|+...      +++.||||++....  ..+.+.+|+.++.++ +|+|++++++++.+...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   80 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLL------NNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   80 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETT------TTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECC------CCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence            3568999999999999999999764      68899999986542  456789999999999 79999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc-----EEEee
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN-----ARLGD  393 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~-----~kL~D  393 (568)
                      .++||||+ +++|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.     +||+|
T Consensus        81 ~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~D  154 (298)
T 1csn_A           81 NVLVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVD  154 (298)
T ss_dssp             EEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred             eEEEEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence            99999999 99999999643  235899999999999999999999   789999999999999987776     99999


Q ss_pred             cCCccccccccccccc--cccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          394 FGLARAIENERNSYAE--HGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       394 FGla~~~~~~~~~~~~--~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      ||+++...........  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .....+
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~  233 (298)
T 1csn_A          155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-QKYERI  233 (298)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-HHHHHH
T ss_pred             CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH-HHHHHH
Confidence            9999987654321110  1123567999999999999999999999999999999999999999864332211 111111


Q ss_pred             HHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       472 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ..........     .+..    .....+.+++..|++.||++|||+++|++.|+..
T Consensus       234 ~~~~~~~~~~-----~~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          234 GEKKQSTPLR-----ELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             HHHHHHSCHH-----HHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HhhccCccHH-----HHHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            1100000000     0111    1235677788899999999999999999999864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.7e-41  Score=340.43  Aligned_cols=259  Identities=27%  Similarity=0.418  Sum_probs=204.3

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ..++|...+.||+|+||.||+|++.....   .+..||+|.+.... ....+.|.+|+.++++++||||+++++++.+ +
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   85 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKG---EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-E   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTC---CEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-S
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCC---CcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C
Confidence            34678899999999999999999764321   45679999997653 3456779999999999999999999999865 4


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++++|.+++...  ...+++..+..++.|++.||.|||   +++++||||||+|||++.++.+||+|||++
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  160 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLS  160 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred             CCEEEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCC
Confidence            568999999999999999542  245899999999999999999999   579999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      +..........    ....+|+.|+|||.+....++.++||||||+++|||++ |+.||.......    ....+..   
T Consensus       161 ~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~----~~~~~~~---  229 (281)
T 3cc6_A          161 RYIEDEDYYKA----SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIGVLEK---  229 (281)
T ss_dssp             GCC-------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG----HHHHHHH---
T ss_pred             ccccccccccc----ccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH----HHHHHhc---
Confidence            87655332111    14467889999999998999999999999999999998 999997543332    1111110   


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                       +         ............+.+++..|++.||.+|||+.|+++.|+.
T Consensus       230 -~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  270 (281)
T 3cc6_A          230 -G---------DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD  270 (281)
T ss_dssp             -T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -C---------CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence             0         0111112233457778889999999999999999999975

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.2e-41  Score=348.57  Aligned_cols=267  Identities=26%  Similarity=0.467  Sum_probs=210.5

Q ss_pred             hcCccccceeccCCceeEEEEEEccCcc-ccccCeEEEEEEeccCC-cccchhhHHHHHHhhcC-CCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQ-YHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  316 (568)
                      .++|...+.||+|+||.||+|.....+. ...++..||||++.... ....+.+.+|+++++++ +||||++++++|...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            4679999999999999999999863221 11257889999997653 23456789999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCC-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSE-------------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL  383 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl  383 (568)
                      +..++||||+++|+|.+++.....             ...+++..+..++.|++.||.|||   +++|+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            999999999999999999975431             234899999999999999999999   5799999999999999


Q ss_pred             cCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 008374          384 DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQ  462 (568)
Q Consensus       384 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~  462 (568)
                      +.++.+||+|||+++..........   .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKK---TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEEC---CSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             cCCCCEEEccccccccccccccccc---cCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            9999999999999987654322111   124457889999999988889999999999999999999 999987543222


Q ss_pred             chhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          463 HAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       463 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                          +...+    ..+         ............+.+++..||+.||.+|||+.|+++.|++..
T Consensus       268 ----~~~~~----~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          268 ----LFKLL----KEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             ----HHHHH----HHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHHHH----hcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                11111    111         111112233456777888999999999999999999998753

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.9e-41  Score=349.66  Aligned_cols=250  Identities=20%  Similarity=0.290  Sum_probs=202.6

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcC-CCCceeeEEEEEE
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRL-RHKHLVHLVGWCH  314 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~  314 (568)
                      ..++|...+.||+|+||+||+|+.+.      +++.||||++.+..   ....+.+..|..++..+ +||||+++++++.
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   91 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKG------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   91 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETT------EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence            34679999999999999999999874      67899999997642   23445688999999988 8999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 008374          315 EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDF  394 (568)
Q Consensus       315 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DF  394 (568)
                      ..+.+++||||+++|+|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+||
T Consensus        92 ~~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DF  165 (353)
T 2i0e_A           92 TMDRLYFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADF  165 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeC
Confidence            99999999999999999999953   346899999999999999999999   579999999999999999999999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      |+++........     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +..     
T Consensus       166 G~a~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~-----  231 (353)
T 2i0e_A          166 GMCKENIWDGVT-----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQ-----  231 (353)
T ss_dssp             TTCBCCCCTTCC-----BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH-----
T ss_pred             CcccccccCCcc-----cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH----HHH-----
Confidence            999864332211     125689999999999999999999999999999999999999997543222    111     


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK-----TEDILQ  523 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt-----~~evl~  523 (568)
                             .++...+.  ++......+..++..|++.||.+||+     ++++++
T Consensus       232 -------~i~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          232 -------SIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             -------HHHHCCCC--CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             -------HHHhCCCC--CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                   11111111  11223345677888999999999995     577764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.2e-41  Score=351.52  Aligned_cols=253  Identities=18%  Similarity=0.242  Sum_probs=194.5

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .++|...++||+|+||.||+++...      +++.||||++.... ...+.+.+|+.++++++||||+++++++...+..
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   91 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKL------TKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   91 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETT------TCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECC------CCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence            4579999999999999999999875      68899999997643 3346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc--EEEeecCCc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN--ARLGDFGLA  397 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~--~kL~DFGla  397 (568)
                      ++||||+++|+|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.  +||+|||++
T Consensus        92 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a  165 (361)
T 3uc3_A           92 AIIMEYASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYS  165 (361)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred             EEEEEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence            999999999999999853   346899999999999999999999   579999999999999987765  999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCcc-chhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE-SDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~-sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      +........      ....||+.|+|||++.+..++.+ +|||||||++|||++|+.||.......   ........   
T Consensus       166 ~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~~~~~---  233 (361)
T 3uc3_A          166 KSSVLHSQP------KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR---DYRKTIQR---  233 (361)
T ss_dssp             ---------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC---CHHHHHHH---
T ss_pred             ccccccCCC------CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH---HHHHHHHH---
Confidence            854332211      14579999999999988887665 899999999999999999998544333   12221111   


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                            +................+.+++.+||+.||++|||+.|+++
T Consensus       234 ------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          234 ------ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             ------HHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ------HhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence                  11111111111122345677888999999999999999987

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.6e-41  Score=350.17  Aligned_cols=246  Identities=23%  Similarity=0.304  Sum_probs=200.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...+.||+|+||.||+|+...      +++.||||++....   ......+.+|+.+++.++||||+++++++...+
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   82 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYK------TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT   82 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCEEEEEEEecCCCeEEEEEEECC------CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            578899999999999999999865      68899999986532   223457889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+ +|+|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||++
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s  155 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLS  155 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCT
T ss_pred             EEEEEEECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccc
Confidence            999999999 7899998853   346999999999999999999999   569999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      +........      ....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.........            
T Consensus       156 ~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------------  217 (336)
T 3h4j_B          156 NIMTDGNFL------KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF------------  217 (336)
T ss_dssp             BTTTTSBTT------CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB------------
T ss_pred             eeccCCccc------ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH------------
Confidence            876543221      24579999999999987776 78999999999999999999999743222100            


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                          ..+....  ...+......+.+++..|++.||.+|||++|+++
T Consensus       218 ----~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          218 ----KKVNSCV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             ----CCCCSSC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ----HHHHcCC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                0000000  0111122345667888999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-41  Score=355.77  Aligned_cols=261  Identities=29%  Similarity=0.463  Sum_probs=194.9

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEe-CCeE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE-KGKL  319 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~  319 (568)
                      .|...++||+|+||.||+|++...+.   ....||||.+.... ....++|.+|+.++++++||||++++++|.+ .+..
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTT---EEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCC---cEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            46667899999999999999864221   34678999987543 3456789999999999999999999999865 4578


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++|+|.+++...  ...+++..+..++.|+++||.|||   +++|+||||||+|||+++++.+||+|||+++.
T Consensus       167 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~  241 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARD  241 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccc
Confidence            9999999999999999643  345889999999999999999999   57999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ........ ........+|+.|+|||.+.+..++.++|||||||++|||++ |..||.......    +...+    ..+
T Consensus       242 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~----~~~~~----~~~  312 (373)
T 3c1x_A          242 MYDKEFDS-VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYL----LQG  312 (373)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC----HHHHH----HTT
T ss_pred             cccccccc-ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH----HHHHH----HcC
Confidence            65432111 111124567889999999999999999999999999999999 667776443322    11111    111


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      .         ....+......+.+++..||+.||.+|||+.|+++.|+..
T Consensus       313 ~---------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          313 R---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1         0111122334677888899999999999999999999864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-40  Score=340.47  Aligned_cols=272  Identities=21%  Similarity=0.312  Sum_probs=201.1

Q ss_pred             HHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC--CCCceeeEEEEE
Q 008374          236 LKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL--RHKHLVHLVGWC  313 (568)
Q Consensus       236 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~g~~  313 (568)
                      -....++|...++||+|+||.||+|+..        ++.||||++...   ....+..|.+++..+  +||||+++++++
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~  100 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--------GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAAD  100 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET--------TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC--------CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence            3445678999999999999999999863        688999998543   233455566665554  899999999999


Q ss_pred             EeC----CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCEEEc
Q 008374          314 HEK----GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY-----DQKVVHRDLKASNILLD  384 (568)
Q Consensus       314 ~~~----~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDikp~NILld  384 (568)
                      ...    ...++||||+++|+|.+++..    ..+++..+..++.|++.||.|||...     .++|+||||||+|||++
T Consensus       101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~  176 (337)
T 3mdy_A          101 IKGTGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK  176 (337)
T ss_dssp             EESCGGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred             ccCCCCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence            887    789999999999999999943    35899999999999999999999321     22999999999999999


Q ss_pred             CCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCcc------chhHHHHHHHHHHHhC-------
Q 008374          385 ADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPE------SDVFGFGAVVLEVVCG-------  451 (568)
Q Consensus       385 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~------sDV~SfGvll~el~tG-------  451 (568)
                      .++.+||+|||+++........... ......||+.|+|||.+.......+      +|||||||++|||++|       
T Consensus       177 ~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~  255 (337)
T 3mdy_A          177 KNGTCCIADLGLAVKFISDTNEVDI-PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV  255 (337)
T ss_dssp             TTSCEEECCCTTCEECC----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCEEEEeCCCceeeccccccccC-CCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence            9999999999999876544322111 1124579999999999987766665      9999999999999999       


Q ss_pred             ---CCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCC-CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          452 ---RSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNIN-SVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       452 ---~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                         +.||........  ..... .........    .+.+... ...+....+.+++..||+.||++|||+.||++.|+.
T Consensus       256 ~~~~~p~~~~~~~~~--~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          256 EEYQLPYHDLVPSDP--SYEDM-REIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             CCCCCTTTTTSCSSC--CHHHH-HHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccccHhhhcCCCC--chhhh-HHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence               556553222211  11111 111111111    1111111 122567788899999999999999999999999987


Q ss_pred             CCC
Q 008374          528 TST  530 (568)
Q Consensus       528 ~~~  530 (568)
                      ..+
T Consensus       329 l~~  331 (337)
T 3mdy_A          329 MSE  331 (337)
T ss_dssp             HHH
T ss_pred             HHh
Confidence            543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.9e-41  Score=340.61  Aligned_cols=258  Identities=25%  Similarity=0.408  Sum_probs=203.8

Q ss_pred             hcCccccc-eeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESM-RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~-~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|...+ .||+|+||.||+|.+...    ..+..||||++.....  ...+++.+|++++++++||||+++++++ ..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   89 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMK----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA   89 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECS----SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred             chhhhhccCccccccCeeeEeeeecCC----CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence            35677777 899999999999976532    1578999999976432  2356799999999999999999999999 66


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +..++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +++++||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  163 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL  163 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             CCcEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCc
Confidence            788999999999999999954   345899999999999999999999   56999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      ++...........  .....+|+.|+|||.+....++.++||||||+++|||++ |+.||.......    +...    .
T Consensus       164 ~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~----~  233 (291)
T 1xbb_A          164 SKALRADENYYKA--QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAM----L  233 (291)
T ss_dssp             CEECCTTCSEEEC------CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHH----H
T ss_pred             ceeeccCCCcccc--cccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHH----H
Confidence            9877554322111  113456789999999988889999999999999999999 999997543322    1111    1


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      ..+         .....+......+.+++..||+.||.+|||+.++++.|+.
T Consensus       234 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  276 (291)
T 1xbb_A          234 EKG---------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  276 (291)
T ss_dssp             HTT---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             HcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            111         1111222344567788889999999999999999999975

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.8e-41  Score=346.08  Aligned_cols=256  Identities=20%  Similarity=0.305  Sum_probs=201.3

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcC-CCCceeeEEEEEEeC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRL-RHKHLVHLVGWCHEK  316 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  316 (568)
                      ++|...+.||+|+||.||+|+.+.      +++.||+|++.+...   ...+.+.+|..++.++ +||||+++++++...
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~   82 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKK------TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE   82 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             hheEEEEEEEecCCeEEEEEEECC------CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence            568899999999999999999875      688999999976432   2345678999999988 899999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +.+++||||+++|+|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~  156 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM  156 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGG
T ss_pred             CEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccc
Confidence            999999999999999999953   346899999999999999999999   57999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccch-hhHHHHHHHHh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHA-YTLVDWVWMLH  475 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~-~~l~~~~~~~~  475 (568)
                      ++........     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....+......
T Consensus       157 a~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i  231 (345)
T 3a8x_A          157 CKEGLRPGDT-----TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI  231 (345)
T ss_dssp             CBCSCCTTCC-----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH
T ss_pred             cccccCCCCc-----ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH
Confidence            9864332211     12568999999999999999999999999999999999999999742211100 00011111111


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHH
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKT------EDILQ  523 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~------~evl~  523 (568)
                              ....+.  .+......+..++..||+.||.+||++      .|+++
T Consensus       232 --------~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          232 --------LEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             --------HHCCCC--CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             --------HcCCCC--CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence                    111111  112233456677889999999999995      56654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3e-41  Score=340.17  Aligned_cols=261  Identities=23%  Similarity=0.360  Sum_probs=198.1

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|...++||+|+||.||+|+..       .++.||+|++.....  ...+.+.+|++++++++||||+++++++...+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN-------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             ccchhhhhcccCCCEEEEEEEcC-------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence            46888999999999999999874       578999999965432  234678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++ +|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  148 (288)
T 1ob3_A           75 LVLVFEHLDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLAR  148 (288)
T ss_dssp             EEEEEECCSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred             EEEEEEecCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECcccc
Confidence            9999999974 999988543  246899999999999999999999   5799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      .........     ....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......   .+.. .......
T Consensus       149 ~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~-~~~~~~~  219 (288)
T 1ob3_A          149 AFGIPVRKY-----THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMR-IFRILGT  219 (288)
T ss_dssp             HHCC--------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH-HHHHHCC
T ss_pred             ccCcccccc-----ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH-HHHHHCC
Confidence            765332211     14568999999999875 458999999999999999999999997544332   1111 1111110


Q ss_pred             Cc---hhh-----hhhhhcCC-------CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 GH---IQD-----AVDQRLNI-------NSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~~---~~~-----~~d~~l~~-------~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ..   ...     ..++.+..       .........+.+++.+|++.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00   000     00111100       001122345677888999999999999999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.1e-41  Score=351.12  Aligned_cols=247  Identities=24%  Similarity=0.368  Sum_probs=199.1

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .+.|...+.||+|+||.||+|+...      +++.||||++.....   ...+++.+|++++++++||||+++++++...
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  126 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVR------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE  126 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hhheeeeeEEccCCCEEEEEEEEcc------CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            3458888999999999999999764      688999999975432   2345789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +..++||||++ |+|.+++...  ...+++..+..++.|+++||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       127 ~~~~lv~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~  200 (348)
T 1u5q_A          127 HTAWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGS  200 (348)
T ss_dssp             TEEEEEEECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             CeEEEEEecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccC
Confidence            99999999996 7888887432  346899999999999999999999   56999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFH---TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      ++......         ...||+.|+|||++.   ...++.++|||||||++|||++|+.||.......       ....
T Consensus       201 a~~~~~~~---------~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------~~~~  264 (348)
T 1u5q_A          201 ASIMAPAN---------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYH  264 (348)
T ss_dssp             CBSSSSBC---------CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHH
T ss_pred             ceecCCCC---------cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-------HHHH
Confidence            98764321         457999999999984   5778999999999999999999999987543221       1111


Q ss_pred             HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       474 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .....      .+.+..   ......+..++..||+.||++|||+.++++
T Consensus       265 ~~~~~------~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          265 IAQNE------SPALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             HHHSC------CCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHhcC------CCCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            11111      111111   122345667788999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=343.75  Aligned_cols=272  Identities=18%  Similarity=0.226  Sum_probs=201.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-----------cchhhHHHHHHhhcCCCCceeeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-----------SKGDFLAELAIIHRLRHKHLVHL  309 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l  309 (568)
                      ++|...++||+|+||.||+|+....+.   .+..+|||++......           ....+.+|+..+..++||||+++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPE---KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCG---GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCC---ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            578999999999999999999874221   5678999998765321           12346788899999999999999


Q ss_pred             EEEEEe----CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC
Q 008374          310 VGWCHE----KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA  385 (568)
Q Consensus       310 ~g~~~~----~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~  385 (568)
                      ++++..    ....++||||+ +++|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~  186 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGY  186 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEES
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEcc
Confidence            999988    67899999999 9999999954   337999999999999999999999   569999999999999998


Q ss_pred             CC--cEEEeecCCccccccccccc--cccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 008374          386 DF--NARLGDFGLARAIENERNSY--AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQ  461 (568)
Q Consensus       386 ~~--~~kL~DFGla~~~~~~~~~~--~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~  461 (568)
                      ++  .+||+|||+++.+.......  .........||..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  266 (345)
T 2v62_A          187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD  266 (345)
T ss_dssp             SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred             CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence            87  99999999998775432211  111112567999999999999999999999999999999999999999632221


Q ss_pred             cchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          462 QHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       462 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                      .   ............ .+...+......   ......+.+++..||+.||++|||+++|++.|+...
T Consensus       267 ~---~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          267 P---VAVQTAKTNLLD-ELPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             H---HHHHHHHHHHHH-TTTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             c---HHHHHHHHhhcc-cccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            1   111111111111 111111111111   023346777888999999999999999999998753

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1e-41  Score=345.35  Aligned_cols=273  Identities=24%  Similarity=0.402  Sum_probs=207.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeC--C
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK--G  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~  317 (568)
                      +.|...++||+|+||.||+|++...+.  .+++.||||++.... ....+.+.+|++++++++||||+++++++...  +
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGD--NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSS--SCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccC--ccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            458888999999999999998643221  268999999997543 33457789999999999999999999999876  6


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++|+|.+++...  ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             eEEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccc
Confidence            789999999999999999543  245899999999999999999999   579999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh--
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH--  475 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~--  475 (568)
                      +...........  .....||..|+|||.+.+..++.++||||||+++|||++|+.|+.....     ..........  
T Consensus       174 ~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~  246 (302)
T 4e5w_A          174 KAIETDKEYYTV--KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA-----LFLKMIGPTHGQ  246 (302)
T ss_dssp             EECCTTCCEEEC--CCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH-----HHHHHHCSCCGG
T ss_pred             ccccCCCcceec--cCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh-----HHhhccCCcccc
Confidence            887654322111  1245688999999999999999999999999999999999988542100     0000000000  


Q ss_pred             -hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          476 -REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       476 -~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                       ....+...+...............+.+++..||+.||.+|||+.|+++.|+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          247 MTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             GHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence             0000111112222222233445667888889999999999999999999975

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=360.73  Aligned_cols=263  Identities=20%  Similarity=0.237  Sum_probs=207.9

Q ss_pred             cCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCcee
Q 008374          231 FKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLV  307 (568)
Q Consensus       231 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv  307 (568)
                      +.+++.....++|...++||+|+||+||+++.+.      +++.||||++.+..   ....+.+.+|..++.+++||||+
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv  124 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ------TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT  124 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBC
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCee
Confidence            4455666677899999999999999999999875      68899999997532   23445688999999999999999


Q ss_pred             eEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC
Q 008374          308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF  387 (568)
Q Consensus       308 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~  387 (568)
                      ++++++.+.+.++|||||+++|+|.+++...  ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++
T Consensus       125 ~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g  199 (412)
T 2vd5_A          125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCG  199 (412)
T ss_dssp             CEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTS
T ss_pred             eEEEEEeeCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCC
Confidence            9999999999999999999999999999542  236899999999999999999999   57999999999999999999


Q ss_pred             cEEEeecCCccccccccccccccccccCCcCCcccCccccc-------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 008374          388 NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH-------TGKATPESDVFGFGAVVLEVVCGRSPGNMIPH  460 (568)
Q Consensus       388 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-------~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~  460 (568)
                      .+||+|||+++..........    ...+||+.|+|||++.       ...++.++|||||||++|||++|+.||.....
T Consensus       200 ~vkL~DFGla~~~~~~~~~~~----~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~  275 (412)
T 2vd5_A          200 HIRLADFGSCLKLRADGTVRS----LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST  275 (412)
T ss_dssp             CEEECCCTTCEECCTTSCEEC----SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             CEEEeechhheeccCCCcccc----ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH
Confidence            999999999987754432111    1467999999999987       45789999999999999999999999975433


Q ss_pred             ccchhhHHHHHHHHhhcCchhhhhhhhcCCC-CcHHHHHHHHHHHHhcCCCCCCCC---CCHHHHHH
Q 008374          461 QQHAYTLVDWVWMLHREGHIQDAVDQRLNIN-SVVDEAKRLLLLGLACSHPIASER---PKTEDILQ  523 (568)
Q Consensus       461 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~l~Cl~~dp~~R---Pt~~evl~  523 (568)
                      ......+..+.              ..+... ........+..++..|+. +|.+|   |+++|+++
T Consensus       276 ~~~~~~i~~~~--------------~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          276 AETYGKIVHYK--------------EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHHHHHHTHH--------------HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHHHHHHHhcc--------------cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            22111111110              011101 011223456667779998 99988   68999876

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.9e-41  Score=377.96  Aligned_cols=251  Identities=25%  Similarity=0.420  Sum_probs=199.3

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYD  324 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  324 (568)
                      ++||+|+||.||+|.+...    ..++.||||+++....  ...++|.+|+++|.+++||||++++++|. .+..++|||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E  449 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMK----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVME  449 (635)
T ss_dssp             EEEEECSSEEEEEEEEECS----SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCC----CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEE
Confidence            4799999999999977532    1568899999976432  33578999999999999999999999996 456899999


Q ss_pred             ecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccccc
Q 008374          325 FMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER  404 (568)
Q Consensus       325 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~  404 (568)
                      ||++|+|.+++..   ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.+....
T Consensus       450 ~~~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          450 MAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  523 (635)
T ss_dssp             CCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred             ccCCCCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence            9999999999953   346899999999999999999999   5799999999999999999999999999999775543


Q ss_pred             ccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCchhhh
Q 008374          405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDA  483 (568)
Q Consensus       405 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  483 (568)
                      .....  .....||+.|+|||++....++.++|||||||++|||++ |+.||.......    +.             +.
T Consensus       524 ~~~~~--~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----~~-------------~~  584 (635)
T 4fl3_A          524 NYYKA--QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VT-------------AM  584 (635)
T ss_dssp             -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HH-------------HH
T ss_pred             ccccc--ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HH-------------HH
Confidence            22111  123457889999999999999999999999999999998 999997553322    11             11


Q ss_pred             hhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          484 VDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       484 ~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      +........+......+.+++..||+.||++|||+.+|++.|+.
T Consensus       585 i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          585 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            11112222233445677888889999999999999999999974

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.3e-41  Score=343.63  Aligned_cols=252  Identities=22%  Similarity=0.294  Sum_probs=193.8

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC----cccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS----IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      .++|...++||+|+||.||+++.....   .+++.||+|++....    ......+.+|+.++++++||||+++++++..
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGA---NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSST---TTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccC---CCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            357899999999999999999875211   268899999997642    2334568899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      .+..++||||+++++|.+++..   ...+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  166 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFG  166 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCC
Confidence            9999999999999999999953   346889999999999999999999   5699999999999999999999999999


Q ss_pred             CccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      +++........     .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......    ...      
T Consensus       167 ~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~------  231 (327)
T 3a62_A          167 LCKESIHDGTV-----THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK----TID------  231 (327)
T ss_dssp             CC---------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHH------
T ss_pred             cccccccCCcc-----ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH----HHH------
Confidence            99865433221     124679999999999999999999999999999999999999997543222    111      


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                            .+....+.  .+......+.+++..|++.||++||     ++.|+++
T Consensus       232 ------~i~~~~~~--~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          232 ------KILKCKLN--LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ------HHHHTCCC--CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ------HHHhCCCC--CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                  11111111  1112234567788899999999999     7788876

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.7e-41  Score=341.42  Aligned_cols=267  Identities=24%  Similarity=0.391  Sum_probs=201.5

Q ss_pred             HHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEE
Q 008374          236 LKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWC  313 (568)
Q Consensus       236 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~  313 (568)
                      +....++|...+.||+|+||.||+|.....+.   .+..||+|.+....  ....+.+.+|+.++++++||||+++++++
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDG---TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTS---CEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCC---ceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            33445678899999999999999998865321   46789999987543  33456799999999999999999999999


Q ss_pred             EeCC-----eEEEEEEecCCCChhhhhccC---CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC
Q 008374          314 HEKG-----KLLLVYDFMPNGSLEKYLYGT---SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA  385 (568)
Q Consensus       314 ~~~~-----~~~lV~Ey~~~gsL~~~L~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~  385 (568)
                      .+.+     ..++||||+++|+|.+++...   .....+++..++.++.|+++||.|||   +++|+||||||+|||++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~  182 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRD  182 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcC
Confidence            8755     359999999999999998532   23456999999999999999999999   679999999999999999


Q ss_pred             CCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccch
Q 008374          386 DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHA  464 (568)
Q Consensus       386 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~  464 (568)
                      ++.+||+|||+++..........   .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......  
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--  257 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYYRQ---GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--  257 (313)
T ss_dssp             TSCEEECSCSCC-------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred             CCcEEEeecCcceecccccccCc---ccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--
Confidence            99999999999987654321111   114457889999999999999999999999999999999 888987544332  


Q ss_pred             hhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          465 YTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       465 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                        +....    ..+         ............+.+++..|++.||.+|||+.++++.|+..
T Consensus       258 --~~~~~----~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          258 --MYDYL----LHG---------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             --HHHHH----HTT---------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHHH----HcC---------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              11111    011         11112223345677888899999999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=347.86  Aligned_cols=269  Identities=22%  Similarity=0.292  Sum_probs=207.4

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEe----
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE----  315 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----  315 (568)
                      .++|...++||+|+||.||+++...      +++.||||++........+.+.+|++++++++||||+++++++..    
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLH------DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA  101 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETT------TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecC------CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence            4679999999999999999999864      688999999977666667889999999999999999999999873    


Q ss_pred             CCeEEEEEEecCCCChhhhhccC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDF  394 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DF  394 (568)
                      ....++||||+++|+|.+++... .....+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+||
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~df  178 (317)
T 2buj_A          102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDL  178 (317)
T ss_dssp             EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEec
Confidence            34789999999999999998642 12356899999999999999999999   569999999999999999999999999


Q ss_pred             CCccccccccccc----cccccccCCcCCcccCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhH
Q 008374          395 GLARAIENERNSY----AEHGLVGVPGTMGYVAPECFHTGK---ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTL  467 (568)
Q Consensus       395 Gla~~~~~~~~~~----~~~~~~~~~Gt~~y~APE~~~~~~---~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l  467 (568)
                      |+++.........    .........||+.|+|||.+....   ++.++||||||+++|||++|+.||........  .+
T Consensus       179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~  256 (317)
T 2buj_A          179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--SV  256 (317)
T ss_dssp             SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--CH
T ss_pred             CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--hh
Confidence            9988654321110    000011345799999999987544   68899999999999999999999852111100  11


Q ss_pred             HHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC
Q 008374          468 VDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVP  532 (568)
Q Consensus       468 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~p  532 (568)
                      .             ..+...............+.+++..||+.||.+|||+.++++.|+...+.+
T Consensus       257 ~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          257 A-------------LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             H-------------HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             h-------------HHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence            1             111111111111223456778888999999999999999999999875544

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.2e-41  Score=347.03  Aligned_cols=244  Identities=24%  Similarity=0.397  Sum_probs=202.6

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--------ccchhhHHHHHHhhcCCCCceeeEE
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--------KSKGDFLAELAIIHRLRHKHLVHLV  310 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~  310 (568)
                      ..++|...+.||+|+||.||+|+...      +++.||||++.....        ...+.+.+|+.++++++||||++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~   95 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKE------KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVL   95 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETT------TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEE
T ss_pred             cccceEEEeEEEecCCEEEEEEEECC------CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            35679999999999999999999875      688999999976532        1345788999999999999999999


Q ss_pred             EEEEeCCeEEEEEEecCCC-ChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcE
Q 008374          311 GWCHEKGKLLLVYDFMPNG-SLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA  389 (568)
Q Consensus       311 g~~~~~~~~~lV~Ey~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~  389 (568)
                      +++.+.+..++||||+.+| +|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+
T Consensus        96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~  169 (335)
T 3dls_A           96 DIFENQGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTI  169 (335)
T ss_dssp             EEEECSSEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCE
T ss_pred             EEEeeCCEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcE
Confidence            9999999999999999877 99999954   346999999999999999999999   5799999999999999999999


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHH
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV  468 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~  468 (568)
                      ||+|||+++........      ....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......      
T Consensus       170 kL~Dfg~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------  237 (335)
T 3dls_A          170 KLIDFGSAAYLERGKLF------YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------  237 (335)
T ss_dssp             EECCCTTCEECCTTCCB------CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------
T ss_pred             EEeecccceECCCCCce------eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------
Confidence            99999999877554321      14579999999999988777 789999999999999999999986422111      


Q ss_pred             HHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          469 DWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       469 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                                      ......  +......+.+++..|++.||++|||+.|+++.
T Consensus       238 ----------------~~~~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 ----------------EAAIHP--PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ----------------TTCCCC--SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ----------------hhccCC--CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                            111111  11123456778889999999999999999874

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.6e-41  Score=336.94  Aligned_cols=248  Identities=22%  Similarity=0.364  Sum_probs=201.0

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      +.++|...+.||+|+||.||+|....      ++..||+|++....   ......+.+|+.++++++||||+++++++.+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   80 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQ------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence            35679999999999999999999875      67899999986532   2234568899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      .+..++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg  154 (279)
T 3fdn_A           81 ATRVYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG  154 (279)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEecc
Confidence            9999999999999999999953   346899999999999999999999   6899999999999999999999999999


Q ss_pred             CccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      ++........       ....||..|+|||.+.+..++.++||||||+++|||++|+.||.......    ...   . .
T Consensus       155 ~~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~---~-~  219 (279)
T 3fdn_A          155 WSVHAPSSRR-------TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----TYK---R-I  219 (279)
T ss_dssp             EESCC---------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHH---H-H
T ss_pred             ccccCCcccc-------cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH----HHH---H-H
Confidence            9866543321       14578999999999999999999999999999999999999997543222    110   0 0


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .        .  .....+......+.+++..|++.||.+|||++|+++
T Consensus       220 ~--------~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          220 S--------R--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             H--------H--TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             H--------h--CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0        0  011111223345667888999999999999999997

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.8e-41  Score=344.30  Aligned_cols=256  Identities=27%  Similarity=0.442  Sum_probs=203.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCe--EEEEEEeccC-CcccchhhHHHHHHhhcC-CCCceeeEEEEEEeC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNT--QIAVKKFSRD-SIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEK  316 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  316 (568)
                      ++|...+.||+|+||.||+|+...      ++.  .+|+|++... .....+.+.+|++++.++ +||||+++++++.+.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~   98 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKK------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   98 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEE------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             HHccceeeeecCCCceEEEEEEcc------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence            578889999999999999999875      444  4599998753 334567799999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTS-------------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL  383 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl  383 (568)
                      +..++||||+++|+|.+++....             ....+++.++..++.|++.||.|||   +++|+||||||+|||+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~  175 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILV  175 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEE
Confidence            99999999999999999996542             2346899999999999999999999   5799999999999999


Q ss_pred             cCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 008374          384 DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQ  462 (568)
Q Consensus       384 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~  462 (568)
                      +.++.+||+|||+++........      ....+|..|+|||.+....++.++||||||+++|||++ |+.||.......
T Consensus       176 ~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~  249 (327)
T 1fvr_A          176 GENYVAKIADFGLSRGQEVYVKK------TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE  249 (327)
T ss_dssp             CGGGCEEECCTTCEESSCEECCC----------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             cCCCeEEEcccCcCccccccccc------cCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH
Confidence            99999999999999854332211      13457889999999988889999999999999999998 999997543221


Q ss_pred             chhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          463 HAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       463 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                          +.    ....         ..............+.+++..|++.||.+|||+.|+++.|+..
T Consensus       250 ----~~----~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          250 ----LY----EKLP---------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             ----HH----HHGG---------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HH----HHhh---------cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                11    1111         1111112223345677888899999999999999999988764

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.5e-41  Score=338.58  Aligned_cols=253  Identities=23%  Similarity=0.394  Sum_probs=200.0

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLL  321 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  321 (568)
                      +|.....||+|+||.||+|+...      ++..||||.+........+.+.+|+.++++++||||+++++++...+..++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   96 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLS------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI   96 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETT------TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECC------CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence            34555689999999999999865      678999999987766667789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-CCcEEEeecCCcccc
Q 008374          322 VYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA-DFNARLGDFGLARAI  400 (568)
Q Consensus       322 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~-~~~~kL~DFGla~~~  400 (568)
                      ||||+++++|.+++........+++..+..++.|++.||.|||   +++++||||||+||+++. ++.+||+|||+++..
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A           97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            9999999999999976544456788999999999999999999   579999999999999987 899999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGK--ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~--~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ......     .....||..|+|||.+....  ++.++||||||+++|||++|+.||.......   ... +....    
T Consensus       174 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~-~~~~~----  240 (295)
T 2clq_A          174 AGINPC-----TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---AAM-FKVGM----  240 (295)
T ss_dssp             CC----------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---HHH-HHHHH----
T ss_pred             CCCCCc-----ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---HHH-Hhhcc----
Confidence            543211     11457899999999987643  7899999999999999999999986432211   000 00000    


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                             ..............+.+++..|++.||++|||+.|+++
T Consensus       241 -------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          241 -------FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             -------HCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             -------ccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                   01111112223446677888999999999999999985

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.7e-41  Score=348.47  Aligned_cols=261  Identities=21%  Similarity=0.281  Sum_probs=183.7

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-CCceeeEEEEEEeCCeEEEEEE
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-HKHLVHLVGWCHEKGKLLLVYD  324 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E  324 (568)
                      .++||+|+||.||+|+...      +++.||||++...   ....+.+|+.++.++. ||||+++++++.+.+..++|||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e   86 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKK------SNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME   86 (325)
T ss_dssp             SCCSEEETTEEEEEEEETT------TCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCccccCCCeEEEEEEECC------CCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence            4689999999999999875      6889999999653   3456789999999997 9999999999999999999999


Q ss_pred             ecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC---cEEEeecCCccccc
Q 008374          325 FMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF---NARLGDFGLARAIE  401 (568)
Q Consensus       325 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~---~~kL~DFGla~~~~  401 (568)
                      |+++|+|.+++..   ...+++.++..++.|++.||.|||   +++|+||||||+|||++.++   .+||+|||+++...
T Consensus        87 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~  160 (325)
T 3kn6_A           87 LLNGGELFERIKK---KKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP  160 (325)
T ss_dssp             CCCSCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred             ccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence            9999999999954   346999999999999999999999   57999999999999997665   89999999998765


Q ss_pred             cccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchh
Q 008374          402 NERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQ  481 (568)
Q Consensus       402 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  481 (568)
                      ......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.............+.. .....+.. 
T Consensus       161 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~i~~~~~-  233 (325)
T 3kn6_A          161 PDNQPL-----KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-KKIKKGDF-  233 (325)
T ss_dssp             C---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH-HHHTTTCC-
T ss_pred             CCCCcc-----cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH-HHHHcCCC-
Confidence            433221     24578999999999999999999999999999999999999997543321111111111 11111110 


Q ss_pred             hhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCCCCCCC
Q 008374          482 DAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISGTSTVPY  533 (568)
Q Consensus       482 ~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L~~~~~~p~  533 (568)
                           .+...........+.+++..|++.||.+|||++|+++  .++...+.+.
T Consensus       234 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~  282 (325)
T 3kn6_A          234 -----SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS  282 (325)
T ss_dssp             -----CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCC
T ss_pred             -----CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCC
Confidence                 0000001123456777888999999999999999974  3444444443

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-41  Score=337.96  Aligned_cols=262  Identities=25%  Similarity=0.345  Sum_probs=204.8

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE-
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL-  319 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~-  319 (568)
                      .|...++||+|+||.||+|++.....   .+..+|+|.+..... ...+.|.+|+.++++++||||+++++++.+.+.. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQ---NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSS---CEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             EEccCceeccCCCceEEEEEEecCCC---ceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            35566889999999999999764321   345899999976433 3457899999999999999999999999876655 


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+.+|+|.+++...  ...+++..+..++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++.
T Consensus        99 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  173 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARD  173 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred             EEEEecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence            9999999999999999653  356899999999999999999999   56999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      ....... .........+|..|+|||.+.+..++.++||||||+++|||++|+.|+.......   .+.....       
T Consensus       174 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~---~~~~~~~-------  242 (298)
T 3pls_A          174 ILDREYY-SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF---DLTHFLA-------  242 (298)
T ss_dssp             TTTGGGG-CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG---GHHHHHH-------
T ss_pred             ccCCccc-ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH---HHHHHhh-------
Confidence            6543211 1111225578899999999999999999999999999999999666654222222   2222111       


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                            ..............+.+++..|++.||.+|||++++++.|+..
T Consensus       243 ------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          243 ------QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             ------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------cCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                  1111111222334677888899999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.6e-41  Score=345.84  Aligned_cols=275  Identities=25%  Similarity=0.395  Sum_probs=214.2

Q ss_pred             cCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcC-CCCceee
Q 008374          231 FKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRL-RHKHLVH  308 (568)
Q Consensus       231 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~  308 (568)
                      +...+.....++|...+.||+|+||.||+|+....+ ...+++.||||++..... ...+.+.+|+.++.++ +||||++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID-KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS-STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCC-ccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            344455556788999999999999999999875311 112678999999976533 3456789999999999 7999999


Q ss_pred             EEEEEEeCC-eEEEEEEecCCCChhhhhccCCC-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 008374          309 LVGWCHEKG-KLLLVYDFMPNGSLEKYLYGTSE-------------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHR  374 (568)
Q Consensus       309 l~g~~~~~~-~~~lV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  374 (568)
                      ++++|...+ ..++||||+++|+|.+++.....             ...+++..+..++.|++.||.|||   +++|+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence            999998764 58999999999999999975432             123889999999999999999999   5799999


Q ss_pred             CCCCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCC
Q 008374          375 DLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRS  453 (568)
Q Consensus       375 Dikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~  453 (568)
                      ||||+|||++.++.+||+|||+++...........   ....||+.|+|||.+.+..++.++||||||+++|||++ |+.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~  249 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  249 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEE---TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceec---cCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999876543221111   14467899999999999999999999999999999998 999


Q ss_pred             CCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          454 PGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       454 P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ||.......   .+...    ...+         ............+.+++..||+.||.+|||+.|+++.|+..
T Consensus       250 p~~~~~~~~---~~~~~----~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          250 PYPGVKIDE---EFCRR----LKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             SSTTCCCSH---HHHHH----HHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcccchhH---HHHHH----hccC---------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            997543322   11111    1111         11111122334577788899999999999999999999753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.8e-41  Score=354.63  Aligned_cols=270  Identities=21%  Similarity=0.282  Sum_probs=211.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC--
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG--  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--  317 (568)
                      ++|...++||+|+||.||+|+...      +++.||||++.... ....+.+.+|++++++++||||+++++++...+  
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   82 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKK------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CceEEEEEEEcCCCeEEEEEEECC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence            568889999999999999999875      68899999997643 234567889999999999999999999998765  


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----cCCCcEEEee
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL----DADFNARLGD  393 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl----d~~~~~kL~D  393 (568)
                      ..++||||+++|+|.+++........+++..+..++.|++.||.|||   +++|+||||||+|||+    +.++.+||+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred             eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence            78999999999999999976544445999999999999999999999   5799999999999999    7888899999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCcccccc--------CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchh
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT--------GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY  465 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--------~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~  465 (568)
                      ||+++........      ....||..|+|||++..        ..++.++|||||||++|||++|+.||......... 
T Consensus       160 FG~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~-  232 (396)
T 4eut_A          160 FGAARELEDDEQF------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-  232 (396)
T ss_dssp             GGGCEECCCGGGS------SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC-
T ss_pred             CCCceEccCCCcc------ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch-
Confidence            9999876554321      14579999999999864        56788999999999999999999999743332211 


Q ss_pred             hHHHHHHHHhhcCc---hhhh---hh------hh--cCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          466 TLVDWVWMLHREGH---IQDA---VD------QR--LNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       466 ~l~~~~~~~~~~~~---~~~~---~d------~~--l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                        .+..........   +..+   .+      ..  ............+..++..|++.||++|||++|+++.|+..
T Consensus       233 --~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          233 --KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             --HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             --HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence              111111111110   0000   00      00  11123456777888899999999999999999999887653

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3e-41  Score=344.07  Aligned_cols=256  Identities=22%  Similarity=0.279  Sum_probs=193.4

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|...++||+|+||.||+|+...      +++.||||++.....   .....+.+|+.++.+++||||+++++++...
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   84 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLR------DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE   84 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECC------CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence            3578999999999999999999864      688999999976432   2345789999999999999999999998765


Q ss_pred             C----eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          317 G----KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       317 ~----~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                      .    ..++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+
T Consensus        85 ~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~  158 (311)
T 3ork_A           85 TPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVM  158 (311)
T ss_dssp             ETTEEEEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEEC
T ss_pred             CCCCcccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEe
Confidence            4    35999999999999999953   346899999999999999999999   5799999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      |||+++...........  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......       ...
T Consensus       159 Dfg~a~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-------~~~  229 (311)
T 3ork_A          159 DFGIARAIADSGNSVTQ--TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAY  229 (311)
T ss_dssp             CCSCC--------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHH
T ss_pred             eccCccccccccccccc--ccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-------HHH
Confidence            99999877554322111  124579999999999999999999999999999999999999997543222       111


Q ss_pred             HHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ...........   ..    .......+..++..||+.||++||+..++++
T Consensus       230 ~~~~~~~~~~~---~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          230 QHVREDPIPPS---AR----HEGLSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             HHHHCCCCCHH---HH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             HHhcCCCCCcc---cc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            11111111000   00    0112345677888999999999997666553

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=349.90  Aligned_cols=252  Identities=21%  Similarity=0.326  Sum_probs=196.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCC--CceeeEEEEEEe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRH--KHLVHLVGWCHE  315 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~  315 (568)
                      .+.|...++||+|+||.||++...       +++.||||++....  ....+.+.+|+.++.+++|  |||+++++++..
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   80 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   80 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence            346888999999999999999875       57889999987543  3345678999999999976  999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      .+..++||| +.+++|.+++..   ...+++.++..++.|++.||.|||   +++|+||||||+|||++ ++.+||+|||
T Consensus        81 ~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG  152 (343)
T 3dbq_A           81 DQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFG  152 (343)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred             CCEEEEEEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecc
Confidence            999999999 568899999954   346899999999999999999999   57999999999999997 5789999999


Q ss_pred             CccccccccccccccccccCCcCCcccCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccch
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-----------GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHA  464 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----------~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~  464 (568)
                      +++..........   .....||+.|+|||++..           ..++.++|||||||++|||++|+.||.......  
T Consensus       153 ~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--  227 (343)
T 3dbq_A          153 IANQMQPDTTSVV---KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--  227 (343)
T ss_dssp             SSCCC---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--
T ss_pred             cccccCccccccc---CCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH--
Confidence            9987754432211   124579999999999864           678999999999999999999999997433221  


Q ss_pred             hhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          465 YTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       465 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                         ..          +...+++......+......+.+++..||+.||.+|||+.|+++.
T Consensus       228 ---~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          228 ---SK----------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             ---HH----------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---HH----------HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence               11          112223333222222233456778889999999999999999873

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.2e-40  Score=350.48  Aligned_cols=272  Identities=18%  Similarity=0.204  Sum_probs=204.9

Q ss_pred             hcCccccceeccC--CceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          240 TNNFHESMRLGEG--GFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       240 t~~f~~~~~LG~G--~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      .++|...++||+|  +||.||+|+...      +++.||||++....  ....+.+.+|+.++++++||||+++++++.+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKP------TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETT------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcC------CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            4578999999999  999999999875      68899999997643  2344678889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      .+..++|||||++|+|.+++.... ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg  173 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLR  173 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGG
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccc
Confidence            999999999999999999996532 245899999999999999999999   5799999999999999999999999999


Q ss_pred             Cccccccccccc--cccccccCCcCCcccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          396 LARAIENERNSY--AEHGLVGVPGTMGYVAPECFHT--GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       396 la~~~~~~~~~~--~~~~~~~~~Gt~~y~APE~~~~--~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      ++..........  .........||+.|+|||++..  ..++.++|||||||++|||++|+.||.......   .+....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~  250 (389)
T 3gni_B          174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKL  250 (389)
T ss_dssp             GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT---HHHHC-
T ss_pred             cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHh
Confidence            987654321111  1111123478999999999987  678999999999999999999999997544332   111100


Q ss_pred             HHHhh----------------------cCchhhhhh---hh------cCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 008374          472 WMLHR----------------------EGHIQDAVD---QR------LNINSVVDEAKRLLLLGLACSHPIASERPKTED  520 (568)
Q Consensus       472 ~~~~~----------------------~~~~~~~~d---~~------l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~e  520 (568)
                      .....                      .....+.+.   ++      ............+.+++.+||+.||.+|||+.|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e  330 (389)
T 3gni_B          251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST  330 (389)
T ss_dssp             -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence            00000                      000000000   00      000111223345788899999999999999999


Q ss_pred             HHHH
Q 008374          521 ILQI  524 (568)
Q Consensus       521 vl~~  524 (568)
                      +++.
T Consensus       331 ll~h  334 (389)
T 3gni_B          331 LLNH  334 (389)
T ss_dssp             HTTS
T ss_pred             HhcC
Confidence            9863

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5e-41  Score=341.84  Aligned_cols=266  Identities=23%  Similarity=0.306  Sum_probs=199.1

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|...++||+|+||.||+|+...      +++.||||++.....  ...+.+.+|++++++++||||+++++++...+.
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   76 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRD------TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR   76 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCC------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCe
Confidence            578899999999999999999875      688999999865432  234668899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++++|..++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        77 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  150 (311)
T 4agu_A           77 LHLVFEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFAR  150 (311)
T ss_dssp             EEEEEECCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEeCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCch
Confidence            9999999999999998843   345899999999999999999999   5799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH------
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV------  471 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~------  471 (568)
                      .........     ....||..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+....      
T Consensus       151 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  225 (311)
T 4agu_A          151 LLTGPSDYY-----DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR  225 (311)
T ss_dssp             ECC-----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             hccCccccc-----CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccc
Confidence            765432221     14578999999999876 678999999999999999999999997654332111111100      


Q ss_pred             -HHHhhcCchhhhhh-hhcCCCC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          472 -WMLHREGHIQDAVD-QRLNINS-----VVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       472 -~~~~~~~~~~~~~d-~~l~~~~-----~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       .............. +......     .......+.+++..|++.||.+|||++|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence             00000000000000 0000000     0122345778888999999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.1e-40  Score=341.38  Aligned_cols=252  Identities=22%  Similarity=0.310  Sum_probs=204.2

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc------cchhhHHHHHHhhcCCCCceeeEEEEE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK------SKGDFLAELAIIHRLRHKHLVHLVGWC  313 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~g~~  313 (568)
                      .++|...+.||+|+||.||+|+...      +++.||+|.+......      ..+++.+|+.++++++||||+++++++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   84 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKS------TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY   84 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECC------CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            4668999999999999999999875      6789999999764322      245789999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC----cE
Q 008374          314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF----NA  389 (568)
Q Consensus       314 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~----~~  389 (568)
                      .+.+..++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++    .+
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~  158 (321)
T 2a2a_A           85 ENRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHI  158 (321)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCE
T ss_pred             ecCCEEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCE
Confidence            999999999999999999999954   346899999999999999999999   57999999999999999888    79


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~  469 (568)
                      ||+|||+++........      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......   .+  
T Consensus       159 kl~Dfg~~~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~--  227 (321)
T 2a2a_A          159 KLIDFGLAHEIEDGVEF------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL--  227 (321)
T ss_dssp             EECCCTTCEECCTTCCC------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH--
T ss_pred             EEccCccceecCccccc------cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---HH--
Confidence            99999999876543221      24579999999999999999999999999999999999999997543322   11  


Q ss_pred             HHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          470 WVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       470 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        ... .....  ..++..    .......+.+++..|++.||.+|||+.|+++
T Consensus       228 --~~i-~~~~~--~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          228 --ANI-TSVSY--DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             --HHH-HTTCC--CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             --HHH-Hhccc--ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              110 00000  000000    0112345677888999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.5e-40  Score=332.06  Aligned_cols=254  Identities=24%  Similarity=0.337  Sum_probs=204.0

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .++|...+.||+|+||.||+|+...      +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRV------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECC------CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE
Confidence            4678999999999999999999874      67899999986543 2345678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||++.
T Consensus        80 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  153 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLAT  153 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCcc
Confidence            9999999999999999943   346899999999999999999999   5799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      .........   ......||..|+|||.+....+ +.++||||||++++||++|+.||........  ....|.     .
T Consensus       154 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~-----~  223 (276)
T 2yex_A          154 VFRYNNRER---LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWK-----E  223 (276)
T ss_dssp             ECEETTEEC---CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHHH-----T
T ss_pred             ccCCCcchh---cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhh-----h
Confidence            765432111   1125679999999999987665 7799999999999999999999975433221  111111     1


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ..        ............+.+++..|++.||.+|||+.|+++
T Consensus       224 ~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          224 KK--------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             TC--------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cc--------cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            00        000111122345667888999999999999999975

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.6e-41  Score=337.84  Aligned_cols=260  Identities=27%  Similarity=0.457  Sum_probs=194.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      .++|...++||+|+||.||+|+..         ..||||++....  ....+.|.+|+.++++++||||+++++++ ..+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~   92 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH---------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP   92 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS---------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc---------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence            457889999999999999999753         359999987543  33456799999999999999999999976 456


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++++|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  167 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLA  167 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred             ccEEEEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceec
Confidence            789999999999999999543  356899999999999999999999   579999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFH---TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      +..........   .....||+.|+|||.+.   ...++.++||||||+++|||++|+.||.......   .+.+.+.  
T Consensus       168 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~--  239 (289)
T 3og7_A          168 TEKSRWSGSHQ---FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIEMVG--  239 (289)
T ss_dssp             -------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH---HHHHHHH--
T ss_pred             ccccccccccc---ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH---HHHHHhc--
Confidence            86654222111   12457999999999986   5678889999999999999999999997544332   2222211  


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                        .+...    +.+ ..........+.+++..|++.||.+|||+.|+++.|+...
T Consensus       240 --~~~~~----~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          240 --RGSLS----PDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             --HTSCC----CCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             --ccccC----cch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence              11111    000 0111233456788888999999999999999999998754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.6e-40  Score=356.16  Aligned_cols=253  Identities=25%  Similarity=0.379  Sum_probs=206.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...+.||+|+||.||+|+...      +++.||||++.....   ...+.+.+|+.+++.++||||+++++++...+
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~   89 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHEL------TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS   89 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETT------TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            568889999999999999999875      688999999965422   23457889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++|+|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++++||+|||++
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a  163 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLS  163 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             EEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccch
Confidence            99999999999999999953   356999999999999999999999   779999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      +.......      .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......    +..       
T Consensus       164 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~----~~~-------  226 (476)
T 2y94_A          164 NMMSDGEF------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT----LFK-------  226 (476)
T ss_dssp             EECCTTCC------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH----HHH-------
T ss_pred             hhcccccc------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH----HHH-------
Confidence            87654321      124579999999999988765 689999999999999999999997543221    111       


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCCC
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISGTS  529 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L~~~~  529 (568)
                           .+.+....  .+......+.+++..|++.||.+|||+.|+++  .+....
T Consensus       227 -----~i~~~~~~--~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          227 -----KICDGIFY--TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             -----HHHTTCCC--CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             -----HHhcCCcC--CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence                 11111111  11112345677888999999999999999997  565543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=349.37  Aligned_cols=270  Identities=20%  Similarity=0.268  Sum_probs=193.9

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-CCceeeEEEEEE---
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-HKHLVHLVGWCH---  314 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~---  314 (568)
                      ...+|...++||+|+||.||+|+...      +++.||||++........+.+.+|+.++.++. ||||+++++++.   
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~   99 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVG------SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK   99 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETT------TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred             cCceEEEEEEEccCCceEEEEEEECC------CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence            34578999999999999999999865      67899999997766666778999999999996 999999999994   


Q ss_pred             -----eCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEEcCCC
Q 008374          315 -----EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQK--VVHRDLKASNILLDADF  387 (568)
Q Consensus       315 -----~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDikp~NILld~~~  387 (568)
                           .....++||||+. |+|.+++........+++..+..++.|++.||.|||   +++  |+||||||+|||++.++
T Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~  175 (337)
T 3ll6_A          100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQG  175 (337)
T ss_dssp             TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTS
T ss_pred             cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCC
Confidence                 3346899999995 899999865334456999999999999999999999   567  99999999999999999


Q ss_pred             cEEEeecCCccccccccccccc-------cccccCCcCCcccCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008374          388 NARLGDFGLARAIENERNSYAE-------HGLVGVPGTMGYVAPECF---HTGKATPESDVFGFGAVVLEVVCGRSPGNM  457 (568)
Q Consensus       388 ~~kL~DFGla~~~~~~~~~~~~-------~~~~~~~Gt~~y~APE~~---~~~~~t~~sDV~SfGvll~el~tG~~P~~~  457 (568)
                      .+||+|||+++...........       .......||+.|+|||.+   ....++.++||||||+++|||++|+.||..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            9999999999877543221100       001134689999999998   566789999999999999999999999864


Q ss_pred             CCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCC
Q 008374          458 IPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQF  537 (568)
Q Consensus       458 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~p~~p~~  537 (568)
                      .....                    ++...............+..++..||+.||.+|||+.|+++.|+........++.
T Consensus       256 ~~~~~--------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~  315 (337)
T 3ll6_A          256 GAKLR--------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK  315 (337)
T ss_dssp             ------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTT
T ss_pred             hhHHH--------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCC
Confidence            32211                    0111111111111123356788899999999999999999999876444333333


Q ss_pred             C
Q 008374          538 K  538 (568)
Q Consensus       538 ~  538 (568)
                      .
T Consensus       316 ~  316 (337)
T 3ll6_A          316 S  316 (337)
T ss_dssp             S
T ss_pred             c
Confidence            3

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.5e-40  Score=337.18  Aligned_cols=249  Identities=23%  Similarity=0.382  Sum_probs=204.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .+.|...++||+|+||.||+|+...      +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   94 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNR------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK   94 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECC------CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            3568889999999999999998764      67899999997653 3345789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++++|.+++..    ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++
T Consensus        95 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  167 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAG  167 (303)
T ss_dssp             EEEEEECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccce
Confidence            9999999999999999943    46899999999999999999999   5699999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      .........     ....||..|+|||.+....++.++||||||+++|||++|+.||.......    ....+    ..+
T Consensus       168 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~----~~~  234 (303)
T 3a7i_A          168 QLTDTQIKR-----NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK----VLFLI----PKN  234 (303)
T ss_dssp             ECBTTBCCB-----CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHH----HHS
T ss_pred             ecCcccccc-----CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH----HHHHh----hcC
Confidence            765432211     24578999999999999999999999999999999999999987543221    11111    001


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .     .+.+..    .....+..++..||+.||.+|||+.|+++
T Consensus       235 ~-----~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          235 N-----PPTLEG----NYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             C-----CCCCCS----SCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             C-----CCCCcc----ccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0     111111    22345677888999999999999999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.1e-40  Score=334.59  Aligned_cols=252  Identities=20%  Similarity=0.321  Sum_probs=203.5

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      .++|...++||+|+||.||+|....      +++.||+|++....  ....+.+.+|+.++++++||||+++++++...+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKT------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES   78 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcC------CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC
Confidence            4679999999999999999999875      67899999986543  234567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc---EEEeec
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN---ARLGDF  394 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~---~kL~DF  394 (568)
                      ..++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +++++||||||+||+++.++.   +||+||
T Consensus        79 ~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Df  152 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADF  152 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeec
Confidence            99999999999999998853   346899999999999999999999   579999999999999987655   999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      |++.........      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......    +....   
T Consensus       153 g~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~---  219 (284)
T 3kk8_A          153 GLAIEVNDSEAW------HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----LYAQI---  219 (284)
T ss_dssp             TTCEECCSSCBC------CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH---
T ss_pred             eeeEEcccCccc------cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH----HHHHH---
Confidence            999876543221      24579999999999999999999999999999999999999997543322    11110   


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       ..+..      .............+.+++..|++.||++|||+.|+++
T Consensus       220 -~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          220 -KAGAY------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             -HHTCC------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -Hhccc------cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             01100      0000001122345677888999999999999999987

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.2e-41  Score=342.47  Aligned_cols=263  Identities=22%  Similarity=0.344  Sum_probs=197.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|...+.||+|+||.||+|....      +++.||||++....   ....+++.+|+.++++++||||+++++++...
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  104 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLL------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED  104 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETT------TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             ccceEEEEeecCCCCceEEEEEEcC------CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            4579999999999999999999864      67899999997532   33456789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      +..++||||+++++|.+++... .....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg  181 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLG  181 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEecc
Confidence            9999999999999999998542 12346899999999999999999999   5799999999999999999999999999


Q ss_pred             CccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      +++.........     ....||..|+|||.+....++.++||||||+++|||++|+.||......     ....... .
T Consensus       182 ~~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~-~  250 (310)
T 2wqm_A          182 LGRFFSSKTTAA-----HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCKK-I  250 (310)
T ss_dssp             ----------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-----HHHHHHH-H
T ss_pred             ceeeecCCCccc-----cccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-----HHHHHHH-h
Confidence            998765432211     1456899999999999999999999999999999999999998743221     1111111 1


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST  530 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~  530 (568)
                      .....     +.+   ........+.+++..||+.||.+|||+.+|++.|+...+
T Consensus       251 ~~~~~-----~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          251 EQCDY-----PPL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             HTTCS-----CCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcccC-----CCC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            11111     000   011223456778889999999999999999999987533

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.2e-40  Score=346.48  Aligned_cols=211  Identities=23%  Similarity=0.265  Sum_probs=182.9

Q ss_pred             cccCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-----C
Q 008374          229 REFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-----H  303 (568)
Q Consensus       229 ~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H  303 (568)
                      ..+++++.....++|...++||+|+||.||+|+...      +++.||||++... ....+.+..|+.++.+++     |
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h   95 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID------NKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINN   95 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTG
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECC------CCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCC
Confidence            345566666677899999999999999999999875      6789999999643 334566788999999986     9


Q ss_pred             CceeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 008374          304 KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL  383 (568)
Q Consensus       304 ~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl  383 (568)
                      |||+++++++...+..++||||+ +++|.+++.... ...+++..+..++.|++.||.|||   +++|+||||||+|||+
T Consensus        96 ~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  170 (360)
T 3llt_A           96 NNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILL  170 (360)
T ss_dssp             GGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEE
Confidence            99999999999999999999999 999999996543 235899999999999999999999   5799999999999999


Q ss_pred             cC-------------------------CCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchh
Q 008374          384 DA-------------------------DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDV  438 (568)
Q Consensus       384 d~-------------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV  438 (568)
                      +.                         ++.+||+|||+++......        ....||+.|+|||++.+..++.++||
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~Di  242 (360)
T 3llt_A          171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH--------GSIINTRQYRAPEVILNLGWDVSSDM  242 (360)
T ss_dssp             SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC--------CSCCSCGGGCCHHHHTTCCCCTTHHH
T ss_pred             ccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC--------cCccCcccccCcHHHcCCCCCCccch
Confidence            76                         7899999999998654322        14578999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCC
Q 008374          439 FGFGAVVLEVVCGRSPGNMIP  459 (568)
Q Consensus       439 ~SfGvll~el~tG~~P~~~~~  459 (568)
                      |||||++|||++|+.||....
T Consensus       243 wslG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          243 WSFGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSS
T ss_pred             HHHHHHHHHHHHCCCCCCCCc
Confidence            999999999999999997543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5e-41  Score=353.77  Aligned_cols=251  Identities=21%  Similarity=0.320  Sum_probs=196.5

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCC--CCceeeEEEEEEeC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLR--HKHLVHLVGWCHEK  316 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~  316 (568)
                      +.|...++||+|+||.||++...       .++.||||++....  ....+.+.+|+.++.+++  ||||+++++++...
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~  128 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  128 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             CceEEEEEEccCCCeEEEEEEcC-------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC
Confidence            45899999999999999999865       47889999987543  334577999999999996  59999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +.+++||| +.+++|.+++...   ..+++.++..++.||+.||.|||   +++|+||||||+|||++ ++.+||+|||+
T Consensus       129 ~~~~lv~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~  200 (390)
T 2zmd_A          129 QYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGI  200 (390)
T ss_dssp             SEEEEEEE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSS
T ss_pred             CEEEEEEe-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCc
Confidence            99999999 5689999999643   46889999999999999999999   67999999999999995 58899999999


Q ss_pred             ccccccccccccccccccCCcCCcccCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-----------GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY  465 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----------~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~  465 (568)
                      ++..........   .....||+.|+|||++..           ..++.++|||||||++|||++|+.||.......   
T Consensus       201 a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---  274 (390)
T 2zmd_A          201 ANQMQPDTTSVV---KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---  274 (390)
T ss_dssp             SCCC------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---
T ss_pred             cccccCCCcccc---CCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH---
Confidence            987754332111   124679999999999865           468899999999999999999999997433221   


Q ss_pred             hHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          466 TLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       466 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                         ..         +..+++.......+......+.+++..||+.||.+|||+.|+++.
T Consensus       275 ---~~---------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          275 ---SK---------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             ---HH---------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---HH---------HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence               11         112223222222222223456778889999999999999999873

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.6e-41  Score=339.97  Aligned_cols=265  Identities=22%  Similarity=0.320  Sum_probs=205.8

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEe--
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE--  315 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--  315 (568)
                      .++|...+.||+|+||.||++....      +++.||+|.+....  ....+.+.+|+.++++++||||+++++++..  
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKS------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   78 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred             hhheeeehhccCCCCcEEEEEEECC------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence            4678899999999999999999875      67899999997643  3345678999999999999999999998854  


Q ss_pred             CCeEEEEEEecCCCChhhhhccCC-CcccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTS-EQVTLNWNHRYKILTGVASAVYYLQNEY--DQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                      .+..++||||+++++|.+++.... ....+++..+..++.|++.||.|||...  ..+++||||||+|||++.++.+||+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~  158 (279)
T 2w5a_A           79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  158 (279)
T ss_dssp             GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred             CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence            578999999999999999996432 2335899999999999999999999541  1229999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      |||+++.........     ....||..|+|||.+....++.++||||||+++|||++|+.||.......    +...  
T Consensus       159 dfg~~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~--  227 (279)
T 2w5a_A          159 DFGLARILNHDTSFA-----KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----LAGK--  227 (279)
T ss_dssp             CCCHHHHC---CHHH-----HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH--
T ss_pred             cCchheeeccccccc-----cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH----HHHH--
Confidence            999998765432111     13468999999999998899999999999999999999999997543221    1111  


Q ss_pred             HHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC
Q 008374          473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVP  532 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~p  532 (568)
                        ...+..         ...+......+.+++..||+.||.+|||+.|+++.+....+.+
T Consensus       228 --i~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  276 (279)
T 2w5a_A          228 --IREGKF---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH  276 (279)
T ss_dssp             --HHHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred             --Hhhccc---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence              111111         0111123346777888999999999999999998776655444

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.9e-40  Score=335.02  Aligned_cols=249  Identities=22%  Similarity=0.338  Sum_probs=204.1

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|...+.||+|+||.||++....      +++.+|+|.+....   ....+.+.+|+.++++++||||+++++++.+.
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   87 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDAD------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN   87 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECC------CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence            3568889999999999999999875      67899999986542   23456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +..++||||+++++|.+++..   ...+++.++..++.|++.||.|||   +++++||||||+|||++.++.+||+|||+
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  161 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGL  161 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccC
Confidence            999999999999999998843   346899999999999999999999   56999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ++.........     ....||+.|+|||.+.+..++.++||||||++++||++|+.||.......   ..    .. ..
T Consensus       162 ~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~----~~-~~  228 (294)
T 2rku_A          162 ATKVEYDGERK-----KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TY----LR-IK  228 (294)
T ss_dssp             CEECCSTTCCB-----CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH----HH-HH
T ss_pred             ceecccCcccc-----ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HH-Hh
Confidence            98765432211     14579999999999998899999999999999999999999997543222   11    11 11


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .+        ..  .........+.+++.+|++.||++|||++|+++
T Consensus       229 ~~--------~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          229 KN--------EY--SIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             TT--------CC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hc--------cC--CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            11        11  111122345667888999999999999999987

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.7e-41  Score=338.38  Aligned_cols=262  Identities=29%  Similarity=0.448  Sum_probs=201.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEe-CCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE-KGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~  318 (568)
                      .+|...++||+|+||.||+|+....+.   ....+|+|.+.... ....+.+.+|+.++++++||||++++++|.+ .+.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC--------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCC---ceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            457788999999999999999764221   34579999987643 3345779999999999999999999999754 568


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             eEEEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccc
Confidence            89999999999999999643  346899999999999999999999   5799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCG-RSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG-~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ......... ........||+.|+|||.+.+..++.++||||||++++||++| ..|+.......    ......    .
T Consensus       177 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~----~~~~~~----~  247 (298)
T 3f66_A          177 DMYDKEYYS-VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLL----Q  247 (298)
T ss_dssp             CCSCGGGCB-C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT----HHHHHH----T
T ss_pred             cccccchhc-cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH----HHHHHh----c
Confidence            775432211 1112255688899999999999999999999999999999995 45555433222    111110    0


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      +         .....+......+.+++..|++.||.+|||+.|+++.|+..
T Consensus       248 ~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          248 G---------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C---------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1         00111112234577788899999999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.1e-40  Score=351.04  Aligned_cols=254  Identities=21%  Similarity=0.319  Sum_probs=193.4

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--------cccchhhHHHHHHhhcCCCCceeeE
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--------IKSKGDFLAELAIIHRLRHKHLVHL  309 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l  309 (568)
                      ...++|...++||+|+||.||+|+...      +++.||||++....        ......+.+|+.++++++||||+++
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  205 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERK------TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI  205 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCC
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECC------CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeE
Confidence            456789999999999999999999875      67899999986532        1223468899999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC---
Q 008374          310 VGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD---  386 (568)
Q Consensus       310 ~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~---  386 (568)
                      ++++. .+..++|||||++|+|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.+   
T Consensus       206 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~  278 (419)
T 3i6u_A          206 KNFFD-AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEED  278 (419)
T ss_dssp             CEEEE-SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSS
T ss_pred             EEEEe-cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCc
Confidence            99975 5668999999999999999853   356999999999999999999999   5699999999999999654   


Q ss_pred             CcEEEeecCCccccccccccccccccccCCcCCcccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q 008374          387 FNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH---TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH  463 (568)
Q Consensus       387 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~  463 (568)
                      ..+||+|||+++.......      .....||+.|+|||++.   ...++.++|||||||++|||++|+.||....... 
T Consensus       279 ~~~kl~DFG~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-  351 (419)
T 3i6u_A          279 CLIKITDFGHSKILGETSL------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-  351 (419)
T ss_dssp             CCEEECCSSTTTSCC-----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-
T ss_pred             ceEEEeecccceecCCCcc------ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-
Confidence            4599999999987654321      12567999999999985   3678889999999999999999999997543332 


Q ss_pred             hhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          464 AYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       464 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        .+.+..    ..+.... ..+     ........+.+++..|++.||++|||+.|+++
T Consensus       352 --~~~~~i----~~~~~~~-~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          352 --SLKDQI----TSGKYNF-IPE-----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             --CHHHHH----HTTCCCC-CHH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --HHHHHH----hcCCCCC-Cch-----hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence              222211    1111000 000     00112346778888999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.7e-41  Score=335.09  Aligned_cols=249  Identities=29%  Similarity=0.463  Sum_probs=196.2

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeC-Ce
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK-GK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~  318 (568)
                      .++|...+.||+|+||.||+|..        .++.||||.+....  ..+.+.+|++++++++||||+++++++.+. +.
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~--------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY--------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--------TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             hhhceEEeEEecCCCceEEEEEE--------cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            46788999999999999999976        36789999997543  456799999999999999999999997654 47


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++++|.+++.... ...+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  165 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK  165 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             eEEEEecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccc
Confidence            899999999999999995421 234889999999999999999999   5799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      .......        ...++..|+|||.+.+..++.++||||||+++|||++ |+.||.......    +...       
T Consensus       166 ~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----~~~~-------  226 (278)
T 1byg_A          166 EASSTQD--------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPR-------  226 (278)
T ss_dssp             ------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----HHHH-------
T ss_pred             ccccccc--------CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH-------
Confidence            6543321        3357889999999999999999999999999999998 999997543322    1111       


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                            +...............+.+++..|++.||.+|||+.|+++.|+.
T Consensus       227 ------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  270 (278)
T 1byg_A          227 ------VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  270 (278)
T ss_dssp             ------HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------HhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence                  11111112222334567788889999999999999999999975

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=334.08  Aligned_cols=250  Identities=23%  Similarity=0.359  Sum_probs=182.7

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|...+.||+|+||.||+|+...      +++.||||.+....   ....+.+.+|+.++++++||||+++++++.+.
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   83 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIH------TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS   83 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS
T ss_pred             cccceeeeeecCCCceEEEEEEEcc------CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC
Confidence            3578899999999999999999864      67899999996532   12346789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +..++||||+++++|.+++...  ...+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||+
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~  158 (278)
T 3cok_A           84 NYVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGL  158 (278)
T ss_dssp             SEEEEEEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTT
T ss_pred             CeEEEEEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecc
Confidence            9999999999999999999643  246899999999999999999999   56999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ++.........     ....||+.|+|||.+....++.++||||||+++|||++|+.||.......   .+.        
T Consensus       159 ~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~--------  222 (278)
T 3cok_A          159 ATQLKMPHEKH-----YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN---TLN--------  222 (278)
T ss_dssp             CEECC---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------
T ss_pred             eeeccCCCCcc-----eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH---HHH--------
Confidence            98765432211     14568999999999998889999999999999999999999997543222   000        


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                           .+.....  ..+......+.+++.+|++.||++|||++++++
T Consensus       223 -----~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          223 -----KVVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ------CCSSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -----HHhhccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                 0000011  111122345677888999999999999999975

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=338.63  Aligned_cols=264  Identities=23%  Similarity=0.264  Sum_probs=199.2

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-----ccchhhHHHHHHhhcCC---CCceeeEE
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-----KSKGDFLAELAIIHRLR---HKHLVHLV  310 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---H~nIv~l~  310 (568)
                      .+++|...++||+|+||+||+|+...      +++.||||++.....     .....+.+|+.++++++   ||||++++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~   80 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPH------SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLM   80 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTT------TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECC------CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence            46789999999999999999998764      688999999864321     22346778888877775   99999999


Q ss_pred             EEEEeCC-----eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC
Q 008374          311 GWCHEKG-----KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA  385 (568)
Q Consensus       311 g~~~~~~-----~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~  385 (568)
                      ++|....     ..++||||+. ++|.+++.... ...+++..+..++.|++.||+|||   +++|+||||||+|||++.
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~  155 (308)
T 3g33_A           81 DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTS  155 (308)
T ss_dssp             EEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECT
T ss_pred             eeeeccCCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcC
Confidence            9998765     5899999996 69999996543 234999999999999999999999   579999999999999999


Q ss_pred             CCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchh
Q 008374          386 DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY  465 (568)
Q Consensus       386 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~  465 (568)
                      ++.+||+|||+++........      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......   
T Consensus       156 ~~~~kl~Dfg~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---  226 (308)
T 3g33_A          156 GGTVKLADFGLARIYSYQMAL------TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---  226 (308)
T ss_dssp             TSCEEECSCSCTTTSTTCCCS------GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---
T ss_pred             CCCEEEeeCccccccCCCccc------CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence            999999999999876543221      24578999999999999999999999999999999999999997544333   


Q ss_pred             hHHHHHHHHhhcCc---hhh---hhhhhcC--CCC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          466 TLVDWVWMLHREGH---IQD---AVDQRLN--INS-----VVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       466 ~l~~~~~~~~~~~~---~~~---~~d~~l~--~~~-----~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .+.. .........   +..   .....+.  ...     ..+....+.+++..|++.||++|||+.|+++
T Consensus       227 ~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          227 QLGK-IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHH-HHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHH-HHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            1111 111111000   000   0000000  000     0122345677888999999999999999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.9e-40  Score=338.31  Aligned_cols=275  Identities=21%  Similarity=0.311  Sum_probs=210.3

Q ss_pred             cCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhc--CCCCceee
Q 008374          231 FKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHR--LRHKHLVH  308 (568)
Q Consensus       231 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~  308 (568)
                      .....-....++|...+.||+|+||.||+|+.        .++.||||++...   ..+.+.+|.+++..  ++||||++
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~  100 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--------RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILG  100 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--------TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCC
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEE--------cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEE
Confidence            33444455667899999999999999999986        3689999999643   34567889988887  78999999


Q ss_pred             EEEEEEeCC----eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCC
Q 008374          309 LVGWCHEKG----KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY-----DQKVVHRDLKAS  379 (568)
Q Consensus       309 l~g~~~~~~----~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDikp~  379 (568)
                      +++++....    ..++||||+++|+|.+++..    ..+++..+..++.|++.||.|||...     +++|+||||||+
T Consensus       101 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~  176 (342)
T 1b6c_B          101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK  176 (342)
T ss_dssp             EEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGG
T ss_pred             EEeeecccCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHH
Confidence            999998776    89999999999999999953    35899999999999999999999321     469999999999


Q ss_pred             CEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCC------CCccchhHHHHHHHHHHHhC--
Q 008374          380 NILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK------ATPESDVFGFGAVVLEVVCG--  451 (568)
Q Consensus       380 NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~------~t~~sDV~SfGvll~el~tG--  451 (568)
                      |||++.++.+||+|||+++.......... .......||+.|+|||.+....      ++.++||||||+++|||++|  
T Consensus       177 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~  255 (342)
T 1b6c_B          177 NILVKKNGTCCIADLGLAVRHDSATDTID-IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS  255 (342)
T ss_dssp             GEEECTTSCEEECCCTTCEEEETTTTEEE-ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred             HEEECCCCCEEEEECCCceeccccccccc-cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccC
Confidence            99999999999999999987765432211 0112557999999999987652      34689999999999999999  


Q ss_pred             --------CCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCC-CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 008374          452 --------RSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNIN-SVVDEAKRLLLLGLACSHPIASERPKTEDIL  522 (568)
Q Consensus       452 --------~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl  522 (568)
                              +.||........  ....+.... .....    .+.+... ...+....+.+++..||+.||.+|||+.||+
T Consensus       256 ~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~  328 (342)
T 1b6c_B          256 IGGIHEDYQLPYYDLVPSDP--SVEEMRKVV-CEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK  328 (342)
T ss_dssp             BTTBCCCCCCTTTTTSCSSC--CHHHHHHHH-TTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             cCCcccccccCccccCcCcc--cHHHHHHHH-HHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHH
Confidence                    677764322210  112221111 11111    1111111 1235677888999999999999999999999


Q ss_pred             HHHhCC
Q 008374          523 QIISGT  528 (568)
Q Consensus       523 ~~L~~~  528 (568)
                      +.|+..
T Consensus       329 ~~L~~i  334 (342)
T 1b6c_B          329 KTLSQL  334 (342)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.1e-40  Score=348.84  Aligned_cols=246  Identities=26%  Similarity=0.322  Sum_probs=191.5

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHH-hhcCCCCceeeEEEEEEe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAI-IHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~  315 (568)
                      .++|...+.||+|+||+||+|+.+.      +++.||||++.+...   .....+..|..+ ++.++||||+++++++.+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~------~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~  110 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKA------EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT  110 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETT------TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcC------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe
Confidence            4679999999999999999999875      678999999976432   234456777776 577899999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      .+.+++||||+++|+|.+++..   ...+++.....++.||+.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus       111 ~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG  184 (373)
T 2r5t_A          111 ADKLYFVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFG  184 (373)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCc
Confidence            9999999999999999999953   346889999999999999999999   5799999999999999999999999999


Q ss_pred             CccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      +++........     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +.+      
T Consensus       185 ~a~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~------  249 (373)
T 2r5t_A          185 LCKENIEHNST-----TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYD------  249 (373)
T ss_dssp             BCGGGBCCCCC-----CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH----HHH------
T ss_pred             cccccccCCCc-----cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH----HHH------
Confidence            99864332211     125689999999999999999999999999999999999999997543222    111      


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTED  520 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~e  520 (568)
                            .++...+.  ........+..++..|++.||.+||++.+
T Consensus       250 ------~i~~~~~~--~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          250 ------NILNKPLQ--LKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             ------HHHHSCCC--CCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             ------HHHhcccC--CCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence                  11111111  11122345667778999999999999853

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.3e-40  Score=333.63  Aligned_cols=262  Identities=21%  Similarity=0.215  Sum_probs=198.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|...+.||+|+||.||+|+...      +++.||+|.+.....   ...+.+.+|+.++++++||||+++++++...
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTV------RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID  106 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETT------TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcC------CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence            4689999999999999999999864      678999999976432   2246789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +..++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~  180 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGI  180 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC
T ss_pred             CeEEEEEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCcc
Confidence            999999999999999999953   346899999999999999999999   56999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ++..........    ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......        .......
T Consensus       181 ~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~  248 (309)
T 2h34_A          181 ASATTDEKLTQL----GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--------VMGAHIN  248 (309)
T ss_dssp             --------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--------HHHHHHH
T ss_pred             Cccccccccccc----cccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--------HHHHHhc
Confidence            987654322211    1456899999999999999999999999999999999999999753221        1111111


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhCCCCCC
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-KTEDILQIISGTSTVP  532 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-t~~evl~~L~~~~~~p  532 (568)
                      ... .   ..   ..........+.+++..||+.||++|| +++++++.|+......
T Consensus       249 ~~~-~---~~---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          249 QAI-P---RP---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             SCC-C---CG---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             cCC-C---Cc---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            110 0   00   001112234567788899999999999 9999999999765444

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-40  Score=334.10  Aligned_cols=253  Identities=21%  Similarity=0.312  Sum_probs=197.5

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .++|...++||+|+||.||++....      ++..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   94 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERS------SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN   94 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhheeecceeccCCCeEEEEEEEcc------CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence            3568999999999999999999865      67899999987653 2345778999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---cCCCcEEEeec
Q 008374          319 LLLVYDFMPNGSLEKYLYGTS-EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL---DADFNARLGDF  394 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl---d~~~~~kL~DF  394 (568)
                      .++||||+++|+|.+++.... ....+++..+..++.|++.||.|||   +++|+||||||+|||+   +.++.+||+||
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Df  171 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDF  171 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEee
Confidence            999999999999999985431 2356899999999999999999999   5799999999999999   45688999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      |+++........      ....||+.|+|||.+. +.++.++||||||+++|||++|+.||.......    +..   ..
T Consensus       172 g~a~~~~~~~~~------~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~----~~~---~~  237 (285)
T 3is5_A          172 GLAELFKSDEHS------TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE----VQQ---KA  237 (285)
T ss_dssp             CCCCC----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH---HH
T ss_pred             ecceecCCcccC------cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH----HHh---hh
Confidence            999876543221      1457999999999985 578999999999999999999999997543221    111   10


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ...       ....... .......+.+++..|++.||++|||+.|+++
T Consensus       238 ~~~-------~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          238 TYK-------EPNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHC-------CCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccC-------Ccccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000       0000000 0012345667888999999999999999985

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A*

Probab=100.00  E-value=2.7e-41  Score=327.51  Aligned_cols=154  Identities=32%  Similarity=0.496  Sum_probs=137.9

Q ss_pred             CCCCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC-C-CCCCCeeeEecCCcccccccc
Q 008374            7 PAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG-F-DPDDNHLGLNINSVVSRKNVP   84 (568)
Q Consensus         7 ~~~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~-~-d~~~~hvgidins~~s~~~~~   84 (568)
                      ++...+||||||||+|....|+  +.||||||+|.+++ +..||+|||||||++|. | ||++|||||||||+.|.++++
T Consensus        81 ~~~~~~gdGlAF~lap~~~~~~--~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNsi~S~~t~~  157 (251)
T 3ipv_A           81 PNIATIADGLAFFLAPVASAPD--SGGGFLGLFDSAVS-GSTYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVK  157 (251)
T ss_dssp             SSTTSCCEEEEEEEEETTCCCC--CCGGGTTTCSSSSC-CTTSCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEE
T ss_pred             CCCCCCCCceEEEEecCCCCCC--CCCceeeeccccCC-CccCcEEEEEEecccccccCCCCCCeEEEEcCCCcccccce
Confidence            3446689999999999877654  57999999998766 77899999999999996 7 999999999999999999987


Q ss_pred             CCCCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCcc---cccccc
Q 008374           85 LKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPH---IQLNCV  161 (568)
Q Consensus        85 ~~~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~---~~~~~i  161 (568)
                      |      +|.+|+.++|||+||+.+++|+|+|++.+.  |.+|+|++.+||+++|+++|||||||+||. .   .+.|++
T Consensus       158 ~------~l~~G~~~~v~I~Yd~~tk~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~-~~~~~e~h~I  228 (251)
T 3ipv_A          158 W------SLANGEAAKVLITYNSAVKLLVASLVYPSS--KTSFILADIVDLSSVLPEWVRVGFSAATGA-SGGKIETHDV  228 (251)
T ss_dssp             C------CCCTTCEEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCHHHHSCSEEEEEEEEEECS-STTCCCCCEE
T ss_pred             e------EecCCCEEEEEEEEeCCCCEEEEEEecCCC--CccceEEEEechHHhCCCcEEEEEEEecCC-CccccceeEE
Confidence            6      357899999999999999999999998764  678899999999999999999999999997 7   899999


Q ss_pred             ccccccccccc
Q 008374          162 RSWTLDIDVIQ  172 (568)
Q Consensus       162 ~sWs~~~~~~~  172 (568)
                      ++|+|+.....
T Consensus       229 lsWsF~s~l~~  239 (251)
T 3ipv_A          229 FSWSFASKLAG  239 (251)
T ss_dssp             EEEEEEEEECC
T ss_pred             EEEEEEEECCC
Confidence            99999877543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.8e-41  Score=348.04  Aligned_cols=268  Identities=25%  Similarity=0.389  Sum_probs=204.7

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .++|...+.||+|+||.||+|++.... ...++..||||.+... ......++.+|+.++++++||||+++++++...+.
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMP-NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC---------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCC-CCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            467899999999999999999864211 0125789999999754 33445679999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---CCcEEE
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSE----QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA---DFNARL  391 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~---~~~~kL  391 (568)
                      .++||||+++++|.+++.....    ...+++..++.++.|++.||.|||   +++|+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEE
Confidence            9999999999999999975421    245899999999999999999999   579999999999999984   456999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHH
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~  470 (568)
                      +|||+++..........   .....||+.|+|||.+....++.++||||||+++|||++ |+.||.......    +.+.
T Consensus       185 ~Dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~  257 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRK---GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----VLEF  257 (327)
T ss_dssp             CCCHHHHHHHC---------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHH
T ss_pred             Ccccccccccccccccc---CCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH----HHHH
Confidence            99999986644322111   114467899999999999999999999999999999998 999987543221    1111


Q ss_pred             HHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC
Q 008374          471 VWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTV  531 (568)
Q Consensus       471 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~  531 (568)
                      +    ..+         ............+.+++..||+.||.+|||+.++++.|+.....
T Consensus       258 ~----~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          258 V----TSG---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             H----HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             H----hcC---------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            1    111         01111222345677888899999999999999999999865433

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.8e-41  Score=351.11  Aligned_cols=209  Identities=27%  Similarity=0.441  Sum_probs=166.3

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCC-CCceeeEEEEEE
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLR-HKHLVHLVGWCH  314 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~  314 (568)
                      ...++|...++||+|+||.||+|+...      +++.||||++...  .....+.+.+|+.++.++. ||||+++++++.
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~   79 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRR------TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLR   79 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETT------TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECC------CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEe
Confidence            346789999999999999999999875      6889999998654  2334567889999999997 999999999997


Q ss_pred             eCC--eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          315 EKG--KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       315 ~~~--~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                      ..+  .+++|||||+ ++|..++..    ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus        80 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~  151 (388)
T 3oz6_A           80 ADNDRDVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVA  151 (388)
T ss_dssp             CTTSSCEEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCCEEEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEec
Confidence            554  7999999997 699999853    36899999999999999999999   5799999999999999999999999


Q ss_pred             ecCCcccccccccc----------------ccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCC
Q 008374          393 DFGLARAIENERNS----------------YAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPG  455 (568)
Q Consensus       393 DFGla~~~~~~~~~----------------~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~  455 (568)
                      |||+|+........                ..........||+.|+|||++.+ ..++.++|||||||+++||++|+.||
T Consensus       152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  231 (388)
T 3oz6_A          152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF  231 (388)
T ss_dssp             CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence            99999876431110                00111235679999999999876 67899999999999999999999999


Q ss_pred             CCCCc
Q 008374          456 NMIPH  460 (568)
Q Consensus       456 ~~~~~  460 (568)
                      .....
T Consensus       232 ~~~~~  236 (388)
T 3oz6_A          232 PGSST  236 (388)
T ss_dssp             CCSSH
T ss_pred             CCCCH
Confidence            75443

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.2e-40  Score=332.07  Aligned_cols=266  Identities=17%  Similarity=0.227  Sum_probs=202.5

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEE-EeCC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWC-HEKG  317 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~-~~~~  317 (568)
                      ..++|...+.||+|+||.||+|+...      +++.||||++....  ..+++.+|+.++.+++|++++..++++ ...+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIA------AGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETT------TTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcC------CCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence            45789999999999999999999764      68899999876543  345689999999999988877666665 6677


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---cCCCcEEEeec
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL---DADFNARLGDF  394 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl---d~~~~~kL~DF  394 (568)
                      ..++||||+ +++|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||+   ++++.+||+||
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Df  152 (296)
T 4hgt_A           79 YNVMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDF  152 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCC
T ss_pred             ceEEEEEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecC
Confidence            889999999 99999999643  245899999999999999999999   5799999999999999   78999999999


Q ss_pred             CCcccccccccccc--ccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          395 GLARAIENERNSYA--EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       395 Gla~~~~~~~~~~~--~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      |+++..........  ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.....
T Consensus       153 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  232 (296)
T 4hgt_A          153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  232 (296)
T ss_dssp             TTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred             ccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc
Confidence            99998765432110  0112256799999999999999999999999999999999999999985433321111111111


Q ss_pred             HHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      .... ...     +.+..    .....+.+++..|++.||++|||+.+|++.|+..
T Consensus       233 ~~~~-~~~-----~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          233 KKMS-TPI-----EVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HHHH-SCH-----HHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             cccc-chh-----hhhhc----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            1000 000     00001    1134677788899999999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.9e-40  Score=332.74  Aligned_cols=251  Identities=22%  Similarity=0.318  Sum_probs=200.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc------cchhhHHHHHHhhcCCCCceeeEEEEEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK------SKGDFLAELAIIHRLRHKHLVHLVGWCH  314 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~g~~~  314 (568)
                      ++|...+.||+|+||.||+|+...      +++.||+|.+......      ..+.+.+|+.++++++||||+++++++.
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   78 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKG------TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE   78 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcC------CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec
Confidence            568899999999999999999875      6789999998764321      3467899999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC----cEE
Q 008374          315 EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF----NAR  390 (568)
Q Consensus       315 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~----~~k  390 (568)
                      ..+..++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +++++||||||+||+++.++    .+|
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~k  152 (283)
T 3bhy_A           79 NKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIK  152 (283)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEE
T ss_pred             CCCeEEEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceE
Confidence            99999999999999999999953   346899999999999999999999   57999999999999998877    899


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~  470 (568)
                      |+|||+++........      ....||+.|+|||.+....++.++||||||+++|||++|+.||.......   .+.. 
T Consensus       153 l~dfg~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~-  222 (283)
T 3bhy_A          153 LIDFGIAHKIEAGNEF------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---TLTN-  222 (283)
T ss_dssp             ECCCTTCEECC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHH-
T ss_pred             EEecccceeccCCCcc------cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---HHHH-
Confidence            9999999876543221      14568999999999998999999999999999999999999997543322   1111 


Q ss_pred             HHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          471 VWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       471 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                          .....      ..............+.+++..|++.||.+|||+.|+++
T Consensus       223 ----~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          223 ----ISAVN------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             ----HHTTC------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----hHhcc------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence                00000      00000000112345677888999999999999999987

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.6e-40  Score=340.99  Aligned_cols=253  Identities=21%  Similarity=0.342  Sum_probs=206.1

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|...+.||+|+||.||+++...      +++.+|+|.+....   ....+.+.+|+.++++++||||+++++++.+.
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  113 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDAD------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN  113 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            4578899999999999999999875      67899999986542   23456789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +..++||||+++++|.+++..   ...+++.++..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  187 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGL  187 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             CeEEEEEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccC
Confidence            999999999999999999843   346899999999999999999999   56999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ++.........     ....||..|+|||.+.+..++.++||||||+++|||++|+.||.......   ..    .... 
T Consensus       188 ~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~----~~~~-  254 (335)
T 2owb_A          188 ATKVEYDGERK-----KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TY----LRIK-  254 (335)
T ss_dssp             CEECCSTTCCB-----CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH----HHHH-
T ss_pred             ceecccCcccc-----cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---HH----HHHh-
Confidence            98765432211     24579999999999999899999999999999999999999997543222   11    1100 


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhC
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISG  527 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L~~  527 (568)
                      .+        ...  ........+.+++..||+.||++|||+.|+++  .+..
T Consensus       255 ~~--------~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~  297 (335)
T 2owb_A          255 KN--------EYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS  297 (335)
T ss_dssp             HT--------CCC--CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             cC--------CCC--CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            01        110  11112235667888999999999999999987  4544

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.5e-40  Score=333.42  Aligned_cols=247  Identities=22%  Similarity=0.349  Sum_probs=196.8

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEe----
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE----  315 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----  315 (568)
                      .|...++||+|+||.||+|....      ++..||+|.+...  .....+.+.+|+.++++++||||+++++++..    
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  100 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTE------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG  100 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred             eEEeeeeccCCCCeEEEEeEecC------CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence            36777889999999999998875      6789999998754  23345678999999999999999999999875    


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEEc-CCCcEEEe
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQK--VVHRDLKASNILLD-ADFNARLG  392 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDikp~NILld-~~~~~kL~  392 (568)
                      ....++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +++  ++||||||+|||++ .++.+||+
T Consensus       101 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~  174 (290)
T 1t4h_A          101 KKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIG  174 (290)
T ss_dssp             CEEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred             CceEEEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEe
Confidence            3568999999999999999953   346899999999999999999999   556  99999999999998 78999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      |||++........       ....||+.|+|||.+. +.++.++||||||+++|||++|+.||.......   .+..   
T Consensus       175 Dfg~~~~~~~~~~-------~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~---  240 (290)
T 1t4h_A          175 DLGLATLKRASFA-------KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA---QIYR---  240 (290)
T ss_dssp             CTTGGGGCCTTSB-------EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH---HHHH---
T ss_pred             eCCCccccccccc-------ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH---HHHH---
Confidence            9999976543321       1457999999999886 568999999999999999999999997543322   1111   


Q ss_pred             HHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       ....+.....        ........+.+++..||+.||.+|||+.|+++
T Consensus       241 -~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          241 -RVTSGVKPAS--------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -HHTTTCCCGG--------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -HHhccCCccc--------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence             1111111111        11112245778888999999999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-40  Score=345.37  Aligned_cols=259  Identities=20%  Similarity=0.244  Sum_probs=203.4

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC----cccchhhHHHHHHhhcC-CCCceeeEEEEEE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS----IKSKGDFLAELAIIHRL-RHKHLVHLVGWCH  314 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~  314 (568)
                      .++|...++||+|+||.||+++...+.   .+++.||||++....    ....+.+.+|++++.++ +||||+++++++.
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGH---DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSST---TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccC---CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            357999999999999999999885311   268899999987542    23346688999999999 6999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 008374          315 EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDF  394 (568)
Q Consensus       315 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DF  394 (568)
                      ..+..++||||+++|+|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+||
T Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Df  203 (355)
T 1vzo_A          130 TETKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDF  203 (355)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred             eCceEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeC
Confidence            99999999999999999999954   346899999999999999999999   569999999999999999999999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT--GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      |+++..........    ....||+.|+|||++.+  ..++.++|||||||++|||++|+.||.......   .......
T Consensus       204 G~a~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~~~~  276 (355)
T 1vzo_A          204 GLSKEFVADETERA----YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISR  276 (355)
T ss_dssp             SEEEECCGGGGGGG----CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---CHHHHHH
T ss_pred             CCCeecccCCCCcc----cCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc---hHHHHHH
Confidence            99987654322211    14579999999999975  347899999999999999999999997543332   1112111


Q ss_pred             HHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 008374          473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQII  525 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~~L  525 (568)
                      ....         .  ......+....+.+++..||+.||.+||     |++|+++..
T Consensus       277 ~~~~---------~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          277 RILK---------S--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHHH---------C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             HHhc---------c--CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            1111         0  0111222334567788899999999999     999998743

>3ujo_A Legume lectin; carbohydrate-binding, galactose, adenine binding protein; HET: ADE GAL; 2.00A {Dolichos lablab} PDB: 3ujq_A* 3uk9_A* 3ul2_A* 1fat_A* 1g8w_A*

Probab=100.00  E-value=7.6e-41  Score=327.80  Aligned_cols=155  Identities=30%  Similarity=0.509  Sum_probs=137.9

Q ss_pred             CCCCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC-CCCCCCeeeEecCCccccccccC
Q 008374            7 PAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG-FDPDDNHLGLNINSVVSRKNVPL   85 (568)
Q Consensus         7 ~~~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~-~d~~~~hvgidins~~s~~~~~~   85 (568)
                      ++...+||||||||+|....|+  +.||||||+|.+++ +..||+|||||||++|. |||++|||||||||+.|.++++|
T Consensus       101 ~~~~~~gdGlAF~laP~~~~p~--~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~N~e~Dp~~nHVGIDvNSi~S~~t~~~  177 (281)
T 3ujo_A          101 PNAASPADGLAFALVPVGSQPK--DKGGFLGLFDSKNY-ASSNQTVAVEFDTFYNGGWDPTERHIGIDVNSIKSIKTTSW  177 (281)
T ss_dssp             SSTTSCCEEEEEEEEETTCCCC--CCGGGTTTCSCSSC-CTTSCCEEEEECCSCCCSSCCSSSEEEEEESSSCCSCEEEC
T ss_pred             CCCCCCCCceEEEEecCCCCCC--CCcceeeeccccCC-CccCcEEEEEEeccccccCCCCCCeEEEEcCCCCccccccc
Confidence            3446789999999999877643  78999999998766 78899999999999995 99999999999999999999887


Q ss_pred             CCCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCC--cccccccccc
Q 008374           86 KDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGY--PHIQLNCVRS  163 (568)
Q Consensus        86 ~~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~--~~~~~~~i~s  163 (568)
                      .      +.+|+.++|||+||+.+++|+|+|++.+.  |++|++++.+||+++|+++|||||||+||.  ...+.|++++
T Consensus       178 ~------l~~G~~~~vwI~Yd~~tk~L~V~l~~~~~--~~~~~lS~~vDL~~~L~e~v~VGFSAsTG~~~~~~e~H~Ils  249 (281)
T 3ujo_A          178 D------FANGENAEVLITYDSSTNLLVASLVHPSQ--KTSFIVSERVDLTSVLPEWVSVGFSATTGLSKGYVETNEVLS  249 (281)
T ss_dssp             C------CCSSCCEEEEEEECTTTCEEEEEEECTTT--CCCEEEEEECCSTTTSCSEEEEEEEEEECSSTTSCCCCEEEE
T ss_pred             c------ccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCCceEEEEechHHhccCcEEEEEEeecCCCCcccceeEEEE
Confidence            4      46899999999999999999999998774  568899999999999999999999999995  1589999999


Q ss_pred             ccccccccc
Q 008374          164 WTLDIDVIQ  172 (568)
Q Consensus       164 Ws~~~~~~~  172 (568)
                      |+|+.....
T Consensus       250 WSFss~l~~  258 (281)
T 3ujo_A          250 WSFASKLSI  258 (281)
T ss_dssp             EEEEEEECS
T ss_pred             EEEEEEcCC
Confidence            999977544

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=340.65  Aligned_cols=274  Identities=22%  Similarity=0.375  Sum_probs=209.7

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC--
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG--  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--  317 (568)
                      .++|...++||+|+||.||++++....  ..+++.||||++........+.+.+|++++++++||||+++++++...+  
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQ--DNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTS--SSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             HHHceeeeeeccCCCeEEEEEEecccc--CCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence            346888899999999999999864211  1268899999998766666778999999999999999999999987654  


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++++|.+++....  ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             ceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence            7899999999999999996532  35899999999999999999999   579999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH----
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM----  473 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~----  473 (568)
                      +...........  .....+|..|+|||.+.+..++.++||||||+++|||++|+.|+......     ..+....    
T Consensus       193 ~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~-----~~~~~~~~~~~  265 (326)
T 2w1i_A          193 KVLPQDKEYYKV--KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQG  265 (326)
T ss_dssp             EECCSSCSEEEC--SSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH-----HHHHHCTTCCT
T ss_pred             hhcccccccccc--ccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH-----HHHhhccccch
Confidence            887654322111  11345788899999998888999999999999999999999887532100     0000000    


Q ss_pred             HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       474 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      ......+.+.+...............+.+++..||+.||++|||+.||++.|+.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~  319 (326)
T 2w1i_A          266 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  319 (326)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             hhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            000001112222222222233344667888889999999999999999999975

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.9e-40  Score=332.59  Aligned_cols=252  Identities=23%  Similarity=0.391  Sum_probs=203.8

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEe---
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE---  315 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~---  315 (568)
                      ..++|...+.||+|+||.||+|+...      +++.||+|++....    +.+.+|++++++++||||+++++++..   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   78 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRI------DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDY   78 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETT------TCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred             hccccceeeeeccCCceEEEEEEEcC------CCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence            34578999999999999999999874      67899999997543    468899999999999999999998864   


Q ss_pred             -------------CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 008374          316 -------------KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL  382 (568)
Q Consensus       316 -------------~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIL  382 (568)
                                   ....++||||+++++|.+++.... ...+++..+..++.|++.||.|||   +++|+||||||+|||
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil  154 (284)
T 2a19_B           79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIF  154 (284)
T ss_dssp             C---------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred             CcccccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEE
Confidence                         456899999999999999996432 346899999999999999999999   569999999999999


Q ss_pred             EcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 008374          383 LDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ  462 (568)
Q Consensus       383 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~  462 (568)
                      ++.++.+||+|||+++........      ....||+.|+|||.+.+..++.++||||||+++|||++|..|+..     
T Consensus       155 ~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----  223 (284)
T 2a19_B          155 LVDTKQVKIGDFGLVTSLKNDGKR------TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----  223 (284)
T ss_dssp             EEETTEEEECCCTTCEESSCCSCC------CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----
T ss_pred             EcCCCCEEECcchhheeccccccc------cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----
Confidence            999999999999999877554321      145699999999999999999999999999999999999987531     


Q ss_pred             chhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC
Q 008374          463 HAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVP  532 (568)
Q Consensus       463 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~p  532 (568)
                          .... ......+        .+....    ...+.+++..|++.||.+|||+.|+++.|+.....|
T Consensus       224 ----~~~~-~~~~~~~--------~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          224 ----TSKF-FTDLRDG--------IISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             ----HHHH-HHHHHTT--------CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             ----HHHH-HHHhhcc--------cccccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence                0111 1111111        111112    234567788999999999999999999998765444

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.5e-40  Score=357.42  Aligned_cols=255  Identities=22%  Similarity=0.292  Sum_probs=205.0

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...+.||+|+||+||+|+.+.      +++.||+|++.+..   ....+.+.+|+.++.+++||||+++++++...+
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  258 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKA------TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT  258 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hheEEEEEEeeCCCeEEEEEEECC------CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence            578888999999999999999875      68899999996542   233457889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTS-EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      .+++||||+++|+|..++.... ....+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGl  335 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGL  335 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecce
Confidence            9999999999999999996543 2446999999999999999999999   57999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ++........     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ...+....   
T Consensus       336 a~~~~~~~~~-----~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~---~~~~~~~~---  404 (543)
T 3c4z_A          336 AVELKAGQTK-----TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKELKQR---  404 (543)
T ss_dssp             CEECCTTCCC-----BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC---CHHHHHHH---
T ss_pred             eeeccCCCcc-----cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch---hHHHHHHH---
Confidence            9876543321     114589999999999999999999999999999999999999998543322   11111111   


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKT-----EDILQ  523 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~-----~evl~  523 (568)
                            +.....  ..+......+..++..|++.||.+||++     +++++
T Consensus       405 ------i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          405 ------VLEQAV--TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ------HHHCCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ------Hhhccc--CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                  111111  1112233456677789999999999975     66653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.6e-40  Score=338.90  Aligned_cols=263  Identities=19%  Similarity=0.271  Sum_probs=196.8

Q ss_pred             cCccc-cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCe
Q 008374          241 NNFHE-SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~-~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  318 (568)
                      +.|.. .+.||+|+||.||+|+...      +++.||||++........+.+.+|++++.++ +||||+++++++.+.+.
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~   85 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLI------TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR   85 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSS------SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             eeEEecCceecCCceEEEEEEEEcC------CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            45666 3679999999999998764      6789999999876656677899999999985 79999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc---EEEeecC
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN---ARLGDFG  395 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~---~kL~DFG  395 (568)
                      .++||||+++|+|.+++..   ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.   +||+|||
T Consensus        86 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg  159 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFD  159 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred             EEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence            9999999999999999954   346899999999999999999999   569999999999999998776   9999999


Q ss_pred             Ccccccccccc--ccccccccCCcCCcccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhH-
Q 008374          396 LARAIENERNS--YAEHGLVGVPGTMGYVAPECFHT-----GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTL-  467 (568)
Q Consensus       396 la~~~~~~~~~--~~~~~~~~~~Gt~~y~APE~~~~-----~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l-  467 (568)
                      +++........  ..........||+.|+|||.+..     ..++.++|||||||++|||++|+.||............ 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  239 (316)
T 2ac3_A          160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG  239 (316)
T ss_dssp             CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred             CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence            99876432211  11111224569999999999865     56789999999999999999999999754322110000 


Q ss_pred             ------HHHHHHHhhcCchhhhhhhhcCCCCc--HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          468 ------VDWVWMLHREGHIQDAVDQRLNINSV--VDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       468 ------~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                            ........        ..........  ......+.+++.+|++.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~i--------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          240 EACPACQNMLFESI--------QEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             -CCHHHHHHHHHHH--------HHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccchhHHHHHHHHH--------hccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                  00011111        1111111000  012345778888999999999999999987

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1e-40  Score=347.07  Aligned_cols=265  Identities=21%  Similarity=0.288  Sum_probs=203.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...++||+|+||.||+|....      ++..||+|++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  106 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKP------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI  106 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred             ccceeeeeecCCCCeEEEEEEECC------CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence            568899999999999999999875      67899999997653 33456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++++|.+++..   ...+++..+..++.+++.||.|||+.  .+|+||||||+|||++.++.+||+|||+++.
T Consensus       107 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  181 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  181 (360)
T ss_dssp             EEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             EEEEECCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence            999999999999999954   34689999999999999999999941  3899999999999999999999999999976


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhH------------
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTL------------  467 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l------------  467 (568)
                      ......       ....||+.|+|||++.+..++.++|||||||++|||++|+.||............            
T Consensus       182 ~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  254 (360)
T 3eqc_A          182 LIDSMA-------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP  254 (360)
T ss_dssp             HHHHC-----------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------
T ss_pred             cccccc-------cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCC
Confidence            643321       1457999999999999999999999999999999999999999754322110000            


Q ss_pred             ----------HHHHHHHhhcCchhhhhhhhcC----CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          468 ----------VDWVWMLHREGHIQDAVDQRLN----INSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       468 ----------~~~~~~~~~~~~~~~~~d~~l~----~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                                ..+...........+.++....    ..........+.+++..|++.||++|||++|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                      0000000000111111111110    0011112345777888999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.3e-40  Score=331.60  Aligned_cols=246  Identities=22%  Similarity=0.335  Sum_probs=202.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...+.||+|+||.||+|+...      ++..||+|.+....   ....+.+.+|++++++++||||+++++++.+.+
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   87 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQ------NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK   87 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhceeeheecCCCCeEEEEEEEcC------CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence            578999999999999999999875      67899999986532   223457899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||++
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~  161 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS  161 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEeccccc
Confidence            99999999999999999954   246899999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ........       ....||..|+|||.+.+..++.++||||||+++|||++|+.||.......       ....    
T Consensus       162 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~----  223 (284)
T 2vgo_A          162 VHAPSLRR-------RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-------THRR----  223 (284)
T ss_dssp             EECSSSCB-------CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHH----
T ss_pred             ccCccccc-------ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-------HHHH----
Confidence            76543221       14578999999999999999999999999999999999999997543222       1011    


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                           +.....  ..+......+.+++..|++.||.+|||+.|+++
T Consensus       224 -----~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          224 -----IVNVDL--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             -----HHTTCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----Hhcccc--CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                 111111  111122345677888999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-40  Score=342.72  Aligned_cols=265  Identities=20%  Similarity=0.297  Sum_probs=194.1

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      ...++|...++||+|+||+||+|+...      +++.||||++.....  ...+.+.+|+.++++++||||+++++++..
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTV------TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH  104 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETT------TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECC------CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence            445789999999999999999998775      688999999975432  234678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE-----cCCCcEE
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL-----DADFNAR  390 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl-----d~~~~~k  390 (568)
                      .+..++||||++ |+|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||+     ++++.+|
T Consensus       105 ~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~k  177 (329)
T 3gbz_A          105 NHRLHLIFEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLK  177 (329)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEE
T ss_pred             CCEEEEEEecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEE
Confidence            999999999997 599999954   345899999999999999999999   5799999999999999     4556699


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~  469 (568)
                      |+|||+++.........     ....||..|+|||++.+. .++.++|||||||++|||++|+.||.......   .+..
T Consensus       178 l~Dfg~a~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~  249 (329)
T 3gbz_A          178 IGDFGLARAFGIPIRQF-----THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFK  249 (329)
T ss_dssp             ECCTTHHHHHC----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH
T ss_pred             ECcCCCccccCCccccc-----CCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHH
Confidence            99999998765432221     245689999999999774 48999999999999999999999997544332   1211


Q ss_pred             HHHHHhhcC--chhhhh--------hhhcCCCCcH-----HHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          470 WVWMLHREG--HIQDAV--------DQRLNINSVV-----DEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       470 ~~~~~~~~~--~~~~~~--------d~~l~~~~~~-----~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .........  ......        .+........     .....+.+++..|++.||++|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          250 IFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            111110000  000000        0000000000     12345678888999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=5.6e-41  Score=339.61  Aligned_cols=267  Identities=20%  Similarity=0.319  Sum_probs=185.5

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ..++|...+.||+|+||.||+|....      +++.||||++.... ....+++.+|+.++++++||||+++++++...+
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   86 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAP------KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD   86 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred             chhhhhhhheeccccceEEEEEEECC------CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence            35679999999999999999998764      57899999986543 334567899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccC-----CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          318 KLLLVYDFMPNGSLEKYLYGT-----SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                      ..++||||+++++|.+++...     .....+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~  163 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIA  163 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEE
Confidence            999999999999999998531     12346899999999999999999999   5699999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      |||+++..................||+.|+|||.+.. ..++.++||||||+++|||++|+.||.......   .+.. .
T Consensus       164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~-~  239 (303)
T 2vwi_A          164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLML-T  239 (303)
T ss_dssp             CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHH-H
T ss_pred             eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHHH-H
Confidence            9999987654321111111124579999999999865 568999999999999999999999998544332   1111 0


Q ss_pred             HHHhhcCchh-hhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          472 WMLHREGHIQ-DAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       472 ~~~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ... ...... ...+.....    .....+.+++..||+.||.+|||+.|+++
T Consensus       240 ~~~-~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          240 LQN-DPPSLETGVQDKEMLK----KYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HTS-SCCCTTC-----CCCC----CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hcc-CCCccccccccchhhh----hhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            000 000000 001111111    12345677888999999999999999985

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.1e-40  Score=347.18  Aligned_cols=262  Identities=19%  Similarity=0.280  Sum_probs=194.8

Q ss_pred             cCcccc-ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhh-cCCCCceeeEEEEEEe---
Q 008374          241 NNFHES-MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIH-RLRHKHLVHLVGWCHE---  315 (568)
Q Consensus       241 ~~f~~~-~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~H~nIv~l~g~~~~---  315 (568)
                      ++|... +.||+|+||+||+++...      +++.||||++..     ...+.+|++++. ..+||||+++++++..   
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~------~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKR------TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccceeccceeeeccCeEEEEEEECC------CCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            456655 689999999999999875      688999999853     245778888874 4589999999999876   


Q ss_pred             -CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---CCcEEE
Q 008374          316 -KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA---DFNARL  391 (568)
Q Consensus       316 -~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~---~~~~kL  391 (568)
                       .+.++||||||++|+|.+++.... ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.   ++.+||
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl  205 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKL  205 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEE
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEE
Confidence             567999999999999999996532 346999999999999999999999   579999999999999998   789999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      +|||+++.......      .....||+.|+|||++....++.++|||||||++|||++|+.||...............+
T Consensus       206 ~DFG~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i  279 (400)
T 1nxk_A          206 TDFGFAKETTSHNS------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI  279 (400)
T ss_dssp             CCCTTCEECC-----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH
T ss_pred             EecccccccCCCCc------cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH
Confidence            99999987654321      125678999999999999999999999999999999999999997543322111111111


Q ss_pred             HHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCCCCCCC
Q 008374          472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISGTSTVPY  533 (568)
Q Consensus       472 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L~~~~~~p~  533 (568)
                      .    .+..      .+...........+.+++..||+.||.+|||+.|+++  .+.+....|.
T Consensus       280 ~----~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~  333 (400)
T 1nxk_A          280 R----MGQY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ  333 (400)
T ss_dssp             H----HTCC------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSCC
T ss_pred             H----cCcc------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCCC
Confidence            1    0100      0000001123345677888999999999999999998  3444444443

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.9e-40  Score=336.85  Aligned_cols=259  Identities=23%  Similarity=0.317  Sum_probs=205.7

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .++|...+.||+|+||.||+++...      +++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRL------TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHY   81 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccceeeeeccCCCCceEEEEEECC------CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence            4578999999999999999999864      6789999999876555566789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---cCCCcEEEeecCC
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL---DADFNARLGDFGL  396 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl---d~~~~~kL~DFGl  396 (568)
                      ++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+++||||||+||++   ++++.+||+|||+
T Consensus        82 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~  155 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGL  155 (304)
T ss_dssp             EEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred             EEEEEcCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence            999999999999999853   346899999999999999999999   5699999999999999   7889999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ++.......       ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......    +...    ..
T Consensus       156 ~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~----i~  220 (304)
T 2jam_A          156 SKMEQNGIM-------STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK----LFEK----IK  220 (304)
T ss_dssp             TCCCCCBTT-------HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHH----HH
T ss_pred             ceecCCCcc-------ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHH----HH
Confidence            986543211       13468999999999999999999999999999999999999997543221    1111    11


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCCCCC
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISGTSTV  531 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L~~~~~~  531 (568)
                      .+..      .............+.+++..|++.||.+|||+.|+++  .+++..+.
T Consensus       221 ~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  271 (304)
T 2jam_A          221 EGYY------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTAL  271 (304)
T ss_dssp             HCCC------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSC
T ss_pred             cCCC------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCcc
Confidence            1110      0011111223356777888999999999999999987  56654433

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} SCOP: b.29.1.1 PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ...

Probab=100.00  E-value=7.2e-41  Score=325.49  Aligned_cols=154  Identities=32%  Similarity=0.517  Sum_probs=137.3

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCC-CCCcEEEEEeeCC---CCC-CCCCCCeeeEecCCccccccc
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGN-KANHFVAIEFDTV---KQG-FDPDDNHLGLNINSVVSRKNV   83 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~-~~~~~~aVEfDt~---~~~-~d~~~~hvgidins~~s~~~~   83 (568)
                      ...+||||||||+|.....|.+++||||||+|.+++++ ..||+|||||||+   +|. |||++|||||||||+.|.+++
T Consensus        90 ~~~~gdGlAF~lap~~~~~p~~~~g~~LGL~n~~~~g~~~~n~~vAVEFDT~~~~~n~~~Dp~~nHVGIdvNsi~S~~s~  169 (261)
T 3zyr_A           90 LSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIRSSKVV  169 (261)
T ss_dssp             SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCCTTTTTCGGGCCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEE
T ss_pred             CCCCCccEEEEEccCCCCCCCCCCCceeeeecccccCCCccCcEEEEEEeccccccCcCCCCCCCeEEEEcCCCCccccc
Confidence            45689999999999876534458999999999987754 5789999999999   885 999999999999999999998


Q ss_pred             cCCCCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCcccccccccc
Q 008374           84 PLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRS  163 (568)
Q Consensus        84 ~~~~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~~~i~s  163 (568)
                      +|.      +.+|+.++|||+||+.+++|+|+|++.+.   .+|+|+..+||+++|++++||||||+||. ..+.|++++
T Consensus       170 ~~~------l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~e~v~VGFSAsTG~-~~e~h~Ils  239 (261)
T 3zyr_A          170 RWE------RREGKTLNVLVTYNPSTRTIDVVATYPDG---QRYQLSHVVDLTTILPEWVRVGFSAASGE-QFQTHNLES  239 (261)
T ss_dssp             ECC------CCTTCCEEEEEEEETTTTEEEEEEECTTC---CEEEEEEECCGGGTSCSEEEEEEEEEESS-SCCEEEEEE
T ss_pred             ccc------ccCCceEEEEEEEcCCCCEEEEEEEcCCC---CCeEEEEEechHHhCcCcEEEEEEecCCC-ccceEEEEE
Confidence            874      46899999999999999999999998763   38899999999999999999999999997 899999999


Q ss_pred             ccccccccc
Q 008374          164 WTLDIDVIQ  172 (568)
Q Consensus       164 Ws~~~~~~~  172 (568)
                      |+|+....+
T Consensus       240 WsF~s~l~~  248 (261)
T 3zyr_A          240 WSFTSTLLY  248 (261)
T ss_dssp             EEEEEEECC
T ss_pred             EEEEEEcCC
Confidence            999877544

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.5e-41  Score=337.88  Aligned_cols=264  Identities=24%  Similarity=0.388  Sum_probs=199.4

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|...++||+|+||.||+|++.....   ....||||.+....   ....+.+.+|++++++++||||+++++++...
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSG---KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTS---CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCC---ceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            3578899999999999999998753211   23479999987542   33457899999999999999999999999876


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      . .++|+||+++++|.+++...  ...+++..+..++.|++.||.|||   +++++||||||+|||++.++.+||+|||+
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~  167 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL  167 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             C-ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccc
Confidence            5 89999999999999999643  346899999999999999999999   56999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      ++...........  .....+|..|+|||.+....++.++||||||+++|||++ |+.||.......    +..   ...
T Consensus       168 ~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~---~~~  238 (291)
T 1u46_A          168 MRALPQNDDHYVM--QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILH---KID  238 (291)
T ss_dssp             CEECCC-CCEEEC-------CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHH---HHH
T ss_pred             cccccccccchhh--hccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH----HHH---HHH
Confidence            9887554322111  114467889999999988889999999999999999999 999997543222    111   111


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST  530 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~  530 (568)
                      ..         .............+.+++..|++.||.+|||+.++++.|+...+
T Consensus       239 ~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          239 KE---------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             TS---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cc---------CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            11         11111122334567788889999999999999999999987543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.3e-40  Score=359.23  Aligned_cols=254  Identities=25%  Similarity=0.319  Sum_probs=205.6

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|...+.||+|+||.||+|+...      +++.||||++....   ......+.+|+.+|.+++||||+++++++.+.
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~------tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  256 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRA------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK  256 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC
Confidence            4568899999999999999999875      68899999996542   23345688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +.+++||||+++|+|.+++.... ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGl  332 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGL  332 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEeccc
Confidence            99999999999999999996543 345899999999999999999999   57999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      ++........      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...+.    
T Consensus       333 a~~~~~~~~~------~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~----  402 (576)
T 2acx_A          333 AVHVPEGQTI------KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK----  402 (576)
T ss_dssp             CEECCTTCCE------ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH----
T ss_pred             ceecccCccc------cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh----
Confidence            9876543221      145799999999999998999999999999999999999999985433221111111111    


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                      ..          ...+.......+..++..|++.||.+||     +++||++
T Consensus       403 ~~----------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          403 EV----------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             cc----------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            00          0111122234566777899999999999     7888875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.5e-40  Score=343.83  Aligned_cols=253  Identities=23%  Similarity=0.306  Sum_probs=199.9

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeEEEEEEeCC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKG  317 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  317 (568)
                      ..++|...+.||+|+||.||+++.+.      +++.||||.+....    ..+.+|++++.++ +||||+++++++.+.+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKA------TNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            35679999999999999999999875      68899999997543    3456889998888 7999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC----CcEEEee
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD----FNARLGD  393 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~----~~~kL~D  393 (568)
                      ..++||||+++|+|.+++..   ...+++..+..++.||+.||.|||   +++|+||||||+|||+.++    +.+||+|
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~D  163 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICD  163 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred             EEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEE
Confidence            99999999999999999954   346899999999999999999999   5799999999999998543    3599999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      ||+++.........     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    ..+.. .
T Consensus       164 fg~a~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~~-~  233 (342)
T 2qr7_A          164 FGFAKQLRAENGLL-----MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT----PEEIL-A  233 (342)
T ss_dssp             CTTCEECBCTTCCB-----CCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC----HHHHH-H
T ss_pred             CCCcccCcCCCCce-----eccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC----HHHHH-H
Confidence            99998765432211     25679999999999988888999999999999999999999997532221    11111 1


Q ss_pred             HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       474 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ....+..      .+...........+.+++..|++.||++|||+.|+++
T Consensus       234 ~i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          234 RIGSGKF------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHHCCC------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHccCCc------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1111111      0111111123345667788999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=7.6e-40  Score=330.38  Aligned_cols=265  Identities=17%  Similarity=0.218  Sum_probs=205.0

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEE-EeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWC-HEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~-~~~~~  318 (568)
                      .++|...+.||+|+||.||+|+...      +++.||||++....  ..+++.+|+.++.+++|++++..+.++ ...+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIA------AGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT------TTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcC------CCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence            4679999999999999999999764      68899999986543  345789999999999988866666655 56778


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---cCCCcEEEeecC
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL---DADFNARLGDFG  395 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl---d~~~~~kL~DFG  395 (568)
                      .++||||+ +++|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||+   +.++.+||+|||
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  153 (296)
T 3uzp_A           80 NVMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             eEEEEEec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence            89999999 99999999632  246899999999999999999999   5799999999999999   588999999999


Q ss_pred             Cccccccccccccc--cccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          396 LARAIENERNSYAE--HGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       396 la~~~~~~~~~~~~--~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      +++...........  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  233 (296)
T 3uzp_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  233 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc
Confidence            99887654321100  0112567999999999999999999999999999999999999999854322211111111111


Q ss_pred             HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       474 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ... ..     .+.+..    .....+.+++..||+.||.+|||+.+|++.|+..
T Consensus       234 ~~~-~~-----~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          234 KMS-TP-----IEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HHH-SC-----HHHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             ccC-Cc-----hHHHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            000 00     000111    1234577788899999999999999999999864

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.5e-40  Score=331.74  Aligned_cols=247  Identities=21%  Similarity=0.329  Sum_probs=198.2

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcC-CCCceeeEEEEEEe
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHE  315 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~  315 (568)
                      ..++|...++||+|+||.||+|+...      +++.||+|++...  ......++.+|+..+.++ +||||+++++++.+
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~   82 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRL------DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE   82 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcC------CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence            35679999999999999999999875      6889999998764  233456788999999999 99999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCC-cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---------
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSE-QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA---------  385 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~---------  385 (568)
                      .+..++||||+++++|.+++..... ...+++..+..++.|++.||.|||   +++|+||||||+|||++.         
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~  159 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASE  159 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccc
Confidence            9999999999999999999964321 246899999999999999999999   579999999999999984         


Q ss_pred             ----------CCcEEEeecCCccccccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCC
Q 008374          386 ----------DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSP  454 (568)
Q Consensus       386 ----------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P  454 (568)
                                ...+||+|||+++......         ...||..|+|||.+... .++.++||||||++++||++|+.|
T Consensus       160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~  230 (289)
T 1x8b_A          160 EGDEDDWASNKVMFKIGDLGHVTRISSPQ---------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL  230 (289)
T ss_dssp             ----------CCCEEECCCTTCEETTCSC---------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             ccccccccCCceEEEEcccccccccCCcc---------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence                      4479999999998765432         34589999999999765 566899999999999999999877


Q ss_pred             CCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          455 GNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       455 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      +....      ..     .....+..     +.+    +......+.+++..|++.||.+|||+.|+++
T Consensus       231 ~~~~~------~~-----~~~~~~~~-----~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          231 PRNGD------QW-----HEIRQGRL-----PRI----PQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             CSSSH------HH-----HHHHTTCC-----CCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             Ccchh------HH-----HHHHcCCC-----CCC----CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            54221      00     11111111     111    1122345677888999999999999999975

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.2e-40  Score=338.80  Aligned_cols=269  Identities=23%  Similarity=0.356  Sum_probs=194.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHH--hhcCCCCceeeEEEEEEe--
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAI--IHRLRHKHLVHLVGWCHE--  315 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~nIv~l~g~~~~--  315 (568)
                      .++|...++||+|+||.||+|+.        +++.||||++....   ...+..|.++  +..++||||+++++++..  
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~   80 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--------DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVT   80 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--------TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             hHHhheeeecccCCCeEEEEEEE--------CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence            35789999999999999999976        47899999996532   3344444444  556899999999986643  


Q ss_pred             ---CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCC---------CeEecCCCCCCEEE
Q 008374          316 ---KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQ---------KVVHRDLKASNILL  383 (568)
Q Consensus       316 ---~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~---------~ivHrDikp~NILl  383 (568)
                         ....++||||+++|+|.+++..    ...++..+..++.|++.||.|||   ++         +|+||||||+|||+
T Consensus        81 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill  153 (336)
T 3g2f_A           81 ADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLV  153 (336)
T ss_dssp             TTSCEEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEE
T ss_pred             cCCCceEEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEE
Confidence               2367999999999999999943    34589999999999999999999   55         99999999999999


Q ss_pred             cCCCcEEEeecCCccccccccccc---cccccccCCcCCcccCcccccc-------CCCCccchhHHHHHHHHHHHhCCC
Q 008374          384 DADFNARLGDFGLARAIENERNSY---AEHGLVGVPGTMGYVAPECFHT-------GKATPESDVFGFGAVVLEVVCGRS  453 (568)
Q Consensus       384 d~~~~~kL~DFGla~~~~~~~~~~---~~~~~~~~~Gt~~y~APE~~~~-------~~~t~~sDV~SfGvll~el~tG~~  453 (568)
                      +.++.+||+|||+++.+.......   .........||+.|+|||++.+       ..++.++|||||||++|||++|+.
T Consensus       154 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~  233 (336)
T 3g2f_A          154 KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT  233 (336)
T ss_dssp             CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred             cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCC
Confidence            999999999999998775432110   0111224579999999999976       456678999999999999999987


Q ss_pred             CCCCCCc-ccchhhHH---------HHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          454 PGNMIPH-QQHAYTLV---------DWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       454 P~~~~~~-~~~~~~l~---------~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      |+..... ......+.         +..............+.+.  ..........+.+++..||+.||++|||+.|+++
T Consensus       234 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             GGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence            7642211 11000000         0000111110000000000  0112345667889999999999999999999999


Q ss_pred             HHhCC
Q 008374          524 IISGT  528 (568)
Q Consensus       524 ~L~~~  528 (568)
                      .|+..
T Consensus       312 ~L~~l  316 (336)
T 3g2f_A          312 RMAEL  316 (336)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.9e-40  Score=353.17  Aligned_cols=263  Identities=21%  Similarity=0.244  Sum_probs=195.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeC-
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK-  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-  316 (568)
                      .++|...++||+|+||.||+|+...      +++.||||++...  .....+.+.+|+.++++++||||+++++++... 
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAV------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK  134 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETT------TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECC------CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence            4679999999999999999998875      6889999999764  333456788999999999999999999999654 


Q ss_pred             -----CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 008374          317 -----GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL  391 (568)
Q Consensus       317 -----~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL  391 (568)
                           ...+||||||++ +|.+.+.     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||
T Consensus       135 ~~~~~~~~~lv~E~~~~-~l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl  205 (464)
T 3ttj_A          135 TLEEFQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI  205 (464)
T ss_dssp             STTTCCEEEEEEECCSE-EHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred             ccccCCeEEEEEeCCCC-CHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEE
Confidence                 468999999965 5666662     24899999999999999999999   569999999999999999999999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      +|||+|+.......      .....||+.|+|||++.+..++.++|||||||+++||++|+.||...........+.+..
T Consensus       206 ~DFG~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~l  279 (464)
T 3ttj_A          206 LDFGLARTAGTSFM------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL  279 (464)
T ss_dssp             CCCCCC-----CCC------C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EEEEeeeecCCCcc------cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999987654321      125679999999999999999999999999999999999999997644322111111100


Q ss_pred             H----HHhhc--Cchhhhhhh---------------hcC-CC--CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          472 W----MLHRE--GHIQDAVDQ---------------RLN-IN--SVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       472 ~----~~~~~--~~~~~~~d~---------------~l~-~~--~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .    ..+..  ......++.               .+. ..  ........+.+++.+||+.||++|||++|+++
T Consensus       280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          280 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             CSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0    00000  000000000               000 00  01112456788889999999999999999987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.2e-39  Score=334.55  Aligned_cols=256  Identities=17%  Similarity=0.233  Sum_probs=199.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-CCceeeEEEEEEe--CC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-HKHLVHLVGWCHE--KG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~--~~  317 (568)
                      ++|...++||+|+||.||+|+...      +++.||||++...   ..+.+.+|+.++++++ ||||+++++++..  ..
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~  106 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINIT------NNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSR  106 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CceEEEEEecccCCeEEEEEEECC------CCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence            578899999999999999998865      6789999999643   3567899999999997 9999999999987  66


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-cEEEeecCC
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF-NARLGDFGL  396 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~-~~kL~DFGl  396 (568)
                      ..++||||+++++|.+++.      .+++..+..++.|++.||.|||   +++|+||||||+|||++.++ .+||+|||+
T Consensus       107 ~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~  177 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL  177 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ceEEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence            8999999999999999983      4888999999999999999999   57999999999999999776 899999999


Q ss_pred             ccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      ++........      ....||..|+|||.+.. ..++.++|||||||++|||++|+.||........  .+.... ...
T Consensus       178 a~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~l~~~~-~~~  248 (330)
T 3nsz_A          178 AEFYHPGQEY------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIA-KVL  248 (330)
T ss_dssp             CEECCTTCCC------CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHH-HHH
T ss_pred             ceEcCCCCcc------ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH--HHHHHH-Hhc
Confidence            9876543321      14578999999999877 6789999999999999999999999963322210  111111 100


Q ss_pred             hcCchhhhhhh-----------------------hcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          476 REGHIQDAVDQ-----------------------RLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       476 ~~~~~~~~~d~-----------------------~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ......+.++.                       .............+.+++..|++.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          249 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00001111100                       0011111123456788888999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.2e-40  Score=335.23  Aligned_cols=262  Identities=22%  Similarity=0.335  Sum_probs=195.7

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...++||+|+||.||+|+...      +++.||||++..... .....+.+|++++++++||||+++++++...+..
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   75 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKL------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   75 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECC------CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEE
Confidence            578889999999999999999875      678999999975433 2334677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||++ |+|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  149 (324)
T 3mtl_A           76 TLVFEYLD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARA  149 (324)
T ss_dssp             EEEEECCS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEEC
T ss_pred             EEEecccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCccccc
Confidence            99999996 6999988643  346899999999999999999999   57999999999999999999999999999986


Q ss_pred             cccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc-
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE-  477 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~-  477 (568)
                      ........     ....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......    ....+...... 
T Consensus       150 ~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~  220 (324)
T 3mtl_A          150 KSIPTKTY-----DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE----QLHFIFRILGTP  220 (324)
T ss_dssp             C-----------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCC
T ss_pred             ccCCcccc-----ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCC
Confidence            65432221     14568999999999876 568999999999999999999999998654332    12222111110 


Q ss_pred             --Cchhhhhhh---------hcCCCC----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 --GHIQDAVDQ---------RLNINS----VVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 --~~~~~~~d~---------~l~~~~----~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        ..+......         ......    .......+.+++..|++.||.+|||++|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          221 TEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence              000000000         000000    0112345677888999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.3e-41  Score=354.62  Aligned_cols=243  Identities=13%  Similarity=0.089  Sum_probs=189.1

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC---CcccchhhHHHH---HHhhcCCCCceeeEE---
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD---SIKSKGDFLAEL---AIIHRLRHKHLVHLV---  310 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~nIv~l~---  310 (568)
                      .++|...+.||+|+||.||+|+...      +++.||||++...   .....+.|.+|+   +++++++||||++++   
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~  145 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQE------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF  145 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-C------CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred             CceEEEcceeecCCCEEEEEEEECC------CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence            4678888999999999999999764      6889999999743   333457789999   566666899999998   


Q ss_pred             ----EEEEeCC-----------------eEEEEEEecCCCChhhhhccCC----CcccCCHHHHHHHHHHHHHHHHHHHh
Q 008374          311 ----GWCHEKG-----------------KLLLVYDFMPNGSLEKYLYGTS----EQVTLNWNHRYKILTGVASAVYYLQN  365 (568)
Q Consensus       311 ----g~~~~~~-----------------~~~lV~Ey~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~  365 (568)
                          +++...+                 ..+|||||+ +|+|.+++....    ....+++..+..++.|++.||+||| 
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-  223 (377)
T 3byv_A          146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-  223 (377)
T ss_dssp             CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH-
Confidence                6666553                 289999999 689999996421    1234557899999999999999999 


Q ss_pred             cCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccC-----------CCCc
Q 008374          366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-----------KATP  434 (568)
Q Consensus       366 ~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-----------~~t~  434 (568)
                        +++|+||||||+|||++.++.+||+|||+++......        ....| +.|+|||++...           .++.
T Consensus       224 --~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~  292 (377)
T 3byv_A          224 --HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV--------VSSVS-RGFEPPELEARRATISYHRDRRTLMTF  292 (377)
T ss_dssp             --HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTCEE--------ECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH
T ss_pred             --hCCeecCCCCHHHEEEcCCCCEEEEechhheecCCcc--------cCCCC-cCccChhhhcccccccccccccccCCh
Confidence              5699999999999999999999999999998643311        14567 999999999877           8999


Q ss_pred             cchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCC
Q 008374          435 ESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASE  514 (568)
Q Consensus       435 ~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~  514 (568)
                      ++|||||||++|||++|+.||........                ...+.. .. .    .....+.+++..||+.||.+
T Consensus       293 ~~DvwSlG~il~elltg~~Pf~~~~~~~~----------------~~~~~~-~~-~----~~~~~~~~li~~~L~~dp~~  350 (377)
T 3byv_A          293 SFDAWALGLVIYWIWCADLPITKDAALGG----------------SEWIFR-SC-K----NIPQPVRALLEGFLRYPKED  350 (377)
T ss_dssp             HHHHHHHHHHHHHHHHSSCCC------CC----------------SGGGGS-SC-C----CCCHHHHHHHHHHTCSSGGG
T ss_pred             hhhHHHHHHHHHHHHHCCCCCcccccccc----------------hhhhhh-hc-c----CCCHHHHHHHHHHcCCCchh
Confidence            99999999999999999999974322210                111111 00 1    12345677888999999999


Q ss_pred             CCCHHHHHH
Q 008374          515 RPKTEDILQ  523 (568)
Q Consensus       515 RPt~~evl~  523 (568)
                      |||+.|+++
T Consensus       351 Rpt~~e~l~  359 (377)
T 3byv_A          351 RLLPLQAME  359 (377)
T ss_dssp             CCCHHHHHT
T ss_pred             CCCHHHHhh
Confidence            999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.5e-40  Score=337.72  Aligned_cols=267  Identities=23%  Similarity=0.346  Sum_probs=199.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc--cchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK--SKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      .++|...+.||+|+||.||+|+...      +++.||||++......  ..+.+.+|+.++++++||||++++++|.+.+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   97 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKD------TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK   97 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETT------TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhhheeeeEEeecCCEEEEEEEECC------CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence            3578899999999999999999875      6889999998654332  3456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++++|..++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  171 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFA  171 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCc
Confidence            99999999999999988743   345899999999999999999999   579999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH------
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW------  470 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~------  470 (568)
                      +.........     ....||..|+|||.+.+. .++.++|||||||++|||++|+.||...........+...      
T Consensus       172 ~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (331)
T 4aaa_A          172 RTLAAPGEVY-----DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP  246 (331)
T ss_dssp             -----------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             eeecCCcccc-----CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence            8765432221     145789999999999765 7899999999999999999999999865433311111100      


Q ss_pred             -HHHHhhcCch-hhhhhhhcCCCCc-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          471 -VWMLHREGHI-QDAVDQRLNINSV-----VDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       471 -~~~~~~~~~~-~~~~d~~l~~~~~-----~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       ....+..... .....+.+.....     ......+.+++..||+.||.+|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          247 RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             0000000000 0000011111111     123456788888999999999999999976

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5e-40  Score=337.65  Aligned_cols=263  Identities=19%  Similarity=0.316  Sum_probs=205.4

Q ss_pred             cCHHHHHHHhcCcccc-ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCC-CCce
Q 008374          231 FKYKELKKATNNFHES-MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLR-HKHL  306 (568)
Q Consensus       231 ~~~~el~~at~~f~~~-~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nI  306 (568)
                      ..++......+.|... ++||+|+||.||+|+...      +++.||+|++....  .....++.+|+.++.+++ ||||
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i   91 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKS------TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV   91 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTB
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECC------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCE
Confidence            3344455556677776 889999999999999875      68899999987643  233567899999999994 6999


Q ss_pred             eeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-
Q 008374          307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA-  385 (568)
Q Consensus       307 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~-  385 (568)
                      +++++++...+..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||   +++|+||||||+|||++. 
T Consensus        92 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~  167 (327)
T 3lm5_A           92 INLHEVYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSI  167 (327)
T ss_dssp             CCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCB
T ss_pred             EEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecC
Confidence            999999999999999999999999999985432 356899999999999999999999   579999999999999998 


Q ss_pred             --CCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q 008374          386 --DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH  463 (568)
Q Consensus       386 --~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~  463 (568)
                        ++.+||+|||+++........      ....||+.|+|||++....++.++||||||+++|||++|+.||....... 
T Consensus       168 ~~~~~~kL~Dfg~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-  240 (327)
T 3lm5_A          168 YPLGDIKIVDFGMSRKIGHACEL------REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-  240 (327)
T ss_dssp             TTBCCEEECCGGGCEEC---------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred             CCCCcEEEeeCccccccCCcccc------ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-
Confidence              789999999999877543221      14579999999999999999999999999999999999999997543322 


Q ss_pred             hhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          464 AYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       464 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        .... ...  .        ...............+.+++..|++.||.+|||++|+++
T Consensus       241 --~~~~-i~~--~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          241 --TYLN-ISQ--V--------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             --HHHH-HHH--T--------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --HHHH-HHh--c--------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence              1111 000  0        001111111223445677888999999999999999976

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.8e-40  Score=341.18  Aligned_cols=259  Identities=25%  Similarity=0.370  Sum_probs=205.2

Q ss_pred             HHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc--------cchhhHHHHHHhhcC-CC
Q 008374          233 YKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK--------SKGDFLAELAIIHRL-RH  303 (568)
Q Consensus       233 ~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~H  303 (568)
                      +.......++|...+.||+|+||.||+|+...      +++.||||++......        ..+.+.+|+.++.++ +|
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h  159 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA------TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH  159 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECC------CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            34445566789999999999999999999864      6889999998654321        135678999999999 79


Q ss_pred             CceeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 008374          304 KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL  383 (568)
Q Consensus       304 ~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl  383 (568)
                      |||+++++++...+..++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+++||||||+|||+
T Consensus       160 p~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~  233 (365)
T 2y7j_A          160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILL  233 (365)
T ss_dssp             TTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence            9999999999999999999999999999999953   346899999999999999999999   5699999999999999


Q ss_pred             cCCCcEEEeecCCccccccccccccccccccCCcCCcccCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008374          384 DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT------GKATPESDVFGFGAVVLEVVCGRSPGNM  457 (568)
Q Consensus       384 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~------~~~t~~sDV~SfGvll~el~tG~~P~~~  457 (568)
                      +.++.+||+|||++..+......      ....||+.|+|||++.+      ..++.++|||||||++|||++|+.||..
T Consensus       234 ~~~~~ikl~DfG~~~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  307 (365)
T 2y7j_A          234 DDNMQIRLSDFGFSCHLEPGEKL------RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH  307 (365)
T ss_dssp             CTTCCEEECCCTTCEECCTTCCB------CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCCCEEEEecCcccccCCCccc------ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence            99999999999999877643221      24679999999999863      3588899999999999999999999975


Q ss_pred             CCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          458 IPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       458 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .....    ....+    ..+... ...+..     ......+..++..|++.||.+|||+.|+++
T Consensus       308 ~~~~~----~~~~i----~~~~~~-~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          308 RRQIL----MLRMI----MEGQYQ-FSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             SSHHH----HHHHH----HHTCCC-CCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCHHH----HHHHH----HhCCCC-CCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            32221    11111    111000 000000     012345677888999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.6e-40  Score=334.92  Aligned_cols=253  Identities=21%  Similarity=0.337  Sum_probs=198.7

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .++|...+.||+|+||.||+|+...      ++..||+|.+........+.+.+|++++++++||||+++++++...+..
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKE------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL   91 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETT------TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred             ccceeecceeccCCCeEEEEEEEcC------CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence            4678999999999999999999875      6789999999877666678899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||.|||   +++++||||||+|||++.++.+||+|||++..
T Consensus        92 ~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK  166 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred             EEEEEeCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence            9999999999999998542  245899999999999999999999   56999999999999999999999999999865


Q ss_pred             cccccccccccccccCCcCCcccCcccc-----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECF-----HTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~-----~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      .......     .....||..|+|||.+     ....++.++||||||+++|||++|+.|+.......   .+    ...
T Consensus       167 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~----~~~  234 (302)
T 2j7t_A          167 NLKTLQK-----RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VL----LKI  234 (302)
T ss_dssp             HHHHHHC----------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH----HHH
T ss_pred             ccccccc-----cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HH----HHH
Confidence            4322111     1145689999999998     36778999999999999999999999987543221   11    111


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .....      +  ...........+..++..|++.||.+|||+.|+++
T Consensus       235 ~~~~~------~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          235 AKSDP------P--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHSCC------C--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             hccCC------c--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            11100      0  00111222345677888999999999999999975

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2e-40  Score=333.56  Aligned_cols=253  Identities=21%  Similarity=0.288  Sum_probs=186.0

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-cc-chhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KS-KGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      .++|...++||+|+||.||+|+...      +++.||||++..... .. .+.+..+...++.++||||+++++++.+.+
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~   79 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVP------SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG   79 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecC------CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC
Confidence            4678999999999999999999865      688999999976422 22 233445555688889999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccC-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          318 KLLLVYDFMPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVASAVYYLQNEYDQ-KVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      ..++||||++ |+|.+++... .....+++..+..++.|++.||.|||   ++ +++||||||+|||++.++.+||+|||
T Consensus        80 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T 3fme_A           80 DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFG  155 (290)
T ss_dssp             SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred             CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecC
Confidence            9999999996 5888877531 22357999999999999999999999   45 99999999999999999999999999


Q ss_pred             CccccccccccccccccccCCcCCcccCcccc----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECF----HTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~----~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      +++........      ....||+.|+|||.+    ....++.++||||||+++|||++|+.||.......     .. .
T Consensus       156 ~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~-~  223 (290)
T 3fme_A          156 ISGYLVDDVAK------DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-----QQ-L  223 (290)
T ss_dssp             --------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-----HH-H
T ss_pred             Ccccccccccc------cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-----HH-H
Confidence            99876554322      134699999999996    56678999999999999999999999997432211     11 1


Q ss_pred             HHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       472 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ...         +...............+.+++..|++.||++|||+.|+++
T Consensus       224 ~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          224 KQV---------VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHH---------HHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHH---------hccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            111         1111111111122345677888999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1e-39  Score=354.38  Aligned_cols=252  Identities=24%  Similarity=0.360  Sum_probs=198.2

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      ..+.|...++||+|+||.||+|+...      ++..||+|++....  ......+.+|+.++++++||||++++++|.+.
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  108 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKV------THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK  108 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETT------TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECC------CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            34569999999999999999999875      67899999997653  33456789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC---CcEEEee
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD---FNARLGD  393 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~---~~~kL~D  393 (568)
                      +..++|||||++|+|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++..   +.+||+|
T Consensus       109 ~~~~lv~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  182 (494)
T 3lij_A          109 RNYYLVMECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVD  182 (494)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEE
Confidence            999999999999999998853   346899999999999999999999   5799999999999999764   5599999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      ||+++........      ....||+.|+|||++. +.++.++|||||||++|||++|+.||.......    +...+  
T Consensus       183 fG~a~~~~~~~~~------~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i--  249 (494)
T 3lij_A          183 FGLSAVFENQKKM------KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE----ILRKV--  249 (494)
T ss_dssp             CTTCEECBTTBCB------CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH--
T ss_pred             CCCCeECCCCccc------cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHH--
Confidence            9999877654221      2457999999999985 579999999999999999999999998543322    11111  


Q ss_pred             HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       474 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        ..+...      +...........+..++..||+.||.+|||+.|+++
T Consensus       250 --~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          250 --EKGKYT------FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             --HHTCCC------CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --HhCCCC------CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence              111100      000001122345667888999999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=6.5e-40  Score=341.94  Aligned_cols=259  Identities=14%  Similarity=0.120  Sum_probs=200.7

Q ss_pred             HHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC---CCceeeEEEEE
Q 008374          237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR---HKHLVHLVGWC  313 (568)
Q Consensus       237 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~  313 (568)
                      ....++|...++||+|+||.||+|+..... ....++.||||++...   ...++..|++++.+++   |+||+++++++
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLN-DAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC--------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCc-ccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            344577999999999999999999643211 1126889999999754   3456788888888886   99999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhccC--CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC------
Q 008374          314 HEKGKLLLVYDFMPNGSLEKYLYGT--SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA------  385 (568)
Q Consensus       314 ~~~~~~~lV~Ey~~~gsL~~~L~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~------  385 (568)
                      ...+..+||||||++|+|.+++...  .....+++..+..++.|++.||+|||   +++|+||||||+|||++.      
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC-
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcc
Confidence            9999999999999999999999642  12456999999999999999999999   679999999999999998      


Q ss_pred             -----CCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 008374          386 -----DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPH  460 (568)
Q Consensus       386 -----~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~  460 (568)
                           ++.+||+|||+|+.+........   .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTI---FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEE---ECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCce---eeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence                 89999999999986543221111   1256799999999999999999999999999999999999999853211


Q ss_pred             ccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhC
Q 008374          461 QQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASER-PKTEDILQIISG  527 (568)
Q Consensus       461 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~R-Pt~~evl~~L~~  527 (568)
                      ...                   .+...+......+.   +..+...|++.+|.+| |+++++.+.|+.
T Consensus       291 ~~~-------------------~~~~~~~~~~~~~~---~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          291 GEC-------------------KPEGLFRRLPHLDM---WNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             TEE-------------------EECSCCTTCSSHHH---HHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             Cce-------------------eechhccccCcHHH---HHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence            110                   01111111122333   3445557889999988 678888887765

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=331.05  Aligned_cols=252  Identities=24%  Similarity=0.365  Sum_probs=200.0

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ..++|...+.||+|+||.||+|+...      +++.||+|.+....  ..+++.+|+.++.+++||||+++++++...+.
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   98 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKE------TGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTD   98 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETT------TCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECC------CCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence            45679999999999999999999874      68899999997643  45678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++||||+++++|.+++..  ....+++..+..++.+++.||.|||   +.+++||||||+||+++.++.+||+|||+++
T Consensus        99 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  173 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAG  173 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccch
Confidence            9999999999999999853  2346899999999999999999999   5799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      .........     ....||..|+|||.+....++.++||||||+++|||++|+.||.......       .........
T Consensus       174 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~  241 (314)
T 3com_A          174 QLTDTMAKR-----NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-------AIFMIPTNP  241 (314)
T ss_dssp             ECBTTBSCB-----CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSC
T ss_pred             hhhhhcccc-----CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHhcCC
Confidence            765432211     24578999999999999999999999999999999999999997543221       011110000


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                            .+.+  .........+.+++..|++.||.+|||+.++++
T Consensus       242 ------~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          242 ------PPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ------CCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ------Cccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                  0011  111122346777888999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-40  Score=338.76  Aligned_cols=262  Identities=23%  Similarity=0.372  Sum_probs=200.1

Q ss_pred             ccCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceee
Q 008374          230 EFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVH  308 (568)
Q Consensus       230 ~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~  308 (568)
                      .+++.++....++|...+.||+|+||.||+|+...      +++.||||++.... ...+.+.+|+.++.++ +||||++
T Consensus        13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~   85 (326)
T 2x7f_A           13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVK------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIAT   85 (326)
T ss_dssp             ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCC
T ss_pred             hccchhccCCCCcEEEEEEeccCCCEEEEEEEECC------CCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeee
Confidence            34555566678889999999999999999999864      67899999986543 3456789999999999 8999999


Q ss_pred             EEEEEEe------CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 008374          309 LVGWCHE------KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL  382 (568)
Q Consensus       309 l~g~~~~------~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIL  382 (568)
                      +++++..      .+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||   +++++||||||+|||
T Consensus        86 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl  161 (326)
T 2x7f_A           86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVL  161 (326)
T ss_dssp             EEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEE
T ss_pred             eeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEE
Confidence            9999987      468999999999999999996532 346899999999999999999999   569999999999999


Q ss_pred             EcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008374          383 LDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH-----TGKATPESDVFGFGAVVLEVVCGRSPGNM  457 (568)
Q Consensus       383 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~t~~sDV~SfGvll~el~tG~~P~~~  457 (568)
                      ++.++.+||+|||++..........     ....||..|+|||.+.     ...++.++|||||||++|||++|+.||..
T Consensus       162 ~~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  236 (326)
T 2x7f_A          162 LTENAEVKLVDFGVSAQLDRTVGRR-----NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  236 (326)
T ss_dssp             ECTTCCEEECCCTTTC------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             EcCCCCEEEeeCcCceecCcCcccc-----ccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999998765432111     1457899999999986     56789999999999999999999999975


Q ss_pred             CCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          458 IPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       458 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .....   .+    ..... ..     .+.+..   ......+..++..||+.||.+|||+.|+++
T Consensus       237 ~~~~~---~~----~~~~~-~~-----~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          237 MHPMR---AL----FLIPR-NP-----APRLKS---KKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             SCHHH---HH----HHHHH-SC-----CCCCSC---SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CcHHH---HH----HHhhc-Cc-----cccCCc---cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            43221   11    11110 00     011111   112345677788999999999999999987

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.8e-40  Score=327.49  Aligned_cols=253  Identities=25%  Similarity=0.369  Sum_probs=196.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|...+.||+|+||.||+|+...      +++.||||.+....   ....+.+.+|+.++++++||||+++++++...
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   83 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQL------TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP   83 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             eccEEEEeeecCCCCeEEEEEEECC------CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            3578899999999999999999874      67899999986542   23345788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +..++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||+
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~  157 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGL  157 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCG
T ss_pred             CeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeeccc
Confidence            999999999999999999954   345899999999999999999999   56999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      +.........      ....||+.|+|||.+.+..+ +.++||||||++++||++|+.||.......    +.+.    .
T Consensus       158 ~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~----~  223 (276)
T 2h6d_A          158 SNMMSDGEFL------RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT----LFKK----I  223 (276)
T ss_dssp             GGCCCC-------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----H
T ss_pred             ccccCCCcce------ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH----HHHH----h
Confidence            9876543211      14568999999999987765 689999999999999999999997532211    1111    1


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HhCC
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI--ISGT  528 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~--L~~~  528 (568)
                      ..+.        .  ..+......+..++..|++.||.+|||+.|+++.  ++..
T Consensus       224 ~~~~--------~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          224 RGGV--------F--YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHCC--------C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             hcCc--------c--cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            1110        0  0111223456778889999999999999999973  4443

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.2e-39  Score=365.76  Aligned_cols=250  Identities=20%  Similarity=0.291  Sum_probs=204.2

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC---CcccchhhHHHHHHhhcC-CCCceeeEEEEEE
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD---SIKSKGDFLAELAIIHRL-RHKHLVHLVGWCH  314 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~  314 (568)
                      ..++|...++||+|+||+||+|+...      +++.||||++++.   .....+.+..|..++..+ +||||+++++++.
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~  412 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKG------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ  412 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESS------SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred             cccceEEEEEEccCCCEEEEEEEECC------CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence            35689999999999999999999875      6789999999753   223456688899999988 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 008374          315 EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDF  394 (568)
Q Consensus       315 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DF  394 (568)
                      +.+.++|||||+++|+|..++..   ...+++..+..++.||+.||.|||   +++|+||||||+||||+.++.+||+||
T Consensus       413 ~~~~~~lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DF  486 (674)
T 3pfq_A          413 TMDRLYFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADF  486 (674)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCC
T ss_pred             eCCEEEEEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeec
Confidence            99999999999999999999954   346899999999999999999999   579999999999999999999999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      |+|+........     .....||+.|+|||++....++.++|||||||++|||++|+.||.......    +..     
T Consensus       487 Gla~~~~~~~~~-----~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~----~~~-----  552 (674)
T 3pfq_A          487 GMCKENIWDGVT-----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQ-----  552 (674)
T ss_dssp             TTCEECCCTTCC-----BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH-----
T ss_pred             ceeeccccCCcc-----cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH----HHH-----
Confidence            999864332221     125689999999999999999999999999999999999999997543322    111     


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKT-----EDILQ  523 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~-----~evl~  523 (568)
                             .++...+  .++......+..++..||+.||.+||++     +||++
T Consensus       553 -------~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          553 -------SIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -------HHHSSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -------HHHhCCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                   1111111  1122334456777789999999999997     77764

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.4e-39  Score=331.55  Aligned_cols=253  Identities=22%  Similarity=0.307  Sum_probs=196.7

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--------cccchhhHHHHHHhhcCCCCceeeEE
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--------IKSKGDFLAELAIIHRLRHKHLVHLV  310 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~  310 (568)
                      ..++|...+.||+|+||.||+|+...      +++.||||.+....        ......+.+|++++++++||||++++
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   81 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERK------TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK   81 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcC------CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEe
Confidence            45679999999999999999999875      67899999986532        12234688999999999999999999


Q ss_pred             EEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc--
Q 008374          311 GWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN--  388 (568)
Q Consensus       311 g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~--  388 (568)
                      +++.... .++||||+++++|.+++..   ...+++.....++.|++.||.|||   +++|+||||||+|||++.++.  
T Consensus        82 ~~~~~~~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~  154 (322)
T 2ycf_A           82 NFFDAED-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDC  154 (322)
T ss_dssp             EEEESSS-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSC
T ss_pred             eEEcCCc-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCC
Confidence            9987654 8999999999999999853   356899999999999999999999   579999999999999987654  


Q ss_pred             -EEEeecCCccccccccccccccccccCCcCCcccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccch
Q 008374          389 -ARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH---TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHA  464 (568)
Q Consensus       389 -~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~  464 (568)
                       +||+|||+++........      ....||+.|+|||++.   ...++.++|||||||++|||++|+.||.......  
T Consensus       155 ~~kl~Dfg~~~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--  226 (322)
T 2ycf_A          155 LIKITDFGHSKILGETSLM------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--  226 (322)
T ss_dssp             CEEECCCTTCEECCCCHHH------HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--
T ss_pred             eEEEccCccceeccccccc------ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--
Confidence             999999999876543211      1346899999999974   5678999999999999999999999997543332  


Q ss_pred             hhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          465 YTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       465 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       .+...+..    +....  .+..    .......+.+++..|++.||.+|||+.|+++
T Consensus       227 -~~~~~~~~----~~~~~--~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          227 -SLKDQITS----GKYNF--IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -CHHHHHHH----TCCCC--CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -HHHHHHHh----Ccccc--Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             22221111    11000  0000    0112346778888999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=337.90  Aligned_cols=266  Identities=21%  Similarity=0.345  Sum_probs=201.0

Q ss_pred             HHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEE
Q 008374          235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGW  312 (568)
Q Consensus       235 el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~  312 (568)
                      +.....++|...+.||+|+||.||+|...         ..+|+|.+....  ....+.|.+|+.++++++||||++++++
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~---------~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   97 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWH---------GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA   97 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEES---------SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEE
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEc---------CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence            33344577899999999999999999874         249999987542  3345678999999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          313 CHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       313 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                      +...+..++||||+++++|.+++...  ...+++..+..++.|++.||.|||   +++++||||||+|||++ ++.+||+
T Consensus        98 ~~~~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~  171 (319)
T 2y4i_B           98 CMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVIT  171 (319)
T ss_dssp             EECSSCEEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEEC
T ss_pred             EecCCceEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEe
Confidence            99999999999999999999999543  346899999999999999999999   56999999999999998 6799999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCcccccc---------CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT---------GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH  463 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~---------~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~  463 (568)
                      |||+++..................||..|+|||.+..         ..++.++||||||+++|||++|+.||....... 
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-  250 (319)
T 2y4i_B          172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-  250 (319)
T ss_dssp             CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-
T ss_pred             ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence            9999887643222111112224569999999999864         457889999999999999999999997543322 


Q ss_pred             hhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC
Q 008374          464 AYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTV  531 (568)
Q Consensus       464 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~  531 (568)
                            ..+.. ..+.     .+.+..   ......+.+++..||+.||.+|||+.+++++|+.....
T Consensus       251 ------~~~~~-~~~~-----~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          251 ------IIWQM-GTGM-----KPNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             ------HHHHH-HTTC-----CCCCCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             ------HHHHh-ccCC-----CCCCCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence                  11111 1111     111111   11223467788899999999999999999999986543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9e-40  Score=338.43  Aligned_cols=267  Identities=23%  Similarity=0.271  Sum_probs=197.3

Q ss_pred             HHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-----cchhhHHHHHHhhcCCCCceeeEEE
Q 008374          237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-----SKGDFLAELAIIHRLRHKHLVHLVG  311 (568)
Q Consensus       237 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~g  311 (568)
                      ....++|...+.||+|+||.||+|+...      +++.||||++......     ..+.+.+|++++++++||||+++++
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   79 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKN------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD   79 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSS------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECC------CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEE
Confidence            3445789999999999999999999864      6789999998753221     2356889999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 008374          312 WCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL  391 (568)
Q Consensus       312 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL  391 (568)
                      ++...+..++||||+++ +|..++...  ...+++..+..++.|+++||.|||   +++|+||||||+|||++.++.+||
T Consensus        80 ~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl  153 (346)
T 1ua2_A           80 AFGHKSNISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKL  153 (346)
T ss_dssp             EECCTTCCEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             EEeeCCceEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEE
Confidence            99999999999999975 888888543  346889999999999999999999   579999999999999999999999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~  470 (568)
                      +|||+++.........     ....||+.|+|||.+.+. .++.++|||||||++|||++|..||.......   .+...
T Consensus       154 ~Dfg~a~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i  225 (346)
T 1ua2_A          154 ADFGLAKSFGSPNRAY-----THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRI  225 (346)
T ss_dssp             CCCGGGSTTTSCCCCC-----CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH
T ss_pred             EecccceeccCCcccC-----CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHH
Confidence            9999998765432221     245789999999998654 58899999999999999999999987544332   11111


Q ss_pred             HHHHhhcCc---hhh---hhhhhc---CCCCc-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          471 VWMLHREGH---IQD---AVDQRL---NINSV-----VDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       471 ~~~~~~~~~---~~~---~~d~~l---~~~~~-----~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                       ........   ..+   ..+...   .....     ......+.+++..|++.||.+|||+.|+++.
T Consensus       226 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          226 -FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             -HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             -HHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence             11111000   000   000000   00000     1223567788889999999999999999874

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-40  Score=342.16  Aligned_cols=272  Identities=14%  Similarity=0.147  Sum_probs=204.7

Q ss_pred             cCccccceeccCCceeEEEEEEccCccc--cccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceee----------
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQY--HVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVH----------  308 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~----------  308 (568)
                      ++|...+.||+|+||.||+|+.......  ...++.||||.+...     +.+.+|++++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            5789999999999999999998742110  003688999998654     46899999999999999988          


Q ss_pred             -----EEEEEEe-CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 008374          309 -----LVGWCHE-KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL  382 (568)
Q Consensus       309 -----l~g~~~~-~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIL  382 (568)
                           +++++.. .+..++||||+ +++|.+++.... ...+++..+..++.|++.||.|||   +++|+||||||+|||
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF  191 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence                 6788876 67899999999 999999996432 357999999999999999999999   569999999999999


Q ss_pred             EcCCC--cEEEeecCCccccccccccc--cccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008374          383 LDADF--NARLGDFGLARAIENERNSY--AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMI  458 (568)
Q Consensus       383 ld~~~--~~kL~DFGla~~~~~~~~~~--~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~  458 (568)
                      ++.++  .+||+|||+++.+.......  .........||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  99999999998776443211  111112457999999999999999999999999999999999999999743


Q ss_pred             CcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          459 PHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       459 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                      ....  ..+..........  .....+....   .......+.+++..|++.||.+|||+++|++.|+...
T Consensus       272 ~~~~--~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  335 (352)
T 2jii_A          272 LPNT--EDIMKQKQKFVDK--PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL  335 (352)
T ss_dssp             TTCH--HHHHHHHHHHHHS--CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             CcCH--HHHHHHHHhccCC--hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence            3111  0222221111110  0011111100   0112355677788999999999999999999998753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.4e-39  Score=329.03  Aligned_cols=253  Identities=25%  Similarity=0.345  Sum_probs=203.2

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---------ccchhhHHHHHHhhcCC-CCceee
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---------KSKGDFLAELAIIHRLR-HKHLVH  308 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~nIv~  308 (568)
                      ..++|...+.||+|+||.||+|+...      +++.||||.+.....         ...+.+.+|++++.+++ ||||++
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~   88 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKP------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ   88 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             hhhccceeeeecCCCceEEEEEEEcC------cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEee
Confidence            35689999999999999999999875      688999999965431         22456889999999995 999999


Q ss_pred             EEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc
Q 008374          309 LVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN  388 (568)
Q Consensus       309 l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~  388 (568)
                      +++++...+..++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +++++||||||+||+++.++.
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~  162 (298)
T 1phk_A           89 LKDTYETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMN  162 (298)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCC
T ss_pred             eeeeeccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCc
Confidence            99999999999999999999999999953   346899999999999999999999   579999999999999999999


Q ss_pred             EEEeecCCccccccccccccccccccCCcCCcccCccccc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 008374          389 ARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH------TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ  462 (568)
Q Consensus       389 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~------~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~  462 (568)
                      +||+|||+++........      ....||..|+|||.+.      ...++.++||||||++++||++|+.||.......
T Consensus       163 ~kl~dfg~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  236 (298)
T 1phk_A          163 IKLTDFGFSCQLDPGEKL------REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML  236 (298)
T ss_dssp             EEECCCTTCEECCTTCCB------CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEEecccchhhcCCCccc------ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH
Confidence            999999999876543221      2457899999999885      4568899999999999999999999997543221


Q ss_pred             chhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          463 HAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       463 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                          ...   . ...+..      .............+.+++..|++.||.+|||+.|+++
T Consensus       237 ----~~~---~-~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          237 ----MLR---M-IMSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             ----HHH---H-HHHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ----HHH---H-HhcCCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence                111   1 111100      0011111233456778888999999999999999975

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.1e-40  Score=344.02  Aligned_cols=263  Identities=21%  Similarity=0.269  Sum_probs=197.0

Q ss_pred             HHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       237 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      ....++|...++||+|+||.||+|+...      +++.||||++...    .....+|+++++.++||||+++++++...
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~------~~~~vAiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~   72 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIE------SGKRFALKKVLQD----PRYKNRELDIMKVLDHVNIIKLVDYFYTT   72 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETT------TCCEEEEEEEECC----TTSCCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECC------CCCEEEEEEEecC----cchHHHHHHHHHHcCCCCccchhheeeec
Confidence            4456789999999999999999999875      6889999998654    23345899999999999999999998543


Q ss_pred             --------------------------------------CeEEEEEEecCCCChhhhhccC-CCcccCCHHHHHHHHHHHH
Q 008374          317 --------------------------------------GKLLLVYDFMPNGSLEKYLYGT-SEQVTLNWNHRYKILTGVA  357 (568)
Q Consensus       317 --------------------------------------~~~~lV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia  357 (568)
                                                            ..+++||||++ |+|.+.+... .....+++..+..++.|++
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF  151 (383)
T ss_dssp             -------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence                                                  34899999997 6887777531 2235699999999999999


Q ss_pred             HHHHHHHhcCCCCeEecCCCCCCEEEc-CCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccC-CCCcc
Q 008374          358 SAVYYLQNEYDQKVVHRDLKASNILLD-ADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPE  435 (568)
Q Consensus       358 ~~L~yLH~~~~~~ivHrDikp~NILld-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~  435 (568)
                      +||.|||   +.+|+||||||+|||++ .++.+||+|||+++........      ....||..|+|||.+.+. .++.+
T Consensus       152 ~aL~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~  222 (383)
T 3eb0_A          152 RAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS------VAYICSRFYRAPELMLGATEYTPS  222 (383)
T ss_dssp             HHHHHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC------CCCCCCSSCCCHHHHTTCSSCCTH
T ss_pred             HHHHHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC------cCcccCCCccCHHHhcCCCCCCcc
Confidence            9999999   78999999999999998 6899999999999876543322      145789999999998764 58999


Q ss_pred             chhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhh--hhh--------cCCC-----CcHHHHHHH
Q 008374          436 SDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAV--DQR--------LNIN-----SVVDEAKRL  500 (568)
Q Consensus       436 sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--d~~--------l~~~-----~~~~~~~~l  500 (568)
                      +|||||||++|||++|+.||.......   .+...+.. ........+.  ++.        +...     ........+
T Consensus       223 ~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (383)
T 3eb0_A          223 IDLWSIGCVFGELILGKPLFSGETSID---QLVRIIQI-MGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA  298 (383)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHH-HCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHH
T ss_pred             hhhhhHHHHHHHHHhCCCCCCCCChHH---HHHHHHHH-hCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHH
Confidence            999999999999999999998654333   22221111 1100000000  000        0000     111233457


Q ss_pred             HHHHHhcCCCCCCCCCCHHHHHH
Q 008374          501 LLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       501 ~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .+++..|++.||.+|||+.|+++
T Consensus       299 ~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          299 IDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHccCChhhCCCHHHHhc
Confidence            78888999999999999999985

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-39  Score=350.80  Aligned_cols=199  Identities=27%  Similarity=0.430  Sum_probs=156.0

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeC-
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK-  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-  316 (568)
                      .++|...++||+|+||+||+|+...      +++.||||++...  .....+.+.+|+++|++++||||+++++++... 
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  125 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKL------EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD  125 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECC------CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            3679999999999999999999875      6889999999664  233456789999999999999999999999543 


Q ss_pred             ----CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          317 ----GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       317 ----~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                          ..+++||||+ +++|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+||||+.++.+||+
T Consensus       126 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~  198 (458)
T 3rp9_A          126 VEKFDELYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVC  198 (458)
T ss_dssp             TTTCCCEEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEEC
T ss_pred             cccCceEEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeec
Confidence                5799999998 5799999853   346999999999999999999999   5799999999999999999999999


Q ss_pred             ecCCcccccccccccc----------------------ccccccCCcCCcccCcccc-ccCCCCccchhHHHHHHHHHHH
Q 008374          393 DFGLARAIENERNSYA----------------------EHGLVGVPGTMGYVAPECF-HTGKATPESDVFGFGAVVLEVV  449 (568)
Q Consensus       393 DFGla~~~~~~~~~~~----------------------~~~~~~~~Gt~~y~APE~~-~~~~~t~~sDV~SfGvll~el~  449 (568)
                      |||+|+..........                      .......+||+.|+|||++ ....++.++|||||||++|||+
T Consensus       199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell  278 (458)
T 3rp9_A          199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL  278 (458)
T ss_dssp             CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH
Confidence            9999997753321100                      0122356789999999976 5667999999999999999999


Q ss_pred             hC
Q 008374          450 CG  451 (568)
Q Consensus       450 tG  451 (568)
                      +|
T Consensus       279 tg  280 (458)
T 3rp9_A          279 NM  280 (458)
T ss_dssp             TT
T ss_pred             Hh
Confidence            94

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.8e-39  Score=353.40  Aligned_cols=250  Identities=22%  Similarity=0.361  Sum_probs=200.1

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-------------ccchhhHHHHHHhhcCCCCc
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-------------KSKGDFLAELAIIHRLRHKH  305 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~n  305 (568)
                      ..++|...++||+|+||+||+|+...      ++..||||++.....             ...+.+.+|+.++++++|||
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  107 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKN------GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN  107 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETT------TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTT
T ss_pred             cccceEEEeEecccCCeEEEEEEECC------CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCC
Confidence            46789999999999999999999875      678999999875421             23457889999999999999


Q ss_pred             eeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC
Q 008374          306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA  385 (568)
Q Consensus       306 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~  385 (568)
                      |+++++++.+.+..++|||||++|+|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.
T Consensus       108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~  181 (504)
T 3q5i_A          108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLEN  181 (504)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESS
T ss_pred             CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEec
Confidence            99999999999999999999999999999853   346999999999999999999999   579999999999999987


Q ss_pred             CC---cEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 008374          386 DF---NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ  462 (568)
Q Consensus       386 ~~---~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~  462 (568)
                      ++   .+||+|||+++........      ....||+.|+|||++. +.++.++|||||||++|||++|+.||.......
T Consensus       182 ~~~~~~~kl~Dfg~a~~~~~~~~~------~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  254 (504)
T 3q5i_A          182 KNSLLNIKIVDFGLSSFFSKDYKL------RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD  254 (504)
T ss_dssp             TTCCSSEEECCCTTCEECCTTSCB------CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             CCCCccEEEEECCCCEEcCCCCcc------ccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            75   6999999999877554221      2457999999999986 579999999999999999999999998543322


Q ss_pred             chhhHHHHHHHHhhcCchhhhhhhhcCCCCc--HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          463 HAYTLVDWVWMLHREGHIQDAVDQRLNINSV--VDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       463 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                          +...    ...+.        +.....  ......+.+++..|++.||.+|||++|+++
T Consensus       255 ----~~~~----i~~~~--------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          255 ----IIKK----VEKGK--------YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             ----HHHH----HHHCC--------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----HHHH----HHcCC--------CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                1111    11111        100000  012345677888999999999999999986

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1

Probab=100.00  E-value=2.4e-40  Score=320.44  Aligned_cols=152  Identities=31%  Similarity=0.478  Sum_probs=135.6

Q ss_pred             CCCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCC---C-CCCCCCeeeEecCCccccccc
Q 008374            8 AWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQ---G-FDPDDNHLGLNINSVVSRKNV   83 (568)
Q Consensus         8 ~~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~---~-~d~~~~hvgidins~~s~~~~   83 (568)
                      ....+||||||||+|..+..|.++.||||||+|.+ +++..||+|||||||++|   . |||++|||||||||+.|.+++
T Consensus        81 ~~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~-~~~~~~~~vAVEFDT~~n~~~~~~Dp~~nHVGIdvNs~~S~~~~  159 (239)
T 1dbn_A           81 NPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNS-NSDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTV  159 (239)
T ss_dssp             STTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSS-CCCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEE
T ss_pred             CCCCCCCCEEEEEecCCCCCCcCCCCCcccccccC-CCCccccEEEEEEeccccCcccccCCCCCcEEEecCCccccceE
Confidence            34568999999999987633345899999999976 457789999999999999   6 899999999999999999988


Q ss_pred             cCCCCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCcc--cccccc
Q 008374           84 PLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPH--IQLNCV  161 (568)
Q Consensus        84 ~~~~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~--~~~~~i  161 (568)
                      +|      +|.+|+.++|||+||+.+++|+|+|++.+.  |.+|+|+..+||+++|+++|||||||+||. .  .+.|+|
T Consensus       160 ~~------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~-~~~~~~h~I  230 (239)
T 1dbn_A          160 QW------DWINGGVAFATITYLAPNKTLIASLVYPSN--QTTFSVAASVDLKEILPEWVRVGFSAATGY-PTEVETHDV  230 (239)
T ss_dssp             EC------CCCTTCCEEEEEEEEGGGTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECS-GGGCCCCEE
T ss_pred             cc------cccCCCEEEEEEEEeCCCcEEEEEEccCCC--CCcceEEEEechHHhCCccEEEEEEeccCC-CccceeeEE
Confidence            76      367899999999999999999999998763  667899999999999999999999999997 8  899999


Q ss_pred             cccccccc
Q 008374          162 RSWTLDID  169 (568)
Q Consensus       162 ~sWs~~~~  169 (568)
                      ++|+|+.+
T Consensus       231 lsWsF~s~  238 (239)
T 1dbn_A          231 LSWSFTST  238 (239)
T ss_dssp             EEEEEEEE
T ss_pred             EEEEeEec
Confidence            99999754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.1e-39  Score=337.70  Aligned_cols=263  Identities=21%  Similarity=0.242  Sum_probs=192.6

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      .++|...+.||+|+||.||+|+...      +++.||||++....  ....+.+.+|+.++++++||||+++++++...+
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   97 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAI------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   97 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECC------CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence            4678999999999999999998864      68899999997642  234567889999999999999999999997654


Q ss_pred             ------eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 008374          318 ------KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL  391 (568)
Q Consensus       318 ------~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL  391 (568)
                            ..++||||++ ++|.+++.     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||
T Consensus        98 ~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl  168 (371)
T 2xrw_A           98 SLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI  168 (371)
T ss_dssp             STTTCCEEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred             ccccccceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEE
Confidence                  7899999996 57888873     34889999999999999999999   579999999999999999999999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH--
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD--  469 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~--  469 (568)
                      +|||+++.......      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.+  
T Consensus       169 ~Dfg~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~  242 (371)
T 2xrw_A          169 LDFGLARTAGTSFM------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL  242 (371)
T ss_dssp             CCCCC----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-C
T ss_pred             EEeecccccccccc------cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            99999987654321      1145799999999999999999999999999999999999999975433221000000  


Q ss_pred             ------H-------HHHHhhc------CchhhhhhhhcCC---CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          470 ------W-------VWMLHRE------GHIQDAVDQRLNI---NSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       470 ------~-------~~~~~~~------~~~~~~~d~~l~~---~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                            +       .......      ..+..........   .........+.+++.+|++.||.+|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          243 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                  0       0000000      0000000000000   011223567888999999999999999999987

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.8e-39  Score=333.36  Aligned_cols=267  Identities=25%  Similarity=0.365  Sum_probs=200.5

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEe--
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHE--  315 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--  315 (568)
                      .++|...++||+|+||.||+|+...      +++.||||++.....  .....+.+|+.++++++||||+++++++..  
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   89 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRK------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA   89 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETT------TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred             ccceeEEEEEecCCCcEEEEEEECC------CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence            3579999999999999999999865      688999999865432  234578899999999999999999999987  


Q ss_pred             ------CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcE
Q 008374          316 ------KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA  389 (568)
Q Consensus       316 ------~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~  389 (568)
                            .+..++||||++ ++|.+.+...  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+
T Consensus        90 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~  163 (351)
T 3mi9_A           90 SPYNRCKGSIYLVFDFCE-HDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVL  163 (351)
T ss_dssp             -------CEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred             cccccCCceEEEEEeccC-CCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCE
Confidence                  457899999997 4777777543  245899999999999999999999   5799999999999999999999


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHH
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV  468 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~  468 (568)
                      ||+|||+++.......... .......||+.|+|||++.+ ..++.++|||||||+++||++|+.||.......    ..
T Consensus       164 kl~Dfg~a~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~  238 (351)
T 3mi9_A          164 KLADFGLARAFSLAKNSQP-NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH----QL  238 (351)
T ss_dssp             EECCCTTCEECCCCSSSSC-CCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HH
T ss_pred             EEccchhcccccccccccc-cccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH----HH
Confidence            9999999987654322211 11225678999999999876 457999999999999999999999998644332    11


Q ss_pred             HHHHHHhhc---Cchhhhhhh----hc-----CCCCcHHH------HHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          469 DWVWMLHRE---GHIQDAVDQ----RL-----NINSVVDE------AKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       469 ~~~~~~~~~---~~~~~~~d~----~l-----~~~~~~~~------~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ..+......   ......-..    .+     ......+.      ...+.+++..|++.||++|||++|+++
T Consensus       239 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          239 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            111111110   000000000    00     00001111      234678888999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3e-39  Score=339.54  Aligned_cols=262  Identities=18%  Similarity=0.244  Sum_probs=202.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC--------CCceeeEEE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR--------HKHLVHLVG  311 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~g  311 (568)
                      .++|...++||+|+||+||+|+...      +++.||||++... ....+.+.+|+.++++++        |+||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~  108 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQ------GKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD  108 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecC------CCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence            3679999999999999999998865      6889999999654 334567889999999985        788999999


Q ss_pred             EEE----eCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCEEEcCC
Q 008374          312 WCH----EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQ-KVVHRDLKASNILLDAD  386 (568)
Q Consensus       312 ~~~----~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDikp~NILld~~  386 (568)
                      ++.    .....++||||+ +++|.+++.... ...+++..+..++.||+.||.|||   ++ +|+||||||+|||++.+
T Consensus       109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~  183 (397)
T 1wak_A          109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVN  183 (397)
T ss_dssp             EEEEEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCC
T ss_pred             ceeecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEecc
Confidence            987    456899999999 566666664332 246899999999999999999999   56 99999999999999977


Q ss_pred             C-------------------------------------------------cEEEeecCCccccccccccccccccccCCc
Q 008374          387 F-------------------------------------------------NARLGDFGLARAIENERNSYAEHGLVGVPG  417 (568)
Q Consensus       387 ~-------------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~~~~G  417 (568)
                      +                                                 .+||+|||+++......        ....|
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~--------~~~~g  255 (397)
T 1wak_A          184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--------TEDIQ  255 (397)
T ss_dssp             HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS--------CSCCS
T ss_pred             chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC--------ccCCC
Confidence            5                                                 79999999998765431        14578


Q ss_pred             CCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchh--hHHHHHHHHhhc--------Cch-------
Q 008374          418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY--TLVDWVWMLHRE--------GHI-------  480 (568)
Q Consensus       418 t~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~--~l~~~~~~~~~~--------~~~-------  480 (568)
                      |..|+|||++.+..++.++|||||||++|||++|+.||..........  ............        +..       
T Consensus       256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  335 (397)
T 1wak_A          256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK  335 (397)
T ss_dssp             CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred             CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence            999999999999999999999999999999999999997543322110  111111111110        000       


Q ss_pred             ---------------hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          481 ---------------QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       481 ---------------~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                                     .+.+..  ......+....+.+++.+||+.||++|||++|+++
T Consensus       336 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          336 KGDLKHITKLKPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             TSSBSSCCCCCCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccccccccCCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                           000001  11234567778899999999999999999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-39  Score=338.65  Aligned_cols=262  Identities=20%  Similarity=0.289  Sum_probs=194.4

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeC-
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK-  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-  316 (568)
                      .++|...+.||+|+||.||+|+...      +++.||||++....  ....+.+.+|++++++++||||+++++++... 
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   97 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGR------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   97 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETT------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             cceEEEeEEeeecCCeEEEEEEECC------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence            4678999999999999999999865      68899999996542  23356788999999999999999999999765 


Q ss_pred             -----CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 008374          317 -----GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL  391 (568)
Q Consensus       317 -----~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL  391 (568)
                           ...++||||+ +++|.+++..    ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl  169 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKI  169 (367)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred             ccccCceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEE
Confidence                 3569999999 8899999853    45899999999999999999999   579999999999999999999999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~  470 (568)
                      +|||+++......        ....||..|+|||++.+ ..++.++||||+||+++||++|+.||...........+...
T Consensus       170 ~Dfg~a~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~  241 (367)
T 1cm8_A          170 LDFGLARQADSEM--------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV  241 (367)
T ss_dssp             CCCTTCEECCSSC--------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             Eeeeccccccccc--------CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999998765321        24578999999999877 68999999999999999999999999854432211111110


Q ss_pred             H-------HHHhhcCchhhhhhh--hc-CC---CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          471 V-------WMLHREGHIQDAVDQ--RL-NI---NSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       471 ~-------~~~~~~~~~~~~~d~--~l-~~---~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .       +...........+..  .. ..   .........+.+++.+|++.||.+|||+.|+++
T Consensus       242 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          242 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            0       000000000000000  00 00   001122345677888999999999999999988

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.9e-39  Score=335.71  Aligned_cols=272  Identities=22%  Similarity=0.265  Sum_probs=194.2

Q ss_pred             HHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEE
Q 008374          234 KELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWC  313 (568)
Q Consensus       234 ~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~  313 (568)
                      .+.....++|...++||+|+||.||+|+...      +++.||||++... ......+.+|++.+..++||||+++++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~   88 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKS------TGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYF   88 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETT------TCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECC------CCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhh
Confidence            4566778899999999999999999999875      6789999998654 33455678888999999999999999999


Q ss_pred             EeCCe-------EEEEEEecCCCChhhhhcc-CCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC
Q 008374          314 HEKGK-------LLLVYDFMPNGSLEKYLYG-TSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA  385 (568)
Q Consensus       314 ~~~~~-------~~lV~Ey~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~  385 (568)
                      ...+.       .++||||++++ |...+.. ......+++..+..++.|++.||.|||. ++++|+||||||+|||++.
T Consensus        89 ~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~  166 (360)
T 3e3p_A           89 YTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNE  166 (360)
T ss_dssp             EEECSSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEET
T ss_pred             hccccccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeC
Confidence            76443       89999999764 4443321 1334568899999999999999999993 3679999999999999997


Q ss_pred             -CCcEEEeecCCccccccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q 008374          386 -DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH  463 (568)
Q Consensus       386 -~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~  463 (568)
                       ++.+||+|||+++........      ....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... 
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-  239 (360)
T 3e3p_A          167 ADGTLKLCDFGSAKKLSPSEPN------VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-  239 (360)
T ss_dssp             TTTEEEECCCTTCBCCCTTSCC------CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred             CCCcEEEeeCCCceecCCCCCc------ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-
Confidence             899999999999877644321      145789999999998654 48999999999999999999999998654333 


Q ss_pred             hhhHHHHHHHHhhcC-chhhhhhhh----------------cCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          464 AYTLVDWVWMLHREG-HIQDAVDQR----------------LNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       464 ~~~l~~~~~~~~~~~-~~~~~~d~~----------------l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        .+........... .....+++.                ............+.+++..||+.||.+|||+.|+++
T Consensus       240 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          240 --QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             --HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence              1222111110000 000000000                000111123567788889999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6.9e-40  Score=348.44  Aligned_cols=259  Identities=22%  Similarity=0.282  Sum_probs=194.1

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeC----
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK----  316 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~----  316 (568)
                      .+|...++||+|+||.||+|+...      +++.||||++...    ...+.+|++++++++||||++++++|...    
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~------~~~~vaiK~~~~~----~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  123 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKK  123 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECC------CCcEEEEEEeccc----chhHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence            358888999999999999999875      6889999998653    23355899999999999999999998642    


Q ss_pred             --CeEEEEEEecCCCChhhhhcc-CCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-CcEEEe
Q 008374          317 --GKLLLVYDFMPNGSLEKYLYG-TSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD-FNARLG  392 (568)
Q Consensus       317 --~~~~lV~Ey~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~-~~~kL~  392 (568)
                        ..+++||||+++ +|.+.+.. ......+++..+..++.||++||.|||   +++|+||||||+|||++.+ +.+||+
T Consensus       124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~  199 (420)
T 1j1b_A          124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLC  199 (420)
T ss_dssp             TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEec
Confidence              236799999975 66655532 122356999999999999999999999   6899999999999999965 678999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      |||+++.+......      ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.......   .+.+.+
T Consensus       200 DFG~a~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~---~l~~i~  270 (420)
T 1j1b_A          200 DFGSAKQLVRGEPN------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEII  270 (420)
T ss_dssp             CCTTCEECCTTCCC------CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred             cchhhhhcccCCCc------eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence            99999976543221      145789999999998764 78999999999999999999999998654333   222222


Q ss_pred             HHHhhcCchhhh--hhhh--------cCCC-----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          472 WMLHREGHIQDA--VDQR--------LNIN-----SVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       472 ~~~~~~~~~~~~--~d~~--------l~~~-----~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ...- ......+  .++.        +...     +.......+.+|+.+||+.||.+|||+.|+++
T Consensus       271 ~~lg-~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          271 KVLG-TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHC-SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhC-CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            2110 0000000  0110        0000     01122356778888999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.3e-40  Score=354.56  Aligned_cols=251  Identities=25%  Similarity=0.376  Sum_probs=203.2

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|...++||+|+||.||+|+...      +++.||||++....   ....+.+.+|+.++++++||||+++++++.+.
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   98 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKI------TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK   98 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cCceEEeeEEecCCCEEEEEEEECC------CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            4578999999999999999999875      68899999996543   23456789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---cCCCcEEEee
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL---DADFNARLGD  393 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl---d~~~~~kL~D  393 (568)
                      +..++||||+++|+|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||+   +.++.+||+|
T Consensus        99 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  172 (484)
T 3nyv_A           99 GYFYLVGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIID  172 (484)
T ss_dssp             SEEEEEECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             CEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence            999999999999999999854   346899999999999999999999   5799999999999999   5678999999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      ||+++........      ....||+.|+|||++.+ .++.++|||||||++|||++|+.||.......    +...+  
T Consensus       173 fg~a~~~~~~~~~------~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i--  239 (484)
T 3nyv_A          173 FGLSTHFEASKKM------KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD----ILKKV--  239 (484)
T ss_dssp             TTHHHHBCCCCSH------HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH--
T ss_pred             eeeeEEccccccc------ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH----HHHHH--
Confidence            9999876544321      14579999999999865 79999999999999999999999997543322    11111  


Q ss_pred             HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       474 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        ..+...      ............+..++..|++.||.+|||+.|+++
T Consensus       240 --~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          240 --EKGKYT------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             --HHCCCC------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HcCCCC------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence              111100      000111123345677888999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2e-39  Score=351.40  Aligned_cols=252  Identities=22%  Similarity=0.332  Sum_probs=201.4

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      ..++|...++||+|+||+||+|+...      +++.||||++....  ......+.+|++++++++||||+++++++...
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   93 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRI------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS   93 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETT------TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECC------CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC
Confidence            34679999999999999999999874      68899999986532  23456789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc---CCCcEEEee
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD---ADFNARLGD  393 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld---~~~~~kL~D  393 (568)
                      +..++||||+++|+|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++   .++.+||+|
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  167 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIID  167 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred             CEEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEE
Confidence            999999999999999998853   346899999999999999999999   57999999999999995   456799999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      ||+++........      ....||+.|+|||++.+ .++.++|||||||++|||++|+.||.......    +...+  
T Consensus       168 fg~a~~~~~~~~~------~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i--  234 (486)
T 3mwu_A          168 FGLSTCFQQNTKM------KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILKRV--  234 (486)
T ss_dssp             CSCTTTBCCC----------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH--
T ss_pred             CCcCeECCCCCcc------CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHH--
Confidence            9999876543221      24579999999999865 69999999999999999999999997543322    11111  


Q ss_pred             HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       474 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        ..+...      ............+.+++..||+.||.+|||+.|+++
T Consensus       235 --~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          235 --ETGKYA------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             --HHTCCC------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --HhCCCC------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              111100      000111122345677888999999999999999997

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=7.9e-39  Score=324.50  Aligned_cols=258  Identities=20%  Similarity=0.251  Sum_probs=199.4

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC----cccchhhHHHHHHhhcCCCCceeeEEEEEE-
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS----IKSKGDFLAELAIIHRLRHKHLVHLVGWCH-  314 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~-  314 (568)
                      .++|...+.||+|+||.||++....      +++.||+|.+....    ....+.+.+|+.++++++||||+++++++. 
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSE------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN   77 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTT------TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccceeEeeEEecCCCeEEEEEEECC------CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence            4679999999999999999998764      67899999996542    234567999999999999999999999984 


Q ss_pred             -eCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEee
Q 008374          315 -EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD  393 (568)
Q Consensus       315 -~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~D  393 (568)
                       +.+..++||||++++ |.+++.... ...+++..+..++.|++.||.|||   +++++||||||+|||++.++.+||+|
T Consensus        78 ~~~~~~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~d  152 (305)
T 2wtk_C           78 EEKQKMYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISA  152 (305)
T ss_dssp             C---CEEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             CCCCeEEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeec
Confidence             456899999999876 767665432 346899999999999999999999   57999999999999999999999999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK--ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~--~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      ||+++..........   .....||..|+|||.+.+..  ++.++||||||+++|||++|+.||.......    +.+  
T Consensus       153 fg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~--  223 (305)
T 2wtk_C          153 LGVAEALHPFAADDT---CRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK----LFE--  223 (305)
T ss_dssp             CTTCEECCTTCSSCE---ECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHH--
T ss_pred             cccccccCccccccc---cccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH----HHH--
Confidence            999987654322111   12456999999999987644  3779999999999999999999997543221    111  


Q ss_pred             HHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCCC
Q 008374          472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISGTS  529 (568)
Q Consensus       472 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L~~~~  529 (568)
                        ....+        ..  .........+.+++.+|++.||.+|||++|+++  .+.+..
T Consensus       224 --~i~~~--------~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          224 --NIGKG--------SY--AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH  271 (305)
T ss_dssp             --HHHHC--------CC--CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred             --HHhcC--------CC--CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence              11111        11  111123345667888999999999999999997  455543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.2e-39  Score=328.18  Aligned_cols=271  Identities=20%  Similarity=0.269  Sum_probs=196.4

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEE-----
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCH-----  314 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~-----  314 (568)
                      .++|...+.||+|+||.||+|+...      +++.||+|++........+++.+|++++++++||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   83 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDND------CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ   83 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETT------TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred             CCceeEEEEeccCCCeEEEEEEECC------CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence            3578889999999999999999875      68899999998776666788999999999999999999999873     


Q ss_pred             ---------eCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc-
Q 008374          315 ---------EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD-  384 (568)
Q Consensus       315 ---------~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld-  384 (568)
                               +.+..++||||++ |+|.+++..    ..+++..+..++.|++.||+|||   +++|+||||||+|||++ 
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~  155 (320)
T 2i6l_A           84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINT  155 (320)
T ss_dssp             CCC----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEET
T ss_pred             cccccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcC
Confidence                     4468899999997 799999842    46899999999999999999999   57999999999999997 


Q ss_pred             CCCcEEEeecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q 008374          385 ADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH  463 (568)
Q Consensus       385 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~  463 (568)
                      +++.+||+|||+++..........  ......||..|+|||.+.. ..++.++||||||+++|||++|+.||........
T Consensus       156 ~~~~~kl~Dfg~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  233 (320)
T 2i6l_A          156 EDLVLKIGDFGLARIMDPHYSHKG--HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ  233 (320)
T ss_dssp             TTTEEEECCCTTCBCC----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CCCeEEEccCccccccCCCccccc--ccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            567999999999987654321111  1124467899999998865 6789999999999999999999999985443221


Q ss_pred             hhhHHHH-------HHHHhhcCchhhhhhhhcCCC-Cc-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhC
Q 008374          464 AYTLVDW-------VWMLHREGHIQDAVDQRLNIN-SV-----VDEAKRLLLLGLACSHPIASERPKTEDILQ--IISG  527 (568)
Q Consensus       464 ~~~l~~~-------~~~~~~~~~~~~~~d~~l~~~-~~-----~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L~~  527 (568)
                      ...+..-       .+.... ..+...+....... ..     ......+.+++..|++.||.+|||+.|+++  .++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (320)
T 2i6l_A          234 MQLILESIPVVHEEDRQELL-SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI  311 (320)
T ss_dssp             HHHHHHHSCCCCHHHHHHHH-TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred             HHHHHHhcCCCchhhhhhhh-hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence            1111000       000000 00000011111000 00     112456778888999999999999999987  4554

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.6e-40  Score=345.77  Aligned_cols=254  Identities=12%  Similarity=0.071  Sum_probs=181.7

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHH---HHhhcCCCCceeeEE---
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAEL---AIIHRLRHKHLVHLV---  310 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~H~nIv~l~---  310 (568)
                      ..+|...++||+|+||.||+|+...      +++.||||++.....   ...+.+.+|+   .+|+. +||||++++   
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~  133 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVE------RLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRL  133 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CB
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECC------CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeE
Confidence            3458889999999999999999875      688999999987543   2345677785   45555 799988755   


Q ss_pred             ----EEEEeC-----------------CeEEEEEEecCCCChhhhhccCCCcccCCHHHH------HHHHHHHHHHHHHH
Q 008374          311 ----GWCHEK-----------------GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR------YKILTGVASAVYYL  363 (568)
Q Consensus       311 ----g~~~~~-----------------~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~------~~i~~~ia~~L~yL  363 (568)
                          +++...                 ...+||||||+ |+|.+++...  ...+.+..+      ..++.||+.||+||
T Consensus       134 ~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~L  210 (371)
T 3q60_A          134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANL  210 (371)
T ss_dssp             CCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence                455433                 34899999998 9999999643  223566666      78889999999999


Q ss_pred             HhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCcccccc--CCCCccchhHHH
Q 008374          364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT--GKATPESDVFGF  441 (568)
Q Consensus       364 H~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~t~~sDV~Sf  441 (568)
                      |   +++|+||||||+|||++.++.+||+|||+++.......        ...+|+.|+|||++.+  ..++.++|||||
T Consensus       211 H---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~--------~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl  279 (371)
T 3q60_A          211 Q---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP--------ASSVPVTYAPREFLNASTATFTHALNAWQL  279 (371)
T ss_dssp             H---HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE--------GGGSCGGGCCHHHHTCSEEECCHHHHHHHH
T ss_pred             H---HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc--------CccCCcCCcChhhccCCCCCcCccccHHHH
Confidence            9   57999999999999999999999999999987643221        2356799999999987  679999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHH
Q 008374          442 GAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDI  521 (568)
Q Consensus       442 Gvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~ev  521 (568)
                      ||++|||++|+.||..........         +............+...........+.+++..||+.||++|||+.|+
T Consensus       280 G~il~elltg~~Pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  350 (371)
T 3q60_A          280 GLSIYRVWCLFLPFGLVTPGIKGS---------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA  350 (371)
T ss_dssp             HHHHHHHHHSSCSTTBCCTTCTTC---------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHH
T ss_pred             HHHHHHHHhCCCCCCCcCcccccc---------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            999999999999997542221000         00000001111111111112334567778889999999999999999


Q ss_pred             HH
Q 008374          522 LQ  523 (568)
Q Consensus       522 l~  523 (568)
                      ++
T Consensus       351 l~  352 (371)
T 3q60_A          351 ME  352 (371)
T ss_dssp             TT
T ss_pred             hc
Confidence            74

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.4e-39  Score=345.52  Aligned_cols=204  Identities=25%  Similarity=0.398  Sum_probs=168.4

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeC-
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK-  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-  316 (568)
                      .++|...+.||+|+||.||+|+...      +++.||||++....  ....+.+.+|++++++++||||+++++++... 
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~   98 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKN------TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD   98 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETT------TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECC------CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            4679999999999999999999875      68899999997642  23456789999999999999999999999766 


Q ss_pred             ----CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          317 ----GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       317 ----~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                          +.+++||||+. ++|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus        99 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~  171 (432)
T 3n9x_A           99 LLKFDELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVC  171 (432)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             CCcCCeEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEc
Confidence                57999999995 699999953   346999999999999999999999   5799999999999999999999999


Q ss_pred             ecCCcccccccccccc-----------------ccccccCCcCCcccCcccc-ccCCCCccchhHHHHHHHHHHHhCCCC
Q 008374          393 DFGLARAIENERNSYA-----------------EHGLVGVPGTMGYVAPECF-HTGKATPESDVFGFGAVVLEVVCGRSP  454 (568)
Q Consensus       393 DFGla~~~~~~~~~~~-----------------~~~~~~~~Gt~~y~APE~~-~~~~~t~~sDV~SfGvll~el~tG~~P  454 (568)
                      |||+|+..........                 ........||+.|+|||++ ....++.++|||||||++|||++|..|
T Consensus       172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  251 (432)
T 3n9x_A          172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS  251 (432)
T ss_dssp             CCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred             cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence            9999998754321100                 0112367899999999986 566799999999999999999986555


Q ss_pred             CC
Q 008374          455 GN  456 (568)
Q Consensus       455 ~~  456 (568)
                      +.
T Consensus       252 ~~  253 (432)
T 3n9x_A          252 HI  253 (432)
T ss_dssp             TC
T ss_pred             cc
Confidence            43

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.4e-39  Score=345.15  Aligned_cols=202  Identities=17%  Similarity=0.251  Sum_probs=173.1

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC------CCCceeeEEEEE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL------RHKHLVHLVGWC  313 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~g~~  313 (568)
                      ..+|...++||+|+||.||+|+...      +++.||||++... ....+++.+|+.++..+      +|+||+++++++
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~------~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~  168 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHK------VHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF  168 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETT------TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECC------CCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence            4568999999999999999998875      6889999999754 23345677888888776      577999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc--EEE
Q 008374          314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN--ARL  391 (568)
Q Consensus       314 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~--~kL  391 (568)
                      ...+..++||||+. ++|.+++.... ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.  +||
T Consensus       169 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL  243 (429)
T 3kvw_A          169 TFRNHICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKV  243 (429)
T ss_dssp             EETTEEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEE
T ss_pred             ccCCeEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEE
Confidence            99999999999995 69999886543 235899999999999999999999   569999999999999999987  999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQ  461 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~  461 (568)
                      +|||+++......        ....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       244 ~DFG~a~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~  305 (429)
T 3kvw_A          244 IDFGSSCYEHQRV--------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG  305 (429)
T ss_dssp             CCCTTCEETTCCC--------CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             eecccceecCCcc--------cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence            9999997654321        1457899999999999999999999999999999999999999865443

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A*

Probab=100.00  E-value=3.3e-40  Score=318.72  Aligned_cols=149  Identities=34%  Similarity=0.551  Sum_probs=133.1

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC-CCCCCCeeeEecCCccccccccCCC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG-FDPDDNHLGLNINSVVSRKNVPLKD   87 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~-~d~~~~hvgidins~~s~~~~~~~~   87 (568)
                      ...+||||||||+|.... + ++.||||||+|.+ +++..||+|||||||++|. |||++|||||||||+.|.++++|  
T Consensus        82 ~~~~gdGlAF~l~p~~~~-~-~~~g~~LGl~n~~-~~~~~~~~vAVEFDT~~n~~~Dp~~nHVGIdvNsi~S~~~~~~--  156 (237)
T 1fny_A           82 PATTADGLAFFLAPVDTQ-P-LDLGGMLGIFKDG-YFNKSNQIVAVEFDTFSNGDWDPKGRHLGINVNSIESIKTVPW--  156 (237)
T ss_dssp             TTSCCEEEEEEEEETTCC-C-CCCGGGTTTCC----CCTTSCCEEEEEECSCCTTTCCSSSEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCCEEEEeccCCCC-C-CCCCCcccccccC-CCCccccEEEEEeecccCcccCCCCCceEEecCCccccccccc--
Confidence            456899999999998664 4 3899999999976 4577999999999999998 99999999999999999998886  


Q ss_pred             CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCcc---ccccccccc
Q 008374           88 NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPH---IQLNCVRSW  164 (568)
Q Consensus        88 ~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~---~~~~~i~sW  164 (568)
                          +|.+|+.++|||+||+.+++|+|+|++.+.  |.+|+|+..+||+++|+++|||||||+||. .   .+.|++++|
T Consensus       157 ----~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~-~~~~~~~h~IlsW  229 (237)
T 1fny_A          157 ----NWTNGEVANVFISYEASTKSLTASLVYPSL--ETSFIIDAIVDVKIVLPEWVRFGFSATTGI-DKGYVQTNDVLSW  229 (237)
T ss_dssp             ----CCCTTCCEEEEEEEEGGGTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECS-STTCCCCCEEEEE
T ss_pred             ----cccCCCEEEEEEEEeCCCcEEEEEEecCCC--CCcceEEEEechHHhCCCcEEEEEEEeeCC-CCcccceeEEEEE
Confidence                367899999999999999999999998763  667899999999999999999999999997 7   899999999


Q ss_pred             ccccc
Q 008374          165 TLDID  169 (568)
Q Consensus       165 s~~~~  169 (568)
                      +|+..
T Consensus       230 sF~s~  234 (237)
T 1fny_A          230 SFESN  234 (237)
T ss_dssp             EEEEE
T ss_pred             EEEEe
Confidence            99865

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.6e-39  Score=336.69  Aligned_cols=270  Identities=21%  Similarity=0.230  Sum_probs=199.2

Q ss_pred             cCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc-----------chhhHHHHHHhh
Q 008374          231 FKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-----------KGDFLAELAIIH  299 (568)
Q Consensus       231 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~  299 (568)
                      ...+++....++|...+.||+|+||.||+|+..       .+..||||++.......           .+.+.+|+++++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   84 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN   84 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECT-------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECC-------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHH
Confidence            345678888999999999999999999999875       57899999986532211           267899999999


Q ss_pred             cCCCCceeeEEEEEEeC-----CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 008374          300 RLRHKHLVHLVGWCHEK-----GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHR  374 (568)
Q Consensus       300 ~l~H~nIv~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  374 (568)
                      +++||||+++++++...     ...++||||++ |+|.+++...  ...+++..+..++.|++.||.|||   +++|+||
T Consensus        85 ~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~  158 (362)
T 3pg1_A           85 HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLH---EAGVVHR  158 (362)
T ss_dssp             HCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred             hCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCcCEec
Confidence            99999999999998543     36899999997 6888888643  346899999999999999999999   5699999


Q ss_pred             CCCCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCC
Q 008374          375 DLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRS  453 (568)
Q Consensus       375 Dikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~  453 (568)
                      ||||+|||++.++.+||+|||+++........      ....||..|+|||.+.+ ..++.++|||||||++|||++|+.
T Consensus       159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~  232 (362)
T 3pg1_A          159 DLHPGNILLADNNDITICDFNLAREDTADANK------THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA  232 (362)
T ss_dssp             CCCGGGEEECTTCCEEECCTTC---------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCChHHEEEcCCCCEEEEecCccccccccccc------ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCC
Confidence            99999999999999999999999865443221      14578999999999876 678999999999999999999999


Q ss_pred             CCCCCCcccchhhHHHHHHHHhhcCchh-----------hhhhhhcCC---C----CcHHHHHHHHHHHHhcCCCCCCCC
Q 008374          454 PGNMIPHQQHAYTLVDWVWMLHREGHIQ-----------DAVDQRLNI---N----SVVDEAKRLLLLGLACSHPIASER  515 (568)
Q Consensus       454 P~~~~~~~~~~~~l~~~~~~~~~~~~~~-----------~~~d~~l~~---~----~~~~~~~~l~~l~l~Cl~~dp~~R  515 (568)
                      ||...........+.    .........           +.+...+..   .    ........+.+++..|++.||.+|
T Consensus       233 pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  308 (362)
T 3pg1_A          233 LFRGSTFYNQLNKIV----EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR  308 (362)
T ss_dssp             SCCCSSHHHHHHHHH----HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGS
T ss_pred             CCCCCCHHHHHHHHH----HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhC
Confidence            998544322111111    111111110           011011000   0    001123457788889999999999


Q ss_pred             CCHHHHHH
Q 008374          516 PKTEDILQ  523 (568)
Q Consensus       516 Pt~~evl~  523 (568)
                      ||+.|+++
T Consensus       309 pt~~ell~  316 (362)
T 3pg1_A          309 ISTEQALR  316 (362)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHHc
Confidence            99999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-39  Score=364.92  Aligned_cols=259  Identities=24%  Similarity=0.380  Sum_probs=204.5

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ..++|...+.||+|+||.||+|++...+.   .+..||||++.... ....+.|.+|+.++++++||||+++++++. .+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPEN---PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN  463 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSS---CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCC---ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            34678888999999999999999864321   46789999987643 334467999999999999999999999985 46


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCC
Confidence            789999999999999999643  246899999999999999999999   579999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      +..........    ....+|+.|+|||.+....++.++||||||+++|||++ |+.||.......    +...+.    
T Consensus       539 ~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~----~~~~i~----  606 (656)
T 2j0j_A          539 RYMEDSTYYKA----SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRIE----  606 (656)
T ss_dssp             CSCCC--------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHH----
T ss_pred             eecCCCcceec----cCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHH----
Confidence            87754332211    13457889999999998999999999999999999997 999997543322    111111    


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      .+         .....+......+..++..||+.||.+|||+.|+++.|+.
T Consensus       607 ~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~  648 (656)
T 2j0j_A          607 NG---------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  648 (656)
T ss_dssp             HT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cC---------CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            11         1111222334567788889999999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.8e-39  Score=334.28  Aligned_cols=259  Identities=22%  Similarity=0.324  Sum_probs=202.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCccc---c--------------hhhHHHHHHhhcCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS---K--------------GDFLAELAIIHRLR  302 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~---~--------------~~~~~E~~~l~~l~  302 (568)
                      .++|...+.||+|+||.||+|..        +++.||||.+.......   .              +.+.+|+.++.+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  101 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK  101 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence            46799999999999999999987        47899999986542211   1              77999999999999


Q ss_pred             CCceeeEEEEEEeCCeEEEEEEecCCCChhhh------hccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 008374          303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKY------LYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDL  376 (568)
Q Consensus       303 H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~------L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDi  376 (568)
                      ||||+++++++.+.+..++||||+++++|.++      +... ....+++..+..++.|++.||.|||.  .++++||||
T Consensus       102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl  178 (348)
T 2pml_X          102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDV  178 (348)
T ss_dssp             CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCC
T ss_pred             CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCC
Confidence            99999999999999999999999999999999      5332 24679999999999999999999994  279999999


Q ss_pred             CCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccC-CCCc-cchhHHHHHHHHHHHhCCCC
Q 008374          377 KASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATP-ESDVFGFGAVVLEVVCGRSP  454 (568)
Q Consensus       377 kp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~-~sDV~SfGvll~el~tG~~P  454 (568)
                      ||+|||++.++.+||+|||+++.......       ....||..|+|||.+.+. .++. ++||||||+++|||++|+.|
T Consensus       179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  251 (348)
T 2pml_X          179 KPSNILMDKNGRVKLSDFGESEYMVDKKI-------KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP  251 (348)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECBTTEE-------CSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ChHhEEEcCCCcEEEeccccccccccccc-------cCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999987654311       246799999999999877 6666 99999999999999999999


Q ss_pred             CCCCCcccchhhHHHHHHHHhhcCchhhhhh------hhc---CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          455 GNMIPHQQHAYTLVDWVWMLHREGHIQDAVD------QRL---NINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       455 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d------~~l---~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      |.......   .+...    ...+......+      +..   ...........+.+++..||+.||.+|||+.|+++
T Consensus       252 f~~~~~~~---~~~~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          252 FSLKISLV---ELFNN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             SCCSSCSH---HHHHH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCCcHH---HHHHH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            98543322   11111    11111100000      000   00001223456778888999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.7e-39  Score=342.44  Aligned_cols=259  Identities=20%  Similarity=0.255  Sum_probs=193.3

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe--
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK--  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~--  318 (568)
                      .+|...++||+|+||.||+|+..       .+..+|+|++....    ....+|+++++.++||||+++++++...+.  
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~-------~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  108 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLV-------ESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKK  108 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEET-------TTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred             ceEEEeEEEeeCCCeEEEEEEEC-------CCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence            46888999999999999999986       34559999886432    234479999999999999999999965443  


Q ss_pred             ----EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc-CCCcEEEee
Q 008374          319 ----LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD-ADFNARLGD  393 (568)
Q Consensus       319 ----~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld-~~~~~kL~D  393 (568)
                          +++||||++++.+............+++..+..++.|+++||.|||   +++|+||||||+|||++ .++.+||+|
T Consensus       109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~D  185 (394)
T 4e7w_A          109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLID  185 (394)
T ss_dssp             SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred             CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEee
Confidence                8899999987554443322223457899999999999999999999   57999999999999999 799999999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      ||+++........      ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.......   .+.....
T Consensus       186 FG~a~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~l~~i~~  256 (394)
T 4e7w_A          186 FGSAKILIAGEPN------VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID---QLVEIIK  256 (394)
T ss_dssp             CTTCEECCTTCCC------CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH
T ss_pred             CCCcccccCCCCC------cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHH
Confidence            9999876543322      145789999999998764 58999999999999999999999998654433   2222211


Q ss_pred             HHhhcCchhh--hhhhhc--------CCC-----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          473 MLHREGHIQD--AVDQRL--------NIN-----SVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       473 ~~~~~~~~~~--~~d~~l--------~~~-----~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .. .......  ..++..        ...     +.......+.+++..||+.||.+|||+.|+++
T Consensus       257 ~~-g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          257 VL-GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HH-CCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             Hh-CCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            11 0000000  000000        000     01113346778888999999999999999987

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.7e-39  Score=333.36  Aligned_cols=265  Identities=22%  Similarity=0.268  Sum_probs=201.8

Q ss_pred             HhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeC-
Q 008374          239 ATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK-  316 (568)
Q Consensus       239 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-  316 (568)
                      ..++|...++||+|+||.||+|+...      ++..||||++.... ....+.+.+|++++.+++||||+++++++... 
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   98 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNL------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT   98 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECC------CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence            34679999999999999999998865      68899999997543 23346789999999999999999999999765 


Q ss_pred             ----CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          317 ----GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       317 ----~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                          ...++||||+. |+|.+++..    ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+
T Consensus        99 ~~~~~~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~  170 (364)
T 3qyz_A           99 IEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKIC  170 (364)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             ccccceEEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEE
Confidence                47899999996 699998843    35899999999999999999999   5799999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      |||+++..........  ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...........+.   
T Consensus       171 Dfg~a~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---  245 (364)
T 3qyz_A          171 DFGLARVADPDHDHTG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---  245 (364)
T ss_dssp             CCTTCEECCGGGCBCC--TTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH---
T ss_pred             eCcceEecCCCCCccc--cccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH---
Confidence            9999987754432211  1125679999999998654 458999999999999999999999998654433111111   


Q ss_pred             HHHhhcCchh-----------hhhhhhc-CCCCc-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          472 WMLHREGHIQ-----------DAVDQRL-NINSV-----VDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       472 ~~~~~~~~~~-----------~~~d~~l-~~~~~-----~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       .........           ....... .....     ......+.+++..|++.||.+|||+.|+++
T Consensus       246 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          246 -GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             -HHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             111000000           0000000 00000     112345678888999999999999999987

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.5e-38  Score=331.89  Aligned_cols=267  Identities=17%  Similarity=0.246  Sum_probs=203.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-----------CCceeeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-----------HKHLVHL  309 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l  309 (568)
                      ++|...++||+|+||.||+|+...      +++.||||++... ....+.+.+|+.++.+++           ||||+++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMV------NNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CeEEEEEeeeecCCeEEEEEEecC------CCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            578999999999999999999864      6889999999653 234567889999999886           8999999


Q ss_pred             EEEEEeCC----eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCEEEc
Q 008374          310 VGWCHEKG----KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQ-KVVHRDLKASNILLD  384 (568)
Q Consensus       310 ~g~~~~~~----~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDikp~NILld  384 (568)
                      ++++...+    ..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||   ++ +|+||||||+|||++
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~  166 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLME  166 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEE
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEe
Confidence            99998654    789999999 999999996532 245899999999999999999999   56 999999999999994


Q ss_pred             ------CCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008374          385 ------ADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMI  458 (568)
Q Consensus       385 ------~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~  458 (568)
                            ..+.+||+|||+++......        ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       167 ~~~~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  238 (373)
T 1q8y_A          167 IVDSPENLIQIKIADLGNACWYDEHY--------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  238 (373)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTBCC--------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             ccCCCcCcceEEEcccccccccCCCC--------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence                  44589999999998765432        1457899999999999999999999999999999999999999844


Q ss_pred             Ccccch---hhHHHHHHHHhhc--------Cc----------------------hhhhhhhhcCCCCcHHHHHHHHHHHH
Q 008374          459 PHQQHA---YTLVDWVWMLHRE--------GH----------------------IQDAVDQRLNINSVVDEAKRLLLLGL  505 (568)
Q Consensus       459 ~~~~~~---~~l~~~~~~~~~~--------~~----------------------~~~~~d~~l~~~~~~~~~~~l~~l~l  505 (568)
                      ......   ..+.... .....        +.                      +.+.+..  ...........+.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~  315 (373)
T 1q8y_A          239 EGHSYTKDDDHIAQII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLS  315 (373)
T ss_dssp             ------CHHHHHHHHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHG
T ss_pred             cccccCChHHHHHHHH-HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHH
Confidence            321100   0111111 10000        00                      0011111  12344567788899999


Q ss_pred             hcCCCCCCCCCCHHHHHH--HHhCCCC
Q 008374          506 ACSHPIASERPKTEDILQ--IISGTST  530 (568)
Q Consensus       506 ~Cl~~dp~~RPt~~evl~--~L~~~~~  530 (568)
                      .||+.||.+|||+.|+++  .+.+...
T Consensus       316 ~~L~~dP~~Rpt~~ell~hp~f~~~~~  342 (373)
T 1q8y_A          316 PMLQLDPRKRADAGGLVNHPWLKDTLG  342 (373)
T ss_dssp             GGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred             HHhccCccccCCHHHHhhChhhhcccC
Confidence            999999999999999987  4554433

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3e-38  Score=340.71  Aligned_cols=264  Identities=17%  Similarity=0.226  Sum_probs=205.7

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCC-CceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRH-KHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~  318 (568)
                      .++|...++||+|+||.||+|+...      +++.||||++....  ...++..|++++..++| +++..+..++...+.
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~   77 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQ------TNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDY   77 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETT------TCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECC------CCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence            3678999999999999999999764      68899999886543  34568999999999987 566677777788889


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---cCCCcEEEeecC
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL---DADFNARLGDFG  395 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl---d~~~~~kL~DFG  395 (568)
                      .+|||||+ +++|.+++...  ...+++..++.++.||+.||.|||   +++|+||||||+||||   +.++.+||+|||
T Consensus        78 ~~lvme~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG  151 (483)
T 3sv0_A           78 NVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (483)
T ss_dssp             EEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             EEEEEECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCC
Confidence            99999999 99999999643  346999999999999999999999   5799999999999999   688999999999


Q ss_pred             Ccccccccccccc--ccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          396 LARAIENERNSYA--EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       396 la~~~~~~~~~~~--~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      +++.+........  ........||..|+|||++.+..++.++|||||||++|||++|+.||...........+.. +..
T Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-i~~  230 (483)
T 3sv0_A          152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK-ISE  230 (483)
T ss_dssp             TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH-HHH
T ss_pred             cceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH-Hhh
Confidence            9998765432111  0112256799999999999999999999999999999999999999986543321111111 111


Q ss_pred             HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       474 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      ......+..+.     .    .....+.+++..||+.+|++||++.+|+++|+.
T Consensus       231 ~~~~~~~~~l~-----~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~  275 (483)
T 3sv0_A          231 KKVATSIEALC-----R----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD  275 (483)
T ss_dssp             HHHHSCHHHHH-----T----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             ccccccHHHHh-----c----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            11001111100     1    123467788889999999999999999998875

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.2e-39  Score=336.29  Aligned_cols=258  Identities=21%  Similarity=0.299  Sum_probs=183.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeC-
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK-  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-  316 (568)
                      .++|...+.||+|+||.||+|+...      +++.||||++....  ....+.+.+|+.++++++||||+++++++... 
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  101 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTK------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR  101 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETT------TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CCceEEeeEEeecCCeEEEEEEECC------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            4678999999999999999998765      68899999997542  23456788999999999999999999998754 


Q ss_pred             -----CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 008374          317 -----GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL  391 (568)
Q Consensus       317 -----~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL  391 (568)
                           ...++|+||+ +++|.+++..    ..+++..+..++.|+++||.|||   +++|+||||||+|||++.++.+||
T Consensus       102 ~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL  173 (367)
T 2fst_X          102 SLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI  173 (367)
T ss_dssp             SGGGCCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             ccccCCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEE
Confidence                 5689999999 7899998843    46999999999999999999999   579999999999999999999999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~  470 (568)
                      +|||+++......        ....||..|+|||++.+ ..++.++|||||||+++||++|+.||.......   .+ ..
T Consensus       174 ~DFG~a~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l-~~  241 (367)
T 2fst_X          174 LDFGLARHTADEM--------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QL-KL  241 (367)
T ss_dssp             CC-----------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH-HH
T ss_pred             eeccccccccccC--------CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH-HH
Confidence            9999998754321        14578999999999876 678999999999999999999999997544322   11 11


Q ss_pred             HHHHhhcC-----------chhhhhhhhcC-CCCcH-----HHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          471 VWMLHREG-----------HIQDAVDQRLN-INSVV-----DEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       471 ~~~~~~~~-----------~~~~~~d~~l~-~~~~~-----~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      +.......           .....+..... .....     .....+.+++.+|++.||.+|||+.|+++
T Consensus       242 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          242 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            11111000           00000000000 00000     11345677888999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1e-38  Score=333.83  Aligned_cols=258  Identities=21%  Similarity=0.283  Sum_probs=195.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      .++|...+.||+|+||.||+|+...      +++.||||++.....  ...+.+.+|+.++++++||||+++++++...+
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  114 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKR------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS  114 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             cccEEEEeEEecCCCeEEEEEEECC------CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence            4678889999999999999999875      688999999976432  23567889999999999999999999998776


Q ss_pred             eE------EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 008374          318 KL------LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL  391 (568)
Q Consensus       318 ~~------~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL  391 (568)
                      ..      ++||||+. ++|.+++.     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||
T Consensus       115 ~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL  185 (371)
T 4exu_A          115 SLRNFYDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKI  185 (371)
T ss_dssp             SSTTCCCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEE
T ss_pred             CcccceeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEE
Confidence            54      99999996 78988872     34899999999999999999999   569999999999999999999999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~  470 (568)
                      +|||+++......        ....||+.|+|||++.+ ..++.++|||||||+++||++|+.||.......   .+...
T Consensus       186 ~Dfg~a~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i  254 (371)
T 4exu_A          186 LDFGLARHADAEM--------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQI  254 (371)
T ss_dssp             CSTTCC----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH
T ss_pred             EecCcccccccCc--------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHH
Confidence            9999998664432        14578999999999877 788999999999999999999999998544332   11111


Q ss_pred             HHHHhhcC---------c-hhhhhhhh---cCCCC---cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          471 VWMLHREG---------H-IQDAVDQR---LNINS---VVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       471 ~~~~~~~~---------~-~~~~~d~~---l~~~~---~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ........         . ........   .....   .......+.+++..|++.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          255 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            11000000         0 00000000   00000   0112456778888999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=9.6e-40  Score=333.03  Aligned_cols=262  Identities=20%  Similarity=0.317  Sum_probs=198.5

Q ss_pred             cccCHHHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCC--CC
Q 008374          229 REFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLR--HK  304 (568)
Q Consensus       229 ~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~  304 (568)
                      +.+.++.+....++|...+.||+|+||.||+++..       +++.||||.+....  ....+.+.+|+.++.+++  ||
T Consensus        16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~   88 (313)
T 3cek_A           16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD   88 (313)
T ss_dssp             ----CCEEEETTEEEEEEEEEECCSSEEEEEEECT-------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCT
T ss_pred             CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCC
Confidence            34445555556678999999999999999999875       57889999987543  334577899999999997  59


Q ss_pred             ceeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc
Q 008374          305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD  384 (568)
Q Consensus       305 nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld  384 (568)
                      ||+++++++...+..++||| +.+++|.+++..   ...+++..+..++.|+++||.|||   +++|+||||||+|||++
T Consensus        89 ~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~  161 (313)
T 3cek_A           89 KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV  161 (313)
T ss_dssp             TBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE
T ss_pred             ceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEE
Confidence            99999999999999999999 568999999954   346899999999999999999999   56999999999999996


Q ss_pred             CCCcEEEeecCCccccccccccccccccccCCcCCcccCcccccc-----------CCCCccchhHHHHHHHHHHHhCCC
Q 008374          385 ADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-----------GKATPESDVFGFGAVVLEVVCGRS  453 (568)
Q Consensus       385 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----------~~~t~~sDV~SfGvll~el~tG~~  453 (568)
                      + +.+||+|||+++..........   .....||+.|+|||.+..           ..++.++||||||+++|||++|+.
T Consensus       162 ~-~~~kL~Dfg~~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~  237 (313)
T 3cek_A          162 D-GMLKLIDFGIANQMQPDTTSVV---KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT  237 (313)
T ss_dssp             T-TEEEECCCSSSCC-----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             C-CeEEEeeccccccccCcccccc---ccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCC
Confidence            5 8999999999987754322111   114568999999999865           478889999999999999999999


Q ss_pred             CCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          454 PGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       454 P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ||.......      ..         +...++..............+.+++..||+.||.+|||+.|+++
T Consensus       238 pf~~~~~~~------~~---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          238 PFQQIINQI------SK---------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             TTTTCCSHH------HH---------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhhHHHHH------HH---------HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            997443221      11         11122222222222222346677888999999999999999986

>1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A*

Probab=100.00  E-value=1.4e-39  Score=315.31  Aligned_cols=152  Identities=28%  Similarity=0.448  Sum_probs=136.2

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCC----CCCCCCCCCeeeEecCCcccccccc
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTV----KQGFDPDDNHLGLNINSVVSRKNVP   84 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~----~~~~d~~~~hvgidins~~s~~~~~   84 (568)
                      ...+||||||||+|.....|.++.||||||+|.++ ++..||+|||||||+    +|.|||++|||||||||+.|.++++
T Consensus        81 ~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~~~~~N~~Dp~~nHVGIdvNs~~S~~~~~  159 (242)
T 1qnw_A           81 KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD-SKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVK  159 (242)
T ss_dssp             SSCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSS-CCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEEE
T ss_pred             CCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEeecccccccCCCCCCCCcEEEecCCccccceec
Confidence            35689999999999775334458999999999764 577899999999999    9889999999999999999999887


Q ss_pred             CCCCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCcc--ccccccc
Q 008374           85 LKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPH--IQLNCVR  162 (568)
Q Consensus        85 ~~~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~--~~~~~i~  162 (568)
                      |      +|.+|+.++|||+||+.+++|+|+|++.+.  |.+|+|+..+||+.+|++++||||||+||. .  .+.|+|+
T Consensus       160 ~------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~-~~~~~~h~Il  230 (242)
T 1qnw_A          160 W------DWRNGEVADVVITYRAPTKSLTVCLSYPSD--GTSNIITASVDLKAILPEWVSVGFSGGVGN-AAEFETHDVL  230 (242)
T ss_dssp             C------CCCTTCCEEEEEEEEGGGTEEEEEEECTTT--CCEEEEEEECCHHHHSCSEEEEEEEEEESC-GGGCBCCEEE
T ss_pred             c------cccCCCEEEEEEEEeCCCcEEEEEEecCCC--CcceeEEEeechHHhcCCceEEEEEeccCC-CccceEEEEE
Confidence            6      367899999999999999999999998763  678999999999999999999999999997 8  8999999


Q ss_pred             cccccccc
Q 008374          163 SWTLDIDV  170 (568)
Q Consensus       163 sWs~~~~~  170 (568)
                      +|+|....
T Consensus       231 sWsF~s~l  238 (242)
T 1qnw_A          231 SWYFTSNL  238 (242)
T ss_dssp             EEEEEEEC
T ss_pred             EEEeEeec
Confidence            99998764

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.1e-38  Score=330.49  Aligned_cols=206  Identities=20%  Similarity=0.277  Sum_probs=174.6

Q ss_pred             HHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-CC-----ceeeEE
Q 008374          237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-HK-----HLVHLV  310 (568)
Q Consensus       237 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~  310 (568)
                      ....++|...++||+|+||+||+|+...      +++.||||++... ....+++..|+.++..++ |+     +|++++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRV------EQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETT------TTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcC------CCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            3456789999999999999999999875      6789999999753 233556778888888774 44     499999


Q ss_pred             EEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc--CCCc
Q 008374          311 GWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD--ADFN  388 (568)
Q Consensus       311 g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld--~~~~  388 (568)
                      +++...+..++||||++ |+|.+++.... ...+++..+..++.|++.||.|||.. ..+|+||||||+|||++  .++.
T Consensus       123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~  199 (382)
T 2vx3_A          123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSA  199 (382)
T ss_dssp             EEEEETTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCC
T ss_pred             eeeccCCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCc
Confidence            99999999999999995 59999986543 23589999999999999999999942 57999999999999994  5788


Q ss_pred             EEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 008374          389 ARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPH  460 (568)
Q Consensus       389 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~  460 (568)
                      +||+|||+++......        ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       200 ~kL~DFG~a~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          200 IKIVDFGSSCQLGQRI--------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             EEECCCTTCEETTCCC--------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEEEeccCceeccccc--------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999998764321        145789999999999999999999999999999999999999986543

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1

Probab=100.00  E-value=1.9e-39  Score=313.32  Aligned_cols=149  Identities=27%  Similarity=0.497  Sum_probs=134.6

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecCCccccccccCCCC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKDN   88 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidins~~s~~~~~~~~~   88 (568)
                      ...+||||||||+|....| . +.||||||+|.+ +++..||+|||||||++|.|||++||||||+||+.|.++.+|   
T Consensus        80 ~~~~gdGlAF~l~p~~~~p-~-~~g~~LGl~n~~-~~~~~n~~vAVEFDT~~N~~Dp~~nHvGIdvns~~S~~~~~~---  153 (233)
T 1n47_A           80 AAAVADGLAFFLAPPDTQP-Q-ARGGFLGLFADR-AHDASYQTVAVEFDTYSNAWDPNYTHIGIDTNGIESKKTTPF---  153 (233)
T ss_dssp             TTSCCEEEEEEEECTTCCC-C-CCGGGTTTCSSS-SCCGGGCCEEEEEECSCCTTSCSSCEEEEEESSSSCSEEEEC---
T ss_pred             CCCCCCcEEEEEecCCCCC-C-CCCCcccccccC-CCCccCceEEEEeccccCCCCCCCCcEEEccCCccccccccc---
Confidence            4568999999999987764 3 889999999976 457889999999999999999999999999999999998876   


Q ss_pred             cccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCcc---cccccccccc
Q 008374           89 YNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPH---IQLNCVRSWT  165 (568)
Q Consensus        89 ~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~---~~~~~i~sWs  165 (568)
                         +|.+|+.++|||+||+.+++|+|+|++.+.  +++|+|+..+||+.+|++++||||||+||. .   .+.|++++|+
T Consensus       154 ---~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~~~~~vGFSAsTG~-~~~~~~~h~IlsWs  227 (233)
T 1n47_A          154 ---DMVYGEKANIVITYQASTKALAASLVFPVS--QTSYAVSARVDLRDILPEYVRVGFSATTGL-NAGVVETHDIVSWS  227 (233)
T ss_dssp             ---CCCTTSCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCGGGTSCSEEEEEEEEEECS-STTCCCCCEEEEEE
T ss_pred             ---cccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeccCC-CccccceeEEEEEE
Confidence               367899999999999999999999998764  357899999999999999999999999997 7   8999999999


Q ss_pred             cccc
Q 008374          166 LDID  169 (568)
Q Consensus       166 ~~~~  169 (568)
                      |+..
T Consensus       228 F~s~  231 (233)
T 1n47_A          228 FAVS  231 (233)
T ss_dssp             EEEE
T ss_pred             EEee
Confidence            9764

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.8e-38  Score=325.88  Aligned_cols=260  Identities=21%  Similarity=0.281  Sum_probs=201.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCc------eeeEEEEE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKH------LVHLVGWC  313 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~~  313 (568)
                      .++|...++||+|+||.||+|+...     .+++.||||++... ....+.+.+|+.++..++|+|      ++++++++
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHK-----AGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT-----TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecC-----CCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            3578999999999999999998742     15789999999654 234567889999999887654      99999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC--------
Q 008374          314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA--------  385 (568)
Q Consensus       314 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~--------  385 (568)
                      ...+..++||||+ +++|.+++.... ...+++..+..++.|++.||.|||   +++|+||||||+|||++.        
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccC
Confidence            9999999999999 899999986532 236889999999999999999999   579999999999999987        


Q ss_pred             -----------CCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 008374          386 -----------DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP  454 (568)
Q Consensus       386 -----------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P  454 (568)
                                 ++.+||+|||+++......        ....||+.|+|||.+.+..++.++|||||||++|||++|+.|
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  233 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDEHH--------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV  233 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTSCC--------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CccccccccccCCCceEeeCcccccCcccc--------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence                       6689999999998654321        145789999999999999999999999999999999999999


Q ss_pred             CCCCCcccchhhHHHHHHHHhhcCchhhhh--------------------------hhh---c--CCCCcHHHHHHHHHH
Q 008374          455 GNMIPHQQHAYTLVDWVWMLHREGHIQDAV--------------------------DQR---L--NINSVVDEAKRLLLL  503 (568)
Q Consensus       455 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--------------------------d~~---l--~~~~~~~~~~~l~~l  503 (568)
                      |.......   .+ .........- -....                          ...   +  ...........+.++
T Consensus       234 f~~~~~~~---~~-~~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  308 (339)
T 1z57_A          234 FPTHDSKE---HL-AMMERILGPL-PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL  308 (339)
T ss_dssp             CCCSCHHH---HH-HHHHHHHCSC-CHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHH
T ss_pred             CCCCChHH---HH-HHHHHHhCCC-CHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHH
Confidence            97543322   11 1111110000 00000                          000   0  011123456778899


Q ss_pred             HHhcCCCCCCCCCCHHHHHH
Q 008374          504 GLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       504 ~l~Cl~~dp~~RPt~~evl~  523 (568)
                      +..|++.||.+|||+.|+++
T Consensus       309 i~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          309 IQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHhCcCcccccCHHHHhc
Confidence            99999999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.9e-39  Score=334.77  Aligned_cols=266  Identities=21%  Similarity=0.297  Sum_probs=199.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeC--
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK--  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--  316 (568)
                      .++|...+.||+|+||.||+|+...      +++.||||++.... ......+.+|+.++++++||||+++++++...  
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   83 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKP------TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSF   83 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECC------CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence            4679999999999999999999874      68899999996543 23456788999999999999999999998764  


Q ss_pred             ---CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEee
Q 008374          317 ---GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGD  393 (568)
Q Consensus       317 ---~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~D  393 (568)
                         ...++||||+. ++|.+++..    ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|
T Consensus        84 ~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~D  155 (353)
T 2b9h_A           84 ENFNEVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCD  155 (353)
T ss_dssp             TTCCCEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECC
T ss_pred             CccceEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEe
Confidence               68999999996 699998853    46899999999999999999999   57999999999999999999999999


Q ss_pred             cCCcccccccccccc-----ccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhH
Q 008374          394 FGLARAIENERNSYA-----EHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTL  467 (568)
Q Consensus       394 FGla~~~~~~~~~~~-----~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l  467 (568)
                      ||+++..........     ........||+.|+|||.+.. ..++.++|||||||++|||++|+.||.......   .+
T Consensus       156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~  232 (353)
T 2b9h_A          156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QL  232 (353)
T ss_dssp             CTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH
T ss_pred             cccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HH
Confidence            999987754321110     011224578999999998754 778999999999999999999999998544322   11


Q ss_pred             HHHHHHHhhcCc------------hhhhhhhhcC-CCC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          468 VDWVWMLHREGH------------IQDAVDQRLN-INS-----VVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       468 ~~~~~~~~~~~~------------~~~~~d~~l~-~~~-----~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .. .........            ..+.+..... ...     .......+.+++..|++.||++|||+.|+++
T Consensus       233 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          233 LL-IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HH-HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HH-HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            11 111110000            0000000000 000     0122345678888999999999999999987

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.5e-39  Score=323.10  Aligned_cols=256  Identities=24%  Similarity=0.379  Sum_probs=192.8

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEe----
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE----  315 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----  315 (568)
                      .++|...+.||+|+||.||+|+...      +++.||||++... ....+.+.+|+.++++++||||+++++++.+    
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   77 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNAL------DSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNF   77 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCC
T ss_pred             cccchhhheeccCCcEEEEEEEEcC------CCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcch
Confidence            4678999999999999999999864      6789999999643 3345678999999999999999999999865    


Q ss_pred             ---------CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC
Q 008374          316 ---------KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD  386 (568)
Q Consensus       316 ---------~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~  386 (568)
                               .+..++||||+++|+|.+++...  ...+++..+..++.|++.||+|||   +++++||||||+|||++.+
T Consensus        78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~  152 (303)
T 1zy4_A           78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDES  152 (303)
T ss_dssp             CC------CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTT
T ss_pred             hhhhcccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCC
Confidence                     35789999999999999999643  346788999999999999999999   5699999999999999999


Q ss_pred             CcEEEeecCCccccccccccc---------cccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 008374          387 FNARLGDFGLARAIENERNSY---------AEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGN  456 (568)
Q Consensus       387 ~~~kL~DFGla~~~~~~~~~~---------~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~  456 (568)
                      +.+||+|||+++.........         .........||..|+|||.+.+. .++.++||||||+++|||++   |+.
T Consensus       153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~  229 (303)
T 1zy4_A          153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS  229 (303)
T ss_dssp             SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence            999999999998765321100         01112245789999999999754 78999999999999999998   443


Q ss_pred             CCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          457 MIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       457 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ...      ...+..... ..      ....+...........+.+++..|++.||.+|||+.|+++
T Consensus       230 ~~~------~~~~~~~~~-~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          230 TGM------ERVNILKKL-RS------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             SHH------HHHHHHHHH-HS------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Cch------hHHHHHHhc-cc------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            211      111111111 10      0111122223344456678888999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.7e-39  Score=328.69  Aligned_cols=266  Identities=23%  Similarity=0.300  Sum_probs=201.9

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcC---CCCceeeEEEE
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRL---RHKHLVHLVGW  312 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~g~  312 (568)
                      .+.++|...+.||+|+||.||+|+....     +++.||+|++....  ......+.+|+.+++++   +||||++++++
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~   82 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKN-----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV   82 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCC-----CCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeee
Confidence            3557899999999999999999998521     57899999986532  22345677888887776   89999999999


Q ss_pred             EE-----eCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC
Q 008374          313 CH-----EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF  387 (568)
Q Consensus       313 ~~-----~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~  387 (568)
                      |.     .....++||||++ |+|.+++.... ...+++..+..++.|++.||.|||   +++++||||||+|||++.++
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~  157 (326)
T 1blx_A           83 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSG  157 (326)
T ss_dssp             EEEEECSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTC
T ss_pred             eeecccCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCC
Confidence            97     4568999999997 69999986543 235899999999999999999999   56999999999999999999


Q ss_pred             cEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhH
Q 008374          388 NARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTL  467 (568)
Q Consensus       388 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l  467 (568)
                      .+||+|||+++.......      .....||..|+|||.+....++.++||||||+++|||++|+.||.......   .+
T Consensus       158 ~~kl~Dfg~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~  228 (326)
T 1blx_A          158 QIKLADFGLARIYSFQMA------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QL  228 (326)
T ss_dssp             CEEECSCCSCCCCCGGGG------GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH
T ss_pred             CEEEecCcccccccCCCC------ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HH
Confidence            999999999987654321      124678999999999999999999999999999999999999998544332   11


Q ss_pred             HHHHHHHhhcCchhhh------hhhhcC-------CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          468 VDWVWMLHREGHIQDA------VDQRLN-------INSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       468 ~~~~~~~~~~~~~~~~------~d~~l~-------~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       ..+............      ....+.       ..........+.+++..|++.||.+|||+.|+++
T Consensus       229 -~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          229 -GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             -HHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -HHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             111111100000000      000000       0011123345677888999999999999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9e-39  Score=321.74  Aligned_cols=253  Identities=21%  Similarity=0.320  Sum_probs=201.4

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      ...++|...++||+|+||.||+|+...      +++.||+|++....  ....+.+.+|++++++++||||+++++++..
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRI------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED   92 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcC------CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC
Confidence            345689999999999999999999864      67899999986543  2345678999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC---CcEEEe
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD---FNARLG  392 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~---~~~kL~  392 (568)
                      .+..++|+||+++++|.+++..   ...+++..+..++.|++.||.|||   +++++||||||+||+++.+   +.+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~  166 (287)
T 2wei_A           93 SSSFYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKII  166 (287)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CCeEEEEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEe
Confidence            9999999999999999998853   346899999999999999999999   5699999999999999764   479999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      |||+++........      ....||..|+|||.+.+ .++.++||||||+++|||++|+.||.......    +..   
T Consensus       167 Dfg~~~~~~~~~~~------~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~---  232 (287)
T 2wei_A          167 DFGLSTCFQQNTKM------KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILK---  232 (287)
T ss_dssp             STTGGGTBCCCSSC------SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH---
T ss_pred             ccCcceeecCCCcc------ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH----HHH---
Confidence            99999876543221      13458899999999865 58999999999999999999999997543221    111   


Q ss_pred             HHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       ....+...      ............+.+++..|++.||++|||+.|+++
T Consensus       233 -~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          233 -RVETGKYA------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             -HHHHCCCC------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -HHHcCCCC------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence             11111110      000001122345677888999999999999999987

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus}

Probab=100.00  E-value=2.9e-39  Score=311.22  Aligned_cols=148  Identities=30%  Similarity=0.499  Sum_probs=133.3

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCC---CeeeEecCCccccccccC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDD---NHLGLNINSVVSRKNVPL   85 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~---~hvgidins~~s~~~~~~   85 (568)
                      ...+||||||||+|.....|.++.||||||+|.+   ++.||+|||||||++|.|||++   |||||||||+.|.++++|
T Consensus        75 ~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~~Dp~~~~~nHVGIdvNsi~S~~~~~~  151 (234)
T 2eig_A           75 RYPPTDGVVFFLAPWGTEIPPNSQGGYLGITDSS---NSQNQFVAVEFDSHPNVWDPKSLRSSHIGIDVNSIMSLKAVNW  151 (234)
T ss_dssp             TSCCCCEEEEEEEETTCCCCTTCCGGGTTTCCTT---CSCCCCEEEEEECSCCTTSCTTTCSSEEEEEESSSSCSEEEEC
T ss_pred             CCCCCCcEEEEEecCCCCCCcCCCCCccccccCC---CccccEEEEEeccccCccCCCCCCCCceEEecCCccccceecc
Confidence            4568999999999977533335899999999975   6789999999999999999999   999999999999998876


Q ss_pred             CCCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccC--CCcccccccccc
Q 008374           86 KDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSAST--GYPHIQLNCVRS  163 (568)
Q Consensus        86 ~~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsast--G~~~~~~~~i~s  163 (568)
                            +|.+|+.++|||+||+.+++|+|+|++ +  .|.+|+|+..+||+++|++++||||||+|  |. . +.|+|++
T Consensus       152 ------~l~~g~~~~v~I~Yd~~~~~L~V~l~~-~--~~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~-~-~~h~Ils  220 (234)
T 2eig_A          152 ------NRVSGSLEKATIIYDSDTKILTVVMTH-Q--NGQITTISQEIDLKTVLPEKVSVGFSATTWNPE-R-ERHDIYS  220 (234)
T ss_dssp             ------CCCTTCCEEEEEEEETTTTEEEEEEEE-T--TSCEEEEEEECCHHHHSCSEEEEEEEEEECSSC-C-EEEEEEE
T ss_pred             ------cccCCCEEEEEEEEeCCCcEEEEEEec-C--CCCcceEeEeechHHhcCCceEEEEEeeecCCC-c-ceeEEEE
Confidence                  367899999999999999999999999 5  47789999999999999999999999999  97 7 9999999


Q ss_pred             ccccccc
Q 008374          164 WTLDIDV  170 (568)
Q Consensus       164 Ws~~~~~  170 (568)
                      |+|....
T Consensus       221 WsF~s~l  227 (234)
T 2eig_A          221 WSFTSTL  227 (234)
T ss_dssp             EEEEEEC
T ss_pred             EEEEecC
Confidence            9998764

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A*

Probab=100.00  E-value=2.8e-39  Score=313.01  Aligned_cols=150  Identities=27%  Similarity=0.451  Sum_probs=133.7

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCC-CCCCCeeeEecCCccccccccCCC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGF-DPDDNHLGLNINSVVSRKNVPLKD   87 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~-d~~~~hvgidins~~s~~~~~~~~   87 (568)
                      ...+||||||||+|.... + ++.||||||+|.+ +++..||+|||||||++|.| ||++|||||||||+.|.++++|  
T Consensus        84 ~~~~gdGlAF~l~p~~~~-~-~~~g~~LGl~n~~-~~~~~~~~vAVEFDT~~n~~dDp~~nHVGIdvns~~S~~~~~~--  158 (239)
T 1gzc_A           84 RPLPADGLVFFMGPTKSK-P-AQGYGYLGVFNNS-KQDNSYQTLAVEFDTFSNPWDPPQVPHIGIDVNSIRSIKTQPF--  158 (239)
T ss_dssp             SSCCCEEEEEEEECSSCC-C-CCCGGGTTTCSSS-SCCGGGCCEEEEEECSCCTTSCSSSSEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCcEEEEEecCCCC-C-CCCCCcccccccC-CCCccccEEEEEEecccccCCCCCCCeEEEecCCccccccccc--
Confidence            456899999999998664 4 3899999999976 45778999999999999987 5999999999999999998876  


Q ss_pred             CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCc--ccccccccccc
Q 008374           88 NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYP--HIQLNCVRSWT  165 (568)
Q Consensus        88 ~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~--~~~~~~i~sWs  165 (568)
                          +|.+|+.++|||+||+.+++|+|+|++.+.  |.+|+|++.+||+++|+++|||||||+||.-  ..+.|++++|+
T Consensus       159 ----~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~h~IlsWs  232 (239)
T 1gzc_A          159 ----QLDNGQVANVVIKYDAPSKILHVVLVYPSS--GAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWS  232 (239)
T ss_dssp             ----CCCTTCEEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEE
T ss_pred             ----cccCCCEEEEEEEEeCCCcEEEEEEecCCC--CccceEEEEechHHhCCCceEEEEEeccCCCccccceEEEEEEE
Confidence                367899999999999999999999998763  6679999999999999999999999999961  38999999999


Q ss_pred             cccc
Q 008374          166 LDID  169 (568)
Q Consensus       166 ~~~~  169 (568)
                      |+..
T Consensus       233 F~s~  236 (239)
T 1gzc_A          233 FQAS  236 (239)
T ss_dssp             EEEE
T ss_pred             eEEe
Confidence            9865

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.6e-39  Score=328.87  Aligned_cols=256  Identities=23%  Similarity=0.329  Sum_probs=178.4

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHH-HhhcCCCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELA-IIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      .++|...+.||+|+||.||+|+...      +++.||||++.... .....++..|+. +++.++||||+++++++...+
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~   94 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKP------SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG   94 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETT------TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred             HHHhhehheeccCCCEEEEEEEEcC------CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence            3678889999999999999999865      68899999997653 233445666666 777889999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccC--CCcccCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCEEEcCCCcEEEeec
Q 008374          318 KLLLVYDFMPNGSLEKYLYGT--SEQVTLNWNHRYKILTGVASAVYYLQNEYDQ-KVVHRDLKASNILLDADFNARLGDF  394 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDikp~NILld~~~~~kL~DF  394 (568)
                      ..++||||++ |+|.+++...  .....+++..+..++.|++.||.|||   ++ +++||||||+|||++.++.+||+||
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Df  170 (327)
T 3aln_A           95 DCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDF  170 (327)
T ss_dssp             EEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             ceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccC
Confidence            9999999997 4888777421  12456899999999999999999999   45 9999999999999999999999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCcccc----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECF----HTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~----~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~  470 (568)
                      |+++........      ....||..|+|||.+    ....++.++||||||+++|||++|+.||.......      +.
T Consensus       171 g~~~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~  238 (327)
T 3aln_A          171 GISGQLVDSIAK------TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF------DQ  238 (327)
T ss_dssp             SSSCC------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------
T ss_pred             CCceeccccccc------ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH------HH
Confidence            999876543221      134699999999998    45678999999999999999999999997432111      00


Q ss_pred             HHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          471 VWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       471 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .      ........+.+...........+.+++..||+.||.+|||+.|+++
T Consensus       239 ~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          239 L------TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             -------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             H------HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            0      0000000111111111123446778888999999999999999976

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.5e-39  Score=330.38  Aligned_cols=244  Identities=23%  Similarity=0.383  Sum_probs=199.2

Q ss_pred             HHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc------cchhhHHHHHHhhcCC--CCceee
Q 008374          237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK------SKGDFLAELAIIHRLR--HKHLVH  308 (568)
Q Consensus       237 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~  308 (568)
                      ....++|...++||+|+||.||+|+...      +++.||||.+......      ..+.+.+|+.++++++  |+||++
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~  112 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVS------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR  112 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETT------TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECC------CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceE
Confidence            3445679999999999999999998865      6889999999764322      2356889999999996  599999


Q ss_pred             EEEEEEeCCeEEEEEEecCC-CChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc-CC
Q 008374          309 LVGWCHEKGKLLLVYDFMPN-GSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD-AD  386 (568)
Q Consensus       309 l~g~~~~~~~~~lV~Ey~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld-~~  386 (568)
                      +++++...+..++|+||+.+ ++|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++ ++
T Consensus       113 ~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~  186 (320)
T 3a99_A          113 LLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNR  186 (320)
T ss_dssp             EEEEEECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTT
T ss_pred             EEEEEecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCC
Confidence            99999999999999999976 899999953   356899999999999999999999   57999999999999999 78


Q ss_pred             CcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCcccchh
Q 008374          387 FNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY  465 (568)
Q Consensus       387 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~  465 (568)
                      +.+||+|||+++.......       ....||+.|+|||++....+ +.++||||||+++|||++|+.||.....     
T Consensus       187 ~~~kL~Dfg~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----  254 (320)
T 3a99_A          187 GELKLIDFGSGALLKDTVY-------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----  254 (320)
T ss_dssp             TEEEECCCTTCEECCSSCB-------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----
T ss_pred             CCEEEeeCccccccccccc-------cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----
Confidence            9999999999987654321       14569999999999987766 6789999999999999999999863210     


Q ss_pred             hHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          466 TLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       466 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       ..        .+..      .+..    .....+.+++.+||+.||.+|||+.|+++
T Consensus       255 -~~--------~~~~------~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          255 -II--------RGQV------FFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             -HH--------HCCC------CCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -hh--------cccc------cccc----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00        0000      0111    12345677888999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.5e-38  Score=327.97  Aligned_cols=263  Identities=21%  Similarity=0.258  Sum_probs=177.6

Q ss_pred             HhcCccccc-eeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHH-HHhhcCCCCceeeEEEEEEe-
Q 008374          239 ATNNFHESM-RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAEL-AIIHRLRHKHLVHLVGWCHE-  315 (568)
Q Consensus       239 at~~f~~~~-~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~H~nIv~l~g~~~~-  315 (568)
                      ..++|...+ .||+|+||.||+|+...      +++.||||++....     ...+|+ ..+..++||||+++++++.. 
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~   94 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRR------TGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENM   94 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECC------CCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence            456788854 69999999999999875      68899999986531     122333 34566799999999999876 


Q ss_pred             ---CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---CCcE
Q 008374          316 ---KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA---DFNA  389 (568)
Q Consensus       316 ---~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~---~~~~  389 (568)
                         ....++||||+++|+|.+++.... ...+++.++..++.|++.||.|||   +++|+||||||+|||++.   ++.+
T Consensus        95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~  170 (336)
T 3fhr_A           95 HHGKRCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVL  170 (336)
T ss_dssp             ETTEEEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCE
T ss_pred             cCCCceEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceE
Confidence               456899999999999999996542 246999999999999999999999   569999999999999976   4559


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~  469 (568)
                      ||+|||+++.......       ....||+.|+|||++....++.++||||||+++|||++|+.||..............
T Consensus       171 kl~Dfg~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  243 (336)
T 3fhr_A          171 KLTDFGFAKETTQNAL-------QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR  243 (336)
T ss_dssp             EECCCTTCEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred             EEeccccceecccccc-------ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH
Confidence            9999999986653321       145689999999999888899999999999999999999999974433221000000


Q ss_pred             HHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCCCCCCC
Q 008374          470 WVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISGTSTVPY  533 (568)
Q Consensus       470 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L~~~~~~p~  533 (568)
                      .    ...+      ...+...........+.+++..|++.||.+|||+.|+++  .++.....|.
T Consensus       244 ~----~~~~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  299 (336)
T 3fhr_A          244 R----IRLG------QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ  299 (336)
T ss_dssp             -----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCC
T ss_pred             h----hhcc------ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCC
Confidence            0    0000      000111111123445677888999999999999999998  5666544443

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A*

Probab=100.00  E-value=3.9e-39  Score=312.23  Aligned_cols=149  Identities=27%  Similarity=0.386  Sum_probs=134.0

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC---CCCCCCeeeEecCCccccccccC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG---FDPDDNHLGLNINSVVSRKNVPL   85 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~---~d~~~~hvgidins~~s~~~~~~   85 (568)
                      ...+||||||||+|.... + ++.||||||+|.++ ++..||+|||||||++|.   |||++|||||||||+.|.++++|
T Consensus        82 ~~~~gdGlAF~l~p~~~~-~-~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~~~~Dp~~nHVGIdvNs~~S~~~~~~  158 (242)
T 1fx5_A           82 PKAATDGLTFFLAPPDSP-L-RRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERW  158 (242)
T ss_dssp             GGGCCCEEEEEEECTTCC-C-CBCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEEEC
T ss_pred             CCCCCCcEEEEEecCCCC-C-CCCCCcccccccCC-CCccCcEEEEEeccccCcccccCCCCCeEEEecCCccccceecc
Confidence            355899999999998664 3 38999999999764 578899999999999997   89999999999999999998876


Q ss_pred             CCCcccccCCC--ceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccC--CCcccccccc
Q 008374           86 KDNYNITLSDG--TSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSAST--GYPHIQLNCV  161 (568)
Q Consensus        86 ~~~~~~~l~~g--~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsast--G~~~~~~~~i  161 (568)
                            +|.+|  +.++|||+||+.+++|+|+|++.+.  |.+|+|+..+||+++|++++||||||+|  |. . +.|+|
T Consensus       159 ------~l~~G~~~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~-~-~~h~I  228 (242)
T 1fx5_A          159 ------NKRYGLNNVANVEIIYEASSKTLTASLTYPSD--QTSISVTSIVDLKEILPEWVSVGFSGSTYIGR-Q-ATHEV  228 (242)
T ss_dssp             ------CCCCSGGGCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCGGGTSCSEEEEEEEEEEETTS-C-EEEEE
T ss_pred             ------cccCCCceeEEEEEEEeCCCCEEEEEEecCCC--CccceeeEEechHHhCCccEEEEEEecccCCC-c-ceeEE
Confidence                  36789  9999999999999999999998764  6678999999999999999999999999  97 7 99999


Q ss_pred             ccccccccc
Q 008374          162 RSWTLDIDV  170 (568)
Q Consensus       162 ~sWs~~~~~  170 (568)
                      ++|+|....
T Consensus       229 lsWsF~s~l  237 (242)
T 1fx5_A          229 LNWYFTSTF  237 (242)
T ss_dssp             EEEEEEEES
T ss_pred             EEEEeEeec
Confidence            999998764

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-39  Score=327.46  Aligned_cols=246  Identities=26%  Similarity=0.407  Sum_probs=191.3

Q ss_pred             HHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc------ccchhhHHHHHHhhcC----CCC
Q 008374          235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI------KSKGDFLAELAIIHRL----RHK  304 (568)
Q Consensus       235 el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~H~  304 (568)
                      +.....++|...++||+|+||.||+|+...      +++.||||++.....      .....+.+|+.++.++    +||
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~   98 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLT------DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP   98 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTT------TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCS
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEcc------CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCC
Confidence            344556789999999999999999998764      678999999976432      2345678899999998    899


Q ss_pred             ceeeEEEEEEeCCeEEEEEEe-cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 008374          305 HLVHLVGWCHEKGKLLLVYDF-MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL  383 (568)
Q Consensus       305 nIv~l~g~~~~~~~~~lV~Ey-~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl  383 (568)
                      ||+++++++...+..++|+|| +.+++|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+||++
T Consensus        99 ~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~  172 (312)
T 2iwi_A           99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILI  172 (312)
T ss_dssp             SBCCEEEEC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEE
T ss_pred             CeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEE
Confidence            999999999999999999999 789999999954   346899999999999999999999   4699999999999999


Q ss_pred             c-CCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 008374          384 D-ADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKAT-PESDVFGFGAVVLEVVCGRSPGNMIPHQ  461 (568)
Q Consensus       384 d-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t-~~sDV~SfGvll~el~tG~~P~~~~~~~  461 (568)
                      + .++.+||+|||+++.......       ....||..|+|||++....+. .++||||||+++|||++|+.||....  
T Consensus       173 ~~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--  243 (312)
T 2iwi_A          173 DLRRGCAKLIDFGSGALLHDEPY-------TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--  243 (312)
T ss_dssp             ETTTTEEEECCCSSCEECCSSCB-------CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--
T ss_pred             eCCCCeEEEEEcchhhhcccCcc-------cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--
Confidence            9 889999999999987654321       145699999999999877765 48999999999999999999986321  


Q ss_pred             cchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          462 QHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       462 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                          .                +.+...  .........+.+++..|++.||++|||+.|+++
T Consensus       244 ----~----------------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          244 ----E----------------ILEAEL--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ----H----------------HHHTCC--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----H----------------Hhhhcc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0                001111  111122345677888999999999999999997

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=336.47  Aligned_cols=205  Identities=24%  Similarity=0.349  Sum_probs=155.2

Q ss_pred             Cccc-cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEe--CCe
Q 008374          242 NFHE-SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE--KGK  318 (568)
Q Consensus       242 ~f~~-~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~  318 (568)
                      .|.. .++||+|+||.||+|+.+..    .++..||||++....  ....+.+|+.++++++||||+++++++..  ...
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~----~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDG----KDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRK   94 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSS----SCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccC----CCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence            3554 45799999999999997632    157889999996542  34568899999999999999999999965  678


Q ss_pred             EEEEEEecCCCChhhhhccC------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----cCCCc
Q 008374          319 LLLVYDFMPNGSLEKYLYGT------SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL----DADFN  388 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl----d~~~~  388 (568)
                      .++||||+. |+|.+++...      .....+++..+..++.||+.||.|||   +++|+||||||+|||+    +.++.
T Consensus        95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred             EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCc
Confidence            999999996 5888877421      11235899999999999999999999   5799999999999999    77899


Q ss_pred             EEEeecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008374          389 ARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMI  458 (568)
Q Consensus       389 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~  458 (568)
                      +||+|||+++...........  .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLAD--LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             EEECCTTCCC------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EEEEECCCceecCCCCccccc--CCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            999999999887543221111  225679999999999977 45899999999999999999999999743

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A*

Probab=100.00  E-value=3.8e-39  Score=313.94  Aligned_cols=149  Identities=30%  Similarity=0.499  Sum_probs=134.6

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecCCccccccccCCCC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKDN   88 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidins~~s~~~~~~~~~   88 (568)
                      ...+||||||||+|.... + ++.||||||+|.+   ++.||+|||||||++|.|||++|||||||||+.|.++.+|   
T Consensus        83 ~~~~gdGlAF~l~p~~~~-~-~~~g~~LGL~n~~---~~~n~~vAVEFDT~~N~~Dp~~nHVGIdvNs~~S~~t~~~---  154 (253)
T 1sbf_A           83 TKRLADGLAFFLAPIDTK-P-QTHAGYLGLFNEN---ESGDQVVAVEFDTFRNSWDPPNPHIGINVNSIRSIKTTSW---  154 (253)
T ss_dssp             TTSCCEEEEEEEEETTCC-C-CCCGGGTTTCCTT---SCCCSCEEEEEECSCCTTCCSSSEEEEEESSSSCSEEEEC---
T ss_pred             CCCCCCcEEEEEecCCCC-C-CCCCCccccccCC---CcccceEEEEeccccCCCCCCCCcEEEEcCCccccceecc---
Confidence            456899999999998664 3 4889999999975   6789999999999999999999999999999999998876   


Q ss_pred             cccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCcc--ccccccccccc
Q 008374           89 YNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPH--IQLNCVRSWTL  166 (568)
Q Consensus        89 ~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~--~~~~~i~sWs~  166 (568)
                         +|.+|+.++|||+||+.+++|+|+|++.+.  |.+|+++..+||+.+|++++||||||+||. .  .+.|++++|+|
T Consensus       155 ---~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~-~~~~~~H~IlsWsF  228 (253)
T 1sbf_A          155 ---DLANNKVAKVLITYDASTSLLVASLVYPSQ--RTSNILSDVVDLKTSLPEWVRIGFSAATGL-DIPGESHDVLSWSF  228 (253)
T ss_dssp             ---CCCTTCCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECS-SSCCCEEEEEEEEE
T ss_pred             ---cccCCCeeEEEEEEeCCCcEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeccCC-CccceeeEEEEEEe
Confidence               367899999999999999999999998763  667899999999999999999999999997 7  89999999999


Q ss_pred             ccccc
Q 008374          167 DIDVI  171 (568)
Q Consensus       167 ~~~~~  171 (568)
                      .....
T Consensus       229 ~s~l~  233 (253)
T 1sbf_A          229 ASNLP  233 (253)
T ss_dssp             EEEEC
T ss_pred             EeecC
Confidence            87653

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4e-38  Score=326.80  Aligned_cols=256  Identities=20%  Similarity=0.287  Sum_probs=194.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|...+.||+|+||.||+|+...      +++.||||++....  ....+.+.+|+.++++++||||+++++++...+.
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   97 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKR------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS   97 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             ceEEEeeeEecCCCeEEEEEEECC------CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence            568889999999999999999875      68899999997643  2234678899999999999999999999987653


Q ss_pred             ------EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          319 ------LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       319 ------~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                            .++||||++ ++|.+++.     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+
T Consensus        98 ~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~  168 (353)
T 3coi_A           98 LRNFYDFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKIL  168 (353)
T ss_dssp             GGGCCCCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEEC
T ss_pred             cccceeEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEe
Confidence                  599999996 69988873     24899999999999999999999   5799999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      |||+++......        ....||+.|+|||.+.+ ..++.++|||||||+++||++|+.||.......   .+.. .
T Consensus       169 Dfg~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~-i  236 (353)
T 3coi_A          169 DFGLARHADAEM--------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQ-I  236 (353)
T ss_dssp             STTCTTC----------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHH-H
T ss_pred             ecccccCCCCCc--------cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH-H
Confidence            999998754321        14578999999999876 678999999999999999999999997543322   1111 1


Q ss_pred             HHHhhcC----------c-hhhhhh---hhcC---CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          472 WMLHREG----------H-IQDAVD---QRLN---INSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       472 ~~~~~~~----------~-~~~~~d---~~l~---~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .......          . ....+.   ....   ..........+.+++..|++.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          237 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1100000          0 000000   0000   0011123456777888999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7e-38  Score=323.87  Aligned_cols=260  Identities=19%  Similarity=0.253  Sum_probs=200.4

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCc------eeeEEEEE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKH------LVHLVGWC  313 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~~  313 (568)
                      .++|...++||+|+||.||+|+....     .+..||+|++... ....+.+.+|+.++++++|++      ++.+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~   91 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHAR-----GKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF   91 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCC-----CceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence            46799999999999999999998642     2478999999653 334567889999999997766      99999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----------
Q 008374          314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL----------  383 (568)
Q Consensus       314 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl----------  383 (568)
                      ...+..++||||+ +++|.+++.... ...+++.++..++.|++.||.|||   +++|+||||||+|||+          
T Consensus        92 ~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           92 NFHGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             eeCCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccc
Confidence            9999999999999 667777775432 246899999999999999999999   6799999999999999          


Q ss_pred             ---------cCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 008374          384 ---------DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP  454 (568)
Q Consensus       384 ---------d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P  454 (568)
                               +.++.+||+|||+++......        ....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  238 (355)
T 2eu9_A          167 EHKSCEEKSVKNTSIRVADFGSATFDHEHH--------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL  238 (355)
T ss_dssp             CC-CCCEEEESCCCEEECCCTTCEETTSCC--------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccccccccCCCcEEEeecCccccccccc--------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCC
Confidence                     678899999999998644322        145799999999999999999999999999999999999999


Q ss_pred             CCCCCcccchhhHHHHHHHHhhcCchhhh--------------------------hhhhc-----CCCCcHHHHHHHHHH
Q 008374          455 GNMIPHQQHAYTLVDWVWMLHREGHIQDA--------------------------VDQRL-----NINSVVDEAKRLLLL  503 (568)
Q Consensus       455 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~--------------------------~d~~l-----~~~~~~~~~~~l~~l  503 (568)
                      |.......   .+. ........- -...                          .....     ...........+.++
T Consensus       239 f~~~~~~~---~~~-~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  313 (355)
T 2eu9_A          239 FQTHENRE---HLV-MMEKILGPI-PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL  313 (355)
T ss_dssp             CCCSSHHH---HHH-HHHHHHCCC-CHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHH
T ss_pred             CCCCCHHH---HHH-HHHHHcCCC-cHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHH
Confidence            98544332   111 111110000 0000                          00000     001122345578889


Q ss_pred             HHhcCCCCCCCCCCHHHHHH
Q 008374          504 GLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       504 ~l~Cl~~dp~~RPt~~evl~  523 (568)
                      +..||+.||.+|||+.|+++
T Consensus       314 i~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          314 MRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHhcCChhhCcCHHHHhc
Confidence            99999999999999999974

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii}

Probab=100.00  E-value=1.4e-38  Score=308.96  Aligned_cols=152  Identities=26%  Similarity=0.401  Sum_probs=134.6

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC--CCCCCCeeeEecCCccccccccCC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG--FDPDDNHLGLNINSVVSRKNVPLK   86 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~--~d~~~~hvgidins~~s~~~~~~~   86 (568)
                      ...+||||||||+|....|+.++.||||||+|.+++++..||+|||||||++|.  |||++|||||||||+.|.++.+| 
T Consensus        81 ~~~~gdGlAF~l~p~~~~p~~g~~g~~LGl~n~~~~~~~~n~~vAVEfDT~~N~~~~Dp~~nHvgIdvns~~S~~s~~~-  159 (240)
T 2fmd_A           81 SSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASKW-  159 (240)
T ss_dssp             SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSCCC----CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC-
T ss_pred             CCCCCCcEEEEEecCCCCCCccCCCCcccccccCcCCCCcCcEEEEEeccccccccCCCCCCceeeccccccccceeEE-
Confidence            356899999999998777654588999999998877788999999999999997  89999999999999999998876 


Q ss_pred             CCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCccccccccccccc
Q 008374           87 DNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTL  166 (568)
Q Consensus        87 ~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~~~i~sWs~  166 (568)
                           ++.+|+.++|||+||+.+++|+|+|++.+.   .+|+|+..+||+.+|++++||||||+||. ..+.|+|++|+|
T Consensus       160 -----~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~~~~yvGFSAsTG~-~~~~H~IlsWsF  230 (240)
T 2fmd_A          160 -----DWQNGKTATAHISYNSASKRLSVVSSYPNS---SPVVVSFDVELNNVBPBWVRVGFSATTGQ-YTQTNNILAWSF  230 (240)
T ss_dssp             -----CCCSSCEEEEEEEEETTTTEEEEEEECTTS---CCEEEEEECCGGGTSCSEEEEEEEEECCS-SCBCCEEEEEEE
T ss_pred             -----EeeCCCEEEEEEEEeCCCCEEEEEEecCCC---CceEEEEEechHHhCCCceEEEEEeccCC-ccccEEEEEEEe
Confidence                 356899999999999999999999998764   57899999999999999999999999997 899999999999


Q ss_pred             cccc
Q 008374          167 DIDV  170 (568)
Q Consensus       167 ~~~~  170 (568)
                      ....
T Consensus       231 ~s~~  234 (240)
T 2fmd_A          231 RSSL  234 (240)
T ss_dssp             EEEE
T ss_pred             EecC
Confidence            8764

>2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1

Probab=100.00  E-value=1.1e-38  Score=308.67  Aligned_cols=151  Identities=28%  Similarity=0.483  Sum_probs=134.8

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC-CCCC--CCeeeEecCCccccccccC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG-FDPD--DNHLGLNINSVVSRKNVPL   85 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~-~d~~--~~hvgidins~~s~~~~~~   85 (568)
                      ...+||||||+|+|....|.  +.||||||+|.+ +++..||+|||||||++|. |||+  +|||||||||+.|.++.+|
T Consensus        76 ~~~~gdGlAF~l~p~~~~p~--~~g~~LGl~n~~-~~~~~~~~vAVEFDT~~N~~~Dp~~~~nHVgIdvns~~S~~s~~~  152 (234)
T 2bqp_A           76 SYNVADGFTFFIAPVDTKPQ--TGGGYLGVFNSA-EYDKTTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSW  152 (234)
T ss_dssp             TTSCCCEEEEEEEETTCCCC--CCGGGTTTCSCS-SCCGGGCCEEEEEECSCCTTTSCTTCCCEEEEEESSSSCSEEEEC
T ss_pred             CCCCCCcEEEEEecCCCCCC--CCCCcccccccc-CCCCCCcEEEEEEecccCcccCCCCCCCceeEeeCCccccceEee
Confidence            35689999999999877643  889999999976 4577899999999999998 8999  9999999999999998876


Q ss_pred             CCCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCC---CCCCCeeeEeeCccccCCCcccccccccCCCccccccccc
Q 008374           86 KDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGET---MPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVR  162 (568)
Q Consensus        86 ~~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~---~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~~~i~  162 (568)
                            ++.+|+.++|||+||+.+++|+|+|++.+..   +|.+|+++..+||+.+|++++||||||+||. ..+.|+|+
T Consensus       153 ------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~p~~~~ls~~vdL~~~l~~~~yvGFSAsTG~-~~~~H~Il  225 (234)
T 2bqp_A          153 ------KLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGA-EYAAHEVL  225 (234)
T ss_dssp             ------CCCTTCEEEEEEEEETTTTEEEEEEEECC------CEEEEEEEECCGGGTSCSEEEEEEEEECSS-SCCEEEEE
T ss_pred             ------EEcCCCEEEEEEEEeCCCCEEEEEEecCCCCcccCCCcceEEEEechHHhCCCceEEEEEeccCC-CcccEEEE
Confidence                  3578999999999999999999999988765   6788999999999999999999999999997 89999999


Q ss_pred             ccccccc
Q 008374          163 SWTLDID  169 (568)
Q Consensus       163 sWs~~~~  169 (568)
                      +|+|+..
T Consensus       226 sWsF~s~  232 (234)
T 2bqp_A          226 SWSFHSE  232 (234)
T ss_dssp             EEEEEEE
T ss_pred             EEEEEee
Confidence            9999764

>1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A*

Probab=100.00  E-value=8.7e-39  Score=311.80  Aligned_cols=151  Identities=25%  Similarity=0.459  Sum_probs=135.5

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC-CCCCCCeeeEecCCccccccccCCC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG-FDPDDNHLGLNINSVVSRKNVPLKD   87 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~-~d~~~~hvgidins~~s~~~~~~~~   87 (568)
                      ...+||||||||+|.... + ++.||||||+|.++ ++..||+|||||||++|. |||++|||||||||+.|.++.+|  
T Consensus        80 ~~~~gdGlAF~l~p~~~~-~-~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~~Dp~~nHVGIdvns~~S~~t~~~--  154 (253)
T 1g7y_A           80 KSSSADGIAFALVPVGSE-P-KSNSGFLGVFDSDV-YDNSAQTVAVEFDTFSNTDWDPTSRHIGIDVNSIKSIRTASW--  154 (253)
T ss_dssp             GGGCCCEEEEEEEETTCC-C-CCCGGGTTTCSCSS-CCGGGCCEEEEEECSCCTTTCCSSCEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCcEEEEEecCCCC-C-CCCCCcccccccCC-CCccCceEEEEecceeccCcCCCCCcEeeccCCccccceecc--
Confidence            345899999999998664 3 48899999999764 477899999999999998 99999999999999999998876  


Q ss_pred             CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCcc---ccccccccc
Q 008374           88 NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPH---IQLNCVRSW  164 (568)
Q Consensus        88 ~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~---~~~~~i~sW  164 (568)
                          +|.+|+.++|||+||+.+++|+|+|++.+.  |.+|+++..+||+.+|++++||||||+||. .   .+.|++++|
T Consensus       155 ----~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~-~~~~~~~H~IlsW  227 (253)
T 1g7y_A          155 ----GLANGQNAEILITYNAATSLLVASLVHPSR--RTSYIVSERVDITNELPEYVSIGFSATTGL-SEGYTETHDVLSW  227 (253)
T ss_dssp             ----CCCTTSEEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEECCS-SSSCCCCCEEEEE
T ss_pred             ----ccCCCCeEEEEEEEeCCCCEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeCcCC-CCcccceeEEEEE
Confidence                367899999999999999999999998763  667899999999999999999999999997 7   899999999


Q ss_pred             ccccccc
Q 008374          165 TLDIDVI  171 (568)
Q Consensus       165 s~~~~~~  171 (568)
                      +|.....
T Consensus       228 sF~s~l~  234 (253)
T 1g7y_A          228 SFASKLP  234 (253)
T ss_dssp             EEEEEEC
T ss_pred             EEEeeCC
Confidence            9987653

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ...

Probab=100.00  E-value=1e-38  Score=307.32  Aligned_cols=148  Identities=33%  Similarity=0.524  Sum_probs=131.2

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCC-CCcceecccCCCCCCCCCcEEEEEeeCCCCC--CCCCCCeeeEecCCccccccccC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESS-YGQWLGLTNAFTDGNKANHFVAIEFDTVKQG--FDPDDNHLGLNINSVVSRKNVPL   85 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~-~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~--~d~~~~hvgidins~~s~~~~~~   85 (568)
                      ...+||||||||+|..+..|.++ .||||||+|.    ++.||+|||||||++|.  |||++|||||||||+.|.++++|
T Consensus        78 ~~~~gdGlAF~l~p~~~~~p~~~~~g~~LGl~n~----~~~~~~vAVEFDT~~n~~~~Dp~~nHVGIdvns~~S~~~~~~  153 (232)
T 1v6i_A           78 DYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDT----KGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW  153 (232)
T ss_dssp             SSBCCCEEEEEEEETTCCCCTTCCCGGGTTTSCT----TSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEEC
T ss_pred             CCCCCCCEEEEEecCCCCCCCCcCCCcccccccC----CCcccEEEEEeecccccccCCCCCCeEEEEcCCccccccccc
Confidence            35689999999999765333347 8999999986    56899999999999997  89999999999999999998876


Q ss_pred             CCCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCc-cccccccccc
Q 008374           86 KDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYP-HIQLNCVRSW  164 (568)
Q Consensus        86 ~~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~-~~~~~~i~sW  164 (568)
                            +|.+|+.++|||+||+.+++|+|+|++ +  .|.+|+|+..+||+++|+++|||||| +||.. ..+.|++++|
T Consensus       154 ------~l~~G~~~~v~I~Yd~~~~~L~V~l~~-~--~~~~~~ls~~vdL~~~l~e~v~VGFS-sTG~~~~~~~h~IlsW  223 (232)
T 1v6i_A          154 ------NSVSGAVVKVTVIYDSSTKTLSVAVTN-D--NGDITTIAQVVDLKAKLPERVKFGFS-ASGSLGGRQIHLIRSW  223 (232)
T ss_dssp             ------CCCTTCEEEEEEEEETTTTEEEEEEEC-T--TSCEEEEEEECCHHHHSCSEEEEEEE-EECCSSBCCEEEEEEE
T ss_pred             ------cccCCCEEEEEEEEeCCCcEEEEEEec-C--CCCcceEEEEechHHhCCccEEEEEE-ecCCCccccEEEEEEE
Confidence                  367899999999999999999999998 5  47789999999999999999999999 99962 3899999999


Q ss_pred             cccccc
Q 008374          165 TLDIDV  170 (568)
Q Consensus       165 s~~~~~  170 (568)
                      +|....
T Consensus       224 sF~s~l  229 (232)
T 1v6i_A          224 SFTSTL  229 (232)
T ss_dssp             EEEEEE
T ss_pred             EEEeec
Confidence            998653

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A*

Probab=100.00  E-value=1.5e-38  Score=309.86  Aligned_cols=149  Identities=31%  Similarity=0.511  Sum_probs=134.3

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC-CCCCCCeeeEecCCccccccccCCC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG-FDPDDNHLGLNINSVVSRKNVPLKD   87 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~-~d~~~~hvgidins~~s~~~~~~~~   87 (568)
                      ...+||||||||+|.... + ++.||||||+|.+   ++.||+|||||||++|. |||++|||||||||+.|.++.+|  
T Consensus        81 ~~~~gdGlAF~l~p~~~~-~-~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~~~Dp~~nHVGIdvNs~~S~~~~~~--  153 (252)
T 1fat_A           81 NAGPADGLAFALVPVGSQ-P-KDKGGFLGLFDGS---NSNFHTVAVEFDTLYNKDWDPTERHIGIDVNSIRSIKTTRW--  153 (252)
T ss_dssp             SCBCCEEEEEEEEETTCC-C-CCSGGGTTTCCSS---CCCCCCEEEEEECSCCTTTCCSSCEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCcEEEEEccCCCC-C-CCCCccccccccC---CccCcEEEEEeecccCCCCCCCCCeEEEecCCccccceecc--
Confidence            456899999999998664 3 4899999999975   66899999999999998 89999999999999999998876  


Q ss_pred             CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCcc---ccccccccc
Q 008374           88 NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPH---IQLNCVRSW  164 (568)
Q Consensus        88 ~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~---~~~~~i~sW  164 (568)
                          +|.+|+.++|||+||+.+++|+|+|++.+.  |.+|+++..+||+.+|++++||||||+||. .   .+.|++++|
T Consensus       154 ----~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~-~~~~~~~H~IlsW  226 (252)
T 1fat_A          154 ----DFVNGENAEVLITYDSSTNLLVASLVYPSQ--KTSFIVSDTVDLKSVLPEWVSVGFSATTGI-NKGNVETNDVLSW  226 (252)
T ss_dssp             ----CCCTTCEEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECS-STTBCCCCEEEEE
T ss_pred             ----cccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeccCC-CCcccceEEEEEE
Confidence                367899999999999999999999998763  667899999999999999999999999997 7   899999999


Q ss_pred             ccccccc
Q 008374          165 TLDIDVI  171 (568)
Q Consensus       165 s~~~~~~  171 (568)
                      +|.....
T Consensus       227 sF~s~l~  233 (252)
T 1fat_A          227 SFASKLS  233 (252)
T ss_dssp             EEEEEEC
T ss_pred             EEEeeCC
Confidence            9987643

>1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A*

Probab=100.00  E-value=1.8e-38  Score=307.60  Aligned_cols=147  Identities=31%  Similarity=0.562  Sum_probs=132.4

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecCCccccccccCCCC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKDN   88 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidins~~s~~~~~~~~~   88 (568)
                      ...+||||||||+|.... + ++.||||||+|.+    +.||+|||||||++|.|||++|||||||||+.|.++.+|   
T Consensus        83 ~~~~gdGlAF~l~p~~~~-~-~~~g~~LGl~n~~----~~~~~vAVEFDT~~N~~Dp~~nHVGIdvNs~~S~~~~~~---  153 (242)
T 1wbf_A           83 RPHPADGLVFFIAPPNTQ-T-GEGGGYFGIYNPL----SPYPFVAVEFDTFRNTWDPQIPHIGIDVNSVISTKTVPF---  153 (242)
T ss_dssp             SSCCCEEEEEEEECSSCC-C-CCCGGGTTTCCTT----SCCCCEEEEEECSCCTTCCSSSEEEEEESSSSCSEEEEC---
T ss_pred             CCCCCCcEEEEEecCCCC-C-CCCCCccccccCC----CcCcEEEEEeccccCCCCCCCCeEEEECCCccccceeee---
Confidence            456899999999998664 3 3889999999864    679999999999999999999999999999999998876   


Q ss_pred             cccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccC----CCcc---cccccc
Q 008374           89 YNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSAST----GYPH---IQLNCV  161 (568)
Q Consensus        89 ~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsast----G~~~---~~~~~i  161 (568)
                         +|.+|+.++|||+||+.+++|+|+|++.+.  |.+|+|+..+||+.+|++++||||||+|    |. .   .+.|++
T Consensus       154 ---~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTg~~~G~-~~~~~~~h~I  227 (242)
T 1wbf_A          154 ---TLDNGGIANVVIKYDASTKILHVVLVFPSL--GTIYTIADIVDLKQVLPESVNVGFSAATGDPSGK-QRNATETHDI  227 (242)
T ss_dssp             ---CCCTTSCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGC-CTTCCCCCEE
T ss_pred             ---EecCCCEEEEEEEEeCCCCEEEEEEccCCC--CCcceEEEEechHHhcCCceEEEEEEeecCcCCc-cccccceEEE
Confidence               367899999999999999999999998764  5678999999999999999999999999    86 7   899999


Q ss_pred             ccccccccc
Q 008374          162 RSWTLDIDV  170 (568)
Q Consensus       162 ~sWs~~~~~  170 (568)
                      ++|+|....
T Consensus       228 lsWsF~s~l  236 (242)
T 1wbf_A          228 LSWSFSASL  236 (242)
T ss_dssp             EEEEEEEEC
T ss_pred             EEEEeEecC
Confidence            999998764

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.1e-37  Score=332.86  Aligned_cols=254  Identities=20%  Similarity=0.254  Sum_probs=184.6

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCeEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  320 (568)
                      .|...+.||+|+||+||.+...       +++.||||++...   ..+.+.+|+.++.++ +||||+++++++.+.+..+
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~-------~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   85 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSF-------QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY   85 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEES-------SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             eeeccCeEeeCCCeEEEEEEEE-------CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence            3555678999999999765433       5889999998653   234678999999876 8999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcc----cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC----------
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQV----TLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD----------  386 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~----------  386 (568)
                      +|||||. |+|.+++.......    ..++..+..++.||+.||.|||   +++|+||||||+|||++.+          
T Consensus        86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccC
Confidence            9999995 79999996542211    1234456789999999999999   5799999999999999654          


Q ss_pred             ---CcEEEeecCCccccccccccccccccccCCcCCcccCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCC
Q 008374          387 ---FNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-------GKATPESDVFGFGAVVLEVVC-GRSPG  455 (568)
Q Consensus       387 ---~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-------~~~t~~sDV~SfGvll~el~t-G~~P~  455 (568)
                         +.+||+|||+++........... ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  240 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRT-NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF  240 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC---------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCceEEEEcccccceecCCCCcccee-eecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence               58999999999987654322111 1124679999999999865       678999999999999999999 99999


Q ss_pred             CCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          456 NMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       456 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .......     .....     +...   .+.+...........+.+++.+|++.||.+|||+.||++
T Consensus       241 ~~~~~~~-----~~i~~-----~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          241 GDKYSRE-----SNIIR-----GIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             CSTTTHH-----HHHHH-----TCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCchhhH-----HHHhc-----CCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            7432211     11100     0000   001111123455677888999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=7.3e-38  Score=319.13  Aligned_cols=253  Identities=22%  Similarity=0.320  Sum_probs=178.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-cc-hhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SK-GDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      .++|...+.||+|+||.||+|+...      +++.||||++...... .. +.+..+..+++.++||||+++++++...+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~   97 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRK------TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT   97 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETT------TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hccccccceeeecCCeeEEEEEEec------CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence            4678889999999999999999875      6789999999765322 22 33445556788889999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+ ++.+..+...  ....+++..+..++.|++.||.|||+.  .+++||||||+|||++.++.+||+|||++
T Consensus        98 ~~~lv~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  172 (318)
T 2dyl_A           98 DVFIAMELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGIS  172 (318)
T ss_dssp             EEEEEECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cEEEEEecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCc
Confidence            999999999 4555554432  134689999999999999999999941  38999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFH-----TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      +........      ....||+.|+|||.+.     ...++.++||||||+++|||++|+.||.......   ....   
T Consensus       173 ~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~---  240 (318)
T 2dyl_A          173 GRLVDDKAK------DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF---EVLT---  240 (318)
T ss_dssp             --------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH---HHHH---
T ss_pred             hhccCCccc------cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH---HHHH---
Confidence            876543221      1456899999999984     5678899999999999999999999997532221   1111   


Q ss_pred             HHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ......      .+.+.  ........+..++..||+.||.+|||++|+++
T Consensus       241 ~~~~~~------~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          241 KVLQEE------PPLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HHHHSC------CCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHhccC------CCCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            111110      00111  01122345677888999999999999999976

>1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A*

Probab=100.00  E-value=3.1e-38  Score=308.62  Aligned_cols=153  Identities=31%  Similarity=0.502  Sum_probs=135.8

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCC-CCCCCCcEEEEEeeCCCCC-C-CCCCCeeeEecCCccccccccC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFT-DGNKANHFVAIEFDTVKQG-F-DPDDNHLGLNINSVVSRKNVPL   85 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~-~~~~~~~~~aVEfDt~~~~-~-d~~~~hvgidins~~s~~~~~~   85 (568)
                      ...+||||||||+|.... + ++.||||||+|.++ +++..||+|||||||++|. | ||++|||||||||+.|.++.+|
T Consensus        83 ~~~~gdGlAF~l~p~~~~-~-~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHVGIdvNs~~S~~s~~~  160 (257)
T 1hql_A           83 GNGPADGLAFFLAPPDSD-V-KDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRW  160 (257)
T ss_dssp             SSCCCCEEEEEEECTTCC-C-CCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEEEEC
T ss_pred             CCCCCCcEEEEEecCCCC-C-CCCCccccccccccccCCccCceEEEEecccccccccCCCCCceeeeeCCccccceecc
Confidence            356899999999998664 3 48899999999875 3778899999999999998 7 9999999999999999999887


Q ss_pred             CCCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCC-Cccccccccccc
Q 008374           86 KDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTG-YPHIQLNCVRSW  164 (568)
Q Consensus        86 ~~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG-~~~~~~~~i~sW  164 (568)
                      ..   .+|.+|+.++|||+||+.+++|+|+|++.+.   .+|+|+..+||+.+|++++||||||+|| . ..+.|++++|
T Consensus       161 ~~---~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~e~~~vGFSAsTG~~-~~~~H~IlsW  233 (257)
T 1hql_A          161 ED---SDIFSGKIATARISYDGSAEILTVVLSYPDG---SDYILSHSVDMRQNLPESVRVGISASTGNN-QFLTVYILSW  233 (257)
T ss_dssp             CH---HHHTSCSCEEEEEEEETTTTEEEEEEEETTT---EEEEEEEECCGGGTSCSEEEEEEEEECCSC-CCEEEEEEEE
T ss_pred             Cc---ccccCCceEEEEEEEeCCCCEEEEEEecCCC---CceeeEEeechHHhcCCceEEEEEeccCCC-ccceeEEEEE
Confidence            42   1366799999999999999999999998764   4689999999999999999999999999 8 8999999999


Q ss_pred             cccccc
Q 008374          165 TLDIDV  170 (568)
Q Consensus       165 s~~~~~  170 (568)
                      +|....
T Consensus       234 sF~s~~  239 (257)
T 1hql_A          234 RFSSNL  239 (257)
T ss_dssp             EEEEEC
T ss_pred             EeEecC
Confidence            998764

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A*

Probab=100.00  E-value=2.6e-38  Score=306.32  Aligned_cols=147  Identities=27%  Similarity=0.492  Sum_probs=132.6

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecCCccccccccCCCC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKDN   88 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidins~~s~~~~~~~~~   88 (568)
                      ...+||||||||+|.... + ++.||||||+|.+   +. ||+|||||||++|.|||++|||||||||+.|.++.+|   
T Consensus        83 ~~~~gdGlAF~l~p~~~~-~-~~~g~~LGl~n~~---~~-~~~vAVEFDT~~N~~Dp~~nHVgIdvns~~S~~s~~~---  153 (238)
T 1f9k_A           83 YPEPADGLTFFMVPPNSP-Q-GEDGGNLGVFKPP---EG-DNAFAVEFDTFQNTWDPQVPHIGIDVNSIVSSKTLHF---  153 (238)
T ss_dssp             SSCCCEEEEEEEECTTCC-C-CCSGGGTTTCCSS---CC-SCCEEEEEECSCCTTCCSSSEEEEEESSSSCSEEEEC---
T ss_pred             CCCCCCcEEEEEccCCCC-C-CCCCCcccccccC---CC-CcEEEEEEecccCCCCCCCCeEEEecCCccccceEee---
Confidence            456899999999998664 3 4889999999975   55 9999999999999999999999999999999998875   


Q ss_pred             cccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCC--cccccccccCCCcc---cccccccc
Q 008374           89 YNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKP--ESYFGFSASTGYPH---IQLNCVRS  163 (568)
Q Consensus        89 ~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~--~~~vGfsastG~~~---~~~~~i~s  163 (568)
                         +|.+|+.++|||+||+.+++|+|+|++.+.  |.+|+++..+||+.+|++  ++||||||+||. .   .+.|++++
T Consensus       154 ---~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~~~~~~~vGFSAsTG~-~~~~~~~h~Ils  227 (238)
T 1f9k_A          154 ---QLENGGVANVVIKYDSPTKILNVVLAFHSV--GTVYTLSNIVDLKQEFPNSEWVNVGLSATTGY-QKNAVETHEIIS  227 (238)
T ss_dssp             ---CCCTTCCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSTTCSEEEEEEEEEECS-STTCCCEEEEEE
T ss_pred             ---cccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCceeEEEEechHHhCCCCceEEEEEEeCcCC-CCcccceEEEEE
Confidence               367899999999999999999999998763  667899999999999999  999999999997 7   89999999


Q ss_pred             ccccccc
Q 008374          164 WTLDIDV  170 (568)
Q Consensus       164 Ws~~~~~  170 (568)
                      |+|....
T Consensus       228 WsF~s~~  234 (238)
T 1f9k_A          228 WSFTSSL  234 (238)
T ss_dssp             EEEEEEC
T ss_pred             eEeEeec
Confidence            9998763

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=331.37  Aligned_cols=251  Identities=23%  Similarity=0.329  Sum_probs=184.7

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  318 (568)
                      ..+|...++||+|+||+||.....       +++.||||++....   ...+.+|+.+++++ +||||+++++++.+.+.
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~-------~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~   92 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMF-------DNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQF   92 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEES-------SSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEe-------CCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence            456888899999999996543322       57899999996532   34578999999999 79999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-----CCcEEEee
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA-----DFNARLGD  393 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~-----~~~~kL~D  393 (568)
                      .++|||||+ |+|.+++....  ..+.+.....++.|++.||.|||   +++|+||||||+|||++.     ...+||+|
T Consensus        93 ~~lv~E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~D  166 (432)
T 3p23_A           93 QYIAIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISD  166 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred             EEEEEECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEec
Confidence            999999995 69999996543  23445566789999999999999   579999999999999943     34688999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCccccc---cCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHH
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH---TGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~  469 (568)
                      ||+++...........  .....||+.|+|||++.   ...++.++|||||||++|||++ |+.||.......     ..
T Consensus       167 FG~a~~~~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-----~~  239 (432)
T 3p23_A          167 FGLCKKLAVGRHSFSR--RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-----AN  239 (432)
T ss_dssp             TTEEECC--------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-----HH
T ss_pred             ccceeeccCCCcceee--ccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-----HH
Confidence            9999887654322111  12567999999999997   4667889999999999999999 899986432211     00


Q ss_pred             HHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          470 WVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       470 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                         ........     ..+  .........+.+++..||+.||.+|||+.||++
T Consensus       240 ---~~~~~~~~-----~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          240 ---ILLGACSL-----DCL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             ---HHTTCCCC-----TTS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---HHhccCCc-----ccc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence               00110000     000  111233445677888999999999999999984

>1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A*

Probab=100.00  E-value=4.3e-38  Score=305.39  Aligned_cols=149  Identities=32%  Similarity=0.501  Sum_probs=133.3

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCC-CCCCCcEEEEEeeCCCCC-C-CCCCCeeeEecCCccccccccC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTD-GNKANHFVAIEFDTVKQG-F-DPDDNHLGLNINSVVSRKNVPL   85 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~-~~~~~~~~aVEfDt~~~~-~-d~~~~hvgidins~~s~~~~~~   85 (568)
                      ...+||||||||+|.... + ++.||||||+|.+++ ++..||+|||||||++|. | ||++|||||||||+.|.++.+|
T Consensus        84 ~~~~gdGlAF~l~p~~~~-~-~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHvGIdvns~~S~~~~~~  161 (243)
T 1gsl_A           84 GAPTADGLAFFLAPVDSS-V-KDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRW  161 (243)
T ss_dssp             SSSCBCEEEEEEEETTCC-C-CCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC
T ss_pred             CCCCCCCEEEEEecCCCC-C-CCCCCcccccccccccCCccCcEEEEEeccccccccCCCCCCceeeccCCccccceeee
Confidence            356899999999998664 3 488999999998764 778899999999999997 7 9999999999999999998876


Q ss_pred             CCCcccccCC---CceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCccccccccc
Q 008374           86 KDNYNITLSD---GTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVR  162 (568)
Q Consensus        86 ~~~~~~~l~~---g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~~~i~  162 (568)
                      .      |.+   |+.++|||+||+.+++|+|+|++.+.   .+|+|+..+||+.+|++++||||||+||  ..+.|+++
T Consensus       162 ~------l~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~~~~~vGFSAsTG--~~~~h~Il  230 (243)
T 1gsl_A          162 E------NDDAYGSSIATAHITYDARSKILTVLLSYEHG---RDYILSHVVDLAKVLPQKVRIGFSAGVG--YDEVTYIL  230 (243)
T ss_dssp             C------HHHHTSCCEEEEEEEEETTTTEEEEEEEETTS---CEEEEEEECCHHHHSCSEEEEEEEEEEC--BSEEEEEE
T ss_pred             E------EeccCCCcEEEEEEEEeCCCCEEEEEEecCCC---CceeEEEEechHHhCCCceEEEEEeccC--CcceeEEE
Confidence            3      456   99999999999999999999998764   4689999999999999999999999999  68999999


Q ss_pred             cccccccc
Q 008374          163 SWTLDIDV  170 (568)
Q Consensus       163 sWs~~~~~  170 (568)
                      +|+|....
T Consensus       231 sWsF~s~l  238 (243)
T 1gsl_A          231 SWHFFSTL  238 (243)
T ss_dssp             EEEEEEEC
T ss_pred             EEEEEeec
Confidence            99998764

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=9e-37  Score=307.65  Aligned_cols=229  Identities=12%  Similarity=0.104  Sum_probs=180.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|...++||+|+||.||+|+...      +++.||||.+.....   ...+.|.+|+.++.+++||||+++++++...+
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  104 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTA------LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA  104 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETT------TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             CcEEEEEEEcccCCeEEEEEEecC------CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC
Confidence            569999999999999999999864      688999999976532   23467999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+++++|.+++..     .....+..+++.|++.||.|||   +++|+||||||+|||++.++.+||++++  
T Consensus       105 ~~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~--  174 (286)
T 3uqc_A          105 GGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA--  174 (286)
T ss_dssp             EEEEEEECCCEEEHHHHHTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC--
T ss_pred             cEEEEEEecCCCCHHHHHhc-----CCChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc--
Confidence            99999999999999999942     1355678899999999999999   5799999999999999999999998432  


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                                             |++       .++.++|||||||++|||++|+.||...........           
T Consensus       175 -----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-----------  213 (286)
T 3uqc_A          175 -----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-----------  213 (286)
T ss_dssp             -----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-----------
T ss_pred             -----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-----------
Confidence                                   333       368899999999999999999999985433220000           


Q ss_pred             CchhhhhhhhcCC--CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 008374          478 GHIQDAVDQRLNI--NSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTS  529 (568)
Q Consensus       478 ~~~~~~~d~~l~~--~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~  529 (568)
                        ....+......  .........+..++.+||+.||.+| |+.|+++.|+...
T Consensus       214 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          214 --AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             --CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             --HHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence              00000000000  0001223456778889999999999 9999999998743

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.1e-38  Score=347.88  Aligned_cols=260  Identities=24%  Similarity=0.351  Sum_probs=198.1

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcCCCCceeeEEEEEEe---
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE---  315 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~---  315 (568)
                      .++|...++||+|+||.||+|....      +++.||||++... .....+.+.+|++++++++||||+++++++..   
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~------tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~   86 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQD------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK   86 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTT------TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECC------CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence            3679999999999999999998764      6788999998764 33445679999999999999999999999765   


Q ss_pred             ---CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc---E
Q 008374          316 ---KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN---A  389 (568)
Q Consensus       316 ---~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~---~  389 (568)
                         .+..++||||+++|+|.+++........+++..+..++.+++.||.|||   +.+|+||||||+|||++.++.   +
T Consensus        87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~v  163 (676)
T 3qa8_A           87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIH  163 (676)
T ss_dssp             CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEE
T ss_pred             ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeE
Confidence               6678999999999999999976555557999999999999999999999   579999999999999997664   9


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~  469 (568)
                      ||+|||+++........      ....||..|+|||.+.+..++.++||||||+++|||++|+.||.....      ...
T Consensus       164 KL~DFG~a~~~~~~~~~------~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~------~~~  231 (676)
T 3qa8_A          164 KIIDLGYAKELDQGELC------TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ------PVQ  231 (676)
T ss_dssp             EECSCCCCCBTTSCCCC------CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH------HHH
T ss_pred             EEccccccccccccccc------ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc------hhh
Confidence            99999999877544321      246799999999999999999999999999999999999999964211      111


Q ss_pred             HHHHHhhcCc----hhhhhhhhc--------CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 008374          470 WVWMLHREGH----IQDAVDQRL--------NINSVVDEAKRLLLLGLACSHPIASERPKTED  520 (568)
Q Consensus       470 ~~~~~~~~~~----~~~~~d~~l--------~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~e  520 (568)
                      |.........    ..+.....+        ...........+..++..|++.||++|||+.|
T Consensus       232 ~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          232 WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             SSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            1110000000    000000000        11123345667888888999999999999966

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1

Probab=100.00  E-value=2.4e-37  Score=296.86  Aligned_cols=145  Identities=27%  Similarity=0.410  Sum_probs=129.3

Q ss_pred             CCCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecCCccccccccCCC
Q 008374            8 AWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKD   87 (568)
Q Consensus         8 ~~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidins~~s~~~~~~~~   87 (568)
                      +...+||||||||+|....|+  +.||||||+|.+ +++..||+|||||||+       +|||||||||+.|.++++|. 
T Consensus        77 ~~~~~gdGlAF~l~p~~~~p~--~~g~~LGl~n~~-~~~~~~~~vAVEFDT~-------~nHVGIdvNs~~S~~t~~~~-  145 (226)
T 1avb_A           77 NIENSAYGLAFALVPVGSRPK--LKGRYLGLFNTT-NYDRDAHTVAVVFDTV-------SNRIEIDVNSIRPIATESCN-  145 (226)
T ss_dssp             STTSCCEEEEEEEEETTCCCC--CCGGGTTTCSCS-SCCGGGCCEEEEEETT-------TTEEEEEESSSSCSEEEECC-
T ss_pred             CCCCCCCcEEEEEecCCCCCC--CCCCcccccccC-CCCCcccEEEEEecCc-------CCccceeecCcccCccccCC-
Confidence            345689999999999877643  889999999975 5577899999999998       69999999999999998874 


Q ss_pred             CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCcc---ccccccccc
Q 008374           88 NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPH---IQLNCVRSW  164 (568)
Q Consensus        88 ~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~---~~~~~i~sW  164 (568)
                         +.|.+|+.++|||+||+.+++|+|+|++.+.  +++|+++..+||+++|++++||||||+||. .   .+.|++++|
T Consensus       146 ---~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~-~~~~~~~h~IlsW  219 (226)
T 1avb_A          146 ---FGHNNGEKAEVRITYDSPKNDLRVSLLYPSS--EEKCHVSATVPLEKEVEDWVSVGFSATSGS-KKETTETHNVLSW  219 (226)
T ss_dssp             ---SGGGTTCEEEEEEEEEGGGTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECS-SGGGCEEEEEEEE
T ss_pred             ---ccccCCCeEEEEEEEeCCCcEEEEEEeecCC--CccceEEEEechHHhCCCceEEEEEeccCC-CCcccceeEEEEE
Confidence               3677999999999999999999999998764  347899999999999999999999999997 7   899999999


Q ss_pred             ccccc
Q 008374          165 TLDID  169 (568)
Q Consensus       165 s~~~~  169 (568)
                      +|+..
T Consensus       220 sF~s~  224 (226)
T 1avb_A          220 SFSSN  224 (226)
T ss_dssp             EEEEE
T ss_pred             EEEee
Confidence            99764

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1

Probab=100.00  E-value=3.9e-37  Score=297.84  Aligned_cols=146  Identities=24%  Similarity=0.357  Sum_probs=130.2

Q ss_pred             CCCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecCCccccccccCCC
Q 008374            8 AWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKD   87 (568)
Q Consensus         8 ~~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidins~~s~~~~~~~~   87 (568)
                      +...+||||||||+|....|+  +.||||||+|.+ +++..||+|||||||+       +|||||||||+.|.++++|. 
T Consensus        79 ~~~~~gdGlAF~l~p~~~~p~--~~g~~LGL~n~~-~~~~~~~~vAVEFDT~-------~nHVGIdvNs~~S~~t~~~~-  147 (240)
T 1ioa_A           79 NQSISAYGLAFALVPVNSPPQ--KKQEFLGIFNTN-NPEPNARTVAVVFNTF-------KNRIDFDKNFIKPYVNENCD-  147 (240)
T ss_dssp             CTTSCCEEEEEEEEETTCCCC--CCGGGTTTCCCS-SCCGGGCCEEEEEETT-------TTEEEEEESSSSCSEEEECC-
T ss_pred             CCCCCCCcEEEEEecCCCCCC--CCCCcccccccC-CCCCcCcEEEEEecCc-------CCceeeeeCCccccccccCC-
Confidence            345689999999999877643  889999999975 5577899999999998       69999999999999998863 


Q ss_pred             CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCcc---ccccccccc
Q 008374           88 NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPH---IQLNCVRSW  164 (568)
Q Consensus        88 ~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~---~~~~~i~sW  164 (568)
                         +.|.+|+.++|||+||+.+++|+|+|++.+.  +++|+++..+||+++|++++||||||+||. .   .+.|++++|
T Consensus       148 ---~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~-~~~~~~~H~IlsW  221 (240)
T 1ioa_A          148 ---FHKYNGEKTDVQITYDSSNNDLRVFLHFTVS--QVKCSVSATVHLEKEVDEWVSVGFSPTSGL-TEDTTETHDVLSW  221 (240)
T ss_dssp             ---HHHHCSSCEEEEEEEETTTTEEEEEEEETTT--CCEEEEEEECCGGGTSCSEEEEEEEEEECS-STTTCBCCEEEEE
T ss_pred             ---ccccCCCEEEEEEEEeCCCcEEEEEEecCCC--CccceeEEEechHHhCCCceEEEEEeccCC-CCcccceeEEEEE
Confidence               4677999999999999999999999998764  457999999999999999999999999997 7   899999999


Q ss_pred             cccccc
Q 008374          165 TLDIDV  170 (568)
Q Consensus       165 s~~~~~  170 (568)
                      +|....
T Consensus       222 sF~s~~  227 (240)
T 1ioa_A          222 SFSSKF  227 (240)
T ss_dssp             EEEEEE
T ss_pred             EEEeeC
Confidence            998764

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-36  Score=340.94  Aligned_cols=239  Identities=20%  Similarity=0.298  Sum_probs=190.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe-
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK-  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-  318 (568)
                      ++|...++||+|+||.||+|+...     .+++.||||++.... ......|.+|++++.+++||||++++++|...+. 
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRN-----VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGG-----GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcC-----CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            679999999999999999999863     147899999986543 3345678999999999999999999999987665 


Q ss_pred             ----EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 008374          319 ----LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDF  394 (568)
Q Consensus       319 ----~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DF  394 (568)
                          .+|||||+++++|.+++..     .+++.++..++.||+.||.|||   +++|+||||||+|||++.+ .+||+||
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DF  225 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDL  225 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCC
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEec
Confidence                7999999999999988732     6999999999999999999999   5799999999999999986 8999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      |+++.....         ....||+.|+|||++.+. ++.++|||||||+++||++|..|+.......            
T Consensus       226 G~a~~~~~~---------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------  283 (681)
T 2pzi_A          226 GAVSRINSF---------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG------------  283 (681)
T ss_dssp             TTCEETTCC---------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS------------
T ss_pred             ccchhcccC---------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc------------
Confidence            999876543         145799999999998765 4899999999999999999988876321111            


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHHHhC
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK-TEDILQIISG  527 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt-~~evl~~L~~  527 (568)
                           +.       ...........+..++.+|++.||.+||+ ++++.+.|.+
T Consensus       284 -----~~-------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          284 -----LP-------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             -----CC-------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -----cc-------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                 00       00011122345677888999999999995 5666655543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-36  Score=320.88  Aligned_cols=242  Identities=15%  Similarity=0.100  Sum_probs=181.0

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCC-Cce---------
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRH-KHL---------  306 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~nI---------  306 (568)
                      +.+|...++||+|+||.||+|+...      +++.||||++.....   ...+.|.+|+.++..++| +|.         
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~  150 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQE------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF  150 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCB
T ss_pred             ceeEEEecccccCCCEEEEEEEecC------CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccc
Confidence            3457788899999999999999875      688999999874322   336779999999999987 221         


Q ss_pred             -ee-----------EEEEEEe-----CCeEEEEEEecCCCChhhhhcc----CCCcccCCHHHHHHHHHHHHHHHHHHHh
Q 008374          307 -VH-----------LVGWCHE-----KGKLLLVYDFMPNGSLEKYLYG----TSEQVTLNWNHRYKILTGVASAVYYLQN  365 (568)
Q Consensus       307 -v~-----------l~g~~~~-----~~~~~lV~Ey~~~gsL~~~L~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~  365 (568)
                       +.           +..++..     ....+++|+++ +++|.+++..    ......+++..++.++.|+++||.||| 
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-  228 (413)
T 3dzo_A          151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-  228 (413)
T ss_dssp             CCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             ccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence             11           1111111     22467788866 7899998841    123456889999999999999999999 


Q ss_pred             cCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCcccc----------ccCCCCcc
Q 008374          366 EYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECF----------HTGKATPE  435 (568)
Q Consensus       366 ~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~----------~~~~~t~~  435 (568)
                        +++|+||||||+|||++.++.+||+|||+++......        ....| +.|+|||++          ....++.+
T Consensus       229 --~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~--------~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~  297 (413)
T 3dzo_A          229 --HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASA--------VSPIG-RGFAPPETTAERMLPFGQHHPTLMTFA  297 (413)
T ss_dssp             --HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEEE--------CCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHH
T ss_pred             --hCCcccCCcccceEEEecCCeEEEEeccceeecCCcc--------ccCCC-CceeCchhhhccccccccccCcCCCch
Confidence              6799999999999999999999999999998755431        14567 999999999          55568889


Q ss_pred             chhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCC
Q 008374          436 SDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASER  515 (568)
Q Consensus       436 sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~R  515 (568)
                      +|||||||++|||++|+.||........                ...++...  .    .....+.+++..||+.||++|
T Consensus       298 ~DvwSlGvil~elltg~~Pf~~~~~~~~----------------~~~~~~~~--~----~~~~~~~~li~~~l~~dP~~R  355 (413)
T 3dzo_A          298 FDTWTLGLAIYWIWCADLPNTDDAALGG----------------SEWIFRSC--K----NIPQPVRALLEGFLRYPKEDR  355 (413)
T ss_dssp             HHHHHHHHHHHHHHHSSCCCCTTGGGSC----------------SGGGGSSC--C----CCCHHHHHHHHHHTCSSGGGS
T ss_pred             hhHHHHHHHHHHHHHCCCCCCCcchhhh----------------HHHHHhhc--c----cCCHHHHHHHHHHccCChhhC
Confidence            9999999999999999999975432220                11111111  1    112557778889999999999


Q ss_pred             CCHHHHH
Q 008374          516 PKTEDIL  522 (568)
Q Consensus       516 Pt~~evl  522 (568)
                      ||+.|++
T Consensus       356 pt~~~~l  362 (413)
T 3dzo_A          356 LLPLQAM  362 (413)
T ss_dssp             CCHHHHT
T ss_pred             cCHHHHH
Confidence            9976664

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2e-35  Score=299.31  Aligned_cols=240  Identities=18%  Similarity=0.279  Sum_probs=181.8

Q ss_pred             hcCcccc-ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHh-hcCCCCceeeEEEEEEe--
Q 008374          240 TNNFHES-MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAII-HRLRHKHLVHLVGWCHE--  315 (568)
Q Consensus       240 t~~f~~~-~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~g~~~~--  315 (568)
                      .++|... +.||+|+||.||++....      +++.||+|++..     ...+.+|+.++ +.++||||+++++++..  
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   84 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKR------TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLY   84 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcC------CCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence            3556666 679999999999999865      678999999854     34577899888 56699999999999987  


Q ss_pred             --CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---CCcEE
Q 008374          316 --KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA---DFNAR  390 (568)
Q Consensus       316 --~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~---~~~~k  390 (568)
                        ....++||||+++|+|.+++.... ...+++..+..++.|++.||.|||   +++|+||||||+|||++.   ++.+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~k  160 (299)
T 3m2w_A           85 AGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILK  160 (299)
T ss_dssp             TTEEEEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEE
T ss_pred             CCCceEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEE
Confidence              678999999999999999996532 246899999999999999999999   579999999999999998   78999


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~  470 (568)
                      |+|||+++...                           ...++.++|||||||++|||++|+.||.........      
T Consensus       161 l~Dfg~a~~~~---------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------  207 (299)
T 3m2w_A          161 LTDFGFAKETT---------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------  207 (299)
T ss_dssp             ECCCTTCEECT---------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------
T ss_pred             Eeccccccccc---------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------
Confidence            99999986432                           234677899999999999999999999743221100      


Q ss_pred             HHHHhhcCchhhhhhhhcCCCC--cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCCCCCCC
Q 008374          471 VWMLHREGHIQDAVDQRLNINS--VVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISGTSTVPY  533 (568)
Q Consensus       471 ~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L~~~~~~p~  533 (568)
                            ......+.........  .......+..++..|++.||.+|||+.|+++  .+.+....|.
T Consensus       208 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~  268 (299)
T 3m2w_A          208 ------PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ  268 (299)
T ss_dssp             ------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCC
T ss_pred             ------HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCC
Confidence                  0000000000000000  0122456777888999999999999999997  4555444443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.8e-35  Score=304.75  Aligned_cols=241  Identities=18%  Similarity=0.227  Sum_probs=181.7

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--------ccchhhHHHHHHhhcCC---------
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--------KSKGDFLAELAIIHRLR---------  302 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------  302 (568)
                      .++|...++||+|+||+||+|+.        +++.||||++.....        ...+.+.+|+.++++++         
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~   90 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNR   90 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSB
T ss_pred             cccchheeeecccCceEEEEEEe--------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhcccccc
Confidence            45688899999999999999986        368999999976532        22367889999988885         


Q ss_pred             CCceeeEEEEEE------------------------------eCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHH
Q 008374          303 HKHLVHLVGWCH------------------------------EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKI  352 (568)
Q Consensus       303 H~nIv~l~g~~~------------------------------~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i  352 (568)
                      ||||+++.+.+.                              ..+.++|||||+++|++.+.+.+    ..+++..+..+
T Consensus        91 h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i  166 (336)
T 2vuw_A           91 TEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSI  166 (336)
T ss_dssp             CCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHH
T ss_pred             CCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHH
Confidence            888888877643                              26789999999999987777632    45899999999


Q ss_pred             HHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC--------------------cEEEeecCCcccccccccccccccc
Q 008374          353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF--------------------NARLGDFGLARAIENERNSYAEHGL  412 (568)
Q Consensus       353 ~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~  412 (568)
                      +.||+.||.|||+  +++|+||||||+|||++.++                    .+||+|||+|+.....         
T Consensus       167 ~~qi~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---------  235 (336)
T 2vuw_A          167 LHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---------  235 (336)
T ss_dssp             HHHHHHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---------
T ss_pred             HHHHHHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---------
Confidence            9999999999992  24899999999999999887                    8999999999876532         


Q ss_pred             ccCCcCCcccCccccccCCCCccchhHHHHHH-HHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhh--hhhhcC
Q 008374          413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAV-VLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDA--VDQRLN  489 (568)
Q Consensus       413 ~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvl-l~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~d~~l~  489 (568)
                       ...||+.|+|||++.+.. +.++||||++++ .+++++|..||..          ..|......  .+...  ......
T Consensus       236 -~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~----------~~~~~~~~~--~~~~~~~~~~~~~  301 (336)
T 2vuw_A          236 -IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN----------VLWLHYLTD--KMLKQMTFKTKCN  301 (336)
T ss_dssp             -EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH----------HHHHHHHHH--HHHHTCCCSSCCC
T ss_pred             -cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc----------hhhhhHHHH--hhhhhhccCcccc
Confidence             346999999999997655 889999998777 7778889888631          111111000  00000  000111


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 008374          490 INSVVDEAKRLLLLGLACSHPIASERPKTEDIL  522 (568)
Q Consensus       490 ~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl  522 (568)
                      ..........+.+++..||+.|     |++|++
T Consensus       302 ~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          302 TPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             SHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            1123345677888999999976     999887

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1

Probab=100.00  E-value=5.1e-35  Score=254.25  Aligned_cols=113  Identities=30%  Similarity=0.414  Sum_probs=104.6

Q ss_pred             CcEEEEEeeCCCCC--CCCCCCeeeEecCCccccccccCCCCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCC
Q 008374           49 NHFVAIEFDTVKQG--FDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQK  126 (568)
Q Consensus        49 ~~~~aVEfDt~~~~--~d~~~~hvgidins~~s~~~~~~~~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~  126 (568)
                      ||+|||||||++|.  |||++|||||||||+.|.++++|      +|.+|+.++|||+||+.+++|+|+|++.+.   ++
T Consensus         1 n~~vAVEFDT~~N~e~~Dp~~nHVGIdvNsi~S~~s~~~------~l~sG~~~~v~I~Yd~~~~~L~V~l~~~~~---~~   71 (133)
T 1qmo_E            1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKW------DWQNGKIATAHISYNSVSKRLSVTSYYAGS---KP   71 (133)
T ss_dssp             CCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC------CCCTTSCEEEEEEEETTTTEEEEEEECSSS---CC
T ss_pred             CCEEEEEEeCCcCccccCCCCCeeEEecccccccceeee------EEcCCCEEEEEEEEeCCCcEEEEEEccCCC---cc
Confidence            68999999999997  89999999999999999999876      357999999999999999999999998764   37


Q ss_pred             CeeeEeeCccccCCCcccccccccCCCcccccccccccccccccc
Q 008374          127 PLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVI  171 (568)
Q Consensus       127 ~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~~~i~sWs~~~~~~  171 (568)
                      |+|+..+||+++|+++|||||||+||. ..+.|++++|+|.....
T Consensus        72 p~ls~~vdLs~~l~e~v~VGFSAsTG~-~~~~h~IlsWsF~s~l~  115 (133)
T 1qmo_E           72 ATLSYDIELHTVLPEWVRVGLSASTGQ-DKERNTVHSWSFTSSLW  115 (133)
T ss_dssp             EEEEEECCGGGTSCSEEEEEEEEECSS-SCCEEEEEEEEEEEEEE
T ss_pred             ceEEEeechHHhccccEEEEEEeccCC-CcceeEEEEEEEEeeCC
Confidence            899999999999999999999999998 89999999999987653

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B*

Probab=99.97  E-value=7.9e-32  Score=257.19  Aligned_cols=128  Identities=24%  Similarity=0.374  Sum_probs=108.5

Q ss_pred             CCCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecCCccccccccCCC
Q 008374            8 AWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKD   87 (568)
Q Consensus         8 ~~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidins~~s~~~~~~~~   87 (568)
                      +...+||||||||+|....|+                    +++|||||||+       +||||||+||+ |.++++|. 
T Consensus        74 ~~~~~gdGlAF~l~p~~~~p~--------------------~~~vAVEFDT~-------~nHVGIdvNsi-S~~~~~~~-  124 (223)
T 1dhk_B           74 RQANSAVGLDFVLVPVQPESK--------------------GDTVTVEFDTF-------LSRISIDVNNN-DIKSVPWD-  124 (223)
T ss_dssp             C---CCSEEEEEEEEC--------------------------CCEEEEEETT-------TTEEEEEETTE-EEEEEECC-
T ss_pred             CCCCCCCceEEEEecCCCCCC--------------------ccEEEEEecCC-------CCcccccCCcc-ccccccCC-
Confidence            345689999999999755422                    25899999998       69999999999 99988863 


Q ss_pred             CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCcc---ccccccccc
Q 008374           88 NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPH---IQLNCVRSW  164 (568)
Q Consensus        88 ~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~---~~~~~i~sW  164 (568)
                         +.|.+|+.++|||+||+.+++|+|+|++.+.  +++|+++..+||+++|++++||||||+||. .   .+.|++++|
T Consensus       125 ---~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdLs~~l~e~~~VGFSAsTG~-~~~~~~~H~IlsW  198 (223)
T 1dhk_B          125 ---VHDYDGQNAEVRITYNSSTKVFSVSLSNPST--GKSNNVSTTVELEKEVYDWVSVGFSATSGA-YQWSYETHDVLSW  198 (223)
T ss_dssp             ---GGGTTTSCEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCCCSGGGSEEEEEEEEEECS-GGGSCCEEEEEEE
T ss_pred             ---ccccCCCEEEEEEEEeCCCCEEEEEEecCCC--CccceEEEEechHHhCCCceEEEEEeccCC-CccccceEEEEEE
Confidence               4777999999999999999999999998764  457999999999999999999999999997 7   899999999


Q ss_pred             cccccc
Q 008374          165 TLDIDV  170 (568)
Q Consensus       165 s~~~~~  170 (568)
                      +|....
T Consensus       199 sF~s~~  204 (223)
T 1dhk_B          199 SFSSKF  204 (223)
T ss_dssp             EEEEEC
T ss_pred             EEEecc
Confidence            998764

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ...

Probab=99.97  E-value=4.1e-31  Score=254.28  Aligned_cols=114  Identities=26%  Similarity=0.423  Sum_probs=105.3

Q ss_pred             CCcEEEEEeeCCCCC-C-CCCCCeeeEecCCccccccccCCCCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCC
Q 008374           48 ANHFVAIEFDTVKQG-F-DPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQ  125 (568)
Q Consensus        48 ~~~~~aVEfDt~~~~-~-d~~~~hvgidins~~s~~~~~~~~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~  125 (568)
                      +||+|||||||++|. | ||++|||||||||+.|.++++|      +|.+|+.++|||+||+.+++|+|+|++.+.   .
T Consensus         1 ~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNs~~S~~~~~~------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~   71 (237)
T 1nls_A            1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW------NMQNGKVGTAHIIYNSVDKRLSAVVSYPNA---D   71 (237)
T ss_dssp             CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC------CCCTTCEEEEEEEEETTTTEEEEEEECTTS---C
T ss_pred             CCCEEEEEEeCCCCcccCCCCCCeeeEecCCccccccccc------cccCCCEEEEEEEEeCCCCEEEEEEecCCC---C
Confidence            479999999999997 7 9999999999999999999886      357999999999999999999999998763   6


Q ss_pred             CCeeeEeeCccccCCCcccccccccCCCcccccccccccccccccc
Q 008374          126 KPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVI  171 (568)
Q Consensus       126 ~~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~~~i~sWs~~~~~~  171 (568)
                      +|+|+..+||+++|+++|||||||+||. ..+.|++++|+|.....
T Consensus        72 ~~~ls~~vdLs~~l~e~~~VGFSAsTG~-~~~~h~IlsWsF~s~~~  116 (237)
T 1nls_A           72 SATVSYDVDLDNVLPEWVRVGLSASTGL-YKETNTILSWSFTSKLK  116 (237)
T ss_dssp             CEEEEEECCGGGTSCSEEEEEEEEECSS-SCCCCEEEEEEEEEEEE
T ss_pred             cceEEEeeChHHhCccccEEEEEeccCC-cceeeeeEEEEEEeccc
Confidence            7899999999999999999999999998 89999999999987653

>2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A*

Probab=99.96  E-value=4.9e-30  Score=236.63  Aligned_cols=102  Identities=29%  Similarity=0.530  Sum_probs=91.8

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC-CCCC--CCeeeEecCCccccccccC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG-FDPD--DNHLGLNINSVVSRKNVPL   85 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~-~d~~--~~hvgidins~~s~~~~~~   85 (568)
                      ...+||||||||+|..+.|+  +.||||||+|.+ +++..||+|||||||++|. |||+  +|||||||||+.|.++++|
T Consensus        76 ~~~~gdGlAF~l~p~~~~p~--~~g~~LGL~n~~-~~~~~n~~vAVEFDT~~n~~~Dp~~~~nHVGIdvNs~~S~~t~~~  152 (181)
T 2ltn_A           76 SYNVADGFTFFIAPVDTKPQ--TGGGYLGVFNSA-EYDKTTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSW  152 (181)
T ss_dssp             TTSCCCEEEEEEEETTCCCC--CCGGGTTTCSCS-SCCTTSCCEEEEEECSCCTTTSCTTCCCEEEEEESSSSCSEEEEC
T ss_pred             CCCCCCceEEEEecCCCCCC--CCCccccccccC-CCCccccEEEEEeccccccccCCCCCCCEEEEEcCCccccceecc
Confidence            45689999999999877643  889999999976 4578899999999999998 9999  9999999999999999886


Q ss_pred             CCCcccccCCCceEEEEEEEcCcccEEEEEEeeC
Q 008374           86 KDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDRE  119 (568)
Q Consensus        86 ~~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~  119 (568)
                            +|.+|+.++|||+||+.+++|+|+|++.
T Consensus       153 ------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~  180 (181)
T 2ltn_A          153 ------KLQNGEEANVVIAFNAATNVLTVSLTYP  180 (181)
T ss_dssp             ------CCCTTCCEEEEEEEETTTTEEEEEEEEC
T ss_pred             ------ccCCCCEEEEEEEEECCCCEEEEEEecC
Confidence                  3578999999999999999999999874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=1.1e-29  Score=279.26  Aligned_cols=185  Identities=16%  Similarity=0.090  Sum_probs=128.2

Q ss_pred             eccCCceeEEEEEEccCccccccCeEEEEEEeccCC----------cccchhhHHHHHHhhcC-CCCceeeEEEEEEeCC
Q 008374          249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS----------IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKG  317 (568)
Q Consensus       249 LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  317 (568)
                      .+.|++|.+..++-.      ..++.++||.+....          ....++|.+|+++|+++ .|+||+++++++.+++
T Consensus       242 ~~~~~~~~h~~~rr~------~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~  315 (569)
T 4azs_A          242 PYAGAGLAHKRSRRY------FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ  315 (569)
T ss_dssp             -C--------CCEEE------EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS
T ss_pred             cccCCcccccccccc------cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC
Confidence            445555554443332      157789999986542          12345799999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .+||||||++|++|.++|...   ..++..   +|+.||+.||+|+|   +++||||||||+||||++++.+||+|||+|
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlA  386 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSI  386 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTE
T ss_pred             EEEEEEecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccC
Confidence            999999999999999999543   345543   58999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP  454 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P  454 (568)
                      +........     ....+||++|||||++. +.+..++|+||+|++++++.++..+
T Consensus       387 r~~~~~~~~-----~~t~vGTp~YmAPE~l~-g~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          387 VTTPQDCSW-----PTNLVQSFFVFVNELFA-ENKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ESCC---CC-----SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             eeCCCCCcc-----ccCceechhhccHHHhC-CCCCCcccccccccchhhhccccch
Confidence            977654322     12567999999999985 4567789999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=3e-27  Score=258.35  Aligned_cols=188  Identities=13%  Similarity=0.117  Sum_probs=145.8

Q ss_pred             cccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc--------cchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK--------SKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       244 ~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      ...++||+|+||.||+|..        .+..+++|+.......        ..+.|.+|++++++++||||+++..++..
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  410 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD  410 (540)
T ss_dssp             ---------CCEEEEEEEC--------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE--------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe
Confidence            4467899999999999954        4678899986442211        13458999999999999999977777777


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      .+..+|||||+++++|.+++..           +..++.|+++||.|||   +++|+||||||+|||++.  ++||+|||
T Consensus       411 ~~~~~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFG  474 (540)
T 3en9_A          411 LDNKRIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFG  474 (540)
T ss_dssp             TTTTEEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCT
T ss_pred             CCccEEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECc
Confidence            8888999999999999999943           4588999999999999   579999999999999999  99999999


Q ss_pred             Cccccccccccccc--cccccCCcCCcccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCC
Q 008374          396 LARAIENERNSYAE--HGLVGVPGTMGYVAPECFHT--GKATPESDVFGFGAVVLEVVCGRSPG  455 (568)
Q Consensus       396 la~~~~~~~~~~~~--~~~~~~~Gt~~y~APE~~~~--~~~t~~sDV~SfGvll~el~tG~~P~  455 (568)
                      +++...........  .......||+.|||||++..  ..|+..+|+|+..+-.++-+.++.++
T Consensus       475 la~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          475 LGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             TCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            99987653221100  00125679999999999976  66888899999999999988887765

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=5.5e-23  Score=206.28  Aligned_cols=148  Identities=14%  Similarity=0.089  Sum_probs=116.9

Q ss_pred             HHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc------------------ccchhhHHHHHHhh
Q 008374          238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI------------------KSKGDFLAELAIIH  299 (568)
Q Consensus       238 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~  299 (568)
                      .....|...+.||+|+||.||+|...       +++.||||.++....                  .....+.+|+.+++
T Consensus        87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~  159 (282)
T 1zar_A           87 RSGKVDAIGKLMGEGKESAVFNCYSE-------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ  159 (282)
T ss_dssp             HTTSCSEEEEEEEECSSEEEEEEEET-------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHH
T ss_pred             hCCeEEEecCEeccCCCceEEEEEeC-------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHH
Confidence            33445667799999999999999983       688999999964321                  12456889999999


Q ss_pred             cCCCCceeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 008374          300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKAS  379 (568)
Q Consensus       300 ~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~  379 (568)
                      +++  | +++.+++.. +..++||||+++++|.+ +..         .....++.|++.||.|||   +.+|+||||||+
T Consensus       160 ~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~  222 (282)
T 1zar_A          160 KLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQY  222 (282)
T ss_dssp             HTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTT
T ss_pred             hcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHH
Confidence            999  4 566665433 55699999999999998 521         123469999999999999   679999999999


Q ss_pred             CEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccc
Q 008374          380 NILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFH  428 (568)
Q Consensus       380 NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~  428 (568)
                      |||++ ++.+||+|||+|+.                  +..|+|||++.
T Consensus       223 NILl~-~~~vkl~DFG~a~~------------------~~~~~a~e~l~  252 (282)
T 1zar_A          223 NVLVS-EEGIWIIDFPQSVE------------------VGEEGWREILE  252 (282)
T ss_dssp             SEEEE-TTEEEECCCTTCEE------------------TTSTTHHHHHH
T ss_pred             HEEEE-CCcEEEEECCCCeE------------------CCCCCHHHHHH
Confidence            99999 99999999999863                  23468899874

>2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A*

Probab=99.87  E-value=1.4e-22  Score=198.94  Aligned_cols=141  Identities=21%  Similarity=0.208  Sum_probs=105.2

Q ss_pred             CCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecCCccccccccCCCC-
Q 008374           10 DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKDN-   88 (568)
Q Consensus        10 ~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidins~~s~~~~~~~~~-   88 (568)
                      ..+||||||+|+|...     ..|++||+.+       .++.|||||||++|.++++  |++++||++.+..+..+... 
T Consensus        79 ~~~gdGlAF~l~~~~~-----~~G~~lG~~~-------~~~gvAVefDT~~n~~~~~--~~~~~I~~~~n~gs~~~d~~~  144 (253)
T 2dur_A           79 NLHGDGIALWYTRDRL-----VPGPVFGSKD-------NFHGLAIFLDTYPNDETTE--RVFPYISVMVNNGSLSYDHSK  144 (253)
T ss_dssp             TCCCCEEEEEEESCCS-----CEETBTEECS-------SCEEEEEEEECSCCCTTCC--SCSSEEEEEEEESCCCCCGGG
T ss_pred             CcCCCcEEEEEECCCC-----CCCcccCcCC-------CCCEEEEEEECCCCCCCCC--CCCcEEEEEecCCceeeeccC
Confidence            4689999999999644     3578999743       2578999999999976544  77788887777766554210 


Q ss_pred             ---------ccccc-CCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCccccc
Q 008374           89 ---------YNITL-SDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQL  158 (568)
Q Consensus        89 ---------~~~~l-~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~  158 (568)
                               ...++ ..|+.++|||+||+.  +|+|++++.+. .+.+++++  ++ ..+||+.+||||||+||. ..+.
T Consensus       145 dg~~~~~~~c~~~~~n~g~~~~v~I~Y~~~--~L~V~l~~~~~-~~~~~~~~--~~-~v~Lp~~~yvGfSAaTG~-~~~~  217 (253)
T 2dur_A          145 DGRWTELAGCTADFRNRDHDTFLAVRYSRG--RLTVMTDLEDK-NEWKNCID--IT-GVRLPTGYYFGASAGTGD-LSDN  217 (253)
T ss_dssp             TTGGGCCEEEECCCBTCSSCEEEEEEEETT--EEEEEEECSSS-SCCEEEEE--EC-CEECCSSBEEEEEEEESS-SCCE
T ss_pred             CCcccccccccHhhccCCCCeEEEEEEECC--EEEEEEeCCCC-CCceEEEE--eC-CcccCCCcEEEEEeccCC-Ccce
Confidence                     11133 348899999999976  89999998654 24445543  34 345899999999999997 8999


Q ss_pred             ccccccccccccc
Q 008374          159 NCVRSWTLDIDVI  171 (568)
Q Consensus       159 ~~i~sWs~~~~~~  171 (568)
                      |++++|+|..-..
T Consensus       218 h~Ilswsf~sl~~  230 (253)
T 2dur_A          218 HDIISMKLFQLMV  230 (253)
T ss_dssp             EEEEEEEEEECCC
T ss_pred             EEEEEEEEEeccc
Confidence            9999999975443

>1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A

Probab=99.84  E-value=3.1e-21  Score=189.79  Aligned_cols=139  Identities=17%  Similarity=0.166  Sum_probs=103.0

Q ss_pred             CCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCC---CC------CCCeeeEecCC-cccc
Q 008374           11 ISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGF---DP------DDNHLGLNINS-VVSR   80 (568)
Q Consensus        11 ~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~---d~------~~~hvgidins-~~s~   80 (568)
                      .+||||||+|+|...     ..|++||+.+       .++.|||||||+.|.+   +|      |++|+|||+|+ +.|.
T Consensus       102 ~~gdGlAF~l~~~~~-----~~g~~~G~~~-------~~~gvaVefDT~~N~~~~~~p~I~~~indg~~~~d~~~d~~s~  169 (260)
T 1gv9_A          102 IGADGLAIWYTENQG-----LDGPVFGSAD-------MWNGVGIFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGATQ  169 (260)
T ss_dssp             CCCCEEEEEEESSCC-----CEEEETTECS-------CCEEEEEEEECCCC-----CCEEEEEEEESCCCCCHHHHHHHH
T ss_pred             CCCCeEEEEEecCCC-----CCCCccCCCC-------CCCEEEEEEECCCCCCCCCCCceEEEeCCCceEeecCCCcccc
Confidence            689999999999644     3568888842       3577999999999874   23      47788888886 5554


Q ss_pred             ccccCCCCccccc-CCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCcccccc
Q 008374           81 KNVPLKDNYNITL-SDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLN  159 (568)
Q Consensus        81 ~~~~~~~~~~~~l-~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~~  159 (568)
                      ....+..    .+ .+|..++|||+||+.  +|+|++++..........++..+| ..+||+.+||||||+||. ..+.|
T Consensus       170 ~~~~c~~----~~~n~g~~~~~~I~Y~~~--~L~V~l~~~~~~~~~~~~~~~~vd-~~~LP~~~~vGfSAaTG~-~~e~h  241 (260)
T 1gv9_A          170 ALASCQR----DFRNKPYPVRAKITYYQK--TLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGG-LADDH  241 (260)
T ss_dssp             CSEEECC----CCBSCSSCEEEEEEEETT--EEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEECCS-SCCEE
T ss_pred             eeeccCh----hhccCCCcEEEEEEEECC--EEEEEEeeccCCCCCcceEEEEEc-ccccCCCcEEEEEEeCCC-CcceE
Confidence            4333221    12 258999999999987  799999874211111235777888 678999999999999997 89999


Q ss_pred             cccccccccc
Q 008374          160 CVRSWTLDID  169 (568)
Q Consensus       160 ~i~sWs~~~~  169 (568)
                      ++++|+|..-
T Consensus       242 dIlsw~~~~l  251 (260)
T 1gv9_A          242 DVLSFLTFQL  251 (260)
T ss_dssp             EEEEEEEEEE
T ss_pred             EEEEEEEEEe
Confidence            9999998653

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.77  E-value=8e-19  Score=173.57  Aligned_cols=139  Identities=19%  Similarity=0.141  Sum_probs=105.0

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeE--EEEEEeccCCcc------------------------cchhhHHHHH
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQ--IAVKKFSRDSIK------------------------SKGDFLAELA  296 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~  296 (568)
                      |...+.||+|+||.||+|....      +++.  ||||.++.....                        ....+.+|+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~------~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  122 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVF------DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR  122 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEE------TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcC------CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH
Confidence            5567889999999999999843      5778  999987543111                        0125788999


Q ss_pred             HhhcCCCCce--eeEEEEEEeCCeEEEEEEecCC-C----ChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 008374          297 IIHRLRHKHL--VHLVGWCHEKGKLLLVYDFMPN-G----SLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQ  369 (568)
Q Consensus       297 ~l~~l~H~nI--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~  369 (568)
                      ++.+++|+++  ..++.+    +..+|||||+.+ |    +|.++...      .++.....++.|++.+|.|||.  +.
T Consensus       123 ~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~--~~  190 (258)
T 1zth_A          123 NLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQ--EA  190 (258)
T ss_dssp             HHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHH--TS
T ss_pred             HHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHH--HC
Confidence            9999988754  344432    356899999942 4    56555421      2345677899999999999994  35


Q ss_pred             CeEecCCCCCCEEEcCCCcEEEeecCCccccc
Q 008374          370 KVVHRDLKASNILLDADFNARLGDFGLARAIE  401 (568)
Q Consensus       370 ~ivHrDikp~NILld~~~~~kL~DFGla~~~~  401 (568)
                      +|+||||||+|||++.  .++|+|||+|....
T Consensus       191 givHrDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          191 ELVHADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             CEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             CEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence            9999999999999998  99999999997653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.60  E-value=2.1e-16  Score=163.45  Aligned_cols=139  Identities=13%  Similarity=0.171  Sum_probs=96.9

Q ss_pred             ccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-----ccch---------hh--------HHHHHHhhc
Q 008374          243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-----KSKG---------DF--------LAELAIIHR  300 (568)
Q Consensus       243 f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~---------~~--------~~E~~~l~~  300 (568)
                      |....+||+|+||.||+|...       +|+.||||+++....     ....         ..        ..|...|.+
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r  169 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA  169 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEecCEeeeCCceEEEEEECC-------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            788899999999999999875       688999998754211     0000         11        234555555


Q ss_pred             CCCCceeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 008374          301 LRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASN  380 (568)
Q Consensus       301 l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~N  380 (568)
                      +.+.++....-+...  ..+|||||+++++|.++...         .....++.|++.+|.|||   ..+||||||||.|
T Consensus       170 L~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~N  235 (397)
T 4gyi_A          170 LYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLA---KHGLIHGDFNEFN  235 (397)
T ss_dssp             HHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTS
T ss_pred             HHhcCCCCCeeeecc--CceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHH
Confidence            544333211111112  23799999999988776521         123467899999999999   5699999999999


Q ss_pred             EEEcCCC----------cEEEeecCCcccccc
Q 008374          381 ILLDADF----------NARLGDFGLARAIEN  402 (568)
Q Consensus       381 ILld~~~----------~~kL~DFGla~~~~~  402 (568)
                      ||+++++          .+.|+||+-+....+
T Consensus       236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~h  267 (397)
T 4gyi_A          236 ILIREEKDAEDPSSITLTPIIIXFPQMVSMDH  267 (397)
T ss_dssp             EEEEEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred             EEEeCCCCcccccccccceEEEEeCCcccCCC
Confidence            9998776          389999997765443

>2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13

Probab=99.47  E-value=3.3e-14  Score=138.97  Aligned_cols=134  Identities=13%  Similarity=0.132  Sum_probs=96.2

Q ss_pred             CCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCC-----CCCCCeeeEecCCccccccccC
Q 008374           11 ISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGF-----DPDDNHLGLNINSVVSRKNVPL   85 (568)
Q Consensus        11 ~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~-----d~~~~hvgidins~~s~~~~~~   85 (568)
                      .+||||||++++....|   ..|+.+|..+.       ..-+||||||+.|..     ..|+.|+++|.+++.+.....+
T Consensus        84 ~~gdGlAfwlt~~~~~~---~~g~~~G~~~~-------f~GlaV~fDT~~n~~p~i~~~~Ndg~~~~d~~~~~~~~~~~c  153 (256)
T 2a6y_A           84 QTDGGISFWFVQDSNIP---RDKQLYNGPVN-------YDGLQLLVDNNGPLGPTLRGQLNDGQKPVDKTKIYDQSFASC  153 (256)
T ss_dssp             CCSCEEEEEEEECSSSC---CCCTBTTBCTT-------CEEEEEEEESCSTTCSEEEEEEEESSSCCCGGGHHHHCSEEE
T ss_pred             CCCCeEEEEEeCCCCcc---cCCcccCcCCC-------CCEEEEEEECCCCCCceEEEEECCCceecccCCCcccceecc
Confidence            37999999999965432   46678888642       134899999998731     2247788888887444443332


Q ss_pred             CCCcccccCCCceEEEEEEEc-CcccEEEEEEeeCCCCCCCCCeeeEeeCcccc-CCCcc-cccccccCC---Ccccccc
Q 008374           86 KDNYNITLSDGTSYTVWVQYD-GKSKLIQVFMDREGETMPQKPLLKETINLKDY-LKPES-YFGFSASTG---YPHIQLN  159 (568)
Q Consensus        86 ~~~~~~~l~~g~~~~~~I~Yd-~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~-l~~~~-~vGfsastG---~~~~~~~  159 (568)
                      ..  .+. .+|..++|||+|+ +..+.|+|.+++       +    ..+++..+ ||+.. |+||||+||   . ..+.|
T Consensus       154 ~~--~~r-n~~~~~~v~I~Y~~~~~~~L~V~i~~-------~----~c~~~~~v~LP~~~~~~GfSAaTG~~~~-~~d~h  218 (256)
T 2a6y_A          154 LM--GYQ-DSSVPSTIRVTYDLEDDNLLKVQVDN-------K----VCFQTRKVRFPSGSYRIGVTAQNGAVNN-NAESF  218 (256)
T ss_dssp             EC--CCT-TCSSCEEEEEEEEGGGTSEEEEEETT-------E----EEEEESCEECCSEEEEEEEEEECCSGGG-CCCEE
T ss_pred             ee--ecc-cCCCcEEEEEEEecCCCcEEEEEEcC-------E----EEEEECcEEeCCCCeEEEEEEeCCCCCC-CcceE
Confidence            11  111 3688999999999 778899999965       1    23444444 78887 699999999   5 67889


Q ss_pred             cccccccccc
Q 008374          160 CVRSWTLDID  169 (568)
Q Consensus       160 ~i~sWs~~~~  169 (568)
                      .+++|+|...
T Consensus       219 dIls~~~~~~  228 (256)
T 2a6y_A          219 EIFKMQFFNG  228 (256)
T ss_dssp             EEEEEEEEES
T ss_pred             EEEEEEEEec
Confidence            9999998764

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.34  E-value=8.7e-12  Score=122.78  Aligned_cols=149  Identities=17%  Similarity=0.091  Sum_probs=117.0

Q ss_pred             HHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-CCceeeEEEEE
Q 008374          235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-HKHLVHLVGWC  313 (568)
Q Consensus       235 el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~  313 (568)
                      .+....++|.....++.|+++.||+...        .+..+++|+...........+.+|.++++.+. +..+.++++++
T Consensus         8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~--------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~   79 (263)
T 3tm0_A            8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE   79 (263)
T ss_dssp             HHHHHHTTSEEEECCSCCSSSEEEEEEC--------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred             HHHHHhccceeEeeccCCCCCeEEEEEC--------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence            3455567788888889899999999863        35789999986533234457899999999884 67788999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhc---------------------------
Q 008374          314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE---------------------------  366 (568)
Q Consensus       314 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------  366 (568)
                      ...+..++||||+++.+|.+.+..        ......++.+++++|..||..                           
T Consensus        80 ~~~~~~~lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (263)
T 3tm0_A           80 RHDGWSNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA  151 (263)
T ss_dssp             EETTEEEEEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred             ecCCceEEEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccc
Confidence            999999999999999999876411        122347888999999999971                           


Q ss_pred             -----------------------------CCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          367 -----------------------------YDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       367 -----------------------------~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                                                   ....++|+|+++.|||++++..+.|+||+.+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                         014599999999999998776678999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.15  E-value=8.5e-11  Score=115.00  Aligned_cols=138  Identities=17%  Similarity=0.095  Sum_probs=100.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCc--eeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKH--LVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~~  318 (568)
                      .++......+.|..+.||+....       ++..+++|.....   ....+..|+.+++.+.+.+  +.+++++....+.
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~-------~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~   89 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQ-------GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGR   89 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECT-------TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred             CCCceEecccCCCCceEEEEecC-------CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence            34444333345556999998653       4567999997543   3356889999999886544  4568898888888


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY-------------------------------  367 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------  367 (568)
                      .++||||+++.+|.  ...      .+   ...++.++++.|..||...                               
T Consensus        90 ~~~v~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (264)
T 1nd4_A           90 DWLLLGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL  158 (264)
T ss_dssp             EEEEEECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred             CEEEEEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence            99999999998884  211      11   2256777888888888531                               


Q ss_pred             ------------------------CCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          368 ------------------------DQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       368 ------------------------~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                                              ...++|+|++|.|||++++..+.|.||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                    12399999999999998877678999998754

>2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B

Probab=99.06  E-value=1.8e-11  Score=87.59  Aligned_cols=44  Identities=30%  Similarity=0.450  Sum_probs=40.9

Q ss_pred             CCeeeEeeCccccCCCcccccccccCCCccccccccccccccccc
Q 008374          126 KPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDV  170 (568)
Q Consensus       126 ~~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~~~i~sWs~~~~~  170 (568)
                      +|+|+..+||+++|+++|||||||+||. ..+.|++++|+|....
T Consensus         3 ~p~ls~~vdLs~~l~e~v~VGFSAsTG~-~~~~h~IlsWsF~s~~   46 (52)
T 2ltn_B            3 SYTLSDVVSLKDVVPEWVRIGFSATTGA-EYAAHEVLSWSFHSEL   46 (52)
T ss_dssp             EEEEEEECCHHHHSCSEEEEEEEEECCS-SCCEEEEEEEEEEEEE
T ss_pred             eeeEEEEEcHHHhcCceEEEEEEeccCC-cceeEEEEEeEEEeec
Confidence            4789999999999999999999999997 8999999999998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.03  E-value=1.3e-09  Score=112.42  Aligned_cols=144  Identities=12%  Similarity=0.190  Sum_probs=108.6

Q ss_pred             ccceeccCCceeEEEEEEccCccccccCeEEEEEEec--cCC-cccchhhHHHHHHhhcCC--CCceeeEEEEEEeC---
Q 008374          245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS--RDS-IKSKGDFLAELAIIHRLR--HKHLVHLVGWCHEK---  316 (568)
Q Consensus       245 ~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~---  316 (568)
                      ..+.|+.|.++.||+....        +..+++|+..  ... ......+.+|..+++.+.  +..+.+++.++.+.   
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~  113 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI  113 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT
T ss_pred             eEEEcCCcccceEEEEEEC--------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc
Confidence            3457899999999998653        4578888875  322 123457889999999987  45688999998776   


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY-----------------------------  367 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----------------------------  367 (568)
                      +..++||||+++..+.+..     ...++..++..++.++++.|+.||...                             
T Consensus       114 g~~~~vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (359)
T 3dxp_A          114 GRAFYIMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL  188 (359)
T ss_dssp             SSCEEEEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence            4589999999998885422     124678888999999999999999731                             


Q ss_pred             --------------------------CCCeEecCCCCCCEEEcCCCc--EEEeecCCccccc
Q 008374          368 --------------------------DQKVVHRDLKASNILLDADFN--ARLGDFGLARAIE  401 (568)
Q Consensus       368 --------------------------~~~ivHrDikp~NILld~~~~--~kL~DFGla~~~~  401 (568)
                                                ...++|+|+++.|||++.++.  +.|.||+.+..-.
T Consensus       189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~  250 (359)
T 3dxp_A          189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH  250 (359)
T ss_dssp             HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred             cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence                                      257999999999999987753  6899999987643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.80  E-value=4.9e-09  Score=105.46  Aligned_cols=182  Identities=16%  Similarity=0.171  Sum_probs=121.2

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-CCc--eeeEEEEEEeCC---eEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-HKH--LVHLVGWCHEKG---KLL  320 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--Iv~l~g~~~~~~---~~~  320 (568)
                      +.++.|....||+.           +..+++|.....  .....+.+|.++++.+. +..  +.+++......+   ..+
T Consensus        26 ~~~~~G~~n~v~~v-----------~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~   92 (304)
T 3sg8_A           26 EISGEGNDCIAYEI-----------NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSF   92 (304)
T ss_dssp             CEEEECSSEEEEES-----------TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSC
T ss_pred             EecCCCCcceEEEE-----------CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcce
Confidence            45899999999985           235888886432  33567889999998873 332  345555543333   348


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE----------------------------------  366 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------------  366 (568)
                      +|||++++.+|.....     ..++..++..++.++++.|+.||..                                  
T Consensus        93 ~vm~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           93 AGFTKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             EEEECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             EEEcccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            8999999988875432     3467777888888888888888851                                  


Q ss_pred             ---------------------CCCCeEecCCCCCCEEEcC--CCcEEEeecCCccccccccccccccccccCCcCCcc--
Q 008374          367 ---------------------YDQKVVHRDLKASNILLDA--DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGY--  421 (568)
Q Consensus       367 ---------------------~~~~ivHrDikp~NILld~--~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y--  421 (568)
                                           ....++|+|+++.||++++  +..+.|.||+.+...+....-         .....+  
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl---------~~~~~~~~  238 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF---------ISLMEDDE  238 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH---------HTTCCTTT
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH---------HHHHhhcc
Confidence                                 0145899999999999998  566899999998765332100         000011  


Q ss_pred             -cCcccccc-----CCC---------CccchhHHHHHHHHHHHhCCCCC
Q 008374          422 -VAPECFHT-----GKA---------TPESDVFGFGAVVLEVVCGRSPG  455 (568)
Q Consensus       422 -~APE~~~~-----~~~---------t~~sDV~SfGvll~el~tG~~P~  455 (568)
                       ..|+....     +..         ....+.|+++.++|++.+|..++
T Consensus       239 ~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          239 EYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             SCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             ccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             12221110     111         11258999999999999998653

>2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A

Probab=98.63  E-value=2.6e-08  Score=95.02  Aligned_cols=131  Identities=15%  Similarity=0.226  Sum_probs=75.0

Q ss_pred             CCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCC-----CCCCCeeeEecCCccccccccC
Q 008374           11 ISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGF-----DPDDNHLGLNINSVVSRKNVPL   85 (568)
Q Consensus        11 ~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~-----d~~~~hvgidins~~s~~~~~~   85 (568)
                      .+||||||.+++....+   ..|..+|..+.- +|      +||+|||+.|..     ..|+.|..+|.++..   +..+
T Consensus        77 ~~gdGlA~W~t~~~~~~---~~g~~~G~~~~f-~G------L~I~~Dt~~n~~p~i~~~~ndG~~~yd~~~~~---~~~~  143 (222)
T 2a6z_A           77 QTDGGISFWFVQDSNIP---RDKQLYNGPVNY-DG------LQLLVDNNGPLGPTLRGQLNDGQKPVDKTKIY---DQSF  143 (222)
T ss_dssp             CCSCEEEEEEEECSSSC---CCCTBTTBCTTC-EE------EEEEEESCSTTSSEEEEEEEESSSCCCGGGHH---HHCS
T ss_pred             CCCCEEEEEEECCCccc---CCCcccCCCCCC-CE------EEEEEECCCCCCceEEEEECCCCeeeccCCCc---cccc
Confidence            47999999999864311   223333432211 11      699999988721     122333333332200   1111


Q ss_pred             CC-CcccccCCCceEEEEEEEc-CcccEEEEEEeeCCCCCCCCCeeeE-eeCccccCCCcc-cccccccCC---Cccccc
Q 008374           86 KD-NYNITLSDGTSYTVWVQYD-GKSKLIQVFMDREGETMPQKPLLKE-TINLKDYLKPES-YFGFSASTG---YPHIQL  158 (568)
Q Consensus        86 ~~-~~~~~l~~g~~~~~~I~Yd-~~~~~l~v~~~~~~~~~~~~~~~~~-~~dl~~~l~~~~-~vGfsastG---~~~~~~  158 (568)
                      +. ...+. ..+.+.+++|+|+ ...+.|.|.++.       +.++.. .++    ||... |+||||+||   . ..+.
T Consensus       144 ~~C~~~~r-n~~~~~~~rI~Y~~~~~~~l~v~id~-------~~C~~~~~v~----LP~~~~y~G~SA~TG~l~~-~~d~  210 (222)
T 2a6z_A          144 ASCLMGYQ-DSSVPSTIRVTYDLEDDNLLKVQVDN-------KVCFQTRKVR----FPSGSYRIGVTAQNGAVNN-NAES  210 (222)
T ss_dssp             EEEECCCT-TEEEEEEEEEEEEGGGTSEEEEEETT-------EEEEEESCCC----CCSSEEEEEEEEECCSGGG-CCCE
T ss_pred             cccceecc-CCCCcEEEEEEEEcCCCcEEEEEEcC-------eEEEEeCCee----cCCCCcEEEEEEcCCCCCC-CCcc
Confidence            11 01111 2467889999999 667788888854       223222 233    46564 699999999   5 6677


Q ss_pred             ccccccccc
Q 008374          159 NCVRSWTLD  167 (568)
Q Consensus       159 ~~i~sWs~~  167 (568)
                      |.+++|++.
T Consensus       211 hdil~~~~~  219 (222)
T 2a6z_A          211 FEIFKMQFF  219 (222)
T ss_dssp             EEEEEEEEE
T ss_pred             EEEEEEEEE
Confidence            888887754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.36  E-value=2.2e-06  Score=84.07  Aligned_cols=136  Identities=17%  Similarity=0.155  Sum_probs=96.0

Q ss_pred             eeccCCce-eEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-CCceeeEEEEEEeCCeEEEEEEe
Q 008374          248 RLGEGGFG-IVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-HKHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       248 ~LG~G~fG-~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      .+..|..| .||+-....      .+..+++|+-...   ...++.+|...|+.+. +--+.++++++.+.+..++|||+
T Consensus        31 ~~~~G~S~~~v~rl~~~~------~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~  101 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKP------NAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTA  101 (272)
T ss_dssp             EEECSSSSCEEEEEECCT------TCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             EccCCCcCCeEEEEEecC------CCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEe
Confidence            34556555 689876543      4567889986533   3456788999988774 33467889999999999999999


Q ss_pred             cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 008374          326 MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY--------------------------------------  367 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--------------------------------------  367 (568)
                      +++.++.+....       .......+..+++..|.-||...                                      
T Consensus       102 l~G~~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (272)
T 4gkh_A          102 IPGKTAFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW  174 (272)
T ss_dssp             CCSEEHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred             eCCccccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence            999887765421       11223345566666666666210                                      


Q ss_pred             -----------------CCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          368 -----------------DQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       368 -----------------~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                                       ...++|+|+.+.|||++.++.+-|.||+.+..
T Consensus       175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                             12389999999999999887778999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.24  E-value=6.6e-06  Score=82.67  Aligned_cols=137  Identities=17%  Similarity=0.156  Sum_probs=92.8

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCC---ceeeEEEEEE-eCCeEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHK---HLVHLVGWCH-EKGKLLLV  322 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~g~~~-~~~~~~lV  322 (568)
                      ..++.|....||+.           +..+++|.-..  ......+.+|.++|..+.+.   .+.+++.++. ..+..++|
T Consensus        25 ~~l~~G~~n~v~~v-----------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v   91 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVG   91 (306)
T ss_dssp             EEEEECSSEEEEEE-----------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEE
T ss_pred             eecCCCcceeEEEE-----------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEE
Confidence            45788888899986           23478887422  23346788999999998652   3566777764 34567899


Q ss_pred             EEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhc------------------------------------
Q 008374          323 YDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE------------------------------------  366 (568)
Q Consensus       323 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------  366 (568)
                      |||+++..|.+...     ..++..++..++.++++.|..||..                                    
T Consensus        92 ~e~i~G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~  166 (306)
T 3tdw_A           92 YRKVQGQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDE  166 (306)
T ss_dssp             EECCCSEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCH
T ss_pred             EeccCCeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccch
Confidence            99999988876321     1233444444555555555555432                                    


Q ss_pred             ---------------------CCCCeEecCCCCCCEEEcC---CCc-EEEeecCCccccc
Q 008374          367 ---------------------YDQKVVHRDLKASNILLDA---DFN-ARLGDFGLARAIE  401 (568)
Q Consensus       367 ---------------------~~~~ivHrDikp~NILld~---~~~-~kL~DFGla~~~~  401 (568)
                                           ....++|+|+++.|||++.   ++. ..|.||+.+..-+
T Consensus       167 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          167 SLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             hhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                                 2346799999999999987   355 5899999887543

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.20  E-value=5.8e-06  Score=84.71  Aligned_cols=87  Identities=5%  Similarity=-0.035  Sum_probs=57.0

Q ss_pred             cee-ccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCC-C--CceeeEEEEEEeC---
Q 008374          247 MRL-GEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLR-H--KHLVHLVGWCHEK---  316 (568)
Q Consensus       247 ~~L-G~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~nIv~l~g~~~~~---  316 (568)
                      +.| +.|....+|+............+..+++|+.....   ......+.+|..+++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            457 78888999987653000000015678888865432   112356888999998884 2  3567788888665   


Q ss_pred             CeEEEEEEecCCCChhh
Q 008374          317 GKLLLVYDFMPNGSLEK  333 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~  333 (568)
                      +..++||||+++..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999877654

>1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1

Probab=98.16  E-value=1e-06  Score=74.29  Aligned_cols=33  Identities=39%  Similarity=0.438  Sum_probs=27.6

Q ss_pred             CCCCCCCcEEEEEccCCCCCCCCCCCcceecccCC
Q 008374            8 AWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAF   42 (568)
Q Consensus         8 ~~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~   42 (568)
                      ....+||||||||+|..+. |. +.||||||+|.+
T Consensus        80 ~~~~~gdGlAF~lap~~~~-p~-s~g~~LGL~n~~  112 (113)
T 1qmo_A           80 YTSRIADGLAFFIAPPDSV-IS-YHGGFLGLFPNA  112 (113)
T ss_dssp             SSSCCCCEEEEEEECTTCC-CC-CCGGGTTTCSSC
T ss_pred             CCCCCCCeEEEEecCCCCC-CC-CCccccccccCC
Confidence            3456899999999998776 44 899999999864

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.86  E-value=4.7e-05  Score=79.20  Aligned_cols=76  Identities=11%  Similarity=0.110  Sum_probs=49.2

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-------ccchhhHHHHHHhhcCCC--Cc-eeeEEEEEEe
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-------KSKGDFLAELAIIHRLRH--KH-LVHLVGWCHE  315 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~n-Iv~l~g~~~~  315 (568)
                      .+.||.|.++.||++....      .+..++||.......       .....+..|.+++..+..  +. +.+++.+  +
T Consensus        35 ~~~lg~G~~n~vyrv~~~~------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d  106 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQE------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D  106 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred             EEECCCCceEEEEEEEECC------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c
Confidence            4578999999999997642      357899998643211       123456789888887732  33 4456554  3


Q ss_pred             CCeEEEEEEecCCC
Q 008374          316 KGKLLLVYDFMPNG  329 (568)
Q Consensus       316 ~~~~~lV~Ey~~~g  329 (568)
                      .+..++||||+++.
T Consensus       107 ~~~~~lvmE~l~g~  120 (397)
T 2olc_A          107 TEMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTTEEEECCCTTS
T ss_pred             CCccEEEEEeCCCc
Confidence            44568999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.76  E-value=0.00015  Score=73.21  Aligned_cols=141  Identities=15%  Similarity=0.210  Sum_probs=80.0

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-----CCceeeEE-E--EEEeCCe
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-----HKHLVHLV-G--WCHEKGK  318 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~l~-g--~~~~~~~  318 (568)
                      ..|+.|..+.||+....        +..+++|+....    ..+...|..++..+.     .|.++... |  +....+.
T Consensus        38 ~~l~gG~~n~~~~v~~~--------~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~  105 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD--------SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSF  105 (346)
T ss_dssp             EECC----CEEEEEEET--------TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTE
T ss_pred             eeccccccCcEEEEEeC--------CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCE
Confidence            34666778899998653        345899998652    223344555555442     34443311 1  1234677


Q ss_pred             EEEEEEecCCCChh--------------hhhccC------CC-----cccCCHHHHH-----------------------
Q 008374          319 LLLVYDFMPNGSLE--------------KYLYGT------SE-----QVTLNWNHRY-----------------------  350 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~--------------~~L~~~------~~-----~~~l~~~~~~-----------------------  350 (568)
                      .+++|||+++..+.              ..+|..      ..     ...-.|...+                       
T Consensus       106 ~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  185 (346)
T 2q83_A          106 LFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFS  185 (346)
T ss_dssp             EEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHH
T ss_pred             EEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHH
Confidence            89999999987653              111110      00     0012332211                       


Q ss_pred             --------HHHHHHHHHHHHHHh----------cCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          351 --------KILTGVASAVYYLQN----------EYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       351 --------~i~~~ia~~L~yLH~----------~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                              .+...+..++.+|+.          .....++|+|+++.|||++.++.+.|.||+.+..
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          186 QLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence                    011223445666663          1367899999999999998888999999997753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.60  E-value=0.00023  Score=70.38  Aligned_cols=79  Identities=19%  Similarity=0.240  Sum_probs=57.3

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCC---CceeeEEEEEEeCCe
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRH---KHLVHLVGWCHEKGK  318 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~g~~~~~~~  318 (568)
                      .+.....+|.|..+.||+.++.       +|+.+.+|+...........|..|...|+.|.-   --+.+++++.    .
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~   84 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----D   84 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----T
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----C
Confidence            4555677999999999999886       688999998765544445568899999888742   1344555543    2


Q ss_pred             EEEEEEecCCCCh
Q 008374          319 LLLVYDFMPNGSL  331 (568)
Q Consensus       319 ~~lV~Ey~~~gsL  331 (568)
                      -++||||++.+..
T Consensus        85 ~~lv~e~l~~~~~   97 (288)
T 3f7w_A           85 RTLAMEWVDERPP   97 (288)
T ss_dssp             TEEEEECCCCCCC
T ss_pred             ceEEEEeecccCC
Confidence            3789999987654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.55  E-value=0.00062  Score=68.30  Aligned_cols=139  Identities=14%  Similarity=0.132  Sum_probs=91.9

Q ss_pred             ccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC---CCceeeEEEEEEeCCeEEE
Q 008374          245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR---HKHLVHLVGWCHEKGKLLL  321 (568)
Q Consensus       245 ~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~l  321 (568)
                      ..+.|+.|....+|+...        ++..+++|+....   ....|..|...|+.|.   ...+.+++.++...+..++
T Consensus        40 ~~~~l~gG~~n~~y~v~~--------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~l  108 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFL  108 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEE
T ss_pred             eeEEeCCccceeeeEEEE--------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEE
Confidence            345689999999999764        3567889987543   3556888998888873   3568889999888889999


Q ss_pred             EEEecCCCChhh-----------hhccCCC--c-----------------ccCCHHHHH---HHHH--------------
Q 008374          322 VYDFMPNGSLEK-----------YLYGTSE--Q-----------------VTLNWNHRY---KILT--------------  354 (568)
Q Consensus       322 V~Ey~~~gsL~~-----------~L~~~~~--~-----------------~~l~~~~~~---~i~~--------------  354 (568)
                      ||||+++..+..           .||....  .                 -.-+|...+   ++..              
T Consensus       109 vme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~  188 (312)
T 3jr1_A          109 LLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGN  188 (312)
T ss_dssp             EEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSC
T ss_pred             EEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHH
Confidence            999999876532           1222111  0                 012454322   1111              


Q ss_pred             --HHHHH-HHHHHh-cCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          355 --GVASA-VYYLQN-EYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       355 --~ia~~-L~yLH~-~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                        .+... ...|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus       189 ~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          189 IDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence              11111 123321 2256899999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.34  E-value=0.00054  Score=71.71  Aligned_cols=81  Identities=12%  Similarity=0.028  Sum_probs=50.2

Q ss_pred             CCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccC---CCCccchhHHHHH
Q 008374          367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG---KATPESDVFGFGA  443 (568)
Q Consensus       367 ~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~---~~t~~sDV~SfGv  443 (568)
                      ....++|+|+++.|||++.++ ++|.||+.+..-.....-...    ...-...|++|+.....   ......++.....
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~----l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAY----LGNLILAFFAQDGHATQENDRKEYKQWILRTIE  304 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHH----HHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHH----HHHHHHHHHhcccccccccchHHHHHHHHHHHH
Confidence            367899999999999998876 999999998765432110000    00001345666655321   1122355667888


Q ss_pred             HHHHHHhCC
Q 008374          444 VVLEVVCGR  452 (568)
Q Consensus       444 ll~el~tG~  452 (568)
                      .+|+.++++
T Consensus       305 ~~~~~y~~~  313 (420)
T 2pyw_A          305 QTWNLFNKR  313 (420)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            888887754

>2a6v_A EMP46P; beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.52A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a6w_A 2a6x_A

Probab=97.18  E-value=0.0015  Score=61.88  Aligned_cols=57  Identities=16%  Similarity=0.175  Sum_probs=39.6

Q ss_pred             CCceEEEEEEEc-CcccEEEEEEeeCCCCCCCCCeeeE-eeCccccCCCcc--cccccccCCCcccccccccc
Q 008374           95 DGTSYTVWVQYD-GKSKLIQVFMDREGETMPQKPLLKE-TINLKDYLKPES--YFGFSASTGYPHIQLNCVRS  163 (568)
Q Consensus        95 ~g~~~~~~I~Yd-~~~~~l~v~~~~~~~~~~~~~~~~~-~~dl~~~l~~~~--~vGfsastG~~~~~~~~i~s  163 (568)
                      .+.+.+++|.|+ ...+.|.|.++.       +.++.. .++    ||...  |+||||+||. ..+.|-+++
T Consensus       154 ~~~~t~~ri~Y~~~~~~~l~v~id~-------~~Cf~~~~v~----LP~g~~~yfGiSAaTg~-~~D~hdils  214 (226)
T 2a6v_A          154 SMVPSTLRLTYNPLDNHLLKLQMDN-------RVCFQTRKVK----FMGSSPFRIGTSAINDA-SKESFEILK  214 (226)
T ss_dssp             CSSCEEEEEEEEGGGTSEEEEEETT-------EEEEEESCCC----GGGTSCBEEEEEEECCT-TCCEEEEEE
T ss_pred             CCCCEEEEEEEEccCCCEEEEEEcC-------CeeEEECCee----cCCCCccEEEEEEcCCC-CcccEEEEE
Confidence            467889999997 456789998853       123331 123    35555  9999999997 777777664

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.16  E-value=0.0016  Score=65.18  Aligned_cols=160  Identities=16%  Similarity=0.181  Sum_probs=90.3

Q ss_pred             ccCHHHHHHHhcCccc-----cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCC
Q 008374          230 EFKYKELKKATNNFHE-----SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHK  304 (568)
Q Consensus       230 ~~~~~el~~at~~f~~-----~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~  304 (568)
                      .++.+++......|..     .+.|+.|....+|+....        +..+++|.....  ....++..|..++..+...
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~--------~g~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~   75 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT--------KDPLILTLYEKR--VEKNDLPFFLGLMQHLAAK   75 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES--------SCCEEEEEECC-----CCHHHHHHHHHHHHHHT
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC--------CccEEEEEeCCC--CCHHHHHHHHHHHHHHHHC
Confidence            3555667666666654     234667888899998653        236889988652  1234566777777766321


Q ss_pred             c--eeeEEEE------EEeCCeEEEEEEecCCCChhh--------------hhccC------CC---cccCCHHHHHHH-
Q 008374          305 H--LVHLVGW------CHEKGKLLLVYDFMPNGSLEK--------------YLYGT------SE---QVTLNWNHRYKI-  352 (568)
Q Consensus       305 n--Iv~l~g~------~~~~~~~~lV~Ey~~~gsL~~--------------~L~~~------~~---~~~l~~~~~~~i-  352 (568)
                      .  +.+++..      ....+..+++++|+++..+..              .+|..      ..   .....|...+.- 
T Consensus        76 g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~  155 (322)
T 2ppq_A           76 GLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKS  155 (322)
T ss_dssp             TCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHH
T ss_pred             CCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHH
Confidence            2  2233311      123467799999998866432              01110      00   001123321110 


Q ss_pred             -----------HHHHHHHHHHHHhcC----CCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          353 -----------LTGVASAVYYLQNEY----DQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       353 -----------~~~ia~~L~yLH~~~----~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                                 ...+...+.+++...    ...++|+|+.+.|||++++..+.|.||+.+..
T Consensus       156 ~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          156 EERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             GGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                       112445566665432    35799999999999999876668999987753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.80  E-value=0.0067  Score=60.99  Aligned_cols=33  Identities=33%  Similarity=0.360  Sum_probs=28.7

Q ss_pred             CCCeEecCCCCCCEEEcCC----CcEEEeecCCcccc
Q 008374          368 DQKVVHRDLKASNILLDAD----FNARLGDFGLARAI  400 (568)
Q Consensus       368 ~~~ivHrDikp~NILld~~----~~~kL~DFGla~~~  400 (568)
                      ...++|+|+.+.|||++.+    ..+.|.||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            5689999999999999875    68999999988754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.75  E-value=0.0023  Score=67.20  Aligned_cols=79  Identities=15%  Similarity=0.276  Sum_probs=49.9

Q ss_pred             ceeccCCceeEEEEEEccCcc-ccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCce-eeEEEEEEeCCeEEEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQ-YHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHL-VHLVGWCHEKGKLLLVYD  324 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E  324 (568)
                      +.|+.|-...+|+........ ....+..+++|+....  .....+..|..++..+...++ .++++.+..    .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            457888889999987652100 0012467889887432  111456789998888753333 567776542    28999


Q ss_pred             ecCCCCh
Q 008374          325 FMPNGSL  331 (568)
Q Consensus       325 y~~~gsL  331 (568)
                      |+++.+|
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9986554

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.70  E-value=0.0071  Score=59.97  Aligned_cols=139  Identities=11%  Similarity=0.086  Sum_probs=75.4

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCce-eeEEEEEEeCCeEEEEEE
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHL-VHLVGWCHEKGKLLLVYD  324 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E  324 (568)
                      .+.|+.|....+|+.  .          .+++|+..... ....+..+|..+++.+....+ .++++++  .+.-++++|
T Consensus        23 i~~l~gG~tN~~~~~--~----------~~vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e   87 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA--G----------DLCLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTR   87 (301)
T ss_dssp             CEEEESCSSEEEEEE--T----------TEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEE
T ss_pred             eeEcCCcccccccee--e----------eEEEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEe
Confidence            567888999999997  2          37888875432 222334678877777642222 4555543  333478999


Q ss_pred             ec-CCCChhhh------------------hccCCCc--ccCCH-HHHHHHHH--------------HHHHHHH----HHH
Q 008374          325 FM-PNGSLEKY------------------LYGTSEQ--VTLNW-NHRYKILT--------------GVASAVY----YLQ  364 (568)
Q Consensus       325 y~-~~gsL~~~------------------L~~~~~~--~~l~~-~~~~~i~~--------------~ia~~L~----yLH  364 (568)
                      |+ ++.+|...                  +|.....  ..... ........              .+...+.    .|.
T Consensus        88 ~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~  167 (301)
T 3dxq_A           88 YIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALA  167 (301)
T ss_dssp             CCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHH
T ss_pred             ecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHH
Confidence            99 66555321                  1111100  00111 11101000              0111111    111


Q ss_pred             h-cCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          365 N-EYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       365 ~-~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      . .....++|+|+.+.||+ ..++.+.|.||..+..-
T Consensus       168 ~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          168 AHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             SSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             hcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            1 12346899999999999 56677899999988653

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.62  E-value=0.018  Score=60.87  Aligned_cols=75  Identities=13%  Similarity=0.080  Sum_probs=47.8

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCce-eeEEEEEEeCCeEEEEEEe
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHL-VHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey  325 (568)
                      +.|+.|-...+|+.....      .+..+++|+..... ...-+..+|..++..|...++ .++++.+.  +  .+||||
T Consensus       114 ~~lsgG~tN~~y~v~~~~------~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~  182 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMS------KQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEF  182 (458)
T ss_dssp             EEECC--CEEEEEEEETT------TTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEEC
T ss_pred             EEcCCCeEeEEEEEEECC------CCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEe
Confidence            468888889999987642      24678888874432 122223589999988865444 46777663  2  259999


Q ss_pred             cCCCChh
Q 008374          326 MPNGSLE  332 (568)
Q Consensus       326 ~~~gsL~  332 (568)
                      +++.+|.
T Consensus       183 I~G~~l~  189 (458)
T 2qg7_A          183 MDGYALS  189 (458)
T ss_dssp             CCSEECC
T ss_pred             eCCccCC
Confidence            9876553

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.61  E-value=0.017  Score=57.73  Aligned_cols=159  Identities=18%  Similarity=0.168  Sum_probs=88.4

Q ss_pred             cCHHHHHHHhcCccc-----cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCC-
Q 008374          231 FKYKELKKATNNFHE-----SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHK-  304 (568)
Q Consensus       231 ~~~~el~~at~~f~~-----~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~-  304 (568)
                      .+.+++..+.+.|..     ...|+ |....||+....       +++.+++|...... .....+..|..++..+... 
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-------~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g   81 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDE   81 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTT
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-------CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcC
Confidence            444555555444432     23466 778899987543       35579999986331 1334566787777766321 


Q ss_pred             -ceeeEEEE-----EEeCCeEEEEEEecCCCChhh----h----------hcc----CC--CcccCCHHHH----HHH--
Q 008374          305 -HLVHLVGW-----CHEKGKLLLVYDFMPNGSLEK----Y----------LYG----TS--EQVTLNWNHR----YKI--  352 (568)
Q Consensus       305 -nIv~l~g~-----~~~~~~~~lV~Ey~~~gsL~~----~----------L~~----~~--~~~~l~~~~~----~~i--  352 (568)
                       .+.+++..     ....+..+++|||+++..+..    .          +|.    ..  ....+++...    ..+  
T Consensus        82 ~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~  161 (328)
T 1zyl_A           82 VPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFE  161 (328)
T ss_dssp             CSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHH
T ss_pred             CeecceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHh
Confidence             23334332     223556789999998765431    0          111    00  0112222211    001  


Q ss_pred             -------------HHHHHHHHHHHHhc----CCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          353 -------------LTGVASAVYYLQNE----YDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       353 -------------~~~ia~~L~yLH~~----~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                                   ...+...+..+...    ....++|+|+++.|||++ + .+.|.||+.+..-
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          162 DATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             TCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             hcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence                         11112223333322    245789999999999999 4 8999999987643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.56  E-value=0.0068  Score=62.41  Aligned_cols=149  Identities=13%  Similarity=0.173  Sum_probs=83.3

Q ss_pred             ceeccCCceeEEEEEEccCc-cccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-CCceeeEEEEEEeCCeEEEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHND-QYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-HKHLVHLVGWCHEKGKLLLVYD  324 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E  324 (568)
                      +.|..|-...+|+....... ....++..+++|+.... ......+.+|.++++.+. +.-..++++.+.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            35666777889998764210 00113468899886332 223456678999988774 2223566766643    29999


Q ss_pred             ecCCCChhhh-----------------hccCCC--cccCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 008374          325 FMPNGSLEKY-----------------LYGTSE--QVTLN--WNHRYKILTGVA-------------------SAVYYLQ  364 (568)
Q Consensus       325 y~~~gsL~~~-----------------L~~~~~--~~~l~--~~~~~~i~~~ia-------------------~~L~yLH  364 (568)
                      |+++..|..-                 ||....  .....  |.+..++..++.                   ..+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998665421                 111100  11112  334444433321                   1233332


Q ss_pred             h-----cCCCCeEecCCCCCCEEEcCC----CcEEEeecCCcccc
Q 008374          365 N-----EYDQKVVHRDLKASNILLDAD----FNARLGDFGLARAI  400 (568)
Q Consensus       365 ~-----~~~~~ivHrDikp~NILld~~----~~~kL~DFGla~~~  400 (568)
                      .     .....++|+|+.+.|||++.+    +.+.|.||..+..-
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~  255 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN  255 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence            1     123479999999999999876    78999999988653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.29  E-value=0.014  Score=59.62  Aligned_cols=148  Identities=12%  Similarity=0.163  Sum_probs=77.2

Q ss_pred             ceeccCCceeEEEEEEccCcc--ccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCc-eeeEEEEEEeCCeEEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQ--YHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKH-LVHLVGWCHEKGKLLLVY  323 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~  323 (568)
                      ..|+.|....+|+......+.  ....+..+++|+..... ....+...|..++..+...+ ..++++..  .+  ++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence            457778888999987642100  00012578888865432 22223467888888774333 34666543  22  6899


Q ss_pred             EecCCCChhhh-----------------hccCCC----cccCC-----HHHHHHH--------------------HHHHH
Q 008374          324 DFMPNGSLEKY-----------------LYGTSE----QVTLN-----WNHRYKI--------------------LTGVA  357 (568)
Q Consensus       324 Ey~~~gsL~~~-----------------L~~~~~----~~~l~-----~~~~~~i--------------------~~~ia  357 (568)
                      ||+++..+...                 +|....    ...+.     |.....+                    ...+.
T Consensus       114 e~i~G~~l~~~~~~~~~~~~~~a~~La~lH~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (369)
T 3c5i_A          114 EWLYGDPLRIDDLKNPTILIGIANVLGKFHTLSRKRHLPEHWDRTPCIFKMMEKWKNQLFKYKNIEKYNCDIHKYIKESD  193 (369)
T ss_dssp             ECCCSEECCGGGGGCHHHHHHHHHHHHHHHTHHHHSCCCTTSCCSCHHHHHHHHHHHHHTTCSSGGGC-CCHHHHHHHHH
T ss_pred             EEecCCcCChhhcCChHHHHHHHHHHHHHHcCcccccCcccCCCCCcHHHHHHHHHHHHhhhhhHHHHHhhHHHHHHHHH
Confidence            99987654210                 111000    00011     1111111                    11122


Q ss_pred             HHHHHHHh-------cCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          358 SAVYYLQN-------EYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       358 ~~L~yLH~-------~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      ..+.+|..       .....++|+|+.+.|||++++. +.|+||..+..-
T Consensus       194 ~l~~~l~~~~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~g  242 (369)
T 3c5i_A          194 KFIKFMKVYSKSDNLANTIVFCHNDLQENNIINTNKC-LRLIDFEYSGFN  242 (369)
T ss_dssp             HHHHHHHHHTTSSCGGGCEEEECSCCCGGGEEECC-C-EEECCCTTCEEE
T ss_pred             HHHHHHHHhhhhcccCCCeEEEeCCCCcccEEecCCc-EEEEEecCCCCC
Confidence            23344432       1235799999999999998655 899999988653

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.34  E-value=0.11  Score=52.19  Aligned_cols=34  Identities=18%  Similarity=0.249  Sum_probs=29.4

Q ss_pred             CCCeEecCCCCCCEEEcCCCcEEEeecCCccccc
Q 008374          368 DQKVVHRDLKASNILLDADFNARLGDFGLARAIE  401 (568)
Q Consensus       368 ~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~  401 (568)
                      ...++|+|+.+.||++++++.+.|.||+.+....
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence            3579999999999999988889999998877543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.20  E-value=0.18  Score=47.22  Aligned_cols=170  Identities=13%  Similarity=0.068  Sum_probs=90.0

Q ss_pred             CCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccccccc
Q 008374          328 NGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY  407 (568)
Q Consensus       328 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~  407 (568)
                      .-||.+.|..  ...+++..+.+.++.|.+.+|.-+-.  .+.-..+=+.|..|+|..+|++.+.+ ..+.         
T Consensus        32 ~vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           32 ALSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             cccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc---------
Confidence            3478888853  24579999999999999999866521  11111334457899999999988764 1110         


Q ss_pred             cccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhh
Q 008374          408 AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQR  487 (568)
Q Consensus       408 ~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  487 (568)
                              .....+.|||... ...+.+.=|||+|+++|.-+-=..|-+  .+.+....|-..+..+.....-....|+.
T Consensus        98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~--eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG  166 (229)
T 2yle_A           98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN--EERELSPPLEQLIDHMANTVEADGSNDEG  166 (229)
T ss_dssp             -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT--EEECCCHHHHHHHHHHTTCCC--------
T ss_pred             --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc--cchhhCHHHHHHHHHHHhccccccccccc
Confidence                    0112356788763 455678899999999999886443322  11111112322222222211111123333


Q ss_pred             cCCC--CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC
Q 008374          488 LNIN--SVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVP  532 (568)
Q Consensus       488 l~~~--~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~p  532 (568)
                      +...  .+.++-.          ...+..|++.++|++.-....+.|
T Consensus       167 ~~~~~eg~~d~~~----------~~~~~~~~sl~~Vi~~C~~hl~~p  203 (229)
T 2yle_A          167 YEAAEEGLGDEDE----------KRKISAIRSYRDVMKLCAAHLPTE  203 (229)
T ss_dssp             ------------C----------CSCCCCCCSHHHHHHHHHTTSSSG
T ss_pred             ccccccccccccc----------cccccCcCCHHHHHHHHHhhccCc
Confidence            3210  0000000          245789999999999988876655

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.52  E-value=0.35  Score=50.26  Aligned_cols=148  Identities=14%  Similarity=0.178  Sum_probs=84.4

Q ss_pred             ceeccCCceeEEEEEEccCcc-ccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCc-eeeEEEEEEeCCeEEEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQ-YHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKH-LVHLVGWCHEKGKLLLVYD  324 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~E  324 (568)
                      +.|..|-...+|+........ ....+..+++++..... ...-+..+|..+++.+.-.+ ..++++.+  .+  ++|||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence            457677788999987752110 00115788998864432 22334568888888774222 34566533  22  78999


Q ss_pred             ecCCCChhhh-----------------hccC-------C---CcccCCHHHHHHHHHH-------------------HHH
Q 008374          325 FMPNGSLEKY-----------------LYGT-------S---EQVTLNWNHRYKILTG-------------------VAS  358 (568)
Q Consensus       325 y~~~gsL~~~-----------------L~~~-------~---~~~~l~~~~~~~i~~~-------------------ia~  358 (568)
                      |+++..|..-                 ||..       .   .....-|.+..+...+                   +..
T Consensus       151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  230 (424)
T 3mes_A          151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE  230 (424)
T ss_dssp             CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred             EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence            9998765321                 1110       0   0111123333332222                   122


Q ss_pred             HHHHHHh---------------------cCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          359 AVYYLQN---------------------EYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       359 ~L~yLH~---------------------~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      .+.+|..                     .....++|+|+.+.||+ +.++.+.|.||..|..-
T Consensus       231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~  292 (424)
T 3mes_A          231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN  292 (424)
T ss_dssp             HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence            2333321                     11346899999999999 88889999999998754

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=86.39  E-value=0.48  Score=48.79  Aligned_cols=31  Identities=29%  Similarity=0.305  Sum_probs=26.0

Q ss_pred             CeEecCCCCCCEEE------cCCCcEEEeecCCcccc
Q 008374          370 KVVHRDLKASNILL------DADFNARLGDFGLARAI  400 (568)
Q Consensus       370 ~ivHrDikp~NILl------d~~~~~kL~DFGla~~~  400 (568)
                      .++|+|+.+.|||+      +++..++++||.+|..-
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            36799999999999      45678999999988653

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.26  E-value=0.085  Score=55.71  Aligned_cols=61  Identities=7%  Similarity=0.066  Sum_probs=17.3

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEE------EEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEe
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAV------KKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE  315 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  315 (568)
                      .++||   ||.||+|.+..      ...+|||      |.....  +.+....|.+|..++..++|||+++.+++...
T Consensus       147 ~~~lG---fG~v~~g~~~~------~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYK------KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             TTTSS---BCCC---------------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccCC---chhhhcccccc------cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            34566   99999999964      2357888      766543  22344578899999999999999999887653

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=81.72  E-value=0.45  Score=32.09  Aligned_cols=16  Identities=25%  Similarity=0.324  Sum_probs=7.2

Q ss_pred             HHHHHHHHHHHHhhcc
Q 008374          195 VLLVLCAIAYVKKRRS  210 (568)
Q Consensus       195 ~~~~~~~~~~~~~rr~  210 (568)
                      +++++.+++|.||||.
T Consensus        25 vi~~l~~~~~~RRR~~   40 (44)
T 2jwa_A           25 VVLGVVFGILIKRRQQ   40 (44)
T ss_dssp             HHHHHHHHHHHHHHCS
T ss_pred             HHHHHHHHhheehhhh
Confidence            3334444445554443

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=81.39  E-value=2.9  Score=38.97  Aligned_cols=115  Identities=10%  Similarity=0.033  Sum_probs=75.5

Q ss_pred             CCCceeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCCC
Q 008374          302 RHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVY-YLQNEYDQKVVHRDLKASN  380 (568)
Q Consensus       302 ~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~-yLH~~~~~~ivHrDikp~N  380 (568)
                      .||+.  -..+-.+.+.+.+.|+.-+++.=...+      ..++...+++++..|+.... ++     ..-+|--+.|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~-----~~r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHS-----ARRLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCC-----SSSEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhh-----hCceeEEEeCce
Confidence            67777  334446677777777765343222233      35777888888888776654 33     366888999999


Q ss_pred             EEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008374          381 ILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGN  456 (568)
Q Consensus       381 ILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~  456 (568)
                      +++|.++.++|.-.|+-..                      ++|.-+     +..-=.-.+=+++..++.++..|+
T Consensus       115 L~f~~~~~p~i~hRGi~~~----------------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKES----------------------LPPDEW-----DDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EEECTTCCEEESCCEETTT----------------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EEEeCCCcEEEEEcCCccc----------------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999987775332                      233221     111123467778888888887664

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=80.86  E-value=1.5  Score=29.49  Aligned_cols=11  Identities=27%  Similarity=0.594  Sum_probs=4.5

Q ss_pred             HHHHHHHHhhc
Q 008374          199 LCAIAYVKKRR  209 (568)
Q Consensus       199 ~~~~~~~~~rr  209 (568)
                      +.+++|.|+|+
T Consensus        28 ~~~~~~~RRRr   38 (44)
T 2l2t_A           28 LTFAVYVRRKS   38 (44)
T ss_dssp             HHHHHHHHTTC
T ss_pred             HHHHHHhhhhh
Confidence            33344444443

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=80.58  E-value=1.1  Score=30.33  Aligned_cols=11  Identities=18%  Similarity=0.392  Sum_probs=4.6

Q ss_pred             HHHHHHHHhhc
Q 008374          199 LCAIAYVKKRR  209 (568)
Q Consensus       199 ~~~~~~~~~rr  209 (568)
                      +.+++|.|+|+
T Consensus        29 ~~~~~~~RRr~   39 (44)
T 2ks1_B           29 LGIGLFMRRRH   39 (44)
T ss_dssp             HHHHHHHHTTT
T ss_pred             HHHHHHhhhhH
Confidence            33344444443

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	568
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-57
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-55
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-54
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-53
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-53
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-52
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-52
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-51
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-51
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-51
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-51
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-49
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-49
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-49
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-49
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-48
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-48
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-48
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-47
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-47
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-47
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-47
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-46
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-45
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-45
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-45
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-45
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-43
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-43
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-42
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-41
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-40
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-39
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-39
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-39
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-39
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-37
d1hqla_	236	b.29.1.1 (A:) Legume lectin {Griffonia simplicifol	2e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-36
d1gzca_	239	b.29.1.1 (A:) Legume lectin {Cockspur coral tree (	2e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-35
d1fx5a_	240	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	4e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-35
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-34
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-34
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-34
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-34
d1qnwa_	237	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	3e-34
d2d3sa1	237	b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso	7e-34
d1f9ka_	234	b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca	7e-34
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-34
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-34
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-33
d1n47a_	233	b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi	2e-33
d1leda_	243	b.29.1.1 (A:) Legume lectin {West-central african	2e-33
d1v6ia_	232	b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog	2e-33
d1g9fa_	251	b.29.1.1 (A:) Legume lectin {Soybean (Glycine max)	4e-33
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-33
d1g7ya_	253	b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos	2e-32
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-31
d1g8wa_	233	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	2e-31
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-30
d1nlsa_	237	b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia	2e-30
d1nlsa_	237	b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia	1e-06
d1ukga_	241	b.29.1.1 (A:) Legume lectin {Bloodwood tree (Ptero	3e-30
d1ioaa_	228	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	1e-29
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-29
g1qmo.1	230	b.29.1.1 (A:,E:) Legume lectin {Field bean (Dolich	2e-29
d1dbna_	239	b.29.1.1 (A:) Legume lectin {Maackia amurensis, le	4e-29
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-29
d1fnya_	237	b.29.1.1 (A:) Legume lectin {Black locust (Robinia	4e-27
d1avba_	226	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	7e-27
g2ltn.1	229	b.29.1.1 (A:,B:) Legume lectin {Garden pea (Pisum	2e-26
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-25
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-22
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-22
d1dhkb_	204	b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar	1e-19
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-16
d1gv9a_	228	b.29.1.13 (A:) Carbohydrate-recognition domain of	7e-15

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  192 bits (488), Expect = 2e-57
 Identities = 78/306 (25%), Positives = 138/306 (45%), Gaps = 36/306 (11%)

Query: 231 FKYKELKKATNNFHESM---------RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFS 281
           F +++  +A   F + +          +G G FG V  G +    +       +A+K   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGK---REIFVAIKTLK 63

Query: 282 RDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSE 340
                K + DFL+E +I+ +  H +++HL G   +   ++++ +FM NGSL+ +L     
Sbjct: 64  SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 123

Query: 341 QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI 400
           Q T        +L G+A+ + YL    D   VHRDL A NIL++++   ++ DFGL+R +
Sbjct: 124 QFT--VIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178

Query: 401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSPGNMIP 459
           E++ +       +G    + + APE     K T  SDV+ +G V+ EV+  G  P   + 
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238

Query: 460 HQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTE 519
           +Q                  + +A++Q   +   +D    L  L L C     + RPK  
Sbjct: 239 NQD-----------------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281

Query: 520 DILQII 525
            I+  +
Sbjct: 282 QIVNTL 287

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 2e-55
 Identities = 68/290 (23%), Positives = 119/290 (41%), Gaps = 35/290 (12%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAII 298
                  R+G G FG VYKG           +  +AVK  +  +   +    F  E+ ++
Sbjct: 8   GQITVGQRIGSGSFGTVYKG---------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 58

Query: 299 HRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVAS 358
            + RH +++  +G+     +L +V  +    SL  +L+    +          I    A 
Sbjct: 59  RKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQ 115

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
            + YL   + + ++HRDLK++NI L  D   ++GDFGLA        S+    L    G+
Sbjct: 116 GMDYL---HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS---GS 169

Query: 419 MGYVAPECFHT---GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH 475
           + ++APE          + +SDV+ FG V+ E++ G+ P              D +  + 
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-------YSNINNRDQIIFMV 222

Query: 476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
             G++   + +    ++     KRL+     C      ERP    IL  I
Sbjct: 223 GRGYLSPDLSKVR--SNCPKAMKRLM---AECLKKKRDERPLFPQILASI 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 5e-54
 Identities = 61/286 (21%), Positives = 119/286 (41%), Gaps = 33/286 (11%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHR 300
           +       +G G FG+V+ G       Y ++  ++A+K     ++  + DF+ E  ++ +
Sbjct: 5   SELTFVQEIGSGQFGLVHLG-------YWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMK 56

Query: 301 LRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
           L H  LV L G C E+  + LV++FM +G L  YL   +++          +   V   +
Sbjct: 57  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGM 114

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            YL    +  V+HRDL A N L+  +   ++ DFG+ R + +++ + +     G    + 
Sbjct: 115 AYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVK 167

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI 480
           + +PE F   + + +SDV+ FG ++ EV                   +   + L++    
Sbjct: 168 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 227

Query: 481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS 526
              V Q                +   C      +RP    +L+ ++
Sbjct: 228 STHVYQ----------------IMNHCWKERPEDRPAFSRLLRQLA 257

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 2e-53
 Identities = 49/220 (22%), Positives = 100/220 (45%), Gaps = 19/220 (8%)

Query: 236 LKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLAE 294
           ++   ++F +   LG G  G+V+K        +      +A K    +   + +   + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKV------SHKPSGLVMARKLIHLEIKPAIRNQIIRE 54

Query: 295 LAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILT 354
           L ++H     ++V   G  +  G++ +  + M  GSL++ L    +   +      K+  
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSI 111

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
            V   + YL+ +   K++HRD+K SNIL+++    +L DFG++  + +   +        
Sbjct: 112 AVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-------S 162

Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
             GT  Y++PE       + +SD++  G  ++E+  GR P
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 7e-53
 Identities = 67/298 (22%), Positives = 119/298 (39%), Gaps = 33/298 (11%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
            +G+G FG V++G             ++AVK FS    +S     AE+     LRH++++
Sbjct: 10  SIGKGRFGEVWRGKW--------RGEEVAVKIFSSREERSW-FREAEIYQTVMLRHENIL 60

Query: 308 HLVGWCHEKG----KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYL 363
             +   ++      +L LV D+  +GSL  YL     + T+      K+    AS + +L
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 116

Query: 364 QNEY-----DQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
             E         + HRDLK+ NIL+  +    + D GLA   ++  ++  +       GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI-DIAPNHRVGT 175

Query: 419 MGYVAPECFHT------GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY---TLVD 469
             Y+APE           ++   +D++  G V  E+    S G +    Q  Y      D
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235

Query: 470 WVWMLHREGHIQDAVDQRLNINSVVDEAKRLLL-LGLACSHPIASERPKTEDILQIIS 526
                 R+   +  +   +       EA R++  +   C +   + R     I + +S
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 5e-52
 Identities = 73/293 (24%), Positives = 130/293 (44%), Gaps = 26/293 (8%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIH 299
           +       +G G FG VYKG++  +         +A+K        K + DFL E  I+ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGK--KEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64

Query: 300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASA 359
           +  H +++ L G   +   ++++ ++M NG+L+K+L    +    +      +L G+A+ 
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR--EKDGEFSVLQLVGMLRGIAAG 122

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
           + YL N      VHRDL A NIL++++   ++ DFGL+R +E++  +   +   G    +
Sbjct: 123 MKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT--YTTSGGKIPI 177

Query: 420 GYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH 479
            + APE     K T  SDV+ FG V+ EV+                      W L     
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELSNH-E 221

Query: 480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVP 532
           +  A++    + + +D    +  L + C     + RPK  DI+ I+      P
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  177 bits (449), Expect = 8e-52
 Identities = 73/316 (23%), Positives = 129/316 (40%), Gaps = 45/316 (14%)

Query: 232 KYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGD 290
           K   L+   NN      +GEG FG V++         +   T +AVK    ++    + D
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQAD 62

Query: 291 FLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVT------- 343
           F  E A++    + ++V L+G C     + L++++M  G L ++L   S           
Sbjct: 63  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 344 --------------LNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA 389
                         L+   +  I   VA+ + YL    ++K VHRDL   N L+  +   
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVV 179

Query: 390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV 449
           ++ DFGL+R I +     A+         + ++ PE     + T ESDV+ +G V+ E+ 
Sbjct: 180 KIADFGLSRNIYSADYYKADG---NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236

Query: 450 CGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSH 509
                    P+   A+   + V    R+G+I    +      +   E   L+ L   C  
Sbjct: 237 SYGLQ----PYYGMAH---EEVIYYVRDGNILACPE------NCPLELYNLMRL---CWS 280

Query: 510 PIASERPKTEDILQII 525
            + ++RP    I +I+
Sbjct: 281 KLPADRPSFCSIHRIL 296

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 1e-51
 Identities = 67/285 (23%), Positives = 122/285 (42%), Gaps = 33/285 (11%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHR 300
                  RLG G FG V+ G        +  +T++AVK   + S+     FLAE  ++ +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGY-------YNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQ 64

Query: 301 LRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
           L+H+ LV L     +   + ++ ++M NGSL  +L  T   + L  N    +   +A  +
Sbjct: 65  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGM 122

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            ++    ++  +HRDL+A+NIL+    + ++ DFGLAR IE+           G    + 
Sbjct: 123 AFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY----TAREGAKFPIK 175

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI 480
           + APE  + G  T +SDV+ FG ++ E+V                  ++  + + R  + 
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235

Query: 481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
            + + Q                L   C      +RP  + +  ++
Sbjct: 236 PEELYQ----------------LMRLCWKERPEDRPTFDYLRSVL 264

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 1e-51
 Identities = 63/286 (22%), Positives = 119/286 (41%), Gaps = 35/286 (12%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHR 300
            +      LG G FG+V  G              +A+K     S+    +F+ E  ++  
Sbjct: 4   KDLTFLKELGTGQFGVVKYGK-------WRGQYDVAIKMIKEGSMSED-EFIEEAKVMMN 55

Query: 301 LRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
           L H+ LV L G C ++  + ++ ++M NG L  YL     +         ++   V  A+
Sbjct: 56  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAM 113

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            YL++   ++ +HRDL A N L++     ++ DFGL+R + ++         VG    + 
Sbjct: 114 EYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY----TSSVGSKFPVR 166

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSPGNMIPHQQHAYTLVDWVWMLHREGH 479
           +  PE     K + +SD++ FG ++ E+   G+ P                 +       
Sbjct: 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP-----------------YERFTNSE 209

Query: 480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
             + + Q L +      ++++  +  +C H  A ERP  + +L  I
Sbjct: 210 TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 6e-51
 Identities = 75/304 (24%), Positives = 130/304 (42%), Gaps = 27/304 (8%)

Query: 225 PGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS 284
           P + +  ++  +  ++   H +  +G G FG VY G +  ND         AVK  +R +
Sbjct: 11  PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRIT 67

Query: 285 -IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE-KGKLLLVYDFMPNGSLEKYLYGTSEQV 342
            I     FL E  I+    H +++ L+G C   +G  L+V  +M +G L  ++   +   
Sbjct: 68  DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 127

Query: 343 TLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIEN 402
           T+     + +          ++    +K VHRDL A N +LD  F  ++ DFGLAR + +
Sbjct: 128 TVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182

Query: 403 ERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ 462
           +    + H   G    + ++A E   T K T +SDV+ FG ++ E++   +P    P+  
Sbjct: 183 K-EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PY-- 235

Query: 463 HAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDIL 522
                 D    L +   +              D    ++L    C HP A  RP   +++
Sbjct: 236 PDVNTFDITVYLLQGRRLLQP-------EYCPDPLYEVMLK---CWHPKAEMRPSFSELV 285

Query: 523 QIIS 526
             IS
Sbjct: 286 SRIS 289

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  174 bits (442), Expect = 8e-51
 Identities = 66/298 (22%), Positives = 126/298 (42%), Gaps = 31/298 (10%)

Query: 228 PREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS 287
           P    Y + +    +     +LG G +G VY+G+             +AVK    D+++ 
Sbjct: 4   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSL------TVAVKTLKEDTMEV 57

Query: 288 KGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWN 347
           + +FL E A++  ++H +LV L+G C  +    ++ +FM  G+L  YL   + Q  ++  
Sbjct: 58  E-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAV 115

Query: 348 HRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY 407
               + T ++SA+ YL     +  +HRDL A N L+  +   ++ DFGL+R +  +    
Sbjct: 116 VLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-- 170

Query: 408 AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTL 467
                 G    + + APE     K + +SDV+ FG ++ E+                   
Sbjct: 171 --TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------- 215

Query: 468 VDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
               +       + + +++   +       +++  L  AC     S+RP   +I Q  
Sbjct: 216 ---PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 9e-51
 Identities = 59/289 (20%), Positives = 117/289 (40%), Gaps = 35/289 (12%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAIIH 299
           ++     +G G +G   K       +   D   +  K+    S+        ++E+ ++ 
Sbjct: 5   DYEVLYTIGTGSYGRCQKI------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 58

Query: 300 RLRHKHLVHLVGWCHEK--GKLLLVYDFMPNGSLEKYLY-GTSEQVTLNWNHRYKILTGV 356
            L+H ++V       ++    L +V ++   G L   +  GT E+  L+     +++T +
Sbjct: 59  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118

Query: 357 ASAVYYL--QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
             A+     +++    V+HRDLK +N+ LD   N +LGDFGLAR + ++           
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-----TSFAKA 173

Query: 415 VPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML 474
             GT  Y++PE  +      +SD++  G ++ E+     P      ++        +   
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGK 225

Query: 475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
            REG  +    +        DE   ++       +     RP  E+IL+
Sbjct: 226 IREGKFRRIPYR------YSDELNEII---TRMLNLKDYHRPSVEEILE 265

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 2e-49
 Identities = 71/324 (21%), Positives = 131/324 (40%), Gaps = 51/324 (15%)

Query: 228 PREFKYK---ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS 284
            RE++Y    E  +   N      LG G FG V      +       + Q+AVK     +
Sbjct: 23  FREYEYDLKWEFPR--ENLEFGKVLGSGAFGKVMNAT-AYGISKTGVSIQVAVKMLKEKA 79

Query: 285 IKS-KGDFLAELAIIHRL-RHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQV 342
             S +   ++EL ++ +L  H+++V+L+G C   G + L++++   G L  YL    E+ 
Sbjct: 80  DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 139

Query: 343 T--------------------LNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL 382
           +                    L +         VA  + +L     +  VHRDL A N+L
Sbjct: 140 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVL 196

Query: 383 LDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFG 442
           +      ++ DFGLAR I ++ N             + ++APE    G  T +SDV+ +G
Sbjct: 197 VTHGKVVKICDFGLARDIMSDSNYVVRG---NARLPVKWMAPESLFEGIYTIKSDVWSYG 253

Query: 443 AVVLEVV-CGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLL 501
            ++ E+   G +P   IP   + Y L+   + + +  +               +E   ++
Sbjct: 254 ILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYA-------------TEEIYIIM 300

Query: 502 LLGLACSHPIASERPKTEDILQII 525
               +C    + +RP   ++   +
Sbjct: 301 ---QSCWAFDSRKRPSFPNLTSFL 321

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 2e-49
 Identities = 70/295 (23%), Positives = 127/295 (43%), Gaps = 32/295 (10%)

Query: 234 KELKKATNNFH-ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDF 291
           K+L    +N     + LG G FG V +G+             +A+K   + + K+   + 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEM 56

Query: 292 LAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYK 351
           + E  I+H+L + ++V L+G C +   L+LV +    G L K+L G  E+  +  ++  +
Sbjct: 57  MREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAE 113

Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
           +L  V+  + YL    ++  VHRDL A N+LL     A++ DFGL++A+  + + Y    
Sbjct: 114 LLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY--TA 168

Query: 412 LVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSPGNMIPHQQHAYTLVDW 470
                  + + APEC +  K +  SDV+ +G  + E +  G+ P   +   +        
Sbjct: 169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------- 220

Query: 471 VWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
           V     +G   +             E   L+     C      +RP    + Q +
Sbjct: 221 VMAFIEQGKRMECPP------ECPPELYALMSD---CWIYKWEDRPDFLTVEQRM 266

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 3e-49
 Identities = 71/300 (23%), Positives = 125/300 (41%), Gaps = 34/300 (11%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHR 300
            +    ++LG+G FG V+ G            T++A+K     ++  +  FL E  ++ +
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGT-------WNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKK 68

Query: 301 LRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAV 360
           LRH+ LV L      +  + +V ++M  GSL  +L G + +          +   +AS +
Sbjct: 69  LRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGM 126

Query: 361 YYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
            Y++       VHRDL+A+NIL+  +   ++ DFGLAR IE+           G    + 
Sbjct: 127 AYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIK 179

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI 480
           + APE    G+ T +SDV+ FG ++ E+                       +       +
Sbjct: 180 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV----------------PYPGMVNREV 223

Query: 481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPA 540
            D V++   +    +  + L  L   C      ERP  E +   +    T    PQ++P 
Sbjct: 224 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST-EPQYQPG 282

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 3e-49
 Identities = 61/286 (21%), Positives = 116/286 (40%), Gaps = 40/286 (13%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELAI 297
            +F     LG+G FG VY                +A+K   +  ++  G       E+ I
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAR------EKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 59

Query: 298 IHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
              LRH +++ L G+ H+  ++ L+ ++ P G++ + L   S     +       +T +A
Sbjct: 60  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELA 116

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
           +A+ Y    + ++V+HRD+K  N+LL +    ++ DFG +    + R +        + G
Sbjct: 117 NALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-------LCG 166

Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE 477
           T+ Y+ PE         + D++  G +  E + G+ P          +    +     R 
Sbjct: 167 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----------FEANTYQETYKR- 215

Query: 478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
                           V E  R L+  L   +P  S+RP   ++L+
Sbjct: 216 -----ISRVEFTFPDFVTEGARDLISRLLKHNP--SQRPMLREVLE 254

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  168 bits (427), Expect = 2e-48
 Identities = 59/287 (20%), Positives = 106/287 (36%), Gaps = 43/287 (14%)

Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAIIH 299
           F +   +G G FG VY        +   ++  +A+KK S    +S     D + E+  + 
Sbjct: 17  FSDLREIGHGSFGAVYFA------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASA 359
           +LRH + +   G    +    LV ++    + +        +  L       +  G    
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQG 127

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
           + YL       ++HRD+KA NILL      +LGDFG A  +    +           GT 
Sbjct: 128 LAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS---------FVGTP 175

Query: 420 GYVAPECFHT---GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR 476
            ++APE       G+   + DV+  G   +E+   + P   +      Y +        +
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ 235

Query: 477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
            GH               +  +  +    +C   I  +RP +E +L+
Sbjct: 236 SGHWS-------------EYFRNFV---DSCLQKIPQDRPTSEVLLK 266

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 4e-48
 Identities = 78/287 (27%), Positives = 120/287 (41%), Gaps = 41/287 (14%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHR 300
                   +G+G FG V  G             ++AVK    D+      FLAE +++ +
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY--------RGNKVAVKCIKNDATAQ--AFLAEASVMTQ 56

Query: 301 LRHKHLVHLVGWCHE-KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASA 359
           LRH +LV L+G   E KG L +V ++M  GSL  YL      V L  +   K    V  A
Sbjct: 57  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEA 115

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
           + YL        VHRDL A N+L+  D  A++ DFGL +   + +++            +
Sbjct: 116 MEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT--------GKLPV 164

Query: 420 GYVAPECFHTGKATPESDVFGFGAVVLEVV-CGRSPGNMIPHQQHAYTLVDWVWMLHREG 478
            + APE     K + +SDV+ FG ++ E+   GR P   IP +         V     +G
Sbjct: 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKG 216

Query: 479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
           +  DA D              ++     C H  A+ RP    + + +
Sbjct: 217 YKMDAPD------GCPPAVYEVM---KNCWHLDAAMRPSFLQLREQL 254

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 8e-48
 Identities = 62/327 (18%), Positives = 126/327 (38%), Gaps = 54/327 (16%)

Query: 225 PGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS 284
            G P++ KY   +K          +G+G  G VY  +            ++A+++ +   
Sbjct: 15  VGDPKK-KYTRFEK----------IGQGASGTVYTAM------DVATGQEVAIRQMNLQQ 57

Query: 285 IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTL 344
              K   + E+ ++   ++ ++V+ +       +L +V +++  GSL   +  T      
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---- 113

Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
           +      +      A+ +L   +  +V+HRD+K+ NILL  D + +L DFG    I  E+
Sbjct: 114 DEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170

Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHA 464
           +  +        GT  ++APE        P+ D++  G + +E++ G  P          
Sbjct: 171 SKRSTMV-----GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP---------- 215

Query: 465 YTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI 524
           Y   + +  L+      +   +  N   +    +  L     C      +R   +++LQ 
Sbjct: 216 YLNENPLRALYL--IATNGTPELQNPEKLSAIFRDFL---NRCLDMDVEKRGSAKELLQH 270

Query: 525 ISGTSTVPYVPQFKPAFTWPSTSPPIS 551
                        K A    S +P I+
Sbjct: 271 ----------QFLKIAKPLSSLTPLIA 287

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 1e-47
 Identities = 65/299 (21%), Positives = 116/299 (38%), Gaps = 39/299 (13%)

Query: 233 YKELKKATN--NFHESMR-LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG 289
           Y+ + +  N  +F E +  LG+G FG VYK       Q    +   A K     S +   
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKA------QNKETSVLAAAKVIDTKSEEELE 54

Query: 290 DFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHR 349
           D++ E+ I+    H ++V L+   + +  L ++ +F   G+++  +     +  L  +  
Sbjct: 55  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--ELERPLTESQI 112

Query: 350 YKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAE 409
             +      A+ YL   +D K++HRDLKA NIL   D + +L DFG++            
Sbjct: 113 QVVCKQTLDALNYL---HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR-- 167

Query: 410 HGLVGVPGTMGYVAPECFHTGKA-----TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHA 464
              +G P    ++APE      +       ++DV+  G  ++E+     P        H 
Sbjct: 168 DSFIGTP---YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-------HHE 217

Query: 465 YTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
              +  +  + +      A   R +        K  L     C       R  T  +LQ
Sbjct: 218 LNPMRVLLKIAKSEPPTLAQPSRWS-----SNFKDFL---KKCLEKNVDARWTTSQLLQ 268

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 2e-47
 Identities = 60/305 (19%), Positives = 106/305 (34%), Gaps = 49/305 (16%)

Query: 226 GMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI 285
           GM  + ++ +             +G G F  VYKG+            ++A  +     +
Sbjct: 3   GMSNDGRFLKFDI---------EIGRGSFKTVYKGLDTETTV------EVAWCELQDRKL 47

Query: 286 KSKG--DFLAELAIIHRLRHKHLVHLVGWCHE----KGKLLLVYDFMPNGSLEKYLYGTS 339
                  F  E  ++  L+H ++V            K  ++LV + M +G+L+ YL    
Sbjct: 48  TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--- 104

Query: 340 EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA-DFNARLGDFGLAR 398
               +           +   + +L       ++HRDLK  NI +     + ++GD GLA 
Sbjct: 105 RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163

Query: 399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMI 458
                           V GT  ++APE +   K     DV+ FG  +LE+     P    
Sbjct: 164 LKRASFAK-------AVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYP---- 211

Query: 459 PHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKT 518
                 Y+       ++R   +   V         + E K ++     C      ER   
Sbjct: 212 ------YSECQNAAQIYR--RVTSGVKPASFDKVAIPEVKEII---EGCIRQNKDERYSI 260

Query: 519 EDILQ 523
           +D+L 
Sbjct: 261 KDLLN 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 2e-47
 Identities = 63/304 (20%), Positives = 114/304 (37%), Gaps = 39/304 (12%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIH 299
           N       LG G FG V +   +   +       +AVK     + +  +   ++EL ++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIK-SDAAMTVAVKMLKPSAHLTEREALMSELKVLS 81

Query: 300 RL-RHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYG---------------TSEQVT 343
            L  H ++V+L+G C   G  L++ ++   G L  +L                   +++ 
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 344 LNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE 403
           L+          VA  + +L     +  +HRDL A NILL      ++ DFGLAR I+N+
Sbjct: 142 LDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 404 RNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQH 463
            N   +         + ++APE       T ESDV+ +G  + E+    S          
Sbjct: 199 SNYVVKGNAR---LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------- 246

Query: 464 AYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
                     +  +      + +   + S       +  +   C      +RP  + I+Q
Sbjct: 247 ------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

Query: 524 IISG 527
           +I  
Sbjct: 301 LIEK 304

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 8e-47
 Identities = 71/301 (23%), Positives = 121/301 (40%), Gaps = 44/301 (14%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLAELAIIH 299
           N+      +GEG FG V K  I  +          A+K+    + K    DF  EL ++ 
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGL----RMDAAIKRMKEYASKDDHRDFAGELEVLC 65

Query: 300 RL-RHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYL-------------YGTSEQVTLN 345
           +L  H ++++L+G C  +G L L  ++ P+G+L  +L                S   TL+
Sbjct: 66  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 346 WNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERN 405
                     VA  + YL     ++ +HRDL A NIL+  ++ A++ DFGL+R  E    
Sbjct: 126 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 182

Query: 406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY 465
                        + ++A E  +    T  SDV+ +G ++ E+V         P+     
Sbjct: 183 KTM------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----PY--CGM 230

Query: 466 TLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
           T  +    L +   ++  ++         DE   L+     C      ERP    IL  +
Sbjct: 231 TCAELYEKLPQGYRLEKPLN-------CDDEVYDLMRQ---CWREKPYERPSFAQILVSL 280

Query: 526 S 526
           +
Sbjct: 281 N 281

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 5e-46
 Identities = 65/284 (22%), Positives = 112/284 (39%), Gaps = 33/284 (11%)

Query: 245 ESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAIIHRLR 302
           E   LG G FG V KG              +AVK    ++       + LAE  ++ +L 
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKK----VVKTVAVKILKNEANDPALKDELLAEANVMQQLD 66

Query: 303 HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYY 362
           + ++V ++G C E    +LV +    G L KYL    +   +   +  +++  V+  + Y
Sbjct: 67  NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKY 122

Query: 363 LQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYV 422
           L    +   VHRDL A N+LL     A++ DFGL++A+  + N Y           + + 
Sbjct: 123 L---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGKWPVKWY 177

Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD 482
           APEC +  K + +SDV+ FG ++ E                   +++             
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK------------ 225

Query: 483 AVDQRLNINS-VVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
              +R+   +    E   L+ L   C       RP    +   +
Sbjct: 226 --GERMGCPAGCPREMYDLMNL---CWTYDVENRPGFAAVELRL 264

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  162 bits (410), Expect = 1e-45
 Identities = 52/298 (17%), Positives = 106/298 (35%), Gaps = 36/298 (12%)

Query: 228 PREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS 287
           P E K+  +    +++     LG G FG+V++                A K         
Sbjct: 16  PVEIKHDHV---LDHYDIHEELGTGAFGVVHRVT------ERATGNNFAAKFVMTPHESD 66

Query: 288 KGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWN 347
           K     E+  +  LRH  LV+L     +  +++++Y+FM  G L + +    E   ++ +
Sbjct: 67  KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSED 124

Query: 348 HRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR--LGDFGLARAIENERN 405
              + +  V   + ++   ++   VH DLK  NI+     +    L DFGL   ++ +++
Sbjct: 125 EAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181

Query: 406 SYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY 465
                      GT  + APE          +D++  G +   ++ G SP       +   
Sbjct: 182 VKVTT------GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR 235

Query: 466 TLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
            +    W +                + + ++ K  +           + R      L+
Sbjct: 236 NVKSCDWNMDDS-----------AFSGISEDGKDFI---RKLLLADPNTRMTIHQALE 279

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 3e-45
 Identities = 70/295 (23%), Positives = 120/295 (40%), Gaps = 31/295 (10%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIH 299
                S  LG+G FG+VY+G+           T++A+K  +   S++ + +FL E +++ 
Sbjct: 20  EKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK 78

Query: 300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLY-------GTSEQVTLNWNHRYKI 352
                H+V L+G   +    L++ + M  G L+ YL                + +   ++
Sbjct: 79  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
              +A  + YL      K VHRDL A N ++  DF  ++GDFG+ R I            
Sbjct: 139 AGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW 472
           +     + +++PE    G  T  SDV+ FG V+ E+          P+Q  +    + V 
Sbjct: 196 L---LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----PYQGLSN---EQVL 245

Query: 473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG 527
               EG + D  D      +  D    L+ +   C       RP   +I+  I  
Sbjct: 246 RFVMEGGLLDKPD------NCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKE 291

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 4e-45
 Identities = 72/320 (22%), Positives = 127/320 (39%), Gaps = 31/320 (9%)

Query: 243 FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR-DSIKSKGDFLAELAIIHRL 301
           F +   LG G FG VYKG+     +       +A+K+     S K+  + L E  ++  +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 302 RHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
            + H+  L+G C     + L+   MP G L  Y+    + +     +       +A  + 
Sbjct: 69  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAKGMN 125

Query: 362 YLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGY 421
           YL    D+++VHRDL A N+L+    + ++ DFGLA+ +  E   Y      G    + +
Sbjct: 126 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH---AEGGKVPIKW 179

Query: 422 VAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHI 480
           +A E       T +SDV+ +G  V E++  G  P + IP  +                 I
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------I 222

Query: 481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVP-YVPQFKP 539
              +++   +         + ++ + C    A  RPK  +++   S  +  P      + 
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 282

Query: 540 AFTWPSTSPPISMFDSILSS 559
                  SP  S F   L  
Sbjct: 283 DERMHLPSPTDSNFYRALMD 302

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 4e-45
 Identities = 57/285 (20%), Positives = 97/285 (34%), Gaps = 32/285 (11%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIH 299
            ++     LGEG +G V   +        V    +AVK      ++    +   E+ I  
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 58

Query: 300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASA 359
            L H+++V   G   E     L  ++   G L   +      + +      +    + + 
Sbjct: 59  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAG 115

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
           V YL   +   + HRD+K  N+LLD   N ++ DFGLA            + +    GT+
Sbjct: 116 VVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTL 169

Query: 420 GYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG 478
            YVAPE     +      DV+  G V+  ++ G  P +        Y+            
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS------------ 217

Query: 479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
             ++          +      LL           S R    DI +
Sbjct: 218 DWKEKKTYLNPWKKIDSAPLALL---HKILVENPSARITIPDIKK 259

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 5e-45
 Identities = 65/289 (22%), Positives = 108/289 (37%), Gaps = 31/289 (10%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG---DFLAELAI 297
            +     +LG+G FG+V +G              +AVK    D +       DF+ E+  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSG---KTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 298 IHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
           +H L H++L+ L G       + +V +  P GSL   L     Q         +    VA
Sbjct: 65  MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRYAVQVA 121

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
             + YL     ++ +HRDL A N+LL      ++GDFGL RA+    + Y          
Sbjct: 122 EGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK--V 176

Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHR 476
              + APE   T   +  SD + FG  + E+   G+ P                +  + +
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-------WIGLNGSQILHKIDK 229

Query: 477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
           EG       +RL       +   +  + + C      +RP    +   +
Sbjct: 230 EG-------ERLPRPEDCPQD--IYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  156 bits (395), Expect = 2e-43
 Identities = 55/315 (17%), Positives = 111/315 (35%), Gaps = 43/315 (13%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
            LG G FG+V++ +                K  +      K     E++I+++L H  L+
Sbjct: 36  ELGSGAFGVVHRCV------EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
           +L     +K +++L+ +F+  G L   +   +E   ++       +      + ++   +
Sbjct: 90  NLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHM---H 144

Query: 368 DQKVVHRDLKASNILLDADFNAR--LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
           +  +VH D+K  NI+ +    +   + DFGLA  +  +              T  + APE
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT------ATAEFAAPE 198

Query: 426 CFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVD 485
                     +D++  G +   ++ G SP       +    +    W    +        
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED-------- 250

Query: 486 QRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYVPQFKPAFTWPS 545
                +SV  EAK  +            +R    D L+           P  K   +  +
Sbjct: 251 ---AFSSVSPEAKDFI---KNLLQKEPRKRLTVHDALEH----------PWLKGDHSNLT 294

Query: 546 TSPPISMFDSILSSI 560
           +  P S ++ I   I
Sbjct: 295 SRIPSSRYNKIRQKI 309

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 8e-43
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 18/221 (8%)

Query: 237 KKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLA 293
           KK   +F     LGEG F  V         +    + + A+K   +  I  +        
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTR 57

Query: 294 ELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKIL 353
           E  ++ RL H   V L     +  KL     +  NG L KY+    +  + +        
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYT 114

Query: 354 TGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLV 413
             + SA+ YL   + + ++HRDLK  NILL+ D + ++ DFG A+ +  E      +  V
Sbjct: 115 AEIVSALEYL---HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 171

Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           G      YV+PE      A   SD++  G ++ ++V G  P
Sbjct: 172 GTA---QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-42
 Identities = 74/302 (24%), Positives = 133/302 (44%), Gaps = 42/302 (13%)

Query: 248 RLGEGGFGIVYKGIIHHNDQ-YHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRL-RHK 304
            LGEG FG V        D+      T++AVK    D+  K   D ++E+ ++  + +HK
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 305 HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLY-------------GTSEQVTLNWNHRYK 351
           ++++L+G C + G L ++ ++   G+L +YL                + +  L+      
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
               VA  + YL     +K +HRDL A N+L+  D   ++ DFGLAR I +         
Sbjct: 140 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT- 195

Query: 412 LVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV 471
                  + ++APE       T +SDV+ FG ++ E+          P+       V+ +
Sbjct: 196 --NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----PYPGVP---VEEL 246

Query: 472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ----IISG 527
           + L +EGH  D         +  +E   ++     C H + S+RP  + +++    I++ 
Sbjct: 247 FKLLKEGHRMDKPS------NCTNELYMMM---RDCWHAVPSQRPTFKQLVEDLDRIVAL 297

Query: 528 TS 529
           TS
Sbjct: 298 TS 299

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 5e-42
 Identities = 61/280 (21%), Positives = 113/280 (40%), Gaps = 30/280 (10%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLAELAIIHRLRHKHL 306
            +GEG FG V++GI    +        +A+K     +  S +  FL E   + +  H H+
Sbjct: 14  CIGEGQFGDVHQGIYMSPEN---PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
           V L+G   E   + ++ +    G L  +L     + +L+          +++A+ YL   
Sbjct: 71  VKLIGVITE-NPVWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYL--- 124

Query: 367 YDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPEC 426
             ++ VHRD+ A N+L+ ++   +LGDFGL+R +E+     A  G       + ++APE 
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK----LPIKWMAPES 180

Query: 427 FHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQ 486
            +  + T  SDV+ FG  + E++                  ++    L    +       
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP----- 235

Query: 487 RLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS 526
                        L+     C     S RP+  ++   +S
Sbjct: 236 --------PTLYSLM---TKCWAYDPSRRPRFTELKAQLS 264

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (376), Expect = 3e-41
 Identities = 62/295 (21%), Positives = 110/295 (37%), Gaps = 36/295 (12%)

Query: 233 YKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSK-GDF 291
           +K+ +   + +     LG G F  V         +       +A+K  ++ +++ K G  
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKL------VAIKCIAKKALEGKEGSM 54

Query: 292 LAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYK 351
             E+A++H+++H ++V L       G L L+   +  G L   +    E+         +
Sbjct: 55  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASR 111

Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILL---DADFNARLGDFGLARAIENERNSYA 408
           ++  V  AV YL   +D  +VHRDLK  N+L    D D    + DFGL++  +       
Sbjct: 112 LIFQVLDAVKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS- 167

Query: 409 EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV 468
                   GT GYVAPE       +   D +  G +   ++CG  P       +    ++
Sbjct: 168 -----TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL 222

Query: 469 DWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
              +                  + + D AK  +            +R   E  LQ
Sbjct: 223 KAEYEFDSP-----------YWDDISDSAKDFI---RHLMEKDPEKRFTCEQALQ 263

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  146 bits (369), Expect = 1e-40
 Identities = 57/300 (19%), Positives = 110/300 (36%), Gaps = 40/300 (13%)

Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELA 296
           ++ +     LG GG   V+             +  +AVK    D  +       F  E  
Sbjct: 6   SDRYELGEILGFGGMSEVHLAR------DLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 59

Query: 297 IIHRLRHKHLVHLVGWCHEKGK----LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKI 352
               L H  +V +      +        +V +++   +L   ++    +  +      ++
Sbjct: 60  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEV 116

Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           +     A+ +    +   ++HRD+K +NI++ A    ++ DFG+ARAI +  NS  +   
Sbjct: 117 IADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA- 172

Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW 472
             V GT  Y++PE          SDV+  G V+ EV+ G  P           + V   +
Sbjct: 173 -AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-------FTGDSPVSVAY 224

Query: 473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKT-----EDILQIISG 527
              RE  I            +  +   ++   L         R +T      D++++ +G
Sbjct: 225 QHVREDPIPP----SARHEGLSADLDAVV---LKALAKNPENRYQTAAEMRADLVRVHNG 277

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 1e-40
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 38/302 (12%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG-DFLAELAII- 298
           +       LG G FG V +      D+       +AVK     +  S+    ++EL I+ 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKT-ATCRTVAVKMLKEGATHSEHRALMSELKILI 71

Query: 299 HRLRHKHLVHLVGWCHEKG-KLLLVYDFMPNGSLEKYLYG-------------TSEQVTL 344
           H   H ++V+L+G C + G  L+++ +F   G+L  YL                  +  L
Sbjct: 72  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 345 NWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
              H       VA  + +L +   +K +HRDL A NILL      ++ DFGLAR I  + 
Sbjct: 132 TLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188

Query: 405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHA 464
           +   +         + ++APE       T +SDV+ FG ++ E+    +           
Sbjct: 189 DYVRKGDAR---LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------PYPG 239

Query: 465 YTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI 524
             + +      +EG    A D          E  + +L    C H   S+RP   ++++ 
Sbjct: 240 VKIDEEFCRRLKEGTRMRAPDY------TTPEMYQTMLD---CWHGEPSQRPTFSELVEH 290

Query: 525 IS 526
           + 
Sbjct: 291 LG 292

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 1e-39
 Identities = 47/278 (16%), Positives = 102/278 (36%), Gaps = 34/278 (12%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
            LG G FGIV++ +   + +          K         +     E++I++  RH++++
Sbjct: 12  DLGRGEFGIVHRCVETSSKK------TYMAKFVKVKG-TDQVLVKKEISILNIARHRNIL 64

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
           HL        +L+++++F+    + + +   +    LN       +  V  A+ +L   +
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFL---H 119

Query: 368 DQKVVHRDLKASNILLDADFNAR--LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPE 425
              + H D++  NI+     ++   + +FG AR ++   N               Y APE
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF------TAPEYYAPE 173

Query: 426 CFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVD 485
                  +  +D++  G +V  ++ G +P     +QQ    +++  +    E        
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE-------- 225

Query: 486 QRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
                  +  EA   +             R    + LQ
Sbjct: 226 ---AFKEISIEAMDFV---DRLLVKERKSRMTASEALQ 257

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 1e-39
 Identities = 69/321 (21%), Positives = 122/321 (38%), Gaps = 38/321 (11%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELAI 297
            +F     LG+G FG V+        ++   N   A+K   +D +    D    + E  +
Sbjct: 2   EDFILHKMLGKGSFGKVFLA------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 55

Query: 298 IHR-LRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGV 356
           +     H  L H+      K  L  V +++  G L  ++         + +        +
Sbjct: 56  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEI 112

Query: 357 ASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVP 416
              + +L   + + +V+RDLK  NILLD D + ++ DFG+ +                  
Sbjct: 113 ILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-----FC 164

Query: 417 GTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP--GNMIPHQQHAYTLVDWVWML 474
           GT  Y+APE     K     D + FG ++ E++ G+SP  G       H+  + +  +  
Sbjct: 165 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR 224

Query: 475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVPYV 534
             E   +D + +      V +  KRL + G    HP+  E     +  ++       P+ 
Sbjct: 225 WLEKEAKDLLVKLF----VREPEKRLGVRGDIRQHPLFREI----NWEELERKEIDPPFR 276

Query: 535 PQFKPAFTWPSTSPPISMFDS 555
           P+ K  F         S FD 
Sbjct: 277 PKVKSPFD-------CSNFDK 290

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  145 bits (366), Expect = 3e-39
 Identities = 57/240 (23%), Positives = 93/240 (38%), Gaps = 26/240 (10%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD------FLAE 294
           N+F     +G GGFG VY        +        A+K   +  IK K            
Sbjct: 4   NDFSVHRIIGRGGFGEVYGC------RKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 57

Query: 295 LAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILT 354
           L+++       +V +    H   KL  + D M  G L  +L   S+    +         
Sbjct: 58  LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAA 114

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVG 414
            +   + ++   +++ VV+RDLK +NILLD   + R+ D GLA     ++          
Sbjct: 115 EIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA------- 164

Query: 415 VPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM 473
             GT GY+APE    G A    +D F  G ++ +++ G SP      +         + M
Sbjct: 165 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  142 bits (358), Expect = 5e-39
 Identities = 61/292 (20%), Positives = 103/292 (35%), Gaps = 36/292 (12%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS---------KGDFL 292
           N+     LG G   +V + I      +     + AVK        S         +   L
Sbjct: 4   NYEPKEILGRGVSSVVRRCI------HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATL 57

Query: 293 AELAIIHRLR-HKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYK 351
            E+ I+ ++  H +++ L           LV+D M  G L  YL   +E+VTL+     K
Sbjct: 58  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRK 114

Query: 352 ILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHG 411
           I+  +   +  L   +   +VHRDLK  NILLD D N +L DFG +  ++         G
Sbjct: 115 IMRALLEVICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG 171

Query: 412 LVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV 471
                           +      E D++  G ++  ++ G  P                +
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--------M 223

Query: 472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
             +   G+ Q    +  + +   D  K L+            +R   E+ L 
Sbjct: 224 LRMIMSGNYQFGSPEWDDYS---DTVKDLV---SRFLVVQPQKRYTAEEALA 269

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  138 bits (348), Expect = 3e-37
 Identities = 63/312 (20%), Positives = 118/312 (37%), Gaps = 51/312 (16%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELAI 297
            +F     LG G FG V+     HN +Y       A+K   ++ +           E  +
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRY------YAMKVLKKEIVVRLKQVEHTNDERLM 57

Query: 298 IHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
           +  + H  ++ + G   +  ++ ++ D++  G L   L  +                 V 
Sbjct: 58  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAEVC 114

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
            A+ YL   + + +++RDLK  NILLD + + ++ DFG A+ + +   +          G
Sbjct: 115 LALEYL---HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC--------G 163

Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE 477
           T  Y+APE   T       D + FG ++ E++ G +P       +          +L+ E
Sbjct: 164 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK------ILNAE 217

Query: 478 GHIQDAVDQRLNINSVVDEAKRLL--LLGLACSHPIASERPKTEDILQ-----------I 524
                  +         ++ K LL  L+    S  + + +  TED+             +
Sbjct: 218 LRFPPFFN---------EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268

Query: 525 ISGTSTVPYVPQ 536
           +S     PY P 
Sbjct: 269 LSRNIETPYEPP 280

>d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} Length = 236

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]

 Score =  134 bits (337), Expect = 2e-36
 Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 11/163 (6%)

Query: 6   RPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNK-ANHFVAIEFDTVKQG-- 62
           +   +    GLAF +AP DS       G++LGL N  T      N  VA+EFDT      
Sbjct: 77  KITGNGPADGLAFFLAPPDSDVK--DAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNF 134

Query: 63  FDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGET 122
            +P   H+G+N+NS+VS      +D+    +  G   T  + YDG ++++ V +      
Sbjct: 135 PEPSYRHIGINVNSIVSVATKRWEDS---DIFSGKIATARISYDGSAEILTVVLSYPD-- 189

Query: 123 MPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWT 165
                +L  +++++  L      G SASTG        + SW 
Sbjct: 190 -GSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWR 231

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 5e-36
 Identities = 52/283 (18%), Positives = 100/283 (35%), Gaps = 39/283 (13%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLV 307
           LG G  G V +              + A+K      ++       E+ +  R  +  H+V
Sbjct: 20  LGLGINGKVLQIF------NKRTQEKFALKM-----LQDCPKARREVELHWRASQCPHIV 68

Query: 308 HLVGWCH----EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYL 363
            +V         +  LL+V + +  G L   +    +Q         +I+  +  A+ YL
Sbjct: 69  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYL 127

Query: 364 QNEYDQKVVHRDLKASNILLDADFN---ARLGDFGLARAIENERNSYAEHGLVGVPGTMG 420
              +   + HRD+K  N+L  +       +L DFG A+   +  +            T  
Sbjct: 128 ---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT------TPCYTPY 178

Query: 421 YVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI 480
           YVAPE     K     D++  G ++  ++CG  P     +  H   +   +    R G  
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLAISPGMKTRIRMGQY 234

Query: 481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
           +    +   ++   +E K L+           ++R    + + 
Sbjct: 235 EFPNPEWSEVS---EEVKMLI---RNLLKTEPTQRMTITEFMN 271

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

 Score =  130 bits (329), Expect = 2e-35
 Identities = 41/168 (24%), Positives = 69/168 (41%), Gaps = 14/168 (8%)

Query: 1   MWRDPRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVK 60
              +      +   GL F + P  S P       +LG+ N     N     +A+EFDT  
Sbjct: 76  FSIEQPYTRPLPADGLVFFMGPTKSKPA--QGYGYLGVFNNSKQDNS-YQTLAVEFDTFS 132

Query: 61  QGF-DPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDRE 119
             +  P   H+G+++NS+ S K  P        L +G    V ++YD  SK++ V +   
Sbjct: 133 NPWDPPQVPHIGIDVNSIRSIKTQP------FQLDNGQVANVVIKYDAPSKILHVVLV-- 184

Query: 120 GETMPQKPLLKETINLKDYLKPESYFGFSASTGYPH--IQLNCVRSWT 165
             +      + E +++K  L      G S +TG      + + V SW+
Sbjct: 185 YPSSGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWS 232

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-35
 Identities = 56/286 (19%), Positives = 103/286 (36%), Gaps = 42/286 (14%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD------FLAELAIIHRL 301
            LG G F +V K       +      Q A K   +   KS            E++I+  +
Sbjct: 17  ELGSGQFAVVKKC------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 302 RHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVY 361
           +H +++ L      K  ++L+ + +  G L  +L    E+ +L      + L  + +   
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNG-- 125

Query: 362 YLQNEYDQKVVHRDLKASNILLDAD----FNARLGDFGLARAIENERNSYAEHGLVGVPG 417
            +   +  ++ H DLK  NI+L          ++ DFGLA  I+             + G
Sbjct: 126 -VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK------NIFG 178

Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE 477
           T  +VAPE  +      E+D++  G +   ++ G SP      Q+    +    +    E
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE 238

Query: 478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
                        ++    AK  +            +R   +D LQ
Sbjct: 239 -----------YFSNTSALAKDFI---RRLLVKDPKKRMTIQDSLQ 270

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 3e-35
 Identities = 58/255 (22%), Positives = 102/255 (40%), Gaps = 41/255 (16%)

Query: 207 KRRSRVAEPHHNLGKLRLPGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHND 266
           K  + VA P         P  P+E  Y + K           +G G FG+VY+  +  + 
Sbjct: 2   KVTTVVATPGQG------PDRPQEVSYTDTKV----------IGNGSFGVVYQAKLCDSG 45

Query: 267 QYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK------LL 320
           +       +A+KK  +D          EL I+ +L H ++V L  + +  G+      L 
Sbjct: 46  EL------VAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95

Query: 321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASN 380
           LV D++P        + +  + TL   +    +  +  ++ Y+   +   + HRD+K  N
Sbjct: 96  LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQN 152

Query: 381 ILLDAD-FNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVF 439
           +LLD D    +L DFG A+ +        E  +  +           F     T   DV+
Sbjct: 153 LLLDPDTAVLKLCDFGSAKQLVRG-----EPNVSYICSRYYRAPELIFGATDYTSSIDVW 207

Query: 440 GFGAVVLEVVCGRSP 454
             G V+ E++ G+  
Sbjct: 208 SAGCVLAELLLGQPI 222

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

 Score =  130 bits (327), Expect = 4e-35
 Identities = 41/168 (24%), Positives = 66/168 (39%), Gaps = 12/168 (7%)

Query: 1   MWRDPRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVK 60
            + +       +  GL F +AP DS  P    G + GL N  T  + +   VA+EFDT+ 
Sbjct: 74  FFMETSANPKAATDGLTFFLAPPDS--PLRRAGGYFGLFND-TKCDSSYQTVAVEFDTIG 130

Query: 61  QGF---DPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMD 117
                 DP   H+G+++N V S         +N          V + Y+  SK +   + 
Sbjct: 131 SPVNFWDPGFPHIGIDVNCVKSINAER----WNKRYGLNNVANVEIIYEASSKTLTASLT 186

Query: 118 REGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWT 165
              +       +   ++LK+ L      GFS ST       + V +W 
Sbjct: 187 YPSD--QTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWY 232

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 9e-35
 Identities = 63/315 (20%), Positives = 117/315 (37%), Gaps = 50/315 (15%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELAI 297
           N+F     LG+G FG V         +        A+K   ++ I +K +    + E  +
Sbjct: 5   NDFDYLKLLGKGTFGKVILV------REKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 58

Query: 298 IHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
           +   RH  L  L        +L  V ++   G L  +L   S +              + 
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIV 115

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
           SA   L+  + + VV+RD+K  N++LD D + ++ DFGL +   ++  +     +    G
Sbjct: 116 SA---LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-----MKTFCG 167

Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE 477
           T  Y+APE           D +G G V+ E++CGR P     H++               
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------------- 212

Query: 478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHP---IASERPKTEDILQ----------- 523
              +  + + +     +    + LL GL    P   +       +++++           
Sbjct: 213 -LFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271

Query: 524 IISGTSTVPYVPQFK 538
           ++      P+ PQ  
Sbjct: 272 VVQKKLLPPFKPQVT 286

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 1e-34
 Identities = 59/302 (19%), Positives = 115/302 (38%), Gaps = 32/302 (10%)

Query: 240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKS-KGDFLAELAII 298
              +     +GEG +G+V           +V+  ++A+KK S    ++     L E+ I+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAY------DNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 60

Query: 299 HRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVAS 358
            R RH++++ +           +   ++    +   LY   +   L+ +H    L  +  
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR 120

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
            + Y+   +   V+HRDLK SN+LL+   + ++ DFGLAR  + + +            T
Sbjct: 121 GLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT--EYVAT 175

Query: 419 MGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSP---------GNMIPHQQHAYTLV 468
             Y APE     K  T   D++  G ++ E++  R            N I     + +  
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235

Query: 469 DWVWMLHREGH-------IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDI 521
           D   +++ +          ++ V       +   +A  LL            +R + E  
Sbjct: 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL---DKMLTFNPHKRIEVEQA 292

Query: 522 LQ 523
           L 
Sbjct: 293 LA 294

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 1e-34
 Identities = 67/311 (21%), Positives = 125/311 (40%), Gaps = 44/311 (14%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAII 298
           + + +  ++G+G FG V+K       ++     ++A+KK   ++ K       L E+ I+
Sbjct: 10  SKYEKLAKIGQGTFGEVFKA------RHRKTGQKVALKKVLMENEKEGFPITALREIKIL 63

Query: 299 HRLRHKHLVHLVGWCHE--------KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRY 350
             L+H+++V+L+  C          KG + LV+DF  +             V    +   
Sbjct: 64  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIK 120

Query: 351 KILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEH 410
           +++  + + +YY+   +  K++HRD+KA+N+L+  D   +L DFGLARA    +NS    
Sbjct: 121 RVMQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177

Query: 411 GLVGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSP--------------- 454
               V  T+ Y  PE     +   P  D++G G ++ E+                     
Sbjct: 178 YTNRV-VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236

Query: 455 --GNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIA 512
             G++ P         +    L      +  V  RL        A  L+           
Sbjct: 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI---DKLLVLDP 293

Query: 513 SERPKTEDILQ 523
           ++R  ++D L 
Sbjct: 294 AQRIDSDDALN 304

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-34
 Identities = 59/286 (20%), Positives = 104/286 (36%), Gaps = 52/286 (18%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD------FLAELAIIHRL 301
            LG GGFG VY GI         DN  +A+K   +D I   G+         E+ ++ ++
Sbjct: 11  LLGSGGFGSVYSGI------RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 302 RHKH--LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASA 359
                 ++ L+ W       +L+ +              +E+  L           V  A
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEA 122

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDAD-FNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
           V +    ++  V+HRD+K  NIL+D +    +L DFG    +++   +          GT
Sbjct: 123 VRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-------DFDGT 172

Query: 419 MGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE 477
             Y  PE     +     + V+  G ++ ++VCG  P                       
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE--------------------- 211

Query: 478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
            H ++ +  ++     V    + L+       P  S+RP  E+I  
Sbjct: 212 -HDEEIIRGQVFFRQRVSSECQHLIRWCLALRP--SDRPTFEEIQN 254

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-34
 Identities = 60/294 (20%), Positives = 103/294 (35%), Gaps = 39/294 (13%)

Query: 249 LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD-----FLAELAIIHRLRH 303
           LGEG F  VYK       +    N  +A+KK          D      L E+ ++  L H
Sbjct: 6   LGEGQFATVYKA------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 59

Query: 304 KHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYL 363
            +++ L+     K  + LV+DFM               + L  +H    +      + YL
Sbjct: 60  PNIIGLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYL 116

Query: 364 QNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA 423
              +   ++HRDLK +N+LLD +   +L DFGLA++  +   +Y          T  Y A
Sbjct: 117 ---HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-----VTRWYRA 168

Query: 424 PECFHTGKA-TPESDVFGFGAVVLEVVCGRSP---------GNMIPHQQHAYTLVDWVWM 473
           PE     +      D++  G ++ E++                 I       T   W  M
Sbjct: 169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228

Query: 474 LHREGHIQDAVDQRLNINSVV----DEAKRLLLLGLACSHPIASERPKTEDILQ 523
                ++       + ++ +     D+   L+             R      L+
Sbjct: 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLI---QGLFLFNPCARITATQALK 279

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  130 bits (328), Expect = 3e-34
 Identities = 57/312 (18%), Positives = 100/312 (32%), Gaps = 47/312 (15%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD---FLAELAI 297
           + F     LG G FG V         ++       A+K   +  +         L E  I
Sbjct: 41  DQFDRIKTLGTGSFGRVMLV------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94

Query: 298 IHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
           +  +    LV L     +   L +V +++  G +  +L         +  H       + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIV 151

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPG 417
               YL   +   +++RDLK  N+L+D     ++ DFG A+ ++    +          G
Sbjct: 152 LTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL--------CG 200

Query: 418 TMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE 477
           T   +APE   +       D +  G ++ E+  G  P       Q    +      +   
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVRFP 258

Query: 478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ-----------IIS 526
            H    +   L     VD  KR             + +    DI             I  
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKRF-----------GNLKNGVNDIKNHKWFATTDWIAIYQ 307

Query: 527 GTSTVPYVPQFK 538
                P++P+FK
Sbjct: 308 RKVEAPFIPKFK 319

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

 Score =  127 bits (320), Expect = 3e-34
 Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 14/159 (8%)

Query: 12  SGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVK----QGFDPDD 67
              GLAF +AP +S  P  S     GL ++ +D   +N  +A+EFDT        +DPD 
Sbjct: 82  GVDGLAFFLAPANSQIPSGSSAGMFGLFSS-SDSKSSNQIIAVEFDTYFGKAYNPWDPDF 140

Query: 68  NHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKP 127
            H+G+++NS+ S K V           +G    V + Y   +K + V +     +     
Sbjct: 141 KHIGIDVNSIKSIKTVKW------DWRNGEVADVVITYRAPTKSLTVCLS--YPSDGTSN 192

Query: 128 LLKETINLKDYLKPESYFGFSASTG-YPHIQLNCVRSWT 165
           ++  +++LK  L      GFS   G     + + V SW 
Sbjct: 193 IITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWY 231

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

 Score =  126 bits (318), Expect = 7e-34
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 20/160 (12%)

Query: 12  SGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLG 71
              GL F IAP ++       G + G+ N          FVA+EFDT +  +DP   H+G
Sbjct: 85  PADGLVFFIAPPNTQT--GEGGGYFGIYN----PLSPYPFVAVEFDTFRNTWDPQIPHIG 138

Query: 72  LNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKE 131
           +++NSV+S K          TL +G    V ++YD  +K++ V +      +     + +
Sbjct: 139 IDVNSVISTK------TVPFTLDNGGIANVVIKYDASTKILHVVLVFPS--LGTIYTIAD 190

Query: 132 TINLKDYLKPESYFGFSASTGYPH------IQLNCVRSWT 165
            ++LK  L      GFSA+TG P        + + + SW+
Sbjct: 191 IVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWS 230

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

 Score =  126 bits (318), Expect = 7e-34
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 18/165 (10%)

Query: 5   PRPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFD 64
              A+     GL F + P +S           G         + ++  A+EFDT +  +D
Sbjct: 79  QPYAYPEPADGLTFFMVPPNSPQ------GEDGGNLGVFKPPEGDNAFAVEFDTFQNTWD 132

Query: 65  PDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMP 124
           P   H+G+++NS+VS K +         L +G    V ++YD  +K++ V +     ++ 
Sbjct: 133 PQVPHIGIDVNSIVSSKTLHF------QLENGGVANVVIKYDSPTKILNVVLA--FHSVG 184

Query: 125 QKPLLKETINLKDYLKPES--YFGFSASTGYPH--IQLNCVRSWT 165
               L   ++LK           G SA+TGY    ++ + + SW+
Sbjct: 185 TVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWS 229

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  128 bits (321), Expect = 7e-34
 Identities = 53/296 (17%), Positives = 106/296 (35%), Gaps = 30/296 (10%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAII 298
             +H   ++GEG +G+VYK         +      A+KK   +          + E++I+
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-------QNNYGETFALKKIRLEKEDEGIPSTTIREISIL 54

Query: 299 HRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVAS 358
             L+H ++V L    H K +L+LV++ +     +        +  L        L  + +
Sbjct: 55  KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLN 111

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
            + Y    +D++V+HRDLK  N+L++ +   ++ DFGLARA       Y       +   
Sbjct: 112 GIAYC---HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE----IVTL 164

Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG 478
                     + K +   D++  G +  E+V G      +        +   +   + + 
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224

Query: 479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIA-----------SERPKTEDILQ 523
                   + + N  V E                           ++R   +  L+
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 8e-34
 Identities = 62/307 (20%), Positives = 111/307 (36%), Gaps = 39/307 (12%)

Query: 238 KATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAEL 295
           +A   +     +GEG +G V+K     N    V     A+K+    + +       + E+
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFV-----ALKRVRVQTGEEGMPLSTIREV 58

Query: 296 AIIHRL---RHKHLVHLVGWCH-----EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWN 347
           A++  L    H ++V L   C       + KL LV++ +              +  +   
Sbjct: 59  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTE 116

Query: 348 HRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSY 407
               ++  +   + +L   +  +VVHRDLK  NIL+ +    +L DFGLAR    +    
Sbjct: 117 TIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 173

Query: 408 AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTL 467
                  V  T+ Y APE           D++  G +  E+   +              +
Sbjct: 174 ------SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227

Query: 468 VDWVWMLHREGHIQDAVDQRLNINSV-----------VDEAKRLLLLGLACSHPIASERP 516
           +D + +   E   +D    R   +S            +DE  + LLL     +P  ++R 
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP--AKRI 285

Query: 517 KTEDILQ 523
                L 
Sbjct: 286 SAYSALS 292

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 1e-33
 Identities = 62/299 (20%), Positives = 115/299 (38%), Gaps = 36/299 (12%)

Query: 242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAIIH 299
           NF +  ++GEG +G+VYK       +  +    +A+KK   D+         + E++++ 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56

Query: 300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASA 359
            L H ++V L+   H + KL LV++F+     +      S    +        L  +   
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQG 114

Query: 360 VYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTM 419
           + +    +  +V+HRDLK  N+L++ +   +L DFGLARA      +Y          T+
Sbjct: 115 LAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-----VTL 166

Query: 420 GYVAPECF-HTGKATPESDVFGFGAVVLEVVCGRSP---------GNMIPHQQHAYTLVD 469
            Y APE        +   D++  G +  E+V  R+             I         V 
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226

Query: 470 WVWMLHREGHI-----QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
           W  +     +          D    +  + ++ + LL       H   ++R   +  L 
Sbjct: 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLL---SQMLHYDPNKRISAKAALA 282

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

 Score =  125 bits (315), Expect = 2e-33
 Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 13/158 (8%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNH 69
                GLAF +AP D+ P   + G +LGL       + +   VA+EFDT    +DP+  H
Sbjct: 81  AAVADGLAFFLAPPDTQPQ--ARGGFLGLFAD-RAHDASYQTVAVEFDTYSNAWDPNYTH 137

Query: 70  LGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLL 129
           +G++ N + S+K  P        +  G    + + Y   +K +   +            +
Sbjct: 138 IGIDTNGIESKKTTPFD------MVYGEKANIVITYQASTKALAASLVFPVS--QTSYAV 189

Query: 130 KETINLKDYLKPESYFGFSASTGYPH--IQLNCVRSWT 165
              ++L+D L      GFSA+TG     ++ + + SW+
Sbjct: 190 SARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWS 227

>d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} Length = 243

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]

 Score =  125 bits (315), Expect = 2e-33
 Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 13/158 (8%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNK-ANHFVAIEFDTV--KQGFDPD 66
             +  GLAF +AP DS      YG +LGL    T  +   N  VA+EFDT   K   DP 
Sbjct: 85  APTADGLAFFLAPVDSSVK--DYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPP 142

Query: 67  DNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQK 126
             H+G+++NS+VS          N      +  T  + YD +SK++ V +  E     + 
Sbjct: 143 YPHIGIDVNSIVSVATTRW---ENDDAYGSSIATAHITYDARSKILTVLLSYEH---GRD 196

Query: 127 PLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSW 164
            +L   ++L   L  +   GFSA  GY   ++  + SW
Sbjct: 197 YILSHVVDLAKVLPQKVRIGFSAGVGYD--EVTYILSW 232

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

 Score =  125 bits (314), Expect = 2e-33
 Identities = 51/158 (32%), Positives = 72/158 (45%), Gaps = 14/158 (8%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVK--QGFDPDD 67
                G+ F IAP D+  P  S G   G T   +D   A HFV +EFDT    +  DP  
Sbjct: 79  YDPADGIIFFIAPEDTQIPAGSIG---GGTLGVSDTKGAGHFVGVEFDTYSNSEYNDPPT 135

Query: 68  NHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKP 127
           +H+G+++NSV S K VP           G    V V YD  +K + V +           
Sbjct: 136 DHVGIDVNSVDSVKTVPW------NSVSGAVVKVTVIYDSSTKTLSVAVTN---DNGDIT 186

Query: 128 LLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWT 165
            + + ++LK  L     FGFSAS      Q++ +RSW+
Sbjct: 187 TIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWS 224

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

 Score =  124 bits (313), Expect = 4e-33
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 14/161 (8%)

Query: 6   RPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDP 65
            P       GLAF +AP D+ P   ++  +LGL N    G+     VA+EFDT +  +DP
Sbjct: 80  APDTKRLADGLAFFLAPIDTKP--QTHAGYLGLFNENESGD---QVVAVEFDTFRNSWDP 134

Query: 66  DDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQ 125
            + H+G+N+NS+ S K           L++     V + YD  + L+   +    +    
Sbjct: 135 PNPHIGINVNSIRSIKTTSWD------LANNKVAKVLITYDASTSLLVASLVYPSQ--RT 186

Query: 126 KPLLKETINLKDYLKPESYFGFSASTG-YPHIQLNCVRSWT 165
             +L + ++LK  L      GFSA+TG     + + V SW+
Sbjct: 187 SNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWS 227

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  126 bits (316), Expect = 5e-33
 Identities = 45/283 (15%), Positives = 87/283 (30%), Gaps = 28/283 (9%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           ++G G FG +Y G             ++A+K               E  I   ++    +
Sbjct: 14  KIGSGSFGDIYLGT------DIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGI 65

Query: 308 HLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY 367
             + WC  +G   ++   +   SLE      S +   +      +   + S + Y+   +
Sbjct: 66  PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYI---H 120

Query: 368 DQKVVHRDLKASNIL---LDADFNARLGDFGLARAIENERNS--YAEHGLVGVPGTMGYV 422
            +  +HRD+K  N L           + DFGLA+   + R            + GT  Y 
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 423 APECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQD 482
           +       + +   D+   G V++    G  P   +                 R    + 
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-------RQKYERISEKKM 233

Query: 483 AVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQII 525
           +    +       E    L     C      ++P    + Q+ 
Sbjct: 234 STPIEVLCKGYPSEFATYL---NFCRSLRFDDKPDYSYLRQLF 273

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

 Score =  122 bits (308), Expect = 2e-32
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 14/162 (8%)

Query: 7   PAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVK-QGFDP 65
           P    S  G+AF + P  S P   S   +LG+ ++    N     VA+EFDT     +DP
Sbjct: 78  PNKSSSADGIAFALVPVGSEPK--SNSGFLGVFDSDVYDNS-AQTVAVEFDTFSNTDWDP 134

Query: 66  DDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQ 125
              H+G+++NS+ S +           L++G +  + + Y+  + L+   +     +   
Sbjct: 135 TSRHIGIDVNSIKSIRTAS------WGLANGQNAEILITYNAATSLLVASLV--HPSRRT 186

Query: 126 KPLLKETINLKDYLKPESYFGFSASTGYP--HIQLNCVRSWT 165
             ++ E +++ + L      GFSA+TG    + + + V SW+
Sbjct: 187 SYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWS 228

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  121 bits (305), Expect = 1e-31
 Identities = 42/287 (14%), Positives = 92/287 (32%), Gaps = 32/287 (11%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRH-KHL 306
           R+GEG FG++++G         ++N Q+A+K   R S   +     E      L     +
Sbjct: 12  RIGEGSFGVIFEGT------NLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGI 63

Query: 307 VHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE 366
            ++  +  E    +LV D +     +            +          + + V  +   
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSI--- 117

Query: 367 YDQKVVHRDLKASNILLDADFN-----ARLGDFGLARAIENERNS--YAEHGLVGVPGTM 419
           +++ +V+RD+K  N L+    +       + DFG+ +   +              + GT 
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 420 GYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH 479
            Y++       + +   D+   G V +  + G                        R G 
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS-------LPWQGLKAATNKQKYERIGE 230

Query: 480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS 526
            + +   R       +E  + +       +      P  + +  + S
Sbjct: 231 KKQSTPLRELCAGFPEEFYKYMHY---ARNLAFDATPDYDYLQGLFS 274

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  119 bits (300), Expect = 2e-31
 Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 16/159 (10%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVK-QGFDPDDN 68
                GLAF + P  S P     G +LGL +     N   H VA+EFDT+  + +DP + 
Sbjct: 82  AGPADGLAFALVPVGSQP--KDKGGFLGLFD---GSNSNFHTVAVEFDTLYNKDWDPTER 136

Query: 69  HLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPL 128
           H+G+++NS+ S K             +G +  V + YD  + L+   +    +      +
Sbjct: 137 HIGIDVNSIRSIKTTRW------DFVNGENAEVLITYDSSTNLLVASLVYPSQ--KTSFI 188

Query: 129 LKETINLKDYLKPESYFGFSASTGYP--HIQLNCVRSWT 165
           + +T++LK  L      GFSA+TG    +++ N V SW+
Sbjct: 189 VSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWS 227

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 1e-30
 Identities = 57/339 (16%), Positives = 112/339 (33%), Gaps = 47/339 (13%)

Query: 231 FKYKELKKATNNFHESMR----LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK 286
           F  +E+ K         R    +G G +G V   +            ++A+KK  R    
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGA------KVAIKKLYRPFQS 57

Query: 287 SKG--DFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGT-SEQVT 343
                    EL ++  +RH++++ L+        L    DF           G   +   
Sbjct: 58  ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK 117

Query: 344 LNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE 403
           L  +    ++  +   + Y+   +   ++HRDLK  N+ ++ D   ++ DFGLAR  ++E
Sbjct: 118 LGEDRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174

Query: 404 RNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP--------- 454
              Y       V            +  + T   D++  G ++ E++ G++          
Sbjct: 175 MTGY-------VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 227

Query: 455 -------GNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLAC 507
                      P +       D      +     +  D    + +    A  LL      
Sbjct: 228 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL---EKM 284

Query: 508 SHPIASERPKTEDIL-----QIISGTSTVPYVPQFKPAF 541
               A +R    + L     + +  T   P V ++  +F
Sbjct: 285 LVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSF 323

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

 Score =  117 bits (294), Expect = 2e-30
 Identities = 30/121 (24%), Positives = 50/121 (41%), Gaps = 12/121 (9%)

Query: 48  ANHFVAIEFDTVK--QGFDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQY 105
           A+  VA+E DT       DP   H+G++I SV S+K           + +G   T  + Y
Sbjct: 1   ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW------NMQNGKVGTAHIIY 54

Query: 106 DGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWT 165
           +   K +   +            +   ++L + L      G SASTG  + + N + SW+
Sbjct: 55  NSVDKRLSAVVSYPN---ADSATVSYDVDLDNVLPEWVRVGLSASTG-LYKETNTILSWS 110

Query: 166 L 166
            
Sbjct: 111 F 111

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

 Score = 47.2 bits (112), Expect = 1e-06
 Identities = 12/35 (34%), Positives = 16/35 (45%)

Query: 6   RPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTN 40
           +        G+AF I+  DS  P  S G+ LGL  
Sbjct: 200 KSPDSHPADGIAFFISNIDSSIPSGSTGRLLGLFP 234

>d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} Length = 241

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]

 Score =  116 bits (291), Expect = 3e-30
 Identities = 45/165 (27%), Positives = 74/165 (44%), Gaps = 15/165 (9%)

Query: 6   RPAWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKA-NHFVAIEFDTVK---- 60
           +        G+AF IAP D+  P  S G  LGL    T  N + N  +A+EFDT      
Sbjct: 78  KSPLSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQDS 137

Query: 61  QGFDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREG 120
             +DP+  H+G+++NS+ S K V           DG S  V V ++  ++ + V      
Sbjct: 138 NTWDPNYPHIGIDVNSIRSVKTVKW------DRRDGQSLNVLVTFNPSTRNLDVVATYSD 191

Query: 121 ETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWT 165
                +  +   ++++  L      GFSA++G    Q + + SW+
Sbjct: 192 ---GTRYEVSYEVDVRSVLPEWVRVGFSAASG-EQYQTHTLESWS 232

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

 Score =  114 bits (287), Expect = 1e-29
 Identities = 38/157 (24%), Positives = 65/157 (41%), Gaps = 18/157 (11%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNH 69
            IS +GLAF + P +S P      ++LG+ N   +       VA+ F+T K   D D N 
Sbjct: 81  SISAYGLAFALVPVNSPPQ--KKQEFLGIFNT-NNPEPNARTVAVVFNTFKNRIDFDKNF 137

Query: 70  LGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLL 129
           +   +N            N +    +G    V + YD  +  ++VF+         K  +
Sbjct: 138 IKPYVNE-----------NCDFHKYNGEKTDVQITYDSSNNDLRVFLH--FTVSQVKCSV 184

Query: 130 KETINLKDYLKPESYFGFSASTGYPH--IQLNCVRSW 164
             T++L+  +      GFS ++G      + + V SW
Sbjct: 185 SATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSW 221

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 1e-29
 Identities = 60/299 (20%), Positives = 111/299 (37%), Gaps = 34/299 (11%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAII 298
             + +  ++GEG +G V+K       +    +  +A+K+   D          L E+ ++
Sbjct: 2   QKYEKLEKIGEGTYGTVFKA------KNRETHEIVALKRVRLDDDDEGVPSSALREICLL 55

Query: 299 HRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVAS 358
             L+HK++V L    H   KL LV++F      + +     +    +       L  +  
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLK 112

Query: 359 AVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGT 418
            + +  +   + V+HRDLK  N+L++ +   +L +FGLARA       Y+      V   
Sbjct: 113 GLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE----VVTL 165

Query: 419 MGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP----------GNMIPHQQHAYTLV 468
                   F     +   D++  G +  E+     P             I       T  
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225

Query: 469 DWVWML----HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ 523
            W  M     ++   +  A    +N+   ++   R LL  L   +P   +R   E+ LQ
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNP--VQRISAEEALQ 282

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

 Score =  113 bits (283), Expect = 4e-29
 Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 14/161 (8%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVK----QGFDP 65
           DI+  GLAF +AP DS  P  S  ++LGL N  ++ + +N  VA+EFDT        +DP
Sbjct: 83  DITSDGLAFYLAPPDSQIPSGSVSKYLGLFN-NSNSDSSNQIVAVEFDTYFAHSYDPWDP 141

Query: 66  DDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQ 125
           +  H+G+++N + S K V           +G      + Y   +K +   +     +   
Sbjct: 142 NYRHIGIDVNGIESIKTVQW------DWINGGVAFATITYLAPNKTLIASLV--YPSNQT 193

Query: 126 KPLLKETINLKDYLKPESYFGFSASTGYPH-IQLNCVRSWT 165
              +  +++LK+ L      GFSA+TGYP  ++ + V SW+
Sbjct: 194 TFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWS 234

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 6e-29
 Identities = 58/319 (18%), Positives = 113/319 (35%), Gaps = 46/319 (14%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGD----FLAELA 296
            NF     LG G +G V+          H      A+K   + +I  K         E  
Sbjct: 24  ENFELLKVLGTGAYGKVFLV---RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80

Query: 297 IIHRLRHK-HLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTG 355
           ++  +R    LV L      + KL L+ D++  G L  +L    ++     +     +  
Sbjct: 81  VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGE 137

Query: 356 VASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGV 415
           +  A+ +L   +   +++RD+K  NILLD++ +  L DFGL++    +    A       
Sbjct: 138 IVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD----F 190

Query: 416 PGTMGYVAPECFHTGKA--TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM 473
            GT+ Y+AP+    G +      D +  G ++ E++ G SP  +   +     +   +  
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL- 249

Query: 474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHP---IASERPKTEDILQ------- 523
                               +    + L+  L    P   +       ++I +       
Sbjct: 250 -----------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298

Query: 524 ----IISGTSTVPYVPQFK 538
               + +     P+ P  +
Sbjct: 299 NWDDLAAKKVPAPFKPVIR 317

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

 Score =  107 bits (268), Expect = 4e-27
 Identities = 50/159 (31%), Positives = 79/159 (49%), Gaps = 14/159 (8%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVK-QGFDPDDN 68
             +  GLAF +AP D+ P     G  LG+       NK+N  VA+EFDT     +DP   
Sbjct: 83  ATTADGLAFFLAPVDTQPL--DLGGMLGIFK-DGYFNKSNQIVAVEFDTFSNGDWDPKGR 139

Query: 69  HLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPL 128
           HLG+N+NS+ S K VP         ++G    V++ Y+  +K +   +     ++    +
Sbjct: 140 HLGINVNSIESIKTVPWNW------TNGEVANVFISYEASTKSLTASL--VYPSLETSFI 191

Query: 129 LKETINLKDYLKPESYFGFSASTGYP--HIQLNCVRSWT 165
           +   +++K  L     FGFSA+TG    ++Q N V SW+
Sbjct: 192 IDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWS 230

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  106 bits (266), Expect = 7e-27
 Identities = 36/160 (22%), Positives = 64/160 (40%), Gaps = 22/160 (13%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG--FDPDD 67
           + S +GLAF + P  S P     G++LGL N              + D       FD   
Sbjct: 79  ENSAYGLAFALVPVGSRPK--LKGRYLGLFN----------TTNYDRDAHTVAVVFDTVS 126

Query: 68  NHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKP 127
           N + +++NS+           +N    +G    V + YD     ++V +        +K 
Sbjct: 127 NRIEIDVNSIRPIATESCNFGHN----NGEKAEVRITYDSPKNDLRVSLLYPSS--EEKC 180

Query: 128 LLKETINLKDYLKPESYFGFSASTGYPH--IQLNCVRSWT 165
            +  T+ L+  ++     GFSA++G      + + V SW+
Sbjct: 181 HVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWS 220

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (261), Expect = 3e-25
 Identities = 47/245 (19%), Positives = 86/245 (35%), Gaps = 29/245 (11%)

Query: 241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG--DFLAELAII 298
             +     +G G  GIV            V +  +A+KK SR             EL ++
Sbjct: 17  KRYQNLKPIGSGAQGIVCAA------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70

Query: 299 HRLRHKHLVHLVGWCH------EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKI 352
             + HK+++ L+          E   + LV + M     +        +          +
Sbjct: 71  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE------RMSYL 124

Query: 353 LTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGL 412
           L  +   + +L +     ++HRDLK SNI++ +D   ++ DFGLAR              
Sbjct: 125 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV-- 179

Query: 413 VGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW 472
                T  Y APE           D++  G ++ E+V  +       +      +++ + 
Sbjct: 180 ----VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235

Query: 473 MLHRE 477
               E
Sbjct: 236 TPCPE 240

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  104 bits (260), Expect = 3e-25
 Identities = 43/237 (18%), Positives = 87/237 (36%), Gaps = 33/237 (13%)

Query: 227 MPRE-FKYKELKKATNN---FHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSR 282
            PRE + Y+       N   +    +LG G +  V++ I         +N ++ VK    
Sbjct: 17  RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAI------NITNNEKVVVKILKP 70

Query: 283 DSIKSKGDFLAELAIIHRLR-HKHLVHLVGWCHE--KGKLLLVYDFMPNGSLEKYLYGTS 339
              K       E+ I+  LR   +++ L     +       LV++ + N   ++      
Sbjct: 71  VKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--- 124

Query: 340 EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN-ARLGDFGLAR 398
              TL        +  +  A+ Y    +   ++HRD+K  N+++D +    RL D+GLA 
Sbjct: 125 ---TLTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178

Query: 399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSP 454
                +             +  +  PE     +      D++  G ++  ++  + P
Sbjct: 179 FYHPGQEYNVRV------ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 97.8 bits (242), Expect = 1e-22
 Identities = 37/221 (16%), Positives = 74/221 (33%), Gaps = 26/221 (11%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV 307
           +LG G F  V+        +  V+NT +A+K    D + ++     E+ ++ R+      
Sbjct: 20  KLGWGHFSTVWLA------KDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNT 72

Query: 308 HLVGWCHEKGKLLLVY--DFMPNGSLEKYLYGTSEQVTLNWNHRYK-----------ILT 354
                       LL +     PNG     ++    +  L    +Y+           I  
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132

Query: 355 GVASAVYYLQNEYDQKVVHRDLKASNILLDA-DFNARLGDFGLARAIENERNSYAEHGLV 413
            +   + Y+       ++H D+K  N+L++  D    L    +A                
Sbjct: 133 QLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN-- 188

Query: 414 GVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
               T  Y +PE          +D++    ++ E++ G   
Sbjct: 189 -SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.9 bits (240), Expect = 2e-22
 Identities = 49/237 (20%), Positives = 91/237 (38%), Gaps = 27/237 (11%)

Query: 225 PGMPREFKYKELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD- 283
           P   R+   K + +    +     +G G +G V                 +AVKK SR  
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLR------VAVKKLSRPF 55

Query: 284 -SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTS--- 339
            SI        EL ++  ++H++++ L+        L    D      L  +L G     
Sbjct: 56  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY----LVTHLMGADLNN 111

Query: 340 --EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA 397
             +   L  +H   ++  +   + Y+   +   ++HRDLK SN+ ++ D   ++ DFGLA
Sbjct: 112 IVKCQKLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLA 168

Query: 398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP 454
           R  ++E   Y       V            +        D++  G ++ E++ GR+ 
Sbjct: 169 RHTDDEMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 85.2 bits (210), Expect = 1e-19
 Identities = 29/158 (18%), Positives = 52/158 (32%), Gaps = 36/158 (22%)

Query: 10  DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNH 69
             S  GL FV+ P                             V +EFDT       D N+
Sbjct: 76  ANSAVGLDFVLVPVQPESK--------------------GDTVTVEFDTFLSRISIDVNN 115

Query: 70  LGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLL 129
             +                +++   DG +  V + Y+  +K+  V +        +   +
Sbjct: 116 NDIKSVP------------WDVHDYDGQNAEVRITYNSSTKVFSVSLSNPS--TGKSNNV 161

Query: 130 KETINLKDYLKPESYFGFSASTG--YPHIQLNCVRSWT 165
             T+ L+  +      GFSA++G      + + V SW+
Sbjct: 162 STTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWS 199

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 75.6 bits (185), Expect = 2e-16
 Identities = 31/167 (18%), Positives = 49/167 (29%), Gaps = 27/167 (16%)

Query: 248 RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKG----------DFLAELAI 297
            +GEG    V+         Y     +  VK         K            F      
Sbjct: 7   LMGEGKESAVFNC-------YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59

Query: 298 IHRLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVA 357
             R   + L  L G    K     VY +  N  L + +           N   ++L  + 
Sbjct: 60  SARNEFRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMIL 113

Query: 358 SAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER 404
             V      Y + +VH DL   N+L+  +    + DF  +  +  E 
Sbjct: 114 EEVAKF---YHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG 156

>d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Carbohydrate-recognition domain of P58/ERGIC-53
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 72.1 bits (176), Expect = 7e-15
 Identities = 25/147 (17%), Positives = 43/147 (29%), Gaps = 20/147 (13%)

Query: 12  SGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLG 71
              GLA     N         G   G            + V I FD+       ++  + 
Sbjct: 78  GADGLAIWYTENQGLD-----GPVFG-------SADMWNGVGIFFDSFDNDGKKNNPAIV 125

Query: 72  LNINSVVSRKNVPLKDNYNITLS------DGTSYTVWVQYDGKSKLIQVFMDREGETMPQ 125
           +  N+     +    D     L+          Y V  +     K + V ++  G T  +
Sbjct: 126 VVGNNGQINYDHQ-NDGATQALASCQRDFRNKPYPVRAKITYYQKTLTVMIN-NGFTPDK 183

Query: 126 KPLLKETINLKDYLKPESYFGFSASTG 152
                        +  + +FG SA+TG
Sbjct: 184 NDYEFCAKVENMVIPTQGHFGISAATG 210

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	568
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1hqla_	236	Legume lectin {Griffonia simplicifolia, lectin I-b	100.0
d1leda_	243	Legume lectin {West-central african legume (Griffo	100.0
d1fx5a_	240	Legume lectin {Furze (Ulex europaeus), UEA-I [TaxI	100.0
d1qnwa_	237	Legume lectin {Furze (Ulex europaeus), UEA-II [Tax	100.0
d2d3sa1	237	Legume lectin {Winged bean (Psophocarpus tetragono	100.0
d1gzca_	239	Legume lectin {Cockspur coral tree (Erythrina cris	100.0
d1g9fa_	251	Legume lectin {Soybean (Glycine max) [TaxId: 3847]	99.98
d1f9ka_	234	Legume lectin {Winged bean (Psophocarpus tetragono	99.97
d1n47a_	233	Legume lectin {Hairy vetch (Vicia villosa), isolec	99.97
d1g7ya_	253	Legume lectin {Horse gram (Dolichos biflorus), dif	99.97
d1g8wa_	233	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	99.97
d1dbna_	239	Legume lectin {Maackia amurensis, leukoagglutinin	99.97
d1fnya_	237	Legume lectin {Black locust (Robinia pseudoacacia)	99.96
g1qmo.1	230	Legume lectin {Field bean (Dolichos lablab), Fril	99.96
d1v6ia_	232	Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3	99.96
d1ukga_	241	Legume lectin {Bloodwood tree (Pterocarpus angolen	99.96
d1nlsa_	237	Concanavalin A {Jack bean (Canavalia ensiformis) [	99.95
d1ioaa_	228	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	99.94
g2ltn.1	229	Legume lectin {Garden pea (Pisum sativum) [TaxId:	99.94
d1avba_	226	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	99.93
d1dhkb_	204	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	99.87
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1gv9a_	228	Carbohydrate-recognition domain of P58/ERGIC-53 {R	99.55
d2a6za1	221	Emp47p N-terminal domain {Baker's yeast (Saccharom	98.91
d2a6va1	218	Emp46p N-terminal domain {Baker's yeast (Saccharom	98.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.55
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.77
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.29
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.16
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.79
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.46

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-54  Score=435.10  Aligned_cols=277  Identities=27%  Similarity=0.475  Sum_probs=208.4

Q ss_pred             ccCHHHHHHHhcCc---------cccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhh
Q 008374          230 EFKYKELKKATNNF---------HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIH  299 (568)
Q Consensus       230 ~~~~~el~~at~~f---------~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~  299 (568)
                      .++|+++..++.+|         +..++||+|+||+||+|+++..+.   ....||||++... .....++|.+|+++|+
T Consensus         6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~   82 (299)
T d1jpaa_           6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGK---REIFVAIKTLKSGYTEKQRRDFLSEASIMG   82 (299)
T ss_dssp             GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHHHHHT
T ss_pred             CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCC---EEEEEEEEEECcccCHHHHHHHHHHHHHHH
Confidence            35667777776555         445789999999999999875321   3457999998664 3345678999999999


Q ss_pred             cCCCCceeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 008374          300 RLRHKHLVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKAS  379 (568)
Q Consensus       300 ~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~  379 (568)
                      +++|||||+++|+|.+.+.+++|||||++|+|.+++...  ...++|.+++.++.|||+||.|||   +++|+||||||+
T Consensus        83 ~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~  157 (299)
T d1jpaa_          83 QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAAR  157 (299)
T ss_dssp             TCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGG
T ss_pred             hCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccc
Confidence            999999999999999999999999999999999998643  346999999999999999999999   579999999999


Q ss_pred             CEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 008374          380 NILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMI  458 (568)
Q Consensus       380 NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~  458 (568)
                      ||||+.++.+||+|||+|+.+................||+.|||||.+.++.++.++|||||||++|||+| |+.||...
T Consensus       158 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~  237 (299)
T d1jpaa_         158 NILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM  237 (299)
T ss_dssp             GEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             eEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence            99999999999999999998765443322222234568999999999999999999999999999999998 89999754


Q ss_pred             CcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC
Q 008374          459 PHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTV  531 (568)
Q Consensus       459 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~  531 (568)
                      ....    +...             +........+.+....+.+++.+||+.||.+||||+||++.|++..+.
T Consensus       238 ~~~~----~~~~-------------i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         238 TNQD----VINA-------------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             CHHH----HHHH-------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CHHH----HHHH-------------HHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            3322    2211             111122223334556678889999999999999999999999875443

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=416.10  Aligned_cols=254  Identities=23%  Similarity=0.418  Sum_probs=197.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|...++||+|+||+||+|++.       ++..||||+++... ...++|.+|++++++++|||||+++|+|...+..+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-------~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   76 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-------TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-------CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence            46788899999999999999986       46789999997643 44578999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +|||||++|+|.+++...  ...++|..++.++.|+|+||.|||   +++|+||||||+|||+|+++++||+|||+++..
T Consensus        77 lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  151 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  151 (263)
T ss_dssp             EEEECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred             EEEEecCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheec
Confidence            999999999999998643  356899999999999999999999   579999999999999999999999999999877


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCC-CCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP-GNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P-~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      ........    ....||+.|||||++.+..++.++|||||||++|||+|++.| +......    .+...+.       
T Consensus       152 ~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~----~~~~~i~-------  216 (263)
T d1sm2a_         152 LDDQYTSS----TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVEDIS-------  216 (263)
T ss_dssp             -----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH----HHHHHHH-------
T ss_pred             cCCCceee----cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH----HHHHHHH-------
Confidence            55432221    145799999999999999999999999999999999996544 4432221    1222111       


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                            .......+......+.+++..||+.||++||||+||++.|++.
T Consensus       217 ------~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         217 ------TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             ------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------hcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                  1111112223345677888999999999999999999999863

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.2e-53  Score=422.44  Aligned_cols=258  Identities=24%  Similarity=0.415  Sum_probs=214.2

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .++|...++||+|+||+||+|+++.      +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+.+..
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGG------GTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECC------CCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            4678889999999999999999875      68899999997643 4567899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++|||||++|+|.+++.... ...+++..+..++.||++||.|||   +++|+||||||+||||++++++||+|||+|+.
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             EEEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceee
Confidence            99999999999999996543 357999999999999999999999   57999999999999999999999999999998


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      ..........    ...||+.|||||++.+..++.++|||||||++|||++|+.|+.......   .+.           
T Consensus       165 ~~~~~~~~~~----~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~---~~~-----------  226 (287)
T d1opja_         165 MTGDTYTAHA----GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVY-----------  226 (287)
T ss_dssp             CCSSSSEEET----TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH-----------
T ss_pred             cCCCCceeec----cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH---HHH-----------
Confidence            7654332221    4568999999999999999999999999999999999877764322211   111           


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                        +.+........+......+.+++..||+.||++||||+||++.|+..
T Consensus       227 --~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         227 --ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             --HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             --HHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              12222222233334456678888999999999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-52  Score=413.70  Aligned_cols=255  Identities=26%  Similarity=0.452  Sum_probs=205.6

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .++|+..++||+|+||+||+|+++       ++..||||+++... ...++|.+|++++++++|||||+++|+|.+ +..
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~   82 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI   82 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-------CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCe
Confidence            356888899999999999999986       46789999997643 345689999999999999999999998864 567


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++|||||++|+|.+++.... ...++|..+++|+.||++||.|||   +++|+||||||+||||++++.+||+|||+|+.
T Consensus        83 ~iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~  158 (272)
T d1qpca_          83 YIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARL  158 (272)
T ss_dssp             EEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEE
Confidence            99999999999999885432 335999999999999999999999   57999999999999999999999999999998


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      +........    ....||+.|||||++.++.++.++|||||||++|||+||+.|+.......   .+...+        
T Consensus       159 ~~~~~~~~~----~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~~~~~i--------  223 (272)
T d1qpca_         159 IEDNEYTAR----EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNL--------  223 (272)
T ss_dssp             CSSSCEECC----TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH--------
T ss_pred             ccCCccccc----cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---HHHHHH--------
Confidence            765432222    25679999999999999999999999999999999999766654222211   111111        


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                           ........+......+.+++..||+.||++||||+||+++|+.
T Consensus       224 -----~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         224 -----ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             -----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----HhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence                 1111111222334567788889999999999999999999874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-52  Score=415.20  Aligned_cols=267  Identities=26%  Similarity=0.464  Sum_probs=205.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      +.|...++||+|+||+||+|+++..+.  .....||||++.... .....+|.+|++++++++|||||+++|+|.+.+..
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSG--KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCC--EEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            457888999999999999999875321  123679999997543 33456799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++|||||.+|+|.+++...  ...++|.++..++.|++.||.|||   +++|+||||||+||||+.++.+||+|||+|+.
T Consensus        85 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          85 MIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhc
Confidence            9999999999999988543  346999999999999999999999   57999999999999999999999999999998


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      +.........  .....||+.|||||++..+.++.++|||||||++|||++|+.|+.......   .+.           
T Consensus       160 ~~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~---~~~-----------  223 (283)
T d1mqba_         160 LEDDPEATYT--TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVM-----------  223 (283)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH-----------
T ss_pred             ccCCCccceE--eccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH---HHH-----------
Confidence            7654322111  124578999999999999999999999999999999999776654322211   111           


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTSTVP  532 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~~p  532 (568)
                        +.+........+.+....+.+++.+||+.||++||||.||+++|++....|
T Consensus       224 --~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         224 --KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             --HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             --HHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence              122222333334445567888999999999999999999999998755444

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=411.34  Aligned_cols=258  Identities=25%  Similarity=0.457  Sum_probs=207.1

Q ss_pred             cCccccc-eeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESM-RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~-~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|...+ +||+|+||+||+|+++..+    ++..||||+++... ....++|.+|+++|++++|||||+++|+|.. +.
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~----~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCC----CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            4566666 4999999999999886422    45689999997653 3346789999999999999999999999864 56


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      ++||||||++|+|.+++...  ...+++.++..++.|+++||.|||   +++|+||||||+||||+.++.+||+|||+|+
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~  157 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSK  157 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhh
Confidence            89999999999999998543  346999999999999999999999   5799999999999999999999999999999


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      .+.........  .....||+.|||||++.++.++.++|||||||++|||+| |+.||......+    +...    ...
T Consensus       158 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~----~~~~----i~~  227 (285)
T d1u59a_         158 ALGADDSYYTA--RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMAF----IEQ  227 (285)
T ss_dssp             ECTTCSCEECC--CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH----HHHH----HHT
T ss_pred             ccccccccccc--ccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH----HHHH----HHc
Confidence            87654322211  224578999999999999999999999999999999998 999998554322    1111    111


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      +         .....+......+.+++..||+.||++||||.+|++.|+.
T Consensus       228 ~---------~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         228 G---------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             T---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             C---------CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            1         1112223344567788899999999999999999998874

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-51  Score=407.92  Aligned_cols=253  Identities=23%  Similarity=0.351  Sum_probs=202.3

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|+..++||+|+||+||+|+.+.      +++.||||++.... .+..+.+.+|++++++++||||+++++++.+.+..
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~   78 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRV------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   78 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECC------CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCcee
Confidence            578999999999999999999875      68899999997653 33456799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      +||||||++|+|.+++..   ...+++.++..++.|+++||.|||   +++|+||||||+|||+++++.+||+|||+|+.
T Consensus        79 ~ivmEy~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~  152 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATV  152 (271)
T ss_dssp             EEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhhee
Confidence            999999999999999953   457999999999999999999999   57999999999999999999999999999998


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      .........   ....+||+.|||||++.+..+ +.++|||||||++|||++|+.||........  ....+    .   
T Consensus       153 ~~~~~~~~~---~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~~~~----~---  220 (271)
T d1nvra_         153 FRYNNRERL---LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDW----K---  220 (271)
T ss_dssp             CEETTEECC---BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HHHHH----H---
T ss_pred             eccCCcccc---ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HHHHH----h---
Confidence            754432111   225789999999999988776 5789999999999999999999975433321  11110    0   


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                            ...............+.+++.+||+.||++|||++|+++
T Consensus       221 ------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         221 ------EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ------TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------cCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  111111111122345566778999999999999999864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=411.20  Aligned_cols=251  Identities=25%  Similarity=0.425  Sum_probs=200.5

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEEEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLLLVYD  324 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  324 (568)
                      ++||+|+||+||+|.+....    .++.||||+++...  ....++|.+|+++|++++|||||+++|+|.. +..+||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE   87 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKK----VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME   87 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSS----SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCC----cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEE
Confidence            57999999999999986422    46789999996542  2345679999999999999999999999964 56789999


Q ss_pred             ecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccccccc
Q 008374          325 FMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENER  404 (568)
Q Consensus       325 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~~  404 (568)
                      ||++|+|.+++..   ...+++.+++.++.||+.||.|||   +++|+||||||+||||+.++.+||+|||+|+.+....
T Consensus        88 ~~~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~  161 (277)
T d1xbba_          88 MAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  161 (277)
T ss_dssp             CCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             cCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence            9999999999954   346999999999999999999999   5799999999999999999999999999999876543


Q ss_pred             ccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCchhhh
Q 008374          405 NSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDA  483 (568)
Q Consensus       405 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  483 (568)
                      .....  .....||+.|||||.+....++.++|||||||++|||+| |+.||......+    +...    ...+     
T Consensus       162 ~~~~~--~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~----~~~~----i~~~-----  226 (277)
T d1xbba_         162 NYYKA--QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAM----LEKG-----  226 (277)
T ss_dssp             SEEEC------CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHH----HHTT-----
T ss_pred             ccccc--ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH----HHHH----HHcC-----
Confidence            32221  224579999999999999999999999999999999998 899998543322    1111    1111     


Q ss_pred             hhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          484 VDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       484 ~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                          .....+......+.+++.+||+.||++|||+++|++.|+.
T Consensus       227 ----~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         227 ----ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ----CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence                1122223344567788889999999999999999998863

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-51  Score=409.28  Aligned_cols=258  Identities=27%  Similarity=0.432  Sum_probs=200.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|...++||+|+||+||+|+++         ..||||+++..  .....+.|.+|+.++++++|||||+++|++.+ +.
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~   77 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH---------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQ   77 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS---------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC---------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cE
Confidence            56788899999999999999764         35999998654  34456789999999999999999999999864 56


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      ++||||||++|+|.+++...  ...+++..++.++.|||+||+|||   +++|+||||||+||||+.++.+||+|||+|+
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~  152 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT  152 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred             EEEEEecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEcccccee
Confidence            89999999999999999643  246999999999999999999999   5799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHT---GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~---~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      ..........   .....||+.|||||++..   ..++.++|||||||++|||+||+.||.......   .+...+    
T Consensus       153 ~~~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~~~~~----  222 (276)
T d1uwha_         153 VKSRWSGSHQ---FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIFMV----  222 (276)
T ss_dssp             C---------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHH----
T ss_pred             eccccCCccc---ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HHHHHH----
Confidence            8765432211   225689999999999864   458999999999999999999999998654332   111111    


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                      ..+..    .+.+ .....+....+.+++.+||+.||.+||||+||++.|+..
T Consensus       223 ~~~~~----~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         223 GRGYL----SPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             HHTSC----CCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcCCC----CCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11111    0100 011122345677888899999999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-51  Score=401.15  Aligned_cols=253  Identities=25%  Similarity=0.451  Sum_probs=210.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|+..++||+|+||+||+|+++       ++..||||+++... ...++|.+|+.++++++||||++++|+|.+++.++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-------~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~   75 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-------GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   75 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-------TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-------CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Confidence            57888899999999999999986       57889999998654 34578999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +||||+++|+|..++...  ...+++..+.+++.|+++||.|||   +++|+||||||+|||+++++.+||+|||+++..
T Consensus        76 iv~Ey~~~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~  150 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  150 (258)
T ss_dssp             EEEECCTTEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBC
T ss_pred             EEEEccCCCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheec
Confidence            999999999999998543  356899999999999999999999   579999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      ........    ....||+.|+|||.+....++.++|||||||++|||+| |+.||+.....+    +..    ....  
T Consensus       151 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~----~~~----~i~~--  216 (258)
T d1k2pa_         151 LDDEYTSS----VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----TAE----HIAQ--  216 (258)
T ss_dssp             SSSSCCCC----CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH----HHH----HHHT--
T ss_pred             cCCCceee----cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH----HHH----HHHh--
Confidence            55432221    24679999999999999999999999999999999998 899998654332    111    1111  


Q ss_pred             hhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          480 IQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       480 ~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                             ..+...+......+.+++..||+.||++|||++|+++.|..
T Consensus       217 -------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         217 -------GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -------CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                   11112222334567788889999999999999999998853

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=406.85  Aligned_cols=250  Identities=20%  Similarity=0.355  Sum_probs=207.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|+..++||+|+||+||+|+...      +++.||||++........+.+.+|++++++++||||+++++++.+.+.++
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVA------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTT------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECC------CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence            468899999999999999999765      68899999998765556678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      ||||||++|+|.+++..    ..+++.+...++.||+.||.|||   +++|+||||||+|||++.++++||+|||+|+.+
T Consensus        94 ivmEy~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~  166 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (293)
T ss_dssp             EEEECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheee
Confidence            99999999999998843    35899999999999999999999   579999999999999999999999999999987


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      .......     ....||+.|||||++.+..++.++|||||||++|||++|+.||.......   .+    ......+  
T Consensus       167 ~~~~~~~-----~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~----~~~~~~~--  232 (293)
T d1yhwa1         167 TPEQSKR-----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---AL----YLIATNG--  232 (293)
T ss_dssp             CSTTCCB-----CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH----HHHHHHC--
T ss_pred             ccccccc-----cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH---HH----HHHHhCC--
Confidence            5543221     25679999999999999999999999999999999999999997543222   11    1111111  


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                            .............+.+++.+||+.||.+|||+.|+++
T Consensus       233 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         233 ------TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             ------SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ------CCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  1111122223455677888999999999999999975

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-51  Score=415.99  Aligned_cols=264  Identities=24%  Similarity=0.408  Sum_probs=210.8

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcC-CCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  317 (568)
                      .++|...++||+|+||+||+|++...+.. .....||||++... .......|.+|+.+|.++ +|||||+++++|.+.+
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKT-GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSS-SCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcc-cceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            35788999999999999999998753211 13457999998654 334567899999999998 8999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCC--------------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSE--------------------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLK  377 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDik  377 (568)
                      .++||||||++|+|.++|+....                    ...+++..++.++.||++||+|||   +++|+|||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCc
Confidence            99999999999999999975422                    235899999999999999999999   5799999999


Q ss_pred             CCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008374          378 ASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGN  456 (568)
Q Consensus       378 p~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~  456 (568)
                      |+|||++.++.+||+|||+|+...........   ....||+.|||||++.++.++.++|||||||++|||+| |+.||.
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVR---GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEE---TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeee---ccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            99999999999999999999877654332111   14568999999999999999999999999999999997 899998


Q ss_pred             CCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 008374          457 MIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIIS  526 (568)
Q Consensus       457 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~  526 (568)
                      ......   .+..             ++......+.+......+.+++..||+.||++||||+||++.|.
T Consensus       269 ~~~~~~---~~~~-------------~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         269 GIPVDA---NFYK-------------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TCCCSH---HHHH-------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCHHH---HHHH-------------HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            654433   1211             12222222233334456788888999999999999999999985

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-51  Score=402.32  Aligned_cols=246  Identities=22%  Similarity=0.355  Sum_probs=205.0

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|+..+.||+|+||+||+|+.+.      +++.||+|++.+..   ....+.+.+|++++++++||||+++++++.+.+
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~   79 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQ------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   79 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hHeEEEEEEecCCCcEEEEEEECC------CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence            568999999999999999999875      68899999986532   234567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++|||||++|+|.+++..   ...+++.....++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a  153 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS  153 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSC
T ss_pred             EEEEEEeecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeeccccee
Confidence            99999999999999999953   346999999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +.......       ....||+.|||||++.+..++.++|||||||++|||++|+.||.......    +.    .....
T Consensus       154 ~~~~~~~~-------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~----~~i~~  218 (263)
T d2j4za1         154 VHAPSSRR-------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----TY----KRISR  218 (263)
T ss_dssp             SCCCCCCC-------EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HH----HHHHT
T ss_pred             eecCCCcc-------cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH----HH----HHHHc
Confidence            87654322       25679999999999999999999999999999999999999997543222    11    11111


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      +        ..  ..+......+.+++..||+.||++|||++|+++
T Consensus       219 ~--------~~--~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         219 V--------EF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             T--------CC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C--------CC--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            1        11  111122345667788999999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=405.77  Aligned_cols=252  Identities=22%  Similarity=0.322  Sum_probs=207.3

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      +.|+..++||+|+||+||+|+...      +++.||||++........+.|.+|+++|++++|||||++++++.+.+.++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   85 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKE------TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW   85 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECC------CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEE
Confidence            458889999999999999999875      68899999998877777889999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      ||||||++|+|.+++...  ...+++.++..++.||++||.|||   +++|+||||||+|||++.++++||+|||+|+..
T Consensus        86 lvmEy~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~  160 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN  160 (288)
T ss_dssp             EEEECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhcc
Confidence            999999999999998542  246999999999999999999999   579999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFH-----TGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      ......     .....||+.|||||++.     ...++.++|||||||++|||+||+.||.......   .+...    .
T Consensus       161 ~~~~~~-----~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~~i----~  228 (288)
T d2jfla1         161 TRTIQR-----RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLLKI----A  228 (288)
T ss_dssp             HHHHHH-----HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHHH----H
T ss_pred             CCCccc-----ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHHHH----H
Confidence            543221     12567999999999984     4568899999999999999999999997554333   11110    0


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       .+.       ......+......+.+++.+||+.||.+|||++|+++
T Consensus       229 -~~~-------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         229 -KSE-------PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -HSC-------CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -cCC-------CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             010       0011112233445677888999999999999999975

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-51  Score=407.03  Aligned_cols=257  Identities=28%  Similarity=0.429  Sum_probs=203.1

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      ++|+..++||+|+||+||+|+++       ++..||||+++.. ....++|.+|+.++++++|||||+++|+|.+ +..+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~-------~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~   87 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   87 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-------TTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEEC-------CCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence            57899999999999999999986       4568999999654 3445789999999999999999999999954 5679


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      +|||||++|+|..++.... ...++|.+++.++.||+.||+|||   +++|+||||||+|||||.++++||+|||+|+..
T Consensus        88 lv~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~  163 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI  163 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             EEEEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhc
Confidence            9999999999999986432 245999999999999999999999   579999999999999999999999999999977


Q ss_pred             ccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCch
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHI  480 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  480 (568)
                      ........    ....||+.|+|||++..+.++.++|||||||++|||+||+.|+.......   .+...+         
T Consensus       164 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~---~~~~~i---------  227 (285)
T d1fmka3         164 EDNEYTAR----QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQV---------  227 (285)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH---------
T ss_pred             cCCCceee----ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHH---------
Confidence            54432222    24679999999999999999999999999999999999877765332222   222221         


Q ss_pred             hhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 008374          481 QDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST  530 (568)
Q Consensus       481 ~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~  530 (568)
                          .............+.+.+++.+||+.||++||||++|+++|+...+
T Consensus       228 ----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         228 ----ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             ----HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ----HhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence                1111222233344567888899999999999999999999998543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-51  Score=405.71  Aligned_cols=255  Identities=23%  Similarity=0.374  Sum_probs=194.0

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEe--C
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE--K  316 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~  316 (568)
                      ++|+..+.||+|+||+||+|+.+.      +++.||||.+....  ....+.|.+|++++++++|||||++++++.+  .
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   77 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKS------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN   77 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred             hhCEEeEEEecCCCeEEEEEEECC------CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence            679999999999999999999875      68899999997653  2345678999999999999999999999865  4


Q ss_pred             CeEEEEEEecCCCChhhhhccCC-CcccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCEEEcCCCcEEEee
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTS-EQVTLNWNHRYKILTGVASAVYYLQNEY--DQKVVHRDLKASNILLDADFNARLGD  393 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDikp~NILld~~~~~kL~D  393 (568)
                      +.+++|||||++|+|.+++.... ....+++..+..++.|++.||.|||+..  ..+|+||||||+|||++.++.+||+|
T Consensus        78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D  157 (269)
T d2java1          78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  157 (269)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence            56899999999999999986432 2456999999999999999999999642  24599999999999999999999999


Q ss_pred             cCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          394 FGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       394 FGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      ||+|+.+.......     ....||+.|||||++.+..++.++|||||||++|||+||+.||......+    +..    
T Consensus       158 FG~a~~~~~~~~~~-----~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~----~~~----  224 (269)
T d2java1         158 FGLARILNHDTSFA-----KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----LAG----  224 (269)
T ss_dssp             HHHHHHC----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHH----
T ss_pred             ccceeecccCCCcc-----ccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH----HHH----
Confidence            99999876543221     25689999999999999999999999999999999999999997543322    111    


Q ss_pred             HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       474 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ....+...     .+    +......+.+++.+||+.||.+|||++|+++
T Consensus       225 ~i~~~~~~-----~~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         225 KIREGKFR-----RI----PYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHHTCCC-----CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHcCCCC-----CC----CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            11111111     11    1122345667788999999999999999975

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-50  Score=408.43  Aligned_cols=201  Identities=24%  Similarity=0.389  Sum_probs=178.4

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .++|+..++||+|+||+||+|+...      +++.||+|+++... ....+.+.+|+.+|++++|||||+++++|.+.++
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   78 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKP------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE   78 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETT------TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECC------CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            5689999999999999999999875      68999999997653 3345678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      ++||||||++|+|.+++.+   ...+++..+..++.|++.||.|||+.  .+|+||||||+|||+++++.+||+|||+|+
T Consensus        79 ~~iVmEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~  153 (322)
T d1s9ja_          79 ISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSG  153 (322)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             EEEEEEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCcc
Confidence            9999999999999999954   34699999999999999999999952  389999999999999999999999999999


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMI  458 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~  458 (568)
                      .......       ...+||+.|||||++.+..++.++||||+||++|||++|+.||...
T Consensus       154 ~~~~~~~-------~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         154 QLIDSMA-------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             HHHHHTC----------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             ccCCCcc-------ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            7654321       2568999999999999999999999999999999999999999754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=395.69  Aligned_cols=245  Identities=22%  Similarity=0.359  Sum_probs=194.6

Q ss_pred             cccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEe----CC
Q 008374          244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE----KG  317 (568)
Q Consensus       244 ~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~  317 (568)
                      +..++||+|+||+||+|+...      +++.||+|++...  .....+.|.+|+++|++++|||||++++++..    ..
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~------~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   85 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTE------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK   85 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             EeeeEEecCcCcEEEEEEECC------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence            456689999999999999875      6789999998754  23345679999999999999999999999865    34


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEEc-CCCcEEEeec
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQK--VVHRDLKASNILLD-ADFNARLGDF  394 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDikp~NILld-~~~~~kL~DF  394 (568)
                      .+++||||+++|+|.+++..   ...+++..+..++.||++||+|||   +++  |+||||||+|||++ +++.+||+||
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DF  159 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDL  159 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             EEEEEEeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeec
Confidence            68999999999999999953   346899999999999999999999   455  99999999999996 5789999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      |+|+.......       ....||+.|||||++.+ .++.++|||||||++|||++|+.||.......   .+..    .
T Consensus       160 Gla~~~~~~~~-------~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~---~~~~----~  224 (270)
T d1t4ha_         160 GLATLKRASFA-------KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA---QIYR----R  224 (270)
T ss_dssp             TGGGGCCTTSB-------EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH---HHHH----H
T ss_pred             CcceeccCCcc-------CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH---HHHH----H
Confidence            99986543221       25689999999999864 69999999999999999999999997443322   1111    1


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ...+....    .+    +......+.+++.+||++||++|||++|+++
T Consensus       225 i~~~~~~~----~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         225 VTSGVKPA----SF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HTTTCCCG----GG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHcCCCCc----cc----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            11111111    11    1112234667788999999999999999975

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.8e-50  Score=405.31  Aligned_cols=270  Identities=26%  Similarity=0.412  Sum_probs=214.6

Q ss_pred             HHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-cchhhHHHHHHhhcCCCCceeeEEEEE
Q 008374          235 ELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-SKGDFLAELAIIHRLRHKHLVHLVGWC  313 (568)
Q Consensus       235 el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~  313 (568)
                      +++...++|+..++||+|+||+||+|+++.... ..+++.||||++...... ..++|.+|++++++++||||++++++|
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~-~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLP-YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSST-TSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCcc-CCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            344456789999999999999999999864211 125688999999765433 456799999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhccCC---------------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 008374          314 HEKGKLLLVYDFMPNGSLEKYLYGTS---------------------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVV  372 (568)
Q Consensus       314 ~~~~~~~lV~Ey~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv  372 (568)
                      ...+..++||||+++|+|.++++...                     ....+++..++.++.|++.||+|||   +++++
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeE
Confidence            99999999999999999999996421                     1235899999999999999999999   67999


Q ss_pred             ecCCCCCCEEEcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCC
Q 008374          373 HRDLKASNILLDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGR  452 (568)
Q Consensus       373 HrDikp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~  452 (568)
                      ||||||+|||+|.++++||+|||+|+..........   .....||+.|+|||.+....++.++|||||||++|||++|.
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~  239 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA---DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  239 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC-------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccc---cCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence            999999999999999999999999987654432211   12567899999999999999999999999999999999996


Q ss_pred             -CCCCCCCcccchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          453 -SPGNMIPHQQHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       453 -~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                       .||......+    +...    ..++..         ...+...+..+.+++..||+.||++||||.||+++|++.
T Consensus       240 ~~p~~~~~~~e----~~~~----v~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         240 LQPYYGMAHEE----VIYY----VRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             CCTTTTSCHHH----HHHH----HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCCCCCHHH----HHHH----HHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence             4666543322    1111    111211         112223345678889999999999999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-49  Score=403.16  Aligned_cols=250  Identities=22%  Similarity=0.352  Sum_probs=202.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      +.|+..++||+|+||+||+|+...      +++.||||++.....   ...+.|.+|+++|++++|||||++++++.+.+
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   88 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVR------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH   88 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETT------TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             HhcEeeEEEecCCCeEEEEEEECC------CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC
Confidence            348889999999999999999875      688999999976533   23457899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++|||||++|+|..++..   ...+++.++..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|
T Consensus        89 ~~~iv~E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a  162 (309)
T d1u5ra_          89 TAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA  162 (309)
T ss_dssp             EEEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred             EEEEEEEecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccc
Confidence            99999999999999877643   346999999999999999999999   579999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHT---GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~---~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      +......         ...||+.|||||++.+   +.++.++|||||||++|||++|+.||.......       .....
T Consensus       163 ~~~~~~~---------~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-------~~~~i  226 (309)
T d1u5ra_         163 SIMAPAN---------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHI  226 (309)
T ss_dssp             BSSSSBC---------CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHH
T ss_pred             cccCCCC---------ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-------HHHHH
Confidence            8654321         4579999999999853   568999999999999999999999997543222       11111


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhC
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISG  527 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L~~  527 (568)
                      .. +.     .+.+..   ......+.+++..||+.||.+|||++|+++  .+.+
T Consensus       227 ~~-~~-----~~~~~~---~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         227 AQ-NE-----SPALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             HH-SC-----CCCCSC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             Hh-CC-----CCCCCC---CCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence            11 10     111111   122345667778999999999999999987  4544

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-49  Score=403.27  Aligned_cols=257  Identities=23%  Similarity=0.322  Sum_probs=192.5

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      .+.|+..++||+|+||+||+|+.+.      +++.||||++..... ...+.+.+|+.+|++++||||+++++++.+.+.
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   81 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKR------TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGH   81 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETT------TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECC------CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            4668999999999999999999875      688999999976533 334568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc---CCCcEEEeecC
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD---ADFNARLGDFG  395 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld---~~~~~kL~DFG  395 (568)
                      ++||||||++|+|.+++..   ...+++.+...++.||+.||.|||   +++|+||||||+|||+.   +++.+||+|||
T Consensus        82 ~~lvmE~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG  155 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFG  155 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-
T ss_pred             EEEEEeccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccc
Confidence            9999999999999999954   356999999999999999999999   67999999999999994   57899999999


Q ss_pred             CccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHh
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLH  475 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  475 (568)
                      +|+........      ...+||+.|||||++.+..++.++|||||||++|||++|+.||.......    +...    .
T Consensus       156 ~a~~~~~~~~~------~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~----i  221 (307)
T d1a06a_         156 LSKMEDPGSVL------STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK----LFEQ----I  221 (307)
T ss_dssp             -----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHH----H
T ss_pred             eeEEccCCCee------eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH----HHHH----H
Confidence            99876543221      24679999999999999999999999999999999999999997543222    1111    1


Q ss_pred             hcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCC
Q 008374          476 REGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISGT  528 (568)
Q Consensus       476 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L~~~  528 (568)
                      ..+.      ..+...........+.+++..||+.||++|||++|+++  .+.+.
T Consensus       222 ~~~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         222 LKAE------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HTTC------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             hccC------CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            1111      01111111223345677888999999999999999987  35543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=392.12  Aligned_cols=249  Identities=30%  Similarity=0.454  Sum_probs=197.3

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEe-CCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE-KGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~  319 (568)
                      ++|+..++||+|+||.||+|+++        +..||||+++..  ...++|.+|++++++++||||++++|+|.+ .+.+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--------~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--------TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--------CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            46778899999999999999974        578999999654  345779999999999999999999999965 4568


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++|+|.++|... ....++|..+++++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~lv~ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~  152 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  152 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeeccccccee
Confidence            9999999999999999643 2335899999999999999999999   57999999999999999999999999999987


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ......        ...+|..|+|||++.++.++.++|||||||++|||+| |+.|+......+    +..++.      
T Consensus       153 ~~~~~~--------~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~----~~~~i~------  214 (262)
T d1byga_         153 ASSTQD--------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVE------  214 (262)
T ss_dssp             -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----HHHHHT------
T ss_pred             cCCCCc--------cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH----HHHHHH------
Confidence            654321        3468899999999999999999999999999999998 677776543332    332221      


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                             ...+.+.+......+.+++.+||+.||.+||||.+++++|+..
T Consensus       215 -------~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         215 -------KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             -------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------cCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence                   1122223333445677888899999999999999999999753

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-49  Score=401.76  Aligned_cols=260  Identities=25%  Similarity=0.427  Sum_probs=205.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .+|+..++||+|+||+||+|++..+++.  ...+||+|++... +.+..++|.+|++++++++|||||+++|+|.+. ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCE--EEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            3589999999999999999998753321  2457999998754 344567899999999999999999999999865 56


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++++||+.+|+|.+++...  ...+++..+++++.|||.||.|||   +++|+||||||+|||++.++.+||+|||+|+.
T Consensus        86 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             eEEEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeecccccee
Confidence            7889999999999988653  356899999999999999999999   57999999999999999999999999999998


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ..........   ....||+.|||||++.++.++.++|||||||++|||+| |+.||......+    +..         
T Consensus       161 ~~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~----~~~---------  224 (317)
T d1xkka_         161 LGAEEKEYHA---EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISS---------  224 (317)
T ss_dssp             TTTTCC-----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG----HHH---------
T ss_pred             cccccccccc---cccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH----HHH---------
Confidence            7654332221   24568999999999999999999999999999999998 788887554333    111         


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                          .+....+...+......+.+++.+||+.||.+|||+.||++.|+..
T Consensus       225 ----~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         225 ----ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             ----HHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence                1111222222334455678888999999999999999999988754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-49  Score=393.48  Aligned_cols=257  Identities=24%  Similarity=0.395  Sum_probs=197.5

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|+..++||+|+||.||+|++...+.   .+..||||.++.... ...+.|.+|++++++++||||++++|+|. .+.+
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPEN---PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCc---eeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            578889999999999999999864321   457899999876433 34567999999999999999999999996 4678


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                      ++||||+++|+|.+++...  ...+++..++.++.||++||.|||   +++|+||||||+||+++.++.+||+|||+|+.
T Consensus        83 ~iv~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhhee
Confidence            9999999999999987543  346899999999999999999999   67999999999999999999999999999998


Q ss_pred             cccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhhcC
Q 008374          400 IENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHREG  478 (568)
Q Consensus       400 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  478 (568)
                      ..........    ...||+.|+|||.+....++.++|||||||++|||+| |+.||......+    +...+    ..+
T Consensus       158 ~~~~~~~~~~----~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~----~~~~i----~~~  225 (273)
T d1mp8a_         158 MEDSTYYKAS----KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRI----ENG  225 (273)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHH----HTT
T ss_pred             ccCCcceecc----ceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH----HHHHH----HcC
Confidence            7654332222    4578999999999999999999999999999999998 888988654433    22111    111


Q ss_pred             chhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          479 HIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       479 ~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      .         ....+......+.+++..||+.||.+|||+.||++.|+.
T Consensus       226 ~---------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         226 E---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C---------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            1         111222334567788889999999999999999998874

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=397.91  Aligned_cols=250  Identities=23%  Similarity=0.283  Sum_probs=202.5

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|+..+.||+|+||+||+|+.+.      +++.||||++.+..   ....+.+.+|++++++++||||+++++++.+.+
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   81 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELA------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE   81 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence            569999999999999999999875      68899999986532   234467899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .+++|||||++|+|.+++..   ...+++.....++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a  155 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA  155 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEEccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccc
Confidence            99999999999999999853   356999999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +.+........   .....||+.|||||++.+..++.++|||||||++|||++|+.||.......    +..    ....
T Consensus       156 ~~~~~~~~~~~---~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~----~i~~  224 (288)
T d1uu3a_         156 KVLSPESKQAR---ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----IFQ----KIIK  224 (288)
T ss_dssp             EECC-------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHHT
T ss_pred             eecccCCcccc---cccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH----HHH----HHHc
Confidence            98764432211   125679999999999999999999999999999999999999998543222    111    1111


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      +        .+  ..+......+.+++..||+.||.+|||++|+++
T Consensus       225 ~--------~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         225 L--------EY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             T--------CC--CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             C--------CC--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            1        11  111122345667888999999999999998743

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-48  Score=402.44  Aligned_cols=254  Identities=18%  Similarity=0.255  Sum_probs=208.7

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .++|...++||+|+||+||+|+.+.      +++.||||++........+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~------~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERA------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT------TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECC------CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            4689999999999999999999875      6899999999877666677899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc--CCCcEEEeecCCc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD--ADFNARLGDFGLA  397 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld--~~~~~kL~DFGla  397 (568)
                      +||||||++|+|.+++...  ...+++..+..++.||+.||.|||   +++|+||||||+|||++  .++.+||+|||+|
T Consensus        99 ~ivmE~~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a  173 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLT  173 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEEcCCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchh
Confidence            9999999999999998543  346999999999999999999999   67999999999999995  4578999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +.+......      ....||+.|||||++.+..++.++|||||||++|||++|+.||.......    +..   ... .
T Consensus       174 ~~~~~~~~~------~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~~---~i~-~  239 (350)
T d1koaa2         174 AHLDPKQSV------KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----TLR---NVK-S  239 (350)
T ss_dssp             EECCTTSCE------EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH---HHH-H
T ss_pred             eeccccccc------ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH----HHH---HHH-h
Confidence            987654322      24679999999999999999999999999999999999999997543322    111   110 0


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI  524 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~  524 (568)
                      +.      ..+...........+.+++.+||+.||.+|||++|+++.
T Consensus       240 ~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         240 CD------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             TC------CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CC------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00      000111111223456677889999999999999999883

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-49  Score=393.33  Aligned_cols=260  Identities=25%  Similarity=0.390  Sum_probs=199.5

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|+..++||+|+||.||+|++.....   ....||||++....   .+..++|.+|+++|++++||||++++|+|.+ +
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~---~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSG---KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTS---CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCC---cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            468889999999999999999864321   34579999987642   3345689999999999999999999999965 4


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++|||||++|+|.+++...  ...+++..++.++.|+|.||.|||   +++|+||||||+||||+.++.+||+|||++
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~  158 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLM  158 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             chheeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhh
Confidence            678999999999999988543  346999999999999999999999   579999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      +...........  .....||..|+|||.+.+..++.++|||||||++|||+| |+.||.......    ...++   ..
T Consensus       159 ~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~----~~~~i---~~  229 (273)
T d1u46a_         159 RALPQNDDHYVM--QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKI---DK  229 (273)
T ss_dssp             EECCC-CCEEEC-------CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHH---HT
T ss_pred             hhcccCCCccee--cCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH----HHHHH---Hh
Confidence            987654332211  124568899999999999999999999999999999998 899997543332    11111   11


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      .         ....+........+.+++.+||+.||.+||||.||+++|+.
T Consensus       230 ~---------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         230 E---------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             S---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C---------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            1         11122222334567788889999999999999999999975

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=395.53  Aligned_cols=258  Identities=27%  Similarity=0.423  Sum_probs=205.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcC-CCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  318 (568)
                      ++|+..++||+|+||+||+|+++.++    ....||||++... .....++|.+|+++|.++ +|||||+++|+|.+.+.
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   85 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   85 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETT----EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCC----eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence            57888899999999999999987521    1246889988654 344567899999999999 79999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccC-------------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC
Q 008374          319 LLLVYDFMPNGSLEKYLYGT-------------SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA  385 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~  385 (568)
                      +++||||+++|+|.++|+..             .....++|.++..++.|||+||.|||   +++|+||||||+|||++.
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGE  162 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECG
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcC
Confidence            99999999999999999653             22457999999999999999999999   679999999999999999


Q ss_pred             CCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCC-CCCCCCcccch
Q 008374          386 DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRS-PGNMIPHQQHA  464 (568)
Q Consensus       386 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~-P~~~~~~~~~~  464 (568)
                      ++.+||+|||+|+........      ....||..|+|||.+..+.++.++|||||||++|||++|.. ||.......  
T Consensus       163 ~~~~kl~DfG~a~~~~~~~~~------~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--  234 (309)
T d1fvra_         163 NYVAKIADFGLSRGQEVYVKK------TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--  234 (309)
T ss_dssp             GGCEEECCTTCEESSCEECCC----------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--
T ss_pred             CCceEEccccccccccccccc------cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--
Confidence            999999999999876543322      14568999999999999999999999999999999999765 565432221  


Q ss_pred             hhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          465 YTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       465 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                        +.+.    ..         ...+...+......+..++.+||+.||++||||.||++.|++.
T Consensus       235 --~~~~----i~---------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         235 --LYEK----LP---------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             --HHHH----GG---------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHH----HH---------hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              1111    11         1111222233445677788899999999999999999998875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=391.16  Aligned_cols=252  Identities=22%  Similarity=0.297  Sum_probs=204.7

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc------ccchhhHHHHHHhhcCCCCceeeEEEEE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI------KSKGDFLAELAIIHRLRHKHLVHLVGWC  313 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~  313 (568)
                      .+.|+..++||+|+||+||+|+.+.      +++.||||++.+...      ...+.|.+|+.+|++++|||||++++++
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKS------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY   82 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECC------CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3679999999999999999999875      688999999875422      2246789999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC----cE
Q 008374          314 HEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF----NA  389 (568)
Q Consensus       314 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~----~~  389 (568)
                      .+.+.++||||||++|+|.+++..   ...+++.....++.|++.||+|||   +++|+||||||+|||++.++    .+
T Consensus        83 ~~~~~~~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~v  156 (293)
T d1jksa_          83 ENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRI  156 (293)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCE
T ss_pred             EECCEEEEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccce
Confidence            999999999999999999999953   346999999999999999999999   67999999999999998776    59


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~  469 (568)
                      ||+|||+|+........      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+    ...
T Consensus       157 kl~DfG~a~~~~~~~~~------~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~  226 (293)
T d1jksa_         157 KIIDFGLAHKIDFGNEF------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLA  226 (293)
T ss_dssp             EECCCTTCEECTTSCBC------SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH
T ss_pred             EecchhhhhhcCCCccc------cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH----HHH
Confidence            99999999887544322      24679999999999999999999999999999999999999998543322    111


Q ss_pred             HHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          470 WVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       470 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                         . ...+..      .............+.+++.+||+.||.+|||++|+++
T Consensus       227 ---~-i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         227 ---N-VSAVNY------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             ---H-HHTTCC------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---H-HHhcCC------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               1 111100      0000001112345667888999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=393.83  Aligned_cols=266  Identities=24%  Similarity=0.381  Sum_probs=200.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcC-CCCceeeEEEEEEeC-
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRL-RHKHLVHLVGWCHEK-  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-  316 (568)
                      .++|...++||+|+||.||+|++...+. ..+++.||||+++... ....+.+.+|..++.++ +|+||+++++++.+. 
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~-~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTS-SSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCc-ccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            3678999999999999999999864321 2356789999997643 33456788888888877 689999999998765 


Q ss_pred             CeEEEEEEecCCCChhhhhccCCC-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSE-------------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILL  383 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILl  383 (568)
                      +.+++|||||++|+|.++|+....             ...+++.++..++.||++||.|||   +++|+||||||+||||
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl  167 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILL  167 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeE
Confidence            468999999999999999965321             235899999999999999999999   5799999999999999


Q ss_pred             cCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCC-CCCCCCCccc
Q 008374          384 DADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGR-SPGNMIPHQQ  462 (568)
Q Consensus       384 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~-~P~~~~~~~~  462 (568)
                      ++++++||+|||+|+..........   .....||+.|||||.+.+..++.++|||||||++|||+||. .||.......
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVR---KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCC---TTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             CCCCcEEEccCcchhhccccccccc---cCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999987654432211   12567999999999999999999999999999999999975 5776443332


Q ss_pred             chhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          463 HAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       463 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                         .+..             .+........+......+.+++.+||+.||.+|||++||++.|+..
T Consensus       245 ---~~~~-------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         245 ---EFCR-------------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             ---HHHH-------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHH-------------HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               1111             1111111222223345677888999999999999999999999753

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-48  Score=392.80  Aligned_cols=258  Identities=28%  Similarity=0.455  Sum_probs=203.2

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-CcccchhhHHHHHHhhcCCCCceeeEEEEEEe-CCeEEEEE
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE-KGKLLLVY  323 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~  323 (568)
                      .++||+|+||+||+|++...++   ....||||+++.. +....++|.+|+++|++++||||++++|+|.+ ++..++||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC-------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCC---EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            5689999999999999875321   3457999999754 44456789999999999999999999999876 46899999


Q ss_pred             EecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCccccccc
Q 008374          324 DFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAIENE  403 (568)
Q Consensus       324 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~~~~  403 (568)
                      |||++|+|.+++...  ...+++..+++++.|+++||.|||   +++|+||||||+||||++++.+||+|||+++.....
T Consensus       109 E~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             ECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             EEeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            999999999998653  345788999999999999999999   579999999999999999999999999999987654


Q ss_pred             cccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCchhhh
Q 008374          404 RNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGHIQDA  483 (568)
Q Consensus       404 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  483 (568)
                      ...... ......||..|+|||.+.++.++.++||||||+++|||+||+.|+.......   .+..++.    .+.    
T Consensus       184 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~---~~~~~i~----~g~----  251 (311)
T d1r0pa_         184 EFDSVH-NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLL----QGR----  251 (311)
T ss_dssp             TCCCTT-CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHHH----TTC----
T ss_pred             ccccce-ecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH---HHHHHHH----cCC----
Confidence            322211 1224679999999999999999999999999999999999888876432221   1122211    111    


Q ss_pred             hhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          484 VDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       484 ~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                         +  ...+......+.+++..||+.||++||||.||++.|++.
T Consensus       252 ---~--~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         252 ---R--LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             ---C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---C--CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               1  111122334677888899999999999999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.4e-48  Score=397.79  Aligned_cols=257  Identities=18%  Similarity=0.257  Sum_probs=210.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .++|+..++||+|+||+||+|+...      +++.||||++........+.+.+|+++|++++|||||++++++.+.+.+
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~  101 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKA------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  101 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECC------CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3579999999999999999999875      6889999999876656667889999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc--CCCcEEEeecCCc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD--ADFNARLGDFGLA  397 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld--~~~~~kL~DFGla  397 (568)
                      +||||||++|+|.+++...  ...+++.+...++.||+.||.|||   +++|+||||||+||||+  .++.+||+|||+|
T Consensus       102 ~ivmE~~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla  176 (352)
T d1koba_         102 VLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLA  176 (352)
T ss_dssp             EEEEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred             EEEEEcCCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccc
Confidence            9999999999999887432  346999999999999999999999   57999999999999998  6789999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +.+......      ....||+.|||||++.+..++.++|||||||++|||+||+.||.......    +...+    ..
T Consensus       177 ~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~~~~i----~~  242 (352)
T d1koba_         177 TKLNPDEIV------KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----TLQNV----KR  242 (352)
T ss_dssp             EECCTTSCE------EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHH----HH
T ss_pred             eecCCCCce------eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH----HHHHH----Hh
Confidence            987654322      14579999999999999999999999999999999999999997543322    11111    11


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HhC
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQI--ISG  527 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~--L~~  527 (568)
                      +      +..+...........+.+++..||+.||.+|||++|+++.  +++
T Consensus       243 ~------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~  288 (352)
T d1koba_         243 C------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG  288 (352)
T ss_dssp             C------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred             C------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            1      0111111112233456778889999999999999999873  544

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-48  Score=388.53  Aligned_cols=269  Identities=23%  Similarity=0.294  Sum_probs=200.7

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC---
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG---  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~---  317 (568)
                      ++|...++||+|+||.||+|++        +++.||||+++.... ....+..|+..+.+++||||++++|+|.+.+   
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--------~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~   73 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--------RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTW   73 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--------TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--------CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence            4577788999999999999986        478999999964321 1222344556667889999999999998764   


Q ss_pred             -eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCCEEEcCCCcEEE
Q 008374          318 -KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNE-----YDQKVVHRDLKASNILLDADFNARL  391 (568)
Q Consensus       318 -~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivHrDikp~NILld~~~~~kL  391 (568)
                       .+++|||||++|+|.++|+.    ..++|..+++++.|+|.||+|||..     ++++|+||||||+||||+.++++||
T Consensus        74 ~~~~lv~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl  149 (303)
T d1vjya_          74 TQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             EEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             eEEEEEEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence             68999999999999999954    3599999999999999999999953     3579999999999999999999999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCccccccCC------CCccchhHHHHHHHHHHHhCCCCCCCCCcccchh
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGK------ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAY  465 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~------~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~  465 (568)
                      +|||+++.......... .......||+.|||||++....      ++.++|||||||+||||+||..|+..........
T Consensus       150 ~DFGl~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         150 ADLGLAVRHDSATDTID-IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             CCCTTCEEEETTTTEEC-C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EecCccccccCCCccee-ccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            99999998765432211 1122568999999999986542      5779999999999999999998875322211100


Q ss_pred             -------hHHHHHHHHhhcCchhhhhhhhcCCC-CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          466 -------TLVDWVWMLHREGHIQDAVDQRLNIN-SVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       466 -------~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                             ...+........+..    ++.+... ...+....+..++.+||+.||++||||.||++.|+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         229 YDLVPSDPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             hhcccccchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence                   011111111111111    1111111 133566778889999999999999999999999875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-48  Score=391.96  Aligned_cols=265  Identities=26%  Similarity=0.447  Sum_probs=209.2

Q ss_pred             cCccccceeccCCceeEEEEEEccCcc-ccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcC-CCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQ-YHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  317 (568)
                      ++|...++||+|+||.||+|+....+. ....+..||||++..... ....++.+|...+.++ +|||||+++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            568888999999999999999865332 122457899999976543 3457899999999888 8999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCC-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSE-------------QVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD  384 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld  384 (568)
                      ..++|||||++|+|.++|.....             ...+++.+++.++.|++.||+|||   +++|+||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence            99999999999999999965431             246899999999999999999999   67999999999999999


Q ss_pred             CCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccc
Q 008374          385 ADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVC-GRSPGNMIPHQQH  463 (568)
Q Consensus       385 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~t-G~~P~~~~~~~~~  463 (568)
                      .++.+||+|||+++..........   .....||+.|+|||.+.++.++.++|||||||++|||++ |+.||....... 
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-  245 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKK---TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-  245 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCC---CTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred             CCCCeEeccchhhccccccccccc---cccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-
Confidence            999999999999998866433221   225679999999999999999999999999999999998 688886543321 


Q ss_pred             hhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 008374          464 AYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGT  528 (568)
Q Consensus       464 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~  528 (568)
                         +.    ...         ........+......+.+++.+||+.||.+|||+.||++.|++.
T Consensus       246 ---~~----~~i---------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         246 ---LF----KLL---------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             ---HH----HHH---------HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HH----HHH---------HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence               11    111         11222222233445678899999999999999999999999864

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-48  Score=392.18  Aligned_cols=266  Identities=25%  Similarity=0.414  Sum_probs=212.7

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      ++|...++||+|+||+||+|.++.... ..++..||||+++... .+....|.+|++++++++||||++++|+|...+..
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~-~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVK-DEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEET-TEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCccc-CCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            678889999999999999999863110 1145789999997643 33445799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccC-------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          320 LLVYDFMPNGSLEKYLYGT-------SEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                      ++|||||++|+|.+++...       .....+++..+.+++.|+|+||.|||   +++|+||||||+|||+|+++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence            9999999999999998642       12245799999999999999999999   5799999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCC-CCCCCCCcccchhhHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGR-SPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~-~P~~~~~~~~~~~~l~~~~  471 (568)
                      |||+|+...........   ....||+.|+|||.+.+..++.++||||||+++|||+||+ .|+......+       ..
T Consensus       176 DFGla~~~~~~~~~~~~---~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-------~~  245 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKG---GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VL  245 (308)
T ss_dssp             CTTCCCGGGGGGCEEGG---GSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------HH
T ss_pred             ecccceeccCCcceeec---cceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-------HH
Confidence            99999987654332221   2456899999999999999999999999999999999985 6665443322       11


Q ss_pred             HHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 008374          472 WMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISGTST  530 (568)
Q Consensus       472 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~~~~  530 (568)
                      ... ..+.         ....+......+.+++..||+.||.+||||+||+++|++..+
T Consensus       246 ~~i-~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         246 RFV-MEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHH-HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHH-HhCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            111 1111         111122334568888899999999999999999999998644

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.9e-47  Score=388.26  Aligned_cols=245  Identities=22%  Similarity=0.290  Sum_probs=203.3

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC---CcccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD---SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|+..++||+|+||+||+|+.+.      +++.||||++.+.   .....+.+.+|+.++++++||||+++++++.+.+
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   77 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRH------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   77 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             hHeEEEEEEecCcCcEEEEEEECC------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence            578999999999999999999875      6889999999653   2234567899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      .+++|||||++|+|..++..   ...+++.....++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a  151 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFA  151 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             eeeeEeeecCCccccccccc---cccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccc
Confidence            99999999999999999854   346788888999999999999999   789999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +......        ...+||+.|||||++.+..++.++|||||||++|||++|+.||.......    +.   ..    
T Consensus       152 ~~~~~~~--------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~---~~----  212 (316)
T d1fota_         152 KYVPDVT--------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----TY---EK----  212 (316)
T ss_dssp             EECSSCB--------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HH---HH----
T ss_pred             eEecccc--------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH----HH---HH----
Confidence            8765432        15689999999999999999999999999999999999999997543322    11   11    


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                           +.....  ..+......+.+++.+|++.||.+||     |++++++
T Consensus       213 -----i~~~~~--~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         213 -----ILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             -----HHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----HHcCCC--CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                 111111  11112234566778899999999996     8999975

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-48  Score=392.21  Aligned_cols=265  Identities=24%  Similarity=0.364  Sum_probs=213.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc-ccchhhHHHHHHhhcC-CCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI-KSKGDFLAELAIIHRL-RHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  317 (568)
                      .++|+..++||+|+||.||+|++..... ...++.||||+++.... ....+|.+|+.+++++ +|||||+++|+|.+.+
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~-~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIK-SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSS-TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEecccc-CCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            3678889999999999999999864211 12678999999976543 3456799999999999 6999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCC---------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTS---------------EQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNIL  382 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIL  382 (568)
                      ..++|||||++|+|.++++...               ....+++..+..++.||++||+|||   +++++||||||+|||
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccc
Confidence            9999999999999999997532               2336899999999999999999999   679999999999999


Q ss_pred             EcCCCcEEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCC-CCCCCcc
Q 008374          383 LDADFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSP-GNMIPHQ  461 (568)
Q Consensus       383 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P-~~~~~~~  461 (568)
                      ++.++.+||+|||+++..........   .....||+.|+|||.+.++.++.++|||||||++|||+|++.| +......
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVV---KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEE---CSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             ccccCcccccccchheeccCCCcceE---eeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999998765433221   1256799999999999999999999999999999999995544 5443332


Q ss_pred             cchhhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          462 QHAYTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       462 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      .   .+.             ++++.......+......+.+|+.+||+.||.+||||.||+++|++
T Consensus       255 ~---~~~-------------~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         255 S---KFY-------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             H---HHH-------------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             H---HHH-------------HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            2   111             2222223233333345667888899999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-47  Score=389.76  Aligned_cols=249  Identities=23%  Similarity=0.303  Sum_probs=205.0

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|+..+.||+|+||+||+|+.+.      +++.||||++++..   ....+.+.+|+.+|++++||||+++++++.+.
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   77 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKA------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH   77 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECC------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc
Confidence            3579999999999999999999875      78899999997542   23456789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +.+++|||||++|+|.+++..   ...++......++.|++.||.|||   +++|+||||||+|||+++++.+||+|||+
T Consensus        78 ~~~~iv~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~  151 (337)
T d1o6la_          78 DRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGL  151 (337)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             cccccceeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccc
Confidence            999999999999999999854   346888999999999999999999   67999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      |+........     ....+||+.|||||++.+..++.++||||+||++|||++|+.||.......    +..    ...
T Consensus       152 a~~~~~~~~~-----~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~----~~~----~i~  218 (337)
T d1o6la_         152 CKEGISDGAT-----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFE----LIL  218 (337)
T ss_dssp             CBCSCCTTCC-----BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHH
T ss_pred             ccccccCCcc-----cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH----HHH----HHh
Confidence            9976543222     125689999999999999999999999999999999999999997543322    111    111


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK-----TEDILQ  523 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt-----~~evl~  523 (568)
                      .+        .+  ..+......+..++..||++||.+||+     ++|+++
T Consensus       219 ~~--------~~--~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         219 ME--------EI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HC--------CC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             cC--------CC--CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            11        11  111122334567778999999999995     788876

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.3e-47  Score=380.93  Aligned_cols=260  Identities=21%  Similarity=0.256  Sum_probs=200.3

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhHHHHHHhhcCCCCceeeEEEEEEeC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFLAELAIIHRLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  316 (568)
                      .++|...+.||+|+||+||+|+...      +++.||||.++....   ...+.|.+|++++++++||||+++++++...
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~   79 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLR------LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE   79 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECC------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec
Confidence            3679999999999999999999875      688999999976432   2345789999999999999999999999765


Q ss_pred             C----eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          317 G----KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       317 ~----~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                      +    .++|||||+++++|.+++..   ...+++.+...++.||+.||.|||   +++|+||||||+|||++.++..+|+
T Consensus        80 ~~~~~~~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~  153 (277)
T d1o6ya_          80 TPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVM  153 (277)
T ss_dssp             CSSSEEEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEEC
T ss_pred             cCCCceEEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceee
Confidence            4    48999999999999998843   346999999999999999999999   5799999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      |||.++..........  ......||+.|||||++.+..++.++|||||||++|||+||+.||.......       ...
T Consensus       154 d~~~~~~~~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~  224 (277)
T d1o6ya_         154 DFGIARAIADSGNSVT--QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAY  224 (277)
T ss_dssp             CCTTCEECC------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHH
T ss_pred             hhhhhhhhcccccccc--ccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-------HHH
Confidence            9999987654332211  1225689999999999999999999999999999999999999997543222       111


Q ss_pred             HHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhC
Q 008374          473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-KTEDILQIISG  527 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-t~~evl~~L~~  527 (568)
                      .....+...    +.   ....+....+.+++.+|+++||.+|| |++++++.|.+
T Consensus       225 ~~~~~~~~~----~~---~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         225 QHVREDPIP----PS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             HHHHCCCCC----GG---GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHhcCCCC----Cc---hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            222211110    00   01112234566778899999999999 89999888764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=7.6e-47  Score=376.65  Aligned_cols=251  Identities=25%  Similarity=0.342  Sum_probs=203.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc---------cchhhHHHHHHhhcCC-CCceeeEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK---------SKGDFLAELAIIHRLR-HKHLVHLV  310 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-H~nIv~l~  310 (568)
                      ++|+..++||+|+||+||+|+...      +++.||||++......         ..+.+.+|+.++++++ ||||++++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~   76 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKP------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   76 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             ccCEEceEEecCcCeEEEEEEECC------CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            578999999999999999998864      6889999999764321         1235889999999997 99999999


Q ss_pred             EEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEE
Q 008374          311 GWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNAR  390 (568)
Q Consensus       311 g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~k  390 (568)
                      +++.+.+..+||||||++|+|.++|..   +..+++.++..++.||++||+|||   +++|+||||||+|||++.++.+|
T Consensus        77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~k  150 (277)
T d1phka_          77 DTYETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIK  150 (277)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEE
T ss_pred             eecccCcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeE
Confidence            999999999999999999999999953   457999999999999999999999   57999999999999999999999


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccch
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT------GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHA  464 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~------~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~  464 (568)
                      |+|||+++........      ....||..|+|||.+.+      ..++.++||||+||+++||++|+.||.......  
T Consensus       151 l~DFG~a~~~~~~~~~------~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~--  222 (277)
T d1phka_         151 LTDFGFSCQLDPGEKL------REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--  222 (277)
T ss_dssp             ECCCTTCEECCTTCCB------CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred             EccchheeEccCCCce------eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH--
Confidence            9999999987654321      25679999999998853      457889999999999999999999998543322  


Q ss_pred             hhHHHHHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          465 YTLVDWVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       465 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                        .    ......+..      .+...........+.+++.+||++||++|||++||++
T Consensus       223 --~----~~~i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         223 --M----LRMIMSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             --H----HHHHHHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --H----HHHHHhCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              1    111111111      1111112233456777888999999999999999865

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-46  Score=387.54  Aligned_cols=245  Identities=21%  Similarity=0.252  Sum_probs=203.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      ++|+..++||+|+||.||+|+.+.      +++.||||++.+..   ....+.+.+|+++|++++||||+++++++...+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~------~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  114 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKE------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCeEEEEEeecCcCcEEEEEEECC------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc
Confidence            579999999999999999999875      68899999986532   234467899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCc
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLA  397 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla  397 (568)
                      ..++||||+.+|+|..++..   ...+++.....++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a  188 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA  188 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ccccccccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceee
Confidence            99999999999999999953   346999999999999999999999   679999999999999999999999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +.+....        ....||+.|||||++.+..++.++|||||||++|||+||+.||.......    +...       
T Consensus       189 ~~~~~~~--------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~-------  249 (350)
T d1rdqe_         189 KRVKGRT--------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----IYEK-------  249 (350)
T ss_dssp             EECSSCB--------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH-------
T ss_pred             eeccccc--------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH----HHHH-------
Confidence            9775432        14679999999999999999999999999999999999999997543221    1111       


Q ss_pred             CchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          478 GHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                           +.....  ..+......+.+++..||+.||.+|+     |++|+++
T Consensus       250 -----i~~~~~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         250 -----IVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----HHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----HhcCCC--CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                 111111  11112234566777899999999994     8999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.6e-46  Score=388.75  Aligned_cols=249  Identities=22%  Similarity=0.279  Sum_probs=197.7

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc---ccchhhH---HHHHHhhcCCCCceeeEEEEEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI---KSKGDFL---AELAIIHRLRHKHLVHLVGWCH  314 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~H~nIv~l~g~~~  314 (568)
                      ++|+..++||+|+||.||+|+...      +++.||||++.+...   .....+.   .|+.+++.++|||||++++++.
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~------t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~   77 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKAD------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH   77 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECC------CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE
Confidence            579999999999999999999875      688999999864321   1222333   4477788889999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 008374          315 EKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDF  394 (568)
Q Consensus       315 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DF  394 (568)
                      +.+.+++|||||++|+|.++|..   ...+++.....++.||+.||.|||   +++|+||||||+|||++.++.+||+||
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DF  151 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDL  151 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCC
T ss_pred             ECCEEEEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeee
Confidence            99999999999999999999953   356889999999999999999999   679999999999999999999999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      |+|+.......       ....||+.|||||++.. ..++.++|||||||++|||+||+.||.......    ... +..
T Consensus       152 Gla~~~~~~~~-------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~-~~~  219 (364)
T d1omwa3         152 GLACDFSKKKP-------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHE-IDR  219 (364)
T ss_dssp             TTCEECSSSCC-------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC----HHH-HHH
T ss_pred             ceeeecCCCcc-------cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH----HHH-HHH
Confidence            99987654422       25679999999999975 468999999999999999999999997543322    111 111


Q ss_pred             HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 008374          474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPK-----TEDILQ  523 (568)
Q Consensus       474 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt-----~~evl~  523 (568)
                      ...        ...  ...+......+.+++..||+.||.+|||     ++|+++
T Consensus       220 ~~~--------~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         220 MTL--------TMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HSS--------SCC--CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             hcc--------cCC--CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            100        001  1111122345667778999999999999     688875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=383.18  Aligned_cols=248  Identities=23%  Similarity=0.282  Sum_probs=201.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC---cccchhhHHHHHHhh-cCCCCceeeEEEEEEeC
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS---IKSKGDFLAELAIIH-RLRHKHLVHLVGWCHEK  316 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~H~nIv~l~g~~~~~  316 (568)
                      ++|...++||+|+||+||+|+.+.      +++.||||++++..   ....+.+..|..++. .++||||+++++++.++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~------t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~   75 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKK------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   75 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECC------CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence            578999999999999999999875      78999999997532   233456777877765 68999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCC
Q 008374          317 GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGL  396 (568)
Q Consensus       317 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGl  396 (568)
                      +.++||||||++|+|.+++..   ...++..+...++.||+.||.|||   +++|+||||||+|||+++++++||+|||+
T Consensus        76 ~~~yivmEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~  149 (320)
T d1xjda_          76 ENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGM  149 (320)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CceeEEEeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccch
Confidence            999999999999999999953   346889999999999999999999   57999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhh
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHR  476 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  476 (568)
                      |+.........     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +.    ....
T Consensus       150 a~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~----~~----~~i~  216 (320)
T d1xjda_         150 CKENMLGDAKT-----NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----LF----HSIR  216 (320)
T ss_dssp             CBCCCCTTCCB-----CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HH----HHHH
T ss_pred             hhhcccccccc-----cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH----HH----HHHH
Confidence            98765433221     25679999999999999999999999999999999999999998543322    11    1111


Q ss_pred             cCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHH
Q 008374          477 EGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTE-DILQ  523 (568)
Q Consensus       477 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~-evl~  523 (568)
                      .+        ..  ..+......+..++.+||+.||.+|||+. |+++
T Consensus       217 ~~--------~~--~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         217 MD--------NP--FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             HC--------CC--CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             cC--------CC--CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            11        11  11112234466777799999999999995 6753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-46  Score=376.46  Aligned_cols=257  Identities=22%  Similarity=0.250  Sum_probs=194.6

Q ss_pred             cceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc-----cchhhHHHHHHhhcCCCCceeeEEEEEEeCCeEE
Q 008374          246 SMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK-----SKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKLL  320 (568)
Q Consensus       246 ~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  320 (568)
                      .++||+|+||+||+|+.+.      +++.||||+++.....     ..+.+.+|+.++++++|||||++++++...+..+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~   76 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKN------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   76 (299)
T ss_dssp             EEEEEEETTEEEEEEECSS------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             ceEeccCcCeEEEEEEECC------CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCcee
Confidence            5689999999999999875      6889999998654322     2356889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcccc
Q 008374          321 LVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLARAI  400 (568)
Q Consensus       321 lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~~~  400 (568)
                      |||||+.++++..+..   ....+++..+..++.||+.||.|||   +++|+||||||+|||+++++.+||+|||+|+..
T Consensus        77 ivmE~~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~  150 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  150 (299)
T ss_dssp             EEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             ehhhhhcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCcccccc
Confidence            9999998887776663   3456888999999999999999999   679999999999999999999999999999876


Q ss_pred             ccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhcCc
Q 008374          401 ENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHREGH  479 (568)
Q Consensus       401 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  479 (568)
                      .......     ....||+.|+|||++... .++.++|||||||++|||++|+.||......+   .+.. +........
T Consensus       151 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~-i~~~~~~~~  221 (299)
T d1ua2a_         151 GSPNRAY-----THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTR-IFETLGTPT  221 (299)
T ss_dssp             TSCCCCC-----CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH-HHHHHCCCC
T ss_pred             CCCcccc-----cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHH-HHHhcCCCC
Confidence            5543221     145799999999998654 57999999999999999999999997544332   1111 111111000


Q ss_pred             hhh---hhhh----hcC--CCCc-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          480 IQD---AVDQ----RLN--INSV-----VDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       480 ~~~---~~d~----~l~--~~~~-----~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ...   ....    ...  ....     ......+.+++.+|++.||++|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         222 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            000   0000    000  0000     012345778888999999999999999987

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-46  Score=378.39  Aligned_cols=250  Identities=18%  Similarity=0.275  Sum_probs=204.1

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeCCeE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGKL  319 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  319 (568)
                      .++|...+.||+|+||+||+|+.+.      +++.||||.++... .....+.+|+++|++++|||||++++++.+.+.+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~------~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETS------SKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECC------CCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            4678999999999999999999875      68899999997653 2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC--CcEEEeecCCc
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD--FNARLGDFGLA  397 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~--~~~kL~DFGla  397 (568)
                      +||||||++|+|.+++...  ...+++.+...++.||+.||.|||   +++|+||||||+|||++.+  ..+||+|||++
T Consensus        77 ~lvmE~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~  151 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA  151 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred             EEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchh
Confidence            9999999999999999542  236899999999999999999999   6799999999999999854  58999999999


Q ss_pred             cccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          398 RAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      +........      ....||+.|+|||.+.+..++.++||||+||++|||++|+.||.......    +..   .    
T Consensus       152 ~~~~~~~~~------~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~----~~~---~----  214 (321)
T d1tkia_         152 RQLKPGDNF------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----IIE---N----  214 (321)
T ss_dssp             EECCTTCEE------EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHH---H----
T ss_pred             hccccCCcc------cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH----HHH---H----
Confidence            876543322      14568999999999999999999999999999999999999997543322    111   1    


Q ss_pred             CchhhhhhhhcCCCC--cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 GHIQDAVDQRLNINS--VVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~~~~~~~d~~l~~~~--~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                           +.........  .......+.+++..|++.||.+|||++|+++
T Consensus       215 -----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         215 -----IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -----HHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----HHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 1111111000  0012345677888999999999999999998

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-46  Score=380.39  Aligned_cols=263  Identities=19%  Similarity=0.276  Sum_probs=202.5

Q ss_pred             hcCccccc-eeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcC-CCCceeeEEEEEEe--
Q 008374          240 TNNFHESM-RLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRL-RHKHLVHLVGWCHE--  315 (568)
Q Consensus       240 t~~f~~~~-~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~--  315 (568)
                      .++|.... .||+|+||+||+|+...      +++.||||+++.     ...+.+|++++.++ +|||||++++++.+  
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~------~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKR------TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECC------CCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            46787765 59999999999999875      688999999864     34577899987654 89999999999875  


Q ss_pred             --CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---CCcEE
Q 008374          316 --KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA---DFNAR  390 (568)
Q Consensus       316 --~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~---~~~~k  390 (568)
                        ...++||||||++|+|.++|.... ...+++.+...++.||+.||+|||   +++|+||||||+|||++.   .+.+|
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~K  154 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILK  154 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEE
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccc
Confidence              467899999999999999996532 346999999999999999999999   679999999999999985   46799


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~  470 (568)
                      |+|||+|+........      ....||+.|||||++.+..++.++|||||||++|||+||+.||.......    ....
T Consensus       155 l~DFG~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~----~~~~  224 (335)
T d2ozaa1         155 LTDFGFAKETTSHNSL------TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPG  224 (335)
T ss_dssp             ECCCTTCEECCCCCCC------CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------
T ss_pred             ccccceeeeccCCCcc------ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH----HHHH
Confidence            9999999877654322      25679999999999999999999999999999999999999997433222    0110


Q ss_pred             HHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCCCCCCC
Q 008374          471 VWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ--IISGTSTVPY  533 (568)
Q Consensus       471 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L~~~~~~p~  533 (568)
                      .......+.      ..+...........+.+++..|++.||++|||+.|+++  .+.+....|.
T Consensus       225 ~~~~i~~~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~  283 (335)
T d2ozaa1         225 MKTRIRMGQ------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ  283 (335)
T ss_dssp             ---CCCSCS------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCC
T ss_pred             HHHHHhcCC------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCC
Confidence            000000000      00011111233456778888999999999999999998  3555544444

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=371.83  Aligned_cols=268  Identities=24%  Similarity=0.330  Sum_probs=200.4

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|+..++||+|+||+||+|+...      +++.||||+++....  ...+.+.+|++++++++||||+++++++.+.+.
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~   75 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKL------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK   75 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCCEeccEEecCcCeEEEEEEECC------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc
Confidence            689999999999999999999875      688999999965432  345779999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      +++||||+.++ +..++... ....+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+|+
T Consensus        76 ~~iv~e~~~~~-~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~  150 (298)
T d1gz8a_          76 LYLVFEFLHQD-LKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR  150 (298)
T ss_dssp             EEEEEECCSEE-HHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred             eeEEEeecCCc-hhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcce
Confidence            99999999654 44444332 2346999999999999999999999   5799999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      .........     ....||+.|+|||.+.... ++.++|||||||++|||++|+.||.......   .+..-.......
T Consensus       151 ~~~~~~~~~-----~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~i~~~~~~~  222 (298)
T d1gz8a_         151 AFGVPVRTY-----THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTP  222 (298)
T ss_dssp             HHCCCSBCT-----TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC
T ss_pred             eccCCcccc-----eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHHHHHhcCCC
Confidence            765433221     2457999999999877655 5789999999999999999999997543322   111111110000


Q ss_pred             C-c-hhhh---hhhh-----cCCCC----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HhC
Q 008374          478 G-H-IQDA---VDQR-----LNINS----VVDEAKRLLLLGLACSHPIASERPKTEDILQI--ISG  527 (568)
Q Consensus       478 ~-~-~~~~---~d~~-----l~~~~----~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~--L~~  527 (568)
                      . . ....   .+..     .....    .......+.+++.+|++.||++|||++|+++.  ++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~  288 (298)
T d1gz8a_         223 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD  288 (298)
T ss_dssp             CTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred             chhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence            0 0 0000   0000     00000    00112456777889999999999999999984  543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-46  Score=368.95  Aligned_cols=240  Identities=24%  Similarity=0.385  Sum_probs=194.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc------ccchhhHHHHHHhhcCC--CCceeeEEEE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI------KSKGDFLAELAIIHRLR--HKHLVHLVGW  312 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~nIv~l~g~  312 (568)
                      ++|...++||+|+||+||+|+...      +++.||||++.....      ....++.+|+.++++++  |||||+++++
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~   77 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVS------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW   77 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECC------CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEE
Confidence            568999999999999999999875      688999999875422      12345789999999986  8999999999


Q ss_pred             EEeCCeEEEEEEecCC-CChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-CcEE
Q 008374          313 CHEKGKLLLVYDFMPN-GSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDAD-FNAR  390 (568)
Q Consensus       313 ~~~~~~~~lV~Ey~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~-~~~k  390 (568)
                      +.+.+..++||||+.+ +++.+++..   ...+++.++..++.|++.||.|||   +++|+||||||+|||++.+ +.+|
T Consensus        78 ~~~~~~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vk  151 (273)
T d1xwsa_          78 FERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELK  151 (273)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEE
T ss_pred             EeeCCeEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEE
Confidence            9999999999999976 577777743   456999999999999999999999   6799999999999999854 7999


Q ss_pred             EeecCCccccccccccccccccccCCcCCcccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH
Q 008374          391 LGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKA-TPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       391 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~  469 (568)
                      |+|||+|+.......       ....||+.|||||++.+..+ +.++|||||||++|||++|+.||....      .+. 
T Consensus       152 l~DFG~a~~~~~~~~-------~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~-  217 (273)
T d1xwsa_         152 LIDFGSGALLKDTVY-------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII-  217 (273)
T ss_dssp             ECCCTTCEECCSSCB-------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH-
T ss_pred             ECccccceecccccc-------cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHh-
Confidence            999999987544321       25679999999999987766 567899999999999999999996321      010 


Q ss_pred             HHHHHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          470 WVWMLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       470 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                             .+.      ..+...    ....+.+++.+|++.||++|||++|+++
T Consensus       218 -------~~~------~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         218 -------RGQ------VFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -------HCC------CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------hcc------cCCCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                   010      011111    2245667778999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.8e-45  Score=363.49  Aligned_cols=261  Identities=22%  Similarity=0.333  Sum_probs=198.3

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|...++||+|+||+||+|+.+       +++.||||++.....  ...+.+.+|+.+|++++||||+++++++...+.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   74 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             CCceeccEEecCCCcEEEEEEeC-------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence            57889999999999999999875       578999999976532  335679999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++++||+.++.+..+..   ....++...+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|.
T Consensus        75 ~~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~  148 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLAR  148 (286)
T ss_dssp             EEEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred             eeEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccce
Confidence            999999998877777663   3457999999999999999999999   5699999999999999999999999999998


Q ss_pred             ccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      .........     ....|++.|+|||.+.. ..++.++|||||||+++||++|+.||.......   .+.. +......
T Consensus       149 ~~~~~~~~~-----~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~---~~~~-i~~~~~~  219 (286)
T d1ob3a_         149 AFGIPVRKY-----THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMR-IFRILGT  219 (286)
T ss_dssp             HHCC--------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH-HHHHHCC
T ss_pred             ecccCcccc-----ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH---HHHH-HHHhhCC
Confidence            765432211     14468999999999875 456899999999999999999999997543322   1111 1111110


Q ss_pred             Cc------hhhhh--hhhcC-------CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 GH------IQDAV--DQRLN-------INSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~~------~~~~~--d~~l~-------~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ..      .....  +....       ..........+.+++.+|++.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00      00000  00000       0001112345667888999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-45  Score=367.25  Aligned_cols=265  Identities=22%  Similarity=0.260  Sum_probs=197.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcC---CCCceeeEEEEEE
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRL---RHKHLVHLVGWCH  314 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~  314 (568)
                      .++|+..++||+|+||+||+|+....     .++.||||++....  ......+.+|+.+++.+   +||||++++++|.
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~   80 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKN-----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT   80 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECC-----CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence            46899999999999999999997542     36779999986542  22345677888887766   7999999999986


Q ss_pred             e-----CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcE
Q 008374          315 E-----KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA  389 (568)
Q Consensus       315 ~-----~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~  389 (568)
                      .     ...++++|||+.++++......  ....+++.....++.|++.||+|||   +++|+||||||+|||+++++.+
T Consensus        81 ~~~~~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~  155 (305)
T d1blxa_          81 VSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQI  155 (305)
T ss_dssp             EEECSSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCE
T ss_pred             ccccccCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCe
Confidence            3     3478999999988877655432  3456899999999999999999999   5799999999999999999999


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHH
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVD  469 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~  469 (568)
                      ||+|||+++........      ....||+.|||||++.+..++.++||||+||++|||++|+.||.......   .+..
T Consensus       156 kl~dfg~~~~~~~~~~~------~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~  226 (305)
T d1blxa_         156 KLADFGLARIYSFQMAL------TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGK  226 (305)
T ss_dssp             EECSCCSCCCCCGGGGG------CCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH
T ss_pred             eecchhhhhhhcccccC------CCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH---HHHH
Confidence            99999999876543321      25689999999999999999999999999999999999999998554332   1111


Q ss_pred             HHHHHhhcCchh-----hhhhhhc---C----CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          470 WVWMLHREGHIQ-----DAVDQRL---N----INSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       470 ~~~~~~~~~~~~-----~~~d~~l---~----~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      -...........     .......   .    ........+.+.+++.+|++.||++|||++|+++
T Consensus       227 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         227 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            111110000000     0000000   0    0011122345566788999999999999999975

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=365.88  Aligned_cols=259  Identities=22%  Similarity=0.256  Sum_probs=194.1

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCceeeEEEEEEeC-----
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLVHLVGWCHEK-----  316 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----  316 (568)
                      +|...++||+|+||+||+|+...      +++.||||++....    ..+.+|+++|++++||||++++++|...     
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~------~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~   90 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD   90 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred             CcEeeeEEeeCcCeEEEEEEECC------CCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence            47778899999999999999875      68899999997643    2345899999999999999999998643     


Q ss_pred             -CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-cEEEeec
Q 008374          317 -GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF-NARLGDF  394 (568)
Q Consensus       317 -~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~-~~kL~DF  394 (568)
                       ..++||||||+++.+..+.........+++.++..++.||+.||+|||   +++|+||||||+|||++.++ .+||+||
T Consensus        91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DF  167 (350)
T d1q5ka_          91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDF  167 (350)
T ss_dssp             CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCC
T ss_pred             ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecc
Confidence             358999999987655444432234457999999999999999999999   78999999999999999775 8999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      |+++........      ....||..|+|||.+.. ..++.++||||+||++|||++|+.||.......   .+......
T Consensus       168 G~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~---~l~~i~~~  238 (350)
T d1q5ka_         168 GSAKQLVRGEPN------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKV  238 (350)
T ss_dssp             TTCEECCTTSCC------CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHH
T ss_pred             cchhhccCCccc------ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH---HHHHHHHH
Confidence            999877554322      14579999999998765 578999999999999999999999997554333   12111111


Q ss_pred             HhhcCch---hh----hhhhhc---C-----CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          474 LHREGHI---QD----AVDQRL---N-----INSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       474 ~~~~~~~---~~----~~d~~l---~-----~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      . .....   ..    ..+..+   .     ..........+.+|+.+|++.||++|||++|+++
T Consensus       239 ~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         239 L-GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             H-CCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             h-CCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0 00000   00    000000   0     0001122345677788999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-43  Score=355.74  Aligned_cols=270  Identities=23%  Similarity=0.322  Sum_probs=195.9

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccC--CcccchhhHHHHHHhhcCCCCceeeEEEEEEe--
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD--SIKSKGDFLAELAIIHRLRHKHLVHLVGWCHE--  315 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--  315 (568)
                      .++|+..++||+|+||+||+|+...      +++.||||++...  .....+++.+|+++|++++||||+++++++..  
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~   82 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRK------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA   82 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECC------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence            3679999999999999999999875      6889999998654  23345678999999999999999999999855  


Q ss_pred             ------CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcE
Q 008374          316 ------KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNA  389 (568)
Q Consensus       316 ------~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~  389 (568)
                            .+..++||||+.++.+..+..   ....++......++.|++.||.|||   +++|+||||||+|||++.++.+
T Consensus        83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~  156 (318)
T d3blha1          83 SPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVL  156 (318)
T ss_dssp             --------CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCE
T ss_pred             ccccccCceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcE
Confidence                  346899999998887776552   3346888899999999999999999   6799999999999999999999


Q ss_pred             EEeecCCccccccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHH
Q 008374          390 RLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLV  468 (568)
Q Consensus       390 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~  468 (568)
                      ||+|||+++........... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+.
T Consensus       157 kl~dfg~~~~~~~~~~~~~~-~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~  235 (318)
T d3blha1         157 KLADFGLARAFSLAKNSQPN-RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS  235 (318)
T ss_dssp             EECCCTTCEECCC-----CC-CCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             Eeeecceeeecccccccccc-cccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH
Confidence            99999999876543322111 12245799999999998765 68999999999999999999999997544332111111


Q ss_pred             HHHHHHhhcCchhh--------hhhhhcCCCC-cHH------HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          469 DWVWMLHREGHIQD--------AVDQRLNINS-VVD------EAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       469 ~~~~~~~~~~~~~~--------~~d~~l~~~~-~~~------~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      ..... ........        .......... ..+      ....+.+|+.+||+.||++|||++|+++
T Consensus       236 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         236 QLCGS-ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHCC-CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhcCC-CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            10000 00000000        0000000000 111      1234567888999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-43  Score=357.89  Aligned_cols=256  Identities=21%  Similarity=0.263  Sum_probs=201.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC----cccchhhHHHHHHhhcCCC-CceeeEEEEEEe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS----IKSKGDFLAELAIIHRLRH-KHLVHLVGWCHE  315 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~  315 (568)
                      ++|+..++||+|+||+||+|+.....   .+++.||||.+++..    ....+.+.+|++++++++| |||+++++++.+
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGH---DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSST---TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccC---CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            67999999999999999999875321   268899999986542    2234678899999999976 899999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 008374          316 KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFG  395 (568)
Q Consensus       316 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFG  395 (568)
                      ....++|||||.+|+|.+++..   ...+.......++.|++.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG  174 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFG  174 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             CCceeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeecc
Confidence            9999999999999999999954   335677888999999999999999   5799999999999999999999999999


Q ss_pred             CccccccccccccccccccCCcCCcccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          396 LARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG--KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       396 la~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~--~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      +|+..........    ....||+.|+|||.+...  .++.++|||||||+||||++|+.||...........+..   .
T Consensus       175 ~a~~~~~~~~~~~----~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~---~  247 (322)
T d1vzoa_         175 LSKEFVADETERA----YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---R  247 (322)
T ss_dssp             EEEECCGGGGGGG----CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH---H
T ss_pred             chhhhcccccccc----cccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH---h
Confidence            9987754433222    256799999999998754  468899999999999999999999975544331111111   0


Q ss_pred             HhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 008374          474 LHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERP-----KTEDILQ  523 (568)
Q Consensus       474 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RP-----t~~evl~  523 (568)
                      .         ....  ...+......+..++..|+++||++||     |++|+++
T Consensus       248 ~---------~~~~--~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         248 I---------LKSE--PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             H---------HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             c---------ccCC--CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            0         0111  111223445667778899999999999     4888875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-43  Score=360.18  Aligned_cols=271  Identities=22%  Similarity=0.260  Sum_probs=197.2

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC-cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC-
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS-IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG-  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-  317 (568)
                      +++|+..++||+|+||+||+|+.+.      +++.||||++.... ....+.+.+|+++|++++||||+++++++.... 
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNV------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETT------TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECC------CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            3568899999999999999999765      68899999997643 234567899999999999999999999997643 


Q ss_pred             ---eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 008374          318 ---KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDF  394 (568)
Q Consensus       318 ---~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DF  394 (568)
                         ..+++++|+.+|+|.+++..    ..+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+||
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~Df  153 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDF  153 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             cccceEEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEccc
Confidence               23444556679999999943    36999999999999999999999   579999999999999999999999999


Q ss_pred             CCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHH
Q 008374          395 GLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWM  473 (568)
Q Consensus       395 Gla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~  473 (568)
                      |+|+...........  .....||+.|+|||.+.. ..++.++||||+||+++||++|+.||.......   ........
T Consensus       154 G~a~~~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~---~~~~~~~~  228 (345)
T d1pmea_         154 GLARVADPDHDHTGF--LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGI  228 (345)
T ss_dssp             TTCEECCGGGCBCCT--TCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHH
T ss_pred             CceeeccCCCcccee--eccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH---HHHHHhhh
Confidence            999877554322211  235679999999999854 567889999999999999999999997543322   11110000


Q ss_pred             HhhcCc-------hhhhhhh--hc--CCCCcH-----HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HhCC
Q 008374          474 LHREGH-------IQDAVDQ--RL--NINSVV-----DEAKRLLLLGLACSHPIASERPKTEDILQI--ISGT  528 (568)
Q Consensus       474 ~~~~~~-------~~~~~d~--~l--~~~~~~-----~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~--L~~~  528 (568)
                      ......       .....+.  ..  ......     .....+.+++..|++.||.+|||+.|+++.  |+..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         229 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             ccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            000000       0000000  00  000000     112356778889999999999999999873  5443

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-42  Score=349.61  Aligned_cols=263  Identities=16%  Similarity=0.181  Sum_probs=196.6

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCcee-eEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHLV-HLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~  319 (568)
                      ++|+..++||+|+||.||+|+...      +++.||||.+....  ..+++..|++++++++|+|++ .+.++..+.+..
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~------~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~   78 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIA------AGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   78 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT------TTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECC------CCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence            468999999999999999999865      68899999987643  345689999999999877655 555556778899


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc---CCCcEEEeecCC
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLD---ADFNARLGDFGL  396 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld---~~~~~kL~DFGl  396 (568)
                      ++||||+ +++|...+...  ...+++..+..++.|++.||+|||   +++|+||||||+|||++   .+..+||+|||+
T Consensus        79 ~ivme~~-~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~  152 (299)
T d1ckia_          79 VMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL  152 (299)
T ss_dssp             EEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred             EEEEEEc-CCchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCc
Confidence            9999999 55666655432  346899999999999999999999   67999999999999985   456799999999


Q ss_pred             cccccccccccc--ccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHH
Q 008374          397 ARAIENERNSYA--EHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWML  474 (568)
Q Consensus       397 a~~~~~~~~~~~--~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~  474 (568)
                      |+.+........  ........||+.|||||.+.+..++.++|||||||++|||++|+.||..............+....
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ckia_         153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK  232 (299)
T ss_dssp             CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH
T ss_pred             ceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc
Confidence            998765432111  111235689999999999999999999999999999999999999997544333111111111100


Q ss_pred             hhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          475 HREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       475 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      .. ..     .+.+..    ..+..+.+++..|++.||++||++.++.+.|+.
T Consensus       233 ~~-~~-----~~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         233 MS-TP-----IEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             HH-SC-----HHHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             CC-CC-----hhHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            00 00     011111    122456777889999999999999999888764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-42  Score=347.29  Aligned_cols=263  Identities=22%  Similarity=0.285  Sum_probs=202.8

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeCCe
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEKGK  318 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  318 (568)
                      ++|+..++||+|+||+||+|+...      +++.||||+++....  ...+.+.+|+.++++++||||++++++|.....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   75 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRE------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECC------CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc
Confidence            578999999999999999999875      688999999965432  345678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          319 LLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       319 ~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                      .++|+|++.+++|..++..   ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||.|+
T Consensus        76 ~~iv~~~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~  149 (292)
T d1unla_          76 LTLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLAR  149 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             eeEEeeecccccccccccc---ccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhh
Confidence            9999999999999888743   356889999999999999999999   5799999999999999999999999999999


Q ss_pred             ccccccccccccccccCCcCCcccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHHHHhhc
Q 008374          399 AIENERNSYAEHGLVGVPGTMGYVAPECFHTGK-ATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVWMLHRE  477 (568)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  477 (568)
                      ..........     ...++..|+|||.+.... ++.++|||||||+++||++|+.||.......   ....-+......
T Consensus       150 ~~~~~~~~~~-----~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~---~~~~~~~~~~~~  221 (292)
T d1unla_         150 AFGIPVRCYS-----AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGT  221 (292)
T ss_dssp             ECCSCCSCCC-----SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH---HHHHHHHHHHCC
T ss_pred             cccCCCccce-----eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH---HHHHHHHhhcCC
Confidence            8765433221     446788999999987655 6899999999999999999999975433222   111111111111


Q ss_pred             C---ch---hhhhhhhc---------CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          478 G---HI---QDAVDQRL---------NINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       478 ~---~~---~~~~d~~l---------~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                      .   ..   ....+...         ...........+.+++.+|++.||.+|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0   00   00000000         00111122345667778999999999999999975

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-42  Score=356.09  Aligned_cols=264  Identities=20%  Similarity=0.281  Sum_probs=194.7

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEeCC
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHEKG  317 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  317 (568)
                      .++|...++||+|+||+||+|+...      +++.||||+++...  ....+.+.+|+++|++++|||||+++++|...+
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~   90 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGR------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   90 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETT------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECC------CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence            3578899999999999999999875      68899999997642  233567889999999999999999999997654


Q ss_pred             ------eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 008374          318 ------KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARL  391 (568)
Q Consensus       318 ------~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL  391 (568)
                            .+++||||+ +.+|..+..    ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||
T Consensus        91 ~~~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl  162 (346)
T d1cm8a_          91 TLDDFTDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKI  162 (346)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred             cccccceEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccc
Confidence                  579999999 567777763    346999999999999999999999   679999999999999999999999


Q ss_pred             eecCCccccccccccccccccccCCcCCcccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH
Q 008374          392 GDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHT-GKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW  470 (568)
Q Consensus       392 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~  470 (568)
                      +|||+|+......        ....||+.|+|||.+.+ ..++.++||||+||+++||++|+.||.......   .+...
T Consensus       163 ~Dfg~a~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~---~~~~~  231 (346)
T d1cm8a_         163 LDFGLARQADSEM--------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEI  231 (346)
T ss_dssp             CCCTTCEECCSSC--------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH
T ss_pred             ccccceeccCCcc--------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH---HHHHH
Confidence            9999998765432        25679999999999876 456899999999999999999999997554332   11111


Q ss_pred             HHHHhh-------cCc--hhhhhhhhc---CC----CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HhCC
Q 008374          471 VWMLHR-------EGH--IQDAVDQRL---NI----NSVVDEAKRLLLLGLACSHPIASERPKTEDILQI--ISGT  528 (568)
Q Consensus       471 ~~~~~~-------~~~--~~~~~d~~l---~~----~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~--L~~~  528 (568)
                      ......       ...  ........+   ..    .........+.+++.+|++.||.+|||++|+++.  |+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence            110000       000  000000000   00    0011122345678889999999999999999973  5543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4e-42  Score=345.57  Aligned_cols=263  Identities=17%  Similarity=0.209  Sum_probs=204.5

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCC-CceeeEEEEEEeCCeE
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRH-KHLVHLVGWCHEKGKL  319 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~  319 (568)
                      ++|...++||+|+||+||+|+...      +++.||||.++...  ....+.+|++.+..++| +|++.+++++......
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~------~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   76 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLL------NNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   76 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETT------TTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECC------CCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence            578999999999999999999875      68899999986542  34568899999999975 8999999999999999


Q ss_pred             EEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-----CCcEEEeec
Q 008374          320 LLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA-----DFNARLGDF  394 (568)
Q Consensus       320 ~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~-----~~~~kL~DF  394 (568)
                      ++||||+ +++|.+++...  ...+++.+...++.|++.||+|||   +++|+||||||+|||++.     ++.+||+||
T Consensus        77 ~~vme~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DF  150 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF  150 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             EEEEEec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEccc
Confidence            9999999 78999988543  246899999999999999999999   789999999999999974     578999999


Q ss_pred             CCccccccccccc--cccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHHH
Q 008374          395 GLARAIENERNSY--AEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWVW  472 (568)
Q Consensus       395 Gla~~~~~~~~~~--~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~~  472 (568)
                      |+|+.........  .........||+.|||||.+.+..++.++|||||||++|||++|+.||............ ..+.
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~-~~i~  229 (293)
T d1csna_         151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIG  229 (293)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-HHHH
T ss_pred             ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH-HHHH
Confidence            9999875432211  111223568999999999999999999999999999999999999999854433211111 1111


Q ss_pred             HHhhcCchhhhhhhhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 008374          473 MLHREGHIQDAVDQRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQIISG  527 (568)
Q Consensus       473 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~~L~~  527 (568)
                      ........     +.+....    +..+.+++..|++.+|++||+++.+.+.|+.
T Consensus       230 ~~~~~~~~-----~~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         230 EKKQSTPL-----RELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             HHHHHSCH-----HHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             hccCCCCh-----HHhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            10000001     1111112    2456677778999999999999998887764

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.9e-42  Score=349.95  Aligned_cols=259  Identities=16%  Similarity=0.219  Sum_probs=195.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-CCceeeEEEEEEeC--C
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-HKHLVHLVGWCHEK--G  317 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~--~  317 (568)
                      ++|+..++||+|+||+||+|+...      +++.||||+++..   ..+++.+|+++|++++ ||||+++++++...  .
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~------~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~  105 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINIT------NNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSR  105 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECC------CCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence            579999999999999999999875      6899999999654   3467889999999995 99999999999744  5


Q ss_pred             eEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-cEEEeecCC
Q 008374          318 KLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADF-NARLGDFGL  396 (568)
Q Consensus       318 ~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~-~~kL~DFGl  396 (568)
                      .+++|||||++++|..+.      ..++...+..++.||+.||.|||   +++|+||||||+|||++.++ .+||+|||+
T Consensus       106 ~~~~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~  176 (328)
T d3bqca1         106 TPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL  176 (328)
T ss_dssp             SEEEEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred             ceeEEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeeccccc
Confidence            699999999999998765      35899999999999999999999   67999999999999998655 699999999


Q ss_pred             ccccccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccch-hhHHHH----
Q 008374          397 ARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHA-YTLVDW----  470 (568)
Q Consensus       397 a~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~-~~l~~~----  470 (568)
                      |+........      ....||+.|+|||.+... .++.++||||+||+++||++|+.||......... ..+...    
T Consensus       177 a~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~  250 (328)
T d3bqca1         177 AEFYHPGQEY------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  250 (328)
T ss_dssp             CEECCTTCCC------CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred             ceeccCCCcc------cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCc
Confidence            9877654321      256789999999998765 4799999999999999999999999744322110 011100    


Q ss_pred             -HHHHhhcCch------hhhhh--------hhcCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          471 -VWMLHREGHI------QDAVD--------QRLNINSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       471 -~~~~~~~~~~------~~~~d--------~~l~~~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                       ..........      .....        ..............+.+|+.+|++.||++|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0000000000      00000        00000111122345677888999999999999999985

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-41  Score=349.90  Aligned_cols=262  Identities=20%  Similarity=0.204  Sum_probs=189.9

Q ss_pred             cCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCC--cccchhhHHHHHHhhcCCCCceeeEEEEEEe---
Q 008374          241 NNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDS--IKSKGDFLAELAIIHRLRHKHLVHLVGWCHE---  315 (568)
Q Consensus       241 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~---  315 (568)
                      ++|+..++||+|+||+||+|+...      +++.||||++....  ....+.+.+|+.++++++||||+++++++..   
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~------t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~   90 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAV------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT   90 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETT------TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred             CCeEEEEEeecCcCeEEEEEEECC------CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence            578999999999999999999875      68999999997643  3344578899999999999999999999964   


Q ss_pred             ---CCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          316 ---KGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       316 ---~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                         ...+|+|||||.++.+ +.+.     ..+++.....++.||+.||.|||   +++|+||||||+|||++.++.+|++
T Consensus        91 ~~~~~~~~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~  161 (355)
T d2b1pa1          91 LEEFQDVYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_dssp             TTTCCEEEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             cccCceeEEEEeccchHHH-Hhhh-----cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeee
Confidence               3689999999966544 4442     35889999999999999999999   6799999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHH--
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDW--  470 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~--  470 (568)
                      |||+++........      ....||+.|+|||.+.+..+++++||||+||+++||++|+.||...........+..-  
T Consensus       162 df~~~~~~~~~~~~------~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~  235 (355)
T d2b1pa1         162 DFGLARTAGTSFMM------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG  235 (355)
T ss_dssp             CCCC---------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             chhhhhcccccccc------ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhcc
Confidence            99999876554322      2557999999999999999999999999999999999999999754322211011000  


Q ss_pred             -------------HHHHhhc-C-----chhhhhhhhcCC---CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 008374          471 -------------VWMLHRE-G-----HIQDAVDQRLNI---NSVVDEAKRLLLLGLACSHPIASERPKTEDILQ  523 (568)
Q Consensus       471 -------------~~~~~~~-~-----~~~~~~d~~l~~---~~~~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~  523 (568)
                                   ....... .     ............   .........+.+++.+|++.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                         0000000 0     000111111111   112234567788999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-41  Score=345.94  Aligned_cols=267  Identities=19%  Similarity=0.257  Sum_probs=195.6

Q ss_pred             hcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCc--ccchhhHHHHHHhhcCCCCceeeEEEEEEeC-
Q 008374          240 TNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSI--KSKGDFLAELAIIHRLRHKHLVHLVGWCHEK-  316 (568)
Q Consensus       240 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-  316 (568)
                      .++|+..++||+|+||+||+|+...      +++.||||+++....  ...+.+.+|+++|++++|||++++++++... 
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~   90 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTK------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   90 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETT------TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECC------CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence            4679999999999999999999875      689999999976432  3445788999999999999999999998643 


Q ss_pred             ----CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCcEEEe
Q 008374          317 ----GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFNARLG  392 (568)
Q Consensus       317 ----~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~~kL~  392 (568)
                          ...+++++|+.+|+|.+++..    ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+|++
T Consensus        91 ~~~~~~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~  163 (348)
T d2gfsa1          91 SLEEFNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL  163 (348)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             ccccCceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCcccccccccccccc
Confidence                345667788889999999943    35999999999999999999999   6799999999999999999999999


Q ss_pred             ecCCccccccccccccccccccCCcCCcccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccchhhHHHHH
Q 008374          393 DFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTG-KATPESDVFGFGAVVLEVVCGRSPGNMIPHQQHAYTLVDWV  471 (568)
Q Consensus       393 DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~~~~~l~~~~  471 (568)
                      |||++.......        ....||..|+|||.+... .++.++|||||||++|||++|+.||...........+....
T Consensus       164 dfg~a~~~~~~~--------~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~  235 (348)
T d2gfsa1         164 DFGLARHTDDEM--------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV  235 (348)
T ss_dssp             CC----CCTGGG--------SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             ccchhcccCccc--------ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999998654432        256799999999987665 46889999999999999999999997543322111111100


Q ss_pred             H----HHhhcCc---hhhhhhhhcC-CCCc-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhC
Q 008374          472 W----MLHREGH---IQDAVDQRLN-INSV-----VDEAKRLLLLGLACSHPIASERPKTEDILQ--IISG  527 (568)
Q Consensus       472 ~----~~~~~~~---~~~~~d~~l~-~~~~-----~~~~~~l~~l~l~Cl~~dp~~RPt~~evl~--~L~~  527 (568)
                      .    .......   .......... ....     ......+.+++.+|++.||.+|||++|+++  .+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             CCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             CCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence            0    0000000   0000000000 0000     012234567888999999999999999987  4544

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.8e-37  Score=319.19  Aligned_cols=265  Identities=17%  Similarity=0.190  Sum_probs=193.9

Q ss_pred             CccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-----------CCceeeEE
Q 008374          242 NFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-----------HKHLVHLV  310 (568)
Q Consensus       242 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~  310 (568)
                      +|...++||+|+||+||+|+...      +++.||||+++... ...+.+.+|+.++++++           |+||++++
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~------~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMV------NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             cEEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            48889999999999999999875      68999999997643 23456788998888775           57899999


Q ss_pred             EEEEeC--CeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCc
Q 008374          311 GWCHEK--GKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDADFN  388 (568)
Q Consensus       311 g~~~~~--~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~~~~  388 (568)
                      +++...  ...+++++++..+..............+++..+..++.||+.||.|||+  ..+|+||||||+|||++.++.
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~  164 (362)
T d1q8ya_          87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDS  164 (362)
T ss_dssp             EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEET
T ss_pred             EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCc
Confidence            988653  5677788877666544444333445678899999999999999999995  479999999999999986653


Q ss_pred             ------EEEeecCCccccccccccccccccccCCcCCcccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 008374          389 ------ARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVAPECFHTGKATPESDVFGFGAVVLEVVCGRSPGNMIPHQQ  462 (568)
Q Consensus       389 ------~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~t~~sDV~SfGvll~el~tG~~P~~~~~~~~  462 (568)
                            +|++|||.+.......        ....||+.|+|||.+....++.++||||+||+++||++|+.||.......
T Consensus       165 ~~~~~~~kl~dfg~s~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~  236 (362)
T d1q8ya_         165 PENLIQIKIADLGNACWYDEHY--------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS  236 (362)
T ss_dssp             TTTEEEEEECCCTTCEETTBCC--------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             ccccceeeEeeccccccccccc--------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence                  9999999998654322        14579999999999999999999999999999999999999997432211


Q ss_pred             ch---hhHHHHHHHHhh-------cCc-hhhhhhh-------------------hcCCCCcHHHHHHHHHHHHhcCCCCC
Q 008374          463 HA---YTLVDWVWMLHR-------EGH-IQDAVDQ-------------------RLNINSVVDEAKRLLLLGLACSHPIA  512 (568)
Q Consensus       463 ~~---~~l~~~~~~~~~-------~~~-~~~~~d~-------------------~l~~~~~~~~~~~l~~l~l~Cl~~dp  512 (568)
                      ..   ..+...++..-.       .+. .....+.                   .............+.+++..|++.||
T Consensus       237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP  316 (362)
T d1q8ya_         237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP  316 (362)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence            10   111111111100       000 0000000                   00122345667788999999999999


Q ss_pred             CCCCCHHHHHH
Q 008374          513 SERPKTEDILQ  523 (568)
Q Consensus       513 ~~RPt~~evl~  523 (568)
                      .+|||++|+++
T Consensus       317 ~~Rpta~e~L~  327 (362)
T d1q8ya_         317 RKRADAGGLVN  327 (362)
T ss_dssp             TTCBCHHHHHT
T ss_pred             hHCcCHHHHhc
Confidence            99999999987

>d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]

Probab=100.00  E-value=3e-36  Score=290.08  Aligned_cols=152  Identities=30%  Similarity=0.486  Sum_probs=132.9

Q ss_pred             CCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCC-CCCcEEEEEeeCCCCC--CCCCCCeeeEecCCccccccccCC
Q 008374           10 DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGN-KANHFVAIEFDTVKQG--FDPDDNHLGLNINSVVSRKNVPLK   86 (568)
Q Consensus        10 ~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~-~~~~~~aVEfDt~~~~--~d~~~~hvgidins~~s~~~~~~~   86 (568)
                      ..+||||||||+|....+  ++.|++||+++..+++. ..|++|||||||++|.  +||++||||||+||+.|..+.++.
T Consensus        81 ~~~gDGlAFvl~p~~~~~--~~~G~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHIgIdvns~~s~~~~~~~  158 (236)
T d1hqla_          81 NGPADGLAFFLAPPDSDV--KDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWE  158 (236)
T ss_dssp             SCCCCEEEEEEECTTCCC--CCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEEEECC
T ss_pred             CCCCceEEEEEeCCCCCC--CCCccccccccccccCCcccCceEEEEeeCccCCCCCCCCCCEEEEEcCCcccccccccc
Confidence            468999999999965433  47899999999876654 5799999999999997  599999999999999999888764


Q ss_pred             CCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCccccccccccccc
Q 008374           87 DNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTL  166 (568)
Q Consensus        87 ~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~~~i~sWs~  166 (568)
                      .   .+|.+|+.++|||+||+.+++|+|+|++.+   |..|++++.+||+++|+++|||||||+||....+.|+|++|+|
T Consensus       159 ~---~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~---~~~~~ls~~vdL~~~l~~~v~vGFSasTG~~~~~~h~I~sWsF  232 (236)
T d1hqla_         159 D---SDIFSGKIATARISYDGSAEILTVVLSYPD---GSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRF  232 (236)
T ss_dssp             H---HHHTSCSCEEEEEEEETTTTEEEEEEEETT---TEEEEEEEECCGGGTSCSEEEEEEEEECCSCCCEEEEEEEEEE
T ss_pred             c---ccccCCCEEEEEEEEeCCCcEEEEEEecCC---CCCeeEEEEeCHHHhCCCcEEEEEEeECCCCCceEEEEEEeEe
Confidence            3   468899999999999999999999999754   6778999999999999999999999999963457789999999


Q ss_pred             ccc
Q 008374          167 DID  169 (568)
Q Consensus       167 ~~~  169 (568)
                      +.+
T Consensus       233 ~s~  235 (236)
T d1hqla_         233 SSN  235 (236)
T ss_dssp             EEE
T ss_pred             Eec
Confidence            864

>d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]

Probab=100.00  E-value=5.9e-36  Score=288.97  Aligned_cols=152  Identities=31%  Similarity=0.490  Sum_probs=134.1

Q ss_pred             CCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCC-CCCcEEEEEeeCCCCC--CCCCCCeeeEecCCccccccccCC
Q 008374           10 DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGN-KANHFVAIEFDTVKQG--FDPDDNHLGLNINSVVSRKNVPLK   86 (568)
Q Consensus        10 ~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~-~~~~~~aVEfDt~~~~--~d~~~~hvgidins~~s~~~~~~~   86 (568)
                      ..+||||||||+|.... + +..|++|||++..++++ ..||+|||||||++|.  .||++||||||+|++.|..+..+.
T Consensus        85 ~~~gdGlAF~l~p~~~~-~-~~~g~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~d~~~nHVgIdvns~~s~~~~~~~  162 (243)
T d1leda_          85 APTADGLAFFLAPVDSS-V-KDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWE  162 (243)
T ss_dssp             SSCBCEEEEEEEETTCC-C-CCCGGGTTTCCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEECC
T ss_pred             CCCCCceEEEEcCCCCC-C-CCCccccccccccccCCCccCcEEEEEEeCccccccCCCCCCceEEEecCcccccccccc
Confidence            56899999999997553 3 47899999999887655 5799999999999997  499999999999999999988865


Q ss_pred             CCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCccccccccccccc
Q 008374           87 DNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTL  166 (568)
Q Consensus        87 ~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~~~i~sWs~  166 (568)
                      .   .++.+|+.++|||+||+.+++|+|+|++.   +|..|++++.+||+++|+++|||||||+||.  .+.|+|++|+|
T Consensus       163 ~---~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~---~~~~p~ls~~idL~~~l~~~vyvGFSAsTG~--~~~h~I~sWsF  234 (243)
T d1leda_         163 N---DDAYGSSIATAHITYDARSKILTVLLSYE---HGRDYILSHVVDLAKVLPQKVRIGFSAGVGY--DEVTYILSWHF  234 (243)
T ss_dssp             H---HHHTSCCEEEEEEEEETTTTEEEEEEEET---TSCEEEEEEECCHHHHSCSEEEEEEEEEECB--SEEEEEEEEEE
T ss_pred             c---CCcccCceeEEEEEEECCCCEEEEEEeeC---CCCCceEEEecCHHHhcCCcEEEEEEcccCC--cceeeEEEEEE
Confidence            3   46788999999999999999999999975   4678899999999999999999999999995  59999999999


Q ss_pred             ccccc
Q 008374          167 DIDVI  171 (568)
Q Consensus       167 ~~~~~  171 (568)
                      +.+..
T Consensus       235 ~s~l~  239 (243)
T d1leda_         235 FSTLD  239 (243)
T ss_dssp             EEECT
T ss_pred             EeeCC
Confidence            87643

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

Probab=100.00  E-value=1e-34  Score=280.81  Aligned_cols=153  Identities=25%  Similarity=0.350  Sum_probs=133.2

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC---CCCCCCeeeEecCCccccccccC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG---FDPDDNHLGLNINSVVSRKNVPL   85 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~---~d~~~~hvgidins~~s~~~~~~   85 (568)
                      +..+||||||||+|+.. + .++.|++|||+|.+ +++..+++|||||||++|.   +||++||||||+||+.+..+..+
T Consensus        82 ~~~ggdG~AFvl~p~~~-~-~~~~g~~lGl~~~~-~~~~~~~~vAVEFDT~~n~~~~~D~~~nHIgid~ns~~s~~~~~~  158 (240)
T d1fx5a_          82 PKAATDGLTFFLAPPDS-P-LRRAGGYFGLFNDT-KCDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERW  158 (240)
T ss_dssp             GGGCCCEEEEEEECTTC-C-CCBCGGGTTTBSSS-CCCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEEEC
T ss_pred             CCCCCCcEEEEECCCCC-C-CCCCCccccccccC-CCCccCceEEEEeeccccccccCCCCCCceEEccCCccccccccc
Confidence            34689999999999643 4 35899999999965 3556789999999999985   69999999999999999888776


Q ss_pred             CCCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCcccccccccccc
Q 008374           86 KDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWT  165 (568)
Q Consensus        86 ~~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~~~i~sWs  165 (568)
                      ..    .+.+|+.++|||+||+.+++|.|+|++.+  +|..|+++..+||+.+|+++|||||||+||....+.|+|++|+
T Consensus       159 ~~----~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdLs~~l~~~v~vGFSasTG~~~~~~H~I~sWs  232 (240)
T d1fx5a_         159 NK----RYGLNNVANVEIIYEASSKTLTASLTYPS--DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWY  232 (240)
T ss_dssp             CC----CCSGGGCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCGGGTSCSEEEEEEEEEEETTSCEEEEEEEEE
T ss_pred             cc----ccCCCCeEEEEEEEcCCCCEEEEEEecCC--CceeeEEeEEEchHHhCCCcEEEEEEeECCCCCCceEEEEEEE
Confidence            54    56789999999999999999999999866  6778999999999999999999999999985256889999999


Q ss_pred             ccccc
Q 008374          166 LDIDV  170 (568)
Q Consensus       166 ~~~~~  170 (568)
                      |+.+.
T Consensus       233 Fsst~  237 (240)
T d1fx5a_         233 FTSTF  237 (240)
T ss_dssp             EEEES
T ss_pred             eEEec
Confidence            98764

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

Probab=100.00  E-value=2.5e-34  Score=277.75  Aligned_cols=152  Identities=28%  Similarity=0.449  Sum_probs=133.2

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC----CCCCCCeeeEecCCcccccccc
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG----FDPDDNHLGLNINSVVSRKNVP   84 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~----~d~~~~hvgidins~~s~~~~~   84 (568)
                      ...+||||||||+|.....+.++.+++||+.|. .++...+++|||||||++|.    +||++||||||+|++.|..++.
T Consensus        79 ~~~ggdG~aF~l~p~~~~~~~~~~~~~~g~~~~-~~~~~~~~~vAVEFDT~~n~~~~~~d~~~nHvgid~ns~~s~~~~~  157 (237)
T d1qnwa_          79 KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSS-SDSKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVK  157 (237)
T ss_dssp             SSCCCCEEEEEEEETTCCCCTTCCGGGTTTCSS-SSCCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEEE
T ss_pred             CCCCcceeEEEEeCCCCCCCCCCccccccccCC-CCCCCcccEEEEEeeceecCCcCCCCCCCCeEEEECCCCCcccccc
Confidence            356899999999997776666789999999885 34567899999999999985    4799999999999999988766


Q ss_pred             CCCCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCc-ccccccccc
Q 008374           85 LKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYP-HIQLNCVRS  163 (568)
Q Consensus        85 ~~~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~-~~~~~~i~s  163 (568)
                      +      ++.+|+.++|||+||+.+++|+|+|++.+  +|..|+|++.+||+.+|+++|||||||+||.. ..|.|+|++
T Consensus       158 ~------~~~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~p~ls~~vDLs~~l~~~vyvGFSasTG~~~~~q~h~I~s  229 (237)
T d1qnwa_         158 W------DWRNGEVADVVITYRAPTKSLTVCLSYPS--DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLS  229 (237)
T ss_dssp             C------CCCTTCCEEEEEEEEGGGTEEEEEEECTT--TCCEEEEEEECCHHHHSCSEEEEEEEEEESCGGGCBCCEEEE
T ss_pred             c------ccCCCcEEEEEEEEcCCCcEEEEEEecCC--CCccceEEEEEChHHhCCCcEEEEEEeECCCCCCccEeEEEE
Confidence            4      45789999999999999999999999765  78899999999999999999999999999972 258999999


Q ss_pred             cccccc
Q 008374          164 WTLDID  169 (568)
Q Consensus       164 Ws~~~~  169 (568)
                      |+|+.+
T Consensus       230 WsF~s~  235 (237)
T d1qnwa_         230 WYFTSN  235 (237)
T ss_dssp             EEEEEE
T ss_pred             eEeEEe
Confidence            999864

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

Probab=100.00  E-value=7.4e-34  Score=274.07  Aligned_cols=147  Identities=32%  Similarity=0.595  Sum_probs=129.0

Q ss_pred             CCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecCCccccccccCCCCc
Q 008374           10 DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKDNY   89 (568)
Q Consensus        10 ~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidins~~s~~~~~~~~~~   89 (568)
                      ..+||||||+|+|... + .++.||+||+++..    ..+++|||||||++|.+||++||||||+|++.|.++..+    
T Consensus        83 ~~g~dGlaFvl~p~~~-~-~~~~gg~lG~~~~~----~~~~~vaVEFDT~~n~~d~~~nHvgI~vns~~s~~~~~~----  152 (237)
T d2d3sa1          83 PHPADGLVFFIAPPNT-Q-TGEGGGYFGIYNPL----SPYPFVAVEFDTFRNTWDPQIPHIGIDVNSVISTKTVPF----  152 (237)
T ss_dssp             SCCCEEEEEEEECSSC-C-CCBCGGGTTTBCTT----SCCCCEEEEEECSCCTTCCSSSEEEEEESSSSCSEEEEC----
T ss_pred             CCCCCeEEEEeCCCCc-c-CCccccccccccCC----CcCceEEEEEEeecCCCCCCCCcEEEEcCCCccccccce----
Confidence            4678999999998654 3 35899999998863    457899999999999999999999999999999877654    


Q ss_pred             ccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCc------ccccccccc
Q 008374           90 NITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYP------HIQLNCVRS  163 (568)
Q Consensus        90 ~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~------~~~~~~i~s  163 (568)
                        ++.+|+.++|||+||+.+++|.|+|++.+  +|..|+++..+||+.+|+++|||||||+||..      .++.|+|++
T Consensus       153 --~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSasTG~~~~~~~~~~e~h~I~s  228 (237)
T d2d3sa1         153 --TLDNGGIANVVIKYDASTKILHVVLVFPS--LGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILS  228 (237)
T ss_dssp             --CCCTTCEEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCCTTCCCCCEEEE
T ss_pred             --eecCCCEEEEEEEEECCCCEEEEEEEcCC--CCcccceeeEechHHhCCCcEEEEEEeECCCCccCccccceeeEEEE
Confidence              46789999999999999999999999866  57788999999999999999999999999951      468999999


Q ss_pred             ccccccc
Q 008374          164 WTLDIDV  170 (568)
Q Consensus       164 Ws~~~~~  170 (568)
                      |+|+.+.
T Consensus       229 WsFss~l  235 (237)
T d2d3sa1         229 WSFSASL  235 (237)
T ss_dssp             EEEEEEC
T ss_pred             eEeEeeC
Confidence            9998763

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

Probab=100.00  E-value=1.6e-33  Score=272.22  Aligned_cols=151  Identities=26%  Similarity=0.434  Sum_probs=131.6

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC-CCCCCCeeeEecCCccccccccCCC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG-FDPDDNHLGLNINSVVSRKNVPLKD   87 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~-~d~~~~hvgidins~~s~~~~~~~~   87 (568)
                      ...+||||||+|+|....+  ++.+|+||+++.... ...++.|||||||++|. +||++||||||+|++.|..+.++  
T Consensus        84 ~~~g~dG~aF~l~p~~~~~--~~~~g~lg~~~~~~~-~~~~~~vaVEFDT~~n~~~d~~~~HvgI~vn~~~s~~t~~~--  158 (239)
T d1gzca_          84 RPLPADGLVFFMGPTKSKP--AQGYGYLGVFNNSKQ-DNSYQTLAVEFDTFSNPWDPPQVPHIGIDVNSIRSIKTQPF--  158 (239)
T ss_dssp             SSCCCEEEEEEEECSSCCC--CCCGGGTTTCSSSSC-CGGGCCEEEEEECSCCTTSCSSSSEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCeEEEEECCCCCCC--CCCcccccccccCCC-CCccceEEEEEEccccCCCCCCCCEEEEEECCccccccCCc--
Confidence            3468999999999976533  378899999886543 45688999999999998 69999999999999999887664  


Q ss_pred             CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCc--ccccccccccc
Q 008374           88 NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYP--HIQLNCVRSWT  165 (568)
Q Consensus        88 ~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~--~~~~~~i~sWs  165 (568)
                          +|.+|+.++|||+||+.+++|+|+|++..  +|..|++++.+||+.+|+++|||||||+||..  ..+.|++++|+
T Consensus       159 ----~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~H~V~sWs  232 (239)
T d1gzca_         159 ----QLDNGQVANVVIKYDAPSKILHVVLVYPS--SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWS  232 (239)
T ss_dssp             ----CCCTTCEEEEEEEEETTTTEEEEEEECTT--TCCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEE
T ss_pred             ----cccCCCEEEEEEEEeCCCcEEEEEEecCC--CCcceeeeeEechHHhcCCcEEEEEEEEcCCCCCCceeeEEEEEE
Confidence                56789999999999999999999999765  68899999999999999999999999999952  56899999999


Q ss_pred             ccccc
Q 008374          166 LDIDV  170 (568)
Q Consensus       166 ~~~~~  170 (568)
                      |+.+.
T Consensus       233 F~s~l  237 (239)
T d1gzca_         233 FQASL  237 (239)
T ss_dssp             EEEEE
T ss_pred             eEeeC
Confidence            99764

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

Probab=99.98  E-value=3.3e-33  Score=272.02  Aligned_cols=152  Identities=30%  Similarity=0.505  Sum_probs=128.3

Q ss_pred             CCCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecCCccccccccCCC
Q 008374            8 AWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKD   87 (568)
Q Consensus         8 ~~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidins~~s~~~~~~~~   87 (568)
                      ....+||||||+|+|.... + +..||+||+++..   ...++.|||||||++|.+||+++|||||+|++.|..+..+  
T Consensus        82 ~~~~~gDGlAFvl~p~~~~-~-~~~~g~lG~~~~~---~~~~~~vaVEFDT~~n~~D~~~~Hvgi~~n~~~s~~~~~~--  154 (251)
T d1g9fa_          82 DTKRLADGLAFFLAPIDTK-P-QTHAGYLGLFNEN---ESGDQVVAVEFDTFRNSWDPPNPHIGINVNSIRSIKTTSW--  154 (251)
T ss_dssp             CC--CCEEEEEEEEETTCC-C-CCCGGGTTTCCTT---SCCCSCEEEEEECC-CTTSCSSSEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCCceEEEEecCCCC-C-CCccCccCccccc---CCCcceEEEEEecccCCCCCCCCcEeEEecCcccccccce--
Confidence            3456899999999997553 3 4788999998753   4457899999999999999999999999999999877654  


Q ss_pred             CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCccc--ccccccccc
Q 008374           88 NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHI--QLNCVRSWT  165 (568)
Q Consensus        88 ~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~~--~~~~i~sWs  165 (568)
                          ++.+|+.++|||+||+.+++|.|++++..  +|..|+++..+||+.+|+++|||||||+||. ..  |.|+|++|+
T Consensus       155 ----~l~~g~~~~v~I~Yd~~~~~L~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~-~~~~~~h~I~sWs  227 (251)
T d1g9fa_         155 ----DLANNKVAKVLITYDASTSLLVASLVYPS--QRTSNILSDVVDLKTSLPEWVRIGFSAATGL-DIPGESHDVLSWS  227 (251)
T ss_dssp             ----CCCTTCCEEEEEEEETTTTEEEEEEEEGG--GTEEEEEEEECCC-CCSCSEEEEEEEEEECS-SSCCCEEEEEEEE
T ss_pred             ----EecCCCEEEEEEEEECCccEEEEEEecCC--CCcceeEEEEecchhhCCCcEEEEEEeecCC-CCCCceeEEEEeE
Confidence                56789999999999999999999998754  7888999999999999999999999999996 44  789999999


Q ss_pred             cccccccc
Q 008374          166 LDIDVIQT  173 (568)
Q Consensus       166 ~~~~~~~~  173 (568)
                      |+...+++
T Consensus       228 F~s~~~~~  235 (251)
T d1g9fa_         228 FASNLPHA  235 (251)
T ss_dssp             EEEEECC-
T ss_pred             eECCCCCC
Confidence            98775443

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

Probab=99.97  E-value=1.3e-32  Score=264.99  Aligned_cols=148  Identities=28%  Similarity=0.524  Sum_probs=127.1

Q ss_pred             CCCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecCCccccccccCCC
Q 008374            8 AWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKD   87 (568)
Q Consensus         8 ~~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidins~~s~~~~~~~~   87 (568)
                      +...+||||||+|+|... +. ++.|+++|+++..    ..++.|||||||++|.+||++||||||+|++.|..+..+  
T Consensus        82 ~~~~g~dG~aF~i~p~~~-~~-~~~g~~~g~~~~~----~~~~~vaVEFDT~~n~~Dp~~nHvgi~~ns~~s~~~~~~--  153 (234)
T d1f9ka_          82 AYPEPADGLTFFMVPPNS-PQ-GEDGGNLGVFKPP----EGDNAFAVEFDTFQNTWDPQVPHIGIDVNSIVSSKTLHF--  153 (234)
T ss_dssp             SSSCCCEEEEEEEECTTC-CC-CCSGGGTTTCCSS----CCSCCEEEEEECSCCTTCCSSSEEEEEESSSSCSEEEEC--
T ss_pred             CCCCccceEEEEECCCCC-Cc-ccccccccccCCC----CccceEEEEEeccccCCCCCCCcEeEecCCccccccccc--
Confidence            345678999999998654 33 5899999998763    456789999999999999999999999999998877553  


Q ss_pred             CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCC--CcccccccccCCCc--ccccccccc
Q 008374           88 NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLK--PESYFGFSASTGYP--HIQLNCVRS  163 (568)
Q Consensus        88 ~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~--~~~~vGfsastG~~--~~~~~~i~s  163 (568)
                          +|.+|+.++|||+||+.+++|+|++++.+  +|..|+|++.|||+.+|+  ++|||||||+||..  ..+.|+|++
T Consensus       154 ----~l~~G~~~~v~I~Yd~~~~~l~V~l~~~~--~~~~~~ls~~idL~~~l~~~~~v~vGFSasTG~~~~~~~~h~I~s  227 (234)
T d1f9ka_         154 ----QLENGGVANVVIKYDSPTKILNVVLAFHS--VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIIS  227 (234)
T ss_dssp             ----CCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTTCCCEEEEEE
T ss_pred             ----cccCCCEEEEEEEEcCCCcEEEEEEEeCC--CCccceEEEEEcHHHhcCCCCEEEEEEEeecCCCCCceeeeEEEE
Confidence                57899999999999999999999999876  567789999999999996  55999999999952  468899999


Q ss_pred             cccccc
Q 008374          164 WTLDID  169 (568)
Q Consensus       164 Ws~~~~  169 (568)
                      |+|+.+
T Consensus       228 WsF~s~  233 (234)
T d1f9ka_         228 WSFTSS  233 (234)
T ss_dssp             EEEEEE
T ss_pred             EEeEEe
Confidence            999864

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

Probab=99.97  E-value=1.2e-31  Score=258.70  Aligned_cols=151  Identities=27%  Similarity=0.486  Sum_probs=131.2

Q ss_pred             CCCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecCCccccccccCCC
Q 008374            8 AWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKD   87 (568)
Q Consensus         8 ~~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidins~~s~~~~~~~~   87 (568)
                      ....+||||||+|+|....+  ++.||+|||++.... +..++.|||||||++|.+||++||||||+|++.|..+.++  
T Consensus        79 ~~~~~gDGlAF~l~~~~~~~--~~~gg~lGl~~~~~~-~~~~~~~aVefDT~~n~~d~~~~higi~~n~~~s~~~~~~--  153 (233)
T d1n47a_          79 AAAAVADGLAFFLAPPDTQP--QARGGFLGLFADRAH-DASYQTVAVEFDTYSNAWDPNYTHIGIDTNGIESKKTTPF--  153 (233)
T ss_dssp             STTSCCEEEEEEEECTTCCC--CCCGGGTTTCSSSSC-CGGGCCEEEEEECSCCTTSCSSCEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCCceEEEECCCCCCC--CCCCCccccccccCC-CCcCceEEEEEEeeecCCCCCCCceeEccCCccccccccc--
Confidence            44568999999999976533  478899999986443 5678889999999999999999999999999998877664  


Q ss_pred             CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCc--ccccccccccc
Q 008374           88 NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYP--HIQLNCVRSWT  165 (568)
Q Consensus        88 ~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~--~~~~~~i~sWs  165 (568)
                          .+.+|+.++|||+||+.+++|.|++.+..  +|..|.++..+||+.+|+++|||||||+||..  ..+.|+|++|+
T Consensus       154 ----~l~~g~~~~v~I~Y~~~~~~l~v~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~H~I~sWs  227 (233)
T d1n47a_         154 ----DMVYGEKANIVITYQASTKALAASLVFPV--SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWS  227 (233)
T ss_dssp             ----CCCTTSCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCCCCEEEEEE
T ss_pred             ----eecCCCEEEEEEEEcCCCeEEEEEEEeCC--CCccEEEEEEechHHhcCCcEEEEEEEecCCCCCcccccEEEEEE
Confidence                45789999999999999999999998765  68888999999999999999999999999941  56889999999


Q ss_pred             cccc
Q 008374          166 LDID  169 (568)
Q Consensus       166 ~~~~  169 (568)
                      |+.+
T Consensus       228 Fss~  231 (233)
T d1n47a_         228 FAVS  231 (233)
T ss_dssp             EEEE
T ss_pred             eEEE
Confidence            9865

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

Probab=99.97  E-value=1.1e-31  Score=261.96  Aligned_cols=152  Identities=25%  Similarity=0.444  Sum_probs=131.7

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC-CCCCCCeeeEecCCccccccccCCC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG-FDPDDNHLGLNINSVVSRKNVPLKD   87 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~-~d~~~~hvgidins~~s~~~~~~~~   87 (568)
                      ...+||||||+|+|....++  +.||+||+++..+. ...++.+||||||++|. +||+++|||||+|++.|..+..+  
T Consensus        80 ~~~ggDGlAF~l~~~~~~~~--~~~g~lgl~~~~~~-~~~~~~vaVEFDT~~n~~~d~~~~Hvgi~~ns~~s~~~~~~--  154 (253)
T d1g7ya_          80 KSSSADGIAFALVPVGSEPK--SNSGFLGVFDSDVY-DNSAQTVAVEFDTFSNTDWDPTSRHIGIDVNSIKSIRTASW--  154 (253)
T ss_dssp             GGGCCCEEEEEEEETTCCCC--CCGGGTTTCSCSSC-CGGGCCEEEEEECSCCTTTCCSSCEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCceEEEEeCCCCCCC--CCcccccccccCCC-CCcCceEEEEEeceecCCCCCCCCcEEEeeCCcccccccCC--
Confidence            34689999999999776543  68899999986543 45678999999999997 89999999999999999887654  


Q ss_pred             CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCC--cccccccccccc
Q 008374           88 NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGY--PHIQLNCVRSWT  165 (568)
Q Consensus        88 ~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~--~~~~~~~i~sWs  165 (568)
                          .+.+|+.++|||+||+.+++|.|++++..  +|..|++++.+||+.+|+++|||||||+||.  ...+.|+|++|+
T Consensus       155 ----~~~~g~~~~v~I~Yd~~~~~L~v~l~~~~--~~~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~~~~H~IlsWs  228 (253)
T d1g7ya_         155 ----GLANGQNAEILITYNAATSLLVASLVHPS--RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWS  228 (253)
T ss_dssp             ----CCCTTSEEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCCCCCEEEEEE
T ss_pred             ----CccCCCEEEEEEEEeCCcEEEEEEEecCC--CCCceEEEEEechhhcCCCcEEEEEEeEcCCCCCcccccEEEEEE
Confidence                46789999999999999999999998754  7888999999999999999999999999994  257899999999


Q ss_pred             cccccc
Q 008374          166 LDIDVI  171 (568)
Q Consensus       166 ~~~~~~  171 (568)
                      |+...+
T Consensus       229 F~s~lp  234 (253)
T d1g7ya_         229 FASKLP  234 (253)
T ss_dssp             EEEEEC
T ss_pred             eEEeCC
Confidence            987543

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=2.9e-31  Score=255.54  Aligned_cols=148  Identities=31%  Similarity=0.505  Sum_probs=129.0

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC-CCCCCCeeeEecCCccccccccCCC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG-FDPDDNHLGLNINSVVSRKNVPLKD   87 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~-~d~~~~hvgidins~~s~~~~~~~~   87 (568)
                      ...+||||||+|+|....+  ++.|++||+++..   +..++.|||||||++|. +||+++||||++|++.|..+..+  
T Consensus        81 ~~~~gDGlAF~l~~~~~~~--g~~g~~lG~~~g~---~~~~~~vaVEFDT~~N~~~d~~~~Hvgi~~n~~~s~~~~~~--  153 (233)
T d1g8wa_          81 NAGPADGLAFALVPVGSQP--KDKGGFLGLFDGS---NSNFHTVAVEFDTLYNKDWDPTERHIGIDVNSIRSIKTTRW--  153 (233)
T ss_dssp             SCBCCEEEEEEEEETTCCC--CCCGGGTTTCCSS---CCCCCCEEEEEECSCCTTTCCSSCEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCeEEEEEecCCCCC--CcccccCCccccC---CCcccEEEEEeecccCCCCCCCCCeEEEECCCcceeeeccc--
Confidence            3468999999999976633  5789999998753   44678999999999997 89999999999999998877654  


Q ss_pred             CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCC--cccccccccccc
Q 008374           88 NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGY--PHIQLNCVRSWT  165 (568)
Q Consensus        88 ~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~--~~~~~~~i~sWs  165 (568)
                          ++.+|+.++|||+||+.+++|.|++.+.+  +|..|+++..+||+.+|++++||||||+||.  ...|.|+|++|+
T Consensus       154 ----~~~~g~~~~~~I~yd~~~~~l~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~~~h~I~sWs  227 (233)
T d1g8wa_         154 ----DFVNGENAEVLITYDSSTNLLVASLVYPS--QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWS  227 (233)
T ss_dssp             ----CCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBCCCCEEEEEE
T ss_pred             ----cccCCcEEEEEEEEeCCCcEEEEEEEeCC--CCCcEEEEEEechhHcCCCcEEEEEEEEcCCCCCCceeeEEEEEE
Confidence                45789999999999999999999999866  6788899999999999999999999999995  256789999999


Q ss_pred             cccc
Q 008374          166 LDID  169 (568)
Q Consensus       166 ~~~~  169 (568)
                      |+.+
T Consensus       228 Fss~  231 (233)
T d1g8wa_         228 FASK  231 (233)
T ss_dssp             EEEE
T ss_pred             EEEE
Confidence            9865

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

Probab=99.97  E-value=3.5e-31  Score=256.80  Aligned_cols=153  Identities=31%  Similarity=0.486  Sum_probs=132.0

Q ss_pred             CCCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC----CCCCCCeeeEecCCccccccc
Q 008374            8 AWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG----FDPDDNHLGLNINSVVSRKNV   83 (568)
Q Consensus         8 ~~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~----~d~~~~hvgidins~~s~~~~   83 (568)
                      ....+||||||+|+|.....+.++.|++||+++.. +++..++.+||||||++|.    +||+.+|||||+|++.|..+.
T Consensus        81 ~~~~~gdG~AF~l~~~~~~~~~~~~g~~lGl~~~~-~~~~~~~~~aVEfDT~~n~~~~~~d~~~~hvgid~n~~~s~~~~  159 (239)
T d1dbna_          81 NPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNS-NSDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTV  159 (239)
T ss_dssp             STTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSS-CCCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEE
T ss_pred             CCCCCCCCEEEEEeCCCccCCcccCcccccccccc-CCCcccCeeeeEEeeeecCCCCCCCCCCceeeEEcCCccccccc
Confidence            34568999999999977655556899999999865 4567799999999999985    489999999999999988776


Q ss_pred             cCCCCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCc-cccccccc
Q 008374           84 PLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYP-HIQLNCVR  162 (568)
Q Consensus        84 ~~~~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~-~~~~~~i~  162 (568)
                      ...      +.+|+.++|||+||+.++.|.|++.+..  +|..|.++..+||+.+|+++|||||||+||.. ..|.|+|+
T Consensus       160 ~~~------~~~g~~~~~~i~y~~~~~~l~v~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~H~I~  231 (239)
T d1dbna_         160 QWD------WINGGVAFATITYLAPNKTLIASLVYPS--NQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVL  231 (239)
T ss_dssp             ECC------CCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSGGGCCCCEEE
T ss_pred             cce------EeCCceeEEEEEEcCCCCEEEEEEEecC--CCccEEEEEecchHHhcCCcEEEEEEEeCCCCCCcceeEEE
Confidence            543      4679999999999999999999998865  67788999999999999999999999999952 36789999


Q ss_pred             ccccccc
Q 008374          163 SWTLDID  169 (568)
Q Consensus       163 sWs~~~~  169 (568)
                      +|+|+.+
T Consensus       232 sWsFss~  238 (239)
T d1dbna_         232 SWSFTST  238 (239)
T ss_dssp             EEEEEEE
T ss_pred             EEEeEEe
Confidence            9999864

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

Probab=99.96  E-value=2.2e-30  Score=250.92  Aligned_cols=152  Identities=34%  Similarity=0.547  Sum_probs=130.1

Q ss_pred             CCCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC-CCCCCCeeeEecCCccccccccCC
Q 008374            8 AWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG-FDPDDNHLGLNINSVVSRKNVPLK   86 (568)
Q Consensus         8 ~~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~-~d~~~~hvgidins~~s~~~~~~~   86 (568)
                      ....+||||||+|+|....+  +..||+||+++.. ..+..++.+||||||++|. +||+++|||||+|++.|..+... 
T Consensus        81 ~~~~~gDG~AF~l~~~~~~~--~~~gg~lg~~~~~-~~~~~~~~~aVefDT~~n~~~d~~~~Higi~~n~~~s~~~~~~-  156 (237)
T d1fnya_          81 NPATTADGLAFFLAPVDTQP--LDLGGMLGIFKDG-YFNKSNQIVAVEFDTFSNGDWDPKGRHLGINVNSIESIKTVPW-  156 (237)
T ss_dssp             STTSCCEEEEEEEEETTCCC--CCCGGGTTTCC----CCTTSCCEEEEEECSCCTTTCCSSSEEEEEESSSSCSEEEEC-
T ss_pred             CCCCCCCeeEEEEcCCCCCc--ccccCcccccCCC-CccCccceEEEEeccccccCCCCCCceEEEecCCCcccccccc-
Confidence            34578999999999976543  4788999998753 3456789999999999997 89999999999999999877653 


Q ss_pred             CCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCC--ccccccccccc
Q 008374           87 DNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGY--PHIQLNCVRSW  164 (568)
Q Consensus        87 ~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~--~~~~~~~i~sW  164 (568)
                           ++.+|+.++|||+||+..++|.|++.+.+  ++..|+++..+||+.++++++||||||+||.  ...+.|+|++|
T Consensus       157 -----~~~~g~~~~v~I~Y~~~~~~l~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~s~~~e~H~I~sW  229 (237)
T d1fnya_         157 -----NWTNGEVANVFISYEASTKSLTASLVYPS--LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSW  229 (237)
T ss_dssp             -----CCCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEE
T ss_pred             -----cccCCcEEEEEEEEeCCccEEEEEEEeCC--CCcceeEEEEechhhcCCCcEEEEEEEECCCCCCcccccEEEEe
Confidence                 45789999999999999999999999876  5778899999999999999999999999994  15688999999


Q ss_pred             cccccc
Q 008374          165 TLDIDV  170 (568)
Q Consensus       165 s~~~~~  170 (568)
                      +|+.+.
T Consensus       230 sF~s~l  235 (237)
T d1fnya_         230 SFESNL  235 (237)
T ss_dssp             EEEEEE
T ss_pred             EeEEeC
Confidence            999763

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

Probab=99.96  E-value=1e-29  Score=244.90  Aligned_cols=151  Identities=33%  Similarity=0.498  Sum_probs=123.1

Q ss_pred             CCCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC--CCCCCCeeeEecCCccccccccC
Q 008374            8 AWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG--FDPDDNHLGLNINSVVSRKNVPL   85 (568)
Q Consensus         8 ~~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~--~d~~~~hvgidins~~s~~~~~~   85 (568)
                      .+..+||||||+|+|.....+.   +++.|+.....+.+..++.|||||||++|.  .||+++|||||+|++.+......
T Consensus        77 ~~~~~gDG~AF~l~~~~~~~~~---~~~~g~~~~~~~~~~~~~~~aVEfDT~~n~~~~d~~~~Higid~n~~~s~~~~~~  153 (232)
T d1v6ia_          77 KDYDPADGIIFFIAPEDTQIPA---GSIGGGTLGVSDTKGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW  153 (232)
T ss_dssp             SSSBCCCEEEEEEEETTCCCCT---TCCCGGGTTTSCTTSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEEC
T ss_pred             CCCCCCCeEEEEEECCCCCCCC---CccCCcccccccCCCCCceEEEEEEeEecCCCCCCCCccEeEeeCCccccccccc
Confidence            3456899999999997654432   223333333334566789999999999997  59999999999999988876543


Q ss_pred             CCCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCcccccccccccc
Q 008374           86 KDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWT  165 (568)
Q Consensus        86 ~~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~~~i~sWs  165 (568)
                            ++.+|+.++|||+||+.+++|.|++++..   +..|.++..+||+.+|++.+||||||+||....+.|+|++|+
T Consensus       154 ------~~~~g~~~~v~I~Yd~~~~~L~V~~~~~~---~~~~~l~~~vdL~~~l~~~vyvGFSAsTG~~~~~~H~I~sWs  224 (232)
T d1v6ia_         154 ------NSVSGAVVKVTVIYDSSTKTLSVAVTNDN---GDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWS  224 (232)
T ss_dssp             ------CCCTTCEEEEEEEEETTTTEEEEEEECTT---SCEEEEEEECCHHHHSCSEEEEEEEEECCSSBCCEEEEEEEE
T ss_pred             ------ccCCCCEEEEEEEEeCCceEEEEEEecCC---CCcceEEEEEchhhccCCcEEEEEEEECCCCCCcccEEEEeE
Confidence                  45789999999999999999999998754   667889999999999999999999999996245899999999


Q ss_pred             ccccc
Q 008374          166 LDIDV  170 (568)
Q Consensus       166 ~~~~~  170 (568)
                      |+.+.
T Consensus       225 Fss~l  229 (232)
T d1v6ia_         225 FTSTL  229 (232)
T ss_dssp             EEEEE
T ss_pred             eEEee
Confidence            98753

>d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]

Probab=99.96  E-value=2.2e-29  Score=244.36  Aligned_cols=151  Identities=30%  Similarity=0.474  Sum_probs=130.8

Q ss_pred             CCCCCcEEEEEccCCCCCCCCCCCcceecccCCCC-CCCCCcEEEEEeeCCCCC----CCCCCCeeeEecCCcccccccc
Q 008374           10 DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTD-GNKANHFVAIEFDTVKQG----FDPDDNHLGLNINSVVSRKNVP   84 (568)
Q Consensus        10 ~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~-~~~~~~~~aVEfDt~~~~----~d~~~~hvgidins~~s~~~~~   84 (568)
                      ..+||||||||.|.....+.+..|+++|+++.... +...|+.+||||||++|.    +||+++|||||+|++.|..+..
T Consensus        82 ~~~~~g~~f~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~n~~vaVEfDt~~n~~~~~~~~~~~Higid~n~~~s~~~~~  161 (241)
T d1ukga_          82 SNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTVK  161 (241)
T ss_dssp             SSCCCEEEEEEECTTCCCCTTCCGGGTTTSCGGGTTCGGGCCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEEE
T ss_pred             CCCCCceEEEEeCCCCCcccccCcccccccccccccCCccCcccceeccCEecCccCCCCCCCccEeeecCCcccccccc
Confidence            45899999999986655555688899998887654 456789999999999875    4689999999999999987655


Q ss_pred             CCCCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCccccccccccc
Q 008374           85 LKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSW  164 (568)
Q Consensus        85 ~~~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~~~i~sW  164 (568)
                      +      .+.+|+.++|||+||+.+++|+|++++.+   |..|.+++.+||+.+++++|||||||+||. ..+.|+|++|
T Consensus       162 ~------~~~~g~~~~v~I~Yd~~~~~L~v~~~~~~---~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~-~~~~H~IlsW  231 (241)
T d1ukga_         162 W------DRRDGQSLNVLVTFNPSTRNLDVVATYSD---GTRYEVSYEVDVRSVLPEWVRVGFSAASGE-QYQTHTLESW  231 (241)
T ss_dssp             C------CCCTTCCEEEEEEEETTTTEEEEEEEETT---CCEEEEEEECCGGGTSCSEEEEEEEEEESS-SCCEEEEEEE
T ss_pred             c------ccCCCcEEEEEEEEeCCCcEEEEEEccCC---CCceEEEEEEehHHhCCCcEEEEEEEecCC-CCceeEEEEe
Confidence            3      45789999999999999999999998854   677889999999999999999999999997 9999999999


Q ss_pred             cccccc
Q 008374          165 TLDIDV  170 (568)
Q Consensus       165 s~~~~~  170 (568)
                      +|+.+.
T Consensus       232 sFss~l  237 (241)
T d1ukga_         232 SFTSTL  237 (241)
T ss_dssp             EEEEEE
T ss_pred             EEEEEe
Confidence            998764

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

Probab=99.95  E-value=1.1e-28  Score=234.69  Aligned_cols=115  Identities=26%  Similarity=0.395  Sum_probs=105.0

Q ss_pred             CCcEEEEEeeCCCCC--CCCCCCeeeEecCCccccccccCCCCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCC
Q 008374           48 ANHFVAIEFDTVKQG--FDPDDNHLGLNINSVVSRKNVPLKDNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQ  125 (568)
Q Consensus        48 ~~~~~aVEfDt~~~~--~d~~~~hvgidins~~s~~~~~~~~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~  125 (568)
                      +||+|||||||++|.  +||++||||||+|++.|.++..+      +|.+|+.++|||+||+.+++|.|++++.   +|.
T Consensus         1 an~ivAVEFDT~~N~~~~Dp~~nHIgIdvns~~S~~~~~~------~l~~G~~~~v~I~Yd~~~~~L~V~~~~~---~~~   71 (237)
T d1nlsa_           1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW------NMQNGKVGTAHIIYNSVDKRLSAVVSYP---NAD   71 (237)
T ss_dssp             CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC------CCCTTCEEEEEEEEETTTTEEEEEEECT---TSC
T ss_pred             CCCEEEEEEECCcCCCCCCCCCCEEEEEeCCCCccceecc------cccCCCEEEEEEEEecCCcEEEEEEecC---CCC
Confidence            479999999999997  79999999999999999887664      5689999999999999999999999875   477


Q ss_pred             CCeeeEeeCccccCCCcccccccccCCCccccccccccccccccccc
Q 008374          126 KPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCVRSWTLDIDVIQ  172 (568)
Q Consensus       126 ~~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~~~i~sWs~~~~~~~  172 (568)
                      .|++++.+||+.+|+++|||||+|+||. ..+.|++++|+|+.+..+
T Consensus        72 ~~~ls~~vdL~~~l~~~vyvGFSAsTG~-~~~~h~I~sWsFsS~~~~  117 (237)
T d1nlsa_          72 SATVSYDVDLDNVLPEWVRVGLSASTGL-YKETNTILSWSFTSKLKS  117 (237)
T ss_dssp             CEEEEEECCGGGTSCSEEEEEEEEECSS-SCCCCEEEEEEEEEEEEE
T ss_pred             CeEEEEEEChHHhCCCcEEEEEEeecCC-CccceEEEEEEEEeeccc
Confidence            8899999999999999999999999997 999999999999876544

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

Probab=99.94  E-value=1.5e-28  Score=236.40  Aligned_cols=146  Identities=25%  Similarity=0.370  Sum_probs=123.4

Q ss_pred             CCCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecCCccccccccCCC
Q 008374            8 AWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKD   87 (568)
Q Consensus         8 ~~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidins~~s~~~~~~~~   87 (568)
                      +...+||||||+|+|.... + +..|++||+++.+ .++..++.|||||||++|.+|++.+|+++++++..+        
T Consensus        79 ~~~~~gDGlAF~l~~~~~~-~-~~~g~~lgl~~~~-~~~~~~~~vave~dt~~n~~~~~~~~~~~~~~~~~~--------  147 (228)
T d1ioaa_          79 NQSISAYGLAFALVPVNSP-P-QKKQEFLGIFNTN-NPEPNARTVAVVFNTFKNRIDFDKNFIKPYVNENCD--------  147 (228)
T ss_dssp             CTTSCCEEEEEEEEETTCC-C-CCCGGGTTTCCCS-SCCGGGCCEEEEEETTTTEEEEEESSSSCSEEEECC--------
T ss_pred             CCCCCCCEEEEEEeCCCCC-C-CCCcccccccccc-CCCCcceeEEEEecCccccccCCCCccceecccccc--------
Confidence            3456899999999997553 3 4789999999854 456678999999999998788888888888875322        


Q ss_pred             CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCC--cccccccccccc
Q 008374           88 NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGY--PHIQLNCVRSWT  165 (568)
Q Consensus        88 ~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~--~~~~~~~i~sWs  165 (568)
                         ..+.+|+.++|||+||+.+++|+|++++..  +|..|.++..+||+.+|++.|||||||+||.  ...|.|+|++|+
T Consensus       148 ---~~~~~g~~~~v~I~Yd~~~~~l~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~h~I~sWs  222 (228)
T d1ioaa_         148 ---FHKYNGEKTDVQITYDSSNNDLRVFLHFTV--SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWS  222 (228)
T ss_dssp             ---HHHHCSSCEEEEEEEETTTTEEEEEEEETT--TCCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTCBCCEEEEEE
T ss_pred             ---cccccCcEEEEEEEEcCCCCEEEEEEEeCC--CCceeeEEEEEchHHcCCCcEEEEEEeecCCCCCCceEEEEEEEE
Confidence               255789999999999999999999999865  6888999999999999999999999999994  156889999999


Q ss_pred             cccc
Q 008374          166 LDID  169 (568)
Q Consensus       166 ~~~~  169 (568)
                      |+.+
T Consensus       223 Fss~  226 (228)
T d1ioaa_         223 FSSK  226 (228)
T ss_dssp             EEEE
T ss_pred             eEEe
Confidence            9864

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.93  E-value=3.4e-27  Score=226.53  Aligned_cols=143  Identities=24%  Similarity=0.354  Sum_probs=125.0

Q ss_pred             CCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCC--CCCCCCeeeEecCCccccccccCC
Q 008374            9 WDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQG--FDPDDNHLGLNINSVVSRKNVPLK   86 (568)
Q Consensus         9 ~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~--~d~~~~hvgidins~~s~~~~~~~   86 (568)
                      +..+||||||+|+|....+  +..||++|+++.          ++|||||+.|.  +|++.||||||+|+..+..+....
T Consensus        78 ~~~~gDG~aF~i~~~~~~~--g~~gg~~gl~~~----------~~v~fdt~~~~~~~d~~~nhi~i~~n~~~s~~~~~~~  145 (226)
T d1avba_          78 IENSAYGLAFALVPVGSRP--KLKGRYLGLFNT----------TNYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESCN  145 (226)
T ss_dssp             TTSCCEEEEEEEEETTCCC--CCCGGGTTTCSC----------SSCCGGGCCEEEEEETTTTEEEEEESSSSCSEEEECC
T ss_pred             CCCCCceEEEEEccCCCCC--CCccccCCcccc----------ccccccceeccccccCCCCEEEEeCCCCccccccccc
Confidence            4568999999999976644  478899999875          36899999886  799999999999999998887755


Q ss_pred             CCcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCC--ccccccccccc
Q 008374           87 DNYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGY--PHIQLNCVRSW  164 (568)
Q Consensus        87 ~~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~--~~~~~~~i~sW  164 (568)
                      .    .+.+|+.++|||+||+.+++|+|++++.+  +|..|.++..+||+.+|++++|+||||+||.  ...+.|+|++|
T Consensus       146 ~----~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~~~~~vdL~~~l~~~~y~GFSAaTG~~s~~~~~H~IlsW  219 (226)
T d1avba_         146 F----GHNNGEKAEVRITYDSPKNDLRVSLLYPS--SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSW  219 (226)
T ss_dssp             S----GGGTTCEEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEEEEEE
T ss_pred             c----ccCCCeEEEEEEEEcCCCcEEEEEEEeCC--CCccEEEEEEecHHHccCCcEEEEEEEEcCCCCCCeeeeEEEEE
Confidence            4    67899999999999999999999999876  6888899999999999999999999999995  24678999999


Q ss_pred             ccccc
Q 008374          165 TLDID  169 (568)
Q Consensus       165 s~~~~  169 (568)
                      +|+.+
T Consensus       220 sF~s~  224 (226)
T d1avba_         220 SFSSN  224 (226)
T ss_dssp             EEEEE
T ss_pred             EeEEe
Confidence            99865

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.87  E-value=9.6e-23  Score=191.94  Aligned_cols=128  Identities=23%  Similarity=0.373  Sum_probs=99.7

Q ss_pred             CCCCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecCCccccccccCCC
Q 008374            8 AWDISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVPLKD   87 (568)
Q Consensus         8 ~~~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidins~~s~~~~~~~~   87 (568)
                      +...+||||||+|+|...                    ...++.+||||||++       ||+++|+|+...... .   
T Consensus        74 ~~~~~gdGlaf~~~~~~~--------------------~~~~~~~~vefDt~~-------n~~~~d~~~~~~~~~-~---  122 (204)
T d1dhkb_          74 RQANSAVGLDFVLVPVQP--------------------ESKGDTVTVEFDTFL-------SRISIDVNNNDIKSV-P---  122 (204)
T ss_dssp             C---CCSEEEEEEEEC--------------------------CCEEEEEETTT-------TEEEEEETTEEEEEE-E---
T ss_pred             CCCCCCceEEEEecCCCC--------------------CCCCcEeeEeeEccc-------ccccCcccccccccc-c---
Confidence            345689999999998532                    123467999999987       678888877543322 2   


Q ss_pred             CcccccCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCC--cccccccccccc
Q 008374           88 NYNITLSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGY--PHIQLNCVRSWT  165 (568)
Q Consensus        88 ~~~~~l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~--~~~~~~~i~sWs  165 (568)
                       ..+.+.+|+.++|||+||+..++|+|++++.+  +|..|.++..+||+.++++++||||||+||.  ...+.|+|++|+
T Consensus       123 -~~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAaTG~~~~~~e~H~IlsWs  199 (204)
T d1dhkb_         123 -WDVHDYDGQNAEVRITYNSSTKVFSVSLSNPS--TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWS  199 (204)
T ss_dssp             -CCGGGTTTSCEEEEEEEETTTTEEEEEEECTT--TCCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEEEE
T ss_pred             -cccEecCCCEEEEEEEEcCCCEEEEEEEecCC--CCCceeEEEEecchhccCCcEEEEEEeecCCCCCCceeeEEEEEE
Confidence             23467889999999999999999999999876  5777889999999999999999999999995  135789999999


Q ss_pred             cccc
Q 008374          166 LDID  169 (568)
Q Consensus       166 ~~~~  169 (568)
                      |+.+
T Consensus       200 Fss~  203 (204)
T d1dhkb_         200 FSSK  203 (204)
T ss_dssp             EEEE
T ss_pred             EEec
Confidence            9853

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=1.2e-22  Score=189.47  Aligned_cols=163  Identities=14%  Similarity=0.161  Sum_probs=118.3

Q ss_pred             cccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcc------------------cchhhHHHHHHhhcCCCCc
Q 008374          244 HESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIK------------------SKGDFLAELAIIHRLRHKH  305 (568)
Q Consensus       244 ~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~H~n  305 (568)
                      ...++||+|+||+||+|+..       +++.||||.+......                  ....+..|...+.++.|.+
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   75 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA   75 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred             hhCCEeeeCcceEEEEEECC-------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC
Confidence            35689999999999999875       5789999987532110                  0123456888899999999


Q ss_pred             eeeEEEEEEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC
Q 008374          306 LVHLVGWCHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEYDQKVVHRDLKASNILLDA  385 (568)
Q Consensus       306 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NILld~  385 (568)
                      ++..+++..    .+++|||+++..+.+          ++......++.|++.+|.|||   +++|+||||||+|||+++
T Consensus        76 v~~~~~~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~  138 (191)
T d1zara2          76 VPKVYAWEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSE  138 (191)
T ss_dssp             SCCEEEEET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEET
T ss_pred             cceEEEecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeC
Confidence            998876532    279999998765543          233445678999999999999   579999999999999986


Q ss_pred             CCcEEEeecCCccccccccccccccccccCCcCCcccC------ccccccCCCCccchhHHHHHHH
Q 008374          386 DFNARLGDFGLARAIENERNSYAEHGLVGVPGTMGYVA------PECFHTGKATPESDVFGFGAVV  445 (568)
Q Consensus       386 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~y~A------PE~~~~~~~t~~sDV~SfGvll  445 (568)
                      + .++|+|||+|+...+.....             |..      .|. ..+.|..++|+||..--+
T Consensus       139 ~-~~~liDFG~a~~~~~~~~~~-------------~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         139 E-GIWIIDFPQSVEVGEEGWRE-------------ILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             T-EEEECCCTTCEETTSTTHHH-------------HHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             C-CEEEEECCCcccCCCCCcHH-------------HHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            5 58999999998765432211             111      111 145678899999975443

>d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Carbohydrate-recognition domain of P58/ERGIC-53
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.55  E-value=3.4e-15  Score=142.31  Aligned_cols=140  Identities=17%  Similarity=0.133  Sum_probs=87.7

Q ss_pred             CCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecCCccccccc------
Q 008374           10 DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNV------   83 (568)
Q Consensus        10 ~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidins~~s~~~~------   83 (568)
                      ..+||||||+|+++..     ..|+.+|...       ..+-+||||||+.|.+|++.+|+.+++|........      
T Consensus        76 ~~ggdG~aF~i~~~~~-----~~g~~~G~~~-------~~~glaVefDt~~n~~~~~~~~~~~~~n~~~~~~~~~~~~~~  143 (228)
T d1gv9a_          76 RIGADGLAIWYTENQG-----LDGPVFGSAD-------MWNGVGIFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGAT  143 (228)
T ss_dssp             SCCCCEEEEEEESSCC-----CEEEETTECS-------CCEEEEEEEECCCC-----CCEEEEEEEESCCCCCHHHHHHH
T ss_pred             CCCCCEEEEEEecCCC-----CCCCccCcCC-------CCceEEEEEEcccccCCCCCCcEEEEecCCcceeeecCCCcc
Confidence            4689999999998642     3455555422       224589999999999899999999888754321110      


Q ss_pred             -cCCCCcccc-cCCCceEEEEEEEcCcccEEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCcccccccc
Q 008374           84 -PLKDNYNIT-LSDGTSYTVWVQYDGKSKLIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCV  161 (568)
Q Consensus        84 -~~~~~~~~~-l~~g~~~~~~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~~~i  161 (568)
                       .... .... ...+..+++|++|  ..+.|+|+++.........+.+...++ ...+++.+|+||||+||. ..+.|.+
T Consensus       144 ~~~~~-~~~~~~~~~~~~~i~~~~--~~~~l~v~i~~~~~~~~~~~~~~~~~~-~~~l~~~~y~GFTAsTG~-~~~~H~I  218 (228)
T d1gv9a_         144 QALAS-CQRDFRNKPYPVRAKITY--YQKTLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGG-LADDHDV  218 (228)
T ss_dssp             HCSEE-ECCCCBSCSSCEEEEEEE--ETTEEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEECCS-SCCEEEE
T ss_pred             ccccc-eeeeecCCceEEEEEEEe--cCCEEEEEEeccccCCCcceeEEEEec-ccccCCCEEEEEEEeCCC-CcCeEEE
Confidence             0110 0111 1234555666666  467788988766543444333333333 456789999999999997 8999999


Q ss_pred             ccccc
Q 008374          162 RSWTL  166 (568)
Q Consensus       162 ~sWs~  166 (568)
                      ++|.+
T Consensus       219 ~s~~~  223 (228)
T d1gv9a_         219 LSFLT  223 (228)
T ss_dssp             EEEEE
T ss_pred             EEEEE
Confidence            88765

>d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp47p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=98.91  E-value=1.3e-09  Score=102.14  Aligned_cols=129  Identities=14%  Similarity=0.085  Sum_probs=70.4

Q ss_pred             CCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecCCcccccccc----C
Q 008374           10 DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVVSRKNVP----L   85 (568)
Q Consensus        10 ~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidins~~s~~~~~----~   85 (568)
                      ..+||||||++++.....   ..|+++|..+.       ..-+||||||+.|  +....|+.++-++..-..+..    .
T Consensus        75 ~~ggdG~af~~~~~~~~~---~~g~~~G~~~~-------~~GlaV~fDt~~n--~~~~~~~~~ndgt~~~~~~~~~~~~~  142 (221)
T d2a6za1          75 GQTDGGISFWFVQDSNIP---RDKQLYNGPVN-------YDGLQLLVDNNGP--LGPTLRGQLNDGQKPVDKTKIYDQSF  142 (221)
T ss_dssp             SCCSCEEEEEEEECSSSC---CCCTBTTBCTT-------CEEEEEEEESCST--TSSEEEEEEEESSSCCCGGGHHHHCS
T ss_pred             CCCCCcEEEEEEcCCCcc---ccccccccCCC-------CceEEEEEECCCC--CCCceEEEecCCCccccccCCccccc
Confidence            468999999999753322   23444443221       1238999999887  222233344433322111111    1


Q ss_pred             CCCcccc-cCCCceEEEEEEEcCccc-EEEEEEeeCCCCCCCCCeeeEeeCccccCCCcccccccccCCCcccccccc
Q 008374           86 KDNYNIT-LSDGTSYTVWVQYDGKSK-LIQVFMDREGETMPQKPLLKETINLKDYLKPESYFGFSASTGYPHIQLNCV  161 (568)
Q Consensus        86 ~~~~~~~-l~~g~~~~~~I~Yd~~~~-~l~v~~~~~~~~~~~~~~~~~~~dl~~~l~~~~~vGfsastG~~~~~~~~i  161 (568)
                      .. ..+. +.++...+++|.|+..++ .|.|.++..       .++.  ++--.+.++..|+||||+||. ..+.|-+
T Consensus       143 ~~-~~~~~~~~~~~~~~~I~y~~~~~~~l~v~id~~-------~c~~--~~~v~lp~~~~~fG~SA~TG~-~~~~hd~  209 (221)
T d2a6za1         143 AS-CLMGYQDSSVPSTIRVTYDLEDDNLLKVQVDNK-------VCFQ--TRKVRFPSGSYRIGVTAQNGA-VNNNAES  209 (221)
T ss_dssp             EE-EECCCTTEEEEEEEEEEEEGGGTSEEEEEETTE-------EEEE--ESCCCCCSSEEEEEEEEECCS-GGGCCCE
T ss_pred             ce-eeecccCCCCCEEEEEEEecCccceEEEEecCc-------EeEE--ECCeecCCCCEEEEEEEccCC-ccCCCce
Confidence            10 1111 234677899999987664 477777431       1211  221122245578999999997 6666653

>d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp46p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=98.90  E-value=1.8e-09  Score=100.98  Aligned_cols=134  Identities=13%  Similarity=0.063  Sum_probs=80.9

Q ss_pred             CCCCCcEEEEEccCCCCCCCCCCCcceecccCCCCCCCCCcEEEEEeeCCCCCCCCCCCeeeEecCCcc-ccccc---cC
Q 008374           10 DISGHGLAFVIAPNDSFPPESSYGQWLGLTNAFTDGNKANHFVAIEFDTVKQGFDPDDNHLGLNINSVV-SRKNV---PL   85 (568)
Q Consensus        10 ~~~~~G~aF~i~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~~~~d~~~~hvgidins~~-s~~~~---~~   85 (568)
                      ..+||||||.+.+.....+.+..+|..+.++.          +||||||+.|    +.+||.+-+|.=. .....   .+
T Consensus        74 ~~~~dG~afw~~~~~~~~~~~~~~G~~~~f~G----------laV~fDt~~n----~~~~i~~~~ndGs~~~~~~~d~~~  139 (218)
T d2a6va1          74 GSTKGGLAFWLKQGNEGDSTELFGGSSKKFNG----------LMILLRLDDK----LGESVTAYLNDGTKDLDIESSPYF  139 (218)
T ss_dssp             SCCSCEEEEEEECSCCCCCCTBTTTBCSSCEE----------EEEEEEEETT----TEEEEEEEEEESSSCCCTTTSCCS
T ss_pred             CCCCCcEEEEEEcCCcccCCCcccccCCCcce----------EEEEEECCCC----CCCeEEEEeCCCCccccccCCccc
Confidence            46799999999985443332233444444442          7999999876    3467776554211 10000   01


Q ss_pred             CCCccc-ccCCCceEEEEEEEcCccc-EEEEEEeeCCCCCCCCCeee-EeeCccccCCCcccccccccCCCccccccccc
Q 008374           86 KDNYNI-TLSDGTSYTVWVQYDGKSK-LIQVFMDREGETMPQKPLLK-ETINLKDYLKPESYFGFSASTGYPHIQLNCVR  162 (568)
Q Consensus        86 ~~~~~~-~l~~g~~~~~~I~Yd~~~~-~l~v~~~~~~~~~~~~~~~~-~~~dl~~~l~~~~~vGfsastG~~~~~~~~i~  162 (568)
                      +. -.+ ...++...+++|.|+.... .+.|.++.       +.++. ..++|  ..++..|+||||+||. ..+.|.++
T Consensus       140 g~-c~~~~~~~~~~~~~~i~Y~~~~~~~l~v~id~-------~~c~~t~~i~l--p~~~~~yfG~SA~Tg~-~~d~~dIl  208 (218)
T d2a6va1         140 AS-CLFQYQDSMVPSTLRLTYNPLDNHLLKLQMDN-------RVCFQTRKVKF--MGSSPFRIGTSAINDA-SKESFEIL  208 (218)
T ss_dssp             EE-EECCCSSCSSCEEEEEEEEGGGTSEEEEEETT-------EEEEEESCCCG--GGTSCBEEEEEEECCT-TCCEEEEE
T ss_pred             ce-EEecccCCCCcEEEEEEEECcccceEEEEeCC-------cEEEEECCeec--CCCCcEEEEEEECCCC-CcCcEEEE
Confidence            00 000 1245778899999987664 46776642       12222 12333  3356689999999997 89999999


Q ss_pred             cccccc
Q 008374          163 SWTLDI  168 (568)
Q Consensus       163 sWs~~~  168 (568)
                      +|.+..
T Consensus       209 s~~~~~  214 (218)
T d2a6va1         209 KMKLYD  214 (218)
T ss_dssp             EEEEES
T ss_pred             EEEEEe
Confidence            887653

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.55  E-value=3e-07  Score=87.59  Aligned_cols=150  Identities=17%  Similarity=0.098  Sum_probs=103.9

Q ss_pred             HHHHHHhcCccccceeccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCC-CCceeeEEEE
Q 008374          234 KELKKATNNFHESMRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLR-HKHLVHLVGW  312 (568)
Q Consensus       234 ~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~  312 (568)
                      .|++.....|...+..+-+..+.||+...        ++..+.+|+...........+.+|...+..+. +--+.+++.+
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~   78 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHF   78 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC--------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe--------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEE
Confidence            46677777777655544444568998753        45678899987665555667888998887764 3335678888


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHHhcC-------------------------
Q 008374          313 CHEKGKLLLVYDFMPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQNEY-------------------------  367 (568)
Q Consensus       313 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------  367 (568)
                      +...+..++||+++++.++.+.....        .....++.++++.++.||...                         
T Consensus        79 ~~~~~~~~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (263)
T d1j7la_          79 ERHDGWSNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL  150 (263)
T ss_dssp             EEETTEEEEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred             EecCCceEEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHh
Confidence            88889999999999998876544211        112234455555555555210                         


Q ss_pred             -------------------------------CCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          368 -------------------------------DQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       368 -------------------------------~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                                                     ...++|+|+.|.|||++++...-|.||+.+..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                           12378999999999999877778999998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.77  E-value=4.3e-05  Score=71.61  Aligned_cols=130  Identities=18%  Similarity=0.120  Sum_probs=83.3

Q ss_pred             eccCCc-eeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCC--CceeeEEEEEEeCCeEEEEEEe
Q 008374          249 LGEGGF-GIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRH--KHLVHLVGWCHEKGKLLLVYDF  325 (568)
Q Consensus       249 LG~G~f-G~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lV~Ey  325 (568)
                      +..|.. +.||+....       .+..+.+|.....   ...++..|...++.+..  -.+.+++.++.+.+..++||+|
T Consensus        18 ~~~G~s~~~v~r~~~~-------~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~   87 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ-------GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   87 (255)
T ss_dssp             CSCTTSSCEEEEEECT-------TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             cCCcccCCeEEEEEeC-------CCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence            445543 678988754       4566888876443   23457788888877632  3366788888888899999999


Q ss_pred             cCCCChhhhhccCCCcccCCHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 008374          326 MPNGSLEKYLYGTSEQVTLNWNHRYKILTGVASAVYYLQ-----------------------------------------  364 (568)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-----------------------------------------  364 (568)
                      +++.++.+...        .   ....+.+++..|.-||                                         
T Consensus        88 i~G~~~~~~~~--------~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (255)
T d1nd4a_          88 VPGQDLLSSHL--------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  156 (255)
T ss_dssp             CSSEETTTSCC--------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             eeccccccccc--------c---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhh
Confidence            98877644210        0   0011112222222222                                         


Q ss_pred             ----------hc----CCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          365 ----------NE----YDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       365 ----------~~----~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                                ..    ....++|+|+.|.|||++++..+-|.||+.+..
T Consensus       157 ~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         157 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                      21    123489999999999999887778999987653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.29  E-value=0.00037  Score=69.90  Aligned_cols=76  Identities=11%  Similarity=0.058  Sum_probs=47.3

Q ss_pred             ceeccCCceeEEEEEEccCccccccCeEEEEEEeccC-------CcccchhhHHHHHHhhcCC-C--CceeeEEEEEEeC
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRD-------SIKSKGDFLAELAIIHRLR-H--KHLVHLVGWCHEK  316 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-H--~nIv~l~g~~~~~  316 (568)
                      +.||.|....||+.....      .++.++||.-...       ..........|.+.|..+. +  ..+.+++.+.  .
T Consensus        32 ~eig~G~~N~vfrV~~~~------~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~  103 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQE------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T  103 (392)
T ss_dssp             EECCSSSSEEEEEEEC----------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T
T ss_pred             EEeCCCceEeEEEEEeCC------CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--C
Confidence            468999999999987653      4678999974321       1112334556888777652 2  3455666554  4


Q ss_pred             CeEEEEEEecCCCC
Q 008374          317 GKLLLVYDFMPNGS  330 (568)
Q Consensus       317 ~~~~lV~Ey~~~gs  330 (568)
                      ...++|||++++..
T Consensus       104 ~~~~lvmE~L~~~~  117 (392)
T d2pula1         104 EMAVTVMEDLSHLK  117 (392)
T ss_dssp             TTTEEEECCCTTSE
T ss_pred             CCCEEEEeccCCcc
Confidence            45578999997654

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.16  E-value=0.0061  Score=60.62  Aligned_cols=80  Identities=15%  Similarity=0.255  Sum_probs=50.9

Q ss_pred             ceeccCCceeEEEEEEccCccc-cccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCce-eeEEEEEEeCCeEEEEEE
Q 008374          247 MRLGEGGFGIVYKGIIHHNDQY-HVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHL-VHLVGWCHEKGKLLLVYD  324 (568)
Q Consensus       247 ~~LG~G~fG~Vy~g~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E  324 (568)
                      +.|+.|-.-.+|+......... ......|.+++...  .....+..+|..+++.+.-.++ .++++++..    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            4677788889999887643211 12345677766542  2233456688888888743344 477887743    68999


Q ss_pred             ecCCCChh
Q 008374          325 FMPNGSLE  332 (568)
Q Consensus       325 y~~~gsL~  332 (568)
                      |+++..|.
T Consensus       122 fi~g~~l~  129 (395)
T d1nw1a_         122 YIPSRPLS  129 (395)
T ss_dssp             CCCEEECC
T ss_pred             EeccccCC
Confidence            99876553

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.79  E-value=0.014  Score=56.20  Aligned_cols=135  Identities=18%  Similarity=0.193  Sum_probs=77.0

Q ss_pred             eeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCCCce-----eeEE--EEEEeCCeEEEEEEecC
Q 008374          255 GIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRHKHL-----VHLV--GWCHEKGKLLLVYDFMP  327 (568)
Q Consensus       255 G~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-----v~l~--g~~~~~~~~~lV~Ey~~  327 (568)
                      -.||+....       +|..+++|..... ....+++..|...+..|....+     +..-  ......+..+.++++++
T Consensus        36 N~vy~v~~~-------dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          36 NRVYQFQDE-------DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             SEEEEECCT-------TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             ceeEEEEcC-------CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence            579998775       5788999997543 2345667788888777642221     1111  12345667899999998


Q ss_pred             CCChhhh----h----------c----c--CCCcccCCHH-------------------HHHHHHHHHHHHHHHHHhc--
Q 008374          328 NGSLEKY----L----------Y----G--TSEQVTLNWN-------------------HRYKILTGVASAVYYLQNE--  366 (568)
Q Consensus       328 ~gsL~~~----L----------~----~--~~~~~~l~~~-------------------~~~~i~~~ia~~L~yLH~~--  366 (568)
                      +..+...    +          |    .  ......+++.                   .+-.+...+...+..+...  
T Consensus       108 G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~  187 (325)
T d1zyla1         108 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR  187 (325)
T ss_dssp             CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred             CcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcc
Confidence            6543210    0          0    0  0011112211                   1111222233333333322  


Q ss_pred             --CCCCeEecCCCCCCEEEcCCCcEEEeecCCccc
Q 008374          367 --YDQKVVHRDLKASNILLDADFNARLGDFGLARA  399 (568)
Q Consensus       367 --~~~~ivHrDikp~NILld~~~~~kL~DFGla~~  399 (568)
                        ...+++|+|+.+.|||++++  ..+.||+-+..
T Consensus       188 ~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         188 EDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             SCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence              24579999999999999754  45899998764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.46  E-value=0.026  Score=53.71  Aligned_cols=158  Identities=14%  Similarity=0.051  Sum_probs=83.9

Q ss_pred             cCHHHHHHHhcCccccce-----eccCCceeEEEEEEccCccccccCeEEEEEEeccCCcccchhhHHHHHHhhcCCC--
Q 008374          231 FKYKELKKATNNFHESMR-----LGEGGFGIVYKGIIHHNDQYHVDNTQIAVKKFSRDSIKSKGDFLAELAIIHRLRH--  303 (568)
Q Consensus       231 ~~~~el~~at~~f~~~~~-----LG~G~fG~Vy~g~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--  303 (568)
                      .+-+|+.....+|..++.     |..|---+.|+.+..        +..+++|+....  ...++...|++++..|..  
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~--------~g~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g   72 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT--------KDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKG   72 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES--------SCCEEEEEECC-----CCHHHHHHHHHHHHHHTT
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC--------CCcEEEEEcCCC--CCHHHHHHHHHHHHhhhhcc
Confidence            456788888888876544     334555778987654        345899987543  233445566777766632  


Q ss_pred             ---CceeeEE---EEEEeCCeEEEEEEecCCCChhhhh--------------cc------CCCc-ccC------------
Q 008374          304 ---KHLVHLV---GWCHEKGKLLLVYDFMPNGSLEKYL--------------YG------TSEQ-VTL------------  344 (568)
Q Consensus       304 ---~nIv~l~---g~~~~~~~~~lV~Ey~~~gsL~~~L--------------~~------~~~~-~~l------------  344 (568)
                         |..+...   .+.........++.+..+......-              +.      .... ...            
T Consensus        73 ~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (316)
T d2ppqa1          73 LSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSE  152 (316)
T ss_dssp             CCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHG
T ss_pred             ccccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHH
Confidence               2222110   0122345667778877665432210              00      0000 000            


Q ss_pred             -----CHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEEcCCCcEEEeecCCcc
Q 008374          345 -----NWNHRYKILTGVASAVYYLQN-EYDQKVVHRDLKASNILLDADFNARLGDFGLAR  398 (568)
Q Consensus       345 -----~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDikp~NILld~~~~~kL~DFGla~  398 (568)
                           ........+......+.-.+. ....++||+|+.+.||+++.+...-|.||+.+.
T Consensus       153 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         153 ERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             GGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhhhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence                 001111112222222222221 124689999999999999998878899999875